PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tang, KH; Blankenship, RE				Tang, Kuo-Hsiang; Blankenship, Robert E.			Both Forward and Reverse TCA Cycles Operate in Green Sulfur Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-CITRATE LYASE; COENZYME-A SYNTHETASE; CITRIC-ACID CYCLE; PHOTOSYNTHETIC BACTERIUM; CHLOROBIUM-LIMICOLA; REACTION-MECHANISM; CARBON METABOLISM; ENZYME; FLUOROACETATE; FLUOROCITRATE	The anoxygenic green sulfur bacteria (GSBs) assimilate CO2 autotrophically through the reductive (reverse) tricarboxylic acid (RTCA) cycle. Some organic carbon sources, such as acetate and pyruvate, can be assimilated during the phototrophic growth of the GSBs, in the presence of CO2 or HCO3-. It has not been established why the inorganic carbonis required for incorporating organic carbon for growth and how the organic carbons are assimilated. In this report, we probed carbon flux during autotrophic and mixotrophic growth of the GSB Chlorobaculum tepidum. Our data indicate the following: (a) the RTCA cycle is active during autotrophic and mixotrophic growth; (b) the flux from pyruvate to acetyl-CoA is very low and acetyl-CoA is synthesized through the RTCA cycle and acetate assimilation; (c) pyruvate is largely assimilated through the RTCA cycle; and (d) acetate can be assimilated via both of the RTCA as well as the oxidative (forward) TCA (OTCA) cycle. The OTCA cycle revealed herein may explain better cell growth during mixotrophic growth with acetate, as energy is generated through the OTCA cycle. Furthermore, the genes specific for the OTCA cycle are either absent or down-regulated during phototrophic growth, implying that the OTCA cycle is not complete, and CO2 is required for the RTCA cycle to produce metabolites in the TCA cycle. Moreover, CO2 is essential for assimilating acetate and pyruvate through the CO2-anaplerotic pathway and pyruvate synthesis from acetyl-CoA.	[Blankenship, Robert E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Blankenship, RE (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	blankenship@wustl.edu			Exobiology Program of NASA [NNX08AP62G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391] Funding Source: NIH RePORTER	Exobiology Program of NASA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant NNX08AP62G from the Exobiology Program of NASA (to R. E. B.).	BEH M, 1993, ARCH MICROBIOL, V160, P306, DOI 10.1007/BF00292082; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZH, 2004, PLANTA, V219, P48, DOI 10.1007/s00425-004-1220-y; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; EVANS MCW, 1966, SCIENCE, V152, P673, DOI 10.1126/science.152.3722.673-b; GRIBBLE GW, 1973, J CHEM EDUC, V50, P460, DOI 10.1021/ed050p460; Hosoya-Matsuda N, 2009, MOL PLANT, V2, P336, DOI 10.1093/mp/ssn077; HOWELL BF, 1979, CLIN CHEM, V25, P269; Imhoff JF, 2010, PHOTOSYNTH RES, V104, P123, DOI 10.1007/s11120-009-9510-7; INOUE H, 1968, J BIOCHEM-TOKYO, V63, P89, DOI 10.1093/oxfordjournals.jbchem.a128753; Kanao T, 2002, EUR J BIOCHEM, V269, P3409, DOI 10.1046/j.1432-1033.2002.03016.x; Kanao T, 2002, EUR J BIOCHEM, V269, P1926, DOI 10.1046/j.1432-1033.2002.02849.x; KELLY DP, 2006, PROKARYOTES, V2, P441; Kim W, 2006, J BACTERIOL, V188, P6544, DOI 10.1128/JB.00523-06; Kouyianou K, 2010, PHOTOSYNTH RES, V104, P153, DOI 10.1007/s11120-010-9544-x; Kuang Y, 2007, J BIOCHEM BIOPH METH, V70, P649, DOI 10.1016/j.jbbm.2007.02.008; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Lebedeva NV, 2002, MICROBIOLOGY+, V71, P657, DOI 10.1023/A:1021471621183; Ma K, 1997, P NATL ACAD SCI USA, V94, P9608, DOI 10.1073/pnas.94.18.9608; MARCUS A, 1956, J BIOL CHEM, V218, P823; MOLLER D, 1987, ARCH MICROBIOL, V148, P202, DOI 10.1007/BF00414812; Ormerod J, 2003, PHOTOSYNTH RES, V76, P135, DOI 10.1023/A:1024938531382; Overmann J, 2006, PROKARYOTES, V7, P359, DOI DOI 10.1007/0-387-30747-8_13; PATEL SS, 1987, J BIOL CHEM, V262, P7132; PICKETT MW, 1994, PHOTOSYNTH RES, V41, P75, DOI 10.1007/BF02184147; Proudfoot Alex T, 2006, Toxicol Rev, V25, P213, DOI 10.2165/00139709-200625040-00002; SADLER WR, 1960, P NATL ACAD SCI USA, V46, P1328, DOI 10.1073/pnas.46.10.1328; Sattley WM, 2008, J BACTERIOL, V190, P4687, DOI 10.1128/JB.00299-08; SIREVAG R, 1970, SCIENCE, V169, P186, DOI 10.1126/science.169.3941.186; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; VILLAFRANCA JJ, 1973, BIOCHEM BIOPH RES CO, V55, P1197, DOI 10.1016/S0006-291X(73)80021-X; WAHLUND TM, 1991, ARCH MICROBIOL, V156, P81, DOI 10.1007/BF00290978	36	48	50	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35848	35854		10.1074/jbc.M110.157834	http://dx.doi.org/10.1074/jbc.M110.157834			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20650900	Green Published, hybrid			2022-12-25	WOS:000283845300062
J	Ythier, D; Larrieu, D; Binet, R; Binda, O; Brambilla, C; Gazzeri, S; Pedeux, R				Ythier, D.; Larrieu, D.; Binet, R.; Binda, O.; Brambilla, C.; Gazzeri, S.; Pedeux, R.			Sumoylation of ING2 regulates the transcription mediated by Sin3A	ONCOGENE			English	Article						sumoylation; Sin3A; SUMO1; transcription	DNA-REPLICATION FORKS; PHD-FINGER; EXPRESSION; PROTEIN; GENE; SUMO; GROWTH; MOTIF; P53; ACETYLATION	ING2 (inhibitor of growth 2) is a candidate tumor-suppressor gene involved in cell cycle control, apoptosis and senescence. Although the functions of ING2 within the chromatin remodeling complex Sin3A/histone deacetylase (HDAC) and in the p53 pathway have been described, how ING2 itself is regulated remains unknown. In this study we report for the first time that ING2 can be sumoylated by small ubiquitin-like modifier 1 (SUMO1) on lysine 195 both in vitro and in vivo. Strikingly, ING2 sumoylation enhances its association with Sin3a. We provide evidences that ING2 can bind to the promoter of genes to mediate their expression and that sumoylation of ING2 is required for this binding to some of these genes. Among them, we identified the gene TMEM71 (transmembrane protein 71), whose expression is regulated by ING2 sumoylation. ING2 must be sumoylated to bind to the promoter of TMEM71 and to recruit the Sin3A chromatin-modifying complex to this promoter, in order to regulate TMEM71 transcription. Hence, sumoylation of ING2 enhances its binding to the Sin3A/HDAC complex and is required to regulate gene transcriptions. Oncogene (2010) 29, 5946-5956; doi:10.1038/onc.2010.325; published online 2 August 2010	[Ythier, D.; Larrieu, D.; Binet, R.; Brambilla, C.; Gazzeri, S.; Pedeux, R.] Univ Grenoble 1, INSERM, U823, Inst Albert Bonniot, Grenoble, France; [Binda, O.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Pedeux, R.] Univ Rennes 1, INSERM, U917, IFR140,Fac Med, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Pedeux, R (corresponding author), INSERM, U917 MICA, Fac Med Rennes, Batiment 2,Piece 117,2 Ave Pr Leon Bernard, F-35043 Rennes, France.	remy.pedeux@univ-rennes1.fr	Binet, Romuald/I-7938-2012; PEDEUX, Rémy M/I-2603-2014; gazzeri, sylvie/U-4669-2019; Binda, Olivier/A-5941-2009; gazzeri, sylvie/M-1961-2013	Binet, Romuald/0000-0003-0636-2195; PEDEUX, Rémy M/0000-0002-2553-7934; gazzeri, sylvie/0000-0001-5817-1839; Binda, Olivier/0000-0002-1539-0828; gazzeri, sylvie/0000-0001-5817-1839	ARC; IASLC; Marie Curie International Reintegration Grant [MIRG-CT-2006-042148]; INCa; FRM; French Ministry of Education and Research; Agir a dom	ARC(Australian Research Council); IASLC; Marie Curie International Reintegration Grant(European Commission); INCa(Institut National du Cancer (INCA) France); FRM(Fondation pour la Recherche Medicale); French Ministry of Education and Research; Agir a dom	We thank D Nissou for technical assisstance; Dr O Gozani and C Harris for antibodies, plasmids and scientific discussion, and Dr Marc Piechaczyk and Dr Guillaume Bossis for scientific discussion and advising. RP was supported by ARC, the IASLC, an 'Agir a dom' grant and a Marie Curie International Reintegration Grant (MIRG-CT-2006-042148). DY, RB and DL were funded by the INCa, ARC, the FRM (Prix Mariane Josso) and the French Ministry of Education and Research, respectively.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Borkosky SS, 2009, J CANCER RES CLIN, V135, P703, DOI 10.1007/s00432-008-0507-y; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Farhana L, 2009, MOL CANCER THER, V8, P1625, DOI 10.1158/1535-7163.MCT-08-0964; Feng XL, 2006, MOL CELL BIOL, V26, P9244, DOI 10.1128/MCB.01538-06; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gong W, 2006, MOL CELL BIOL, V26, P2947, DOI 10.1128/MCB.26.8.2947-2954.2006; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Larrieu D, 2009, CELL CYCLE, V8, P3623, DOI 10.4161/cc.8.22.9947; Larrieu D, 2009, EMBO REP, V10, P1168, DOI 10.1038/embor.2009.180; Lu F, 2006, BRIT J CANCER, V95, P80, DOI 10.1038/sj.bjc.6603205; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Morimoto I, 2002, GENE CHROMOSOME CANC, V33, P270, DOI 10.1002/gcc.10020; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sarker KP, 2008, J BIOL CHEM, V283, P13269, DOI 10.1074/jbc.M708834200; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shiseki M, 2003, CANCER RES, V63, P2373; Skowyra D, 2001, J BIOL CHEM, V276, P8734, DOI 10.1074/jbc.M007664200; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Ythier D, 2008, INT J CANCER, V123, P1483, DOI 10.1002/ijc.23790; Ythier D, 2010, LUNG CANCER, V69, P180, DOI 10.1016/j.lungcan.2009.11.006; Zhang HK, 2008, CANCER LETT, V261, P183, DOI 10.1016/j.canlet.2007.11.019	33	22	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	44					5946	5956		10.1038/onc.2010.325	http://dx.doi.org/10.1038/onc.2010.325			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20676127				2022-12-25	WOS:000283843400008
J	Da Silva, P; Rahioui, I; Laugier, C; Jouvensal, L; Meudal, H; Chouabe, C; Delmas, AF; Gressent, F				Da Silva, Pedro; Rahioui, Isabelle; Laugier, Christian; Jouvensal, Laurence; Meudal, Herve; Chouabe, Christophe; Delmas, Agnes F.; Gressent, Frederic			Molecular Requirements for the Insecticidal Activity of the Plant Peptide Pea Albumin 1 Subunit b (PA1b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTINE-KNOT MOTIF; CHEMICAL-SHIFT; 4-KDA PEPTIDE; PROTEIN; BINDING; ENTOMOTOXIN; CYCLOTIDES; ASSIGNMENT; COMPONENTS; RESIDUES	PA1b (pea albumin 1, subunit b) is a small and compact 37-amino acid protein, isolated from pea seeds (Pisum sativum), that adopts a cystine knot fold. It acts as a potent insecticidal agent against major pests in stored crops and vegetables, making it a promising bioinsecticide. Here, we investigate the influence of individual residues on the structure and bioactivity of PA1b. A collection of 13 PA1b mutants was successfully chemically synthesized in which the residues involved in the definition of PA1b amphiphilic and electrostatic characteristics were individually replaced with an alanine. The three-dimensional structure of PA1b was outstandingly tolerant of modifications. Remarkably, receptor binding and insecticidal activities were both dependent on common well defined clusters of residues located on one single face of the toxin, with Phe-10, Arg-21, Ile-23, and Leu-27 being key residues of the binding interaction. The inactivity of the mutants is clearly due to a change in the nature of the side chain rather than to a side effect, such as misfolding or degradation of the peptide, in the insect digestive tract. We have shown that a hydrophobic patch is the putative site of the interaction of PA1b with its binding site. Overall, the mutagenesis data provide major insights into the functional elements responsible for PA1b entomotoxic properties and give some clues toward a better understanding of the PA1b mode of action.	[Gressent, Frederic] Univ Lyon, INRA, INSA Lyon, IFR 41,UMR203 BF21, F-69621 Villeurbanne, France; [Jouvensal, Laurence; Meudal, Herve; Delmas, Agnes F.] Univ Orleans, CNRS, UPR 4301, Ctr Biophys Mol, F-45071 Orleans 2, France; [Jouvensal, Laurence; Meudal, Herve; Delmas, Agnes F.] INSERM, F-45071 Orleans, France; [Chouabe, Christophe] Univ Lyon 1, CNRS, UMR 5123, F-69622 Villeurbanne, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1		pedro.da-silva@insa-lyon.fr	Meudal, Hervé/B-5851-2016	Meudal, Hervé/0000-0002-9642-3643; GRESSENT, Frederic/0000-0002-7029-8709	INSA-Lyon; Region Centre [PA1bbio]	INSA-Lyon; Region Centre(Region Centre-Val de Loire)	This work was supported in part by INSA-Lyon and Region Centre (PA1bbio) grants.	Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; CHAGOLLALOPEZ A, 1994, J BIOL CHEM, V269, P23675; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craik DJ, 2010, CELL MOL LIFE SCI, V67, P9, DOI 10.1007/s00018-009-0159-3; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Da Silva P, 2009, BIOPOLYMERS, V92, P436, DOI 10.1002/bip.21217; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELOBEL B, 2004, Patent No. 9958695; Dun XP, 2008, PEPTIDES, V29, P891, DOI 10.1016/j.peptides.2008.01.013; Dun XP, 2007, FEBS J, V274, P751, DOI 10.1111/j.1742-4658.2006.05619.x; Grenier AM, 1997, HEREDITY, V79, P15, DOI 10.1038/hdy.1997.118; Gressent F, 2003, EUR J BIOCHEM, V270, P2429, DOI 10.1046/j.1432-1033.2003.03611.x; Gressent F, 2007, J INSECT SCI, V7; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Hanada K, 2003, EUR J BIOCHEM, V270, P2583, DOI 10.1046/j.1432-1033.2003.03627.x; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jouvensal L, 2003, BIOCHEMISTRY-US, V42, P11915, DOI 10.1021/bi034803l; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Louis S, 2004, PLANT SCI, V167, P705, DOI 10.1016/j.plantsci.2004.04.018; Louis S, 2007, PHYTOCHEMISTRY, V68, P521, DOI 10.1016/j.phytochem.2006.11.032; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Rahioui I, 2007, BIOCHIMIE, V89, P1539, DOI 10.1016/j.biochi.2007.07.021; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rosengren KJ, 2002, BIOCHEMISTRY-US, V41, P3294, DOI 10.1021/bi011932y; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Taylor WG, 2004, J AGR FOOD CHEM, V52, P7499, DOI 10.1021/jf030807l; Taylor WG, 2004, J AGR FOOD CHEM, V52, P7491, DOI 10.1021/jf030806t; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamazaki T, 2003, EUR J BIOCHEM, V270, P1269, DOI 10.1046/j.1432-1033.2003.03489.x	33	21	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32689	32694		10.1074/jbc.M110.147199	http://dx.doi.org/10.1074/jbc.M110.147199			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20660598	Green Published, hybrid			2022-12-25	WOS:000283048200003
J	Kuhlberg, A; Haid, M; Metzger, S				Kuehlberg, Axel; Haid, Mark; Metzger, Sabine			Characterization of O-Phosphohydroxyproline in Rat alpha-Crystallin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; B-CRYSTALLIN; PROLINE HYDROXYLATION; A-CRYSTALLIN; HIF-ALPHA; PHOSPHORYLATION; COLLAGEN; KINASE; MUSCLE; HYDROXYPROLINE	Post-translational modifications have major importance for the structure and function of a multiplicity of proteins. Phosphorylation is a widespread phenomenon among eukaryotic proteins. Whereas O-phosphorylation on the side chains of serine, threonine, and tyrosine in proteins is well known and has been studied extensively, to our knowledge the endogenous phosphorylation of hydroxyproline has not previously been reported. In the present work, we provide evidence for the first time that O-phosphohydroxyproline (Hyp(P)) is a proteinogenic amino acid. To detect Hyp(P) in proteins we generated a Hyp(P)-specific polyclonal antibody. We could identify Hyp(P) in various proteins by Western blot analysis, and we characterized the sequence position of Hyp(P) in the protein alpha-crystallin A by electrospray ionization-tandem mass spectrometry. Our experiments clearly demonstrate hydroxylation and subsequent phosphorylation of a proline residue in alpha-crystallin A in the eye as well as in heart tissue of rat.	Univ Dusseldorf, Biol Med Res Ctr, D-40225 Dusseldorf, Germany; [Haid, Mark] Leibniz Inst Plant Biochem, D-06120 Halle, Saale, Germany	Heinrich Heine University Dusseldorf; Leibniz Institut fur Pflanzenbiochemie		metzger@uni-duesseldorf.de	Haid, Mark/J-4304-2019	Haid, Mark/0000-0001-6118-1333				Abgar S, 2000, EUR J BIOCHEM, V267, P5916, DOI 10.1046/j.1432-1327.2000.01646.x; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Augusteyn Robert C, 2002, Clin Exp Optom, V85, P83; Bhat SP, 2003, PROG DRUG RES, V60, P205; Boelens WC, 1998, BBA-PROTEIN STRUCT M, V1388, P513, DOI 10.1016/S0167-4838(98)00215-5; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FERAMISCO JR, 1979, J BIOL CHEM, V254, P6987; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Hoffmann R, 1997, J PEPT RES, V49, P163; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kalume DE, 2003, CURR OPIN CHEM BIOL, V7, P64, DOI 10.1016/S1367-5931(02)00009-1; Kappe G, 2001, BBA-GENE STRUCT EXPR, V1520, P1, DOI 10.1016/S0167-4781(01)00237-8; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KNOX JP, 1995, FASEB J, V9, P1004, DOI 10.1096/fasebj.9.11.7544308; Koteiche HA, 1999, J MOL BIOL, V294, P561, DOI 10.1006/jmbi.1999.3242; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; Krief S, 1999, J BIOL CHEM, V274, P36592, DOI 10.1074/jbc.274.51.36592; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; MARTENSEN TM, 1984, METHOD ENZYMOL, V107, P3; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; PAQUET A, 1982, CAN J CHEM, V60, P976, DOI 10.1139/v82-146; PEARSON RB, 1988, ARCH BIOCHEM BIOPHYS, V260, P37, DOI 10.1016/0003-9861(88)90421-3; Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100; PROROK M, 1989, J BIOL CHEM, V264, P17727; Quadroni M, 2000, EXS, V88, P199; Quinlan RA, 1999, EYE, V13, P409, DOI 10.1038/eye.1999.115; ROBERTS K, 1985, J CELL SCI, P105; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Schaefer H, 2003, ANAL BIOANAL CHEM, V376, P966, DOI 10.1007/s00216-003-1983-1; Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.0.CO;2-V; SPECTOR A, 1984, INVEST OPHTH VIS SCI, V25, P130; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; URUSHIZAKI Y, 1985, P NATL ACAD SCI USA, V82, P3091, DOI 10.1073/pnas.82.10.3091; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; WIJFFELS GL, 1994, BIOCHEM J, V299, P781, DOI 10.1042/bj2990781; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	48	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31484	31490		10.1074/jbc.M109.035428	http://dx.doi.org/10.1074/jbc.M109.035428			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682783	hybrid, Green Published			2022-12-25	WOS:000282764600042
J	Li, CH; Chen, P; Palladino, A; Narayan, S; Russell, LK; Sayed, S; Xiong, GX; Chen, J; Stokes, D; Butt, YM; Jones, PM; Collins, HW; Cohen, NA; Cohen, AS; Nissim, I; Smith, TJ; Strauss, AW; Matschinsky, FM; Bennett, MJ; Stanley, CA				Li, Changhong; Chen, Pan; Palladino, Andrew; Narayan, Srinivas; Russell, Laurie K.; Sayed, Samir; Xiong, Guoxiang; Chen, Jie; Stokes, David; Butt, Yasmeen M.; Jones, Patricia M.; Collins, Heather W.; Cohen, Noam A.; Cohen, Akiva S.; Nissim, Itzhak; Smith, Thomas J.; Strauss, Arnold W.; Matschinsky, Franz M.; Bennett, Michael J.; Stanley, Charles A.			Mechanism of Hyperinsulinism in Short-chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Involves Activation of Glutamate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; FATTY-ACID OXIDATION; INSULIN-SECRETION; MASS-SPECTROMETRY; FASTING HYPOGLYCEMIA; METABOLISM; MUTATIONS; GENE; L-3-HYDROXYACYL-COENZYME; GLUTAMINOLYSIS	The mechanism of insulin dysregulation in children with hyperinsulinism associated with inactivating mutations of short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD) was examined in mice with a knock-out of the hadh gene (hadh(-/-)). The hadh(-/-) mice had reduced levels of plasma glucose and elevated plasma insulin levels, similar to children with SCHAD deficiency. hadh(-/-) mice were hypersensitive to oral amino acid with decrease of glucose level and elevation of insulin. Hypersensitivity to oral amino acid in hadh(-/-) mice can be explained by abnormal insulin responses to a physiological mixture of amino acids and increased sensitivity to leucine stimulation in isolated perifused islets. Measurement of cytosolic calcium showed normal basal levels and abnormal responses to amino acids in hadh(-/-) islets. Leucine, glutamine, and alanine are responsible for amino acid hypersensitivity in islets. hadh(-/-) islets have lower intracellular glutamate and aspartate levels, and this decrease can be prevented by high glucose. hadh(-/-) islets also have increased [U-C-14] glutamine oxidation. In contrast, hadh(-/-) mice have similar glucose tolerance and insulin sensitivity compared with controls. Perifused hadh(-/-) islets showed no differences from controls in response to glucose-stimulated insulin secretion, even with addition of either a medium-chain fatty acid (octanoate) or a long-chain fatty acid (palmitate). Pull-down experiments with SCHAD, anti-SCHAD, or anti-GDH antibodies showed protein-protein interactions between SCHAD and GDH. GDH enzyme kinetics of hadh(-/-) islets showed an increase in GDH affinity for its substrate, alpha-ketoglutarate. These studies indicate that SCHAD deficiency causes hyperinsulinism by activation of GDH via loss of inhibitory regulation of GDH by SCHAD.	[Li, Changhong; Chen, Pan; Palladino, Andrew; Sayed, Samir; Stokes, David; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; [Narayan, Srinivas; Chen, Jie; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Russell, Laurie K.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Xiong, Guoxiang; Cohen, Noam A.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Butt, Yasmeen M.; Jones, Patricia M.] Univ Texas SW Med Ctr, Childrens Med Ctr, Houston, TX 75235 USA; [Collins, Heather W.; Matschinsky, Franz M.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Childrens Hosp Philadelphia, Div Child Dev & Pediat Rehabil, Philadelphia, PA 19104 USA; [Smith, Thomas J.] Danforth Plant Res Inst, St Louis, MO 63132 USA; [Strauss, Arnold W.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Saint Louis University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Donald Danforth Plant Science Center; University System of Ohio; University of Cincinnati	Stanley, CA (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	stanleyc@email.chop.edu	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793; STANLEY, CHARLES/0000-0003-4881-9392; Cohen, Noam/0000-0002-9462-3932; Jones, Peter/0000-0003-1201-2335	National Institutes of Health [DK53012, DK22122, DK 53761, HL075421]; Society for Inherited Metabolic Disorders; Radioimmunoassay and Islet Cores of the Diabetes Research Center of the University of Pennsylvania School of Medicine [DK19525]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053761, P30DK019525, R01DK022122, R01DK053761, R37DK022122, R01DK053012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Inherited Metabolic Disorders; Radioimmunoassay and Islet Cores of the Diabetes Research Center of the University of Pennsylvania School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53012 (to C. A. S.), DK22122 (to F. M. M.), DK 53761 (to I. N.), HL075421 (to A. W. S.). This work was also supported by a fellowship award from Society for Inherited Metabolic Disorders (to A. P.). Additional support was provided by the Radioimmunoassay and Islet Cores of the Diabetes Research Center of the University of Pennsylvania School of Medicine (Grant DK19525) and Clinical & Translational Research Center (UL1-RR-024134). The work was presented in part at the annual meeting of Society for Inherited Metabolic Disorder (March 25-28, 2007, Nashville, Tennessee) and 69th annual meeting of American Diabetes Association (June 5-9, 2009, New Orleans).	Bennett MJ, 2006, MOL GENET METAB, V89, P74, DOI 10.1016/j.ymgme.2006.04.004; Bennett MJ, 1996, PEDIATR RES, V39, P185, DOI 10.1203/00006450-199601000-00031; Bennett MJ, 1999, PEDIATR DEVEL PATHOL, V2, P337, DOI 10.1007/s100249900132; Clayton PT, 2001, J CLIN INVEST, V108, P457; De Leon DD, 2008, J BIOL CHEM, V283, P25786, DOI 10.1074/jbc.M804372200; De Leon DD, 2007, NAT CLIN PRACT ENDOC, V3, P57, DOI 10.1038/ncpendmet0368; Filling C, 2008, BIOCHEM BIOPH RES CO, V368, P6, DOI 10.1016/j.bbrc.2007.10.188; Gao Z, 1999, DIABETES, V48, P1535, DOI 10.2337/diabetes.48.8.1535; GREGERSEN N, 1979, PEDIATR RES, V13, P977, DOI 10.1203/00006450-197909000-00005; GYLFE E, 1988, J BIOL CHEM, V263, P13750; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; Hsu BYL, 2001, J PEDIATR-US, V138, P383, DOI 10.1067/mpd.2001.111818; Hussain K, 2005, J PEDIATR-US, V146, P706, DOI 10.1016/j.jpeds.2005.01.032; JACKSON S, 1991, PEDIATR RES, V29, P406, DOI 10.1203/00006450-199104000-00016; Jeffery CJ, 2005, MASS SPECTROM REV, V24, P772, DOI 10.1002/mas.20041; Jones PM, 2000, CLIN CHEM, V46, P149; Kapoor RR, 2009, J CLIN ENDOCR METAB, V94, P2221, DOI 10.1210/jc.2009-0423; Kelly A, 2001, J CLIN ENDOCR METAB, V86, P3724, DOI 10.1210/jc.86.8.3724; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; Molven A, 2004, DIABETES, V53, P221, DOI 10.2337/diabetes.53.1.221; PASSONNEAU JV, 1993, ENZYMATIC ANAL, P274; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Stanley CA, 2004, MOL GENET METAB, V81, pS45, DOI 10.1016/j.ymgme.2003.10.013; Stanley CA, 2006, DISORDERS MITOCHONDR; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; SWEETMAN L, 1991, ORGANIC ACID ANAL, P143; TEIN I, 1991, ANN NEUROL, V30, P415, DOI 10.1002/ana.410300315; Treberg JR, 2010, ADV ENZYME REGUL, V50, P34, DOI 10.1016/j.advenzreg.2009.10.029	36	119	122	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31806	31818		10.1074/jbc.M110.123638	http://dx.doi.org/10.1074/jbc.M110.123638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670938	Green Published, hybrid			2022-12-25	WOS:000282764600072
J	Vilgelm, AE; Hong, SM; Washington, MK; Wei, J; Chen, H; El-Rifai, W; Zaika, A				Vilgelm, A. E.; Hong, S-M; Washington, M. K.; Wei, J.; Chen, H.; El-Rifai, W.; Zaika, A.			Characterization of Delta Np73 expression and regulation in gastric and esophageal tumors	ONCOGENE			English	Article						p73; gastric tumor; esophageal tumor	FACTOR-BINDING SITES; FEEDBACK LOOP; P53; CANCER; FAMILY; P73; PROMOTER; TAP73; DEATH; DNP73	p73 is a member of the p53 protein family. Although the tumor suppressor function of p53 is clearly defined, the role of p73 in tumorigenesis is still a matter of debate. A complex pattern of expression of p73 isoforms makes it difficult to unambiguously interpret the experimental results. Previously, we along with others have found that the N-terminally truncated isoform of p73, Delta Np73, has potent anti-apoptotic and oncogenic properties in vitro and in vivo. In this study, we analyzed, for the first time, the regulation of Delta Np73 in a large number of gastric, gastroesophageal junction and esophageal tumors. We found that expression of Delta Np73 mRNA and protein is increased in these neoplasms. Furthermore, the upregulation of the Delta Np73 protein is significantly associated with poor patient survival. Oncogenic properties of Delta Np73 were further confirmed by finding that Delta Np73 facilitates anchorage-independent growth of gastric epithelial cells in soft agar. As little is currently known about the regulation of Delta Np73 transcription, we investigated the alternative p73 gene promoter that mediates the Delta Np73 expression. Analyzing the Delta Np73 promoter in silico as well as by using chromatin immunoprecipitation, site-directed mutagenesis and deletion analyses, we identified the evolutionary conserved region within the Delta Np73 promoter that contains binding sites for HIC1 (hypermethylated in cancer) protein. We found that HIC1 negatively regulates Delta Np73 transcription in mucosal epithelial cells. This leads to a decrease in Delta Np73 protein levels and may normally control the oncogenic potential of the Delta Np73 isoform. Oncogene (2010) 29, 5861-5868; doi: 10.1038/onc.2010.319; published online 2 August 2010	[Vilgelm, A. E.; Wei, J.; El-Rifai, W.; Zaika, A.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Vilgelm, A. E.; Washington, M. K.; Wei, J.; Chen, H.; El-Rifai, W.; Zaika, A.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Vilgelm, A. E.] Russian Acad Sci, Dept Cell Biol, VA Engelhardt Mol Biol Inst, Moscow, Russia; [Hong, S-M] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Washington, M. K.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [El-Rifai, W.; Zaika, A.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Johns Hopkins University; Johns Hopkins Medicine; Vanderbilt University; Vanderbilt University	Zaika, A (corresponding author), Dept Surg & Canc Biol, 1255 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	alexander.zaika@vanderbilt.edu		Vilgelm, Anna/0000-0002-4446-913X; Hong, Seung-Mo/0000-0002-8888-6007	National Cancer Institute [NIH CA108956]; Vanderbilt CTSA [UL1 RR024975]; NATIONAL CANCER INSTITUTE [R01CA108956, R01CA138833] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Cancer Institute grant NIH CA108956 and Vanderbilt CTSA grant UL1 RR024975. We thank Dr Castells and Dr Pera of University of Barcelona for their assistance.	Buhlmann S, 2008, BBA-REV CANCER, V1785, P207, DOI 10.1016/j.bbcan.2008.01.002; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; Chen WY, 2005, CELL CYCLE, V4, P10, DOI 10.4161/cc.4.1.1361; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Kanai Y, 1998, CANCER LETT, V122, P135, DOI 10.1016/S0304-3835(97)00380-7; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Lin KW, 2004, NEOPLASIA, V6, P546, DOI 10.1593/neo.04205; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; Stiewe T, 2004, CLIN CANCER RES, V10, P626, DOI 10.1158/1078-0432.CCR-0153-03; Tannapfel A, 2008, CARCINOGENESIS, V29, P211, DOI 10.1093/carcin/bgm236; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vilgelm A, 2008, ONCOGENE, V27, P2170, DOI 10.1038/sj.onc.1210862; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Zaika AI, 2006, CELL DEATH DIFFER, V13, P935, DOI 10.1038/sj.cdd.4401897	21	25	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	43					5861	5868		10.1038/onc.2010.319	http://dx.doi.org/10.1038/onc.2010.319			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20676143	Green Accepted			2022-12-25	WOS:000283586200011
J	Nyathi, Y; Lousa, CDM; van Roermund, CW; Wanders, RJA; Johnson, B; Baldwin, SA; Theodoulou, FL; Baker, A				Nyathi, Yvonne; Lousa, Carine De Marcos; van Roermund, Carlo W.; Wanders, Ronald J. A.; Johnson, Barbara; Baldwin, Stephen A.; Theodoulou, Frederica L.; Baker, Alison			The Arabidopsis Peroxisomal ABC Transporter, Comatose, Complements the Saccharomyces cerevisiae pxa1 pxa2 Delta Mutant for Metabolism of Long-chain Fatty Acids and Exhibits Fatty Acyl-CoA-stimulated ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-CASSETTE TRANSPORTER; HUMAN ADRENOLEUKODYSTROPHY PROTEIN; P-GLYCOPROTEIN; BETA-OXIDATION; COENZYME-A; SEEDLING DEVELOPMENT; MEMBRANE-PROTEIN; GENE-PRODUCT; YEAST; GERMINATION	The Arabidopsis ABC transporter Comatose (CTS; AtABCD1) is required for uptake into the peroxisome of a wide range of substrates for beta-oxidation, but it is uncertain whether CTS itself is the transporter or if the transported substrates are free acids or CoA esters. To establish a system for its biochemical analysis, CTS was expressed in Saccharomyces cerevisiae. The plant protein was correctly targeted to yeast peroxisomes, was assembled into the membrane with its nucleotide binding domains in the cytosol, and exhibited basal ATPase activity that was sensitive to aluminum fluoride and abrogated by mutation of a conserved Walker A motif lysine residue. The yeast pxa1 pxa2 Delta mutant lacks the homologous peroxisomal ABC transporter and is unable to grow on oleic acid. Consistent with its exhibiting a function in yeast akin to that in the plant, CTS rescued the oleate growth phenotype of the pxa1 pxa2 Delta mutant, and restored beta-oxidation of fatty acids with a range of chain lengths and varying degrees of desaturation. When expressed in yeast peroxisomal membranes, the basal ATPase activity of CTS could be stimulated by fatty acyl-CoAs but not by fatty acids. The implications of these findings for the function and substrate specificity of CTS are discussed.	[Nyathi, Yvonne; Lousa, Carine De Marcos; Johnson, Barbara; Baker, Alison] Univ Leeds, Ctr Plant Sci, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [van Roermund, Carlo W.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat & Clin Chem, NL-1105 AZ Amsterdam, Netherlands; [van Roermund, Carlo W.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Theodoulou, Frederica L.] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England	University of Leeds; University of Leeds; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Baker, A (corresponding author), Univ Leeds, Ctr Plant Sci, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	a.baker@leeds.ac.uk		De Marcos Lousa, Carine/0000-0002-5041-6261; Baker, Alison/0000-0003-2181-4057; Theodoulou, Frederica/0000-0002-8306-0716	Biotechnology and Biosciences Research Council [BB/F007299/1, BB/F007108/1]; BBSRC of the United Komgdom; BBSRC [BB/F007108/1, BB/D524875/1, BB/F007299/1, BBS/E/C/00004948] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004948, BB/F007108/1, BB/D524875/1, BB/F007299/1] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC of the United Komgdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biosciences Research Council Grants BB/F007299/1 (to A. B. and S. A. B.) and BB/F007108/1 (to F. L. T.) and a BBSRC doctoral training studentship (to Y. N.). Rothamsted Research receives support from the BBSRC of the United Komgdom.	Arai Y, 2008, PLANT CELL, V20, P3227, DOI 10.1105/tpc.108.062877; Belli S, 2009, J PHARM SCI-US, V98, P1905, DOI 10.1002/jps.21558; Carrera E, 2007, PLANT PHYSIOL, V143, P1669, DOI 10.1104/pp.107.096057; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; CONSTANTINIDES PP, 1986, ARCH BIOCHEM BIOPHYS, V250, P267, DOI 10.1016/0003-9861(86)90726-5; CONSTANTINIDES PP, 1985, J BIOL CHEM, V260, P7573; Contreras M, 1996, ARCH BIOCHEM BIOPHYS, V334, P369, DOI 10.1006/abbi.1996.0467; DAUM G, 1982, J BIOL CHEM, V257, P3075; De Marcos Lousa Carine, 2009, Commun Integr Biol, V2, P97; Dietrich D, 2009, MOL BIOL CELL, V20, P530, DOI 10.1091/mbc.E08-07-0745; Distel Ben, 2006, Methods Mol Biol, V313, P21; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; ELGERSMA Y, 1993, GENETICS, V135, P731; ERDMANN R, 1994, YEAST, V10, P1173, DOI 10.1002/yea.320100905; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Footitt S, 2007, PLANT PHYSIOL, V144, P1467, DOI 10.1104/pp.107.099903; Footitt S, 2006, J EXP BOT, V57, P2805, DOI 10.1093/jxb/erl045; Fourcade S, 2009, AM J PHYSIOL-ENDOC M, V296, pE211, DOI 10.1152/ajpendo.90736.2008; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Guimaraes CP, 2005, J HUM GENET, V50, P99, DOI 10.1007/s10038-004-0226-4; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hooks MA, 2007, BIOCHEM J, V406, P399, DOI 10.1042/BJ20070258; Hunt MC, 2008, PROG LIPID RES, V47, P405, DOI 10.1016/j.plipres.2008.05.001; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kanai M, 2010, PLANT J, V62, P936, DOI 10.1111/j.1365-313X.2010.04205.x; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Kunz HH, 2009, PLANT CELL, V21, P2733, DOI 10.1105/tpc.108.064857; Landgraf P, 2003, EUR J CELL BIOL, V82, P401, DOI 10.1078/0171-9335-00331; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Linka N, 2008, PLANT CELL, V20, P3241, DOI 10.1105/tpc.108.062042; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Morita M, 2006, BIOL PHARM BULL, V29, P1836, DOI 10.1248/bpb.29.1836; Muller M, 2006, FEBS LETT, V580, P6139, DOI 10.1016/j.febslet.2006.10.012; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; Pinfield-Wells H, 2005, PLANT J, V43, P861, DOI 10.1111/j.1365-313X.2005.02498.x; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rottensteiner H, 2006, BBA-MOL CELL RES, V1763, P1527, DOI 10.1016/j.bbamcr.2006.08.012; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Saveria T, 2007, EUKARYOT CELL, V6, P1439, DOI 10.1128/EC.00084-07; Shani N, 1996, P NATL ACAD SCI USA, V93, P11901, DOI 10.1073/pnas.93.21.11901; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; SIKORSKI RS, 1989, GENETICS, V122, P19; Simonsen AC, 2003, FEBS LETT, V552, P253, DOI 10.1016/S0014-5793(03)00970-0; Slocombe SP, 2009, PLANT BIOTECHNOL J, V7, P694, DOI 10.1111/j.1467-7652.2009.00435.x; Sparkes IA, 2003, PLANT PHYSIOL, V133, P1809, DOI 10.1104/pp.103.031252; Swartzman EE, 1996, J CELL BIOL, V132, P549, DOI 10.1083/jcb.132.4.549; SZENTE L, 1993, J INCLUS PHENOM MOL, V16, P339, DOI 10.1007/BF00708714; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; Taylor KM, 1996, BIOCHEM J, V319, P255, DOI 10.1042/bj3190255; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; Turner JE, 2005, J BIOL CHEM, V280, P2780, DOI 10.1074/jbc.M407291200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; VAN ROERMUND CWT, 2008, FASEB J, V22, P4201; Velamakanni S, 2008, MOL PHARMACOL, V73, P12, DOI 10.1124/mol.108.038299; Verleur N, 1997, EUR J BIOCHEM, V249, P657, DOI 10.1111/j.1432-1033.1997.00657.x; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	79	58	60	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29892	29902		10.1074/jbc.M110.151225	http://dx.doi.org/10.1074/jbc.M110.151225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20659892	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-25	WOS:000281984300026
J	Ovsyannikova, IG; Vierkant, RA; Pankratz, VS; Jacobson, RM; Poland, GA				Ovsyannikova, Inna G.; Vierkant, Robert A.; Pankratz, V. Shane; Jacobson, Robert M.; Poland, Gregory A.			Extended LTA, TNF, LST1 and HLA Gene Haplotypes and Their Association with Rubella Vaccine-Induced Immunity	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TUMOR-NECROSIS-FACTOR; E1 ENVELOPE PROTEIN; T-CELL; VIRUS-INFECTION; EMERGING FIELD; ALPHA PROMOTER; POLYMORPHISMS; DISEASE; SUSCEPTIBILITY	Background: Recent studies have suggested the importance of HLA genes in determining immune responses following rubella vaccine. The telomeric class III region of the HLA complex harbors several genes, including lymphotoxin alpha (LTA), tumor necrosis factor (TNF) and leukocyte specific transcript -1 (LST1) genes, located between the class I B and class II DRB1 loci. Apart from HLA, little is known about the effect of this extended genetic region on HLA haplotypic backgrounds as applied to immune responses. Methodology/Principal Findings: We examined the association between immune responses and extended class I-class II-class III haplotypes among 714 healthy children after two doses of rubella vaccination. These extended haplotypes were then compared to the HLA-only haplotypes. The most significant association was observed between haplotypes extending across the HLA class I region, ten-SNP haplotypes, and the HLA class II region (i.e. A-C-B-LTA-TNF-LST1-DRB1-DQA1-DQB1-DPA1-DPB1) and rubella-specific antibodies (global p-value of 0.03). Associations were found between both extended A*02-C*03-B*15-AAAACGGGGC-DRB1*04-DQA1*03-DQB1*03-DPA1*01-DPB1*04 (p = 0.002) and HLA-only *02-C*03-B*15-DRB1*04-DQA1*03-DQB1*03-DPA1*01-DPB1*04 haplotypes (p = 0.009) and higher levels of rubella antibodies. The class II HLA-only haplotype DRB1*13-DQA1*01-DQB1*06-DPA1*01-DPB1*04 (p = 0.04) lacking LTA-TNF-LST1 SNPs was associated with lower rubella antibody responses. Similarly, the class I-class II HLA-only A*01-C*07-B*08-DRB1*03-DQA1*05-DQB1*02DPA1*01-DPB1*04 haplotype was associated with increased TNF-alpha secretion levels (p = 0.009). In contrast, the extended AAAACGGGGC-DRB1*01-DQA1*01-DQB1*05-DPA1*01-DPB1*04 (p = 0.01) haplotype was found to trend with decreased rubella-specific IL-6 secretion levels. Conclusions/Significance: These data suggest the importance of examining both HLA genes and genes in the class III region as part of the extended haplotypes useful in understanding genomic drivers regulating immune responses to rubella vaccine.	[Ovsyannikova, Inna G.; Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA; [Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [Vierkant, Robert A.; Pankratz, V. Shane] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Ovsyannikova, IG (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.	ovsyannikova.inna@mayo.edu; poland.gregory@mayo.edu	Vierkant, Robert/AAP-4927-2020	Vierkant, Robert/0000-0001-6242-5221; Jacobson, Robert/0000-0002-6355-8752	National Center for Research Resources (NCRR), NIH [1 UL1 RR024150-01, AI 48793, AI 33144]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048793, R01AI033144, R37AI048793] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI 48793 (to G. A. P.), AI 33144 (to G. A. P.) and 1 UL1 RR024150-01 from the National Center for Research Resources (NCRR), a component of the NIH, and the NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Hohler T, 1998, CLIN EXP IMMUNOL, V111, P579; Kerr JR, 2003, J CLIN PATHOL, V56, P725, DOI 10.1136/jcp.56.10.725; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Lanas A, 2001, GENES IMMUN, V2, P415, DOI 10.1038/sj.gene.6363798; Mewar D, 2006, GENES IMMUN, V7, P625, DOI 10.1038/sj.gene.6364339; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Mulcahy H, 2006, IMMUNOGENETICS, V57, P893, DOI 10.1007/s00251-005-0057-2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nepom GT, 1997, VACCINE, V15, P648, DOI 10.1016/S0264-410X(96)00194-6; OU DW, 1994, HUM IMMUNOL, V39, P177, DOI 10.1016/0198-8859(94)90258-5; Ovsyannikova IG, 2006, J INFECT DIS, V193, P655, DOI 10.1086/500144; Ovsyannikova IG, 2004, HUM IMMUNOL, V65, P1506, DOI 10.1016/j.humimm.2004.07.001; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Ovsyannikova IG, 2009, VACCINE, V27, P6926, DOI 10.1016/j.vaccine.2009.08.109; Ovsyannikova IG, 2009, VACCINE, V27, P3359, DOI 10.1016/j.vaccine.2009.01.079; Ovsyannikova IG, 2009, VACCINE, V27, P3349, DOI 10.1016/j.vaccine.2009.01.080; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 2008, EXPERT OPIN BIOL TH, V8, P1659, DOI [10.1517/14712598.8.11.1659, 10.1517/14712598.8.11.1659 ]; Posch PE, 2003, GENES IMMUN, V4, P547, DOI 10.1038/sj.gene.6364023; RAU H, 1995, EUR J IMMUNOGENET, V22, P277, DOI 10.1111/j.1744-313X.1995.tb00242.x; Robinson JH, 2002, IMMUNOLOGY, V105, P252, DOI 10.1046/j.0019-2805.2001.01358.x; Rollinger-Holzinger I, 2000, J IMMUNOL, V164, P3169, DOI 10.4049/jimmunol.164.6.3169; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Tomoyose T, 2002, THYROID, V12, P673, DOI 10.1089/105072502760258640; Vejbaesya S, 2009, J INFECT DIS, V199, P1442, DOI 10.1086/597422; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Yang Y, 1996, IMMUNOL RES, V15, P208, DOI 10.1007/BF02918250; 1997, VIROLOGY, V235, P286	32	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11806	10.1371/journal.pone.0011806	http://dx.doi.org/10.1371/journal.pone.0011806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668555	Green Published, gold, Green Submitted			2022-12-25	WOS:000280371800010
J	Das, ST; Rajagopalan, L; Guerrero-Plata, A; Sai, J; Richmond, A; Garofalo, RP; Rajarathnam, K				Das, Sandhya Thulasi; Rajagopalan, Lavanya; Guerrero-Plata, Antonieta; Sai, Jiqing; Richmond, Ann; Garofalo, Roberto P.; Rajarathnam, Krishna			Monomeric and Dimeric CXCL8 Are Both Essential for In Vivo Neutrophil Recruitment	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR1; HEPARAN-SULFATE; HOST-DEFENSE; INTERLEUKIN-8; BINDING; GLYCOSAMINOGLYCANS; OLIGOMERIZATION; ANTAGONISTS; ACTIVATION; RESPONSES	Rapid mobilization of neutrophils from vasculature to the site of bacterial/viral infections and tissue injury is a critical step in successful resolution of inflammation. The chemokine CXCL8 plays a central role in recruiting neutrophils. A characteristic feature of CXCL8 is its ability to reversibly exist as both monomers and dimers, but whether both forms exist in vivo, and if so, the relevance of each form for in vivo function is not known. In this study, using a 'trapped' non-associating monomer and a non-dissociating dimer, we show that (i) wild type (WT) CXCL8 exists as both monomers and dimers, (ii) the in vivo recruitment profiles of the monomer, dimer, and WT are distinctly different, and (iii) the dimer is essential for initial robust recruitment and the WT is most active for sustained recruitment. Using a microfluidic device, we also observe that recruitment is not only dependent on the total amount of CXCL8 but also on the steepness of the gradient, and the gradients created by different CXCL8 variants elicit different neutrophil migratory responses. CXCL8 mediates its function by binding to CXCR2 receptor on neutrophils and glycosaminoglycans (GAGs) on endothelial cells. On the basis of our data, we propose that dynamic equilibrium between CXCL8 monomers and dimers and their differential binding to CXCR2 and GAGs mediates and regulates in vivo neutrophil recruitment. Our finding that both CXCL8 monomer and dimer are functional in vivo is novel, and indicates that the CXCL8 monomer-dimer equilibrium and neutrophil recruitment are intimately linked in health and disease.	[Das, Sandhya Thulasi; Rajagopalan, Lavanya; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Guerrero-Plata, Antonieta; Garofalo, Roberto P.; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Garofalo, Roberto P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX USA; [Sai, Jiqing; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Vet Affairs, Nashville, TN 37212 USA; [Sai, Jiqing; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Vanderbilt University; Vanderbilt University	Das, ST (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA.	krrajara@utmb.edu	DAS, SANDHYA/I-1763-2018; Garofalo, Roberto P./ABL-2322-2022; Sawant, Kirti V/H-3778-2013; Garofalo, Roberto P./AAF-7385-2022	Tripp, Ralph/0000-0002-2924-9956; RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health [AI-069152, CA34590]; Department of Veterans Affairs; McLaughlin Foundation; NATIONAL CANCER INSTITUTE [R23CA034590, R01CA034590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); McLaughlin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health AI-069152 (K.R.) and CA34590 (A.R.) and the Department of Veterans Affairs (A.R.). S.T.D. and L.R. were supported in part by the McLaughlin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Frevert CW, 2002, J IMMUNOL, V168, P3550, DOI 10.4049/jimmunol.168.7.3550; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Fu WX, 2005, CYTOKINE, V31, P9, DOI 10.1016/j.cyto.2005.02.005; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; HECHTMAN DH, 1991, J IMMUNOL, V147, P883; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kolli D, 2008, J VIROL, V82, P8560, DOI 10.1128/JVI.00699-08; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; LEE J, 1995, J IMMUNOL, V155, P2158; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Moepps B, 2006, MOL IMMUNOL, V43, P897, DOI 10.1016/j.molimm.2005.06.043; Moore TA, 2000, J IMMUNOL, V164, P908, DOI 10.4049/jimmunol.164.2.908; MOSER B, 1993, J BIOL CHEM, V268, P7125; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; RAJARATHNAM K, 1995, BIOCHEMISTRY-US, V34, P12983, DOI 10.1021/bi00040a008; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Russo RC, 2009, AM J RESP CELL MOL, V40, P410, DOI 10.1165/rcmb.2007-0364OC; SQUIER MKT, 1995, J LEUKOCYTE BIOL, V57, P2, DOI 10.1002/jlb.57.1.2; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; VANHAL PTW, 1995, CELL PROLIFERAT, V28, P533, DOI 10.1111/j.1365-2184.1995.tb00042.x; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233	50	79	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11754	10.1371/journal.pone.0011754	http://dx.doi.org/10.1371/journal.pone.0011754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668677	Green Published, Green Submitted, gold			2022-12-25	WOS:000280297300004
J	Irie, HY; Shrestha, Y; Selfors, LM; Frye, F; Iida, N; Wang, ZG; Zou, LH; Yao, J; Lu, YL; Epstein, CB; Natesan, S; Richardson, AL; Polyak, K; Mills, GB; Hahn, WC; Brugge, JS				Irie, Hanna Y.; Shrestha, Yashaswi; Selfors, Laura M.; Frye, Fabianne; Iida, Naoko; Wang, Zhigang; Zou, Lihua; Yao, Jun; Lu, Yiling; Epstein, Charles B.; Natesan, Sridaran; Richardson, Andrea L.; Polyak, Kornelia; Mills, Gordon B.; Hahn, William C.; Brugge, Joan S.			PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; BRK TYROSINE KINASE; BREAST-CANCER CELLS; LONG-TERM SURVIVAL; FACTOR-I RECEPTOR; GROWTH-FACTOR; IGF-I; OVARIAN-CANCER; EXPRESSION; ANOIKIS	Background: Proteins that are required for anchorage-independent survival of tumor cells represent attractive targets for therapeutic intervention since this property is believed to be critical for survival of tumor cells displaced from their natural niches. Anchorage-independent survival is induced by growth factor receptor hyperactivation in many cell types. We aimed to identify molecules that critically regulate IGF-1-induced anchorage-independent survival. Methods and Results: We conducted a high-throughput siRNA screen and identified PTK6 as a critical component of IGF-1 receptor (IGF-1R)-induced anchorage-independent survival of mammary epithelial cells. PTK6 downregulation induces apoptosis of breast and ovarian cancer cells deprived of matrix attachment, whereas its overexpression enhances survival. Reverse-phase protein arrays and subsequent analyses revealed that PTK6 forms a complex with IGF-1R and the adaptor protein IRS-1, and modulates anchorage-independent survival by regulating IGF-1R expression and phosphorylation. PTK6 is highly expressed not only in the previously reported Her2(+) breast cancer subtype, but also in high grade ER(+), Luminal B tumors and high expression is associated with adverse outcomes. Conclusions: These findings highlight PTK6 as a critical regulator of anchorage-independent survival of breast and ovarian tumor cells via modulation of IGF-1 receptor signaling, thus supporting PTK6 as a potential therapeutic target for multiple tumor types. The combined genomic and proteomic approaches in this report provide an effective strategy for identifying oncogenes and their mechanism of action.	[Irie, Hanna Y.; Selfors, Laura M.; Frye, Fabianne; Iida, Naoko; Hahn, William C.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Irie, Hanna Y.; Shrestha, Yashaswi; Yao, Jun; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wang, Zhigang; Zou, Lihua; Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Epstein, Charles B.; Natesan, Sridaran] Sanofi Aventis, Cambridge, MA USA; [Epstein, Charles B.; Hahn, William C.] Broad Inst Harvard & Massachusetts Inst Technol M, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center; Sanofi-Aventis; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Irie, HY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Joan_Brugge@hms.harvard.edu		SELFORS, LAURA/0000-0002-1317-7353; Epstein, Charles B./0000-0001-8358-8345	National Institutes of Health (NIH) [CA105134, 5K08 CA107231]; Sanofi-Aventis; NATIONAL CANCER INSTITUTE [R33CA128625, P01CA099031, K08CA107231, P50CA098258, P30CA016672, P50CA089393, R01CA105134] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi-Aventis(Sanofi-Aventis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Institutes of Health (NIH) grant CA105134, a grant from Sanofi-Aventis, and a gift from Lee Jeans through the Entertainment Industry Foundation to JSB. HYI was supported by 5K08 CA107231 (NIH), the Terri Brodeur Breast Cancer Research Foundation and a Development Pilot Award from the SPORE in Breast Cancer (NIH P50 CA089393). YS was supported by a fellowship from the Department of Defense (DoD) (W81XWH-08-1-0767), and WH was supported by W81XWH-07-1-0408 (DoD) and R33 CA128625 (NIH/National Cancer Institute [NCI]). GBM and YL were supported by the Kleberg Center for Molecular Markers, P30 CA1667 and P01CA099031. ZW was supported by a grant from the Breast Cancer Research Foundation. JY, KP and LZ were supported by the Specialized Programs of Research Excellence (SPORE) in Breast Cancer (NIH P50 CA089393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA A, 1994, GENE CHROMOSOME CANC, V11, P63, DOI 10.1002/gcc.2870110110; Aubele M, 2008, BRIT J CANCER, V99, P1089, DOI 10.1038/sj.bjc.6604660; Aubele M, 2007, BRIT J CANCER, V96, P801, DOI 10.1038/sj.bjc.6603613; Aubele M, 2009, VIRCHOWS ARCH, V455, P117, DOI 10.1007/s00428-009-0809-8; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; BERNS EMJJ, 1992, EUR J CANCER, V28A, P697, DOI 10.1016/S0959-8049(05)80129-7; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Brokaw J, 2007, GROWTH FACTORS, V25, P346, DOI 10.1080/08977190701838402; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Haegebarth A, 2005, CELL CYCLE, V4, P1239, DOI 10.4161/cc.4.9.1965; Haegebarth A, 2009, GASTROENTEROLOGY, V137, P945, DOI 10.1053/j.gastro.2009.05.054; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Litzenburger BC, 2009, CLIN CANCER RES, V15, P226, DOI 10.1158/1078-0432.CCR-08-0801; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Mawji IA, 2007, CANCER RES, V67, P8307, DOI 10.1158/0008-5472.CAN-07-1687; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Serfas MS, 2003, ONCOL RES, V13, P409; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105	54	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11729	10.1371/journal.pone.0011729	http://dx.doi.org/10.1371/journal.pone.0011729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668531	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243800009
J	Chen, L; Zhong, DB; Zhang, DH; Shi, LN; Zhou, GF; Gong, MQ; Zhou, HY; Sun, Y; Ma, L; He, J; Hong, SC; Zhou, D; Xiong, CR; Chen, C; Zou, P; Zhu, CL; Yan, GY				Chen, Lin; Zhong, Daibin; Zhang, Donghui; Shi, Linna; Zhou, Guofa; Gong, Maoqing; Zhou, Huayun; Sun, Yan; Ma, Lei; He, Ji; Hong, Shanchao; Zhou, Dan; Xiong, Chunrong; Chen, Chen; Zou, Ping; Zhu, Changliang; Yan, Guiyun			Molecular Ecology of Pyrethroid Knockdown Resistance in Culex pipiens pallens Mosquitoes	PLOS ONE			English	Article							ANOPHELES-GAMBIAE S.S; SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; KDR MUTATION; WEST-AFRICA; INCIPIENT SPECIATION; CROSS-RESISTANCE; GERMAN-COCKROACH; POINT MUTATIONS; BURKINA-FASO	Pyrethroid insecticides have been extensively used in China and worldwide for public health pest control. Accurate resistance monitoring is essential to guide the rational use of insecticides and resistance management. Here we examined the nucleotide diversity of the para-sodium channel gene, which confers knockdown resistance (kdr) in Culex pipiens pallens mosquitoes in China. The sequence analysis of the para-sodium channel gene identified L1014F and L1014S mutations. We developed and validated allele-specific PCR and the real-time TaqMan methods for resistance diagnosis. The real-time TaqMan method is more superior to the allele-specific PCR method as evidenced by higher amplification rate and better sensitivity and specificity. Significant positive correlation between kdr allele frequency and bioassay-based resistance phenotype demonstrates that the frequency of L1014F and L1014S mutations in the kdr gene can be used as a molecular marker for deltamethrin resistance monitoring in natural Cx. pipiens pallens populations in the East China region. The laboratory selection experiment found that L1014F mutation frequency, but not L1014S mutation, responded to deltamethrin selection, suggesting that the L1014F mutation is the key mutation conferring resistance to deltamethrin. High L1014F mutation frequency detected in six populations of Cx. pipens pallens suggests high prevalence of pyrethroid resistance in Eastern China, calling for further surveys to map the resistance in China and for investigating alternative mosquito control strategies.	[Chen, Lin; Zhang, Donghui; Shi, Linna; Sun, Yan; Ma, Lei; He, Ji; Hong, Shanchao; Zhou, Dan; Chen, Chen; Zou, Ping; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Chen, Lin; Zhang, Donghui; Shi, Linna; Sun, Yan; Ma, Lei; He, Ji; Hong, Shanchao; Zhou, Dan; Chen, Chen; Zou, Ping; Zhu, Changliang] Key Lab Modern Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhong, Daibin; Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Gong, Maoqing] Shandong Inst Parasit Dis, Jining, Shandong, Peoples R China; [Zhou, Huayun; Xiong, Chunrong] Jiangsu Inst Parasit Dis, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; University of California System; University of California Irvine	Chen, L (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	clzhu@njmu.edu.cn; guiyuny@uci.edu	Zhong, Daibin/GRF-0564-2022		National Institutes of Health of US [R01 AI075746]; National Science and Technology Major Project of China [2008ZX10004-010]; National Natural Science Foundation of China [30972564, 30901244]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	National Institutes of Health of US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health of US (R01 AI075746), National Science and Technology Major Project of China (No. 2008ZX10004-010) and National Natural Science Foundation of China (No. 30972564 and 30901244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott F F, 1925, Cal West Med, V23, P758; [Anonymous], 1998, WHOCDCMAL98; Anstead JA, 2005, INSECT BIOCHEM MOLEC, V35, P249, DOI 10.1016/j.ibmb.2004.12.004; Awolola TS, 2003, TROP MED INT HEALTH, V8, P420, DOI 10.1046/j.1365-3156.2003.01034.x; Baker MB, 2007, J ECON ENTOMOL, V100, P1871, DOI 10.1603/0022-0493(2007)100[1871:PAIOCO]2.0.CO;2; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Cao GC, 2006, PEST MANAG SCI, V62, P746, DOI 10.1002/ps.1234; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Diabate A, 2004, J AM MOSQUITO CONTR, V20, P195; Dong K, 1997, INSECT BIOCHEM MOLEC, V27, P93, DOI 10.1016/S0965-1748(96)00082-3; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; FINNEY DJ, 1971, METHOD INFORM MED, V10, P237; Himeidan YE, 2007, AM J TROP MED HYG, V77, P1066, DOI 10.4269/ajtmh.2007.77.1066; Jia BT, 2009, PEST MANAG SCI, V65, P996, DOI 10.1002/ps.1785; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Li AY, 2003, J MED ENTOMOL, V40, P942, DOI 10.1603/0022-2585-40.6.942; Luby J P, 1979, Epidemiol Rev, V1, P55; Martin RL, 2000, INSECT BIOCHEM MOLEC, V30, P1051, DOI 10.1016/S0965-1748(00)00080-1; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McAbee RD, 2004, PEST MANAG SCI, V60, P359, DOI 10.1002/ps.799; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Pittendrigh B, 1997, MOL GEN GENET, V256, P602, DOI 10.1007/s004380050608; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; ROWLAND M, 1991, MED VET ENTOMOL, V5, P193, DOI 10.1111/j.1365-2915.1991.tb00542.x; SCOTT JG, 1994, COMP BIOCHEM PHYS B, V109, P191, DOI 10.1016/0305-0491(94)90002-7; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Song FL, 2007, INT J PEST MANAGE, V53, P25, DOI 10.1080/09670870601002625; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Verhaeghen K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-84; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; Wang TY, 2005, ENVIRON INT, V31, P813, DOI 10.1016/j.envint.2005.05.043; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Wondji CS, 2008, TROP MED INT HEALTH, V13, P548, DOI 10.1111/j.1365-3156.2008.02033.x; Wong MH, 2005, CHEMOSPHERE, V60, P740, DOI 10.1016/j.chemosphere.2005.04.028; Yawson AE, 2004, MED VET ENTOMOL, V18, P372, DOI 10.1111/j.0269-283X.2004.00519.x; Zhou L, 2009, J MED ENTOMOL, V46, P321, DOI 10.1603/033.046.0217	49	60	68	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11681	10.1371/journal.pone.0011681	http://dx.doi.org/10.1371/journal.pone.0011681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657783	Green Published, gold			2022-12-25	WOS:000280197500022
J	Shirai, Y; Kouzuki, T; Kakefuda, K; Moriguchi, S; Oyagi, A; Horie, K; Morita, S; Shimazawa, M; Fukunaga, K; Takeda, J; Saito, N; Hara, H				Shirai, Yasuhito; Kouzuki, Takeshi; Kakefuda, Kenichi; Moriguchi, Shigeki; Oyagi, Atsushi; Horie, Kyoji; Morita, Shin-ya; Shimazawa, Masamitsu; Fukunaga, Kohji; Takeda, Junji; Saito, Naoaki; Hara, Hideaki			Essential Role of Neuron-Enriched Diacylglycerol Kinase (DGK), DGK beta in Neurite Spine Formation, Contributing to Cognitive Function	PLOS ONE			English	Article							MOLECULAR-CLONING; MAMMALIAN TARGET; GAMMA; CELL; LOCALIZATION; ACTIVATION; BRAIN	Background: Diacylglycerol (DG) kinase (DGK) phosphorylates DG to produce phosphatidic acid (PA). Of the 10 subtypes of mammalian DGKs, DGK beta is a membrane-localized subtype and abundantly expressed in the cerebral cortex, hippocampus, and caudate-putamen. However, its physiological roles in neurons and higher brain function have not been elucidated. Methodology/Principal Findings: We, therefore, developed DGKb KO mice using the Sleeping Beauty transposon system, and found that its long-term potentiation in the hippocampal CA1 region was reduced, causing impairment of cognitive functions including spatial and long-term memories in Y-maze and Morris water-maze tests. The primary cultured hippocampal neurons from KO mice had less branches and spines compared to the wild type. This morphological impairment was rescued by overexpression of DGKb. In addition, overexpression of DGKb in SH-SY5Y cells or primary cultured mouse hippocampal neurons resulted in branch-and spine-formation, while a splice variant form of DGKb, which has kinase activity but loses membrane localization, did not induce branches and spines. In the cells overexpressing DGKb but not the splice variant form, DGK product, PA, was increased and the substrate, DG, was decreased on the plasma membrane. Importantly, lower spine density and abnormality of PA and DG contents in the CA1 region of the KO mice were confirmed. Conclusions/Significance: These results demonstrate that membrane-localized DGKb regulates spine formation by regulation of lipids, contributing to the maintenance of neural networks in synaptic transmission of cognitive processes including memory.	[Shirai, Yasuhito; Kouzuki, Takeshi; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 657, Japan; [Kakefuda, Kenichi; Oyagi, Atsushi; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Moriguchi, Shigeki; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Dept Social & Environm Med, Grad Sch Med, Suita, Osaka, Japan; [Morita, Shin-ya] Kobe Univ, Pharmaceut Technol Lab, Kobe, Hyogo 657, Japan	Kobe University; Gifu Pharmaceutical University; Tohoku University; Osaka University; Kobe University	Shirai, Y (corresponding author), Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 657, Japan.	hidehara@gifu-pu.ac.jp	Morita, Shin-ya/U-2793-2019; Shirai, Yasuhito/O-3255-2018; Fukunaga, Kohji/AAI-8811-2021	Morita, Shin-ya/0000-0003-4079-707X; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Scientific Research from the Global Center of Excellence (GCOE) Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Takeda Science Foundation. The funders had no role in study design, data collection and any analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Goto K, 2006, ADV ENZYME REGUL, V46, P192, DOI 10.1016/j.advenzreg.2006.01.005; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Hozumi Y, 2008, EUR J NEUROSCI, V28, P2409, DOI 10.1111/j.1460-9568.2008.06547.x; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Kanaho Y, 2009, BBA-MOL CELL BIOL L, V1791, P898, DOI 10.1016/j.bbalip.2009.03.010; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kim HJ, 2009, MOL PHARMACOL, V75, P1021, DOI 10.1124/mol.108.052357; Kim K, 2010, J NEUROCHEM, V112, P577, DOI 10.1111/j.1471-4159.2009.06499.x; Kim K, 2009, EMBO J, V28, P1170, DOI 10.1038/emboj.2009.44; Kobayashi N, 2007, EUR J CELL BIOL, V86, P433, DOI 10.1016/j.ejcb.2007.05.002; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; Matsubara T, 2006, J BIOL CHEM, V281, P6152, DOI 10.1074/jbc.M509873200; MATUS A, 2005, CURR OPIN NEUROBIOL, V5, P771; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Moriguchi S, 2008, J NEUROCHEM, V106, P1092, DOI 10.1111/j.1471-4159.2008.05440.x; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Sakai N, 2004, GENES CELLS, V9, P945, DOI 10.1111/j.1365-2443.2004.00779.x; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Stace C, 2008, ADV ENZYME REGUL, V48, P55, DOI 10.1016/j.advenzreg.2007.11.008; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; THOMAS JVV, 2005, J NEUROSCI, V25, P9488; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Yakubchyk Y, 2005, MOL CELL BIOL, V25, P7289, DOI 10.1128/MCB.25.16.7289-7302.2005; ZHA Y, 2006, NATURE IMMUNOL, V11, P1166	38	54	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11602	10.1371/journal.pone.0011602	http://dx.doi.org/10.1371/journal.pone.0011602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657643	Green Published, gold, Green Submitted			2022-12-25	WOS:000279924500006
J	Leroy, A; Landrieu, I; Huvent, I; Legrand, D; Codeville, B; Wieruszeski, JM; Lippens, G				Leroy, Arnaud; Landrieu, Isabelle; Huvent, Isabelle; Legrand, Dominique; Codeville, Bernadette; Wieruszeski, Jean-Michel; Lippens, Guy			Spectroscopic Studies of GSK3 beta Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-terminal Domain of Apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DISEASE-LIKE PHOSPHORYLATION; HEPARIN-BINDING-SITES; ALZHEIMERS-DISEASE; NMR-SPECTROSCOPY; TRANSGENIC MICE; HUMAN BRAIN; MAMMALIAN-CELLS; CHEMICAL-SHIFTS; NERVOUS-SYSTEM	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-beta peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated Tau protein. Tau is mostly found in a hyperphosphorylated form in these tangles. Glycogen synthase kinase 3 beta (GSK3 beta) is a proline-directed kinase generally considered as one of the major players that (hyper)phosphorylates Tau. The kinase phosphorylates mainly (Ser/Thr)-Pro motifs and is believed to require a priming activity by another kinase. Here, we use an in vitro phosphorylation assay and NMR spectroscopy to characterize in a qualitative and quantitative manner the phosphorylation of Tau by GSK3 beta. We find that three residues can be phosphorylated (Ser-396, Ser-400, and Ser-404) by GSK3 beta alone, without priming. Ser-404 is essential in this process, as its mutation to Ala prevents all activity of GSK3 beta. However, priming enhances the catalytic efficacy of the kinase, as initial phosphorylation of Ser-214 by the cAMP-dependent protein kinase (PKA) leads to the rapid modification by GSK3 beta of four regularly spaced additional sites. Because the regular incorporation of negative charges by GSK3 beta leads to a potential parallel between phospho-Tau and heparin, we investigated its interaction with the heparin/low density lipoprotein receptor binding domain of human apolipoprotein E. We indeed observed an interaction between the GSK3 beta-promoted regular phospho-pattern on Tau and the apolipoprotein E fragment but none in the absence of phosphorylation or the presence of an irregular phosphorylation pattern by the prolonged activity of PKA. Apolipoprotein E is therefore able to discriminate and interact with specific phosphorylation patterns of Tau.	[Leroy, Arnaud; Landrieu, Isabelle; Huvent, Isabelle; Legrand, Dominique; Codeville, Bernadette; Wieruszeski, Jean-Michel; Lippens, Guy] Univ Sci & Tech Lille Flandres Artois, CNRS, Struct & Funct Glycobiol Unit, UMR8576, F-59655 Villeneuve Dascq, France; [Leroy, Arnaud] Univ Paris 11, Fac Pharm Chatenay Malabry, Lab Biochim Appl, F-92296 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Paris Saclay	Leroy, A (corresponding author), Univ Sci & Tech Lille Flandres Artois, CNRS, Struct & Funct Glycobiol Unit, UMR8576, F-59655 Villeneuve Dascq, France.	Arnaud.Leroy@univ-lille1.fr; guy.lippens@univ-lille1.fr	Legrand, Dominique/AAT-5715-2021; Landrieu, Isabelle/AAF-8495-2019	Landrieu, Isabelle/0000-0002-4883-2637; LEGRAND, Dominique/0000-0002-0814-221X; Lippens, Guy/0000-0002-8236-0901; Huvent, Isabelle/0000-0002-7241-0290	Region Nord-Pas de Calais (France); CNRS; University of Lille 1; Institut Pasteur de Lille	Region Nord-Pas de Calais (France)(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 1; Institut Pasteur de Lille	We thank Prof. Schwalbe (Frankfurt, Germany) for the PKA sample, and Dr. G. Divita for the GSK3 beta clone. The NMR facility used in this study was funded by the Region Nord-Pas de Calais (France), the CNRS, the University of Lille 1, and the Institut Pasteur de Lille.	Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Aoki K, 2003, STROKE, V34, P875, DOI 10.1161/01.STR.0000064320.73388.C6; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; Boschert U, 1999, NEUROBIOL DIS, V6, P508, DOI 10.1006/nbdi.1999.0251; BRAAK H, 1988, STAIN TECHNOL, V63, P197, DOI 10.3109/10520298809107184; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brownlees J, 1997, NEUROREPORT, V8, P3251, DOI 10.1097/00001756-199710200-00013; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Dekroon RM, 2001, GLIA, V33, P298, DOI 10.1002/1098-1136(20010315)33:4<298::AID-GLIA1028>3.0.CO;2-N; Dong J, 2001, BIOCHEMISTRY-US, V40, P2826, DOI 10.1021/bi002417n; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FIOL CJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P797, DOI 10.1016/0003-9861(88)90089-6; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI 10.1586/ERN.09.104; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALAZAR A, 1989, J BIOL CHEM, V264, P8447; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Langer T, 2004, CHEMBIOCHEM, V5, P1508, DOI 10.1002/cbic.200400129; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Lippens G, 2004, CHEMBIOCHEM, V5, P73, DOI 10.1002/cbic.200300763; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mahley Robert W., 1995, Current Opinion in Lipidology, V6, P86, DOI 10.1097/00041433-199504000-00005; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MONTEILHET C, 1993, GENE, V125, P223, DOI 10.1016/0378-1119(93)90333-X; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Peterson DW, 2010, P NATL ACAD SCI USA, V107, P2884, DOI 10.1073/pnas.0912718107; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; RICHEY PL, 1995, BIOCHEM BIOPH RES CO, V208, P657, DOI 10.1006/bbrc.1995.1389; Roses AD, 1997, NEUROBIOL DIS, V4, P170, DOI 10.1006/nbdi.1997.0161; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Sengupta A, 1997, MOL CELL BIOCHEM, V167, P99, DOI 10.1023/A:1006883924775; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Wang JZ, 1998, FEBS LETT, V436, P28, DOI 10.1016/S0014-5793(98)01090-4; WANG QM, 1994, J BIOL CHEM, V269, P14566; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; Weisgraber Karl H., 1994, Current Opinion in Lipidology, V5, P110, DOI 10.1097/00041433-199404000-00007; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200	74	51	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33435	33444		10.1074/jbc.M110.149419	http://dx.doi.org/10.1074/jbc.M110.149419			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20679343	Green Published, hybrid			2022-12-25	WOS:000283048200078
J	Yao, Y; Tsirka, SE				Yao, Yao; Tsirka, Stella E.			The C Terminus of Mouse Monocyte Chemoattractant Protein 1 (MCP1) Mediates MCP1 Dimerization while Blocking Its Chemotactic Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED ENDOCYTOSIS; CENTRAL-NERVOUS-SYSTEM; MICROGLIAL CELLS; IN-VIVO; PLASMINOGEN-ACTIVATOR; NEURONAL DEGENERATION; MULTIPLE-SCLEROSIS; AMEBOID MICROGLIA; BRAIN PARENCHYMA; RECEPTOR	The extracellular protease plasmin cleaves mouse MCP1 (monocyte chemoattractant protein 1) at lysine 104, releasing a 50-amino acid C-terminal domain. The cleavage event increases the chemotactic activity of MCP1 and, by doing so, promotes the progression of excitotoxic injury in the central nervous system in pathological settings. The mechanism through which the cleavage event enhances MCP1-mediated chemoattraction is unknown; to investigate it, we use wild-type and mutant forms of recombinant MCP1. Full-length MCP1 (FL-MCP1) is secreted by cells as a dimer or multimer. We show that a mutant truncated at the C terminus, K104Stop-MCP1, does not dimerize, revealing that the C terminus mediates the interaction. MCP1 interacts with the monocyte/microglia receptor CCR2. The interaction is critical to the function of MCP1 because CCR2(-/-) microglia do not undergo chemotaxis in response to MCP1 stimulation. We show that stimulation of microglia with FL-MCP1 or K104Stop-MCP1 triggers CCR2 internalization, whereas a mutant form unable to be cleaved at lysine 104 (K104A-MCP1) is relatively ineffective in this assay, suggesting that the C-terminal region interferes with the MCP1-CCR2 interaction. Moreover, FL-MCP1 and K104Stop-MCP1 stimulation leads to activation of Rac1, a small GTPase involved in cell migration. Conversely, MCP1-stimulated microglial migration is blocked by the Rac1 inhibitor, NSC23766, demonstrating the requirement for Rac1 effector pathways in this response. Taken together, we propose a model for MCP1 localization, activation, and function based on the initial presence and then removal of its C terminus, coupled with a requisite downstream signaling pathway from CCR2 stimulation to Rac1 activation.	[Yao, Yao; Tsirka, Stella E.] SUNY Stony Brook, Program Mol & Cellular Pharmacol, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tsirka, SE (corresponding author), SBU, Dept Pharmacol, BST8-192, Stony Brook, NY 11794 USA.	stella@pharm.stonybrook.edu	Yao, Yao/AFJ-8136-2022; Tsirka, Stella/AAD-4018-2019; Yao, Yao/G-1904-2012	Yao, Yao/0000-0001-8020-9696; 	National Institutes of Health [NS42168]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS42168.	ABROMSONLEEMAN S, 1993, J NEUROIMMUNOL, V45, P89, DOI 10.1016/0165-5728(93)90168-X; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen BP, 2001, J IMMUNOL, V167, P4585, DOI 10.4049/jimmunol.167.8.4585; Chen YL, 1999, ATHEROSCLEROSIS, V143, P115, DOI 10.1016/S0021-9150(98)00285-8; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Favre N, 2008, PROTEOMICS, V8, P4560, DOI 10.1002/pmic.200800211; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Ge SJ, 2008, J NEUROCHEM, V104, P1219, DOI 10.1111/j.1471-4159.2007.05056.x; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Kim GH, 2008, J NEUROSURG, V109, P38, DOI 10.3171/JNS/2008/109/7/0038; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Kowala MC, 2000, ATHEROSCLEROSIS, V149, P323, DOI 10.1016/S0021-9150(99)00342-1; Kunkel SL, 1996, J LEUKOCYTE BIOL, V59, P6, DOI 10.1002/jlb.59.1.6; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lamkhioued B, 2000, AM J RESP CRIT CARE, V162, P723, DOI 10.1164/ajrccm.162.2.9901080; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; LING EA, 1979, J ANAT, V128, P847; Maghazachi AA, 2000, INT J BIOCHEM CELL B, V32, P931, DOI 10.1016/S1357-2725(00)00035-2; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Martins-Green M, 2001, INT J BIOCHEM CELL B, V33, P427, DOI 10.1016/S1357-2725(01)00029-2; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Morimoto H, 2008, CARDIOVASC RES, V78, P554, DOI 10.1093/cvr/cvn035; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ono K, 1999, BIOCHEM BIOPH RES CO, V262, P610, DOI 10.1006/bbrc.1999.1223; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Rogove AD, 1999, J CELL SCI, V112, P4007; Sheehan JJ, 2007, J NEUROSCI, V27, P1738, DOI 10.1523/JNEUROSCI.4987-06.2007; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Tillie-Leblond I, 2000, AM J RESP CRIT CARE, V162, P586, DOI 10.1164/ajrccm.162.2.9907014; Tsirka SE, 1997, J NEUROSCI, V17, P543; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; Vakili J, 2001, J IMMUNOL, V167, P3406, DOI 10.4049/jimmunol.167.6.3406; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Wu YP, 2000, AM J PATHOL, V156, P1849, DOI 10.1016/S0002-9440(10)65058-4; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851; Zhang Yujun, 1996, Methods (Orlando), V10, P93, DOI 10.1006/meth.1996.0083	63	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31509	31516		10.1074/jbc.M110.124891	http://dx.doi.org/10.1074/jbc.M110.124891			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682771	Green Published, hybrid			2022-12-25	WOS:000282764600045
J	Doyon, P; Servant, MJ				Doyon, Priscilla; Servant, Marc J.			Tumor Necrosis Factor Receptor-associated Factor-6 and Ribosomal S6 Kinase Intracellular Pathways Link the Angiotensin II AT1 Receptor to the Phosphorylation and Activation of the I kappa B Kinase Complex in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-BETA SUBUNIT; SIGNALING PATHWAY; TRANSCRIPTION FACTORS; TISSUE RENIN; ATHEROSCLEROSIS; INFLAMMATION; MECHANISMS; DISEASE; INVOLVEMENT; INHIBITOR	Activation of NF-kappa B transcription factors by locally produced angiotensin II (Ang II) is proposed to be involved in chronic inflammatory reactions leading to atherosclerosis development. However, a clear understanding of the signaling cascades coupling the Ang II AT1 receptors to the activation of NF-kappa B transcription factors is still lacking. Using primary cultured aortic vascular smooth muscle cells, we show that activation of the IKK complex and NF-kappa B transcription factors by Ang II is regulated by phosphorylation of the catalytic subunit IKK beta on serine residues 177 and 181 in the activation T-loop. The use of pharmacological inhibitors against conventional protein kinases C (PKCs), mitogen-activated/extracellular signal-regulated kinase (MEK) 1/2, ribosomal S6 kinase (RSK), and silencing RNA technology targeting PKC alpha, IKK beta subunit, tumor growth factor beta-activating kinase-1 (TAK1), the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor-6 (TRAF6), and RSK isoforms, demonstrates the requirement of two distinct signaling pathway for the phosphorylation of IKK beta and the activation of the IKK complex by Ang II. Rapid phosphorylation of IKK beta requires a second messenger-dependent pathway composed of PKC alpha-TRAF6-TAK1, whereas sustained phosphorylation and activation of IKK beta requires the MEK1/2-ERK1/2-RSK pathway. Importantly, simultaneously targeting components of these two pathways completely blunts the phosphorylation of IKK beta and the proinflammatory effect of the octapeptide. This is the first report demonstrating activation of TAK1 by the AT1R. We propose a model whereby TRAF6-TAK1 and ERK-RSK intracellular pathways independently and sequentially converge to the T-loop phosphorylation for full activation of IKK beta, which is an essential step in the proinflammatory activity of Ang II.	Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Servant, MJ (corresponding author), CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	marc.servant@umontreal.ca			Canadian Institutes of Health [MOP-53282]; Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Canadian Institutes of Health Research Grant MOP-53282 and the Heart and Stroke Foundation of Canada (to M. J. S.).; Supported by a studentship from the Natural Sciences and Engineering Research Council of Canada.	Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Choudhary S, 2007, MOL ENDOCRINOL, V21, P2203, DOI 10.1210/me.2006-0465; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; de Gasparo M, 2000, PHARMACOL REV, V52, P415; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Han YQ, 1999, CIRC RES, V84, P695, DOI 10.1161/01.RES.84.6.695; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Jamaluddin M, 2000, MOL ENDOCRINOL, V14, P99, DOI 10.1210/me.14.1.99; Kalra D, 2002, CIRCULATION, V105, P2198, DOI 10.1161/01.CIR.0000015603.84788.47; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin Michael, 2005, Proc Am Thorac Soc, V2, P386, DOI 10.1513/pats.200504-034SR; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LEE MA, 1993, CIRCULATION, V87, P7; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2008, NAT IMMUNOL, V9, P231, DOI 10.1038/ni0308-231; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Miyahara T, 2004, CARDIOVASC RES, V64, P154, DOI 10.1016/j.cardiores.2004.06.014; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; SEINO Y, 1994, CYTOKINE, V6, P87, DOI 10.1016/1043-4666(94)90013-2; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; WEGENER E, 2007, SCI STKE, pPE21; Wu L, 2006, J HYPERTENS, V24, P123, DOI 10.1097/01.hjh.0000198031.30095.d1; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang LP, 2005, ARTERIOSCL THROM VAS, V25, P1148, DOI 10.1161/01.ATV.0000164624.00099.e7; Zhang LP, 2005, CIRC RES, V97, P975, DOI 10.1161/01.RES.0000190589.52286.41; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	54	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30708	30718		10.1074/jbc.M110.126433	http://dx.doi.org/10.1074/jbc.M110.126433			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659889	hybrid, Green Published			2022-12-25	WOS:000282135500039
J	Park, JA; Drazen, JM; Tschumperlin, DJ				Park, Jin-Ah; Drazen, Jeffrey M.; Tschumperlin, Daniel J.			The Chitinase-like Protein YKL-40 Is Secreted by Airway Epithelial Cells at Base Line and in Response to Compressive Mechanical Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM YKL-40; ARTICULAR CHONDROCYTES; KINASE-C; GENE-EXPRESSION; I COLLAGEN; HB-EGF; ASTHMA; LUNG; MECHANOTRANSDUCTION; CHI3L1	The chitinase-like protein YKL-40, encoded by the CHI3L1 gene, is a biomarker and functional effector of chronic inflammatory and allergic diseases. In the lung it is associated with asthma severity and reduced lung function. The cellular sources of YKL-40 in human airways and the mechanisms regulating YKL-40 expression are poorly understood. We previously showed that mechanical stress similar to that experienced during bronchoconstriction triggers epithelial cell signaling through epidermal growth factor receptor (EGFR), fibrotic mediator release, and goblet cell hyperplasia consistent with airway remodeling in asthma. We now show that well differentiated normal human bronchial epithelial cells express CHI3L1 and secrete YKL-40 under base-line culture conditions. Mechanical stress (30-cm H2O transcellular compressive stress) applied for 3 h induces CHI3L1 expression by similar to 4-fold compared with time matched controls, resulting in increased secretion of YKL-40 by 3.6-fold 24 h after onset of the 3-h stimulus. Inhibition of EGFR or MEK1/2 (ERK kinase) significantly but incompletely attenuates mechanical stress-induced up-regulation of CHI3L1 expression in normal human bronchial epithelial cells. Direct activation of EGFR utilizing EGF-family ligands induces CHI3L1 expression. Our results reveal that human airway epithelial cells are a source of YKL-40 and demonstrate that mechanical stress potently induces CHI3L1 expression leading to increased secretion of YKL-40 protein in an EGFR and MEK1/2-dependent pathway. In the asthmatic airway mechanical stress may contribute to enhanced YKL-40 levels.	[Park, Jin-Ah; Drazen, Jeffrey M.; Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Tschumperlin, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Dept Environm Hlth, 665 Huntington Ave,SPH1-309, Boston, MA 02115 USA.	Hdtschump@hsph.harvard.edu	Drazen, Jeffrey M/E-5841-2012	Park, Jin-Ah/0000-0002-8930-9287	National Institutes of Health [HL082856, HL88028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088028, R01HL082856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082856 and HL88028.	Allahverdian S, 2008, AM J RESP CELL MOL, V38, P153, DOI 10.1165/rcmb.2007-0173OC; Bhat KP, 2008, FEBS LETT, V582, P3193, DOI 10.1016/j.febslet.2008.08.010; Bigg HF, 2006, J BIOL CHEM, V281, P21082, DOI 10.1074/jbc.M601153200; Booth BW, 2001, AM J RESP CELL MOL, V25, P739, DOI 10.1165/ajrcmb.25.6.4659; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Chu EK, 2006, AM J RESP CELL MOL, V35, P628, DOI 10.1165/rcmb.2006-0040OC; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DE CEUNINCK F, 2001, BIOCHEM BIOPH RES CO, V285, P926; DING DJ, 1987, J APPL PHYSIOL, V62, P1324, DOI 10.1152/jappl.1987.62.3.1324; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hartl D, 2009, CURR OPIN ALLERGY CL, V9, P60, DOI 10.1097/ACI.0b013e32831f8ee0; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Huang K, 2009, J INT MED RES, V37, P18, DOI 10.1177/147323000903700102; Iwata T, 2009, BIOCHEM BIOPH RES CO, V388, P511, DOI 10.1016/j.bbrc.2009.08.024; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2004, LUNG CANCER-J IASLC, V46, P333, DOI 10.1016/j.lungcan.2004.05.010; Johansen JS, 2001, ARTHRITIS RHEUM-US, V44, P826; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Kojic N, 2010, FASEB J, V24, P1604, DOI 10.1096/fj.09-145367; Koutroubakis IE, 2003, INT J COLORECTAL DIS, V18, P254, DOI 10.1007/s00384-002-0446-z; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Park JA, 2007, AM J PATHOL, V171, P1822, DOI 10.2353/ajpath.2007.070318; Park JA, 2009, AM J RESP CELL MOL, V41, P459, DOI 10.1165/rcmb.2008-0195OC; Pungpopong S, 2008, LIVER TRANSPLANT, V14, P1294, DOI 10.1002/lt.21508; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Rathcke CN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006106; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Ressler B, 2000, AM J PHYSIOL-LUNG C, V278, pL1264, DOI 10.1152/ajplung.2000.278.6.L1264; Sallee JL, 2009, J BIOL CHEM, V284, P14997, DOI 10.1074/jbc.M901901200; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Shim M, 2003, J BIOL CHEM, V278, P19674, DOI 10.1074/jbc.M301356200; Shuhui L, 2009, INT ARCH ALLERGY IMM, V149, P369, DOI 10.1159/000205583; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Tschumperlin DJ, 2002, AM J PHYSIOL-LUNG C, V282, pL904, DOI 10.1152/ajplung.00270.2001; Wiggs BR, 1997, J APPL PHYSIOL, V83, P1814, DOI 10.1152/jappl.1997.83.6.1814; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	49	59	63	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29817	29825		10.1074/jbc.M110.103416	http://dx.doi.org/10.1074/jbc.M110.103416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650887	Green Published, hybrid			2022-12-25	WOS:000281984300017
J	Dieng, H; Saifur, RGM; Abu Hassan, A; Salmah, MRC; Boots, M; Satho, T; Jaal, Z; AbuBakar, S				Dieng, Hamady; Saifur, Rahman G. M.; Abu Hassan, Ahmad; Salmah, M. R. Che; Boots, Michael; Satho, Tomomitsu; Jaal, Zairi; AbuBakar, Sazaly			Indoor-Breeding of Aedes albopictus in Northern Peninsular Malaysia and Its Potential Epidemiological Implications	PLOS ONE			English	Article							DENGUE TRANSMISSION; JAPANESE ENCEPHALITIS; ACTIVITY PATTERNS; VIRUS-INFECTION; HOST-SEEKING; PUERTO-RICO; AEGYPTI; MOSQUITO; DIPTERA; CULICIDAE	Background: The mosquito Ae. albopictus is usually adapted to the peri-domestic environment and typically breeds outdoors. However, we observed its larvae in most containers within homes in northern peninsular Malaysia. To anticipate the epidemiological implications of this indoor-breeding, we assessed some fitness traits affecting vectorial capacity during colonization process. Specifically, we examined whether Ae. albopictus exhibits increased survival, gonotrophic activity and fecundity due to the potential increase in blood feeding opportunities. Methodology/Principal Findings: In a series of experiments involving outdoors and indoors breeding populations, we found that Ae. albopictus lives longer in the indoor environment. We also observed increased nighttime biting activity and lifetime fecundity in indoor/domestic adapted females, although they were similar to recently colonized females in body size. Conclusion/Significance: Taken together these data suggest that accommodation of Ae. albopictus to indoor/domestic environment may increase its lifespan, blood feeding success, nuisance and thus vectorial capacity (both in terms of increased vector-host contacts and vector population density). These changes in the breeding behavior of Ae. albopictus, a potential vector of several human pathogens including dengue viruses, require special attention.	[Dieng, Hamady; Saifur, Rahman G. M.; Abu Hassan, Ahmad; Salmah, M. R. Che; Jaal, Zairi] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Boots, Michael] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Satho, Tomomitsu] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka 81401, Japan; [AbuBakar, Sazaly] Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Sains Malaysia; University of Sheffield; Fukuoka University; Universiti Malaya	Dieng, H (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.	hamachan1@yahoo.com	abubakar, sazaly/B-3957-2010; ahmad, abuhassan/E-5918-2013; Ahmad, Abu Hassan/C-2706-2011	abubakar, sazaly/0000-0002-9267-1420; 	RU [1001/229/29301/CIPS/AUPE001];  [07-05-16-MG1-GMB15];  [1001/PBIOLOGI/842004]	RU; ; 	The research was partially funded by grants 07-05-16-MG1-GMB15, 1001/PBIOLOGI/842004 and fellowship grant #RU:1001/229/29301/CIPS/AUPE001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F., 2006, American Journal of Environmental Sciences, V2, P121, DOI 10.3844/ajessp.2006.121.128; Ali M, 2003, AM J TROP MED HYG, V69, P634, DOI 10.4269/ajtmh.2003.69.634; Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2; Blackmore MS, 2000, J VECTOR ECOL, V25, P212; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; CHADEE DD, 1990, ANN TROP MED PARASIT, V84, P429, DOI 10.1080/00034983.1990.11812492; Chadee DD, 2002, J VECTOR ECOL, V27, P172; Chadee DD, 2000, J VECTOR ECOL, V25, P158; CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P629; Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578; Clements A. N., 1992, BIOL MOSQUITOES, V1; CLEMENTS AN, 1999, BIOL MOSQUITOES, V2, pR16; Deen JL, 2004, TROP MED INT HEALTH, V9, P1, DOI 10.1046/j.1365-3156.2003.01159.x; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Effler PV, 2005, EMERG INFECT DIS, V11, P742; FAY R. W., 1966, MOSQUITO NEWS, V26, P531; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; GOH K T, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P295; GOMA LKH, 1966, MOSQUITOES; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Guzman Maria G, 2004, Expert Rev Anti Infect Ther, V2, P895, DOI 10.1586/14789072.2.6.895; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177; Hurd H, 2001, P ROY SOC B-BIOL SCI, V268, P1749, DOI 10.1098/rspb.2001.1729; Kawada H, 2005, J MED ENTOMOL, V42, P312, DOI 10.1603/0022-2585(2005)042[0312:CSONBO]2.0.CO;2; KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Leisnham PT, 2008, J MED ENTOMOL, V45, P210, DOI 10.1603/0022-2585(2008)45[210:GVIASA]2.0.CO;2; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Makiya K., 1968, Japanese Journal of Sanitary Zoology, V19, P223; MCCRAE AWR, 1983, ANN TROP MED PARASIT, V77, P615, DOI 10.1080/00034983.1983.11811761; Mitchell C. J., 1995, Parassitologia (Rome), V37, P109; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; NAYAR JK, 1975, J INSECT PHYSIOL, V21, P1965, DOI 10.1016/0022-1910(75)90229-2; Nur AH, 2008, TROP BIOMED, V25, P117; Pang TK, 2003, CURR OPIN BIOTECH, V14, P332, DOI 10.1016/S0958-1669(03)00061-2; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Preechaporn W., 2006, Dengue Bulletin, V30, P204; REISEN W K, 1989, Bulletin of the Society for Vector Ecology, V14, P67; Reisen WK, 2003, WAG UR FRON, V2, P25; REITER P, 1986, J AM MOSQUITO CONTR, V2, P219; Ritchie SA, 2003, J MED ENTOMOL, V40, P249, DOI 10.1603/0022-2585-40.3.249; RODRIGUEZFIGUEROA L, 1995, AM J TROP MED HYG, V52, P496, DOI 10.4269/ajtmh.1995.52.496; ROITBERG BD, 1993, NATURE, V364, P108, DOI 10.1038/364108a0; ROSEN L, 1987, AM J TROP MED HYG, V37, P398; ROSEN L, 1985, AM J TROP MED HYG, V34, P603, DOI 10.4269/ajtmh.1985.34.603; Rozilawati H, 2007, TROP BIOMED, V24, P83; RUDNICK A, 1965, BRIT MED J, V1, P1269, DOI 10.1136/bmj.1.5445.1269; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2; SOTA T, 1992, J MED ENTOMOL, V29, P296, DOI 10.1093/jmedent/29.2.296; *STAT SPSS INC, 2004, SYST 11 SOFTW; Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283, DOI 10.4269/ajtmh.1998.58.283; Sumba Leunita A, 2004, J Circadian Rhythms, V2, P6, DOI 10.1186/1740-3391-2-6; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x; Thavara U, 2001, J VECTOR ECOL, V26, P172; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; WATERMAN SH, 1985, AM J TROP MED HYG, V34, P625, DOI 10.4269/ajtmh.1985.34.625; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P362; *WHO, 1999, WHO REG PUBL SEARO, V29; Woke PA, 1937, AM J HYG, V25, P372, DOI 10.1093/oxfordjournals.aje.a118313; 1992, WKLY EPIDEMIOL REC, V67, P99	68	66	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11790	10.1371/journal.pone.0011790	http://dx.doi.org/10.1371/journal.pone.0011790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668543	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000280371800004
J	Sepulveda, FJ; Parodi, J; Peoples, RW; Opazo, C; Aguayo, LG				Sepulveda, Fernando J.; Parodi, Jorge; Peoples, Robert W.; Opazo, Carlos; Aguayo, Luis G.			Synaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating Property	PLOS ONE			English	Article							ION CHANNELS; PROTEIN-KINASE; ALPHA-LATROTOXIN; COMMON MECHANISM; DISEASE; GLYCINE; PEPTIDE; OLIGOMERS; NEURONS; GABA	The mechanisms that induce Alzheimer's disease (AD) are largely unknown thereby deterring the development of disease-modifying therapies. One working hypothesis of AD is that A beta excess disrupts membranes causing pore formation leading to alterations in ionic homeostasis. However, it is largely unknown if this also occurs in native brain neuronal membranes. Here we show that similar to other pore forming toxins, A beta induces perforation of neuronal membranes causing an increase in membrane conductance, intracellular calcium and ethidium bromide influx. These data reveal that the target of A beta is not another membrane protein, but that A beta itself is the cellular target thereby explaining the failure of current therapies to interfere with the course of AD. We propose that this novel effect of A beta could be useful for the discovery of anti AD drugs capable of blocking these "A beta perforates". In addition, we demonstrate that peptides that block A beta neurotoxicity also slow or prevent the membrane-perforating action of A beta.	[Sepulveda, Fernando J.; Parodi, Jorge; Aguayo, Luis G.] Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile; [Opazo, Carlos] Univ Concepcion, Dept Physiol, Lab Neurobiomet, Concepcion, Chile; [Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53233 USA; [Aguayo, Luis G.] Univ Concepcion, Ctr Invest Avanzada Educ, Concepcion, Chile	Universidad de Concepcion; Universidad de Concepcion; Marquette University; Universidad de Concepcion	Sepulveda, FJ (corresponding author), Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile.	laguayo@udec.cl		Parodi, Jorge/0000-0002-9117-5433; Opazo, Carlos/0000-0003-3473-7548	FONDECYT [1060368, 1100502]; Ring of Research PBCT [ACT-04, CIE-05]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ring of Research PBCT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT)	This work was supported by FONDECYT grant 1060368, FONDECYT grant 1100502, Ring of Research PBCT ACT-04, CIE-05 (L.G.A. and C.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2006, PEPTIDES, V27, P95, DOI 10.1016/j.peptides.2005.07.004; Andersen OS, 2005, IEEE T NANOBIOSCI, V4, P10, DOI 10.1109/TNB.2004.842470; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; ARISPE N, 1994, ANN NY ACAD SCI, V747, P256; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Ashton AC, 2001, J BIOL CHEM, V276, P44695, DOI 10.1074/jbc.M108088200; Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Daniels WMU, 2001, METAB BRAIN DIS, V16, P175, DOI 10.1023/A:1012541011123; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Diaz JC, 2006, BIOL RES, V39, P447, DOI 10.4067/S0716-97602006000300007; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B, 2001, ION CHANNELS EXCITAB, Vxviii, P814; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P255, DOI 10.1023/A:1010995121153; Le Foll F, 1998, J PHYSIOL-LONDON, V507, P55, DOI 10.1111/j.1469-7793.1998.055bu.x; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Matsuoka Y, 2007, J MOL NEUROSCI, V31, P165, DOI 10.1385/JMN/31:02:165; MORALES A, 1994, P NATL ACAD SCI USA, V91, P3097, DOI 10.1073/pnas.91.8.3097; Orlova EV, 2000, NAT STRUCT BIOL, V7, P48, DOI 10.1038/71247; Pancetti F, 2004, NEUROTOXICOLOGY, V25, P817, DOI 10.1016/j.neuro.2004.01.008; Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; RHEE JS, 1994, J NEUROPHYSIOL, V72, P1103, DOI 10.1152/jn.1994.72.3.1103; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sepulveda FJ, 2009, MOL CELL NEUROSCI, V41, P420, DOI 10.1016/j.mcn.2009.04.012; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soto C, 2005, SUB CELL BIOCHEM, V38, P351; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; Tajima Y, 1996, AM J PHYSIOL-CELL PH, V271, pC524, DOI 10.1152/ajpcell.1996.271.2.C524; Tapia JC, 2001, NEUROSCIENCE, V108, P493, DOI 10.1016/S0306-4522(01)00348-7; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Yavlovich A, 2010, BIOPHYS J, V98, p602A, DOI 10.1016/j.bpj.2009.12.3279; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095	42	113	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11820	10.1371/journal.pone.0011820	http://dx.doi.org/10.1371/journal.pone.0011820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676404	Green Published, gold			2022-12-25	WOS:000280371800019
J	Fonseca, MGP; Forsythe, S; Menezes, A; Vuthoori, S; Possas, C; Veloso, V; Lucena, FD; Stover, J				Fonseca, Maria Goretti P.; Forsythe, Steven; Menezes, Alexandre; Vuthoori, Shilpa; Possas, Cristina; Veloso, Valdilea; Lucena, Francisca de Fatima; Stover, John			Modeling HIV Vaccines in Brazil: Assessing the Impact of a Future HIV Vaccine on Reducing New Infections, Mortality and Number of People Receiving ARV	PLOS ONE			English	Article							RISK BEHAVIOR-CHANGE; TRANSMISSION; COUNTRIES; EPIDEMIC; EXAMPLE	Background: The AIDS epidemic in Brazil remains concentrated in populations with high vulnerability to HIV infection, and the development of an HIV vaccine could make an important contribution to prevention. This study modeled the HIV epidemic and estimated the potential impact of an HIV vaccine on the number of new infections, deaths due to AIDS and the number of people receiving ARV treatment, under various scenarios. Methods and Findings: The historical HIV prevalence was modeled using Spectrum and projections were made from 2010 to 2050 to study the impact of an HIV vaccine with 40% to 70% efficacy, and 80% coverage of adult population, specific groups such as MSM, IDU, commercial sex workers and their partners, and 15 year olds. The possibility of disinhibition after vaccination, neglecting medium-and high-risk groups, and a disease-modifying vaccine were also considered. The number of new infections and deaths were reduced by 73% and 30%, respectively, by 2050, when 80% of adult population aged 1549 was vaccinated with a 40% efficacy vaccine. Vaccinating medium-and high-risk groups reduced new infections by 52% and deaths by 21%. A vaccine with 70% efficacy produced a great decline in new infections and deaths. Neglecting medium-and high-risk population groups as well as disinhibition of vaccinated population reduced the impact or even increased the number of new infections. Disease-modifying vaccine also contributed to reducing AIDS deaths, the need for ART and new HIV infections. Conclusions: Even in a country with a concentrated epidemic and high levels of ARV coverage, such as Brazil, moderate efficacy vaccines as part of a comprehensive package of treatment and prevention could have a major impact on preventing new HIV infections and AIDS deaths, as well as reducing the number of people on ARV. Targeted vaccination strategies may be highly effective and cost-beneficial.	[Fonseca, Maria Goretti P.; Veloso, Valdilea] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Forsythe, Steven; Stover, John] Futures Inst, Glastonbury, CT USA; [Menezes, Alexandre] Int AIDS Vaccine Initiat, New York, NY USA; [Vuthoori, Shilpa] Rabin Strateg Partners, New York, NY USA; [Possas, Cristina] Minist Saude, Dept DST AIDS & Hepatites Virais, Brasilia, DF, Brazil; [Lucena, Francisca de Fatima] Minist Desenvolvimento Social & Combate Fome, Brasilia, DF, Brazil	Fundacao Oswaldo Cruz; International AIDS Vaccine Initiative	Fonseca, MGP (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	gorettifonseca@fiocruz.br	Veloso, Valdilea Gonçalves/J-6189-2012; Forsythe, Steven/AAL-7558-2020; Possas, Cristina/AAJ-3840-2020	Forsythe, Steven/0000-0002-4409-5991; 	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	The authors acknowledge the International AIDS Vaccine Initiative for financially supporting this study as part of its Impact Modeling Project, which was made possible by the generous support of the American people through the United States for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funding sources had no involvement in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication.	Anderson R, 2005, J INFECT DIS, V191, pS85, DOI 10.1086/425267; Andersson KM, 2007, JAIDS-J ACQ IMM DEF, V46, P78; BARTHJONES DC, 2002, P INT C HLTH SCI SIM; BLOWER SM, 1994, SCIENCE, V265, P1451, DOI 10.1126/science.8073289; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; BLOWER SM, 2003, AID SCI, V3, P21; Bollinger LA, 2008, AIDS, V22, pS51, DOI 10.1097/01.aids.0000327623.31856.45; *BRAS MIN SAUD SEC, 2010, NUM PAC TER ANT REG; Chor Dóra, 2005, Cad. Saúde Pública, V21, P1586, DOI 10.1590/S0102-311X2005000500033; Edwards DM, 1998, INTERFACES, V28, P144, DOI 10.1287/inte.28.3.144; Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS333, DOI 10.1590/S0102-311X2007001500002; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Hacker Mariana A., 2006, Cad. Saúde Pública, V22, P751, DOI 10.1590/S0102-311X2006000400014; *INT AIDS VACC IN, 2006, 8 INT AIDS VACC INT; *INT AIDS VACC IN, 2005, 5 INT AIDS VACC IN; Jorge Maria Helena Prado de Mello, 2002, Rev. bras. epidemiol., V5, P197, DOI 10.1590/S1415-790X2002000200007; MELLO MB, 2008, ASSESSMENT RISK FACT; *MIN SAUD SECR POL, 2000, SER AV PN DST AIDS, V4; *MIN SAUD SECR POL, 2001, SER AV MIN SAUD, V8; *MIN SAUD SECR POL, 2001, SER AV MIN SAUD, V6; *MIN SAUD SECR POL, 2002, SER EST PESQ AV, V2; *MIN SAUD SECR POL, 2004, SER EST PESQ AV, V7; *MIN SAUD SECR VIG, 2005, PCAP PESQ CONH AT PR; *MIN SAUD SECR VIG, 2008, B EP AIDS DST V 01; *MIN SAUD SECR VIG, 2010, REC TER ANT AD INF P; *MIN SAUD SECR VIG, 2008, PLAN NAC ENFR EP AID; *MIN SAUD SECR VIG, 2007, REC PROF TRANSM VERT; Nagelkerke N, 2003, 2978 WORLD BANK; Osmanov S, 2005, AIDS, V19, pW1, DOI 10.1097/01.aids.0000181014.08127.a7; Owens DK, 1998, AIDS, V12, P1057, DOI 10.1097/00002030-199809000-00013; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P1; Smith RJ, 2004, LANCET INFECT DIS, V4, P636, DOI 10.1016/S1473-3099(04)01148-X; *SOC CIV BEMFAM, 1996, PROGR PESQ DEM SAUD; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; STOVER J, 2002, 2811 WORLD BANK; Stover J, 2007, HEALTH AFFAIR, V26, P1147, DOI 10.1377/hlthaff.26.4.1147; Szwarcwald Célia Landmann, 2005, Clinics, V60, P367, DOI 10.1590/S1807-59322005000500004; SZWARCWALD CL, 2006, B EPIDEMIOLOGICO AID; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; WELLER S, 2004, COCHRANE LIB	43	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11736	10.1371/journal.pone.0011736	http://dx.doi.org/10.1371/journal.pone.0011736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668523	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800011
J	King, BJ; Hoefel, D; Wong, PE; Monis, PT				King, Brendon J.; Hoefel, Daniel; Wong, Pao Ee; Monis, Paul T.			Solar Radiation Induces Non-Nuclear Perturbations and a False Start to Regulated Exocytosis in Cryptosporidium parvum	PLOS ONE			English	Article							UV-B PENETRATION; DNA-DAMAGE; OZONE DEPLETION; PYRIMIDINE DIMERS; GLIDING MOTILITY; FLOW-CYTOMETRY; CELL INVASION; MEMBRANE; CALCIUM; REPAIR	Stratospheric ozone depletion, climate warming and acidification of aquatic ecosystems have resulted in elevated levels of solar radiation reaching many aquatic environments with an increased deleterious impact on a wide range of living organisms. While detrimental effects on living organisms are thought to occur primarily through DNA damage, solar UV can also damage cellular proteins, lipids and signalling pathways. Cryptosporidium, a member of the eukaryotic phylum Apicomplexa, contain numerous vesicular secretory organelles and their discharge via regulated exocytosis is essential for the successful establishment of infection. Using flow cytometric techniques we demonstrate that solar UV rapidly induces sporozoite exocytosis resulting in a significant reduction in the ability of sporozoites to attach and invade host cells. We found that solar UV induced sporozoite membrane depolarization, resulting in reduced cellular ATP and increased cytosolic calcium. These changes were accompanied by a reduction in the internal granularity of sporozoites, indicative of apical organelle discharge, which was confirmed by analysis of sporozoites with an exocytosis-sensitive dye. The precise timing of apical organelle discharge in the presence of a compatible host cell is critical for sporozoite attachment and invasion. Our results demonstrate for the first time how solar UV radiation can interfere with exocytosis, a fundamental cellular process in all eukaryotic cells. We contend that not only may the forecast increases in solar radiation in both aquatic and terrestrial environments significantly affect members of the Apicomplexa, solar UV-induced membrane depolarizations resulting in cytosolic calcium perturbation may affect a wider range of eukaryotic organisms through antagonistic effects on a myriad of calcium dependant cellular functions.	[King, Brendon J.; Hoefel, Daniel; Monis, Paul T.] S Australian Water Corp, Australian Water Qual Ctr, Cooperat Res Ctr Water Qual & Treatment, Adelaide, SA, Australia; [Wong, Pao Ee] Flinders Univ S Australia, Sch Med, Dept Med Biotechnol, Adelaide, SA 5001, Australia	Flinders University South Australia	King, BJ (corresponding author), S Australian Water Corp, Australian Water Qual Ctr, Cooperat Res Ctr Water Qual & Treatment, Adelaide, SA, Australia.	brendon.king@sawater.com.au	Monis, Paul T/B-8539-2011	Monis, Paul T/0000-0002-9052-4742; King, Brendon/0000-0002-6114-0950	South Australian Water Corporation; Cooperative Research Centre for Water Quality and Treatment; Water Research Foundation (WRF)	South Australian Water Corporation; Cooperative Research Centre for Water Quality and Treatment(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Water Research Foundation (WRF)	The authors thank the South Australian Water Corporation, the Cooperative Research Centre for Water Quality and Treatment and the Water Research Foundation (WRF) for financial, technical, and administrative assistance in funding the project through which this information was discovered. SA Water Corporation is a wholly owned government water utility that has an interest in water quality issues and pathogen inactivation research as part of verifying water quality in South Australia. SA Water Corporation agreed to support this project by providing in-kind time for Brendon King, Paul Monis and Daniel Hoefel. However SA water had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mention of trade names or commercial products does not constitute WRF endorsement or recommendations for use. Similarly, omission of products or trade names indicates nothing concerning WRF's position regarding product effectiveness or applicability. The comments and views detailed herein may not necessarily reflect the views of the WRF, its officers, directors, affiliates or agents. The CRC AND WRF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGO KR, 1994, MAR ECOL PROG SER, V114, P1, DOI 10.3354/meps114001; Ben Amor K, 2002, APPL ENVIRON MICROB, V68, P5209, DOI 10.1128/AEM.68.11.5209-5216.2002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BOONEN GJJC, 1994, CYTOMETRY, V15, P230, DOI 10.1002/cyto.990150308; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Chen XM, 2004, INFECT IMMUN, V72, P6806, DOI 10.1128/IAI.72.12.6806-6816.2004; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cohen R, 2005, BIOPHYS J, V89, P4364, DOI 10.1529/biophysj.105.064642; Connelly SJ, 2007, ENVIRON SCI TECHNOL, V41, P7101, DOI 10.1021/es071324r; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; FLETCHER MP, 1985, J LEUKOCYTE BIOL, V37, P431, DOI 10.1002/jlb.37.4.431; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gomez-Couso H, 2009, ACTA TROP, V112, P43, DOI 10.1016/j.actatropica.2009.06.004; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; HIDE I, 1993, J CELL BIOL, V123, P585, DOI 10.1083/jcb.123.3.585; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Keegan AR, 2003, APPL ENVIRON MICROB, V69, P2505, DOI 10.1128/AEM.69.5.2505-2511.2003; King BJ, 2008, J APPL MICROBIOL, V104, P1311, DOI 10.1111/j.1365-2672.2007.03658.x; King BJ, 2007, PARASITOLOGY, V134, P309, DOI 10.1017/S0031182006001491; King BJ, 2009, PARASITOLOGY, V136, P953, DOI 10.1017/S0031182009006519; King BJ, 2005, APPL ENVIRON MICROB, V71, P3848, DOI 10.1128/AEM.71.7.3848-3857.2005; Koga T, 2002, BRAIN RES, V952, P282, DOI 10.1016/S0006-8993(02)03253-5; Li G, 1996, AM J PATHOL, V148, P1113; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; MEUNIER O, 1995, CYTOMETRY, V21, P241, DOI 10.1002/cyto.990210304; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Morita S, 2002, APPL ENVIRON MICROB, V68, P5387, DOI 10.1128/AEM.68.11.5387-5393.2002; ODONOGHUE PJ, 1995, INT J PARASITOL, V25, P139, DOI 10.1016/0020-7519(94)E0059-V; Oguma K, 2001, APPL ENVIRON MICROB, V67, P4630, DOI 10.1128/AEM.67.10.4630-4637.2001; Peccia J, 2002, APPL ENVIRON MICROB, V68, P2542, DOI 10.1128/AEM.68.5.2542-2549.2002; Pienitz R, 2000, NATURE, V404, P484, DOI 10.1038/35006616; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; ROCHELLE PA, 2004, INVESTIGATION UV DIS; Rousseaux MC, 1999, P NATL ACAD SCI USA, V96, P15310, DOI 10.1073/pnas.96.26.15310; Schindler DW, 1996, NATURE, V379, P705, DOI 10.1038/379705a0; SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666; Sikorsky JA, 2004, BIOCHEM BIOPH RES CO, V323, P823, DOI 10.1016/j.bbrc.2004.08.168; SINHA RP, 1995, ACTA PROTOZOOL, V34, P187; Sinha RP, 1996, PHOTOCHEM PHOTOBIOL, V64, P887, DOI 10.1111/j.1751-1097.1996.tb01852.x; Tetley L, 1998, MICROBIOL-SGM, V144, P3249, DOI 10.1099/00221287-144-12-3249; Wetzel DM, 2005, INFECT IMMUN, V73, P5379, DOI 10.1128/IAI.73.9.5379-5387.2005; Yan ND, 1996, NATURE, V381, P141, DOI 10.1038/381141a0; Zenoff VF, 2006, APPL ENVIRON MICROB, V72, P7857, DOI 10.1128/AEM.01333-06; Zimmer JL, 2003, WATER RES, V37, P3517, DOI 10.1016/S0043-1354(03)00238-0	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11773	10.1371/journal.pone.0011773	http://dx.doi.org/10.1371/journal.pone.0011773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668710	gold, Green Submitted, Green Published			2022-12-25	WOS:000280243800035
J	Stieler, K; Fischer, N				Stieler, Kristin; Fischer, Nicole			Apobec 3G Efficiently Reduces Infectivity of the Human Exogenous Gammaretrovirus XMRV	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; CYTIDINE DEAMINASES; LTR-RETROTRANSPOSON; POTENT INHIBITORS; IN-VIVO; RETROVIRUS; REPLICATION; PROTEINS	Background: The human exogenous gammaretrovirus XMRV is thought to be implicated in prostate cancer and chronic fatigue syndrome. Besides pressing epidemiologic questions, the elucidation of the tissue and cell tropism of the virus, as well as its sensitivity to retroviral restriction factors is of fundamental importance. The Apobec3 (A3) proteins, a family of cytidine deaminases, are one important group of host proteins that control primary infection and efficient viral spread. Methodology/Principal Findings: Here we demonstrate that XMRV is resistant to human Apobec 3B, 3C and 3F, while being highly susceptible to the human A3G protein, a factor which is known to confer antiviral activity against most retroviruses. We show that XMRV as well as MoMLV virions package Apobec proteins independent of their specific restriction activity. hA3G was found to be a potent inhibitor of XMRV as well as of MoMLV infectivity. In contrast to MoMLV, XMRV infection can also be partially reduced by low concentrations of mA3. Interestingly, established prostate cancer cell lines, which are highly susceptible to XMRV infection, do not or only weakly express hA3G. Conclusions: Our findings confirm and extend recently published data that show restriction of XMRV infection by hA3G. The results will be of value to explore which cells are infected with XMRV and efficiently support viral spread in vivo. Furthermore, the observation that XMRV infection can be reduced by mA3 is of interest with regard to the current natural reservoir of XMRV infection.	[Stieler, Kristin; Fischer, Nicole] Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Stieler, K (corresponding author), Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.	nfischer@uke.de			Wilhelm Sander Stiftung [2005/166.1]	Wilhelm Sander Stiftung	This work was supported by the Wilhelm Sander Stiftung, grant 2005/166.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudu A, 2006, CURR BIOL, V16, P1565, DOI 10.1016/j.cub.2006.06.055; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Browne EP, 2008, J VIROL, V82, P1305, DOI 10.1128/JVI.01371-07; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chiu YL, 2006, J BIOL CHEM, V281, P8309, DOI 10.1074/jbc.R500021200; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Doehle BP, 2006, J VIROL, V80, P12102, DOI 10.1128/JVI.01600-06; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Groom HC, 2010, P NATL ACAD SCI US; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Jern P, 2008, CELL HOST MICROBE, V4, P196, DOI 10.1016/j.chom.2008.08.008; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; LAKER C, 1987, P NATL ACAD SCI USA, V84, P8458, DOI 10.1073/pnas.84.23.8458; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Low A, 2009, VIROLOGY, V385, P455, DOI 10.1016/j.virol.2008.11.051; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Refsland E. W., 2010, NUCL ACIDS RES; RODRIGUEZ JJ, 2009, J VIROL; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Stieler KSC, 2010, VIROLOGY; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Takeda E, 2008, J VIROL, V82, P10998, DOI 10.1128/JVI.01311-08; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhang L, 2008, VIROLOGY, V378, P69, DOI 10.1016/j.virol.2008.05.006; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	49	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11738	10.1371/journal.pone.0011738	http://dx.doi.org/10.1371/journal.pone.0011738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668529	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800012
J	Bridge, D; Theofiles, AG; Holler, RL; Marcinkevicius, E; Steele, RE; Martinez, DE				Bridge, Diane; Theofiles, Alexander G.; Holler, Rebecca L.; Marcinkevicius, Emily; Steele, Robert E.; Martinez, Daniel E.			FoxO and Stress Responses in the Cnidarian Hydra vulgaris	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TRANSCRIPTION FACTOR FOXO3A; PROTEIN-KINASE B; GENE-EXPRESSION; CELL-CYCLE; CAENORHABDITIS-ELEGANS; STEM-CELLS; LIFE-SPAN; NURSE CELLS; GROWTH	Background: In the face of changing environmental conditions, the mechanisms underlying stress responses in diverse organisms are of increasing interest. In vertebrates, Drosophila, and Caenorhabditis elegans, FoxO transcription factors mediate cellular responses to stress, including oxidative stress and dietary restriction. Although FoxO genes have been identified in early-arising animal lineages including sponges and cnidarians, little is known about their roles in these organisms. Methods/Principal Findings: We have examined the regulation of FoxO activity in members of the well-studied cnidarian genus Hydra. We find that Hydra FoxO is expressed at high levels in cells of the interstitial lineage, a cell lineage that includes multipotent stem cells that give rise to neurons, stinging cells, secretory cells and gametes. Using transgenic Hydra that express a FoxO-GFP fusion protein in cells of the interstitial lineage, we have determined that heat shock causes localization of the fusion protein to the nucleus. Our results also provide evidence that, as in bilaterian animals, Hydra FoxO activity is regulated by both Akt and JNK kinases. Conclusions: These findings imply that basic mechanisms of FoxO regulation arose before the evolution of bilaterians and raise the possibility that FoxO is involved in stress responses of other cnidarian species, including corals.	[Bridge, Diane; Theofiles, Alexander G.; Holler, Rebecca L.] Elizabethtown Coll, Dept Biol, Elizabethtown, PA 17022 USA; [Marcinkevicius, Emily; Martinez, Daniel E.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Steele, Robert E.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Steele, Robert E.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA	Claremont Colleges; Pomona College; University of California System; University of California Irvine; University of California System; University of California Irvine	Bridge, D (corresponding author), Elizabethtown Coll, Dept Biol, Elizabethtown, PA 17022 USA.	bridged@etown.edu		Marcinkevicius, Emily/0000-0003-3454-3719	National Science Foundation [IBN-0316065]; Elizabethtown College	National Science Foundation(National Science Foundation (NSF)); Elizabethtown College	The research described was funded by National Science Foundation grant IBN-0316065 and by an Elizabethtown College faculty grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alexandrova O, 2005, DEV BIOL, V281, P91, DOI 10.1016/j.ydbio.2005.02.015; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bode HR, 1996, J CELL SCI, V109, P1155; BODE HR, 1976, J CELL SCI, V20, P29; Bode HR, 1984, PATTERN FORMATION PR, V1, P213; Bottger A, 2007, SEMIN CANCER BIOL, V17, P134, DOI 10.1016/j.semcancer.2006.11.008; BOSCH TCG, 1987, DEV BIOL, V121, P182, DOI 10.1016/0012-1606(87)90151-5; BOSCH TCG, 1988, P NATL ACAD SCI USA, V85, P7927, DOI 10.1073/pnas.85.21.7927; BOSCH TCG, 1984, DEV BIOL, V104, P161, DOI 10.1016/0012-1606(84)90045-9; Brennecke T, 1998, EUR J BIOCHEM, V255, P703, DOI 10.1046/j.1432-1327.1998.2550703.x; BRIEN PAUL, 1950, ANN SOC ROY ZOOL BELGIQUE, V81, P33; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; CAMPBELL RD, 1973, J CELL SCI, V13, P651; CAMPBELL RD, 1967, J MORPHOL, V121, P19, DOI 10.1002/jmor.1051210103; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; DAVID CN, 1977, DEV BIOL, V58, P372, DOI 10.1016/0012-1606(77)90098-7; DAVID CN, 1974, J CELL SCI, V16, P359; DAVID CN, 1973, ROUX ARCH DEV BIOL, V171, P259, DOI 10.1007/BF00577724; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DUBEL S, 1987, DIFFERENTIATION, V35, P181, DOI 10.1111/j.1432-0436.1987.tb00167.x; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Gaillard P, 2005, J MED CHEM, V48, P4596, DOI 10.1021/jm0310986; GELLNER K, 1992, EUR J BIOCHEM, V210, P683, DOI 10.1111/j.1432-1033.1992.tb17469.x; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HONEGGER TG, 1989, TISSUE CELL, V21, P381, DOI 10.1016/0040-8166(89)90052-9; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Juhasz G, 2007, CELL DEATH DIFFER, V14, P1181, DOI 10.1038/sj.cdd.4402123; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Lasi M, 2010, APOPTOSIS, V15, P269, DOI 10.1007/s10495-009-0442-7; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MARCUM BA, 1978, J CELL SCI, V32, P233; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; Martinez DE, 1997, DEV BIOL, V192, P523, DOI 10.1006/dbio.1997.8715; Miller MA, 2000, DEV BIOL, V224, P286, DOI 10.1006/dbio.2000.9786; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; OTTO JJ, 1977, J CELL SCI, V28, P117; Philipp I, 2005, GENE EXPR PATTERNS, V5, P397, DOI 10.1016/j.modgep.2004.09.007; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; SENECA FO, 2009, PATTERNS GENE EXPRES; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Steele RE, 1996, DEV GENES EVOL, V206, P247, DOI 10.1007/s004270050050; SUGIYAMA T, 1978, J CELL SCI, V32, P215; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Technau U, 2003, DEV BIOL, V260, P191, DOI 10.1016/S0012-1606(03)00241-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weis VM, 2009, SCIENCE, V324, P1153, DOI 10.1126/science.1172540; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	86	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11686	10.1371/journal.pone.0011686	http://dx.doi.org/10.1371/journal.pone.0011686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657733	Green Published, gold			2022-12-25	WOS:000280197500025
J	Hurtado, LA; Mateos, M; Santamaria, CA				Hurtado, Luis A.; Mateos, Mariana; Santamaria, Carlos A.			Phylogeography of Supralittoral Rocky Intertidal Ligia Isopods in the Pacific Region from Central California to Central Mexico	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; BAJA-CALIFORNIA; CRYPTIC VICARIANCE; EVOLUTION; PATTERNS; DIVERGENCE; HISTORY; DIVERSIFICATION; DIFFERENTIATION; BIOGEOGRAPHY	Background: Ligia isopods are widely distributed in the Pacific rocky intertidal shores from central California to central Mexico, including the Gulf of California. Yet, their biological characteristics restrict them to complete their life cycles in a very narrow range of the rocky intertidal supralittoral. Herein, we examine phylogeographic patterns of Ligia isopods from 122 localities between central California and central Mexico. We expect to find high levels of allopatric diversity. In addition, we expect the phylogeographic patterns to show signatures of past vicariant events that occurred in this geologically dynamic region. Methodology/Principal Findings: We sequenced two mitochondrial genes (Cytochrome Oxidase I and 16S ribosomal DNA). We conducted Maximum Likelihood and Bayesian phylogenetic analyses. We found many divergent clades that, in general, group according to geography. Some of the most striking features of the Ligia phylogeographic pattern include: (1) deep mid-peninsular phylogeographic breaks on the Pacific and Gulf sides of Baja peninsula; (2) within the Gulf lineages, the northern peninsula is most closely related to the northern mainland, while the southern peninsula is most closely related to the central-southern mainland; and, (3) the southernmost portion of the peninsula (Cape Region) is most closely related to the southernmost portion of mainland. Conclusions/Significance: Our results shed light on the phylogenetic relationships of Ligia populations in the study area. This study probably represents the finest-scale phylogeographic examination for any organism to date in this region. Presence of highly divergent lineages suggests multiple Ligia species exist in this region. The phylogeographic patterns of Ligia in the Gulf of California and Baja peninsula are incongruent with a widely accepted vicariant scenario among phylogeographers, but consistent with aspects of alternative geological hypotheses and phylo- and biogeographic patterns of several other taxa. Our findings contribute to the ongoing debate regarding the geological origin of this important biogeographic region.	[Hurtado, Luis A.; Mateos, Mariana; Santamaria, Carlos A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hurtado, LA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lhurtado@tamu.edu	Santamaria, Carlos A/T-9447-2017; Hurtado, Luis A/B-5953-2008; Mateos, Mariana/B-5235-2008	Santamaria, Carlos A/0000-0001-8576-463X; Hurtado, Luis A/0000-0002-9773-4996; Mateos, Mariana/0000-0001-5738-0145	National Science Foundation (NSF) [DEB 0743782]; Texas A&M University-Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT); Texas AM University; Sloan Minority PhD Program; Hispanic Leaders in Agriculture and the Environment Program; Division Of Environmental Biology [0743782] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Texas A&M University-Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Texas AM University; Sloan Minority PhD Program; Hispanic Leaders in Agriculture and the Environment Program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) grant DEB 0743782 to LAH and MM, by a Texas A&M University-Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT) grant to LAH, and by Texas A&M University. Partial support for CAS was provided by the Sloan Minority PhD Program and by the Hispanic Leaders in Agriculture and the Environment Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, EVOLUTIONARY BIOL LA; Bernardi G, 2003, EVOLUTION, V57, P1599; Boyer SL, 2007, J BIOGEOGR, V34, P2070, DOI 10.1111/j.1365-2699.2007.01755.x; Brusca R.C., 1980, COMMON INTERTIDAL IN, V2nd; BRUSCA RC, 2005, BIODIVERSITY ECOSYST; Calsbeek R, 2003, MOL ECOL, V12, P1021, DOI 10.1046/j.1365-294X.2003.01794.x; Carefoot Thomas H., 1995, Crustacean Issues, V9, P47; Carreno Ana Luisa, 2002, P14; Crews SC, 2006, MOL PHYLOGENET EVOL, V38, P470, DOI 10.1016/j.ympev.2005.11.010; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Devitt TJ, 2006, MOL ECOL, V15, P4387, DOI 10.1111/j.1365-294X.2006.03015.x; DURHAM JW, 1960, SYST ZOOL, V9, P47, DOI 10.2307/2411859; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Grismer L. Lee, 2002, Herpetological Review, V33, P15; Grismer L. Lee, 1994, Herpetological Natural History, V2, P51; Helenes J, 2009, MAR MICROPALEONTOL, V72, P10, DOI 10.1016/j.marmicro.2009.02.003; Helenes J, 1999, J S AM EARTH SCI, V12, P589, DOI 10.1016/S0895-9811(99)00042-5; Holt JW, 2000, GEOL SOC AM BULL, V112, P540, DOI 10.1130/0016-7606(2000)112<540:AACOGO>2.0.CO;2; Huang D, 2001, MAR BIOL, V138, P421, DOI 10.1007/s002270000454; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Johnson M. E., 2009, ATLAS COASTAL ECOSYS; Jung J, 2008, MOL CELLS, V25, P523; KARIG DE, 1972, EARTH PLANET SC LETT, V17, P169, DOI 10.1016/0012-821X(72)90272-5; Keen A. M., 1971, SEA SHELLS TROPICAL, VSecond; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; LARSON RL, 1968, SCIENCE, V161, P781, DOI 10.1126/science.161.3843.781; Leache AD, 2007, MOL ECOL, V16, P5216, DOI 10.1111/j.1365-294X.2007.03556.x; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Ledesma-Vasquez J, 2002, REV MEXICANA CIENCIA, V19, P145; Ledesma-Vazquez J., 2009, ATLAS COASTAL ECOSYS; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Lindell J, 2005, MOL PHYLOGENET EVOL, V36, P682, DOI 10.1016/j.ympev.2005.04.031; Lindell J, 2006, J BIOGEOGR, V33, P1327, DOI 10.1111/j.1365-2699.2006.01532.x; Lonsdale P., 1989, E PACIFIC OCEAN HAWA, VN, P499, DOI [DOI 10.1130/DNAG-GNA-N.499, 10.1130/DNAG-GNA-N.499]; LONSDALE P, 1991, GULF PENINSULAR PROV, V47, P87, DOI DOI 10.1306/M47542C7; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Mateos M, 2005, J BIOGEOGR, V32, P775, DOI 10.1111/j.1365-2699.2005.01236.x; McGill T., 1978, THESIS U CALIFORNIA; MILLER WE, 1980, J PALEONTOL, V54, P762; Morris R.H., 1980, INTERTIDAL INVERTEBR; Murphy Robert W., 2002, P181; MURPHY RW, 1983, OCCAS PAP CALIF ACAD, V137, P1; Oskin M, 2003, GEOLOGY, V31, P23, DOI 10.1130/0091-7613(2003)031<0023:MISWPB>2.0.CO;2; Palumbi Stephen R., 1996, P205; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Riginos C, 2005, EVOLUTION, V59, P2678; Rocha-Olivares A, 2001, MOL BIOL EVOL, V18, P1088, DOI 10.1093/oxfordjournals.molbev.a003880; SCHMALFUSS H, 2003, WORLD CATALOG TERRES; SCHOENHERR AA, 1999, NATURAL HIST ISLANDS; Schotte M., 1995, WORLD LIST MARINE FR; Schultz M, 2005, BRYOLOGIST, V108, P520, DOI 10.1639/0007-2745(2005)108[0520:PAANLS]2.0.CO;2; Sinclair EA, 2004, AM NAT, V164, P396, DOI 10.1086/381404; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Upton DE, 1997, MOL PHYLOGENET EVOL, V8, P104, DOI 10.1006/mpev.1996.0392; Willett CS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-139; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zwickl D., 2006, GARLI GENETIC ALGORI; [No title captured]; [No title captured]; [No title captured]; [No title captured]	67	67	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11633	10.1371/journal.pone.0011633	http://dx.doi.org/10.1371/journal.pone.0011633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657776	Green Published, Green Submitted, gold			2022-12-25	WOS:000280197500011
J	Rodrigues, LA; Henriques, G; Borges, ST; Hunt, P; Sanchez, CP; Martinelli, A; Cravo, P				Rodrigues, Louise A.; Henriques, Gisela; Borges, Sofia T.; Hunt, Paul; Sanchez, Cecilia P.; Martinelli, Axel; Cravo, Pedro			Experimental Evolution of Resistance to Artemisinin Combination Therapy Results in Amplification of the mdr1 Gene in a Rodent Malaria Parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PFMDR1 GENE; MEFLOQUINE RESISTANCE; DRUG-RESISTANCE; HALOFANTRINE RESISTANCE; MULTIDRUG-RESISTANCE; NORTHWESTERN BORDER; P-GLYCOPROTEIN; LUMEFANTRINE; ARTEMETHER	Background: Lacking suitable alternatives, the control of malaria increasingly depends upon Artemisinin Combination Treatments (ACT): resistance to these drugs would therefore be disastrous. For ACTs, the biology of resistance to the individual components has been investigated, but experimentally induced resistance to component drugs in combination has not been generated. Methodology/Principal Findings: We have used the rodent malaria parasite Plasmodium chabaudi to select in vivo resistance to the artesunate (ATN) + mefloquine (MF) version of ACT, through prolonged exposure of parasites to both drugs over many generations. The selection procedure was carried out over twenty-seven consecutive sub-inoculations under increasing ATN + MF doses, after which a genetically stable resistant parasite, AS-ATNMF1, was cloned. AS-ATNMF1 showed increased resistance to ATN + MF treatment and to artesunate or mefloquine administered separately. Investigation of candidate genes revealed an mdr1 duplication in the resistant parasites and increased levels of mdr1 transcripts and protein. There were no point mutations in the atpase6 or ubp1genes. Conclusion: Resistance to ACTs may evolve even when the two drugs within the combination are taken simultaneously and amplification of the mdr1 gene may contribute to this phenotype. However, we propose that other gene(s), as yet unidentified, are likely to be involved.	[Rodrigues, Louise A.; Henriques, Gisela; Borges, Sofia T.; Martinelli, Axel; Cravo, Pedro] Ctr Malaria & Outras Doencas Trop IHMT UNL, UEI Biol Mol, UEI Malaria, Lisbon, Portugal; [Hunt, Paul] Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Sanchez, Cecilia P.] Univ Klinikum Heidelberg, Abt Parasitol, Inst Hyg, Heidelberg, Germany	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Edinburgh; Ruprecht Karls University Heidelberg	Rodrigues, LA (corresponding author), Ctr Malaria & Outras Doencas Trop IHMT UNL, UEI Biol Mol, UEI Malaria, Lisbon, Portugal.	pcravo@ihmt.unl.pt	Cravo, Pedro VL/G-3532-2012; Cravo, Pedro/AET-0639-2022	Cravo, Pedro VL/0000-0003-1675-4504; Cravo, Pedro/0000-0003-1675-4504; Rodrigues, Louise/0000-0002-8354-2686	FCT/MCTES of Portugal through FEDER [PTDC/SAL/MII/65028/2006]; MRC [G0400476] Funding Source: UKRI; Medical Research Council [G0400476] Funding Source: researchfish	FCT/MCTES of Portugal through FEDER(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by FCT/MCTES of Portugal (www.fct.mctes.pt), through FEDER, project ref. PTDC/SAL/MII/65028/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Carlton JMR, 2001, TRENDS PARASITOL, V17, P236, DOI 10.1016/S1471-4922(01)01899-2; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; CHAVCHICH M, 2010, ANTIMICROB AGENTS CH, V29; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Cravo PVL, 2003, ANTIMICROB AGENTS CH, V47, P709, DOI 10.1128/AAC.47.2.709-718.2003; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Ferreira ID, 2004, MOL BIOCHEM PARASIT, V136, P43, DOI 10.1016/j.molbiopara.2004.02.008; Hayton K, 2002, ANTIMICROB AGENTS CH, V46, P2482, DOI 10.1128/AAC.46.8.2482-2489.2002; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; ROSARIO V, 1981, SCIENCE, V212, P1037, DOI 10.1126/science.7015505; Schlagenhauf P, 2009, EXPERT REV ANTI-INFE, V7, P1039, DOI 10.1586/ERI.09.85; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Uhlemann AC, 2007, J INFECT DIS, V195, P134, DOI 10.1086/509809; Vinayak S, 2010, J INFECT DIS, V201, P1551, DOI 10.1086/651949; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHITE NJ, 1991, ACT LEIDENS, V60, P141; WHO, 2006, WHO GUID TREATM MAL; WILSON CM, 1993, MOL BIOCHEM PARASIT, V57, P151, DOI 10.1016/0166-6851(93)90252-S; Wongsrichanalai Chansuda, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P41; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; Zhang ZG, 2004, MOL PHARMACOL, V66, P395, DOI 10.1124/mol.104.001966	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11593	10.1371/journal.pone.0011593	http://dx.doi.org/10.1371/journal.pone.0011593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657645	Green Published, gold, Green Submitted			2022-12-25	WOS:000279924500004
J	Hewitt, SC; Kissling, GE; Fieselman, KE; Jayes, FL; Gerrish, KE; Korach, KS				Hewitt, Sylvia C.; Kissling, Grace E.; Fieselman, Karen E.; Jayes, Friederike L.; Gerrish, Kevin E.; Korach, Kenneth S.			Biological and biochemical consequences of global deletion of exon 3 from the ER alpha gene	FASEB JOURNAL			English	Article						estrogen receptor; uterus; knockout	ESTROGEN-RECEPTOR-ALPHA; KNOCKOUT MICE; GROWTH-FACTOR; REPRODUCTIVE PHENOTYPES; VASCULAR INJURY; CROSS-TALK; IN-VIVO; MOUSE; BONE; SPECIFICITY	To address issues resulting from alpha estrogen receptor-knockout (alpha ERKO) residual N-terminal truncated estrogen receptor alpha, and to allow tissue-selective deletion of ER alpha, we generated loxP-flanked exon 3 mice. Initial characterization of global sox2 cre-derived exon 3-deleted Ex3 alpha ERKO mice indicated no ER alpha protein in uterine tissue and recapitulation of previously described female phenotypes, confirming successful ablation of ER alpha. Body weights of Ex3 alpha ERKO female mice were 1.4-fold higher than wild-tupe (WT) females and comparable to WT males. Microarray indicated the Ex3 alpha ERKO uterus is free of residual estrogen responses. RT-PCR showed Nr4a1 is increased 41-fold by estrogen in WT and 7.4-fold in alpha ERKO, and not increased in Ex3 alpha ERKO. Nr4a1, Cdkn1a, and c-fos transcripts were evaluated in WT and Ex3 alpha ERKO mice following estrogen, IGF1, or EGF injections. All 3 were increased by all treatments in WT. None were increased by estrogen in Ex3 alpha ERKO. Nr4a1 increased 24.5- and 14.7-fold, Cdkn1a increased 14.2- and 12.3-fold, and c-fos increased 20.9-fold and 16.2-fold after IGF1 and EGF treatments, respectively, in the Ex3 alpha ERKO mice, confirming that growth factor regulation is independent of ER alpha. Our Ex3 alpha ER alpha model will be useful in studies of complete or selective ablation of ER alpha in target tissues.-Hewitt, S. C., Kissling, G. E., Fieselman, K. E., Jayes, F. L., Gerrish, K. E., Korach, K. S. Biological and biochemical consequences of global deletion of exon 3 from the ER alpha gene. FASEB J. 24, 4660-4667 (2010). www.fasebj.org	[Hewitt, Sylvia C.; Fieselman, Karen E.; Jayes, Friederike L.; Korach, Kenneth S.] NIEHS, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA; [Kissling, Grace E.] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hewitt, SC (corresponding author), 111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	curtiss@niehs.nih.gov	Hewitt, Sylvia/W-8752-2019	Hewitt, Sylvia/0000-0001-7713-0805; Jayes, Friederike/0000-0001-8862-9345; Korach, Kenneth/0000-0002-7765-418X	U.S. National Institutes of Health, National Institute of Environmental Health Sciences [Z01ES 70065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES070065, ZICES102425] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank David Monroy for breeding expertise and for collecting animal weights; the National Institute of Environmental Health Sciences (NIEHS) Microarray Core for microarray studies and analysis; the NIEHS Histology Core for tissue sample preparation; Dr. Manas K. Ray and Mr. Greg Scott (NIEHS Knockout Mice Core) for generating the floxed Ex3 ER alpha mice; Comparative Medicine Branch surgeons James Clark, Page Myers, and David Goulding for ovariectomies and implanting osmotic pumps; and Karina Rodriguez for the hormone assays. This research was supported (in part) by the Intramural Research Program of the U.S. National Institutes of Health, National Institute of Environmental Health Sciences project number Z01ES 70065.	Bielmeier SR, 2004, TOXICOL SCI, V77, P101, DOI 10.1093/toxsci/kfh017; Chen M, 2009, MOL CELL BIOCHEM, V321, P145, DOI 10.1007/s11010-008-9928-9; Couse J, 1999, BIOL REPROD, V60, P88; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Curtis SW, 1996, P NATL ACAD SCI USA, V93, P12626, DOI 10.1073/pnas.93.22.12626; Dupont S, 2000, DEVELOPMENT, V127, P4277; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hewitt SC, 2006, ENDOCRINOLOGY, V147, P2203, DOI 10.1210/en.2005-1292; Hewitt SC, 2005, MOL ENDOCRINOL, V19, P657, DOI 10.1210/me.2004-0142; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2002, CANCER RES, V62, P2798; Hewitt SC, 2009, MOL ENDOCRINOL, V23, P2111, DOI 10.1210/me.2009-0356; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; LESHNER AI, 1973, PHYSIOL BEHAV, V11, P671, DOI 10.1016/0031-9384(73)90253-9; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Ohlsson C, 2000, BIOCHEM BIOPH RES CO, V278, P640, DOI 10.1006/bbrc.2000.3827; ORNOY A, 1994, BONE MINER, V24, P43, DOI 10.1016/S0169-6009(08)80130-4; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Tromp AM, 2006, CALCIFIED TISSUE INT, V79, P404, DOI 10.1007/s00223-006-0045-z; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474	25	107	109	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2010	24	12					4660	4667		10.1096/fj.10-163428	http://dx.doi.org/10.1096/fj.10-163428			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20667977	Green Published			2022-12-25	WOS:000284824400007
J	Tran, QT; Mahendran, KR; Hajjar, E; Ceccarelli, M; Davin-Regli, A; Winterhalter, M; Weingart, H; Pages, JM				Tran, Que-Tien; Mahendran, Kozhinjampara R.; Hajjar, Eric; Ceccarelli, Matteo; Davin-Regli, Anne; Winterhalter, Mathias; Weingart, Helge; Pages, Jean-Marie			Implication of Porins in beta-Lactam Resistance of Providencia stuartii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; OUTER-MEMBRANE; IDENTIFICATION; ENTEROBACTERIACEAE; MUTAGENESIS; RESIDUES; PROTEUS; CEPHALOSPORINS; SUSCEPTIBILITY	An integrative approach combining biophysical and microbiological methods was used to characterize the antibiotic translocation through the outer membrane of Providencia stuartii. Two novel members of the General Bacterial Porin family of Enterobacteriaceae, named OmpPst1 and OmpPst2, were identified in P. stuartii. In the presence of ertapenem (ERT), cefepime (FEP), and cefoxitin (FOX) in growth media, several resistant derivatives of P. stuartii ATCC 29914 showed OmpPst1-deficiency. These porin-deficient strains showed significant decrease of susceptibility to beta-lactam antibiotics. OmpPst1 and OmpPst2 were purified to homogeneity and reconstituted into planar lipid bilayers to study their biophysical characteristics and their interactions with beta-lactam molecules. Determination of beta-lactam translocation through OmpPst1 and OmpPst2 indicated that the strength of interaction decreased in the order of ertapenem >> cefepime > cefoxitin. Moreover, the translocation of these antibiotics through OmpPst1 was more efficient than through OmpPst2. Heterologous expression of OmpPst1 in the porin-deficient E. coli strain BL21(DE3) omp8 was associated with a higher antibiotic susceptibility of the E. coli cells to beta-lactams compared with expression of OmpPst2. All our data enlighten the involvement of porins in the resistance of P. stuartii to beta-lactam antibiotics.	[Tran, Que-Tien; Winterhalter, Mathias; Weingart, Helge] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Tran, Que-Tien; Davin-Regli, Anne; Pages, Jean-Marie] Univ Mediterranee, Fac Med & Pharm, UMR MD1, F-13385 Marseille, France; [Hajjar, Eric; Ceccarelli, Matteo] Univ Cagliari, Dept Phys, CNR INFM SLACS, I-09042 Cagliari, Italy	Jacobs University; UDICE-French Research Universities; Aix-Marseille Universite; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Cagliari	Tran, QT (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Campus Ring 1, D-28759 Bremen, Germany.	q.tran@jacobs-university.de	Ceccarelli, Matteo/C-8557-2018; PAGES, jean-marie/F-2555-2013	Ceccarelli, Matteo/0000-0003-4272-902X; PAGES, jean-marie/0000-0001-7092-7977; Winterhalter, Mathias/0000-0002-1604-3318	EU [MRTN-CT-2005-019335]; COST Action [BM0701]; Universite de la Mediterannee; Universite Franco-Allemande (Deutsch- Franzosische Hochschule) Cotutelle [CT-11-06]	EU(European Commission); COST Action(European Cooperation in Science and Technology (COST)); Universite de la Mediterannee; Universite Franco-Allemande (Deutsch- Franzosische Hochschule) Cotutelle	This work was supported by EU Grant MRTN-CT-2005-019335 (Translocation), the COST Action BM0701 (Atens), the Universite de la Mediterannee and the Service de Sante des Armees, Universite Franco-Allemande (Deutsch- Franzosische Hochschule) Cotutelle CT-11-06.	Arbing MA, 2001, BIOCHEMISTRY-US, V40, P14621, DOI 10.1021/bi015611y; Arpin C, 2003, ANTIMICROB AGENTS CH, V47, P3506, DOI 10.1128/AAC.47.11.3506-3514.2003; Aubert D, 2005, ANTIMICROB AGENTS CH, V49, P3590, DOI 10.1128/AAC.49.8.3590-3592.2005; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Berezhkovskii AM, 2005, BIOPHYS J, V88, pL17, DOI 10.1529/biophysj.104.057588; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bornet C, 2004, ANTIMICROB AGENTS CH, V48, P2153, DOI 10.1128/AAC.48.6.2153-2158.2004; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bredin J, 2003, BIOCHEM J, V376, P245, DOI 10.1042/BJ20030814; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; De Champs C, 2001, ANTIMICROB AGENTS CH, V45, P1278, DOI 10.1128/AAC.45.4.1278-1280.2001; Domenech-Sanchez A, 1999, J BACTERIOL, V181, P2726; Franceschini N, 1998, ANTIMICROB AGENTS CH, V42, P1459, DOI 10.1128/AAC.42.6.1459; Franklin K, 2001, ANTIMICROB AGENTS CH, V45, P2238, DOI 10.1128/AAC.45.8.2238-2244.2001; Galani I, 2008, J ANTIMICROB CHEMOTH, V61, P548, DOI 10.1093/jac/dkm535; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Hajjar E, 2010, BIOPHYS J, V98, P569, DOI 10.1016/j.bpj.2009.10.045; James CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005453; Lavigne JP, 2004, J CLIN MICROBIOL, V42, P3805, DOI 10.1128/JCM.42.8.3805-3808.2004; Lincopan N, 2006, J MED MICROBIOL, V55, P1611, DOI 10.1099/jmm.0.46771-0; Luzzaro F, 2006, J CLIN MICROBIOL, V44, P1659, DOI 10.1128/JCM.44.5.1659-1664.2006; Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P1669, DOI 10.1128/AAC.43.7.1669; Miriagou V, 2007, J ANTIMICROB CHEMOTH, V60, P183, DOI 10.1093/jac/dkm139; MITSUYAMA J, 1987, ANTIMICROB AGENTS CH, V31, P379, DOI 10.1128/AAC.31.3.379; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359; Murbach V, 2001, CLIN MICROBIOL INFEC, V7, P661, DOI 10.1046/j.1469-0691.2001.00336.x; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; PAGES JM, 2004, BACTERIAL EUKARYOTIC; PENNER JL, 2005, BERGEYS MANUAL SYSTE; Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k; Plante I, 2003, J ANTIMICROB CHEMOTH, V51, P787, DOI 10.1093/jac/dkg169; Prilipov A, 1998, J BACTERIOL, V180, P3388, DOI 10.1128/JB.180.13.3388-3392.1998; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Sambrook J, 2001, MOL CLONING LAB MANU; Shiroto K, 2005, J MED MICROBIOL, V54, P1065, DOI 10.1099/jmm.0.46194-0; Simonet V, 1996, FEMS MICROBIOL LETT, V136, P91; Stock I, 1998, J MED MICROBIOL, V47, P629, DOI 10.1099/00222615-47-7-629; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Tumbarello M, 2004, J ANTIMICROB CHEMOTH, V53, P277, DOI 10.1093/jac/dkh047; Vidal S, 2005, J MED CHEM, V48, P1395, DOI 10.1021/jm049652e; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661	49	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32273	32281		10.1074/jbc.M110.143305	http://dx.doi.org/10.1074/jbc.M110.143305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20667831	Green Published, hybrid			2022-12-25	WOS:000282683000040
J	Iglesias-Ara, A; Zenarruzabeitia, O; Fernandez-Rueda, J; Sanchez-Tillo, E; Field, SJ; Celada, A; Zubiaga, AM				Iglesias-Ara, A.; Zenarruzabeitia, O.; Fernandez-Rueda, J.; Sanchez-Tillo, E.; Field, S. J.; Celada, A.; Zubiaga, A. M.			Accelerated DNA replication in E2F1-and E2F2-deficient macrophages leads to induction of the DNA damage response and p21(CIP1)-dependent senescence	ONCOGENE			English	Article						E2F; macrophage; DNA damage response; senescence; DNA hyper-replication	ONCOGENE-INDUCED SENESCENCE; T-CELL PROLIFERATION; CYCLIN-E; PROGENITOR CELLS; E2F2; EXPRESSION; TRANSCRIPTION; SUPPRESSION; MATURATION; P53	E2F1-3 proteins appear to have distinct roles in progenitor cells and in differentiating cells undergoing cell cycle exit. However, the function of these proteins in paradigms of terminal differentiation that involve continued cell division has not been examined. Using compound E2F1/E2F2-deficient mice, we have examined the effects of E2F1 and E2F2 loss on the differentiation and simultaneous proliferation of bone-marrow-derived cells toward the macrophage lineage. We show that E2F1/E2F2 deficiency results in accelerated DNA replication and cellular division during the initial cell division cycles of bone-marrow-derived cells, arguing that E2F1/E2F2 are required to restrain proliferation of pro-monocyte progenitors during their differentiation into macrophages, without promoting their cell cycle exit. Accelerated proliferation is accompanied by early expression of DNA replication and cell cycle regulators. Remarkably, rapid proliferation of E2F1/E2F2 compound mutant cultures is temporally followed by induction of a DNA damage response and the implementation of a p21(CIP1)-dependent senescence. We further show that differentiating E2F1/E2F2-knockout macrophages do not trigger a DNA damage response pathway in the absence of DNA replication. These findings underscore the relevance of E2F1 and E2F2 as suppressors of hematopoietic progenitor expansion. Our data indicate that their absence in differentiating macrophages initiates a senescence program that results from enforcement of a DNA damage response triggered by DNA hyper-replication. Oncogene (2010) 29, 5579-5590; doi:10.1038/onc.2010.296; published online 2 August 2010	[Iglesias-Ara, A.; Zenarruzabeitia, O.; Fernandez-Rueda, J.; Zubiaga, A. M.] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Bilbao 64448080, Spain; [Sanchez-Tillo, E.; Celada, A.] Inst Res Biomed IRB Barcelona, Macrophage Biol Grp, Barcelona, Spain; [Sanchez-Tillo, E.; Celada, A.] Univ Barcelona, Barcelona, Spain; [Field, S. J.] Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University of Basque Country; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of California System; University of California San Diego	Zubiaga, AM (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Bilbao 64448080, Spain.	ana.zubiaga@ehu.es	Iglesias, Ainhoa/AAB-8731-2022; Zenarruzabeitia, Olatz/AAD-6772-2019; Celada, Antonio/I-1714-2016; zubiaga, ana/S-3457-2019; Iglesias, Ainhoa/H-3021-2015	Iglesias, Ainhoa/0000-0002-2056-8213; Zenarruzabeitia, Olatz/0000-0002-0869-9034; zubiaga, ana/0000-0002-2132-9708; Iglesias, Ainhoa/0000-0002-2056-8213; Field, Seth/0000-0002-8893-4806; Celada, Antonio/0000-0003-3883-2171	Spanish Ministry of Science and Innovation [SAF2009-12037, CSD2007-00017]; Basque Government Department of Industry [Etortek-IE06-178]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government Department of Industry(Basque Government)	We thank members of the Zubiaga laboratory for helpful discussions, Naiara Zorrilla for technical support and Dimitri Balomenos for p21<SUP>CIP1</SUP> <SUP>/</SUP> mice. AI is a recipient of the University of the Basque Country postdoctoral fellowship. OZ and JF are recipients of Basque Government fellowships for graduate students. This work was supported by grants to AMZ from the Spanish Ministry of Science and Innovation (SAF2009-12037 and Consolider-Ingenio 2010 Programme, CSD2007-00017) and the Basque Government Department of Industry (Etortek-IE06-178).	Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; BRACKMAN D, 1995, J LEUKOCYTE BIOL, V58, P547, DOI 10.1002/jlb.58.5.547; Braun SE, 1998, BLOOD CELL MOL DIS, V24, P138, DOI 10.1006/bcmd.1998.0181; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Iglesias A, 2004, J CLIN INVEST, V113, P1398, DOI 10.1172/JCI200418879; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Kinross KM, 2006, BLOOD, V108, P886, DOI 10.1182/blood-2005-09-008656; Li FX, 2003, MOL CELL BIOL, V23, P3607, DOI 10.1128/MCB.23.10.3607-3622.2003; Liu Q, 1999, MOL CELL BIOL, V19, P6229; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lukas J, 1996, MOL CELL BIOL, V16, P6917; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Pusapati RV, 2010, MOL CARCINOGEN, V49, P152, DOI 10.1002/mc.20584; Scheijen B, 2004, J BIOL CHEM, V279, P10476, DOI 10.1074/jbc.M313682200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Wang ZM, 1998, P NATL ACAD SCI USA, V95, P15583, DOI 10.1073/pnas.95.26.15583; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xaus J, 1999, IMMUNITY, V11, P103, DOI 10.1016/S1074-7613(00)80085-0; Young AP, 2003, ONCOGENE, V22, P7209, DOI 10.1038/sj.onc.1206804; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001	41	20	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	41					5579	5590		10.1038/onc.2010.296	http://dx.doi.org/10.1038/onc.2010.296			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FX	20676136				2022-12-25	WOS:000282946900005
J	Jin, XJ; Jin, HR; Jung, HS; Lee, SJ; Lee, JH; Lee, JJ				Jin, Xuejun; Jin, Hong Ri; Jung, Haeng Sun; Lee, Se Jeong; Lee, Jeong-Hyung; Lee, Jung Joon			An Atypical E3 Ligase Zinc Finger Protein 91 Stabilizes and Activates NF-kappa B-inducing Kinase via Lys(63)-linked Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DEPENDENT APOPTOSIS; TNF-ALPHA; CONJUGATING ENZYME; CANCER DEVELOPMENT; RECEPTOR; TRAF2; NIK; PATHWAYS; CELLS; CIAP1	The NF-kappa B transcription factors control many physiological processes, including inflammation, immunity, and apoptosis. Its activity contributes to the development of various cell malignancies. NF-kappa B-inducing kinase (NIK) plays a pivotal role in NF-kappa B activation. However, the molecular mechanism to stabilize and activate NIK remains elusive, although it is known that cIAP1/2 (cellular inhibitor of apoptosis 1 and 2) ubiquitinate NIK for degradation. Here, we report a novel NF-kappa B-related zinc finger protein 91 (ZFP91) that stabilizes and activates NIK in a ubiquitination-dependent manner. We show that ZFP91 interacts with and promotes the Lys(63)-linked ubiquitination of NIK and subsequent processing of p100 to p52. The results of in vitro biochemical assays indicate that ZFP91 functions as an E3 ligase directly to NIK. Remarkably, the ubiquitination of NIK coincides with its Thr(559) phosphorylation. Furthermore, knockdown of ZFP91 expression by RNA interference inhibits the CD40ligation-induced activation of NIK and p100 processing as well as the expression of noncanonical NF-kappa B target genes. These data clearly indicate that ZFP91 is an important regulator of the noncanonical NF-kappa B pathway.	[Jin, Xuejun; Jin, Hong Ri; Jung, Haeng Sun; Lee, Se Jeong; Lee, Jung Joon] Korea Res Inst Biosci & Biotechnol, Ctr Mol Canc Res, Ochang 363883, Chungbuk, South Korea; [Jin, Hong Ri; Lee, Jung Joon] Korea Univ Sci & Technol, Taejon 305333, South Korea; [Jin, Xuejun] Yanbian Univ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Peoples R China; [Lee, Jeong-Hyung] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Kangwon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yanbian University; Kangwon National University	Lee, JJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Ctr Mol Canc Res, Ochang 363883, Chungbuk, South Korea.	jjlee@kribb.re.kr			Ministry of Education and Science and Technology, Republic of Korea	Ministry of Education and Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the 21C Frontier Genome Project from the Ministry of Education and Science and Technology, Republic of Korea.	Ait-Ghezala G, 2005, MOL BRAIN RES, V140, P73, DOI 10.1016/j.molbrainres.2005.07.014; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Gomes EM, 2009, CLIN CANCER RES, V15, P1317, DOI 10.1158/1078-0432.CCR-08-1360; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hirano A, 1999, BLOOD, V93, P2999; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Lapchak PH, 2004, AM J PHYSIOL-RENAL, V287, pF512, DOI 10.1152/ajprenal.00070.2004; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Unoki M, 2003, INT J ONCOL, V22, P1217; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	43	68	73	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30539	30547		10.1074/jbc.M110.129551	http://dx.doi.org/10.1074/jbc.M110.129551			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20682767	Green Published, hybrid			2022-12-25	WOS:000282135500022
J	Pines, G; Huang, PH; Zwang, Y; White, FM; Yarden, Y				Pines, G.; Huang, P. H.; Zwang, Y.; White, F. M.; Yarden, Y.			EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism	ONCOGENE			English	Article						EGFR mutations; glioblastoma; growth factor; signal transduction; tyrosine kinase	EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; C-TERMINAL TAIL; HUMAN GLIOBLASTOMAS; EGF RECEPTOR; V-ERBB; DOMAIN; ACTIVATION; CELLS; MUTATIONS	Tumor cells often subvert normal regulatory mechanisms of signal transduction. This study shows this principle by studying yet uncharacterized mutants of the epidermal growth factor receptor (EGFR) previously identified in glioblastoma multiforme, which is the most aggressive brain tumor in adults. Unlike the well-characterized EGFRvIII mutant form, which lacks a portion of the ligand-binding cleft within the extracellular domain, EGFRvIVa and EGFRvIVb lack internal segments distal to the intracellular tyrosine kinase domain. By constructing the mutants and by ectopic expression in naive cells, we show that both mutants confer an oncogenic potential in vitro, as well as tumorigenic growth in animals. The underlying mechanisms entail constitutive receptor dimerization and basal activation of the kinase domain, likely through a mechanism that relieves a restraining molecular fold, along with stabilization due to association with HSP90. Phospho-proteomic analyses delineated the signaling pathways preferentially engaged by EGFRvIVb-identified unique substrates. This information, along with remarkable sensitivities to tyrosine kinase blockers and to a chaperone inhibitor, proposes strategies for pharmacological interception in brain tumors harboring EGFRvIV mutations. Oncogene (2010) 29, 5850-5860; doi: 10.1038/onc.2010.313; published online 2 August 2010	[Pines, G.; Zwang, Y.; Yarden, Y.] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Huang, P. H.; White, F. M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Weizmann Institute of Science; Massachusetts Institute of Technology (MIT)	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, Candiotty Bldg,Room 302,1 Hertzl St, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	Pines, Gur/X-7501-2019; YARDEN, YOSEF/K-1467-2012; Huang, Paul H./H-8591-2015	Pines, Gur/0000-0002-1757-6722; Huang, Paul H./0000-0003-3972-5087; White, Forest/0000-0002-1545-1651	Goldhirsh Foundation; US National Cancer Institute (NCI) [CA072981, CA118705, CA141556, U54-CA112967]; Israel Science Foundation; Dr Miriam and Sheldon G Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [U54CA112967, R01CA118705, R37CA072981, U01CA141556, R01CA072981] Funding Source: NIH RePORTER	Goldhirsh Foundation; US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Science Foundation(Israel Science Foundation); Dr Miriam and Sheldon G Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	YY is the incumbent of the Harold and Zelda Goldenberg Professorial Chair. Our work is supported by research grants from the Goldhirsh Foundation, the US National Cancer Institute (NCI; CA072981 to YY, CA118705, CA141556 and U54-CA112967 to FMW), the Israel Science Foundation and Dr Miriam and Sheldon G Adelson Medical Research Foundation.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Chiara F, 2004, J BIOL CHEM, V279, P19732, DOI 10.1074/jbc.M314070200; Chiosis G, 2003, MOL CANCER THER, V2, P123; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Frederick L, 2000, CANCER RES, V60, P1383; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jeuken J, 2009, BRAIN PATHOL, V19, P661, DOI 10.1111/j.1750-3639.2009.00320.x; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Lavictoire SJ, 2003, J BIOL CHEM, V278, P5292, DOI 10.1074/jbc.M209494200; Li JJ, 2009, ONCOGENE, V28, P1759, DOI 10.1038/onc.2009.15; McManus MJ, 1997, P NATL ACAD SCI USA, V94, P11351, DOI 10.1073/pnas.94.21.11351; Nagane M, 1996, CANCER RES, V56, P5079; PULCIANI S, 1982, J CELL BIOCHEM, V20, P51, DOI 10.1002/jcb.240200106; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; SHU HKG, 1991, J VIROL, V65, P6173, DOI 10.1128/JVI.65.11.6173-6180.1991; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	39	46	48	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	43					5850	5860		10.1038/onc.2010.313	http://dx.doi.org/10.1038/onc.2010.313			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20676128	Green Accepted, Green Published			2022-12-25	WOS:000283586200010
J	Rajanbabu, V; Pan, CY; Lee, SC; Lin, WJ; Lin, CC; Li, CL; Chen, JY				Rajanbabu, Venugopal; Pan, Chieh-Yu; Lee, Shang-Chun; Lin, Wei-Ju; Lin, Ching-Chun; Li, Chung-Leung; Chen, Jyh-Yih			Tilapia Hepcidin 2-3 Peptide Modulates Lipopolysaccharide-induced Cytokines and Inhibits Tumor Necrosis Factor-alpha through Cyclooxygenase-2 and Phosphodiesterase 4D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; RAW 264.7 MACROPHAGES; PROTEIN-KINASE; INFLAMMATORY CYTOKINES; ANTIMICROBIAL PEPTIDE; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; IMMUNE-RESPONSE; INNATE IMMUNITY	The antimicrobial peptide, tilapia hepcidin (TH) 2-3, belongs to the hepcidin family, and its antibacterial function has been reported. Here, we examined the TH2-3-mediated regulation of proinflammatory cytokines in bacterial endotoxin lipopolysaccharide (LPS)-stimulated mouse macrophages. The presence of TH2-3 in LPS-stimulated cells reduced the amount of tumor necrosis factor (TNF)-alpha secretion. From a microarray, real-time polymerase chain reaction (PCR), and cytokine array studies, we showed down-regulation of the proinflammatory cytokines TNF-alpha, interleukin (IL)-1 alpha, IL-1 beta, IL-6, and the prostaglandin synthesis gene, cyclooxygenase (COX)-2, by TH2-3. Studies with the COX-2-specific inhibitor, melaxicam, and with COX-2-overexpressing cells demonstrated the positive regulation of TNF-alpha and negative regulation of cAMP degradation-specific phosphodiesterase (PDE) 4D by COX-2. In LPS-stimulated cells, TH2-3 acts like melaxicam and down-regulates COX-2 and up-regulates PDE4D. The reduction in intracellular cAMP by TH2-3 or melaxicam in LPS-stimulated cells supports the negative regulation of PDE4D by COX-2 and TH2-3. This demonstrates that the inhibition of COX-2 is among the mechanisms through which TH2-3 controls TNF-alpha release. At 1 h after treatment, the presence of TH2-3 in LPS-stimulated cells had suppressed the induction of pERK1/2 and prevented the LPS-stimulated nuclear accumulation of NF-kappa B family proteins of p65, NF-kappa B2, and c-Rel. In conclusion, TH2-3 inhibits TNF-alpha and other proinflammatory cytokines through COX-2-, PDE4D-, and pERK1/2-dependent mechanisms.	[Rajanbabu, Venugopal; Pan, Chieh-Yu; Lee, Shang-Chun; Lin, Wei-Ju; Lin, Ching-Chun; Chen, Jyh-Yih] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi 262, Ilan, Taiwan; [Li, Chung-Leung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Rajanbabu, Venugopal; Chen, Jyh-Yih] Natl Chung Hsing Univ, Taiwan Int Grad Program, Taipei 115, Taiwan; [Rajanbabu, Venugopal; Chen, Jyh-Yih] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 402, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University	Chen, JY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, 23-10 Dahuen Rd, Jiaushi 262, Ilan, Taiwan.	zoocjy@gate.sinica.edu.tw	Chen, Jyh-Yih/F-3412-2014; Rajanbabu, Venugopal/AAE-5576-2020	Chen, Jyh-Yih/0000-0001-7858-8236; Rajanbabu, Venugopal/0000-0001-8761-3333	Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Taiwan	Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Taiwan(Academia Sinica - Taiwan)	This work was supported by the Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Ilan 262, Taiwan.	Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cerioni L, 2003, FEBS LETT, V547, P92, DOI 10.1016/S0014-5793(03)00675-6; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Chen CC, 1999, J BIOL CHEM, V274, P31559, DOI 10.1074/jbc.274.44.31559; Chen CC, 1999, MOL PHARMACOL, V55, P481; Cognasse F, 2003, IMMUNOL LETT, V90, P49, DOI 10.1016/S0165-2478(03)00173-1; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; Falzacappa MVV, 2005, GENE, V364, P37, DOI 10.1016/j.gene.2005.07.020; FOURNIER T, 1995, J IMMUNOL, V155, P2123; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Godowski PJ, 2005, NAT IMMUNOL, V6, P544, DOI 10.1038/ni0605-544; HOUSLAY MD, 2003, BIOCHEM J, V15, P1; Hsieh JC, 2010, FISH SHELLFISH IMMUN, V29, P430, DOI 10.1016/j.fsi.2010.05.001; Huang PH, 2007, MOL IMMUNOL, V44, P1922, DOI 10.1016/j.molimm.2006.09.031; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jeon YJ, 2000, IMMUNOPHARMACOLOGY, V48, P173, DOI 10.1016/S0162-3109(00)00199-5; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; KOIDE M, 1993, J BIOL CHEM, V268, P24959; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lolis E, 2003, NAT REV DRUG DISCOV, V2, P635, DOI 10.1038/nrd1153; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wang GQ, 2008, J IMMUNOL, V180, P8306, DOI 10.4049/jimmunol.180.12.8306; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhang X, 2008, INFLAMM RES, V57, P524, DOI 10.1007/s00011-008-8007-8; Zhong J, 2009, P NATL ACAD SCI USA, V106, P4372, DOI 10.1073/pnas.0812642106	44	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30577	30586		10.1074/jbc.M110.137935	http://dx.doi.org/10.1074/jbc.M110.137935			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20675368	Green Published, hybrid			2022-12-25	WOS:000282135500026
J	Schwarze, F; Meraner, J; Lechner, M; Loidl, A; Stasyk, T; Laich, A; Loidl, P				Schwarze, F.; Meraner, J.; Lechner, M.; Loidl, A.; Stasyk, T.; Laich, A.; Loidl, P.			Cell cycle-dependent acetylation of Rb2/p130 in NIH3T3 cells	ONCOGENE			English	Article						Rb2/p130; cell cycle; acetylation; p300; posttranslational modification	RETINOBLASTOMA TUMOR-SUPPRESSOR; FAMILY PROTEINS; POCKET PROTEINS; P130; PHOSPHORYLATION; RB	The retinoblastoma protein (pRb) and the pRb-related proteins, p130 and p107, form the 'pocket protein' family of cell cycle regulatory factors. A well characterized function of these proteins is the cell cycle-dependent regulation of E2F-responsive genes. The biological activity of pocket proteins is regulated by phosphorylation and for the founding member pRb it has been shown that acetylation also has an important role in modulating its function during the cell cycle. Here, we show that hyperphosphorylated retinoblastoma 2 (Rb2)/p130 also exists in an acetylated form in NIH3T3 cells. Acetylated p130 is present in the nucleus but not in the cytoplasm. Acetylation is cell cycle dependent, starting in S-phase and persisting until late G(2)-period. Using recombinant p130 and truncated forms for in vitro acetylation by the acetyltransferase p300, we could identify K1079 in the C-terminal part as the major acetylation site by mass spectrometry. Minor acetylation sites were pinpointed to K1068 and K1111 in the C-terminus, and K128 and K130 in the N-terminus. The human papilloma virus 16 protein-E7 preferentially binds to acetylated p130 and significantly increases in vitro p130 acetylation by p300. Oncogene (2010) 29, 5755-5760; doi:10.1038/onc.2010.311; published online 2 August 2010	[Schwarze, F.; Meraner, J.; Lechner, M.; Loidl, A.; Loidl, P.] Innsbruck Med Univ, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria; [Stasyk, T.] Innsbruck Med Univ, Div Cell Biol, Bioctr, A-6020 Innsbruck, Austria; [Laich, A.] Tyrolean Canc Res Inst, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Loidl, P (corresponding author), Innsbruck Med Univ, Div Mol Biol, Bioctr, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	Peter.Loidl@i-med.ac.at	Loidl, Alois/L-8199-2015	Loidl, Alois/0000-0002-5579-0746; Schwarze, Florian/0000-0002-1334-1301; Stasyk, Taras/0000-0003-0568-6841	Tyrolean Science Foundation	Tyrolean Science Foundation	We thank A Giordano for providing a p130 plasmid, J Kadonaga for a p300 vector, F Marx-Ladurner for PAF, G Bonn for mass spectrometry facilities and L Huber, A Lusser and M Saeed for valuable discussions. This work was supported by a grant of the Tyrolean Science Foundation to JM.	Brosch G, 2008, FEMS MICROBIOL REV, V32, P409, DOI 10.1111/j.1574-6976.2007.00100.x; Canhoto AJ, 2000, ONCOGENE, V19, P5116, DOI 10.1038/sj.onc.1203893; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chestukhin A, 2002, MOL CELL BIOL, V22, P453, DOI 10.1128/MCB.22.2.453-468.2002; Choi CH, 2003, NATURE, V424, P965, DOI 10.1038/nature01899; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Claudio P, 2002, GENOME BIOL, V3; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hansen K, 1999, ELECTROPHORESIS, V20, P372, DOI 10.1002/(SICI)1522-2683(19990201)20:2<372::AID-ELPS372>3.0.CO;2-R; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Mayol X, 1996, ONCOGENE, V13, P237; Meraner J, 2006, NUCLEIC ACIDS RES, V34, P1798, DOI 10.1093/nar/gkl101; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Popov B, 2005, BIOCHEM BIOPH RES CO, V336, P762, DOI 10.1016/j.bbrc.2005.08.163; Roman A, 2006, CELL CYCLE, V5, P567, DOI 10.4161/cc.5.6.2571; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	29	6	7	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5755	5760		10.1038/onc.2010.311	http://dx.doi.org/10.1038/onc.2010.311			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20676144	Green Published, hybrid			2022-12-25	WOS:000283262500011
J	Luo, YD; Yang, CF; Lu, WQ; Xie, R; Jin, CL; Huang, P; Wang, F; McKeehan, WL				Luo, Yongde; Yang, Chaofeng; Lu, Weiqin; Xie, Rui; Jin, Chengliu; Huang, Peng; Wang, Fen; McKeehan, Wallace L.			Metabolic Regulator beta Klotho Interacts with Fibroblast Growth Factor Receptor 4 (FGFR4) to Induce Apoptosis and Inhibit Tumor Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID SYNTHESIS; HEPARAN-SULFATE; MAMMALIAN TARGET; ENDOCRINE REGULATION; CRYSTAL-STRUCTURE; RAPAMYCIN MTOR; BREAST-CANCER; FACTOR FAMILY; PPAR-ALPHA; COMPLEX	In organs involved in metabolic homeostasis, transmembrane alpha and beta klothos direct FGFR signaling to control of metabolic pathways. Coordinate expression of beta klotho and FGFR4 is a property of mature hepatocytes. Genetic deletion of FGFR4 or beta klotho in mice disrupts hepatic cholesterol/bile acid and lipid metabolism. The deletion of FGFR4 has no effect on the proliferative response of hepatocytes after liver injury. However, its absence results in accelerated progression of dimethynitrosamine- initiated hepatocellular carcinomas, indicating that FGFR4 suppresses hepatoma proliferation. The mechanism underlying the FGFR4-mediated hepatoma suppression has not been addressed. Here we show that beta klotho expression is more consistently down-regulated in human and mouse hepatomas than FGFR4. Co-expression and activation by either endocrine FGF19 or cellular FGF1 of the FGFR4 kinase in a complex with beta klotho restricts cell population growth through induction of apoptotic cell death in both hepatic and nonhepatic cells. The beta klotho-FGFR4 partnership caused a depression of activated AKT and mammalian target of rapamycin while activating ERK1/2 that may underlie the pro-apoptotic effect. Our results show that beta klotho not only interacts with heparan sulfate-FGFR4 to form a complex with high affinity for endocrine FGF19 but also impacts the quality of downstream signaling and biological end points activated by either FGF19 or canonical FGF1. Thus the same beta klotho-heparan sulfate-FGFR4 partnership that mediates endocrine control of hepatic metabolism plays a role in cellular homeostasis and hepatoma suppression through negative control of cell population growth mediated by pro-apoptotic signaling.	[Luo, Yongde; Yang, Chaofeng; Jin, Chengliu; Wang, Fen; McKeehan, Wallace L.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Luo, Yongde; Xie, Rui; McKeehan, Wallace L.] Texas A&M Hlth Sci Ctr, IBT Prote & Nanotechnol Lab, Houston, TX 77030 USA; [Lu, Weiqin; Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center	McKeehan, WL (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	wmckeehan@ibt.tamhsc.edu	XIE, RUI/N-7325-2014		United States Public Health Service [DK56338, P50 CA140388]; Susan Komen Breast Cancer Foundation; John S. Dunn Research Foundation; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); John S. Dunn Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants DK56338 (to Y. L.) and P50 CA140388 (to W. L. M. and F. W.), the Susan Komen Breast Cancer Foundation, and the John S. Dunn Research Foundation.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barthel TK, 2007, J STEROID BIOCHEM, V103, P381, DOI 10.1016/j.jsbmb.2006.12.054; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chen PY, 2009, BIOCHEM BIOPH RES CO, V382, P424, DOI 10.1016/j.bbrc.2009.03.040; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Feng SJ, 1997, CANCER RES, V57, P5369; Ferlini C, 2007, NAT PROTOC, V2, P3111, DOI 10.1038/nprot.2007.397; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Huang CJ, 2009, J APPL METEOROL CLIM, V48, P553, DOI 10.1175/2008JAMC1818.1; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Huang XQ, 2006, CANCER RES, V66, P1481, DOI 10.1158/0008-5472.CAN-05-2412; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kan M, 1996, J BIOL CHEM, V271, P26143, DOI 10.1074/jbc.271.42.26143; KAN M, 1991, METHOD ENZYMOL, V198, P158; Kan MK, 2001, IN VITRO CELL DEV-AN, V37, P575; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2008, CURR OPIN NEPHROL HY, V17, P368, DOI 10.1097/MNH.0b013e3282ffd994; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kwiatkowski BA, 2008, J CELL PHYSIOL, V215, P803, DOI 10.1002/jcp.21365; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Lee S, 2009, INT J ONCOL, V34, P161, DOI 10.3892/ijo_00000138; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lopez-Serra L, 2008, ONCOGENE, V27, P3556, DOI 10.1038/sj.onc.1211022; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Luo YD, 1996, J BIOL CHEM, V271, P26876, DOI 10.1074/jbc.271.43.26876; Luo YD, 2006, J CELL BIOCHEM, V97, P1241, DOI 10.1002/jcb.20724; Luo YD, 2006, J BIOL CHEM, V281, P21052, DOI 10.1074/jbc.M601559200; Luo YD, 2009, CELL SIGNAL, V21, P1370, DOI 10.1016/j.cellsig.2009.04.004; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McKeehan WL, 1999, J BIOL CHEM, V274, P21511, DOI 10.1074/jbc.274.31.21511; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Medici D, 2008, J CELL BIOL, V182, P459, DOI 10.1083/jcb.200803024; Moore DD, 2007, SCIENCE, V316, P1436, DOI 10.1126/science.1144837; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olson DC, 1998, CELL GROWTH DIFFER, V9, P557; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Seitzer N, 2010, CANCER RES, V70, P802, DOI 10.1158/0008-5472.CAN-09-3239; SHAOUL E, 1995, ONCOGENE, V10, P1553; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Uematsu F, 2001, BIOCHEM BIOPH RES CO, V283, P791, DOI 10.1006/bbrc.2001.4850; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; WANG F, 1995, J BIOL CHEM, V270, P10222, DOI 10.1074/jbc.270.17.10222; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Wu XL, 2010, J BIOL CHEM, V285, P5165, DOI 10.1074/jbc.M109.068783; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	71	41	44	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30069	30078		10.1074/jbc.M110.148288	http://dx.doi.org/10.1074/jbc.M110.148288			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20657013	Green Published, hybrid			2022-12-25	WOS:000281984300045
J	Morimoto, R; Shindou, H; Oda, Y; Shimizu, T				Morimoto, Ryo; Shindou, Hideo; Oda, Yoshiya; Shimizu, Takao			Phosphorylation of Lysophosphatidylcholine Acyltransferase 2 at Ser(34) Enhances Platelet-activating Factor Production in Endotoxin-stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAPKAP KINASE 2; P38 KINASE; ACETYLTRANSFERASE; IDENTIFICATION; BIOSYNTHESIS; PATHWAY; BINDING; ALPHA; CELLS	Platelet-activating factor (PAF) is a potent proinflammatory phospholipid mediator that elicits various cellular functions under physiological and pathological conditions. We have recently identified two enzymes involved in PAF production: lysophosphatidylcholine acyltransferase-1 (LPCAT1) and LPCAT2. We found that LPCAT2 is highly expressed in inflammatory cells and is activated by lipopolysaccharide (LPS) treatment through Toll-like receptor 4. However, the molecular mechanism for the activation remains elusive. In this study, Phos-tag SDS-PAGE revealed the LPS-induced phosphorylation of LPCAT2. Furthermore, mass spectrometry and mutagenesis analyses identified Ser(34) of LPCAT2 as the phosphorylation site to enhance the catalytic activities. The experiments using inhibitors and siRNA against MAPK cascades demonstrated that LPCAT2 phosphorylation through LPS-TLR4 signaling may directly depend on MAPK-activated protein kinase 2 (MAPKAP kinase 2 or MK2). These findings develop a further understanding of both PAF production and phospholipid remodeling triggered by inflammatory stimuli. Specific inhibition of the PAF biosynthetic activity by phosphorylated LPCAT2 will provide a novel target for the regulation of inflammatory disorders.	[Morimoto, Ryo; Shindou, Hideo; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Oda, Yoshiya] Univ Tokyo, Fac Med, Dept Metabolome, Tokyo 1130033, Japan; [Oda, Yoshiya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3328613, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Shindou, H (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Hongo 7-3-1, Tokyo 1130033, Japan.	hshindou-tky@umin.ac.jp	Shimizu, Takao/AAV-7052-2021	Morimoto, Ryo/0000-0002-5497-4666	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; (University of Tokyo) from the Japan Society for Promotion of Sciences; Center for NanoBio Integration at the University of Tokyo; Ministry of Health, Labor, and Welfare; MEXT of Japan; Uehara Memorial Foundation; Cell Science Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); (University of Tokyo) from the Japan Society for Promotion of Sciences; Center for NanoBio Integration at the University of Tokyo; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan)	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. S.) and the Global Centers of Excellence Program (University of Tokyo) from the Japan Society for Promotion of Sciences (to T. S.).; Supported by the Center for NanoBio Integration at the University of Tokyo.; Supported by Health and Labor Sciences Research Grants (Research on Allergic Disease and Immunology) from the Ministry of Health, Labor, and Welfare; by a Grant-in-Aid for Young Scientists (B) from MEXT of Japan; and by grants of the Uehara Memorial Foundation and the Cell Science Research Foundation. To whom correspondence should be addressed. Tel.: 81-3-5802-2925; Fax: 81-3-3813-8732; E-mail: hshindou-tky@umin.ac.jp.	Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cano E, 1996, ONCOGENE, V12, P805; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Hale KK, 1999, J IMMUNOL, V162, P4246; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Katayama H, 2004, RAPID COMMUN MASS SP, V18, P2388, DOI 10.1002/rcm.1637; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Nakamura T, 2010, J PROTEOME RES, V9, P1385, DOI 10.1021/pr900918h; NIETO ML, 1988, J BIOL CHEM, V263, P2217; Nixon AB, 1999, J BIOL CHEM, V274, P5469, DOI 10.1074/jbc.274.9.5469; Owen JS, 2005, BBA-MOL CELL BIOL L, V1733, P120, DOI 10.1016/j.bbalip.2004.12.016; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Smith DA, 2000, PAC HIST REV, V69, P145, DOI 10.2307/3641273; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; WYKLE RL, 1980, J BIOL CHEM, V255, P256	27	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29857	29862		10.1074/jbc.M110.147025	http://dx.doi.org/10.1074/jbc.M110.147025			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663880	Green Published, hybrid			2022-12-25	WOS:000281984300022
J	Musri, MM; Carmona, MC; Hanzu, FA; Kaliman, P; Gomis, R; Parrizas, M				Musri, Melina M.; Carmona, Mari Carmen; Hanzu, Felicia A.; Kaliman, Perla; Gomis, Ramon; Parrizas, Marcelina			Histone Demethylase LSD1 Regulates Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; C/EBP-ALPHA; DEVELOPMENTAL REGULATORS; GENE ACTIVATION; CELL FATE; METHYLATION; DIFFERENTIATION; PTIP; TRANSCRIPTION; ACETYLATION	Epigenetic mechanisms, in particular the enzymatic modification of histones, are a crucial element of cell differentiation, a regulated process that allows a precursor cell basically to turn into a different cell type while maintaining the same genetic equipment. We have previously described that the promoters of adipogenic genes display significant levels of dimethylation at the Lys(4) of histone H3 (H3K4) in preadipocytes, where these genes are still silenced, thus maintaining the chromatin of the precursor cell in a receptive state. Here, we show that the expression of several histone demethylases and methyltransferases increases during adipogenesis, suggesting an important role for these proteins in this process. Knockdown of the H3K4/K9 demethylase LSD1 results in markedly decreased differentiation of 3T3-L1 preadipocytes. This outcome is associated with decreased H3K4 dimethylation and increased H3K9 dimethylation at the promoter of transcription factor cebpa, whose expression must be induced > 200-fold upon stimulation of differentiation. Thus, our data suggest that LSD1 acts to maintain a permissive state of the chromatin in this promoter by opposing the action of a H3K9 methyltransferase. Knockdown of H3K9 methyltransferase SETDB1 produced the opposite results, by decreasing H3K9 dimethylation and increasing H3K4 dimethylation levels at the cebpa promoter and favoring differentiation. These findings indicate that the histone methylation status of adipogenic genes as well as the expression and function of the proteins involved in its maintenance play a crucial role in adipogenesis.	[Parrizas, Marcelina] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Endocrinol & Nutr Unit, Inst Invest Biomed August Pi & Sunyer, Lab Diabet & Obesitat, Barcelona 08036, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Parrizas, M (corresponding author), Ctr Invest Biomed Red Diabet & Enfermedades Metab, Endocrinol & Nutr Unit, Inst Invest Biomed August Pi & Sunyer, Lab Diabet & Obesitat, Casanova 143,Pl 3,Lab 334, Barcelona 08036, Spain.	badcell@gmail.com	Parrizas, Marcelina/AAS-3629-2021; Musri, Melina M/C-9078-2015	Musri, Melina M/0000-0002-9159-5497; Carmona Orozco, Mamen/0000-0001-5911-6938; Parrizas, Marcelina/0000-0003-1296-8302; Hanzu, Felicia Alexandra/0000-0002-2399-4023	Spanish Ministry of Science and Innovation (MICINN) [BFU2009-09988/BMC, SAF2007-63353, SAF2006-07382]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Spanish Ministry of Science and Innovation (MICINN) Grants BFU2009-09988/BMC (to M. P.), SAF2007-63353 (to P. K.), and SAF2006-07382 (to R. G.).	Atkinson SP, 2008, STEM CELLS, V26, P1174, DOI 10.1634/stemcells.2007-0497; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Kim D, 2009, STEM CELLS, V27, P1516, DOI 10.1002/stem.79; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Musri MM, 2010, ORGANOGENESIS, V6, P15, DOI 10.4161/org.6.1.10226; Musri Melina N., 2008, V456, P231, DOI 10.1007/978-1-59745-245-8_17; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Takada I, 2007, ANN NY ACAD SCI, V1116, P182, DOI 10.1196/annals.1402.034; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200	44	121	128	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30034	30041		10.1074/jbc.M110.151209	http://dx.doi.org/10.1074/jbc.M110.151209			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20656681	Green Published, hybrid			2022-12-25	WOS:000281984300041
J	Laguna-Torres, VA; Gomez, J; Aguilar, PV; Ampuero, JS; Munayco, C; Ocana, V; Perez, J; Gamero, ME; Arrasco, JC; Paz, I; Chavez, E; Cruz, R; Chavez, J; Mendocilla, S; Gomez, E; Antigoni, J; Gonzalez, S; Tejada, C; Chowell, G; Kochel, TJ				Alberto Laguna-Torres, Victor; Gomez, Jorge; Aguilar, Patricia V.; Ampuero, Julia S.; Munayco, Cesar; Ocana, Victor; Perez, Juan; Gamero, Maria E.; Carlos Arrasco, Juan; Paz, Irmia; Chavez, Edward; Cruz, Rollin; Chavez, Jaime; Mendocilla, Silvia; Gomez, Elizabeth; Antigoni, Juana; Gonzalez, Sofia; Tejada, Cesar; Chowell, Gerardo; Kochel, Tadeusz J.		Peru Influenza Working Grp	Changes in the Viral Distribution Pattern after the Appearance of the Novel Influenza A H1N1 (pH1N1) Virus in Influenza-Like Illness Patients in Peru	PLOS ONE			English	Article								Background: We describe the temporal variation in viral agents detected in influenza like illness (ILI) patients before and after the appearance of the ongoing pandemic influenza A (H1N1) (pH1N1) in Peru between 4-January and 13-July 2009. Methods: At the health centers, one oropharyngeal swab was obtained for viral isolation. From epidemiological week (EW) 1 to 18, at the US Naval Medical Research Center Detachment (NMRCD) in Lima, the specimens were inoculated into four cell lines for virus isolation. In addition, from EW 19 to 28, the specimens were also analyzed by real time-polymerase-chain-reaction (rRT-PCR). Results: We enrolled 2,872 patients: 1,422 cases before the appearance of the pH1N1 virus, and 1,450 during the pandemic. Non-pH1N1 influenza A virus was the predominant viral strain circulating in Peru through (EW) 18, representing 57.8% of the confirmed cases; however, this predominance shifted to pH1N1 (51.5%) from EW 19-28. During this study period, most of pH1N1 cases were diagnosed in the capital city (Lima) followed by other cities including Cusco and Trujillo. In contrast, novel influenza cases were essentially absent in the tropical rain forest (jungle) cities during our study period. The city of Iquitos (Jungle) had the highest number of influenza B cases and only one pH1N1 case. Conclusions: The viral distribution in Peru changed upon the introduction of the pH1N1 virus compared to previous months. Although influenza A viruses continue to be the predominant viral pathogen, the pH1N1 virus predominated over the other influenza A viruses.	[Alberto Laguna-Torres, Victor; Aguilar, Patricia V.; Ampuero, Julia S.; Perez, Juan; Gamero, Maria E.; Kochel, Tadeusz J.] US Naval Med Res Ctr Detachment, Dept Virol, Lima, Peru; [Gomez, Jorge; Munayco, Cesar; Carlos Arrasco, Juan] Minist Salud, Direcc Gen Epidemiol, Lima, Peru; [Ocana, Victor] Minist Salud, Direcc Reg Salud Piura, Piura, Peru; [Paz, Irmia] Univ Nacl San Agustin, Arequipa, Peru; [Chavez, Edward] Ctr Med Mil 32 Brigada Infanteri Ejercito, Trujillo, Peru; [Cruz, Rollin] Jefatura Salud Ejercito Peru, Lima, Peru; [Chavez, Jaime] Direcc Reg Salud Callao, Lima, Peru; [Mendocilla, Silvia] Minist Salud, Hosp Daniel Alcides Carr Callao, Callao, Peru; [Gomez, Elizabeth] Minist Salud, Direcc Reg Salud Puno, Puno, Peru; [Antigoni, Juana] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru; [Gonzalez, Sofia] Ctr Med Naval, Callao, Peru; [Tejada, Cesar] Minist Salud, Hosp Santa Rosa Lima, Lima, Peru; [Chowell, Gerardo] Arizona State Univ, Math & Computat Modeling Sci Ctr, Sch Human Evolut & Social Change, Tempe, AZ USA; [Chowell, Gerardo] NIH, Div Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA	Universidad Nacional de San Agustin de Arequipa; Seguro Social de Salud del Peru; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Laguna-Torres, VA (corresponding author), US Naval Med Res Ctr Detachment, Dept Virol, Lima, Peru.	alberto.laguna@med.navy.mil	Munayco, Cesar/G-9990-2013; Chowell, Gerardo/F-5038-2012; Segura, Moises Apolaya/N-5239-2017; Gomez, Jorge/E-5258-2012	Munayco, Cesar/0000-0001-7872-8913; Chowell, Gerardo/0000-0003-2194-2251; Segura, Moises Apolaya/0000-0001-5650-9998; Paz, Irmia/0000-0003-3926-9982; Arrasco, Juan/0000-0002-4961-3858; Chavez-Cruzado, Edward/0000-0001-5379-8624; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301; Ampuero, Julia/0000-0001-5486-1656; Gomez, Jorge/0000-0003-1342-3507	Ministry of Health of Peru; United States Dpartment of Defense [10107_09_LI];  [62787A.873.H.B000]	Ministry of Health of Peru; United States Dpartment of Defense; 	The study was funded by the Ministry of Health of Peru and the United States Dpartment of Defense Global Emerging Infections Systems grant number 10107_09_LI. The Naval Medical Research Center participation was under Protocol NMRCD.2002.0019 in compliance with all applicable federal regulations governing the protection of human subjects. This work was supported and funded by work unit number No. 62787A.873.H.B000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; ANDERSON RMM, 1991, INFECT DIS HUMANS, P3; Belshe RB, 2004, VIRUS RES, V103, P177, DOI 10.1016/j.virusres.2004.02.031; *CDC, 2009, INFLUENZA; *CHIL MOH, 2009, INFL GOV 2009 H1N1 P; *CHIL MOH, 2010, INFL PAND H1N1 2009; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; FRANK AL, 1983, J MED VIROL, V12, P17, DOI 10.1002/jmv.1890120103; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gomez J, 2009, EURO SURVEILL, V4; *MIN SAL P, 2005, PLAN NAC PREP RESP F; Munayco C, 2009, EURO SURVEILL, V14; Nishiura H, 2009, EUROSURVEILLANCE, V14; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7	15	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11719	10.1371/journal.pone.0011719	http://dx.doi.org/10.1371/journal.pone.0011719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668548	Green Submitted, gold, Green Published			2022-12-25	WOS:000280371800002
J	Fujiwara, Y; Kawato, M; Noda, C; Kinoshita, G; Yamanaka, T; Fujita, Y; Uematsu, K; Miyazaki, JI				Fujiwara, Yoshihiro; Kawato, Masaru; Noda, Chikayo; Kinoshita, Gin; Yamanaka, Toshiro; Fujita, Yuko; Uematsu, Katsuyuki; Miyazaki, Jun-Ichi			Extracellular and Mixotrophic Symbiosis in the Whale-Fall Mussel Adipicola pacifica: A Trend in Evolution from Extra- to Intracellular Symbiosis	PLOS ONE			English	Article							BACTERIAL ENDOSYMBIONTS; OLIGONUCLEOTIDE PROBES; BIVALVE MOLLUSKS; WOODEN STEPS; SP. NOV.; DEEP; ASSOCIATION; GILLS; ADAPTATIONS; DISPERSAL	Background: Deep-sea mussels harboring chemoautotrophic symbionts from hydrothermal vents and seeps are assumed to have evolved from shallow-water asymbiotic relatives by way of biogenic reducing environments such as sunken wood and whale falls. Such symbiotic associations have been well characterized in mussels collected from vents, seeps and sunken wood but in only a few from whale falls. Methodology/Principal Finding: Here we report symbioses in the gill tissues of two mussels, Adipicola crypta and Adipicola pacifica, collected from whale-falls on the continental shelf in the northwestern Pacific. The molecular, morphological and stable isotopic characteristics of bacterial symbionts were analyzed. A single phylotype of thioautotrophic bacteria was found in A. crypta gill tissue and two distinct phylotypes of bacteria (referred to as Symbiont A and Symbiont C) in A. pacifica. Symbiont A and the A. crypta symbiont were affiliated with thioautotrophic symbionts of bathymodiolin mussels from deep-sea reducing environments, while Symbiont C was closely related to free-living heterotrophic bacteria. The symbionts in A. crypta were intracellular within epithelial cells of the apical region of the gills and were extracellular in A. pacifica. No spatial partitioning was observed between the two phylotypes in A. pacifica in fluorescence in situ hybridization experiments. Stable isotopic analyses of carbon and sulfur indicated the chemoautotrophic nature of A. crypta and mixotrophic nature of A. pacifica. Molecular phylogenetic analyses of the host mussels showed that A. crypta constituted a monophyletic clade with other intracellular symbiotic (endosymbiotic) mussels and that A. pacifica was the sister group of all endosymbiotic mussels. Conclusions/Significance: These results strongly suggest that the symbiosis in A. pacifica is at an earlier stage in evolution than other endosymbiotic mussels. Whale falls and other modern biogenic reducing environments may act as refugia for primal chemoautotrophic symbioses between eukaryotes and prokaryotes since the extinction of ancient large marine vertebrates.	[Fujiwara, Yoshihiro; Kawato, Masaru] Japan Agcy Marine Earth Sci & Technol, Chemoecosyst Evolut Res ChEER Team, Yokosuka, Kanagawa 2370061, Japan; [Kinoshita, Gin] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan; [Yamanaka, Toshiro] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Fujita, Yuko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Uematsu, Katsuyuki] Marine Work Japan Ltd, Dept Tech Serv, Yokosuka, Kanagawa, Japan; [Miyazaki, Jun-Ichi] Univ Yamanashi, Fac Educ & Human Sci, Kofu, Yamanashi, Japan; [Noda, Chikayo] Keikyu Aburatsubo Marine Pk, Miura, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Hiroshima University; Okayama University; University of Tsukuba; University of Yamanashi	Fujiwara, Y (corresponding author), Japan Agcy Marine Earth Sci & Technol, Chemoecosyst Evolut Res ChEER Team, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	fujiwara@jamstec.go.jp	YAMANAKA, Toshiro/B-2644-2011	YAMANAKA, Toshiro/0000-0002-6807-6904	Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Marine Work Japan Ltd; Keikyu Aburatsubo Marine Park (KAMP)	Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Marine Work Japan Ltd; Keikyu Aburatsubo Marine Park (KAMP)	This work was funded by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC) (Grant number: ChEER, URL: www.jamstec.go.jp); Marine Work Japan Ltd (MWJ) (Grant number: N/A, URL: http://www.mwj.co.jp/en/); Keikyu Aburatsubo Marine Park (KAMP) (Grant number: N/A, URL: http://www.aburatsubo.co.jp/). Japan Agency for Marine-Earth Science and Technology had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Marine Work Japan Ltd had a role in data collection. Marine Work Japan Ltd and Keikyu Aburatsubo Marine Park were funders due to employment of one author of this study from each company. One of the co-authors, Chikayo Noda from Keikyu Aburatsubo Marine Park, was a post-graduate student in Fujiwara's laboratory at the time of the study. Therefore, Keikyu Aburatsubo Marine Park has no commitment to this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amano K, 2005, PALAEOGEOGR PALAEOCL, V215, P345, DOI 10.1016/j.palaeo.2004.10.003; Baker P, 2007, J SHELLFISH RES, V26, P345, DOI 10.2983/0730-8000(2007)26[345:RADOAT]2.0.CO;2; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Bowman JP, 1998, INT J SYST BACTERIOL, V48, P1171, DOI 10.1099/00207713-48-4-1171; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; DISTEL DL, 1988, J BACTERIOL, V170, P2506, DOI 10.1128/jb.170.6.2506-2510.1988; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Dufour SC, 2005, BIOL BULL-US, V208, P200, DOI 10.2307/3593152; Duperron S, 2008, FEMS MICROBIOL ECOL, V63, P338, DOI 10.1111/j.1574-6941.2008.00438.x; Duperron S, 2008, ENVIRON MICROBIOL, V10, P433, DOI 10.1111/j.1462-2920.2007.01465.x; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; FELBECK H, 1981, NATURE, V293, P291, DOI 10.1038/293291a0; FIALAMEDIONI A, 1986, MAR BIOL, V92, P65, DOI 10.1007/BF00392747; FIALAMEDIONI A, 1986, J EXP MAR BIOL ECOL, V96, P191, DOI 10.1016/0022-0981(86)90242-X; FIALAMEDIONI A, 1987, SYMBIOSIS, V4, P63; FISHER CR, 1992, SYMBIOSIS, V12, P221; Fujiwara Y, 2001, MAR ECOL PROG SER, V214, P151, DOI 10.3354/meps214151; Fujiwara Y, 2000, MAR ECOL PROG SER, V208, P147, DOI 10.3354/meps208147; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Fujiwara Yoshihiro, 2009, Venus (Tokyo), V68, P27; Gros O, 2007, ZOOMORPHOLOGY, V126, P163, DOI 10.1007/s00435-007-0035-3; Gros O, 2007, CAH BIOL MAR, V48, P103; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOGLER JA, 1994, PALAIOS, V9, P42, DOI 10.2307/3515077; Holloway MG, 2002, MAR ECOL PROG SER, V235, P43, DOI 10.3354/meps235043; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kaim A, 2008, ACTA PALAEONTOL POL, V53, P97, DOI 10.4202/app.2008.0106; Kiel S, 2006, SCIENCE, V313, P1429, DOI 10.1126/science.1126286; Kiel S, 2006, PALAIOS, V21, P548, DOI 10.2110/palo.2005.p05-086r; Kyuno Akiko, 2009, Journal of Marine Biology, V2009, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; Le Pennec M, 1988, J SHELLFISH RES, V7, P483; LEPENNEC M, 1992, CAN J ZOOL, V70, P2298; LEPENNEC M, 1995, COMP BIOCHEM PHYS A, V111, P183, DOI 10.1016/0300-9629(94)00211-B; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; MARSHALL BA, 1994, NAUTILUS, V108, P1; MARTILL DM, 1991, NATURE, V351, P193, DOI 10.1038/351193a0; McKiness ZP, 2005, MAR BIOL, V148, P109, DOI 10.1007/s00227-005-0065-7; Miyazaki JI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010363; Mizota C, 1998, GEOCHEM J, V32, P421, DOI 10.2343/geochemj.32.421; Mizota Chitoshi, 2003, Japanese Journal of Benthology, V58, P56; Nogi Y, 2004, INT J SYST EVOL MICR, V54, P1627, DOI 10.1099/ijs.0.03049-0; Nylander J, 2004, MR MODELTEST V2 PROG; Okutani T., 2003, VENUS, V63, P61; PAGE HM, 1991, DEEP-SEA RES, V38, P1455, DOI 10.1016/0198-0149(91)90084-S; PAGE HM, 1990, MAR BIOL, V104, P251, DOI 10.1007/BF01313266; Rinke C, 2006, APPL ENVIRON MICROB, V72, P2014, DOI 10.1128/AEM.72.3.2014-2021.2006; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; ROSATI G, 2004, SYMBIOSIS MECH MODEL, P475; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Samadi S, 2007, CR BIOL, V330, P446, DOI 10.1016/j.crvi.2007.04.001; Skurikhina L. A., 2001, Genetika, V37, P1717; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; SMITH DC, 1979, PROC R SOC SER B-BIO, V204, P115, DOI 10.1098/rspb.1979.0017; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; YANAGISAWA F, 1983, ANAL CHEM, V55, P985, DOI 10.1021/ac00257a046; Yumoto I, 1998, INT J SYST BACTERIOL, V48, P1357, DOI 10.1099/00207713-48-4-1357	67	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11808	10.1371/journal.pone.0011808	http://dx.doi.org/10.1371/journal.pone.0011808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676405	Green Submitted, Green Published, gold			2022-12-25	WOS:000280371800012
J	Kumper, S; Ridley, AJ				Kuemper, Sandra; Ridley, Anne J.			p120ctn and P-Cadherin but Not E-Cadherin Regulate Cell Motility and Invasion of DU145 Prostate Cancer Cells	PLOS ONE			English	Article							RHO-FAMILY GTPASES; EPITHELIAL-CELLS; ALPHA-CATENIN; BETA-CATENIN; TYROSINE PHOSPHORYLATION; INDEPENDENT MECHANISM; ADHESION PROTEINS; CARCINOMA-CELLS; DOWN-REGULATION; P120-CATENIN	Background: Adherens junctions consist of transmembrane cadherins, which interact intracellularly with p120ctn, beta-catenin and alpha-catenin. p120ctn is known to regulate cell-cell adhesion by increasing cadherin stability, but the effects of other adherens junction components on cell-cell adhesion have not been compared with that of p120ctn. Methodology/Principal Findings: We show that depletion of p120ctn by small interfering RNA (siRNA) in DU145 prostate cancer and MCF10A breast epithelial cells reduces the expression levels of the adherens junction proteins, E-cadherin, P-cadherin, beta-catenin and alpha-catenin, and induces loss of cell-cell adhesion. p120ctn-depleted cells also have increased migration speed and invasion, which correlates with increased Rap1 but not Rac1 or RhoA activity. Downregulation of P-cadherin, beta-catenin and alpha-catenin but not E-cadherin induces a loss of cell-cell adhesion, increased migration and enhanced invasion similar to p120ctn depletion. However, only p120ctn depletion leads to a decrease in the levels of other adherens junction proteins. Conclusions/Significance: Our data indicate that P-cadherin but not E-cadherin is important for maintaining adherens junctions in DU145 and MCF10A cells, and that depletion of any of the cadherin-associated proteins, p120ctn, beta-catenin or alpha-catenin, is sufficient to disrupt adherens junctions in DU145 cells and increase migration and cancer cell invasion.	[Kuemper, Sandra; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London	Kumper, S (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	anne.ridley@kcl.ac.uk		Kumper, Sandra/0000-0002-5478-0503; Ridley, Anne/0000-0001-8186-5708	Cancer Research UK; Bettencourt-Schueller Foundation; European Commission [LSHG-CT-2003-502935]; Kings College London School of Biomedical and Health Sciences	Cancer Research UK(Cancer Research UK); Bettencourt-Schueller Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Kings College London School of Biomedical and Health Sciences	This research was supported by Cancer Research UK, Bettencourt-Schueller Foundation, and a European Commission Framework 6 contract (LSHG-CT-2003-502935; MAIN). SK was supported by a PhD studentship from Kings College London School of Biomedical and Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Asuri S, 2008, J CELL BIOCHEM, V105, P1027, DOI 10.1002/jcb.21902; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Grosheva I, 2001, J CELL SCI, V114, P695; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; Kallakury BVS, 2001, CANCER, V92, P2786, DOI 10.1002/1097-0142(20011201)92:11<2786::AID-CNCR10128>3.0.CO;2-I; Kallakury BVS, 2001, HUM PATHOL, V32, P849, DOI 10.1053/hupa.2001.26463; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Luo J, 1999, CANCER RES, V59, P3552; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Noe V, 1999, J CELL SCI, V112, P127; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Parachoniak CA, 2009, J BIOL CHEM, V284, P8382, DOI 10.1074/jbc.M807607200; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perrin-Tricaud C, 2007, MOL CELL NEUROSCI, V35, P120, DOI 10.1016/j.mcn.2007.02.010; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sanders DSA, 1999, J CLIN PATHOL-MOL PA, V52, P151, DOI 10.1136/mp.52.3.151; Sarrio D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-74; SIMPSON KJ, 2008, NAT CELL BIOL; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	53	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11801	10.1371/journal.pone.0011801	http://dx.doi.org/10.1371/journal.pone.0011801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668551	gold, Green Published, Green Submitted			2022-12-25	WOS:000280371800007
J	Devun, F; Walter, L; Belliere, J; Cottet-Rousselle, C; Leverve, X; Fontaine, E				Devun, Flavien; Walter, Ludivine; Belliere, Julie; Cottet-Rousselle, Cecile; Leverve, Xavier; Fontaine, Eric			Ubiquinone Analogs: A Mitochondrial Permeability Transition Pore-Dependent Pathway to Selective Cell Death	PLOS ONE			English	Article							RESPIRATORY-CHAIN COMPLEX; CYCLOPHILIN-D; CYTOCHROME-C; IN-VITRO; SITE; PROGRESS; RELEASE; CALCIUM; TARGET	Background: Prolonged opening of the mitochondrial permeability transition pore (PTP) leads to cell death. Various ubiquinone analogs have been shown to regulate PTP opening but the outcome of PTP regulation by ubiquinone analogs on cell fate has not been studied yet. Methodology/Principal Findings: The effects of ubiquinone 0 (Ub(0)), ubiquinone 5 (Ub(5)), ubiquinone 10 (Ub(10)) and decylubiquinone (DUb) were studied in freshly isolated rat hepatocytes, cultured rat liver Clone-9 cells and cancerous rat liver MH1C1 cells. PTP regulation by ubiquinones differed significantly in permeabilized Clone-9 and MH1C1 cells from that previously reported in liver mitochondria. Ub0 inhibited PTP opening in isolated hepatocytes and Clone-9 cells, whereas it induced PTP opening in MH1C1 cells. Ub5 did not affect PTP opening in isolated hepatocytes and MH1C1 cells, but it induced PTP opening in Clone-9 cells. Ub10 regulated PTP in isolated hepatocytes, whereas it did not affect PTP opening in Clone-9 and MH1C1 cells. Only DUb displayed the same effect on PTP regulation in the three hepatocyte lines tested. Despite such modifications in PTP regulation, competition between ubiquinones still occurred in Clone-9 and MH1C1 cells. As expected, Ub5 induced a PTP-dependent cell death in Clone-9, while it did not affect MH1C1 cell viability. Ub0 induced a PTP-dependent cell death in MH1C1 cells, but was also slightly cytotoxic in Clone-9 by an oxidative stress-dependent mechanism. Conclusions/Significance: We found that various ubiquinone analogs regulate PTP in different ways depending on the cell studied. We took advantage of this unique property to develop a PTP opening-targeted strategy that leads to cell death specifically in cells where the ubiquinone analog used induces PTP opening, while sparing the cells in which it does not induce PTP opening.	[Devun, Flavien; Walter, Ludivine; Belliere, Julie; Cottet-Rousselle, Cecile; Leverve, Xavier; Fontaine, Eric] INSERM, U884, F-38041 Grenoble, France; [Devun, Flavien; Walter, Ludivine; Belliere, Julie; Cottet-Rousselle, Cecile; Leverve, Xavier; Fontaine, Eric] Univ Grenoble 1, Lab Bioenerget Fondamentale & Appl, F-38041 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Devun, F (corresponding author), INSERM, U884, F-38041 Grenoble, France.	eric.fontaine@ujf-grenoble.fr	Fontaine, Eric/ABA-8853-2020; Walter, Ludivine/S-4456-2017	Fontaine, Eric/0000-0002-5204-9477; Walter, Ludivine/0000-0001-7214-0676; COTTET-ROUSSELLE, Cecile/0000-0003-1208-8911	INSERM; Agence Nationale de la Recherche (QuinoMitEAO); Ministere de l'Enseignement de la Recherche et de la Technologie (MERT); Ligue Nationale contre le Cancer; Region Rhone-Alpes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (QuinoMitEAO)(French National Research Agency (ANR)); Ministere de l'Enseignement de la Recherche et de la Technologie (MERT); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by grants from INSERM, Agence Nationale de la Recherche (QuinoMitEAO) and the Ministere de l'Enseignement de la Recherche et de la Technologie (MERT). FD was supported by fellowship from the Ligue Nationale contre le Cancer. LW was supported by fellowship from the Region Rhone-Alpes (programme Emergence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; Armstrong JS, 2003, J BIOL CHEM, V278, P49079, DOI 10.1074/jbc.M307841200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bouchier-Hayes L, 2005, J CLIN INVEST, V115, P2640, DOI 10.1172/JCI26274; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; De Oliveira F, 2006, ONCOGENE, V25, P2646, DOI 10.1038/sj.onc.1209293; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; Guigas B, 2004, BIOCHEM J, V382, P877, DOI 10.1042/BJ20040885; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Kantrow SP, 1997, BIOCHEM BIOPH RES CO, V232, P669, DOI 10.1006/bbrc.1997.6353; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P10014, DOI 10.1073/pnas.1633614100; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nogueira V, 2005, J BIOENERG BIOMEMBR, V37, P25, DOI 10.1007/s10863-005-4120-3; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Rousselle C, 2001, IN VITRO CELL DEV-AN, V37, P646; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	33	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11792	10.1371/journal.pone.0011792	http://dx.doi.org/10.1371/journal.pone.0011792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668684	Green Published, gold			2022-12-25	WOS:000280297300021
J	Chantret, I; Fasseu, M; Zaoui, K; Le Bizec, C; Yaye, HS; Dupre, T; Moore, SEH				Chantret, Isabelle; Fasseu, Magali; Zaoui, Karim; Le Bizec, Christiane; Yaye, Hassane Sadou; Dupre, Thierry; Moore, Stuart E. H.			Identification of Roles for Peptide: N-Glycanase and Endo-beta-N-Acetylglucosaminidase (Engase1p) during Protein N-Glycosylation in Human HepG2 Cells	PLOS ONE			English	Article							POLYMANNOSE-TYPE OLIGOSACCHARIDES; NEWLY SYNTHESIZED GLYCOPROTEINS; RETICULUM-ASSOCIATED DEGRADATION; ALPHA-D-MANNOSIDASE; ENDOPLASMIC-RETICULUM; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; LINKED OLIGOSACCHARIDES; CAENORHABDITIS-ELEGANS; CYTOSOL	Background: During mammalian protein N-glycosylation, 20% of all dolichol-linked oligosaccharides (LLO) appear as free oligosaccharides (fOS) bearing the di-N-acetylchitobiose (fOSGN2), or a single N-acetylglucosamine (fOSGN), moiety at their reducing termini. After sequential trimming by cytosolic endo beta-N-acetylglucosaminidase (ENGase) and Man2c1 mannosidase, cytosolic fOS are transported into lysosomes. Why mammalian cells generate such large quantities of fOS remains unexplored, but fOSGN2 could be liberated from LLO by oligosaccharyltransferase, or from glycoproteins by NGLY1-encoded Peptide-N-Glycanase (PNGase). Also, in addition to converting fOSGN2 to fOSGN, the ENGASE-encoded cytosolic ENGase of poorly defined function could potentially deglycosylate glycoproteins. Here, the roles of Ngly1p and Engase1p during fOS metabolism were investigated in HepG2 cells. Methods/Principal Findings: During metabolic radiolabeling and chase incubations, RNAi-mediated Engase1p down regulation delays fOSGN2-to-fOSGN conversion, and it is shown that Engase1p and Man2c1p are necessary for efficient clearance of cytosolic fOS into lysosomes. Saccharomyces cerevisiae does not possess ENGase activity and expression of human Engase1p in the png1D deletion mutant, in which fOS are reduced by over 98%, partially restored fOS generation. In metabolically radiolabeled HepG2 cells evidence was obtained for a small but significant Engase1p-mediated generation of fOS in 1 h chase but not 30 min pulse incubations. Ngly1p down regulation revealed an Ngly1p-independent fOSGN2 pool comprising mainly Man(8)GlcNAc(2), corresponding to similar to 70% of total fOS, and an Ngly1p-dependent fOSGN2 pool enriched in Glc(1)Man(9)GlcNAc(2) and Man(9)GlcNAc(2) that corresponds to similar to 30% of total fOS. Conclusions/Significance: As the generation of the bulk of fOS is unaffected by co-down regulation of Ngly1p and Engase1p, alternative quantitatively important mechanisms must underlie the liberation of these fOS from either LLO or glycoproteins during protein N-glycosylation. The fully mannosylated structures that occur in the Ngly1p-dependent fOSGN2 pool indicate an ERAD process that does not require N-glycan trimming.	[Chantret, Isabelle; Fasseu, Magali; Zaoui, Karim; Moore, Stuart E. H.] INSERM, U773, Ctr Rech Bichat Beaujon, Paris, France; [Chantret, Isabelle; Fasseu, Magali; Zaoui, Karim; Moore, Stuart E. H.] Univ Paris 07, Paris, France; [Le Bizec, Christiane; Yaye, Hassane Sadou; Dupre, Thierry] Hop Bichat Claude Bernard, AP HP, F-75877 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Chantret, I (corresponding author), INSERM, U773, Ctr Rech Bichat Beaujon, Paris, France.	isabelle.chantret@inserm.fr	Moore, Stuart/AAF-3920-2021; CHANTRET, Isabelle/AAF-7134-2021	Moore, Stuart/0000-0002-1020-2242; CHANTRET, Isabelle/0000-0002-0896-1274	Mizutani Foundation; GIS-Institut des maladies rares/INSERM; EUROGLYCANET [LSHM-CT-2005-512131]; INSERM	Mizutani Foundation; GIS-Institut des maladies rares/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); EUROGLYCANET; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Financial support was from The Mizutani Foundation; the GIS-Institut des maladies rares/INSERM funded French CDG Research Network; EUROGLYCANET (LSHM-CT-2005-512131), La Fondation pour la Recherche Medicale (FRM); institutional funding from INSERM. S. E. H. M. is the recipient of a Hospital/INSERM Interface Contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Cacan R, 1996, BIOCHEM J, V313, P597, DOI 10.1042/bj3130597; Cacan R, 2001, J BIOL CHEM, V276, P22307, DOI 10.1074/jbc.M101077200; Cacan R, 1998, BIOCHIMIE, V80, P59, DOI 10.1016/S0300-9084(98)80057-6; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Durrant C, 2002, BIOCHEM J, V365, P239, DOI 10.1042/BJ20011786; Duvet S, 1998, BIOCHEM J, V335, P389, DOI 10.1042/bj3350389; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; HALVORSON H, 1958, BIOCHIM BIOPHYS ACTA, V30, P28, DOI 10.1016/0006-3002(58)90237-3; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; JONES EW, 1977, GENETICS, V85, P23; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 1997, J BIOCHEM, V122, P1167, DOI 10.1093/oxfordjournals.jbchem.a021877; Kato T, 2007, J BIOL CHEM, V282, P22080, DOI 10.1074/jbc.M700805200; Kawaguchi S, 2007, CELL, V129, P1230; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Moore SEH, 1999, TRENDS CELL BIOL, V9, P441, DOI 10.1016/S0962-8924(99)01648-7; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Moore SEH, 1998, GLYCOBIOLOGY, V8, P373, DOI 10.1093/glycob/8.4.373; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; Nothaft H, 2009, P NATL ACAD SCI USA, V106, P15019, DOI 10.1073/pnas.0903078106; OKU H, 1991, J BIOCHEM-TOKYO, V110, P982, DOI 10.1093/oxfordjournals.jbchem.a123700; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; PIERCE RJ, 1979, BIOCHEM J, V180, P673, DOI 10.1042/bj1800673; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Scott SV, 1995, J CELL BIOL, V131, P1727, DOI 10.1083/jcb.131.6.1727; SHOUP VA, 1976, J BIOL CHEM, V251, P3845; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V304, P326, DOI 10.1016/S0006-291X(03)00600-4; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; SUZUKI T, 1995, J BIOL CHEM, V270, P15181, DOI 10.1074/jbc.270.25.15181; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; VILLERS C, 1994, BIOCHEM J, V298, P135, DOI 10.1042/bj2980135; Xiao YT, 2008, INT J BIOCHEM CELL B, V40, P2002, DOI 10.1016/j.biocel.2007.08.006; Yanagida K, 2006, GLYCOBIOLOGY, V16, P294, DOI 10.1093/glycob/cwj074; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	52	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11734	10.1371/journal.pone.0011734	http://dx.doi.org/10.1371/journal.pone.0011734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668520	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800010
J	Capparelli, R; Nocerino, N; Lanzetta, R; Silipo, A; Amoresano, A; Giangrande, C; Becker, K; Blaiotta, G; Evidente, A; Cimmino, A; Iannaccone, M; Parlato, M; Medaglia, C; Roperto, S; Roperto, F; Ramunno, L; Iannelli, D				Capparelli, Rosanna; Nocerino, Nunzia; Lanzetta, Rosa; Silipo, Alba; Amoresano, Angela; Giangrande, Chiara; Becker, Karsten; Blaiotta, Giuseppe; Evidente, Antonio; Cimmino, Alessio; Iannaccone, Marco; Parlato, Marianna; Medaglia, Chiara; Roperto, Sante; Roperto, Franco; Ramunno, Luigi; Iannelli, Domenico			Bacteriophage-Resistant Staphylococcus aureus Mutant Confers Broad Immunity against Staphylococcal Infection in Mice	PLOS ONE			English	Article							METHICILLIN-RESISTANT; TEICHOIC-ACID; CELL-WALL; PHAGE; VACCINE; PROTECTION; STRAINS; CARDIOTOXICITY; SENSITIVITY; DYNAMICS	In the presence of a bacteriophage (a bacteria-attacking virus) resistance is clearly beneficial to the bacteria. As expected in such conditions, resistant bacteria emerge rapidly. However, in the absence of the phage, resistant bacteria often display reduced fitness, compared to their sensitive counterparts. The present study explored the fitness cost associated with phage-resistance as an opportunity to isolate an attenuated strain of S. aureus. The phage-resistant strain A172 was isolated from the phage-sensitive strain A170 in the presence of the M-Sa phage. Acquisition of phage-resistance altered several properties of A172, causing reduced growth rate, under-expression of numerous genes and production of capsular polysaccharide. In vivo, A172 modulated the transcription of the TNF-alpha, IFN-gamma and Il-1 beta genes and, given intramuscularly, protected mice from a lethal dose of A170 (18/20). The heat-killed vaccine also afforded protection from heterologous methicillin-resistant S. aureus (MRSA) (8/10 mice) or vancomycin-intermediate S. aureus (VISA) (9/10 mice). The same vaccine was also effective when administered as an aerosol. Anti-A172 mouse antibodies, in the dose of 10 mu l/mouse, protected the animals (10/10, in two independent experiments) from a lethal dose of A170. Consisting predominantly of the sugars glucose and galactose, the capsular polysaccharide of A172, given in the dose of 25 mu g/mouse, also protected the mice (20/20) from a lethal dose of A170. The above results demonstrate that selection for phage-resistance can facilitate bacterial vaccine preparation.	[Capparelli, Rosanna; Nocerino, Nunzia; Iannaccone, Marco; Parlato, Marianna] Univ Naples Federico II, Fac Biotechnol, Naples, Italy; [Lanzetta, Rosa; Silipo, Alba; Amoresano, Angela; Giangrande, Chiara] Univ Naples Federico II, Dept Organ Chem & Biochem, Naples, Italy; [Becker, Karsten] Univ Klinikum Munster, Inst Med Mikrobiol, Munster, Germany; [Blaiotta, Giuseppe; Evidente, Antonio; Cimmino, Alessio; Medaglia, Chiara; Ramunno, Luigi; Iannelli, Domenico] Univ Naples Federico II, Sch Agr, Naples, Italy; [Roperto, Sante; Roperto, Franco] Univ Naples Federico II, Dept Pathol & Anim Hlth, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Naples Federico II; University of Naples Federico II	Capparelli, R (corresponding author), Univ Naples Federico II, Fac Biotechnol, Naples, Italy.	iannelli@unina.it	Silipo, Alba/L-5929-2014; Parlato, Marianna/H-9467-2017; Cimmino, Alessio/I-2121-2012; Becker, Karsten/O-2302-2018; Iannaccone, Marco/K-7559-2016; Capparelli, Rosanna/Q-3144-2017; Evidente, Antonio/N-9357-2013	Cimmino, Alessio/0000-0002-1551-4237; Becker, Karsten/0000-0002-6391-1341; Iannaccone, Marco/0000-0002-2283-6613; Capparelli, Rosanna/0000-0001-8614-6251; Evidente, Antonio/0000-0001-9110-1656; Giangrande, Chiara/0000-0002-0287-9958; silipo, alba/0000-0002-5394-6532; LANZETTA, Rosa/0000-0002-1472-5825; roperto, sante/0000-0001-6210-5519; BLAIOTTA, Giuseppe/0000-0002-2174-8259; AMORESANO, Angela/0000-0002-8386-655X				Baggesen DL, 1997, J CLIN MICROBIOL, V35, P330, DOI 10.1128/JCM.35.1.330-333.1997; Blaiotta G, 2004, J APPL MICROBIOL, V97, P719, DOI 10.1111/j.1365-2672.2004.02349.x; Blaiotta G, 2001, J DAIRY RES, V68, P139, DOI 10.1017/S0022029900004672; Blaiotta G, 2006, APPL ENVIRON MICROB, V72, P6117, DOI 10.1128/AEM.00773-06; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Capparelli R, 2010, J INFECT DIS, V201, P52, DOI 10.1086/648478; Cimmino A, 2008, CARBOHYD RES, V343, P392, DOI 10.1016/j.carres.2007.10.023; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COYETTE J, 1968, BIOCHEMISTRY-US, V7, P2385, DOI 10.1021/bi00846a048; Dinarello CA, 1996, CURR TOP MICROBIOL, V216, P133; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; GLASER L, 1966, BIOCHIM BIOPHYS ACTA, V124, P415, DOI 10.1016/0304-4165(66)90211-X; Goerke C, 2007, ENVIRON MICROBIOL, V9, P3134, DOI 10.1111/j.1462-2920.2007.01423.x; Goodner K, 1935, J EXP MED, V62, P359, DOI 10.1084/jem.62.3.359; HORMAECHE CE, 1991, MICROB PATHOGENESIS, V10, P149, DOI 10.1016/0882-4010(91)90075-L; Hu DL, 2003, J INFECT DIS, V188, P743, DOI 10.1086/377308; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; KORMAN RZ, 1975, J BACTERIOL, V124, P724, DOI 10.1128/JB.124.2.724-730.1975; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; LACHICA RVF, 1979, J CLIN MICROBIOL, V10, P752, DOI 10.1128/JCM.10.5.752-753.1979; Lederberg J, 1996, P NATL ACAD SCI USA, V93, P3167, DOI 10.1073/pnas.93.8.3167; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luria SE, 1943, GENETICS, V28, P491; Marris E, 2005, NAT MED, V11, P461, DOI 10.1038/nm0505-461b; Mason WJ, 2001, J CLIN MICROBIOL, V39, P3332, DOI 10.1128/JCM.39.9.3332-3338.2001; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Middelboe M, 2001, MICROBIAL ECOL, V42, P395, DOI 10.1007/s00248-001-0012-1; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; SANDERSON AR, 1962, J BIOL CHEM, V237, P3603; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Sparano JA, 2000, LANCET, V356, P1947, DOI 10.1016/S0140-6736(00)03304-3; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; Telford JL, 2008, CELL HOST MICROBE, V3, P408, DOI 10.1016/j.chom.2008.05.004; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Yeh ETH, 2006, ANNU REV MED, V57, P485, DOI 10.1146/annurev.med.57.121304.131240; YOUNG FE, 1967, P NATL ACAD SCI USA, V58, P2377, DOI 10.1073/pnas.58.6.2377; Zahid MSH, 2008, INFECT IMMUN, V76, P5266, DOI 10.1128/IAI.00578-08	48	65	68	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11720	10.1371/journal.pone.0011720	http://dx.doi.org/10.1371/journal.pone.0011720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661301	Green Submitted, gold, Green Published			2022-12-25	WOS:000280243300021
J	Marshall, RM; Robles, MD; Majka, DR; Haney, JA				Marshall, Robert M.; Robles, Marcos D.; Majka, Daniel R.; Haney, Jeanmarie A.			Sustainable Water Management in the Southwestern United States: Reality or Rhetoric?	PLOS ONE			English	Article						m	FLOW; ARIZONA; GROWTH; SYSTEM	Background: While freshwater sustainability is generally defined as the provisioning of water for both people and the environment, in practice it is largely focused only on supplying water to furnish human population growth. Symptomatic of this is the state of Arizona, where rapid growth outside of the metropolitan Phoenix-Tucson corridor relies on the same groundwater that supplies year-round flow in rivers. Using Arizona as a case study, we present the first study in the southwestern United States that evaluates the potential impact of future population growth and water demand on streamflow depletion across multiple watersheds. Methodology/Principal Findings: We modeled population growth and water demand through 2050 and used four scenarios to explore the potential effects of alternative growth and water management strategies on river flows. Under the base population projection, we found that rivers in seven of the 18 study watersheds could be dewatered due to municipal demand. Implementing alternative growth and water management strategies, however, could prevent four of these rivers from being dewatered. Conclusions/Significance: The window of opportunity to implement water management strategies is narrowing. Because impacts from groundwater extraction are cumulative and cannot be immediately reversed, proactive water management strategies should be implemented where groundwater will be used to support new municipal demand. Our approach provides a low-cost method to identify where alternative water and growth management strategies may have the most impact, and demonstrates that such strategies can maintain a continued water supply for both people and the environment.	[Marshall, Robert M.; Robles, Marcos D.; Majka, Daniel R.; Haney, Jeanmarie A.] Nat Conservancy Ctr Sci & Publ Policy, Tucson, AZ USA	Nature Conservancy	Marshall, RM (corresponding author), Nat Conservancy Ctr Sci & Publ Policy, Tucson, AZ USA.	rmarshall@tnc.org			Nature Conservancy	Nature Conservancy	This study was supported by general operating funds of The Nature Conservancy, a membership-supported organization. No other entity, beyond the study's authors, had a role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ADOC, 2006, 2006 2055 COMM POP P; *ADWR, 2009, AR WAT ATL IN PRESS; *AGFD HDMS, 2009, BIOT DAT VERS 4; Alley WM, 2007, GROUND WATER, V45, P251, DOI 10.1111/j.1745-6584.2006.00274.x; Alley WM, 1999, SUSTAINABILITY GROUN, V1186; Arthington AH, 2003, RIVER RES APPL, V19, P377, DOI 10.1002/rra.745; *AUSTR GOV NAT WAT, 2005, ENV WAT PROV; *AZ DEP WAT RES, 2009, WAT RERS ISS SE AR P; Barnett TP, 2009, P NATL ACAD SCI USA, V106, P7334, DOI 10.1073/pnas.0812762106; BLINN DW, 2005, RIVERS N AM, P482; CARLSON C A, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P220; Deacon JE, 2007, BIOSCIENCE, V57, P688, DOI 10.1641/B570809; Ellis AW, 2008, CLIM RES, V35, P227, DOI 10.3354/cr00727; Flint LE, 2007, 1703 US GEOL SURV; Gleick PH, 1998, ECOL APPL, V8, P571, DOI 10.1890/1051-0761(1998)008[0571:WICPTS]2.0.CO;2; Glennon Robert., 2009, UNQUENCHABLE AM WATE; Kalf FRP, 2005, HYDROGEOL J, V13, P295, DOI 10.1007/s10040-004-0401-x; King J, 2010, FRESHWATER BIOL, V55, P127, DOI 10.1111/j.1365-2427.2009.02316.x; LEENHOUTS JM, 2006, 20065163 US GEOL SUR; *MA DEP ENV PROT, 2005, 310 MASS DEP ENV PRO; *MAG, 2005, AR GROWTH MAPS ALG; MCLAUGHLIN SP, 2004, RIPARIAN AREAS SW US, P127; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; Minckley WL, 2002, COPEIA, P687, DOI 10.1643/0045-8511(2002)002[0687:TNPSCT]2.0.CO;2; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; POSTEL SL, 2007, J AM WATER RESOUR AS, V99, P2; Santhi C, 2008, J HYDROL, V351, P139, DOI 10.1016/j.jhydrol.2007.12.018; Serrat-Capdevila A, 2007, J HYDROL, V347, P48, DOI 10.1016/j.jhydrol.2007.08.028; SOPHOCLEOUS MA, 2000, NAT RESOUR RES, V9, P99; Tharme RE, 2003, RIVER RES APPL, V19, P397, DOI 10.1002/rra.736; Theobald DM, 2005, ECOL SOC, V10; Thomas BE, 2006, 1712 US GEOL SURV; Timmons D, 2006, PRESCOTT AMA GROUNDW; *TNC, 2008, EC ASS GEOD W N AM; Travis W. R., 2005, W FUTURES LOOK PATTE; Turner DS, 2007, AQUAT CONSERV, V17, P737, DOI 10.1002/aqc.802; *US BUR RECL, 2010, SIERR VIST WAT RECL; *US FISH WILDL SER, 2010, ENV CONS ONL SYST SP; *USFWS, 1998, 88 USFWS; Webb RH, 2007, RIBBON GREEN CHANGE	40	26	26	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11687	10.1371/journal.pone.0011687	http://dx.doi.org/10.1371/journal.pone.0011687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657735	Green Published, gold			2022-12-25	WOS:000280197500026
J	Sahawneh, MA; Ricart, KC; Roberts, BR; Bomben, VC; Basso, M; Ye, YZ; Sahawneh, J; Franco, MC; Beckman, JS; Estevez, AG				Sahawneh, Mary Anne; Ricart, Karina C.; Roberts, Blaine R.; Bomben, Valerie C.; Basso, Manuela; Ye, Yaozu; Sahawneh, John; Franco, Maria Clara; Beckman, Joseph S.; Estevez, Alvaro G.			Cu, Zn-Superoxide Dismutase Increases Toxicity of Mutant and Zinc-deficient Superoxide Dismutase by Enhancing Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON APOPTOSIS; NITRIC-OXIDE SYNTHASE; FREE-ENERGY SURFACE; ALS-LINKED SOD1; WILD-TYPE SOD1; MOTONEURON DEATH; DISULFIDE REDUCTION; TYROSINE NITRATION; CEREBRAL-ISCHEMIA	When replete with zinc and copper, amyotrophic lateral sclerosis (ALS)-associated mutant SOD proteins can protect motor neurons in culture from trophic factor deprivation as efficiently as wild-type SOD. However, the removal of zinc from either mutant or wild-type SOD results in apoptosis of motor neurons through a copper-and peroxynitrite-dependent mechanism. It has also been shown that motor neurons isolated from transgenic mice expressing mutant SODs survive well in culture but undergo apoptosis when exposed to nitric oxide via a Fas-dependent mechanism. We combined these two parallel approaches for understanding SOD toxicity in ALS and found that zinc-deficient SOD-induced motor neuron death required Fas activation, whereas the nitric oxide-dependent death of G93A SOD-expressing motor neurons required copper and involved peroxynitrite formation. Surprisingly, motor neuron death doubled when Cu,Zn-SOD protein was either delivered intracellularly to G93A SOD-expressing motor neurons or co-delivered with zinc-deficient SOD to nontransgenic motor neurons. These results could be rationalized by biophysical data showing that heterodimer formation of Cu, Zn-SOD with zinc-deficient SOD prevented the monomerization and subsequent aggregation of zinc-deficient SOD under thiol-reducing conditions. ALS mutant SOD was also stabilized by mutating cysteine 111 to serine, which greatly increased the toxicity of zinc-deficient SOD. Thus, stabilization of ALS mutant SOD by two different approaches augmented its toxicity to motor neurons. Taken together, these results are consistent with copper-containing zinc-deficient SOD being the elusive "partially unfolded intermediate" responsible	[Roberts, Blaine R.; Beckman, Joseph S.; Estevez, Alvaro G.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Sahawneh, Mary Anne; Basso, Manuela; Ye, Yaozu; Sahawneh, John; Franco, Maria Clara; Estevez, Alvaro G.] Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA; [Sahawneh, Mary Anne; Basso, Manuela; Franco, Maria Clara; Estevez, Alvaro G.] Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10022 USA; [Ricart, Karina C.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Bomben, Valerie C.] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; [Ricart, Karina C.] Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA	Oregon State University; Cornell University; Cornell University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Estevez, AG (corresponding author), Oregon State Univ, Dept Biochem & Biophys, ALS 2011, Corvallis, OR 97331 USA.	esteveza@onid.orst.edu	Basso, Manuela/AAA-9147-2020; Franco, Maria/O-7862-2015	Basso, Manuela/0000-0002-9278-8960; Roberts, Blaine/0000-0001-5466-0053	National Institutes of Health [NS36761, NS42834, NS058628, AT002034, ES00240]; Burke Medical Research Institute; New York State Spinal Cord Injury Center of Research Excellence; Amyotrophic Lateral Sclerosis Association; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT002034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036761, R01NS058628, R01NS042834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Medical Research Institute; New York State Spinal Cord Injury Center of Research Excellence; Amyotrophic Lateral Sclerosis Association; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS36761, NS42834 (to A. G. E.), NS058628, AT002034, and ES00240. This work was also supported by funds from the Burke Medical Research Institute, the New York State Spinal Cord Injury Center of Research Excellence, and the Amyotrophic Lateral Sclerosis Association (to J. S. B.).	Abe K, 1997, NEUROL RES, V19, P124; ABE K, 1995, NEUROSCI LETT, V199, P152, DOI 10.1016/0304-3940(95)12039-7; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Crow JP, 1997, J NEUROCHEM, V69, P1936; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Estevez AG, 1998, PROG BRAIN RES, V118, P269; Estevez AG, 1998, J NEUROSCI, V18, P923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Estevez AG, 2000, FREE RADICAL BIO MED, V28, P437, DOI 10.1016/S0891-5849(99)00261-0; Estevez AG, 2002, NEUROSCI LETT, V326, P201, DOI 10.1016/S0304-3940(02)00341-5; Estevez AG, 1998, J NEUROSCI, V18, P3708; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Leinweber B, 2004, FREE RADICAL BIO MED, V36, P911, DOI 10.1016/j.freeradbiomed.2003.12.021; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Marklund SL, 1997, J NEUROCHEM, V69, P675; Maroney AC, 1998, J NEUROSCI, V18, P104; Mulligan VK, 2008, J MOL BIOL, V383, P424, DOI 10.1016/j.jmb.2008.08.024; Museth AK, 2009, BIOCHEMISTRY-US, V48, P8817, DOI 10.1021/bi900703v; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; OLSEN PH, 1992, BIOCHEMISTRY-US, V31, P746, DOI 10.1021/bi00118a016; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Pehar M, 2007, J NEUROSCI, V27, P7777, DOI 10.1523/JNEUROSCI.0823-07.2007; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 2006, P NATL ACAD SCI USA, V103, P6007, DOI 10.1073/pnas.0508774103; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Ricart K, 2006, J NEUROCHEM, V97, P222, DOI 10.1111/j.1471-4159.2006.03739.x; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Rumfeldt JAO, 2009, J MOL BIOL, V385, P278, DOI 10.1016/j.jmb.2008.10.003; Sasaki S, 2001, J NEUROPATH EXP NEUR, V60, P839, DOI 10.1093/jnen/60.9.839; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Witan H, 2008, HUM MOL GENET, V17, P1373, DOI 10.1093/hmg/ddn025; Witan H, 2009, NEUROBIOL DIS, V36, P331, DOI 10.1016/j.nbd.2009.07.024; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200	65	32	33	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33885	33897		10.1074/jbc.M110.118901	http://dx.doi.org/10.1074/jbc.M110.118901			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20663894	Green Published, hybrid			2022-12-25	WOS:000283354000035
J	Cusdin, FS; Nietlispach, D; Maman, J; Dale, TJ; Powell, AJ; Clare, JJ; Jackson, AP				Cusdin, Fiona S.; Nietlispach, Daniel; Maman, Joseph; Dale, Timothy J.; Powell, Andrew J.; Clare, Jeffrey J.; Jackson, Antony P.			The Sodium Channel beta 3-Subunit Induces Multiphasic Gating in Na(v)1.3 and Affects Fast Inactivation via Distinct Intracellular Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTRICTION INJURY MODEL; BETA-1 SUBUNIT; AUXILIARY SUBUNIT; EXTRACELLULAR DOMAIN; NEUROPATHIC PAIN; MAMMALIAN-CELLS; SENSORY NEURONS; NERVE INJURY; DRG NEURONS; HUMAN BRAIN	Electrical excitability in neurons depends on the activity of membrane-bound voltage gated sodium channels (Na-v) that are assembled from an ion conducting alpha-subunit and often auxiliary beta-subunits. The alpha-subunit isoform Na(v)1.3 occurs in peripheral neurons together with the Na-v beta 3-subunit, both of which are coordinately up-regulated in rat dorsal root ganglion neurons after nerve injury. Here we examine the effect of the beta 3-subunit on the gating behavior of Na(v)1.3 using whole cell patch clamp electrophysiology in HEK-293 cells. We show that beta 3 depolarizes the voltage sensitivity of Na(v)1.3 activation and inactivation and induces biphasic components of the inactivation curve. We detect both a fast and a novel slower component of inactivation, and we show that the beta 3-subunit increases the fraction of channels inactivating by the slower component. Using CD and NMR spectroscopy, we report the first structural analysis of the intracellular domain of any Na-v beta-subunit. We infer the presence of a region within the beta 3-subunit intracellular domain that has a propensity to form a short amphipathic alpha-helix followed by a structurally disordered sequence, and we demonstrate a role for both of these regions in the selective stabilization of fast inactivation. The complex gating behavior induced by beta 3 may contribute to the known hyperexcitability of peripheral neurons under those physiological conditions where expression of beta 3 and Na(v)1.3 are both enhanced.	[Cusdin, Fiona S.; Nietlispach, Daniel; Maman, Joseph; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Cusdin, Fiona S.; Dale, Timothy J.; Powell, Andrew J.; Clare, Jeffrey J.] GlaxoSmithKline Inc, Stevenage SG1 2NY, Herts, England	University of Cambridge; GlaxoSmithKline	Jackson, AP (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	apj10@bioc.cam.ac.uk		Nietlispach, Daniel/0000-0003-4364-9291; Jackson, Antony Philip/0000-0002-2895-7387; Powell, Andrew/0000-0003-1540-537X	Biotechnology and Biological Sciences Research Council (UK); University of Cambridge; Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Cambridge(University of Cambridge); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a Biotechnology and Biological Sciences Research Council (UK) Cooperative Award in Science and Engineering studentship and by funds from the University of Cambridge.	BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Black JA, 1999, J NEUROPHYSIOL, V82, P2776, DOI 10.1152/jn.1999.82.5.2776; Chen YH, 2000, EUR J NEUROSCI, V12, P4281, DOI 10.1111/j.1460-9568.2000.01336.x; Chopra SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-113; CLARK DJ, 1988, EMBO J, V7, P69, DOI 10.1002/j.1460-2075.1988.tb02784.x; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Dib-Hajj SD, 1999, PAIN, V83, P591, DOI 10.1016/S0304-3959(99)00169-4; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hakim P, 2010, ACTA PHYSIOL, V198, P47, DOI 10.1111/j.1748-1716.2009.02048.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Meadows L, 2001, J NEUROCHEM, V76, P1871, DOI 10.1046/j.1471-4159.2001.00192.x; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; Megy S, 2004, PROTEIN SCI, V13, P3151, DOI 10.1110/ps.04745004; Merrick EC, 2010, PFLUG ARCH EUR J PHY, V460, P743, DOI 10.1007/s00424-009-0739-y; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; PATTON DE, 1994, J BIOL CHEM, V269, P17649; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shah BS, 2001, J PHYSIOL-LONDON, V534, P763, DOI 10.1111/j.1469-7793.2001.t01-1-00763.x; Shah BS, 2000, EUR J NEUROSCI, V12, P3985, DOI 10.1046/j.1460-9568.2000.00294.x; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Takahashi N, 2003, NEUROSCIENCE, V121, P441, DOI 10.1016/S0306-4522(03)00432-9; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yu EJ, 2005, BIOCHEM J, V392, P519, DOI 10.1042/BJ20050518; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	41	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33404	33412		10.1074/jbc.M110.114058	http://dx.doi.org/10.1074/jbc.M110.114058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20675377	hybrid, Green Published			2022-12-25	WOS:000283048200075
J	Zhao, NN; Gao, JW; Enns, CA; Knutson, MD				Zhao, Ningning; Gao, Junwei; Enns, Caroline A.; Knutson, Mitchell D.			ZRT/IRT-like Protein 14 (ZIP14) Promotes the Cellular Assimilation of Iron from Transferrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOMA-CELLS; NONTRANSFERRIN-BOUND IRON; ACUTE-PHASE RESPONSE; RAT HEPATOCYTES; HEREDITARY HEMOCHROMATOSIS; ENDOGENOUS PROTEINS; HEPG2 CELLS; TRANSPORTER; RECEPTOR; LIVER	ZIP14 is a transmembrane metal ion transporter that is abundantly expressed in the liver, heart, and pancreas. Previous studies of HEK 293 cells and the hepatocyte cell lines AML12 and HepG2 established that ZIP14 mediates the uptake of non-transferrin-bound iron, a form of iron that appears in the plasma during pathologic iron overload. In this study we investigated the role of ZIP14 in the cellular assimilation of iron from transferrin, the circulating plasma protein that normally delivers iron to cells by receptor-mediated endocytosis. We also determined the subcellular localization of ZIP14 in HepG2 cells. We found that overexpression of ZIP14 in HEK 293T cells increased the assimilation of iron from transferrin without increasing levels of transferrin receptor 1 or the uptake of transferrin. To allow for highly specific and sensitive detection of endogenous ZIP14 in HepG2 cells, we used a targeted knock-in approach to generate a cell line expressing a FLAG-tagged ZIP14 allele. Confocal microscopic analysis of these cells detected ZIP14 at the plasma membrane and in endosomes containing internalized transferrin. HepG2 cells in which endogenous ZIP14 was suppressed by siRNA assimilated 50% less iron from transferrin compared with controls. The uptake of transferrin, however, was unaffected. We also found that ZIP14 can mediate the transport of iron at pH 6.5, the pH at which iron dissociates from transferrin within the endosome. These results suggest that endosomal ZIP14 participates in the cellular assimilation of iron from transferrin, thus identifying a potentially new role for ZIP14 in iron metabolism.	[Knutson, Mitchell D.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Gao, Junwei; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	State University System of Florida; University of Florida; Oregon Health & Science University	Knutson, MD (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, POB 110370, Gainesville, FL 32611 USA.	mknutson@ufl.edu			National Institutes of Health [DK 080706, DK 054488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067864, R01DK054488, R01DK080706, R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK 080706 (to M. D. K.) and DK 054488 (to C. A. E.).	Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; CHENEY BA, 1967, AM J PHYSIOL, V212, P376, DOI 10.1152/ajplegacy.1967.212.2.376; Chua ACG, 2004, BLOOD, V104, P1519, DOI 10.1182/blood-2003-11-3872; Chua ACG, 2008, HEPATOLOGY, V47, P1737, DOI 10.1002/hep.22180; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Gao J, 2008, J BIOL CHEM, V283, P21462, DOI 10.1074/jbc.M803150200; Georgieff MK, 2000, PLACENTA, V21, P799, DOI 10.1053/plac.2000.0566; Graham RM, 1998, EUR J BIOCHEM, V253, P139, DOI 10.1046/j.1432-1327.1998.2530139.x; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Herbison CE, 2009, AM J PHYSIOL-CELL PH, V297, pC1567, DOI 10.1152/ajpcell.00649.2008; HIRAYAMA M, 1993, HEPATOLOGY, V18, P874, DOI 10.1002/hep.1840180420; Ikuta K, 2004, INT J BIOCHEM CELL B, V36, P340, DOI 10.1016/S1357-2725(03)00258-9; Kawabata H, 2001, BLOOD, V98, P2714, DOI 10.1182/blood.V98.9.2714; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Lambe T, 2009, BLOOD, V113, P1805, DOI 10.1182/blood-2007-11-120402; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; McArdle HJ, 2008, J NEUROENDOCRINOL, V20, P427, DOI 10.1111/j.1365-2826.2008.01658.x; MORGAN EH, 1986, FASEB J, V45, P2810; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nomura N, 1994, DNA Res, V1, P223, DOI 10.1093/dnares/1.5.223; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; POTTER BJ, 1989, AM J PHYSIOL, V257, pG524, DOI 10.1152/ajpgi.1989.257.4.G524; Sheikh N, 2007, LAB INVEST, V87, P713, DOI 10.1038/labinvest.3700553; Shindo M, 2006, HEPATOL RES, V35, P152, DOI 10.1016/j.hepres.2006.03.011; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Trinder D, 1997, HEPATOLOGY, V26, P691, DOI 10.1053/jhep.1997.v26.pm0009303500; Trinder D, 1996, HEPATOLOGY, V23, P1512, DOI 10.1002/hep.510230631; TRINDER D, 1986, HEPATOLOGY, V6, P852, DOI 10.1002/hep.1840060508; Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270; TRINDER D, 1988, BIOCHIM BIOPHYS ACTA, V943, P440, DOI 10.1016/0005-2736(88)90375-6; Wang ZH, 2009, METHODS MOL BIOL, V567, P87, DOI 10.1007/978-1-60327-414-2_6; Wetli HA, 2006, CHEM BIOL, V13, P965, DOI 10.1016/j.chembiol.2006.08.005; Worthington MT, 2000, AM J PHYSIOL-GASTR L, V279, pG1265, DOI 10.1152/ajpgi.2000.279.6.G1265; Zhang AS, 2008, EXP HEMATOL, V36, P1227, DOI 10.1016/j.exphem.2008.04.014; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]	44	119	120	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32141	32150		10.1074/jbc.M110.143248	http://dx.doi.org/10.1074/jbc.M110.143248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20682781	Green Published, hybrid			2022-12-25	WOS:000282683000027
J	Barbier, P; Dorleans, A; Devred, F; Sanz, L; Allegro, D; Alfonso, C; Knossow, M; Peyrot, V; Andreu, JM				Barbier, Pascale; Dorleans, Audrey; Devred, Francois; Sanz, Laura; Allegro, Diane; Alfonso, Carlos; Knossow, Marcel; Peyrot, Vincent; Andreu, Jose M.			Stathmin and Interfacial Microtubule Inhibitors Recognize a Naturally Curved Conformation of Tubulin Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BETA-TUBULIN; COLCHICINE ANALOGS; MAMMALIAN BRAIN; CHIRAL ISOMERS; DOUBLE RINGS; IN-VITRO; BINDING; PROTEIN; DEPOLYMERIZATION; THERMODYNAMICS	Tubulin is able to switch between a straight microtubule-like structure and a curved structure in complex with the stathmin-like domain of the RB3 protein (T(2)RB3). GTP hydrolysis following microtubule assembly induces protofilament curvature and disassembly. The conformation of the labile tubulin heterodimers is unknown. One important question is whether free GDP-tubulin dimers are straightened by GTP binding or if GTP-tubulin is also curved and switches into a straight conformation upon assembly. We have obtained insight into the bending flexibility of tubulin by analyzing the interplay of tubulin-stathmin association with the binding of several small molecule inhibitors to the colchicine domain at the tubulin intradimer interface, combining structural and biochemical approaches. The crystal structures of T(2)RB3 complexes with the chiral R and S isomers of ethyl-5-amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b] pyrazin-7-yl-carbamate, show that their binding site overlaps with colchicine ring A and that both complexes have the same curvature as unliganded T(2)RB3. The binding of these ligands is incompatible with a straight tubulin structure in microtubules. Analytical ultracentrifugation and binding measurements show that tubulin-stathmin associations (T(2)RB3, T(2)Stath) and binding of ligands (R, S, TN-16, or the colchicine analogue MTC) are thermodynamically independent from one another, irrespective of tubulin being bound to GTP or GDP. The fact that the interfacial ligands bind equally well to tubulin dimers or stathmin complexes supports a bent conformation of the free tubulin dimers. It is tempting to speculate that stathmin evolved to recognize curved structures in unassembled and disassembling tubulin, thus regulating microtubule assembly.	[Peyrot, Vincent] Aix Marseille Univ, Fac Pharm, Ctr Rech Oncol Biol & Oncopharmacol, INSERM UMR 911, F-13385 Marseille 05, France; [Dorleans, Audrey; Knossow, Marcel] CNRS, Lab Enzymol & Biochim Struct, UPR3082, F-91198 Gif Sur Yvette, France; [Sanz, Laura; Alfonso, Carlos; Andreu, Jose M.] CSIC, Ctr Invest Biol, Madrid 28040, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)		pascale.barbier@univmed.fr; j.m.andreu@cib.csic.es	Barbier, Pascale/AAE-1781-2019; Devred, Francois/AAO-6337-2020; Alfonso, Carlos/K-1316-2014; peyrot, vincent/B-6365-2015	Devred, Francois/0000-0001-5990-8898; Alfonso, Carlos/0000-0001-7165-4800; Andreu, Jose M/0000-0001-8064-6933	Ministerio de Ciencia [BFU2008-00013]; FPU; Association pour la Recherche contre le Cancer [1035]	Ministerio de Ciencia(Spanish Government); FPU(Spanish Government); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grant from Ministerio de Ciencia BFU2008-00013 (to J.M.A.), a FPU fellowship (L.S.), and a grant from the Association pour la Recherche contre le Cancer n<SUP>o</SUP> 1035 (to F.D.).	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Andreu JM, 1998, BIOCHEMISTRY-US, V37, P8356, DOI 10.1021/bi9728553; ANDREU JM, 1984, BIOCHEMISTRY-US, V23, P1742, DOI 10.1021/bi00303a025; Andreu Jose Manuel, 2007, Methods Mol Med, V137, P17, DOI 10.1007/978-1-59745-442-1_2; ARAI T, 1983, FEBS LETT, V155, P273, DOI 10.1016/0014-5793(82)80619-4; Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; Barbier P, 1998, BIOCHEMISTRY-US, V37, P758, DOI 10.1021/bi970568t; Barbier P, 1995, BIOCHEMISTRY-US, V34, P16821, DOI 10.1021/bi00051a033; Barbier P, 2001, BIOCHEMISTRY-US, V40, P13510, DOI 10.1021/bi010926z; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Cormier A, 2008, EMBO REP, V9, P1101, DOI 10.1038/embor.2008.171; DEINES C, 1994, CANCER RES, V54, P75; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devred F, 2008, FEBS LETT, V582, P2484, DOI 10.1016/j.febslet.2008.06.035; DIAZ JF, 1994, J MOL BIOL, V238, P214, DOI 10.1006/jmbi.1994.1282; DIEZ JC, 1987, CELL MOTIL CYTOSKEL, V7, P178, DOI 10.1002/cm.970070210; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dorleans Audrey, 2007, Methods Mol Med, V137, P235, DOI 10.1007/978-1-59745-442-1_16; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; ESNOUF RM, 1997, J MOL GRAPH MODEL, V134, P112; FITZGERALD TJ, 1976, BIOCHEM PHARMACOL, V25, P1383; Gajate C, 2000, CANCER RES, V60, P2651; Gebremichael Y, 2008, BIOPHYS J, V95, P2487, DOI 10.1529/biophysj.108.129072; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; HOWARD WD, 1986, BIOCHEMISTRY-US, V25, P8292, DOI 10.1021/bi00373a025; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KIRSCHNER MW, 1974, P NATL ACAD SCI USA, V71, P1159, DOI 10.1073/pnas.71.4.1159; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; LEYNADIER D, 1993, BIOCHEMISTRY-US, V32, P10675, DOI 10.1021/bi00091a018; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lobert S, 2007, BIOPHYS CHEM, V126, P50, DOI 10.1016/j.bpc.2006.05.023; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MELKI R, 1989, BIOCHEMISTRY-US, V28, P9143, DOI 10.1021/bi00449a028; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moores CA, 2008, J MOL BIOL, V377, P647, DOI 10.1016/j.jmb.2008.01.079; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P894, DOI 10.1021/bi00170a007; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P885, DOI 10.1021/bi00170a006; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; TEMPLE C, 1989, J MED CHEM, V32, P2089, DOI 10.1021/jm00129a012; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wyman J, 1990, BINDING LINKAGE FUNC	69	80	81	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31672	31681		10.1074/jbc.M110.141929	http://dx.doi.org/10.1074/jbc.M110.141929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675373	Green Published, hybrid			2022-12-25	WOS:000282764600059
J	Chua, YL; Dufour, E; Dassa, EP; Rustin, P; Jacobs, HT; Taylor, CT; Hagen, T				Chua, Yee Liu; Dufour, Eric; Dassa, Emmanuel P.; Rustin, Pierre; Jacobs, Howard T.; Taylor, Cormac T.; Hagen, Thilo			Stabilization of Hypoxia-inducible Factor-1 alpha Protein in Hypoxia Occurs Independently of Mitochondrial Reactive Oxygen Species Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE DEFICIENCY; ALTERNATIVE OXIDASE; RESPIRATORY-CHAIN; COMPLEX-III; HUMAN-CELLS; OXIDATIVE-PHOSPHORYLATION; EXPRESSION; HIF; MECHANISM; GENERATION	The transcription factor hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a master regulator of the cellular response to low oxygen. HIF-1 alpha protein accumulates in hypoxia due to inhibition of prolyl hydroxylase enzymes, which under normoxic conditions use molecular oxygen to hydroxylate HIF-1 alpha on two conserved proline residues (Pro(402) and Pro(564)), thus targeting the protein for 26 S proteasome-dependent degradation. A functional mitochondrial electron transport chain is known to be necessary for HIF-1 alpha stabilization in hypoxia. It has been reported that reactive oxygen species (ROS), produced under hypoxia by complex III of the mitochondrial electron transport chain, play a critical role in the stabilization of the HIF-1 alpha protein, possibly by directly inhibiting prolyl hydroxylase enzymes. In contrast, we found that ROS production by complex III is not required for hypoxia-induced HIF-1 alpha stabilization. Thus, reestablishing mitochondrial oxygen consumption in the presence of a complex III inhibitor by using an artificial electron donor to complex IV or by overexpressing Ciona intestinalis alternative oxidase results in HIF-1 alpha protein stabilization in hypoxia. Furthermore, five inhibitors that target different sites of the mitochondrial electron transport chain have similar effects on the HIF-1 alpha protein half-life in hypoxia but vary in their effects on mitochondrial ROS production. Finally, ROS do not regulate prolyl hydroxylase activity directly. We conclude that HIF-1 alpha protein stabilization in hypoxia occurs independently of mitochondrial ROS production. However, mitochondria can modulate the cellular hypoxic response through altered respiratory activity, likely by regulating the cellular oxygen availability.	[Chua, Yee Liu; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Dufour, Eric; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland; [Dufour, Eric; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, Ctr Lab Med, FI-33014 Tampere, Finland; [Dassa, Emmanuel P.; Rustin, Pierre] Univ Paris 07, Fac Med Denis, F-75870 Paris, France; [Dassa, Emmanuel P.; Rustin, Pierre] Hop Robert Debre, INSERM, U676, F-75870 Paris, France; [Taylor, Cormac T.] Univ Coll Dublin 4, Conway Inst Biomed & Biochem Res, Dublin D4, Ireland	National University of Singapore; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University College Dublin	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.	bchth@nus.edu.sg	Jacobs, Howard T/G-2434-2011; Dufour, Eric/AAF-6210-2020	Jacobs, Howard/0000-0003-1895-6003; Dufour, Eric/0000-0001-6690-5329; Taylor, Cormac/0000-0002-0946-1247	Singapore National Medical Research Council; National University of Singapore; School of Medicine; Academy of Finland; INSERM; Tampere University; Sigrid Juselius Foundation	Singapore National Medical Research Council(National Medical Research Council, Singapore); National University of Singapore(National University of Singapore); School of Medicine; Academy of Finland(Academy of Finland); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Tampere University; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from the Singapore National Medical Research Council and National University of Singapore, the School of Medicine, Academy of Finland, INSERM, the Tampere University Hospital Medical Research Fund, and the Sigrid Juselius Foundation.	Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Brown ST, 2008, AM J PHYSIOL-CELL PH, V294, pC1305, DOI 10.1152/ajpcell.00007.2008; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chew EH, 2006, BIOCHEM BIOPH RES CO, V346, P242, DOI 10.1016/j.bbrc.2006.05.106; Chua YS, 2010, MOL CANCER THER, V9, P224, DOI 10.1158/1535-7163.MCT-09-1003; Dassa EP, 2009, PHYSIOL PLANTARUM, V137, P427, DOI 10.1111/j.1399-3054.2009.01248.x; Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; FANDREY J, 1994, BIOCHEM J, V303, P507, DOI 10.1042/bj3030507; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Gong YQ, 2005, AM J PHYSIOL-CELL PH, V288, pC1023, DOI 10.1152/ajpcell.00443.2004; Grishko V, 2001, FASEB J, V15, P1267, DOI 10.1096/fj.00-0755fje; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; McDonald AE, 2008, FUNCT PLANT BIOL, V35, P535, DOI 10.1071/FP08025; Mehta JP, 2008, CHEST, V133, P1410, DOI 10.1378/chest.07-2984; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Rustin P, 2009, PHYSIOL PLANTARUM, V137, P362, DOI 10.1111/j.1399-3054.2009.01249.x; Schroedl C, 2002, AM J PHYSIOL-LUNG C, V283, pL922, DOI 10.1152/ajplung.00014.2002; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Tuttle SW, 2007, J BIOL CHEM, V282, P36790, DOI 10.1074/jbc.M700327200; Van Aken O, 2009, PHYSIOL PLANTARUM, V137, P354, DOI 10.1111/j.1399-3054.2009.01240.x; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Yang SQ, 2008, J BIOL CHEM, V283, P28767, DOI 10.1074/jbc.M803013200	42	131	136	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31277	31284		10.1074/jbc.M110.158485	http://dx.doi.org/10.1074/jbc.M110.158485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675386	Green Published, hybrid			2022-12-25	WOS:000282764600022
J	Jaiswal, R; Patel, RY; Asthana, J; Jindal, B; Balaji, PV; Panda, D				Jaiswal, Richa; Patel, Ronak Y.; Asthana, Jayant; Jindal, Bhavya; Balaji, Petety V.; Panda, Dulal			E93R Substitution of Escherichia coli FtsZ Induces Bundling of Protofilaments, Reduces GTPase Activity, and Impairs Bacterial Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; MYCOBACTERIUM-TUBERCULOSIS FTSZ; ASSEMBLY DYNAMICS; FUNCTIONAL-PROPERTIES; MICROTUBULE DYNAMICS; CRYSTAL-STRUCTURE; Z-RING; POLYMERIZATION; HYDROLYSIS; SULA	Recently, we found that divalent calcium has no detectable effect on the assembly of Mycobacterium tuberculosis FtsZ (MtbFtsZ), whereas it strongly promoted the assembly of Escherichia coli FtsZ (EcFtsZ). While looking for potential calcium binding residues in EcFtsZ, we found a mutation (E93R) that strongly promoted the assembly of EcFtsZ. The mutation increased the stability and bundling of the FtsZ protofilaments and produced a dominating effect on the assembly of the wild type FtsZ (WT-FtsZ). Although E93R-FtsZ was found to bind to GTP similarly to the WT-FtsZ, it displayed lower GTPase activity than the WT-FtsZ. E93R-FtsZ complemented for its wild type counterpart as observed by a complementation test using JKD7-1/pKD3 cells. However, the bacterial cells became elongated upon overexpression of the mutant allele. We modeled the structure of E93R-FtsZ using the structures of MtbFtsZ/Methanococcus jannaschi FtsZ (MjFtsZ) dimers as templates. The MtbFtsZ-based structure suggests that the Arg93-Glu138 salt bridge provides the additional stability, whereas the effect of mutation appears to be indirect (allosteric) if the EcFtsZ dimer is similar to that of MjFtsZ. The data presented in this study suggest that an increase in the stability of the FtsZ protofilaments is detrimental for the bacterial cytokinesis.	[Jaiswal, Richa; Patel, Ronak Y.; Asthana, Jayant; Jindal, Bhavya; Balaji, Petety V.; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Asthana, Jayant/AFQ-7879-2022; Jindal, Bhavya/AAW-6369-2021	Balaji, Petety/0000-0002-6018-6957; Asthana, Dr. Jayant/0000-0002-8961-6308	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by a grant from the Department of Science and Technology, Government of India (to D. P.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Addinall SG, 1996, J BACTERIOL, V178, P7167, DOI 10.1128/jb.178.24.7167-7172.1996; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Bates PA, 2001, PROTEINS, P39; Bates PA, 1999, PROTEINS, P47; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; DAI K, 1994, J BACTERIOL, V176, P130, DOI 10.1128/JB.176.1.130-136.1994; DeLano W. L., 2002, PYMOL MOL GENETICS G; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Jaiswal R, 2008, PROTEIN SCI, V17, P846, DOI 10.1110/ps.083452008; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Jaiswal R, 2009, J BIOCHEM, V146, P733, DOI 10.1093/jb/mvp120; Kapoor S, 2009, EXPERT OPIN THER TAR, V13, P1037, DOI 10.1517/14728220903173257; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 2005, FEBS J, V272, P2760, DOI 10.1111/j.1742-4658.2005.04696.x; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Pednekar D, 2009, PROTEINS, V74, P155, DOI 10.1002/prot.22142; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Santra MK, 2007, PROTEINS, V67, P177, DOI 10.1002/prot.21178; Santra MK, 2005, PROTEINS, V61, P1101, DOI 10.1002/prot.20671; Santra MK, 2003, J BIOL CHEM, V278, P21336, DOI 10.1074/jbc.M301303200; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Scheffers DJ, 2000, MOL MICROBIOL, V35, P1211, DOI 10.1046/j.1365-2958.2000.01791.x; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Sossong TM, 1999, BIOCHEMISTRY-US, V38, P14843, DOI 10.1021/bi990917e; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Thilo C, 2006, J BIOL CHEM, V281, P8950, DOI 10.1074/jbc.M507121200; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	54	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31796	31805		10.1074/jbc.M110.138719	http://dx.doi.org/10.1074/jbc.M110.138719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667825	Green Published, hybrid			2022-12-25	WOS:000282764600071
J	Ren, JL; Albinsson, S; Hellstrand, P				Ren, Jingli; Albinsson, Sebastian; Hellstrand, Per			Distinct Effects of Voltage- and Store-dependent Calcium Influx on Stretch-induced Differentiation and Growth in Vascular Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; TRANSCRIPTION FACTOR; CARDIOVASCULAR DEVELOPMENT; ACTIN POLYMERIZATION; CELL-PROLIFERATION; GENE-EXPRESSION; MYOCARDIN; ACTIVATION; PROTEINS; KINASE	Stretch of the vascular wall stimulates smooth muscle hypertrophy by activating the MAPK and Rho/Rho kinase (ROK) pathways. We investigated the role of calcium in this response. Stretch-stimulated expression of contractile and cytoskeletal proteins in mouse portal vein was inhibited at mRNA and protein levels by blockade of voltage-dependent Ca2+ entry (VDCE). In contrast, blockade of store-operated Ca2+ entry (SOCE) did not affect smooth muscle marker expression but decreased global protein synthesis. Activation of VDCE caused membrane translocation of RhoA followed by phosphorylation of its downstream effectors LIMK-2 and cofilin-2. Stretch-activated cofilin-2 phosphorylation depended on VDCE but not on SOCE. VDCE was associated with increased mRNA expression of myocardin, myocyte enhancer factor (MEF) -2A and -2D, and smooth muscle marker genes, all of which depended on ROK activity. SOCE increased ERK1/2 phosphorylation and c-Fos expression but had no effect on phosphorylation of LIMK-2 and cofilin-2 or on myocardin and MEF2 expression. Knockdown of MEF2A or -2D eliminated the VDCE-induced activation of myocardin expression and increased basal c-Jun and c-Fos mRNA levels. These results indicate that MEF2 mediates VDCE dependent stimulation of myocardin expression via the Rho/ROK pathway. In addition, SOCE activates the expression of immediate-early genes, known to be regulated by MEF2 via Ca2+-dependent phosphorylation of histone deacetylases, but this mode of Ca2+ entry does not affect the Rho/ROK pathway. Compartmentation of Ca2+ entry pathways appears as one mechanism whereby extracellular and membrane signals influence smooth muscle phenotype regulation, with MEF2 as a focal point.	[Ren, Jingli; Albinsson, Sebastian; Hellstrand, Per] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University	Hellstrand, P (corresponding author), Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden.	Per.Hellstrand@med.lu.se	Albinsson, Sebastian/B-4105-2010	Albinsson, Sebastian/0000-0001-6936-3967	Swedish Research Council [64X-28]; Heart-Lung Foundation; Medical Faculty, Lund University; Torsten Foundation; Ragnar Soderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty, Lund University; Torsten Foundation; Ragnar Soderberg Foundation	This work was supported by the Swedish Research Council Grant 64X-28, the Heart-Lung Foundation, the Vascular Wall Program, Medical Faculty, Lund University, and the Torsten and Ragnar Soderberg Foundations.	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Bergdahl A, 2005, AM J PHYSIOL-CELL PH, V288, pC872, DOI 10.1152/ajpcell.00334.2004; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Cartin L, 2000, CIRC RES, V86, P760, DOI 10.1161/01.RES.86.7.760; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dreja K, 2001, J VASC RES, V38, P324, DOI 10.1159/000051063; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Golovina VA, 1999, AM J PHYSIOL-CELL PH, V277, pC343, DOI 10.1152/ajpcell.1999.277.2.C343; Gordon JW, 2009, J BIOL CHEM, V284, P19027, DOI 10.1074/jbc.M109.000539; Guibert C, 2008, PROG BIOPHYS MOL BIO, V98, P10, DOI 10.1016/j.pbiomolbio.2008.05.001; JOHANSSON B, 1976, ACTA PHYSIOL SCAND, V98, P381, DOI 10.1111/j.1748-1716.1976.tb10324.x; Kumar B, 2006, CIRC RES, V98, P557, DOI 10.1161/01.RES.0000204724.29685.db; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Lin Q, 1998, DEVELOPMENT, V125, P4565; MALMQVIST U, 1988, ACTA PHYSIOL SCAND, V133, P49, DOI 10.1111/j.1748-1716.1988.tb08380.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; OWENS GK, 1995, PHYSIOL REV, V75, P487; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pulver RA, 2004, CIRC RES, V94, P1351, DOI 10.1161/01.RES.0000127618.34500.FD; Pulver-Kaste RA, 2006, AM J PHYSIOL-HEART C, V291, pH97, DOI 10.1152/ajpheart.00753.2005; Ratz PH, 2006, EUR J PHARMACOL, V541, P177, DOI 10.1016/j.ejphar.2006.05.014; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, pE48; Zeidan A, 2003, ARTERIOSCL THROM VAS, V23, P1528, DOI 10.1161/01.ATV.0000090129.75275.C2; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002	36	27	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31829	31839		10.1074/jbc.M109.097576	http://dx.doi.org/10.1074/jbc.M109.097576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675376	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000282764600074
J	Krig, SR; Miller, JK; Frietze, S; Beckett, LA; Neve, RM; Farnham, PJ; Yaswen, PI; Sweeney, CA				Krig, S. R.; Miller, J. K.; Frietze, S.; Beckett, L. A.; Neve, R. M.; Farnham, P. J.; Yaswen, P. I.; Sweeney, C. A.			ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells	ONCOGENE			English	Article						ZNF217; ErbB3; CtBP2; 20q13; breast cancer	COMPARATIVE GENOMIC HYBRIDIZATION; TERMINAL BINDING-PROTEINS; LUNG-CANCER; TRANSCRIPTION FACTORS; TAMOXIFEN RESISTANCE; REPRESSOR COMPLEX; TUMOR-GROWTH; THERAPY; GENES; HER3	Understanding the mechanisms underlying ErbB3 overexpression in breast cancer will facilitate the rational design of therapies to disrupt ErbB2-ErbB3 oncogenic function. Although ErbB3 overexpression is frequently observed in breast cancer, the factors mediating its aberrant expression are poorly understood. In particular, the ErbB3 gene is not significantly amplified, raising the question as to how ErbB3 overexpression is achieved. In this study we showed that the ZNF217 transcription factor, amplified at 20q13 in similar to 20% of breast tumors, regulates ErbB3 expression. Analysis of a panel of human breast cancer cell lines (n=50) and primary human breast tumors (n=15) showed a strong positive correlation between ZNF217 and ErbB3 expression. Ectopic expression of ZNF217 in human mammary epithelial cells induced ErbB3 expression, whereas ZNF217 silencing in breast cancer cells resulted in decreased ErbB3 expression. Although ZNF217 has previously been linked with transcriptional repression because of its close association with C-terminal-binding protein (CtBP)1/2 repressor complexes, our results show that ZNF217 also activates gene expression. We showed that ZNF217 recruitment to the ErbB3 promoter is CtBP1/2-independent and that ZNF217 and CtBP1/2 have opposite roles in regulating ErbB3 expression. In addition, we identify ErbB3 as one of the mechanisms by which ZNF217 augments PI-3K/Akt signaling. Oncogene (2010) 29, 5500-5510; doi:10.1038/onc.2010.289; published online 26 July 2010	[Krig, S. R.; Miller, J. K.; Sweeney, C. A.] Univ Calif Davis, Ctr Canc, Div Basic Sci, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Frietze, S.; Farnham, P. J.] Univ Calif Davis, Div Biostat, Dept Publ Hlth, Davis, CA 95616 USA; [Beckett, L. A.] Genentech Inc, San Francisco, CA 94080 USA; [Neve, R. M.] Univ Calif Davis, Genome Ctr, Dept Pharmacol, Davis, CA 95616 USA; [Yaswen, P. I.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; Roche Holding; Genentech; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Krig, SR (corresponding author), Univ Calif Davis, Ctr Canc, Div Basic Sci, Dept Biochem & Mol Med, Res Bldg 3,Room 1100A,4645 2nd Ave, Sacramento, CA 95817 USA.	skrig@ucdavis.edu; casweeney@ucdavis.edu		Farnham, Peggy/0000-0003-4469-7914	NIH [R01 CA118384, RO1 CA45250, U54 CA112970]; Office of Energy Research, Office of Health and Biological Research, US Department of Energy [DE-AC03-76SF00098]; NIH Center for Research Resources (NCRR) [UL1 RR024146]; DOD [W81XWH-06-1-0402]; Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR024146]; NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [R01CA045240, R01CA118384, P30CA093373, U54CA112970] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Energy Research, Office of Health and Biological Research, US Department of Energy(United States Department of Energy (DOE)); NIH Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOD(United States Department of Defense); Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH grant R01 CA118384 (CS); NIH grant RO1 CA45250 (PJF); U54 CA112970 (PY, RN), and the Office of Energy Research, Office of Health and Biological Research, US Department of Energy under Contract No. DE-AC03-76SF00098 (PY) and NIH Center for Research Resources (NCRR) UL1 RR024146 (LAB). JM was a recipient of a DOD Breast Cancer Research Program Predoctoral fellowship: W81XWH-06-1-0402. We thank Dr Nelly Auersperg (U Vancouver) for the recombinant adenoviral ZNF217 construct and Jeremy Semeiks for his assistance with the adenoviral transduction experiments. We thank Dr Jeffrey Hildebrand for the CtBP2-null mef-90 fibroblasts and Dr Merlin Crossly for the CtBP2_ pcDNA_ 3.1 expression construct. We thank Dr Hongwu Chen for the pCmX vector, Dr James Trimmer for the co-REST ascites and Dr Martha Stampfer for the HMEC 184 cells. CTCS statistical support is made possible by Grant Number UL1 RR024146 from the Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. A special thank you to members of the Farnham lab for valuable discussions.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; *CORETEAM R D, 2006, R LANG ENV STAT COMP; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Folgiero V, 2007, CANCER RES, V67, P1645, DOI 10.1158/0008-5472.CAN-06-2980; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Frank DA, 2009, IDRUGS, V12, P29; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Heidenreich Olaf, 2009, V487, P221, DOI 10.1007/978-1-60327-547-7_11; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang GQ, 2005, HUM MOL GENET, V14, P3219, DOI 10.1093/hmg/ddi352; IWABUCHI H, 1995, CANCER RES, V55, P6172; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Lee JY, 2007, SCIENCE, V317, P206, DOI 10.1126/science.1146073; Li PX, 2007, INT J CANCER, V120, P1863, DOI 10.1002/ijc.22300; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nonet GH, 2001, CANCER RES, V61, P1250; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Plowright L, 2009, BRIT J CANCER, V100, P470, DOI 10.1038/sj.bjc.6604857; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; SCHLEGEL J, 1995, CANCER RES, V55, P6002; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shakya A, 2009, NAT CELL BIOL, V11, P320, DOI 10.1038/ncb1840; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; SolinasToldo S, 1996, CANCER RES, V56, P3803; Tanner MM, 1995, CLIN CANCER RES, V1, P1455; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Xue CS, 2006, CANCER RES, V66, P1418, DOI 10.1158/0008-5472.CAN-05-0550; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	46	40	43	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	40					5500	5510		10.1038/onc.2010.289	http://dx.doi.org/10.1038/onc.2010.289			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FM	20661224	Green Accepted, Green Submitted			2022-12-25	WOS:000282945800007
J	Martins, VD; Okura, M; Maric, D; Engman, DM; Vieira, M; Docampo, R; Moreno, SNJ				Martins, Vicente de Paulo; Okura, Michael; Maric, Danijela; Engman, David M.; Vieira, Mauricio; Docampo, Roberto; Moreno, Silvia N. J.			Acylation-dependent Export of Trypanosoma cruzi Phosphoinositide-specific Phospholipase C to the Outer Surface of Amastigotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-FLUORESCENT PROTEIN; N-MYRISTOYLTRANSFERASE; CALCIUM HOMEOSTASIS; FLAGELLAR MEMBRANE; CA2+ OSCILLATIONS; PLASMA-MEMBRANE; TRANS-SIALIDASE; CELL INVASION; LIPID RAFTS; H+-ATPASE	Phosphoinositide phospholipase C (PI-PLC) plays an essential role in cell signaling. A unique Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid-modified in its N terminus and localizes to the plasma membrane of amastigotes. Here, we show that TcPI-PLC is located onto the extracellular phase of the plasma membrane of amastigotes and that its N-terminal 20 amino acids are necessary and sufficient to target the fused GFP to the outer surface of the parasite. Mutagenesis of the predicted acylated residues confirmed that myristoylation of a glycine residue in the 2nd position and acyl modification of a cysteine in the 4th but not in the 8th or 15th position of the coding sequence are required for correct plasma membrane localization in T. cruzi epimastigotes or amastigotes. Interestingly, mutagenesis of the cysteine at the 8th position increased its flagellar localization. When expressed as fusion constructs with GFP, the N-terminal 6 and 10 amino acids fused to GFP are predominantly located in the cytosol and concentrated in a compartment that co-localizes with a Golgi complex marker. The N-terminal 20 amino acids of TcPI-PLC associate with lipid rafts when dually acylated. Taken together, these results indicate that N-terminal acyl modifications serve as a molecular addressing system for sending TcPI-PLC to the outer surface of the cell.	[Martins, Vicente de Paulo; Docampo, Roberto; Moreno, Silvia N. J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Martins, Vicente de Paulo; Docampo, Roberto; Moreno, Silvia N. J.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Okura, Michael; Vieira, Mauricio; Docampo, Roberto; Moreno, Silvia N. J.] Univ Illinois, Dept Pathobiol, Urbana, IL 61802 USA; [Maric, Danijela; Engman, David M.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University	Moreno, SNJ (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	smoreno@cb.uga.edu	de paulo martins, vicente/H-7182-2019	de paulo martins, vicente/0000-0001-7611-861X	National Institutes of Health [AI-058297]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-058297 (to S. N. J. M.).	Agusti R, 1997, GLYCOBIOLOGY, V7, P731, DOI 10.1093/glycob/7.6.731; ANDREWS NW, 1988, J EXP MED, V167, P300, DOI 10.1084/jem.167.2.300; Benchimol M, 1998, BIOCHEM J, V332, P695, DOI 10.1042/bj3320695; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bertello LE, 1996, MOL BIOCHEM PARASIT, V79, P143, DOI 10.1016/0166-6851(96)02645-X; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Field H, 2000, MOL BIOCHEM PARASIT, V106, P21, DOI 10.1016/S0166-6851(99)00192-9; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; FREVERT U, 1992, INFECT IMMUN, V60, P2349, DOI 10.1128/IAI.60.6.2349-2360.1992; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; HALLAK H, 1994, J BIOL CHEM, V269, P4571; Hannun YA, 2004, CURR BIOL, V14, pR163, DOI 10.1016/j.cub.2004.01.049; Irvine R, 1996, NATURE, V380, P581, DOI 10.1038/380581a0; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; MARTINS V, 2010, INFECT IMMU IN PRESS; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; MORENO SNJ, 1992, MOL BIOCHEM PARASIT, V52, P251, DOI 10.1016/0166-6851(92)90057-Q; Mortara RA, 2001, J EUKARYOT MICROBIOL, V48, P27, DOI 10.1111/j.1550-7408.2001.tb00413.x; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Okura M, 2005, J BIOL CHEM, V280, P16235, DOI 10.1074/jbc.M414535200; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PIMENTA PFP, 1989, EUR J CELL BIOL, V50, P263; Pollevick GD, 2000, J BIOL CHEM, V275, P27671; Prasad KK, 2008, MINI-REV MED CHEM, V8, P142; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Salto ML, 2002, MOL BIOCHEM PARASIT, V119, P131, DOI 10.1016/S0166-6851(01)00392-9; Saunders CM, 2002, DEVELOPMENT, V129, P3533; SCHMATZ DM, 1982, PARASITOLOGY, V85, P115, DOI 10.1017/S0031182000054202; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Vieira M, 2005, BIOCHEM J, V392, P467, DOI 10.1042/BJ20051319; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003	45	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30906	30917		10.1074/jbc.M110.142190	http://dx.doi.org/10.1074/jbc.M110.142190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20647312	Green Published, hybrid			2022-12-25	WOS:000282135500056
J	Shin, SY; Nam, JS; Lim, Y; Lee, YH				Shin, Soon Young; Nam, Jeong-Seok; Lim, Yoongho; Lee, Young Han			TNF alpha-exposed Bone Marrow-derived Mesenchymal Stem Cells Promote Locomotion of MDA-MB-231 Breast Cancer Cells through Transcriptional Activation of CXCR3 Ligand Chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; STROMAL FIBROBLASTS; RECEPTOR CXCR3; UP-REGULATION; KAPPA-B; EXPRESSION; MYOFIBROBLASTS; CXCL10; GROWTH; RHOA	Bone marrow-derived mesenchymal stem cells (BM-MSCs) are often recruited to solid tumors, integrate into the tumor stroma, and contribute to tumor development. TNF alpha is a major inflammatory cytokine present in the tumor microenvironment and has a profound influence on the progression of tumor development. This study was aimed to investigate the role of BM-MSCs in tumor promotion in response to TNF alpha. Quantitative real-time PCR arrays show that diverse cytokines/chemokines were induced in TNF alpha-treated BM-MSCs; in particular, CXCR3 ligand chemokines, including CXCL9, CXCL10, and CXCL11, were potently induced. A serial and site-directed mutation analysis in the CXCL9, CXCL10, and CXCL11 promoters revealed that NF-kappa B binding elements were responsible for TNF alpha-induced promoter activation of CXCR3 ligand chemokines. TNF alpha stimulated NF-kappa B activity, and ectopic expression of NF-kappa B enhanced TNF alpha-induced promoter activities of the CXCR3 ligand chemokines. Gel shift and supershift assays showed that NF-kappa B was associated with CXCR3 ligand chemokine promoters in response to TNF alpha treatment. All three CXCR3 ligand chemokines enhanced the migration and invasive motility of MDA-MB-231 breast cancer cells expressing CXCR3. Treatment of MDA-MB-231 cells with CXCL10 activated small GTPase of Rho family proteins, such as RhoA and Cdc42. CXCL9-, CXCL10-, or CXCL11-induced invasive capability of MDA-MB-231 cells was completely abrogated in the presence of a neutralizing anti-CXCR3 antibody in the culture medium. Moreover, CXCL9, CXCL10, and CXCL11 stimulated the expression of MMP-9, but not MMP-2, in MDA-MB-231 cells. These results suggest that BM-MSCs promote the locomotion of breast cancer cells through CXCR3 ligand-mediated actin rearrangement by TNF alpha in the tumor microenvironment.	[Shin, Soon Young; Lee, Young Han] Konkuk Univ Hosp, Inst Biomed Sci & Technol, Seoul 143729, South Korea; [Shin, Soon Young; Lee, Young Han] Konkuk Univ, Dept Biomed Sci & Technol, Res Ctr Transcript Control, Seoul 143701, South Korea; [Lim, Yoongho] Konkuk Univ, Div Biosci & Biotechnol, Biomol Informat Ctr, Seoul 143701, South Korea; [Nam, Jeong-Seok] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Gachon University	Lee, YH (corresponding author), 1 Hwayang Dong, Seoul 143701, South Korea.	yhlee58@konkuk.ac.kr			Disease Network Research Program [2009-0084181]; Ministry of Education, Science, and Technology, Republic of Korea [20090076856]	Disease Network Research Program; Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Disease Network Research Program Grant 2009-0084181) and by Basic Science Research Program Grant 20090076856 through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, Republic of Korea.	Ali S, 2007, CANCER METAST REV, V26, P401, DOI 10.1007/s10555-007-9073-z; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Emura M, 2000, IN VITRO CELL DEV-AN, V36, P77; Fries M, 2003, EUR J BIOCHEM, V270, P861, DOI 10.1046/j.1432-1033.2003.03444.x; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Goldberg-Bittman L, 2004, IMMUNOL LETT, V92, P171, DOI 10.1016/j.imlet.2003.10.020; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Suyama T, 2005, CANCER-AM CANCER SOC, V103, P258, DOI 10.1002/cncr.20747; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Tannenbaum CS, 1998, J IMMUNOL, V161, P927; Teichmann M, 2005, J PATHOL, V206, P68, DOI 10.1002/path.1745; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Zhao YY, 2009, EXP MOL MED, V41, P478, DOI 10.3858/emm.2009.41.7.053	50	66	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30731	30740		10.1074/jbc.M110.128124	http://dx.doi.org/10.1074/jbc.M110.128124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20650898	Green Published, hybrid			2022-12-25	WOS:000282135500041
J	Cantin, L; Lenoir, M; Augier, E; Vanhille, N; Dubreucq, S; Serre, F; Vouillac, C; Ahmed, SH				Cantin, Lauriane; Lenoir, Magalie; Augier, Eric; Vanhille, Nathalie; Dubreucq, Sarah; Serre, Fuschia; Vouillac, Caroline; Ahmed, Serge H.			Cocaine Is Low on the Value Ladder of Rats: Possible Evidence for Resilience to Addiction	PLOS ONE			English	Article							SELF-ADMINISTERED COCAINE; RHESUS-MONKEYS; FOOD ADDICTION; DRUG-ADDICTION; BEHAVIORAL SENSITIZATION; ALTERNATIVE REINFORCER; SUBJECTIVE RESPONSES; PARKINSONS-DISEASE; EXTENDED ACCESS; CHOICE	Background: Assessing the relative value of cocaine and how it changes with chronic drug use represents a long-standing goal in addiction research. Surprisingly, recent experiments in rats - by far the most frequently used animal model in this field - suggest that the value of cocaine is lower than previously thought. Methodology/Principal Findings: Here we report a series of choice experiments that better define the relative position of cocaine on the value ladder of rats (i.e., preference rank-ordering of different rewards). Rats were allowed to choose either taking cocaine or drinking water sweetened with saccharin - a nondrug alternative that is not biologically essential. By systematically varying the cost and concentration of sweet water, we found that cocaine is low on the value ladder of the large majority of rats, near the lowest concentrations of sweet water. In addition, a retrospective analysis of all experiments over the past 5 years revealed that no matter how heavy was past cocaine use most rats readily give up cocaine use in favor of the nondrug alternative. Only a minority, fewer than 15% at the heaviest level of past cocaine use, continued to take cocaine, even when hungry and offered a natural sugar that could relieve their need of calories. Conclusions/Significance: This pattern of results (cocaine abstinence in most rats; cocaine preference in few rats) maps well onto the epidemiology of human cocaine addiction and suggests that only a minority of rats would be vulnerable to cocaine addiction while the large majority would be resilient despite extensive drug use. Resilience to drug addiction has long been suspected in humans but could not be firmly established, mostly because it is difficult to control retrospectively for differences in drug self-exposure and/or availability in human drug users. This conclusion has important implications for preclinical research on the neurobiology of cocaine addiction and for future medication development.	Univ Victor Segalen Bordeaux 2, Inst Sante Publ Epidemiol & Dev, CNRS, UMR 5227, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Cantin, L (corresponding author), Univ Victor Segalen Bordeaux 2, Inst Sante Publ Epidemiol & Dev, CNRS, UMR 5227, Bordeaux, France.	sahmed@u-bordeaux2.fr	SERRE, Fuschia/AAU-3161-2020; AHMED, Serge H/D-5236-2014; Lenoir, Magalie/E-5797-2019	SERRE, Fuschia/0000-0002-0228-3572; Lenoir, Magalie/0000-0001-7983-1824; Ahmed, Serge/0000-0002-1225-9234	Centre National de la Recherche Scientifique (CNRS); Universite Victor-Segalen Bordeaux 2; Conseil Regional d'Aquitaine; National Research Agency (ANR); Fondation pour la Recherche Medicale (FRM); Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Victor-Segalen Bordeaux 2; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); National Research Agency (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT)	This work was supported by grants from the Centre National de la Recherche Scientifique (CNRS), the Universite Victor-Segalen Bordeaux 2, the Conseil Regional d'Aquitaine, the National Research Agency (ANR), the Fondation pour la Recherche Medicale (FRM) and the Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2006, NEUROPSYCHOPHARMACOL, V31, P563, DOI 10.1038/sj.npp.1300834; Ahmed SH, 2005, EUR J PHARMACOL, V526, P9, DOI 10.1016/j.ejphar.2005.09.036; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; AHMED SH, 2010, NEUROSCI BI IN PRESS; AHMED SH, 2009, NEUROMETHOD IN PRESS; AIGNER TG, 1978, SCIENCE, V201, P534, DOI 10.1126/science.96531; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P224; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Brown G, 2002, BEHAV PHARMACOL, V13, P157, DOI 10.1097/00008877-200203000-00007; CARROLL ME, 1989, PSYCHOPHARMACOLOGY, V97, P23, DOI 10.1007/BF00443407; CARROLL ME, 1993, PSYCHOPHARMACOLOGY, V110, P5, DOI 10.1007/BF02246944; Carroll ME, 1997, PSYCHOPHARMACOLOGY, V129, P206, DOI 10.1007/s002130050182; Christensen CJ, 2008, PSYCHOPHARMACOLOGY, V198, P221, DOI 10.1007/s00213-008-1120-0; Christensen CJ, 2009, BEHAV NEUROSCI, V123, P165, DOI 10.1037/a0013736; Christensen CJ, 2008, PHARMACOL BIOCHEM BE, V91, P209, DOI 10.1016/j.pbb.2008.07.009; DACKIS CA, 1985, NEUROSCI BIOBEHAV R, V9, P469, DOI 10.1016/0149-7634(85)90022-3; DAVIDSON ES, 1993, ADDICT BEHAV, V18, P445, DOI 10.1016/0306-4603(93)90062-E; Davis KL, 2002, NEUROPSYCHOPHARMACOL, P1557; Degenhardt L, 2008, DRUG ALCOHOL DEPEN, V93, P227, DOI 10.1016/j.drugalcdep.2007.09.024; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; ELSMORE TF, 1980, PHARMACOL BIOCHEM BE, V13, P729, DOI 10.1016/0091-3057(80)90018-0; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Evans AH, 2004, CURR OPIN NEUROL, V17, P393, DOI 10.1097/01.wco.0000137528.23126.41; FITCH TE, 1993, DRUG ALCOHOL DEPEN, V33, P119, DOI 10.1016/0376-8716(93)90053-S; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Goldstein RZ, 2010, J PSYCHOPHARMACOL, V24, P257, DOI 10.1177/0269881108096982; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; HAERTZEN CA, 1983, DRUG ALCOHOL DEPEN, V11, P147, DOI 10.1016/0376-8716(83)90076-5; Haney M, 2009, ADDICT BIOL, V14, P9, DOI 10.1111/j.1369-1600.2008.00121.x; HIGGINS ST, 1994, LIFE SCI, V55, P179, DOI 10.1016/0024-3205(94)00878-7; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HOLLARD V, 1971, J EXP ANAL BEHAV, V16, P375, DOI 10.1901/jeab.1971.16-375; Hughes JR, 2006, DRUG ALCOHOL DEPEN, V85, P91, DOI 10.1016/j.drugalcdep.2006.04.004; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kippin TE, 2006, PSYCHOPHARMACOLOGY, V187, P60, DOI 10.1007/s00213-006-0386-3; Knackstedt LA, 2007, J PHARMACOL EXP THER, V322, P1103, DOI 10.1124/jpet.107.122861; Koob GF, 2009, NAT REV DRUG DISCOV, V8, P500, DOI 10.1038/nrd2828; Lambert NM, 2006, ADDICTION, V101, P713, DOI 10.1111/j.1360-0443.2006.01408.x; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Mantsch JR, 2004, PSYCHOPHARMACOLOGY, V175, P26, DOI 10.1007/s00213-004-1778-x; Martelle JL, 2008, BEHAV PHARMACOL, V19, P743, DOI 10.1097/FBP.0b013e3283123c6c; Mattson BJ, 2003, PSYCHOPHARMACOLOGY, V167, P1, DOI 10.1007/s00213-002-1351-4; Mattson BJ, 2001, BEHAV NEUROSCI, V115, P683, DOI 10.1037/0735-7044.115.3.683; MAZUR JE, 1991, TECHNIQUES BEHAV N 1, P219; MILLER HL, 1976, J EXP ANAL BEHAV, V26, P335, DOI 10.1901/jeab.1976.26-335; NADER MA, 1991, PSYCHOPHARMACOLOGY, V105, P169, DOI 10.1007/BF02244304; Negus SS, 2005, PSYCHOPHARMACOLOGY, V181, P244, DOI 10.1007/s00213-005-2266-7; Negus SS, 2003, NEUROPSYCHOPHARMACOL, V28, P919, DOI 10.1038/sj.npp.1300096; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Paterson NE, 2003, NEUROREPORT, V14, P2229, DOI 10.1097/00001756-200312020-00019; Pelchat ML, 2009, J NUTR, V139, P620, DOI 10.3945/jn.108.097816; PICKENS R, 1968, J PHARMACOL EXP THER, V161, P122; PONCELET M, 1983, PSYCHOPHARMACOLOGY, V80, P184, DOI 10.1007/BF00427967; Reboussin BA, 2006, NEUROPSYCHOPHARMACOL, V31, P2055, DOI 10.1038/sj.npp.1301037; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; ROBINS LN, 1993, ADDICTION, V88, P1041, DOI 10.1111/j.1360-0443.1993.tb02123.x; ROBINS LN, 1974, AM J EPIDEMIOL, V99, P235, DOI 10.1093/oxfordjournals.aje.a121608; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; Russ BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007834; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Seip KM, 2008, PSYCHOPHARMACOLOGY, V199, P119, DOI 10.1007/s00213-008-1140-9; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Sofuoglu M, 2000, AM J DRUG ALCOHOL AB, V26, P591, DOI 10.1081/ADA-100101897; SPEALMAN RD, 1979, SCIENCE, V204, P1231, DOI 10.1126/science.109920; Stafford D, 1998, PSYCHOPHARMACOLOGY, V139, P169, DOI 10.1007/s002130050702; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; VANDYKE C, 1982, SCI AM, V246, P128, DOI 10.1038/scientificamerican0382-128; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Walsh SL, 2010, DRUG ALCOHOL DEPEN, V106, P28, DOI 10.1016/j.drugalcdep.2009.07.011; WEEKS JR, 1962, SCIENCE, V138, P143, DOI 10.1126/science.138.3537.143; Woolverton WL, 2002, J PHARMACOL EXP THER, V303, P211, DOI 10.1124/jpet.102.037812	81	126	126	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11592	10.1371/journal.pone.0011592	http://dx.doi.org/10.1371/journal.pone.0011592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676364	gold, Green Submitted, Green Published			2022-12-25	WOS:000280520100001
J	Rodriguez-Paris, J; Pique, L; Colen, T; Roberson, J; Gardner, P; Schrijver, I				Rodriguez-Paris, Juan; Pique, Lynn; Colen, Tahl; Roberson, Joseph; Gardner, Phyllis; Schrijver, Iris			Genotyping with a 198 Mutation Arrayed Primer Extension Array for Hereditary Hearing Loss: Assessment of Its Diagnostic Value for Medical Practice	PLOS ONE			English	Article							COCHLEAR MOTOR PROTEIN; PENDRED-SYNDROME; PHENOTYPE CORRELATION; RECESSIVE DEAFNESS; FREQUENCY; PRESTIN; GENE; PDS; IVS2-2A-GREATER-THAN-G; ENLARGEMENT	Molecular diagnostic testing of individuals with congenital sensorineural hearing loss typically begins with DNA sequencing of the GJB2 gene. If the cause of the hearing loss is not identified in GJB2, additional testing can be ordered. However, the step-wise analysis of several genes often results in a protracted diagnostic process. The more comprehensive Hereditary Hearing Loss Arrayed Primer Extension microarray enables analysis of 198 mutations across eight genes (GJB2, GJB6, GJB3, GJA1, SLC26A4, SLC26A5, MTRNR1 and MTTS1) in a single test. To evaluate the added diagnostic value of this microarray for our ethnically diverse patient population, we tested 144 individuals with congenital sensorineural hearing loss who were negative for biallelic GJB2 or GJB6 mutations. The array successfully detected all GJB2 changes previously identified in the study group, confirming excellent assay performance. Additional mutations were identified in the SLC26A4, SLC26A5 and MTRNR1 genes of 12/144 individuals (8.3%), four of whom (2.8%) had genotypes consistent with pathogenicity. These results suggest that the current format of this microarray falls short of adding diagnostic value beyond the customary testing of GJB2, perhaps reflecting the array's limitations on the number of mutations included for each gene, but more likely resulting from unknown genetic contributors to this phenotype. We conclude that mutations in other hearing loss associated genes should be incorporated in the array as knowledge of the etiology of hearing loss evolves. Such future modification of the flexible configuration of the Hereditary Hearing Loss Arrayed Primer Extension microarray would improve its impact as a diagnostic tool.	[Rodriguez-Paris, Juan; Pique, Lynn; Schrijver, Iris] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Colen, Tahl; Roberson, Joseph] Calif Ear Inst, Palo Alto, CA USA; [Gardner, Phyllis] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Schrijver, Iris] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Rodriguez-Paris, J (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	ischrijver@stanfordmed.org			Pete and Arline Harman Pediatric Clinical Scholar grant	Pete and Arline Harman Pediatric Clinical Scholar grant	This work was generously funded by the Pete and Arline Harman Pediatric Clinical Scholar grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicego M, 2006, HUM MOL GENET, V15, P2569, DOI 10.1093/hmg/ddl184; Blons H, 2004, CLIN GENET, V66, P333, DOI 10.1111/j.1399-0004.2004.00296.x; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Cremers FPM, 2007, J MED GENET, V44, P153, DOI 10.1136/jmg.2006.044784; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Gardner P, 2006, PEDIATRICS, V118, P985, DOI 10.1542/peds.2005-2519; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Kurg A, 2000, GENET TEST, V4, P1, DOI 10.1089/109065700316408; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu GP, 2000, INT J SYST SCI, V31, P63, DOI 10.1080/002077200291460; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Liu XZ, 2001, HUM MOL GENET, V10, P2945, DOI 10.1093/hmg/10.25.2945; LIU XZ, 2009, HUM GENET, V62, pCX26; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Putcha GV, 2007, GENET MED, V9, P413, DOI 10.1097/GIM.0b013e3180a03276; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; Tang HY, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-30; Teek R, 2009, INT J PEDIATR OTORHI, V73, P103, DOI 10.1016/j.ijporl.2008.10.003; TRANEBAERG L, 2008, INT J AUDIOL, V535, P45; Vele Oana, 2008, Expert Opin Med Diagn, V2, P231, DOI 10.1517/17530059.2.3.231; White KR, 2004, AM J MED GENET A, V130A, P29, DOI 10.1002/ajmg.a.30048	30	17	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11804	10.1371/journal.pone.0011804	http://dx.doi.org/10.1371/journal.pone.0011804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668687	Green Published, Green Submitted, gold			2022-12-25	WOS:000280297300027
J	Neplioueva, V; Dobrikova, EY; Mukherjee, N; Keene, JD; Gromeier, M				Neplioueva, Valentina; Dobrikova, Elena Y.; Mukherjee, Neelanjan; Keene, Jack D.; Gromeier, Matthias			Tissue Type-Specific Expression of the dsRNA-Binding Protein 76 and Genome-Wide Elucidation of Its Target mRNAs	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; NUCLEAR FACTOR-90; RIBONUCLEOPROTEIN COMPLEXES; MITOCHONDRIAL BIOGENESIS; ILF3 GENE; NF90; CELLS; IDENTIFICATION; TRANSLATION; CANCER	Background: RNA-binding proteins accompany all steps in the life of mRNAs and provide dynamic gene regulatory functions for rapid adjustment to changing extra-or intracellular conditions. The association of RNA-binding proteins with their targets is regulated through changing subcellular distribution, post-translational modification or association with other proteins. Methodology: We demonstrate that the dsRNA binding protein 76 (DRBP76), synonymous with nuclear factor 90, displays inherently distinct tissue type-specific subcellular distribution in the normal human central nervous system and in malignant brain tumors of glial origin. Altered subcellular localization and isoform distribution in malignant glioma indicate that tumor-specific changes in DRBP76-related gene products and their regulatory functions may contribute to the formation and/or maintenance of these tumors. To identify endogenous mRNA targets of DRBP76, we performed RNA-immunoprecipitation and genome-wide microarray analyses in HEK293 cells, and identified specific classes of transcripts encoding critical functions in cellular metabolism. Significance: Our data suggest that physiologic DRBP76 expression, isoform distribution and subcellular localization are profoundly altered upon malignant transformation. Thus, the functional role of DRBP76 in co- or post-transcriptional gene regulation may contribute to the neoplastic phenotype.	[Neplioueva, Valentina; Dobrikova, Elena Y.; Gromeier, Matthias] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA; [Mukherjee, Neelanjan; Keene, Jack D.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University		grome001@mc.duke.edu		Mukherjee, Neelanjan/0000-0003-0017-1400	Public Health Service [CA124756]; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE [R01CA124756] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grant CA124756 (M. G.) and a grant from Alex's Lemonade Stand Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Buaas FW, 1999, MAMM GENOME, V10, P451, DOI 10.1007/s003359901022; Buness A, 2005, BIOINFORMATICS, V21, P554, DOI 10.1093/bioinformatics/bti052; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; KAO PN, 1994, J BIOL CHEM, V269, P20691; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Marzluff William F., 1992, Gene Expression, V2, P93; Merrill MK, 2006, J VIROL, V80, P6936, DOI 10.1128/JVI.00243-06; Merrill MK, 2006, J VIROL, V80, P3147, DOI 10.1128/JVI.80.7.3147-3156.2006; Merrill RA, 2002, P NATL ACAD SCI USA, V99, P3422, DOI 10.1073/pnas.052017399; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Parrott AM, 2007, METHOD ENZYMOL, V429, P243, DOI 10.1016/S0076-6879(07)29012-3; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Reichman TW, 2003, CELL SIGNALING HDB, V3, P335; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Satoh M, 1999, J BIOL CHEM, V274, P34598, DOI 10.1074/jbc.274.49.34598; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Viranaicken W, 2006, GENOMICS, V88, P622, DOI 10.1016/j.ygeno.2006.08.006; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xu YH, 2005, MOL GENET METAB, V84, P252, DOI 10.1016/j.ymgme.2004.10.005; Xu YH, 1999, MOL GENET METAB, V68, P441, DOI 10.1006/mgme.1999.2934	51	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11710	10.1371/journal.pone.0011710	http://dx.doi.org/10.1371/journal.pone.0011710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668518	gold, Green Published, Green Submitted			2022-12-25	WOS:000280243800005
J	To, S; Rodda, SJ; Rathjen, PD; Keough, RA				To, Sarah; Rodda, Stephen J.; Rathjen, Peter D.; Keough, Rebecca A.			Modulation of CP2 Family Transcriptional Activity by CRTR-1 and Sumoylation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; SUMO MODIFICATION; LBP PROTEINS; DNA-BINDING; MOUSE; GENE; CONJUGATION; INHIBITION; ACTIVATION	CRTR-1 is a member of the CP2 family of transcription factors. Unlike other members of the family which are widely expressed, CRTR-1 expression shows specific spatio-temporal regulation. Gene targeting demonstrates that CRTR-1 plays a central role in the maturation and function of the salivary glands and the kidney. CRTR-1 has also recently been identified as a component of the complex transcriptional network that maintains pluripotency in embryonic stem (ES) cells. CRTR-1 was previously shown to be a repressor of transcription. We examine the activity of CRTR-1 in ES and other cells and show that CRTR-1 is generally an activator of transcription and that it modulates the activity of other family members, CP2, NF2d9 and altNF2d9, in a cell specific manner. We also demonstrate that CRTR-1 activity is regulated by sumoylation at a single major site, residue K30. These findings imply that functional redundancy with other family members may mask important roles for CRTR-1 in other tissues, including the blastocyst stage embryo and embryonic stem cells.	[To, Sarah; Rodda, Stephen J.; Rathjen, Peter D.; Keough, Rebecca A.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [To, Sarah; Rodda, Stephen J.; Rathjen, Peter D.; Keough, Rebecca A.] Univ Adelaide, ARC Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia; [Rathjen, Peter D.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Adelaide; University of Adelaide; University of Melbourne	To, S (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	rebecca.keough@adelaide.edu.au			University of Adelaide; Australian Research Council Special Centre for the Molecular Genetics of Development	University of Adelaide; Australian Research Council Special Centre for the Molecular Genetics of Development(Australian Research Council)	This work was funded by the University of Adelaide and the Australian Research Council Special Centre for the Molecular Genetics of Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Huang NW, 2005, MOL ENDOCRINOL, V19, P409, DOI 10.1210/me.2004-0086; Huang NW, 2000, J BIOL CHEM, V275, P2852, DOI 10.1074/jbc.275.4.2852; Kang HC, 2005, MOL CELL BIOL, V25, P6005, DOI 10.1128/MCB.25.14.6005-6020.2005; KANG T, 1993, J BIOL CHEM, V268, P9629; LIM LC, 1993, J BIOL CHEM, V268, P18008; Linke S, 2007, METHOD ENZYMOL, V435, P61, DOI 10.1016/S0076-6879(07)35004-0; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Murata T, 1998, GENES CELLS, V3, P443, DOI 10.1046/j.1365-2443.1998.00204.x; Pelton TA, 2002, J CELL SCI, V115, P329; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; Rodda S, 2001, J BIOL CHEM, V276, P3324, DOI 10.1074/jbc.M008167200; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Shirra MK, 1998, J BIOL CHEM, V273, P19260, DOI 10.1074/jbc.273.30.19260; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Veljkovic J, 2004, GENE, V343, P23, DOI 10.1016/j.gene.2004.08.010; Yamaguchi Y, 2005, DEV DYNAM, V233, P484, DOI 10.1002/dvdy.20348; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; YOON JB, 1994, MOL CELL BIOL, V14, P1776, DOI 10.1128/MCB.14.3.1776	29	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11702	10.1371/journal.pone.0011702	http://dx.doi.org/10.1371/journal.pone.0011702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661472	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300008
J	Stollhoff, R; Jost, J; Elze, T; Kennerknecht, I				Stollhoff, Rainer; Jost, Juergen; Elze, Tobias; Kennerknecht, Ingo			The Early Time Course of Compensatory Face Processing in Congenital Prosopagnosia	PLOS ONE			English	Article							HUMAN NEURAL SYSTEM; DEVELOPMENTAL PROSOPAGNOSIA; PSYCHOMETRIC FUNCTION; DETAILED EXPLORATION; COVERT RECOGNITION; 1ST REPORT; AGNOSIA; PREVALENCE; PERCEPTION; STIMULI	Background: Prosopagnosia is a selective deficit in facial identification which can be either acquired, (e.g., after brain damage), or present from birth (congenital). The face recognition deficit in prosopagnosia is characterized by worse accuracy, longer reaction times, more dispersed gaze behavior and a strong reliance on featural processing. Methods/Principal Findings: We introduce a conceptual model of an apperceptive/associative type of congenital prosopagnosia where a deficit in holistic processing is compensated by a serial inspection of isolated, informative features. Based on the model proposed we investigated performance differences in different face and shoe identification tasks between a group of 16 participants with congenital prosopagnosia and a group of 36 age-matched controls. Given enough training and unlimited stimulus presentation prosopagnosics achieved normal face identification accuracy evincing longer reaction times. The latter increase was paralleled by an equally-sized increase in stimulus presentation times needed achieve an accuracy of 80%. When the inspection time of stimuli was limited (50ms to 750ms), prosopagnosics only showed worse accuracy but no difference in reaction time. Tested for the ability to generalize from frontal to rotated views, prosopagnosics performed worse than controls across all rotation angles but the magnitude of the deficit didn't change with increasing rotation. All group differences in accuracy, reaction or presentation times were selective to face stimuli and didn't extend to shoes. Conclusions/Significance: Our study provides a characterization of congenital prosopagnosia in terms of early processing differences. More specifically, compensatory processing in congenital prosopagnosia requires an inspection of faces that is sufficiently long to allow for sequential focusing on informative features. This characterization of dysfunctional processing in prosopagnosia further emphasizes fast and holistic information encoding as two defining characteristics of normal face processing.	[Stollhoff, Rainer; Jost, Juergen; Elze, Tobias] Max Planck Inst Math Sci, Leipzig, Germany; [Jost, Juergen] Santa Fe Inst, Santa Fe, NM 87501 USA; [Kennerknecht, Ingo] Univ Munster, Inst Human Genet, D-4400 Munster, Germany	Max Planck Society; The Santa Fe Institute; University of Munster	Stollhoff, R (corresponding author), Max Planck Inst Math Sci, Leipzig, Germany.	rainer.stollhoff@mis.mpg.de		Elze, Tobias/0000-0002-2032-0496				Ariel R, 1996, CORTEX, V32, P221, DOI 10.1016/S0010-9452(96)80048-7; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Baayen R., 2008, J MEMORY LANGUAGE; Barton JJS, 2003, NEUROPSYCHOLOGIA, V41, P1703, DOI 10.1016/S0028-3932(03)00115-5; Barton JJS, 2001, NEUROLOGY, V57, P1161, DOI 10.1212/WNL.57.7.1161; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Bindemann M, 2008, PERCEPTION, V37, P33; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BURTON AM, 1991, COGNITION, V39, P129, DOI 10.1016/0010-0277(91)90041-2; Curby KM, 2009, J VISION, V9, DOI 10.1167/9.6.7; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; Della Sala S, 2003, CORTEX, V39, P533; DERENZI E, 1991, CORTEX, V27, P213, DOI 10.1016/S0010-9452(13)80125-6; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine BC, 2004, NEUROLOGY, V62, P1219, DOI 10.1212/01.WNL.0000118297.03161.B3; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Elze T, 2006, PERCEPTION, V35, P52; ELZE T, 2009, J VIS, V9, P58; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1993, PSYCHOL REV, V100, P571, DOI 10.1037/0033-295X.100.4.571; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Farkas L.G., 1981, ANTHROPOMETRY HEAD F; Faust C, 1947, NERVENARZT, V18, P294; Fox CJ, 2008, CORTEX, V44, P996, DOI 10.1016/j.cortex.2008.04.003; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; GRAND RL, 2006, BRAIN COGNITION, V61, P139; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Gruter T, 2009, NEUROSCI LETT, V453, P135, DOI 10.1016/j.neulet.2009.02.021; GRUTER M, 2004, THESIS MUNSTER U MD; Hadfield J., 2009, MCMC METHODS MULTIRE; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HECAEN H, 1962, ARCH NEUROL-CHICAGO, V7, P92, DOI 10.1001/archneur.1962.04210020014002; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennerknecht I, 2008, AM J MED GENET A, V146A, P2863, DOI 10.1002/ajmg.a.32552; Kennerknecht I, 2008, FRONT BIOSCI-LANDMRK, V13, P3150, DOI 10.2741/2916; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; KESTEN H, 1958, ANN MATH STAT, V29, P41, DOI 10.1214/aoms/1177706705; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Lange J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007414; Lissauer H., 1890, ARCH PSYCHIAT NERVEN, V21, P22; MCCONACHIE HR, 1976, CORTEX, V12, P76, DOI 10.1016/S0010-9452(76)80033-0; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Palmeri TJ, 2004, TRENDS COGN SCI, V8, P378, DOI 10.1016/j.tics.2004.06.001; R Development Core Team, 2009, R FDN STAT COMP; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RENZI ED, 1994, NEUROPSYCHOLOGIA, V32, P893; Riddoch JM, 1993, BORB BIRMINGHAM OBJE; Schmalzl L, 2008, J NEUROPSYCHOL, V2, P99, DOI 10.1348/174866407X256554; Schmalzl L, 2008, COGN NEUROPSYCHOL, V25, P704, DOI 10.1080/02643290802299350; Schwarzer G, 2007, PSYCHOL RES-PSYCH FO, V71, P583, DOI 10.1007/s00426-006-0068-0; Shepherd J.W., 1974, INT J PSYCHOL, V9, P205, DOI [10.1080/00207597408247104, DOI 10.1080/00207597408247104]; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; Thomas M, 2002, BEHAV BRAIN SCI, V25, P727, DOI 10.1017/S0140525X02000134; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Tuerlinckx F, 2006, BRIT J MATH STAT PSY, V59, P225, DOI 10.1348/000711005x79857; ULLMAN S, 1997, HIGH LEVEL VISION OB, P432; Warrington EK., 1991, VISUAL OBJECT SPACE; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WILBRAND H, 1892, DTSCH Z NERVENHEILKD, V2, P361, DOI DOI 10.1007/BF01667704	72	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11482	10.1371/journal.pone.0011482	http://dx.doi.org/10.1371/journal.pone.0011482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KQ	20657764	Green Submitted, Green Published, gold			2022-12-25	WOS:000280197500002
J	Borchert, GM; Holton, NW; Edwards, KA; Vogel, LA; Larson, ED				Borchert, Glen M.; Holton, Nathaniel W.; Edwards, Kevin A.; Vogel, Laura A.; Larson, Erik D.			Histone H2A and H2B Are Monoubiquitinated at AID-Targeted Loci	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; ACTIVATION-INDUCED DEAMINASE; CELL NUCLEAR ANTIGEN; SOMATIC HYPERMUTATION; GENE CONVERSION; MISMATCH; REPAIR; DNA; UBIQUITINATION	Background: Somatic hypermutation introduces base substitutions into the rearranged and expressed immunoglobulin (Ig) variable regions to promote immunity. This pathway requires and is initiated by the Activation Induced Deaminase (AID) protein, which deaminates cytidine to produce uracils and UG mismatches at the Ig genes. Subsequent processing of uracil by mismatch repair and base excision repair factors contributes to mutagenesis. While selective for certain genomic targets, the chromatin modifications which distinguish hypermutating from non-hypermutating loci are not defined. Methodology/Principal Findings: Here, we show that AID-targeted loci in mammalian B cells contain ubiquitinated chromatin. Chromatin immunoprecipitation (ChIP) analysis of a constitutively hypermutating Burkitt's B cell line, Ramos, revealed the presence of monoubiquitinated forms of both histone H2A and H2B at two AID-associated loci, but not at control loci which are expressed but not hypermutated. Similar analysis using LPS activated primary murine splenocytes showed enrichment of the expressed V(H) and S gamma 3 switch regions upon ChIP with antibody specific to AID and to monoubiquitinated H2A and H2B. In the mechanism of mammalian hypermutation, AID may interact with ubiquitinated chromatin because confocal immunofluorescence microscopy visualized AID colocalized with monoubiquitinated H2B within discrete nuclear foci. Conclusions/Significance: Our results indicate that monoubiquitinated histones accompany active somatic hypermutation, revealing part of the histone code marking AID-targeted loci. This expands the current view of the chromatin state during hypermutation by identifying a specific nucleosome architecture associated with somatic hypermutation.	[Borchert, Glen M.; Holton, Nathaniel W.; Edwards, Kevin A.; Vogel, Laura A.; Larson, Erik D.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	Illinois State University	Borchert, GM (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.	elarson@ilstu.edu	Edwards, Kevin Andrew/GOE-3539-2022	Edwards, Kevin Andrew/0000-0003-4721-5626; Vogel, Laura/0000-0002-9305-175X; borchert, glen/0000-0002-6182-7154; Holton, Nate/0000-0001-7937-773X	National Institutes of Health [R15CA137608]; ISU School of Biological Sciences; NATIONAL CANCER INSTITUTE [R15CA137608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISU School of Biological Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health R15CA137608 to E.D.L. and the ISU School of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bachl J, 2006, P NATL ACAD SCI USA, V103, P12081, DOI 10.1073/pnas.0605146103; Bemark M, 2000, ONCOGENE, V19, P3404, DOI 10.1038/sj.onc.1203686; Blaeser Anthony, 2008, Immun Ageing, V5, P15, DOI 10.1186/1742-4933-5-15; Cascalho M, 1999, Dev Immunol, V7, P43, DOI 10.1155/1999/24514; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Game JC, 2009, DNA REPAIR, V8, P470, DOI 10.1016/j.dnarep.2009.01.007; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kitao H, 2008, INT IMMUNOL, V20, P277, DOI 10.1093/intimm/dxm140; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Langerak P, 2009, PHILOS T R SOC B, V364, P621, DOI 10.1098/rstb.2008.0223; Larson ED, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-211; Larson ED, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-94; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; Simpson LJ, 2006, EMBO REP, V7, P927, DOI 10.1038/sj.embor.7400777; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; van der Knaap JA, 2010, MOL CELL BIOL, V30, P736, DOI 10.1128/MCB.01121-09; VASSILEV AP, 1995, J CELL SCI, V108, P1205; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yang GB, 2005, P NATL ACAD SCI USA, V102, P17083, DOI 10.1073/pnas.0501338102	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11641	10.1371/journal.pone.0011641	http://dx.doi.org/10.1371/journal.pone.0011641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661291	Green Published, Green Submitted, gold			2022-12-25	WOS:000279980800023
J	Eshaghi, M; Lee, JH; Zhu, L; Poon, SY; Li, JT; Cho, KH; Chu, ZQ; Karuturi, RKM; Liu, J				Eshaghi, Majid; Lee, Jong Hoon; Zhu, Lei; Poon, Suk Yean; Li, Juntao; Cho, Kwang-Hyun; Chu, Zhaoqing; Karuturi, R. Krishna M.; Liu, Jianhua			Genomic Binding Profiling of the Fission Yeast Stress-Activated MAPK Sty1 and the bZIP Transcriptional Activator Atf1 in Response to H2O2	PLOS ONE			English	Article							RECOMBINATION HOT-SPOT; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; MEIOTIC RECOMBINATION; PROTEIN-KINASE; CELL-CYCLE; REGULATED GENES; SPC1 KINASE; GROWTH-RATE; PHOSPHORYLATION	Background: The evolutionally conserved MAPK Sty1 and bZIP transcriptional activator Atf1 are known to play a pivotal role in response to the reactive oxygen species in S. pombe. However, it is unclear whether all of the H2O2-induced genes are directly regulated by the Sty1-Atf1 pathway and involved in growth fitness under H2O2-induced stress conditions. Methodology/Principal Findings: Here we present the study on ChIP-chip mapping of the genomic binding sites for Sty1, Atf1, and the Atf1's binding partner Pcr1; the genome-wide transcriptional profiling of the atf1 Delta and pcr1 Delta strains in response to H2O2; and the phenotypic assessment of similar to 90 Atf1/Pcr1-bound or unbound genes for growth fitness under H2O2 conditions. ChIP-chip analysis shows that Atf1 and Pcr1 binding sites are overlapped in the genome and constitutively present before H2O2 stress. On the other hand, Sty1 recruitment primarily occurs at the Atf1/Pcr1 binding sites and is induced by H2O2. We found that Atf1/Pcr1 is clearly responsible for the high-level transcriptional response to H2O2. Furthermore, phenotypic assessment indicates that among the H2O2-induced genes, Atf1/Pcr1-bound genes exhibit a higher likelihood of functional requirement for growth fitness under the stress condition than the Atf1/Pcr1-unbound genes do. Notably, we found that the Atf1/Pcr1-bound genes regardless of their responsiveness to H2O2 show a high probability of requirement for growth fitness. Conclusion/Significance: Together, our analyses on global mapping of protein binding sites, genome-wide transcriptional profiling, and phenotypic assessment provide insight into mechanisms for global transcriptional regulation by the Sty1-Atf1 pathway in response to H2O2-induced reactive oxygen species.	[Eshaghi, Majid; Zhu, Lei; Poon, Suk Yean; Li, Juntao; Chu, Zhaoqing; Karuturi, R. Krishna M.; Liu, Jianhua] Genome Inst Singapore, Singapore, Singapore; [Lee, Jong Hoon; Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon, South Korea; [Liu, Jianhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Korea Advanced Institute of Science & Technology (KAIST); National University of Singapore	Eshaghi, M (corresponding author), Genome Inst Singapore, Singapore, Singapore.	liujh@gis.a-star.edu.sg	Cho, Kwang-Hyun/C-1684-2011	Liu, Jianhua/0000-0003-1165-9348; ?, ??/0000-0002-3982-9858	Korea Ministry of Education, Science & Technology (MEST) [2009-0086964, 2010-0017662]; GIS and Agency for Science, Technology and Research (A-STAR), Singapore [GIS/06-113401]	Korea Ministry of Education, Science & Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); GIS and Agency for Science, Technology and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was partly supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Ministry of Education, Science & Technology (MEST) through the grants (2009-0086964 and 2010-0017662) to KHC and by the GIS and Agency for Science, Technology and Research (A-STAR), Singapore (Grant GIS/06-113401) to J. Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CLEVELAND WS, 1979, BIOL PSYCHIAT, V44, P775; DAVIDSON PW, 2004, J POLICY PRACT INTEL, V1, P2, DOI DOI 10.1111/J.1741-1130.2004.04001.X; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gao J, 2008, NUCLEIC ACIDS RES, V36, P2838, DOI 10.1093/nar/gkn037; Gao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005533; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harrison C, 2005, EMBO J, V24, P599, DOI 10.1038/sj.emboj.7600536; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kon N, 1998, MOL CELL BIOL, V18, P7575, DOI 10.1128/MCB.18.12.7575; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Ohmiya R, 1999, MOL GEN GENET, V261, P297, DOI 10.1007/s004380050970; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rodriguez-Gabriel MA, 2005, EUKARYOT CELL, V4, P1396, DOI 10.1128/EC.4.8.1396-1402.2005; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	54	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11620	10.1371/journal.pone.0011620	http://dx.doi.org/10.1371/journal.pone.0011620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661279	Green Submitted, Green Published, gold			2022-12-25	WOS:000279980800009
J	Chaste, P; Clement, N; Mercati, O; Guillaume, JL; Delorme, R; Botros, HG; Pagan, C; Perivier, S; Scheid, I; Nygren, G; Anckarsater, H; Rastam, M; Stahlberg, O; Gillberg, C; Serrano, E; Lemiere, N; Launay, JM; Mouren-Simeoni, MC; Leboyer, M; Gillberg, C; Jockers, R; Bourgeron, T				Chaste, Pauline; Clement, Nathalie; Mercati, Oriane; Guillaume, Jean-Luc; Delorme, Richard; Botros, Hany Goubran; Pagan, Cecile; Perivier, Samuel; Scheid, Isabelle; Nygren, Gudrun; Anckarsater, Henrik; Rastam, Maria; Stahlberg, Ola; Gillberg, Carina; Serrano, Emilie; Lemiere, Nathalie; Launay, Jean Marie; Mouren-Simeoni, Marie Christine; Leboyer, Marion; Gillberg, Christopher; Jockers, Ralf; Bourgeron, Thomas			Identification of Pathway-Biased and Deleterious Melatonin Receptor Mutants in Autism Spectrum Disorders and in the General Population	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; DIAGNOSTIC INTERVIEW; SLEEP PATTERNS; CHILDREN; GPR50; HETERODIMERIZATION; VARIANT; MTNR1B	Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders ( ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatoninrelated receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The majority of these variations altered receptor function. Particularly interesting mutants are MT1-I49N, which is devoid of any melatonin binding and cell surface expression, and MT1-G166E and MT1-I212T, which showed severely impaired cell surface expression. Of note, several mutants possessed pathway-selective signaling properties, some preferentially inhibiting the adenylyl cyclase pathway, others preferentially activating the MAPK pathway. The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for ASD ( MTNR1A case 3.6% vs controls 4.4%; MTNR1B case 4.7% vs 3% controls). Concerning GPR50, we detected a significant association between ASD and two variations, D502-505 and T532A, in affected males, but it did not hold up after Bonferonni correction for multiple testing. Our results represent the first functional ascertainment of melatonin receptors in humans and constitute a basis for future structure-function studies and for interpreting genetic data on the melatonin pathway in patients.	[Chaste, Pauline; Mercati, Oriane; Delorme, Richard; Botros, Hany Goubran; Pagan, Cecile; Scheid, Isabelle; Serrano, Emilie; Lemiere, Nathalie; Bourgeron, Thomas] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Delorme, Richard; Perivier, Samuel; Mouren-Simeoni, Marie Christine] Hop Robert Debre, AP HP, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] INSERM, U1016, Paris, France; [Nygren, Gudrun; Anckarsater, Henrik; Stahlberg, Ola; Gillberg, Carina] Gothenburg Univ, Dept Child & Adolescent Psychiat, Gothenburg, Sweden; [Anckarsater, Henrik] Lund Univ, Inst Clin Sci, Malmo, Sweden; [Rastam, Maria] Lund Univ, Dept Clin Sci Lund, Lund, Sweden; [Launay, Jean Marie] Hop Lariboisiere, AP HP, IFR 139, Serv Biochim,EA 3621, F-75475 Paris, France; [Leboyer, Marion] Univ Paris 12, INSERM, Inst Mondor Rech Biomed, U955, Creteil, France; [Leboyer, Marion; Bourgeron, Thomas] Fdn Fondamental, Creteil, France; [Gillberg, Christopher; Bourgeron, Thomas] St George Hosp, Sch Med, London, England; [Bourgeron, Thomas] Univ Paris 07, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Gothenburg; Lund University; Lund University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); St Georges University London; UDICE-French Research Universities; Universite Paris Cite	Chaste, P (corresponding author), Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France.	ralf.jockers@inserm.fr	Jockers, Ralf/Q-2100-2019; Jockers, Ralf/P-2272-2017; Leboyer, Marion/AAW-3648-2021	Jockers, Ralf/0000-0002-4354-1750; Jockers, Ralf/0000-0002-4354-1750; Leboyer, Marion/0000-0001-5473-3697; Bourgeron, Thomas/0000-0001-8164-9220; Delorme, Richard/0000-0002-5614-3663	Institut Pasteur; University Denis Diderot Paris 7; University Paris Descarte; INSERM; CNRS; Fondation pour la Recherche Medicale; Foundation Orange; Fondation de France; Foundation FondaMentale; Swedish Science Council	Institut Pasteur(European Commission); University Denis Diderot Paris 7; University Paris Descarte; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Foundation Orange; Fondation de France(Fondation de France); Foundation FondaMentale; Swedish Science Council	This work was supported by the Institut Pasteur, University Denis Diderot Paris 7, University Paris Descartes, INSERM, CNRS, Fondation pour la Recherche Medicale ("Equipe FRM'', RJ), Foundation Orange, Fondation de France, Foundation FondaMentale, and by the Swedish Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allik H, 2006, J AUTISM DEV DISORD, V36, P585, DOI 10.1007/s10803-006-0099-9; Andersen IM, 2008, J CHILD NEUROL, V23, P482, DOI 10.1177/0883073807309783; Arendt J, 2003, J NEUROENDOCRINOL, V15, P427, DOI 10.1046/j.1365-2826.2003.00987.x; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Cann HM, 2002, SCIENCE, V296, P261; Garstang J, 2006, CHILD CARE HLTH DEV, V32, P585, DOI 10.1111/j.1365-2214.2006.00616.x; Gillberg C, 2001, AUTISM, V5, P57, DOI 10.1177/1362361301005001006; Grunewald E, 2009, MOL CELL NEUROSCI, V42, P363, DOI 10.1016/j.mcn.2009.08.007; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hare DJ, 2006, AUTISM, V10, P565, DOI 10.1177/1362361306068509; Ishizaki Asayo, 1999, No To Hattatsu, V31, P428; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Jonsson L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-10; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Melke J, 2008, MOL PSYCHIATR, V13, P90, DOI 10.1038/sj.mp.4002016; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Paavonen EJ, 2003, J CHILD ADOL PSYCHOP, V13, P83, DOI 10.1089/104454603321666225; Patzold LM, 1998, J PAEDIATR CHILD H, V34, P528, DOI 10.1046/j.1440-1754.1998.00291.x; Petit L, 1999, BIOCHEM PHARMACOL, V58, P633, DOI 10.1016/S0006-2952(99)00134-3; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Taira M, 1998, PSYCHIAT CLIN NEUROS, V52, P182, DOI 10.1111/j.1440-1819.1998.tb01018.x; Tani P, 2004, NEUROPSYCHOBIOLOGY, V50, P147, DOI 10.1159/000079106; Thomson PA, 2005, MOL PSYCHIATR, V10, P470, DOI 10.1038/sj.mp.4001593; Wiggs L, 2004, DEV MED CHILD NEUROL, V46, P372; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Wirojanan J, 2009, J CLIN SLEEP MED, V5, P145	33	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11495	10.1371/journal.pone.0011495	http://dx.doi.org/10.1371/journal.pone.0011495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625VR	20657642	Green Published, Green Submitted, gold			2022-12-25	WOS:000279924500002
J	Bublil, EM; Pines, G; Patel, G; Fruhwirth, G; Ng, T; Yarden, Y				Bublil, Erez M.; Pines, Gur; Patel, Gargi; Fruhwirth, Gilbert; Ng, Tony; Yarden, Yosef			Kinase-mediated quasi-dimers of EGFR	FASEB JOURNAL			English	Article						growth factor; kinase inhibitor; oncogene; receptor tyrosine kinase; receptor dimerization	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR EGFR; TYROSINE KINASE; CRYSTAL-STRUCTURE; EXTRACELLULAR REGION; ERBB RECEPTORS; DOMAIN; ACTIVATION; MECHANISM; INHIBITOR	Ligand-induced dimerization of the epidermal growth factor receptor (ErbB-1/EGFR) involves conformational changes that expose an extracellular dimerization interface. Subsequent alterations within the cytoplasmic kinase domain, which culminate in tyrosine phosphorylation, are less understood. Our study addressed this question by using two strategies: a chimeric receptor approach employed ErbB-3, whose defective kinase domain was replaced by the respective part of EGFR. The implanted full-length kinase, unlike its subdomains, conferred dimerization and catalysis. The data infer that the kinase function of EGFR is restrained by the carboxyl tail; once grafted distally to the ectopic tail of ErbB-3, the kinase domain acquires quasi-dimerization and activation. In an attempt to alternatively refold the cytoplasmic tail, our other approach employed kinase inhibitors. Biophysical measurements and covalent cross-linking analyses showed that inhibitors targeting the active conformation of EGFR, in contrast to a compound recognizing the inactive conformation, induce quasi-dimers in a manner similar to the chimeric ErbB-3 molecule. Collectively, these observations unveil kinase domain-mediated quasi-dimers, which are regulated by an autoinhibitory carboxyl tail. On the basis of these observations, we propose that quasi-dimers precede formation of ligand-induced, fully active dimers, which are stabilized by both extracellular and intracellular receptor-receptor interactions.-Bublil, E. M., Pines, G., Patel, G., Fruhwirth, G., Ng, T., Yosef Yarden. Kinase-mediated quasi-dimers of EGFR. FASEB J. 24, 4744-4755 (2010). www.fasebj.org	[Bublil, Erez M.; Pines, Gur; Yarden, Yosef] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Patel, Gargi; Fruhwirth, Gilbert; Ng, Tony] Kings Coll London, Randall Div, Richard Dimbleby Dept Canc Res, London WC2R 2LS, England; [Patel, Gargi; Fruhwirth, Gilbert; Ng, Tony] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Weizmann Institute of Science; University of London; King's College London; University of London; King's College London	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, Candiotty Bldg,Room 302,1 Hertzl St, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	Pines, Gur/X-7501-2019; YARDEN, YOSEF/K-1467-2012; Patel, Gargi/AAG-2715-2019; Fruhwirth, Gilbert/AAP-5559-2021	Pines, Gur/0000-0002-1757-6722; Fruhwirth, Gilbert/0000-0002-1438-2674; Patel, Gargi/0000-0002-5268-4753; Ng, Tony/0000-0003-3894-5619	Cancer Research UK; Engineering and Physical Sciences Research Council; Medical Research Council; UK Department of Health; U.S. National Cancer Institute (NCI) [CA072981]; German Science Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [R37CA072981, R01CA072981] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health; U.S. National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Science Foundation(German Research Foundation (DFG)); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank members of their groups for insightful comments. G.P. is supported by a Cancer Research UK Clinical Training Fellowship. G.F. is supported by the King's College London-University College London Comprehensive Cancer Imaging Centre, funded by Cancer Research UK and the Engineering and Physical Sciences Research Council, in association with the Medical Research Council and the UK Department of Health. Y.Y. is the incumbent of the Harold and Zelda Goldenberg Professorial Chair. The EGFR-mGFP plasmid was a kind gift of Melanie Keppler (Richard Dimbleby Laboratory, King's College London). The multiphoton FLIM systems with in-house acquisition/analysis software were built by Simon Ameer-Beg (King's College London), Paul Barber (Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK), and Borivoj Vojnovic (Gray Institute). This work is supported by grants from the U.S. National Cancer Institute (NCI; CA072981), the German Science Foundation, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.	Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Berger MB, 2004, FEBS LETT, V569, P332, DOI 10.1016/j.febslet.2004.06.014; Boerner JL, 2003, EXP CELL RES, V284, P111, DOI 10.1016/S0014-4827(02)00096-4; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Frederick L, 2000, CANCER RES, V60, P1383; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; Landgraf R, 2000, BIOCHEMISTRY-US, V39, P8503, DOI 10.1021/bi000953+; Makrogianneli K, 2009, MOL CELL BIOL, V29, P2997, DOI 10.1128/MCB.01008-08; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; Spector N, 2008, CLIN BREAST CANCER, V8, pS94, DOI 10.3816/CBC.2008.s.005; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	43	39	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4744	4755		10.1096/fj.10-166199	http://dx.doi.org/10.1096/fj.10-166199			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20682838	Green Published			2022-12-25	WOS:000284824400015
J	Knowles, HJ; Cleton-Jansen, AM; Korsching, E; Athanasou, NA				Knowles, Helen J.; Cleton-Jansen, Anne-Marie; Korsching, Eberhard; Athanasou, Nicholas A.			Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4	FASEB JOURNAL			English	Article						osteoblast; proliferation; differentiation; osteoclastogenesis; pathological bone resorption	ENDOTHELIAL-CELL ADHESION; GENE-EXPRESSION; TARGET GENE; IN-VITRO; TUMOR; ANGIOGENESIS; INHIBITION; MICE; DIFFERENTIATION; ADIPONECTIN	Hypoxia and the hypoxia-inducible factor (HIF) transcription factor regulate angiogenic-osteogenic coupling and osteoclast-mediated bone resorption. To determine how HIF might coordinate osteoclast and osteoblast function, we studied angiopoietin-like 4 (ANGPTL4), the top HIF target gene in an Illumina HumanWG-6 v3.0 48k array of normoxic vs. hypoxic osteoclasts differentiated from human CD14(+) monocytes (14.3-fold induction, P<0.0004). ANGPTL4 mRNA and protein were induced by 24 h at 2% O-2 in human primary osteoclasts, monocytes, and osteoblasts. ANGPTL4 protein was observed by immunofluorescence in osteoclasts and osteoblasts in vivo. Normoxic inducers of HIF (CoCl2, desferrioxamine, and L-mimosine) and 100 ng/ml ANGPTL4 stimulated osteoclastic resorption 2- to 3-fold in assays of lacunar dentine resorption, without affecting osteoclast viability. Isoform-specific HIF-1 alpha small interfering RNA ablated hypoxic induction of ANGPTL4 and of resorption, which was rescued by addition of exogenous ANGPTL4 (P<0.001). In the osteoblastic Saos2 cell line, ANGPTL4 caused a dose-dependent increase in proliferation (P<0.01, 100 ng/ml) and, at lower doses (1-25 ng/ml), mineralization. These results demonstrate that HIF is sufficient to enhance osteoclast-mediated bone resorption and that ANGPTL4 can compensate for HIF-1 alpha deficiency with respect to stimulation of osteoclast activity and also augments osteoblast proliferation and differentiation.-Knowles, H. J., Cleton-Jansen, A.-M., Korsching, E., and Athanasou, N.A. Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB J. 24, 4648-4659 (2010). www.fasebj.org	[Knowles, Helen J.] Univ Oxford, Nuffield Orthopaed Ctr, Botnar Res Ctr, Oxford OX3 7LD, England; [Athanasou, Nicholas A.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Dept Pathol, Oxford, England; [Cleton-Jansen, Anne-Marie] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Korsching, Eberhard] Univ Munster, Inst Pathol, Munster, Germany	Nuffield Orthopaedic Centre; University of Oxford; Nuffield Orthopaedic Centre; University of Oxford; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Munster	Knowles, HJ (corresponding author), Univ Oxford, Nuffield Orthopaed Ctr, Botnar Res Ctr, Oxford OX3 7LD, England.	helen.knowles@ndorms.ox.ac.uk	Knowles, Helen/F-3857-2018	Knowles, Helen/0000-0002-9575-6067	EuroBoNeT; European Commission [LSH-CCT-2006-018 814]; Arthritis Research UK [MP/19200]; Oxford National Institute Health Research Biomedical Research Unit (NIHR BRU); German Bundesministerium fur Bildung und Forschung [01GM0869]; Versus Arthritis [19200] Funding Source: researchfish	EuroBoNeT(European CommissionEuropean Commission Joint Research Centre); European Commission(European CommissionEuropean Commission Joint Research Centre); Arthritis Research UK(Versus Arthritis); Oxford National Institute Health Research Biomedical Research Unit (NIHR BRU); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Versus Arthritis(Versus Arthritis)	This study was funded by EuroBoNeT, a European Commission-granted European Network of Excellence for studying the pathology and genetics of bone tumors (LSH-CCT-2006-018 814). H.J.K. is also funded by Arthritis Research UK (MP/19200). H.J.K. and N.A.A. acknowledge support from the Oxford National Institute Health Research Biomedical Research Unit (NIHR BRU). E.K. is also funded by the German Bundesministerium fur Bildung und Forschung (01GM0869).	Adachi H, 2009, BIOCHEM BIOPH RES CO, V379, P806, DOI 10.1016/j.bbrc.2008.12.018; ADERKA D, 1989, J IMMUNOL, V143, P3517; Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321; Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Cornish J, 2006, BONE, V38, pS9, DOI 10.1016/j.bone.2006.01.071; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Fuller K, 2007, CLIN SCI, V112, P567, DOI 10.1042/CS20060274; Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grey A, 2008, OSTEOPOROSIS INT, V19, P129, DOI 10.1007/s00198-007-0477-y; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Ito Y, 2003, CANCER RES, V63, P6651; JOYNER CJ, 1992, BONE MINER, V16, P37, DOI 10.1016/0169-6009(92)90820-4; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; Knowles HJ, 2009, HISTOL HISTOPATHOL, V24, P337, DOI 10.14670/HH-24.337; Knowles HJ, 2009, J PATHOL, V218, P256, DOI 10.1002/path.2534; Komatsu DE, 2007, J BONE MINER RES, V22, P366, DOI 10.1359/JBMR.061207; Kurosaka D, 2003, ANN RHEUM DIS, V62, P677, DOI 10.1136/ard.62.7.677; Lau YS, 2005, HUM PATHOL, V36, P945, DOI 10.1016/j.humpath.2005.07.005; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Mandard S, 2006, J BIOL CHEM, V281, P21575; Murata M, 2009, J ORTHOP RES, V27, P50, DOI 10.1002/jor.20703; Muzylak M, 2006, CALCIFIED TISSUE INT, V79, P301, DOI 10.1007/s00223-006-0082-7; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pan BQ, 2004, BONE, V34, P112, DOI 10.1016/j.bone.2003.08.013; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Patntirapong S, 2009, BIOMATERIALS, V30, P548, DOI 10.1016/j.biomaterials.2008.09.062; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Seitz S, 2006, GENE CHROMOSOME CANC, V45, P612, DOI 10.1002/gcc.20325; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Sowter HM, 2003, CANCER RES, V63, P6130; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thommesein L, 2006, J CELL BIOCHEM, V99, P824, DOI 10.1002/jcb.20915; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000	64	82	87	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2010	24	12					4648	4659		10.1096/fj.10-162230	http://dx.doi.org/10.1096/fj.10-162230			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20667978	Green Published			2022-12-25	WOS:000284824400006
J	Idris, AI; Krishnan, M; Simic, P; Landao-Bassonga, E; Mollat, P; Vukicevic, S; Ralston, SH				Idris, Aymen I.; Krishnan, Maala; Simic, Petra; Landao-Bassonga, Euphemie; Mollat, Patrick; Vukicevic, Slobodan; Ralston, Stuart H.			Small molecule inhibitors of I kappa B kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo	FASEB JOURNAL			English	Article						IKK; TAK1; NF kappa B; osteoblast; osteoporosis	HIGHLY SELECTIVE INHIBITOR; MICE; DIFFERENTIATION; ARTHRITIS; APOPTOSIS; BLOCKS; ALPHA; INFLAMMATION; PARTHENOLIDE; BMS-345541	The NF kappa B pathway plays a critical role in the regulation of osteoclast activity, and activation of the pathway is dependent on I kappa B kinase (IKK), which phosphorylates I kappa B, targeting it for proteasomal degradation. Pharmacological inhibitors of IKK exhibit anti-inflammatory properties and prevent bone erosions in models of inflammatory arthritis. However, the effects of these agents on osteoblast function and ovariectomy-induced bone loss remain unknown. Here we examined the effects of the IKK inhibitors celastrol, BMS-345541, and parthenolide on bone cell function in vitro and ovariectomy-induced bone loss in vivo. All three compounds inhibited RANKL-induced signaling in osteoclasts, caused osteoclast apoptosis, and inhibited osteoclast formation. Although parthenolide and BMS-345541 had no inhibitory effects on osteoblast function, celastrol prevented IL1 beta-induced TAK1 activation and inhibited osteoblast growth, differentiation, and bone nodule formation. The selective IKK inhibitors parthenolide and BMS-345541 prevented ovariectomy-induced bone loss by inhibiting osteoclastic bone resorption. We conclude that pharmacological inhibitors of IKK inhibit several critical signaling pathways in osteoclasts necessary for cell survival, formation, and activity in vitro and bone loss in vivo. Accordingly, IKK inhibitors may be of value in the prevention and treatment of bone diseases characterized by increased bone loss such as postmenopausal osteoporosis.-Idris, A. I., Krishnan, M., Simic, P., Landao-Bassonga, E., Mollat, P., Vukicevic, S., Ralston, S. H. Small molecule inhibitors of I kappa B kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo. FASEB J. 24, 4545-4555 (2010). www.fasebj.org	[Idris, Aymen I.; Krishnan, Maala; Landao-Bassonga, Euphemie; Ralston, Stuart H.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Rheumat Dis Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Simic, Petra; Vukicevic, Slobodan] Univ Zagreb, Sch Med, Dept Anat, Zagreb 41001, Croatia; [Mollat, Patrick] Galapagos Soc Act Simplifiee Unipersonnelle, Romainville, France	University of Edinburgh; University of Zagreb	Ralston, SH (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Rheumat Dis Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	stuart.ralston@ed.ac.uk	Vukicevic, Slobodan/AEG-2646-2022; Idris, Aymen I/AAX-1138-2020	Vukicevic, Slobodan/0000-0003-4076-0285; Idris, Aymen I/0000-0003-4327-5306; Landao-Bassonga, Euphemie/0000-0002-5142-2946	Arthritis Research Campaign (UK) (ARC) [17687, 15389]; European Calcified Tissue Society (ECTS)/Amgen	Arthritis Research Campaign (UK) (ARC)(Versus Arthritis); European Calcified Tissue Society (ECTS)/Amgen(Amgen)	These studies were supported in part by grants from the Arthritis Research Campaign (UK) (ARC 17687 and 15389) and by an European Calcified Tissue Society (ECTS)/Amgen fellowship grant to A.I.I.	Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Hehner SP, 1999, J IMMUNOL, V163, P5617; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Idris A, 2008, BIOCHEM BIOPH RES CO, V371, P94, DOI 10.1016/j.bbrc.2008.04.014; Idris AI, 2008, ENDOCRINOLOGY, V149, P5619, DOI 10.1210/en.2008-0150; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Idris AI, 2009, MOL CANCER THER, V8, P2339, DOI 10.1158/1535-7163.MCT-09-0133; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Schopf L, 2006, ARTHRITIS RHEUM-US, V54, P3163, DOI 10.1002/art.22081; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Stewart TL, 2005, CALCIFIED TISSUE INT, V77, P113, DOI 10.1007/s00223-004-0188-8; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; VANTHOF RJ, 2003, BONE RES PROTOCOLS, P145; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220; Yip KH, 2004, J BONE MINER RES, V19, pS284	36	36	36	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4545	4555		10.1096/fj.10-164095	http://dx.doi.org/10.1096/fj.10-164095			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20647545				2022-12-25	WOS:000283861100039
J	Xiao, JX; Addabbo, RM; Lauer, JL; Fields, GB; Baum, J				Xiao, Jianxi; Addabbo, Rayna M.; Lauer, Janelle L.; Fields, Gregg B.; Baum, Jean			Local Conformation and Dynamics of Isoleucine in the Collagenase Cleavage Site Provide a Recognition Signal for Matrix Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; HUMAN NEUTROPHIL COLLAGENASE; HUMAN FIBROBLAST; STRUCTURAL-PROPERTIES; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; I COLLAGEN; PEPTIDE; SEQUENCE; SPECIFICITY	The mechanism by which enzymes recognize the "uniform" collagen triple helix is not well understood. Matrix metalloproteinases ( MMPs) cleave collagen after the Gly residue of the triplet sequence Gly similar to [Ile/Leu]-[Ala/Leu] at a single, unique, position along the peptide chain. Sequence analysis of types I-III collagen has revealed a 5-triplet sequence pattern in which the natural cleavage triplets are always flanked by a specific distribution of imino acids. NMR and MMP kinetic studies of a series of homotrimer peptides that model type III collagen have been performed to correlate conformation and dynamics at, and near, the cleavage site to collagenolytic activity. A peptide that models the natural cleavage site is significantly more active than a peptide that models a potential but non-cleavable site just 2-triplets away and NMR studies show clearly that the Ile in the leading chain of the cleavage peptide is more exposed to solvent and less locally stable than the Ile in the middle and lagging chains. We propose that the unique local instability of Ile at the cleavage site in part arises from the placement of the conserved Pro at the P3 subsite. NMR studies of peptides with Pro substitutions indicate that the local dynamics of the three chains are directly modulated by their proximity to Pro. Correlation of peptide activity to NMR data shows that a single locally unstable chain at the cleavage site, rather than two or three labile chains, is more favorable for cleavage by MMP-1 and may be the determining factor for collagen recognition.	[Xiao, Jianxi; Addabbo, Rayna M.; Baum, Jean] Rutgers State Univ, BIOMAPS Inst, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Lauer, Janelle L.; Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	Rutgers State University New Brunswick; University of Texas System; University of Texas Health San Antonio	Baum, J (corresponding author), Rutgers State Univ, BIOMAPS Inst, Dept Chem & Chem Biol, 610 Taylor Rd, Piscataway, NJ 08854 USA.	jean.baum@rutgers.edu	Xiao, Jianxi/Q-8692-2017	Xiao, Jianxi/0000-0002-9863-572X; Addabbo, Rayna/0000-0001-5963-9392	National Institutes of Health [GM45302, CA98799, DE14318]; National Science Foundation [DBI-0403062, DBI-0320746]; Robert A. Welch Foundation; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM045302, R01GM045302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (GM45302, to J. B., CA98799, to G. B. F., and DE14318 COSTAR Program, to J. L. L.), the National Science Foundation (DBI-0403062 and DBI-0320746, to J. B.), and the Robert A. Welch Foundation (to G. B. F.).	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baragi VM, 1997, SCAND J GASTROENTERO, V32, P419, DOI 10.3109/00365529709025075; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cawston T, 1999, ANN NY ACAD SCI, V878, P120, DOI 10.1111/j.1749-6632.1999.tb07678.x; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Fields G B, 1992, Matrix Suppl, V1, P68; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; FIELDS GB, 1987, J BIOL CHEM, V262, P6221; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GROSS J, 1980, COLLAGENASE NORMAL P; HASTY KA, 1993, MATRIX, V13, P181, DOI 10.1016/S0934-8832(11)80001-6; HIGHBERGER JH, 1979, BIOCHEM BIOPH RES CO, V89, P202, DOI 10.1016/0006-291X(79)90964-1; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kielty C.M., 2002, CONNECTIVE TISSUE IT; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; Li YJ, 2009, J BIOL CHEM, V284, P20660, DOI 10.1074/jbc.M109.018077; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; MALLYA SK, 1990, BIOCHEMISTRY-US, V29, P10628, DOI 10.1021/bi00499a008; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; MILLER EJ, 1976, BIOCHEMISTRY-US, V15, P787, DOI 10.1021/bi00649a009; MILLER EJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P631, DOI 10.1016/0003-9861(76)90300-3; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Moy FJ, 1998, BIOCHEMISTRY-US, V37, P1495, DOI 10.1021/bi972181w; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4; Palmer Arthur G. Iii, 1993, Current Opinion in Biotechnology, V4, P385, DOI 10.1016/0958-1669(93)90002-E; Ramachandran G N., 1967, TREATISE COLLAGEN; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Riley GP, 1995, EYE, V9, P703, DOI 10.1038/eye.1995.182; RYHANEN L, 1983, ARCH BIOCHEM BIOPHYS, V223, P562, DOI 10.1016/0003-9861(83)90621-5; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075; VANDERREST M, 1991, BIOCHEM SOC T, V19, P820, DOI 10.1042/bst0190820; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WELGUS HG, 1982, J BIOL CHEM, V257, P1534; Woessner JF, 1998, BIOL EXTRAC, P1; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; Xiao JX, 2009, J AM CHEM SOC, V131, P18194, DOI 10.1021/ja9056823	64	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34181	34190		10.1074/jbc.M110.128355	http://dx.doi.org/10.1074/jbc.M110.128355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20679339	hybrid, Green Published			2022-12-25	WOS:000283354000063
J	Bui, M; Gilady, SY; Fitzsimmons, REB; Benson, MD; Lynes, EM; Gesson, K; Alto, NM; Strack, S; Scott, JD; Simmen, T				Bui, Michael; Gilady, Susanna Y.; Fitzsimmons, Ross E. B.; Benson, Matthew D.; Lynes, Emily M.; Gesson, Kevin; Alto, Neal M.; Strack, Stefan; Scott, John D.; Simmen, Thomas			Rab32 Modulates Apoptosis Onset and Mitochondria-associated Membrane (MAM) Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TRAIL-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; OXIDATIVE-METABOLISM; CA2+ CONCENTRATION; IN-VITRO; PHOSPHORYLATION; CALCIUM; COMPLEX; CAMP	The mitochondria-associated membrane (MAM) has emerged as an endoplasmic reticulum (ER) signaling hub that accommodates ER chaperones, including the lectin calnexin. At the MAM, these chaperones control ER homeostasis but also play a role in the onset of ER stress-mediated apoptosis, likely through the modulation of ER calcium signaling. These opposing roles of MAM-localized chaperones suggest the existence of mechanisms that regulate the composition and the properties of ER membrane domains. Our results now show that the GTPase Rab32 localizes to the ER and mitochondria, and we identify this protein as a regulator of MAM properties. Consistent with such a role, Rab32 modulates ER calcium handling and disrupts the specific enrichment of calnexin on the MAM, while not affecting the ER distribution of protein-disulfide isomerase and mitofusin-2. Furthermore, Rab32 determines the targeting of PKA to mitochondrial and ER membranes and through its overexpression or inactivation increases the phosphorylation of Bad and of Drp1. Through a combination of its functions as a PKA-anchoring protein and a regulator of MAM properties, the activity and expression level of Rab32 determine the speed of apoptosis onset.	[Simmen, Thomas] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Alto, Neal M.] Univ Texas SW, Dept Microbiol, Dallas, TX 75390 USA; [Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Alberta; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; University of Iowa	Simmen, T (corresponding author), Univ Alberta, Fac Med & Dent, Dept Cell Biol, Sch Mol & Syst Med, Med Sci Bldg,Rm 5-65, Edmonton, AB T6G 2H7, Canada.	Thomas.Simmen@ualberta.ca		Fitzsimmons, Ross/0000-0002-4856-6252; Strack, Stefan/0000-0002-6175-7280	Alberta Health Services/Alberta Cancer Board [24170]; Natural Sciences and Engineering Research Council of Canada [386757-2010]; NCIC/CCSRI [17291/2010-700306]; Alberta Heritage Foundation for Medical Research [200500396]; Terry Fox Foundation; National Institutes of Health [R01 DK54441, R01 NS043254, NS056244, NS057714]; Alberta Health Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS056244, R01NS043254, R01NS056244, R01NS057714] Funding Source: NIH RePORTER	Alberta Health Services/Alberta Cancer Board; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NCIC/CCSRI; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Terry Fox Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Health Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Alberta Health Services/Alberta Cancer Board Grant 24170, Natural Sciences and Engineering Research Council of Canada Grant 386757-2010, NCIC/CCSRI Grants 17291/2010-700306, Alberta Heritage Foundation for Medical Research Scholarship 200500396, and by The Terry Fox Foundation. This work was also supported, in whole or in part, by National Institutes of Health Grant R01 DK54441 (to the Scott laboratory) and Grants R01 NS043254, NS056244, and NS057714 (to the Strack laboratory).; Supported by Alberta Health Services Studentships.	Affaitati A, 2003, J BIOL CHEM, V278, P4286, DOI 10.1074/jbc.M209941200; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Bao XK, 2002, EUR J BIOCHEM, V269, P259, DOI 10.1046/j.0014-2956.2001.02645.x; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cohen-Solal KA, 2003, BBA-PROTEINS PROTEOM, V1651, P68, DOI 10.1016/S1570-9639(03)00236-X; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kang YC, 2004, CELL DEATH DIFFER, V11, P1287, DOI 10.1038/sj.cdd.4401489; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Laude AJ, 2009, FEBS J, V276, P1800, DOI 10.1111/j.1742-4658.2009.06927.x; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Osibow K, 2006, BIOCHEM J, V396, P173, DOI 10.1042/BJ20060099; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; Turner MD, 1997, J BIOL CHEM, V272, P13479, DOI 10.1074/jbc.272.21.13479; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016	60	119	120	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31590	31602		10.1074/jbc.M110.101584	http://dx.doi.org/10.1074/jbc.M110.101584			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670942	hybrid, Green Published			2022-12-25	WOS:000282764600053
J	Fong, JE; Le Nihouannen, D; Komarova, SV				Fong, Jenna E.; Le Nihouannen, Damien; Komarova, Svetlana V.			Tumor-supportive and Osteoclastogenic Changes Induced by Breast Cancer-derived Factors Are Reversed by Inhibition of gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE METASTASIS; RANK LIGAND; TGF-BETA; KAPPA-B; CELLS; OSTEOBLASTS; EXPRESSION; DIFFERENTIATION; OSTEOPROTEGERIN; PRECURSORS	During breast cancer metastasis to bone, tumor cells home to bone marrow, likely targeting the stem cell niche, and stimulate osteoclasts, which mediate osteolysis required for tumor expansion. Although osteoblasts contribute to the regulation of the hematopoietic stem cell niche and control osteoclastogenesis through production of proresorptive cytokine RANKL(receptor activator of NF-kappa B ligand), their role in cancer metastases to bone is not fully understood. C57BL/6J mouse bone marrow cells were treated for 3-12 days with ascorbic acid (50 mu g/ml) in the presence or absence of 10% medium conditioned by breast carcinoma cells MDA-MB-231, 4T1, or MCF7. Treatment with cancer-derived factors resulted in a sustained 40-60% decrease in osteoblast differentiation markers, compared with treatment with ascorbic acid alone, and induced an osteoclastogenic change in the RANKL/osteoprotegerin ratio. Importantly, exposure of bone cells to breast cancer-derived factors stimulated the subsequent attachment of cancer cells to immature osteoblasts. Inhibition of gamma-secretase using pharmacological inhibitors DAPT and Compound E completely reversed cancer-induced osteoclastogenesis as well as cancer-induced enhancement of cancer cell attachment, identifying gamma-secretase activity as a key mediator of these effects. Thus, we have uncovered osteoblasts as critical intermediary of premetastatic signaling by breast cancer cells and pinpointed gamma-secretase as a robust target for developing therapeutics potentially capable of reducing both homing and progression of cancer metastases to bone.	[Fong, Jenna E.; Le Nihouannen, Damien; Komarova, Svetlana V.] McGill Univ, Fac Dent, Montreal, PQ H3A 1A4, Canada	McGill University	Komarova, SV (corresponding author), 740 Dr Penfield Ave 2201, Montreal, PQ H3A 1A4, Canada.	svetlana.komarova@mcgill.ca		LE NIHOUANNEN, Damien/0000-0003-1539-5183	Institute for Musculoskeletal Health and Arthritis/Canadian Institute for Health Research; Canadian Institute for Health Research in Skeletal Health Research; McGill University; Canadian Arthritis Network; les Fonds de la Recherche en Sante du Quebec	Institute for Musculoskeletal Health and Arthritis/Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Health Research in Skeletal Health Research(Canadian Institutes of Health Research (CIHR)); McGill University; Canadian Arthritis Network; les Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Institute for Musculoskeletal Health and Arthritis/Canadian Institute for Health Research.; Supported by the Canadian Institute for Health Research Training Program in Skeletal Health Research and by McGill University.; Supported by the Canadian Institute for Health Research Training Program in Skeletal Health Research, the Canadian Arthritis Network, and les Fonds de la Recherche en Sante du Quebec.	Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Baldock PA, 2006, J BONE MINER RES, V21, P1618, DOI 10.1359/JBMR.060714; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Canalis E, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe17; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Fromigue O, 2001, J BONE MINER RES, V16, P1600, DOI 10.1359/jbmr.2001.16.9.1600; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Guo YB, 2008, BONE, V43, P386, DOI 10.1016/j.bone.2008.03.026; HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER METAST REV, V25, P521, DOI 10.1007/s10555-006-9036-9; KIM CJ, 2004, BREAST COMPREHENSIVE; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Lau YS, 2007, BREAST CANCER RES TR, V105, P7, DOI 10.1007/s10549-006-9438-y; Mendoza M, 2009, INT J BIOCHEM CELL B, V41, P1452, DOI 10.1016/j.biocel.2009.01.015; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Neiva K, 2005, BRAZ J MED BIOL RES, V38, P1449, DOI 10.1590/S0100-879X2005001000001; Phadke PA, 2006, CLIN CANCER RES, V12, P1431, DOI 10.1158/1078-0432.CCR-05-1806; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Shiozawa Y, 2008, LEUKEMIA, V22, P941, DOI 10.1038/leu.2008.48; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stenbeck G, 2002, SEMIN CELL DEV BIOL, V13, P285, DOI 10.1016/S1084952102000587; STEWART AF, 1982, J CLIN ENDOCR METAB, V55, P219, DOI 10.1210/jcem-55-2-219; Taichman RS, 1998, STEM CELLS, V16, P7, DOI 10.1002/stem.160007; TAUBE T, 1994, BONE, V15, P161, DOI 10.1016/8756-3282(94)90703-X; Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Tiedemann K, 2009, J BIOL CHEM, V284, P33662, DOI 10.1074/jbc.M109.010785; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200	52	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31427	31434		10.1074/jbc.M110.114496	http://dx.doi.org/10.1074/jbc.M110.114496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20679341	Green Published, hybrid			2022-12-25	WOS:000282764600037
J	Kanagawa, M; Omori, Y; Sato, S; Kobayashi, K; Miyagoe-Suzuki, Y; Takeda, S; Endo, T; Furukawa, T; Toda, T				Kanagawa, Motoi; Omori, Yoshihiro; Sato, Shigeru; Kobayashi, Kazuhiro; Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi; Endo, Tamao; Furukawa, Takahisa; Toda, Tatsushi			Post-translational Maturation of Dystroglycan Is Necessary for Pikachurin Binding and Ribbon Synaptic Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; BETA-DYSTROGLYCAN; LAMININ-BINDING; SKELETAL-MUSCLE; PHOTORECEPTOR TERMINALS; GLYCOSYLATION DEFECTS; MUTATIONS; MICE	Pikachurin, the most recently identified ligand of dystroglycan, plays a crucial role in the formation of the photoreceptor ribbon synapse. It is known that glycosylation of dystroglycan is necessary for its ligand binding activity, and hypoglycosylation is associated with a group of muscular dystrophies that often involve eye abnormalities. Because little is known about the interaction between pikachurin and dystroglycan and its impact on molecular pathogenesis, here we characterize the interaction using deletion constructs and mouse models of muscular dystrophies with glycosylation defects (Large(myd) and POMGnT1-deficient mice). Pikachurin-dystroglycan binding is calcium-dependent and relatively less sensitive to inhibition by heparin and high NaCl concentration, as compared with other dystroglycan ligand proteins. Using deletion constructs of the laminin globular domains in the pikachurin C terminus, we show that a certain steric structure formed by the second and the third laminin globular domains is necessary for the pikachurin-dystroglycan interaction. Binding assays using dystroglycan deletion constructs and tissue samples from Large-deficient (Large(myd)) mice show that Large-dependent modification of dystroglycan is necessary for pikachurin binding. In addition, the ability of pikachurin to bind to dystroglycan prepared from POMGnT1-deficient mice is severely reduced, suggesting that modification of the GlcNAc-beta 1,2-branch on O-mannose is also necessary for the interaction. Immunofluorescence analysis reveals a disruption of pikachurin localization in the photoreceptor ribbon synapse of these model animals. Together, our data demonstrate that post-translational modification on O-mannose, which is mediated by Large and POMGnT1, is essential for pikachurin binding and proper localization, and suggest that their disruption underlies the molecular pathogenesis of eye abnormalities in a group of muscular dystrophies.	[Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Omori, Yoshihiro; Sato, Shigeru; Furukawa, Takahisa] Japan Sci & Technol Agcy, Osaka Biosci Inst, Dept Dev Biol, Suita, Osaka 5650874, Japan; [Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan; [Endo, Tamao] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan	Kobe University; Japan Science & Technology Agency (JST); National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Gerontology	Toda, T (corresponding author), 7-5-1 Kusunoki Chou,Chuo Ku, Kobe, Hyogo 6500017, Japan.	toda@med.kobe-u.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Kanagawa, Motoi/0000-0003-0984-6398	Ministry of Health, Labor, and Welfare of Japan [20B-13]; Research on Psychiatric and Neurological Diseases and Mental Health [H20-016]; Japan Society for the Promotion of Science [21790318, 20056020]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research on Psychiatric and Neurological Diseases and Mental Health; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Ministry of Health, Labor, and Welfare of Japan Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry 20B-13, Research on Psychiatric and Neurological Diseases and Mental Health Grant H20-016 (to T. T.), Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (B) 21790318, and Grant-in-aid for Scientific Research on Priority Areas 20056020 (to M. K.).	Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Blank M, 1999, EUR J NEUROSCI, V11, P2121, DOI 10.1046/j.1460-9568.1999.00636.x; Blank M, 1997, J COMP NEUROL, V389, P668; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Chiba A, 1997, J BIOL CHEM, V272, P2156; CIBIS GW, 1993, INVEST OPHTH VIS SCI, V34, P3646; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; Jastrow H, 2006, INVEST OPHTH VIS SCI, V47, P17, DOI 10.1167/iovs.05-0597; Kameya S, 1997, HUM MOL GENET, V6, P2195, DOI 10.1093/hmg/6.13.2195; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Koulen P, 1998, J NEUROSCI RES, V51, P735, DOI 10.1002/(SICI)1097-4547(19980315)51:6<735::AID-JNR7>3.0.CO;2-C; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Miyagoe-Suzuki Y, 2009, MECH DEVELOP, V126, P107, DOI 10.1016/j.mod.2008.12.001; MONTANARO F, 1995, J NEUROSCI RES, V42, P528, DOI 10.1002/jnr.490420411; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Pillers DAH, 1999, HUM GENET, V105, P2, DOI 10.1007/s004390051056; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Satz JS, 2009, J NEUROSCI, V29, P13136, DOI 10.1523/JNEUROSCI.0474-09.2009; SIGESMUND DA, 1994, OPHTHALMOLOGY, V101, P856; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	45	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31208	31216		10.1074/jbc.M110.116343	http://dx.doi.org/10.1074/jbc.M110.116343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682766	Green Published, hybrid			2022-12-25	WOS:000282764600015
J	Nam, SY; Seo, HH; Park, HS; An, S; Kim, JY; Yang, KH; Kim, CS; Jeong, M; Jin, YW				Nam, Seon Young; Seo, Hyung Ho; Park, Hyung Sun; An, Sungkwan; Kim, Ji-Young; Yang, Kwang Hee; Kim, Cha Soon; Jeong, Meeseon; Jin, Young-Woo			Phosphorylation of CLK2 at Serine 34 and Threonine 127 by AKT Controls Cell Survival after Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY PROTEIN-KINASES; LOW-DOSE RADIATION; INDUCED APOPTOSIS; PHOSPHATIDYLINOSITOL 3-KINASE; INTRANUCLEAR DISTRIBUTION; ACTIVATION; PATHWAY; PROLIFERATION; INDUCTION; FAMILY	AKT phosphorylates components of the intrinsic cell survival machinery and promotes survival to various stimuli. In the present study, we identified CDC-like kinase 2 (CLK2) as a new substrate of AKT activation and elucidated its role in cell survival to ionizing radiation. AKT directly binds to and phosphorylates CLK2 on serine 34 and threonine 127, in vitro and in vivo. CLK2 phosphorylation was detected in HeLa cells overexpressing active AKT. In addition, we demonstrated that ionizing radiation induces CLK2 phosphorylation via AKT activation. In contrast, the suppression of endogenous AKT expression by siRNA inhibited CLK2 phosphorylation in response to 2 gray of gamma-ray or insulin. Furthermore, we examined the effect of CLK2 on the survival of irradiated CCD-18Lu cells overexpressing Myc-CLK2. CLK2 overexpression significantly increased cell growth and inhibited cell death induced by 2 gray. The role of CLK2 in cell survival to ionizing radiation was dependent on the phosphorylation of serine 34 and threonine 127. Our results suggest that AKT activation controls cell survival to ionizing radiation by phosphorylating CLK2, revealing an important regulatory mechanism required for promoting cell survival.	[Kim, Cha Soon; Jeong, Meeseon; Jin, Young-Woo] Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Res Inst, Seoul 132703, South Korea; [An, Sungkwan] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea	Korea Hydro & Nuclear Power; Konkuk University	Nam, SY (corresponding author), 388-1 Ssangmun Dong, Seoul 132703, South Korea.	seonynam@khnp.co.kr			Korea Hydro & Nuclear Power Co., Ltd. [E09NS02]; Ministry of Knowledge Economy, Republic of Korea [R-2006-1-043]	Korea Hydro & Nuclear Power Co., Ltd.; Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by Grant E09NS02 from Korea Hydro & Nuclear Power Co., Ltd. and Grant R-2006-1-043 from the Ministry of Knowledge Economy, Republic of Korea.	BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; Choi KM, 2007, ONCOL REP, V17, P1183; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; DOUVILLE E, 1994, CANCER METAST REV, V13, P1, DOI 10.1007/BF00690414; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gu QY, 2004, RADIAT RES, V161, P692, DOI 10.1667/RR3158; HANES J, 1994, J MOL BIOL, V244, P665, DOI 10.1006/jmbi.1994.1763; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; JOHNSON KW, 1991, J BIOL CHEM, V266, P3402; Kim CS, 2007, J RADIAT RES, V48, P407, DOI 10.1269/jrr.07032; Kim SJ, 1998, BIOCHEM MOL BIOL INT, V46, P187; Krasilnikov M, 1999, MOL CARCINOGEN, V24, P64, DOI 10.1002/(SICI)1098-2744(199901)24:1<64::AID-MC9>3.0.CO;2-2; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; Lu PJ, 1998, BIOCHEMISTRY-US, V37, P5738, DOI 10.1021/bi972551g; Marchisio M, 1998, BIOCHEM BIOPH RES CO, V253, P346, DOI 10.1006/bbrc.1998.9787; Mishra KP, 2004, J ENVIRON PATHOL TOX, V23, P61, DOI 10.1615/JEnvPathToxOncol.v23.i1.60; Moeslein FM, 1999, J BIOL CHEM, V274, P26697, DOI 10.1074/jbc.274.38.26697; MYERS MP, 1994, MOL CELL BIOL, V14, P6954, DOI 10.1128/MCB.14.10.6954; Nayler O, 1998, J BIOL CHEM, V273, P34341, DOI 10.1074/jbc.273.51.34341; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Park HS, 2009, EUR J CELL BIOL, V88, P563, DOI 10.1016/j.ejcb.2009.05.004; Pollycove M, 2003, HUM EXP TOXICOL, V22, P290, DOI 10.1191/0960327103ht365oa; Portess DI, 2007, CANCER RES, V67, P1246, DOI 10.1158/0008-5472.CAN-06-2985; Soderlund K, 2005, INT J ONCOL, V26, P25; Suzuki K, 2001, CANCER RES, V61, P5396; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wang GJ, 2000, TOXICOL SCI, V53, P369, DOI 10.1093/toxsci/53.2.369; Wang ZB, 2007, CELL BIOL INT, V31, P1353, DOI 10.1016/j.cellbi.2007.05.009	36	26	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31157	31163		10.1074/jbc.M110.122044	http://dx.doi.org/10.1074/jbc.M110.122044			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682768	Green Published, hybrid			2022-12-25	WOS:000282764600009
J	Rosenfeld, RJ; Bonaventura, J; Szymczyna, BR; MacCoss, MJ; Arvai, AS; Yates, JR; Tainer, JA; Getzoff, ED				Rosenfeld, Robin J.; Bonaventura, Joseph; Szymczyna, Blair R.; MacCoss, Michael J.; Arvai, Andrew S.; Yates, John R., III; Tainer, John A.; Getzoff, Elizabeth D.			Nitric-oxide Synthase Forms N-NO-pterin and S-NO-Cys IMPLICATIONS FOR ACTIVITY, ALLOSTERY, AND REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGENASE DIMER; NITROSOTRYPTOPHAN DERIVATIVES; ELECTRON-TRANSFER; NMR-SPECTROSCOPY; STRUCTURAL BASIS; NITROSYLATION; TETRAHYDROBIOPTERIN; BINDING; NITROSOTHIOLS; GLUTATHIONE	Inducible nitric-oxide synthase (iNOS) produces biologically stressful levels of nitric oxide (NO) as a potent mediator of cellular cytotoxicity or signaling. Yet, how this nitrosative stress affects iNOS function in vivo is poorly understood. Here we define two specific non-heme iNOS nitrosation sites discovered by combining UV-visible spectroscopy, chemiluminescence, mass spectrometry, and x-ray crystallography. We detected auto-S-nitrosylation during enzymatic turnover by using chemiluminescence. Selective S-nitrosylation of the ZnS4 site, which bridges the dimer interface, promoted a dimer-destabilizing order-to-disorder transition. The nitrosated iNOS crystal structure revealed an unexpected N-NO modification on the pterin cofactor. Furthermore, the structurally defined N-NO moiety is solvent-exposed and available to transfer NO to a partner. We investigated glutathione (GSH) as a potential transnitrosation partner because the intracellular GSH concentration is high and NOS can form S-nitrosoglutathione. Our computational results predicted a GSH binding site adjacent to the N-NO-pterin. Moreover, we detected GSH binding to iNOS with saturation transfer difference NMR spectroscopy. Collectively, these observations resolve previous paradoxes regarding this uncommon pterin cofactor in NOS and suggest means for regulating iNOS activity via N-NO-pterin and S-NO-Cys modifications. The iNOS self-nitrosation characterized here appears appropriate to help control NO production in response to cellular conditions.	[Rosenfeld, Robin J.; Szymczyna, Blair R.; Arvai, Andrew S.; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [MacCoss, Michael J.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bonaventura, Joseph] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Bonaventura, Joseph] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Bonaventura, Joseph] Bonaventis Res Inst, Rincon, PR 00677 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Duke University; Duke University	Getzoff, ED (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edg@scripps.edu	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429	National Institutes of Health [R01-HL58883, RR011823]; Skaggs Institute for Chemical Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL58883 (to E. D. G.) and RR011823 (to J.R.Y.) and the Skaggs Institute for Chemical Biology (to R.J.R.).	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Aoyagi M, 2001, BIOCHEMISTRY-US, V40, P12826, DOI 10.1021/bi011183k; ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YS, 2002, BIOCHEMISTRY-US, V41, P4618, DOI 10.1021/bi011877t; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Connolly S, 2004, J MED CHEM, V47, P3320, DOI 10.1021/jm031035n; Crane BR, 2000, BIOCHEMISTRY-US, V39, P4608, DOI 10.1021/bi992409a; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Dijkers PF, 2009, MOL BIOL CELL, V20, P4083, DOI 10.1091/mbc.E09-05-0362; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Erwin PA, 2006, J BIOL CHEM, V281, P151, DOI 10.1074/jbc.M510421200; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garcin ED, 2008, NAT CHEM BIOL, V4, P700, DOI 10.1038/nchembio.115; Gorren ACF, 2002, CURR DRUG METAB, V3, P133, DOI 10.2174/1389200024605154; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Harbrecht BG, 1997, ANN SURG, V225, P76, DOI 10.1097/00000658-199701000-00009; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HOFMANN H, 1995, BIOCHEMISTRY-US, V34, P13443, DOI 10.1021/bi00041a023; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kirsch M, 2007, ORG BIOMOL CHEM, V5, P3889, DOI 10.1039/b713377b; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Li D, 2006, J BIOL CHEM, V281, P8197, DOI 10.1074/jbc.M507328200; LOWEMA CK, 1990, ACTA CRYSTALLOGR C, V46, P1853, DOI 10.1107/S0108270189013739; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mayer B, 1998, J BIOL CHEM, V273, P3264, DOI 10.1074/jbc.273.6.3264; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mitchell DA, 2005, BIOCHEMISTRY-US, V44, P4636, DOI 10.1021/bi0474463; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panda K, 2003, J BIOL CHEM, V278, P37122, DOI 10.1074/jbc.M304456200; Panda K, 2002, J BIOL CHEM, V277, P31020, DOI 10.1074/jbc.M203749200; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Perry JJP, 2007, NEUROSCIENCE, V145, P1280, DOI 10.1016/j.neuroscience.2006.10.045; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Reif A, 1999, J BIOL CHEM, V274, P24921, DOI 10.1074/jbc.274.35.24921; Rosenfeld RJ, 2002, BIOCHEMISTRY-US, V41, P13915, DOI 10.1021/bi026313j; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Schreiter ER, 2007, J BIOL CHEM, V282, P19773, DOI 10.1074/jbc.M701363200; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Slama-Schwok A, 2002, J BIOL CHEM, V277, P7581, DOI 10.1074/jbc.M108657200; Sonnenschein K, 2004, J BIOL CHEM, V279, P45433, DOI 10.1074/jbc.M405987200; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; STUEHR DJ, 1990, BIOCHEM BIOPH RES CO, V168, P558, DOI 10.1016/0006-291X(90)92357-6; Stuehr DJ, 1996, METHOD ENZYMOL, V268, P324; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; Wei CC, 2003, BIOCHEMISTRY-US, V42, P1969, DOI 10.1021/bi026898h; Woodward JJ, 2010, J AM CHEM SOC, V132, P5105, DOI 10.1021/ja909378n; Zhang YY, 1996, J BIOL CHEM, V271, P14271, DOI 10.1074/jbc.271.24.14271	70	27	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31581	31589		10.1074/jbc.M109.072496	http://dx.doi.org/10.1074/jbc.M109.072496			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20659888	Green Published, hybrid			2022-12-25	WOS:000282764600052
J	Yao, WJ; Sung, LA				Yao, Weijuan; Sung, Lanping Amy			Erythrocyte Tropomodulin Isoforms with and without the N-terminal Actin-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; TROPOMYOSIN-BINDING; ALPHA-SPECTRIN; POINTED ENDS; CYTOSKELETAL PROTEIN; JUNCTIONAL COMPLEX; MEMBRANE SKELETON; MOUSE; GENE; EXPRESSION	Erythrocyte tropomodulin (E-Tmod or Tmod1) of 41 kDa is a tropomyosin (TM)-binding protein that caps the slow-growing end of the actin filaments. Its N-terminal half is flexible, whereas the C-terminal half has a single domain structure. E-Tmod/TM5 complex may function as a "molecular ruler" generating actin protofilaments of similar to 37 nm. Here we report the discovery of a short isoform of 29 kDa that lacks the N-terminal actin-binding domain (N-ABD) but retains the C-terminal actin-binding domain (C-ABD). E-Tmod29 can be generated by alternative splicing from an upstream promoter or by multiple transcriptional start sites from a downstream promoter. Promoter switching leads to a surge of E-Tmod41 in reticulocytes, which degrades quickly in the cytosol. We expressed recombinant isoforms in Escherichia coli and tested their binding toward TM5, G-actin, and F-actin. Solid-phase binding assays show that, without the N-terminal 102 residues, E-Tmod29 binds to TM5 or G-actin more strongly than E-Tmod41 does, but barely binds to F-actin after TM5 binding. Differential bindings explain the distinct localizations of E-Tmod29 in the cytosol and E-Tmod41 on the membrane. Sequential bindings and immunofluorescent staining further suggest that 1) TM5 binding to E-Tmod41 may open up the flexible N-terminal half, exposing N-ABD and unblocking C-ABD; 2) N-ABD binds to F-actin and C-ABD binds to G-actin; and 3) F-actin binding to N-ABD may prevent G-actin from binding to C-ABD. E-Tmod29 may thus modulate the availability of TM5 and G-actin for E-Tmod41 to construct the protofilament-based membrane skeletal network for circulating erythrocytes.	[Yao, Weijuan; Sung, Lanping Amy] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Sung, LA (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	amysung@bioeng.ucsd.edu			National Institutes of Health [PO1 HL43026-11]; Whitaker Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL043026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitaker Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant (PO1 HL43026-11). This research utilized the Biotech Core and Instrumentation Core in the Bioengineering Department established with the support from the Whitaker Foundation.	Allingham JS, 2005, P NATL ACAD SCI USA, V102, P14527, DOI 10.1073/pnas.0502089102; Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; BALDINI M, 1960, BLOOD, V15, P614, DOI 10.1182/blood.V15.5.614.614; CHASIS JA, 1989, BLOOD, V74, P1112, DOI 10.1182/blood.V74.3.1112.1112; Chishti A H, 1998, Curr Opin Hematol, V5, P116; CHO YJ, 1990, J BIOL CHEM, V265, P538; Chu X, 2000, GENE, V256, P271, DOI 10.1016/S0378-1119(00)00327-9; Chu X, 2003, AM J PHYSIOL-HEART C, V284, pH1827, DOI 10.1152/ajpheart.00947.2002; CHU ZL, 1994, BLOOD, V84, P1992; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; CONBOY JG, 1988, P NATL ACAD SCI USA, V85, P9062, DOI 10.1073/pnas.85.23.9062; CORSI D, 1995, J BIOL CHEM, V270, P8928, DOI 10.1074/jbc.270.15.8928; Costa DB, 2005, BLOOD, V106, P4367, DOI 10.1182/blood-2005-05-1813; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; DISCHER DE, 1995, J CELL BIOL, V130, P897, DOI 10.1083/jcb.130.4.897; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; FOWLER VM, 1993, J CELL BIOL, V120, P411, DOI 10.1083/jcb.120.2.411; FOWLER VM, 1990, J CELL BIOL, V111, P471, DOI 10.1083/jcb.111.2.471; FOWLER VM, 1987, J BIOL CHEM, V262, P12792; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Gallagher PG, 1997, J BIOL CHEM, V272, P19220, DOI 10.1074/jbc.272.31.19220; Gallagher PG, 2006, WILLIAMS HEMATOLOGY, P571; Galluzzi L, 2000, EUR J BIOCHEM, V267, P2812, DOI 10.1046/j.1432-1327.2000.01322.x; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Gutierrez E, 2007, J MEMBRANE BIOL, V219, P93, DOI 10.1007/s00232-007-9065-5; HANSPAL M, 1992, SEMIN HEMATOL, V29, P305; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; ITO M, 1995, DEV BIOL, V167, P317, DOI 10.1006/dbio.1995.1026; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; KORSGREN C, 1991, P NATL ACAD SCI USA, V88, P4840, DOI 10.1073/pnas.88.11.4840; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2001, BIOPHYS J, V81, P345, DOI 10.1016/S0006-3495(01)75704-9; Lavie L, 2004, GENOME RES, V14, P2253, DOI 10.1101/gr.2745804; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; Parra MK, 2003, BLOOD, V101, P4164, DOI 10.1182/blood-2002-06-1796; SCHOFIELD AE, 1994, BLOOD, V84, P2000; SHEN BW, 1984, J CELL BIOL, V99, P810, DOI 10.1083/jcb.99.3.810; SUNG LA, 1994, BIOCHEM BIOPH RES CO, V201, P627, DOI 10.1006/bbrc.1994.1747; Sung LA, 2000, BLOOD, V95, P1473, DOI 10.1182/blood.V95.4.1473.004k50_1473_1480; Sung LA, 2003, ANN BIOMED ENG, V31, P1314, DOI 10.1114/1.1635820; SUNG LA, 1992, J BIOL CHEM, V267, P2616; SUNG LPA, 1992, BLOOD, V79, P2763; Sussman MA, 1998, J CLIN INVEST, V101, P51, DOI 10.1172/JCI1167; URSITTI JA, 1994, J CELL SCI, V107, P1633; Vera C, 2000, ARCH BIOCHEM BIOPHYS, V378, P16, DOI 10.1006/abbi.2000.1802; Vera C, 2005, ARCH BIOCHEM BIOPHYS, V444, P130, DOI 10.1016/j.abb.2005.10.002; Vera C, 2005, ANN BIOMED ENG, V33, P1387, DOI 10.1007/s10439-005-4698-y; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; WOO MK, 1994, J CELL SCI, V107, P1359; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yao W, 2007, GENE EXPR PATTERNS, V8, P36, DOI 10.1016/j.modgep.2007.08.002; Yun S, 2007, BIOCHEM BIOPH RES CO, V363, P727, DOI 10.1016/j.bbrc.2007.09.033; Zhu Q, 2007, BIOPHYS J, V93, P386, DOI 10.1529/biophysj.106.094383	57	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31408	31417		10.1074/jbc.M110.130278	http://dx.doi.org/10.1074/jbc.M110.130278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675374	Green Published, hybrid			2022-12-25	WOS:000282764600035
J	Kiselak, EA; Shen, XN; Song, JM; Gude, DR; Wang, JN; Brody, SL; Strauss, JF; Zhang, ZB				Kiselak, Elizabeth Anne; Shen, Xuening; Song, Jingmei; Gude, David Roberto; Wang, Jiannan; Brody, Steven L.; Strauss, Jerome F., III; Zhang, Zhibing			Transcriptional Regulation of an Axonemal Central Apparatus Gene, Sperm-associated Antigen 6, by a SRY-related High Mobility Group Transcription Factor, S-SOX5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS PF16; MAMMALIAN ORTHOLOGUE; CARTILAGE FORMATION; FLAGELLAR MOTILITY; RECEPTOR-ALPHA; SOX5 L-SOX5; LONG FORM; EXPRESSION; PROTEIN; MICE	SOX5 is a transcription factor with homology to the high mobility group box region of the testis-determining factor, SRY. Both the mouse and human SOX5 genes encode a 48-kDa SOX5 protein (S-SOX5) that is only present in tissues containing cells with motile cilia/flagella. The mammalian sperm-associated antigen 6 gene (SPAG6) encodes an axoneme central apparatus protein. Because human and mouse SPAG6 gene promoters contain multiple potential binding sites for SOX5, SPAG6 gene regulation by S-SOX5 was investigated in BEAS-2B cells, a line derived from human bronchial cells. Like FOXJ1, a transcription factor known to be essential for motile ciliogenesis, S-SOX5 stimulated mouse and human SPAG6 promoter function in BEAS-2B cells, but the effect was abrogated when the SOX5 binding sites were mutated or deleted. S-SOX5 and FOXJ1 functioned cooperatively in stimulating SPAG6 promoter activity. The SPAG6 message was up-regulated when S-SOX5 was over-expressed in BEAS-2B cells, and silencing of S-SOX5 by RNA interference down-regulated SPAG6 transcripts. Chromatin immunoprecipitation and EMSA experiments demonstrated that S-SOX5 associates with the SPAG6 promoter directly. The present study demonstrates that SPAG6 is a S-SOX5 target gene, indicating a key role for S-SOX5 in the formation and function of motile cilia.	[Kiselak, Elizabeth Anne; Shen, Xuening; Song, Jingmei; Gude, David Roberto; Wang, Jiannan; Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA; [Brody, Steven L.; Zhang, Zhibing] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Virginia Commonwealth University; Washington University (WUSTL)	Zhang, ZB (corresponding author), 11028A Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA.	zzhang4@vcu.edu	Nagarkatti-Gude, David/AAF-6996-2020		National Institutes of Health [HD37416]; National Institutes of Health through NICHD [IF3IHD0G2314-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD37416 (to J.F.S. III).; Supported by National Institutes of Health F31 Predoctoral Fellowship IF3IHD0G2314-01 through the NICHD.	Blaise R, 1999, J BIOL CHEM, V274, P9327, DOI 10.1074/jbc.274.14.9327; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Bonnelye E, 2007, ENDOCRINOLOGY, V148, P1195, DOI 10.1210/en.2006-0962; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Brody SL, 1997, GENOMICS, V45, P509, DOI 10.1006/geno.1997.4970; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Budde LM, 2002, MOL BIOL CELL, V13, P4179, DOI 10.1091/mbc.01-07-0373; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128; Christiano AM, 2008, CELL STEM CELL, V3, P3, DOI 10.1016/j.stem.2008.06.014; Degnan BM, 2009, CURR OPIN GENET DEV, V19, P591, DOI 10.1016/j.gde.2009.09.008; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Donner AL, 2007, DEV BIOL, V303, P784, DOI 10.1016/j.ydbio.2006.10.047; Dy P, 2008, GENESIS, V46, P294, DOI 10.1002/dvg.20392; GONZALEZ IL, 1986, AM J HUM GENET, V38, P419; Haag J, 2008, PATHOBIOLOGY, V75, P195, DOI 10.1159/000124980; Hiraoka Y, 1998, BBA-GENE STRUCT EXPR, V1399, P40, DOI 10.1016/S0167-4781(98)00086-4; Horowitz E, 2005, MOL HUM REPROD, V11, P307, DOI 10.1093/molehr/gah163; Ikeda T, 2002, GENE, V298, P59, DOI 10.1016/S0378-1119(02)00927-7; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Lonergan KM, 2006, AM J RESP CELL MOL, V35, P651, DOI 10.1165/rcmb.2006-0056OC; Hernandez-Hernandez JM, 2009, J MOL BIOL, V394, P1, DOI 10.1016/j.jmb.2009.08.057; Neilson LI, 1999, GENOMICS, V60, P272, DOI 10.1006/geno.1999.5914; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Phochanukul N, 2010, INT J BIOCHEM CELL B, V42, P453, DOI 10.1016/j.biocel.2009.06.013; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Smith EF, 2000, CELL MOTIL CYTOSKEL, V46, P157, DOI 10.1002/1097-0169(200007)46:3<157::AID-CM1>3.0.CO;2-D; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Wunderle VM, 1996, GENOMICS, V36, P354, DOI 10.1006/geno.1996.0474; Xu WM, 2009, MOL BIOL REP, V36, P1187, DOI 10.1007/s11033-008-9296-2; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002; Zhang ZB, 2001, MOL PHARMACOL, V60, P480; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189	48	48	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30496	30505		10.1074/jbc.M110.121590	http://dx.doi.org/10.1074/jbc.M110.121590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20668334	Green Published, hybrid			2022-12-25	WOS:000282135500017
J	Sander, J; Nowaczyk, M; Buchta, J; Dau, H; Vass, I; Deak, Z; Dorogi, M; Iwai, M; Rogner, M				Sander, Julia; Nowaczyk, Marc; Buchta, Joachim; Dau, Holger; Vass, Imre; Deak, Zsuzsanna; Dorogi, Marta; Iwai, Masako; Roegner, Matthias			Functional Characterization and Quantification of the Alternative PsbA Copies in Thermosynechococcus elongatus and Their Role in Photoprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; THERMOPHILIC CYANOBACTERIUM; CHARGE RECOMBINATION; FLUORESCENCE; ADAPTATION; RESOLUTION; PATHWAYS; PCC-7942; PROTEIN; GENES	The D1 protein (PsbA) of photosystem II (PSII) from Thermosynechococcus elongatus is encoded by a psbA gene family that is typical of cyanobacteria. Although the transcription of these three genes has been studied previously (Kos, P. B., Deak, Z., Cheregi, O., and Vass, I. (2008) Biochim. Biophys. Acta 1777, 74-83), the protein quantification had not been possible due to the high sequence identity between the three PsbA copies. The successful establishment of a method to quantify the PsbA proteins on the basis of reverse phase-LC-electrospray mass ionization-MS/MS (RP-LC-ESI-MS/MS) enables an accurate comparison of transcript and protein level for the first time ever. Upon high light incubation, about 70% PsbA3 could be detected, which closely corresponds to the transcript level. It was impossible to detect any PsbA2 under all tested conditions. The construction of knock-out mutants enabled for the first time a detailed characterization of both whole cells and also isolated PSII complexes. PSII complexes of the Delta psbA1/psbA2 mutant contained only copy PsbA3, whereas only PsbA1 could be detected in PSII complexes from the Delta psbA3 mutant. In whole cells as well as in isolated complexes, a shift of the free energy between the redox pairs in the PsbA3 complexes in comparison with PsbA1 could be detected by thermoluminescence and delayed fluorescence measurements. This change is assigned to a shift of the redox potential of pheophytin toward more positive values. Coincidentally, no differences in the Q(A)-Q(B) electron transfer could be observed in flash-induced fluorescence decay or prompt fluorescence measurements. In conclusion, PsbA3 complexes yield a better protection against photoinhibition due to a higher probability of the harmless dissipation of excess energy.	[Sander, Julia; Nowaczyk, Marc; Roegner, Matthias] Ruhr Univ Bochum, D-44780 Bochum, Germany; [Sander, Julia] Max Planck Inst Bioinorgan Chem, D-45413 Mulheim, Germany; [Buchta, Joachim; Dau, Holger] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Vass, Imre; Deak, Zsuzsanna; Dorogi, Marta] Biol Res Ctr, Inst Plant Biol, H-6726 Szeged, Hungary; [Iwai, Masako] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Tokyo 1628601, Japan	Ruhr University Bochum; Max Planck Society; Free University of Berlin; Hungarian Academy of Sciences; Hungarian Biological Research Center; Tokyo University of Science	Rogner, M (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44780 Bochum, Germany.	Matthias.Roegner@rub.de	Vass, Imre/AAS-6171-2021; Nowaczyk, Marc/D-4214-2014	Vass, Imre/0000-0003-4987-7842; Nowaczyk, Marc/0000-0002-9269-0672; Iwai, Masako/0000-0001-6121-7543; Dau, Holger/0000-0001-6482-7494	German Research Council; Deutsche Forschungsgemeinschaft [SFB 480, C1]; European Union (SOLAR-H)	German Research Council(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (SOLAR-H)(European Commission)	This work was supported by grants from the German Research Council, Deutsche Forschungsgemeinschaft (SFB 480, Project C1), and the European Union (SOLAR-H).	Buchta J, 2007, BBA-BIOENERGETICS, V1767, P565, DOI 10.1016/j.bbabio.2007.04.003; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haussmann U, 2009, PROTEOMICS, V9, P3635, DOI 10.1002/pmic.200900025; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Kuhl H, 2000, J BIOL CHEM, V275, P20652, DOI 10.1074/jbc.M001321200; KULKARNI RD, 1994, J BACTERIOL, V176, P959, DOI 10.1128/JB.176.4.959-965.1994; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Muhlenhoff U, 1996, MOL GEN GENET, V252, P93, DOI 10.1007/s004389670011; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Sane PV, 2002, J BIOL CHEM, V277, P32739, DOI 10.1074/jbc.M200444200; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916	17	41	41	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29851	29856		10.1074/jbc.M110.127142	http://dx.doi.org/10.1074/jbc.M110.127142			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663887	Green Published, hybrid			2022-12-25	WOS:000281984300021
J	Toth, B; Csanady, L				Toth, Balazs; Csanady, Laszlo			Identification of Direct and Indirect Effectors of the Transient Receptor Potential Melastatin 2 (TRPM2) Cation Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; HYDROGEN-PEROXIDE; INTRACELLULAR CALCIUM; EMERGING ROLES; T-LYMPHOCYTES; CELL-DEATH; ACTIVATION; LTRPC2; BRAIN	Transient receptor potential melastatin 2 (TRPM2) is a Ca2+ permeable cation channel involved in physiological and pathophysiological processes linked to oxidative stress. TRPM2 channels are co-activated by intracellular Ca2+ and ADP-ribose (ADPR) but also modulated in intact cells by several additional factors. Superfusion of TRPM2-expressing cells with H2O2 or intracellular dialysis of cyclic ADPR (cADPR) or nicotinic acid adenine dinucleotide phosphate (NAADP) activates, whereas dialysis ofAMPinhibits, TRPM2 whole-cell currents. Additionally, H2O2, cADPR, and NAADP enhance ADPR sensitivity of TRPM2 currents in intact cells. Because in whole-cell recordings the entire cellular machinery for nucleotide and Ca2+ homeostasis is intact, modulators might affect TRPM2 activity either directly, by binding to TRPM2, or indirectly, by altering the local concentrations of the primary ligands ADPR and Ca2+. To identify direct modulators of TRPM2, we have studied the effects of H2O2, AMP, cADPR, NAADP, and nicotinic acid adenine dinucleotide in inside-out patches from Xenopus oocytes expressing human TRPM2, by directly exposing the cytosolic faces of the patches to these compounds. H2O2 (1mM) and enzymatically purified cADPR (10 mu M) failed to activate, whereas AMP (200 mu M) failed to inhibit TRPM2 currents. NAADP was a partial agonist (maximal efficacy, similar to 50%), and nicotinic acid adenine dinucleotide was a full agonist, but both had very low affinities (K-0.5 = 104 and 35 mu M). H2O2, cADPR, and NAADP did not enhance activation by ADPR. Considering intracellular concentrations of these compounds, none of them are likely to directly affect the TRPM2 channel protein in a physiological context.	[Toth, Balazs; Csanady, Laszlo] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary	Semmelweis University	Csanady, L (corresponding author), Semmelweis Univ, Dept Med Biochem, Tuzolto U 37-47, H-1094 Budapest, Hungary.	laszlo.csanady@eok.sote.hu	Csanády, László/O-5784-2017	Csanády, László/0000-0002-6547-5889	Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [F 68143]	Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) Grant F 68143 (to L. C.).	Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Brasen JC, 2010, CELL CALCIUM, V47, P339, DOI 10.1016/j.ceca.2010.01.005; Churamani D, 2004, BIOCHEM J, V380, P449, DOI 10.1042/BJ20031754; Csanady L, 2004, J GEN PHYSIOL, V123, P743, DOI 10.1085/jgp.200309008; Csanady L, 2003, BIOPHYS J, V85, P313, DOI 10.1016/S0006-3495(03)74476-2; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Heiner I, 2006, BIOCHEM J, V398, P225, DOI 10.1042/BJ20060183; Higashida H, 1997, J BIOL CHEM, V272, P31272, DOI 10.1074/jbc.272.50.31272; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; TAKAHASHI K, 1995, FEBS LETT, V371, P204, DOI 10.1016/0014-5793(95)00914-U; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	34	74	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30091	30102		10.1074/jbc.M109.066464	http://dx.doi.org/10.1074/jbc.M109.066464			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650899	Green Published, hybrid			2022-12-25	WOS:000281984300047
J	Wen, XY; Li, YJ; Liu, YH				Wen, Xiaoyan; Li, Yingjian; Liu, Youhua			Opposite Action of Peroxisome Proliferator-activated Receptor-gamma in Regulating Renal Inflammation FUNCTIONAL SWITCH BY ITS LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; NF-KAPPA-B; PPAR-GAMMA; KIDNEY; ALPHA; SUMOYLATION; CELLS; PIOGLITAZONE; RANTES/CCL5; MECHANISMS	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists, a new class of antidiabetic agents, have been shown to possess antiinflammatory activity. In this study, we investigated the molecular mechanism by which PPAR gamma agonists inhibit proinflammatory cytokine expression in rat glomerular mesangial cells. Both natural and synthetic PPAR gamma agonists potently inhibited RANTES (regulated upon activation, normal T cell expressed and secreted) and monocyte chemoattractant protein- 1 expression induced by TNF-alpha in mesangial cells, which was dependent on NF-kappa B signaling. However, PPAR gamma agonists had little effect on TNF-alpha-triggered I kappa B alpha phosphorylation and its subsequent degradation, p65 phosphorylation, and nuclear translocation. In the absence of PPAR gamma ligand, TNF-alpha induced a physical interaction between nuclear p65 and PPAR gamma, as demonstrated by co-immunoprecipitation. Such an interaction was mediated by the C-terminal region of p65. Activation of PPAR gamma by its agonist prevented PPAR gamma p65 complex formation. Chromatin immunoprecipitation assay revealed that TNF-alpha induced p65 binding to the cis-acting kappa B elements in rat RANTES promoter, whereas disruption of PPAR gamma p65 by its agonist blocked p65 interaction with its cognate kappa B sites. Knockdown of PPAR gamma via siRNA strategy completely abolished TNF-alpha-mediated p65 binding to kappa B sites and negated RANTES induction, suggesting that unliganded PPAR gamma is obligatory for NF-kappa B signaling. Consistently, overexpression of PPAR gamma in the absence of its ligand sensitized mesangial cells to TNF-alpha stimulation. These results uncover a paradoxical action of the unliganded and ligand-activated PPAR gamma in regulating NF-kappa B signaling and demonstrate PPAR gamma ligand as a molecular switch that controls its ability to modulate inflammatory responses in opposite directions.	[Wen, Xiaoyan; Li, Yingjian; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, S-405 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	liuy@upmc.edu		Liu, Youhua/0000-0002-4740-805X	National Institutes of Health [DK061408, DK064005, DK071040]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064005, R01DK071040, R01DK061408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061408, DK064005, and DK071040.	Buroker NE, 2009, FEBS J, V276, P3247, DOI 10.1111/j.1742-4658.2009.07039.x; Calkin AC, 2006, NEPHROL DIAL TRANSPL, V21, P2399, DOI 10.1093/ndt/gfl212; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Fogo AB, 2008, CURR OPIN NEPHROL HY, V17, P282, DOI 10.1097/MNH.0b013e3282f9b1c0; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Haberstroh U, 2002, KIDNEY INT, V62, P1264, DOI 10.1046/j.1523-1755.2002.00572.x; Haraguchi Kazutaka, 2003, Clin Exp Nephrol, V7, P27, DOI 10.1007/s101570300003; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hounoki H, 2008, BONE, V42, P765, DOI 10.1016/j.bone.2007.11.016; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Jiang JG, 2001, J BIOL CHEM, V276, P25049, DOI 10.1074/jbc.M101611200; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kim EK, 2007, INT J BIOCHEM CELL B, V39, P1260, DOI 10.1016/j.biocel.2007.04.005; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li YJ, 2006, J AM SOC NEPHROL, V17, P54, DOI 10.1681/ASN.2005030257; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lu XH, 2004, J CELL BIOCHEM, V92, P833, DOI 10.1002/jcb.20143; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pocock J, 2003, J IMMUNOL, V170, P6280, DOI 10.4049/jimmunol.170.12.6280; Pritts EA, 2002, J CLIN ENDOCR METAB, V87, P1841, DOI 10.1210/jc.87.4.1841; Rangan G, 2009, FRONT BIOSCI-LANDMRK, V14, P3496, DOI 10.2741/3467; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ruan XZ, 2008, AM J PHYSIOL-RENAL, V294, pF1032, DOI 10.1152/ajprenal.00152.2007; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Toblli JE, 2009, NEPHROL DIAL TRANSPL, V24, P2384, DOI 10.1093/ndt/gfp103; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Wan HY, 2008, BIOMED PHARMACOTHER, V62, P466, DOI 10.1016/j.biopha.2007.10.012; Wen XY, 2005, AM J PATHOL, V167, P947, DOI 10.1016/S0002-9440(10)61185-6; Wu J, 2009, FRONT BIOSCI-LANDMRK, V14, P995, DOI 10.2741/3291; Yang HC, 2009, J AM SOC NEPHROL, V20, P2380, DOI 10.1681/ASN.2008111138; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zelcer N, 2005, CELL METAB, V2, P273, DOI 10.1016/j.cmet.2005.10.004	44	25	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29981	29988		10.1074/jbc.M110.110908	http://dx.doi.org/10.1074/jbc.M110.110908			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663893	Green Published, hybrid			2022-12-25	WOS:000281984300035
J	Wolny, PM; Banerji, S; Gounou, C; Brisson, AR; Day, AJ; Jackson, DG; Richter, RP				Wolny, Patricia M.; Banerji, Suneale; Gounou, Celine; Brisson, Alain R.; Day, Anthony J.; Jackson, David G.; Richter, Ralf P.			Analysis of CD44-Hyaluronan Interactions in an Artificial Membrane System INSIGHTS INTO THE DISTINCT BINDING PROPERTIES OF HIGH AND LOW MOLECULAR WEIGHT HYALURONAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONAN-BINDING; PERICELLULAR MATRIX; CELL-SURFACE; QCM-D; CD44; RECEPTOR; DOMAIN; ADSORPTION; PROMOTES; PERSISTENCE	CD44 is a major cell surface receptor for the large polydisperse glycosaminoglycan hyaluronan (HA). Binding of the long and flexible HA chains is thought to be stabilized by the multivalent nature of the sugar molecule. In addition, high and low molecular weight forms of HA provoke distinct proinflammatory and anti-inflammatory effects upon binding to CD44 and can deliver either proliferative or antiproliferative signals in appropriate cell types. Despite the importance of such interactions, however, neither the stoichiometry of multivalent HA binding at the cell surface nor the molecular basis for functional distinction between different HA size categories is understood. Here we report on the design of a supported lipid bilayer system that permits quantitative analysis of multivalent binding through presentation of CD44 in a stable, natively oriented manner and at controlled density. Using this system in combination with biophysical techniques, we show that the amount of HA binding to bilayers that are densely coated with CD44 increases as a function of HA size, with half-maximal saturation at similar to 30 kDa. Moreover, reversible binding was confined to the smaller HA species (molecular weight of <= 10 kDa), whereas the interaction was essentially irreversible with larger polymers. The amount of bound HA decreased with decreasing receptor surface density, but the stability of binding was not affected. From a physico-chemical perspective, the binding properties of HA share many similarities with the typical behavior of a flexible polymer as it adsorbs onto a homogeneously attractive surface. These findings provide new insight into the multivalent nature of CD44-HA interactions and suggest a molecular basis for the distinct biological properties of different size fractions of hyaluronan.	[Richter, Ralf P.] CIC Bioma GUNE, Biosurfaces Unit, Ctr Invest Cooperat Biomat, Donostia San Sebastian 20009, Spain; [Wolny, Patricia M.; Richter, Ralf P.] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Banerji, Suneale; Jackson, David G.] Univ Oxford, Med Res Council Human Immunol Unit, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; [Gounou, Celine; Brisson, Alain R.] Univ Bordeaux 1, ENITAB, Lab Imagerie Mol & Nanobiotechnol, Inst Europeen Chim & Biol,UMR 5248 CBMN,CNRS, F-33402 Talence, France; [Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	CIC biomaGUNE; Max Planck Society; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; University of Manchester	Richter, RP (corresponding author), CIC Bioma GUNE, Biosurfaces Unit, Ctr Invest Cooperat Biomat, Paseo Miramon 182, Donostia San Sebastian 20009, Spain.	rrichter@cicbiomagune.es	Richter, Ralf Peter/B-3343-2013; Day, Anthony/O-1658-2015; biomaGUNE, CIC/J-9136-2014	Richter, Ralf Peter/0000-0003-3071-2837; Day, Anthony/0000-0002-1415-3134; , david/0000-0002-4133-9364; banerji, suneale/0000-0002-1179-3152; biomaGUNE, CIC/0000-0001-7690-0660	German Federal Ministry of Education and Research [0315157]; Spanish Ministry of Science and Innovation [MAT2008-04192, RYC2009-04275]; Department of Industry of the Basque Government; Max-Planck-Society; MRC [MC_U137884182] Funding Source: UKRI; Medical Research Council [G1000800c, MC_U137884182] Funding Source: researchfish	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Department of Industry of the Basque Government; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by German Federal Ministry of Education and Research Grant 0315157, Spanish Ministry of Science and Innovation Grants MAT2008-04192 and RYC2009-04275, the Department of Industry of the Basque Government, and the Max-Planck-Society (to R.P.R. and P.M.W.).	Alves CS, 2008, AM J PHYSIOL-CELL PH, V294, pC907, DOI 10.1152/ajpcell.00463.2007; ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Benes M, 2004, LANGMUIR, V20, P10129, DOI 10.1021/la048811u; BERAT R, 2007, THESIS U BORDEAUX 1; Bingen P, 2008, ANAL CHEM, V80, P8880, DOI 10.1021/ac8011686; Boehm H, 2009, SOFT MATTER, V5, P4331, DOI 10.1039/b905574f; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Camenisch TD, 2000, AM J RESP CELL MOL, V23, P431, DOI 10.1165/ajrcmb.23.4.f201; Chen JA, 2010, MICRON, V41, P198, DOI 10.1016/j.micron.2009.11.002; Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; De Gennes P.-G., 1979, SCALING CONCEPTS POL; DE LA MOTTE CA, 2003, AM J PATHOL, V163, P121; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; English NM, 1998, CANCER RES, V58, P3736; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fleer G. J., 1993, POLYM INTERFACES; Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329; HAYNES BF, 1991, CANCER CELL-MON REV, V3, P347; Johannsmann D, 2009, ANAL CHEM, V81, P8167, DOI 10.1021/ac901381z; Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3; KNUDSON W, 1991, J CELL SCI, V99, P227; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kuhner M, 1996, LANGMUIR, V12, P4866, DOI 10.1021/la960282+; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Lata S, 2006, J AM CHEM SOC, V128, P6, DOI 10.1021/ja054700l; LEE GM, 1993, J CELL BIOL, V123, P1899, DOI 10.1083/jcb.123.6.1899; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Mahoney DJ, 2001, GLYCOBIOLOGY, V11, P1025, DOI 10.1093/glycob/11.12.1025; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Nijenhuis N, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025014; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Richter RP, 2005, BIOPHYS J, V89, P3372, DOI 10.1529/biophysj.105.064337; Richter RP, 2004, LANGMUIR, V20, P4609, DOI 10.1021/la049827n; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schilling J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021901; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takahashi R, 1999, BIOPOLYMERS, V50, P87, DOI 10.1002/(SICI)1097-0282(199907)50:1<87::AID-BIP8>3.3.CO;2-B; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Vats K, 2010, ACS CHEM BIOL, V5, P393, DOI 10.1021/cb900303s; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wolny PM, 2010, LANGMUIR, V26, P1029, DOI 10.1021/la902226b; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	64	151	156	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30170	30180		10.1074/jbc.M110.137562	http://dx.doi.org/10.1074/jbc.M110.137562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663884	Green Published, hybrid			2022-12-25	WOS:000281984300054
J	Dasari, VR; Velpula, KK; Kaur, K; Fassett, D; Klopfenstein, JD; Dinh, DH; Gujrati, M; Rao, JS				Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Kaur, Kiranpreet; Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Gujrati, Meena; Rao, Jasti S.			Cord Blood Stem Cell-Mediated Induction of Apoptosis in Glioma Downregulates X-Linked Inhibitor of Apoptosis Protein (XIAP)	PLOS ONE			English	Article							CANCER-CELLS; IN-VIVO; BCL-2 FAMILY; NUDE-MICE; EXPRESSION; NECROSIS; RECEPTOR; DEATH; MITOCHONDRIA; LIGAND	Background: XIAP (X-linked inhibitor of apoptosis protein) is one of the most important members of the apoptosis inhibitor family. XIAP is upregulated in various malignancies, including human glioblastoma. It promotes invasion, metastasis, growth and survival of malignant cells. We hypothesized that downregulation of XIAP by human umbilical cord blood mesenchymal stem cells (hUCBSC) in glioma cells would cause them to undergo apoptotic death. Methodology/Principal Findings: We observed the effect of hUCBSC on two malignant glioma cell lines (SNB19 and U251) and two glioma xenograft cell lines (4910 and 5310). In co-cultures of glioma cells with hUCBSC, proliferation of glioma cells was significantly inhibited. This is associated with increased cytotoxicity of glioma cells, which led to glioma cell death. Stem cells induced apoptosis in glioma cells, which was evaluated by TUNEL assay, FACS analyses and immunoblotting. The induction of apoptosis is associated with inhibition of XIAP in co-cultures of hUCBSC. Similar results were obtained by the treatment of glioma cells with shRNA to downregulate XIAP (siXIAP). Downregulation of XIAP resulted in activation of caspase-3 and caspase-9 to trigger apoptosis in glioma cells. Apoptosis is characterized by the loss of mitochondrial membrane potential and upregulation of mitochondrial apoptotic proteins Bax and Bad. Cell death of glioma cells was marked by downregulation of Akt and phospho-Akt molecules. We observed similar results under in vivo conditions in U251- and 5310-injected nude mice brains, which were treated with hUCBSC. Under in vivo conditions, Smac/DIABLO was found to be colocalized in the nucleus, showing that hUCBSC induced apoptosis is mediated by inhibition of XIAP and activation of Smac/DIABLO. Conclusions/Significance: Our results indicate that downregulation of XIAP by hUCBSC treatment induces apoptosis, which led to the death of the glioma cells and xenograft cells. This study demonstrates the therapeutic potential of XIAP and hUCBSC to treat malignant gliomas.	[Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Kaur, Kiranpreet; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Dasari, VR (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu	Dasari, Venkata Ramesh/B-3098-2009; Kaur, Kiran/R-3535-2018	Dasari, Venkata Ramesh/0000-0003-0819-2935; Kaur, Kiran/0000-0002-7285-5513	National Institute of Neurological Disorders and Stroke (NINDS) [NS057529]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), NS057529. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Ehtesham M, 2002, CANCER RES, V62, P7170; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; HAN L, 2009, MED ONCOL; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao CH, 2001, CANCER RES, V61, P1162; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hassouna I, 1996, NEUROSCI LETT, V204, P85, DOI 10.1016/0304-3940(96)12323-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holcik M, 2000, ONCOGENE, V19, P4174, DOI 10.1038/sj.onc.1203765; Jeong JA, 2005, STEM CELLS, V23, P584, DOI 10.1634/stemcells.2004-0304; Kang SG, 2008, CHILD NERV SYST, V24, P293, DOI 10.1007/s00381-007-0515-2; Kim DS, 2009, STEM CELLS DEV, V18, P511, DOI 10.1089/scd.2008.0050; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McManus DC, 2004, ONCOGENE, V23, P8105, DOI 10.1038/sj.onc.1207967; Nagane M, 2000, CANCER RES, V60, P847; Naumann U, 2007, GENE THER, V14, P147, DOI 10.1038/sj.gt.3302845; PASTORINO JG, 1993, J BIOL CHEM, V268, P13791; Perez-Ortiz JM, 2004, J BIOL CHEM, V279, P8976, DOI 10.1074/jbc.M308518200; Roth W, 1999, BIOCHEM BIOPH RES CO, V265, P479, DOI 10.1006/bbrc.1999.1693; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sasaki H, 2000, CANCER RES, V60, P5659; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schimmer AD, 2004, CANCER RES, V64, P7183, DOI 10.1158/0008-5472.CAN-04-1918; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Song JH, 2003, BRAIN PATHOL, V13, P539; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tong QS, 2005, CANCER GENE THER, V12, P509, DOI 10.1038/sj.cgt.7700813; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Wrzesien-Kus A, 2004, APOPTOSIS, V9, P705, DOI 10.1023/B:APPT.0000045788.61012.b2; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zander T, 2002, J NEUROCHEM, V81, P1052, DOI 10.1046/j.1471-4159.2002.00899.x	59	62	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11813	10.1371/journal.pone.0011813	http://dx.doi.org/10.1371/journal.pone.0011813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676365	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520100006
J	Li, XY; Swaggerty, CL; Kogut, MH; Chiang, HI; Wang, Y; Genovese, KJ; He, HQ; Zhou, HJ				Li, Xianyao; Swaggerty, Christina L.; Kogut, Michael H.; Chiang, Hsin-I; Wang, Ying; Genovese, Kenneth J.; He, Haiqi; Zhou, Huaijun			Gene Expression Profiling of the Local Cecal Response of Genetic Chicken Lines That Differ in Their Susceptibility to Campylobacter jejuni Colonization	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINE; MESSENGER-RNA EXPRESSION; CIRCADIAN CLOCK; SALMONELLA INFECTION; HETEROPHILS; CELLS; NUTRITION; RESISTANT; IMMUNITY; IDENTIFICATION	Campylobacter jejuni (C. jejuni) is one of the most common causes of human bacterial enteritis worldwide primarily due to contaminated poultry products. Previously, we found a significant difference in C. jejuni colonization in the ceca between two genetically distinct broiler lines (Line A (resistant) has less colony than line B (susceptible) on day 7 post inoculation). We hypothesize that different mechanisms between these two genetic lines may affect their ability to resist C. jejuni colonization in chickens. The molecular mechanisms of the local host response to C. jejuni colonization in chickens have not been well understood. In the present study, to profile the cecal gene expression in the response to C. jejuni colonization and to compare differences between two lines at the molecular level, RNA of ceca from two genetic lines of chickens (A and B) were applied to a chicken whole genome microarray for a pair-comparison between inoculated (I) and non-inoculated (N) chickens within each line and between lines. Our results demonstrated that metabolism process and insulin receptor signaling pathways are key contributors to the different response to C. jejuni colonization between lines A and B. With C. jejuni inoculation, lymphocyte activation and lymphoid organ development functions are important for line A host defenses, while cell differentiation, communication and signaling pathways are important for line B. Interestingly, circadian rhythm appears play a critical role in host response of the more resistant A line to C. jejuni colonization. A dramatic differential host response was observed between these two lines of chickens. The more susceptible line B chickens responded to C. jejuni inoculation with a dramatic up-regulation in lipid, glucose, and amino acid metabolism, which is undoubtedly for use in the response to the colonization with little or no change in immune host defenses. However, in more resistant line A birds the host defense responses were characterized by an up-regulation lymphocyte activation, probably by regulatory T cells and an increased expression of the NLR recognition receptor NALP1. To our knowledge, this is the first time each of these responses has been observed in the avian response to an intestinal bacterial pathogen.	[Li, Xianyao; Chiang, Hsin-I; Wang, Ying; Zhou, Huaijun] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA; [Swaggerty, Christina L.; Kogut, Michael H.; Genovese, Kenneth J.; He, Haiqi] ARS, So Plains Agr Res Ctr, USDA, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA)	Li, XY (corresponding author), Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA.	michael.kogut@ars.usda.gov; hjzhou@poultry.tamu.edu	Kogut, Michael H./Z-3119-2019; Chiang, Hsin-I/AAF-6578-2020	Chiang, Hsin-I/0000-0002-2815-4314; Kogut, Michael/0000-0001-5821-3728	United States Department of Agriculture (USDA) [2007-35604-17903]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	This project was supported by National Research Initiative Grant no. 2007-35604-17903 from the United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service Animal Genome program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Albrecht U, 2004, FRONT BIOSCI-LANDMRK, V9, P48, DOI 10.2741/1196; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; ASCHOFF J, 1976, BRAIN RES, V101, P1, DOI 10.1016/0006-8993(76)90983-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; BERMAN A, 1978, J PHYSIOL-LONDON, V282, P419, DOI 10.1113/jphysiol.1978.sp012472; Born J, 1997, J IMMUNOL, V158, P4454; Boyd Y, 2005, IMMUNOGENETICS, V57, P248, DOI 10.1007/s00251-005-0790-6; Bumstead N., 2003, Poultry genetics, breeding and biotechnology, P311, DOI 10.1079/9780851996608.0311; Buzby JC, 1997, J INFECT DIS, V176, pS192, DOI 10.1086/513785; BUZBY JC, 1997, ESTIMATED ANN COSTS; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Chiang HI, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-526; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cormican P, 2008, IMMUNOGENETICS, V60, P147, DOI 10.1007/s00251-007-0269-8; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Ferro PJ, 2004, EPIDEMIOL INFECT, V132, P1029, DOI 10.1017/S0950268804002687; Floyd RA, 1997, NEUROREPORT, V8, P915, DOI 10.1097/00001756-199703030-00020; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Hickey TE, 1999, INFECT IMMUN, V67, P88, DOI 10.1128/IAI.67.1.88-93.1999; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jones MA, 2003, INFECT IMMUN, V71, P2626, DOI 10.1128/IAI.71.5.2626-2633.2003; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klasing KC, 2007, BRIT POULTRY SCI, V48, P525, DOI 10.1080/00071660701671336; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Kogut MH, 2009, J APPL POULTRY RES, V18, P111, DOI 10.3382/japr.2008-00081; Kogut MH, 2009, J APPL POULTRY RES, V18, P103, DOI 10.3382/japr.2008-00080; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Li X, 2008, POULTRY SCI, V87, P1742, DOI 10.3382/ps.2008-00136; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Monteleone Giovanni, 2006, Dig Liver Dis, V38 Suppl 2, pS256, DOI 10.1016/S1590-8658(07)60005-X; Nakao N, 2007, ENDOCRINOLOGY, V148, P3031, DOI 10.1210/en.2007-0044; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Panteleeva NG, 2004, B EXP BIOL MED+, V137, P288, DOI 10.1023/B:BEBM.0000031572.40934.c5; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosenberger CM, 2001, MICROBES INFECT, V3, P1353, DOI 10.1016/S1286-4579(01)01497-6; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sick C, 2000, CYTOKINE, V12, P181, DOI 10.1006/cyto.1999.0543; Smith CK, 2005, INFECT IMMUN, V73, P2094, DOI 10.1128/IAI.73.4.2094-2100.2005; Smith J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-49; Smith J, 2004, IMMUNOGENETICS, V56, P122, DOI 10.1007/s00251-004-0669-y; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Swaggerty CL, 2008, VET IMMUNOL IMMUNOP, V126, P35, DOI 10.1016/j.vetimm.2008.06.005; Swaggerty CL, 2005, FOOD AGR IMMUNOL, V16, P1, DOI 10.1080/01421590400029780; Swaggerty CL, 2005, FEMS IMMUNOL MED MIC, V43, P149, DOI 10.1016/j.femsim.2004.07.013; Swaggerty CL, 2004, IMMUNOLOGY, V113, P139, DOI 10.1111/j.1365-2567.2004.01939.x; Swaggerty CL, 2003, AVIAN PATHOL, V32, P483, DOI 10.1080/0307945031000154071; Swaggerty CL, 2003, AVIAN PATHOL, V32, P95, DOI 10.1080/0307945021000070769; Tazawa H, 2002, COMP BIOCHEM PHYS A, V132, P675, DOI 10.1016/S1095-6433(02)00125-3; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Van Hemert S, 2007, VET RES, V38, P51, DOI 10.1051/vetres:2006048; van Hemert S, 2006, VET IMMUNOL IMMUNOP, V114, P247, DOI 10.1016/j.vetimm.2006.08.007; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhou H, 2007, CYTOGENET GENOME RES, V117, P131, DOI 10.1159/000103173; Zilbauer M, 2005, INFECT IMMUN, V73, P7281, DOI 10.1128/IAI.73.11.7281-7289.2005	65	53	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11827	10.1371/journal.pone.0011827	http://dx.doi.org/10.1371/journal.pone.0011827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676366	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520100010
J	Romano, CM; de Matos, AM; Araujo, ESA; Villas-Boas, LS; da Silva, WC; Oliveira, OMNPF; Carvalho, KI; de Souza, ACM; Rodrigues, CL; Levi, JE; Kallas, EG; Pannuti, CS				Romano, Camila Malta; de Matos, Andreia Manso; Araujo, Evaldo Stanislau A.; Villas-Boas, Lucy Santos; da Silva, Wanessa Cardoso; Oliveira, Olimpia M. N. P. F.; Carvalho, Karina I.; Mamana de Souza, Ana Carolina; Rodrigues, Celia L.; Levi, Jose Eduardo; Kallas, Esper G.; Pannuti, Claudio Sergio			Characterization of Dengue Virus Type 2: New Insights on the 2010 Brazilian Epidemic	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SEROTYPES; OUTBREAK; AMERICA; STATE	Dengue viruses (DENV) serotypes 1, 2, and 3 have been causing yearly outbreaks in Brazil. In this study, we report the reintroduction of DENV2 in the coast of Sao Paulo State. Partial envelope viral genes were sequenced from eighteen patients with dengue fever during the 2010 epidemic. Phylogenetic analysis showed this strain belongs to the American/Asian genotype and was closely related to the virus that circulated in Rio de Janeiro in 2007 and 2008. The phylogeny also showed no clustering by clinical presentation, suggesting that the disease severity could not be explained by distinct variants or genotypes. The time of the most recent common ancestor of American/Asian genotype and the Sao Paulo and Rio de Janeiro (SP/RJ) monophyletic cluster was estimated to be around 40 and 10 years, respectively. Since this virus was first identified in Brazil in 2007, we suggest that it was already circulating in the country before causing the first documented outbreak. This is the first description of the 2010 outbreak in the State of Sao Paulo, Brazil, and should contribute to efforts to control and monitor the spread of DENVs in endemic areas.	[Romano, Camila Malta; Villas-Boas, Lucy Santos; da Silva, Wanessa Cardoso; Mamana de Souza, Ana Carolina; Rodrigues, Celia L.; Levi, Jose Eduardo; Pannuti, Claudio Sergio] Univ Sao Paulo, Dept Molestias Infecciosas & Parasitarias, LIMHC, Inst Med Trop Sao Paulo, Sao Paulo, Brazil; [de Matos, Andreia Manso; Carvalho, Karina I.; Kallas, Esper G.] Univ Sao Paulo, Fac Med, Disciplina Imunol Clin & Alergia LIM 60, Sao Paulo, Brazil; [Araujo, Evaldo Stanislau A.; Oliveira, Olimpia M. N. P. F.] Hosp Ana Costa, Santos, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Romano, CM (corresponding author), Univ Sao Paulo, Dept Molestias Infecciosas & Parasitarias, LIMHC, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.	cmromano@usp.br	Carvalho, Karina IL/J-6789-2012; Kallas, Esper G/C-9539-2012; Pannuti, Claudio/B-7649-2012; Romano, Camila/ABC-2883-2020; Romano, Camila M/C-8185-2013	Carvalho, Karina IL/0000-0002-7763-8139; Romano, Camila/0000-0003-4550-1987; Kallas, Esper/0000-0003-2026-6925	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior, Brazilian Ministry of Education; Brazilian Ministry of Science and Technology (CNPq) [476088/2009-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior, Brazilian Ministry of Education; Brazilian Ministry of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazilian Ministry of Science and Technology (CNPq, grant #476088/2009-7 to EGK). AMM and EGK's scholarships were supported by CNPq. KIC's scholarship was supported by the Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior, Brazilian Ministry of Education. URL of CNPq: URL www.cnpq.br; URL of CAPES: www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390; DESOUZA RV, 1995, MEM I OSWALDO CRUZ, V90, P345, DOI 10.1590/S0074-02761995000300006; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Kumar SRP, 2010, J GEN VIROL, V91, P707, DOI 10.1099/vir.0.017954-0; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Messer William B., 2002, American Journal of Tropical Medicine and Hygiene, V66, P765; Miagostovich MP, 1998, MEM I OSWALDO CRUZ, V93, P625, DOI 10.1590/S0074-02761998000500011; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; PAHO, 2008, NUMB REP CAS DENG DE; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	29	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11811	10.1371/journal.pone.0011811	http://dx.doi.org/10.1371/journal.pone.0011811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676363	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520100005
J	Collino, F; Deregibus, MC; Bruno, S; Sterpone, L; Aghemo, G; Viltono, L; Tetta, C; Camussi, G				Collino, Federica; Deregibus, Maria Chiara; Bruno, Stefania; Sterpone, Luca; Aghemo, Giulia; Viltono, Laura; Tetta, Ciro; Camussi, Giovanni			Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs	PLOS ONE			English	Article							MICRORNA EXPRESSION; CELLULAR MICROPARTICLES; MULTIVESICULAR BODIES; HORIZONTAL TRANSFER; MEDIATED TRANSFER; STRESS GRANULES; MESSENGER-RNA; GENE; LUNG; MECHANISM	Background: Cell-derived microvesicles (MVs) have been described as a new mechanism of cell-to-cell communication. MVs after internalization within target cells may deliver genetic information. Human bone marrow derived mesenchymal stem cells (MSCs) and liver resident stem cells (HLSCs) were shown to release MVs shuttling functional mRNAs. The aim of the present study was to evaluate whether MVs derived from MSCs and HLSCs contained selected micro-RNAs (miRNAs). Methodology/Principal Findings: MVs were isolated from MSCs and HLSCs. The presence in MVs of selected ribonucleoproteins involved in the traffic and stabilization of RNA was evaluated. We observed that MVs contained TIA, TIAR and HuR multifunctional proteins expressed in nuclei and stress granules, Stau1 and 2 implicated in the transport and stability of mRNA and Ago2 involved in miRNA transport and processing. RNA extracted from MVs and cells of origin was profiled for 365 known human mature miRNAs by real time PCR. Hierarchical clustering and similarity analysis of miRNAs showed 41 co-expressed miRNAs in MVs and cells. Some miRNAs were accumulated within MVs and absent in the cells after MV release; others were retained within the cells and not secreted in MVs. Gene ontology analysis of predicted and validated targets showed that the high expressed miRNAs in cells and MVs could be involved in multi-organ development, cell survival and differentiation. Few selected miRNAs shuttled by MVs were also associated with the immune system regulation. The highly expressed miRNAs in MVs were transferred to target cells after MV incorporation. Conclusions: This study demonstrated that MVs contained ribonucleoproteins involved in the intracellular traffic of RNA and selected pattern of miRNAs, suggesting a dynamic regulation of RNA compartmentalization in MVs. The observation that MV-highly expressed miRNAs were transferred to target cells, rises the possibility that the biological effect of stem cells may, at least in part, depend on MV-shuttled miRNAs. Data generated from this study, stimulate further functional investigations on the predicted target genes and pathways involved in the biological effect of human adult stem cells.	[Collino, Federica; Deregibus, Maria Chiara; Bruno, Stefania; Aghemo, Giulia; Viltono, Laura; Camussi, Giovanni] Univ Turin, Dept Internal Med, Turin, Italy; [Collino, Federica; Deregibus, Maria Chiara; Bruno, Stefania; Aghemo, Giulia; Viltono, Laura; Camussi, Giovanni] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Sterpone, Luca] Politecn Torino, Dept Automat & Informat, Turin, Italy; [Bruno, Stefania] SiS Ter SpA, Palazzo Pignano, Crema, Italy; [Tetta, Ciro] Fresenius Med Care, Bad Homburg, Germany	University of Turin; University of Turin; Polytechnic University of Turin	Collino, F (corresponding author), Univ Turin, Dept Internal Med, Turin, Italy.	giovanni.camussi@unito.it	Sterpone, Luca/AAL-2464-2020; Collino, Federica/B-9956-2018; Camussi, Giovanni/J-7624-2016	Collino, Federica/0000-0002-3619-7701; Camussi, Giovanni/0000-0003-2795-232X; BRUNO, Stefania/0000-0002-8879-9536; Sterpone, Luca/0000-0002-3080-2560	Associazione Italiana per la Ricerca sul Cancro (AIRC) [CT 8912]; Ministero Universita e Ricerca Scientifica; Regione Piemonte; Piattaforme Biotecnologiche; Progetto PiSTEM; Sis-Ter; Fresenius Medical Care	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Universita e Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte(Regione Piemonte); Piattaforme Biotecnologiche; Progetto PiSTEM; Sis-Ter; Fresenius Medical Care	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) CT 8912, Ministero Universita e Ricerca Scientifica, PRIN and by Grants from Regione Piemonte, Piattaforme Biotecnologiche, Progetto PiSTEM, Sis-Ter and Fresenius Medical Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Cocucci E, 2007, TRAFFIC, V8, P742, DOI 10.1111/j.1600-0854.2007.00566.x; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Deregibus MC, 2010, HISTOL HISTOPATHOL, V25, P397, DOI 10.14670/HH-25.397; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Dooner MS, 2008, STEM CELLS DEV, V17, P207, DOI 10.1089/scd.2007.0195; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Doublier S, 2005, INT J MOL MED, V16, P49; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; GEORGE JN, 1982, BLOOD, V60, P834; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Heijnen Harry F. G., 1999, Blood, V94, P3791; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; HERRERA MB, 2009, J CELL MOL MED; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Masaki Shizuka, 2008, Rinsho Byori, V56, P1086; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Quesenberry PJ, 2008, STEM CELL REV, V4, P137, DOI 10.1007/s12015-008-9036-y; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh Shree Ram, 2008, V450, P45, DOI 10.1007/978-1-60327-214-8_3; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stadler BM, 2008, CELL, V132, P563, DOI 10.1016/j.cell.2008.02.005; STERPONE L, ADV EXPT ME IN PRESS; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126; ZHU W, 2010, INT J CANC	67	454	487	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11803	10.1371/journal.pone.0011803	http://dx.doi.org/10.1371/journal.pone.0011803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668554	Green Published, Green Submitted, gold			2022-12-25	WOS:000280371800009
J	Ikmi, A; Gibson, MC				Ikmi, Aissam; Gibson, Matthew C.			Identification and In Vivo Characterization of NvFP-7R, a Developmentally Regulated Red Fluorescent Protein of Nematostella vectensis	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENE-EXPRESSION; GENOME REVEALS; EVOLUTION; COMPLEXITY; DIVERSITY; ORIGINS; FAMILY	Background: In recent years, the sea anemone Nematostella vectensis has emerged as a critical model organism for comparative genomics and developmental biology. Although Nematostella is a member of the anthozoan cnidarians (known for producing an abundance of diverse fluorescent proteins (FPs)), endogenous patterns of Nematostella fluorescence have not been described and putative FPs encoded by the genome have not been characterized. Methodology/Principal Findings: We described the spatiotemporal expression of endogenous red fluorescence during Nematostella development. Spatially, there are two patterns of red fluorescence, both restricted to the oral endoderm in developing polyps. One pattern is found in long fluorescent domains associated with the eight mesenteries and the other is found in short fluorescent domains situated between tentacles. Temporally, the long domains appear simultaneously at the 12-tentacle stage. In contrast, the short domains arise progressively between the 12- and 16-tentacle stage. To determine the source of the red fluorescence, we used bioinformatic approaches to identify all possible putative Nematostella FPs and a Drosophila S2 cell culture assay to validate NvFP-7R, a novel red fluorescent protein. We report that both the mRNA expression pattern and spectral signature of purified NvFP-7R closely match that of the endogenous red fluorescence. Strikingly, the red fluorescent pattern of NvFP-7R exhibits asymmetric expression along the directive axis, indicating that the nvfp-7r locus senses the positional information of the body plan. At the tissue level, NvFP-7R exhibits an unexpected subcellular localization and a complex complementary expression pattern in apposed epithelia sheets comprising each endodermal mesentery. Conclusions/Significance: These experiments not only identify NvFP-7R as a novel red fluorescent protein that could be employed as a research tool; they also uncover an unexpected spatio-temporal complexity of gene expression in an adult cnidarian. Perhaps most importantly, our results define Nematostella as a new model organism for understanding the biological function of fluorescent proteins in vivo.	[Ikmi, Aissam; Gibson, Matthew C.] Stowers Inst Med Res, Kansas City, MO USA; [Gibson, Matthew C.] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Ikmi, A (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	mg2@stowers.org		Gibson, Matthew/0000-0001-5588-8842; Ikmi, Aissam/0000-0001-6310-8404	Stowers Institute for Medical Research; Burroughs Wellcome Fund	Stowers Institute for Medical Research; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the Stowers Institute for Medical Research (www.stowers-institute.org) and the Burroughs Wellcome Fund Career Award in Biological Sciences (http://www.bwfund.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Burton PM, 2009, DEV GENES EVOL, V219, P79, DOI 10.1007/s00427-009-0271-2; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; GENIKHOVICH G, 2009, CSH PROTOC; HAND C, 1992, BIOL BULL, P169; Kao HT, 2007, MAR BIOTECHNOL, V9, P733, DOI 10.1007/s10126-007-9025-1; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Mavrakis M, 2010, DEVELOPMENT, V137, P373, DOI 10.1242/dev.031690; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; Miller DJ, 2008, TRENDS GENET, V24, P1, DOI 10.1016/j.tig.2007.10.002; Miyawaki A, 2002, CELL STRUCT FUNCT, V27, P343, DOI 10.1247/csf.27.343; Murate M, 1996, CELL TISSUE RES, V283, P455, DOI 10.1007/s004410050556; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Palmer CV, 2009, BIOL BULL-US, V216, P68, DOI 10.1086/BBLv216n1p68; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Rentzsch F, 2008, DEVELOPMENT, V135, P1761, DOI 10.1242/dev.020784; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Sun Y, 2004, FEBS LETT, V570, P175, DOI 10.1016/j.febslet.2004.06.043; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wachter RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P339, DOI 10.1562/2005-10-02-IR-708; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	39	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11807	10.1371/journal.pone.0011807	http://dx.doi.org/10.1371/journal.pone.0011807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668556	Green Published, Green Submitted, gold			2022-12-25	WOS:000280371800011
J	O'Connor, RP; Madison, SD; Leveque, P; Roderick, HL; Bootman, MD				O'Connor, Rodney P.; Madison, Steve D.; Leveque, Philippe; Roderick, H. Llewelyn; Bootman, Martin D.			Exposure to GSM RF Fields Does Not Affect Calcium Homeostasis in Human Endothelial Cells, Rat Pheocromocytoma Cells or Rat Hippocampal Neurons	PLOS ONE			English	Article							FREQUENCY ELECTROMAGNETIC-FIELDS; MOBILE PHONE RADIATION; ION EFFLUX; RADIOFREQUENCY RADIATION; INTRACELLULAR CALCIUM; NEUROBLASTOMA-CELLS; BATTERY CURRENT; CA2+ RELEASE; BRAIN-TISSUE; PC12 CELLS	In the course of modern daily life, individuals are exposed to numerous sources of electromagnetic radiation that are not present in the natural environment. The strength of the electromagnetic fields from sources such as hairdryers, computer display units and other electrical devices is modest. However, in many home and office environments, individuals can experience perpetual exposure to an "electromagnetic smog", with occasional peaks of relatively high electromagnetic field intensity. This has led to concerns that such radiation can affect health. In particular, emissions from mobile phones or mobile phone masts have been invoked as a potential source of pathological electromagnetic radiation. Previous reports have suggested that cellular calcium (Ca2+) homeostasis is affected by the types of radiofrequency fields emitted by mobile phones. In the present study, we used a high-throughput imaging platform to monitor putative changes in cellular Ca2+ during exposure of cells to 900 MHz GSM fields of differing power (specific absorption rate 0.012-2 W/Kg), thus mimicking the type of radiation emitted by current mobile phone handsets. Data from cells experiencing the 900 Mhz GSM fields were compared with data obtained from paired experiments using continuous wave fields or no field. We employed three cell types (human endothelial cells, PC-12 neuroblastoma and primary hippocampal neurons) that have previously been suggested to be sensitive to radiofrequency fields. Experiments were designed to examine putative effects of radiofrequency fields on resting Ca2+, in addition to Ca2+ signals evoked by an InsP3-generating agonist. Furthermore, we examined putative effects of radiofrequency field exposure on Ca2+ store emptying and store-operated Ca2+ entry following application of the Ca2+ ATPase inhibitor thapsigargin. Multiple parameters (e. g., peak amplitude, integrated Ca2+ signal, recovery rates) were analysed to explore potential impact of radiofrequency field exposure on Ca2+ signals. Our data indicate that 900 MHz GSM fields do not affect either basal Ca2+ homeostasis or provoked Ca2+ signals. Even at the highest field strengths applied, which exceed typical phone exposure levels, we did not observe any changes in cellular Ca2+ signals. We conclude that under the conditions employed in our experiments, and using a highly-sensitive assay, we could not detect any consequence of RF exposure.	[O'Connor, Rodney P.; Madison, Steve D.; Roderick, H. Llewelyn; Bootman, Martin D.] Babraham Inst, Mol Signalling Lab, Cambridge, England; [Roderick, H. Llewelyn] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Leveque, Philippe] Univ Limoges, XLIM, Limoges, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Universite de Limoges	O'Connor, RP (corresponding author), Babraham Inst, Mol Signalling Lab, Cambridge, England.	martin.bootman@bbsrc.ac.uk	Bootman, Martin/AAB-3330-2019; LEVEQUE, Philippe/N-8749-2014	Bootman, Martin/0000-0002-6447-3451; LEVEQUE, Philippe/0000-0003-3687-436X; O'Connor, Rodney/0000-0002-3916-3101; Roderick, Hywel/0000-0001-7065-3523	Biotechnology and Biological Sciences Research Council; Mobile Telecommunications and Health Research Programme; Biotechnology and Biological Sciences Research Council [BBS/E/B/00001116, BBS/E/B/0000C116] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Mobile Telecommunications and Health Research Programme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and the Mobile Telecommunications and Health Research Programme. HLR is a Royal Society Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; ALBERT EN, 1987, RADIAT RES, V109, P19, DOI 10.2307/3576863; BAWIN SM, 1975, ANN NY ACAD SCI, V247, P74, DOI 10.1111/j.1749-6632.1975.tb35984.x; BAWIN SM, 1984, BRAIN RES, V323, P227, DOI 10.1016/0006-8993(84)90293-2; Bennett DL, 1998, BIOCHEM J, V329, P349; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BLACKMAN C F, 1980, Bioelectromagnetics, V1, P35, DOI 10.1002/bem.2250010104; BLACKMAN CF, 1991, BIOELECTROMAGNETICS, V12, P173, DOI 10.1002/bem.2250120305; BLACKMAN CF, 1985, BIOELECTROMAGNETICS, V6, P1, DOI 10.1002/bem.2250060102; Bootman MD, 2001, J CELL SCI, V114, P2213; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; DUTTA SK, 1984, BIOELECTROMAGNETICS, V5, P71, DOI 10.1002/bem.2250050108; DUTTA SK, 1989, BIOELECTROMAGNETICS, V10, P197, DOI 10.1002/bem.2250100208; Friedman J, 2007, BIOCHEM J, V405, P559, DOI 10.1042/BJ20061653; Green AC, 2005, INT J RADIAT BIOL, V81, P869, DOI 10.1080/09553000600555389; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; Ilvonen S, 2005, BIOELECTROMAGNETICS, V26, P648, DOI 10.1002/bem.20159; Ivaschuk OI, 1997, BIOELECTROMAGNETICS, V18, P223, DOI 10.1002/(SICI)1521-186X(1997)18:3<223::AID-BEM4>3.0.CO;2-4; Jokela K, 2004, HEALTH PHYS, V86, P56, DOI 10.1097/00004032-200401000-00008; Koizumi S, 1999, J BIOL CHEM, V274, P33327, DOI 10.1074/jbc.274.47.33327; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; LIBURDY RP, 1988, RADIAT RES, V114, P500, DOI 10.2307/3577121; LIBURDY RP, 1992, FEBS LETT, V301, P53, DOI 10.1016/0014-5793(92)80209-Y; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MERRITT JH, 1982, BIOELECTROMAGNETICS, V3, P475, DOI 10.1002/bem.2250030411; Moisescu MG, 2008, BIOELECTROCHEMISTRY, V74, P9, DOI 10.1016/j.bioelechem.2007.11.003; Nylund R, 2004, PROTEOMICS, V4, P1359, DOI 10.1002/pmic.200300773; Nylund R, 2006, PROTEOMICS, V6, P4769, DOI 10.1002/pmic.200600076; Pessina GP, 2001, BIOELECTROMAGNETICS, V22, P503, DOI 10.1002/bem.79; Roderick HL, 2007, BIOCHEM SOC T, V35, P957, DOI 10.1042/BST0350957; SCHWARTZ JL, 1993, BIOELECTROMAGNETICS, V14, P521, DOI 10.1002/bem.2250140604; Selvam R, 2007, LIFE SCI, V80, P2403, DOI 10.1016/j.lfs.2007.03.019; Shahidain R, 2001, INT J RADIAT BIOL, V77, P241, DOI 10.1080/09553000010013779; SHELTON W W JR, 1981, Bioelectromagnetics, V2, P161, DOI 10.1002/bem.2250020207; Sisken JE, 2000, RADIAT RES, V153, P699, DOI 10.1667/0033-7587(2000)153[0699:PFEFAT]2.0.CO;2; Tattersall JEH, 2001, BRAIN RES, V904, P43, DOI 10.1016/S0006-8993(01)02434-9; Tonini R, 2001, BIOPHYS J, V81, P2580, DOI 10.1016/S0006-3495(01)75902-4; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Wolke S, 1996, BIOELECTROMAGNETICS, V17, P144, DOI 10.1002/(SICI)1521-186X(1996)17:2<144::AID-BEM9>3.0.CO;2-3; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	47	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11828	10.1371/journal.pone.0011828	http://dx.doi.org/10.1371/journal.pone.0011828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676401	gold, Green Published, Green Accepted			2022-12-25	WOS:000280371800022
J	Kapoor, A; Mehta, N; Esper, F; Poljsak-Prijatelj, M; Quan, PL; Qaisar, N; Delwart, E; Lipkin, WI				Kapoor, Amit; Mehta, Natasha; Esper, Frank; Poljsak-Prijatelj, Mateja; Quan, Phenix-Lan; Qaisar, Natasha; Delwart, Eric; Lipkin, W. Ian			Identification and Characterization of a New Bocavirus Species in Gorillas	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; HOSPITALIZED CHILDREN; PARVOVIRUS; CANINE; GASTROENTERITIS; SAMPLES; VIRUS; EMERGENCE; EVOLUTION; PATHOGEN	A novel parvovirus, provisionally named Gorilla Bocavirus species 1 (GBoV1), was identified in four stool samples from Western gorillas (Gorilla gorilla) with acute enteritis. The complete genomic sequence of the new parvovirus revealed three open reading frames (ORFs) with an organization similar to that of known bocaviruses. Phylogenetic analysis using complete capsid and non structural (NS) gene sequence suggested that the new parvovirus is most closely related to human bocaviruses (HBoV). However, the NS ORF is more similar in length to the NS ORF found in canine minute virus and bovine parvovirus than in HBoV. Comparative genetic analysis using GBoV and HBoV genomes enabled characterization of unique splice donor and acceptor sites that appear to be highly conserved among all four HBoV species, and provided evidence for expression of two different NS proteins in all primate bocaviruses. GBoV is the first non-human primate bocavirus identified and provides new insights into the genetic diversity and evolution of this highly prevalent and recently discovered group of parvoviruses.	[Kapoor, Amit; Mehta, Natasha; Quan, Phenix-Lan; Qaisar, Natasha; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA; [Esper, Frank] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Poljsak-Prijatelj, Mateja] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Delwart, Eric] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA	Columbia University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Ljubljana; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute	Kapoor, A (corresponding author), Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA.	ak3117@columbia.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Delwart, Eric/0000-0002-6296-4484; Qaisar, Natasha/0000-0001-6838-941X	Google.org; National Institutes of Health (Northeast Biodefense Center - Lipkin) [AI57158]; USAID Predict; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	Google.org; National Institutes of Health (Northeast Biodefense Center - Lipkin)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID Predict(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Google.org, National Institutes of Health award AI57158 (Northeast Biodefense Center - Lipkin), and USAID Predict. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Anderson LJ, 2007, CLIN INFECT DIS, V44, P911, DOI 10.1086/512438; Appel MJG, 1999, ADV VETER MED AP, V41, P309; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; Brieu N, 2008, PEDIATR INFECT DIS J, V27, P969, DOI 10.1097/INF.0b013e31817acfaa; Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014; Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P959, DOI 10.1097/INF.0b013e3181256583; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chieochansin T, 2008, J INFECTION, V56, P137, DOI 10.1016/j.jinf.2007.11.006; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; CLAUDE M, 2004, VIRUS TAXONOMY 8 REP; DEVRIES JJ, 2009, J CLIN MICROBIOL; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; GAGLIARDI TB, 2009, EPIDEMIOL INFECT, P1, DOI DOI 10.1017/S0950268808001842; Gerna G, 2007, NEW MICROBIOL, V30, P383; HOELZER K, VET RES, V41, P39; Hoelzer K, 2008, J GEN VIROL, V89, P2280, DOI 10.1099/vir.0.2008/002055-0; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; KAPOOR A, J INFECT DIS, V201, P1643; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; LEDERMAN M, 1984, J VIROL, V49, P315, DOI 10.1128/JVI.49.2.315-318.1984; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Patel JR, 2009, VACCINE, V27, P491, DOI 10.1016/j.vaccine.2008.11.027; Paul MA, 2006, J AM ANIM HOSP ASSOC, V42, P80, DOI 10.5326/0420080; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schildgen O, 2007, EMERG INFECT DIS, V13, P1620, DOI 10.3201/eid1310.070436; Schultz RD, 2006, VET MICROBIOL, V117, P75, DOI 10.1016/j.vetmic.2006.04.013; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Vicente D, 2007, EMERG INFECT DIS, V13, P636, DOI 10.3201/eid1304.061501; Wellehan JFX, 2009, VET MICROBIOL, V133, P34, DOI 10.1016/j.vetmic.2008.06.011; Ziegler S, 2008, J CLIN VIROL, V43, P349, DOI 10.1016/j.jcv.2008.07.006	45	90	101	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11948	10.1371/journal.pone.0011948	http://dx.doi.org/10.1371/journal.pone.0011948			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668709	Green Published, gold			2022-12-25	WOS:000280243800037
J	Koh, YS; Koo, JE; Biswas, A; Kobayashi, KS				Koh, Young-Sang; Koo, Jung-Eun; Biswas, Amlan; Kobayashi, Koichi S.			MyD88-Dependent Signaling Contributes to Host Defense against Ehrlichial Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; ANIMAL-MODEL; ADAPTIVE IMMUNITY; COXIELLA-BURNETII; DENDRITIC CELLS; MICE DEFICIENT; STRANDED-RNA; IFN-GAMMA; RECOGNITION	The ehrlichiae are small Gram-negative obligate intracellular bacteria in the family Anaplasmataceae. Ehrlichial infection in an accidental host may result in fatal diseases such as human monocytotropic ehrlichiosis, an emerging, tick-borne disease. Although the role of adaptive immune responses in the protection against ehrlichiosis has been well studied, the mechanism by which the innate immune system is activated is not fully understood. Using Ehrlichia muris as a model organism, we show here that MyD88-dependent signaling pathways play a pivotal role in the host defense against ehrlichial infection. Upon E. muris infection, MyD88-deficient mice had significantly impaired clearance of E. muris, as well as decreased inflammation, characterized by reduced splenomegaly and recruitment of macrophages and neutrophils. Furthermore, MyD88-deficient mice produced markedly lower levels of IL-12, which correlated well with an impaired Th1 immune response. In vitro, dendritic cells, but not macrophages, efficiently produced IL-12 upon E. muris infection through a MyD88-dependent mechanism. Therefore, MyD88-dependent signaling is required for controlling ehrlichial infection by playing an essential role in the immediate activation of the innate immune system and inflammatory cytokine production, as well as in the activation of the adaptive immune system at a later stage by providing for optimal Th1 immune responses.	[Koh, Young-Sang; Biswas, Amlan; Kobayashi, Koichi S.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Koh, Young-Sang; Biswas, Amlan; Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Koh, Young-Sang; Koo, Jung-Eun] Jeju Natl Univ, Sch Med, Dept Microbiol, Cheju, Jeju Do, South Korea; [Koh, Young-Sang; Koo, Jung-Eun] Jeju Natl Univ, Sch Med, Brain Korea Program 21, Cheju, Jeju Do, South Korea	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Jeju National University; Jeju National University	Koh, YS (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	Koichi_Kobayashi@dfci.harvard.edu		Kobayashi, Koichi/0000-0003-2930-0114	NIH [R01DK074738]; Cancer Research Institute; Claudia Adams Barr Award; Korea Research Foundation [KRF-2008-313-C00807]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Claudia Adams Barr Award; Korea Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the NIH (R01DK074738) to KSK. KSK is a recipient of the Investigator Award from the Cancer Research Institute and the Claudia Adams Barr Award, and YSK is a recipient of and was supported by the Korea Research Foundation Grant (KRF-2008-313-C00807). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; EWING SA, 1995, J MED ENTOMOL, V32, P368, DOI 10.1093/jmedent/32.3.368; Feng HM, 2004, INFECT IMMUN, V72, P966, DOI 10.1128/IAI.72.2.966-971.2004; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; FICHTENBAUM CJ, 1993, AM J MED, V95, P351, DOI 10.1016/0002-9343(93)90302-6; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glimcher LH, 2000, GENE DEV, V14, P1693; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Kawahara M, 1996, MICROBIOL IMMUNOL, V40, P575, DOI 10.1111/j.1348-0421.1996.tb01111.x; KAWAHARA M, 1993, J CLIN MICROBIOL, V31, P89, DOI 10.1128/JCM.31.1.89-96.1993; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LAMKANFI M, 2007, J LEUKOC BIOL; Li JSY, 2001, J IMMUNOL, V166, P1855; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McQuiston JH, 1999, EMERG INFECT DIS, V5, P635, DOI 10.3201/eid0505.990504; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Nandi B, 2007, INFECT IMMUN, V75, P5453, DOI 10.1128/IAI.00713-07; Nandi B, 2009, INFECT IMMUN, V77, P4643, DOI 10.1128/IAI.01433-08; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Olano JP, 2002, MED CLIN N AM, V86, P375, DOI 10.1016/S0025-7125(03)00093-2; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; PADDOCK CD, 1993, NEW ENGL J MED, V329, P1164, DOI 10.1056/NEJM199310143291605; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Shibata S, 2000, J CLIN MICROBIOL, V38, P1331, DOI 10.1128/JCM.38.4.1331-1338.2000; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Sotomayor EA, 2001, AM J PATHOL, V158, P757, DOI 10.1016/S0002-9440(10)64018-7; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Uematsu Satoshi, 2008, V183, P1; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	67	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11758	10.1371/journal.pone.0011758	http://dx.doi.org/10.1371/journal.pone.0011758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668698	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243800027
J	Kong, XX; Wang, R; Xue, Y; Liu, XJ; Zhang, HB; Chen, Y; Fang, F; Chang, YS				Kong, Xingxing; Wang, Rui; Xue, Yuan; Liu, Xiaojun; Zhang, Huabing; Chen, Yong; Fang, Fude; Chang, Yongsheng			Sirtuin 3, a New Target of PGC-1 alpha, Plays an Important Role in the Suppression of ROS and Mitochondrial Biogenesis	PLOS ONE			English	Article							ERR-ALPHA; RECEPTOR-ALPHA; SIR2 HOMOLOG; HEPATIC GLUCONEOGENESIS; ENERGY-METABOLISM; GENE-EXPRESSION; DEACETYLASE; GAMMA; IDENTIFICATION; COACTIVATORS	Background: Sirtuin 3 (SIRT3) is one of the seven mammalian sirtuins, which are homologs of the yeast Sir2 gene. SIRT3 is the only sirtuin with a reported association with the human life span. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) plays important roles in adaptive thermogenesis, gluconeogenesis, mitochondrial biogenesis and respiration. PGC-1 alpha induces several key reactive oxygen species (ROS)-detoxifying enzymes, but the molecular mechanism underlying this is not well understood. Results: Here we show that PGC-1 alpha strongly stimulated mouse Sirt3 gene expression in muscle cells and hepatocytes. Knockdown of PGC-1 alpha led to decreased Sirt3 gene expression. PGC-1 alpha activated the mouse SIRT3 promoter, which was mediated by an estrogen-related receptor (ERR) binding element (ERRE) (-407/-399) mapped to the promoter region. Chromatin immunoprecipitation and electrophoretic mobility shift assays confirmed that ERR alpha bound to the identified ERRE and PGC-1 alpha co-localized with ERR alpha in the mSirt3 promoter. Knockdown of ERR alpha reduced the induction of Sirt3 by PGC-1 alpha in C2C12 myotubes. Furthermore, Sirt3 was essential for PGC-1 alpha-dependent induction of ROS-detoxifying enzymes and several components of the respiratory chain, including glutathione peroxidase-1, superoxide dismutase 2, ATP synthase 5c, and cytochrome c. Overexpression of SIRT3 or PGC-1 alpha in C2C12 myotubes decreased basal ROS level. In contrast, knockdown of mSIRT3 increased basal ROS level and blocked the inhibitory effect of PGC-1 alpha on cellular ROS production. Finally, SIRT3 stimulated mitochondrial biogenesis, and SIRT3 knockdown decreased the stimulatory effect of PGC-1 alpha on mitochondrial biogenesis in C2C12 myotubes. Conclusion: Our results indicate that Sirt3 functions as a downstream target gene of PGC-1 alpha and mediates the PGC-1 alpha effects on cellular ROS production and mitochondrial biogenesis. Thus, SIRT3 integrates cellular energy metabolism and ROS generation. The elucidation of the molecular mechanisms of SIRT3 regulation and its physiological functions may provide a novel target for treating ROS-related disease.	[Kong, Xingxing; Wang, Rui; Liu, Xiaojun; Zhang, Huabing; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Kong, Xingxing; Wang, Rui; Liu, Xiaojun; Zhang, Huabing; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Yuan; Chen, Yong] Hubei Prov Key Lab Biotechnol Chinese Tradit Med, Wuhan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Kong, XX (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	cy101610@npc.gov.cn; fangfd@vip.sina.com; changy@ibms.pumc.edu.cn	Wang, Rui/I-5643-2019	Wang, Rui/0000-0001-7015-0272	Major State Basic Research Development Program of China [2006CB503909]; National High Technology Research and Development Program of China [2006AA02Z192, 2006AA02A409]; National Natural Science Foundation of China [30700386, 30721063, 30800389, 90919019]; Natural Science Foundation of Beijing [7082056]	Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by collective grants from the Major State Basic Research Development Program of China (973 Program 2006CB503909), National High Technology Research and Development Program of China (863 Program 2006AA02Z192 and 2006AA02A409), the National Natural Science Foundation of China (Grant No. 30700386, No. 30721063, No. 30800389 and No. 90919019) and Natural Science Foundation of Beijing (Grant No. 7082056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kong XX, 2009, MOL PHARMACOL, V76, P854, DOI 10.1124/mol.109.056424; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Leong PHW, 2005, J STAT SOFTW, V12, P1; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; REMELS AH, 2009, MOL CELL ENDOCRINOL; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wang YJ, 2004, WORLD J GASTROENTERO, V10, P699, DOI 10.3748/wjg.v10.i5.699; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YH, 2000, GENOMICS, V69, P355, DOI 10.1006/geno.2000.6360; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhao LJ, 2003, GENE, V316, P137, DOI 10.1016/S0378-1119(03)00750-9	56	523	540	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11707	10.1371/journal.pone.0011707	http://dx.doi.org/10.1371/journal.pone.0011707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661474	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300011
J	Bull, JC; Bonsall, MB				Bull, James C.; Bonsall, Michael B.			Predators Reduce Extinction Risk in Noisy Metapopulations	PLOS ONE			English	Article							DEMOGRAPHIC STOCHASTICITY; APPARENT COMPETITION; ENVIRONMENTAL NOISE; SPATIAL SYNCHRONY; DYNAMICS; PERSISTENCE; DISPERSAL; STABILITY; MODELS; CYCLES	Background: Spatial structure across fragmented landscapes can enhance regional population persistence by promoting local "rescue effects.'' In small, vulnerable populations, where chance or random events between individuals may have disproportionately large effects on species interactions, such local processes are particularly important. However, existing theory often only describes the dynamics of metapopulations at regional scales, neglecting the role of multispecies population dynamics within habitat patches. Findings: By coupling analysis across spatial scales we quantified the interaction between local scale population regulation, regional dispersal and noise processes in the dynamics of experimental host-parasitoid metapopulations. We find that increasing community complexity increases negative correlation between local population dynamics. A potential mechanism underpinning this finding was explored using a simple population dynamic model. Conclusions: Our results suggest a paradox: parasitism, whilst clearly damaging to hosts at the individual level, reduces extinction risk at the population level.	[Bull, James C.] Univ Warwick, Dept Biol Sci, Populat & Dis Grp, Coventry CV4 7AL, W Midlands, England; [Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England	University of Warwick; University of Oxford	Bull, JC (corresponding author), Univ Warwick, Dept Biol Sci, Populat & Dis Grp, Coventry CV4 7AL, W Midlands, England.	michael.bonsall@zoo.ox.ac.uk		Bull, James/0000-0002-4373-6830; Bonsall, Michael/0000-0003-0250-0423	Natural Environment Research Council [NER/A/S/2000/01288]; Natural Environment Research Council [NE/F010095/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by a grant from the Natural Environment Research Council to MBB (NER/A/S/2000/01288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; Amarasekare P, 1998, AM NAT, V152, P298, DOI 10.1086/286169; Benton TG, 2002, J ANIM ECOL, V71, P320, DOI 10.1046/j.1365-2656.2002.00601.x; Bjornstad ON, 1998, J ANIM ECOL, V67, P110, DOI 10.1046/j.1365-2656.1998.00168.x; Bonsall MB, 2005, P ROY SOC B-BIOL SCI, V272, P1465, DOI 10.1098/rspb.2005.3111; Bonsall MB, 1997, NATURE, V388, P371, DOI 10.1038/41084; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Bull JC, 2008, J ANIM ECOL, V77, P1296, DOI 10.1111/j.1365-2656.2008.01449.x; Bull JC, 2007, P ROY SOC B-BIOL SCI, V274, P87, DOI 10.1098/rspb.2006.3691; Bull JC, 2006, J ANIM ECOL, V75, P899, DOI 10.1111/j.1365-2656.2006.01107.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; COMINS HN, 1992, J ANIM ECOL, V61, P735, DOI 10.2307/5627; COMINS HN, 1987, THEOR POPUL BIOL, V31, P393, DOI 10.1016/0040-5809(87)90013-X; Comins HN, 1996, J THEOR BIOL, V183, P19, DOI 10.1006/jtbi.1996.0197; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Earn DJD, 2000, SCIENCE, V290, P1360, DOI 10.1126/science.290.5495.1360; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; GURNEY WSC, 1998, ECOLOGICAL DYNAMICS; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holt RD, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P333; Holyoak M, 1996, J ANIM ECOL, V65, P640, DOI 10.2307/5743; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; Ranta E, 2000, P ROY SOC B-BIOL SCI, V267, P1851, DOI 10.1098/rspb.2000.1220; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Royama T., 1992, ANAL POPULATION ECOL; Vogwill T, 2009, ECOL LETT, V12, P1194, DOI 10.1111/j.1461-0248.2009.01374.x; Wilson HB, 1997, P ROY SOC B-BIOL SCI, V264, P1189, DOI 10.1098/rspb.1997.0164; Zhou SR, 2004, MATH BIOSCI, V189, P103, DOI 10.1016/j.mbs.2003.06.001	36	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11635	10.1371/journal.pone.0011635	http://dx.doi.org/10.1371/journal.pone.0011635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657767	Green Published, Green Submitted, gold			2022-12-25	WOS:000280197500012
J	Kuta, A; Deng, WH; El-Kadi, AM; Banks, GT; Hafezparast, M; Pfister, KK; Fisher, EMC				Kuta, Anna; Deng, Wenhan; El-Kadi, Ali Morsi; Banks, Gareth T.; Hafezparast, Majid; Pfister, K. Kevin; Fisher, Elizabeth M. C.			Mouse Cytoplasmic Dynein Intermediate Chains: Identification of New Isoforms, Alternative Splicing and Tissue Distribution of Transcripts	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; ARM DYNEIN; BINDS; SUBUNIT; PHOSPHORYLATION; MICROTUBULES; ORGANIZATION; TRANSPORT; DYNACTIN; DEFECTS	Background: Intracellular transport of cargoes including organelles, vesicles, signalling molecules, protein complexes, and RNAs, is essential for normal function of eukaryotic cells. The cytoplasmic dynein complex is an important motor that moves cargos along microtubule tracks within the cell. In mammals this multiprotein complex includes dynein intermediate chains 1 and 2 which are encoded by two genes, Dync1i1 and Dync1i2. These proteins are involved in dynein cargo binding and dynein complexes with different intermediate chains bind to specific cargoes, although the mechanisms to achieve this are not known. The DYNC1I1 and DYNC1I2 proteins are translated from different splice isoforms, and specific forms of each protein are essential for the function of different dynein complexes in neurons. Methodology/Principal Findings: Here we have undertaken a systematic survey of the dynein intermediate chain splice isoforms in mouse, basing our study on mRNA expression patterns in a range of tissues, and on bioinformatics analysis of mouse, rat and human genomic and cDNA sequences. We found a complex pattern of alternative splicing of both dynein intermediate chain genes, with maximum complexity in the embryonic and adult nervous system. We have found novel transcripts, including some with orthologues in human and rat, and a new promoter and alternative non-coding exon 1 for Dync1i2. Conclusions/Significance: These data, including the cloned isoforms will be essential for understanding the role of intermediate chains in the cytoplasmic dynein complex, particularly their role in cargo binding within individual tissues including different brain regions.	[Kuta, Anna; Banks, Gareth T.; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Deng, Wenhan; El-Kadi, Ali Morsi; Hafezparast, Majid] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Pfister, K. Kevin] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of London; University College London; University of Sussex; University of Virginia	Kuta, A (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London, England.	e.fisher@prion.ucl.ac.uk	Hafezparast, Majid/H-6728-2018; Fisher, Elizabeth MC/C-2168-2008; Hafezparast, Majid/N-8292-2019	Fisher, Elizabeth MC/0000-0003-2850-9936; Hafezparast, Majid/0000-0002-5262-7150; Banks, Gareth/0000-0002-8647-667X	Wellcome Trust; European Union; UK Medical Research Council; National Institute of General Medical Science (National Institutes of Health); BBSRC [BB/D012309/1] Funding Source: UKRI; MRC [G0300854] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D012309/1] Funding Source: researchfish; Medical Research Council [G0300854] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of General Medical Science (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These authors are supported by the Wellcome Trust, the ENDOCYTE Research and Training Network funded by the European Union and the UK Medical Research Council and the National Institute of General Medical Science (National Institutes of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Crackower MA, 1999, GENOMICS, V55, P257, DOI 10.1006/geno.1998.5665; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guittot SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008454; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1997, J BIOL CHEM, V272, P5887, DOI 10.1074/jbc.272.9.5887; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Levin M, 1997, MED HYPOTHESES, V49, P429, DOI 10.1016/S0306-9877(97)90092-X; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009482; Lo KWH, 2007, J BIOL CHEM, V282, P36871, DOI 10.1074/jbc.M705991200; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; PASCHAL BM, 1987, NATURE, V330, P672, DOI 10.1038/330672a0; PASCHAL BM, 1992, J CELL BIOL, V118, P1133, DOI 10.1083/jcb.118.5.1133; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1996, MOL BIOL CELL, V7, P331, DOI 10.1091/mbc.7.2.331; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Salata MW, 2001, J NEUROSCI RES, V65, P408, DOI 10.1002/jnr.1168; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Towns WL, 2009, CELL MOTIL CYTOSKEL, V66, P80, DOI 10.1002/cm.20327; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Wagner OI, 2004, MOL BIOL CELL, V15, P5092, DOI 10.1091/mbc.E04-05-0401; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335	45	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11682	10.1371/journal.pone.0011682	http://dx.doi.org/10.1371/journal.pone.0011682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657784	Green Published, gold, Green Accepted			2022-12-25	WOS:000280197500023
J	Goller, CC; Seed, PC				Goller, Carlos C.; Seed, Patrick C.			High-Throughput Identification of Chemical Inhibitors of E. coli Group 2 Capsule Biogenesis as Anti-Virulence Agents	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; UROPATHOGENIC ESCHERICHIA-COLI; ACUTE UNCOMPLICATED CYSTITIS; INTRACELLULAR BACTERIAL COMMUNITIES; BLADDER EPITHELIAL-CELLS; ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANT; BACTERIOPHAGE K1F; POLYSACCHARIDE; WOMEN	Rising antibiotic resistance among Escherichia coli, the leading cause of urinary tract infections (UTIs), has placed a new focus on molecular pathogenesis studies, aiming to identify new therapeutic targets. Anti-virulence agents are attractive as chemotherapeutics to attenuate an organism during disease but not necessarily during benign commensalism, thus decreasing the stress on beneficial microbial communities and lessening the emergence of resistance. We and others have demonstrated that the K antigen capsule of E. coli is a preeminent virulence determinant during UTI and more invasive diseases. Components of assembly and export are highly conserved among the major K antigen capsular types associated with UTI-causing E. coli and are distinct from the capsule biogenesis machinery of many commensal E. coli, making these attractive therapeutic targets. We conducted a screen for anti-capsular small molecules and identified an agent designated "C7'' that blocks the production of K1 and K5 capsules, unrelated polysaccharide types among the Group 2-3 capsules. Herein lies proof-of-concept that this screen may be implemented with larger chemical libraries to identify second-generation small-molecule inhibitors of capsule biogenesis. These inhibitors will lead to a better understanding of capsule biogenesis and may represent a new class of therapeutics.	[Goller, Carlos C.; Seed, Patrick C.] Duke Univ, Dept Pediat, Ctr Microbial Pathogenesis, Durham, NC 27706 USA	Duke University	Goller, CC (corresponding author), Duke Univ, Dept Pediat, Ctr Microbial Pathogenesis, Durham, NC 27706 USA.	patrick.seed@duke.edu	Goller, Carlos C./AAJ-9924-2021	Goller, Carlos/0000-0002-2013-0334	National Institutes of Health (NIH) [K08DK074443]; NIH Office of Research on Women's Health SCOR [P50DK064540]; National Science Foundation (NSF); Duke Children's Miracle Network; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540, K08DK074443] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research on Women's Health SCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Science Foundation (NSF)(National Science Foundation (NSF)); Duke Children's Miracle Network; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PCS received support from National Institutes of Health (NIH) grant K08DK074443 and NIH Office of Research on Women's Health SCOR P50DK064540. CCG received support from a National Science Foundation (NSF) Facilitating Academic Careers in Engineering and Science (FACES) fellowship award and a Duke Children's Miracle Network grant and currently is a postdoctoral fellow of the Hartwell Foundation (http://www.thehartwellfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; ALLEN PZ, 1982, J CLIN MICROBIOL, V15, P324, DOI 10.1128/JCM.15.2.324-329.1982; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Anderson GG, 2004, MICROBES INFECT, V6, P1094, DOI 10.1016/j.micinf.2004.05.023; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Clarke BR, 2000, J BACTERIOL, V182, P3761, DOI 10.1128/JB.182.13.3761-3766.2000; FINKE A, 1991, J BACTERIOL, V173, P4088, DOI 10.1128/jb.173.13.4088-4094.1991; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Gupta K, 2005, J ANTIMICROB CHEMOTH, V56, P243, DOI 10.1093/jac/dki169; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; Hames L, 2007, J AM COLL HEALTH, V56, P153, DOI 10.3200/JACH.56.2.153-158; Hang L, 1998, J UROLOGY, V159, P2185, DOI 10.1016/S0022-5347(01)63303-2; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kahlmeter G, 2000, J ANTIMICROB CHEMOTH, V46, P15, DOI 10.1093/jac/46.suppl_1.15; Karlowsky JA, 2006, ANTIMICROB AGENTS CH, V50, P2251, DOI 10.1128/AAC.00123-06; Li K, 2008, MOL IMMUNOL, V45, P954, DOI 10.1016/j.molimm.2007.07.037; LITWIN MS, 2007, NIH PUBLICATION, P3; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Manzi A, 2001, Curr Protoc Mol Biol, VChapter 17, DOI 10.1002/0471142727.mb1709s32; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mushtaq N, 2005, J ANTIMICROB CHEMOTH, V56, P160, DOI 10.1093/jac/dki177; Olson RP, 2009, ANTIMICROB AGENTS CH, V53, P1285, DOI 10.1128/AAC.01188-08; PELKONEN S, 1988, J BACTERIOL, V170, P2646, DOI 10.1128/jb.170.6.2646-2653.1988; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; ROBERTS IS, 1995, MICROBIOL-SGM, V141, P2023, DOI 10.1099/13500872-141-9-2023; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Sambrook J., 2002, MOL CLONING LAB MANU; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Scholl D, 2005, J BACTERIOL, V187, P8499, DOI 10.1128/JB.187.24.8499-8503.2005; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; SVANBORG C, 1993, ZBL BAKT-INT J MED M, V278, P359, DOI 10.1016/S0934-8840(11)80852-2; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583; Taylor CM, 2006, J BACTERIOL, V188, P1165, DOI 10.1128/JB.188.3.1165-1168.2006; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; VIMR ER, 1992, J BACTERIOL, V174, P6191, DOI 10.1128/JB.174.19.6191-6197.1992; VIMR ER, 1985, J BACTERIOL, V164, P854, DOI 10.1128/JB.164.2.854-860.1985; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427; ZAPATA G, 1992, J BACTERIOL, V174, P315, DOI 10.1128/jb.174.1.315-319.1992; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	53	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11642	10.1371/journal.pone.0011642	http://dx.doi.org/10.1371/journal.pone.0011642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657847	Green Published, gold, Green Submitted			2022-12-25	WOS:000280065600008
J	Thoren, LA; Norgaard, GA; Weischenfeldt, J; Waage, J; Jakobsen, JS; Damgaard, I; Bergstrom, FC; Blom, AM; Borup, R; Bisgaard, HC; Porse, BT				Thoren, Lina A.; Norgaard, Gitte A.; Weischenfeldt, Joachim; Waage, Johannes; Jakobsen, Janus S.; Damgaard, Inge; Bergstrom, Frida C.; Blom, Anna M.; Borup, Rehannah; Bisgaard, Hanne Cathrine; Porse, Bo T.			UPF2 Is a Critical Regulator of Liver Development, Function and Regeneration	PLOS ONE			English	Article							MESSENGER-RNA DECAY; NONSENSE; EXPRESSION; PROTEINS; COMPLEX; CELLS; BINDING	Background: Nonsense-mediated mRNA decay (NMD) is a post-transcriptional RNA surveillance process that facilitates the recognition and destruction of mRNAs bearing premature terminations codons (PTCs). Such PTC-containing (PTC+) mRNAs may arise from different processes, including erroneous processing and expression of pseudogenes, but also from more regulated events such as alternative splicing coupled NMD (AS-NMD). Thus, the NMD pathway serves both as a silencer of genomic noise and a regulator of gene expression. Given the early embryonic lethality in NMD deficient mice, uncovering the full regulatory potential of the NMD pathway in mammals will require the functional assessment of NMD in different tissues. Methodology/Principal Findings: Here we use mouse genetics to address the role of UPF2, a core NMD component, in the development, function and regeneration of the liver. We find that loss of NMD during fetal liver development is incompatible with postnatal life due to failure of terminal differentiation. Moreover, deletion of Upf2 in the adult liver results in hepatosteatosis and disruption of liver homeostasis. Finally, NMD was found to be absolutely required for liver regeneration. Conclusion/Significance: Collectively, our data demonstrate the critical role of the NMD pathway in liver development, function and regeneration and highlights the importance of NMD for mammalian biology.	[Thoren, Lina A.; Norgaard, Gitte A.; Weischenfeldt, Joachim; Waage, Johannes; Jakobsen, Janus S.; Damgaard, Inge; Porse, Bo T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Thoren, Lina A.; Norgaard, Gitte A.; Weischenfeldt, Joachim; Waage, Johannes; Jakobsen, Janus S.; Damgaard, Inge; Porse, Bo T.] Univ Copenhagen, Rigshosp, Sect Gene Therapy Res, DK-2100 Copenhagen, Denmark; [Jakobsen, Janus S.] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Bergstrom, Frida C.; Blom, Anna M.] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Malmo, Sweden; [Borup, Rehannah] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Bisgaard, Hanne Cathrine] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Lund University; Skane University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen	Thoren, LA (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	bo.porse@bric.dk	Porse, Bo/B-1332-2012; Blom, Anna/AFS-7369-2022; Weischenfeldt, Joachim/O-3681-2015; Blom, Anna/B-9607-2009; Jakobsen, Janus Schou/P-1679-2014	Weischenfeldt, Joachim/0000-0002-3917-5524; Blom, Anna/0000-0002-1348-1734; Jakobsen, Janus Schou/0000-0001-6135-5815; Waage, Johannes/0000-0002-0603-8822; Porse, Bo/0000-0001-6043-0844	Lundbeck Foundation; Alfred Benzon Foundation; Danish Natural Science Research Council; Novo Nordisk Foundation; Copenhagen Hospital Cooperation, Region H; Lundbeck Foundation [R5-2006-99] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Alfred Benzon Foundation; Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Copenhagen Hospital Cooperation, Region H; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation, The Alfred Benzon Foundation (postdoctoral position to LAT), The Danish Natural Science Research Council, The Novo Nordisk Foundation and the Copenhagen Hospital Cooperation, Region H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Azzalin CM, 2006, CELL CYCLE, V5, P1496, DOI 10.4161/cc.5.14.3093; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Hasemann MS, 2008, BLOOD, V111, P4309, DOI 10.1182/blood-2007-06-097790; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lindqvist AKB, 2006, J IMMUNOL, V177, P3952, DOI 10.4049/jimmunol.177.6.3952; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Yamashita A, 2009, GENE DEV, V23, P1091, DOI 10.1101/gad.1767209; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83; Zhu J, 2001, NANO LETT, V1, P8, DOI 10.1021/nl005512q	42	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11650	10.1371/journal.pone.0011650	http://dx.doi.org/10.1371/journal.pone.0011650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657840	gold, Green Submitted, Green Published			2022-12-25	WOS:000280065600014
J	McGill, BM; Sutton-Grier, AE; Wright, JP				McGill, Bonnie M.; Sutton-Grier, Ariana E.; Wright, Justin P.			Plant Trait Diversity Buffers Variability in Denitrification Potential over Changes in Season and Soil Conditions	PLOS ONE			English	Article							TEMPERATE FOREST SOILS; NITROUS-OXIDE; BIODIVERSITY; COMMUNITY; INTERFACE; CARBON; RATES; WATER	Background: Denitrification is an important ecosystem service that removes nitrogen (N) from N-polluted watersheds, buffering soil, stream, and river water quality from excess N by returning N to the atmosphere before it reaches lakes or oceans and leads to eutrophication. The denitrification enzyme activity (DEA) assay is widely used for measuring denitrification potential. Because DEA is a function of enzyme levels in soils, most ecologists studying denitrification have assumed that DEA is less sensitive to ambient levels of nitrate (NO3-) and soil carbon and thus, less variable over time than field measurements. In addition, plant diversity has been shown to have strong effects on microbial communities and belowground processes and could potentially alter the functional capacity of denitrifiers. Here, we examined three questions: (1) Does DEA vary through the growing season? (2) If so, can we predict DEA variability with environmental variables? (3) Does plant functional diversity affect DEA variability? Methodology/Principal Findings: The study site is a restored wetland in North Carolina, US with native wetland herbs planted in monocultures or mixes of four or eight species. We found that denitrification potentials for soils collected in July 2006 were significantly greater than for soils collected in May and late August 2006 (p<0.0001). Similarly, microbial biomass standardized DEA rates were significantly greater in July than May and August (p<0.0001). Of the soil variables measured soil moisture, organic matter, total inorganic nitrogen, and microbial biomass-none consistently explained the pattern observed in DEA through time. There was no significant relationship between DEA and plant species richness or functional diversity. However, the seasonal variance in microbial biomass standardized DEA rates was significantly inversely related to plant species functional diversity (p<0.01). Conclusions/Significance: These findings suggest that higher plant functional diversity may support a more constant level of DEA through time, buffering the ecosystem from changes in season and soil conditions.	[McGill, Bonnie M.; Sutton-Grier, Ariana E.; Wright, Justin P.] Duke Univ, Durham, NC 27706 USA	Duke University	McGill, BM (corresponding author), Duke Univ, Durham, NC 27706 USA.	bonniemcgill@gmail.com	McGill, Bonnie/AAT-7426-2020; Wright, Justin/AAG-6461-2019	McGill, Bonnie/0000-0002-5417-3519; Wright, Justin/0000-0002-9102-5347; Sutton-Grier, Ariana/0000-0002-1242-7728	National Science Foundation (NSF) [DEB0508763]; Association of University Women Educational Foundation; Society of Wetland Scientist; Duke Wetlands Center; USDA Natural Resources Conservation Service; Smithsonian Environmental Research Center	National Science Foundation (NSF)(National Science Foundation (NSF)); Association of University Women Educational Foundation; Society of Wetland Scientist; Duke Wetlands Center; USDA Natural Resources Conservation Service(United States Department of Agriculture (USDA)); Smithsonian Environmental Research Center(Smithsonian InstitutionSmithsonian Environmental Research Center)	This work was supported by National Science Foundation (NSF) Grant DEB0508763, an NSF Graduate Research Fellowship (http://www.nsfgrfp.org); an American Fellowship from the Association of University Women Educational Foundation (http://www.aauw.org/education/fga); a Society of Wetland Scientist Student Research Grant (http://www.sws.org/studentgrants); the Duke Wetlands Center Case Study Endowment (http://www.nicholas.duke.edu/wetland); and a grant from the USDA Natural Resources Conservation Service (http://www.nrcs.usda.gov). AS-G was also partially supported by a Smithsonian Fellowship from the Smithsonian Environmental Research Center (http://www.serc.si.edu/pro_training). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P831, DOI 10.1016/0038-0717(85)90143-9; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Dybzinski R, 2008, OECOLOGIA, V158, P85, DOI 10.1007/s00442-008-1123-x; Ettema CH, 1999, SOIL BIOL BIOCHEM, V31, P1609, DOI 10.1016/S0038-0717(99)00071-1; FORNARA DA, 2008, PLANT FUNCTIONAL COM, P314; GOODROAD LL, 1984, CAN J SOIL SCI, V64, P187, DOI 10.4141/cjss84-020; Groffman P., 1994, CURRENT TOPICS WETLA, V1, P15, DOI DOI 10.1016/J.GEOMORPH.2006.01.010; Groffman PM, 2009, BIOGEOCHEMISTRY, V93, P49, DOI 10.1007/s10533-008-9277-5; GROFFMAN PM, 1989, SOIL BIOL BIOCHEM, V21, P621, DOI 10.1016/0038-0717(89)90054-0; Groffman PM, 1999, LT EC RES NETWK SER, V2, P272; Groffman PM, 2003, J ENVIRON QUAL, V32, P1144, DOI 10.2134/jeq2003.1144; Hall K., 2003, RECOMMENDED NATIVE P; Hernandez ME, 2007, J ENVIRON QUAL, V36, P333, DOI 10.2134/jeq2006.0139; Hill AR, 2004, SOIL SCI SOC AM J, V68, P320, DOI 10.2136/sssaj2004.0320; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; JENSEN CR, 1969, AGRON J, V61, P474, DOI 10.2134/agronj1969.00021962006100030045x; Kirby R M, 1971, SOIL SURVEY DURHAM C; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Liang BC, 1997, CAN J SOIL SCI, V77, P21, DOI 10.4141/S96-018; Lowrance R, 2001, J ENVIRON QUAL, V30, P617, DOI 10.2134/jeq2001.302617x; Maynard D.G., 1993, SOIL SAMPLING METHOD, V1st ed., P39; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; MORAGHAN JT, 1977, SOIL SCI SOC AM J, V41, P1201, DOI 10.2136/sssaj1977.03615995004100060038x; MYROLD DD, 1988, SOIL SCI SOC AM J, V52, P412, DOI 10.2136/sssaj1988.03615995005200020019x; PARSONS LL, 1991, SOIL SCI SOC AM J, V55, P90, DOI 10.2136/sssaj1991.03615995005500010016x; Pelletier F, 1999, CAN J SOIL SCI, V79, P551, DOI 10.4141/S99-022; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Schimel J., 2001, GLOBAL BIOGEOCHEM CY, P177, DOI [10.1016/b978-012631260-7/50015-7, DOI 10.1016/B978-012631260-7/50015-7]; SCHIPPER LA, 1994, J ENVIRON QUAL, V23, P923, DOI 10.2134/jeq1994.00472425002300050012x; SCHMIDT J, 1988, J ATMOS CHEM, V6, P95, DOI 10.1007/BF00048334; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Strauss EA, 2006, J N AM BENTHOL SOC, V25, P596, DOI 10.1899/0887-3593(2006)25[596:VARODI]2.0.CO;2; SUTTONGRIER AE, 2008, THESIS DUKE U DURHAM; TIEDJE JM, 1989, PLANT SOIL, V115, P261, DOI 10.1007/BF02202594; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Voroney R.P., 1993, SOIL SAMPLING METHOD, P277; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Wallenstein MD, 2006, ECOL APPL, V16, P2168, DOI 10.1890/1051-0761(2006)016[2168:NFEODA]2.0.CO;2; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 2002, COMMUNITIES ECOSYSTE; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2	52	39	40	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11618	10.1371/journal.pone.0011618	http://dx.doi.org/10.1371/journal.pone.0011618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661464	Green Published, Green Submitted			2022-12-25	WOS:000279980800007
J	Quijano, JC; Stinchfield, MJ; Zerlanko, B; Gibbens, YY; Takaesu, NT; Hyman-Walsh, C; Wotton, D; Newfeld, SJ				Quijano, Janine C.; Stinchfield, Michael J.; Zerlanko, Brad; Gibbens, Ying Y.; Takaesu, Norma T.; Hyman-Walsh, Cathy; Wotton, David; Newfeld, Stuart J.			The Sno Oncogene Antagonizes Wingless Signaling during Wing Development in Drosophila	PLOS ONE			English	Article							TGF-BETA; GENE-EXPRESSION; PROTEIN; GROWTH; ENCODES; ACHAETE; FAMILY; BLADE; TRUNCATIONS; ACTIVATION	The Sno oncogene (Snoo or dSno in Drosophila) is a highly conserved protein and a well-established antagonist of Transforming Growth Factor-beta signaling in overexpression assays. However, analyses of Sno mutants in flies and mice have proven enigmatic in revealing developmental roles for Sno proteins. Thus, to identify developmental roles for dSno we first reconciled conflicting data on the lethality of dSno mutations. Then we conducted analyses of wing development in dSno loss of function genotypes. These studies revealed ectopic margin bristles and ectopic campaniform sensilla in the anterior compartment of the wing blade suggesting that dSno functions to antagonize Wingless (Wg) signaling. A subsequent series of gain of function analyses yielded the opposite phenotype (loss of bristles and sensilla) and further suggested that dSno antagonizes Wg signal transduction in target cells. To date Sno family proteins have not been reported to influence the Wg pathway during development in any species. Overall our data suggest that dSno functions as a tissue-specific component of the Wg signaling pathway with modest antagonistic activity under normal conditions but capable of blocking significant levels of extraneous Wg, a role that may be conserved in vertebrates.	[Quijano, Janine C.; Stinchfield, Michael J.; Takaesu, Norma T.; Newfeld, Stuart J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Zerlanko, Brad; Hyman-Walsh, Cathy; Wotton, David] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Zerlanko, Brad; Hyman-Walsh, Cathy; Wotton, David] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Gibbens, Ying Y.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Arizona State University; Arizona State University-Tempe; University of Virginia; University of Virginia; University of Minnesota System; University of Minnesota Twin Cities	Quijano, JC (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	newfeld@asu.edu	Stinchfield, Michael/AAW-8983-2020	Gibbens, Ying/0000-0002-1125-7157; Wotton, David/0000-0002-4652-5350; Quijano, Janine/0000-0001-7755-3154	Inter Tribal Council of Arizona, Science Foundation Arizona; European Commission/ENFIN; N.I.H. [HD39926, CA109552, T32-HD007480]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039926, T32HD007480] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA109552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER	Inter Tribal Council of Arizona, Science Foundation Arizona; European Commission/ENFIN(European CommissionEuropean Commission Joint Research Centre); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Inter Tribal Council of Arizona, Science Foundation Arizona and the European Commission/ENFIN to S.J.N. and by N.I.H. grants to D.W. (HD39926) and S.J.N. (CA109552). Y.Y.G. thanks Mike O'Connor for support via N.I.H. training grant (T32-HD007480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Barrio R, 2007, DEV BIOL, V306, P66, DOI 10.1016/j.ydbio.2007.02.039; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; BLAIR SS, 1992, DEV BIOL, V152, P263, DOI 10.1016/0012-1606(92)90134-3; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Chen DH, 2003, CANCER RES, V63, P6626; CHOU TB, 1992, GENETICS, V131, P643; Emerald BS, 2004, DEV BIOL, V267, P462, DOI 10.1016/j.ydbio.2003.12.006; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; GOMEZSKARMETA JL, 1995, GENE DEV, V9, P1869, DOI 10.1101/gad.9.15.1869; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; JACK J, 1991, DEVELOPMENT, V113, P735; Konikoff CE, 2008, J MOL EVOL, V67, P323, DOI 10.1007/s00239-008-9159-4; Marquez RM, 2001, GENETICS, V157, P1639; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Pai LM, 1997, DEVELOPMENT, V124, P2255; Parker DS, 2002, DEVELOPMENT, V129, P2565; Pearson-White S, 2003, MOL CELL BIOL, V23, P5446, DOI 10.1128/MCB.23.15.5446-5459.2003; Penton A, 2002, GENETICS, V161, P747; Peterson-Nedry W, 2008, DEV BIOL, V320, P226, DOI 10.1016/j.ydbio.2008.05.521; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Ramel MC, 2007, MECH DEVELOP, V124, P304, DOI 10.1016/j.mod.2006.12.006; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RIPOLL P, 1988, DEVELOPMENT, V103, P757; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Saller E, 2002, GENE DEV, V16, P1828, DOI 10.1101/gad.230002; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Sarker KP, 2008, J BIOL CHEM, V283, P13269, DOI 10.1074/jbc.M708834200; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shravage BV, 2007, DEVELOPMENT, V134, P2261, DOI 10.1242/dev.02856; SIMPSON P, 1988, DEVELOPMENT, V103, P391; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Takaesu NT, 2005, DEVELOPMENT, V132, P4883, DOI 10.1242/dev.02048; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Willert K, 1999, DEVELOPMENT, V126, P4165; Wrighton KH, 2007, J BIOL CHEM, V282, P6517, DOI 10.1074/jbc.M610206200; XU T, 1993, DEVELOPMENT, V117, P1223; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang F, 2003, CANCER RES, V63, P5005	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11619	10.1371/journal.pone.0011619	http://dx.doi.org/10.1371/journal.pone.0011619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661280	Green Submitted, Green Published, gold			2022-12-25	WOS:000279980800008
J	Yin, FF; Dumont, M; Banerjee, R; Ma, Y; Li, HH; Lin, MT; Beal, MF; Nathan, C; Thomas, B; Ding, AH				Yin, Fangfang; Dumont, Magali; Banerjee, Rebecca; Ma, Yao; Li, Huihong; Lin, Michael T.; Beal, M. Flint; Nathan, Carl; Thomas, Bobby; Ding, Aihao			Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia	FASEB JOURNAL			English	Article						neurodegeneration; TDP-43; ubiquitin; transgenic mice	LOBAR DEGENERATION; EPITHELIN PRECURSOR; HOST-DEFENSE; INFLAMMATION; INCLUSIONS; ACROGRANIN; MUTATIONS; DISEASE; REPAIR; ROLES	Progranulin haploinsufficiency causes frontotemporal dementia with tau-negative, ubiquitin-positive neuronal inclusion pathology. In this study, we showed that progranulin-deficient mice displayed increased depression- and disinhibition-like behavior, as well as deficits in social recognition from a relatively young age. These mice did not have any deficit in locomotion or exploration. Eighteen-month-old progranulin-deficient mice demonstrated impaired spatial learning and memory in the Morris water maze. In addition to behavioral deficits, progranulin-deficient mice showed a progressive development of neuropathology from 12 mo of age, including enhanced activation of microglia and astro-cytes and ubiquitination and cytoplasmic accumulation of phosphorylated TDP-43. Thus, progranulin deficiency induced FTD-like behavioral and neuropathological deficits. These mice may serve as an important tool for deciphering underlying mechanisms in frontotemporal dementia.-Yin, F., Dumont, M., Banerjee, R., Ma, Y., Li, H., Lin, M. T., Beal, M. F., Nathan, C., Thomas, B., Ding, A. Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia. FASEB J. 24, 4639-4647 (2010). www.fasebj.org	[Yin, Fangfang; Ma, Yao; Li, Huihong; Nathan, Carl; Ding, Aihao] Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Dumont, Magali; Banerjee, Rebecca; Lin, Michael T.; Beal, M. Flint; Thomas, Bobby] Cornell Univ, Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; [Yin, Fangfang; Nathan, Carl; Ding, Aihao] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA; [Ma, Yao] Chinese Acad Med Sci, Inst Materia Med, Beijing 100037, Peoples R China	Cornell University; Cornell University; Cornell University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Ding, AH (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	ahding@med.cornell.edu	瑶, 马/GYV-3500-2022	DUMONT, MAGALI/0000-0001-9990-6512	National Institutes of Health [GM061710, AI030165, NS060885, NS062165]; Cancer Research Institute; Appel Established Investigatorship; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030165, R29AI030165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062165, R01NS060885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Appel Established Investigatorship; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants GM061710 and AI030165 (to A.D.), NS060885, NS062165 (to B.T.), a predoctoral fellowship from the Cancer Research Institute (to F.Y.), and an Appel Established Investigatorship (to C.N.). The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation. The authors thank Dr. Haruhiko Akiyama, Masato Hasegawa, and Tetsuaki Arai (Tokyo Institute of Psychiatry, Tokyo, Japan) for antibody against phosphorylated TDP-43 (pS409/410).	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Chiba S, 2009, J REPROD DEVELOP, V55, P518, DOI 10.1262/jrd.20239; Christian LM, 2009, BRAIN BEHAV IMMUN, V23, P750, DOI 10.1016/j.bbi.2009.02.012; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; de Vugt ME, 2006, DEMENT GERIATR COGN, V22, P35, DOI 10.1159/000093102; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Goodman WK, 2006, PSYCHIAT CLIN N AM, V29, P445, DOI 10.1016/j.psc.2006.02.003; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P551, DOI 10.1007/s00401-006-0123-3; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rao R, 2007, AIDS CARE, V19, P828, DOI 10.1080/09540120601133659; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Suzuki M, 2009, J REPROD DEVELOP, V55, P351, DOI 10.1262/jrd.20249; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Viskontas IV, 2007, ANN NY ACAD SCI, V1121, P528, DOI 10.1196/annals.1401.025; Witt Rochelle M, 2009, J Vis Exp, DOI 10.3791/949; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	27	125	128	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4639	4647		10.1096/fj.10-161471	http://dx.doi.org/10.1096/fj.10-161471			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20667979	Green Published			2022-12-25	WOS:000284824400005
J	Huang, H; Zhao, K; Arnett, DR; Fanning, E				Huang, Hao; Zhao, Kun; Arnett, Diana R.; Fanning, Ellen			A Specific Docking Site for DNA Polymerase alpha-Primase on the SV40 Helicase Is Required for Viral Primosome Activity, but Helicase Activity Is Dispensable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; REPLICATION PROTEIN-A; ORIGIN-BINDING DOMAIN; LARGE TUMOR-ANTIGEN; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; FUNCTIONAL INTERACTIONS; MUTATIONAL ANALYSIS; PRIMER SYNTHESIS; STRAND SYNTHESIS	Replication of simian virus 40 (SV40) DNA, a model for eukaryotic chromosomal replication, can be reconstituted in vitro using the viral helicase (large tumor antigen, or Tag) and purified human proteins. Tag interacts physically with two cellular proteins, replication protein A and DNA polymerase alpha-primase (pol-prim), constituting the viral primosome. Like the well characterized primosomes of phages T7 and T4, this trio of proteins coordinates parental DNA unwinding with primer synthesis to initiate the leading strand at the viral origin and each Okazaki fragment on the lagging strand template. We recently determined the structure of a previously unrecognized pol-prim domain (p68N) that docks on Tag, identified the p68N surface that contacts Tag, and demonstrated its vital role in primosome function. Here, we identify the p68N-docking site on Tag by using structure-guided mutagenesis of the Tag helicase surface. A charge reverse substitution in Tag disrupted both p68N-binding and primosome activity but did not affect docking with other pol-prim subunits. Unexpectedly, the substitution also disrupted Tag ATPase and helicase activity, suggesting a potential link between p68N docking and ATPase activity. To assess this possibility, we examined the primosome activity of Tag with a single residue substitution in the Walker B motif. Although this substitution abolished ATPase and helicase activity as expected, it did not reduce pol-prim docking on Tag or primosome activity on single-stranded DNA, indicating that Tag ATPase is dispensable for primosome activity in vitro.	[Huang, Hao; Zhao, Kun; Arnett, Diana R.; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Fanning, E (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	Ellen.fanning@vanderbilt.edu			National Institutes of Health [GM52948, P30 CA068485]; Vanderbilt University; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM52948 (to E. F.) and P30 CA068485 (to the Vanderbilt-Ingram Cancer Center). This work was also supported by Vanderbilt University and the Alexander von Humboldt Foundation.	Ahuja D, 2009, J VIROL, V83, P8781, DOI 10.1128/JVI.00621-09; Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bochkareva E, 2006, EMBO J, V25, P5961, DOI 10.1038/sj.emboj.7601452; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; Bullock PA, 1997, CRIT REV BIOCHEM MOL, V32, P503, DOI 10.3109/10409239709082001; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; Conger KL, 1999, J BIOL CHEM, V274, P2696, DOI 10.1074/jbc.274.5.2696; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15345, DOI 10.1021/bi9810959; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; Luo XL, 1996, NAT STRUCT BIOL, V3, P1034, DOI 10.1038/nsb1296-1034; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Marians KJ, 2008, NAT STRUCT MOL BIOL, V15, P125, DOI 10.1038/nsmb0208-125; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Meinke G, 2007, PLOS BIOL, V5, P144, DOI 10.1371/journal.pbio.0050023; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; MURAKAMI Y, 1986, P NATL ACAD SCI USA, V83, P6347, DOI 10.1073/pnas.83.17.6347; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; PARK P, 1994, P NATL ACAD SCI USA, V91, P8700, DOI 10.1073/pnas.91.18.8700; Pyle AM, 2009, CELL, V139, P458, DOI 10.1016/j.cell.2009.10.016; Reese DK, 2006, J VIROL, V80, P12248, DOI 10.1128/JVI.01201-06; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; SCHNEIDER C, 1994, MOL CELL BIOL, V14, P3176, DOI 10.1128/MCB.14.5.3176; Simmons DT, 2000, ADV VIRUS RES, V55, P75, DOI 10.1016/S0065-3527(00)55002-7; Smelkova NV, 1997, J VIROL, V71, P8766, DOI 10.1128/JVI.71.11.8766-8773.1997; SPENCE SL, 1994, VIROLOGY, V204, P200, DOI 10.1006/viro.1994.1524; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; Weisshart K, 1998, J VIROL, V72, P9771, DOI 10.1128/JVI.72.12.9771-9781.1998; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	74	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33475	33484		10.1074/jbc.M110.156240	http://dx.doi.org/10.1074/jbc.M110.156240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20685648	Green Published, hybrid			2022-12-25	WOS:000283048200082
J	Bukur, J; Herrmann, F; Handke, D; Recktenwald, C; Seliger, B				Bukur, Juergen; Herrmann, Felix; Handke, Diana; Recktenwald, Christian; Seliger, Barbara			Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; HLA CLASS-I; COORDINATED DOWN-REGULATION; HUMAN-LEUKOCYTE ANTIGEN; RENAL-CELL CARCINOMA; MOLECULAR-MECHANISMS; CHROMATIN MODIFIERS; IMMUNE-RESPONSES; INTERFERON-GAMMA; GENE-EXPRESSION	HER-2/neu overexpression in tumor cells caused abnormalities of MHC class I surface expression due to impaired expression of components of the antigen-processing machinery (APM) including the low molecular weight proteins, the transporter associated with antigen processing (TAP), and the chaperone tapasin, whereas the expression of MHC class I heavy chain as well as beta(2)-microglobulin was only marginally affected. This oncogene-mediated deficient APM component expression could be reverted by interferon-gamma treatment, suggesting a deregulation rather than structural alterations as underlying molecular mechanisms. To determine the level of regulation, the transcriptional activity of APM components was analyzed in HER-2/neu(-) and HER-2/neu(+) cells. All major APM components were transcriptionally down-regulated in HER-2/neu(+) when compared with HER-2/neu(-) cells, which was accompanied by a reduced binding of RNA polymerase II to the APM promoters. Site-directed mutagenesis of the p300- and E2F-binding sites in the APM promoters did not reconstitute the oncogene-mediated decreased transcription rate with the exception of tapasin, which was restored in HER-2/neu(+) cells to levels of wild type tapasin promoter activity in HER-2/neu(-) fibroblasts. The E2F-directed control of tapasin expression was further confirmed by chromatin immunoprecipitation analyses showing that E2F1 and p300 bind to the tapasin and APM promoters in both cell lines. Moreover, siRNA-mediated silencing of E2F1 was associated with an increased tapasin expression, whereas transient overexpression of E2F1 launch a reduced tapasin transcription, suggesting that E2F1 is an essential transcription factor for tapasin.	[Bukur, Juergen; Herrmann, Felix; Handke, Diana; Recktenwald, Christian; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, D-06112 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Seliger, B (corresponding author), Magdeburger Str 2, D-06112 Halle, Saale, Germany.	Barbara.Seliger@medizin.uni-halle.de		Seliger, Barbara/0000-0002-5544-4958; Recktenwald, Christian Viktor/0000-0003-1710-1863	Deutsche Forschungsgemeinschaft (DFG) [SE-589/11-1, 11-2, SE-581/9-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Grant SE-589/11-1, 11-2 and Grant SE-581/9-2.	Abarca-Heidemann K, 2002, IMMUNOL LETT, V83, P197, DOI 10.1016/S0165-2478(02)00104-9; ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; Agrawal S, 2000, J HEMATOTH STEM CELL, V9, P795, DOI 10.1089/152581600750062237; Aptsiauri N, 2008, CANCER IMMUNOL IMMUN, V57, P1727, DOI 10.1007/s00262-008-0532-3; Ares M, 2005, CELL, V120, P163, DOI 10.1016/j.cell.2005.01.002; Arons E, 2001, J IMMUNOL, V166, P3942, DOI 10.4049/jimmunol.166.6.3942; Atkins D, 2004, INT J CANCER, V109, P265, DOI 10.1002/ijc.11681; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Bennett EM, 1999, J IMMUNOL, V162, P5049; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Brucet M, 2004, GENES IMMUN, V5, P26, DOI 10.1038/sj.gene.6364035; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; Cabrera CM, 2005, INT J CANCER, V113, P611, DOI 10.1002/ijc.20526; Cabrera CM, 2003, TISSUE ANTIGENS, V61, P211, DOI 10.1034/j.1399-0039.2003.00020.x; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Chang CC, 2006, J BIOL CHEM, V281, P18763, DOI 10.1074/jbc.M511525200; Chatterjee-Kishore M, 1998, J BIOL CHEM, V273, P16177, DOI 10.1074/jbc.273.26.16177; Choudhury A, 2004, INT J CANCER, V108, P71, DOI 10.1002/ijc.11497; Delp K, 2000, BONE MARROW TRANSPL, V25, pS88, DOI 10.1038/sj.bmt.1702363; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dissemond J, 2003, ARCH DERMATOL RES, V295, P43, DOI 10.1007/s00403-003-0393-8; Doody GM, 2007, J IMMUNOL, V179, P7614, DOI 10.4049/jimmunol.179.11.7614; Dovhey SE, 2000, CANCER RES, V60, P5789; EPPERSON DE, 1992, J IMMUNOL, V149, P3297; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; FERRONE S, 1995, IMMUNOL TODAY, V16, P487, DOI 10.1016/0167-5699(95)80033-6; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Fujita T, 2009, FEBS LETT, V583, P2893, DOI 10.1016/j.febslet.2009.07.050; Garbi N, 2005, IMMUNOL REV, V207, P77, DOI 10.1111/j.0105-2896.2005.00303.x; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Garcia-Lora A, 2003, INT J CANCER, V106, P521, DOI 10.1002/ijc.11241; Garrido C, 2010, CANCER IMMUNOL IMMUN, V59, P13, DOI 10.1007/s00262-009-0716-5; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Gobin SJP, 1997, J IMMUNOL, V158, P3587; Gobin SJP, 1999, J IMMUNOL, V163, P1428; Griffioen M, 1998, MOL IMMUNOL, V35, P829, DOI 10.1016/S0161-5890(98)00074-1; Guo Y, 2002, INT IMMUNOL, V14, P189, DOI 10.1093/intimm/14.2.189; Handen Jeffrey S., 1997, Frontiers in Bioscience (online), V2, pC9; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Herberg JA, 1998, EUR J IMMUNOL, V28, P459, DOI 10.1002/(SICI)1521-4141(199802)28:02<459::AID-IMMU459>3.3.CO;2-Q; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Herrmann F, 2003, IMMUNOGENETICS, V55, P379, DOI 10.1007/s00251-003-0597-2; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Jung D, 1999, SCAND J IMMUNOL, V50, P242; Khan ANH, 2008, CANCER IMMUNOL IMMUN, V57, P647, DOI 10.1007/s00262-007-0402-4; KISHI F, 1993, GENE, V133, P243; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; Lou YM, 2005, CANCER RES, V65, P7926, DOI 10.1158/0008-5472.CAN-04-3977; Maleno I, 2002, CANCER IMMUNOL IMMUN, V51, P389, DOI 10.1007/s00262-002-0296-0; Mehta AM, 2009, GENE CHROMOSOME CANC, V48, P410, DOI 10.1002/gcc.20648; Min W, 1996, J IMMUNOL, V156, P3174; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Moschonas A, 2008, MOL CELL BIOL, V28, P6208, DOI 10.1128/MCB.00611-08; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Pupa SM, 1999, ONCOGENE, V18, P651, DOI 10.1038/sj.onc.1202363; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Raffaghello L, 2005, ONCOGENE, V24, P4634, DOI 10.1038/sj.onc.1208594; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Rescigno M, 2007, BBA-REV CANCER, V1776, P108, DOI 10.1016/j.bbcan.2007.07.003; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; Romero JM, 2005, INT J CANCER, V113, P605, DOI 10.1002/ijc.20499; RotemYehudar R, 1996, J EXP MED, V183, P499, DOI 10.1084/jem.183.2.499; Rouyez MC, 2005, J IMMUNOL, V174, P3948, DOI 10.4049/jimmunol.174.7.3948; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Seliger B, 2001, TISSUE ANTIGENS, V57, P39, DOI 10.1034/j.1399-0039.2001.057001039.x; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Seliger B, 2001, CANCER RES, V61, P8647; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; Sers C, 2009, INT J CANCER, V125, P1626, DOI 10.1002/ijc.24557; Setiadi AF, 2007, MOL CELL BIOL, V27, P7886, DOI 10.1128/MCB.01547-07; Setiadi AF, 2008, CANCER RES, V68, P9601, DOI 10.1158/0008-5472.CAN-07-5270; Smahel M, 2001, BRIT J CANCER, V84, P374, DOI 10.1054/bjoc.2000.1615; Takahashi Y, 2000, GENE DEV, V14, P804; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; van den Elsen PJ, 1998, IMMUNOL TODAY, V19, P308, DOI 10.1016/S0167-5699(98)01287-0; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; Vertegaal ACO, 2003, J BIOL CHEM, V278, P139, DOI 10.1074/jbc.M206267200; Vertuani S, 2009, CANCER IMMUNOL IMMUN, V58, P653, DOI 10.1007/s00262-008-0587-1; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; Ye Q, 2010, TISSUE ANTIGENS, V75, P30, DOI 10.1111/j.1399-0039.2009.01390.x; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	89	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30419	30426		10.1074/jbc.M109.094284	http://dx.doi.org/10.1074/jbc.M109.094284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663889	hybrid, Green Published			2022-12-25	WOS:000282135500008
J	Karbat, I; Ilan, N; Zhang, JZ; Cohen, L; Kahn, R; Benveniste, M; Scheuer, T; Catterall, WA; Gordon, D; Gurevitz, M				Karbat, Izhar; Ilan, Nitza; Zhang, Joel Z.; Cohen, Lior; Kahn, Roy; Benveniste, Morris; Scheuer, Todd; Catterall, William A.; Gordon, Dalia; Gurevitz, Michael			Partial Agonist and Antagonist Activities of a Mutant Scorpion beta-Toxin on Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-SENSOR; ALPHA-SUBUNIT; NA+ CHANNELS; ION CHANNELS; DOMAIN-II; ACTIVATION; BINDING; HIGHLIGHTS; INSECT; LOOP	Scorpion beta-toxin 4 from Centruroides suffusus suffusus (Css4) enhances the activation of voltage-gated sodium channels through a voltage sensor trapping mechanism by binding the activated state of the voltage sensor in domain II and stabilizing it in its activated conformation. Here we describe the antagonist and partial agonist properties of a mutant derivative of this toxin. Substitution of seven different amino acid residues for Glu(15) in Css4 yielded toxin derivatives with both increased and decreased affinities for binding to neurotoxin receptor site 4 on sodium channels. Css4(E15R) is unique among this set of mutants in that it retained nearly normal binding affinity but lost its functional activity for modification of sodium channel gating in our standard electrophysiological assay for voltage sensor trapping. More detailed analysis of the functional effects of Css4(E15R) revealed weak voltage sensor trapping activity, which was very rapidly reversed upon repolarization and therefore was not observed in our standard assay of toxin effects. This partial agonist activity of Css4(E15R) is observed clearly in voltage sensor trapping assays with brief (5 ms) repolarization between the conditioning prepulse and the test pulse. The effects of Css4(E15R) are fit well by a three-step model of toxin action involving concentration-dependent toxin binding to its receptor site followed by depolarization-dependent activation of the voltage sensor and subsequent voltage sensor trapping. Because it is a partial agonist with much reduced efficacy for voltage sensor trapping, Css4(E15R) can antagonize the effects of wild-type Css4 on sodium channel activation and can prevent paralysis by Css4 when injected into mice. Our results define the first partial agonist and antagonist activities for scorpion toxins and open new avenues of research toward better understanding of the structure-function relationships for toxin action on sodium channel voltage sensors and toward potential toxin-based therapeutics to prevent lethality from scorpion envenomation.	[Zhang, Joel Z.; Scheuer, Todd; Catterall, William A.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Benveniste, Morris] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA	University of Washington; University of Washington Seattle; Tel Aviv University; Morehouse School of Medicine	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu			National Institutes of Health [1 U01 NS058039-01]; United States-Israel Binational Agricultural Research and Development [IS-3928-06]; Israeli Science Foundation [1008/05]; German-Israeli Foundation for Scientific Research and Development [G-770-242.1/2002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development; Israeli Science Foundation(Israel Science Foundation); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 U01 NS058039-01 (to W. A. C. and M. G.). This research was also supported by United States-Israel Binational Agricultural Research and Development Grant IS-3928-06 (to M. G., D. G., and W. A. C.), by Israeli Science Foundation Grant 1008/05 (to D. G. and M. G.), and by German-Israeli Foundation for Scientific Research and Development Grant G-770-242.1/2002 (to D. G.).	Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Gilles N, 2000, J NEUROCHEM, V75, P1735, DOI 10.1046/j.1471-4159.2000.0751735.x; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0	20	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30531	30538		10.1074/jbc.M110.150888	http://dx.doi.org/10.1074/jbc.M110.150888			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20682774	Green Published, hybrid			2022-12-25	WOS:000282135500021
J	Palmier, MO; Fulcher, YG; Bhaskaran, R; Duong, VQ; Fields, GB; Van Doren, SR				Palmier, Mark O.; Fulcher, Yan G.; Bhaskaran, Rajagopalan; Duong, Vinh Q.; Fields, Gregg B.; Van Doren, Steven R.			NMR and Bioinformatics Discovery of Exosites That Tune Metalloelastase Specificity for Solubilized Elastin and Collagen Triple Helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE ELASTASE; SUBSTRATE-SPECIFICITY; CATALYTIC DOMAIN; CIGARETTE-SMOKE; ACTIVE-SITE; MATRIX METALLOPROTEINASE-12; ELASTOLYTIC ACTIVITY; HUMAN TROPOELASTIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	The catalytic domain of metalloelastase (matrix metalloproteinase-12 or MMP-12) is unique among MMPs in exerting high proteolytic activity upon fibrils that resist hydrolysis, especially elastin from lungs afflicted with chronic obstructive pulmonary disease or arteries with aneurysms. How does the MMP-12 catalytic domain achieve this specificity? NMR interface mapping suggests that alpha-elastin species cover the primed subsites, a strip across the beta-sheet from beta-strand IV to the II-III loop, and a broad bowl from helix A to helix C. The many contacts may account for the comparatively high affinity, as well as embedding of MMP-12 in damaged elastin fibrils in vivo. We developed a strategy called BINDSIght, for bioinformatics and NMR discovery of specificity of interactions, to evaluate MMP-12 specificity without a structure of a complex. BINDSIght integration of the interface mapping with other ambiguous information from sequences guided choice mutations in binding regions nearer the active site. Single substitutions at each of ten locations impair specific activity toward solubilized elastin. Five of them impair release of peptides from intact elastin fibrils. Eight lesions also impair specific activity toward triple helices from collagen IV or V. Eight sites map to the "primed" side in the III-IV, V-B, and S1' specificity loops. Two map to the "unprimed" side in the IV-V and B-C loops. The ten key residues circumscribe the catalytic cleft, form an exosite, and are distinctive features available for targeting by new diagnostics or therapeutics.	[Palmier, Mark O.; Fulcher, Yan G.; Bhaskaran, Rajagopalan; Duong, Vinh Q.; Van Doren, Steven R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Missouri System; University of Missouri Columbia; University of Texas System; University of Texas Health San Antonio	Van Doren, SR (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	vandorens@missouri.edu		Van Doren, Steven/0000-0003-2838-4598; Fulcher, Yan/0000-0002-7060-3523; Bhaskaran, Raj/0000-0001-8008-9962	National Institutes of Health [R01 GM57289, RR022341, R01 CA098799]; University of Missouri; Robert A. Welch Foundation; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM57289 (to S. R. V.). The 800-MHz NMR spectrometer was purchased with funding from NIH Grant RR022341 and the University of Missouri. THP development was supported by NIH Grant R01 CA098799 and the Robert A. Welch Foundation (to G. B. F.).	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Arumugam S, 1998, BIOCHEMISTRY-US, V37, P9650, DOI 10.1021/bi980128h; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bertini I, 2009, CHEM-EUR J, V15, P7842, DOI 10.1002/chem.200901009; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bhaskaran R, 2007, J MOL BIOL, V374, P1333, DOI 10.1016/j.jmb.2007.10.028; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Churg A, 2003, AM J RESP CRIT CARE, V167, P1083, DOI 10.1164/rccm.200212-1396OC; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; COX BA, 1973, BIOCHIM BIOPHYS ACTA, V317, P209, DOI 10.1016/0005-2795(73)90215-8; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Fu JY, 2001, PROTEIN EXPRES PURIF, V21, P268, DOI 10.1006/prep.2000.1376; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; Goddard T. D., 2000, SPARKY; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; HUEBNER PF, 1976, ANAL BIOCHEM, V74, P419, DOI 10.1016/0003-2697(76)90222-0; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; HUNNINGHAKE GW, 1981, SCIENCE, V212, P925, DOI 10.1126/science.7233186; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; KELLER S, 1971, BIOCHEM MED METAB B, V5, P342, DOI 10.1016/0006-2944(71)90038-X; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Lang R, 2001, J MOL BIOL, V312, P731, DOI 10.1006/jmbi.2001.4954; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lee GI, 2003, P NATL ACAD SCI USA, V100, P11261, DOI 10.1073/pnas.2031918100; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Liang XY, 2010, BIOPHYS J, V99, P273, DOI 10.1016/j.bpj.2010.04.002; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Linsenmayer TF, 1998, PROG RETIN EYE RES, V17, P231; LIOTTA LA, 1981, BIOCHEM BIOPH RES CO, V98, P184, DOI 10.1016/0006-291X(81)91886-6; Liu MZ, 2004, ARTHRITIS RHEUM-US, V50, P3112, DOI 10.1002/art.20567; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; MECHAM RP, 1980, CONNECT TISSUE RES, V7, P247, DOI 10.3109/03008208009152360; Mihalek I, 2006, BIOINFORMATICS, V22, P1656, DOI 10.1093/bioinformatics/btl157; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Moy FJ, 2002, J AM CHEM SOC, V124, P12658, DOI 10.1021/ja027391x; Nar H, 2001, J MOL BIOL, V312, P743, DOI 10.1006/jmbi.2001.4953; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; NIEDZWIECKI L, 1992, BIOCHEMISTRY-US, V31, P12618, DOI 10.1021/bi00165a011; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; ODELL BL, 1966, NATURE, V209, P401, DOI 10.1038/209401a0; Oue S, 1999, J BIOL CHEM, V274, P2344, DOI 10.1074/jbc.274.4.2344; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; PARKS WC, 1990, AM J RESP CELL MOL, V2, P399, DOI 10.1165/ajrcmb/2.5.399; PARTRIDGE SM, 1966, NATURE, V209, P399, DOI 10.1038/209399b0; PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011; Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004; PODRAZKY V, 1968, BIOCHIM BIOPHYS ACTA, V160, P277, DOI 10.1016/0005-2795(68)90104-9; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Saarialho-Kere U, 1999, J INVEST DERMATOL, V113, P664, DOI 10.1046/j.1523-1747.1999.00731.x; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shipley JM, 1996, J BIOL CHEM, V271, P4335; STARCHER B, 1995, CONNECT TISSUE RES, V31, P133, DOI 10.3109/03008209509028401; Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050; STARCHER BC, 1976, ANAL BIOCHEM, V74, P441, DOI 10.1016/0003-2697(76)90224-4; Steele DL, 2000, PROTEIN ENG, V13, P397, DOI 10.1093/protein/13.6.397; Taddese S, 2008, MATRIX BIOL, V27, P420, DOI 10.1016/j.matbio.2008.02.001; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014; Tomatis PE, 2005, P NATL ACAD SCI USA, V102, P13761, DOI 10.1073/pnas.0503495102; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; URRY DW, 1969, NATURE, V222, P795, DOI 10.1038/222795a0; Vaalamo M, 1998, AM J PATHOL, V152, P1005; Valenca SS, 2004, TOXICOL PATHOL, V32, P351, DOI 10.1080/01926230490431466; Van Doren SR, 2011, BIOL EXTRACELL MATR, P123, DOI 10.1007/978-3-642-16861-1_6; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Williams J W, 1979, Methods Enzymol, V63, P437; Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006; YE QZ, 1992, BIOCHEMISTRY-US, V31, P11231, DOI 10.1021/bi00160a038; Zheng XH, 2007, PROTEIN EXPRES PURIF, V56, P160, DOI 10.1016/j.pep.2007.05.005	92	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30918	30930		10.1074/jbc.M110.136903	http://dx.doi.org/10.1074/jbc.M110.136903			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663866	Green Published, hybrid			2022-12-25	WOS:000282135500057
J	Patterson-Fortin, J; Shao, G; Bretscher, H; Messick, TE; Greenberg, RA				Patterson-Fortin, Jeffrey; Shao, Genze; Bretscher, Heidi; Messick, Troy E.; Greenberg, Roger A.			Differential Regulation of JAMM Domain Deubiquitinating Enzyme Activity within the RAP80 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; STRUCTURAL BASIS; BRCA1; BINDING; METALLOPROTEASE; RECOGNITION; DEGRADATION; CHECKPOINTS; PROTEASOME	BRCC36 is a JAMM (JAB1/MPN/Mov34 metalloenzyme) domain, lysine 63-ubiquitin (K63-Ub)-specific deubiquitinating enzyme (DUB) and a member of two protein complexes: the DNA damage-responsive BRCA1-RAP80 complex, and the cytoplasmic BRCC36 isopeptidase complex (BRISC). The presence of several identical constituents in both complexes suggests common regulatory mechanisms and potential competition between K63-Ub-related signaling in cytoplasmic and nuclear compartments. Surprisingly, we discover that BRCC36 DUB activity requires different interactions within the context of each complex. Abraxas and BRCC45 were essential for BRCC36 DUB activity within the RAP80 complex, whereas KIAA0157/Abro was the only interaction required for DUB activity within the BRISC. Poh1 also required protein interactions for activity, suggesting a common regulatory mechanism for JAMM domain DUBs. Finally, BRISC deficiency enhanced formation of the BRCA1-RAP80 complex in vivo, increasing BRCA1 levels at DNA double strand breaks. These findings reveal that JAMM domain DUB activity and K63-Ub levels are regulated by multiple mechanisms within the cell.	[Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Patterson-Fortin, Jeffrey] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Greenberg, RA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, 421 Curie Blvd,513 BRB 2-3, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu		Bretscher, Heidi/0000-0001-5927-4880; Patterson-Fortin, Jeffrey/0000-0001-8493-8060; Messick, Troy/0000-0001-7914-1524	National Institutes of Health, NCI [1R01CA138835-01, 1K08CA106597-01, 3K08CA106597-04S1]; Canadian Institutes for Health Research; Center of Excellence in Environmental Toxicology; University Research Foundation of the University of Pennsylvania; American Cancer Society; Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [K08CA106597, R01CA138835] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Center of Excellence in Environmental Toxicology; University Research Foundation of the University of Pennsylvania; American Cancer Society(American Cancer Society); Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant 1R01CA138835-01 and K08 awards 1K08CA106597-01 and 3K08CA106597-04S1 (to R. A. G.).; Supported in part by a Doctoral Research Award from the Canadian Institutes for Health Research.; Supported in part by funds from the Center of Excellence in Environmental Toxicology and the University Research Foundation of the University of Pennsylvania. Present address: Vironika, 3601 Spruce St., G63, Philadelphia, PA 19104.; Supported by an American Cancer Society research scholar grant, the Sidney Kimmel Foundation Scholar Award, and funds from the Abramson Family Cancer Research Institute. To whom correspondence should be addressed: Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, 421 Curie Blvd., 513 BRB II/III, Philadelphia, PA 19104-6160. Tel.: 215-746-2738; Fax: 215-573-2486; E-mail: rogergr@mail.med.upenn.edu.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Greenberg RA, 2008, CHROMOSOMA, V117, P305, DOI 10.1007/s00412-008-0154-8; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yan J, 2007, NUCLEIC ACIDS RES, V35, P1673, DOI 10.1093/nar/gkl1112; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	48	59	61	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30971	30981		10.1074/jbc.M110.135319	http://dx.doi.org/10.1074/jbc.M110.135319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20656689	hybrid, Green Published			2022-12-25	WOS:000282135500062
J	Kott, O; Sumbera, R; Nemec, P				Kott, Ondrej; Sumbera, Radim; Nemec, Pavel			Light Perception in Two Strictly Subterranean Rodents: Life in the Dark or Blue?	PLOS ONE			English	Article							BLIND MOLE-RAT; VISUAL-SYSTEM; LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; COLOR-VISION; CRYPTOMYS-ANSELLI; SPALAX-EHRENBERGI; SOLITARY; EYE; PHOTORECEPTOR	Background: The African mole-rats (Bathyergidae, Rodentia) are strictly subterranean, congenitally microphthalmic rodents that are hardly ever exposed to environmental light. Because of the lack of an overt behavioural reaction to light, they have long been considered to be blind. However, recent anatomical studies have suggested retention of basic visual capabilities. In this study, we employed behavioural tests to find out if two mole-rat species are able to discriminate between light and dark, if they are able to discriminate colours and, finally, if the presence of light in burrows provokes plugging behaviour, which is assumed to have a primarily anti-predatory function. Methodology/Principal Finding: We used a binary choice test to show that the silvery mole-rat Heliophobius argenteocinereus and the giant mole-rat Fukomys mechowii exhibit a clear photoavoidance response to full-spectrum ("white"), blue and green-yellow light, but no significant reaction to ultraviolet or red light during nest building. The mole-rats thus retain dark/light discrimination capabilities and a capacity to perceive short to medium-wavelength light in the photopic range of intensities. These findings further suggest that the mole-rat S opsin has its absorption maximum in the violet/blue part of the spectrum. The assay did not yield conclusive evidence regarding colour discrimination. To test the putative role of vision in bathyergid anti-predatory behaviour, we examined the reaction of mole-rats to the incidence of light in an artificial burrow system. The presence of light in the burrow effectively induced plugging of the illuminated tunnel. Conclusion/Significance: Our findings suggest that the photopic vision is conserved and that low acuity residual vision plays an important role in predator avoidance and tunnel maintenance in the African mole-rats.	[Kott, Ondrej; Sumbera, Radim] Univ S Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic; [Nemec, Pavel] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic	University of South Bohemia Ceske Budejovice; Charles University Prague	Kott, O (corresponding author), Univ S Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic.	sumbera@prf.jcu.cz	Šumbera, Radim/D-9072-2016; Nemec, Pavel/K-1163-2012	Šumbera, Radim/0000-0001-8658-9378; Nemec, Pavel/0000-0003-0277-0239	University of South Bohemia [SGA 11/2006]; Academy of Sciences of the Czech Republic [IAA601410802]; Czech Science Foundation [206/09/1364]; Ministry of Education, Youth and Sport of the Czech Republic [6007665801, 0021620828]	University of South Bohemia; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Supported by the Grant Agency of the University of South Bohemia (SGA 11/2006, to OK), the Grant Agency of the Academy of Sciences of the Czech Republic IAA601410802 (to RS, gaav.cz), the Czech Science Foundation (206/09/1364, to PN, gacr.cz) and the Ministry of Education, Youth and Sport of the Czech Republic 6007665801 (to RS, msmt.cz) and 0021620828 (to PN, msmt.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Begall S., 2007, SUBTERRANEAN RODENTS; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BURDA H, 1990, PROG CLIN BIOL RES, V335, P269; Carmona FD, 2010, P ROY SOC B-BIOL SCI, V277, P1513, DOI 10.1098/rspb.2009.1744; Carmona FD, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-44; Cernuda-Cernuda R, 2003, EUR J NEUROSCI, V17, P709, DOI 10.1046/j.1460-9568.2003.02485.x; Cernuda-Cernuda R, 2002, INVEST OPHTH VIS SCI, V43, P2374; COOPER HM, 1993, J COMP NEUROL, V328, P313, DOI 10.1002/cne.903280302; Crish SD, 2006, ANAT REC PART A, V288A, P205, DOI 10.1002/ar.a.20288; David-Gray ZK, 2002, EUR J NEUROSCI, V16, P1186, DOI 10.1046/j.1460-9568.2002.02161.x; de Vries JL, 2008, J ZOOL, V276, P343, DOI 10.1111/j.1469-7998.2008.00496.x; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; ELOFF G, 1958, S AFR J SCI, V54, P292; Glosmann M, 2008, J VISION, V8, DOI 10.1167/8.4.23; Hart L, 2004, PHYSIOL BEHAV, V82, P563, DOI 10.1016/j.physbeh.2004.05.008; Hetling JR, 2005, J COMP PHYSIOL A, V191, P317, DOI 10.1007/s00359-004-0584-6; Hood D. C., 1986, HDB PERCEPTION HUMAN, V1; Hunt DM, 2007, PHOTOCHEM PHOTOBIOL, V83, P303, DOI 10.1562/2006-06-27-IR-952; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jeon CJ, 1998, J NEUROSCI, V18, P8936; JOHANNESSONGROSS K, 1988, Z SAUGETIERKD, V53, P193; Kawalika M, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P205, DOI 10.1007/978-3-540-69276-8_15; Lacey EA, 2000, LIFE UNDERGROUND BIO; Land MF, 2002, ANIMAL EYES; LOVEGROVE BG, 1995, PHYSIOL BEHAV, V58, P679, DOI 10.1016/0031-9384(95)00106-S; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; LUND RD, 1965, EXP NEUROL, V13, P302, DOI 10.1016/0014-4886(65)90118-4; LUND RD, 1966, J ZOOL, V149, P95; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; MCFARLAND WN, 1975, LIGHT ECOLOGICAL FAC, P00249; Mills SL, 2004, VISUAL NEUROSCI, V21, P107, DOI 10.1017/S0952523804043020; NAKATANI K, 1991, J GEN PHYSIOL, V97, P413, DOI 10.1085/jgp.97.3.413; Negroni J, 2003, BRAIN RES, V967, P48, DOI 10.1016/S0006-8993(02)04208-7; Nemec P, 2004, EUR J NEUROSCI, V20, P757, DOI 10.1111/j.1460-9568.2004.03510.x; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Nemec P, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P129, DOI 10.1007/978-3-540-69276-8_11; Nevo, 1999, MOSAIC EVOLUTION SUB; Nikitina NV, 2004, ANAT REC PART A, V277A, P317, DOI 10.1002/ar.a.20025; Oelschlager HHA, 2000, BRAIN BEHAV EVOLUT, V55, P209, DOI 10.1159/000006653; Oosthuizen MK, 2005, NEUROSCIENCE, V133, P555, DOI 10.1016/j.neuroscience.2005.01.017; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; Patzenhauerova H, 2010, BEHAV ECOL SOCIOBIOL, V64, P757, DOI 10.1007/s00265-009-0893-4; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2005, J COMP NEUROL, V486, P197, DOI 10.1002/cne.20491; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; RADO R, 1992, ISRAEL J ZOOL, V38, P323; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; SANYAL S, 1990, INVEST OPHTH VIS SCI, V31, P1398; Schottner K, 2006, PHYSIOL BEHAV, V89, P205, DOI 10.1016/j.physbeh.2006.06.014; Skliba J, 2008, J ETHOL, V26, P249, DOI 10.1007/s10164-007-0056-x; Skliba J, 2007, J MAMMAL, V88, P1009, DOI 10.1644/06-MAMM-A-235R1.1; Skliba J, 2009, ETHOLOGY, V115, P217, DOI 10.1111/j.1439-0310.2008.01604.x; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Sumbera R, 2003, NATURWISSENSCHAFTEN, V90, P370, DOI 10.1007/s00114-003-0439-y; Sumbera R, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P221, DOI 10.1007/978-3-540-69276-8_16; Vasicek CA, 2005, PHYSIOL BEHAV, V84, P181, DOI 10.1016/j.physbeh.2004.11.005; Wegner RE, 2006, ANIM BEHAV, V72, P1021, DOI 10.1016/j.anbehav.2006.02.018; Werner SJ, 2005, PHYSIOL BEHAV, V85, P340, DOI 10.1016/j.physbeh.2005.04.024; Williams GA, 2005, J COMP PHYSIOL A, V191, P125, DOI 10.1007/s00359-004-0578-4; Zhao HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008326	67	31	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11810	10.1371/journal.pone.0011810	http://dx.doi.org/10.1371/journal.pone.0011810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676369	gold, Green Submitted, Green Published			2022-12-25	WOS:000280520100004
J	Cherrington, BD; Morency, E; Struble, AM; Coonrod, SA; Wakshlag, JJ				Cherrington, Brian D.; Morency, Eric; Struble, Angela M.; Coonrod, Scott A.; Wakshlag, Joseph J.			Potential Role for Peptidylarginine Deiminase 2 (PAD2) in Citrullination of Canine Mammary Epithelial Cell Histones	PLOS ONE			English	Article							ESTROUS-CYCLE; EXPRESSION; MOUSE; PROTEINS; ENZYMES; MODELS; GENES; GLAND	Peptidylarginine Deiminases (PADs) convert arginine residues on substrate proteins to citrulline. Previous reports have documented that PAD2 expression and activity varies across the estrous cycle in the rodent uterus and pituitary gland, however, the expression and function of PAD2 in mammary tissue has not been previously reported. To gain more insight into potential reproductive roles for PAD2, in this study we evaluated PAD2 expression and localization throughout the estrous cycle in canine mammary tissue and then identified possible PAD2 enzymatic targets. Immunohistochemical and immunofluorescence analysis found PAD2 expression is low in anestrus, limited to a distinct, yet sparse, subset of epithelial cells within ductal alveoli during estrus/early diestrus, and encompasses the entire epithelium of the mammary duct in late diestrus. At the subcellular level, PAD2 is expressed in the cytoplasm, and to a lesser extent, the nucleus of these epithelial cells. Surprisingly, stimulation of canine mammary tumor cells (CMT25) shows that EGF, but not estrogen or progesterone, upregulates PAD2 transcription and translation suggesting EGF regulation of PAD2 and possibly citrullination in vivo. To identify potential PAD2 targets, anti-pan citrulline western blots were performed and results showed that citrullination activity is limited to diestrus with histones appearing to represent major enzymatic targets. Use of site-specific anti-citrullinated histone antibodies found that the N-terminus of histone H3, but not H4, appears to be the primary target of PAD activity in mammary epithelium. This observation supports the hypothesis that PAD2 may play a regulatory role in the expression of lactation related genes via histone citrullination during diestrus.	[Cherrington, Brian D.; Morency, Eric; Coonrod, Scott A.] Cornell Univ, Coll Vet Med, JA Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Struble, Angela M.; Wakshlag, Joseph J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cherrington, BD (corresponding author), Cornell Univ, Coll Vet Med, JA Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	Jw37@cornell.edu		Cherrington, Brian/0000-0001-5847-2295	Department of Defense (DOD) [W81XWH-07-1-0372]	Department of Defense (DOD)(United States Department of Defense)	This work was supported by the Department of Defense (DOD) Era of Hope Scholar Award W81XWH-07-1-0372, Scott A. Coonrod. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TE, 1996, AM J VET RES, V57, P693; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Cardiff RD, 2001, MICROSC RES TECHNIQ, V52, P224, DOI 10.1002/1097-0029(20010115)52:2<224::AID-JEMT1007>3.3.CO;2-1; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; DONNAY I, 1995, VET RES COMMUN, V19, P101, DOI 10.1007/BF01839276; Gama A, 2003, VET PATHOL, V40, P412, DOI 10.1354/vp.40-4-412; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Ishigami A, 2005, J NEUROSCI RES, V80, P120, DOI 10.1002/jnr.20431; Munson Linda, 2007, Breast Dis, V28, P7; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Rehm S, 2007, BIRTH DEFECTS RES B, V80, P233, DOI 10.1002/bdrb.20121; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; SENSHU T, 1989, ENDOCRINOLOGY, V124, P2666, DOI 10.1210/endo-124-6-2666; SENSHU T, 1992, ANAL BIOCHEM, V203, P94, DOI 10.1016/0003-2697(92)90047-B; TAKAHARA H, 1989, J BIOL CHEM, V264, P13361; TAKAHARA H, 1992, J BIOL CHEM, V267, P520; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; WOLFE LG, 1986, J NATL CANCER I, V77, P783, DOI 10.1093/jnci/77.3.783; Wood DD, 2008, LAB INVEST, V88, P354, DOI 10.1038/labinvest.3700748	23	56	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11768	10.1371/journal/pone.0011768	http://dx.doi.org/10.1371/journal/pone.0011768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668670				2022-12-25	WOS:000280297300007
J	Danovi, D; Cremona, CA; Machado-da-Silva, G; Basu, S; Noon, LA; Parrinello, S; Lloyd, AC				Danovi, Davide; Cremona, Catherine A.; Machado-da-Silva, Gisela; Basu, Sreya; Noon, Luke A.; Parrinello, Simona; Lloyd, Alison C.			A Genetic Screen for Anchorage-Independent Proliferation in Mammalian Cells Identifies a Membrane-Bound Neuregulin	PLOS ONE			English	Article							NERVE SHEATH TUMORS; SCHWANN-CELL; SIGNALING PATHWAY; GROWTH-FACTORS; SENESCENCE; CANCER; DIFFERENTIATION; TRANSFORMATION; TUMORIGENESIS; ACCUMULATION	Anchorage-independent proliferation is a hallmark of oncogenic transformation and is thought to be conducive to proliferation of cancer cells away from their site of origin. We have previously reported that primary Schwann cells expressing the SV40 Large T antigen (LT) are not fully transformed in that they maintain a strict requirement for attachment, requiring a further genetic change, such as oncogenic Ras, to gain anchorage-independence. Using the LT-expressing cells, we performed a genetic screen for anchorage-independent proliferation and identified Sensory and Motor Neuron Derived Factor (SMDF), a transmembrane class III isoform of Neuregulin 1. In contrast to oncogenic Ras, SMDF induced enhanced proliferation in normal primary Schwann cells but did not trigger cellular senescence. In cooperation with LT, SMDF drove anchorage-independent proliferation, loss of contact inhibition and tumourigenicity. This transforming ability was shared with membrane-bound class III but not secreted class I isoforms of Neuregulin, indicating a distinct mechanism of action. Importantly, we show that despite being membrane-bound signalling molecules, class III neuregulins transform via a cell intrinsic mechanism, as a result of constitutive, elevated levels of ErbB signalling at high cell density and in anchorage-free conditions. This novel transforming mechanism may provide new targets for cancer therapy.	UCL, MRC Lab Mol Cell Biol, London, England; UCL, UCL Canc Inst, London, England	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	Danovi, D (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	alison.lloyd@ucl.ac.uk	Danovi, Davide/P-2874-2019; Noon, Luke A/H-4141-2014	Danovi, Davide/0000-0003-4119-5337; Noon, Luke A/0000-0002-0502-4322; Cremona, Catherine/0000-0002-5962-7399	Cancer Research UK; European Molecular Biology Organization; Dorothy Hodgkin Fellowship; Medical Research Council; Fundacao para a Ciencia e a Tecnologia; Cancer Research UK [11244] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Dorothy Hodgkin Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK Programme Grant. Davide Danovi was supported by an European Molecular Biology Organization fellowship. Simona Parrinello was supported by a Dorothy Hodgkin Fellowship. Catherine Cremona was supported by a Medical Research Council PHD programme. Gisela Machado da Silva was supported by a studentship from Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bottazzi ME, 1997, TRENDS CELL BIOL, V7, P348, DOI 10.1016/S0962-8924(97)01114-8; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Carroll SL, 2004, J NEUROPATH EXP NEUR, V63, P1115, DOI 10.1093/jnen/63.11.1115; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cockerill S, 2001, BIOORG MED CHEM LETT, V11, P1401, DOI 10.1016/S0960-894X(01)00219-0; Cremona CA, 2009, J CELL SCI, V122, P3272, DOI 10.1242/jcs.047126; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Frohnert PW, 2003, GLIA, V43, P104, DOI 10.1002/glia.10232; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gomez-Sanchez JA, 2009, J NEUROSCI, V29, P11304, DOI 10.1523/JNEUROSCI.1753-09.2009; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansen JR, 2006, GLIA, V53, P593, DOI 10.1002/glia.20316; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; Huijbregts RPH, 2003, J NEUROSCI, V23, P7269; Jones JT, 1998, J BIOL CHEM, V273, P11667, DOI 10.1074/jbc.273.19.11667; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; LOTTI LV, 1992, EXP CELL RES, V202, P274, DOI 10.1016/0014-4827(92)90075-J; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; McClatchey AI, 2007, ANNU REV PATHOL-MECH, V2, P191, DOI 10.1146/annurev.pathol.2.010506.091940; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Mitchell PJ, 2003, MOL CELL BIOL, V23, P2530, DOI 10.1128/MCB.23.7.2530-2542.2003; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stonecypher MS, 2006, J NEUROPATH EXP NEUR, V65, P162, DOI 10.1097/01.jnen.0000199575.93794.2f; Stonecypher MS, 2005, ONCOGENE, V24, P5589, DOI 10.1038/sj.onc.1208730; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11774	10.1371/journal.pone.0011774	http://dx.doi.org/10.1371/journal.pone.0011774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668675	gold, Green Submitted, Green Published			2022-12-25	WOS:000280297300009
J	Ge, XC; Kitten, T; Munro, CL; Conrad, DH; Xu, P				Ge, Xiuchun; Kitten, Todd; Munro, Cindy L.; Conrad, Daniel H.; Xu, Ping			Pooled Protein Immunization for Identification of Cell Surface Antigens in Streptococcus sanguinis	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; VACCINE CANDIDATE ANTIGENS; ANTIBODY-MEDIATED IMMUNITY; GROUP-B STREPTOCOCCUS; INFECTIVE ENDOCARDITIS; PROTECTIVE IMMUNITY; PARASANGUIS ENDOCARDITIS; INTRANASAL IMMUNIZATION; PNEUMONIAE INFECTION; REVERSE VACCINOLOGY	Background: Available bacterial genomes provide opportunities for screening vaccines by reverse vaccinology. Efficient identification of surface antigens is required to reduce time and animal cost in this technology. We developed an approach to identify surface antigens rapidly in Streptococcus sanguinis, a common infective endocarditis causative species. Methods and Findings: We applied bioinformatics for antigen prediction and pooled antigens for immunization. Forty-seven surface-exposed proteins including 28 lipoproteins and 19 cell wall-anchored proteins were chosen based on computer algorithms and comparative genomic analyses. Eight proteins among these candidates and 2 other proteins were pooled together to immunize rabbits. The antiserum reacted strongly with each protein and with S. sanguinis whole cells. Affinity chromatography was used to purify the antibodies to 9 of the antigen pool components. Competitive ELISA and FACS results indicated that these 9 proteins were exposed on S. sanguinis cell surfaces. The purified antibodies had demonstrable opsonic activity. Conclusions: The results indicate that immunization with pooled proteins, in combination with affinity purification, and comprehensive immunological assays may facilitate cell surface antigen identification to combat infectious diseases.	[Ge, Xiuchun; Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA; [Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Kitten, Todd; Conrad, Daniel H.; Xu, Ping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Munro, Cindy L.] Virginia Commonwealth Univ, Dept Adult Hlth Nursing, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Ge, XC (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA.	pxu@vcu.edu	Kitten, Todd/O-6531-2014	Kitten, Todd/0000-0001-6097-7583	National Institutes of Health [R01DE018138, R01AI47841, K02AI05490]; AD Williams Fund [646541]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AD Williams Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE018138 (PX), R01AI47841 (TK), K02AI05490 (TK) from the National Institutes of Health and 646541 from the AD Williams Fund (PX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; AUSUBLE FM, 2000, CURRENT PROTOCALS MO; BAKER CJ, 1988, NEW ENGL J MED, V319, P1180, DOI 10.1056/NEJM198811033191802; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Bryksin AV, 2005, CLIN DIAGN LAB IMMUN, V12, P935, DOI 10.1128/CDLI.12.8.935-940.2005; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Casadevall A, 2004, INFECT IMMUN, V72, P6191, DOI 10.1128/IAI.72.11.6191-6196.2004; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; Cron LE, 2009, MICROBIOL-SGM, V155, P2401, DOI 10.1099/mic.0.026765-0; CROWTHER JR, 2000, METHOD MOL BIOL, V149, P413; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Encheva V, 2009, MICROBIOL-SGM, V155, P2429, DOI 10.1099/mic.0.026138-0; Etz H, 2002, P NATL ACAD SCI USA, V99, P6573, DOI 10.1073/pnas.092569199; FENNO JC, 1995, MOL MICROBIOL, V15, P849, DOI 10.1111/j.1365-2958.1995.tb02355.x; Flock M, 2004, INFECT IMMUN, V72, P3228, DOI 10.1128/IAI.72.6.3228-3236.2004; Ford I, 1997, PLATELETS, V8, P285; Gan WJ, 2010, PARASITOL RES, V106, P873, DOI 10.1007/s00436-010-1729-x; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Gor DO, 2005, INFECT IMMUN, V73, P1304, DOI 10.1128/IAI.73.3.1304-1312.2005; Haake DA, 1999, INFECT IMMUN, V67, P6572; Hajishengallis G, 1998, INFECT IMMUN, V66, P1740, DOI 10.1128/IAI.66.4.1740-1743.1998; Hamilton A, 2006, INFECT IMMUN, V74, P6907, DOI 10.1128/IAI.01116-06; Herzberg MC, 2005, J PERIODONTOL, V76, P2101, DOI 10.1902/jop.2005.76.11-S.2101; Herzberg MC, 1996, CRIT REV ORAL BIOL M, V7, P222, DOI 10.1177/10454411960070030201; Huang Y, 2001, INFECT IMMUN, V69, P2154, DOI 10.1128/IAI.69.4.2154-2161.2001; Jomaa M, 2006, VACCINE, V24, P5133, DOI 10.1016/j.vaccine.2006.04.012; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; KELLY CG, 1995, INFECT IMMUN, V63, P3649, DOI 10.1128/IAI.63.9.3649-3658.1995; Kitten T, 2002, INFECT IMMUN, V70, P422, DOI 10.1128/IAI.70.1.422-425.2002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kucknoor AS, 2007, CELL MICROBIOL, V9, P2586, DOI 10.1111/j.1462-5822.2007.00979.x; Lei BF, 2004, J INFECT DIS, V189, P79, DOI 10.1086/380491; Lindberg J, 1999, SCAND J INFECT DIS, V31, P409, DOI 10.1080/00365549950163888; Liu L, 2009, CURR MICROBIOL, V58, P11, DOI 10.1007/s00284-008-9258-x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; MUNRO CL, 1993, MOL MICROBIOL, V8, P133, DOI 10.1111/j.1365-2958.1993.tb01210.x; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Seo JY, 2002, INFECT IMMUN, V70, P1143, DOI 10.1128/IAI.70.3.1143-1149.2002; Serruto D, 2004, J BIOTECHNOL, V113, P15, DOI 10.1016/j.jbiotec.2004.03.024; Shah P, 2006, INFECT IMMUN, V74, P5888, DOI 10.1128/IAI.00553-06; SULLAM PM, 1985, AM J MED, V78, P110, DOI 10.1016/0002-9343(85)90373-0; Talkington DF, 1996, MICROB PATHOGENESIS, V21, P17, DOI 10.1006/mpat.1996.0038; TELFORD JL, 2004, GENOMICS PROTEOMICS, P203; Tleyjeh IM, 2007, CHEST, V132, P1025, DOI 10.1378/chest.06-2048; TURNER LS, 2009, INFECT IMMUN; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Viscount HB, 1997, INFECT IMMUN, V65, P994, DOI 10.1128/IAI.65.3.994-1002.1997; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; XU P, 2007, J BACTERIOL; Yang XL, 2008, MICROBES INFECT, V10, P1300, DOI 10.1016/j.micinf.2008.07.029; ZHAO YG, 2005, VACCINE	67	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11666	10.1371/journal.pone.0011666	http://dx.doi.org/10.1371/journal.pone.0011666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668678	gold, Green Published, Green Submitted			2022-12-25	WOS:000280297300002
J	Delport, W; Scheffler, K; Gravenor, MB; Muse, SV; Pond, SK				Delport, Wayne; Scheffler, Konrad; Gravenor, Mike B.; Muse, Spencer V.; Pond, Sergei Kosakovsky			Benchmarking Multi-Rate Codon Models	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD APPROACH; SUBSTITUTION MODELS; SELECTIVE PRESSURES; SEQUENCE EVOLUTION; INDIVIDUAL SITES; PROTEIN; TREES	The single rate codon model of non-synonymous substitution is ubiquitous in phylogenetic modeling. Indeed, the use of a non-synonymous to synonymous substitution rate ratio parameter has facilitated the interpretation of selection pressure on genomes. Although the single rate model has achieved wide acceptance, we argue that the assumption of a single rate of non-synonymous substitution is biologically unreasonable, given observed differences in substitution rates evident from empirical amino acid models. Some have attempted to incorporate amino acid substitution biases into models of codon evolution and have shown improved model performance versus the single rate model. Here, we show that the single rate model of non-synonymous substitution is easily outperformed by a model with multiple non-synonymous rate classes, yet in which amino acid substitution pairs are assigned randomly to these classes. We argue that, since the single rate model is so easy to improve upon, new codon models should not be validated entirely on the basis of improved model fit over this model. Rather, we should strive to both improve on the single rate model and to approximate the general time-reversible model of codon substitution, with as few parameters as possible, so as to reduce model over-fitting. We hint at how this can be achieved with a Genetic Algorithm approach in which rate classes are assigned on the basis of sequence information content.	[Delport, Wayne] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Scheffler, Konrad] Univ Stellenbosch, Dept Math Sci, ZA-7600 Stellenbosch, South Africa; [Gravenor, Mike B.] Univ Swansea, Sch Med, Swansea, W Glam, Wales; [Muse, Spencer V.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Pond, Sergei Kosakovsky] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; Stellenbosch University; Swansea University; University of North Carolina; North Carolina State University; University of California System; University of California San Diego	Delport, W (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	wdelport@ucsd.edu	Delport, Wayne/C-1744-2008; Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Scheffler, Konrad/0000-0002-6041-8367	Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative [NSF-0714991]; National Institutes of Health [AI47745]; University of California, San Diego Center for AIDS Research/National Institute of Allergy and Infectious Diseases (NIAID) [AI36214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R01AI047745, R21AI047745] Funding Source: NIH RePORTER	Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Center for AIDS Research/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative through grant NSF-0714991, the National Institutes of Health (AI47745), and by a University of California, San Diego Center for AIDS Research/National Institute of Allergy and Infectious Diseases (NIAID) Developmental Award to W.D. and S.L.K.P (AI36214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Conant GC, 2009, MOL BIOL EVOL, V26, P1155, DOI 10.1093/molbev/msp031; DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, V5, P89; DELPORT W, 2010, PLOS COMP B IN PRESS; Delport W, 2009, BRIEF BIOINFORM, V10, P97, DOI 10.1093/bib/bbn049; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; HASEGAWA M, 1985, MOL BIOL EVOL, V21, P160; Huelsenbeck JP, 2008, PHILOS T R SOC B, V363, P3941, DOI 10.1098/rstb.2008.0175; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; KOSAKOVSKY P, 2010, PLOS ONE IN PRESS; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, MOL BIOL EVOL, V22, P223, DOI 10.1093/molbev/msi009; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; POND SLK, 2006, MOL BIOL EVOL MSL, V144; Sainudiin R, 2005, J MOL EVOL, V60, P315, DOI 10.1007/s00239-004-0153-1; Stanfel LE, 1996, J THEOR BIOL, V183, P195, DOI 10.1006/jtbi.1996.0213; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087; Wong WSW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-148; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11587	10.1371/journal.pone.0011587	http://dx.doi.org/10.1371/journal.pone.0011587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657773	Green Published, Green Submitted, gold			2022-12-25	WOS:000280197500006
J	Milet, J; Nuel, G; Watier, L; Courtin, D; Slaoui, Y; Senghor, P; Migot-Nabias, F; Gaye, O; Garcia, A				Milet, Jacqueline; Nuel, Gregory; Watier, Laurence; Courtin, David; Slaoui, Yousri; Senghor, Paul; Migot-Nabias, Florence; Gaye, Oumar; Garcia, Andre			Genome Wide Linkage Study, Using a 250K SNP Map, of Plasmodium falciparum Infection and Mild Malaria Attack in a Senegalese Population	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; UBIQUITIN-CONJUGATING ENZYME; BLOOD-CELL POLYMORPHISMS; CEREBRAL MALARIA; CHROMOSOME 5Q31-Q33; GENETIC ASSOCIATION; GENERAL PEDIGREES; PROMOTER REGION; DENDRITIC CELLS	Multiple factors are involved in the variability of host's response to P. falciparum infection, like the intensity and seasonality of malaria transmission, the virulence of parasite and host characteristics like age or genetic make-up. Although admitted nowadays, the involvement of host genetic factors remains unclear. Discordant results exist, even concerning the best-known malaria resistance genes that determine the structure or function of red blood cells. Here we report on a genomewide linkage and association study for P. falciparum infection intensity and mild malaria attack among a Senegalese population of children and young adults from 2 to 18 years old. A high density single nucleotide polymorphisms (SNP) genome scan (Affimetrix GeneChip Human Mapping 250K-nsp) was performed for 626 individuals: i.e. 249 parents and 377 children out of the 504 ones included in the follow-up. The population belongs to a unique ethnic group and was closely followed-up during 3 years. Genome-wide linkage analyses were performed on four clinical and parasitological phenotypes and association analyses using the family based association tests (FBAT) method were carried out in regions previously linked to malaria phenotypes in literature and in the regions for which we identified a linkage peak. Analyses revealed three strongly suggestive evidences for linkage: between mild malaria attack and both the 6p25.1 and the 12q22 regions (empirical p-value = 5 x 10(-5) and 96 x 10(-5) respectively), and between the 20p11q11 region and the prevalence of parasite density in asymptomatic children (empirical p-value = 1.5 x 10(-4)). Family based association analysis pointed out one significant association between the intensity of plasmodial infection and a polymorphism located in ARHGAP26 gene in the 5q31-q33 region (p-value = 3.7 x 10(-5)). This study identified three candidate regions, two of them containing genes that could point out new pathways implicated in the response to malaria infection. Furthermore, we detected one gene associated with malaria infection in the 5q31-q33 region.	[Milet, Jacqueline; Courtin, David; Migot-Nabias, Florence; Garcia, Andre] IRD, UMR Mere & Enfant Face Infect Trop 216, Paris, France; [Milet, Jacqueline; Courtin, David; Migot-Nabias, Florence; Garcia, Andre] Univ Paris 05, Parasitol Lab, Paris, France; [Nuel, Gregory; Slaoui, Yousri] Univ Paris 05, CNRS, MAP5, UMR 8145, Paris, France; [Watier, Laurence] INSERM, U657, Garches, France; [Senghor, Paul; Gaye, Oumar] Univ Cheikh Anta Diop, Fac Med, Dept Biol & Explorat Fonct, Lab Parasitol & Mycol, Dakar, Senegal	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University Cheikh Anta Diop Dakar	Milet, J (corresponding author), IRD, UMR Mere & Enfant Face Infect Trop 216, Paris, France.	Andre.Garcia@ird.fr	Garcia, Andre/S-2959-2016; Garcia, Andre/ABA-1820-2020; , Watier/K-8213-2013; courtin, david/A-1584-2017	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X; , Watier/0000-0002-4057-1102; courtin, david/0000-0002-5263-4430; Migot-Nabias, Florence/0000-0001-9982-594X; slaoui, yousri/0000-0001-5295-3311; MILET, Jacqueline/0000-0003-2710-1517	Ministere de la Recherche	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	1. Ministere de la Recherche; Programme PAL+ (suite de VIHPAL): Recherche sur le paludisme et les maladies transmissibles associees, pour les pays en developpement. http://www.enseignementsup-recherche.gouv.fr/. 2. Centre National du Genotypage; http://www.cng.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 2000, GLOB PARTN ROLL BACK; [Anonymous], 2004, STRATEGIC FRAMEWORK; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellenguez C, 2009, HUM HERED, V68, P87, DOI 10.1159/000212501; BOUGERET C, 1992, J IMMUNOL, V148, P318; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; Cabantous S, 2006, INFECT IMMUN, V74, P7040, DOI 10.1128/IAI.01581-05; Canal F, 2007, ARCH BIOCHEM BIOPHYS, V465, P282, DOI 10.1016/j.abb.2007.06.003; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; COT M, 1991, ANN SOC BELG MED TR, V71, P17; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fillol F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-116; Fillol F, 2009, AM J TROP MED HYG, V80, P202, DOI 10.4269/ajtmh.2009.80.202; Flori L, 2003, HUM MOL GENET, V12, P375, DOI 10.1093/hmg/ddg033; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; Garcia A, 2004, MICROBES INFECT, V6, P68, DOI 10.1016/j.micinf.2003.09.021; Ghosh K, 2008, HUM IMMUNOL, V69, P856, DOI 10.1016/j.humimm.2008.08.294; Gyan B, 2009, AM J TROP MED HYG, V80, P541, DOI 10.4269/ajtmh.2009.80.541; Hartgers FC, 2009, J INFECT DIS, V199, P1528, DOI 10.1086/598687; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hommel M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S1; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jallow M, 2009, NAT GENET; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kim CC, 2008, INFECT IMMUN, V76, P5873, DOI 10.1128/IAI.00640-08; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Mathanga DP., 2007, INT J EQUITY HLTH, V6, P22, DOI [10.1186/1475-9276-6-22, DOI 10.1186/1475-9276-6-22]; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; McGuire W, 1999, J INFECT DIS, V179, P287, DOI 10.1086/314533; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Migot-Nabias F, 2006, MICROBES INFECT, V8, P2352, DOI 10.1016/j.micinf.2006.03.021; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Mizui M, 2009, J CLIN IMMUNOL, V29, P1, DOI 10.1007/s10875-008-9263-7; MOLINEAUX L, 1980, AM J TROP MED HYG, V29, P725, DOI 10.4269/ajtmh.1980.29.725; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Peng X, 2007, ANN NY ACAD SCI, V1112, P339, DOI 10.1196/annals.1415.025; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Romani L, 2004, BLOOD, V103, P4232, DOI 10.1182/blood-2003-11-4036; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taoufiq Z, 2008, J INFECT DIS, V197, P1062, DOI 10.1086/528988; Thawan N, 2009, HAEMATOL-HEMATOL J, V94, P195, DOI 10.3324/haematol.13422; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; Valin N, 2006, PARASITE, V13, P79, DOI 10.1051/parasite/2006131079; Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x; Wattavidanage J, 1999, CLIN EXP IMMUNOL, V115, P350, DOI 10.1046/j.1365-2249.1999.00804.x; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zhang P, 2005, EMBO REP, V6, P531, DOI 10.1038/sj.embor.7400433	83	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11616	10.1371/journal.pone.0011616	http://dx.doi.org/10.1371/journal.pone.0011616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657648	Green Published, gold, Green Submitted			2022-12-25	WOS:000279924500015
J	Stenger, C; Hanse, M; Pratte, D; Mbala, ML; Akbar, S; Koziel, V; Escanye, MC; Kriem, B; Malaplate-Armand, C; Olivier, JL; Oster, T; Pillot, T; Yen, FT				Stenger, Christophe; Hanse, Marine; Pratte, Dagmar; Mbala, Marie-Ludvine; Akbar, Samina; Koziel, Violette; Escanye, Marie-Christine; Kriem, Badreddine; Malaplate-Armand, Catherine; Olivier, Jean-Luc; Oster, Thierry; Pillot, Thierry; Yen, Frances T.			Up-regulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase	FASEB JOURNAL			English	Article						leptin receptor; liver; adipose tissue; peripheral leptin resistance	TRIGLYCERIDE-RICH LIPOPROTEINS; CENTRAL-NERVOUS-SYSTEM; ACTIVATED PROTEIN-KINASE; WEIGHT-GAIN; MICE; OBESE; METABOLISM; EXPRESSION; LIPEMIA; LIVER	As a hepatic receptor for triglyceriderich lipoproteins, the lipolysis-stimulated lipoprotein receptor (LSR) may be involved in the dynamics of lipid distribution between the liver and peripheral tissues. Here, we explore the potential role of leptin in regulating LSR. At physiological concentrations (1-10 ng/ml), leptin increased LSR protein and mRNA levels in Hepa1-6 cells through an ERK1/2-dependent and alpha-amanitin-sensitive pathway. In vivo, leptin treatment of C57BL6/Rj mice (1 mu g 2 x /d, 8 d) led to a significant increase in hepatic LSR mRNA and protein, decreased liver triglycerides and increased VLDL secretion as compared to controls. LSR+/- mice with elevated postprandial lipemia placed on a high-fat (60% kcal) diet exhibited accelerated weight gain and increased fat mass as compared to controls. While plasma leptin levels were increased 3-fold, hepatic leptin receptor protein levels and phosphorylation of ERK1/2 were significantly reduced. Therefore, leptin is an important regulator of LSR protein levels providing the means for the control of hepatic uptake of lipids during the postprandial phase. However, this may no longer be functional in LSR+/- mice placed under a chronic dietary fat load, suggesting that this animal model could be useful for the study of molecular mechanisms involved in peripheral leptin resistance.-Stenger, C., Hanse, M., Pratte, D., Mbala, M.-L., Akbar, S., Koziel, V., Escanye, M.-C., Kriem, B., Malaplate-Armand, C., Olivier, J.-L., Oster, T., Pillot, T., Yen, F. T. Upregulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase. FASEB J. 24, 4218-4228 (2010). www.fasebj.org	[Stenger, Christophe; Hanse, Marine; Pratte, Dagmar; Mbala, Marie-Ludvine; Akbar, Samina; Koziel, Violette; Escanye, Marie-Christine; Kriem, Badreddine; Malaplate-Armand, Catherine; Olivier, Jean-Luc; Oster, Thierry; Pillot, Thierry; Yen, Frances T.] Nancy Univ, INPL, ENSAIA, ENSALA, F-54501 Vandoeuvre Les Nancy, France; [Escanye, Marie-Christine; Malaplate-Armand, Catherine; Olivier, Jean-Luc] CHU, Dept Clin Biochem, Nancy, France; [Pillot, Thierry] Univ Paul Verlaine, UFR SciFA, Metz, France	Universite de Lorraine; CHU de Nancy; Universite de Lorraine	Yen, FT (corresponding author), Nancy Univ, INPL, ENSAIA, ENSALA, 2 Ave Foret Haye, F-54501 Vandoeuvre Les Nancy, France.	frances.yenpotin@ensaia.inpl-nancy.fr	Olivier, Jean luc/AAQ-2721-2021; Yen, Frances T/G-9175-2014	Yen, Frances T/0000-0001-8740-4304	Region Lorraine and Nancy University-Institut National Polytechnique de Lorraine; Ministry of Research and Higher Education; French Ministry of Higher Education and Research, Nancy University-INPL; Council for the Lorraine Region; Nancy Commune	Region Lorraine and Nancy University-Institut National Polytechnique de Lorraine(Region Grand-Est); Ministry of Research and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); French Ministry of Higher Education and Research, Nancy University-INPL; Council for the Lorraine Region(Region Grand-Est); Nancy Commune	C.S. and M.H. contributed equally to this work. C.S. received funding from the Region Lorraine and Nancy University-Institut National Polytechnique de Lorraine [Bonus Qualite Recherche (BQR)], and M.H. received funding from the Ministry of Research and Higher Education (thesis fellowship). This work was funded in part by the French Ministry of Higher Education and Research, Nancy University-INPL (BQR grant), and grants from local government agencies, including the Council for the Lorraine Region and the Nancy Commune.	ATTIE AD, 1982, HEPATOLOGY, V2, P269; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Boquist S, 1999, CIRCULATION, V100, P723, DOI 10.1161/01.CIR.100.7.723; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Carpenter LR, 1998, P NATL ACAD SCI USA, V95, P6061, DOI 10.1073/pnas.95.11.6061; Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200; Couillard C, 1998, DIABETES, V47, P953, DOI 10.2337/diabetes.47.6.953; Cui H, 2006, FASEB J, V20, P2654, DOI 10.1096/fj.06-5989fje; DONAHOO WT, 2010, METABOLISM, DOI DOI 10.1016/J.METABOL.2010.03.01; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garza JC, 2008, J BIOL CHEM, V283, P18238, DOI 10.1074/jbc.M800053200; GROOT PHE, 1991, ARTERIOSCLER THROMB, V11, P653, DOI 10.1161/01.ATV.11.3.653; Guerci B, 2000, INT J OBESITY, V24, P468, DOI 10.1038/sj.ijo.0801181; Havel RJ, 1995, METABOLIC MOL BASES, V7th, P1841, DOI [10.1036/ommbid.142, DOI 10.1036/OMMBID.142]; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Leshan RL, 2006, OBESITY, V14, P208, DOI 10.1038/oby.2006.310; LEWIS GF, 1990, J CLIN ENDOCR METAB, V71, P1041, DOI 10.1210/jcem-71-4-1041; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; Mekki N, 1999, J CLIN ENDOCR METAB, V84, P184, DOI 10.1210/jc.84.1.184; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Narvekar P, 2009, DIABETES, V58, P1040, DOI 10.2337/db08-1184; Papathanassoglou E, 2006, J IMMUNOL, V176, P7745, DOI 10.4049/jimmunol.176.12.7745; SCHOTZ MC, 1957, AM J PHYSIOL, V188, P399, DOI 10.1152/ajplegacy.1957.188.2.399; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Yasari S, 2009, MOL CELL BIOCHEM, V324, P13, DOI 10.1007/s11010-008-9979-y; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	35	24	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2010	24	11					4218	4228		10.1096/fj.10-160440	http://dx.doi.org/10.1096/fj.10-160440			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20647547				2022-12-25	WOS:000283861100010
J	Mathes, E; Wang, L; Komives, E; Ghosh, G				Mathes, Erika; Wang, Lily; Komives, Elizabeth; Ghosh, Gourisankar			Flexible Regions within I kappa B alpha Create the Ubiquitin-independent Degradation Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME PATHWAY; PROTEIN-TURNOVER; PHOSPHORYLATION; ACTIVATION; PEPTIDE; COMPLEX; BINDING; DOMAIN; COMMON; UV	Homeostatic regulation of NF-kappa B requires the continuous synthesis of I kappa B alpha and its rapid degradation by the proteasome through a ubiquitin-independent pathway. We previously showed that the ubiquitin-independent degradation signal of unbound I kappa B alpha was located in the C-terminal PEST region, and we have now identified a single tyrosine, Tyr-289, and determined that the hydrophobic character of the tyrosine is important for the rapid turnover of I kappa B alpha. The sequence composition of the PEST peptide surrounding this Tyr-289 imposes a distinct polyproline II conformation. Enhancing the polyproline II helix formation correlates with slower degradation rates of unbound I kappa B alpha. We have further identified a degradation signal located within the 5th ankyrin repeat that is functional once the C terminus is removed. Both the C-terminal and 5th ankyrin repeat degradation signals have inherent flexibility and specific hydrophobic residue(s), which together constitute the ubiquitin-independent degradation signal for I kappa B alpha.	[Mathes, Erika; Wang, Lily; Komives, Elizabeth; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gghosh@ucsd.edu			National Institutes of Health [T32 CA009523]; NRSA [5P01GM071862-04]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Award T32 CA009523, Ruth L. Kirschstein award from NRSA (to E. M.), and Grant 5P01GM071862-04 (to G. G.).	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Chandra S, 2008, J BIOL CHEM, V283, P23950, DOI 10.1074/jbc.M800467200; Croy CH, 2004, PROTEIN SCI, V13, P1767, DOI 10.1110/ps.04731004; Ferreiro DU, 2007, J MOL BIOL, V365, P1201, DOI 10.1016/j.jmb.2006.11.044; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kroll M, 1997, ONCOGENE, V15, P1841, DOI 10.1038/sj.onc.1201560; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163; Shringarpure R, 2002, FREE RADICAL BIO MED, V32, P1084, DOI 10.1016/S0891-5849(02)00824-9; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Truhlar SME, 2008, J MOL BIOL, V380, P67, DOI 10.1016/j.jmb.2008.02.053; Truhlar SME, 2006, P NATL ACAD SCI USA, V103, P18951, DOI 10.1073/pnas.0605794103	30	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32927	32936		10.1074/jbc.M110.107326	http://dx.doi.org/10.1074/jbc.M110.107326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682784	Green Published, hybrid			2022-12-25	WOS:000283048200030
J	Murarka, A; Clomburg, JM; Moran, S; Shanks, JV; Gonzalez, R				Murarka, Abhishek; Clomburg, James M.; Moran, Sean; Shanks, Jacqueline V.; Gonzalez, Ramon			Metabolic Analysis of Wild-type Escherichia coli and a Pyruvate Dehydrogenase Complex (PDHC)-deficient Derivative Reveals the Role of PDHC in the Fermentative Metabolism of Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCOCCUS-FAECALIS; MICROBIAL-METABOLISM; FORMATE-LYASE; IN-VIVO; GLYCEROL; FLUXES; C-13; NMR; QUANTIFICATION; GROWTH	Pyruvate is located at a metabolic junction of assimilatory and dissimilatory pathways and represents a switch point between respiratory and fermentative metabolism. In Escherichia coli, the pyruvate dehydrogenase complex (PDHC) and pyruvate formate-lyase are considered the primary routes of pyruvate conversion to acetyl-CoA for aerobic respiration and anaerobic fermentation, respectively. During glucose fermentation, the in vivo activity of PDHC has been reported as either very low or undetectable, and the role of this enzyme remains unknown. In this study, a comprehensive characterization of wild-type E. coli MG1655 and a PDHC-deficient derivative (Pdh) led to the identification of the role of PDHC in the anaerobic fermentation of glucose. The metabolism of these strains was investigated by using a mixture of C-13-labeled and -unlabeled glucose followed by the analysis of the labeling pattern in protein-bound amino acids via two-dimensional C-13, H-1 NMR spectroscopy. Metabolite balancing, biosynthetic C-13 labeling of proteinogenic amino acids, and isotopomer balancing all indicated a large increase in the flux of the oxidative branch of the pentose phosphate pathway (ox-PPP) in response to the PDHC deficiency. Because both ox-PPP and PDHC generate CO2 and the calculated CO2 evolution rate was significantly reduced in Pdh, it was hypothesized that the role of PDHC is to provide CO2 for cell growth. The similarly negative impact of either PDHC or ox-PPP deficiencies, and an even more pronounced impairment of cell growth in a strain lacking both ox-PPP and PDHC, provided further support for this hypothesis. The three strains exhibited similar phenotypes in the presence of an external source of CO2, thus confirming the role of PDHC. Activation of formate hydrogen-lyase (which converts formate to CO2 and H-2) rendered the PDHC deficiency silent, but its negative impact reappeared in a strain lacking both PDHC and formate hydrogen-lyase. A stoichiometric analysis of CO2 generation via PDHC and ox-PPP revealed that the PDHC route is more carbon-and energy-efficient, in agreement with its beneficial role in cell growth.	[Murarka, Abhishek; Clomburg, James M.; Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Moran, Sean] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Shanks, Jacqueline V.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA	Rice University; Rice University; Rice University; Iowa State University	Gonzalez, R (corresponding author), 6100 Main St,MS-362, Houston, TX 77005 USA.	Ramon.Gonzalez@rice.edu	Murarka, Abhishek/AAF-3594-2020; Shanks, Jacqueline/ABE-5353-2020; Gonzalez, Ramon/B-1961-2010	Shanks, Jacqueline/0000-0001-9947-0181	National Science Foundation [BES-0331388/BES-0601549, EEC-0813570]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Grants BES-0331388/BES-0601549 and EEC-0813570.	Abdel-Hamid AM, 2001, MICROBIOL-SGM, V147, P1483, DOI 10.1099/00221287-147-6-1483; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bagramyan K, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1159, DOI 10.1023/B:BIRY.0000009129.18714.a4; Cronan J. E., 2006, ECOSAL ESCHERICHIA C; Cronan Jr. JE, 2008, ECOSAL ESCHERICHIA C; DANSON MJ, 1978, BIOCHEM J, V175, P193, DOI 10.1042/bj1750193; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dharmadi Y, 2005, J CHROMATOGR A, V1070, P89, DOI 10.1016/j.chroma.2005.02.075; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; Downs DM, 2006, ANNU REV MICROBIOL, V60, P533, DOI 10.1146/annurev.micro.60.080805.142308; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gonzalez R, 2003, BIOTECHNOL BIOENG, V82, P152, DOI 10.1002/bit.10556; Grivet JP, 2009, PROG NUCL MAG RES SP, V54, P1, DOI 10.1016/j.pnmrs.2008.02.001; Harris R. K., 1983, NUCL MAGNETIC RESONA; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang YS, 2004, J BACTERIOL, V186, P4921, DOI 10.1128/JB.186.15.4921-4930.2004; Klapa MI, 1999, BIOTECHNOL BIOENG, V62, P375, DOI 10.1002/(SICI)1097-0290(19990220)62:4<375::AID-BIT1>3.3.CO;2-F; LACOURSIERE A, 1986, APPL MICROBIOL BIOT, V23, P404; MAYER C, 2005, ECOSAL ESCHERICHIA C; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Miller J.H., 1972, EXPT MOL GENETICS; Murarka A, 2008, APPL ENVIRON MICROB, V74, P1124, DOI 10.1128/AEM.02192-07; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nielsen J, 2003, J BACTERIOL, V185, P7031, DOI 10.1128/JB.185.24.7031-7035.2003; NIELSEN J, 2003, BIOREACTION ENG PRIN, P47; REPASKE R, 1978, J BACTERIOL, V135, P1162, DOI 10.1128/JB.135.3.1162-1164.1978; ROMEO T, 2005, ECOSAL ESCHERICHIA C; Sambrook J., 2002, MOL CLONING LAB MANU; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Sawers RG, 2004, ECOSAL ESCHERICHIA C; Self WT, 2004, J BACTERIOL, V186, P580, DOI 10.1128/JB.186.2.580-587.2004; SMITH MW, 1983, J BACTERIOL, V156, P81, DOI 10.1128/JB.156.1.81-88.1983; SNOEP JL, 1990, ARCH MICROBIOL, V154, P50; SNOEP JL, 1993, FEMS MICROBIOL LETT, V114, P279, DOI 10.1016/0378-1097(93)90284-9; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; Sriram G, 2004, METAB ENG, V6, P116, DOI 10.1016/j.ymben.2004.02.003; Sriram G, 2007, PHYTOCHEMISTRY, V68, P2243, DOI 10.1016/j.phytochem.2007.04.009; STAUFFER GV, 2004, ECOSAL ESCHERICHIA C; Stephanopoulos GN, 1998, METABOLIC ENG PRINCI, P309, DOI DOI 10.1016/B978-012666260-3/50009-1; Szyperski T, 1996, TRENDS BIOTECHNOL, V14, P453, DOI 10.1016/S0167-7799(96)10056-1; SZYPERSKI T, 1995, EUR J BIOCHEM, V232, P433, DOI 10.1111/j.1432-1033.1995.433zz.x; Szyperski T, 1998, Q REV BIOPHYS, V31, P41, DOI 10.1017/S0033583598003412; VARENNE S, 1975, MOL GEN GENET, V141, P181, DOI 10.1007/BF00267683; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Yazdani SS, 2008, METAB ENG, V10, P340, DOI 10.1016/j.ymben.2008.08.005	47	25	28	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31548	31558		10.1074/jbc.M110.121095	http://dx.doi.org/10.1074/jbc.M110.121095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667837	Green Published, hybrid			2022-12-25	WOS:000282764600049
J	Swenerton, RK; Knudsen, GM; Sajid, M; Kelly, BL; McKerrow, JH				Swenerton, Ryan K.; Knudsen, Giselle M.; Sajid, Mohammed; Kelly, Ben L.; McKerrow, James H.			Leishmania Subtilisin Is a Maturase for the Trypanothione Reductase System and Contributes to Disease Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED GENE DELETION; HOST-CELL INVASION; IN-GEL DIGESTION; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; PROTEASES; IDENTIFICATION; GLYCOPROTEIN; PROTEINS; HAMSTERS	Proteases are a ubiquitous group of enzymes that play key roles in the life cycle of parasites, in the host-parasite relationship, and in the pathogenesis of parasitic diseases. Furthermore, proteases are druggable targets for the development of new antiparasitic therapy. The subtilisin protease (SUB; Clan SB, family S8) of Leishmania donovani was cloned and found to possess a unique catalytic triad. This gene was then deleted by gene knock-out, which resulted in reduced ability by the parasite to undergo promastigote to amastigote differentiation in vitro. Electron microscopy of SUB knock-out amastigotes revealed abnormal membrane structures, retained flagella, and increased binucleation. SUB-deficient Leishmania displayed reduced virulence in both hamster and murine infection models. Histology of spleens from SUB knock-out-infected hamsters revealed the absence of psammoma body calcifications indicative of the granulomatous lesions that occur during Leishmania infection. To delineate the specific role of SUB in parasite physiology, two-dimensional gel electrophoresis was carried out on SUB-/- versus wild-type parasites. SUB knock-out parasites showed altered regulation of the terminal peroxidases of the trypanothione reductase system. Leishmania and other trypanosomatids lack glutathione reductase, and therefore rely on the novel trypanothione reductase system to detoxify reactive oxygen intermediates and to maintain redox homeostasis. The predominant tryparedoxin peroxidases were decreased in SUB-/- parasites, and higher molecular weight isoforms were present, indicating altered processing. In addition, knock-out parasites showed increased sensitivity to hydroperoxide. These data suggest that subtilisin is the maturase for tryparedoxin peroxidases and is necessary for full virulence.	Univ Calif San Francisco, Sandler Ctr Drug Discovery, Dept Pathol, San Francisco, CA 94158 USA; [Knudsen, Giselle M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Sajid, Mohammed] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Kelly, Ben L.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol, New Orleans, LA 70112 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	McKerrow, JH (corresponding author), 1700 4th St,Box 2550,UCSF QB3, San Francisco, CA 94158 USA.	James.McKerrow@ucsf.edu		Swenerton, Ryan/0000-0002-0994-752X	National Science Foundation; Sandler Foundation; National Institutes of Health National Center for Research Resources [NIH NCRR P41RR001614]; National Institutes of Health [NCRR RR012961]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR012961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Sandler Foundation; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation Graduate Research Fellowship and the Sandler Foundation.; We graciously thank Margaret Mays at the UCSF Morphology Core for tissue histology, K. C. Lim in the UCSF Dept. of Pathology for his help with the hamster infections, and Rick Fetter for the electron microscopy. Mass spectrometry analysis was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at UCSF (A. L. Burlingame, Director) supported by the Biomedical Research Technology Program of the National Institutes of Health National Center for Research Resources, NIH NCRR P41RR001614, and National Institutes of Health NCRR RR012961.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Bal G, 2003, BIOORG MED CHEM LETT, V13, P2875, DOI 10.1016/S0960-894X(03)00579-1; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; Emanuelsson O, 2003, J MOL BIOL, V330, P443, DOI 10.1016/S0022-2836(03)00553-9; Flohe L, 2002, METHOD ENZYMOL, V347, P244; FLOHE L, 2007, SUBCELLULAR BIOCH, V44, P231; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; JOSHI PB, 1995, GENE, V156, P145, DOI 10.1016/0378-1119(95)00042-5; KAHL LP, 1991, AM J TROP MED HYG, V44, P218, DOI 10.4269/ajtmh.1991.44.218; Kim K, 2004, ACTA TROP, V91, P69, DOI 10.1016/j.actaropia.2003.11.016; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; LACALLE RA, 1989, GENE, V79, P375, DOI 10.1016/0378-1119(89)90220-5; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; Maniatis T., 1982, MOL CLONING LAB MANU; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Miller SA, 2003, MOL MICROBIOL, V49, P883, DOI 10.1046/j.1365-2958.2003.03604.x; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; SACKS DL, 1985, J IMMUNOL, V135, P564; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; *SCI WORK GROUP LE, 2004, REP SCI WORK GROUP M; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; SMITH K, 1991, MOL BIOCHEM PARASIT, V48, P109, DOI 10.1016/0166-6851(91)90170-B; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; WALLIS AE, 1987, J EXP MED, V166, P1814, DOI 10.1084/jem.166.6.1814; WILSON ME, 1987, J PARASITOL, V73, P55, DOI 10.2307/3282344; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Wyllie S, 2006, ACTA TROP, V97, P364, DOI 10.1016/j.actatropica.2006.01.004; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	46	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31120	31129		10.1074/jbc.M110.114462	http://dx.doi.org/10.1074/jbc.M110.114462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675366	hybrid, Green Published			2022-12-25	WOS:000282764600005
J	Dagdanova, A; Ilchenko, S; Notari, S; Yang, QW; Obrenovich, ME; Hatcher, K; McAnulty, P; Huang, LQ; Zou, WQ; Kong, QZ; Gambetti, P; Chen, SG				Dagdanova, Ayuna; Ilchenko, Serguei; Notari, Silvio; Yang, Qiwei; Obrenovich, Mark E.; Hatcher, Kristen; McAnulty, Peter; Huang, Lequn; Zou, Wenquan; Kong, Qingzhong; Gambetti, Pierluigi; Chen, Shu G.			Characterization of the Prion Protein in Human Urine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRUNCATED FORMS; SCRAPIE PRION; NEUROBLASTOMA-CELLS; CULTURED-CELLS; PRP; IDENTIFICATION; BIOSYNTHESIS; INFECTIVITY; EXCRETION	The presence of the prion protein (PrP) in normal human urine is controversial and currently inconclusive. This issue has taken a special relevance because prion infectivity has been demonstrated in urine of animals carrying experimental or naturally occurring prion diseases, but the actual presence and tissue origin of the infectious prion have not been determined. We used immunoprecipitation, one-and two-dimensional electrophoresis, and mass spectrometry to prove definitely the presence of PrP in human urine and its post-translational modifications. We show that urinary PrP (uPrP) is truncated mainly at residue 112 but also at other residues up to 122. This truncation makes uPrP undetectable with some commonly used antibodies to PrP. uPrP is glycosylated and carries an anchor which, at variance with that of cellular PrP, lacks the inositol-associated phospholipid moiety, indicating that uPrP is probably shed from the cell surface. The detailed characterization of uPrP reported here definitely proves the presence of PrP in human urine and will help determine the origin of prion infectivity in urine.	[Dagdanova, Ayuna; Notari, Silvio; Yang, Qiwei; Obrenovich, Mark E.; Hatcher, Kristen; Zou, Wenquan; Kong, Qingzhong; Gambetti, Pierluigi; Chen, Shu G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ilchenko, Serguei] Case Western Reserve Univ, Ctr Prote & Mass Spectrometry, Cleveland, OH 44106 USA; [McAnulty, Peter] Nonclin Consultancy, DK-4000 Roskilde, Denmark; [Huang, Lequn] Nanjing Univ, Sch Med, Nanjing 210093, Peoples R China	Case Western Reserve University; Case Western Reserve University; Nanjing University	Gambetti, P (corresponding author), Case Western Reserve Univ, Dept Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	pierluigi.gambetti@case.edu; shu.chen@case.edu	Zou, Wenquan/ABF-2875-2020; Chen, Shu G./AAK-7301-2021; Chen, Shu/Z-2943-2019; Zou, Wenquan/GWQ-3489-2022; Chen, Shu G./O-4750-2014	Chen, Shu G./0000-0001-7180-3001; Chen, Shu G./0000-0001-7180-3001	National Institutes of Health [AG14359]; Centers for Disease Control and Prevention [UR8/CCU515004]; Department of Agriculture National Research Initiative [2002-35201-2608]; Department of Defense [DAMD17-03-1-0283]; Charles S. Britton Fund; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Agriculture National Research Initiative; Department of Defense(United States Department of Defense); Charles S. Britton Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG14359. This work was also supported by Centers for Disease Control and Prevention Grant UR8/CCU515004, Department of Agriculture National Research Initiative Grant 2002-35201-2608, Department of Defense National Prion Research Program Grant DAMD17-03-1-0283, and by the Charles S. Britton Fund.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baldwin MA, 2005, METHOD ENZYMOL, V405, P172, DOI 10.1016/S0076-6879(05)05008-1; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Ecroyd H, 2004, BIOL REPROD, V71, P993, DOI 10.1095/biolreprod.104.029801; *ED TEAM, 2007, EUROSURVEILLANCE, V12; Furukawa H, 2004, J BIOL CHEM, V279, P23661, DOI 10.1074/jbc.M400187200; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Gregori L, 2008, J VIROL METHODS, V149, P251, DOI 10.1016/j.jviromet.2008.01.028; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Harris DA, 1996, CURR TOP MICROBIOL, V207, P77; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Head MW, 2005, NEUROLOGY, V64, P1794, DOI 10.1212/01.WNL.0000161842.68793.8A; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; MacGregor I, 1999, VOX SANG, V77, P88; Maddison BC, 2007, BIOCHEM BIOPH RES CO, V353, P195, DOI 10.1016/j.bbrc.2006.12.006; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Narang HK, 2005, EXP BIOL MED, V230, P343, DOI 10.1177/153537020523000508; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Parizek P, 2001, J BIOL CHEM, V276, P44627, DOI 10.1074/jbc.M107458200; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Rane NS, 2010, J CELL BIOL, V188, P515, DOI 10.1083/jcb.200911115; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Serban A, 2004, J BIOL CHEM, V279, P48817, DOI 10.1074/jbc.M409107200; Shaked GM, 2001, J BIOL CHEM, V276, P31479, DOI 10.1074/jbc.C100278200; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; TAGLIAVINI F, 1992, BIOCHEM BIOPH RES CO, V184, P1398, DOI 10.1016/S0006-291X(05)80038-5; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zhao HX, 2006, VIRUS RES, V115, P43, DOI 10.1016/j.virusres.2005.07.004; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	54	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30489	30495		10.1074/jbc.M110.161794	http://dx.doi.org/10.1074/jbc.M110.161794			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20670940	Green Published, hybrid			2022-12-25	WOS:000282135500016
J	Lu, C; Everhart, L; Tilan, J; Kuo, L; Sun, CCJ; Munivenkatappa, RB; Jonsson-Rylander, AC; Sun, J; Kuan-Celarier, A; Li, L; Abe, K; Zukowska, Z; Toretsky, JA; Kitlinska, J				Lu, C.; Everhart, L.; Tilan, J.; Kuo, L.; Sun, C-C J.; Munivenkatappa, R. B.; Jonsson-Rylander, A.-C.; Sun, J.; Kuan-Celarier, A.; Li, L.; Abe, K.; Zukowska, Z.; Toretsky, J. A.; Kitlinska, J.			Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy	ONCOGENE			English	Article						neuropeptide Y; neuroblastoma; angiogenesis	BAX-DEPENDENT APOPTOSIS; SMOOTH-MUSCLE-CELLS; INDUCED ANGIOGENESIS; NEURO-BLASTOMA; ADRENAL-GLAND; YY2 RECEPTOR; EXPRESSION; BIM; TUMORS; PHOSPHORYLATION	Neuroblastomas are pediatric tumors that develop from sympathetic precursors and express neuronal proteins, such as neuropeptide Y (NPY). NPY is a sympathetic neurotransmitter acting via multiple receptors (Y1-Y5R). Both NPY and Y2Rs are commonly expressed in neuroblastoma cell lines and tissues. The peptide secreted from neuroblastomas stimulates tumor cell proliferation and angiogenesis. As both processes are Y2R-mediated, the aim of this study was to assess Y2R as a potential therapeutic target for neuroblastoma. In vitro, Y2R antagonist (BIIE0246) prevented activation of p44/42 mitogen-activated protein kinase (MAPK) induced by endogenous NPY, which resulted in decreased proliferation and induction of Bim-mediated apoptosis. Similar growth-inhibitory effects were achieved with NPY small interfering RNA (siRNA) and Y2R siRNA. In vivo, Y2R antagonist significantly inhibited growth of SK-N-BE(2) and SK-N-AS xenografts, which was associated with decreased activation of p44/42 MAPK, as well as reduced proliferation (Ki67) and increased apoptosis (TdT-mediated dUTP nick end labeling; TUNEL). The Y2R antagonist also exerted an antiangiogenic effect. In vitro, it reduced the proliferation of endothelial cells induced by neuroblastoma-conditioned media. Consequently, the Y2R antagonist-treated xenografts had decreased vascularization and a high degree of focal fibrosis. In human neuroblastoma tissues, the expression of Y2R was observed in both tumor and endothelial cells, while NPY was predominantly expressed in neuroblastoma cells. In summary, Y2R is a promising new target for neuroblastoma therapy affecting both cancer cells and tumor vasculature. Oncogene (2010) 29, 5630-5642; doi:10.1038/onc.2010.301; published online 2 August 2010	[Lu, C.; Everhart, L.; Tilan, J.; Kuo, L.; Kuan-Celarier, A.; Li, L.; Zukowska, Z.; Kitlinska, J.] Georgetown Univ, Dept Physiol & Biophys, Washington, DC 20057 USA; [Sun, C-C J.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Munivenkatappa, R. B.] Univ Maryland, Sch Med, Dept Surg, Div Transplantat, Baltimore, MD 21201 USA; [Jonsson-Rylander, A.-C.] AstraZeneca, Dept Biosci, Molndal, Sweden; [Sun, J.] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; [Abe, K.] NHLBI, NIH, Bethesda, MD 20892 USA; [Toretsky, J. A.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA	Georgetown University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; AstraZeneca; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Georgetown University	Kitlinska, J (corresponding author), Georgetown Univ, Dept Physiol & Biophys, BSB 231A,3900 Reservoir Rd NW, Washington, DC 20057 USA.	jbk4@georgetown.edu	Lu, Congyi/G-3984-2013		NIH [1R01CA123211-01]; Children's Cancer Foundation (Baltimore, MD, USA); NATIONAL CANCER INSTITUTE [R01CA123211] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Foundation (Baltimore, MD, USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grant 1R01CA123211-01 and funding from Children's Cancer Foundation (Baltimore, MD, USA) to Joanna Kitlinska. The authors would like to thank John Styliaris and David Hur for help in performing experiments. We also thank the Flow Cytometry/Cell Sorting Shared Resources of Lombardi Comprehensive Cancer Center for technical assistance and Children's Oncology Group for providing human samples.	BIEDLER JL, 1978, CANCER RES, V38, P3751; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; COHEN PS, 1990, CANCER RES, V50, P6055; Dotsch J, 1998, REGUL PEPTIDES, V75-6, P185, DOI 10.1016/S0167-0115(98)00067-6; Ekstrand AJ, 2003, P NATL ACAD SCI USA, V100, P6033, DOI 10.1073/pnas.1135965100; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Jonsson-Rylander AC, 2003, PEPTIDES, V24, P255, DOI 10.1016/S0196-9781(03)00041-X; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Kitlinska J, 2002, PEPTIDES, V23, P71, DOI 10.1016/S0196-9781(01)00581-2; KOGNER P, 1994, ACTA PAEDIATR, V83, P423, DOI 10.1111/j.1651-2227.1994.tb18134.x; Korner M, 2004, CLIN CANCER RES, V10, P8426, DOI 10.1158/1078-0432.CCR-04-0821; Koulu M, 2004, ANN MED, V36, P232, DOI 10.1080/07853890410031236; Lee EW, 2003, J CLIN INVEST, V111, P1853, DOI 10.1172/JCI200316929; Lee EW, 2003, PEPTIDES, V24, P99, DOI 10.1016/S0196-9781(02)00281-4; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li Z, 2007, CELL DEATH DIFFER, V14, P318, DOI 10.1038/sj.cdd.4401983; Magni P, 2000, NEUROPHARMACOLOGY, V39, P1628, DOI 10.1016/S0028-3908(99)00231-2; Malmstrom RE, 2001, BRIT J PHARMACOL, V133, P1073, DOI 10.1038/sj.bjp.0704171; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; OHARE MMT, 1989, CANCER RES, V49, P7015; OHARE MMT, 1989, CANCER RES, V49, P7010; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Pons J, 2003, CAN J PHYSIOL PHARM, V81, P177, DOI 10.1139/Y02-166; Pons J, 2008, CAN J PHYSIOL PHARM, V86, P438, DOI [10.1139/Y08-054, 10.1139/y08-054]; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Ribattia Domenico, 2005, Cancer Treatment Reviews, V31, P27, DOI 10.1016/j.ctrv.2004.09.006; Rossler J, 2008, EUR J CANCER, V44, P1645, DOI 10.1016/j.ejca.2008.05.015; Sheriff' S, 1998, REGUL PEPTIDES, V75-6, P309, DOI 10.1016/S0167-0115(98)00083-4; Shusterman S, 2005, CANCER LETT, V228, P171, DOI 10.1016/j.canlet.2005.01.049; Uddman R, 2002, PEPTIDES, V23, P927, DOI 10.1016/S0196-9781(02)00003-7; Wassberg E, 1999, UPSALA J MED SCI, V104, P1; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Yoon HZ, 2002, CLIN EXP OPHTHALMOL, V30, P424, DOI 10.1046/j.1442-9071.2002.00573.x; Zukowska-Grojec Z, 1998, CIRC RES, V83, P187, DOI 10.1161/01.RES.83.2.187; ZUKOWSKAGROJEC Z, 1993, PEPTIDES, V14, P263, DOI 10.1016/0196-9781(93)90040-N	42	42	44	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	41					5630	5642		10.1038/onc.2010.301	http://dx.doi.org/10.1038/onc.2010.301			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FX	20676138	Green Accepted			2022-12-25	WOS:000282946900009
J	Santonico, E; Belleudi, F; Panni, S; Torrisi, MR; Cesareni, G; Castagnoli, L				Santonico, E.; Belleudi, F.; Panni, S.; Torrisi, M. R.; Cesareni, G.; Castagnoli, L.			Multiple modification and protein interaction signals drive the Ring finger protein 11 (RNF11) E3 ligase to the endosomal compartment	ONCOGENE			English	Article						RING E3-ligase; acylation; endosome compartment; ubiquitination	LIPID RAFTS; BREAST-CANCER; WW DOMAIN; STABILITY; HRS; UBIQUITINATION; ENZYMOLOGY; EXPRESSION; PROTEOMICS; CAVEOLAE	Ring finger protein 11 (RNF11) is a small RING E3-ligase overexpressed in numerous human prostate, colon and invasive breast cancers. Although functional studies have implicated RNF11 in a variety of biological processes, including signal transduction and apoptosis, the molecular mechanisms underlying its function are still poorly understood. In this study we show that RNF11 is a membrane-associated E3 ligase co-localizing with markers of both the early and the recycling endosomes. Several modification and protein interaction signals in the RNF11 sequence are shown to affect its compartmentalization. Membrane binding requires two acylation motifs driving the myristoylation of Gly2 and the S-palmitoylation of Cys4. Accordingly, genetic removal of the myristoylating signal results in diffuse staining, whereas an RNF11 protein mutated in the palmitoylation signal is retained in compartments of the early secretory pathway. However, amino-terminal fusion to green fluorescent protein of a 10-residue peptide containing both acylation signals re-localizes the chimera to the plasma membrane, but it is not sufficient to direct it to the recycling compartment suggesting that additional signals contribute to the correct localization. In addition, we show that membrane anchoring through acylation is necessary for RNF11 to be post-translationally modified by the addition of several ubiquitin moieties and that loss of acylation severely impairs the in vivo ubiquitination mediated by the HECT E3-ligases Itch and Nedd4. Finally, in cells transfected with RNF11 we observe a correlation between high RNF11 expression, as in tumor cells, and a swelling of the endosomal compartment suggesting a possible role of the dysregulation of the endosome compartment in tumorigenesis. Oncogene (2010) 29, 5604-5618; doi:10.1038/onc.2010.294; published online 2 August 2010	[Santonico, E.; Cesareni, G.; Castagnoli, L.] Univ Roma Tor Vergata, Dept Mol Biol, I-00133 Rome, Italy; [Belleudi, F.; Torrisi, M. R.] Univ Roma La Sapienza, Dept Mol & Clin Med, Inst Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Panni, S.] Univ Calabria, Dept Cell Biol, Calabria, Italy; [Torrisi, M. R.] Azienda Osped S Andrea, Rome, Italy; [Cesareni, G.] IRCCS Fdn S Lucia, Rome, Italy	University of Rome Tor Vergata; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Calabria; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Santa Lucia	Santonico, E (corresponding author), Univ Roma Tor Vergata, Dept Mol Biol, Via Ric Sci, I-00133 Rome, Italy.	Elena.Santonico@uniroma2.it; Cesareni@uniroma2.it; Castagnoli@uniroma2.it	Santonico, Elena/ABB-8919-2020; Cesareni, Gianni/AAW-1382-2020	Santonico, Elena/0000-0002-3897-8990; Castagnoli, Luisa/0000-0001-5283-8671; panni, simona/0000-0002-7500-4028	AIRC (Italian Association for Cancer Research)	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	The work described in this study has been supported by AIRC (Italian Association for Cancer Research). We thank Dr Maurizio Mattei for RNF11 antibody production and Dr Palma Mattioli for helpful suggestions and support with microscopy.	Anderson LR, 2007, J NEUROPATH EXP NEUR, V66, P955, DOI 10.1097/nen.0b013e3181567f17; Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Azmi PB, 2009, ANTICANCER RES, V29, P2253; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Burger A, 1998, ONCOGENE, V16, P327, DOI 10.1038/sj.onc.1201517; Burger AM, 1998, ONCOGENE, V16, P2459, DOI 10.1038/sj.onc.1201772; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Doray B, 2002, J BIOL CHEM, V277, P18477, DOI 10.1074/jbc.M201879200; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Jacque E, 2009, EMBO J, V28, P455, DOI 10.1038/emboj.2009.18; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kitching R, 2003, BBA-MOL BASIS DIS, V1639, P104, DOI 10.1016/j.bbadis.2003.07.001; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Li HX, 2004, ONCOGENE, V23, P1801, DOI 10.1038/sj.onc.1207319; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Mizuno E, 2004, J BIOCHEM, V135, P385, DOI 10.1093/jb/mvh046; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Santonico Elena, 2007, BMC Biochemistry, V8, P29, DOI 10.1186/1471-2091-8-29; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Seki N, 1999, BBA-GENE STRUCT EXPR, V1489, P421, DOI 10.1016/S0167-4781(99)00190-6; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458	38	23	28	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	41					5604	5618		10.1038/onc.2010.294	http://dx.doi.org/10.1038/onc.2010.294			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FX	20676133				2022-12-25	WOS:000282946900007
J	Cheng, X; Xu, Z; Wang, JF; Zhai, YL; Lu, YJ; Liang, C				Cheng, Xue; Xu, Zhen; Wang, Jiafeng; Zhai, Yuanliang; Lu, Yongjun; Liang, Chun			ATP-dependent Pre-replicative Complex Assembly Is Facilitated by Adk1p in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; NUCLEOTIDE-BINDING SITE; DNA-REPLICATION; ADENYLATE KINASE; SACCHAROMYCES-CEREVISIAE; MCM PROTEINS; CELL-CYCLE; CDC6; INITIATION; ORC	Pre-replicative complex (pre-RC) assembly is a critical part of the mechanism that controls the initiation of DNA replication, and ATP binding and hydrolysis by multiple pre-RC proteins are essential for pre-RC assembly and activation. Here, we demonstrate that Adk1p (adenylate kinase 1 protein) plays an important role in pre-RC assembly in Saccharomyces cerevisiae. Isolated from a genetic screen, adk1(G20S) cells with a mutation within the nucleotide-binding site were defective in replication initiation. adk1 Delta cells were viable at 25 degrees C but not at 37 degrees C. Flow cytometry indicated that both the adk1-td (temperature-inducible degron) and adk1(G20S) mutants were defective in S phase entry. Furthermore, Adk1p bound to chromatin throughout the cell cycle and physically interacted with Orc3p, whereas the Adk1(G20S) protein had a reduced ability to bind chromatin and Orc3p without affecting the cellular ATP level. In addition, Adk1p associated with replication origins by ChIP assay. Finally, Adk1-td protein depletion prevented pre-RC assembly during the M-to-G(1) transition. Wesuggest that Adk1p regulates ATP metabolism on pre-RC proteins to promote pre-RC assembly and activation.	[Liang, Chun] Hong Kong Univ Sci & Technol, Div Life Sci, Sect Biochem & Cell Biol, Kowloon, Hong Kong, Peoples R China; [Wang, Jiafeng; Lu, Yongjun; Liang, Chun] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Sun Yat Sen University; Hong Kong University of Science & Technology	Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Sect Biochem & Cell Biol, Kowloon, Hong Kong, Peoples R China.	bccliang@ust.hk		Zhai, Yuanliang/0000-0002-8897-6416	Hong Kong Research Grants Council [HKUST6115/04M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by Hong Kong Research Grants Council Grant HKUST6115/04M (to C.L.).	BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; BUENO A, 1992, EMBO J, V11, P2167, DOI 10.1002/j.1460-2075.1992.tb05276.x; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; Gu YJ, 2005, J BIOL CHEM, V280, P18604, DOI 10.1074/jbc.M500847200; Han Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007155; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; Herbig U, 1999, MOL BIOL CELL, V10, P2631, DOI 10.1091/mbc.10.8.2631; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Kan JS, 2008, J BIOL CHEM, V283, P33803, DOI 10.1074/jbc.C800182200; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; KONRAD M, 1993, J BIOL CHEM, V268, P11326; KONRAD M, 1988, J BIOL CHEM, V263, P19468; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lei M, 1996, MOL CELL BIOL, V16, P5081; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; LOO S, 1995, MOL BIOL CELL, V6, P741, DOI 10.1091/mbc.6.6.741; Neuwald AF, 1999, GENOME RES, V9, P27; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Ren H, 2005, P NATL ACAD SCI USA, V102, P303, DOI 10.1073/pnas.0407459102; SCHRICKER R, 1992, MOL GEN GENET, V233, P363, DOI 10.1007/BF00265432; SCHRICKER R, 1992, GENE, V122, P111, DOI 10.1016/0378-1119(92)90038-Q; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Stryer L., 1988, BIOCHEMISTRY-US; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; VAN ROMPAY AR, 1999, EUR J BIOCHEM, V261, P509; Wang B, 1999, J BIOL CHEM, V274, P8291, DOI 10.1074/jbc.274.12.8291; Wang JF, 2010, BIOCHEM BIOPH RES CO, V395, P336, DOI 10.1016/j.bbrc.2010.04.006; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149; Yoneda T, 1998, MOL BRAIN RES, V62, P187, DOI 10.1016/S0169-328X(98)00249-6; ZHAI Y, 2010, J CELL SCI IN PRESS; Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	50	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29974	29980		10.1074/jbc.M110.161455	http://dx.doi.org/10.1074/jbc.M110.161455			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20659900	Green Published, hybrid			2022-12-25	WOS:000281984300034
J	Sapin, E; Berod, A; Leger, L; Herman, PA; Luppi, PH; Peyron, C				Sapin, Emilie; Berod, Anne; Leger, Lucienne; Herman, Paul A.; Luppi, Pierre-Herve; Peyron, Christelle			A Very Large Number of GABAergic Neurons Are Activated in the Tuberal Hypothalamus during Paradoxical (REM) Sleep Hypersomnia	PLOS ONE			English	Article							C-FOS EXPRESSION; GLUTAMIC-ACID DECARBOXYLASE; EYE-MOVEMENT SLEEP; RAT-BRAIN; WAKING DISCHARGE; DEPRIVATION; LOCALIZATION; RAPHE; GENE; MICROINJECTION	We recently discovered, using Fos immunostaining, that the tuberal and mammillary hypothalamus contain a massive population of neurons specifically activated during paradoxical sleep (PS) hypersomnia. We further showed that some of the activated neurons of the tuberal hypothalamus express the melanin concentrating hormone (MCH) neuropeptide and that icv injection of MCH induces a strong increase in PS quantity. However, the chemical nature of the majority of the neurons activated during PS had not been characterized. To determine whether these neurons are GABAergic, we combined in situ hybridization of GAD(67) mRNA with immunohistochemical detection of Fos in control, PS deprived and PS hypersomniac rats. We found that 74% of the very large population of Fos-labeled neurons located in the tuberal hypothalamus after PS hypersomnia were GAD-positive. We further demonstrated combining MCH immunohistochemistry and GAD(67) in situ hybridization that 85% of the MCH neurons were also GAD-positive. Finally, based on the number of Fos-ir/GAD(+), Fos-ir/ MCH+, and GAD(+)/MCH+ double-labeled neurons counted from three sets of double-staining, we uncovered that around 80% of the large number of the Fos-ir/GAD(+) neurons located in the tuberal hypothalamus after PS hypersomnia do not contain MCH. Based on these and previous results, we propose that the non-MCH Fos/GABAergic neuronal population could be involved in PS induction and maintenance while the Fos/MCH/GABAergic neurons could be involved in the homeostatic regulation of PS. Further investigations will be needed to corroborate this original hypothesis.	[Sapin, Emilie; Leger, Lucienne; Herman, Paul A.; Luppi, Pierre-Herve; Peyron, Christelle] Univ Lyon 1, CNRS, UMR5167, F-69365 Lyon, France; [Berod, Anne] Univ Lyon 1, CNRS, EAC5006, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sapin, E (corresponding author), Univ Lyon 1, CNRS, UMR5167, F-69365 Lyon, France.	christelle.peyron@univ-lyon1.fr	Luppi, Pierre-Hervé/C-4333-2014; Peyron, Christelle/H-6223-2017	Luppi, Pierre-Hervé/0000-0002-0503-423X; Peyron, Christelle/0000-0002-9317-3546	CNRS; Universite de Lyon; Universite Claude Bernard Lyon 1	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lyon; Universite Claude Bernard Lyon 1	This work was supported by CNRS, Universite de Lyon, Universite Claude Bernard Lyon 1 and a fellowship to E.S. from the "Association Francaise de Narcolepsie-Cataplexie et d'Hypersomnie" and UCB Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnaou A, 2008, EUR J PHARMACOL, V579, P177, DOI 10.1016/j.ejphar.2007.10.017; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; CURRAN T, 1987, ONCOGENE, V2, P79; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Gong H, 2004, J PHYSIOL-LONDON, V556, P935, DOI 10.1113/jphysiol.2003.056622; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; Goutagny R, 2005, NEUROREPORT, V16, P1069, DOI 10.1097/00001756-200507130-00008; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; JOUVET M, 1962, Arch Ital Biol, V100, P125; JOUVET M, 1965, INT J NEUROL, V5, P131; JOUVET M, 1959, CR SOC BIOL, V153, P422; JULIEN JF, 1987, NEUROSCI LETT, V73, P173, DOI 10.1016/0304-3940(87)90013-9; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; Koban M, 2008, SLEEP, V31, P927; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Koyama Y, 2003, NEUROSCIENCE, V119, P1209, DOI 10.1016/S0306-4522(03)00173-8; Lagos P, 2009, BRAIN RES, V1265, P103, DOI 10.1016/j.brainres.2009.02.010; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Leger L, 2009, J CHEM NEUROANAT, V37, P149, DOI 10.1016/j.jchemneu.2008.12.008; Leriche M, 2008, NEUROSCIENCE, V153, P259, DOI 10.1016/j.neuroscience.2008.01.069; LIN JS, 1989, BRAIN RES, V479, P225, DOI 10.1016/0006-8993(89)91623-5; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2004, SLEEP CIRCUITS FUNCT, P272; Maloney KJ, 1999, J NEUROSCI, V19, P3057; Maloney KJ, 2002, EUR J NEUROSCI, V15, P774, DOI 10.1046/j.1460-9568.2002.01907.x; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; McDermott CM, 2003, J NEUROSCI, V23, P9687; MENDELSON W, 1974, J NEUROCHEM, V22, P1157, DOI 10.1111/j.1471-4159.1974.tb04353.x; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Morales FR, 2006, NEUROSCIENCE, V142, P37, DOI 10.1016/j.neuroscience.2006.05.066; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Schmidt MH, 1999, SLEEP, V22, P409, DOI 10.1093/sleep/22.4.409; Semba K, 2001, BEHAV BRAIN RES, V120, P75, DOI 10.1016/S0166-4328(00)00362-4; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19	51	60	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11766	10.1371/journal.pone.0011766	http://dx.doi.org/10.1371/journal.pone.0011766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668680	Green Published, gold, Green Submitted			2022-12-25	WOS:000280297300006
J	Zhao, SW; Li, S				Zhao, Shiwen; Li, Shao			Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification	PLOS ONE			English	Article							PREDICTION; PERFORMANCE; CETIRIZINE; SIMILARITY; MOLECULES; DISCOVERY; THERAPY; DISEASE; GENES	Background: Identifying drug targets is a critical step in pharmacology. Drug phenotypic and chemical indexes are two important indicators in this field. However, in previous studies, the indexes were always isolated and the candidate proteins were often limited to a small subset of the human genome. Methodology/Principal Findings: Based on the correlations observed in pharmacological and genomic spaces, we develop a computational framework, drugCIPHER, to infer drug-target interactions in a genome-wide scale. Three linear regression models are proposed, which respectively relate drug therapeutic similarity, chemical similarity and their combination to the relevance of the targets on the basis of a protein-protein interaction network. Typically, the model integrating both drug therapeutic similarity and chemical similarity, drugCIPHER-MS, achieved an area under the Receiver Operating Characteristic (ROC) curve of 0.988 in the training set and 0.935 in the test set. Based on drugCIPHER-MS, a genome-wide map of drug biological fingerprints for 726 drugs is constructed, within which unexpected drug-drug relations emerged in 501 cases, implying possible novel applications or side effects. Conclusions/Significance: Our findings demonstrate that the integration of phenotypic and chemical indexes in pharmacological space and protein-protein interactions in genomic space can not only speed the genome-wide identification of drug targets but also find new applications for the existing drugs.	[Li, Shao] Tsinghua Univ, MOE Key Lab Bioinformat, Dept Automat, TNLIST, Beijing 100084, Peoples R China; Tsinghua Univ, Bioinformat Div, Dept Automat, TNLIST, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Li, S (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Dept Automat, TNLIST, Beijing 100084, Peoples R China.	shaoli@mail.tsinghua.edu.cn	Li, Shao/GPX-5473-2022	Li, Shao/0000-0002-8709-9167	National Natural Science Foundation of China [60934004, 30873464, 60721003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Nos. 60934004, 30873464 and 60721003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ANATOMICAL THERAPEUT; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cleves AE, 2006, J MED CHEM, V49, P2921, DOI 10.1021/jm051139t; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Dunkel M, 2008, NUCLEIC ACIDS RES, V36, pW55, DOI 10.1093/nar/gkn307; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Ho SM, 2004, J CELL BIOCHEM, V91, P491, DOI 10.1002/jcb.10759; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jordan VC, 2005, BREAST, V14, P624, DOI 10.1016/j.breast.2005.08.022; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khouzam H R, 2000, J Psychosoc Nurs Ment Health Serv, V38, P20; Koutras A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-109; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Lin D., 1998, ICML, V98, P296; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Nigsch F, 2008, J CHEM INF MODEL, V48, P2313, DOI 10.1021/ci800079x; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Portnoy JM, 2004, EXPERT OPIN PHARMACO, V5, P125, DOI 10.1517/14656566.5.1.125; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rognan D, 2007, BRIT J PHARMACOL, V152, P38, DOI 10.1038/sj.bjp.0707307; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Schuffenhauer A, 2003, J CHEM INF COMP SCI, V43, P391, DOI 10.1021/ci025569t; Spiro Zoltan, 2008, J Biol, V7, P20, DOI 10.1186/jbiol81; Theunissen EL, 2006, BRIT J CLIN PHARMACO, V61, P79, DOI 10.1111/j.1365-2125.2005.02524.x; Tom N, 2010, INT J BIOCHEM CELL B, V42, P202, DOI 10.1016/j.biocel.2009.10.008; WILLETT P, 1986, J CHEM INF COMP SCI, V26, P36, DOI 10.1021/ci00049a008; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	40	181	206	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11764	10.1371/journal.pone.0011764	http://dx.doi.org/10.1371/journal.pone.0011764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668676	Green Published, gold, Green Submitted			2022-12-25	WOS:000280297300005
J	Blondel, CJ; Yang, HJ; Castro, B; Chiang, S; Toro, CS; Zaldivar, M; Contreras, I; Andrews-Polymenis, HL; Santiviago, CA				Blondel, Carlos J.; Yang, Hee-Jeong; Castro, Benjamin; Chiang, Sebastian; Toro, Cecilia S.; Zaldivar, Mercedes; Contreras, Ines; Andrews-Polymenis, Helene L.; Santiviago, Carlos A.			Contribution of the Type VI Secretion System Encoded in SPI-19 to Chicken Colonization by Salmonella enterica Serotypes Gallinarum and Enteritidis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; AGROBACTERIUM-TUMEFACIENS; ANALYSIS UNCOVERS; FAMILY PROTEIN; TYPHIMURIUM; VIRULENCE; REQUIRES; CLONING; IDENTIFICATION	Salmonella Gallinarum is a pathogen with a host range specific to poultry, while Salmonella Enteritidis is a broad host range pathogen that colonizes poultry sub-clinically but is a leading cause of gastrointestinal salmonellosis in humans and many other species. Despite recent advances in our understanding of the complex interplay between Salmonella and their hosts, the molecular basis of host range restriction and unique pathobiology of Gallinarum remain largely unknown. Type VI Secretion System (T6SS) represents a new paradigm of protein secretion that is critical for the pathogenesis of many Gram-negative bacteria. We recently identified a putative T6SS in the Salmonella Pathogenicity Island 19 (SPI-19) of Gallinarum. In Enteritidis, SPI-19 is a degenerate element that has lost most of the T6SS functions encoded in the island. In this work, we studied the contribution of SPI-19 to the colonization of Salmonella Gallinarum strain 287/91 in chickens. Non-polar deletion mutants of SPI-19 and the clpV gene, an essential T6SS component, colonized the ileum, ceca, liver and spleen of White Leghorn chicks poorly compared to the wild-type strain after oral inoculation. Return of SPI-19 to the Delta SPI-19 mutant, using VEX-Capture, complemented this colonization defect. In contrast, transfer of SPI-19 from Gallinarum to Enteritidis resulted in transient increase in the colonization of the ileum, liver and spleen at day 1 post-infection, but at days 3 and 5 post-infection a strong colonization defect of the gut and internal organs of the experimentally infected chickens was observed. Our data indicate that SPI-19 and the T6SS encoded in this region contribute to the colonization of the gastrointestinal tract and internal organs of chickens by Salmonella Gallinarum and suggest that degradation of SPI-19 T6SS in Salmonella Enteritidis conferred an advantage in colonization of the avian host.	[Blondel, Carlos J.; Zaldivar, Mercedes; Contreras, Ines; Santiviago, Carlos A.] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Yang, Hee-Jeong; Andrews-Polymenis, Helene L.] Texas A&M Univ Syst Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX USA; [Castro, Benjamin; Chiang, Sebastian; Toro, Cecilia S.] Univ Chile, Programa Microbiol & Micol, Inst Ciencias Biomed, Fac Med, Santiago, Chile	Universidad de Chile; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Universidad de Chile	Blondel, CJ (corresponding author), Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile.	csantiviago@ciq.uchile.cl; handrews@medicine.tamhsc.edu	Santiviago, Carlos/N-9991-2018; Blondel, Carlos/X-7380-2019; Blondel, Carlos J/B-1287-2010	Santiviago, Carlos/0000-0002-7043-7908; Blondel, Carlos/0000-0002-7099-6347; Blondel, Carlos J/0000-0002-7099-6347; Yang, Hee-Jeong/0000-0002-7351-8404	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [ADI-08/2006, 21080373, AT-24091015]; World Bank; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100092]; "Vicerrectoria de Asuntos Academicos" (Departamento de Postgrado y Postitulo, Universidad de Chile); National Institutes of Health (NIH) [R21AI083964, R01AI083646, R56AI077645]; United States Department of Agriculture (USDA) [2009-03579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083964, R01AI083646, R56AI077645] Funding Source: NIH RePORTER	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); World Bank(The World Bank India); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); "Vicerrectoria de Asuntos Academicos" (Departamento de Postgrado y Postitulo, Universidad de Chile); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grant ADI-08/2006 from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) and The World Bank, and grant 1100092 from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT). CJB was supported by fellowships from CONICYT (21080373 and AT-24091015), and from "Vicerrectoria de Asuntos Academicos" (Departamento de Postgrado y Postitulo, Universidad de Chile). HLAP is supported by grants R21AI083964, R01AI083646 and R56AI077645 from the National Institutes of Health (NIH), and grant 2009-03579 from the United States Department of Agriculture (USDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow PA, 2000, AVIAN PATHOL, V29, P423, DOI 10.1080/030794500750047171; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eswarappa SM, 2009, INFECT GENET EVOL, V9, P468, DOI 10.1016/j.meegid.2009.01.004; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Guard-Petter J, 2001, ENVIRON MICROBIOL, V3, P421, DOI 10.1046/j.1462-2920.2001.00213.x; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Iqbal M, 2005, INFECT IMMUN, V73, P2344, DOI 10.1128/IAI.73.4.2344-2350.2005; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Jones MA, 2001, INFECT IMMUN, V69, P5471, DOI 10.1128/IAI.69.9.5471-5476.2001; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lowry VK, 1999, INT J FOOD MICROBIOL, V48, P139, DOI 10.1016/S0168-1605(99)00036-7; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McMeechan A, 2007, RES MICROBIOL, V158, P79, DOI 10.1016/j.resmic.2006.10.008; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; Sivula CP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-182; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Wilson JW, 2007, APPL ENVIRON MICROB, V73, P5911, DOI 10.1128/AEM.00952-07; Wilson JW, 2006, J BIOTECHNOL, V122, P147, DOI 10.1016/j.jbiotec.2005.09.005; Wilson JW, 2004, J MICROBIOL METH, V57, P297, DOI 10.1016/j.mimet.2004.01.007; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	34	55	60	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11724	10.1371/journal.pone.0011724	http://dx.doi.org/10.1371/journal.pone.0011724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661437	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300024
J	Jin, SX; Feig, LA				Jin, Shan-xue; Feig, Larry A.			Long-Term Potentiation in the CA1 Hippocampus Induced by NR2A Subunit-Containing NMDA Glutamate Receptors Is Mediated by Ras-GRF2/Erk Map Kinase Signaling	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; DIFFERENTIAL ROLES; GENE-EXPRESSION; INDUCTION; SUBTYPES; MEMORY; RAS; CONSOLIDATION; DEPRESSION; SYSTEM	Background: NMDA-type glutamate receptors (NMDARs) are major contributors to long-term potentiation (LTP), a form of synaptic plasticity implicated in the process of learning and memory. These receptors consist of calcium-permeating NR1 and multiple regulatory NR2 subunits. A majority of studies show that both NR2A and NR2B-containing NMDARs can contribute to LTP, but their unique contributions to this form of synaptic plasticity remain poorly understood. Methodology/Principal Findings: In this study, we show that NR2A and NR2B-containing receptors promote LTP differently in the CA1 hippocampus of 1-month old mice, with the NR2A receptors functioning through Ras-GRF2 and its downstream effector, Erk Map kinase, and NR2B receptors functioning independently of these signaling molecules. Conclusions/Significance: This study demonstrates that NR2A-, but not NR2B, containing NMDA receptors induce LTP in pyramidal neurons of the CA1 hippocamus from 1 month old mice through Ras-GRF2 and Erk. This difference add new significance to the observation that the relative levels of these NMDAR subtypes is regulated in neurons, such that NR2A-containing receptors become more prominent late in postnatal development, after sensory experience and synaptic activity.	[Jin, Shan-xue; Feig, Larry A.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts University	Jin, SX (corresponding author), Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA.	larry.feig@tufts.edu			NIH [02R01MH083324-2, P30-NS047243]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH 02R01MH083324-2, P30-NS047243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Dumas TC, 2005, HIPPOCAMPUS, V15, P562, DOI 10.1002/hipo.20077; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Flint AC, 1997, J NEUROSCI, V17, P2469; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kohr G, 2003, J NEUROSCI, V23, P10791; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Lisman J., 2006, SCI STKE, V2006, pr; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	23	60	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11732	10.1371/journal.pone.0011732	http://dx.doi.org/10.1371/journal.pone.0011732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661302	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300030
J	Kaler, P; Galea, V; Augenlicht, L; Klampfer, L				Kaler, Pawan; Galea, Vincent; Augenlicht, Leonard; Klampfer, Lidija			Tumor Associated Macrophages Protect Colon Cancer Cells from TRAIL-Induced Apoptosis through IL-1 beta-Dependent Stabilization of Snail in Tumor Cells (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TRANSCRIPTION FACTOR SNAIL; BETA-CATENIN; COLORECTAL-CANCER; GENE-EXPRESSION; E-CADHERIN; CONFERS RESISTANCE; ANTITUMOR-ACTIVITY; DOWN-REGULATION	Background: We recently reported that colon tumor cells stimulate macrophages to release IL-1 beta, which in turn inactivates GSK3 beta and enhances Wnt signaling in colon cancer cells, generating a self-amplifying loop that promotes the growth of tumor cells. Principal Findings: Here we describe that macrophages protect HCT116 and Hke-3 colon cancer cells from TRAIL-induced apoptosis. Inactivation of IL-1 beta by neutralizing IL-1 beta antibody, or silencing of IL-1 beta in macrophages inhibited their ability to counter TRAIL-induced apoptosis. Accordingly, IL-1 beta was sufficient to inhibit TRAIL-induced apoptosis. TRAIL-induced collapse of the mitochondrial membrane potential (Delta psi) and activation of caspases were prevented by macrophages or by recombinant IL-1 beta. Pharmacological inhibition of IL-1 beta release from macrophages by vitamin D-3, a potent chemopreventive agent for colorectal cancer, restored the ability of TRAIL to induce apoptosis of tumor cells cultured with macrophages. Macrophages and IL-1 beta failed to inhibit TRAIL-induced apoptosis in HCT116 cells expressing dnI kappa B, dnAKT or dnTCF4, confirming that they oppose TRAIL-induced cell death through induction of Wnt signaling in tumor cells. We showed that macrophages and IL-1 beta stabilized Snail in tumor cells in an NF-kappa B/Wnt dependent manner and that Snail deficient tumor cells were not protected from TRAIL-induced apoptosis by macrophages or by IL-1 beta, demonstrating a crucial role of Snail in the resistance of tumor cells to TRAIL. Significance: We have identified a positive feedback loop between tumor cells and macrophages that propagates the growth and promotes the survival of colon cancer cells: tumor cells stimulate macrophages to secrete IL-1 beta, which in turn, promotes Wnt signaling and stabilizes Snail in tumor cells, conferring resistance to TRAIL. Vitamin D-3 halts this amplifying loop by interfering with the release of IL-1 beta from macrophages. Accordingly, vitamin D-3 sensitizes tumor cells to TRAIL-induced apoptosis, suggesting that the therapeutic efficacy of TRAIL could be augmented by this readily available chemopreventive agent.	[Kaler, Pawan; Galea, Vincent; Augenlicht, Leonard; Klampfer, Lidija] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, New York, NY USA	Montefiore Medical Center; Yeshiva University	Kaler, P (corresponding author), Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, New York, NY USA.	lklampf@aecom.yu.edu	Galea, Vincent/AAA-8274-2020	Galea, Vincent/0000-0002-6255-9446	National Cancer Institute [CA 111361, U54 CA 100926, P30-13330]; NATIONAL CANCER INSTITUTE [R01CA111361, U54CA100926] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA 111361 (to LK), U54 CA 100926 (to LA) and P30-13330 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\	Abdollahi T, 2005, APOPTOSIS, V10, P1383, DOI 10.1007/s10495-005-2139-x; Abdollahi T, 2003, CANCER RES, V63, P4521; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Doubravska L, 2008, APOPTOSIS, V13, P573, DOI 10.1007/s10495-008-0191-z; El-Deiry WS, 2001, CELL DEATH DIFFER, V8, P1066, DOI 10.1038/sj.cdd.4400943; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Harrison ML, 2007, J CLIN ONCOL, V25, P4542, DOI 10.1200/JCO.2007.11.2136; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; John MAS, 2009, CLIN CANCER RES, V15, P6018, DOI 10.1158/1078-0432.CCR-09-0011; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kaler P, 2009, CANCER MICROENVIRON, V2, P69, DOI 10.1007/s12307-009-0030-y; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kothny-Wilkes G, 1998, J BIOL CHEM, V273, P29247, DOI 10.1074/jbc.273.44.29247; Kumagai T, 2003, J NATL CANCER I, V95, P896, DOI 10.1093/jnci/95.12.896; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Madhusudan S, 2005, J CLIN ONCOL, V23, P5950, DOI 10.1200/JCO.2005.04.127; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Oshima M, 2002, CURR PHARM DESIGN, V8, P1021, DOI 10.2174/1381612023394953; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545; Poppelmann B, 2005, J BIOL CHEM, V280, P15635, DOI 10.1074/jbc.M413006200; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Roy HK, 2004, MOL CANCER THER, V3, P1159; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Zamai L, 1996, CYTOMETRY, V23, P303, DOI 10.1002/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.3.CO;2-B; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	59	64	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11700	10.1371/journal.pone.0011700	http://dx.doi.org/10.1371/journal.pone.0011700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661477	Green Submitted, gold, Green Published			2022-12-25	WOS:000280243300007
J	Larson, EM; Idnurm, A				Larson, Erica M.; Idnurm, Alexander			Two Origins for the Gene Encoding alpha-Isopropylmalate Synthase in Fungi	PLOS ONE			English	Article							PHYCOMYCES-BLAKESLEEANUS; MYCOBACTERIUM-TUBERCULOSIS; SACCHAROMYCES-CEREVISIAE; MUCOR-CIRCINELLOIDES; LEUCINE BIOSYNTHESIS; CRYSTAL-STRUCTURE; EVOLUTION; EXPRESSION; METABOLISM; SEQUENCE	Background: The biosynthesis of leucine is a biochemical pathway common to prokaryotes, plants and fungi, but absent from humans and animals. The pathway is a proposed target for antimicrobial therapy. Methodology/Principal Findings: Here we identified the leuA gene encoding alpha-isopropylmalate synthase in the zygomycete fungus Phycomyces blakesleeanus using a genetic mapping approach with crosses between wild type and leucine auxotrophic strains. To confirm the function of the gene, Phycomyces leuA was used to complement the auxotrophic phenotype exhibited by mutation of the leu3(+) gene of the ascomycete fungus Schizosaccharomyces pombe. Phylogenetic analysis revealed that the leuA gene in Phycomyces, other zygomycetes, and the chytrids is more closely related to homologs in plants and photosynthetic bacteria than ascomycetes or basidiomycetes, and suggests that the Dikarya have acquired the gene more recently. Conclusions/Significance: The identification of leuA in Phycomyces adds to the growing body of evidence that some primary metabolic pathways or parts of them have arisen multiple times during the evolution of fungi, probably through horizontal gene transfer events.	[Larson, Erica M.; Idnurm, Alexander] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Larson, EM (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.	idnurma@umkc.edu	Idnurm, Alexander/AAC-9614-2019; Idnurm, Alexander/K-8558-2013; Idnurm, Alexander/GPX-9055-2022	Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040	University of Missouri-Kansas City (UMKC); US National Science Foundation [MCB-0920581]	University of Missouri-Kansas City (UMKC); US National Science Foundation(National Science Foundation (NSF))	This research was supported by a University of Missouri-Kansas City (UMKC) Faculty Research Grant and US National Science Foundation grant MCB-0920581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALVAREZ MI, 1980, MOL GEN GENET, V179, P447, DOI 10.1007/BF00425475; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; BACON GA, 1950, BRIT J EXP PATHOL, V31, P714; CAMPUZANO V, 1993, CURR GENET, V24, P515, DOI 10.1007/BF00351715; Cavalieri D, 1999, MOL GEN GENET, V261, P152, DOI 10.1007/s004380050952; Cerda-Olmedo E, 2001, FEMS MICROBIOL REV, V25, P503; Chayakulkeeree M, 2006, EUR J CLIN MICROBIOL, V25, P215, DOI 10.1007/s10096-006-0107-1; de Koning AP, 2004, EUKARYOT CELL, V3, P1198, DOI 10.1128/EC.3.5.1198-1205.2004; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; DIAZMINGUEZ JM, 1990, MOL GEN GENET, V224, P269, DOI 10.1007/BF00271561; ESLAVA AP, 1975, P NATL ACAD SCI USA, V72, P4076, DOI 10.1073/pnas.72.10.4076; ESLAVA AP, 1975, GENETICS, V80, P445; Field B, 2006, PLANT MOL BIOL, V60, P717, DOI 10.1007/s11103-005-5547-y; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Goldstein AL, 2001, GENETICS, V159, P499; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Huisman FHA, 2010, BIOCHEM BIOPH RES CO, V393, P168, DOI 10.1016/j.bbrc.2010.01.114; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; ITURRIAGA EA, 1992, CURR GENET, V21, P215, DOI 10.1007/BF00336844; ITURRIAGA EA, 1990, NUCLEIC ACIDS RES, V18, P4612, DOI 10.1093/nar/18.15.4612; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Khaldi N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003036; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liautard JP, 2006, TRENDS MICROBIOL, V14, P109, DOI 10.1016/j.tim.2006.01.005; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; MCADAM RA, 1995, INFECT IMMUN, V63, P1004, DOI 10.1128/IAI.63.3.1004-1012.1995; Mehta BJ, 2001, GENETICS, V158, P635; Miyazaki K, 2005, BIOCHEM BIOPH RES CO, V331, P341, DOI 10.1016/j.bbrc.2005.03.169; Oba T, 2005, BIOSCI BIOTECH BIOCH, V69, P1270, DOI 10.1271/bbb.69.1270; Obraztsova IN, 2004, FUNGAL GENET BIOL, V41, P168, DOI 10.1016/j.fgb.2003.09.007; OREJAS M, 1987, MOL GEN GENET, V210, P69, DOI 10.1007/BF00337760; PETERS MH, 1990, ARCH BIOCHEM BIOPHYS, V276, P294, DOI 10.1016/0003-9861(90)90041-V; REICHENBECHER VE, 1978, J BACTERIOL, V133, P794, DOI 10.1128/JB.133.2.794-801.1978; Ribichich KF, 2005, EUKARYOT CELL, V4, P455, DOI 10.1128/EC.4.2.455-464.2005; Richards TA, 2006, EUKARYOT CELL, V5, P1517, DOI 10.1128/EC.00106-06; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; RONCERO MIG, 1989, GENE, V84, P335, DOI 10.1016/0378-1119(89)90508-8; Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106; Schmitt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004437; Spellberg B, 2009, CLIN INFECT DIS, V48, P1743, DOI 10.1086/599105; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; YAMASAKI Y, 1966, P JPN ACAD, V42, P946, DOI 10.2183/pjab1945.42.946; Yasutake Y, 2004, J MOL BIOL, V344, P325, DOI 10.1016/j.jmb.2004.09.035	56	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11605	10.1371/journal.pone.0011605	http://dx.doi.org/10.1371/journal.pone.0011605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657649	Green Published, gold, Green Submitted			2022-12-25	WOS:000279924500009
J	Zhou, YY; Shaw, N; Li, Y; Zhao, Y; Zhang, RG; Liu, ZJ				Zhou, Yangyan; Shaw, Neil; Li, Yang; Zhao, Yu; Zhang, Rongguang; Liu, Zhi-Jie			Structure-function analysis of human l-prostaglandin D synthase bound with fatty acid molecules	FASEB JOURNAL			English	Article						allergy; arachidonic acid; lipocalin	CEREBROSPINAL-FLUID; ARACHIDONIC-ACID; BETA-TRACE; BINDING; DISEASES; PROTEIN; CLONING; INFLAMMATION; REFINEMENT; EXPRESSION	Human prostaglandin D synthase (L-PGDS) is a lipocalin-type enzyme involved in the metabolism of arachidonic acid and plays a key role in the regulation of sleep, allergy, pain sensation, and the development of male reproductive organs. Here, using a combination of crystallographic, biochemical, mutagenesis, and kinetic studies, we have gained insights into the mode of ligand binding by human L-PGDS and have identified residues involved in catalysis. Interestingly, structural evidence reveals that 2 molecules of fatty acids, one molecule each of oleic and palmitoleic acid, bind inside the beta barrel. The oleic acid is buried and binds in a highly basic patch in proximity to the catalytically critical Cys65, mimicking the binding of prostaglandin H-2. The palmitoleic acid sits in a relatively neutral region with very few interactions with the protein. Mutating Met64, Leu79, Phe83, or Leu131 to alanine reduced the catalytic efficiency by almost 10-fold, while K59A and Y149A mutations enhanced the catalytic efficiency by >2-fold. Met64 seems to function as a kinetic clamp, pushing the thiol group of Cys65 close to the site of nucleophilic attack during catalysis.-Zhou, Y., Shaw, N., Li, Y., Zhao, Y., Zhang, R., Liu, Z.-J. Structure-function analysis of human l-prostaglandin D synthase bound with fatty acid molecules. FASEB J. 24, 4668-4677 (2010). www.fasebj.org	[Zhou, Yangyan; Shaw, Neil; Li, Yang; Zhao, Yu; Zhang, Rongguang; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhou, Yangyan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, ZJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	zjliu@ibp.ac.cn	Liu, Zhi-Jie/A-3946-2012; Li, Yang/M-1246-2013; Li, Yang/G-3685-2011	Liu, Zhi-Jie/0000-0001-7279-2893; Shaw, Neil/0000-0003-2722-9967	Ministry of Science and Technology of China [2006AA02A316, 2009DFB30310, 2006CB910901]; National Natural Science Foundation of China [30670427, 30721003]; Ministry of Health of China [2008ZX10404]; CAS [KSCX2-YW-R-127, INFO-115-D01-2009, 2010Y1SA1]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of China; CAS(Chinese Academy of Sciences)	This work was funded by the Ministry of Science and Technology of China (grants 2006AA02A316, 2009DFB30310, and 2006CB910901), the National Natural Science Foundation of China (grants 30670427 and 30721003), the Ministry of Health of China (grant 2008ZX10404), a CAS research grant (KSCX2-YW-R-127 and INFO-115-D01-2009), and a CAS fellowship for young international scientists (grant 2010Y1SA1) awarded to N.S. Crystallographic data were collected at beamline BL17U1 of the SSRF (Shanghai, China).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Breustedt DA, 2009, ACTA CRYSTALLOGR D, V65, P1118, DOI 10.1107/S0907444909031011; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimori K, 2006, GENE, V375, P14, DOI 10.1016/j.gene.2006.01.037; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Irikura D, 2003, J BIOCHEM, V133, P29, DOI 10.1093/jb/mvg006; Kaiser E, 1999, CRIT REV CL LAB SCI, V36, P65, DOI 10.1080/10408369991239187; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kumasaka T, 2009, J BIOL CHEM, V284, P22344, DOI 10.1074/jbc.M109.018341; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; PHINNEY SD, 1990, AM J CLIN NUTR, V51, P385, DOI 10.1093/ajcn/51.3.385; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Salomon RG, 2000, TRENDS CARDIOVAS MED, V10, P53, DOI 10.1016/S1050-1738(00)00040-2; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang ZJ, 2006, CHEM-BIOL INTERACT, V163, P207, DOI 10.1016/j.cbi.2006.08.005	33	37	41	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4668	4677		10.1096/fj.10-164863	http://dx.doi.org/10.1096/fj.10-164863			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20667974				2022-12-25	WOS:000284824400008
J	Thibodeau, PH; Richardson, JM; Wang, W; Millen, L; Watson, J; Mendoza, JL; Du, K; Fischman, S; Senderowitz, H; Lukacs, GL; Kirk, K; Thomas, PJ				Thibodeau, Patrick H.; Richardson, John M., III; Wang, Wei; Millen, Linda; Watson, Jarod; Mendoza, Juan L.; Du, Kai; Fischman, Sharon; Senderowitz, Hanoch; Lukacs, Gergely L.; Kirk, Kevin; Thomas, Philip J.			The Cystic Fibrosis-causing Mutation Delta F508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; MULTIDRUG ABC TRANSPORTER; IN-VIVO; CONFORMATIONAL MATURATION; ENDOPLASMIC-RETICULUM; CFTR; PROTEIN; RESCUE; MUTANT; ATP	The deletion of phenylalanine 508 in the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator is directly associated with > 90% of cystic fibrosis cases. This mutant protein fails to traffic out of the endoplasmic reticulum and is subsequently degraded by the proteasome. The effects of this mutation may be partially reversed by the application of exogenous osmolytes, expression at low temperature, and the introduction of second site suppressor mutations. However, the specific steps of folding and assembly of full-length cystic fibrosis transmembrane conductance regulator (CFTR) directly altered by the disease-causing mutation are unclear. To elucidate the effects of the Delta F508 mutation, on various steps in CFTR folding, a series of misfolding and suppressor mutations in the nucleotide binding and transmembrane domains were evaluated for effects on the folding and maturation of the protein. The results indicate that the isolated NBD1 responds to both the Delta F508 mutation and intradomain suppressors of this mutation. In addition, identification of a novel second site suppressor of the defect within the second transmembrane domain suggests that Delta F508 also effects interdomain interactions critical for later steps in the biosynthesis of CFTR.	[Thibodeau, Patrick H.; Richardson, John M., III; Millen, Linda; Watson, Jarod; Mendoza, Juan L.; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Mendoza, Juan L.] Univ Texas SW Med Ctr Dallas, Mol Biophys Grad Program, Dallas, TX 75390 USA; [Wang, Wei; Kirk, Kevin] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Du, Kai; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Fischman, Sharon; Senderowitz, Hanoch] Epix Pharmaceut, Lexington, MA 02421 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham; McGill University	Thomas, PJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Philip.Thomas@UTSouthwestern.edu	Thomas, Philip J/F-7115-2012	Thibodeau, Patrick/0000-0002-6790-144X; Mendoza, Juan/0000-0001-6972-7476; Lukacs, Gergely/0000-0003-0900-0675	National Institutes of Health NIDDK [49835, 75302]; Cystic Fibrosis Foundation; Canadian Cystic Fibrosis Foundation; Canadian Foundation of Innovation; Canada Research Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Cystic Fibrosis Foundation; Canadian Foundation of Innovation(Canada Foundation for Innovation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grants 49835 (to P.J.T.) and 75302 (to G.L.L.). This work was also supported by the Cystic Fibrosis Foundation (to P.J.T.) and the Canadian Cystic Fibrosis Foundation (to G.L.L.). The authors declare they have competing financial interests. The beta-galactosidase assay has been licensed to Reata Pharmaceuticals by The University of Texas Southwestern Medical Center at Dallas. P.J.T. is a founding scientist of Reata Pharmaceuticals.; Supported by the Canadian Foundation of Innovation and recipient of a Canada Research Chair.	Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Chiaw PK, 2009, CHEM BIOL, V16, P520, DOI 10.1016/j.chembiol.2009.04.005; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DORK T, 1991, HUM GENET, V87, P441; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Krasnov KV, 2008, HUM MUTAT, V29, P1364, DOI 10.1002/humu.20866; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Pollet JF, 2000, BBA-MOL BASIS DIS, V1500, P59, DOI 10.1016/S0925-4439(99)00088-5; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Stidham Rhesa D, 2003, Methods Mol Biol, V205, P155; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Wilken S, 1996, MOL MICROBIOL, V22, P655, DOI 10.1046/j.1365-2958.1996.d01-1724.x; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200; Zhang Yimao, 2002, Methods Mol Med, V70, P257	44	134	135	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35825	35835		10.1074/jbc.M110.131623	http://dx.doi.org/10.1074/jbc.M110.131623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20667826	Green Published, hybrid			2022-12-25	WOS:000283845300060
J	Honda, A; Hirose, M; Hatori, M; Matoba, S; Miyoshi, H; Inoue, K; Ogura, A				Honda, Arata; Hirose, Michiko; Hatori, Masanori; Matoba, Shogo; Miyoshi, Hiroyuki; Inoue, Kimiko; Ogura, Atsuo			Generation of Induced Pluripotent Stem Cells in Rabbits POTENTIAL EXPERIMENTAL MODELS FOR HUMAN REGENERATIVE MEDICINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSFER; GENE-EXPRESSION; LINES; DERIVATION; DIFFERENTIATION; FERTILIZATION; SPERM	Human induced pluripotent stem (iPS) cells have the potential to establish a new field of promising regenerative medicine. Therefore, the safety and the efficiency of iPS-derived cells must be tested rigorously using appropriate animal models before human trials can commence. Here, we report the establishment of rabbit iPS cells as the first human-type iPS cells generated from a small laboratory animal species. Using lentiviral vectors, four human reprogramming genes (c-MYC, KLF4, SOX2, and OCT3/4) were introduced successfully into adult rabbit liver and stomach cells. The resulting rabbit iPS cells closely resembled human iPS cells; they formed flattened colonies with sharp edges and proliferated indefinitely in the presence of basic FGF. They expressed the endogenous pluripotency markers c-MYC, KLF4, SOX2, OCT3/4, and NANOG, whereas the introduced human genes were completely silenced. Using in vitro differentiating conditions, rabbit iPS cells readily differentiated into ectoderm, mesoderm, and endoderm. They also formed teratomas containing a variety of tissues of all three germ layers in immunodeficient mice. Thus, the rabbit iPS cells fulfilled all of the requirements for the acquisition of the fully reprogrammed state, showing high similarity to their embryonic stem cell counterparts we generated recently. However, their global gene expression analysis revealed a slight but rigid difference between these two types of rabbit pluripotent stem cells. The rabbit model should enable us to compare iPS cells and embryonic stem cells under the same standardized conditions in evaluating their ultimate feasibility for pluripotent cell-based regenerative medicine in humans.	[Honda, Arata; Hirose, Michiko; Hatori, Masanori; Matoba, Shogo; Miyoshi, Hiroyuki; Inoue, Kimiko; Ogura, Atsuo] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Honda, Arata; Hatori, Masanori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Inoue, Kimiko; Ogura, Atsuo] 4 Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Ogura, Atsuo] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med 5, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Honda, A (corresponding author), RIKEN BioResource Ctr, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	a-honda@rtc.riken.jp; ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014; Miyoshi, Hiroyuki/G-9808-2013; MATOBA, Shogo/D-9995-2016	Ogura, Atsuo/0000-0003-0447-1988; MATOBA, Shogo/0000-0003-0474-232X	PRESTO of the Japan Science and Technology Agency	PRESTO of the Japan Science and Technology Agency	This work was supported by PRESTO of the Japan Science and Technology Agency and a grant-in-aid for scientific research (B).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8; BIGGERS JD, 1991, J REPROD FERTIL, V93, P173; Bosze Z, 2003, TRANSGENIC RES, V12, P541, DOI 10.1023/A:1025816809372; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; CHANG MC, 1959, NATURE, V184, P466, DOI 10.1038/184466a0; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Familari M, 2006, MOL REPROD DEV, V73, P123, DOI 10.1002/mrd.20376; Fan JL, 2003, PHARMACOL THERAPEUT, V99, P261, DOI 10.1016/S0163-7258(03)00069-X; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; GRAVES KH, 1993, MOL REPROD DEV, V36, P424, DOI 10.1002/mrd.1080360404; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706, DOI 10.1016/S1472-6483(10)60320-3; Honda A, 2009, EXP CELL RES, V315, P2033, DOI 10.1016/j.yexcr.2009.01.024; Inoue Kimiko, 2002, Cloning and Stem Cells, V4, P311, DOI 10.1089/153623002321024989; Intawicha P, 2009, CLONING STEM CELLS, V11, P27, DOI 10.1089/clo.2008.0040; KASAI M, 1992, BIOL REPROD, V46, P1042, DOI 10.1095/biolreprod46.6.1042; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Koestenbauer S, 2006, AM J REPROD IMMUNOL, V55, P169, DOI 10.1111/j.1600-0897.2005.00354.x; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Liu JL, 2004, BIOL REPROD, V70, P1776, DOI 10.1095/biolreprod.103.025957; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Martins-Taylor K, 2010, J CELL BIOCHEM, V109, P16, DOI 10.1002/jcb.22402; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ogonuki N, 2005, MOL REPROD DEV, V72, P411, DOI 10.1002/mrd.20363; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Shiomi Masashi, 2004, J Atheroscler Thromb, V11, P184; Sparman M, 2009, STEM CELLS, V27, P1255, DOI 10.1002/stem.60; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Weekers F, 2002, ENDOCRINOLOGY, V143, P764, DOI 10.1210/en.143.3.764; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935; Wu YH, 2010, STEM CELL RES, V4, P180, DOI 10.1016/j.scr.2010.02.003; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	51	120	136	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31362	31369		10.1074/jbc.M110.150540	http://dx.doi.org/10.1074/jbc.M110.150540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670936	hybrid, Green Published			2022-12-25	WOS:000282764600030
J	Kozoriz, MG; Church, J; Ozog, MA; Naus, CC; Krebs, C				Kozoriz, Michael G.; Church, John; Ozog, Mark A.; Naus, Christian C.; Krebs, Claudia			Temporary Sequestration of Potassium by Mitochondria in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING CONNEXIN43; BASAL FOREBRAIN NEURONS; CENTRAL-NERVOUS-SYSTEM; K-ATP CHANNELS; CARDIOMYOCYTE MITOCHONDRIA; PERMEABILITY TRANSITION; CULTURED ASTROCYTES; ENDOTHELIAL-CELLS; MOUSE ASTROCYTES; PLASMA-MEMBRANE	Increases in extracellular potassium concentration ([K+](o)), which can occur during neuronal activity and under pathological conditions such as ischemia, lead to a variety of potentially detrimental effects on neuronal function. Although astrocytes are known to contribute to the clearance of excess K+ (o), the mechanisms are not fully understood. We examined the potential role of mitochondria in sequestering K+ in astrocytes. Astrocytes were loaded with the fluorescent K+ indicator PBFI and release of K+ from mitochondria into the cytoplasm was examined after uncoupling the mitochondrial membrane potential with carbonyl cyanide m-chlorophenylhydrazone (CCCP). Under the experimental conditions employed, transient applications of elevated [K+](o) led to increases in K+ within mitochondria, as assessed by increases in the magnitudes of cytoplasmic [K+] ([K+](i)) transients evoked by brief exposures to CCCP. When mitochondrial K+ sequestration was impaired by prolonged application of CCCP, there was a robust increase in [K+](i) upon exposure to elevated [K+](o). Blockade of plasmalemmal K+ uptake routes by ouabain, Ba2+, or a mixture of voltage-activated K+ channel inhibitors reduced K+ uptake into mitochondria. Also, reductions in mitochondrial K+ uptake occurred in the presence of mito-K-ATP channel inhibitors. Rises in [K+](i) evoked by brief applications of CCCP following exposure to high [K+](o) were also reduced by gap junction blockers and in astrocytes isolated from connexin43-null mice, suggesting that connexins also play a role in K+ uptake into astrocyte mitochondria. We conclude that mitochondria play a key role in K+ (o) handling by astrocytes.	[Kozoriz, Michael G.; Church, John; Ozog, Mark A.; Naus, Christian C.; Krebs, Claudia] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Naus, CC (corresponding author), 2350 Hlth Sci Mall,Rm 1352, Vancouver, BC V6T 1Z3, Canada.	cnaus@interchange.ubc.ca		Kozoriz, Michael/0000-0003-1434-8588	Heart and Stroke Foundation of British Columbia and Yukon; Canadian Institutes of Health Research [MOP-77616]; Canadian Institutes of Health Research-Vancouver Coastal Health Research Institute; Michael Smith Foundation for Health Research	Heart and Stroke Foundation of British Columbia and Yukon; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research-Vancouver Coastal Health Research Institute(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by a Grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon (to C. C. N. and C. K.) and Operating Grant MOP-77616 from the Canadian Institutes of Health Research (to J. C.).; Supported by a Canadian Institutes of Health Research-Vancouver Coastal Health Research Institute UBC MD/PhD Studentship Award and by the Michael Smith Foundation for Health Research.	Azarias G, 2008, GLIA, V56, P342, DOI 10.1002/glia.20619; Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boengler K, 2005, CARDIOVASC RES, V67, P234, DOI 10.1016/j.cardiores.2005.04.014; Boengler K, 2009, BASIC RES CARDIOL, V104, P141, DOI 10.1007/s00395-009-0007-5; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Chen KC, 2000, BIOPHYS J, V78, P2776, DOI 10.1016/S0006-3495(00)76822-6; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Garlid KD, 1997, CIRC RES, V81, P1072; Garlid KD, 1996, BBA-BIOENERGETICS, V1275, P123, DOI 10.1016/0005-2728(96)00061-8; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Goubaeva F, 2007, BIOCHEM BIOPH RES CO, V352, P97, DOI 10.1016/j.bbrc.2006.10.177; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Hansson MJ, 2010, J BIOL CHEM, V285, P741, DOI 10.1074/jbc.M109.017731; Holthoff K, 2000, GLIA, V29, P288, DOI 10.1002/(SICI)1098-1136(20000201)29:3<288::AID-GLIA10>3.0.CO;2-8; Iacobas DA, 2003, PHYSIOL GENOMICS, V15, P177, DOI 10.1152/physiolgenomics.00062.2003; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Juthberg SKA, 1997, CELL MOL NEUROBIOL, V17, P367, DOI 10.1023/A:1026331226241; KASNER SE, 1992, AM J PHYSIOL, V262, P462; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kolikova J, 2006, BRAIN CELL BIOL, V35, P75, DOI 10.1007/s11068-006-9000-1; Korge P, 2005, AM J PHYSIOL-HEART C, V289, pH66, DOI 10.1152/ajpheart.01296.2004; Kowaltowski AJ, 2002, J BIOL CHEM, V277, P42802, DOI 10.1074/jbc.M207765200; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Kubota T, 2005, BBA-MOL CELL RES, V1744, P19, DOI 10.1016/j.bbamcr.2004.10.013; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; LEVI AJ, 1994, J CARDIOVASC ELECTR, V5, P241; Li H, 2002, AM J PHYSIOL-HEART C, V282, pH2124, DOI 10.1152/ajpheart.01028.2001; Lian XY, 2004, BRAIN RES, V1012, P177, DOI 10.1016/j.brainres.2004.04.011; Liu D, 2003, J NEUROCHEM, V86, P966, DOI 10.1046/j.1471-4159.2003.01913.x; Ljubkovic M, 2006, J PHYSIOL-LONDON, V577, P17, DOI 10.1113/jphysiol.2006.118299; McLaughlin CW, 2001, AM J PHYSIOL-CELL PH, V281, pC865, DOI 10.1152/ajpcell.2001.281.3.C865; Metea MR, 2007, J NEUROSCI, V27, P2468, DOI 10.1523/JNEUROSCI.3204-06.2007; MINTA A, 1989, J BIOL CHEM, V264, P19449; Miro-Casas E, 2009, CARDIOVASC RES, V83, P747, DOI 10.1093/cvr/cvp157; Murchison D, 2004, CELL CALCIUM, V36, P61, DOI 10.1016/j.ceca.2003.11.010; Murchison D, 2000, BRAIN RES, V854, P139, DOI 10.1016/S0006-8993(99)02297-0; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Naus CCG, 1997, J NEUROSCI RES, V49, P528, DOI 10.1002/(SICI)1097-4547(19970901)49:5<528::AID-JNR3>3.0.CO;2-D; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; OLSON JE, 1986, J CELL PHYSIOL, V128, P209, DOI 10.1002/jcp.1041280211; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Park KS, 2002, PFLUG ARCH EUR J PHY, V443, P344, DOI 10.1007/s004240100703; Pivovarova NB, 1999, J NEUROSCI, V19, P6372; Poburko D, 2004, CELL CALCIUM, V35, P509, DOI 10.1016/j.ceca.2004.01.020; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; PYSH JJ, 1972, BRAIN RES, V36, P1, DOI 10.1016/0006-8993(72)90762-7; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Reyes RC, 2008, J NEUROSCI, V28, P9682, DOI 10.1523/JNEUROSCI.3484-08.2008; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Rose CR, 1996, J PHYSIOL-LONDON, V491, P291, DOI 10.1113/jphysiol.1996.sp021216; Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sato T, 1998, CIRC RES, V83, P110, DOI 10.1161/01.RES.83.1.110; Sheldon C, 2004, J NEUROSCI, V24, P11057, DOI 10.1523/JNEUROSCI.2829-04.2004; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Stys PK, 1997, J NEUROCHEM, V68, P1920; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; WALZ W, 1992, NEUROSCI LETT, V135, P243, DOI 10.1016/0304-3940(92)90446-E; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Xu L, 2009, NEUROBIOL DIS, V34, P291, DOI 10.1016/j.nbd.2009.01.010; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang MK, 2009, J PHARMACOL SCI, V109, P222, DOI 10.1254/jphs.08132FP; ZOETEWEIJ JP, 1994, BIOCHEM J, V299, P539, DOI 10.1042/bj2990539	77	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31107	31119		10.1074/jbc.M109.082073	http://dx.doi.org/10.1074/jbc.M109.082073			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667836	Green Published, hybrid			2022-12-25	WOS:000282764600004
J	Majumder, A; Govindasamy, L; Magis, A; Kiss, R; Polgar, T; Baskin, R; Allan, RW; Agbandje-McKenna, M; Reuther, GW; Keseru, GM; Bisht, KS; Sayeski, PP				Majumder, Anurima; Govindasamy, Lakshmanan; Magis, Andrew; Kiss, Robert; Polgar, Timea; Baskin, Rebekah; Allan, Robert W.; Agbandje-McKenna, Mavis; Reuther, Gary W.; Keseru, Gyoergy M.; Bisht, Kirpal S.; Sayeski, Peter P.			Structure-Function Correlation of G6, a Novel Small Molecule Inhibitor of Jak2 INDISPENSABILITY OF THE STILBENOID CORE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE JAK2; TRANS-RESVERATROL; CELL-LINES; MUTATION; IDENTIFICATION; PICEATANNOL; ACTIVATION; APOPTOSIS; DOMAINS; DEFINES	Somatic mutations in the Jak2 protein, such as V617F, cause aberrant Jak/STAT signaling and can lead to the development of myeloproliferative neoplasms. This discovery has led to the search for small molecule inhibitors that target Jak2. Using structure-based virtual screening, our group recently identified a novel small molecule inhibitor of Jak2 named G6. Here, we identified a structure-function correlation of this compound. Specifically, five derivative compounds of G6 having structural similarity to the original lead compound were obtained and analyzed for their ability to (i) inhibit Jak2-V617F-mediated cell growth, (ii) inhibit the levels of phospho-Jak2, phospho-STAT3, and phospho-STAT5; (iii) induce apoptosis in human erythroleukemia cells; and (iv) suppress pathologic cell growth of Jak2-V617F-expressing human bone marrow cells ex vivo. Additionally, we computationally examined the interactions of these compounds with the ATP-binding pocket of the Jak2 kinase domain. We found that the stilbenoid core-containing derivatives of G6 significantly inhibited Jak2-V617F-mediated cell proliferation in a time- and dose-dependent manner. They also inhibited phosphorylation of Jak2, STAT3, and STAT5 proteins within cells, resulting in higher levels of apoptosis via the intrinsic apoptotic pathway. Finally, the stilbenoid derivatives inhibited the pathologic growth of Jak2-V617F-expressing human bone marrow cells ex vivo. Collectively, our data demonstrate that G6 has a stilbenoid core that is indispensable for maintaining its Jak2 inhibitory potential.	[Majumder, Anurima; Baskin, Rebekah; Sayeski, Peter P.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Govindasamy, Lakshmanan; Agbandje-McKenna, Mavis] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Allan, Robert W.] Univ Florida, Coll Med, Dept Pathol & Lab Med, Gainesville, FL 32610 USA; [Magis, Andrew] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Kiss, Robert] Heriot Watt Univ, Dept Chem Engn, Edinburgh EH14 4A5, Midlothian, Scotland; [Polgar, Timea; Keseru, Gyoergy M.] Budapest Univ Technol & Econ, Dept Gen & Analyt Chem, H-1111 Budapest, Hungary; [Reuther, Gary W.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 32610 USA; [Bisht, Kirpal S.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Urbana-Champaign; Heriot Watt University; Budapest University of Technology & Economics; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Sayeski, PP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, POB 100274, Gainesville, FL 32610 USA.	psayeski@ufl.edu	Reuther, Gary/AFR-2892-2022; Polgár, Tímea/A-2089-2013	Polgár, Tímea/0000-0002-1367-6128; Magis, Andrew/0000-0003-0576-677X; Kiss, Robert/0000-0002-2879-6325; Keseru, Gyorgy M/0000-0003-1039-7809	National Institutes of Health [R01-HL67277]; Biomedical Research Support Program; Howard Hughes Medical Institute; University of Florida/Moffitt Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Support Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Florida/Moffitt Cancer Center(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL67277. This work was also supported by a Biomedical Research Support Program for Medical Schools Award to the University of Florida College of Medicine by the Howard Hughes Medical Institute, a University of Florida Opportunity Fund Award, and a University of Florida/Moffitt Cancer Center Collaborative Initiative Award.	Akwabi-Ameyaw A, 2008, BIOORG MED CHEM LETT, V18, P4339, DOI 10.1016/j.bmcl.2008.06.073; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Antonysamy S, 2009, BIOORG MED CHEM LETT, V19, P279, DOI 10.1016/j.bmcl.2008.08.064; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Belleri M, 2005, MOL PHARMACOL, V67, P1451, DOI 10.1124/mol.104.009043; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Gosslau A, 2005, BRIT J CANCER, V92, P513, DOI 10.1038/sj.bjc.6602300; Griesinger F, 2005, GENE CHROMOSOME CANC, V44, P329, DOI 10.1002/gcc.20235; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; Kimura Y, 2005, IN VIVO, V19, P37; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Larrosa M, 2004, EUR J NUTR, V43, P275, DOI 10.1007/s00394-004-0471-5; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan A, 2010, J BIOL CHEM, V285, P16651, DOI 10.1074/jbc.M109.071191; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Swanson-Mungerson M, 2003, J ANTIMICROB CHEMOTH, V52, P152, DOI 10.1093/jac/dkg306; Szabo G, 2009, BIOORG MED CHEM LETT, V19, P3471, DOI 10.1016/j.bmcl.2009.05.010; Till JH, 2001, J BIOL CHEM, V276, P10049, DOI 10.1074/jbc.M010161200; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	45	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31399	31407		10.1074/jbc.M110.168211	http://dx.doi.org/10.1074/jbc.M110.168211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667821	Green Published, hybrid			2022-12-25	WOS:000282764600034
J	Mitschke, L; Parthier, C; Schroder-Tittmann, K; Coy, J; Ludtke, S; Tittmann, K				Mitschke, Lars; Parthier, Christoph; Schroeder-Tittmann, Kathrin; Coy, Johannes; Luedtke, Stefan; Tittmann, Kai			The Crystal Structure of Human Transketolase and New Insights into Its Mode of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHATE-DEPENDENT ENZYME; THIAMIN CATALYSIS; UP-REGULATION; EXPRESSION; PROTEIN; SITE; CRYSTALLOGRAPHY; IDENTIFICATION; CONTRIBUTES; INHIBITORS	The crystal structure of human transketolase (TKT), a thiamine diphosphate (ThDP) and Ca2+-dependent enzyme that catalyzes the interketol transfer between ketoses and aldoses as part of the pentose phosphate pathway, has been determined to 1.75 angstrom resolution. The recombinantly produced protein crystallized in space group C2 containing one monomer in the asymmetric unit. Two monomers form the homodimeric biological assembly with two identical active sites at the dimer interface. Although the protomer exhibits the typical three (alpha/beta)-domain structure and topology reported for TKTs from other species, structural differences are observed for several loop regions and the linker that connects the PP and Pyr domain. The cofactor and substrate binding sites of human TKT bear high resemblance to those of other TKTs but also feature unique properties, including two lysines and a serine that interact with the beta-phosphate of ThDP. Furthermore, Gln(189) spans over the thiazolium moiety of ThDP and replaces an isoleucine found in most non-mammalian TKTs. The side chain of Gln(428) forms a hydrogen bond with the 4'-amino group of ThDP and replaces a histidine that is invariant in all non-mammalian TKTs. All other amino acids involved in substrate binding and catalysis are strictly conserved. Besides a steady-state kinetic analysis, microscopic equilibria of the donor half-reaction were characterized by an NMR-based intermediate analysis. These studies reveal that formation of the central 1,2-dihydroxyethyl-ThDP carbanion-enamine intermediate is thermodynamically favored with increasing carbon chain length of the donor ketose substrate. Based on the structure of human transketolase and sequence alignments, putative functional properties of the related transketolase-like proteins TKTL1 and -2 are discussed in light of recent findings suggesting that TKTL1 plays a role in cancerogenesis.	[Tittmann, Kai] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Coy, Johannes] TAVARGENIX GmbH, D-64293 Darmstadt, Germany; [Luedtke, Stefan; Tittmann, Kai] Univ Gottingen, Albrecht von Haller Inst, D-37077 Gottingen, Germany; [Luedtke, Stefan; Tittmann, Kai] Univ Gottingen, Gottingen Ctr Mol Biosci, Dept Bioanalyt, D-37077 Gottingen, Germany	Martin Luther University Halle Wittenberg; University of Gottingen; University of Gottingen	Tittmann, K (corresponding author), Ernst Caspari Haus,Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ktittma@gwdg.de			Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the "Fonds der Chemischen Industrie" (stipend to S. L.) and the Deutsche Forschungsgemeinschaft-funded Gottingen Graduate School for Neurosciences and Molecular Biosciences (to K. T.).	Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boros LG, 1997, CANCER RES, V57, P4242; Bykova IA, 2001, BIOCHEM BIOPH RES CO, V280, P845, DOI 10.1006/bbrc.2000.4199; CALINGASAN NY, 1995, J NEUROCHEM, V64, P1034; Cascante M, 2000, NUTR CANCER, V36, P150, DOI 10.1207/S15327914NC3602_2; Charmantray F, 2009, J MOL CATAL B-ENZYM, V57, P6, DOI 10.1016/j.molcatb.2008.06.005; Coy JF, 1996, GENOMICS, V32, P309, DOI 10.1006/geno.1996.0124; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler E, 2002, P NATL ACAD SCI USA, V99, P591, DOI 10.1073/pnas.022510999; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Gerhardt S, 2003, PLANT PHYSIOL, V132, P1941, DOI 10.1104/pp.103.020982; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; Heroux M, 1996, METAB BRAIN DIS, V11, P81, DOI 10.1007/BF02080933; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; Le Huerou Y, 2008, BIOORG MED CHEM LETT, V18, P505, DOI 10.1016/j.bmcl.2007.11.100; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; LITLECHILD J, 1995, ACTA CRYSTALLOGR D, V51, P1074, DOI 10.1107/S0907444995005415; Liu SQ, 2008, RAPID COMMUN MASS SP, V22, P3172, DOI 10.1002/rcm.3725; NIKKOLA M, 1994, J MOL BIOL, V238, P387, DOI 10.1006/jmbi.1994.1299; Nilsson U, 1997, J BIOL CHEM, V272, P1864, DOI 10.1074/jbc.272.3.1864; NIXON PF, 1984, EUR J CLIN INVEST, V14, P278, DOI 10.1111/j.1365-2362.1984.tb01181.x; Sax CM, 1996, J BIOL CHEM, V271, P33568, DOI 10.1074/jbc.271.52.33568; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; Schenk G, 1997, J MOL EVOL, V44, P552, DOI 10.1007/PL00006179; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P369, DOI 10.1016/S1357-2725(97)00154-4; SCHNEIDER G, 1989, J BIOL CHEM, V264, P21619; Schneider G, 1998, BBA-PROTEIN STRUCT M, V1385, P387, DOI 10.1016/S0167-4838(98)00082-X; Shin YK, 2009, ELECTROPHORESIS, V30, P2182, DOI 10.1002/elps.200800806; Sigrun L, 2006, TUMOR BIOL, V27, P48; Singleton CK, 1996, BIOCHEMISTRY-US, V35, P15865, DOI 10.1021/bi9616920; Soh Y, 1998, BIOCHEM J, V333, P367, DOI 10.1042/bj3330367; SPRENGER GA, 1995, EUR J BIOCHEM, V230, P525; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P2206, DOI 10.1016/j.bmcl.2007.11.101; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P509, DOI 10.1016/j.bmcl.2007.11.098; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Tittmann K, 2009, J MOL CATAL B-ENZYM, V61, P93, DOI 10.1016/j.molcatb.2009.02.019; Wikner C, 1997, BIOCHEMISTRY-US, V36, P15643, DOI 10.1021/bi971606b; Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078; Xu ZP, 2002, MOL CELL BIOL, V22, P6142, DOI 10.1128/MCB.22.17.6142-6147.2002; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67; Zhao YL, 2009, J NEUROCHEM, V111, P537, DOI 10.1111/j.1471-4159.2009.06341.x	49	74	77	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31559	31570		10.1074/jbc.M110.149955	http://dx.doi.org/10.1074/jbc.M110.149955			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667822	Green Published, hybrid			2022-12-25	WOS:000282764600050
J	Sun, Y; Prasad, M; Gao, TA; Wang, XF; Zhu, QL; D'Souza, R; Feng, JQ; Qin, CL				Sun, Yao; Prasad, Monica; Gao, Tian; Wang, Xiaofang; Zhu, Qinglin; D'Souza, Rena; Feng, Jian Q.; Qin, Chunlin			Failure to Process Dentin Matrix Protein 1 (DMP1) into Fragments Leads to Its Loss of Function in Osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; ACIDIC PHOSPHOPROTEIN; PHOSPHATE HOMEOSTASIS; DMP1-DEFICIENT MICE; MINERALIZED TISSUES; BONE; EXPRESSION; ROLES; IDENTIFICATION; VITRO	Dentin matrix protein 1 (DMP1), an acidic protein important to the formation of bone and dentin, primarily exists as the processed NH2-terminal and COOH-terminal fragments in the extracellular matrix of the two tissues. Previous in vitro studies showed that the substitution of residue Asp(213) by Ala(213) (D213A) at a cleavage site blocked the processing of mouse DMP1 in cells. In this study, we generated transgenic mice expressing mutant D213A-DMP1 (WT/D213A-Tg mice) to test the hypothesis that the proteolytic processing of DMP1 is an activation step essential to osteogenesis. By crossbreeding WT/D213A-Tg mice with Dmp1 knock-out (Dmp1-KO) mice, we obtained mice expressing D213A-DMP1 in a Dmp1-KO background; these mice will be referred to as "Dmp1-KO/D213A-Tg" mice. Biochemical, radiological, and morphological approaches were used to characterize the skeletal phenotypes of Dmp1-KO/D213A-Tg mice compared with wild-type mice, Dmp1-KO mice, and Dmp1-KO mice expressing the normal Dmp1 transgene. Protein chemistry analyses showed that DMP1 was barely cleaved in the bone of the Dmp1-KO/D213A-Tg mice, indicating that D213A substitution effectively blocked the proteolytic processing of DMP1 in vivo. While the expression of the normal Dmp1 transgene completely rescued the phenotypic skeletal changes of the Dmp1-KO mice, the expression of the mutant D213A-Dmp1 transgene failed to do so. These results indicate that the full-length form of DMP1 is an inactive precursor and its proteolytic processing is an activation step essential to the biological functions of this protein in osteogenesis.	[Sun, Yao; Prasad, Monica; Gao, Tian; Wang, Xiaofang; Zhu, Qinglin; D'Souza, Rena; Feng, Jian Q.; Qin, Chunlin] Texas A&M Univ Syst Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Qin, CL (corresponding author), 3302 Gaston Ave, Dallas, TX 75246 USA.	cqin@bcd.tamhsc.edu		D'Souza, Rena/0000-0002-1505-5173; sun, yao/0000-0002-4323-0506; Wang, Xiaofang/0000-0002-7370-7192	National Institutes of Health [DE 005092, DE015209]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE 005092 (to C. Q.) and DE015209 (to J.Q.F.).	Baba O, 2004, MATRIX BIOL, V23, P371, DOI 10.1016/j.matbio.2004.07.008; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Filanti C, 2000, J BONE MINER RES, V15, P2154, DOI 10.1359/jbmr.2000.15.11.2154; Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gericke A, 2010, J DENT RES, V89, P355, DOI 10.1177/0022034510363250; Hirst KL, 1997, J DENT RES, V76, P754, DOI 10.1177/00220345970760030701; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; MacDougall M, 1998, J BONE MINER RES, V13, P422, DOI 10.1359/jbmr.1998.13.3.422; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; Maciejewska I, 2009, J HISTOCHEM CYTOCHEM, V57, P155, DOI 10.1369/jhc.2008.952630; Peng T, 2009, CELLS TISSUES ORGANS, V189, P192, DOI 10.1159/000151373; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; von Marschall Z, 2008, J BIOL CHEM, V283, P32730, DOI 10.1074/jbc.M804283200; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	28	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31713	31722		10.1074/jbc.M110.137059	http://dx.doi.org/10.1074/jbc.M110.137059			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663874	Green Published, hybrid			2022-12-25	WOS:000282764600063
J	Herrero-Gonzalez, S; Gangoso, E; Giaume, C; Naus, CC; Medina, JM; Tabernero, A				Herrero-Gonzalez, S.; Gangoso, E.; Giaume, C.; Naus, C. C.; Medina, J. M.; Tabernero, A.			Connexin43 inhibits the oncogenic activity of c-Src in C6 glioma cells	ONCOGENE			English	Article						cell cycle; CNS; gap junctions; glia; proliferation	GAP-JUNCTION PROTEIN; INTERCELLULAR COMMUNICATION; TYROSINE PHOSPHORYLATION; CULTURED ASTROCYTES; CYCLIN D1; GROWTH; EXPRESSION; PROLIFERATION; GENE; TRANSCRIPTION	One of the characteristics of gliomas is a decrease in the expression of connexin43, a protein that forms gap junctions. Restoring connexin43 expression in glioma cells reduces their exacerbated rate of cell growth, although it is not yet known how connexin43 modifies the expression of genes involved in cell proliferation. Here, we show that restoring connexin43 to C6 glioma cells impedes their progression from G0/G1 to the S phase of the cell cycle by reducing retinoblastoma phosphorylation and cyclin E expression through the upregulation of p21 and p27. Interestingly, connexin43 diminishes the oncogenic activity of c-Src exhibited by glioma cells. By studying a Tyr247 and Tyr265 mutant connexin43, we show that these residues are required for connexin43 to inhibit c-Src activity and cell proliferation. In conclusion, by acting as a substrate of c-Src, connexin43 reduces its oncogenic activity and decreases the rate of glioma cell proliferation, potentially an early step in the antiproliferative effects of connexin43. Although c-Src is known to phosphorylate connexin43, this study provides the first evidence that connexin43 can also inhibit c-Src activity. Oncogene (2010) 29, 5712-5723; doi:10.1038/onc.2010.299; published online 2 August 2010	[Herrero-Gonzalez, S.; Gangoso, E.; Medina, J. M.; Tabernero, A.] Univ Salamanca, Dept Bioquim & Biol Mol, INCYL, Salamanca 37007, Spain; [Giaume, C.] Coll France, INSERM, U840, F-75231 Paris, France; [Naus, C. C.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of Salamanca; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; University of British Columbia	Tabernero, A (corresponding author), Univ Salamanca, Dept Bioquim & Biol Mol, INCYL, C Pintor Fernando Gallego 1, Salamanca 37007, Spain.	ataber@usal.es	Tabernero, Arantxa/K-5950-2014; IBSAL, Secretaría/H-3719-2011; Gangoso, Ester/B-4825-2016; Gangoso, Ester/J-2604-2019	Tabernero, Arantxa/0000-0001-6302-6134; Gangoso, Ester/0000-0003-4851-9680; Gangoso, Ester/0000-0003-4851-9680	Ministerio de Educacion y Ciencia [SAF2007-64161]; Junta de Castilla y Leon [SA043A09]	Ministerio de Educacion y Ciencia(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by the Ministerio de Educacion y Ciencia, FEDER SAF2007-64161, the Junta de Castilla y Leon SA043A09. S Herrero-Gonzalez and E Gangoso were recipient of a fellowship from the Ministerio de Educacion y Ciencia. We are grateful for the technical assistance of T del Rey and we thank M Sefton for help in preparing the paper.	Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Campbell EJ, 2008, BRIT J CANCER, V99, P1769, DOI 10.1038/sj.bjc.6604768; Cavalla P, 1998, ACTA NEUROPATHOL, V95, P131, DOI 10.1007/s004010050776; Chakrabarty A, 1996, NEUROPATH APPL NEURO, V22, P311, DOI 10.1111/j.1365-2990.1996.tb01109.x; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Dang XT, 2003, MOL CELL BIOCHEM, V242, P35, DOI 10.1023/A:1021152709313; DAVIDPFEUTY T, 1993, J CELL SCI, V105, P613; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Geng Y, 1996, ONCOGENE, V12, P1173; Giepmans BNG, 2006, ADV CARDIOL, V42, P41, DOI 10.1159/000092561; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Herrero-Gonzalez S, 2009, GLIA, V57, P222, DOI 10.1002/glia.20748; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Huang RP, 1998, CANCER RES, V58, P5089; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.3.CO;2-S; Kanemitsu MY, 1998, CELL GROWTH DIFFER, V9, P13; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Koffler L, 2000, J CELL BIOCHEM, V79, P347, DOI 10.1002/1097-4644(20001201)79:3<347::AID-JCB10>3.0.CO;2-2; Krutovskikh VA, 2000, ONCOGENE, V19, P505, DOI 10.1038/sj.onc.1203340; Lai CPK, 2009, ONCOGENE, V28, P4402, DOI 10.1038/onc.2009.283; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; Lin R, 2006, CELL COMMUN ADHES, V13, P199, DOI 10.1080/15419060600848516; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; Naus CCG, 2002, CAN J PHYSIOL PHARM, V80, P136, DOI 10.1139/Y02-009; Naus CCG, 1997, J NEUROSCI RES, V49, P528, DOI 10.1002/(SICI)1097-4547(19970901)49:5<528::AID-JNR3>3.0.CO;2-D; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Pahujaa M, 2007, EXP CELL RES, V313, P4083, DOI 10.1016/j.yexcr.2007.09.010; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Prochnow N, 2008, HISTOCHEM CELL BIOL, V130, P71, DOI 10.1007/s00418-008-0434-7; Pu PY, 2004, CLIN NEUROL NEUROSUR, V107, P49, DOI 10.1016/j.clineuro.2004.03.006; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shinoura N, 1996, J NEUROSURG, V84, P839, DOI 10.3171/jns.1996.84.5.0839; Sin WC, 2008, J CELL BIOCHEM, V103, P1772, DOI 10.1002/jcb.21571; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Soroceanu L, 2001, GLIA, V33, P107, DOI 10.1002/1098-1136(200102)33:2<107::AID-GLIA1010>3.0.CO;2-4; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; SWENSON KI, 1990, CELL REGUL, V1, P989, DOI 10.1091/mbc.1.13.989; Tabernero A, 2006, J NEUROCHEM, V96, P973, DOI 10.1111/j.1471-4159.2005.03623.x; Tabernero A, 1996, GLIA, V16, P187, DOI 10.1002/(SICI)1098-1136(199603)16:3<187::AID-GLIA1>3.0.CO;2-#; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Warn-Cramer BJ, 2003, CELL COMMUN ADHES, V10, P299, DOI 10.1080/714040443; Weissenberger J, 1997, ONCOGENE, V14, P2005, DOI 10.1038/sj.onc.1201168; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamasaki H, 1999, CR ACAD SCI III-VIE, V322, P151, DOI 10.1016/S0764-4469(99)80038-9; Zhang X, 2005, J CLIN NEUROSCI, V12, P166, DOI 10.1016/j.jocn.2004.03.036; Zhang YW, 2001, ONCOGENE, V20, P4138, DOI 10.1038/sj.onc.1204563; Zhang YW, 2003, CANCER RES, V63, P1623; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	60	45	51	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5712	5723		10.1038/onc.2010.299	http://dx.doi.org/10.1038/onc.2010.299			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20676131				2022-12-25	WOS:000283262500007
J	Mayfield, JA; Frederick, RE; Streit, BR; Wencewicz, TA; Ballou, DP; DuBois, JL				Mayfield, Jeffery A.; Frederick, Rosanne E.; Streit, Bennett R.; Wencewicz, Timothy A.; Ballou, David P.; DuBois, Jennifer L.			Comprehensive Spectroscopic, Steady State, and Transient Kinetic Studies of a Representative Siderophore-associated Flavin Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-HYDROXYBENZOATE HYDROXYLASE; BIOCHEMICAL-CHARACTERIZATION; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; ORNITHINE HYDROXYLASE; ASPERGILLUS-FUMIGATUS; IRON; BIOSYNTHESIS; FAD; LYSINE	Many siderophores used for the uptake and intracellular storage of essential iron contain hydroxamate chelating groups. Their biosyntheses are typically initiated by hydroxylation of the primary amine side chains of L-ornithine or L-lysine. This reaction is catalyzed by members of a widespread family of FAD-dependent monooxygenases. Here the kinetic mechanism for a representative family member has been extensively characterized by steady state and transient kinetic methods, using heterologously expressed N-5-L-ornithine monooxygenase from the pathogenic fungus Aspergillus fumigatus. Spectroscopic data and kinetic analyses suggest a model in which a molecule of hydroxylatable substrate serves as an activator for the reaction of the reduced flavin and O-2. The rate acceleration is only similar to 5-fold, a mild effect of substrate on formation of the C4a-hydroperoxide that does not influence the overall rate of turnover. The effect is also observed with the bacterial ornithine monooxygenase PvdA. The C4a-hydroperoxide is stabilized in the absence of hydroxylatable substrate by the presence of bound NADP(+) (t(1/2) = 33 min, 25 degrees C, pH 8). NADP(+) therefore is a likely regulator of O-2 and substrate reactivity in the siderophore-associated monooxygenases. Aside from the activating effect of the hydroxylatable substrate, the siderophore-associated monooxygenases share a kinetic mechanism with the hepatic microsomal flavin monooxygenases and bacterial Baeyer-Villiger monooxygenases, with which they share only moderate sequence homology and from which they are distinguished by their acute substrate specificity. The remarkable specificity of the N-5-L-ornithine monooxygenase-catalyzed reaction suggests added means of reaction control beyond those documented in related well characterized flavoenzymes.	[Mayfield, Jeffery A.; Frederick, Rosanne E.; Streit, Bennett R.; Wencewicz, Timothy A.; DuBois, Jennifer L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Ballou, David P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Notre Dame; University of Michigan System; University of Michigan	DuBois, JL (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Hall, Notre Dame, IN 46556 USA.	jdubois@nd.edu		Streit, Bennett/0000-0001-9174-7019	National Institutes of Health [T32GM075762, GM20877]; National Science Foundation [CHE-0741793]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020877, R01GM020877, F32GM020877, R01GM090260, T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM075762 (a Chemistry-Biochemistry-Biology Interface Program Training Grant, which funded fellowships for T. A. W. and R. E. F.) and GM20877 (to D. P. B.).; We thank Prof. Marvin J. Miller for intellectual and material contributions toward the synthesis and characterization of L-Orn-OH. We thank Dr. Alexander Gehrke of the Hans Knoll Institute (Jena, Germany) for the kind gift of A. fumigatus from which genomic DNA was extracted. Amy Zercher gave technical assistance in cloning the sidA gene. We thank Garrett Moraski for technical assistance and for helpful discussions and Barrie Entsch (University of New England, New South Wales, Australia) for critical reading of the manuscript. NMR facilities were provided by the Lizzadro Magnetic Resonance Research Center at the University of Notre Dame, and mass spectrometry was provided by the University of Notre Dame Mass Spectrometry and Proteomics Facility (N. Sevova, Dr. W. Boggess, and Dr. M. V. Joyce; supported by National Science Foundation Grant CHE-0741793).	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ballou D. P., 1982, FLAVINS FLAVOPROTEIN, P301; BEATY NB, 1980, J BIOL CHEM, V255, P3817; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; COOK PF, 2007, ENZYME KINETICS MECH, P1; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P1; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dick S, 1999, J PROTEIN CHEM, V18, P893, DOI 10.1023/A:1020639514998; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fraaije MW, 2002, FEBS LETT, V518, P43, DOI 10.1016/S0014-5793(02)02623-6; Frederick RE, 2009, BIOMETALS, V22, P583, DOI 10.1007/s10534-009-9236-1; Ge L, 2006, J BACTERIOL, V188, P7205, DOI 10.1128/JB.00949-06; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; ISOWA Y, 1972, B CHEM SOC JPN, V45, P1461, DOI 10.1246/bcsj.45.1461; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; JONES KC, 1986, J BIOL CHEM, V261, P2553; JONES KC, 1985, THESIS U MICHIGAN AN; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lin YM, 1999, J ORG CHEM, V64, P7451, DOI 10.1021/jo990769y; LITTLE DI, 1982, EUR J BIOCHEM, V124, P499; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P995, DOI 10.1111/j.1432-1033.1993.tb17846.x; Macheroux P, 1999, METH MOL B, V131, P1; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; Marrone L, 1997, BBA-PROTEIN STRUCT M, V1343, P263, DOI 10.1016/S0167-4838(97)00129-5; MCDOUGALL S, 1984, J BACTERIOL, V159, P300, DOI 10.1128/JB.159.1.300-305.1984; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; NAEGELI HU, 1978, HELV CHIM ACTA, V61, P2088, DOI 10.1002/hlca.19780610615; Neres J, 2008, J MED CHEM, V51, P5349, DOI 10.1021/jm800567v; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; POLONSKI T, 1974, TETRAHEDRON LETT, P2453; POULSEN LL, 1995, CHEM-BIOL INTERACT, V96, P57, DOI 10.1016/0009-2797(94)03583-T; POULSEN LL, 1979, J BIOL CHEM, V254, P6449; Putignani L, 2004, BIOCHEM BIOPH RES CO, V313, P245, DOI 10.1016/j.bbrc.2003.11.116; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Somu RV, 2006, J MED CHEM, V49, P31, DOI 10.1021/jm051060o; STEENNIS PJ, 1973, FEBS LETT, V36, P177, DOI 10.1016/0014-5793(73)80363-1; Stevens DA, 2000, CLIN INFECT DIS, V30, P696, DOI 10.1086/313756; STORER AC, 1975, BIOCHEM J, V151, P361, DOI 10.1042/bj1510361; STRONG RK, 2005, LIPOCALINS, P204; THARIATH A, 1993, J BACTERIOL, V175, P589, DOI 10.1128/JB.175.3.589-596.1993; TOMLINSON G, 1971, ANAL BIOCHEM, V44, P670, DOI 10.1016/0003-2697(71)90258-2; WALSH CT, 1988, ANGEW CHEM INT EDIT, V27, P333, DOI 10.1002/anie.198803331; Walz AJ, 2007, ORG BIOMOL CHEM, V5, P1621, DOI 10.1039/b703116e; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wyatt MK, 1998, BIOCHEMISTRY-US, V37, P5930, DOI 10.1021/bi972622b; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	65	44	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30375	30388		10.1074/jbc.M110.157578	http://dx.doi.org/10.1074/jbc.M110.157578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20650894	Green Published, hybrid			2022-12-25	WOS:000282135500004
J	Teixeira, CC; Liu, YX; Thant, LM; Pang, J; Palmer, G; Alikhani, M				Teixeira, Cristina C.; Liu, Yuexun; Thant, Lwin M.; Pang, Jason; Palmer, Glyn; Alikhani, Mani			Foxo1, a Novel Regulator of Osteoblast Differentiation and Skeletogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FKHR; GENE-EXPRESSION; SKELETAL-MUSCLE; BONE-FORMATION; STEM-CELLS; OSTEOGENIC DIFFERENTIATION; MYOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; INSULIN SENSITIVITY; PARATHYROID-HORMONE	Skeletogenesis depends on the activity of bone-forming cells derived from mesenchymal cells. The pathways that control mesenchymal cell differentiation are not well understood. We propose that Foxo1 is an early molecular regulator during mesenchymal cell differentiation into osteoblasts. In mouse embryos, Foxo1 expression is higher in skeletal tissues, while Foxo1 silencing has a drastic impact on skeletogenesis and craniofacial development, specially affecting pre-maxilla, nasal bone, mandible, tibia, and clavicle. Similarly, Foxo1 activity and expression increase in mouse mesenchymal cells under the influence of osteogenic stimulants. In addition, silencing Foxo1 blocks the expression of osteogenic markers such as Runx2, alkaline phosphatase, and osteocalcin and results in decreased culture calcification even in the presence of strong osteogenic stimulants. Conversely, the expression of these markers increases significantly in response to Foxo1 overexpression. One mechanism through which Foxo1 affects mesenchymal cell differentiation into osteoblasts is through regulation of a key osteogenic transcription factor, Runx2. Indeed, our results show that Foxo1 directly interacts with the promoter of Runx2 and regulates its expression. Using a tibia organ culture model, we confirmed that silencing Foxo1 decreases the expression of Runx2 and impairs bone formation. Furthermore, our data reveals that Runx2 and Foxo1 interact with each other and cooperate in the transcriptional regulation of osteoblast markers. In conclusion, our in vitro, ex vivo, and in vivo results strongly support the notion that Foxo1 is an early molecular regulator in the differentiation of mesenchymal cells into osteoblast.	[Alikhani, Mani] NYU, Coll Dent, Dept Orthodont, New York, NY 10010 USA; [Teixeira, Cristina C.; Thant, Lwin M.; Pang, Jason; Palmer, Glyn] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA	New York University; New York University	Alikhani, M (corresponding author), NYU, Coll Dent, Dept Orthodont, 345 E 24th St,Rm 850, New York, NY 10010 USA.	mani.alikhani@nyu.edu			National Institutes of Health, NIDCR [5K08DE017426, R03DE019499]; Muscular Skeletal Repair and Regeneration Center at Hospital for Special Surgery, NIH [AR046121]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K08DE017426, R03DE019499] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Muscular Skeletal Repair and Regeneration Center at Hospital for Special Surgery, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants 5K08DE017426 and R03DE019499 from NIDCR. This work was also supported by the Muscular Skeletal Repair and Regeneration Center at Hospital for Special Surgery supported by NIH Grant AR046121.	AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Alikhani M, 2007, AM J PHYSIOL-CELL PH, V292, pC850, DOI 10.1152/ajpcell.00356.2006; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Franceschi RT, 2004, CELLS TISSUES ORGANS, V176, P95, DOI 10.1159/000075031; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gilde AJ, 2003, ACTA PHYSIOL SCAND, V178, P425, DOI 10.1046/j.1365-201X.2003.01161.x; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gratsch TE, 2003, GENESIS, V37, P12, DOI 10.1002/gene.10221; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hatta M, 2002, INT J MOL MED, V9, P147; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kaestner KH, 2000, GENE DEV, V14, P142; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Maiese K, 2008, TRENDS MOL MED, V14, P219, DOI 10.1016/j.molmed.2008.03.002; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; OWEN ME, 1987, J CELL SCI, V87, P731; Peng SL, 2007, AUTOIMMUNITY, V40, P462, DOI 10.1080/08916930701464913; Polter A, 2009, BIOL PSYCHIAT, V65, P150, DOI 10.1016/j.biopsych.2008.08.005; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Ropelle ER, 2009, J PHYSIOL-LONDON, V587, P2341, DOI 10.1113/jphysiol.2009.170050; Scherr M, 2007, CELL CYCLE, V6, P444, DOI 10.4161/cc.6.4.3807; Serra R, 1999, J CELL BIOL, V145, P783, DOI 10.1083/jcb.145.4.783; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Teixeira CC, 2005, BONE, V37, P37, DOI 10.1016/j.bone.2005.03.010; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yasui A, 2007, BIOCHEM BIOPH RES CO, V364, P358, DOI 10.1016/j.bbrc.2007.10.013	56	94	104	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31055	31065		10.1074/jbc.M109.079962	http://dx.doi.org/10.1074/jbc.M109.079962			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20650891	hybrid, Green Published			2022-12-25	WOS:000282135500070
J	Csepeggi, C; Jiang, M; Frolov, A				Csepeggi, Chad; Jiang, Min; Frolov, Andrey			Somatic Cell Plasticity and Niemann-Pick Type C2 Protein ADIPOCYTE DIFFERENTIATION AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; CCAAT/ENHANCER-BINDING PROTEINS; TRANSCRIPTION FACTOR FOXO1; ALPHA GENE-EXPRESSION; NF-KAPPA-B; PPAR-GAMMA; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; CARDIOVASCULAR-DISEASE	The phenotypic stability of somatic cells is essential for the maintenance of both structural and functional organ integrity of the adult human body. Deregulated cell plasticity could result in the development of debilitating diseases such as cancer, fibrosis, atherosclerosis, obesity, and type 2 diabetes. We have previously demonstrated that a nonsense mutation in the NPC2 gene, which encodes ubiquitous, highly conserved, secretory protein with unknown function, leads to activation of human skin fibroblasts. The activated fibroblasts, also known as myofibroblasts, have the properties of mesenchymal stem cells and are able to differentiate along the mesodermal and endodermal lineages. Here we show that NPC2-null, but not the normal skin fibroblasts, possess characteristics of adipogenic progenitors as demonstrated by their specific gene expression pattern as well as the ability for efficient differentiation into white adipocytes. The presence of NPC2 in mature white adipocytes was also necessary for their maintenance because silencing NPC2 in differentiated cells by siRNA stimulated PPARG expression, which was followed by a shift toward a more favorable, brown adipocyte-like metabolic state characterized by up-regulated lipolysis and increased insulin sensitivity. It appears that NPC2 controls both the adipogenesis and the metabolic state of mature white adipocytes through a common mechanism that is linked to activation of FGFR2 that could be followed by induction of PPARG expression. Altogether, the current study highlights NPC2 as a novel intracrine/autocrine factor that controls adipocyte differentiation and function as well as potential therapeutic target for the treatment of type 2 diabetes and related metabolic disorders.	[Csepeggi, Chad; Jiang, Min; Frolov, Andrey] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Frolov, A (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, 231 Albert Sabin Way,ML 0542,CVC 4928,POB 670542, Cincinnati, OH 45267 USA.	andrey.frolov@uc.edu			American Heart Association; University of Cincinnati; Dept. of Internal Medicine	American Heart Association(American Heart Association); University of Cincinnati; Dept. of Internal Medicine	This work was supported by an American Heart Association Scientist Development Grant and the University of Cincinnati Millennium Fund and the Dept. of Internal Medicine Start-Up Fund (to A.F.).	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Chehab FF, 2008, ENDOCRINOLOGY, V149, P925, DOI 10.1210/en.2007-1355; Chew CH, 2007, INT J BIOCHEM CELL B, V39, P1975, DOI 10.1016/j.biocel.2007.05.015; Chinetti-Gbaguidi G, 2005, J LIPID RES, V46, P2717, DOI 10.1194/jlr.M500326-JLR200; Di-Poi N, 2005, J BIOL CHEM, V280, P38700, DOI 10.1074/jbc.M507782200; Festuccia WT, 2006, DIABETOLOGIA, V49, P2427, DOI 10.1007/s00125-006-0336-y; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hammarstedt A, 2005, DIABETOLOGIA, V48, P96, DOI 10.1007/s00125-004-1612-3; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Junker JPE, 2010, CELLS TISSUES ORGANS, V191, P105, DOI 10.1159/000232157; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Tafuri SR, 1996, ENDOCRINOLOGY, V137, P4706, DOI 10.1210/en.137.11.4706; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yamasaki S, 2004, RHEUMATOLOGY, V43, P448, DOI 10.1093/rheumatology/keh092; Yamasaki S, 2002, CLIN EXP IMMUNOL, V129, P379, DOI 10.1046/j.1365-2249.2002.01876.x	52	13	13	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30347	30354		10.1074/jbc.M110.135939	http://dx.doi.org/10.1074/jbc.M110.135939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650896	hybrid, Green Published			2022-12-25	WOS:000281984300070
J	Angel, M; Yanik, MF				Angel, Matthew; Yanik, Mehmet Fatih			Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PLURIPOTENT STEM-CELLS; RIG-I HELICASE; 5'-TRIPHOSPHATE RNA; MESSENGER-RNA; RECOGNITION; LET-7; HMGA2; GENERATION; EXPRESSION	Background: Generating autologous pluripotent stem cells for therapeutic applications will require the development of efficient DNA-free reprogramming techniques. Transfecting cells with in vitro-transcribed, protein-encoding RNA is a straightforward method of directly expressing high levels of reprogramming proteins without genetic modification. However, long-RNA transfection triggers a potent innate immune response characterized by growth inhibition and the production of inflammatory cytokines. As a result, repeated transfection with protein-encoding RNA causes cell death. Methodology/Principal Findings: RNA viruses have evolved methods of disrupting innate immune signaling by destroying or inhibiting specific proteins to enable persistent infection. Starting from a list of known viral targets, we performed a combinatorial screen to identify siRNA cocktails that could desensitize cells to exogenous RNA. We show that combined knockdown of interferon-beta (Ifnb1), Eif2ak2, and Stat2 rescues cells from the innate immune response triggered by frequent long-RNA transfection. Using this technique, we were able to transfect primary human fibroblasts every 24 hours with RNA encoding the reprogramming proteins Oct4, Sox2, Klf4, and Utf1. We provide evidence that the encoded protein is active, and we show that expression can be maintained for many days, through multiple rounds of cell division. Conclusions/Significance: Our results demonstrate that suppressing innate immunity enables frequent transfection with protein-encoding RNA. This technique represents a versatile tool for investigating expression dynamics and protein interactions by enabling precise control over levels and timing of protein expression. Our finding also opens the door for the development of reprogramming and directed-differentiation methods based on long-RNA transfection.	[Angel, Matthew; Yanik, Mehmet Fatih] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Yanik, Mehmet Fatih] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Angel, M (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	yanik@mit.edu		Tripp, Ralph/0000-0002-2924-9956; Yanik, Mehmet/0000-0002-8963-2893	Packard Award; Alfred P. Sloan Award	Packard Award; Alfred P. Sloan Award	This project was funded by a Packard Award and by an Alfred P. Sloan Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ANGEL M, 2008, THESIS MIT CAMBRIDGE; Bode JG, 2007, ARCH BIOCHEM BIOPHYS, V462, P254, DOI 10.1016/j.abb.2007.03.033; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; DAS HK, 1981, J BIOL CHEM, V256, P6491; De Martino I, 2007, ENDOCR-RELAT CANCER, V14, P875, DOI 10.1677/ERC-07-0036; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; JIA F, 2007, NAT METHODS, V7, P197; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; KILBOURNE E, 1961, NATURE, V190, P650, DOI 10.1038/190650a0; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; LEVIN DH, 1981, J BIOL CHEM, V256, P7638; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PATERSON BM, 1979, NATURE, V279, P692, DOI 10.1038/279692a0; Russell JE, 1996, BLOOD, V87, P5314, DOI 10.1182/blood.V87.12.5314.bloodjournal87125314; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Yu J, 2001, MOL CELL BIOL, V21, P5879, DOI 10.1128/MCB.21.17.5879-5888.2001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	51	67	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11756	10.1371/journal.pone.0011756	http://dx.doi.org/10.1371/journal.pone.0011756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668695	Green Submitted, Green Published, gold			2022-12-25	WOS:000280243800025
J	O'Hayre, M; Salanga, CL; Kipps, TJ; Messmer, D; Dorrestein, PC; Handel, TM				O'Hayre, Morgan; Salanga, Catherina L.; Kipps, Thomas J.; Messmer, Davorka; Dorrestein, Pieter C.; Handel, Tracy M.			Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; TUMOR-SUPPRESSOR PDCD4; FACTOR-I; B-CELLS; TRANSFORMATION SUPPRESSOR; BCR/ABL LEUKEMOGENESIS; ZAP-70 EXPRESSION; MASS-SPECTROMETRY; BINDING-PROTEIN; HNRNP A1	Background: Chronic Lymphocytic Leukemia (CLL) pathogenesis has been linked to the prolonged survival and/or apoptotic resistance of leukemic B cells in vivo, and is thought to be due to enhanced survival signaling responses to environmental factors that protect CLL cells from spontaneous and chemotherapy-induced death. Although normally associated with cell migration, the chemokine, CXCL12, is one of the factors known to support the survival of CLL cells. Thus, the signaling pathways activated by CXCL12 and its receptor, CXCR4, were investigated as components of these pathways and may represent targets that if inhibited, could render resistant CLL cells more susceptible to chemotherapy. Methodology/Principal Findings: To determine the downstream signaling targets that contribute to the survival effects of CXCL12 in CLL, we took a phosphoproteomics approach to identify and compare phosphopeptides in unstimulated and CXCL12-stimulated primary CLL cells. While some of the survival pathways activated by CXCL12 in CLL are known, including Akt and ERK1/2, this approach enabled the identification of additional signaling targets and novel phosphoproteins that could have implications in CLL disease and therapy. In addition to the phosphoproteomics results, we provide evidence from western blot validation that the tumor suppressor, programmed cell death factor 4 (PDCD4), is a previously unidentified phosphorylation target of CXCL12 signaling in all CLL cells probed. Additionally, heat shock protein 27 (HSP27), which mediates anti-apoptotic signaling and has previously been linked to chemotherapeutic resistance, was detected in a subset (similar to 25%) of CLL patients cells examined. Conclusions/Significance: Since PDCD4 and HSP27 have previously been associated with cancer and regulation of cell growth and apoptosis, these proteins may have novel implications in CLL cell survival and represent potential therapeutic targets. PDCD4 also represents a previously unknown signaling target of chemokine receptors; therefore, these observations increase our understanding of alternative pathways to migration that may be activated or inhibited by chemokines in the context of cancer cell survival.	[O'Hayre, Morgan; Salanga, Catherina L.; Dorrestein, Pieter C.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kipps, Thomas J.; Messmer, Davorka] Univ Calif San Diego, Rebecca & John Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	O'Hayre, M (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	thandel@ucsd.edu	Dorrestein, Pieter/ABF-2930-2020; Dorrestein, Pieter/D-5012-2012		California Breast Cancer Research Program [14GB-0147]; Ruth L. Kirschstein NIGMS [F31]; National Institutes of Health [RO1-AI37113]; Department of Defense [BC060331]; Lymphoma Research Foundation; V-Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER	California Breast Cancer Research Program; Ruth L. Kirschstein NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Lymphoma Research Foundation; V-Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a California Breast Cancer Research Program Dissertation Award (14GB-0147) to MO (http://www.cbcrp.org), a Ruth L. Kirschstein NIGMS MARC Predoctoral Fellowship (F31) to CLS, and awards from the National Institutes of Health (RO1-AI37113), the Department of Defense (BC060331), and the Lymphoma Research Foundation (http://www.lymphoma.org) to TMH, TJK and DM and the V-Foundation Scholar Award (http://www.jimmyv.org) to PCD. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blees JS, 2010, J BIOMOL SCREEN, V15, P21, DOI 10.1177/1087057109351028; Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Castro JE, 2005, BLOOD, V106, P2506, DOI 10.1182/blood-2005-03-1099; Chauhan D, 2003, CANCER RES, V63, P6174; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; COLLINS RJ, 1989, BRIT J HAEMATOL, V71, P343; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eiring AM, 2008, BLOOD, V111, P816, DOI 10.1182/blood-2007-05-090472; Favaro PMB, 2003, BIOCHEM BIOPH RES CO, V311, P365, DOI 10.1016/j.bbrc.2003.10.012; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gabelloni ML, 2008, BRIT J HAEMATOL, V140, P117, DOI 10.1111/j.1365-2141.2007.06891.x; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Ghia P, 2005, CURR TOP MICROBIOL, V294, P135, DOI 10.1007/3-540-29933-5_8; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Huang MR, 1997, GENE THER, V4, P1093, DOI 10.1038/sj.gt.3300499; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lee JT, 2002, LEUKEMIA, V16, P486, DOI 10.1038/sj/leu/2402460; LIN CS, 1993, J BIOL CHEM, V268, P2781; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Matthiesen R, 2010, METHODS MOL BIOL, V593, P187, DOI 10.1007/978-1-60327-194-3_10; MELHEM RF, 1991, J BIOL CHEM, V266, P17747; Mohle R, 1999, LEUKEMIA, V13, P1954, DOI 10.1038/sj.leu.2401602; Montresor A, 2009, CANCER RES, V69, P9281, DOI 10.1158/0008-5472.CAN-09-2009; Morley SC, 2010, J IMMUNOL, V184, P3628, DOI 10.4049/jimmunol.0903851; Moser K, 2006, J PROTEOME RES, V5, P98, DOI 10.1021/pr0503073; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; O'Hayre M, 2009, METHOD ENZYMOL, V460, P331, DOI 10.1016/S0076-6879(09)05216-1; Obermann EC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-162; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parrado A, 2000, Hematol J, V1, P15, DOI 10.1038/sj.thj.6200012; Payne SH, 2008, J PROTEOME RES, V7, P3373, DOI 10.1021/pr800129m; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schorr RA, 2009, J MAMMAL, V90, P17, DOI 10.1644/07-MAMM-A-392.1; Scielzo C, 2005, J CLIN INVEST, V115, P1644, DOI 10.1172/JCI24276; Shitashige M, 2007, CANCER SCI, V98, P1862, DOI 10.1111/j.1349-7006.2007.00629.x; Shitashige M, 2007, GASTROENTEROLOGY, V132, P1039, DOI 10.1053/j.gastro.2007.01.007; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Till KJ, 2002, BLOOD, V99, P2977, DOI 10.1182/blood.V99.8.2977; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Want EJ, 2005, CHEMBIOCHEM, V6, P1941, DOI 10.1002/cbic.200500151; Wu Y, 2007, BIOCHEM BIOPH RES CO, V358, P170, DOI 10.1016/j.bbrc.2007.04.104; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	60	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11716	10.1371/journal.pone.0011716	http://dx.doi.org/10.1371/journal.pone.0011716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661426	gold, Green Submitted, Green Published			2022-12-25	WOS:000280243300018
J	Johansson, F; Lederer, B; Lind, MI				Johansson, Frank; Lederer, Baptiste; Lind, Martin I.			Trait Performance Correlations across Life Stages under Environmental Stress Conditions in the Common Frog, Rana temporaria	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; POST-METAMORPHIC TRAITS; DEVELOPMENTAL PLASTICITY; LARVAL DEVELOPMENT; NATURAL-SELECTION; SPADEFOOT TOADS; HISTORY TRAITS; ANURAN LARVAE; BODY SHAPE; TREE FROG	If an organism's juvenile and adult life stages inhabit different environments, certain traits may need to be independently adapted to each environment. In many organisms, a move to a different environment during ontogeny is accompanied by metamorphosis. In such organisms phenotypic induction early in ontogeny can affect later phenotypes. In laboratory experiments we first investigated correlations between body morphology and the locomotor performance traits expressed in different life stages of the common frog, Rana temporaria: swimming speed and acceleration in tadpoles; and jump-distance in froglets. We then tested for correlations between these performances across life stages. We also subjected tadpoles to unchanging or decreasing water levels to explore whether decreasing water levels might induce any carry-over effects. Body morphology and performance were correlated in tadpoles; morphology and performance were correlated in froglets: hence body shape and morphology affect performance within each life stage. However, performance was decoupled across life stages, as there was no correlation between performance in tadpoles and performance in froglets. While size did not influence tadpole performance, it was correlated with performance of the metamorphosed froglets. Experiencing decreasing water levels accelerated development time, which resulted in smaller tadpoles and froglets, i.e., a carry-over effect. Interestingly, decreasing water levels positively affected the performance of tadpoles, but negatively affected froglet performance. Our results suggest that performance does not necessarily have to be correlated between life stages. However, froglet performance is size dependent and carried over from the tadpole stage, suggesting that some important size-dependent characters cannot be decoupled via metamorphosis.	[Johansson, Frank; Lederer, Baptiste; Lind, Martin I.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Umea University	Johansson, F (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	frank.johansson@emg.umu.se	Lind, Martin/A-4189-2011	Lind, Martin/0000-0001-5602-1933	Swedish Research Council; Swedish Research Council FORMAS	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Swedish Research Council and Swedish Research Council FORMAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2003, EVOLUTION, V57, P872; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; BLEM CR, 1978, HERPETOLOGICA, V34, P288; BLOUIN MS, 1992, EVOLUTION, V46, P735, DOI 10.1111/j.1558-5646.1992.tb02079.x; Brooks RT, 2009, CLIMATIC CHANGE, V95, P469, DOI 10.1007/s10584-008-9531-9; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.1111/j.1558-5646.1988.tb02514.x; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; Emerson S.B., 1985, P58; EMERSON SB, 1978, EVOLUTION, V32, P551, DOI 10.1111/j.1558-5646.1978.tb04598.x; Ernande B, 2003, J EVOLUTION BIOL, V16, P399, DOI 10.1046/j.1420-9101.2003.00543.x; Ficetola GF, 2006, EVOL ECOL, V20, P143, DOI 10.1007/s10682-005-5508-6; Gasc J. P., 1997, ATLAS AMPHIBIANS REP, P496; Gomez-Mestre I, 2006, P NATL ACAD SCI USA, V103, P19021, DOI 10.1073/pnas.0603562103; Gosner K. L., 1960, Herpetologica, V16, P183; Hadfield JD, 2007, J EVOLUTION BIOL, V20, P549, DOI 10.1111/j.1420-9101.2006.01262.x; Henein J.T., 1997, AM MIDL NAT, V137, P136; Johansson F, 2005, EVOL ECOL RES, V7, P1025; JOHNALDER HB, 1990, COPEIA, P856, DOI 10.2307/1446453; Laugen AT, 2002, BIOL J LINN SOC, V76, P61, DOI 10.1046/j.1095-8312.2002.00048.x; Laurila A, 2002, EVOLUTION, V56, P617; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; Lind MI, 2008, P ROY SOC LOND B BIO, V275, P1071; Liu H, 1996, J EXP BIOL, V199, P1245; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moran N. A., 1994, ANNU REV ECOL SYST, V25, P73; Morey SR, 2004, OIKOS, V104, P172, DOI 10.1111/j.0030-1299.2004.12623.x; Nauwelaerts S, 2007, J ANAT, V210, P304, DOI 10.1111/j.1469-7580.2007.00691.x; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Phillips PC, 1998, J EVOLUTION BIOL, V11, P453, DOI 10.1007/s000360050099; Plaistow SJ, 2004, P ROY SOC B-BIOL SCI, V271, P919, DOI 10.1098/rspb.2004.2682; Relyea RA, 2003, OECOLOGIA, V134, P596, DOI 10.1007/s00442-002-1161-8; Relyea RA, 2001, ECOLOGY, V82, P1947, DOI 10.1890/0012-9658(2001)082[1947:TLEOAP]2.0.CO;2; Richardson JML, 2002, EVOL ECOL RES, V4, P627; Richter-Boix A, 2006, EVOL ECOL RES, V8, P309; ROHLF FJ, 2007, TPS REGR VERSION 1 3; ROHLF FJ, 2003, TPS DIG VERSION 1 37; ROHLF FJ, 2003, TPS PLS VERSION 1 18; Savage R.M., 1961, ECOLOGY LIFE HIST CO; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; *SYSTAT SOFTW INC, 2007, SYST VERS 12 02; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Van Buskirk J, 2000, J EXP BIOL, V203, P2149; Van Buskirk J, 1999, OIKOS, V85, P31, DOI 10.2307/3546789; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 1997, EVOLUTION, V51, P1983, DOI 10.1111/j.1558-5646.1997.tb05119.x; Vences M, 2002, J ZOOL, V257, P155, DOI 10.1017/S0952836902000754; WASSERSUG RJ, 1985, J EXP BIOL, V119, P1; WASSERSUG RJ, 1977, ECOLOGY, V58, P830, DOI 10.2307/1936218; Watkins TB, 2001, EVOLUTION, V55, P1668	51	61	64	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11680	10.1371/journal.pone.0011680	http://dx.doi.org/10.1371/journal.pone.0011680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657779	gold, Green Published, Green Submitted			2022-12-25	WOS:000280197500021
J	Pavie, J; Rachline, A; Loze, B; Niedbalski, L; Delaugerre, C; Laforgerie, E; Plantier, JC; Rozenbaum, W; Chevret, S; Molina, JM; Simon, F				Pavie, Juliette; Rachline, Anne; Loze, Benedicte; Niedbalski, Laurence; Delaugerre, Constance; Laforgerie, Eric; Plantier, Jean-Christophe; Rozenbaum, Willy; Chevret, Sylvie; Molina, Jean-Michel; Simon, Francois			Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; INFECTION; ANTIBODY; DIAGNOSIS; POPULATION; ANTIGEN; AFRICA; ACCESS; ASSAYS	Background: Health authorities in several countries recently recommended the expansion of human immunodeficiency virus (HIV) antibody testing, including the use of rapid tests. Several HIV rapid tests are now licensed in Europe but their sensitivity on total blood and/or oral fluid in routine healthcare settings is not known. Methods and Findings: 200 adults with documented HIV-1 (n = 194) or HIV-2 infection (n = 6) were prospectively screened with five HIV rapid tests using either oral fluid (OF) or finger-stick whole blood (FSB). The OraQuick Advance rapid HIV1/2(R) was first applied to OF and then to FSB, while the other tests were applied to FSB, in the following order: Vikia HIV 1/2(R), Determine HIV 1-2(R), Determine(R) HIV-1/2 Ag/Ab Combo(R) and INSTI HIV-1/HIV-2(R). Tests negative on FSB were repeated on paired serum samples. Twenty randomly selected HIV-seronegative subjects served as controls, and the results were read blindly. Most patients had HIV-1 subtype B infection (63.3%) and most were on antiretroviral therapy (68.5%). Sensitivity was 86.5%, 94.5%, 98.5%, 94.9%, 95.8% and 99% respectively, with OraQuick OF, OraQuick FSB, Vikia, Determine, Determine Ag/Ab Combo and INSTI (p<0.0001). OraQuick was less sensitive on OF than on FSB (p = 0.008). Among the six patients with three or more negative tests, two had recent HIV infection and four patients on antiretroviral therapy had undetectable plasma viral load. When patients positive in all the tests were compared with patients who had at least one negative test, only a plasma HIV RNA level <200 cp/ml was significantly associated with a false-negative result (p = 0.009). When the 33 rapid tests negative on FSB were repeated on serum, all but six (5 negative with OraQuick, 1 with INSTI) were positive. The sensitivity of OraQuick, Determine and Determine Ag/Ab Combo was significantly better on serum than on FSB (97.5%, p = 0.04; 100%, p = 0.004; and 100%, p = 0.02, respectively). Conclusion: When evaluated in a healthcare setting, rapid HIV tests were less sensitive on oral fluid than on finger-stick whole blood and less sensitive on finger-stick whole blood than on serum.	[Pavie, Juliette; Rachline, Anne; Loze, Benedicte; Niedbalski, Laurence; Rozenbaum, Willy; Molina, Jean-Michel] Univ Paris Diderot, Hop St Louis, Serv Malad Infect & Trop, Paris, France; [Delaugerre, Constance; Simon, Francois] Univ Paris Diderot, Hop St Louis, Microbiol Serv, Paris, France; [Laforgerie, Eric] Agence Francaise Secur Sanit & Prod Sante, St Denis, France; [Plantier, Jean-Christophe] CHU Charles Nicolle, Ctr Natl Reference VIH, Lab Associe, Rouen, France; [Chevret, Sylvie] Univ Paris Diderot, Hop St Louis, Dept Biostat & Informat Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Pavie, J (corresponding author), Univ Paris Diderot, Hop St Louis, Serv Malad Infect & Trop, Paris, France.	francois.simon@sls.aphp.fr		PLANTIER, Jean-Christophe/0000-0001-6417-4083; Rozenbaum, Willy/0000-0003-1975-3566; chevret, sylvie/0000-0001-6449-4730	"Agence Francaise pour la Securite Sanitaire et les Produits Sanguins" (AFSSAPS)	"Agence Francaise pour la Securite Sanitaire et les Produits Sanguins" (AFSSAPS)	The official national agency, "Agence Francaise pour la Securite Sanitaire et les Produits Sanguins'' (AFSSAPS), funded this study by buying all the tests and reagents and supporting the management. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. E. Laforgerie, coauthor from Afssaps, participated in the design of the study.	Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; APETREI C, 1996, AIDS, V10, P57; Barin F, 2007, AIDS, V21, P2351, DOI 10.1097/QAD.0b013e3282f15637; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CONS NAT SID, RAPP EV DISP DEP INF; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Everett DB, 2009, J CLIN MICROBIOL, V47, P1058, DOI 10.1128/JCM.01998-08; Facente SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008217; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gautheret-Dejean A, 2008, CLIN INFECT DIS, V46, P1936, DOI 10.1086/588561; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; HOLGUI NA, 2009, J CLIN VIROL, V45, P150; *JOINT UN PROGR HI, 1997, WKLY EPIDEMIOL REC, V72, P81; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Laforgerie E, 2010, J VIROL METHODS, V165, P105, DOI 10.1016/j.jviromet.2009.12.007; Leung DHY, 2009, BIOSTATISTICS, V10, P436, DOI 10.1093/biostatistics/kxp002; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Ly TD, 2007, J VIROL METHODS, V143, P86, DOI 10.1016/j.jviromet.2007.02.013; Makuwa M, 2002, J VIROL METHODS, V103, P183, DOI 10.1016/S0166-0934(02)00026-5; SCHOCHETMAN G, 1992, AIDS TESTING METHODO; Scott LE, 2009, JAIDS-J ACQ IMM DEF, V51, P646, DOI 10.1097/QAI.0b013e3181a448ac; Simon F, 2001, AIDS RES HUM RETROV, V17, P937, DOI 10.1089/088922201750290050; Smith W, 1996, BIOMETRICS, V52, P1063, DOI 10.2307/2533067; SPIELBERG F, 1989, LANCET, V1, P580; Stekler J, 2007, ANN INTERN MED, V147, P147, DOI 10.7326/0003-4819-147-2-200707170-00022; Stekler JD, 2009, CLIN INFECT DIS, V49, P444, DOI 10.1086/600043; TARDY JC, 2009, JOURN NAT INFECTIOLO; VONSYDOW M, 1988, BMJ-BRIT MED J, V296, P238, DOI 10.1136/bmj.296.6617.238; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; Wesolowski LG, 2009, J CLIN MICROBIOL, V47, P3333, DOI 10.1128/JCM.01504-09; 2001, MMWR, V50, P1	34	120	120	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11581	10.1371/journal.pone.0011581	http://dx.doi.org/10.1371/journal.pone.0011581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657834	Green Submitted, Green Published, gold			2022-12-25	WOS:000280065600006
J	Yang, L; Xue, Z; He, Y; Sun, SY; Chen, H; Qi, L				Yang, Liu; Xue, Zhen; He, Yin; Sun, Shengyi; Chen, Hui; Qi, Ling			A Phos-Tag-Based Approach Reveals the Extent of Physiological Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSMEMBRANE PROTEIN; CELL; ER; PANCREAS; KINASE; DEFICIENCY; INDUCTION; TRANSPORT; DISTINCT	Cellular response to endoplasmic reticulum (ER) stress or unfolded protein response (UPR) is a key defense mechanism associated with many human diseases. Despite its basic and clinical importance, the extent of ER stress inflicted by physiological and pathophysiological conditions remains difficult to quantitate, posing a huge obstacle that has hindered our further understanding of physiological UPR and its future therapeutic potential. Here we have optimized a Phos-tag-based system to detect the activation status of two proximal UPR sensors at the ER membrane. This method allowed for a quantitative assessment of the level of stress in the ER. Our data revealed quantitatively the extent of tissue-specific basal ER stress as well as ER stress caused by the accumulation of misfolded proteins and the fasting-refeeding cycle. Our study may pave the foundation for future studies on physiological UPR, aid in the diagnosis of ER-associated diseases and improve and facilitate therapeutic strategies targeting UPR in vivo.	[Yang, Liu; Sun, Shengyi; Qi, Ling] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Xue, Zhen; Qi, Ling] Cornell Univ, Grad Program Nutr, Ithaca, NY USA; [He, Yin; Qi, Ling] Cornell Univ, Grad Program Genet & Dev, Ithaca, NY USA; [Chen, Hui; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY USA	Cornell University; Cornell University; Cornell University; Cornell University	Yang, L (corresponding author), Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA.	lq35@cornell.edu		Qi, Ling/0000-0001-8229-0184; Sun, Shengyi/0000-0002-1734-3902	Stip Olin Fellowship; NIH [5 T32 GM007617, R01DK082582]; Rosalinde and Arthur Foundation/AFAR; American Federation for Aging Research [RAG08061]; ADA Junior Faculty; American Diabetes Association [7-08-JF-47]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER	Stip Olin Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalinde and Arthur Foundation/AFAR; American Federation for Aging Research; ADA Junior Faculty; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L.Y. was supported in part by the Stip Olin Fellowship (to L.Y.) and Y.H. was supported in part by the NIH Predoctoral Training Grant in Genetics and Development (5 T32 GM007617). L. Q. is the recipient of the 2008 Rosalinde and Arthur Foundation/AFAR New Investigator Award in Alzheimer's Diseases and the ADA Junior Faculty Award. This study was supported in part by American Federation for Aging Research (RAG08061), American Diabetes Association (7-08-JF-47) and NIH R01DK082582 (to L.Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Masaki T, 1999, BIOCHEM BIOPH RES CO, V261, P350, DOI 10.1006/bbrc.1999.0972; Miyata Y, 2008, BIOCHEM BIOPH RES CO, V365, P826, DOI 10.1016/j.bbrc.2007.11.045; MORI K, 1993, CELL, V74, P743; MORISSET JA, 1972, J CLIN INVEST, V51, P1, DOI 10.1172/JCI106779; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Reimold AM, 2000, GENE DEV, V14, P152; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SLOT JW, 1979, J CELL BIOL, V80, P692, DOI 10.1083/jcb.80.3.692; SLOT JW, 1979, J CELL BIOL, V80, P708, DOI 10.1083/jcb.80.3.708; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	32	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11621	10.1371/journal.pone.0011621	http://dx.doi.org/10.1371/journal.pone.0011621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661282	Green Submitted, Green Published, gold			2022-12-25	WOS:000279980800010
J	Boland, MP; Hatty, CR; Separovic, F; Hill, AF; Tew, DJ; Barnham, KJ; Haigh, CL; James, M; Masters, CL; Collins, SJ				Boland, Martin P.; Hatty, Claire R.; Separovic, Frances; Hill, Andrew F.; Tew, Deborah J.; Barnham, Kevin J.; Haigh, Cathryn L.; James, Michael; Masters, Colin L.; Collins, Steven J.			Anionic Phospholipid Interactions of the Prion Protein N Terminus Are Minimally Perturbing and Not Driven Solely by the Octapeptide Repeat Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; LIPID-PEROXIDATION; RELAXATION-TIME; COPPER-BINDING; METAL-IONS; CELL-LINE; PHOSPHATIDYLSERINE; SURFACE	Although the N terminus of the prion protein (PrPC) has been shown to directly associate with lipid membranes, the precise determinants, biophysical basis, and functional implications of such binding, particularly in relation to endogenously occurring fragments, are unresolved. To better understand these issues, we studied a range of synthetic peptides: specifically those equating to the N1 (residues 23-110) and N2 (23-89) fragments derived from constitutive processing of PrPC and including those representing arbitrarily defined component domains of the N terminus of mouse prion protein. Utilizing more physiologically relevant large unilamellar vesicles, fluorescence studies at synaptosomal pH (7.4) showed absent binding of all peptides to lipids containing the zwitterionic headgroup phos-phatidylcholine and mixtures containing the anionic headgroups phosphatidylglycerol or phosphatidylserine. At pH 5, typical of early endosomes, quartz crystal microbalance with dissipation showed the highest affinity binding occurred with N1 and N2, selective for anionic lipid species. Of particular note, the absence of binding by individual peptides representing component domains underscored the importance of the combination of the octapeptide repeat and the N-terminal polybasic regions for effective membrane interaction. In addition, using quartz crystal microbalance with dissipation and solid-state NMR, we characterized for the first time that both N1 and N2 deeply insert into the lipid bilayer with minimal disruption. Potential functional implications related to cellular stress responses are discussed.	[Boland, Martin P.; Tew, Deborah J.; Barnham, Kevin J.; Haigh, Cathryn L.; Collins, Steven J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Boland, Martin P.; Hill, Andrew F.; Tew, Deborah J.; Barnham, Kevin J.; Haigh, Cathryn L.; Masters, Colin L.; Collins, Steven J.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia; [Separovic, Frances] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Hill, Andrew F.; Tew, Deborah J.; Barnham, Kevin J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Hatty, Claire R.; James, Michael] Australian Nucl Sci & Technol Org, Bragg Inst, Lucas Heights, NSW 2234, Australia; [Hatty, Claire R.] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [James, Michael] Univ New S Wales, Sch Chem, Kensington, NSW 2052, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Australian Nuclear Science & Technology Organisation; University of Sydney; University of New South Wales Sydney	Collins, SJ (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.	stevenjc@unimelb.edu.au	Separovic, Frances/D-9698-2011; Hill, Andrew F./AAH-2854-2020; James, Michael/A-8960-2011; Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022	Separovic, Frances/0000-0002-6484-2763; James, Michael/0000-0002-4918-2998; Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Haigh, Cathryn/0000-0001-7591-1149; Hatty, Claire/0000-0003-4870-9820	Australian Nuclear Science and Technology Organisation/University of Melbourne; National Health and Medical Research Council [400202]	Australian Nuclear Science and Technology Organisation/University of Melbourne(University of Melbourne); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by an Australian Nuclear Science and Technology Organisation/University of Melbourne collaboration grant.; Supported by National Health and Medical Research Council fellowships with further funding from National Health and Medical Research Council Program Grant 400202.	Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; BEVERS EM, 1989, BIOCHEMISTRY-US, V28, P2382, DOI 10.1021/bi00432a007; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Castegna A, 2004, BRAIN RES, V1004, P193, DOI 10.1016/j.brainres.2004.01.036; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Christ K, 2008, J MEMBRANE BIOL, V226, P9, DOI 10.1007/s00232-008-9134-4; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; Dong SL, 2007, BIOPOLYMERS, V88, P840, DOI 10.1002/bip.20860; DUFOURC EJ, 1992, BIOPHYS J, V61, P42, DOI 10.1016/S0006-3495(92)81814-3; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FADOK VA, 1992, J IMMUNOL, V148, P2207; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Farge E, 1995, BIOPHYS J, V69, P2501, DOI 10.1016/S0006-3495(95)80120-7; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Haigh CL, 2009, CELL RES, V19, P1062, DOI 10.1038/cr.2009.86; Haigh CL, 2009, J CELL SCI, V122, P1518, DOI 10.1242/jcs.043604; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; Koenig BW, 1996, LANGMUIR, V12, P1343, DOI 10.1021/la950580r; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lau TL, 2006, J MOL BIOL, V356, P759, DOI 10.1016/j.jmb.2005.11.091; Lau TL, 2007, BBA-BIOMEMBRANES, V1768, P2400, DOI 10.1016/j.bbamem.2007.05.004; Mechler A, 2007, BIOPHYS J, V93, P3907, DOI 10.1529/biophysj.107.116525; Miura T, 1999, BIOCHEMISTRY-US, V38, P11560, DOI 10.1021/bi9909389; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; MURPHY EJ, 1993, LIPIDS, V28, P67, DOI 10.1007/BF02536364; MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757; Oglecka K, 2008, BBA-BIOMEMBRANES, V1778, P206, DOI 10.1016/j.bbamem.2007.09.034; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PLAGER DA, 1994, BIOCHEMISTRY-US, V33, P7005, DOI 10.1021/bi00188a033; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pukala TL, 2007, BIOCHEMISTRY-US, V46, P3576, DOI 10.1021/bi062306+; Re F, 2008, FEBS LETT, V582, P215, DOI 10.1016/j.febslet.2007.12.003; Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; Separovic F, 2000, CHEM PHYS LIPIDS, V107, P159, DOI 10.1016/S0009-3084(00)00168-7; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang XH, 2006, J BIOL CHEM, V281, P13559, DOI 10.1074/jbc.M512306200; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zeng FN, 2003, J NEUROCHEM, V84, P480, DOI 10.1046/j.1471-4159.2003.01529.x	67	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32282	32292		10.1074/jbc.M110.123398	http://dx.doi.org/10.1074/jbc.M110.123398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679345	Green Published, hybrid			2022-12-25	WOS:000282683000041
J	Drury, GL; Di Marco, S; Dormoy-Raclet, V; Desbarats, J; Gallouzi, IE				Drury, Gillian L.; Di Marco, Sergio; Dormoy-Raclet, Virginie; Desbarats, Julie; Gallouzi, Imed-Eddine			FasL Expression in Activated T Lymphocytes Involves HuR-mediated Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN HUR; AU-RICH ELEMENT; MESSENGER-RNA STABILITY; TNF-ALPHA; KINASE-C; CELL-ACTIVATION; ELAV PROTEINS; PHOSPHORYLATION; GENE; REGION	A prolonged activation of the immune system is one of the main causes of hyperproliferation of lymphocytes leading to defects in immune tolerance and autoimmune diseases. Fas ligand (FasL), a member of the TNF superfamily, plays a crucial role in controlling this excessive lymphoproliferation by inducing apoptosis in T cells leading to their rapid elimination. Here, we establish that posttranscriptional regulation is part of the molecular mechanisms that modulate FasL expression, and we show that in activated T cells FasL mRNA is stable. Our sequence analysis indicates that the FasL 3'-untranslated region (UTR) contains two AU-rich elements (AREs) that are similar in sequence and structure to those present in the 3'-UTR of TNF-alpha mRNA. Through these AREs, the FasL mRNA forms a complex with the RNA-binding protein HuR both in vitro and ex vivo. Knocking down HuR in HEK 293 cells prevented the phorbol 12-myristate 13-acetate-induced expression of a GFP reporter construct fused to the FasL 3'-UTR. Collectively, our data demonstrate that the posttranscriptional regulation of FasL mRNA by HuR represents a novel mechanism that could play a key role in the maintenance and proper functioning of the immune system.	[Di Marco, Sergio; Dormoy-Raclet, Virginie; Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Di Marco, Sergio; Dormoy-Raclet, Virginie; Gallouzi, Imed-Eddine] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 906A,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	imed.gallouzi@mcgill.ca		Desbarats, Julie/0000-0002-2495-7152; Di Marco, Sergio/0000-0002-4039-0600	Fonds de Recherche en Sante du Quebec; Canadian Cancer Society Research Institute [018125]; Canadian Cancer Society (formerly National Cancer Institute of Canada); Tier II Canada Research Chair	Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Cancer Society (formerly National Cancer Institute of Canada); Tier II Canada Research Chair	This work was supported by a Fonds de Recherche en Sante du Quebec Doctoral Research Award (to G. L. D.) and by Operating Grant 018125 from the Canadian Cancer Society Research Institute (to I.-E. G.).; Research Fellow of the Terry Fox Foundation through an award from the Canadian Cancer Society (formerly National Cancer Institute of Canada).; Recipient of a Tier II Canada Research Chair. To whom correspondence should be addressed: Dept. of Biochemistry, McGill University, McIntyre Bldg., Rm. 906A, 3655 Promenade Sir William Osler, Montreal, Quebec H3G 1Y6, Canada. Fax: 1-514-398-7384; E-mail: imed.gallouzi@mcgill.ca.	Antic D, 1998, J CELL SCI, V111, P183; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Atasoy U, 1998, J CELL SCI, V111, P3145; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bol GF, 1997, BBA-MOL CELL RES, V1358, P307, DOI 10.1016/S0167-4889(97)00073-6; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Chemnitz J, 2009, EUR J IMMUNOL, V39, P267, DOI 10.1002/eji.200838619; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Chien EJ, 2001, J CELL BIOCHEM, V81, P604, DOI 10.1002/jcb.1089; Chow WA, 2000, J IMMUNOL, V164, P3512, DOI 10.4049/jimmunol.164.7.3512; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Ford GS, 1999, J IMMUNOL, V162, P4037; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0; HUANG HS, 1991, J COMP PATHOL, V105, P191, DOI 10.1016/S0021-9975(08)80075-8; Jacob CO, 1996, J IMMUNOL, V156, P3043; Jacobs DB, 1996, LIFE SCI, V58, P2083, DOI 10.1016/0024-3205(96)00202-0; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; KATSANOU V, 2006, ERNST SCHERING FOUND, V4, P37; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Li-Weber M, 1999, EUR J IMMUNOL, V29, P3017, DOI 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Sakai K, 2003, MOL IMMUNOL, V39, P879, DOI 10.1016/S0161-5890(03)00007-5; Senju S, 1996, INT IMMUNOL, V8, P423, DOI 10.1093/intimm/8.3.423; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; TOBLER A, 1988, J CLIN INVEST, V81, P1819, DOI 10.1172/JCI113525; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	16	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31130	31138		10.1074/jbc.M110.137919	http://dx.doi.org/10.1074/jbc.M110.137919			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675370	Green Published, hybrid			2022-12-25	WOS:000282764600006
J	Vostrikov, VV; Daily, AE; Greathouse, DV; Koeppe, RE				Vostrikov, Vitaly V.; Daily, Anna E.; Greathouse, Denise V.; Koeppe, Roger E., II			Charged or Aromatic Anchor Residue Dependence of Transmembrane Peptide Tilt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; ALPHA-HELICAL PEPTIDES; HYDROPHOBIC MISMATCH; MEMBRANE-PROTEINS; LIPID-BILAYERS; TRYPTOPHAN RESIDUES; GEOMETRIC ANALYSIS; FLANKING RESIDUES; ROTATION ANGLES; H-2 NMR	The membrane-spanning segments of integral membrane proteins often are flanked by aromatic or charged amino acid residues, which may "anchor" the transmembrane orientation. Single spanning transmembrane peptides such as those of the WALP family, acetyl-GWW(LA)(n)LWWA-amide, furthermore adopt a moderate average tilt within lipid bilayer membranes. To understand the anchor residue dependence of the tilt, we introduce Leu-Ala "spacers" between paired anchors and in some cases replace the outer tryptophans. The resulting peptides, acetyl-GX(2)ALW(LA)(6)LWLAX(22)A-amide, have Trp, Lys, Arg, or Gly in the two X positions. The apparent average orientations of the core helical sequences were determined in oriented phosphatidylcholine bilayer membranes of varying thickness using solid-state H-2 NMR spectroscopy. When X is Lys, Arg, or Gly, the direction of the tilt is essentially constant in different lipids and presumably is dictated by the tryptophans (Trp(5) and Trp(19)) that flank the inner helical core. The Leu-Ala spacers are no longer helical. The magnitude of the apparent helix tilt furthermore scales nicely with the bilayer thickness except when X is Trp. When X is Trp, the direction of tilt is less well defined in each phosphatidylcholine bilayer and varies up to 70 degrees among 1,2-dioleoyl-sn-glycero-3-phosphocholine, 1,2-dimyristoyl-sn-glycero-3-phosphocholine, and 1,2-dilauroyl-sn-glycero-3-phosphocholine bilayer membranes. Indeed, the X = Trp case parallels earlier observations in which WALP family peptides having multiple Trp anchors show little dependence of the apparent tilt magnitude on bilayer thickness. The results shed new light on the interactions of arginine, lysine, tryptophan, and even glycine at lipid bilayer membrane interfaces.	[Vostrikov, Vitaly V.; Daily, Anna E.; Greathouse, Denise V.; Koeppe, Roger E., II] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Koeppe, RE (corresponding author), Univ Arkansas, Dept Chem & Biochem, 119 Chem Bldg, Fayetteville, AR 72701 USA.	rk2@uark.edu	Vostrikov, Vitaly/B-4986-2008; Vossen, Val/O-8144-2019	Vostrikov, Vitaly/0000-0001-9598-0600; Vossen, Val/0000-0001-9598-0600; Koeppe, Roger/0000-0003-0676-6413	National Science Foundation [MCB-0841227]; Arkansas Biosciences Institute; National Institutes of Health [RR 15569]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Arkansas Biosciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Science Foundation Grant MCB-0841227 and by the Arkansas Biosciences Institute.; The NMR facility was supported by National Institutes of Health Grant RR 15569.	Aisenbrey C, 2004, J AM CHEM SOC, V126, P16676, DOI 10.1021/ja0468675; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; Chiang CS, 2005, BIOCHEMISTRY-US, V44, P12589, DOI 10.1021/bi050750r; Daily AE, 2008, BIOPHYS J, V94, P480, DOI 10.1529/biophysj.106.097543; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; de Planque MRR, 1999, J BIOL CHEM, V274, P20839, DOI 10.1074/jbc.274.30.20839; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; DEPLANQUE MR, 2002, J A BIOCH, V41, P8396; DEPLANQUE MR, 1998, J A BIOCH, V37, P9333; Esteban-Martin S, 2007, BIOPHYS J, V93, P4278, DOI 10.1529/biophysj.107.113043; Esteban-Martin S, 2009, BIOCHEMISTRY-US, V48, P11441, DOI 10.1021/bi901017y; Esteban-Martin S, 2009, BIOPHYS J, V96, P3233, DOI 10.1016/j.bpj.2008.12.3950; Gibbons WJ, 2006, BIOPHYS J, V90, P1249, DOI 10.1529/biophysj.105.067884; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Greathouse D V, 1999, Methods Enzymol, V294, P525; Hautbergue GM, 2008, J MAGN RESON, V191, P335, DOI 10.1016/j.jmr.2007.12.017; Holt A, 2010, BIOPHYS J, V98, P1864, DOI 10.1016/j.bpj.2010.01.016; Holt A, 2009, BIOPHYS J, V97, P2258, DOI 10.1016/j.bpj.2009.07.042; Isidro-Llobet A, 2009, CHEM REV, V109, P2455, DOI 10.1021/cr800323s; Killian JA, 1996, BIOCHEMISTRY-US, V35, P1037, DOI 10.1021/bi9519258; Kovacs FA, 2000, J MOL BIOL, V295, P117, DOI 10.1006/jmbi.1999.3322; Morein S, 2002, BIOPHYS J, V82, P1405, DOI 10.1016/S0006-3495(02)75495-7; Nomura K, 2005, BIOPHYS J, V89, P4067, DOI 10.1529/biophysj.105.070292; OCONNELL AM, 1990, SCIENCE, V250, P1256, DOI 10.1126/science.1700867; Ozdirekcan S, 2007, J AM CHEM SOC, V129, P15174, DOI 10.1021/ja073784q; Ozdirekcan S, 2005, BIOCHEMISTRY-US, V44, P1004, DOI 10.1021/bi0481242; Page RC, 2008, STRUCTURE, V16, P787, DOI 10.1016/j.str.2008.02.018; Page RC, 2009, PROTEIN SCI, V18, P134, DOI 10.1002/pro.24; SEPAROVIC F, 1994, BIOPHYS J, V67, P1495, DOI 10.1016/S0006-3495(94)80623-X; Stopar D, 2006, CHEM PHYS LIPIDS, V141, P83, DOI 10.1016/j.chemphyslip.2006.02.023; Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402; Strandberg E, 2002, BIOCHEMISTRY-US, V41, P7190, DOI 10.1021/bi012047i; Strandberg E, 2009, BIOPHYS J, V96, P3223, DOI 10.1016/j.bpj.2009.02.040; Stromstedt AA, 2009, BBA-BIOMEMBRANES, V1788, P1916, DOI 10.1016/j.bbamem.2009.06.001; TENKORTENAAR PBW, 1986, INT J PEPT PROT RES, V27, P398; Thomas R, 2009, BIOCHEMISTRY-US, V48, P11883, DOI 10.1021/bi9016395; van der Wel PCA, 2007, BIOCHEMISTRY-US, V46, P7514, DOI 10.1021/bi700082v; van der Wel PCA, 2002, BIOPHYS J, V83, P1479, DOI 10.1016/S0006-3495(02)73918-0; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Vostrikov VV, 2008, J AM CHEM SOC, V130, P12584, DOI 10.1021/ja803734k; Vostrikov VV, 2010, J AM CHEM SOC, V132, P5803, DOI 10.1021/ja100598e; Vostrikov VV, 2009, BIOPHYS J, V96, p454A, DOI 10.1016/j.bpj.2008.12.2333; White SH, 2005, CURR OPIN STRUC BIOL, V15, P378, DOI 10.1016/j.sbi.2005.07.004; YAU WM, 1998, S H BIOCH, V37, P14713	44	55	55	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31723	31730		10.1074/jbc.M110.152470	http://dx.doi.org/10.1074/jbc.M110.152470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667827	Green Published, hybrid			2022-12-25	WOS:000282764600064
J	Yan, W; Si, Y; Slaymaker, S; Li, JC; Zheng, HL; Young, DL; Aslanian, A; Saunders, L; Verdin, E; Charo, IF				Yan, Wei; Si, Yue; Slaymaker, Sarah; Li, Jiachen; Zheng, Huili; Young, David L.; Aslanian, Ara; Saunders, Laura; Verdin, Eric; Charo, Israel F.			Zmynd15 Encodes a Histone Deacetylase-dependent Transcriptional Repressor Essential for Spermiogenesis and Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERM-CELL APOPTOSIS; GENE-EXPRESSION; HYPERACTIVATED MOTILITY; SPERMATOGENIC CELLS; CAUSES INFERTILITY; TRANSGENIC MICE; PROTEIN; TESTIS; MOUSE; DIFFERENTIATION	Spermatogenesis is a complex process through which male germ line stem cells undergo a multi-step differentiation program and sequentially become spermatogonia, spermatocytes, spermatids, and eventually spermatozoa. In this process, transcription factors act as switches that precisely regulate the expression of genes that in turn control the developmental program of male germ cells. Transcription factors identified to be essential for normal haploid gene expression all display transcription-activating effects and thus serve as the "on" switch for haploid gene expression. Here, we report that ZMYND15 acts as a histone deacetylase-dependent transcriptional repressor and controls normal temporal expression of haploid cell genes during spermiogenesis. Inactivation of Zmynd15 results in early activation of transcription of numerous important haploid genes including Prm1, Tnp1, Spem1, and Catpser3; depletion of late spermatids; and male infertility. ZMYND15 represents the first transcriptional repressor identified to be essential for sperm production and male fertility.	[Si, Yue; Slaymaker, Sarah; Aslanian, Ara; Charo, Israel F.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Yan, Wei; Li, Jiachen; Zheng, Huili; Young, David L.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Saunders, Laura; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yan, W (corresponding author), Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	wyan@medicine.nevada.edu; icharo@gladstone.ucsf.edu	Yan, Wei/G-1618-2011; Verdin, Eric/AAB-7999-2019; Yan, Wei/AAH-7943-2019	Verdin, Eric/0000-0003-3703-3183	National Institutes of Health [HL 52773, HL 63894, HD 048855, HD 05028, P20-RR-016464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050281, R03HD048855] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052773, R01HL063894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 52773 and HL 63894 (to I. F. C.) and HD 048855 and HD 05028 (to W.Y.). This work was also supported by National Institutes of Health Grant P20-RR-016464 (to the Nevada Genomic Center).	Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Aslanian AM, 2006, CIRCULATION, V114, P583, DOI 10.1161/CIRCULATIONAHA.105.540583; Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hecht N B, 1988, Prog Clin Biol Res, V267, P291; HECHT NB, 1990, J REPROD FERTIL, V88, P679, DOI 10.1530/jrf.0.0880679; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; JIN JL, 2005, BIOL REPROD; LAHDETIE J, 1986, MUTAT RES, V172, P255, DOI 10.1016/0165-1218(86)90063-7; Lin YN, 2005, SEMIN REPROD MED, V23, P201, DOI 10.1055/s-2005-872448; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Pinnoji RC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-56; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; ROBINSON MO, 1989, P NATL ACAD SCI USA, V86, P8437, DOI 10.1073/pnas.86.21.8437; Sassone-Corsi P, 1998, SEMIN CELL DEV BIOL, V9, P475, DOI 10.1006/scdb.1998.0200; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; Weiss J, 2003, MOL CELL BIOL, V23, P8084, DOI 10.1128/MCB.23.22.8084-8091.2003; Wu MH, 2003, GENE EXPR PATTERNS, V3, P231, DOI 10.1016/S1567-133X(03)00036-X; Yan W, 2004, P NATL ACAD SCI USA, V101, P7793, DOI 10.1073/pnas.0308025101; Yan W, 2002, MECH DEVELOP, V118, P247, DOI 10.1016/S0925-4773(02)00261-7; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhang LP, 1999, BIOL REPROD, V60, P1329, DOI 10.1095/biolreprod60.6.1329; Zhang Y, 2004, BIOINFORMATICS, V20, P2390, DOI 10.1093/bioinformatics/bth256; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pD156, DOI 10.1093/nar/gkl782; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104	51	40	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31418	31426		10.1074/jbc.M110.116418	http://dx.doi.org/10.1074/jbc.M110.116418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675388	Green Published, hybrid			2022-12-25	WOS:000282764600036
J	Zhou, RF; Kabra, R; Olson, DR; Piper, RC; Snyder, PM				Zhou, Ruifeng; Kabra, Rajesh; Olson, Diane R.; Piper, Robert C.; Snyder, Peter M.			Hrs Controls Sorting of the Epithelial Na+ Channel between Endosomal Degradation and Recycling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; SODIUM-CHANNEL; LIDDLES-SYNDROME; MULTIVESICULAR BODIES; MEMBRANE-PROTEINS; UBIQUITIN-BINDING; WW DOMAINS; NEDD4-2; LIGASE; PHOSPHORYLATION	Epithelial Na+ absorption is regulated by Nedd4-2, an E3 ubiquitin ligase that reduces expression of the epithelial Na+ channel (ENaC) at the cell surface. Defects in this regulation cause Liddle syndrome, an inherited form of hypertension. Previous work found that Nedd4-2 functions through two distinct effects on trafficking, enhancing both ENaC endocytosis and ENaC degradation in lysosomes. To investigate the mechanism by which Nedd4-2 targets ENaC to lysosomes, we tested the role of hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), a component of the endosomal sorting complexes required for transport (ESCRT)-0 complex. We found that alpha-, beta-, and gamma ENaC each interact with Hrs. These interactions were enhanced by Nedd4-2 and were dependent on the catalytic function of Nedd4-2 as well as its WW domains. Mutation of ENaC PY motifs, responsible for inherited hypertension (Liddle syndrome), decreased Hrs binding to ENaC. Moreover, binding of ENaC to Hrs was reduced by dexamethasone/serum- and glucocorticoid-inducible kinase and cAMP, which are signaling pathways that inhibit Nedd4-2. Nedd4-2 bound to Hrs and catalyzed Hrs ubiquitination but did not alter Hrs protein levels. Expression of a dominant negative Hrs lacking its ubiquitin-interacting motif (Hrs-Delta UIM) increased ENaC surface expression and current. This occurred through reduced degradation of the cell surface pool of proteolytically activated ENaC, which enhanced its recycling to the cell surface. In contrast, Hrs-Delta UIM had no effect on degradation of uncleaved inactive channels. The data support a model in which Nedd4-2 induces binding of ENaC to Hrs, which mediates the sorting decision between ENaC degradation and recycling.	[Snyder, Peter M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Piper, Robert C.; Snyder, Peter M.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu		Piper, Robert/0000-0001-9995-5699	National Institutes of Health [HL058812]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058812, R29HL058812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL058812 (to P. M. S. and R. C. P.).	Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Raiborg C, 2001, J CELL SCI, V114, P2255; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	41	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30523	30530		10.1074/jbc.M110.150755	http://dx.doi.org/10.1074/jbc.M110.150755			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20675381	hybrid, Green Published			2022-12-25	WOS:000282135500020
J	Tseng, W; Graham, LS; Geng, YF; Reddy, A; Lu, JX; Effros, RB; Demer, L; Tintut, Y				Tseng, Wendy; Graham, Lucia S.; Geng, Yifan; Reddy, Aneela; Lu, Jinxiu; Effros, Rita B.; Demer, Linda; Tintut, Yin			PKA-induced Receptor Activator of NF-kappa B Ligand (RANKL) Expression in Vascular Cells Mediates Osteoclastogenesis but Not Matrix Calcification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM OSTEOPROTEGERIN LEVELS; LOW-DENSITY-LIPOPROTEIN; HUMAN CAROTID ARTERIES; BONE-FORMATION; IN-VIVO; PLASMA OSTEOPROTEGERIN; HEMODIALYSIS-PATIENTS; DIFFERENTIATION; ATHEROSCLEROSIS; PATHWAY	Vascular calcification is a predictor of cardiovascular mortality and is prevalent in patients with atherosclerosis and chronic renal disease. It resembles skeletal osteogenesis, and many bone cells as well as bone-related factors involved in both formation and resorption have been localized in calcified arteries. Previously, we showed that aortic medial cells undergo osteoblastic differentiation and matrix calcification both spontaneously and in response to PKA agonists. The PKA signaling pathway is also involved in regulating bone resorption in skeletal tissue by stimulating osteoblast-production of osteoclast regulating cytokines, including receptor-activator of nuclear kappa B ligand (RANKL) and interleukins. Therefore, we investigated whether PKA activators regulate osteoclastogenesis in aortic smooth muscle cells (SMC). Treatment of murine SMC with the PKA agonist forskolin stimulated RANKL expression at both mRNA and protein levels. Forskolin also stimulated expression of interleukin-6 but not osteoprotegerin (OPG), an inhibitor of RANKL. Consistent with these results, osteoclastic differentiation was induced when monocytic preosteoclasts (RAW264.7) were cocultured with forskolin- treated aortic SMC. Oxidized phospholipids also slightly induced RANKL expression in T lymphocytes, another potential source of RANKL in the vasculature. Because previous studies have shown that RANKL treatment alone induces matrix calcification of valvular and vascular cells, we next examined whether RANKL mediates forskolin-induced matrix calcification by aortic SMC. RANKL inhibition with OPG had little or no effect on osteoblastic differentiation and matrix calcification of aortic SMC. These findings suggest that, as in skeletal tissues, PKA activation induces bone resorptive factors in the vasculature and that aortic SMC calcification specifically induced by PKA, is not mediated by RANKL.	[Tintut, Yin] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, Los Angeles, CA 90095 USA; [Tseng, Wendy] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Graham, Lucia S.; Effros, Rita B.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lu, Jinxiu; Demer, Linda] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Demer, Linda] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tintut, Y (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, A2-237,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ytintut@mednet.ucla.edu	Demer, Linda L/I-5770-2013	Demer, Linda L/0000-0002-9618-6895	NIDDK [R01DK081346]; NHLBI [R01HL081202]; NIA [AG023720]; F31AG023838; Whit-come Summer Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG023838, R01AG023720] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); F31AG023838; Whit-come Summer Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081346 (to Y. T.) from the NIDDK, Grant R01HL081202 (to L. D.) from the NHLBI, Grant AG023720 (to R. B. E.) from the NIA, and a Fellowship Grant F31AG023838 (to L. S. G.). This work was also supported by a Whit-come Summer Research Fellowship (to W. T.).	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Canfield AE, 2000, FEBS LETT, V487, P267, DOI 10.1016/S0014-5793(00)02363-2; Cassady AI, 2003, J BONE MINER RES, V18, P1901, DOI 10.1359/jbmr.2003.18.10.1901; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Gopalakrishnan R, 2001, ENDOCRINOLOGY, V142, P4379, DOI 10.1210/en.142.10.4379; Graham LS, 2009, CLIN IMMUNOL, V133, P265, DOI 10.1016/j.clim.2009.07.011; Huang MS, 2008, BIOCHEM BIOPH RES CO, V374, P553, DOI 10.1016/j.bbrc.2008.07.062; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Jeziorska M, 1998, J PATHOL, V185, P10; Jeziorska M, 1998, VIRCHOWS ARCH, V433, P559, DOI 10.1007/s004280050289; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Simpson CL, 2007, CARDIOVASC PATHOL, V16, P29, DOI 10.1016/j.carpath.2006.07.001; Morena M, 2006, J AM SOC NEPHROL, V17, P262, DOI 10.1681/ASN.2005030260; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Nitta K, 2004, NEPHROL DIAL TRANSPL, V19, P1886, DOI 10.1093/ndt/gfh263; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Rasmussen LM, 2006, EUR J ENDOCRINOL, V154, P75, DOI 10.1530/eje.1.02049; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Siddappa R, 2009, TISSUE ENG PT A, V15, P2135, DOI 10.1089/ten.tea.2008.0512; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Tintut Y, 2005, J MOL CELL CARDIOL, V39, P389, DOI 10.1016/j.yjmcc.2005.03.019; Tintut Y, 1998, J BIOL CHEM, V273, P7547, DOI 10.1074/jbc.273.13.7547; Vanderborght A, 2004, J RHEUMATOL, V31, P1483; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yamate T, 1997, ENDOCRINOLOGY, V138, P3047, DOI 10.1210/en.138.7.3047; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636	43	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29925	29931		10.1074/jbc.M110.117366	http://dx.doi.org/10.1074/jbc.M110.117366			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663885	Green Published, hybrid			2022-12-25	WOS:000281984300029
J	Cen, B; Mahajan, S; Zemskova, M; Beharry, Z; Lin, YW; Cramer, SD; Lilly, MB; Kraft, AS				Cen, Bo; Mahajan, Sandeep; Zemskova, Marina; Beharry, Zanna; Lin, Ying-Wei; Cramer, Scott D.; Lilly, Michael B.; Kraft, Andrew S.			Regulation of Skp2 Levels by the Pim-1 Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; SCF UBIQUITIN LIGASE; CELL-CYCLE; S-PHASE; PHOSPHORYLATION; DEGRADATION; CANCER; LOCALIZATION; PHOSPHATASE; ACTIVATION	The Pim-1 protein kinase plays an important role in regulating both cell growth and survival and enhancing transformation by multiple oncogenes. The ability of Pim-1 to regulate cell growth is mediated, in part, by the capacity of this protein kinase to control the levels of the p27, a protein that is a critical regulator of cyclin-dependent kinases that mediate cell cycle progression. To understand how Pim-1 is capable of regulating p27 protein levels, we focused our attention on the SCFSkp2 ubiquitin ligase complex that controls the rate of degradation of this protein. We found that expression of Pim-1 increases the level of Skp2 through direct binding and phosphorylation of multiple sites on this protein. Along with known Skp2 phosphorylation sites including Ser(64) and Ser(72), we have identified Thr(417) as a unique Pim-1 phosphorylation target. Phosphorylation of Thr(417) controls the stability of Skp2 and its ability to degrade p27. Additionally, we found that Pim-1 regulates the anaphase-promoting complex or cyclosome (APC/C complex) that mediates the ubiquitination of Skp2. Pim-1 phosphorylates Cdh1 and impairs binding of this protein to another APC/C complex member, CDC27. These modifications inhibit Skp2 from degradation. Marked increases in Skp2 caused by these mechanisms lower cellular p27 levels. Consistent with these observations, we show that Pim-1 is able to cooperate with Skp2 to signal S phase entry. Our data reveal a novel Pim-1 kinase-dependent signaling pathway that plays a crucial role in cell cycle regulation.	[Cen, Bo; Kraft, Andrew S.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Mahajan, Sandeep; Kraft, Andrew S.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Zemskova, Marina] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Beharry, Zanna] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Lin, Ying-Wei] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Cramer, Scott D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Cramer, Scott D.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; [Lilly, Michael B.] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92868 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Irvine	Kraft, AS (corresponding author), 86 Jonathan Lucas St, Charleston, SC 29425 USA.	kraft@musc.edu		Beharry, Zanna/0000-0002-3900-8523; Zemskova, Marina/0000-0002-1454-3714	Department of Defense [W8IXWH-08, W81XWH-10-1-0249];  [1P30-CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085196] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Department of Defense Grants W8IXWH-08 and W81XWH-10-1-0249. The flow cytometry core received support from 1P30-CA138313.	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Balkovetz DF, 1999, INT REV CYTOL, V186, P225; Barclay WW, 2005, PROSTATE, V63, P291, DOI 10.1002/pros.20193; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Beharry Z, 2009, MOL CANCER THER, V8, P1473, DOI 10.1158/1535-7163.MCT-08-1037; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Bullock AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007112; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cen B, 2009, J BIOL CHEM, V284, P5265, DOI 10.1074/jbc.M804531200; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kumar A, 2005, J MOL BIOL, V348, P183, DOI 10.1016/j.jmb.2005.02.039; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Roh M, 2005, J BIOL CHEM, V280, P40568, DOI 10.1074/jbc.M509369200; Roh M, 2003, CANCER RES, V63, P8079; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shim EH, 2003, CANCER RES, V63, P1583; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; VAN LEUKEN R, 2008, BBA-REV CANCER, V1786, P49; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang W, 2003, J BIOL CHEM, V278, P32390, DOI 10.1074/jbc.M305241200; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Xia ZP, 2009, J MED CHEM, V52, P74, DOI 10.1021/jm800937p; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200; Zhang H, 2003, HEPATOLOGY, V38, P305, DOI 10.1053/jhep.2003.50345; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	61	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29128	29137		10.1074/jbc.M110.137240	http://dx.doi.org/10.1074/jbc.M110.137240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20663873	Green Published, hybrid			2022-12-25	WOS:000281740100013
J	Matthews, QL; Fatima, A; Tang, YZ; Perry, BA; Tsuruta, Y; Komarova, S; Timares, L; Zhao, CX; Makarova, N; Borovjagin, AV; Stewart, PL; Wu, HJ; Blackwell, JL; Curiel, DT				Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Perry, Brian A.; Tsuruta, Yuko; Komarova, Svetlana; Timares, Laura; Zhao, Chunxia; Makarova, Natalia; Borovjagin, Anton V.; Stewart, Phoebe L.; Wu, Hongju; Blackwell, Jerry L.; Curiel, David T.			HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach	PLOS ONE			English	Article							VIRUS TYPE-1 HIV-1; IMMUNE-RESPONSES; NEUTRALIZING RESPONSES; GENE-TRANSFER; FIBER KNOB; VECTORS; TRANSGENE; EPITOPE; EXPRESSION; ANTIBODY	Adenoviral (Ad) vectors have been used for a variety of vaccine applications including cancer and infectious diseases. Traditionally, Ad-based vaccines are designed to express antigens through transgene expression of a given antigen. However, in some cases these conventional Ad-based vaccines have had sub-optimal clinical results. These sub-optimal results are attributed in part to pre-existing Ad serotype 5 (Ad5) immunity. In order to circumvent the need for antigen expression via transgene incorporation, the "antigen capsid-incorporation" strategy has been developed and used for Ad-based vaccine development in the context of a few diseases. This strategy embodies the incorporation of antigenic peptides within the capsid structure of viral vectors. The major capsid protein hexon has been utilized for these capsid incorporation strategies due to hexon's natural role in the generation of anti-Ad immune response and its numerical representation within the Ad virion. Using this strategy, we have developed the means to incorporate heterologous peptide epitopes specifically within the major surface-exposed domains of the Ad capsid protein hexon. Our study herein focuses on generation of multivalent vaccine vectors presenting HIV antigens within the Ad capsid protein hexon, as well as expressing an HIV antigen as a transgene. These novel vectors utilize HVR2 as an incorporation site for a twenty-four amino acid region of the HIV membrane proximal ectodomain region (MPER), derived from HIV glycoprotein gp41 (gp41). Our study herein illustrates that our multivalent anti-HIV vectors elicit a cellular anti-HIV response. Furthermore, vaccinations with these vectors, which present HIV antigens at HVR2, elicit a HIV epitope-specific humoral immune response.	[Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Obstet, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Gynecol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Matthews, Qiana L.] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL 35294 USA; [Tang, Yizhe] Univ Alabama Birmingham, Vis Sci Grad Program, Birmingham, AL 35294 USA; [Perry, Brian A.] Davidson Coll, Davidson, NC 28036 USA; [Tsuruta, Yuko; Timares, Laura] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Zhao, Chunxia; Makarova, Natalia; Blackwell, Jerry L.] Emory Univ, Atlanta, GA 30322 USA; [Borovjagin, Anton V.] Univ Alabama Birmingham, Inst Oral Hlth Res, Sch Dent, Birmingham, AL 35294 USA; [Stewart, Phoebe L.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Davidson College; University of Alabama System; University of Alabama Birmingham; Emory University; University of Alabama System; University of Alabama Birmingham; Vanderbilt University	Matthews, QL (corresponding author), Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA.	curiel@uab.edu	Matthews, Qiana/P-9624-2019; Tang, Yizhe/A-8682-2014	Tang, Yizhe/0000-0001-5354-478X	National Institutes of Health [4R33AI076096-03, 2P30AI027767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI076096, R21AI076096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health: 4R33AI076096-03 (Dr. David T. Curiel) and 2P30AI027767 [Supplement] (Drs. Michael Saag and Qiana L. Matthews). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2009, J GENE MED, V11, P570, DOI 10.1002/jgm.1332; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Arnold GF, 1996, INTERVIROLOGY, V39, P72; Barnett BG, 2002, BBA-GENE STRUCT EXPR, V1575, P1, DOI 10.1016/S0167-4781(02)00249-X; Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Blackwell JL, 2000, HUM GENE THER, V11, P1657, DOI 10.1089/10430340050111313; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Challacombe S J, 2006, Adv Dent Res, V19, P29; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; CROMPTON J, 1994, J GEN VIROL, V75, P133, DOI 10.1099/0022-1317-75-1-133; Curiel DT, 1999, ANN NY ACAD SCI, V886, P158, DOI 10.1111/j.1749-6632.1999.tb09409.x; Dmitriev IP, 2002, J VIROL, V76, P6893, DOI 10.1128/JVI.76.14.6893-6899.2002; Douglas JT, 1999, NAT BIOTECHNOL, V17, P470, DOI 10.1038/8647; Gomez-Roman Victor Raul, 2003, AIDS Reviews, V5, P178; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; KassEisler A, 1996, GENE THER, V3, P154; KASSEISLER A, 1994, GENE THER, V1, P395; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Li J, 2005, VIROLOGY, V338, P247, DOI 10.1016/j.virol.2005.04.005; Liu M, 2004, P NATL ACAD SCI USA, V101, P14567, DOI 10.1073/pnas.0404845101; Liu RY, 2005, VIRUS RES, V112, P24, DOI 10.1016/j.virusres.2005.02.009; Lowenstein PR, 2002, METHOD ENZYMOL, V346, P292; Matthews QL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-98; McConnell MJ, 2006, J VIROL, V80, P5361, DOI 10.1128/JVI.00256-06; Mestecky H, 2007, J REPROD IMMUNOL, V73, P85, DOI 10.1016/j.jri.2007.01.005; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; Noureddini SC, 2006, VIRUS RES, V116, P185, DOI 10.1016/j.virusres.2005.10.002; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Pereboev A, 2001, J VIROL, V75, P7107, DOI 10.1128/JVI.75.15.7107-7113.2001; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; Qin LZ, 2004, J VIROL, V78, P7016, DOI 10.1128/JVI.78.13.7016-7022.2004; RESNICK DA, 1995, J VIROL, V69, P2406, DOI 10.1128/JVI.69.4.2406-2411.1995; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; SMITH AD, 1994, J VIROL, V68, P575, DOI 10.1128/JVI.68.1.575-579.1994; Smith AD, 1998, J VIROL, V72, P651, DOI 10.1128/JVI.72.1.651-659.1998; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Tang YZ, 2008, VIROLOGY, V377, P391, DOI 10.1016/j.virol.2008.04.023; Thacker EE, 2009, EXPERT REV VACCINES, V8, P761, DOI [10.1586/erv.09.29, 10.1586/ERV.09.29]; Umana P, 2001, NAT BIOTECHNOL, V19, P582, DOI 10.1038/89349; Vigne E, 1999, J VIROL, V73, P5156, DOI 10.1128/JVI.73.6.5156-5161.1999; WEAVER EA, 2008, HUM GENE THER; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059; WOHLFART C, 1988, J VIROL, V62, P2321, DOI 10.1128/JVI.62.7.2321-2328.1988; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Worgall S, 2004, J VIROL, V78, P2572, DOI 10.1128/JVI.78.5.2572-2580.2004; Worgall S, 2007, J VIROL, V81, P13801, DOI 10.1128/JVI.01246-07; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; Wu HJ, 2002, J VIROL, V76, P12775, DOI 10.1128/JVI.76.24.12775-12782.2002; Xiong WD, 2006, J VIROL, V80, P27, DOI 10.1128/JVI.80.1.27-37.2006; Xiong W, 2008, MOL THER, V16, P343, DOI 10.1038/sj.mt.6300375; Zhang AQ, 1999, BIOL CHEM, V380, P365, DOI 10.1515/BC.1999.048; Zhang HG, 2005, MOL THER, V11, P866, DOI 10.1016/j.ymthe.2005.02.014; Zhao CX, 2009, J VIROL METHODS, V160, P101, DOI 10.1016/j.jviromet.2009.04.028	59	37	43	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11815	10.1371/journal.pone.0011815	http://dx.doi.org/10.1371/journal.pone.0011815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676400	gold, Green Published, Green Submitted			2022-12-25	WOS:000280371800016
J	Xia, B; Joubert, A; Groves, B; Vo, K; Ashraf, D; Djavaherian, D; Awe, J; Xiong, Y; Cherfils, J; Ma, D				Xia, Bin; Joubert, Alexandra; Groves, Benjamin; Vo, Kevin; Ashraf, Davin; Djavaherian, Derek; Awe, Jason; Xiong, Ying; Cherfils, Jacqueline; Ma, Dzwokai			Modulation of Cell Adhesion and Migration by the Histone Methyltransferase Subunit mDpy-30 and Its Interacting Proteins	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; ADP-RIBOSYLATION FACTORS; TRANS-GOLGI NETWORK; BREFELDIN-A; DISTINCT FUNCTIONS; BIG2; LOCALIZATION; INTEGRINS; DOMAINS; KINASE	We have previously shown that a subset of mDpy-30, an accessory subunit of the nuclear histone H3 lysine 4 methyltransferase (H3K4MT) complex, also localizes at the trans-Golgi network (TGN), where its recruitment is mediated by the TGN-localized ARF guanine nucleotide exchange factor (ArfGEF) BIG1. Depletion of mDpy-30 inhibits the endosome-to-TGN transport of internalized CIMPR receptors and concurrently promotes their accumulation at the cell protrusion. These observations suggest mDpy-30 may play a novel role at the crossroads of endosomal trafficking, nuclear transcription and adhesion/migration. Here we provide novel mechanistic and functional insight into this association. First, we demonstrate a direct interaction between mDpy-30 and BIG1 and locate the binding region in the N-terminus of BIG1. Second, we provide evidence that the depletion or overexpression of mDpy-30 enhances or inhibits cellular adhesion/migration of glioma cells in vitro, respectively. A similar increase in cell adhesion/migration is observed in cells with reduced levels of BIG1 or other H3K4MT subunits. Third, knockdown of mDpy-30, BIG1, or the RbBP5 H3K4MT subunit increases the targeting of beta 1 integrin to cell protrusions, and suppression of H3K4MT activity by depleting mDpy-30 or RbBP5 leads to increased protein and mRNA levels of beta 1 integrin. Moreover, stimulation of cell adhesion/migration via mDpy-30 knockdown is abolished after treating cells with a function-blocking antibody to beta 1 integrin. Taken together, these data indicate that mDpy-30 and its interacting proteins function as a novel class of cellular adhesion/migration modulators partially by affecting the subcellular distribution of endosomal compartments as well as the expression of key adhesion/migration proteins such as beta 1 integrin.	[Xia, Bin; Xiong, Ying] Sichuan Univ, W China Univ Hosp 2, Dept Pediat, Chengdu 610064, Peoples R China; [Xia, Bin; Groves, Benjamin; Vo, Kevin; Ashraf, Davin; Djavaherian, Derek; Awe, Jason; Ma, Dzwokai] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Joubert, Alexandra; Cherfils, Jacqueline] CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Ma, Dzwokai] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	Sichuan University; University of California System; University of California Santa Barbara; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Santa Barbara	Xia, B (corresponding author), Sichuan Univ, W China Univ Hosp 2, Dept Pediat, Chengdu 610064, Peoples R China.	ma@lifesci.ucsb.edu	Ashraf, Davin/AAP-4556-2021	Ashraf, Davin/0000-0001-7945-9516; /0000-0002-6129-2938	Cancer Research Coordinating Committee (CRCC) [8-597000-36240]	Cancer Research Coordinating Committee (CRCC)	A small grant from the Cancer Research Coordinating Committee (CRCC, the fund number is as follows: 8-597000-36240), along with the authors' startup funds allowed them to perform this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal R, 2008, PHARMACOL THERAPEUT, V120, P81, DOI 10.1016/j.pharmthera.2008.07.002; Blaschke F, 2002, BIOCHEM BIOPH RES CO, V296, P890, DOI 10.1016/S0006-291X(02)02033-8; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Faruque OM, 2009, AM J PHYSIOL-CELL PH, V296, pC306, DOI 10.1152/ajpcell.00216.2008; FLETCHER SJ, TRENDS CELL BIOL; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; HSU DR, 1994, GENETICS, V137, P999; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Jones HD, 2005, METHOD ENZYMOL, V404, P174, DOI 10.1016/S0076-6879(05)04017-6; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Mukhopadhyay NK, 2004, ANN THORAC SURG, V78, P450, DOI 10.1016/j.athoracsur.2004.01.042; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; SOUTH PF, 2009, J BIOL CHEM; WANG X, 2009, J MOL BIOL; Wood RJ, 2008, J BIOL CHEM, V283, P4165, DOI 10.1074/jbc.M708723200; Xu ZJ, 2009, J CELL BIOL, V186, P343, DOI 10.1083/jcb.200902146; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	28	14	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11771	10.1371/journal.pone.0011771	http://dx.doi.org/10.1371/journal.pone.0011771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668708	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243800034
J	Hayashi, T; Nakamichi, M; Naitou, H; Ohashi, N; Imai, Y; Miyake, M				Hayashi, Tsuyoshi; Nakamichi, Masahiro; Naitou, Hirotaka; Ohashi, Norio; Imai, Yasuyuki; Miyake, Masaki			Proteomic Analysis of Growth Phase-Dependent Expression of Legionella pneumophila Proteins Which Involves Regulation of Bacterial Virulence Traits	PLOS ONE			English	Article							FORMATION-MEDIATED EGRESS; LEGIONNAIRES-DISEASE; STATIONARY-PHASE; PORE FORMATION; TRANSMISSION PHENOTYPE; INTRACELLULAR GROWTH; SECRETION; MACROPHAGES; IDENTIFICATION; PHAGOSOME	Legionella pneumophila, which is a causative pathogen of Legionnaires' disease, expresses its virulent traits in response to growth conditions. In particular, it is known to become virulent at a post-exponential phase in vitro culture. In this study, we performed a proteomic analysis of differences in expression between the exponential phase and post-exponential phase to identify candidates associated with L. pneumophila virulence using 2-Dimentional Fluorescence Difference Gel Electrophoresis (2D-DIGE) combined with Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry (MALDI-TOF-MS). Of 68 identified proteins that significantly differed in expression between the two growth phases, 64 were up-regulated at a post-exponential phase. The up-regulated proteins included enzymes related to glycolysis, ketone body biogenesis and poly-3-hydroxybutyrate (PHB) biogenesis, suggesting that L. pneumophila may utilize sugars and lipids as energy sources, when amino acids become scarce. Proteins related to motility (flagella components and twitching motility-associated proteins) were also up-regulated, predicting that they enhance infectivity of the bacteria in host cells under certain conditions. Furthermore, 9 up-regulated proteins of unknown function were found. Two of them were identified as novel bacterial factors associated with hemolysis of sheep red blood cells (SRBCs). Another 2 were found to be translocated into macrophages via the Icm/Dot type IV secretion apparatus as effector candidates in a reporter assay with Bordetella pertussis adenylate cyclase. The study will be helpful for virulent analysis of L. pneumophila from the viewpoint of physiological or metabolic modulation dependent on growth phase.	[Hayashi, Tsuyoshi; Nakamichi, Masahiro; Imai, Yasuyuki; Miyake, Masaki] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan; [Naitou, Hirotaka] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Shizuoka 4228526, Japan; [Ohashi, Norio] Univ Shizuoka, Microbiol Lab, Dept Food & Nutr Sci, Shizuoka 4228526, Japan; [Ohashi, Norio] Univ Shizuoka, Global COE, Shizuoka 4228526, Japan	University of Shizuoka; University of Shizuoka; University of Shizuoka; University of Shizuoka	Hayashi, T (corresponding author), Natl Agr & Food Res Org, NIAH, Res Team Zoonot Dis, Tsukuba, Ibaraki, Japan.	miyakem@ys7.u-shizuoka-ken.ac.jp	Hayashi, Tsuyoshi/GNW-6250-2022; Imai, Yasuyuki/E-8701-2010	Imai, Yasuyuki/0000-0002-8937-0221	Shizuoka Research Institute; Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [16790258]	Shizuoka Research Institute; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by a grant from Shizuoka Research Institute, and a Grant-in-aid (16790258) and the COE Program in the 21st Century from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Albers U, 2007, MICROBIOL-SGM, V153, P3817, DOI 10.1099/mic.0.2007/009829-0; Alli OAT, 2000, INFECT IMMUN, V68, P6431, DOI 10.1128/IAI.68.11.6431-6440.2000; Bachman MA, 2004, INFECT IMMUN, V72, P3284, DOI 10.1128/IAI.72.6.3284-3293.2004; Bachman MA, 2004, INFECT IMMUN, V72, P2468, DOI 10.1128/IAI.72.5.2468-2476.2004; Bachman MA, 2001, MOL MICROBIOL, V40, P1201, DOI 10.1046/j.1365-2958.2001.02465.x; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Benin AL, 2002, CLIN INFECT DIS, V35, P1039, DOI 10.1086/342903; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bozue JA, 1996, INFECT IMMUN, V64, P668, DOI 10.1128/IAI.64.2.668-673.1996; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Buckles EL, 2006, MICROBIOL-SGM, V152, P153, DOI 10.1099/mic.0.28281-0; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Coil DA, 2009, FEMS MICROBIOL LETT, V293, P271, DOI 10.1111/j.1574-6968.2009.01532.x; Dalebroux ZD, 2009, MOL MICROBIOL, V71, P640, DOI 10.1111/j.1365-2958.2008.06555.x; De Buck E, 2008, INT J MED MICROBIOL, V298, P449, DOI 10.1016/j.ijmm.2007.06.003; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Dumenil G, 2004, J BIOL CHEM, V279, P4686, DOI 10.1074/jbc.M309908200; Edwards RL, 2009, MOL MICROBIOL, V71, P1190, DOI [10.1111/j.1365-2958.2009.06593.x, 10.1111/j.1365-2958.2008.06593.x]; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Hammer BK, 1999, MOL MICROBIOL, V33, P721, DOI 10.1046/j.1365-2958.1999.01519.x; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Ibuki Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P823, DOI 10.1562/2004-09-01-RA-297R1.1; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; James BW, 1999, APPL ENVIRON MICROB, V65, P822; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Katanasaka Y, 2007, BIOL PHARM BULL, V30, P2300, DOI 10.1248/bpb.30.2300; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lebeau I, 2005, RES MICROBIOL, V156, P119, DOI 10.1016/j.resmic.2004.08.010; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Miyake M, 2005, INFECT IMMUN, V73, P6272, DOI 10.1128/IAI.73.10.6272-6282.2005; Molmeret M, 2002, MOL MICROBIOL, V43, P1139, DOI 10.1046/j.1365-2958.2002.02842.x; Molmeret M, 2002, INFECT IMMUN, V70, P69, DOI 10.1128/IAI.70.1.69-78.2002; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Rasis M, 2009, MOL MICROBIOL, V72, P995, DOI 10.1111/j.1365-2958.2009.06705.x; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Sahr T, 2009, MOL MICROBIOL, V72, P741, DOI 10.1111/j.1365-2958.2009.06677.x; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Whitfield NN, 2010, INFECT IMMUN, V78, P423, DOI 10.1128/IAI.00070-09; WIATER LA, 1994, MOL MICROBIOL, V11, P641; Yerushalmi G, 2005, INFECT IMMUN, V73, P7578, DOI 10.1128/IAI.73.11.7578-7587.2005; YOUNG IG, 1971, J BACTERIOL, V105, P769, DOI 10.1128/JB.105.3.769-778.1971; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	77	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11718	10.1371/journal.pone.0011718	http://dx.doi.org/10.1371/journal.pone.0011718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661449	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300020
J	Seewald, AK; Cypser, J; Mendenhall, A; Johnson, T				Seewald, Alexander K.; Cypser, James; Mendenhall, Alexander; Johnson, Thomas			Quantifying Phenotypic Variation in Isogenic Caenorhabditis elegans Expressing Phsp-16.2::gfp by Clustering 2D Expression Patterns	PLOS ONE			English	Article							CELLULAR RESOLUTION; GENE-EXPRESSION	Isogenic populations of animals still show a surprisingly large amount of phenotypic variation between individuals. Using a GFP reporter that has been shown to predict longevity and resistance to stress in isogenic populations of the nematode Caenorhabditis elegans, we examined residual variation in expression of this GFP reporter. We found that when we separated the populations into brightest 3% and dimmest 3% we also saw variation in relative expression patterns that distinguished the bright and dim worms. Using a novel image processing method which is capable of directly analyzing worm images, we found that bright worms (after normalization to remove variation between bright and dim worms) had expression patterns that correlated with other bright worms but that dim worms fell into two distinct expression patterns. We have analysed a small set of worms with confocal microscopy to validate these findings, and found that the activity loci in these clusters are caused by extremely bright intestine cells. We also found that the vast majority of the fluorescent signal for all worms came from intestinal cells as well, which may indicate that the activity of intestinal cells is responsible for the observed patterns. Phenotypic variation in C. elegans is still not well understood but our proposed novel method to analyze complex expression patterns offers a way to enable a better understanding.	[Seewald, Alexander K.] Seewald Solut, Vienna, Austria; [Cypser, James; Mendenhall, Alexander; Johnson, Thomas] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Seewald, AK (corresponding author), Seewald Solut, Vienna, Austria.	alex@seewald.at		CYPSER, JAMES/0000-0001-8436-6437	United States National Institute on Aging	United States National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is a collaboration between the University of Colorado at Boulder and Seewald Solutions. Neither the University of Colorado nor Seewald Solutions provided financial support. Seewald Solutions developed the image processing methods, and the University of Colorado provided the experimental design and setup, and the images themselves. This research was partially supported by the United States National Institute on Aging on a grant which is no longer active. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; GENG W, 2004, THESIS U CALIFORNIA; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; HEINDL A, 2009, 5 PHD S YOUNG SCI AS; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; LONG F, 2009, NAT METH, P667; Long FH, 2008, LECT N BIOINFORMAT, V4955, P128; Luengo Hendriks CL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r123; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Ning F, 2005, IEEE T IMAGE PROCESS, V14, P1360, DOI 10.1109/TIP.2005.852470; Peng HC, 2008, BIOINFORMATICS, V24, P234, DOI 10.1093/bioinformatics/btm569; R Development Core Team, 2009, R FDN STAT COMP; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; SUZUKI R, 2004, 15 INT C GEN INF 200	17	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11426	10.1371/journal.pone.0011426	http://dx.doi.org/10.1371/journal.pone.0011426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657830	gold, Green Published, Green Submitted			2022-12-25	WOS:000280065600001
J	Mburu, P; Romero, MR; Hilton, H; Parker, A; Townsend, S; Kikkawa, Y; Brown, SDM				Mburu, Philomena; Romero, Maria Rosario; Hilton, Helen; Parker, Andrew; Townsend, Stuart; Kikkawa, Yoshiaki; Brown, Steve D. M.			Gelsolin Plays a Role in the Actin Polymerization Complex of Hair Cell Stereocilia	PLOS ONE			English	Article							MYOSIN-XVA; INNER-EAR; WHIRLIN; MOUSE; INTERACTS; FILAMENTS; DEAFNESS; COCHLEA; PROTEIN; BUNDLE	A complex of proteins scaffolded by the PDZ protein, whirlin, reside at the stereocilia tip and are critical for stereocilia development and elongation. We have shown that in outer hair cells (OHCs) whirlin is part of a larger complex involving the MAGUK protein, p55, and protein 4.1R. Whirlin interacts with p55 which is expressed exclusively in outer hair cells (OHC) in both the long stereocilia that make up the stereocilia bundle proper as well as surrounding shorter microvilli that will eventually regress. In erythrocytes, p55 forms a tripartite complex with protein 4.1R and glycophorin C promoting the assembly of actin filaments and the interaction of whirlin with p55 indicates that it plays a similar role in OHC stereocilia. However, the components directly involved in actin filament regulation in stereocilia are unknown. We have investigated additional components of the whirlin interactome by identifying interacting partners to p55. We show that the actin capping and severing protein, gelsolin, is a part of the whirlin complex. Gelsolin is detected in OHC where it localizes to the tips of the shorter rows but not to the longest row of stereocilia and the pattern of localisation at the apical hair cell surface is strikingly similar to p55. Like p55, gelsolin is ablated in the whirler and shaker2 mutants. Moreover, in a gelsolin mutant, stereocilia in the apex of the cochlea become long and straggly indicating defects in the regulation of stereocilia elongation. The identification of gelsolin provides for the first time a link between the whirlin scaffolding protein complex involved in stereocilia elongation and a known actin regulatory molecule.	[Mburu, Philomena; Romero, Maria Rosario; Hilton, Helen; Parker, Andrew; Townsend, Stuart; Brown, Steve D. M.] MRC, Mammalian Genet Unit, Oxford, England; [Kikkawa, Yoshiaki] Tokyo Univ Agr, Dept Bioprod, Abashiri, Japan	Tokyo University of Agriculture	Mburu, P (corresponding author), MRC, Mammalian Genet Unit, Harwell Sci & Innovat Campus, Oxford, England.	s.brown@har.mrc.ac.uk	Kikkawa, Yoshiaki/AAI-7229-2020	Kikkawa, Yoshiaki/0000-0001-8859-4998	MRC; FP6 Integrated Project EUROHEAR [LSHG-CT-2004-512063]; Medical Research Council [MC_U142684172, MC_U142684175] Funding Source: researchfish; MRC [MC_U142684172, MC_U142684175] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FP6 Integrated Project EUROHEAR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC and FP6 Integrated Project EUROHEAR, LSHG-CT-2004-512063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNIKO M, 1983, ANAT EMBRYOL, V166, P355, DOI 10.1007/BF00305923; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Forge A, 1997, SEMIN CELL DEV BIOL, V8, P225, DOI 10.1006/scdb.1997.0147; FURNESS DN, 1989, HEARING RES, V38, P95, DOI 10.1016/0378-5955(89)90131-7; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Mogensen MM, 2007, CELL MOTIL CYTOSKEL, V64, P496, DOI 10.1002/cm.20199; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Rzadzinska AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007097; Spinardi L., 2007, V45, P55; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Yap CC, 2003, J NEUROCHEM, V85, P123, DOI 10.1046/j.1471-4159.2003.01647.x	24	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11627	10.1371/journal.pone.0011627	http://dx.doi.org/10.1371/journal.pone.0011627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661277	gold, Green Published, Green Submitted			2022-12-25	WOS:000279980800015
J	Ferreiro, I; Barragan, M; Gubern, A; Ballestar, E; Joaquin, M; Posas, F				Ferreiro, Isabel; Barragan, Montserrat; Gubern, Albert; Ballestar, Esteban; Joaquin, Manel; Posas, Francesc			The p38 SAPK Is Recruited to Chromatin via Its Interaction with Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; GENE-EXPRESSION; C-FOS; REGULATORY MECHANISMS; SIGNAL-TRANSDUCTION; OSMOTIC-STRESS; UV-LIGHT; IN-VIVO; PATHWAYS	In mammals, the stress-activated protein kinase (SAPK) p38 coordinates a rapid and complex transcriptional program to adapt to sudden changes in the extracellular environment. Although a number of genes have been reported to be under the control of p38, the basic mechanisms of transcriptional regulation by this SAPK remain uncharacterized. Here we show that in response to osmotic shock, anisomycin- or TNF alpha-activated p38 SAPK is recruited to stress-induced genes. The MAPKK MKK6 is also found at stress-responsive promoters. The recruitment of RNA polymerase II complex to the target promoters requires p38 activity. Moreover, when tethered to DNA as a LexA fusion protein, p38 activates transcription in a stress-regulated manner. Thus, p38 activity allows for recruitment of RNA polymerase and transcription initiation. p38 directly phosphorylates and interacts with the transcription factor Elk1. p38 activity is necessary for the recruitment of Elk1 to the c-Fos promoter, and knocking down Elk1 by siRNAs compromises both p38 recruitment to the c-Fos promoter and c-Fos transcriptional up-regulation upon osmostress. In addition, p38 recruitment to the osmoinducible gene Cox2 and the TNF alpha target gene IL8 is mediated by the transcription factors AP1 and NF kappa B, respectively. Therefore, anchoring of active SAPK to target genes is mediated by transcription factors. The presence of active p38 at open reading frames also suggests the involvement of the SAPK in elongation. Taken together, SAPK recruitment to target genes appears to be a broad mechanism to regulate transcription that has been preserved from yeast to mammals.	Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signalling Res Grp, Barcelona 08003, Spain; [Ballestar, Esteban] Inst Invest Biomed Bellvitge IDIBELL, PEBC, Chromatin & Dis Grp, Lhospitalet De Llobregat 08907, Spain	Pompeu Fabra University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)		manel.joaquin@upf.edu; francesc.posas@upf.edu	BARRAGAN, Montse/AFQ-1145-2022; Joaquin, Manel/E-2216-2015; Ballestar, Esteban/ABG-8561-2020; Joaquin, Manel/O-6533-2019; BARRAGAN, Montse/AAL-6772-2020; Posas, Francesc/K-1364-2013; Gubern, Albert/C-9902-2011	Joaquin, Manel/0000-0001-8973-5916; Joaquin, Manel/0000-0001-8973-5916; Posas, Francesc/0000-0002-4164-7076; Gubern, Albert/0000-0001-6458-1498; Ballestar, Esteban/0000-0002-1400-2440; Barragan, Montserrat/0000-0001-8859-6643	MICINN [BFU2007-66503, BFU2010-15939, CSD2007-0015]; European Commission [ERAS-CT-2003-980409]; Fundacion Marcelino Botin and Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia (Generalitat de Catalunya); Ministerio de Ciencia e Innovacion (MICINN); "Ramon y Cajal" program	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Marcelino Botin and Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Ramon y Cajal" program(Spanish Government)	This work was supported by MICINN Grants BFU2007-66503 and BFU2010-15939 (to M.J.) and BIO2009-07762, Consolider Ingenio 2010 programme (Grant CSD2007-0015) and through contract No. ERAS-CT-2003-980409 of the European Commission, DG Research, FP6 as part of a EURYI scheme award (to F. P.). This work was also supported by the Fundacion Marcelino Botin and Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia (Generalitat de Catalunya) (to F. P. laboratory).; Recipient of a PhD fellowship (FPI) from the Ministerio de Ciencia e Innovacion (MICINN).; Supported by the "Ramon y Cajal" program.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Ambrosino C, 2003, MOL CELL BIOL, V23, P370, DOI 10.1128/MCB.23.1.370-381.2003; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jandhyala DM, 2008, CELL MICROBIOL, V10, P1468, DOI 10.1111/j.1462-5822.2008.01139.x; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Lawrence MC, 2009, P NATL ACAD SCI USA, V106, P22181, DOI 10.1073/pnas.0912596106; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Vicent Guillermo P, 2009, Nucl Recept Signal, V7, pe008, DOI 10.1621/nrs.07008; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang XS, 2005, J BIOL CHEM, V280, P19298, DOI 10.1074/jbc.M413059200; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WHITMARSH AJ, 2007, J BIOCHIM BIOPHYS AC, V1773, P1285; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF1, DOI 10.1152/ajprenal.1999.277.1.F1; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	39	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31819	31828		10.1074/jbc.M110.155846	http://dx.doi.org/10.1074/jbc.M110.155846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682780	Green Published, hybrid			2022-12-25	WOS:000282764600073
J	Montserret, R; Saint, N; Vanbelle, C; Salvay, AG; Simorre, JP; Ebel, C; Sapay, N; Renisio, JG; Bockmann, A; Steinmann, E; Pietschmann, T; Dubuisson, J; Chipot, C; Penin, F				Montserret, Roland; Saint, Nathalie; Vanbelle, Christophe; Salvay, Andres Gerardo; Simorre, Jean-Pierre; Ebel, Christine; Sapay, Nicolas; Renisio, Jean-Guillaume; Boeckmann, Anja; Steinmann, Eike; Pietschmann, Thomas; Dubuisson, Jean; Chipot, Christophe; Penin, Francois			NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATION; 3-DIMENSIONAL STRUCTURE; IN-VITRO; SECONDARY STRUCTURE; IMINOSUGAR DERIVATIVES; INFECTIOUS VIRUS; MEMBRANE-PROTEIN; AQUEOUS-SOLUTION; CHEMICAL-SHIFTS; LIPID-BILAYERS	The small membrane protein p7 of hepatitis C virus forms oligomers and exhibits ion channel activity essential for virus infectivity. These viroporin features render p7 an attractive target for antiviral drug development. In this study, p7 from strain HCV-J (genotype 1b) was chemically synthesized and purified for ion channel activity measurements and structure analyses. p7 forms cation-selective ion channels in planar lipid bilayers and at the single-channel level by the patch clamp technique. Ion channel activity was shown to be inhibited by hexamethylene amiloride but not by amantadine. Circular dichroism analyses revealed that the structure of p7 is mainly alpha-helical, irrespective of the membrane mimetic medium (e.g. lysolipids, detergents, or organic solvent/water mixtures). The secondary structure elements of the monomeric form of p7 were determined by H-1 and C-13 NMR in trifluoroethanol/water mixtures. Molecular dynamics simulations in a model membrane were combined synergistically with structural data obtained from NMR experiments. This approach allowed us to determine the secondary structure elements of p7, which significantly differ from predictions, and to propose a three-dimensional model of the monomeric form of p7 associated with the phospholipid bilayer. These studies revealed the presence of a turn connecting an unexpected N-terminal alpha-helix to the first transmembrane helix, TM1, and a long cytosolic loop bearing the dibasic motif and connecting TM1 to TM2. These results provide the first detailed experimental structural framework for a better understanding of p7 processing, oligomerization, and ion channel gating mechanism.	[Sapay, Nicolas; Renisio, Jean-Guillaume; Boeckmann, Anja; Penin, Francois] Univ Lyon, IBCP, UMR 5086, CNRS,BioSci Gerland Lyon Sud IFR128, F-69367 Lyon 07, France; [Saint, Nathalie] INSERM, UMR 554, CNRS, Ctr Biochim Struct,UMR 5048, F-34090 Montpellier, France; [Salvay, Andres Gerardo; Simorre, Jean-Pierre; Ebel, Christine] Univ Grenoble 1, Inst Biol Struct, UMR 5075, CEA,CNRS, F-38000 Grenoble, France; [Steinmann, Eike; Pietschmann, Thomas] Twincore Ctr Expt & Clin Infect Res, Dept Expt Virol, D-30625 Hannover, Germany; [Dubuisson, Jean] Univ Lille Nord France, INSERM, U1019, Inst Pasteur Lille,CNRS,UMR 8204, F-59021 Lille, France; Univ Henri Poincare, CNRS, UMR 7565, Equipe Dynam Assemblages Membranaires, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Helmholtz Association; Helmholtz-Center for Infection Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine	Penin, F (corresponding author), Univ Lyon, IBCP, UMR 5086, CNRS,BioSci Gerland Lyon Sud IFR128, 7 Passage Vercors, F-69367 Lyon 07, France.	f.penin@ibcp.fr	Saint, Nathalie/S-5286-2016; Salvay, Andrés Gerardo/AAC-8505-2021; Pietschmann, Thomas/E-9241-2015; Böckmann, Anja/AAW-6276-2021; Dubuisson, Jean/E-6813-2016	Saint, Nathalie/0000-0001-5219-9486; Pietschmann, Thomas/0000-0001-5138-6239; Böckmann, Anja/0000-0001-8149-7941; Salvay, Andres/0000-0003-4020-1336; Ebel, Christine/0000-0002-6912-500X; simorre, jean-pierre/0000-0002-7943-1342; Dubuisson, Jean/0000-0003-1626-7693; Steinmann, Eike/0000-0002-3654-9965	CNRS; European Commission [LSHM-CT-2004-503359]; French National Agency for Research on AIDS and Viral Hepatitis	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); French National Agency for Research on AIDS and Viral Hepatitis(ANRS)	This work was supported by CNRS and grants from the European Commission (LSHM-CT-2004-503359, VIRGIL Network of Excellence on Antiviral Drug Resistance) (to J.D. and F. P.) and the French National Agency for Research on AIDS and Viral Hepatitis (to F. P. and J.D.). An oral presentation (O-101) of the main part of this work was done at the 13th International Meeting on Hepatitis C and related Viruses (Cairns, Australia, August 2006).	Biggin PC, 2001, CURR BIOL, V11, pR364, DOI 10.1016/S0960-9822(01)00195-6; Brohm C, 2009, J VIROL, V83, P11682, DOI 10.1128/JVI.00691-09; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; Castelain S, 2007, J MED VIROL, V79, P144, DOI 10.1002/jmv.20772; Chew CF, 2009, BIOPHYS J, V96, pL10, DOI 10.1016/j.bpj.2008.10.004; Chew CF, 2008, BIOPHYS J, V95, P5627, DOI 10.1529/biophysj.108.139477; Chipot C, 1996, J AM CHEM SOC, V118, P11217, DOI 10.1021/ja961379l; Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Cook GA, 2010, EUR BIOPHYS J BIOPHY, V39, P1097, DOI 10.1007/s00249-009-0533-y; Cordes FS, 2002, BIOCHEMISTRY-US, V41, P7359, DOI 10.1021/bi025518p; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Favier A, 2002, J MOL BIOL, V317, P131, DOI 10.1006/jmbi.2002.5397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fischer WB, 2000, BIOPOLYMERS, V53, P529, DOI 10.1002/(SICI)1097-0282(200006)53:7<529::AID-BIP1>3.0.CO;2-6; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Grice AL, 1997, FEBS LETT, V405, P299, DOI 10.1016/S0014-5793(97)00198-1; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haqshenas G, 2007, VIROLOGY, V360, P17, DOI 10.1016/j.virol.2006.10.014; Helluin O, 1997, BBA-BIOMEMBRANES, V1330, P284, DOI 10.1016/S0005-2736(97)00139-9; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P341, DOI 10.1113/jphysiol.1947.sp004216; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isherwood BJ, 2005, J GEN VIROL, V86, P667, DOI 10.1099/vir.0.80737-0; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuiken C, 2006, HEPATOLOGY, V43, P1157, DOI 10.1002/hep.21162; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Dain AC, 1998, J BIOL CHEM, V273, P12116, DOI 10.1074/jbc.273.20.12116; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MEDVEDEVA S, 1993, FEBS LETT, V333, P251, DOI 10.1016/0014-5793(93)80664-G; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Meshkat Z, 2009, J VIRAL HEPATITIS, V16, P187, DOI 10.1111/j.1365-2893.2008.01064.x; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Montal M, 2003, FEBS LETT, V552, P47, DOI 10.1016/S0014-5793(03)00849-4; Montserret R, 1999, BIOCHEMISTRY-US, V38, P6479, DOI 10.1021/bi9900222; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Patargias G, 2006, J MED CHEM, V49, P648, DOI 10.1021/jm050721e; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Penin F, 1997, J MOL BIOL, V270, P496, DOI 10.1006/jmbi.1997.1123; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Saint N, 2003, PEPTIDES, V24, P1779, DOI 10.1016/j.peptides.2003.09.015; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; Saint Nathalie, 2009, V510, P125, DOI 10.1007/978-1-59745-394-3_10; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; SALVAY AG, 2006, PROGR COLLOID POLYM, V131, P399; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; StGelais C, 2007, ANTIVIR RES, V76, P48, DOI 10.1016/j.antiviral.2007.05.001; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; THANABAL V, 1994, J BIOMOL NMR, V4, P47; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Van Melckebeke H, 2003, J MOL BIOL, V333, P711, DOI 10.1016/j/jmb.2003.09.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	77	109	110	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31446	31461		10.1074/jbc.M110.122895	http://dx.doi.org/10.1074/jbc.M110.122895			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667830	Green Published, hybrid			2022-12-25	WOS:000282764600039
J	Hayashida, T; Jones, JCR; Lee, CK; Schnaper, HW				Hayashida, Tomoko; Jones, Jonathan C. R.; Lee, Carrie K.; Schnaper, H. William			Loss of beta 1-Integrin Enhances TGF-beta 1-induced Collagen Expression in Epithelial Cells via Increased alpha v beta 3-Integrin and Rac1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; HUMAN MESANGIAL CELLS; HUMAN-LUNG FIBROBLASTS; FOCAL ADHESION KINASE; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; MAP-KINASE; MYOFIBROBLAST DIFFERENTIATION; INTEGRIN ALPHA-V-BETA-3; SIGNAL-TRANSDUCTION	Transforming growth factor beta(TGF-beta) promotes tissue fibrosis via the receptor-specific Smad pathway and non-canonical pathways. We recently reported that TGF-beta 1-stimulated collagen expression by cultured kidney cells requires integrin-dependent activation of focal adhesion kinase (FAK) and consequent ERK MAP kinase activity leading to Smad3 linker region phosphorylation. Here, we defined a role for alpha v beta 3-integrin in this non-canonical pathway. A human kidney tubular cell line in which beta 1-integrin was knocked down (beta 1-k/d) demonstrated enhanced type I collagen mRNA expression and promoter activity. A second shRNA to either alpha v-integrin or beta 3-integrin, but not to another alpha v-binding partner, beta 6-integrin, abrogated the enhanced COL1A2 promoter activity in beta 1-k/d cells. Although alpha v beta 3-integrin surface expression levels were not different, alpha v beta 3-integrins colocalized with sites of focal adhesion significantly more in beta 1-k/d cells, and activated alpha v beta 3-integrin was detected only in beta 1-k/d cells. Further, the collagen response was decreased by a function-blocking antibody or a peptide inhibitor of alpha v beta 3-integrin. In cells lacking alpha v beta 3-integrin, the responses were attenuated, whereas the response was enhanced in alpha v beta 3-overexpressing cells. Rac1 and ERK, previously defined mediators for this non-canonical pathway, showed increased activities in beta 1-k/d cells. Finally, inhibition of alpha v beta 3-integrin decreased Rac1 activity and COL1A2 promoter activity in beta 1-k/d cells. Together, our results indicate that decreasing beta 1 chain causes alpha v beta 3-integrin to become functionally dominant and promotes renal cell fibrogenesis via Rac1-mediated ERK activity.	[Hayashida, Tomoko; Lee, Carrie K.; Schnaper, H. William] Northwestern Univ, Feinberg Sch Med, Div Kidney Dis, Dept Pediat, Chicago, IL 60611 USA; [Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Hayashida, Tomoko; Schnaper, H. William] Childrens Mem Res Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Hayashida, T (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Kidney Dis, Dept Pediat, Pediat W-140,320 E Super St,Searle 4-491, Chicago, IL 60611 USA.	hayashida@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922; Hayashida, Tomoko/0000-0002-4160-7859	National Institutes of Health through NIDDK [DK49362, DK68637]; NCI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068637, R01DK049362, R01DK075663, R56DK049362] Funding Source: NIH RePORTER	National Institutes of Health through NIDDK; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK49362 and DK68637 through the NIDDK. This work was also supported by the flow cytometry and cell imaging facilities of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, supported by NCI Grant.	Adler S, 1999, AM J MED, V107, P371, DOI 10.1016/S0002-9343(99)00233-8; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Borza CM, 2006, J BIOL CHEM, V281, P20932, DOI 10.1074/jbc.M601147200; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; HEINO J, 1989, J BIOL CHEM, V264, P21806; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kagami S, 1996, EXP CELL RES, V229, P1, DOI 10.1006/excr.1996.0336; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Ly DP, 2003, J BIOL CHEM, V278, P21878, DOI 10.1074/jbc.M212538200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ortega-Velazquez R, 2003, FASEB J, V17, P1529, DOI 10.1096/fj.02-0785fje; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Poncelet AC, 1999, KIDNEY INT, V56, P1354, DOI 10.1046/j.1523-1755.1999.00680.x; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; ROBERTS CJ, 1988, J BIOL CHEM, V263, P4586; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359; Zinchuk O, 2005, MOL VIS, V11, P114	52	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30741	30751		10.1074/jbc.M110.105700	http://dx.doi.org/10.1074/jbc.M110.105700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20650890	hybrid, Green Published			2022-12-25	WOS:000282135500042
J	Hughes, SF; Hendricks, BD; Edwards, DR; Middleton, JF				Hughes, Stephen F.; Hendricks, Beverly D.; Edwards, David R.; Middleton, Jim F.			Tourniquet-Applied Upper Limb Orthopaedic Surgery Results in Increased Inflammation and Changes to Leukocyte, Coagulation and Endothelial Markers	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PROTEIN-C; ISCHEMIA; ACTIVATION; DAMAGE	Purpose: During this pilot clinical study, patients scheduled for elective tourniquet-applied upper limb orthopaedic surgery were recruited to investigate the effects of surgery on various biological markers (n = 10 patients). Methods: Three venous blood samples were collected from the arm at the ante-cubital fossa, at baseline (pre-operatively), 5 and 15 minutes after reperfusion (post-operatively). Neutrophil and monocyte leukocyte sub-populations were isolated by density gradient centrifugation techniques. Leukocyte activation was investigated by measuring the cell surface expression of CD62L (L-selectin), CD11b (Mac-1) and the intracellular production of hydrogen peroxide (H2O2), via flow cytometry. C-reactive protein (CRP) was measured using a clinical chemistry analyser. Plasma concentrations of protein C and von Willebrand factor (vWF) were measured using enzyme-linked fluorescent assays (ELFA). Results: Following tourniquet-applied upper limb orthopaedic surgery, there was a decrease in neutrophil CD62L expression (p = 0.001), an increase in CD11b expression and in the intracellular production of H2O2 by neutrophils and monocytes (p<0.05). An increase in CRP concentration (p<0.001), a decrease in protein C concentration (p = 0.004), with a trend towards elevated vWF levels (p = 0.232) were also observed during this time. Conclusions: Conventionally, patients undergoing orthopaedic surgery have been monitored in the peri-operative period by means of CRP, which is a non-specific marker of inflammation. This test cannot differentiate between inflammation due to current or pre-existing disease processes and the development of ischaemia-reperfusion injury surgery. The findings from this study suggest that markers such as CD11b, protein C and H2O2 may provide alternative ways of assessing leukocyte and coagulation activation peri-operatively. It is proposed that by allowing orthopaedic surgeons access to laboratory markers such as CD11b, protein C and H2O2, an accurate assessment of the extent of inflammation due to surgery per se could be made.	[Hughes, Stephen F.] Univ Chester, Dept Biol Sci, Chester, Cheshire, England; [Hendricks, Beverly D.] Glan Clwyd Gen Hosp, Dept Haematol, Conwy, Wales; [Edwards, David R.] Gwynedd Hosp, Dept Haematol, Bangor, Gwynedd, Wales; [Hughes, Stephen F.; Middleton, Jim F.] Keele Univ, Leopold Muller Arthrit Res Ctr, Robert Jones & Agnes Hunt Orthopaed Hosp, Sch Med, Keele, Staffs, England	University of Chester; Keele University	Hughes, SF (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.	stephen.hughes@chester.ac.uk			Institute of Biomedical Science (IBMS); North Wales Research Committee (NWRC); Medical Research Council [G0401634] Funding Source: researchfish; MRC [G0401634] Funding Source: UKRI	Institute of Biomedical Science (IBMS); North Wales Research Committee (NWRC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thankfully acknowledge the Institute of Biomedical Science (IBMS) and the North Wales Research Committee (NWRC) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIOR BM, 1992, NOUV REV FR HEMATOL, V34, pS29; BASS DA, 1983, J IMMUNOL, V130, P1910; BLANN AD, 1994, EUR J VASCULAR SURG, V8, P10, DOI 10.1016/S0950-821X(05)80112-4; Blann AD, 1996, EUR J VASC ENDOVASC, V12, P218, DOI 10.1016/S1078-5884(96)80110-9; BRADBURY AW, 1993, BRIT J SURG, V80, P1503, DOI 10.1002/bjs.1800801204; ENGLER RL, 1989, AM J CARDIOL, V63, pE19, DOI 10.1016/0002-9149(89)90225-7; Foster W, 2009, RHEUMATOLOGY, V48, P285, DOI 10.1093/rheumatology/ken486; Hughes SF, 2006, BRIT J BIOMED SCI, V63, P166, DOI 10.1080/09674845.2006.11732743; Hughes Stephen F, 2007, J Inflamm (Lond), V4, P12, DOI 10.1186/1476-9255-4-12; JANG YS, 1994, J AM COLL CARDIOL, V24, P1591, DOI 10.1016/0735-1097(94)90162-7; Kirkpatrick U J, 2000, Int J Surg Investig, V2, P151; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; Lan W, 2004, EUR J ANAESTH, V21, P892, DOI 10.1017/S0265021504000249; LEFF JA, 1990, BLOOD CELLS, V16, P183; LENNIE SE, 1987, CLIN HEMORHEOL, V7, P811; MARLAR RA, 1989, HUM PATHOL, V20, P1040, DOI 10.1016/0046-8177(89)90221-9; Norwood MGA, 2004, EUR J VASC ENDOVASC, V28, P234, DOI 10.1016/j.ejvs.2004.03.026; Orrego M, 2005, REV MED CHILE, V133, P1341; Pahl MV, 2005, J NATL MED ASSOC, V97, P172; Parslew R, 1997, BRIT J DERMATOL, V136, P734, DOI 10.1111/j.1365-2133.1997.tb03661.x; PRICE CP, 1987, J IMMUNOL METHODS, V99, P205, DOI 10.1016/0022-1759(87)90129-3; SCHMIDSCHONBEIN GW, 1990, BIORHEOLOGY, V27, P859; Seekamp A, 2001, SHOCK, V15, P254, DOI 10.1097/00024382-200115040-00002; SEKAMP A, 1993, AGENTS ACTIONS S, V41, P137; Sutter PM, 1997, WORLD J SURG, V21, P179, DOI 10.1007/s002689900212; SUTTER PM, 1997, WORLD J SURG, P185; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; ten Raa S, 2006, J SURG RES, V136, P45, DOI 10.1016/j.jss.2006.05.006	28	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11846	10.1371/journal.pone.0011846	http://dx.doi.org/10.1371/journal.pone.0011846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676375	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520100018
J	White, AP; Weljie, AM; Apel, D; Zhang, P; Shaykhutdinov, R; Vogel, HJ; Surette, MG				White, Aaron P.; Weljie, Aalim M.; Apel, Dmitry; Zhang, Ping; Shaykhutdinov, Rustem; Vogel, Hans J.; Surette, Michael G.			A Global Metabolic Shift Is Linked to Salmonella Multicellular Development	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SIGMA(S)-DEPENDENT GENE-EXPRESSION; LONG-TERM SURVIVAL; ESCHERICHIA-COLI; BIOFILM FORMATION; AGGREGATIVE FIMBRIAE; RDAR MORPHOTYPE; GLYCINE BETAINE; PERSISTENCE; PROTEIN	Bacteria can elaborate complex patterns of development that are dictated by temporally ordered patterns of gene expression, typically under the control of a master regulatory pathway. For some processes, such as biofilm development, regulators that initiate the process have been identified but subsequent phenotypic changes such as stress tolerance do not seem to be under the control of these same regulators. A hallmark feature of biofilms is growth within a self-produced extracellular matrix. In this study we used metabolomics to compare Salmonella cells in rdar colony biofilms to isogenic csgD deletion mutants that do not produce an extracellular matrix. The two populations show distinct metabolite profiles. Even though CsgD controls only extracellular matrix production, metabolite signatures associated with cellular adaptations associated with stress tolerances were present in the wild type but not the mutant cells. To further explore these differences we examine the temporal gene expression of genes implicated in biofilm development and stress adaptations. In wild type cells, genes involved in a metabolic shift to gluconeogenesis and various stress-resistance pathways exhibited an ordered expression profile timed with multicellular development even though they are not CsgD regulated. In csgD mutant cells, the ordered expression was lost. We conclude that the induction of these pathways results from production of, and growth within, a self produced matrix rather than elaboration of a defined genetic program. These results predict that common physiological properties of biofilms are induced independently of regulatory pathways that initiate biofilm formation.	[White, Aaron P.; Apel, Dmitry; Surette, Michael G.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Weljie, Aalim M.; Zhang, Ping; Shaykhutdinov, Rustem; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	White, AP (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada.	surette@ucalgary.ca	Weljie, Aalim/V-6952-2019; Surette, Michael G/AAE-8825-2020; Weljie, Aalim M/B-6203-2012	Weljie, Aalim/0000-0002-7145-4494; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) to MGS and HJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Andrade SLA, 2007, J BACTERIOL, V189, P9101, DOI 10.1128/JB.01336-07; Anriany YA, 2001, APPL ENVIRON MICROB, V67, P4048, DOI 10.1128/AEM.67.9.4048-4056.2001; Apel D, 2009, APPL ENVIRON MICROB, V75, P4923, DOI 10.1128/AEM.00363-09; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Bourassa L, 2009, MOL MICROBIOL, V72, P124, DOI 10.1111/j.1365-2958.2009.06629.x; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Brombacher E, 2006, J BACTERIOL, V188, P2027, DOI 10.1128/JB.188.6.2027-2037.2006; Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Checroun C, 2004, FEMS MICROBIOL LETT, V236, P221, DOI 10.1016/j.femsle.2004.05.046; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; FRAENKEL DG, 1996, ESCHERICHIA COLI SAL, P189; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gerstel U, 2001, ENVIRON MICROBIOL, V3, P638, DOI 10.1046/j.1462-2920.2001.00235.x; Ghigo JM, 2003, RES MICROBIOL, V154, P1, DOI 10.1016/S0923-2508(02)00012-8; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gjersing EL, 2007, ANAL CHEM, V79, P8037, DOI 10.1021/ac070800t; GOVONS S, 1969, J BACTERIOL, V97, P970, DOI 10.1128/JB.97.2.970-972.1969; Grantcharova N, 2010, J BACTERIOL, V192, P456, DOI 10.1128/JB.01826-08; Gualdi L, 2007, J BACTERIOL, V189, P8034, DOI 10.1128/JB.00900-07; GUTIERREZ JA, 1995, J BACTERIOL, V177, P390, DOI 10.1128/jb.177.2.390-400.1995; Hamilton S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-599; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; LUCHT JM, 1994, FEMS MICROBIOL REV, V14, P3, DOI 10.1016/0168-6445(94)90008-6; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; MALOY SR, 1996, GENETIC ANAL PATHOGE, P466; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; MATIN A, 1989, ANNU REV MICROBIOL, V43, P293, DOI 10.1146/annurev.mi.43.100189.001453; McMeechan A, 2005, MICROBIOL-SGM, V151, P3969, DOI 10.1099/mic.0.28292-0; Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200; Mercado-Lubo R, 2008, INFECT IMMUN, V76, P1128, DOI 10.1128/IAI.01226-07; Moorthy S, 2005, MOL MICROBIOL, V57, P1623, DOI 10.1111/j.1365-2958.2005.04797.x; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993, DOI 10.1128/JB.181.19.5993-6002.1999; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stocki SL, 2007, POULTRY SCI, V86, P2375, DOI 10.3382/ps.2007-00121; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tremoulet F, 2002, FEMS MICROBIOL LETT, V215, P7, DOI 10.1016/S0378-1097(02)00879-0; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; UNDERWOOD AH, 1965, BIOCHEM J, V95, P767, DOI 10.1042/bj0950767; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; White AP, 2008, INFECT IMMUN, V76, P1048, DOI 10.1128/IAI.01383-07; White AP, 2006, J BACTERIOL, V188, P8395, DOI 10.1128/JB.00798-06; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	84	62	63	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11814	10.1371/journal.pone.0011814	http://dx.doi.org/10.1371/journal.pone.0011814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676398	gold, Green Submitted, Green Published			2022-12-25	WOS:000280371800015
J	Thalhauser, CJ; Komarova, NL				Thalhauser, Craig J.; Komarova, Natalia L.			Signal Response Sensitivity in the Yeast Mitogen-Activated Protein Kinase Cascade	PLOS ONE			English	Article							MAP KINASE; SCAFFOLD PROTEINS; SPECIFICITY; DYNAMICS; PATHWAY	The yeast pheromone response pathway is a canonical three-step mitogen activated protein kinase (MAPK) cascade which requires a scaffold protein for proper signal transduction. Recent experimental studies into the role the scaffold plays in modulating the character of the transduced signal, show that the presence of the scaffold increases the biphasic nature of the signal response. This runs contrary to prior theoretical investigations into how scaffolds function. We describe a mathematical model of the yeast MAPK cascade specifically designed to capture the experimental conditions and results of these empirical studies. We demonstrate how the system can exhibit either graded or ultrasensitive (biphasic) response dynamics based on the binding kinetics of enzymes to the scaffold. At the basis of our theory is an analytical result that weak interactions make the response biphasic while tight interactions lead to a graded response. We then show via an analysis of the kinetic binding rate constants how the results of experimental manipulations, modeled as changes to certain of these binding constants, lead to predictions of pathway output consistent with experimental observations. We demonstrate how the results of these experimental manipulations are consistent within the framework of our theoretical treatment of this scaffold-dependent MAPK cascades, and how future efforts in this style of systems biology can be used to interpret the results of other signal transduction observations.	[Thalhauser, Craig J.; Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine	Thalhauser, CJ (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Institutes of Health/National Science Foundation [GM75309]; NIH/National Institute of General Medical Sciences [1P50GM076516-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075309, P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health/National Science Foundation(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health/National Science Foundation joint initiative on Mathematical Biology through NIH grant GM75309 and NIH/National Institute of General Medical Sciences grant 1P50GM076516-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Bardwell L, 2007, BIOPHYS J, V92, P3425, DOI 10.1529/biophysj.106.090084; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; DOHLMAN H, 2008, SCI STKE, V42, pPE46; FERRELL J, 2000, SCI STKE, V52, pPE1; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komarova NL, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100031; LAMSON R, 2006, CURR BIOL, V61, P618; Levchenko A., 2004, Systems Biology, V1, P139, DOI 10.1049/sb:20045014; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Shao DY, 2006, BIOPHYS J, V91, P3986, DOI 10.1529/biophysj.106.081661; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; THALHAUSER C, 2009, BIOPHYSICAL IN PRESS, V66; Zou XF, 2008, J THEOR BIOL, V250, P139, DOI 10.1016/j.jtbi.2007.09.024	25	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11568	10.1371/journal.pone.0011568	http://dx.doi.org/10.1371/journal.pone.0011568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668519	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800001
J	Uva, P; Lahm, A; Sbardellati, A; Grigoriadis, A; Tutt, A; de Rinaldis, E				Uva, Paolo; Lahm, Armin; Sbardellati, Andrea; Grigoriadis, Anita; Tutt, Andrew; de Rinaldis, Emanuele			Comparative Membranome Expression Analysis in Primary Tumors and Derived Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; CLASSIFICATION; SIGNATURE; BREAST; OLIGONUCLEOTIDE; PATTERNS; IDENTIFICATION; CARCINOMAS; MUTATIONS; PROFILES	Despite the wide use of cell lines in cancer research, the extent to which their surface properties correspond to those of primary tumors is poorly characterized. The present study addresses this problem from a transcriptional standpoint, analyzing the expression of membrane protein genes - the Membranome - in primary tumors and immortalized in-vitro cultured tumor cells. 409 human samples, deriving from ten independent studies, were analyzed. These comprise normal tissues, primary tumors and tumor derived cell lines deriving from eight different tissues: brain, breast, colon, kidney, leukemia, lung, melanoma, and ovary. We demonstrated that the Membranome has greater power than the remainder of the transcriptome when used as input for the automatic classification of tumor samples. This feature is maintained in tumor derived cell lines. In most cases primary tumors show maximal similarity in Membranome expression with cell lines of same tissue origin. Differences in Membranome expression between tumors and cell lines were analyzed also at the pathway level and biological themes were identified that were differentially regulated in the two settings. Moreover, by including normal samples in the analysis, we quantified the degree to which cell lines retain the Membranome up-and down-regulations observed in primary tumors with respect to their normal counterparts. We showed that most of the Membranome up-regulations observed in primary tumors are lost in the in-vitro cultured cells. Conversely, the majority of Membranome genes down-regulated upon tumor transformation maintain lower expression levels also in the cell lines. This study points towards a central role of Membranome genes in the definition of the tumor phenotype. The comparative analysis of primary tumors and cell lines identifies the limits of cell lines as a model for the study of cancer-related processes mediated by the cell surface. Results presented allow for a more rational use of the cell lines as a model of cancer.	[Uva, Paolo; Sbardellati, Andrea] Parco Sci & Tecnol POLARIS, CRS4 Bioinformat Lab, Cagliari, Italy; [Lahm, Armin] IRBM, Rome, Italy; [Grigoriadis, Anita; Tutt, Andrew; de Rinaldis, Emanuele] Kings Coll London, Sch Med, Guys Hosp, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England	Merck & Company; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Uva, P (corresponding author), Parco Sci & Tecnol POLARIS, CRS4 Bioinformat Lab, Cagliari, Italy.	emanuele.de_rinaldis@kcl.ac.uk	Uva, Paolo/A-2877-2011	Uva, Paolo/0000-0002-9524-8492; Grigoriadis, Anita/0000-0003-3434-201X; Tutt, Andrew/0000-0001-8715-2901	Breakthrough Breast Cancer Research, United Kingdom	Breakthrough Breast Cancer Research, United Kingdom	This work was supported by Breakthrough Breast Cancer Research, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R PROJECT STAT COMPU; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Josic D, 2008, CURR OPIN MOL THER, V10, P116; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Le XF, 2005, J BIOL CHEM, V280, P2092, DOI 10.1074/jbc.M403080200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Loo DT, 2008, CURR OPIN PHARMACOL, V8, P627, DOI 10.1016/j.coph.2008.08.011; Mah N, 2004, PHYSIOL GENOMICS, V16, P361, DOI 10.1152/physiolgenomics.00080.2003; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Monaci P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001508; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nutt CL, 2003, CANCER RES, V63, P1602; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Roschke AV, 2003, CANCER RES, V63, P8634; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Samoylova T. I., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P9, DOI 10.2174/187152006774755492; Sandberg R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r65; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal NH, 2003, J CLIN ONCOL, V21, P1775, DOI 10.1200/JCO.2003.10.108; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Stein WD, 2004, CANCER RES, V64, P2805, DOI 10.1158/0008-5472.CAN-03-3383; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2001, CANCER RES, V61, P7388; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Virtanen C, 2002, P NATL ACAD SCI USA, V99, P12357, DOI 10.1073/pnas.192240599; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Wang Huixia, 2006, BMC Genomics, V7, P166; WHITESIDE T, 2006, LINK INFLAMMATION CA; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xing-Dong Feng, 2007, Genomics Proteomics & Bioinformatics, V5, P15, DOI 10.1016/S1672-0229(07)60010-2; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	61	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11742	10.1371/journal.pone.0011742	http://dx.doi.org/10.1371/journal.pone.0011742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668533	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800016
J	Seoighe, C; Gehring, C				Seoighe, Cathal; Gehring, Chris			Heritability in the Efficiency of Nonsense-Mediated mRNA Decay in Humans	PLOS ONE			English	Article							GENOME-WIDE SURVEY; GENE-EXPRESSION; SURVEILLANCE; VARIANTS; IDENTIFICATION; MUTATIONS; COMPONENT; COMPLEX; EXONS	Background: In eukaryotes mRNA transcripts of protein-coding genes in which an intron has been retained in the coding region normally result in premature stop codons and are therefore degraded through the nonsense-mediated mRNA decay (NMD) pathway. There is evidence in the form of selective pressure for in-frame stop codons in introns and a depletion of length three introns that this is an important and conserved quality-control mechanism. Yet recent reports have revealed that the efficiency of NMD varies across tissues and between individuals, with important clinical consequences. Principal Findings: Using previously published Affymetrix exon microarray data from cell lines genotyped as part of the International HapMap project, we investigated whether there are heritable, inter-individual differences in the abundance of intron-containing transcripts, potentially reflecting differences in the efficiency of NMD. We identified intronic probesets using EST data and report evidence of heritability in the extent of intron expression in 56 HapMap trios. We also used a genome-wide association approach to identify genetic markers associated with intron expression. Among the top candidates was a SNP in the DCP1A gene, which forms part of the decapping complex, involved in NMD. Conclusions: While we caution that some of the apparent inter-individual difference in intron expression may be attributable to different handling or treatments of cell lines, we hypothesize that there is significant polymorphism in the process of NMD, resulting in heritable differences in the abundance of intronic mRNA. Part of this phenotype is likely to be due to a polymorphism in a decapping enzyme on human chromosome 3.	[Seoighe, Cathal] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland; [Seoighe, Cathal] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Gehring, Chris] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia	Ollscoil na Gaillimhe-University of Galway; University of Cape Town; King Abdullah University of Science & Technology	Seoighe, C (corresponding author), Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland.	Cathal.Seoighe@nuigalway.ie		Gehring, Christoph/0000-0003-4355-4591	Science Foundation Ireland [07/SK/M1211b]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by Science Foundation Ireland (Grant number 07/SK/M1211b; http://www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; AULCHENKO Y, 2009, GENABEL GENOME WIDE; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Chaix R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000184; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Couttet P, 2004, NUCLEIC ACIDS RES, V32, P488, DOI 10.1093/nar/gkh218; Dabney A, 2009, QVALUE Q VALUE ESTIM; ElSharawy A, 2006, HUM MUTAT, V27, P1129, DOI 10.1002/humu.20377; ElSharawy A, 2009, HUM MUTAT, V30, P625, DOI 10.1002/humu.20906; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Linde L, 2007, EUR J HUM GENET, V15, P1156, DOI 10.1038/sj.ejhg.5201889; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Mitrovich QM, 2005, CURR BIOL, V15, P963, DOI 10.1016/j.cub.2005.04.055; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nembaware V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-265; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11657	10.1371/journal.pone.0011657	http://dx.doi.org/10.1371/journal.pone.0011657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657766	gold, Green Published, Green Submitted			2022-12-25	WOS:000280197500014
J	Stern, MD				Stern, Michael D.			Patrimony and the Evolution of Risk-Taking	PLOS ONE			English	Article							GAMBLING BEHAVIOR	The propensity to make risky choices has a genetic component, and recent studies have identified several specific genes that contribute to this trait. Since risk-taking often appears irrational or maladaptive, the question arises how (or if) natural selection favors risk-taking. Here we show, using a stochastic simulation of selection between two hypothetical species, "R'' (risk-seeking) and "A'' (risk-averse) that, when expected reproductive fitness of the individual is unaffected by the making of the risky choice (winnings balanced by losses) natural selection (taken to the point of extinction) favors the risk-averse species. However, the situation is entirely reversed if offspring are permitted to inherit a small fraction of the parent's increased or decreased fitness acquired through risk-taking. This seemingly Lamarckian form of inheritance actually corresponds to the human situation when property or culture are transmitted in families. In the presence of this "cultural inheritance'', the long-shot risk-taking species was overwhelmingly favored, even when 90% of individuals were rendered sterile by a losing choice. Given this strong effect in a minimal model, it is important to consider the co-evolution of genes and culture when interpreting the genetics of risk-taking. This conclusion applies, in principle, to any species where parental resources can directly affect the fecundity of offspring. It might also be relevant to the effects of epigenetic inheritance, if the epigenetic state of zygotes can be affected by parental experiences.	NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stern, MD (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.	sternm@grc.nia.nih.gov		Stern, Michael/0000-0003-4476-7425	National Institute on Aging of the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000241] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was entirely supported by the Intramual Research Program of the National Institute on Aging of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Bednekoff PA, 1996, AM ZOOL, V36, P471; Bell AM, 2009, ADV GENET, V68, P83, DOI 10.1016/S0065-2660(09)68004-4; Bloomfield AN, 2006, MEM COGNITION, V34, P929, DOI 10.3758/BF03193438; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Cooney CA, 2002, J NUTR, V132, p2393S; Dekel E, 1999, J ECON THEORY, V87, P125, DOI 10.1006/jeth.1999.2537; Eisen SA, 1998, ADDICTION, V93, P1375; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; HOUSTON AI, 1991, J EXP ANAL BEHAV, V56, P585, DOI 10.1901/jeab.1991.56-585; Juhasz G, 2010, NEUROPSYCHOPHARMACOL, V35, P1109, DOI 10.1038/npp.2009.216; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Madden GJ, 2007, J GAMBL STUD, V23, P63, DOI 10.1007/s10899-006-9041-5; NEUMANN JV, 1944, THEORIES GAMES EC BE; PETERS H, 2010, J GAMBL STU IN PRESS; Plaistow SJ, 2006, AM NAT, V167, P206, DOI 10.1086/499380; Poethke Hans J., 2008, BMC Ecology, V8, P2, DOI 10.1186/1472-6785-8-2; ROOS P, 2009, 6 C EUR SOC SIM ASS; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van den Bos R, 2006, BEHAV RES METHODS, V38, P470, DOI 10.3758/BF03192801; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516	27	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11656	10.1371/journal.pone.0011656	http://dx.doi.org/10.1371/journal.pone.0011656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	627TK	20668653	Green Published, gold, Green Submitted			2022-12-25	WOS:000280065600018
J	Brugger, SD; Frey, P; Aebi, S; Hinds, J; Muhlemann, K				Brugger, Silvio D.; Frey, Pascal; Aebi, Suzanne; Hinds, Jason; Muehlemann, Kathrin			Multiple Colonization with S. pneumoniae before and after Introduction of the Seven-Valent Conjugated Pneumococcal Polysaccharide Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; NASOPHARYNGEAL COLONIZATION; UNITED-STATES; SEROTYPE 19A; CHILDREN; DISEASE; CARRIAGE; PCR; POPULATION	Background: Simultaneous carriage of more than one strain of Streptococcus pneumoniae promotes horizontal gene transfer events and may lead to capsule switch and acquisition of antibiotic resistance. We studied the epidemiology of cocolonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal vaccine (PCV7). Methodology: Nasopharyngeal swabs (n 1120) were collected from outpatients between 2004 and 2009 within an ongoing nationwide surveillance program. Cocolonization was detected directly from swabs by restriction fragment length polymorphism (RFLP) analysis. Serotypes were identified by agglutination, multiplex PCR and microarray. Principal Findings: Rate of multiple colonization remained stable up to three years after PCV7 introduction. Cocolonization was associated with serotypes of low carriage prevalence in the prevaccine era. Pneumococcal colonization density was higher in cocolonized samples and cocolonizing strains were present in a balanced ratio (median 1.38). Other characteristics of cocolonization were a higher frequency at young age, but no association with recurrent acute otitis media, recent antibiotic exposure, day care usage and PCV7 vaccination status. Conclusions: Pneumococcal cocolonization is dominated by serotypes of low carriage prevalence in the prevaccine era, which coexist in the nasopharynx. Emergence of such previously rare serotypes under vaccine selection pressure may promote cocolonization in the future.	[Brugger, Silvio D.; Frey, Pascal; Aebi, Suzanne; Muehlemann, Kathrin] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Hinds, Jason] Univ London, Div Cellular & Mol Med, London, England; [Muehlemann, Kathrin] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland	University of Bern; University of London; University of Bern; University Hospital of Bern	Brugger, SD (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	kathrin.muehlemann@ifik.unibe.ch	Kummer, Juerg/B-3322-2011; Brugger, Silvio Daniel/AAY-7090-2020	Brugger, Silvio Daniel/0000-0001-9492-9088; Hinds, Jason/0000-0002-2739-1908; Frey, Pascal/0000-0001-6161-0919	Swiss National Science Foundation [320000-113912, 323500-119214]; Wellcome Trust; Pfizer AG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Pfizer AG	The authors acknowledge the Swiss National Science Foundation ( research grant 320000-113912 to K. M.; MD-PhD scholarship 323500-119214 to S. B.), the Wellcome Trust for funding B mu G@S (Bacterial Microarray Group at St George's, University of London), and Pfizer AG for partial support of the pneumococcal surveillance system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2007, J CLIN MICROBIOL, V45, P3408, DOI 10.1128/JCM.01393-07; AURANEN K, AM J EPIDEMIOL, V171, P169; Billal DS, 2008, EUR J PEDIATR, V167, P401, DOI 10.1007/s00431-007-0510-3; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bronsdon MA, 2004, J CLIN MICROBIOL, V42, P1596, DOI 10.1128/JCM.42.4.1596-1600.2004; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Hathaway LJ, 2007, J CLIN MICROBIOL, V45, P803, DOI 10.1128/JCM.02169-06; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; MARGOLIS E, BMC MICROBIOL, V10, P59; Meier PS, 2003, ANTIMICROB AGENTS CH, V47, P863, DOI 10.1128/AAC.47.3.863-868.2003; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Morrison KE, 2000, J CLIN MICROBIOL, V38, P434; Muhlemann K, 2003, J INFECT DIS, V187, P589, DOI 10.1086/367994; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Regev-Yochay G, 2008, CLIN INFECT DIS, V47, P289, DOI 10.1086/589573; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Temime L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003244; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	34	74	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11638	10.1371/journal.pone.0011638	http://dx.doi.org/10.1371/journal.pone.0011638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661289	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000279980800022
J	Del Rizzo, PA; Couture, JF; Dirk, LMA; Strunk, BS; Roiko, MS; Brunzelle, JS; Houtz, RL; Trievel, RC				Del Rizzo, Paul A.; Couture, Jean-Francois; Dirk, Lynnette M. A.; Strunk, Bethany S.; Roiko, Marijo S.; Brunzelle, Joseph S.; Houtz, Robert L.; Trievel, Raymond C.			SET7/9 Catalytic Mutants Reveal the Role of Active Site Water Molecules in Lysine Multiple Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT SPECIFICITY; METHYLTRANSFERASE SET7/9; STRUCTURAL BASIS; MECHANISM; DYNAMICS	SET domain lysine methyltransferases (KMTs) methylate specific lysine residues in histone and non-histone substrates. These enzymes also display product specificity by catalyzing distinct degrees of methylation of the lysine epsilon-amino group. To elucidate the molecular mechanism underlying this specificity, we have characterized the Y245A and Y305F mutants of the human KMT SET7/9 (also known as KMT7) that alter its product specificity from a monomethyltransferase to a di- and a trimethyltransferase, respectively. Crystal structures of these mutants in complex with peptides bearing unmodified, mono-, di-, and trimethylated lysines illustrate the roles of active site water molecules in aligning the lysine epsilon-amino group for methyl transfer with S-adenosylmethionine. Displacement or dissociation of these solvent molecules enlarges the diameter of the active site, accommodating the increasing size of the methylated epsilon-amino group during successive methyl transfer reactions. Together, these results furnish new insights into the roles of active site water molecules in modulating lysine multiple methylation by SET domain KMTs and provide the first molecular snapshots of the mono-, di-, and trimethyl transfer reactions catalyzed by these enzymes.	[Trievel, Raymond C.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Couture, Jean-Francois] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Dirk, Lynnette M. A.; Houtz, Robert L.] Univ Kentucky, Dept Hort, Plant Physiol Biochem Mol Biol Program, Lexington, KY 40546 USA; [Brunzelle, Joseph S.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Ctr Synchrotron Res, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	University of Michigan System; University of Michigan; University of Ottawa; University of Kentucky; Northwestern University	Trievel, RC (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu		Strunk, Bethany/0000-0003-2337-4614	National Institutes of Health, NIDDK [DK020572]; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; American Recovery and Reinvestment Act [R01 GM073839, GM073839-04S1]; Department of Energy [DE-FG02-92ER20075]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073839] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; American Recovery and Reinvestment Act; Department of Energy(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge S. Schiebold for assistance in protein expression, purification, and crystallization and S. Anderson and R. Sanishvili for their assistance with x-ray data collection. We also thank S. Bulfer and S. Horowitz for reading the manuscript and providing useful comments. This work utilized the Protein Structure Facility of the Michigan Diabetes Research and Training Center, University of Michigan, supported by National Institutes of Health Grant DK020572, NIDDK. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract DE-AC02-06CH11357. GM/CA CAT has been funded in whole or in part by National Institutes of Health NCI Grant Y1-CO-1020 and NIGMS Grant Y1-GM-1104. Use of the LS-CAT Sector 21 was supported by Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817 for the support of this research program.; This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073839 (to R. C. T.) and National Institutes of Health Administrative Supplement GM073839-04S1 (to R. C. T.) funded through the American Recovery and Reinvestment Act. This work was also supported by Department of Energy Grant DE-FG02-92ER20075 (to R. L. H.).; Supported by a Canadian Institutes of Health Research postdoctoral fellowship.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandra A, 2002, J PHYS CHEM B, V106, P6779, DOI 10.1021/jp020659m; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Guardia E, 2005, J MOL LIQ, V117, P63, DOI 10.1016/j.molliq.2004.08.004; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Masatsugu T, 2009, BIOCHEM BIOPH RES CO, V381, P22, DOI 10.1016/j.bbrc.2009.01.185; Morgunkova A, 2006, CELL CYCLE, V5, P1308, DOI 10.4161/cc.5.12.2820; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105; Zhang X, 2007, BIOCHEMISTRY-US, V46, P14838, DOI 10.1021/bi7014579	43	46	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31849	31858		10.1074/jbc.M110.114587	http://dx.doi.org/10.1074/jbc.M110.114587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675860	Green Published, hybrid			2022-12-25	WOS:000282764600076
J	Ohmori, T; Kashiwakura, Y; Ishiwata, A; Madoiwa, S; Mimuro, J; Furukawa, Y; Sakata, Y				Ohmori, Tsukasa; Kashiwakura, Yuji; Ishiwata, Akira; Madoiwa, Seiji; Mimuro, Jun; Furukawa, Yusuke; Sakata, Yoichi			Vinculin Is Indispensable for Repopulation by Hematopoietic Stem Cells, Independent of Integrin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BONE-MARROW; LINKED KINASE; FETAL LIVER; N-CADHERIN; TALIN ROD; ACTIVATION; ADHESION; BINDING; NICHE	Vinculin is a highly conserved actin-binding protein that is localized in integrin-mediated focal adhesion complexes. Although critical roles have been proposed for integrins in hematopoietic stem cell (HSC) function, little is known about the involvement of intracellular focal adhesion proteins in HSC functions. This study showed that the ability of c-Kit(+)Sca1(+)Lin(-) HSCs to support reconstitution of hematopoiesis after competitive transplantation was severely impaired by lentiviral transduction with short hairpin RNA sequences for vinculin. The potential of these HSCs to differentiate into granulocytic and monocytic lineages, to migrate toward stromal cell-derived factor 1 alpha, and to home to the bone marrow in vivo were not inhibited by the loss of vinculin. However, the capacities to form long term culture-initiating cells and cobblestone-like areas were abolished in vinculin-silenced c-Kit(+)Sca1(+)Lin(-) HSCs. In contrast, adhesion to the extracellular matrix was inhibited by silencing of talin-1, but not of vinculin. Whole body in vivo luminescence analyses to detect transduced HSCs confirmed the role of vinculin in long term HSC reconstitution. Our results suggest that vinculin is an indispensable factor determining HSC repopulation capacity, independent of integrin functions.	[Sakata, Yoichi] Jichi Med Univ, Ctr Mol Med, Res Div Cell & Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Furukawa, Yusuke] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi 3290498, Japan	Jichi Medical University; Jichi Medical University	Ohmori, T (corresponding author), Yakushiji 3311-1 Shimotsuke, Shimotsuke, Tochigi 3290498, Japan.	tohmori@jichi.ac.jp; yoisaka@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418; OHMORI, TSUKASA/0000-0001-5082-6394	Mitsubishi Pharma Research Foundation; Japanese Ministry of Education and Science; Japanese Ministry of Health, Labour and Welfare;  [20591155];  [21591249];  [21790920]	Mitsubishi Pharma Research Foundation; Japanese Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); ; ; 	This work was supported by Grants from the Mitsubishi Pharma Research Foundation; Grants-in-Aid for Scientific Research (20591155, 21591249, and 21790920) and the Support Program for Strategic Research Infrastructure from the Japanese Ministry of Education and Science; and Health, Labour and Science Research Grants for Research on HIV/AIDS and Research on Intractable Diseases from the Japanese Ministry of Health, Labour and Welfare.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Honda S, 2009, BLOOD, V113, P5304, DOI 10.1182/blood-2008-07-169136; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nakauchi H, 2001, ANN NY ACAD SCI, V938, P18; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Ogaeri T, 2009, STEM CELLS, V27, P1120, DOI 10.1002/stem.42; OHMORI T, 2010, BIOCH BIOPH IN PRESS; Ohmori T, 2007, ARTERIOSCL THROM VAS, V27, P2266, DOI 10.1161/ATVBAHA.107.149872; Ohmori T, 2006, FASEB J, V20, P1522, DOI 10.1096/fj.05-5161fje; OKADA S, 1992, BLOOD, V80, P3044; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Priestley GV, 2007, BLOOD, V109, P109, DOI 10.1182/blood-2006-06-026427; Qian H, 2007, BLOOD, V110, P2399, DOI 10.1182/blood-2006-10-051276; Rawls AS, 2007, BLOOD, V110, P2414, DOI 10.1182/blood-2006-03-007112; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schwartz MA, 2009, SCIENCE, V323, P588, DOI 10.1126/science.1169414; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takizawa H, 2010, J CLIN INVEST, V120, P179, DOI 10.1172/JCI39503; Tucker KL, 2008, BLOOD, V112, P4523, DOI 10.1182/blood-2008-03-148502; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Voura EB, 1997, EXP HEMATOL, V25, P1172; Xu WM, 1998, DEVELOPMENT, V125, P327; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yokota T, 1998, BLOOD, V91, P3263, DOI 10.1182/blood.V91.9.3263.3263_3263_3272; Zamir E, 2001, J CELL SCI, V114, P3583; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	50	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31763	31773		10.1074/jbc.M109.099085	http://dx.doi.org/10.1074/jbc.M109.099085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663867	Green Published, hybrid			2022-12-25	WOS:000282764600068
J	Song, IY; Palle, K; Gurkar, A; Tateishi, S; Kupfer, GM; Vaziri, C				Song, Ihn Young; Palle, Komaraiah; Gurkar, Aditi; Tateishi, Satoshi; Kupfer, Gary M.; Vaziri, Cyrus			Rad18-mediated Translesion Synthesis of Bulky DNA Adducts Is Coupled to Activation of the Fanconi Anemia DNA Repair Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; CROSS-LINK REPAIR; HOMOLOGOUS RECOMBINATION; MONOUBIQUITINATED PCNA; REPLICATION FORKS; POLYMERASE SWITCH; DAMAGE RESPONSE; HUMAN-CELLS; Y-FAMILY; PROTEIN	Fanconi anemia (FA) is a cancer susceptibility syndrome characterized by sensitivity to DNA-damaging agents. The FA proteins (FANCs) are implicated in DNA repair, although the precise mechanisms by which FANCs process DNA lesions are not fully understood. An epistatic relationship between the FA pathway and translesion synthesis (TLS, a post-replication DNA repair mechanism) has been suggested, but the basis for cross-talk between the FA and TLS pathways is poorly understood. We show here that ectopic overexpression of the E3 ubiquitin ligase Rad18 (a central regulator of TLS) induces DNA damage-independent mono-ubiquitination of proliferating cell nuclear antigen (PCNA) (a known Rad18 substrate) and FANCD2. Conversely, DNA damage-induced mono-ubiquitination of both PCNA and FANCD2 is attenuated in Rad18-deficient cells, demonstrating that Rad18 contributes to activation of the FA pathway. WT Rad18 but not an E3 ubiquitin ligase-deficient Rad18 C28F mutant fully complements both PCNA ubiquitination and FANCD2 activation in Rad18-depleted cells. Rad18-induced mono-ubiquitination of FANCD2 is not observed in FA core complex-deficient cells, demonstrating that Rad18 E3 ligase activity alone is insufficient for FANCD2 ubiquitylation. Instead, Rad18 promotes FA core complex-dependent FANCD2 ubiquitination in a manner that is secondary to PCNA mono-ubiquitination. Taken together, these results demonstrate a novel Rad18-dependent mechanism that couples activation of the FA pathway with TLS.	[Palle, Komaraiah; Vaziri, Cyrus] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Song, Ihn Young; Gurkar, Aditi] Boston Univ, Sch Med, Grad Program Genet & Genom, Boston, MA 02118 USA; [Tateishi, Satoshi] Kumamoto Univ, Inst Mol Embryogenesis & Genet, Kumamoto 8620976, Japan; [Kupfer, Gary M.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA	University of North Carolina; University of North Carolina Chapel Hill; Boston University; Kumamoto University; Yale University	Vaziri, C (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, 614 Brinkhous Bullitt Bldg, Chapel Hill, NC 27599 USA.	cyrus_vaziri@med.unc.edu		Gurkar, Aditi/0000-0003-4338-0624	National Institutes of Health [ES09558, ES12917, R01 HL063776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009558, R01ES012917, P30ES010126, R29ES009558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES09558 and ES12917 (to C. V.) and Grant R01 HL063776 (to G. M. K.).	Adar S, 2009, NUCLEIC ACIDS RES, V37, P5737, DOI 10.1093/nar/gkp632; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Barkley LR, 2007, CELL BIOCHEM BIOPHYS, V47, P392, DOI 10.1007/s12013-007-0032-7; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Friedberg EC, 2006, MOL CELL, V22, P150, DOI 10.1016/j.molcel.2006.04.002; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gurtan AM, 2006, DNA REPAIR, V5, P1119, DOI 10.1016/j.dnarep.2006.05.009; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Howlett NG, 2009, J BIOL CHEM, V284, P28935, DOI 10.1074/jbc.M109.016352; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; PAPADOPOULO D, 1990, PROG CLIN BIOL RES, V340, P241; PAPADOPOULO D, 1990, P NATL ACAD SCI USA, V87, P8383, DOI 10.1073/pnas.87.21.8383; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Song IY, 2010, CELL CYCLE, V9, P2375, DOI 10.4161/cc.9.12.11900; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Tsuji Y, 2008, GENES CELLS, V13, P343, DOI 10.1111/j.1365-2443.2008.01176.x; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yan S, 2009, J CELL BIOL, V184, P793, DOI 10.1083/jcb.200810185; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006; Zhang J, 2008, CELL CYCLE, V7, P407, DOI 10.4161/cc.7.3.5156; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	46	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31525	31536		10.1074/jbc.M110.138206	http://dx.doi.org/10.1074/jbc.M110.138206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675655	Green Published, hybrid			2022-12-25	WOS:000282764600047
J	Alonso, AD; Di Clerico, J; Li, B; Corbo, CP; Alaniz, ME; Grundke-Iqbal, I; Iqbal, K				Alonso, Alejandra D.; Di Clerico, John; Li, Bin; Corbo, Christopher P.; Alaniz, Maria E.; Grundke-Iqbal, Inge; Iqbal, Khalid			Phosphorylation of Tau at Thr(212), Thr(231), and Ser(262) Combined Causes Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER NEUROFIBRILLARY DEGENERATION; PROTEIN-TAU; ABNORMAL PHOSPHORYLATION; MICROTUBULE-BINDING; DOWN-SYNDROME; FRONTOTEMPORAL DEMENTIA; HYPERPHOSPHORYLATED TAU; FUNCTIONAL-LINK; IN-VITRO	Abnormal hyperphosphorylation of the microtubule-associated protein Tau is a hallmark of Alzheimer disease and related diseases called tauopathies. As yet, the exact mechanism by which this pathology causes neurodegeneration is not understood. The present study provides direct evidence that Tau abnormal hyperphosphorylation causes its aggregation, breakdown of the microtubule network, and cell death and identifies phosphorylation sites involved in neurotoxicity. We generated pseudophosphorylated Tau proteins by mutating Ser/Thr to Glu and, as controls, to Ala. These mutations involved one, two, or three pathological phosphorylation sites by site-directed mutagenesis using as backbones the wild type or FTDP-17 mutant R406W Tau. Pseudophosphorylated and corresponding control Tau proteins were expressed transiently in PC12 and CHO cells. We found that a single phosphorylation site alone had little influence on the biological activity of Tau, except Thr(212), which, upon mutation to Glu in the R406W background, induced Tau aggregation in cells, suggesting phosphorylation at this site along with a modification on the C-terminal of the protein facilitates self-assembly of Tau. The expression of R406W Tau pseudophosphorylated at Thr(212), Thr(231), and Ser(262) triggered caspase-3 activation in as much as 85% of the transfected cells, whereas the corresponding value for wild type pseudophosphorylated Tau was 30%. Cells transfected with pseudophosphorylated Tau became TUNEL-positive.	[Alonso, Alejandra D.; Corbo, Christopher P.; Alaniz, Maria E.] CUNY Coll Staten Isl, Dept Biol, Staten Isl, NY 10314 USA; [Alonso, Alejandra D.; Corbo, Christopher P.; Alaniz, Maria E.] CUNY Coll Staten Isl, Ctr Dev Neurosci, Staten Isl, NY 10314 USA; [Alonso, Alejandra D.; Corbo, Christopher P.; Alaniz, Maria E.] CUNY, Staten Isl, NY USA; [Di Clerico, John; Li, Bin; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA	City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; Institute for Basic Research in Developmental Disabilities	Alonso, AD (corresponding author), CUNY Coll Staten Isl, Dept Biol, 2800 Victory Blvd, Staten Isl, NY 10314 USA.	Alejandra.Alonso@csi.cuny.edu			National Institutes of Health [AG019158, AG028538, R15AG034524-01]; New York State Office of Mental Retardation and Developmental Disabilities; Alzheimer's Association (Chicago, IL) [IIRG-06-25836, IIRG-09-133206]; Professional Staff Congress-City University of New York [62909-00 40, 80209-0416]; NATIONAL INSTITUTE ON AGING [R01AG028538, R01AG019158, R15AG034524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of Mental Retardation and Developmental Disabilities; Alzheimer's Association (Chicago, IL)(Alzheimer's Association); Professional Staff Congress-City University of New York; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG019158 and AG028538 (to K. I.) and R15AG034524-01 (to A. D. A.). This work was also supported by the New York State Office of Mental Retardation and Developmental Disabilities; Alzheimer's Association (Chicago, IL) Grants IIRG-06-25836 (to K. I.) and IIRG-09-133206 (to A. D. A.); and Professional Staff Congress-City University of New York Research Award 62909-00 40 (to A. D. A.) and 80209-0416 (to A. D. A.).	Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; ALONSO AD, 1995, MOL BRAIN RES, V31, P194, DOI 10.1016/0169-328X(95)00051-S; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2001, J BIOL CHEM, V276, P37967; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alonso AD, 2008, CURR ALZHEIMER RES, V5, P375, DOI 10.2174/156720508785132307; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; BRANDT R, 1994, J BIOL CHEM, V269, P11776; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Fath T, 2002, J NEUROSCI, V22, P9733; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; HUNDELT M, 2009, NEUROBIOL A IN PRESS; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jenkins SM, 1997, BRAIN RES, V767, P305, DOI 10.1016/S0006-8993(97)00615-X; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KREMER L, 1988, ANAL BIOCHEM, V175, P91, DOI 10.1016/0003-2697(88)90365-X; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leschik J, 2007, J NEUROCHEM, V101, P1303, DOI 10.1111/j.1471-4159.2006.04435.x; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Necula M, 2004, J BIOL CHEM, V279, P49694, DOI 10.1074/jbc.M405527200; Perez M, 1996, J NEUROCHEM, V67, P1183; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Santa-Maria I, 2005, BBA-MOL BASIS DIS, V1740, P472, DOI 10.1016/j.bbadis.2004.11.024; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sengupta A, 2006, NEUROCHEM RES, V31, P1473, DOI 10.1007/s11064-006-9205-9; Singh TJ, 1996, FEBS LETT, V387, P145, DOI 10.1016/0014-5793(96)00485-1; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; Vandebroek T, 2005, BIOCHEMISTRY-US, V44, P11466, DOI 10.1021/bi0506775; Wai MSM, 2009, BIOGERONTOLOGY, V10, P457, DOI 10.1007/s10522-008-9189-8; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Zhou LX, 2006, BIOCHEM BIOPH RES CO, V348, P637, DOI 10.1016/j.bbrc.2006.07.099	59	140	148	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30851	30860		10.1074/jbc.M110.110957	http://dx.doi.org/10.1074/jbc.M110.110957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663882	hybrid, Green Published			2022-12-25	WOS:000282135500052
J	Cheng, L; Zhou, Z; Flesken-Nikitin, A; Toshkov, IA; Wang, W; Camps, J; Ried, T; Nikitin, AY				Cheng, L.; Zhou, Z.; Flesken-Nikitin, A.; Toshkov, I. A.; Wang, W.; Camps, J.; Ried, T.; Nikitin, A. Y.			Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency	ONCOGENE			English	Article						breast cancer; genomic maintenance; mouse; models of cancer; oncogenomics; tumor suppressor	CONDITIONAL MOUSE MODEL; TUMOR-SUPPRESSOR; BREAST-CANCER; SOMATIC INACTIVATION; HIGH-FREQUENCY; DNA-DAMAGE; CYCLIN D1; IN-VIVO; MICE; EXPRESSION	Genetically defined mouse models offer an important tool to identify critical secondary genetic alterations with relevance to human cancer pathogenesis. We used newly generated MMTV-Cre105Ayn mice to inactivate p53 and/or Rb strictly in the mammary epithelium, and to determine recurrent genomic changes associated with deficiencies of these genes. p53 inactivation led to formation of estrogen receptor-positive raloxifene-responsive mammary carcinomas with features of luminal subtype B. Rb deficiency was insufficient to initiate carcinogenesis but promoted genomic instability and growth rate of neoplasms associated with p53 inactivation. Genome-wide analysis of mammary carcinomas identified a recurrent amplification at chromosome band 9A1, a locus orthologous to human 11q22, which contains protooncogenes cIAP1 (Birc2), cIAP2 (Birc3) and Yap1. It is interesting that this amplicon was preferentially detected in carcinomas carrying wild-type Rb. However, all three genes were overexpressed in carcinomas with p53 and Rb inactivation, likely due to E2F-mediated transactivation, and cooperated in carcinogenesis according to gene knockdown experiments. These findings establish a model of luminal subtype B mammary carcinoma, identify critical role of cIAP1, cIAP2 and Yap1 co-expression in mammary carcinogenesis and provide an explanation for the lack of recurrent amplifications of cIAP1, cIAP2 and Yap1 in some tumors with frequent Rb deficiency, such as mammary carcinoma. Oncogene (2010) 29, 5700-5711; doi:10.1038/onc.2010.300; published online 2 August 2010	[Cheng, L.; Zhou, Z.; Flesken-Nikitin, A.; Toshkov, I. A.; Nikitin, A. Y.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Wang, W.] Cornell Univ, Microarray Core Facil, Ithaca, NY 14853 USA; [Camps, J.; Ried, T.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA	Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nikitin, AY (corresponding author), Cornell Univ, Dept Biomed Sci, T2 014A VRT Campus Rd, Ithaca, NY 14853 USA.	an58@cornell.edu	Camps, Jordi/AAG-3080-2020	Camps, Jordi/0000-0002-3165-3640	NIH/NCI [R01 CA96823]; NYSTEM [C023050]; NATIONAL CANCER INSTITUTE [ZIABC010836, R01CA096823] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank David C Corney for critical reading of this paper and Dr Anton Berns (Netherlands Cancer Institute, Amsterdam, The Netherlands) for the generous gift of the p53<SUP>floxP/floxP</SUP> and Rb<SUP>floxP/floxP</SUP> mice. This work was supported by grants R01 CA96823 (NIH/NCI) and C023050 (NYSTEM) to AYN.	Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Chai Y, 2000, DEVELOPMENT, V127, P1671; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Geradts J, 1996, AM J PATHOL, V149, P15; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Knudsen ES, 2006, CURR MOL MED, V6, P749; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Li ML, 2000, ONCOGENE, V19, P1010, DOI 10.1038/sj.onc.1203271; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; MALKIN D, 1994, ANNU REV GENET, V28, P443; Marino S, 2000, GENE DEV, V14, P994; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Mayhew CN, 2007, GASTROENTEROLOGY, V133, P976, DOI 10.1053/j.gastro.2007.06.025; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Reed CA, 2009, ONCOGENE, V28, P4434, DOI 10.1038/onc.2009.303; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robinson GW, 2001, ONCOGENE, V20, P7115, DOI 10.1038/sj.onc.1204888; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Scambia G, 2006, ONCOGENE, V25, P5302, DOI 10.1038/sj.onc.1209620; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sporn MB, 2004, CLIN THER, V26, P830, DOI 10.1016/S0149-2918(04)90127-0; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wijnhoven SWP, 2005, CANCER RES, V65, P8166, DOI 10.1158/0008-5472.CAN-05-1650; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	50	33	33	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5700	5711		10.1038/onc.2010.300	http://dx.doi.org/10.1038/onc.2010.300			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20676140	Green Accepted			2022-12-25	WOS:000283262500006
J	Kamiya, Y; Miyazono, K; Miyazawa, K				Kamiya, Yuto; Miyazono, Kohei; Miyazawa, Keiji			Smad7 Inhibits Transforming Growth Factor-beta Family Type I Receptors through Two Distinct Modes of Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEIN RECEPTORS; SPECIFICITY; DOMAIN; ROLES; IDENTIFICATION; ANTAGONIST; PATHWAYS; ELEMENTS; SMURF1; MAD	The inhibitory Smads (I-Smads), i.e. Smad6 and Smad7, are negative regulators of transforming growth factor-beta (TGF-beta) family signaling. I-Smads inhibit TGF-beta family signaling principally through physical interaction with type I receptors (activin receptor-like kinases), so as to compete with receptor-regulated Smads (R-Smads) for activation. However, how I-Smads interact with type I receptors is not well understood. In the present study, we found that Smad7 has two modes of interaction with type I receptors. One is through a three-finger-like structure in the MH2 domain, consisting of residues 331-361, 379-387, and the L3 loop. The other is through a basic groove in the MH2 domain (Mochizuki, T., Miyazaki, H., Hara, T., Furuya, T., Imamura, T., Watabe, T., and Miyazono, K. (2004) J. Biol. Chem. 279, 31568-31574). We also found that Smad6 principally utilizes a basic groove in the MH2 domain for interaction with type I receptors. Smad7 thus has an additional mode of interaction with TGF-beta family type I receptors not possessed by Smad6, which may play roles in mediating the inhibitory effects unique to Smad7.	[Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan; Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan	University of Yamanashi; University of Tokyo	Miyazawa, K (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan.	keiji-miyazawa@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014		KAKENHI; Ministry of Education, Culture, Sports, Science, and Technology of Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by KAKENHI Grants-in-aid for Scientific Research and the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kamiya Y, 2008, FEBS LETT, V582, P2496, DOI 10.1016/j.febslet.2008.05.052; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; NAKAO A, 2006, SMAD SIGNAL TRANSDUC, P379; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; RAFTERY LA, 2006, SMAD SIGNAL TRANSDUC, P55, DOI DOI 10.1007/1-4020-4709-6_3; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	32	47	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30804	30813		10.1074/jbc.M110.166140	http://dx.doi.org/10.1074/jbc.M110.166140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663871	Green Published, hybrid			2022-12-25	WOS:000282135500048
J	Li, MJ; Yin, YC; Hua, H; Sun, XM; Luo, T; Wang, JA; Jiang, YF				Li, Minjing; Yin, Yancun; Hua, Hui; Sun, Xiangming; Luo, Ting; Wang, Jiao; Jiang, Yangfu			The Reciprocal Regulation of gamma-Synuclein and IGF-I Receptor Expression Creates a Circuit That Modulates IGF-I Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; CANCER-CELL-SURVIVAL; HUMAN BREAST-CANCER; GENE CPG ISLAND; COLORECTAL-CANCER; PROSTATE-CANCER; PLASMA-LEVELS; COLON-CANCER; INSULIN; METASTASIS	Insulin-like growth factor (IGF) system plays important roles in carcinogenesis and maintenance of the malignant phenotype. Signaling through the IGF-I receptor (IGF-IR) has been shown to stimulate the growth and motility of a wide range of cancer cells. gamma-Synuclein (SNCG) is primarily expressed in peripheral neurons but also overexpressed in various cancer cells. Overexpression of SNCG correlates with tumor progression. In the present study we demonstrated a reciprocal regulation of IGF-I signaling and SNCG expression. IGF-I induced SNCG expression in various cancer cells. IGF-IR knockdown or IGF-IR inhibitor repressed SNCG expression. Both phosphatidylinositol 3-kinase and mitogen-activated protein kinase were involved in IGF-I induction of SNCG expression. Interestingly, SNCG knockdown led to proteasomal degradation of IGF-IR, thereby decreasing the steady-state levels of IGF-IR. Silencing of SNCG resulted in a decrease in ligand-induced phosphorylation of IGF-IR and its downstream signaling components, including insulin receptor substrate (IRS), Akt, and ERK1/2. Strikingly, SNCG physically interacted with IGF-IR and IRS-2. Silencing of IRS-2 impaired the interaction between SNCG and IGF-IR. Finally, SNCG knockdown suppressed IGF-I-induced cell proliferation and migration. These data reveal that SNCG and IGF-IR are mutually regulated by each other. SNCG blockade may suppress IGF-I-induced cell proliferation and migration. Conversely, IGF-IR inhibitors may be of utility in suppressing the aberrant expression of SNCG in cancer cells and thereby block its pro-tumor effects.	[Jiang, Yangfu] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Sect Signal Transduct & Mol Targeted Therapy, Chengdu 610041, Peoples R China; [Luo, Ting] Sichuan Univ, W China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [Wang, Jiao] Chengdu Univ Tradit Chinese Med, Sch Basic Med, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Chengdu University of Traditional Chinese Medicine	Jiang, YF (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Sect Signal Transduct & Mol Targeted Therapy, Chengdu 610041, Peoples R China.	jyangfu@scu.edu.cn	Jiang, Yangfu/AAX-2645-2020	Jiang, Yangfu/0000-0002-8696-2651; Yin, Yancun/0000-0003-2755-9595; Li, Minjing/0000-0001-9276-4654	National Natural Science Foundation of China [30672360]; Sichuan Science and Technology Program [2007Q14-036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program	This work was supported by National Natural Science Foundation of China Grant 30672360 and the Sichuan Science and Technology Program (2007Q14-036).	Bach LA, 1995, DIABETES REV, V3, P38; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; CHIOU ST, 1992, BIOCHEM BIOPH RES CO, V183, P524, DOI 10.1016/0006-291X(92)90513-K; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Dunn SE, 1998, CANCER RES, V58, P3353; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Grey A, 2003, ENDOCRINOLOGY, V144, P4886, DOI 10.1210/en.2003-0350; Guo J, 2007, INT J CANCER, V121, P1296, DOI 10.1002/ijc.22763; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Gupta A, 2003, CANCER RES, V63, P664; Hakam A, 1999, HUM PATHOL, V30, P1128, DOI 10.1016/S0046-8177(99)90027-8; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hellawell GO, 2002, CANCER RES, V62, P2942; Hibi T, 2009, CLIN CANCER RES, V15, P2864, DOI 10.1158/1078-0432.CCR-08-2946; Hu H, 2009, CLIN CANCER RES, V15, P5485, DOI 10.1158/1078-0432.CCR-08-2491; Hua H, 2009, J PATHOL, V217, P507, DOI 10.1002/path.2465; ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; Jiang YF, 2003, CANCER RES, V63, P3899; Jiang YF, 2004, CANCER RES, V64, P4539, DOI 10.1158/0008-5472.CAN-03-3650; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; LUND PK, 1986, J BIOL CHEM, V261, P4539; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; MONNIER D, 1994, MOL CELL ENDOCRINOL, V104, P139, DOI 10.1016/0303-7207(94)90116-3; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Pan ZZ, 2006, INT J ONCOL, V29, P1201; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; PEYRAT JP, 1993, EUR J CANCER, V29A, P492, DOI 10.1016/S0959-8049(05)80137-6; PRAGER D, 1994, P NATL ACAD SCI USA, V91, P2181, DOI 10.1073/pnas.91.6.2181; Reinmuth N, 2002, LAB INVEST, V82, P1377, DOI 10.1097/01.LAB.0000032411.41603.C2; Resnik JL, 1998, CANCER RES, V58, P1159; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Shen JJ, 2007, MOL CARCINOGEN, V46, P331, DOI 10.1002/mc.20256; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Valverde AM, 1998, MOL ENDOCRINOL, V12, P688, DOI 10.1210/me.12.5.688; Wu YP, 2002, CANCER RES, V62, P1030; Yanagawa N, 2004, CLIN CANCER RES, V10, P2447, DOI 10.1158/1078-0432.CCR-03-0107; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zhang XH, 2000, BREAST CANCER RES, V2, P170, DOI 10.1186/bcr50; Zhao W, 2006, INT J ONCOL, V28, P1081	52	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30480	30488		10.1074/jbc.M110.131698	http://dx.doi.org/10.1074/jbc.M110.131698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20670935	Green Published, hybrid			2022-12-25	WOS:000282135500015
J	Clark, SJ; Perveen, R; Hakobyan, S; Morgan, BP; Sim, RB; Bishop, PN; Day, AJ				Clark, Simon J.; Perveen, Rahat; Hakobyan, Svetlana; Morgan, B. Paul; Sim, Robert B.; Bishop, Paul N.; Day, Anthony J.			Impaired Binding of the Age-related Macular Degeneration-associated Complement Factor H 402H Allotype to Bruch's Membrane in Human Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; DISEASE-ASSOCIATED FORM; AMINO-ACID SEQUENCE; HEPARIN; POLYMORPHISM; RECOGNITION; VARIANT; SITE; IDENTIFICATION; LOCALIZATION	Age-related macular degeneration (AMD) is the predominant cause of blindness in the industrialized world where destruction of the macula, i.e. the central region of the retina, results in loss of vision. AMD is preceded by the formation of deposits in the macula, which accumulate between the Bruch's membrane and the retinal pigment epithelium (RPE). These deposits are associated with complement-mediated inflammation and perturb retinal function. Recent genetic association studies have demonstrated that a common allele (402H) of the complement factor H (CFH) gene is a major risk factor for the development of AMD; CFH suppresses complement activation on host tissues where it is believed to bind via its interaction with polyanionic structures. We have shown previously that this coding change (Y402H; from a tyrosine to histidine residue) alters the binding of the CFH protein to sulfated polysaccharides. Here we demonstrate that the AMD-associated polymorphism profoundly affects CFH binding to sites within human macula. Notably, the AMD-associated 402H variant binds less well to heparan sulfate and dermatan sulfate glycosaminoglycans within Bruch's membrane when compared with the 402Y form; both allotypes exhibit a similar level of binding to the RPE. We propose that the impaired binding of the 402H variant to Bruch's membrane results in an overactivation of the complement pathway leading to local chronic inflammation and thus contributes directly to the development and/or progression of AMD. These studies therefore provide a putative disease mechanism and add weight to the genetic association studies that implicate the 402H allele as an important risk factor in AMD.	[Clark, Simon J.; Bishop, Paul N.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Perveen, Rahat; Bishop, Paul N.] Univ Manchester, Sch Biomed, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Perveen, Rahat; Bishop, Paul N.] Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Hakobyan, Svetlana; Morgan, B. Paul] Cardiff Univ, Complement Biol Grp, Dept Med Biochem & Immunol, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Sim, Robert B.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Manchester; University of Manchester; University of Manchester; Cardiff University; University of Oxford	Bishop, PN (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	paul.n.bishop@manchester.ac.uk; anthony.day@manchester.ac.uk	Day, Anthony/O-1658-2015; Sim, Bob/A-1354-2008	Day, Anthony/0000-0002-1415-3134; Sim, Bob/0000-0002-2855-7455; Bishop, Paul/0000-0001-7937-7932; Clark, Simon/0000-0001-8394-8355; Morgan, Paul/0000-0003-4075-7676	Macular Disease Society, Medical Research Council [G0900592]; University of Manchester Intellectual Property Ltd.; Manchester National Institute for Health Research Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester; Medical Research Council [G0900538] Funding Source: researchfish; MRC [G0900538] Funding Source: UKRI	Macular Disease Society, Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Manchester Intellectual Property Ltd.; Manchester National Institute for Health Research Biomedical Research Centre; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Macular Disease Society, Medical Research Council (Grant G0900592), University of Manchester Intellectual Property Ltd., and Manchester National Institute for Health Research Biomedical Research Centre.; We thank Dr. I. Zambrano and colleagues at the Manchester Royal Eye Hospital Eye Bank for supplying donor eye tissue used in this study, Dr. Barbara Mulloy (National Institute for Biological Standards and Control) for supplying heparin and DS glycosaminoglycans and Jane Knott for help with the microscopy. We also thank Prof. John Gallagher for discussion and advice on technical aspects of the research project. The Bioimaging Facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, Wellcome Trust, and University of Manchester Strategic Fund.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Barlow PN, 2008, ADV EXP MED BIOL, V632, P117, DOI 10.1007/978-0-387-78952-1_10; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; CALL TW, 1990, EXP EYE RES, V51, P451, DOI 10.1016/0014-4835(90)90158-Q; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; CLARK SJ, 2010, BIOCH SOC T IN PRESS; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; DAY AJ, 1988, IMMUNOGENETICS, V27, P211, DOI 10.1007/BF00346588; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Haapasalo K, 2008, MOL MICROBIOL, V70, P583, DOI 10.1111/j.1365-2958.2008.06347.x; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; KAZATCHKINE MD, 1979, J EXP MED, V150, P1202, DOI 10.1084/jem.150.5.1202; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Montes T, 2009, P NATL ACAD SCI USA, V106, P4366, DOI 10.1073/pnas.0812584106; MULLOY B, 1994, CARBOHYD RES, V255, P1, DOI 10.1016/S0008-6215(00)90968-6; Mulloy B, 2000, THROMB HAEMOSTASIS, V84, P1052; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; SIM E, 1983, BIOSCIENCE REP, V3, P1119, DOI 10.1007/BF01120205; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200	39	137	139	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30192	30202		10.1074/jbc.M110.103986	http://dx.doi.org/10.1074/jbc.M110.103986			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20660596	Green Published, hybrid			2022-12-25	WOS:000281984300056
J	Martinez, GJ; Zhang, ZM; Reynolds, JM; Tanaka, S; Chung, Y; Liu, T; Robertson, E; Lin, X; Feng, XH; Dong, C				Martinez, Gustavo J.; Zhang, Zhengmao; Reynolds, Joseph M.; Tanaka, Shinya; Chung, Yeonseok; Liu, Ting; Robertson, Elizabeth; Lin, Xia; Feng, Xin-Hua; Dong, Chen			Smad2 Positively Regulates the Generation of Th17 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; T-CELLS; TRANSCRIPTION	Development of Foxp3(+) regulatory T cells and pro-inflammatory Th17 cells from naive CD4(+) T cells requires transforming growth factor-beta (TGF-beta) signaling. Although Smad4 and Smad3 have been previously shown to regulate Treg cell induction by TGF-beta, they are not required in the development of Th17 cells. Thus, how TGF-beta regulates Th17 cell differentiation remains unclear. In this study, we found that TGF-beta-induced Foxp3 expression was significantly reduced in the absence of Smad2. More importantly, Smad2 deficiency led to reduced Th17 differentiation in vitro and in vivo. In the experimental autoimmune encephalomyelitis model, Smad2 deficiency in T cells significantly ameliorated disease severity and reduced generation of Th17 cells. Furthermore, we found that Smad2 associated with retinoid acid receptor-related orphan receptor-gamma t (ROR gamma t) and enhanced ROR gamma t-induced Th17 cell generation. These results demonstrate that Smad2 positively regulates the generation of inflammatory Th17 cells.	[Zhang, Zhengmao; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Martinez, Gustavo J.; Reynolds, Joseph M.; Dong, Chen] Univ Texas Hlth Sci Ctr,Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Martinez, Gustavo J.; Reynolds, Joseph M.; Dong, Chen] Univ Texas Hlth Sci Ctr,Houston, MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77030 USA; [Martinez, Gustavo J.; Dong, Chen] Univ Texas Hlth Sci Ctr,Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Zhang, Zhengmao; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Liu, Ting; Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Robertson, Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Zhejiang University; University of Oxford	Feng, XH (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	xfeng@bcm.edu; cdong@mdanderson.org	Tanaka, Shinya/AAO-8771-2021; Tanaka, Shinya/D-3586-2011; Huang, Xiaoyan/N-2561-2014; Zhang, Zhengmao/C-4566-2014; dong, chen/B-3181-2009	Tanaka, Shinya/0000-0001-6470-3301; Zhang, Zhengmao/0000-0002-7968-9968; dong, chen/0000-0002-0084-9130; Reynolds, Joseph/0000-0003-3490-0544; ZHANG, ZHENGMAO/0000-0003-4035-0331; Chung, Yeonseok/0000-0001-5780-4841; Martinez, Gustavo/0000-0003-0178-3329	National Institutes of Health [RO1AR050772, RO1AR053591, RO1GM063773, RO1CA108454]; Fundamental Research Funds for the Central Universities [RC2AR059010]; NCI; Schissler Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR059010, R01AR053591, R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Schissler Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants RO1AR050772 (to C. D.), RO1AR053591, RO1GM063773, and RO1CA108454 and the Fundamental Research Funds for the Central Universities (to X.-H. F.), and RC2AR059010 (to C. D. and X.-H. F.), and a T32 training grant from NCI (to J. M. R.). This work was also supported by the Schissler Foundation Fellowship in cancer research (to G. J. M.).	Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Heikkinen PT, 2010, J BIOL CHEM, V285, P3740, DOI 10.1074/jbc.M109.042978; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	20	70	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29039	29043		10.1074/jbc.C110.155820	http://dx.doi.org/10.1074/jbc.C110.155820			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20667820	Green Published, hybrid			2022-12-25	WOS:000281740100003
J	Franckhauser, C; Mamaeva, D; Heron-Milhavet, L; Fernandez, A; Lamb, NJC				Franckhauser, Celine; Mamaeva, Daria; Heron-Milhavet, Lisa; Fernandez, Anne; Lamb, Ned J. C.			Distinct Pools of cdc25C Are Phosphorylated on Specific TP Sites and Differentially Localized in Human Mitotic Cells	PLOS ONE			English	Article							POLO-LIKE KINASE; PROTEIN-KINASE; MAMMALIAN-CELLS; NUCLEAR TRANSLOCATION; PHASE-TRANSITION; CYCLE REGULATION; PHOSPHATASE; MITOSIS; ACTIVATION; PLK1	Background: The dual specificity phosphatase cdc25C was the first human cdc25 family member found to be essential in the activation of cdk1/cyclin B1 that takes place at the entry into mitosis. Human cdc25C is phosphorylated on Proline-dependent SP and TP sites when it becomes active at mitosis and the prevalent model is that this phosphorylation/ activation of cdc25C would be part of an amplification loop with cdk1/cyclin B1. Methodology/Principal Findings: Using highly specific antibodies directed against cdc25C phospho-epitopes, pT67 and pT130, we show here that these two phospho-forms of cdc25C represent distinct pools with differential localization during human mitosis. Phosphorylation on T67 occurs from prophase and the cdc25C-pT67 phospho-isoform closely localizes with condensed chromosomes throughout mitosis. The phospho-T130 form of cdc25C arises in late G2 and associates predominantly with centrosomes from prophase to anaphase B where it colocalizes with Plk1. As shown by immunoprecipitation of each isoform, these two phospho-forms are not simultaneously phosphorylated on the other mitotic TP sites or associated with one another. Phospho-T67 cdc25C co-precipitates with MPM2-reactive proteins while pT130-cdc25C is associated with Plk1. Interaction and colocalization of phosphoT130-cdc25C with Plk1 demonstrate in living cells, that the sequence around pT130 acts as a true Polo Box Domain (PBD) binding site as previously identified from in vitro peptide screening studies. Overexpression of non-phosphorylatable alanine mutant forms for each isoform, but not wild type cdc25C, strongly impairs mitotic progression showing the functional requirement for each site-specific phosphorylation of cdc25C at mitosis. Conclusions/Significance: These results show for the first time that in human mitosis, distinct phospho-isoforms of cdc25C exist with different localizations and interacting partners, thus implying that the long-standing model of a cdc25C/cdk1 multi-site auto amplification loop is implausible.	[Franckhauser, Celine; Mamaeva, Daria; Heron-Milhavet, Lisa; Fernandez, Anne; Lamb, Ned J. C.] CNRS UPR1142, Inst Genet Humain, Cell Biol Unit, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Franckhauser, C (corresponding author), CNRS UPR1142, Inst Genet Humain, Cell Biol Unit, Montpellier, France.	Ned.Lamb@igh.cnrs.fr	Heron-Milhavet, Lisa/O-4339-2017	Heron-Milhavet, Lisa/0000-0002-7099-0850	Aventis-SA; Association Francaise contre le Myopathie (AFM); Association pour la Recherche Contre le Cancer (ARC) [3976]	Aventis-SA; Association Francaise contre le Myopathie (AFM)(Association Francaise contre les Myopathies); Association pour la Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	Association Francaise contre le Myopathie (AFM, http://www.afm-telethon.fr/) to Anne Fernandez, Association pour la Recherche Contre le Cancer (ARC 3976 http://www.arc-cancer.net/) to Ned Lamb and a grant in aid from Aventis-SA to Ned Lamb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahassi ELM, 2004, ONCOGENE, V23, P2658, DOI 10.1038/sj.onc.1207425; Bonnet J, 2008, CELL CYCLE, V7, P1991, DOI 10.4161/cc.7.13.6095; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Bureik M, 2000, INT J ONCOL, V17, P1251; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; GIRARD F, 1992, J CELL BIOL, V118, P785, DOI 10.1083/jcb.118.4.785; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hutchins JRA, 2004, CELL CYCLE, V3, P41; IZUMI T, 1995, MOL BIOL CELL, V6, P215, DOI 10.1091/mbc.6.2.215; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; Joseph James D, 2003, Prog Cell Cycle Res, V5, P477; Lamb NJC, 1997, METHOD ENZYMOL, V283, P72; Lammer C, 1998, J CELL SCI, V111, P2445; Li MG, 2006, CELL SIGNAL, V18, P1318, DOI 10.1016/j.cellsig.2005.10.020; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lobjois V, 2009, BBA-MOL CELL RES, V1793, P462, DOI 10.1016/j.bbamcr.2008.12.015; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Myer DL, 2005, ONCOGENE, V24, P299, DOI 10.1038/sj.onc.1208278; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Peterson, 2002, TECH KNEE SURG, V1, P2; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; SADHU K, 1990, P NATL ACAD SCI USA, V87, P5139, DOI 10.1073/pnas.87.13.5139; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; Varmeh S, 2008, MOL CANCER THER, V7, P3789, DOI 10.1158/1535-7163.MCT-08-0838; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wegener S, 2000, EUR J CELL BIOL, V79, P810, DOI 10.1078/0171-9335-00115; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	47	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11798	10.1371/journal.pone.0011798	http://dx.doi.org/10.1371/journal.pone.0011798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668692	Green Published, gold, Green Submitted			2022-12-25	WOS:000280297300024
J	Goitre, L; Balzac, F; Degani, S; Degan, P; Marchi, S; Pinton, P; Retta, SF				Goitre, Luca; Balzac, Fiorella; Degani, Simona; Degan, Paolo; Marchi, Saverio; Pinton, Paolo; Retta, Saverio Francesco			KRIT1 Regulates the Homeostasis of Intracellular Reactive Oxygen Species	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; FORKHEAD TRANSCRIPTION FACTORS; BLOOD-BRAIN-BARRIER; HUMAN CEREBROVASCULAR MALFORMATIONS; MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS-RESPONSE; CELL-CYCLE REGULATION; ENDOTHELIAL-CELLS; VASCULAR DYSFUNCTION; NADPH OXIDASE	KRIT1 is a gene responsible for Cerebral Cavernous Malformations (CCM), a major cerebrovascular disease characterized by abnormally enlarged and leaky capillaries that predispose to seizures, focal neurological deficits, and fatal intracerebral hemorrhage. Comprehensive analysis of the KRIT1 gene in CCM patients has suggested that KRIT1 functions need to be severely impaired for pathogenesis. However, the molecular and cellular functions of KRIT1 as well as CCM pathogenesis mechanisms are still research challenges. We found that KRIT1 plays an important role in molecular mechanisms involved in the maintenance of the intracellular Reactive Oxygen Species (ROS) homeostasis to prevent oxidative cellular damage. In particular, we demonstrate that KRIT1 loss/down-regulation is associated with a significant increase in intracellular ROS levels. Conversely, ROS levels in KRIT1(-/-) cells are significantly and dose-dependently reduced after restoration of KRIT1 expression. Moreover, we show that the modulation of intracellular ROS levels by KRIT1 loss/restoration is strictly correlated with the modulation of the expression of the antioxidant protein SOD2 as well as of the transcriptional factor FoxO1, a master regulator of cell responses to oxidative stress and a modulator of SOD2 levels. Furthermore, we show that the KRIT1-dependent maintenance of low ROS levels facilitates the downregulation of cyclin D1 expression required for cell transition from proliferative growth to quiescence. Finally, we demonstrate that the enhanced ROS levels in KRIT1(-/-) cells are associated with an increased cell susceptibility to oxidative DNA damage and a marked induction of the DNA damage sensor and repair gene Gadd45 alpha, as well as with a decline of mitochondrial energy metabolism. Taken together, our results point to a new model where KRIT1 limits the accumulation of intracellular oxidants and prevents oxidative stress-mediated cellular dysfunction and DNA damage by enhancing the cell capacity to scavenge intracellular ROS through an antioxidant pathway involving FoxO1 and SOD2, thus providing novel and useful insights into the understanding of KRIT1 molecular and cellular functions.	[Goitre, Luca; Balzac, Fiorella; Degani, Simona; Retta, Saverio Francesco] Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy; [Degan, Paolo] Natl Inst Canc Res, IST, Dept Translat Oncol, Genoa, Italy; [Marchi, Saverio; Pinton, Paolo] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy	University of Turin; University of Genoa; IRCCS AOU San Martino IST; University of Ferrara	Goitre, L (corresponding author), Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy.	francesco.retta@unito.it	Marchi, Saverio/AAK-3308-2021; degan, paolo/AAB-6713-2019; degan, paolo/AAB-4093-2019; Retta, Saverio Francesco/Q-4770-2019; Pinton, Paolo/J-8025-2012; Marchi, Saverio/K-5997-2016	Marchi, Saverio/0000-0003-2708-1843; degan, paolo/0000-0003-0855-8896; Retta, Saverio Francesco/0000-0001-9761-2959; Pinton, Paolo/0000-0001-7108-6508; Marchi, Saverio/0000-0003-2708-1843	Fondazione Telethon [GGP06222]	Fondazione Telethon(Fondazione TelethonEuropean Commission)	Fondazione Telethon (grant n. GGP06222). http://www.telethon.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Adam O, 2008, ARCH TOXICOL, V82, P885, DOI 10.1007/s00204-008-0344-4; Aird WC, 2006, CIRC RES, V98, P159, DOI 10.1161/01.RES.0000204553.32549.a7; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alia M, 2005, J BIOCHEM MOL TOXIC, V19, P119, DOI 10.1002/jbt.20061; Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Belik J, 2009, AM J PHYSIOL-LUNG C, V297, pL1170, DOI 10.1152/ajplung.00168.2009; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Childs EW, 2008, AM J PHYSIOL-HEART C, V294, pH2285, DOI 10.1152/ajpheart.01361.2007; Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; De Luca G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000266; Denier C, 2002, MECH DEVELOP, V117, P363, DOI 10.1016/S0925-4773(02)00209-5; Di Lisa F, 2009, BASIC RES CARDIOL, V104, P131, DOI 10.1007/s00395-009-0008-4; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; DYPBUKT JM, 1994, J BIOL CHEM, V269, P30553; Ekshyyan O, 2005, CELL DEATH DIFFER, V12, P1066, DOI 10.1038/sj.cdd.4401650; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Evans MD, 2006, GENOME DYN, V1, P53, DOI 10.1159/000092500; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Faraci FM, 2006, J APPL PHYSIOL, V100, P2089, DOI 10.1152/japplphysiol.00939.2005; Faraci FM, 2005, STROKE, V36, P186, DOI 10.1161/01.STR.0000153067.27288.8b; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Felbor U, 2006, ZBL NEUROCHIR, V67, P110, DOI 10.1055/s-2006-933537; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gault J, 2009, NEUROSURGERY, V65, P138, DOI 10.1227/01.NEU.0000348049.81121.C1; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Girouard H, 2007, ARTERIOSCL THROM VAS, V27, P303, DOI 10.1161/01.ATV.0000253885.41509.25; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Hogan BM, 2008, HUM MOL GENET, V17, P2424, DOI 10.1093/hmg/ddn142; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Iadecola C, 2009, STROKE, V40, pS40, DOI 10.1161/STROKEAHA.108.533638; Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Jung KH, 2003, ARCH NEUROL-CHICAGO, V60, P1613, DOI 10.1001/archneur.60.11.1613; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kehrer-Sawatzki H, 2002, ACTA NEUROPATHOL, V104, P231, DOI 10.1007/s00401-002-0552-6; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Kuhlmann CRW, 2008, LIFE SCI, V82, P1281, DOI 10.1016/j.lfs.2008.04.017; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Machida S, 2003, J CELL PHYSIOL, V196, P523, DOI 10.1002/jcp.10339; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mattila J, 2008, P NATL ACAD SCI USA, V105, P14873, DOI 10.1073/pnas.0803022105; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miller AA, 2006, ANTIOXID REDOX SIGN, V8, P1113, DOI 10.1089/ars.2006.8.1113; Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Napoli C, 1999, CIRCULATION, V99, P2003, DOI 10.1161/01.CIR.99.15.2003; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; PACHER P, 2007, PHYSIOL REV, V315, P424; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PARK SH, 2009, BIOCH BIOPHYS RES CO; Petit N, 2006, GENE EXPR PATTERNS, V6, P495, DOI 10.1016/j.modgep.2005.11.001; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Retta SF, 2004, GENE, V325, P63, DOI 10.1016/j.gene.2003.09.046; Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sakamaki J, 2009, BIOCHEM BIOPH RES CO, V382, P497, DOI 10.1016/j.bbrc.2009.03.022; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Schroeter ML, 2001, NEUROREPORT, V12, P2513, DOI 10.1097/00001756-200108080-00045; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Shah AM, 2006, CARDIOVASC RES, V71, P191, DOI 10.1016/j.cardiores.2006.05.018; Shenkar R, 2008, NEUROSURGERY, V63, P782, DOI 10.1227/01.NEU.0000325490.80694.A2; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Sure U, 2001, J NEUROSURG, V94, P970, DOI 10.3171/jns.2001.94.6.0972; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; Thum T, 2008, J BIOL CHEM, V283, P19456, DOI 10.1074/jbc.M708309200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Uranishi R, 2001, NEUROSURGERY, V48, P359, DOI 10.1097/00006123-200102000-00024; Usatyuk PV, 2006, J BIOL CHEM, V281, P35554, DOI 10.1074/jbc.M607305200; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Weidinger C, 2008, ENDOCR-RELAT CANCER, V15, P917, DOI 10.1677/ERC-08-0153; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang J, 2008, NEUROSURGERY, V63, P571, DOI 10.1227/01.NEU.0000325255.30268.B0; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR101, DOI 10.1186/bcr958	130	87	95	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11786	10.1371/journal.pone.0011786	http://dx.doi.org/10.1371/journal.pone.0011786			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668652	Green Submitted, Green Published, gold			2022-12-25	WOS:000280297300018
J	Houck, SA; Clark, JI				Houck, Scott A.; Clark, John I.			Dynamic Subunit Exchange and the Regulation of Microtubule Assembly by the Stress Response Protein Human alpha B Crystallin	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; INTERACTIVE DOMAINS; TUBULIN AGGREGATION; OLIGOMER; BINDING; POLYMERIZATION; DISSOCIATION; CYTOSKELETON; INSTABILITY	Background: The small heat shock protein (sHSP), human alpha B crystallin, forms large, polydisperse complexes that modulate the tubulin-microtubule equilibrium using a dynamic mechanism that is poorly understood. The interactive sequences in alpha B crystallin for tubulin are surface exposed, and correspond to interactive sites for the formation of alpha B crystallin complexes. Methodology/Principal Findings: There is sequence homology between tubulin and the interactive domains in the beta 8-strand of the core domain and the C-terminal extension of alpha B crystallin. This study investigated the hypothesis that the formation of tubulin and alpha B crystallin quaternary structures was regulated through common interactive domains that alter the dynamics of their assembly. Size exclusion chromatography (SEC), SDS-PAGE, microtubule assembly assays, aggregation assays, multiple sequence alignment, and molecular modeling characterized the dynamic response of tubulin assembly to increasing concentrations of alpha B crystallin. Low molar ratios of alpha B crystallin: tubulin were favorable for microtubule assembly and high molar ratios of alpha B crystallin: tubulin were unfavorable for microtubule assembly. Interactions between alpha B crystallin and unassembled tubulin were observed using SEC and SDS-PAGE. Conclusions/Significance: Subunits of alpha B crystallin that exchange dynamically with the alpha B crystallin complex can interact with tubulin subunits to regulate the equilibrium between tubulin and microtubules.	[Houck, Scott A.] Univ N Carolina, Med Adm, Chapel Hill, NC 27515 USA; [Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Houck, SA (corresponding author), Univ N Carolina, Med Adm, Chapel Hill, NC 27515 USA.	clarkji@u.washington.edu			National Eye Institute [EY04542]; NATIONAL EYE INSTITUTE [R01EY004542] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by Grant EY04542 from the National Eye Institute: http://www.nei.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1997, CELL STRUCT FUNCT, V22, P539, DOI 10.1247/csf.22.539; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bauer NG, 2006, J MOL NEUROSCI, V29, P153, DOI 10.1385/JMN:29:2:153; BERKOWITZ SA, 1981, J BIOL CHEM, V256, P1216; BONNE D, 1985, J BIOL CHEM, V260, P2819; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; COLNAGO LA, 1987, BIOCHEMISTRY-US, V26, P847, DOI 10.1021/bi00377a028; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000498; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P9878, DOI 10.1021/bi060970k; Gopalakrishnan S., 1993, Transactions of the Kansas Academy of Science, V96, P7, DOI 10.2307/3628308; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Head MW, 2000, NEUROREPORT, V11, P361, DOI 10.1097/00001756-200002070-00028; Husain Mustafa M, 2008, Neuropsychiatr Dis Treat, V4, P765; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Jee H, 2009, J PHYSIOL SCI, V59, P149, DOI 10.1007/s12576-008-0014-6; Jehle S, 2009, J MOL BIOL, V385, P1481, DOI 10.1016/j.jmb.2008.10.097; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kato K, 1996, J BIOL CHEM, V271, P26989, DOI 10.1074/jbc.271.43.26989; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Krushelnitsky A, 2008, Open Biochem J, V2, P116, DOI 10.2174/1874091X00802010116; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Liu LY, 2006, ANAL BIOCHEM, V350, P186, DOI 10.1016/j.ab.2005.12.019; Mitra G, 2007, PROTEINS, V67, P112, DOI 10.1002/prot.21286; Muchowski PJ, 1999, J MOL BIOL, V289, P397, DOI 10.1006/jmbi.1999.2759; Murugesan R, 2008, MOL VIS, V14, P1835; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Oosawa F, 1977, J Mechanochem Cell Motil, V4, P63; Pasta SY, 2004, MOL VIS, V10, P655; Prescott AR, 1996, OPHTHALMIC RES, V28, P58, DOI 10.1159/000267946; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Srinivas V, 2005, MOL VIS, V11, P249; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com	52	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11795	10.1371/journal.pone.0011795	http://dx.doi.org/10.1371/journal.pone.0011795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668689	Green Submitted, Green Published, gold			2022-12-25	WOS:000280297300023
J	Nonaka, E; Ebel, GD; Wearing, HJ				Nonaka, Etsuko; Ebel, Gregory D.; Wearing, Helen J.			Persistence of Pathogens with Short Infectious Periods in Seasonal Tick Populations: The Relative Importance of Three Transmission Routes	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; LYME-DISEASE SPIROCHETE; CO-FEEDING TRANSMISSION; IXODES-SCAPULARIS; POWASSAN VIRUS; UNITED-STATES; DEER TICKS; DYNAMICS; ECOLOGY; HOST	Background: The flaviviruses causing tick-borne encephalitis (TBE) persist at low but consistent levels in tick populations, despite short infectious periods in their mammalian hosts and transmission periods constrained by distinctly seasonal tick life cycles. In addition to systemic and vertical transmission, cofeeding transmission has been proposed as an important route for the persistence of TBE-causing viruses. Because cofeeding transmission requires ticks to feed simultaneously, the timing of tick activity may be critical to pathogen persistence. Existing models of tick-borne diseases do not incorporate all transmission routes and tick seasonality. Our aim is to evaluate the influence of seasonality on the relative importance of different transmission routes by using a comprehensive mathematical model. Methodology/Principal Findings: We developed a stage-structured population model that includes tick seasonality and evaluated the relative importance of the transmission routes for pathogens with short infectious periods, in particular Powassan virus (POWV) and the related "deer tick virus,'' emergent encephalitis-causing flaviviruses in North America. We used the next generation matrix method to calculate the basic reproductive ratio and performed elasticity analyses. We confirmed that cofeeding transmission is critically important for such pathogens to persist in seasonal tick populations over the reasonable range of parameter values. At higher but still plausible rates of vertical transmission, our model suggests that vertical transmission can strongly enhance pathogen prevalence when it operates in combination with cofeeding transmission. Conclusions/Significance: Our results demonstrate that the consistent prevalence of POWV observed in tick populations could be maintained by a combination of low vertical, intermediate cofeeding and high systemic transmission rates. When vertical transmission is weak, nymphal ticks support integral parts of the transmission cycle that are critical for maintaining the pathogen. We also extended the model to pathogens that cause chronic infections in hosts and found that cofeeding transmission could contribute to elevating prevalence even in these systems. Therefore, the common assumption that cofeeding transmission is not relevant in models of chronic host infection, such as Lyme disease, could lead to underestimating pathogen prevalence.	[Nonaka, Etsuko; Wearing, Helen J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Nonaka, Etsuko; Wearing, Helen J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Ebel, Gregory D.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Nonaka, E (corresponding author), Umea Univ, IceLab, Umea, Sweden.	enonaka@unm.edu	Ebel, Gregory/ABG-1052-2021; Ebel, Gregory/D-8324-2017; Nonaka, Etsuko/J-7395-2019	Nonaka, Etsuko/0000-0001-6563-2840; Wearing, Helen/0000-0002-9837-9797	University of New Mexico; National Institute of Allergy and Infectious Disease, National Institutes of Health [AI067380]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067380] Funding Source: NIH RePORTER	University of New Mexico; National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the University of New Mexico Graduate Assistantship to EN and facilitated by start-up funds from the University of New Mexico to HJW. GDE contributions to this work were supported in part by funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health, under grant AI067380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTSOB H, 1989, ARBOVIRUSES EPIDEMIO, V4, P29; Brackney DE, 2008, AM J TROP MED HYG, V79, P971, DOI 10.4269/ajtmh.2008.79.971; Caswell H., 2006, MATRIX POPULATION MO; Costero A, 1996, AM J TROP MED HYG, V55, P536, DOI 10.4269/ajtmh.1996.55.536; Danielova V, 2002, FOLIA PARASIT, V49, P323, DOI 10.14411/fp.2002.060; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195; Ebel GD, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.3.0700268; Ebel GD, 1999, EMERG INFECT DIS, V5, P570, DOI 10.3201/eid0504.990423; Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446; Fukunaga M, 2000, J PARASITOL, V86, P38, DOI 10.1645/0022-3395(2000)086[0038:MPAOIT]2.0.CO;2; Goodwin BJ, 2001, VECTOR-BORNE ZOONOT, V1, P129, DOI 10.1089/153036601316977732; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; Kaiser R, 2008, INFECT DIS CLIN N AM, V22, P561, DOI 10.1016/j.idc.2008.03.013; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Lewellen RH, 1998, ECOL MONOGR, V68, P571, DOI 10.1890/0012-9615(1998)068[0571:TEODDA]2.0.CO;2; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Matser A, 2009, ECOL LETT, V12, P1298, DOI 10.1111/j.1461-0248.2009.01378.x; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden NH, 1997, PARASITOLOGY, V115, P591, DOI 10.1017/S0031182097001868; Ostfeld RS, 1996, J MAMMAL, V77, P266, DOI 10.2307/1382727; Ostfeld RS, 1996, J MED ENTOMOL, V33, P90, DOI 10.1093/jmedent/33.1.90; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; PIESMAN J, 1979, J MED ENTOMOL, V15, P537, DOI 10.1093/jmedent/15.5-6.537; PROCO TC, 1999, IMA J MATH APPL MED, V261, P296; Randolph S, 2003, EMERG INFECT DIS, V9, P893; Randolph S, 2002, INT J MED MICROBIOL, V291, P6, DOI 10.1016/S1438-4221(02)80002-9; Randolph S.E., 2002, P119; RANDOLPH SE, 1995, J MED ENTOMOL, V32, P765, DOI 10.1093/jmedent/32.6.765; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; Randolph SE, 2000, P ROY SOC B-BIOL SCI, V267, P1741, DOI 10.1098/rspb.2000.1204; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Richter D, 2003, EMERG INFECT DIS, V9, P895; Richter D, 2002, EMERG INFECT DIS, V8, P1421, DOI 10.3201/eid0812.010519; Rosa R, 2003, J THEOR BIOL, V224, P359, DOI 10.1016/S0022-5193(03)00173-5; Rosa R, 2007, MATH BIOSCI, V208, P216, DOI 10.1016/j.mbs.2006.10.002; SANDBERG S, 1992, J THEOR BIOL, V157, P203, DOI 10.1016/S0022-5193(05)80621-6; Schauber EM, 2002, ECOL APPL, V12, P1142, DOI 10.1890/1051-0761(2002)012[1142:MTEORC]2.0.CO;2; Sumilo D, 2008, REV MED VIROL, V18, P81, DOI 10.1002/rmv.566; Suss J, 2008, EUROSURVEILLANCE, V13, P1; Tavakoli NP, 2009, NEW ENGL J MED, V360, P2099, DOI 10.1056/NEJMoa0806326; TELFORD SR, 1988, AM J TROP MED HYG, V39, P105, DOI 10.4269/ajtmh.1988.39.105; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209	50	29	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11745	10.1371/journal.pone.0011745	http://dx.doi.org/10.1371/journal.pone.0011745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668521	gold, Green Published, Green Submitted			2022-12-25	WOS:000280243800018
J	Ilc, G; Giachin, G; Jaremko, M; Jaremko, L; Benetti, F; Plavec, J; Zhukov, I; Legname, G				Ilc, Gregor; Giachin, Gabriele; Jaremko, Mariusz; Jaremko, Lukasz; Benetti, Federico; Plavec, Janez; Zhukov, Igor; Legname, Giuseppe			NMR Structure of the Human Prion Protein with the Pathological Q212P Mutation Reveals Unique Structural Features	PLOS ONE			English	Article							STRAUSSLER-SCHEINKER-DISEASE; RESIDUAL DIPOLAR COUPLINGS; TORSION ANGLE DYNAMICS; TRANSGENIC MICE; THERMODYNAMIC STABILITY; PRP; SYSTEM; NEURODEGENERATION; CRYSTALLOGRAPHY; CONVERSION	Prion diseases are fatal neurodegenerative disorders caused by an aberrant accumulation of the misfolded cellular prion protein (PrPC) conformer, denoted as infectious scrapie isoform or PrPSc. In inherited human prion diseases, mutations in the open reading frame of the PrP gene (PRNP) are hypothesized to favor spontaneous generation of PrPSc in specific brain regions leading to neuronal cell degeneration and death. Here, we describe the NMR solution structure of the truncated recombinant human PrP from residue 90 to 231 carrying the Q212P mutation, which is believed to cause Gerstmann-Straussler-Scheinker (GSS) syndrome, a familial prion disease. The secondary structure of the Q212P mutant consists of a flexible disordered tail (residues 90-124) and a globular domain (residues 125-231). The substitution of a glutamine by a proline at the position 212 introduces novel structural differences in comparison to the known wild-type PrP structures. The most remarkable differences involve the C-terminal end of the protein and the beta(2)-alpha(2) loop region. This structure might provide new insights into the early events of conformational transition of PrPC into PrPSc. Indeed, the spontaneous formation of prions in familial cases might be due to the disruptions of the hydrophobic core consisting of beta(2)-alpha(2) loop and alpha(3) helix.	[Ilc, Gregor; Plavec, Janez; Zhukov, Igor] Natl Inst Chem, Slovenian NMR Ctr, Ljubljana, Slovenia; [Giachin, Gabriele; Benetti, Federico; Legname, Giuseppe] SISSA, Lab Prion Biol, Neurobiol Sect, Trieste, Italy; [Jaremko, Mariusz; Jaremko, Lukasz; Zhukov, Igor] Polish Acad Sci, Inst Biochem & Biophys, Lab Biol NMR, Warsaw, Poland; [Jaremko, Lukasz] Warsaw Univ, Fac Chem, Warsaw, Poland; [Benetti, Federico; Legname, Giuseppe] Italian Inst Technol, SISSA Unit, Trieste, Italy; [Plavec, Janez] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Legname, Giuseppe] Sincrotrone Trieste SCpA, ELETTRA Lab, Trieste, Italy	National Institute of Chemistry - Slovenia; International School for Advanced Studies (SISSA); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Ljubljana; Elettra Sincrotrone Trieste	Ilc, G (corresponding author), Natl Inst Chem, Slovenian NMR Ctr, Ljubljana, Slovenia.	janez.plavec@ki.si; legname@sissa.it	Jaremko, Lukasz/A-3101-2009; Legname, Giuseppe/C-1723-2012; Giachin, Gabriele/AAE-2348-2020; Jaremko, Lukasz/GQB-5017-2022; Zhukov, Igor/J-4069-2015	Jaremko, Lukasz/0000-0001-7684-9359; Legname, Giuseppe/0000-0003-0716-4393; Giachin, Gabriele/0000-0001-7550-0307; Jaremko, Mariusz/0000-0002-0787-702X; Benetti, Federico/0000-0001-6491-4715; Zhukov, Igor/0000-0002-9912-1018	European Community [222887]	European Community(European Commission)	The research leading to presented results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n. 222887 - the PRIORITY project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Goddard T.D., SPARKY 3; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Keller R., 2004, COMPUTER AIDED RESON, V1; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl B, P140; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl B, P120; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Mishra RS, 2003, J ALZHEIMERS DIS, V5, P15, DOI 10.3233/JAD-2003-5103; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yao LS, 2009, J BIOMOL NMR, V43, P161, DOI 10.1007/s10858-009-9299-x; Young K, 1998, J NEUROPATH EXP NEUR, V57, P518, DOI 10.1097/00005072-199805000-00213; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	59	62	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11715	10.1371/journal.pone.0011715	http://dx.doi.org/10.1371/journal.pone.0011715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661422	Green Submitted, gold, Green Published			2022-12-25	WOS:000280243300017
J	Yang, RL; Su, B				Yang, Ruolin; Su, Bing			Characterization and Comparison of the Tissue-Related Modules in Human and Mouse	PLOS ONE			English	Article							GENE-EXPRESSION DATA; EVOLUTIONARY RATE; SACCHAROMYCES-CEREVISIAE; ULTRACONSERVED ELEMENTS; MOLECULAR EVOLUTION; METABOLIC NETWORK; TRANSCRIPTION; PATTERNS; RATES; ORGANIZATION	Background: Due to the advances of high throughput technology and data-collection approaches, we are now in an unprecedented position to understand the evolution of organisms. Great efforts have characterized many individual genes responsible for the interspecies divergence, yet little is known about the genome-wide divergence at a higher level. Modules, serving as the building blocks and operational units of biological systems, provide more information than individual genes. Hence, the comparative analysis between species at the module level would shed more light on the mechanisms underlying the evolution of organisms than the traditional comparative genomics approaches. Results: We systematically identified the tissue-related modules using the iterative signature algorithm (ISA), and we detected 52 and 65 modules in the human and mouse genomes, respectively. The gene expression patterns indicate that all of these predicted modules have a high possibility of serving as real biological modules. In addition, we defined a novel quantity, "total constraint intensity,'' a proxy of multiple constraints (of co-regulated genes and tissues where the co-regulation occurs) on the evolution of genes in module context. We demonstrate that the evolutionary rate of a gene is negatively correlated with its total constraint intensity. Furthermore, there are modules coding the same essential biological processes, while their gene contents have diverged extensively between human and mouse. Conclusions: Our results suggest that unlike the composition of module, which exhibits a great difference between human and mouse, the functional organization of the corresponding modules may evolve in a more conservative manner. Most importantly, our findings imply that similar biological processes can be carried out by different sets of genes from human and mouse, therefore, the functional data of individual genes from mouse may not apply to human in certain occasions.	[Yang, Ruolin; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Yang, Ruolin; Su, Bing] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Peoples R China; [Yang, Ruolin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, RL (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	sub@mail.kiz.ac.cn		Yang, Ruolin/0000-0001-6241-6317	National 973 project of China [2007CB947701, 2007CB815705]; Chinese Academy of Sciences [KSCX1-YW-R-34]; National Natural Science Foundation of China [30700445, 30630013, 30771181]; Natural Science Foundation of Yunnan Province of China [2009CD107065]	National 973 project of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province of China(Natural Science Foundation of Yunnan Province)	This study was supported by grants from the National 973 project of China (2007CB947701, 2007CB815705), the Chinese Academy of Sciences (KSCX1-YW-R-34, Westlight Doctoral Program), the National Natural Science Foundation of China (30700445, 30630013 and 30771181), and the Natural Science Foundation of Yunnan Province of China (2009CD107065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; CHARTRAND G, 2005, INTRO GRAPH THEORY, pR12; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P859; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Glasner ME, 2002, BIOCHEMISTRY-US, V41, P8103, DOI 10.1021/bi012179b; Glazov EA, 2005, GENOME RES, V15, P800, DOI 10.1101/gr.3545105; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Liao BY, 2006, MOL BIOL EVOL, V23, P1119, DOI 10.1093/molbev/msj119; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsaparas P, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-70; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang J, 2005, MOL BIOL EVOL, V22, P2113, DOI 10.1093/molbev/msi206; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	54	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11730	10.1371/journal.pone.0011730	http://dx.doi.org/10.1371/journal.pone.0011730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661448	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243300028
J	Beby, F; Housset, M; Fossat, N; Le Greneur, C; Flamant, F; Godement, P; Lamonerie, T				Beby, Francis; Housset, Michael; Fossat, Nicolas; Le Greneur, Coralie; Flamant, Frederic; Godement, Pierre; Lamonerie, Thomas			Otx2 Gene Deletion in Adult Mouse Retina Induces Rapid RPE Dystrophy and Slow Photoreceptor Degeneration	PLOS ONE			English	Article							PIGMENT-EPITHELIUM; TRANSCRIPTION FACTOR; EXPRESSION; MICE; MIDBRAIN; REVEALS; PROTEIN; CELLS; RETINOBLASTOMA; KNOCKOUT	Background: Many developmental genes are still active in specific tissues after development is completed. This is the case for the homeobox gene Otx2, an essential actor of forebrain and head development. In adult mouse, Otx2 is strongly expressed in the retina. Mutations of this gene in humans have been linked to severe ocular malformation and retinal diseases. It is, therefore, important to explore its post-developmental functions. In the mature retina, Otx2 is expressed in three cell types: bipolar and photoreceptor cells that belong to the neural retina and retinal pigment epithelium (RPE), a neighbour structure that forms a tightly interdependent functional unit together with photoreceptor cells. Methodology/Principal Findings: Conditional self-knockout was used to address the late functions of Otx2 gene in adult mice. This strategy is based on the combination of a knock-in CreERT2 allele and a floxed allele at the Otx2 locus. Time-controlled injection of tamoxifen activates the recombinase only in Otx2 expressing cells, resulting in selective ablation of the gene in its entire domain of expression. In the adult retina, loss of Otx2 protein causes slow degeneration of photoreceptor cells. By contrast, dramatic changes of RPE activity rapidly occur, which may represent a primary cause of photoreceptor disease. Conclusions: Our novel mouse model uncovers new Otx2 functions in adult retina. We show that this transcription factor is necessary for long-term maintenance of photoreceptors, likely through the control of specific activities of the RPE.	[Beby, Francis; Le Greneur, Coralie; Flamant, Frederic; Godement, Pierre; Lamonerie, Thomas] Univ Lyon, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,Inst Natl Rech Agron, Lyon, France; [Housset, Michael; Le Greneur, Coralie; Lamonerie, Thomas] Univ Nice Sophia Antipolis, CNRS, Inst Biol Dev & Canc, Nice, France; [Fossat, Nicolas] Univ Sydney, Sydney Med Sch, Childrens Med Res Inst, Embryol Unit, Wentworthville, Australia	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Children's Medical Research Institute - Australia; University of Sydney	Beby, F (corresponding author), Univ Lyon, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,Inst Natl Rech Agron, Lyon, France.	lamonerie@unice.fr		Lamonerie, Thomas/0000-0003-2371-2708	Centre National de la Recherche Scientifique; Retina France	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Retina France	This work was supported by a Centre National de la Recherche Scientifique grant to FF and TL and a Retina France grant to TL. NF was supported by a fellowship from Retina France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Bok D, 2007, ARCH OPHTHALMOL-CHIC, V125, P160, DOI 10.1001/archopht.125.2.160; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Courtois V, 2003, J NEUROCHEM, V84, P840, DOI 10.1046/j.1471-4159.2003.01583.x; EISENFELD AJ, 1984, INVEST OPHTH VIS SCI, V25, P1321; Fong SL, 1999, CURR EYE RES, V18, P283, DOI 10.1076/ceyr.18.4.283.5360; Fossat N, 2005, DEV DYNAM, V233, P154, DOI 10.1002/dvdy.20287; Fossat N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-122; Fossat N, 2006, EMBO REP, V7, P824, DOI 10.1038/sj.embor.7400751; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Glubrecht DD, 2009, J NEUROCHEM, V111, P250, DOI 10.1111/j.1471-4159.2009.06322.x; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Kurokawa D, 2004, DEVELOPMENT, V131, P3319, DOI 10.1242/dev.01220; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Lavado A, 2006, FRONT BIOSCI-LANDMRK, V11, P743, DOI 10.2741/1832; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nishida Akihiro, 2005, Nippon Ganka Gakkai Zasshi, V109, P708; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tajima T, 2009, J CLIN ENDOCR METAB, V94, P314, DOI 10.1210/jc.2008-1219; Takeda K, 2003, BIOCHEM BIOPH RES CO, V300, P908, DOI 10.1016/S0006-291X(02)02934-0; Valamanesh F, 2007, MOL VIS, V13, P1746; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	35	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11673	10.1371/journal.pone.0011673	http://dx.doi.org/10.1371/journal.pone.0011673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657788	Green Published, Green Submitted, gold			2022-12-25	WOS:000280197500018
J	Cole, CL; Hansen, SU; Barath, M; Rushton, G; Gardiner, JM; Avizienyte, E; Jayson, GC				Cole, Claire L.; Hansen, Steen U.; Barath, Marek; Rushton, Graham; Gardiner, John M.; Avizienyte, Egle; Jayson, Gordon C.			Synthetic Heparan Sulfate Oligosaccharides Inhibit Endothelial Cell Functions Essential for Angiogenesis	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FOCAL ADHESION KINASE; MITOGENIC ACTIVITY; IN-VIVO; ACTIVATION; MIGRATION; PROTEOGLYCANS; CAPACITY; BINDING	Background: Heparan sulfate (HS) is an important regulator of the assembly and activity of various angiogenic signalling complexes. However, the significance of precisely defined HS structures in regulating cytokine-dependent angiogenic cellular functions and signalling through receptors regulating angiogenic responses remains unclear. Understanding such structure-activity relationships is important for the rational design of HS fragments that inhibit HS-dependent angiogenic signalling complexes. Methodology/Principal Findings: We synthesized a series of HS oligosaccharides ranging from 7 to 12 saccharide residues that contained a repeating disaccharide unit consisting of iduronate 2-O-sulfate linked to glucosamine with or without N-sulfate. The ability of oligosaccharides to compete with HS for FGF2 and VEGF(165) binding significantly increased with oligosaccharide length and sulfation. Correspondingly, the inhibitory potential of oligosaccharides against FGF2- and VEGF(165)-induced endothelial cell responses was greater in longer oligosaccharide species that were comprised of disaccharides bearing both 2-O- and N-sulfation (2SNS). FGF2- and VEGF(165)-induced endothelial cell migration were inhibited by longer 2SNS oligosaccharide species with 2SNS dodecasaccharide activity being comparable to that of receptor tyrosine kinase inhibitors targeting FGFR or VEGFR-2. Moreover, the 2SNS dodecasaccharide ablated FGF2- or VEGF(165)-induced phosphorylation of FAK and assembly of F-actin in peripheral lamellipodia-like structures. In contrast, FGF2-induced endothelial cell proliferation was only moderately inhibited by longer 2SNS oligosaccharides. Inhibition of FGF2- and VEGF(165)-dependent endothelial tube formation strongly correlated with oligosaccharide length and sulfation with 10-mer and 12-mer 2SNS oligosaccharides being the most potent species. FGF2- and VEGF(165)-induced activation of MAPK pathway was inhibited by biologically active oligosaccharides correlating with the specific phosphorylation events in FRS2 and VEGFR-2, respectively. Conclusion/Significance: These results demonstrate structure-function relationships for synthetic HS saccharides that suppress endothelial cell migration, tube formation and signalling induced by key angiogenic cytokines.	[Cole, Claire L.; Rushton, Graham; Avizienyte, Egle; Jayson, Gordon C.] Univ Manchester, Sch Canc & Enabling Sci, Manchester, Lancs, England; [Hansen, Steen U.; Gardiner, John M.] Univ Manchester, Sch Chem, Manchester, Lancs, England; [Barath, Marek] Slovak Acad Sci, Inst Chem, Ctr Glyc, Bratislava, Slovakia; [Hansen, Steen U.; Gardiner, John M.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	University of Manchester; University of Manchester; Slovak Academy of Sciences; University of Manchester	Cole, CL (corresponding author), Univ Manchester, Sch Canc & Enabling Sci, Manchester, Lancs, England.	Eavizienyte@picr.man.ac.uk	Gardiner, John M/Q-7268-2017; Baráth, Marek/AAR-3869-2021; Jayson, Gordon C/O-8224-2015	Gardiner, John M/0000-0003-1827-6817; Baráth, Marek/0000-0003-2200-9623; Jayson, Gordon C/0000-0002-8515-8944	Medical Research Council [G0601746]; Cancer Research UK - Discovery Committee [C2075/A9106]; Jean Martin Gynaecological Cancer Research; MRC [G0902173, G0601746] Funding Source: UKRI; Medical Research Council [G0902173] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK - Discovery Committee; Jean Martin Gynaecological Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Milstein fund from the Medical Research Council (G0601746), a grant from Cancer Research UK - Discovery Committee (C2075/A9106) and Jean Martin Gynaecological Cancer Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Baleux F, 2009, NAT CHEM BIOL, V5, P743, DOI 10.1038/nchembio.207; Bhattacharya R, 2009, J CELL SCI, V122, P1025, DOI 10.1242/jcs.041913; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; de Paz JL, 2001, CHEMBIOCHEM, V2, P673, DOI 10.1002/1439-7633(20010903)2:9<673::AID-CBIC673>3.0.CO;2-7; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Hansen SU, 2009, ORG LETT, V11, P4528, DOI 10.1021/ol901723m; HANSEN SU, 2009, Patent No. 2009098449; Hasan J, 2005, CLIN CANCER RES, V11, P8172, DOI 10.1158/1078-0432.CCR-05-0452; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; IAGHER JT, 2006, BIOCHEM SOC T, V34, P438; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Leali D, 2001, J BIOL CHEM, V276, P37900; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Ludwig RJ, 2006, THROMB HAEMOSTASIS, V95, P535, DOI 10.1160/TH05-07-0515; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Norrby K, 2006, APMIS, V114, P79, DOI 10.1111/j.1600-0463.2006.apm_235.x; Noti C, 2006, CHEM-EUR J, V12, P8664, DOI 10.1002/chem.200601103; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Zhang FM, 2009, BIOCHEMISTRY-US, V48, P8379, DOI 10.1021/bi9006379	32	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11644	10.1371/journal.pone.0011644	http://dx.doi.org/10.1371/journal.pone.0011644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657775	gold, Green Published, Green Submitted			2022-12-25	WOS:000280197500013
J	Zhang, HM; Robinson, N; Wu, CY; Wang, WL; Harrington, MA				Zhang, Hongmei; Robinson, Natallia; Wu, Chiayen; Wang, Wenlan; Harrington, Melissa A.			Electrophysiological Properties of Motor Neurons in a Mouse Model of Severe Spinal Muscular Atrophy: In Vitro versus In Vivo Development	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTIONS; GENE; PROTEIN; SMA; DEFECTS	We examined the electrophysiological activity of motor neurons from the mouse model of severe spinal muscular atrophy (SMA) using two different methods: whole cell patch clamp of neurons cultured from day 13 embryos; and multi-electrode recording of ventral horns in spinal cord slices from pups on post-natal days 5 and 6. We used the MED64 multi-electrode array to record electrophysiological activity from motor neurons in slices from the lumbar spinal cord of SMA pups and their unaffected littermates. Recording simultaneously from up to 32 sites across the ventral horn, we observed a significant decrease in the number of active neurons in 5-6 day-old SMA pups compared to littermates. Ventral horn activity in control pups is significantly activated by serotonin and depressed by GABA, while these agents had much less effect on SMA slices. In contrast to the large differences observed in spinal cord, neurons cultured from SMA embryos for up to 21 days showed no significant differences in electrophysiological activity compared to littermates. No differences were observed in membrane potential, frequency of spiking and synaptic activity in cells from SMA embryos compared to controls. In addition, we observed no difference in cell survival between cells from SMA embryos and their unaffected littermates. Our results represent the first report on the electrophysiology of SMN-deficient motor neurons, and suggest that motor neuron development in vitro follows a different path than in vivo development, a path in which loss of SMN expression has little effect on motor neuron function and survival.	[Zhang, Hongmei; Robinson, Natallia; Harrington, Melissa A.] Delaware State Univ, Dept Biol Sci, Dover, DE 19901 USA; [Wu, Chiayen; Wang, Wenlan] Alfred I DuPont Hosp Children, Wilmington, DE USA	Delaware State University; Nemours Alfred I. duPont Hospital for Children	Zhang, HM (corresponding author), Delaware State Univ, Dept Biol Sci, Dover, DE 19901 USA.	mharrington@desu.edu			NIH [5S06GM073765-01A2, 5P20RR016472-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM073765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants 5S06GM073765-01A2 and 5P20RR016472-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaydin E., 2004, INTRO MACHINE LEARNI; Bendat J.S., 2000, RANDOM DATA ANAL MEA; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Iannaccone Susan T, 2004, Curr Neurol Neurosci Rep, V4, P74, DOI 10.1007/s11910-004-0016-6; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; LORSON CL, 1999, NAT GENET, V19, P63; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Smith SW, 2002, DIGIT SIGNAL PROCESS; Swash M, 2000, AMYOTROPH LATERAL SC, V1, P105; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Ting CH, 2007, HUM MOL GENET, V16, P499, DOI 10.1093/hmg/ddl482; ZHANG H, 2009, NEUROREPORT, V20, P854	26	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11696	10.1371/journal.pone.0011696	http://dx.doi.org/10.1371/journal.pone.0011696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657731	Green Published, gold, Green Submitted			2022-12-25	WOS:000280197500033
J	Liberloo, M; Luyssaert, S; Bellassen, V; Djomo, SN; Lukac, M; Calfapietra, C; Janssens, IA; Hoosbeek, MR; Viovy, N; Churkina, G; Scarascia-Mugnozza, G; Ceulemans, R				Liberloo, Marion; Luyssaert, Sebastiaan; Bellassen, Valentin; Djomo, Sylvestre Njakou; Lukac, Martin; Calfapietra, Carlo; Janssens, Ivan A.; Hoosbeek, Marcel R.; Viovy, Nicolas; Churkina, Galina; Scarascia-Mugnozza, Giuseppe; Ceulemans, Reinhart			Bio-Energy Retains Its Mitigation Potential Under Elevated CO2	PLOS ONE			English	Article							CARBON SEQUESTRATION; PLANTATION INCREASES; CONIFEROUS FORESTS; BIOMASS PRODUCTION; GREENHOUSE GASES; POPLAR; ROTATION; SOIL; BIOFUELS; FERTILIZATION	Background: If biofuels are to be a viable substitute for fossil fuels, it is essential that they retain their potential to mitigate climate change under future atmospheric conditions. Elevated atmospheric CO2 concentration [CO2] stimulates plant biomass production; however, the beneficial effects of increased production may be offset by higher energy costs in crop management. Methodology/Main Findings: We maintained full size poplar short rotation coppice (SRC) systems under both current ambient and future elevated [CO2] (550 ppm) and estimated their net energy and greenhouse gas balance. We show that a poplar SRC system is energy efficient and produces more energy than required for coppice management. Even more, elevated [CO2] will increase the net energy production and greenhouse gas balance of a SRC system with 18%. Managing the trees in shorter rotation cycles (i.e., 2 year cycles instead of 3 year cycles) will further enhance the benefits from elevated [CO2] on both the net energy and greenhouse gas balance. Conclusions/Significance: Adapting coppice management to the future atmospheric [CO2] is necessary to fully benefit from the climate mitigation potential of bio-energy systems. Further, a future increase in potential biomass production due to elevated [CO2] outweighs the increased production costs resulting in a northward extension of the area where SRC is greenhouse gas neutral. Currently, the main part of the European terrestrial carbon sink is found in forest biomass and attributed to harvesting less than the annual growth in wood. Because SRC is intensively managed, with a higher turnover in wood production than conventional forest, northward expansion of SRC is likely to erode the European terrestrial carbon sink.	[Liberloo, Marion; Djomo, Sylvestre Njakou; Janssens, Ivan A.; Ceulemans, Reinhart] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Luyssaert, Sebastiaan; Bellassen, Valentin; Viovy, Nicolas] CEA, CNRS, Commissariat Energie Atom & Energies Alternat, LSCE,UM, F-91198 Gif Sur Yvette, France; [Luyssaert, Sebastiaan; Bellassen, Valentin; Viovy, Nicolas] Univ Versailles St Quentin Yvelines UVSQ, Gif Sur Yvette, France; [Lukac, Martin] Imperial Coll London, Ctr Populat Biol, NERC, Ascot, Berks, England; [Calfapietra, Carlo; Scarascia-Mugnozza, Giuseppe] CNR, Inst Agroenvironm & Forest Biol IBAF, Monterotondo, Italy; [Hoosbeek, Marcel R.] Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands; [Churkina, Galina] Leibniz Ctr Agr Landscape Res ZALF, Muencheberg, Germany	University of Antwerp; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); Wageningen University & Research; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Liberloo, M (corresponding author), Univ Antwerp, Dept Biol, Antwerp, Belgium.	sebastiaan.luyssaert@lsce.ipsl.fr	Lukac, Martin/A-4379-2013; Janssens, Ivan A/P-1331-2014; Calfapietra, Carlo/E-2269-2015; Ceulemans, Reinhart J M/F-2109-2016; Viovy, Nicolas/S-2631-2018; Njakou Djomo, Sylvestre/E-5330-2015; Luyssaert, Sebastiaan/F-6684-2011	Lukac, Martin/0000-0002-8535-6334; Janssens, Ivan A/0000-0002-5705-1787; Ceulemans, Reinhart J M/0000-0003-4773-9358; Viovy, Nicolas/0000-0002-9197-6417; Njakou Djomo, Sylvestre/0000-0003-1828-0015; Luyssaert, Sebastiaan/0000-0003-1121-1869; Hoosbeek, Marcel/0000-0003-0617-0089; Bellassen, Valentin/0000-0001-8581-2814; Churkina, Galina/0000-0002-5895-7425	EC [EVR1-CT-2002-40027]; Italian Ministry of University and Research (MIUR); Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen); Research Centre of Excellence ECO (UA-Methusalem); ERC [242564]; Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen)(FWO); Research Centre of Excellence ECO (UA-Methusalem); ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided for MLi, MLu, CC, MRH, GSM and RC by the EC Fifth Framework Program, Environment and Climate RTD Program, research contract EVR1-CT-2002-40027 (EUROFACE) and by the Centre of Excellence "Forest and Climate'' of the Italian Ministry of University and Research (MIUR). MLi received a post-doctoral fellowship from the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen) and SL from the Research Centre of Excellence ECO (UA-Methusalem) and ERC Starting Grant 242564. IAJ, SND, NV, GC, VB received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HDB GROW SHORT ROTAT; Calfapietra C, 2005, ENVIRON POLLUT, V137, P525, DOI 10.1016/j.envpol.2005.01.038; Calfapietra C, 2003, NEW PHYTOL, V160, P305, DOI 10.1046/j.1469-8137.2003.00899.x; Calfapietra C, 2003, TREE PHYSIOL, V23, P805, DOI 10.1093/treephys/23.12.805; Churkina G, 2000, CLIMATIC CHANGE, V47, P167, DOI 10.1023/A:1005620808273; Churkina G, 2003, ECOSYSTEMS, V6, P168, DOI 10.1007/s10021-002-0197-2; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; *COMM COTE, 2008, 20080016COD COMM COT; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gasol CM, 2009, BIOMASS BIOENERG, V33, P119, DOI 10.1016/j.biombioe.2008.04.020; Gerbens-Leenes W, 2009, P NATL ACAD SCI USA, V106, P10219, DOI 10.1073/pnas.0812619106; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Hoosbeek MR, 2006, PLANT SOIL, V281, P247, DOI 10.1007/s11104-005-4293-x; Hoosbeek MR, 2009, ECOSYSTEMS, V12, P220, DOI 10.1007/s10021-008-9219-z; Hoosbeek MR, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002127; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Liberloo M, 2005, TREE PHYSIOL, V25, P179, DOI 10.1093/treephys/25.2.179; Liberloo M, 2006, GLOBAL CHANGE BIOL, V12, P1094, DOI 10.1111/j.1365-2486.2006.01118.x; Liberloo M, 2009, NEW PHYTOL, V182, P331, DOI 10.1111/j.1469-8137.2008.02754.x; Lukac M, 2003, GLOBAL CHANGE BIOL, V9, P838, DOI 10.1046/j.1365-2486.2003.00582.x; NAKICENOVIC N, 2000, REPORT EMISSION SCEN; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pontailler JY, 1999, FORESTRY, V72, P157; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Sims REH, 2006, GLOBAL CHANGE BIOL, V12, P2054, DOI 10.1111/j.1365-2486.2006.01163.x; Thornton P., 1998, REGIONAL ECOSYSTEM S; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tricker PJ, 2009, BIOMASS BIOENERG, V33, P200, DOI 10.1016/j.biombioe.2008.05.009; Vetter M, 2005, GLOBAL CHANGE BIOL, V11, P810, DOI 10.1111/j.1365-2486.2005.00932.x; *WRI, 2005, EARTHTR	37	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11648	10.1371/journal.pone.0011648	http://dx.doi.org/10.1371/journal.pone.0011648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657833	Green Published, gold, Green Submitted			2022-12-25	WOS:000280065600012
J	Pang, XLL; Preiksaitis, JK; Wong, S; Li, V; Lee, BE				Pang, Xiaoli L.; Preiksaitis, Jutta K.; Wong, Sallene; Li, Vincent; Lee, Bonita E.			Influence of Novel Norovirus GII.4 Variants on Gastroenteritis Outbreak Dynamics in Alberta and the Northern Territories, Canada between 2000 and 2008	PLOS ONE			English	Article							NORWALK-LIKE VIRUSES; REVERSE TRANSCRIPTION-PCR; ROUND-STRUCTURED VIRUSES; VIRAL GASTROENTERITIS; EPOCHAL EVOLUTION; UNITED-STATES; P2 DOMAIN; STRAIN; CHILDREN; SPREAD	Background: Norovirus GII.4 is the predominant genotype circulating worldwide over the last decade causing 80% of all norovirus outbreaks with new GII.4 variants reported in parallel with periodic epidemic waves of norovirus outbreaks. The circulating new GII.4 variants and the epidemiology of norovirus outbreaks in Alberta, Canada have not been described. Our hypothesis is that the periodic epidemic norovirus outbreak activity in Alberta was driven by new GII.4 variants evolving by genetic drift. Methodology/Principal Findings: The Alberta Provincial Public Health Laboratory performed norovirus testing using RTPCR for suspected norovirus outbreaks in the province and the northern Territories between 2000 and 2008. At least one norovirus strain from 707 out of 1,057 (66.9%) confirmed norovirus outbreaks were successfully sequenced. Phylogenetic analysis was performed using BioNumerics and 617 (91.1%) outbreaks were characterized as caused by GII.4 with 598 assigned as novel variants including: GII.4-1996, GII.4-2002, GII.4-2004, GII.4-2006a, GII.4-2006b, GII.4-2008a and GII.4-2008b. Defining July to June of the following year as the yearly observation period, there was clear biannual pattern of low and high outbreak activity in Alberta. Within this biannual pattern, high outbreak activity followed the emergence of novel GII.4 variants. The two variants that emerged in 2006 had wider geographic distribution and resulted in higher outbreak activity compared to other variants. The outbreak settings were analyzed. Community-based group residence was the most common for both GII.4 variants and non-GII.4 variants. GII.4 variants were more commonly associated with outbreaks in acute care hospitals while outbreaks associated non-GII.4 variants were more commonly seen in school and community social events settings (p < 0.01). Conclusions/Significance: The emergence of new norovirus GII.4 variants resulted in an increased norovirus outbreak activity in the following season in a unique biannual pattern in Alberta over an eight year period. The association between antigenic drift of GII.4 strains and epidemic norovirus outbreak activity could be due to changes in host immunity, viral receptor binding efficiency or virulence factors in the new variants. Early detection of novel GII.4 variants provides vital information that could be used to forecast the norovirus outbreak burden, enhance public health preparedness and allocate appropriate resources for outbreak management.	[Pang, Xiaoli L.; Preiksaitis, Jutta K.; Wong, Sallene; Li, Vincent; Lee, Bonita E.] Prov Lab Publ Hlth, Edmonton, AB, Canada; [Pang, Xiaoli L.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Lee, Bonita E.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Preiksaitis, Jutta K.] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Pang, XLL (corresponding author), Prov Lab Publ Hlth, Edmonton, AB, Canada.	x.pang@provlab.ab.ca			Alberta Health and Wellness	Alberta Health and Wellness	The study was funded by Alberta Health and Wellness. The funders had no role in the study design, data analysis, preparation of the manuscript and the decision to publish.	ANDO T, 1995, J CLIN MICROBIOL, V33, P64, DOI 10.1128/JCM.33.1.64-71.1995; Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Buesa J, 2008, J MED VIROL, V80, P1288, DOI 10.1002/jmv.21182; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Dolin R, 2007, NEW ENGL J MED, V357, P1072, DOI 10.1056/NEJMp078050; Doultree JC, 1999, J HOSP INFECT, V41, P51, DOI 10.1016/S0195-6701(99)90037-3; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Ho ECM, 2006, J MED VIROL, V78, P1473, DOI 10.1002/jmv.20721; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Koopmans M, 2002, FEMS MICROBIOL REV, V26, P187, DOI 10.1016/S0168-6445(02)00096-7; Kroneman A., 2006, EUROSURVEILLANCE, V11; Lee BE, 2008, J MED VIROL, V80, P330, DOI 10.1002/jmv.21061; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lochridge VP, 2005, J GEN VIROL, V86, P2799, DOI 10.1099/vir.0.81134-0; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689; Medici MC, 2006, J MED VIROL, V78, P1486, DOI 10.1002/jmv.20723; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; O'Reilly CE, 2007, CLIN INFECT DIS, V44, P506, DOI 10.1086/511043; Okada M, 2007, ARCH VIROL, V152, P2249, DOI 10.1007/s00705-007-1028-8; Pang XL, 2004, J CLIN MICROBIOL, V42, P4679, DOI 10.1128/JCM.42.10.4679-4685.2004; Pang XLL, 2005, J CLIN VIROL, V33, P168, DOI 10.1016/j.jcv.2004.12.014; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Phan TG, 2006, J MED VIROL, V78, P971, DOI 10.1002/jmv.20649; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Tu ETV, 2008, J CLIN MICROBIOL, V46, P2119, DOI 10.1128/JCM.02198-07; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Vinje J, 1997, J INFECT DIS, V176, P1374, DOI 10.1086/517325; Webby RJ, 2007, CLIN INFECT DIS, V44, P1026, DOI 10.1086/512807; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; 2006, MMWR MORB MORTAL WKL, V56, P842	42	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11599	10.1371/journal.pone.0011599	http://dx.doi.org/10.1371/journal.pone.0011599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661286	Green Published, gold, Green Submitted			2022-12-25	WOS:000279980800005
J	Carey, MA; Bradbury, JA; Rebolloso, YD; Graves, JP; Zeldin, DC; Germolec, DR				Carey, Michelle A.; Bradbury, J. Alyce; Rebolloso, Yvette D.; Graves, Joan P.; Zeldin, Darryl C.; Germolec, Dori R.			Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; G-CSF; ALLERGIC INFLAMMATION; IMMUNE-RESPONSE; DEFICIENT MICE; VIRUS; HYPOTHERMIA; CYCLOOXYGENASES; PROSTAGLANDINS; GRANULOCYTE	Background: We previously demonstrated that cyclooxygenase (COX)-1 deficiency results in greater morbidity and inflammation, whereas COX-2 deficiency leads to reduced morbidity, inflammation and mortality in influenza infected mice. Methodology/Principal Findings: We investigated the effects of COX-1 and COX-2 inhibitors in influenza A viral infection. Mice were given a COX-1 inhibitor (SC-560), a COX-2 inhibitor (celecoxib) or no inhibitor beginning 2 weeks prior to influenza A viral infection (200 PFU) and throughout the course of the experiment. Body weight and temperature were measured daily as indicators of morbidity. Animals were sacrificed on days 1 and 4 post-infection and bronchoalveolar lavage (BAL) fluid was collected or daily mortality was recorded up to 2 weeks post-infection. Treatment with SC-560 significantly increased mortality and was associated with profound hypothermia and greater weight loss compared to celecoxib or control groups. On day 4 of infection, BAL fluid cells were modestly elevated in celecoxib treated mice compared to SC-560 or control groups. Viral titres were similar between treatment groups. Levels of TNF-alpha and G-CSF were significantly attenuated in the SC-560 and celecoxib groups versus control and IL-6 levels were significantly lower in BAL fluid of celecoxib treated mice versus control and versus the SC-560 group. The chemokine KC was significantly lower in SC-560 group versus control. Conclusions/Significance: Treatment with a COX-1 inhibitor during influenza A viral infection is detrimental to the host whereas inhibition of COX-2 does not significantly modulate disease severity. COX-1 plays a critical role in controlling the thermoregulatory response to influenza A viral infection in mice.	[Carey, Michelle A.; Bradbury, J. Alyce; Rebolloso, Yvette D.; Graves, Joan P.; Zeldin, Darryl C.; Germolec, Dori R.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Carey, MA (corresponding author), NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307	National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025043] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu ES, 2007, AM J PHYSIOL-REG I, V292, pR1846, DOI 10.1152/ajpregu.00786.2006; Basu S, 2000, BLOOD, V95, P3725; Carey MA, 2005, J IMMUNOL, V175, P6878, DOI 10.4049/jimmunol.175.10.6878; Carey MA, 2003, PROSTAG LEUKOTR ESS, V69, P157, DOI 10.1016/S0952-3278(03)00076-0; Carey MA, 2003, AM J RESP CRIT CARE, V167, P1509, DOI 10.1164/rccm.200211-1383OC; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Chen JZ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-30; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fedson DS, 2008, LANCET INFECT DIS, V8, P571, DOI 10.1016/S1473-3099(08)70070-7; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Gregory AD, 2007, BLOOD, V109, P3235, DOI 10.1182/blood-2005-01-015081; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6; Leon LR, 2004, FRONT BIOSCI, V9, P1877, DOI 10.2741/1381; LIESCHKE GJ, 1994, BLOOD, V84, P1737; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; MILTON AS, 1989, ANN NY ACAD SCI, V559, P392; Mossad SB, 2009, CLEV CLIN J MED, V76, P337, DOI 10.3949/ccjm.76a.09047; Narko K, 2005, PROSTAG OTH LIPID M, V76, P86, DOI 10.1016/j.prostaglandins.2005.01.002; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Peebles RS, 2002, AM J RESP CRIT CARE, V165, P1154, DOI 10.1164/rccm.2106025; Rainsford K. D., 2006, Inflammopharmacology, V14, P2, DOI 10.1007/s10787-006-0002-5; REED LJ, 1938, AM J HYG, V27; Rocca B, 1999, J CLIN INVEST, V103, P1469, DOI 10.1172/JCI6400; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Schonthal AH, 2007, BRIT J CANCER, V97, P1465, DOI 10.1038/sj.bjc.6604049; Steiner AA, 2009, AM J PHYSIOL-REG I, V297, pR485, DOI 10.1152/ajpregu.91026.2008; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Traynor TR, 2007, BRAIN BEHAV IMMUN, V21, P311, DOI 10.1016/j.bbi.2006.09.007; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Warn PA, 2003, LAB ANIM-UK, V37, P126, DOI 10.1258/00236770360563769; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Wong JP, 1997, LAB ANIM SCI, V47, P143; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhang XW, 2003, DIAM RELAT MATER, V12, P1, DOI 10.1016/S0925-9635(02)00246-7	40	52	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11610	10.1371/journal.pone.0011610	http://dx.doi.org/10.1371/journal.pone.0011610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657653	Green Published, gold, Green Submitted			2022-12-25	WOS:000279924500012
J	Palmieri, LD; Lima, LMTR; Freire, JBB; Bleicher, L; Polikarpov, I; Almeida, FCL; Foguel, D				Palmieri, Leonardo de C.; Lima, Luis Mauricio T. R.; Freire, Juliana B. B.; Bleicher, Lucas; Polikarpov, Igor; Almeida, Fabio C. L.; Foguel, Debora			Novel Zn2+-binding Sites in Human Transthyretin IMPLICATIONS FOR AMYLOIDOGENESIS AND RETINOL-BINDING PROTEIN RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL AMYLOID POLYNEUROPATHY; INDUCED CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ZINC-BINDING; AGGREGATION; FIBRILS; PRESSURE; IDENTIFICATION; RESOLUTION; INSIGHTS	Human transthyretin (TTR) is a homotetrameric protein involved in several amyloidoses. Zn2+ enhances TTR aggregation in vitro, and is a component of ex vivo TTR amyloid fibrils. We report the first crystal structure of human TTR in complex with Zn2+ at pH 4.6-7.5. All four structures reveal three tetra-coordinated Zn2+-binding sites (ZBS 1-3) per monomer, plus a fourth site (ZBS 4) involving amino acid residues from a symmetry-related tetramer that is not visible in solution by NMR.Zn2+ binding perturbs loop E-alpha-helix-loop F, the region involved in holo-retinol-binding protein (holo-RBP) recognition, mainly at acidic pH; TTR affinity for holo-RBP decreases similar to 5-fold in the presence of Zn2+. Interestingly, this same region is disrupted in the crystal structure of the amyloidogenic intermediate of TTR formed at acidic pH in the absence of Zn2+. HNCO and HNCA experiments performed in solution at pH 7.5 revealed that upon Zn2+ binding, although the alpha-helix persists, there are perturbations in the resonances of the residues that flank this region, suggesting an increase in structural flexibility. While stability of the monomer of TTR decreases in the presence of Zn2+, which is consistent with the tertiary structural perturbation provoked by Zn2+ binding, tetramer stability is only marginally affected by Zn2+. These data highlight structural and functional roles of Zn2+ in TTR-related amyloidoses, as well as in holo-RBP recognition and vitamin A homeostasis.	[Palmieri, Leonardo de C.; Freire, Juliana B. B.; Almeida, Fabio C. L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil; [Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Fac Farm, Dept Med, BR-21941590 Rio De Janeiro, Brazil; [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol Jiri Jo, Dept Med, BR-21941590 Rio De Janeiro, Brazil; [Bleicher, Lucas; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Lima, LMTR (corresponding author), Fac Farm UFRJ, Av Carlos Chagas Filho 373,CCS,Bss34, BR-21941902 Rio De Janeiro, Brazil.	mauricio@pharma.ufrj.br; foguel@bioqmed.ufrj.br	Bleicher, Lucas/AAH-9397-2021; Bleicher, Lucas/R-5153-2019; Polikarpov, Igor/D-2575-2012; Palmieri, Leonardo C/A-9341-2013; Lima, Luis Mauricio/AAL-2098-2021; Bleicher, Lucas/B-7967-2013; Almeida, Fabio/O-4989-2018	Bleicher, Lucas/0000-0001-7121-4952; Bleicher, Lucas/0000-0001-7121-4952; Almeida, Fabio/0000-0001-6046-7006; Polikarpov, Igor/0000-0001-9496-4174; Foguel, Debora/0000-0001-7312-7115; TR Lima, Luis Mauricio/0000-0001-6020-0504	CNPq; CAPES; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by CNPq (INCT-Bioimagem e Biologia Estrutural), CAPES Nanobiotec-Brasil 04-2008, and FAPERJ (to D. F. and L. M. T. R. L.).; Supported by a fellowship from CNPq, CAPES PNPD-2009, and FAPERJ.	Ando Yukio, 2005, Medical Molecular Morphology, V38, P142, DOI 10.1007/s00795-005-0288-1; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; BLAKE CCF, 1974, J MOL BIOL, V88, P1, DOI 10.1016/0022-2836(74)90291-5; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; COUTSELINIS A, 1977, CLIN CHEM, V23, P915; Davis DP, 2001, J MOL BIOL, V313, P1021, DOI 10.1006/jmbi.2001.5092; Deng NJ, 2006, BIOPHYS J, V90, P3865, DOI 10.1529/biophysj.105.064444; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200; Ghosh M, 2004, BIOCHEM J, V378, P317, DOI 10.1042/BJ20031706; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; HERBERT J, 1993, NEUROLOGY, V43, pA175; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Inoue S, 1998, J STRUCT BIOL, V124, P1, DOI 10.1006/jsbi.1998.4052; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Keller R. L. J., 2004, THESIS ETH ZURICH ZU; Kingsbury JS, 2007, ANAL CHEM, V79, P1990, DOI 10.1021/ac061546s; Kuser P, 2008, PROTEINS, V72, P731, DOI 10.1002/prot.21956; LAI Z, 1996, J W BIOCH, V35, P6470; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lima LMTR, 2004, EUR J BIOCHEM, V271, P3580, DOI 10.1111/j.0014-2956.2004.04295.x; Liu K, 2000, NAT STRUCT BIOL, V7, P754; Liu K, 2000, J MOL BIOL, V303, P555, DOI 10.1006/jmbi.2000.4164; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MARTONE RL, 1993, AMYLOID AMYLOIDOSIS, P517; Monaco HL, 2000, BBA-PROTEIN STRUCT M, V1482, P65, DOI 10.1016/S0167-4838(00)00140-0; OKUNEWICK JP, 1963, NATURE, V198, P966, DOI 10.1038/198966a0; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Palha JA, 2002, CLIN CHEM LAB MED, V40, P1292, DOI 10.1515/CCLM.2002.223; Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076; Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626; RICCIO P, 1995, NEUROCHEM RES, V20, P1107, DOI 10.1007/BF00995566; Rodriguez-Rodriguez C, 2009, J AM CHEM SOC, V131, P1436, DOI 10.1021/ja806062g; Bachega JFR, 2009, PROTEINS, V77, P26, DOI 10.1002/prot.22412; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; SCOTT BJ, 1983, CLIN CHEM, V29, P629; Sebastiao MP, 1998, J BIOL CHEM, V273, P24715, DOI 10.1074/jbc.273.38.24715; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002; Susuki S, 2008, AMYLOID, V15, P108, DOI 10.1080/13506120802006013; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147; White JT, 2001, P NATL ACAD SCI USA, V98, P13019, DOI 10.1073/pnas.241406698; Wilkinson-White LE, 2007, BIOCHEMISTRY-US, V46, P9123, DOI 10.1021/bi700607z; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang MF, 2005, BIOPHYS J, V89, P433, DOI 10.1529/biophysj.105.059642; Zanotti G, 2008, FEBS J, V275, P5841, DOI 10.1111/j.1742-4658.2008.06705.x; ZHANG Q, 2003, J W BIOCH, V42, P8756	58	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31731	31741		10.1074/jbc.M110.157206	http://dx.doi.org/10.1074/jbc.M110.157206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20659897	Green Published, hybrid			2022-12-25	WOS:000282764600065
J	Omoe, K; Nunomura, W; Kato, H; Li, ZJ; Igarashi, O; Araake, M; Sano, K; Ono, HK; Abe, Y; Hu, DL; Nakane, A; Kiyono, H; Takakuwa, Y; Shinagawa, K; Uchiyama, T; Imanishi, K				Omoe, Katsuhiko; Nunomura, Wataru; Kato, Hidehito; Li, Zhong-Juan; Igarashi, Osamu; Araake, Minako; Sano, Keigo; Ono, Hisaya K.; Abe, Yohei; Hu, Dong-Liang; Nakane, Akio; Kiyono, Hiroshi; Takakuwa, Yuichi; Shinagawa, Kunihiro; Uchiyama, Takehiko; Imanishi, Ken'ichi			High Affinity of Interaction between Superantigen and T Cell Receptor V beta Molecules Induces a High Level and Prolonged Expansion of Superantigen-reactive CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC-SHOCK-SYNDROME; STAPHYLOCOCCAL-ENTEROTOXIN; BACTERIAL SUPERANTIGENS; CRYSTAL-STRUCTURE; ACTIVATION; INDUCTION; TCR; SPECIFICITY; DETERMINES; SELECTION	In mice implanted with an osmotic pump filled with the superantigen (SAG) staphylococcal enterotoxin A (SEA), the V beta 3(+)CD4(+) T cells exhibited a high level of expansion whereas the V beta 11(+)CD4(+) T cells exhibited a mild level of expansion. In contrast, in mice implanted with an osmotic pump filled with SE-like type P (SElP, 78.1% homologous with SEA), the V beta 11(+)CD4(+) T cells exhibited a high level of expansion while the V beta 3(+)CD4(+) T cells exhibited a low level of expansion, suggesting that the level of the SAG-induced response is determined by the affinities between the TCR V beta molecules and SAG. Analyses using several hybrids of SEA and SElP showed that residue 206 of SEA determines the response levels of V beta 3(+)CD4(+) and V beta 11(+)CD4(+) T cells both in vitro and in vivo. Analyses using the above-mentioned hybrids showed that the binding affinities between SEA and the V beta 3/V beta 11 beta chains and between SEA-MHC class II-molecule complex and V beta 3(+)/V beta 11(+) CD4(+) T cells determines the response levels of the SAG-reactive T cells both in vitro and in vivo.	[Kato, Hidehito; Li, Zhong-Juan; Araake, Minako; Sano, Keigo; Imanishi, Ken'ichi] Tokyo Womens Med Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1628666, Japan; [Nunomura, Wataru; Takakuwa, Yuichi] Tokyo Womens Med Univ, Sch Med, Dept Biochem, Tokyo 1628666, Japan; [Omoe, Katsuhiko; Ono, Hisaya K.; Abe, Yohei; Shinagawa, Kunihiro] Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 0208550, Japan; [Igarashi, Osamu; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Aomori 0368562, Japan; [Hu, Dong-Liang; Nakane, Akio] Hirosaki Univ, Sch Med, Dept Bacteriol, Aomori 0368562, Japan; [Uchiyama, Takehiko] Tokiwa Univ, Coll Human Sci, Ibaraki 3108585, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Iwate University; University of Tokyo; Hirosaki University	Imanishi, K (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	imanis17@research.twmu.ac.jp	Kiyono, Hiroshi/AAC-6735-2022; Ono, Hisaya/F-5296-2013; Ono, Hisaya/P-3595-2019					Abe J, 1997, J CLIN INVEST, V99, P1823, DOI 10.1172/JCI119349; Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; Antonsson P, 1997, J IMMUNOL, V158, P4245; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Baker MD, 2004, INT J MED MICROBIOL, V293, P529, DOI 10.1078/1438-4221-00298; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; Chen LQ, 2002, J IMMUNOL, V168, P3817, DOI 10.4049/jimmunol.168.8.3817; De Marzi MC, 2004, EUR J BIOCHEM, V271, P4075, DOI 10.1111/j.1432-1033.2004.04345.x; FRIEDMAN ME, 1971, J BACTERIOL, V106, P289, DOI 10.1128/JB.106.1.289-291.1971; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; Hu DL, 2003, INFECT IMMUN, V71, P567, DOI 10.1128/IAI.71.1.567-570.2003; HUDSON KR, 1993, J EXP MED, V177, P175, DOI 10.1084/jem.177.1.175; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; IRWIN MJ, 1992, NATURE, V359, P841, DOI 10.1038/359841a0; Koyanagi M, 2004, INT IMMUNOL, V16, P315, DOI 10.1093/intimm/dxh027; Kuroda K, 1996, J IMMUNOL, V157, P1422; Lamphear JG, 1996, J IMMUNOL, V156, P2178; Li ZJ, 2009, MICROBIOL IMMUNOL, V53, P451, DOI 10.1111/j.1348-0421.2009.00136.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Matsuda Y, 2003, EMERG INFECT DIS, V9, P387, DOI 10.3201/eid0903.020360; Matsuda Y, 2008, MICROBIOL IMMUNOL, V52, P513, DOI 10.1111/j.1348-0421.2008.00071.x; MOLLICK JA, 1993, J EXP MED, V177, P283, DOI 10.1084/jem.177.2.283; Nunomura W, 2006, FRONT BIOSCI-LANDMRK, V11, P1522, DOI 10.2741/1901; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Omoe K, 2005, INFECT IMMUN, V73, P5540, DOI 10.1128/IAI.73.9.5540-5546.2005; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; Tsukamoto H, 2006, EUR J IMMUNOL, V36, P1926, DOI 10.1002/eji.200535803; Uchiyama T., 2006, COMPREHENSIVE SOURCE, V3rd, P830, DOI [10.1016/B978-012088445-2/50055-X, DOI 10.1016/B978-012088445-2/50055-X]; Uchiyama T, 2007, SUPERANTIGENS: MOLECULAR BASIS FOR THEIR ROLE IN HUMAN DISEASES, P77; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; YAN XJ, 1993, J IMMUNOL, V150, P3873	37	7	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30427	30435		10.1074/jbc.M110.140871	http://dx.doi.org/10.1074/jbc.M110.140871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663890	hybrid, Green Published			2022-12-25	WOS:000282135500009
J	Thi, MM; Suadicani, SO; Spray, DC				Thi, Mia M.; Suadicani, Sylvia O.; Spray, David C.			Fluid Flow-induced Soluble Vascular Endothelial Growth Factor Isoforms Regulate Actin Adaptation in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MARROW STROMAL CELLS; SHEAR-STRESS; BONE-FORMATION; EXPRESSION; VEGF; DIFFERENTIATION; ANGIOGENESIS; NEUROPILIN-1; CYTOSKELETON	Although load-induced mechanical signals play a key role in bone formation and maintenance of bone mass and structure, the cellular mechanisms involved in the translation of these signals are still not well understood. Recent identification of a novel flow-induced mechanosignaling pathway involving VEGF in osteoblasts and the known VEGF regulation of actin reorganization in various cell types has led us to hypothesize that fluid shear stress-induced Vegf up-regulation underlies the actin cytoskeleton adaptation observed in osteoblasts during mechanotransduction. Our results show that MC3T3-E1 cells secrete significant VEGF in response to 5 h of pulsatile fluid shear stress (PFSS; 5 dynes/cm(2) at 1 Hz), whereas expression of VEGF receptors (VEGFR-1, VEGFR-2, or NRP1) is unaffected. These receptors, in particular VEGFR-2, participate in PFSS-induced VEGF release. Exposure to flow-conditioned medium or exogenous VEGF significantly induces stress fiber formation in osteoblasts that is comparable with PFSS-induced stress fiber formation, whereas VEGF knockdown abrogates this response to PFSS, thereby providing evidence that flow-induced VEGF release plays a role in actin polymerization. Using neutralizing antibodies against the receptors and VEGF isoforms, we found that soluble VEGFs, in particular VEGF(164), play a crucial role in transient stress fiber formation during osteoblast mechanotransduction, most likely through VEGFR-2 and NRP1. Based on these data we conclude that flow-induced VEGF release from osteoblasts regulates osteoblast actin adaptation during mechanotransduction and that VEGF paracrine signaling may provide potent cross-talk among bone cells and endothelial cells that is essential for fracture healing, bone remodeling, and osteogenesis.	Yeshiva Univ Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10461 USA; [Thi, Mia M.; Suadicani, Sylvia O.; Spray, David C.] Yeshiva Univ Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Suadicani, Sylvia O.] Yeshiva Univ Albert Einstein Coll Med, Dept Urol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Spray, DC (corresponding author), 1300 Morris Pk Ave,Kennedy Ctr Rm 840, Bronx, NY 10461 USA.	mia.thi@einstein.yu.edu	Thi, Mia Mia/K-8772-2019	Spray, David/0000-0001-8368-5073	National Institutes of Health [F32HL082130, AHA0735377N, NS041282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL082130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32HL082130, AHA0735377N, and NS041282.	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Faure C, 2008, BONE, V42, P1092, DOI 10.1016/j.bone.2008.02.011; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fuh G, 2000, J BIOL CHEM, V275, P26690; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701; Gong Chunhong, 2004, Angiogenesis, V7, P313, DOI 10.1007/s10456-004-7960-2; HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258; Harper J, 2001, J CELL BIOCHEM, V81, P82, DOI 10.1002/1097-4644(20010401)81:1<82::AID-JCB1025>3.0.CO;2-P; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; MAES C, 2007, VEGF DEV, P1; Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Petersen W, 2004, J ORTHOP RES, V22, P847, DOI 10.1016/j.orthres.2003.11.009; Reich K M, 1991, AM J PHYSIOL, V261, P428; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Saunders MM, 2001, AM J PHYSIOL-CELL PH, V281, pC1917, DOI 10.1152/ajpcell.2001.281.6.C1917; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Sharp LA, 2009, ANN BIOMED ENG, V37, P445, DOI 10.1007/s10439-008-9632-7; Singh SP, 2007, J AM COLL SURGEONS, V204, P426, DOI 10.1016/j.jamcollsurg.2006.11.019; Smith JD, 2001, ENDOTHELIUM-J ENDOTH, V8, P41, DOI 10.3109/10623320109063156; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stoletov KV, 2004, EXP CELL RES, V295, P258, DOI 10.1016/j.yexcr.2004.01.008; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Thi MM, 2007, ANN NY ACAD SCI, V1117, P73, DOI 10.1196/annals.1402.020; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; Thi MM, 2003, AM J PHYSIOL-CELL PH, V284, pC389, DOI 10.1152/ajpcell.00052.2002; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tombran-Tink J, 2004, BIOCHEM BIOPH RES CO, V316, P573, DOI 10.1016/j.bbrc.2004.02.076; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102; Zelzer E, 2002, DEVELOPMENT, V129, P1893	43	21	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30931	30941		10.1074/jbc.M110.114975	http://dx.doi.org/10.1074/jbc.M110.114975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20682775	Green Published, hybrid			2022-12-25	WOS:000282135500058
J	Moore, N; Messina, J				Moore, Nathan; Messina, Joseph			A Landscape and Climate Data Logistic Model of Tsetse Distribution in Kenya	PLOS ONE			English	Article							GLOSSINA-PALLIDIPES; LAND-COVER; POPULATION; FLIES; TRYPANOSOMOSIS; DENSITY	Background: Trypanosoma spp, biologically transmitted by the tsetse fly in Africa, are a major cause of illness resulting in both high morbidity and mortality among humans, cattle, wild ungulates, and other species. However, tsetse fly distributions change rapidly due to environmental changes, and fine-scale distribution maps are few. Due to data scarcity, most presence/absence estimates in Kenya prior to 2000 are a combination of local reports, entomological knowledge, and topographic information. The availability of tsetse fly abundance data are limited, or at least have not been collected into aggregate, publicly available national datasets. Despite this limitation, other avenues exist for estimating tsetse distributions including remotely sensed data, climate information, and statistical tools. Methodology/Principal Findings: Here we present a logistic regression model of tsetse abundance. The goal of this model is to estimate the distribution of tsetse fly in Kenya in the year 2000, and to provide a method by which to anticipate their future distribution. Multiple predictor variables were tested for significance and for predictive power; ultimately, a parsimonious subset of variables was identified and used to construct the regression model with the 1973 tsetse map. These data were validated against year 2000 Food and Agriculture Organization (FAO) estimates. Mapcurves Goodness-Of-Fit scores were used to evaluate the modeled fly distribution against FAO estimates and against 1973 presence/absence data, each driven by appropriate climate data. Conclusions/Significance: Logistic regression can be effectively used to produce a model that projects fly abundance under elevated greenhouse gas scenarios. This model identifies potential areas for tsetse abandonment and expansion.	[Moore, Nathan] Zhejiang Univ, Dept Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Moore, Nathan; Messina, Joseph] Michigan State Univ, Dept Geog, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA	Zhejiang University; Michigan State University	Moore, N (corresponding author), Zhejiang Univ, Dept Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	moorena@msu.edu		Messina, Joseph/0000-0002-1978-0778	National Institutes of Health; National Institutes of Health, Office of the Director, Roadmap Initiative; NIGMS [RGM084704A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM084704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Office of the Director, Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by The National Institutes of Health, Office of the Director, Roadmap Initiative, and NIGMS: award # RGM084704A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2005, AFRICA BUSINESS APR; Bett B, 2008, VET PARASITOL, V155, P287, DOI 10.1016/j.vetpar.2008.05.028; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cecchi G, 2008, MED VET ENTOMOL, V22, P364, DOI 10.1111/j.1365-2915.2008.00747.x; Cotton WR, 2003, METEOROL ATMOS PHYS, V82, P5, DOI 10.1007/s00703-001-0584-9; Curran PJ, 2000, ADV PARASIT, V47, P37, DOI 10.1016/S0065-308X(00)47006-5; FAO, 2005, LIV SECT BRIEF; Ford J., 1971, ROLE TRYPANOSOMIASES; GILBERT M, 1999, P JUB M INT SCI COUN; Goovaerts P, 2000, J HYDROL, V228, P113, DOI 10.1016/S0022-1694(00)00144-X; Goovaerts P., 1997, GEOSTATISTICS NATURA; Hargrove JW, 2001, ENTOMOL EXP APPL, V100, P151, DOI 10.1023/A:1019271727810; Hargrove WW, 2006, J GEOGR SYST, V8, P187, DOI 10.1007/s10109-006-0025-x; Hendrickx G, 2000, PARASITOLOGY, V120, P121, DOI 10.1017/S0031182099005338; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; LEAK SGA, 1999, TSETSE BIOL ECOLOGY; LEAK SGA, 2008, COLLECTION BASELINE; Manel S, 1999, ECOL MODEL, V120, P337, DOI 10.1016/S0304-3800(99)00113-1; MCDERMOTT JJ, 2001, AFRICAN TRYPANOSOMES; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Moore N, 2010, INT J CLIMATOL, V30, P1954, DOI 10.1002/joc.2011; Nash TAM, 1933, J ANIM ECOL, V2, P197, DOI 10.2307/957; Pollock J. N., 1982, TRAINING MANUAL TSET, V2; RANDOLPH SE, 1991, MED VET ENTOMOL, V5, P335, DOI 10.1111/j.1365-2915.1991.tb00559.x; Reid RS, 2000, AGR ECOSYST ENVIRON, V77, P227, DOI 10.1016/S0167-8809(99)00103-6; ROGERS D, 1979, J ANIM ECOL, V48, P825, DOI 10.2307/4197; Rogers D., 2000, PREDICTED DISTRIBUTI, P1; ROGERS DJ, 1990, INSECT SCI APPL, V11, P331, DOI 10.1017/S1742758400012753; ROGERS DJ, 1991, NATURE, V351, P739, DOI 10.1038/351739a0; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; WILLIAMS B, 1992, J APPL ECOL, V29, P163, DOI 10.2307/2404359; Wint W., 2001, KILOMETRE RESOLUTION	35	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11809	10.1371/journal.pone.0011809	http://dx.doi.org/10.1371/journal.pone.0011809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676406	gold, Green Published, Green Submitted			2022-12-25	WOS:000280371800013
J	Kanodia, S; Wieder, E; Lu, SJ; Talpaz, M; Alatrash, G; Clise-Dwyer, K; Molldrem, JJ				Kanodia, Shreya; Wieder, Eric; Lu, Sijie; Talpaz, Moshe; Alatrash, Gheath; Clise-Dwyer, Karen; Molldrem, Jeffrey J.			PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; ABL GENOMIC REARRANGEMENT; IN-VITRO; IMATINIB MESYLATE; ALPHA THERAPY; STEM-CELLS; SERINE-PROTEASE; DENDRITIC CELLS; CD34(+) CELLS; LYMPHOCYTES	Background: Interferon-alpha (IFN) induces complete cytogenetic remission (CCR) in 20-25% CML patients and in a small minority of patients; CCR persists after IFN is stopped. IFN induces CCR in part by increasing cytotoxic T lymphocytes (CTL) specific for PR1, the HLA-A2-restricted 9-mer peptide from proteinase 3 and neutrophil elastase, but it is unknown how CCR persists after IFN is stopped. Principal Findings: We reasoned that PR1-CTL persist and mediate CML-specific immunity in patients that maintain CCR after IFN withdrawal. We found that PR1-CTL were increased in peripheral blood of 7/7 HLA-A2+ patients during unmaintained CCR from 3 to 88 months after IFN withdrawal, as compared to no detectable PR1-CTL in 2/2 IFN-treated CML patients not in CCR. Unprimed PR1-CTL secreted IFN gamma and were predominantly CD45RA +/- CD28+CCR7+CD57-, consistent with functional naive and central memory (CM) T cells. Similarly, following stimulation, proliferation occurred predominantly in CM PR1-CTL, consistent with long-term immunity sustained by self-renewing CM T cells. PR1-CTL were functionally anergic in one patient 6 months prior to cytogenetic relapse at 26 months after IFN withdrawal, and in three relapsed patients PR1-CTL were undetectable but re-emerged 3-6 months after starting imatinib. Conclusion: These data support the hypothesis that IFN elicits CML-specific CM CTL that may contribute to continuous CCR after IFN withdrawal and suggest a role for T cell immune therapy with or without tyrosine kinase inhibitors as a strategy to prolong CR in CML.	[Kanodia, Shreya; Wieder, Eric; Lu, Sijie; Alatrash, Gheath; Clise-Dwyer, Karen; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Sect Transplant Immunol, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA; [Talpaz, Moshe] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kanodia, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Transplant Immunol, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA.	jmolldre@mdanderson.org		Alatrash, Gheath/0000-0002-7648-4377; Talpaz, Moshe/0000-0003-3361-3981	National Institutes of Health [CA100632, CA049639]; Leukemia and Lymphoma Society [6031-07, 7262-08]; American Legion Auxiliary Foundation; National Institutes of Health through M. D. Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P01CA049639, P50CA100632, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Legion Auxiliary Foundation; National Institutes of Health through M. D. Anderson's Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA100632, and CA049639 from the National Institutes of Health to JJM; and 6031-07 and 7262-08 from the Leukemia and Lymphoma Society to JJM. This work was also supported in part by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant CA016672. SK was supported, in part, by the American Legion Auxiliary Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Appel S, 2004, BLOOD, V103, P538, DOI 10.1182/blood-2003-03-0975; Aswald JM, 2002, CYTOKINES CELL MOL T, V7, P143, DOI 10.1080/13684730210002319; BAGGIOLINI M, 1978, AGENTS ACTIONS, V8, P3, DOI 10.1007/BF01972395; Bonifazi F, 2001, BLOOD, V98, P3074, DOI 10.1182/blood.V98.10.3074; BORIES D, 1989, CELL, V59, P959, DOI 10.1016/0092-8674(89)90752-6; Branford S, 1999, BRIT J HAEMATOL, V107, P587; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brizard F, 1998, LEUKEMIA, V12, P1076, DOI 10.1038/sj.leu.2401053; Burchert A, 2010, J CLIN ONCOL, V28, P1429, DOI 10.1200/JCO.2009.25.5075; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chomel JC, 2000, BLOOD, V95, P404, DOI 10.1182/blood.V95.2.404; Cornelissen JJ, 1998, J CLIN INVEST, V102, P976, DOI 10.1172/JCI2366; Cwynarski K, 2004, LEUKEMIA, V18, P1332, DOI 10.1038/sj.leu.2403401; DENGLER R, 1995, BRIT J HAEMATOL, V89, P250, DOI 10.1111/j.1365-2141.1995.tb03297.x; Dietz AB, 2004, BLOOD, V104, P1094, DOI 10.1182/blood-2003-12-4266; Gannage M, 2005, J IMMUNOL, V174, P8210, DOI 10.4049/jimmunol.174.12.8210; Guilhot F, 1998, HEMATOL CELL THER, V40, P237; Hamann D, 1999, INT IMMUNOL, V11, P1027, DOI 10.1093/intimm/11.7.1027; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; KANTARJIAN HM, 1995, ANN INTERN MED, V122, P254, DOI 10.7326/0003-4819-122-4-199502150-00003; Kantarjian HM, 2003, CANCER-AM CANCER SOC, V97, P1033, DOI 10.1002/cncr.11223; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Molldrem J, 1996, BLOOD, V88, P2450, DOI 10.1182/blood.V88.7.2450.bloodjournal8872450; Molldrem JJ, 2003, J CLIN INVEST, V111, P639, DOI 10.1172/JCI200316398; Molldrem JJ, 1999, CANCER RES, V59, P2675; Molldrem JJ, 1997, BLOOD, V90, P2529, DOI 10.1182/blood.V90.7.2529.2529_2529_2534; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Mollet L, 1998, INT IMMUNOL, V10, P311, DOI 10.1093/intimm/10.3.311; Nakayama S, 2007, INT J HEMATOL, V86, P208, DOI 10.1007/BF03006921; Sawyers CL, 2007, NAT MED, V13, P1144, DOI 10.1038/nm1007-1144; Seggewiss R, 2008, CYTOTHERAPY, V10, P633, DOI 10.1080/14653240802317639; Seggewiss R, 2005, BLOOD, V105, P2473, DOI 10.1182/blood-2004-07-2527; TALPAZ M, 1994, J CLIN INVEST, V94, P1383, DOI 10.1172/JCI117473; TALPAZ M, 1986, BRIT J HAEMATOL, V64, P87, DOI 10.1111/j.1365-2141.1986.tb07576.x; TALPAZ M, 1983, BLOOD, V62, P689; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Witko-Sarsat V, 2002, J BIOL CHEM, V277, P47338, DOI 10.1074/jbc.M202789200; Yee C, 1999, J IMMUNOL, V162, P2227; Yong ASM, 2007, BLOOD, V110, P770, DOI 10.1182/blood-2007-02-071738; Yong ASM, 2006, BLOOD, V107, P205, DOI 10.1182/blood-2005-05-2155; Zeh HJ, 1999, J IMMUNOL, V162, P989; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	46	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11770	10.1371/journal.pone.0011770	http://dx.doi.org/10.1371/journal.pone.0011770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668669	gold, Green Published, Green Submitted			2022-12-25	WOS:000280297300008
J	Robles-Sikisaka, R; Bohonak, AJ; McClenaghan, LR; Dhar, AK				Robles-Sikisaka, Refugio; Bohonak, Andrew J.; McClenaghan, Leroy R., Jr.; Dhar, Arun K.			Genetic Signature of Rapid IHHNV (Infectious Hypodermal and Hematopoietic Necrosis Virus) Expansion in Wild Penaeus Shrimp Populations	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; MOLECULAR EVOLUTION; PHYLOGENETIC EVIDENCE; SELECTION; RATES; RECOMBINATION; STYLIROSTRIS; GENEALOGIES; PREVALENCE; PARVOVIRUS	Infectious hypodermal and hematopoietic necrosis virus (IHHNV) is a widely distributed single-stranded DNA parvovirus that has been responsible for major losses in wild and farmed penaeid shrimp populations on the northwestern Pacific coast of Mexico since the early 1990's. IHHNV has been considered a slow-evolving, stable virus because shrimp populations in this region have recovered to pre-epizootic levels, and limited nucleotide variation has been found in a small number of IHHNV isolates studied from this region. To gain insight into IHHNV evolutionary and population dynamics, we analyzed IHHNV capsid protein gene sequences from 89 Penaeus shrimp, along with 14 previously published sequences. Using Bayesian coalescent approaches, we calculated a mean rate of nucleotide substitution for IHHNV that was unexpectedly high (1.39610 24 substitutions/site/year) and comparable to that reported for RNA viruses. We found more genetic diversity than previously reported for IHHNV isolates and highly significant subdivision among the viral populations in Mexican waters. Past changes in effective number of infections that we infer from Bayesian skyline plots closely correspond to IHHNV epizootiological historical records. Given the high evolutionary rate and the observed regional isolation of IHHNV in shrimp populations in the Gulf of California, we suggest regular monitoring of wild and farmed shrimp and restriction of shrimp movement as preventative measures for future viral outbreaks.	[Robles-Sikisaka, Refugio; Bohonak, Andrew J.; McClenaghan, Leroy R., Jr.; Dhar, Arun K.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Robles-Sikisaka, R (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	refugio.robles1@gmail.com			California Sea Grant Fund [R/A-121]; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	California Sea Grant Fund; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The work presented in this manuscript was partially funded by a grant from the California Sea Grant Fund (Number R/A-121) to AKD. Partial funding was also provided through a graduate fellowship to RRS from Consejo Nacional de Ciencia y Tecnologia (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohonak AJ, 2006, ARCH HYDROBIOL, V167, P183, DOI 10.1127/0003-9136/2006/0167-0183; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; BONAMI JR, 1990, J GEN VIROL, V71, P2657, DOI 10.1099/0022-1317-71-11-2657; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cordellier M, 2008, J BIOGEOGR, V35, P1580, DOI 10.1111/j.1365-2699.2008.01909.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; EXCOFFIER L, 1992, GENETICS, V131, P491; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Firth C, 2009, J VIROL, V83, P12813, DOI 10.1128/JVI.01719-09; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; JUKES T H, 1969, P21; KALAGAYAN H, 1991, Journal of the World Aquaculture Society, V22, P235, DOI 10.1111/j.1749-7345.1991.tb00740.x; Kautsky N, 2000, AQUACULTURE, V191, P145, DOI 10.1016/S0044-8486(00)00424-5; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lightner D. V., 1999, Journal of Applied Aquaculture, V9, P27, DOI 10.1300/J028v09n02_03; LIGHTNER DV, 1983, J INVERTEBR PATHOL, V42, P62, DOI 10.1016/0022-2011(83)90202-1; LIGHTNER DV, 1992, ICES MAR SC, V194, P97; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Morales-Covarrubias MS, 1999, J AQUAT ANIM HEALTH, V11, P296, DOI 10.1577/1548-8667(1999)011&lt;0296:POIHAH&gt;2.0.CO;2; Nunan LM, 2000, MAR BIOTECHNOL, V2, P319; Pantoja CR, 1999, J AQUAT ANIM HEALTH, V11, P23, DOI 10.1577/1548-8667(1999)011&lt;0023:PAGDOI&gt;2.0.CO;2; Parsyan A, 2007, J GEN VIROL, V88, P428, DOI 10.1099/vir.0.82496-0; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, TRACER V1 6; Rambaut A., 2008, FIGTREE TREE FIGURE; Robles-Sikisaka R, 2002, J GEN VIROL, V83, P3123, DOI 10.1099/0022-1317-83-12-3123; ROBLESSIKISAKA R, 2008, THESIS U CALIFORNIA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; *SAGARPA, 2004, AN EST AC PESC; Scholtissek C, 1995, VIRUS GENES, V11, P209, DOI 10.1007/BF01728660; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Shike H, 2000, VIROLOGY, V277, P167, DOI 10.1006/viro.2000.0589; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tang KFJ, 2003, DIS AQUAT ORGAN, V53, P91, DOI 10.3354/dao053091; Tang KFJ, 2002, DIS AQUAT ORGAN, V49, P93, DOI 10.3354/dao049093; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	52	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11799	10.1371/journal.pone.0011799	http://dx.doi.org/10.1371/journal.pone.0011799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668694	gold, Green Published, Green Submitted			2022-12-25	WOS:000280297300025
J	Narantuya, D; Nagai, A; Sheikh, AM; Masuda, J; Kobayashi, S; Yamaguchi, S; Kim, SU				Narantuya, Dashdemberel; Nagai, Atsushi; Sheikh, Abdullah Md; Masuda, Junichi; Kobayashi, Shotai; Yamaguchi, Shuhei; Kim, Seung U.			Human Microglia Transplanted in Rat Focal Ischemia Brain Induce Neuroprotection and Behavioral Improvement	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; MESSENGER-RNA; STROKE MODEL; GLIAL-CELLS; EXPRESSION; INJURY	Backgrond and Purpose: Microglia are resident immunocompenent and phagocytic cells of central nervous system (CNS), which produce various cytokines and growth factors in response to injury and thereby regulate disease pathology. The purpose of this study is to investigate the effects of microglial transplantation on focal cerebral ischemia model in rat. Methods: Transient middle cerebral artery occlusion (MCAO) in rats was induced by the intraluminal filament technique. HMO6 cells, human microglial cell line, were transplanted intravenously at 48 hours after MCAO. Functional tests were performed and the infarct volume was measured at 7 and 14 days after MCAO. Migration and cell survival of transplanted microglial cells and host glial reaction in the brain were studied by immunohistochemistry. Gene expression of neurotrophic factors, cytokines and chemokines in transplanted cells and host rat glial cells was determined by laser capture microdissection (LCM) and quantitative real time-PCR. Results: HMO6 human microglial cells transplantion group demonstrated significant functional recovery compared with control group. At 7 and 14 days after MCAO, infarct volume was significantly reduced in the HMO group. In the HMO6 group, number of apoptotic cells was time-dependently reduced in the infarct core and penumbra. In addition, number of host rat microglia/macrophages and reactive astrocytes was significantly decreased at 7 and 14 days after MCAO in the penumbra. Gene expression of various neurotrophic factors (GDNF, BDNF, VEGF and BMP7) and anti-inflammatory cytokines (IL4 and IL5) was up-regulated in transplanted HMO6 cells of brain tissue compared with those in culture. The expression of GDNF and VEGF in astrocytes in penumbra was significantly up-regulated in the HMO6 group. Conclusions: Our results indicate that transplantation of HMO6 human microglial cells reduces ischemic deficits and apoptotic events in stroke animals. The results were mediated by modulation of gliosis and neuroinflammation, and neuroprotection provided by neurotrophic factors of endogenous and transplanted cells-origin.	[Narantuya, Dashdemberel; Yamaguchi, Shuhei] Shimane Univ, Sch Med, Dept Neurol, Izumo, Shimane, Japan; [Nagai, Atsushi; Sheikh, Abdullah Md; Masuda, Junichi] Shimane Univ, Sch Med, Dept Lab Med, Izumo, Shimane, Japan; [Kobayashi, Shotai] Shimane Univ, Sch Med, Shimane Univ Hosp, Izumo, Shimane, Japan; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada; [Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea	Shimane University; Shimane University; Shimane University; University of British Columbia; Chung Ang University; Chung Ang University Hospital	Narantuya, D (corresponding author), Shimane Univ, Sch Med, Dept Neurol, Izumo, Shimane, Japan.	anagai@med.shimane-u.ac.jp; sukim@interchange.ubc.ca		Nagai, Atsushi/0000-0002-9280-8044	Canadian Myelin Research Initiative	Canadian Myelin Research Initiative	This study was supported by grants from the Canadian Myelin Research Initiative (SUK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block F, 2000, NEUROREPORT, V11, P963, DOI 10.1097/00001756-200004070-00013; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Buttini M, 1996, NEUROSCIENCE, V71, P1, DOI 10.1016/0306-4522(95)00414-9; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; Chen HL, 2003, BRAIN RES, V994, P81, DOI 10.1016/j.brainres.2003.09.020; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Clausen BH, 2005, NEUROSCIENCE, V132, P879, DOI 10.1016/j.neuroscience.2005.01.031; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Elkabes S, 1996, J NEUROSCI, V16, P2508; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lee HJ, 2009, GENE THER, V16, P1066, DOI 10.1038/gt.2009.51; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Minami M, 2003, LIFE SCI, V74, P321, DOI 10.1016/j.lfs.2003.09.019; Miwa T, 1997, J NEUROSCI RES, V50, P1023; Miyamoto Y, 1999, J NEUROSCI RES, V55, P245, DOI 10.1002/(SICI)1097-4547(19990115)55:2<245::AID-JNR12>3.0.CO;2-Q; Nagai A, 2005, J NEUROSCI RES, V81, P342, DOI 10.1002/jnr.20478; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; NAKAJIMA K, 1993, NEUROSCI RES, V17, P187, DOI 10.1016/0168-0102(93)90047-T; Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Rupalla K, 1998, ACTA NEUROPATHOL, V96, P172, DOI 10.1007/s004010050878; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Takami S, 1997, NEUROSCI LETT, V227, P173, DOI 10.1016/S0304-3940(97)00338-8; Tomimoto H, 1996, ACTA NEUROPATHOL, V92, P281, DOI 10.1007/s004010050519; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Wang W, 2008, J CLIN NEUROSCI, V15, P278, DOI 10.1016/j.jocn.2007.02.004; Xu XH, 2006, LIFE SCI, V78, P704, DOI 10.1016/j.lfs.2005.05.080; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Zhang ZG, 1997, BRAIN RES, V744, P189, DOI 10.1016/S0006-8993(96)01085-2; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	49	86	93	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11746	10.1371/journal.pone.0011746	http://dx.doi.org/10.1371/journal.pone.0011746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668522	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243800019
J	Rajamaki, K; Lappalainen, J; Oorni, K; Valimaki, E; Matikainen, S; Kovanen, PT; Eklund, KK				Rajamaki, Kristiina; Lappalainen, Jani; Oorni, Katariina; Valimaki, Elina; Matikainen, Sampsa; Kovanen, Petri T.; Eklund, Kari K.			Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-4; SMOOTH-MUSCLE CELLS; CATHEPSIN-B; NALP3 INFLAMMASOME; EPOXYSUCCINYL PEPTIDES; SELECTIVE INHIBITOR; GENE-EXPRESSION; FATTY STREAKS; CUTTING EDGE	Background: Chronic inflammation of the arterial wall is a key element in the pathogenesis of atherosclerosis, yet the factors that trigger and sustain the inflammation remain elusive. Inflammasomes are cytoplasmic caspase-1-activating protein complexes that promote maturation and secretion of the proinflammatory cytokines interleukin(IL)-1 beta and IL-18. The most intensively studied inflammasome, NLRP3 inflammasome, is activated by diverse substances, including crystalline and particulate materials. As cholesterol crystals are abundant in atherosclerotic lesions, and IL-1 beta has been linked to atherogenesis, we explored the possibility that cholesterol crystals promote inflammation by activating the inflammasome pathway. Principal Findings: Here we show that human macrophages avidly phagocytose cholesterol crystals and store the ingested cholesterol as cholesteryl esters. Importantly, cholesterol crystals induced dose-dependent secretion of mature IL-1 beta from human monocytes and macrophages. The cholesterol crystal-induced secretion of IL-1 beta was caspase-1-dependent, suggesting the involvement of an inflammasome-mediated pathway. Silencing of the NLRP3 receptor, the crucial component in NLRP3 inflammasome, completely abolished crystal-induced IL-1 beta secretion, thus identifying NLRP3 inflammasome as the cholesterol crystal-responsive element in macrophages. The crystals were shown to induce leakage of the lysosomal protease cathepsin B into the cytoplasm and inhibition of this enzyme reduced cholesterol crystal-induced IL-1 beta secretion, suggesting that NLRP3 inflammasome activation occurred via lysosomal destabilization. Conclusions: The cholesterol crystal-induced inflammasome activation in macrophages may represent an important link between cholesterol metabolism and inflammation in atherosclerotic lesions.	[Rajamaki, Kristiina; Lappalainen, Jani; Oorni, Katariina; Kovanen, Petri T.; Eklund, Kari K.] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Valimaki, Elina; Matikainen, Sampsa] Finnish Inst Occupat Hlth, Helsinki, Finland	Wihuri Research Institute; Finnish Institute of Occupational Health	Rajamaki, K (corresponding author), Wihuri Res Inst, SF-00140 Helsinki, Finland.	kristiina.rajamaki@helsinki.fi	Oorni, Katariina/G-2484-2011; Matikainen, Sampsa/AAH-8654-2021	Oorni, Katariina/0000-0002-9525-0250; Rajamaki, Kristiina/0000-0001-5151-1220	Jenny and Antti Wihuri Foundation	Jenny and Antti Wihuri Foundation	Wihuri Research Institute is maintained by the Jenny and Antti Wihuri Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BOCAN TMA, 1986, AM J PATHOL, V123, P413; BORASCHI D, 1990, EUR J IMMUNOL, V20, P317, DOI 10.1002/eji.1830200213; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Dinarello C A, 1986, Year Immunol, V2, P68; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; DOWER SK, 1986, NATURE, V324, P266, DOI 10.1038/324266a0; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Erridge C, 2008, TRENDS CARDIOVAS MED, V18, P52, DOI 10.1016/j.tcm.2007.12.003; FENTON MJ, 1988, J IMMUNOL, V140, P2267; FENTON MJ, 1992, INT J IMMUNOPHARMACO, V14, P401, DOI 10.1016/0192-0561(92)90170-P; FLYNN GL, 1979, J PHARM SCI, V68, P1090, DOI 10.1002/jps.2600680908; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; GENG YJ, 1995, AM J PATHOL, V147, P251; GUYTON JR, 1993, AM J PATHOL, V143, P1444; HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473; Herman WH, 1999, TRANSPLANT P, V31, P1412, DOI 10.1016/S0041-1345(98)02109-5; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang H, 2006, ARCH PHARM RES, V29, P890, DOI 10.1007/BF02973911; KANNO K, 1993, HYPERTENSION, V22, P34, DOI 10.1161/01.HYP.22.1.34; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; Kellner-Weibel G, 1999, ARTERIOSCL THROM VAS, V19, P1891, DOI 10.1161/01.ATV.19.8.1891; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; KNIGHT CG, 1980, BIOCHEM J, V189, P447, DOI 10.1042/bj1890447; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Kovacs T, 2009, CYTOM PART A, V75A, P650, DOI 10.1002/cyto.a.20756; KRUTH HS, 1995, J CELL BIOL, V129, P133, DOI 10.1083/jcb.129.1.133; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOREE HM, 1994, ARTERIOSCLER THROMB, V14, P230, DOI 10.1161/01.ATV.14.2.230; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MCCONATHY WJ, 1989, ATHEROSCLEROSIS, V77, P221, DOI 10.1016/0021-9150(89)90085-3; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakanishi S, 2009, J LIPID RES, V50, P183, DOI 10.1194/jlr.M800196-JLR200; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pirhonen J, 2001, EUR J IMMUNOL, V31, P726, DOI 10.1002/1521-4141(200103)31:3<726::AID-IMMU726>3.0.CO;2-5; Schoneveld AH, 2008, ATHEROSCLEROSIS, V197, P95, DOI 10.1016/j.atherosclerosis.2007.08.004; TANGIRALA RK, 1994, J LIPID RES, V35, P93; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; TOWATARI T, 1991, FEBS LETT, V280, P311, DOI 10.1016/0014-5793(91)80319-X; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; VanNoorden CJF, 1997, ANAL BIOCHEM, V252, P71, DOI 10.1006/abio.1997.2312; WANG XK, 1995, ATHEROSCLEROSIS, V115, P89, DOI 10.1016/0021-9150(94)05503-B	57	653	679	6	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11765	10.1371/journal.pone.0011765	http://dx.doi.org/10.1371/journal.pone.0011765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668705	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800032
J	Guenard, B; Dunn, RR				Guenard, Benoit; Dunn, Robert R.			A New (Old), Invasive Ant in the Hardwood Forests of Eastern North America and Its Potentially Widespread Impacts	PLOS ONE			English	Article							IMPORTED FIRE ANT; PACHYCONDYLA-CHINENSIS; PHEIDOLE-MEGACEPHALA; SOLENOPSIS-INVICTA; ARGENTINE ANTS; NATIVE ANTS; LINEPITHEMA HUMILE; SEED DISPERSAL; INTRODUCED ANT; ECONOMIC COSTS	Biological invasions represent a serious threat for the conservation of biodiversity in many ecosystems. While many social insect species and in particular ant species have been introduced outside their native ranges, few species have been successful at invading temperate forests. In this study, we document for the first time the relationship between the abundance of the introduced ant, Pachycondyla chinensis, in mature forests of North Carolina and the composition, abundance and diversity of native ant species using both a matched pair approach and generalized linear models. Where present, P. chinensis was more abundant than all native species combined. The diversity and abundance of native ants in general and many individual species were negatively associated with the presence and abundance of P. chinensis. These patterns held regardless of our statistical approach and across spatial scales. Interestingly, while the majority of ant species was strongly and negatively correlated with the abundance and presence of P. chinensis, a small subset of ant species larger than P. chinensis was either as abundant or even more abundant in invaded than in uninvaded sites. The large geographic range of this ant species combined with its apparent impact on native species make it likely to have cascading consequences on eastern forests in years to come, effects mediated by the specifics of its life history which is very different from those of other invasive ants. The apparent ecological impacts of P. chinensis are in addition to public health concerns associated with this species due to its sometimes, deadly sting.	[Guenard, Benoit; Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Guenard, Benoit; Dunn, Robert R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Guenard, B (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	bsguenar@ncsu.edu	Dunn, Robert/B-1360-2013	/0000-0001-6782-917X; Guenard, Benoit/0000-0002-7144-1175; Dunn, Robert/0000-0002-6030-4837	Department of Energy - National Institute for Climate Change Research, DOE-NICCR; Department of Energy [DE-FG02-08ER64510]; NASA [NNX09AK22G]; administration of Historic Yates Mill County Park; Hemlock Bluff Nature Preserve; Schenck Forest	Department of Energy - National Institute for Climate Change Research, DOE-NICCR(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); administration of Historic Yates Mill County Park; Hemlock Bluff Nature Preserve; Schenck Forest	Department of Energy - National Institute for Climate Change Research, DOE-NICCR grant, http://niccr.nau.edu/. Department of Energy - Program for Ecosystem Research, DOE-PER grant DE-FG02-08ER64510, http://www.energy.gov/ NASA award NNX09AK22G, http://www.nasa.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank: Matthew Hamilton, David Bednar, Szabolcs Lengyel and Chris Hirsch for their help in the field and to sort specimens. We also would like to thank the administration of Historic Yates Mill County Park, Hemlock Bluff Nature Preserve, and Schenck Forest for their hospitality and support during our projects. Michael D. Weiser and Sean Menke for valuable discussion and insight. We would like to thank Nathan J. Sanders and Andrew V. Suarez for their valuable comments on the manuscript. Finally, we would like to thank the three anonymous reviewers for their valuable comments and suggestions on this manuscript.	Allen CR, 2004, AM MIDL NAT, V152, P88, DOI 10.1674/0003-0031(2004)152[0088:RIFAIO]2.0.CO;2; Bae GR., 1999, KOREAN J PREVENTIVE, V32, P421; BARONIURBANI C, 1974, ENVIRON ENTOMOL, V3, P755; BEATTIE AJ, 1981, ECOLOGY, V62, P107, DOI 10.2307/1936674; Bestelmeyer Brandon T., 2000, P122; Boer Peter, 2008, Entomologische Berichten (Amsterdam), V68, P121; Carter W. G., 1962, Journal Mitchell Scientific Society Chapel Hill, V78, P150; CARTER WILLIAM G., 1962, JOUR ELISHA MITCHELL SCI SOC, V78, P1; Cho YS, 2002, J ALLERGY CLIN IMMUN, V110, P54, DOI 10.1067/mai.2002.124890; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; CULVER DC, 1978, J ECOL, V66, P53, DOI 10.2307/2259181; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; Deheer CJ, 2004, MOL ECOL, V13, P431, DOI 10.1046/j.1365-294X.2003.2065.x; DUFFY DC, 1992, CONSERV BIOL, V6, P196, DOI 10.1046/j.1523-1739.1992.620196.x; Fowler Harold G., 1992, Ciencia e Cultura (Sao Paulo), V44, P345; Graham JH, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.30; Graham JH, 2008, SOUTHEAST NAT, V7, P429, DOI 10.1656/1528-7092-7.3.429; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; HANDEL SN, 1981, B TORREY BOT CLUB, V108, P430, DOI 10.2307/2484443; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Helms KR, 2001, SOUTHWEST NAT, V46, P396, DOI 10.2307/3672443; Heterick B, 1997, AUST J ECOL, V22, P218, DOI 10.1111/j.1442-9993.1997.tb00661.x; Hoffmann BD, 1999, OECOLOGIA, V120, P595, DOI 10.1007/PL00008824; Hoffmann BD, 2008, BIOL INVASIONS, V10, P1171, DOI 10.1007/s10530-007-9194-x; Holldobler B., 1990, pi; Holway DA, 1998, OECOLOGIA, V116, P252, DOI 10.1007/s004420050586; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holway DA, 2005, BIOL CONSERV, V121, P561, DOI 10.1016/j.biocon.2004.06.005; Holway DA, 1998, OECOLOGIA, V115, P206, DOI 10.1007/s004420050509; HOWARD RW, 1982, ENVIRON ENTOMOL, V11, P1290, DOI 10.1093/ee/11.6.1290; Human KG, 1997, CONSERV BIOL, V11, P1242, DOI 10.1046/j.1523-1739.1997.96264.x; Ivanov K, 2009, ENVIRON ENTOMOL, V38, P1724, DOI 10.1603/022.038.0626; Kennedy TA, 1998, AM MIDL NAT, V140, P343, DOI 10.1674/0003-0031(1998)140[0343:POAIBA]2.0.CO;2; Kim SS, 2001, J ALLERGY CLIN IMMUN, V107, P1095, DOI 10.1067/mai.2001.114341; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; Lach L, 2003, ANN MO BOT GARD, V90, P91, DOI 10.2307/3298529; Lach L, 2008, AUST J ENTOMOL, V47, P275, DOI 10.1111/j.1440-6055.2008.00659.x; Le Breton J, 2003, AUSTRAL ECOL, V28, P204, DOI 10.1046/j.1442-9993.2003.01266.x; Leath TM, 2006, J ALLERGY CLIN IMMUN, V117, pS129, DOI 10.1016/j.jaci.2005.12.517; Lee EK, 2009, CLIN EXP ALLERGY, V39, P602, DOI 10.1111/j.1365-2222.2008.03181.x; Lester PJ, 2005, DIVERS DISTRIB, V11, P279, DOI 10.1111/j.1366-9516.2005.00169.x; Lockwood J, 2005, CONSERV BIOL SER, V8, P365; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; MAC MJ, 1998, STATUES TRENDS NATIO; MacGown J.A., 2009, Midsouth Entomologist, V2, P88; Matsuura K, 2002, BEHAV ECOL SOCIOBIOL, V51, P172, DOI 10.1007/s00265-001-0426-2; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Mitchell CE, 2002, ECOL APPL, V12, P1364, DOI 10.2307/3099977; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; Morrison LW, 2002, ECOLOGY, V83, P2337, DOI 10.1890/0012-9658(2002)083[2337:LTIOAA]2.0.CO;2; Nelder MP, 2006, J MED ENTOMOL, V43, P1094, DOI 10.1603/0022-2585(2006)43[1094:EOTIAP]2.0.CO;2; Ness JH, 2009, OIKOS, V118, P1793, DOI 10.1111/j.1600-0706.2009.17430.x; Ness JH, 2004, BIOL INVASIONS, V6, P445, DOI 10.1023/B:BINV.0000041556.88920.dd; NUHN TP, 1979, AM MIDL NAT, V102, P353, DOI 10.2307/2424662; Ohnishi Y, 2008, ECOL RES, V23, P299, DOI 10.1007/s11284-007-0378-8; Oliva Matthew S., 2005, International Ophthalmology Clinics, V45, P1; Oliver TH, 2008, INSECT CONSERV DIVER, V1, P208, DOI 10.1111/j.1752-4598.2008.00026.x; Orivel J, 2001, ANN ENTOMOL SOC AM, V94, P449, DOI 10.1603/0013-8746(2001)094[0449:RBPMAA]2.0.CO;2; Peck SL, 1998, ENVIRON ENTOMOL, V27, P1102, DOI 10.1093/ee/27.5.1102; Peeters Christian, 1997, P372; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; SANDERS NJ, 2004, SW NAT, V49, P247; Sarty M, 2007, INSECT SOC, V54, P166, DOI 10.1007/s00040-007-0927-8; Smith M. R., 1934, Annals of the Entomological Society of America, V27, P557; SMITH MR, 1947, AM MIDL NAT, V37, P521, DOI 10.2307/2421469; STRUIK GJ, 1965, ECOLOGY, V46, P401, DOI 10.2307/1934873; Stuble KL, 2009, ECOL ENTOMOL, V34, P520, DOI 10.1111/j.1365-2311.2009.01098.x; Suarez AV, 2010, ANT ECOLOGY, P233; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Suarez AV, 2005, P NATL ACAD SCI USA, V102, P17032, DOI 10.1073/pnas.0506119102; Teranishi Y., 1929, ZOOL MAG, V41, P312; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; Ward Philip S., 2000, P99; WARD PS, 1987, HILGARDIA, V55, P1; YASHIRO T, EVOLUTION S IN PRESS; Yun YY, 1999, J ALLERGY CLIN IMMUN, V104, P879, DOI 10.1016/S0091-6749(99)70302-7; Zelikova TJ, 2008, ACTA OECOL, V34, P155, DOI 10.1016/j.actao.2008.05.002	86	50	51	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11614	10.1371/journal.pone.0011614	http://dx.doi.org/10.1371/journal.pone.0011614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657769	Green Published, gold			2022-12-25	WOS:000280197500009
J	Jung, HS; Okegawa, Y; Shih, PM; Kellogg, E; Abdel-Ghany, SE; Pilon, M; Sjolander, K; Shikanai, T; Niyogi, KK				Jung, Hou-Sung; Okegawa, Yuki; Shih, Patrick M.; Kellogg, Elizabeth; Abdel-Ghany, Salah E.; Pilon, Marinus; Sjoelander, Kimmen; Shikanai, Toshiharu; Niyogi, Krishna K.			Arabidopsis thaliana PGR7 Encodes a Conserved Chloroplast Protein That Is Necessary for Efficient Photosynthetic Electron Transport	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHOTOSYSTEM-I; ARABIDOPSIS-THALIANA; XANTHOPHYLL CYCLE; PHYLOGENOMIC INFERENCE; ABSORBENCY CHANGES; LIGHT; FLUORESCENCE; FLOW; PHOTOPROTECTION	A significant fraction of a plant's nuclear genome encodes chloroplast-targeted proteins, many of which are devoted to the assembly and function of the photosynthetic apparatus. Using digital video imaging of chlorophyll fluorescence, we isolated proton gradient regulation 7 (pgr7) as an Arabidopsis thaliana mutant with low nonphotochemical quenching of chlorophyll fluorescence (NPQ). In pgr7, the xanthophyll cycle and the PSBS gene product, previously identified NPQ factors, were still functional, but the efficiency of photosynthetic electron transport was lower than in the wild type. The pgr7 mutant was also smaller in size and had lower chlorophyll content than the wild type in optimal growth conditions. Positional cloning located the pgr7 mutation in the At3g21200 (PGR7) gene, which was predicted to encode a chloroplast protein of unknown function. Chloroplast targeting of PGR7 was confirmed by transient expression of a GFP fusion protein and by stable expression and subcellular localization of an epitope-tagged version of PGR7. Bioinformatic analyses revealed that the PGR7 protein has two domains that are conserved in plants, algae, and bacteria, and the N-terminal domain is predicted to bind a cofactor such as FMN. Thus, we identified PGR7 as a novel, conserved nuclear gene that is necessary for efficient photosynthetic electron transport in chloroplasts of Arabidopsis.	[Jung, Hou-Sung; Shih, Patrick M.; Sjoelander, Kimmen; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Okegawa, Yuki] Kyushu Univ, Grad Sch Agr, Fukuoka 812, Japan; [Okegawa, Yuki; Shikanai, Toshiharu] Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto, Japan; [Kellogg, Elizabeth; Sjoelander, Kimmen] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Abdel-Ghany, Salah E.; Pilon, Marinus] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Kyushu University; Kyoto University; University of California System; University of California Berkeley; Colorado State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Jung, HS (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	niyogi@nature.berkeley.edu	Shikanai, Toshiharu/AAK-9112-2020	Okegawa, Yuki/0000-0001-7712-021X	U.S. Department of Agriculture National Research Initiative [98-35306-6600]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [449A449B]; U.S. National Science Foundation [IBN-0418993, IOS-0847442, 0732065]; JSPS [19-8015, 17GS0316]	U.S. Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Science Foundation(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the U.S. Department of Agriculture National Research Initiative (grant number 98-35306-6600 to K.K.N.) and the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (FWP number 449A449B to K.K.N.), and by the U.S. National Science Foundation (grants IBN-0418993 and IOS-0847442 to M. P. and 0732065 to K. S.) Y.O. and T. S. were supported by a grant-in-aid from JSPS (19-8015 and 17GS0316, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Dytham C, 2003, CHOOSING USING STAT; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GILMORE AM, 1993, PHOTOSYNTH RES, V35, P67, DOI 10.1007/BF02185412; Glanville JG, 2007, NUCLEIC ACIDS RES, V35, pW27, DOI 10.1093/nar/gkm325; Haldrup A, 2003, J BIOL CHEM, V278, P33276, DOI 10.1074/jbc.M305106200; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KLIMYUK VI, 1993, PLANT J, V3, P493, DOI 10.1046/j.1365-313X.1993.t01-26-00999.x; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krishnamurthy N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S12; Krishnamurthy N, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r83; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; LI XP, 2004, J BIOL CHEM; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Muller-Moule P, 2002, PLANT PHYSIOL, V128, P970, DOI 10.1104/pp.010924; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Munekage Y, 2001, PLANT J, V28, P351, DOI 10.1046/j.1365-313X.2001.01178.x; Murakami R, 2002, FEBS LETT, V523, P138, DOI 10.1016/S0014-5793(02)02963-0; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Sjolander K, 2004, BIOINFORMATICS, V20, P170, DOI 10.1093/bioinformatics/bth021; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Varotto C, 2000, PLANT J, V22, P115, DOI 10.1046/j.1365-313x.2000.00717.x; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; Yamazaki H, 2004, PLANT J, V38, P152, DOI 10.1111/j.1365-313X.2004.02035.x	50	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11688	10.1371/journal.pone.0011688	http://dx.doi.org/10.1371/journal.pone.0011688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657737	Green Submitted, Green Published, gold			2022-12-25	WOS:000280197500027
J	Morais, DAD; Harrison, PM				Morais, David A. de Lima; Harrison, Paul M.			Large-Scale Evidence for Conservation of NMD Candidature Across Mammals	PLOS ONE			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; INTRON RETENTION EVENTS; PROTEIN; EXPRESSION; GENOME; GENES; SURVEILLANCE; MUTATIONS; APOPTOSIS	Background: Alternatively-spliced (AS) forms can vary protein function, intracellular localization and post-translational modifications. AS coupled with mRNA nonsense-mediated decay (NMD) can also control the transcript abundance. Here, we have investigated the genome-scale conservation of alternatively-spliced NMD candidates (AS-NMD candidates), in mammals. Methodology/Principal Findings: We mapped >12 million cDNA/EST library transcripts, comprising pooled data from both older and next-generation sequencing techniques, against genomic sequences to annotate AS-NMD candidates generated by in-frame premature termination codons (PTCs), in the human, mouse, rat and cow genomes. In these genomes, we found populations of genes that harbour AS-NMD candidates, varying in number from, similar to 149 to 2,051 genes. We discovered that a highly-significant proportion (27%-35%) of AS-NMD candidate genes in mouse, rat and cow, also have human orthologs targeted for NMD. Intron retention was the most abundant type of AS-NMD, ranging from 43% to 67% of genes harbouring an AS-NMD candidate. Groupings of AS-NMD candidate genes either with or without intron retentions also have highly significant AS-NMD conservation, indicating that the trend is not due primarily to conservation of intron retentions. As a subset, the AS-NMD intron retentions are distinguished from non-retained introns by higher GC content, and codon usage similar to the usage in protein-coding sequences. This indicates that most of these alternatively spliced sequences have coded for proteins in the recent evolutionary past. In general, the AS-NMD candidate genes showed a similar pattern of Gene Ontology functional category enrichments in all four species. Genes linked to nucleic-acid interaction and apoptosis, and involved in pathways linked with cancer, were the most common. Finally, we mapped the AS-NMD candidates to mass spectrometry-derived proteomics data, and gathered evidence of truncated polypeptides for at least 10% of all human AS-NMD candidate transcripts. Conclusions/Significance: In summary, our analysis provides strong statistical evidence for conservation of functional AS-NMD candidature across Mammalia for a large subset of genes. However, because codon usage of AS-NMD intron retentions is similar to the usage in exons, it is difficult to de-couple conservation of AS-NMD-based regulation from conservation for protein-coding ability, for intron retentions.	[Morais, David A. de Lima; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Morais, DAD (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	paul.harrison@mcgill.ca			National Science and Engineering Research Council of Canada; Les Fonds du Quebec de la Recherche and des Technologies	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds du Quebec de la Recherche and des Technologies	This work was funded by the National Science and Engineering Research Council of Canada, and by Les Fonds du Quebec de la Recherche and des Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth C, 2005, NATURE, V438, P726, DOI 10.1038/438726a; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Fewell SW, 1999, MOL CELL BIOL, V19, P826; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hiller M, 2005, NUCLEIC ACIDS RES, V33, P5611, DOI 10.1093/nar/gki870; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KANEHISA M, 2009, NUCL ACIDS RES; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kerem E, 2004, CURR OPIN PULM MED, V10, P547, DOI 10.1097/01.mcp.0000141247.22078.46; Kuenen B C, 2003, Ned Tijdschr Geneeskd, V147, P2044; Kurmangaliyev YZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-13; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Malygin AA, 2007, NUCLEIC ACIDS RES, V35, P6414, DOI 10.1093/nar/gkm701; Mercatante D, 2000, PHARMACOL THERAPEUT, V85, P237, DOI 10.1016/S0163-7258(99)00067-4; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Morais DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-309; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Shi YQ, 2004, EXP CELL RES, V296, P337, DOI 10.1016/j.yexcr.2004.02.009; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stephenson LS, 1996, BIOCHIMIE, V78, P1043, DOI 10.1016/S0300-9084(97)86728-4; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; VIZCAINO JA, NUCL ACIDS RES, V38, pD736; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zavolan M, 2002, GENOME RES, V12, P1377, DOI 10.1101/gr.191702; Zhang ZG, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-23	44	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11695	10.1371/journal.pone.0011695	http://dx.doi.org/10.1371/journal.pone.0011695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657786	Green Published, Green Submitted, gold			2022-12-25	WOS:000280197500032
J	O'Grady, SP; Wende, AR; Remien, CH; Valenzuela, LO; Enright, LE; Chesson, LA; Abel, ED; Cerling, TE; Ehleringer, JR				O'Grady, Shannon P.; Wende, Adam R.; Remien, Christopher H.; Valenzuela, Luciano O.; Enright, Lindsey E.; Chesson, Lesley A.; Abel, E. Dale; Cerling, Thure E.; Ehleringer, James R.			Aberrant Water Homeostasis Detected by Stable Isotope Analysis	PLOS ONE			English	Article							HYDROGEN ISOTOPES; OXYGEN ISOTOPES; BODY-WATER; FRACTIONATION; RATIOS; HAIR; PRECIPITATION; ADAPTATION; PHOSPHATE; TURNOVER	While isotopes are frequently used as tracers in investigations of disease physiology (i.e., (14)C labeled glucose), few studies have examined the impact that disease, and disease-related alterations in metabolism, may have on stable isotope ratios at natural abundance levels. The isotopic composition of body water is heavily influenced by water metabolism and dietary patterns and may provide a platform for disease detection. By utilizing a model of streptozotocin (STZ)-induced diabetes as an index case of aberrant water homeostasis, we demonstrate that untreated diabetes mellitus results in distinct combinations, or signatures, of the hydrogen (delta(2)H) and oxygen (delta(18)O) isotope ratios in body water. Additionally, we show that the delta(2)H and delta(18)O values of body water are correlated with increased water flux, suggesting altered blood osmolality, due to hyperglycemia, as the mechanism behind this correlation. Further, we present a mathematical model describing the impact of water flux on the isotopic composition of body water and compare model predicted values with actual values. These data highlight the importance of factors such as water flux and energy expenditure on predictive models of body water and additionally provide a framework for using naturally occurring stable isotope ratios to monitor diseases that impact water homeostasis.	[O'Grady, Shannon P.; Valenzuela, Luciano O.; Enright, Lindsey E.; Chesson, Lesley A.; Cerling, Thure E.; Ehleringer, James R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Wende, Adam R.; Abel, E. Dale] Div Endocrinol Diabet & Metab, Salt Lake City, UT USA; [Remien, Christopher H.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Valenzuela, Luciano O.; Chesson, Lesley A.; Cerling, Thure E.; Ehleringer, James R.] IsoForensics Inc, Salt Lake City, UT USA; [Cerling, Thure E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	O'Grady, SP (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	ogrady@biology.utah.edu	Wende, Adam/AFG-8878-2022; Ehleringer, James/G-1780-2010	Wende, Adam/0000-0002-5536-4675; Abel, E. Dale/0000-0001-5290-0738; Cerling, Thure/0000-0002-3590-294X; Valenzuela, Luciano/0000-0002-5024-6581	Intelligence Community; Juvenile Diabetes Research Foundation; IsoForensics, Inc.;  [U01HL087947]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087947] Funding Source: NIH RePORTER	Intelligence Community; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); IsoForensics, Inc.; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.P.O. is funded by an Intelligence Community Postdoctoral Fellowship, A. R. W. is funded by a Juvenile Diabetes Research Foundation Advanced Postdoctoral Fellowship, and E. D. A. by U01HL087947. L.O.V., L. A. C., T. E. C. and J.R.E. are partially funded by IsoForensics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AMDCC CONS, 2003, AMDCC PROT, P1; Bowen GJ, 2009, AM J PHYS ANTHROPOL, V139, P494, DOI 10.1002/ajpa.21008; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Chesson LA, 2010, J AGR FOOD CHEM, V58, P2358, DOI 10.1021/jf904151c; Cheung MC, 2009, J SURG RES, V153, P326, DOI 10.1016/j.jss.2008.05.002; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; DANSGAARD W, 1964, TELLUS, V16, P436; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Gretebeck RJ, 1997, J APPL PHYSIOL, V82, P563, DOI 10.1152/jappl.1997.82.2.563; Hobson KA, 2009, J GEOCHEM EXPLOR, V102, P167, DOI 10.1016/j.gexplo.2009.02.007; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Longinelli A., 1980, EUR J MASS SPECTROM, V1, P135; Lu WT, 1998, TRANSPLANT P, V30, P609, DOI 10.1016/S0041-1345(97)01425-5; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Meier-Augenstein W, 2008, SCI JUSTICE, V48, P153, DOI 10.1016/j.scijus.2007.10.010; Pflug K.P., 1979, STABLE ISOTOPES, P553; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Polotsky VY, 2001, AM J RESP CRIT CARE, V163, P624, DOI 10.1164/ajrccm.163.3.2007120; Raman A, 2004, AM J PHYSIOL-RENAL, V286, pF394, DOI 10.1152/ajprenal.00295.2003; Rodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38; Schoeller D.A., 1986, AM J PHYSIOL, V240, P823; Schrier RW, 1997, DIS KIDNEY	26	31	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11699	10.1371/journal.pone.0011699	http://dx.doi.org/10.1371/journal.pone.0011699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657736	Green Submitted, Green Published, gold			2022-12-25	WOS:000280197500036
J	Dai, JX; Hatzakis, E; Hurley, LH; Yang, DZ				Dai, Jixun; Hatzakis, Emmanuel; Hurley, Laurence H.; Yang, Danzhou			I-Motif Structures Formed in the Human c-MYC Promoter Are Highly Dynamic-Insights into Sequence Redundancy and I-Motif Stability	PLOS ONE			English	Article							G-QUADRUPLEX STRUCTURE; NUCLEASE HYPERSENSITIVE ELEMENT; HUMAN TELOMERIC SEQUENCE; RELEVANT G-QUADRUPLEX; POTASSIUM SOLUTION; BURKITT-LYMPHOMA; GENE-EXPRESSION; BREAST-CANCER; CELL-GROWTH; SPIN-ECHO	The GC-rich nuclease hypersensitivity element III1 (NHE III1) of the c-MYC promoter largely controls the transcriptional activity of the c-MYC oncogene. The C-rich strand in this region can form I-motif DNA secondary structures. We determined the folding pattern of the major I-motif formed in the NHE III1, which can be formed at near-neutral pH. While we find that the I-motif formed in the four 3' consecutive runs of cytosines appears to be the most favored, our results demonstrate that the C-rich strand of the c-MYC NHE III1 exhibits a high degree of dynamic equilibration. Using a trisubstituted oligomer of this region, we determined the formation of two equilibrating loop isomers, one of which contains a flipped-out cytosine. Our results indicate that the intercalative cytosine(+)-cytosine base pairs are not always necessary for an intramolecular I-motif. The dynamic character of the c-MYC I-motif is intrinsic to the NHE III1 sequence and appears to provide stability to the c-MYC I-motif.	[Dai, Jixun; Hatzakis, Emmanuel; Hurley, Laurence H.; Yang, Danzhou] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Hurley, Laurence H.; Yang, Danzhou] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; [Hurley, Laurence H.; Yang, Danzhou] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA; [Hurley, Laurence H.; Yang, Danzhou] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; Arizona Center Cancer Care; University of Arizona; University of Arizona	Dai, JX (corresponding author), Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA.	yang@pharmacy.arizona.edu	Dai, Jixun/C-8275-2011; YANG, Dan/HHD-2733-2022; Yang, Danzhou/B-6228-2012	Yang, Danzhou/0000-0001-7489-7111	National Institutes of Health [1S10 RR16659, CA122952]; NATIONAL CANCER INSTITUTE [R01CA122952] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the National Institutes of Health (1S10 RR16659, CA122952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; BERNS EMJJ, 1992, CANCER RES, V52, P1107; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2009, J AM CHEM SOC, V131, P6102, DOI 10.1021/ja900967r; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 1999, MOL CELL BIOL, V19, P1; Freier K, 2003, CANCER RES, V63, P1179; Gallego J, 1997, J MOL BIOL, V273, P840, DOI 10.1006/jmbi.1997.1361; GEHRING K, 1993, NATURE, V363, P561, DOI 10.1038/363561a0; Grand CL, 2002, MOL CANCER THER, V1, P565; Gueron M, 2000, CURR OPIN STRUC BIOL, V10, P326, DOI 10.1016/S0959-440X(00)00091-9; Han XG, 1998, J MOL BIOL, V278, P949, DOI 10.1006/jmbi.1998.1740; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Hurley LH, 2006, SEMIN ONCOL, V33, P498, DOI 10.1053/j.seminoncol.2006.04.012; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Lavelle C, 2008, NAT STRUCT MOL BIOL, V15, P123, DOI 10.1038/nsmb0208-123; LEROY JL, 1995, STRUCTURE, V3, P101, DOI 10.1016/S0969-2126(01)00138-1; Leroy JL, 2003, J MOL BIOL, V333, P125, DOI 10.1016/S0022-2836(03)00945-8; Magrath I, 1990, Adv Cancer Res, V55, P133, DOI 10.1016/S0065-230X(08)60470-4; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Marcu KB, 1997, CURR TOP MICROBIOL, V224, P47; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; NOWELL P, 1983, NATURE, V306, P494, DOI 10.1038/306494a0; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Pelengaris S, 2003, EXPERT OPIN THER TAR, V7, P623, DOI 10.1517/eott.7.5.623.22524; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5; PERTSCHUK LP, 1993, CANCER, V71, P162, DOI 10.1002/1097-0142(19930101)71:1<162::AID-CNCR2820710126>3.0.CO;2-1; Phan AT, 2000, J MOL BIOL, V299, P123, DOI 10.1006/jmbi.2000.3613; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Schlagbauer-Wadl H, 1999, J INVEST DERMATOL, V112, P332, DOI 10.1046/j.1523-1747.1999.00506.x; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 2000, BIOCHEM BIOPH RES CO, V278, P158, DOI 10.1006/bbrc.2000.3783; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; SZEWCZAK AA, 1993, FEBS LETT, V327, P261, DOI 10.1016/0014-5793(93)81000-P; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	50	53	54	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11647	10.1371/journal.pone.0011647	http://dx.doi.org/10.1371/journal.pone.0011647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657837	Green Published, gold, Green Submitted			2022-12-25	WOS:000280065600011
J	Imaizumi, K; Priebe, NJ; Sharpee, TO; Cheung, SW; Schreiner, CE				Imaizumi, Kazuo; Priebe, Nicholas J.; Sharpee, Tatyana O.; Cheung, Steven W.; Schreiner, Christoph E.			Encoding of Temporal Information by Timing, Rate, and Place in Cat Auditory Cortex	PLOS ONE			English	Article							AMPLITUDE-MODULATED SOUNDS; SPECIES-SPECIFIC CALLS; INTERSPIKE INTERVALS; ODOR REPRESENTATIONS; RECEPTIVE-FIELDS; CORTICAL FIELDS; SPIKE PATTERNS; NEURAL CODE; PERIODICITY; SPEECH	A central goal in auditory neuroscience is to understand the neural coding of species-specific communication and human speech sounds. Low-rate repetitive sounds are elemental features of communication sounds, and core auditory cortical regions have been implicated in processing these information-bearing elements. Repetitive sounds could be encoded by at least three neural response properties: 1) the event-locked spike-timing precision, 2) the mean firing rate, and 3) the interspike interval (ISI). To determine how well these response aspects capture information about the repetition rate stimulus, we measured local group responses of cortical neurons in cat anterior auditory field (AAF) to click trains and calculated their mutual information based on these different codes. ISIs of the multiunit responses carried substantially higher information about low repetition rates than either spike-timing precision or firing rate. Combining firing rate and ISI codes was synergistic and captured modestly more repetition information. Spatial distribution analyses showed distinct local clustering properties for each encoding scheme for repetition information indicative of a place code. Diversity in local processing emphasis and distribution of different repetition rate codes across AAF may give rise to concurrent feed-forward processing streams that contribute differently to higher-order sound analysis.	[Imaizumi, Kazuo; Cheung, Steven W.; Schreiner, Christoph E.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, WM Keck Ctr Integrat Neurosci, Coleman Mem Lab, San Francisco, CA 94143 USA; [Imaizumi, Kazuo] Louisiana State Univ Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA USA; [Priebe, Nicholas J.] Univ Texas Austin, Sch Biol Sci, Neurobiol Sect, Austin, TX 78712 USA; [Sharpee, Tatyana O.; Schreiner, Christoph E.] Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; [Sharpee, Tatyana O.] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Austin; University of California System; University of California San Francisco; Salk Institute	Imaizumi, K (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, WM Keck Ctr Integrat Neurosci, Coleman Mem Lab, San Francisco, CA 94143 USA.	kimaiz@lsuhsc.edu; chris@phy.ucsf.edu	Sharpee, Tatyana/E-8663-2010; Imaizumi, Kazuo/U-8586-2019; Imaizumi, Kazuo/R-3892-2019	Imaizumi, Kazuo/0000-0001-7165-9978; Sharpee, Tatyana/0000-0002-7483-5081; Schreiner, Christoph/0000-0002-4571-4328	National Institutes of Health (NIH) [DC-02260, MH-077970, EY019288, MH068904, EY019493]; Veterans Affairs; Hearing Research Inc.; Coleman Memorial Fund; Pew Charitable Trust; Alfred P. Sloan Fellowship; Searle Funds; National Science Foundation (NSF) [IIS-0712852]; McKnight Scholarship; Keck and Ray Thomas Edwards Foundations; Center for Theoretical Biological Physics (NSF) [PHY-0822283]; NATIONAL EYE INSTITUTE [R01EY019288, R01EY019493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970, K25MH068904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Hearing Research Inc.; Coleman Memorial Fund; Pew Charitable Trust; Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Searle Funds; National Science Foundation (NSF)(National Science Foundation (NSF)); McKnight Scholarship; Keck and Ray Thomas Edwards Foundations; Center for Theoretical Biological Physics (NSF); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) grants DC-02260 and MH-077970 to C.E.S., Veterans Affairs Merit Review to S.W.C., as well as Hearing Research Inc., and the Coleman Memorial Fund. N.J.P. was supported by NIH grant EY019288 and the Pew Charitable Trust. T.O.P. was supported by the Alfred P. Sloan Fellowship, the Searle Funds, NIH grants MH068904 and EY019493, National Science Foundation (NSF) grant IIS-0712852, the McKnight Scholarship, the Keck and Ray Thomas Edwards Foundations, and the Center for Theoretical Biological Physics (NSF PHY-0822283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Bieser A, 1996, EXP BRAIN RES, V108, P273; Bizley JK, 2010, J NEUROSCI, V30, P5078, DOI 10.1523/JNEUROSCI.5475-09.2010; Cariani P, 1999, NEURAL PLAST, V6, P147, DOI 10.1155/NP.1999.147; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Cliff A, 1973, SPATIAL AUTOCORRELAT; DEAR SP, 1993, NATURE, V364, P620, DOI 10.1038/364620a0; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2743, DOI 10.1152/jn.1998.80.5.2743; Eggermont JJ, 1996, AUDIT NEUROSCI, V2, P309; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; EGGERMONT JJ, 1993, HEARING RES, V65, P175, DOI 10.1016/0378-5955(93)90212-J; Escabi MA, 2005, J NEUROSCI, V25, P9524, DOI 10.1523/JNEUROSCI.1804-05.2005; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; GOLDBERG JM, 1968, J NEUROPHYSIOL, V31, P539, DOI 10.1152/jn.1968.31.4.639; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hauser M. D., 2003, DESIGN ANIMAL COMMUN; HEFFNER HE, 1984, SCIENCE, V226, P75, DOI 10.1126/science.6474192; Heil P, 1997, J NEUROPHYSIOL, V77, P2616, DOI 10.1152/jn.1997.77.5.2616; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Imaizumi K, 2005, AUDITORY CORTEX: SYNTHESIS OF HUMAN AND ANIMAL RESEARCH, P95; Imaizumi K, 2004, J NEUROPHYSIOL, V92, P444, DOI 10.1152/jn.01173.2003; Imaizumi K, 2007, J NEUROPHYSIOL, V98, P2933, DOI 10.1152/jn.00511.2007; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Krebs B, 2008, J NEUROPHYSIOL, V100, P1602, DOI 10.1152/jn.90374.2008; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; Lee CC, 2004, CEREB CORTEX, V14, P441, DOI 10.1093/cercor/bhh006; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Lundstrom BN, 2006, J NEUROSCI, V26, P9030, DOI 10.1523/JNEUROSCI.0225-06.2006; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Metzner W, 1998, J NEUROSCI, V18, P2283; MOREL A, 1987, J COMP NEUROL, V265, P119, DOI 10.1002/cne.902650109; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Nelken I, 2008, CURR OPIN NEUROBIOL, V18, P413, DOI 10.1016/j.conb.2008.08.014; Nelson ME, 2002, J PHYSIOL-PARIS, V96, P507, DOI 10.1016/S0928-4257(03)00006-8; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Reich DS, 2000, J NEUROSCI, V20, P1964; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; SCHREINER CE, 1986, HEARING RES, V21, P227, DOI 10.1016/0378-5955(86)90221-2; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sincich LC, 2009, J NEUROSCI, V29, P6207, DOI 10.1523/JNEUROSCI.3701-08.2009; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Tan Z.h., 2001, P 7 EUR C SPEECH COM, P473; Theunissen FE, 1998, J NEUROSCI, V18, P3786; TIAN B, 1994, J NEUROPHYSIOL, V71, P1959, DOI 10.1152/jn.1994.71.5.1959; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wong SW, 2003, SPEECH COMMUN, V41, P93, DOI 10.1016/S0167-6393(02)00096-1; Zheng Y, 2008, J NEUROSCI, V28, P14230, DOI 10.1523/JNEUROSCI.2882-08.2008	77	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11531	10.1371/journal.pone.0011531	http://dx.doi.org/10.1371/journal.pone.0011531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657832	Green Published, Green Submitted, gold			2022-12-25	WOS:000280065600002
J	Schulz, K; Rutz, C; Westendorf, C; Ridelis, I; Vogelbein, S; Furkert, J; Schmidt, A; Wiesner, B; Schulein, R				Schulz, Katharina; Rutz, Claudia; Westendorf, Carolin; Ridelis, Ingrid; Vogelbein, Susanne; Furkert, Jens; Schmidt, Antje; Wiesner, Burkhard; Schuelein, Ralf			The Pseudo Signal Peptide of the Corticotropin-releasing Factor Receptor Type 2a Decreases Receptor Expression and Prevents G(i)-mediated Inhibition of Adenylyl Cyclase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-OPIOID RECEPTORS; TRANSLOCATION; STRESS; PROTEINS; MU	The corticotropin-releasing factor receptor type 2a (CRF2(a)R) belongs to the family of G protein-coupled receptors. The receptor possesses an N-terminal pseudo signal peptide that is unable to mediate targeting of the nascent chain to the endoplasmic reticulum membrane during early receptor biogenesis. The pseudo signal peptide remains uncleaved and consequently forms an additional hydrophobic receptor domain with unknown function that is unique within the large G protein-coupled receptor protein family. Here, we have analyzed the functional significance of this domain in comparison with the conventional signal peptide of the homologous corticotropin-releasing factor receptor type 1 (CRF1R). We show that the presence of the pseudo signal peptide leads to a very low cell surface receptor expression of the CRF2(a) R in comparison with the CRF1R. Moreover, whereas the presence of the pseudo signal peptide did not affect coupling to the G(s) protein, G(i)-mediated inhibition of adenylyl cyclase activity was abolished. The properties mediated by the pseudo signal peptide were entirely transferable to the CRF1R in signal peptide exchange experiments. Taken together, our results show that signal peptides do not only influence early protein biogenesis. In the case of the corticotropin-releasing factor receptor subtypes, the use of conventional and pseudo signal peptides have an unexpected influence on signal transduction.	[Schulz, Katharina; Rutz, Claudia; Westendorf, Carolin; Ridelis, Ingrid; Vogelbein, Susanne; Furkert, Jens; Wiesner, Burkhard; Schuelein, Ralf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Schmidt, Antje] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Schulein, R (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	schuelein@fmp-berlin.de			Deutsche Forschungsgemeinschaft [SFB 449]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 449.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Charles AC, 2003, MOL PHARMACOL, V63, P89, DOI 10.1124/mol.63.1.89; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Hauger RL, 2003, PHARMACOL REV, V55, P21, DOI 10.1124/pr.55.1.3; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; Kochl R, 2002, J BIOL CHEM, V277, P16131, DOI 10.1074/jbc.M111674200; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Refojo D, 2009, ANN NY ACAD SCI, V1179, P106, DOI 10.1111/j.1749-6632.2009.04983.x; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sambrook J, 2001, MOL CLONING LAB MANU; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; Valdez GR, 2009, CURR PHARM DESIGN, V15, P1587, DOI 10.2174/138161209788168083; von Heijne G, 1990, CURR OPIN CELL BIOL, V2, P604, DOI 10.1016/0955-0674(90)90100-S; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200	30	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32878	32887		10.1074/jbc.M110.129627	http://dx.doi.org/10.1074/jbc.M110.129627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682782	Green Published, hybrid			2022-12-25	WOS:000283048200025
J	Smagghe, BJ; Huang, PS; Ban, YEA; Baker, D; Springer, TA				Smagghe, Benoit J.; Huang, Po-Ssu; Ban, Yih-En Andrew; Baker, David; Springer, Timothy A.			Modulation of Integrin Activation by an Entropic Spring in the beta-Knee	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; IN-VIVO; AFFINITY; RECEPTOR; PROTEIN; DOMAIN; BINDING; CONFORMATION; SUBUNIT	We show that the length of a loop in the beta-knee, between the first and second cysteines (C1-C2) in integrin EGF-like (I-EGF) domain 2, modulates integrin activation. Three independent sets of mutants, including swaps among different integrin beta-subunits, show that C1-C2 loop lengths of 12 and longer favor the low affinity state and masking of ligand-induced binding site (LIBS) epitopes. Shortening length from 12 to 4 residues progressively increases ligand binding and LIBS epitope exposure. Compared with length, the loop sequence had a smaller effect, which was ascribable to stabilizing loop conformation, and not interactions with the alpha-subunit. The data together with structural calculations support the concept that the C1-C2 loop is an entropic spring and an emerging theme that disordered regions can regulate allostery. Diversity in the length of this loop may have evolved among integrin beta-subunits to adjust the equilibrium between the bent and extended conformations at different set points.	[Smagghe, Benoit J.; Springer, Timothy A.] Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA; [Smagghe, Benoit J.; Springer, Timothy A.] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Huang, Po-Ssu; Ban, Yih-En Andrew; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Huang, Po-Ssu; Ban, Yih-En Andrew; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Springer, TA (corresponding author), Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA.	springer@idi.harvard.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Huang, Possu/0000-0002-7948-2895	National Institutes of Health [HL-48675]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-48675.	Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Mould AP, 2005, J BIOL CHEM, V280, P4238, DOI 10.1074/jbc.M412240200; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Tang RH, 2005, J BIOL CHEM, V280, P29208, DOI 10.1074/jbc.M503239200; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Vanhoorelbeke K, 2009, J BIOL CHEM, V284, P14914, DOI 10.1074/jbc.M809167200; Vomund AN, 2008, BIOCHEMISTRY-US, V47, P11616, DOI 10.1021/bi8015108; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	49	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32954	32966		10.1074/jbc.M110.145177	http://dx.doi.org/10.1074/jbc.M110.145177			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20670939	Green Published, hybrid			2022-12-25	WOS:000283048200033
J	Qiu, H; Yang, B; Pei, ZC; Zhang, Z; Ding, K				Qiu, Hong; Yang, Bo; Pei, Zhi-Chao; Zhang, Zhang; Ding, Kan			WSS25 Inhibits Growth of Xenografted Hepatocellular Cancer Cells in Nude Mice by Disrupting Angiogenesis via Blocking Bone Morphogenetic Protein (BMP)/Smad/Id1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; HEPARAN-SULFATE; BIOLOGICAL-ACTIVITY; TUMOR ANGIOGENESIS; INDUCED ACTIVATION; OVER-EXPRESSION; ID1 EXPRESSION; IN-VITRO; CARCINOMA; ID-1	The highly expressed Id1 (inhibitor of DNA binding/differentiation) protein promotes angiogenesis in HCC and is a well established target for anti-angiogenesis therapeutic strategies. Heparan sulfate (HS) mimetics such as PI-88 can abrogate HS-protein interactions to inhibit angiogenesis. Id1 is the direct downstream effector of bone morphogenetic proteins (BMPs), which are angiogenic and HS-binding proteins. Thus, targeting BMPs by HS mimetics may inhibit angiogenesis via attenuating Id1 expression. We report here that a HS mimetic WSS25 potently inhibited the tube formation of HMEC-1 cells on Matrigel and their migration. Meanwhile, WSS25 (25 mu g/ml) nearly completely blocked Id1 expression in the HMEC-1 cells as demonstrated by oligo-angiogenesis microarray analysis and further confirmed by RT-PCR and Western blotting. BMP/Smad/Id1 signaling also was blocked by WSS25 treatment in HMEC-1 cells. Importantly, Id1 knockdown in HMEC-1 cells caused the disruption of their tube formation on Matrigel. By employing quartz crystal microbalance analysis, we found that WSS25 strongly bound to BMP2. Moreover, WSS25 impaired BMP2-induced tube formation of HMEC-1 cells on Matrigel and angiogenesis in Matrigel transplanted into C57BL6 mice. Furthermore, WSS25 (100 mg/kg) abrogated the growth of HCC cells xenografted in male nude mice. Immunohistochemical analysis showed that both the expression of Id1 and the endothelial cell marker CD31 were lower in the WSS25-treated tumor tissue than in the control. Therefore, WSS25 is a potential drug candidate for HCC therapy as a tumor angiogenesis inhibitor.	[Qiu, Hong; Pei, Zhi-Chao; Zhang, Zhang; Ding, Kan] Chinese Acad Sci, Glycochem & Glycobiol Lab, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Yang, Bo] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ding, Kan] Chinese Acad Sci & Infinitus, Joint Lab Res Chinese Herbal Polysaccharides, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ding, K (corresponding author), 555 Zuchongzhi Rd,Zhangjiang High Tech Pk, Shanghai 201203, Peoples R China.	kding@mail.shcnc.ac.cn	Qiu, Hong/C-5888-2011	Qiu, Hong/0000-0002-4088-7828	National Natural Science Foundation of China [30670470]; National High Technology Research and Development Program (863) of China [2006AA022102]; Shanghai Institute of Materia Medica, Chinese Academy of Sciences [07G604F036]; Chinese Academy of Sciences, China [KSCX1-YW-R-18]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2009ZX09301-001, 2009ZX09103-071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China); Shanghai Institute of Materia Medica, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences, China(Chinese Academy of Sciences); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"	This work was supported by grants from the National Natural Science Foundation of China (30670470); the National High Technology Research and Development Program (863) of China (2006AA022102); the New Drug Research Program of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (07G604F036); the "100 Talents Project" of Chinese Academy of Sciences, China (to K. D.); the Knowledge Innovation Program of Chinese Academy of Sciences (KSCX1-YW-R-18); and the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2009ZX09301-001 and 2009ZX09103-071).	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Doebele RC, 2009, BLOOD, V114, P4592, DOI 10.1182/blood-2009-04-217042; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Jia JH, 2010, PROTEOMICS, V10, P224, DOI 10.1002/pmic.200900607; Kanzaki S, 2008, J CELL PHYSIOL, V216, P844, DOI 10.1002/jcp.21468; Karoli T, 2005, J MED CHEM, V48, P8229, DOI 10.1021/jm050618p; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lee TK, 2006, CLIN CANCER RES, V12, P6910, DOI 10.1158/1078-0432.CCR-06-0489; Lee TKW, 2003, CARCINOGENESIS, V24, P1729, DOI 10.1093/carcin/bgg145; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; MIYAZONO K, 2002, SCI STKE, pPE40; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Parish CR, 1999, CANCER RES, V59, P3433; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Qiu H, 2007, CARBOHYD RES, V342, P2230, DOI 10.1016/j.carres.2007.06.021; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sakurai D, 2004, J IMMUNOL, V173, P5801, DOI 10.4049/jimmunol.173.9.5801; Sun HC, 2004, J CANCER RES CLIN, V130, P307, DOI 10.1007/s00432-003-0530-y; Tam WF, 2008, BLOOD, V112, P1981, DOI 10.1182/blood-2007-07-103010; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; XU YL, 1994, J INVEST DERMATOL, V102, P833, DOI 10.1111/1523-1747.ep12382086	44	44	47	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32638	32646		10.1074/jbc.M110.105544	http://dx.doi.org/10.1074/jbc.M110.105544			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679340	Green Published, hybrid			2022-12-25	WOS:000282683000078
J	Jiang, HB; Jans, R; Xu, W; Rorke, EA; Lin, CY; Chen, YW; Fang, SY; Zhong, YW; Eckert, RL				Jiang, Haibing; Jans, Ralph; Xu, Wen; Rorke, Ellen A.; Lin, Chen-Yong; Chen, Ya-Wen; Fang, Shengyun; Zhong, Yongwang; Eckert, Richard L.			Type I Transglutaminase Accumulation in the Endoplasmic Reticulum May Be an Underlying Cause of Autosomal Recessive Congenital Ichthyosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; STRATIFIED SQUAMOUS EPITHELIA; MEMBRANE ANCHORAGE REGION; CORNIFIED CELL ENVELOPES; CROSS-LINKING ENZYMES; PROLINE-RICH PROTEINS; CHAIN BINDING-PROTEIN; PERMEABILITY BARRIER; TERMINAL DIFFERENTIATION; LAMELLAR ICHTHYOSIS	Type I transglutaminase (TG1) is an enzyme that is responsible for assembly of the keratinocyte cornified envelope. Although TG1 mutation is an underlying cause of autosomal recessive congenital ichthyosis, a debilitating skin disease, the pathogenic mechanism is not completely understood. In the present study we show that TG1 is an endoplasmic reticulum (ER) membrane-associated protein that is trafficked through the ER for ultimate delivery to the plasma membrane. Mutation severely attenuates this processing and a catalytically inactive point mutant, TG1-FLAG(C377A), accumulates in the endoplasmic reticulum and in aggresome-like structures where it is ubiquitinylated. This accumulation results from protein misfolding, as treatment with a chemical chaperone permits it to exit the endoplasmic reticulum and travel to the plasma membrane. ER accumulation is also observed for ichthyosis-associated TG1 mutants. Our findings suggest that misfolding of TG1 mutants leads to ubiquitinylation and accumulation in the ER and aggresomes, and that abnormal intracellular processing of TG1 mutants may be an underlying cause of ichthyosis.	[Jiang, Haibing; Xu, Wen; Rorke, Ellen A.; Lin, Chen-Yong; Chen, Ya-Wen; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Reprod Biol, Baltimore, MD 21201 USA; [Fang, Shengyun; Zhong, Yongwang] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Jans, Ralph] Newcastle Univ, Dept Dermatol Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Newcastle University - UK	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Jans, Ralph/F-2150-2013; Fang, Shengyun/H-3802-2011; Zhong, Yongwang/A-2527-2012	Fang, Shengyun/0000-0001-7280-5463; Chen, Ya-Wen/0000-0003-2382-8444	National Institutes of Health [R01 AR049713]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR049713 (to R.L.E.).	Ahvazi B, 2003, EXP MOL MED, V35, P228, DOI 10.1038/emm.2003.31; Ahvazi B, 2003, J BIOL CHEM, V278, P23834, DOI 10.1074/jbc.M301162200; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BOUTIN JA, 1993, EUR J BIOCHEM, V214, P853, DOI 10.1111/j.1432-1033.1993.tb17989.x; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; BRAAKMAN I, 2001, CURR PROTOC PROTEIN, V14, P1; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Candi E, 1998, J BIOL CHEM, V273, P13693, DOI 10.1074/jbc.273.22.13693; CHAKRAVARTY R, 1990, BIOCHEM J, V271, P25, DOI 10.1042/bj2710025; CHAKRAVARTY R, 1989, J BIOL CHEM, V264, P625; Choate KA, 1998, J INVEST DERMATOL, V110, P8, DOI 10.1046/j.1523-1747.1998.00070.x; Dashti SR, 2001, J BIOL CHEM, V276, P27214, DOI 10.1074/jbc.M100465200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Eckert RL, 2005, PROG EXP TUMOR RES, V38, P115; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; ELIAS PM, 1975, J CELL BIOL, V65, P180, DOI 10.1083/jcb.65.1.180; Farasat S, 2009, J MED GENET, V46, P103, DOI 10.1136/jmg.2008.060905; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Gong B, 2009, MOL VIS, V15, P2829; Gray AC, 2001, TOXICOL IN VITRO, V15, P427, DOI 10.1016/S0887-2333(01)00047-9; GRAYSON S, 1982, J INVEST DERMATOL, V78, P128, DOI 10.1111/1523-1747.ep12505953; Green H, 1980, Harvey Lect, V74, P101; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HENNINGS H, 1981, BIOCHEM BIOPH RES CO, V102, P739, DOI 10.1016/S0006-291X(81)80194-5; Herman ML, 2009, HUM MUTAT, V30, P537, DOI 10.1002/humu.20952; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huber M, 1997, J BIOL CHEM, V272, P21018, DOI 10.1074/jbc.272.34.21018; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; JOSHI HC, 1993, BIOESSAYS, V15, P637, DOI 10.1002/bies.950151002; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; KASTURI L, 1993, EXP CELL RES, V205, P84, DOI 10.1006/excr.1993.1061; KIM SY, 1995, J BIOL CHEM, V270, P18026, DOI 10.1074/jbc.270.30.18026; KIM SY, 1994, J BIOL CHEM, V269, P27979; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Lajemi M, 1997, HISTOCHEM J, V29, P593, DOI 10.1023/A:1026484227851; LISCALJET IM, 2004, HANDBOOD PROTEIN FOL, V3, P73; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; MATOLTSY AG, 1976, J INVEST DERMATOL, V67, P20, DOI 10.1111/1523-1747.ep12512473; MATOLTSY AG, 1955, J BIOPHYS BIOCHEM CY, V1, P191, DOI 10.1083/jcb.1.3.191; MATOLTSY AG, 1966, J INVEST DERMATOL, V46, P127, DOI 10.1038/jid.1966.19; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MICHEL S, 1988, J INVEST DERMATOL, V90, P472, DOI 10.1111/1523-1747.ep12460922; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; NEGI M, 1985, J INVEST DERMATOL, V85, P75, DOI 10.1111/1523-1747.ep12275357; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; OGAWA H, 1976, J BIOL CHEM, V251, P7281; Ohlendieck Kay, 2004, Methods Mol Biol, V244, P283; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pal R, 2010, BIOCHEM BIOPH RES CO, V392, P567, DOI 10.1016/j.bbrc.2010.01.071; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; PHILLIPS MA, 1990, P NATL ACAD SCI USA, V87, P9333, DOI 10.1073/pnas.87.23.9333; PHILLIPS MA, 1993, BIOCHEMISTRY-US, V32, P11057, DOI 10.1021/bi00092a015; PINCUS JH, 1975, ARCH BIOCHEM BIOPHYS, V169, P724, DOI 10.1016/0003-9861(75)90217-9; Planey SL, 2009, MOL BIOL CELL, V20, P1454, DOI 10.1091/mbc.E08-08-0849; POLAKOWSKA RR, 1992, P NATL ACAD SCI USA, V89, P4476, DOI 10.1073/pnas.89.10.4476; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Rice R H, 1988, Adv Exp Med Biol, V231, P51; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; Short B, 2003, CURR BIOL, V13, pR311, DOI 10.1016/S0960-9822(03)00234-3; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SIZEMORE N, 1993, DIFFERENTIATION, V54, P219, DOI 10.1111/j.1432-0436.1993.tb01603.x; Steinert PM, 1999, CELL DEATH DIFFER, V6, P916, DOI 10.1038/sj.cdd.4400568; Steinert PM, 1996, J BIOL CHEM, V271, P26242, DOI 10.1074/jbc.271.42.26242; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; Steinert PM, 1996, BIOCHEM BIOPH RES CO, V221, P101, DOI 10.1006/bbrc.1996.0552; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; STEVEN AC, 1994, J CELL SCI, V107, P693; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Sturniolo MT, 2003, J BIOL CHEM, V278, P48066, DOI 10.1074/jbc.M307215200; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WERTZ PW, 1989, J INVEST DERMATOL, V93, P169, DOI 10.1111/1523-1747.ep12277394; YAFFE MB, 1993, J INVEST DERMATOL, V100, P3, DOI 10.1111/1523-1747.ep12349857; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	91	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31634	31646		10.1074/jbc.M110.128645	http://dx.doi.org/10.1074/jbc.M110.128645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663883	hybrid, Green Published			2022-12-25	WOS:000282764600056
J	Klenk, C; Vetter, T; Zurn, A; Vilardaga, JP; Friedman, PA; Wang, B; Lohse, MJ				Klenk, Christoph; Vetter, Thorsten; Zuern, Alexander; Vilardaga, Jean-Pierre; Friedman, Peter A.; Wang, Bin; Lohse, Martin J.			Formation of a Ternary Complex among NHERF1, beta-Arrestin, and Parathyroid Hormone Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; EXCHANGER REGULATORY FACTOR; PROXIMAL TUBULE CELLS; BETA(2)-ADRENERGIC RECEPTOR; (PTH)/PTH-RELATED PEPTIDE; PHOSPHATE-TRANSPORT; ADENOSINE RECEPTOR; PDZ-DOMAIN; KINASE-C; BINDING	beta-Arrestins are crucial regulators of G-protein coupled receptor (GPCR) signaling, desensitization, and internalization. Despite the long-standing paradigm that agonist-promoted receptor phosphorylation is required for beta-arrestin2 recruitment, emerging evidence suggests that phosphorylation-independent mechanisms play a role in beta-arrestin2 recruitment by GPCRs. Several PDZ proteins are known to interact with GPCRs and serve as cytosolic adaptors to modulate receptor signaling and trafficking. Na+/H+ exchange regulatory factors (NHERFs) exert a major role in GPCR signaling. By combining imaging and biochemical and biophysical methods we investigated the interplay among NHERF1, beta-arrestin2, and the parathyroid hormone receptor type 1 (PTHR). We show that NHERF1 and beta-arrestin2 can independently bind to the PTHR and form a ternary complex in cultured human embryonic kidney cells and Chinese hamster ovary cells. Although NHERF1 interacts constitutively with the PTHR, beta-arrestin2 binding is promoted by receptor activation. NHERF1 interacts directly with beta-arrestin2 without using the PTHR as an interface. Fluorescence resonance energy transfer studies revealed that the kinetics of PTHR and beta-arrestin2 interactions were modulated by NHERF1. These findings suggest a model in which NHERF1 may serve as an adaptor, bringing beta-arrestin2 into close proximity to the PTHR, thereby facilitating beta-arrestin2 recruitment after receptor activation.	[Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Vilardaga, Jean-Pierre] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Vilardaga, Jean-Pierre] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Vilardaga, Jean-Pierre; Friedman, Peter A.; Wang, Bin] Univ Pittsburgh, Sch Med, Lab G Coupled Prot Receptor Biol, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University of Wurzburg; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lohse, MJ (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	lohse@toxi.uni-wuerzburg.de	Klenk, Christoph/E-5158-2014; Lohse, Martin J/A-7160-2012	Klenk, Christoph/0000-0001-5199-7144; Lohse, Martin J/0000-0002-0599-3510; Wang, Bin/0000-0002-5396-6111; Vilardaga, Jean-Pierre/0000-0002-1217-1435	Deutsche Forschungsgemeinschaft; European Research Council; National Institutes of Health [DK54171, DK069998, DK087688]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069998, R01DK054171, R01DK087688] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by grants of the Deutsche Forschungsgemeinschaft and the European Research Council (to M. J. L.). This work was also supported by National Institutes of Health Grants DK54171 and DK069998 (to P. A. F.) and DK087688 (to J.-P. V.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Arslan G, 1999, N-S ARCH PHARMACOL, V359, P28, DOI 10.1007/PL00005319; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Castro M, 2002, ENDOCRINOLOGY, V143, P3854, DOI 10.1210/en.2002-220232; Clark RB, 2003, MOL PHARMACOL, V64, P1015, DOI 10.1124/mol.64.5.1015; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; DUZIC E, 1992, J BIOL CHEM, V267, P24045; Ferrari SL, 2001, MOL ENDOCRINOL, V15, P149, DOI 10.1210/me.15.1.149; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Gardella T J, 2000, Rev Endocr Metab Disord, V1, P317, DOI 10.1023/A:1026522619828; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Offermanns S, 1996, MOL ENDOCRINOL, V10, P566, DOI 10.1210/me.10.5.566; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; Raman D, 1999, BIOCHEMISTRY-US, V38, P5117, DOI 10.1021/bi9824588; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Trifilieff A, 2002, BRIT J PHARMACOL, V135, P1655, DOI 10.1038/sj.bjp.0704616; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Vilardaga JP, 2001, J BIOL CHEM, V276, P33435, DOI 10.1074/jbc.M011495200; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Watson C, 2000, MOL PHARMACOL, V58, P1230, DOI 10.1124/mol.58.6.1230; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200	42	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30355	30362		10.1074/jbc.M110.114900	http://dx.doi.org/10.1074/jbc.M110.114900			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20656684	Green Published, hybrid			2022-12-25	WOS:000281984300071
J	Pereira, PM; Marques, JP; Soares, AR; Carreto, L; Santos, MAS				Pereira, Patricia M.; Marques, Joao Paulo; Soares, Ana R.; Carreto, Laura; Santos, Manuel A. S.			MicroRNA Expression Variability in Human Cervical Tissues	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; DOWN-REGULATION; CANCER; GENES; CARCINOMA; PROFILES; SIGNATURES; NEOPLASIA; PATTERNS	MicroRNAs (miRNAs) are short (similar to 22 nt) non-coding regulatory RNAs that control gene expression at the post-transcriptional level. Deregulation of miRNA expression has been discovered in a wide variety of tumours and it is now clear that they contribute to cancer development and progression. Cervical cancer is one of the most common cancers in women worldwide and there is a strong need for a non-invasive, fast and efficient method to diagnose the disease. We investigated miRNA expression profiles in cervical cancer using a microarray platform containing probes for mature miRNAs. We have evaluated miRNA expression profiles of a heterogeneous set of cervical tissues from 25 different patients. This set included 19 normal cervical tissues, 4 squamous cell carcinoma, 5 high-grade squamous intraepithelial lesion (HSIL) and 9 low-grade squamous intraepithelial lesion (LSIL) samples. We observed high variability in miRNA expression especially among normal cervical samples, which prevented us from obtaining a unique miRNA expression signature for this tumour type. However, deregulated miRNAs were identified in malignant and pre-malignant cervical tissues after tackling the high expression variability observed. We were also able to identify putative target genes of relevant candidate miRNAs. Our results show that miRNA expression shows natural variability among human samples, which complicates miRNA data profiling analysis. However, such expression noise can be filtered and does not prevent the identification of deregulated miRNAs that play a role in the malignant transformation of cervical squamous cells. Deregulated miRNAs highlight new candidate gene targets allowing for a better understanding of the molecular mechanism underlying the development of this tumour type.	[Pereira, Patricia M.; Soares, Ana R.; Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal; [Pereira, Patricia M.; Soares, Ana R.; Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Marques, Joao Paulo] Univ Coimbra, Fac Med, CIMAGO, Coimbra, Portugal; [Soares, Ana R.] Ctr Neurosci, Expt Biol & Biomed PhD Program, Coimbra, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra; Universidade de Coimbra	Pereira, PM (corresponding author), Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal.	msantos@ua.pt	Santos, Manuel/E-6704-2010; Soares, Ana RSCM/G-7331-2014	Santos, Manuel/0000-0002-0437-1146; Soares, Ana RSCM/0000-0003-4000-7461; Pereira, Patricia/0000-0002-4828-7632	Portuguese Foundation for Science and Technology (FCT); Calouste Gulbenkian Foundation/CIMAGO; FCT/FEDER [PTDC/BIA-BCM/64745/2006]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/64745/2006] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Calouste Gulbenkian Foundation/CIMAGO; FCT/FEDER(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	PMP and ARS are supported by the Portuguese Foundation for Science and Technology (FCT). This project was funded by Calouste Gulbenkian Foundation/CIMAGO and FCT/FEDER Project Ref: PTDC/BIA-BCM/64745/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Alami Y, 1999, BIOCHEM BIOPH RES CO, V257, P738, DOI 10.1006/bbrc.1999.0516; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATESHEN C, 2002, NAT REV CANCER, V2, P777; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cantile M, 2003, EUR J CANCER, V39, P257, DOI 10.1016/S0959-8049(02)00599-3; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; HAKAMA M, 2008, EUR J CANC; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kohno T, 1998, GENE CHROMOSOME CANC, V21, P236, DOI 10.1002/(SICI)1098-2264(199803)21:3<236::AID-GCC8>3.0.CO;2-0; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Mutirangura A, 1998, INT J CANCER, V78, P153, DOI 10.1002/(SICI)1097-0215(19981005)78:2<153::AID-IJC5>3.0.CO;2-Y; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nowak J, 2009, MOL BIOL CELL, V20, P870, DOI 10.1091/mbc.E08-07-0671; Pett MR, 2006, P NATL ACAD SCI USA, V103, P3822, DOI 10.1073/pnas.0600078103; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Stoler MH, 2000, INT J GYNECOL PATHOL, V19, P16, DOI 10.1097/00004347-200001000-00004; Thomison J, 2008, HUM PATHOL, V39, P154, DOI 10.1016/j.humpath.2007.11.002; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	44	139	145	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11780	10.1371/journal.pone.0011780	http://dx.doi.org/10.1371/journal.pone.0011780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668671	Green Published, gold			2022-12-25	WOS:000280297300015
J	Akieda-Asai, S; Zaima, N; Ikegami, K; Kahyo, T; Yao, I; Hatanaka, T; Iemura, S; Sugiyama, R; Yokozeki, T; Eishi, Y; Koike, M; Ikeda, K; Chiba, T; Yamaza, H; Shimokawa, I; Song, SY; Matsuno, A; Mizutani, A; Sawabe, M; Chao, MV; Tanaka, M; Kanaho, Y; Natsume, T; Sugimura, H; Date, Y; McBurney, MW; Guarente, L; Setou, M				Akieda-Asai, Sayaka; Zaima, Nobuhiro; Ikegami, Koji; Kahyo, Tomoaki; Yao, Ikuko; Hatanaka, Takahiro; Iemura, Shun-ichiro; Sugiyama, Rika; Yokozeki, Takeaki; Eishi, Yoshinobu; Koike, Morio; Ikeda, Kyoji; Chiba, Takuya; Yamaza, Haruyoshi; Shimokawa, Isao; Song, Si-Young; Matsuno, Akira; Mizutani, Akiko; Sawabe, Motoji; Chao, Moses V.; Tanaka, Masashi; Kanaho, Yasunori; Natsume, Tohru; Sugimura, Haruhiko; Date, Yukari; McBurney, Michael W.; Guarente, Leonard; Setou, Mitsutoshi			SIRT1 Regulates Thyroid-Stimulating Hormone Release by Enhancing PIP5K gamma Activity through Deacetylation of Specific Lysine Residues in Mammals	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; CALORIE RESTRICTION; INSULIN SENSITIVITY; LONGEVITY PROTEIN; INCREASED DOSAGE; LIFE-SPAN; GH3 CELL; RECEPTOR; THYROTROPIN; MICE	Background: SIRT1, a NAD-dependent deacetylase, has diverse roles in a variety of organs such as regulation of endocrine function and metabolism. However, it remains to be addressed how it regulates hormone release there. Methodology/Principal Findings: Here, we report that SIRT1 is abundantly expressed in pituitary thyrotropes and regulates thyroid hormone secretion. Manipulation of SIRT1 level revealed that SIRT1 positively regulated the exocytosis of TSH-containing granules. Using LC/MS-based interactomics, phosphatidylinositol-4-phosphate 5-kinase (PIP5K) c was identified as a SIRT1 binding partner and deacetylation substrate. SIRT1 deacetylated two specific lysine residues (K265/K268) in PIP5K gamma and enhanced PIP5K gamma enzyme activity. SIRT1-mediated TSH secretion was abolished by PIP5K gamma knockdown. SIRT1 knockdown decreased the levels of deacetylated PIP5K gamma, PI(4,5) P-2, and reduced the secretion of TSH from pituitary cells. These results were also observed in SIRT1-knockout mice. Conclusions/Significance: Our findings indicated that the control of TSH release by the SIRT1-PIP5K gamma pathway is important for regulating the metabolism of the whole body.	[Akieda-Asai, Sayaka; Date, Yukari] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan; [Akieda-Asai, Sayaka; Zaima, Nobuhiro; Ikegami, Koji; Kahyo, Tomoaki; Yao, Ikuko; Hatanaka, Takahiro; Song, Si-Young; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan; [Zaima, Nobuhiro; Ikegami, Koji; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Shizuoka, Japan; [Kahyo, Tomoaki; Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Pathol, Shizuoka, Japan; [Yao, Ikuko] Kansai Med Univ, Dept Med Chem, Osaka, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan; [Sugiyama, Rika; Yokozeki, Takeaki; Kanaho, Yasunori] Univ Tsukuba, Dept Physiol Chem, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Sugiyama, Rika; Yokozeki, Takeaki; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Ibaraki, Japan; [Eishi, Yoshinobu; Koike, Morio] Tokyo Med & Dent Univ, Dept Human Pathol, Tokyo, Japan; [Ikeda, Kyoji] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Res Inst, Aichi, Japan; [Chiba, Takuya; Yamaza, Haruyoshi; Shimokawa, Isao] Nagasaki Univ, Grad Sch Biomed Sci, Dept Investigat Pathol, Nagasaki 852, Japan; [Yamaza, Haruyoshi] Kyushu Univ, Sect Pediat Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan; [Matsuno, Akira] Teikyo Univ Chica Med Ctr, Dept Neurosurg, Chiba, Japan; [Mizutani, Akiko] Tokai Univ, Sch Med, Hiratsuka, Kanagawa 25912, Japan; [Sawabe, Motoji] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Sawabe, Motoji] Tokyo Metropolitan Geriatr Hosp, Bioresource Ctr Geriatr Res, Tokyo 173, Japan; [Sawabe, Motoji] Inst Gerontol, Tokyo, Japan; [Chao, Moses V.] NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY USA; [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [McBurney, Michael W.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [McBurney, Michael W.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Guarente, Leonard] MIT, Dept Biol, Cambridge, MA USA	University of Miyazaki; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kansai Medical University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tsukuba; Tokyo Medical & Dental University (TMDU); National Center for Geriatrics & Gerontology; Nagasaki University; Kyushu University; Teikyo University; Tokai University; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; New York University; Tokyo Metropolitan Institute of Gerontology; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Massachusetts Institute of Technology (MIT)	Akieda-Asai, S (corresponding author), Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan.	setou@hama-med.ac.jp	Natsume, Tohru/M-7627-2018; Eishi, Yoshinobu/N-3602-2017; Yamaza, Haruyoshi/AAD-4011-2019	Natsume, Tohru/0000-0002-1510-2582; Eishi, Yoshinobu/0000-0002-0521-1670; Yamaza, Haruyoshi/0000-0003-1138-3943; Chao, Moses/0000-0002-6969-3744	Mitsubishi Kagaku Institute of Life Sciences and WAKATE S for Scientific Research	Mitsubishi Kagaku Institute of Life Sciences and WAKATE S for Scientific Research	This study was supported by the Mitsubishi Kagaku Institute of Life Sciences and WAKATE S for Scientific Research to M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, J CLIN INVEST, V107, P1017, DOI 10.1172/JCI10858; Allison SJ, 2009, AGING-US, V1, P316, DOI 10.18632/aging.100028; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Asai S, 2006, ENDOCRINE, V30, P161, DOI 10.1385/ENDO:30:2:161; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blagosklonny MV, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.17; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Castellino AM, 1997, J BIOL CHEM, V272, P5861, DOI 10.1074/jbc.272.9.5861; Chubb SAP, 2005, J CLIN ENDOCR METAB, V90, P5317, DOI 10.1210/jc.2005-0298; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gary KA, 2003, J PHARMACOL EXP THER, V305, P410, DOI 10.1124/jpet.102.044040; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; ISHII K, 1998, ENG DESIGN AUTOMATIO, V4, P5; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Letinic K, 2009, P NATL ACAD SCI USA, V106, P11342, DOI 10.1073/pnas.0904244106; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Matsuno A, 2005, J HISTOCHEM CYTOCHEM, V53, P1177, DOI 10.1369/jhc.5B6708.2005; Matsuno A, 2008, FOLIA HISTOCHEM CYTO, V46, P419, DOI 10.2478/v10042-008-0069-5; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nikrodhanond AA, 2006, J BIOL CHEM, V281, P5000, DOI 10.1074/jbc.M511530200; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Renz M, 2000, J BIOL CHEM, V275, P10429, DOI 10.1074/jbc.275.14.10429; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SCHALLY AV, 1978, ANNU REV BIOCHEM, V47, P89, DOI 10.1146/annurev.bi.47.070178.000513; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shin DJ, 2003, J BIOL CHEM, V278, P34114, DOI 10.1074/jbc.M305417200; Shindler KS, 1996, J HISTOCHEM CYTOCHEM, V44, P1331, DOI 10.1177/44.11.8918908; Stace C, 2008, ADV ENZYME REGUL, V48, P55, DOI 10.1016/j.advenzreg.2007.11.008; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Swayze RD, 2001, J BIOL CHEM, V276, P19729, DOI 10.1074/jbc.M005711200; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; THOTAKURA NR, 1995, GLYCOBIOLOGY, V5, P3, DOI 10.1093/glycob/5.1.3; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vinciguerra M, 2010, AGING-US, V2, P43; Weiss RE, 1997, ENDOCRINOLOGY, V138, P3624, DOI 10.1210/en.138.9.3624; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	71	36	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11755	10.1371/journal.pone.0011755	http://dx.doi.org/10.1371/journal.pone.0011755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668706	gold, Green Published, Green Submitted			2022-12-25	WOS:000280243800024
J	McMillan, DJ; Bessen, DE; Pinho, M; Ford, C; Hall, GS; Melo-Cristino, J; Ramirez, M				McMillan, David J.; Bessen, Debra E.; Pinho, Marcos; Ford, Candace; Hall, Gerod S.; Melo-Cristino, Jose; Ramirez, Mario			Population Genetics of Streptococcus dysgalactiae Subspecies equisimilis Reveals Widely Dispersed Clones and Extensive Recombination	PLOS ONE			English	Article							GROUP-A; GROUP-C; HORIZONTAL TRANSFER; PYOGENES; EMM; EVOLUTION; STRAINS; DISEASE; PROTEIN; EBURST	Background: Streptococcus dysgalactiae subspecies equisimilis (SDSE) is an emerging global pathogen that can colonize and infect humans. Although most SDSE isolates possess the Lancefield group G carbohydrate, a significant minority have the group C carbohydrate. Isolates are further sub-typed on the basis of differences within the emm gene. To gain a better understanding of their molecular epidemiology and evolutionary relationships, multilocus sequence typing (MLST) analysis was performed on SDSE isolates collected from Australia, Europe and North America. Methodology/Principal Findings: The 178 SDSE isolates, representing 37 emm types, segregate into 80 distinct sequence types (STs) that form 17 clonal complexes (CCs). Eight STs recovered from all three continents account for >50% of the isolates. Thus, a small number of STs are highly prevalent and have a wide geographic distribution. Both ST and CC strongly correlate with group carbohydrate. In contrast, eleven STs were associated with >1 emm type, suggestive of recombinational replacements involving the emm gene; furthermore, 35% of the emm types are associated with genetically distant STs. Data also reveal a history of extensive inter-and intra-species recombination involving the housekeeping genes used for MLST. Sequence analysis of single locus variants identified through goeBURST indicates that genetic change mediated by recombination occurred similar to 4.4 times more frequently than by point mutation. Conclusions/Significance: A few genetic lineages with an intercontinental distribution dominate among SDSE causing infections in humans. The distinction between group C and G isolates reflects recent evolution, and no long-term genetic isolation between them was found. Lateral gene transfer and recombination involving housekeeping genes and the emm gene are important mechanisms driving genetic variability in the SDSE population.	[McMillan, David J.] Queensland Inst Med Res, Bacterial Pathogenesis Lab, Herston, Qld 4006, Australia; [McMillan, David J.] Griffith Med Res Coll, Herston, Qld, Australia; [Bessen, Debra E.; Ford, Candace; Hall, Gerod S.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Pinho, Marcos; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Inst Microbiol, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal	QIMR Berghofer Medical Research Institute; Griffith University; New York Medical College; Universidade de Lisboa	McMillan, DJ (corresponding author), Queensland Inst Med Res, Bacterial Pathogenesis Lab, Bramston Terrace, Herston, Qld 4006, Australia.	debra_bessen@nymc.edu	Melo-Cristino, Jose A G/H-3726-2013; McMillan, David/P-5582-2016; Ramirez, Mario/B-4993-2008; Pinho, Marcos D/E-5834-2019	Melo-Cristino, Jose A G/0000-0001-8643-1722; McMillan, David/0000-0002-9339-0639; Ramirez, Mario/0000-0002-4084-6233; Pinho, Marcos D/0000-0002-4298-0014	Australian Government; National Institutes of Health [AI-065572, GM-060793]; Fundao para a Cincia e a Tecnologia [PTDC/SAU-ESA/72321/2006]; Fundao Calouste Gulbenkian, Portugal; Glaxo Smithkline, Portugal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060793] Funding Source: NIH RePORTER	Australian Government(Australian GovernmentCGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundao para a Cincia e a Tecnologia; Fundao Calouste Gulbenkian, Portugal; Glaxo Smithkline, Portugal(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DM is supported by an Australian Government NHMRC Program grant and NHMRC Project grant. DEB received support from the National Institutes of Health (AI-065572; GM-060793). Work conducted by MR was supported in part by Fundao para a Cincia e a Tecnologia (PTDC/SAU-ESA/72321/2006), Fundao Calouste Gulbenkian, Portugal and from an unrestricted grant from Glaxo Smithkline, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, J CLIN MICROBIOL, V47, P2046, DOI 10.1128/JCM.00246-09; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; BENNASR A, 1994, EUR J BIOCHEM, V222, P267, DOI 10.1111/j.1432-1033.1994.tb18865.x; Bessen DE, 2005, J BACTERIOL, V187, P4163, DOI 10.1128/JB.187.12.4163-4172.2005; BESSEN DE, 2010, FUTURE MICR IN PRESS; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Bramhachari PV, 2010, J MED MICROBIOL, V59, P220, DOI 10.1099/jmm.0.015644-0; Broyles LN, 2009, CLIN INFECT DIS, V48, P706, DOI 10.1086/597035; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Chhatwal G. S., 2006, Gram-positive pathogens, P213; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Davies MR, 2007, CLIN INFECT DIS, V44, P1442, DOI 10.1086/516780; Efstratiou A, 1997, J APPL MICROBIOL, V83, pS72, DOI 10.1046/j.1365-2672.83.s1.8.x; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; Humar D, 2002, LANCET, V359, P124, DOI 10.1016/S0140-6736(02)07371-3; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Igwe EI, 2003, FEMS MICROBIOL LETT, V229, P259, DOI 10.1016/S0378-1097(03)00842-5; Ikebe T, 2004, EPIDEMIOL INFECT, V132, P145, DOI 10.1017/S0950268803001262; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Korman TM, 2004, J CLIN MICROBIOL, V42, P2866, DOI 10.1128/JCM.42.6.2866-2869.2004; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; McDonald M, 2007, EMERG INFECT DIS, V13, P1694, DOI 10.3201/eid1311.061258; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; Panchaud A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-198; Pinho MD, 2006, J CLIN MICROBIOL, V44, P841, DOI 10.1128/JCM.44.3.841-846.2006; PINHO MD, ANTIMICROB IN PRESS; Sakota V, 2006, J CLIN MICROBIOL, V44, P2160, DOI 10.1128/JCM.02456-05; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; SIMPSON WJ, 1992, INFECT IMMUN, V60, P1890, DOI 10.1128/IAI.60.5.1890-1893.1992; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka D, 2008, J CLIN MICROBIOL, V46, P1526, DOI 10.1128/JCM.02188-07; Towers RJ, 2004, J CLIN MICROBIOL, V42, P5357, DOI 10.1128/JCM.42.11.5357-5361.2004; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Woo PCY, 2001, J CLIN MICROBIOL, V39, P3147, DOI 10.1128/JCM.39.9.3147-3155.2001	46	41	42	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11741	10.1371/journal.pone.0011741	http://dx.doi.org/10.1371/journal.pone.0011741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668530	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800015
J	Aguilar-Yanes, JM; Portillo-Lara, R; Mendoza-Ochoa, GI; Garcia-Echauri, SA; Lopes-Pacheco, F; Bulnes-Abundis, D; Salgado-Gallegos, J; Lara-Mayorga, IM; Webb-Vargas, Y; Leon-Angel, FO; Rivero-Aranda, RE; Oropeza-Almazan, Y; Ruiz-Palacios, GM; Zertuche-Guerra, MI; DuBois, RM; White, SW; Schultz-Cherry, S; Russell, CJ; Alvarez, MM				Aguilar-Yanes, Jose M.; Portillo-Lara, Roberto; Mendoza-Ochoa, Gonzalo I.; Garcia-Echauri, Sergio A.; Lopes-Pacheco, Felipe; Bulnes-Abundis, David; Salgado-Gallegos, Johari; Lara-Mayorga, Itzel M.; Webb-Vargas, Yenny; Leon-Angel, Felipe O.; Rivero-Aranda, Ramon E.; Oropeza-Almazan, Yuriana; Ruiz-Palacios, Guillermo M.; Zertuche-Guerra, Manuel I.; DuBois, Rebecca M.; White, Stephen W.; Schultz-Cherry, Stacey; Russell, Charles J.; Alvarez, Mario M.			An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli	PLOS ONE			English	Article							SIZE-DISTRIBUTION ANALYSIS; VIRUS HEMAGGLUTININ; ANTIGENIC STRUCTURE; RECEPTOR-BINDING; CELL CULTURE; H5N1 VIRUS; PROTEINS; PATHOGENESIS; EXPRESSION; ANTIBODY	Background: The A/H1N1/2009 influenza pandemic made evident the need for faster and higher-yield methods for the production of influenza vaccines. Platforms based on virus culture in mammalian or insect cells are currently under investigation. Alternatively, expression of fragments of the hemagglutinin (HA) protein in prokaryotic systems can potentially be the most efficacious strategy for the manufacture of large quantities of influenza vaccine in a short period of time. Despite experimental evidence on the immunogenic potential of HA protein constructs expressed in bacteria, it is still generally accepted that glycosylation should be a requirement for vaccine efficacy. Methodology/Principal Findings: We expressed the globular HA receptor binding domain, referred to here as HA(63-286)-RBD, of the influenza A/H1N1/2009 virus in Escherichia coli using a simple, robust and scalable process. The recombinant protein was refolded and purified from the insoluble fraction of the cellular lysate as a single species. Recombinant HA(63-286)-RBD appears to be properly folded, as shown by analytical ultracentrifugation and bio-recognition assays. It binds specifically to serum antibodies from influenza A/H1N1/2009 patients and was found to be immunogenic, to be capable of triggering the production of neutralizing antibodies, and to have protective activity in the ferret model. Conclusions/Significance: Projections based on our production/purification data indicate that this strategy could yield up to half a billion doses of vaccine per month in a medium-scale pharmaceutical production facility equipped for bacterial culture. Also, our findings demonstrate that glycosylation is not a mandatory requirement for influenza vaccine efficacy.	[Aguilar-Yanes, Jose M.; Portillo-Lara, Roberto; Mendoza-Ochoa, Gonzalo I.; Garcia-Echauri, Sergio A.; Lopes-Pacheco, Felipe; Bulnes-Abundis, David; Salgado-Gallegos, Johari; Lara-Mayorga, Itzel M.; Webb-Vargas, Yenny; Leon-Angel, Felipe O.; Rivero-Aranda, Ramon E.; Oropeza-Almazan, Yuriana; Ruiz-Palacios, Guillermo M.; Zertuche-Guerra, Manuel I.; Alvarez, Mario M.] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Mexico; [DuBois, Rebecca M.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Schultz-Cherry, Stacey; Russell, Charles J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN USA	Tecnologico de Monterrey; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Aguilar-Yanes, JM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Mexico.	mario.alvarez@itesm.mx	Schultz-Cherry, Stacey/N-2506-2018; Oropeza-Almazan, Yuriana/AAS-5240-2021; Russell, Charles/K-4824-2013; Russell, Charles/AAU-6006-2020; White, Stephen W/N-8164-2018; Portillo-Lara, Roberto/AAX-5002-2020; Ruiz-Palacios, Guillermo/GYQ-5462-2022	Russell, Charles/0000-0001-5683-3990; Russell, Charles/0000-0001-5683-3990; Portillo-Lara, Roberto/0000-0002-1781-3126; Aguilar-Yanez, Jose M/0000-0002-8590-9111; Mendoza-Ochoa, Gonzalo I/0000-0002-7361-8915; Lara Mayorga, Itzel Montserrat/0000-0001-5444-5177; Alvarez, Mario Moises/0000-0002-9131-5344; DuBois, Rebecca/0000-0003-4185-5673; Garcia, Sergio/0000-0001-8738-7356; Oropeza-Almazan, Yuriana/0000-0003-0387-3686	Zambrano-Hellion family; FEMSA; Tecnologico de Monterrey [CAT-122]; National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200700005C]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities (ALSAC); Childrens Infection Defense Center (CIDC) at St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	Zambrano-Hellion family; FEMSA; Tecnologico de Monterrey; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Center; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Childrens Infection Defense Center (CIDC) at St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Zambrano-Hellion family, FEMSA, and Tecnologico de Monterrey (seed fund CAT-122). This work was also funded by the National Institutes of Health, National Institute of Allergy and Infectious Diseases, under contract number HHSN266200700005C, Cancer Center core grant CA21765, the American Lebanese Syrian Associated Charities (ALSAC), and the Childrens Infection Defense Center (CIDC) at St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010176; BALBO A, 2007, CURR PROTOC IMMUNOL, V18, P1; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Berhanu A, 2008, J VIROL, V82, P3517, DOI 10.1128/JVI.01854-07; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; DAVIS AR, 1981, P NATL ACAD SCI-BIOL, V78, P5376, DOI 10.1073/pnas.78.9.5376; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Fang M, 2006, VIROLOGY, V345, P231, DOI 10.1016/j.virol.2005.09.056; Fedson DS, 2008, BIOLOGICALS, V36, P346, DOI 10.1016/j.biologicals.2008.07.001; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; HIDAYATULLAH TA, 2009, INT J INTEGRATIVE BI, V6, P137; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; King JC, 2009, VACCINE, V27, P6589, DOI 10.1016/j.vaccine.2009.08.032; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LIU J, 2008, Patent No. 20080286850; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Paal M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-7; Panda AK, 2003, ADV BIOCHEM ENG BIOT, V85, P43; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwahn AB, 2009, J IMMUNOASS IMMUNOCH, V30, P245, DOI 10.1080/15321810903084350; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Szymczakiewicz-Multanowska A, 2009, J INFECT DIS, V200, P841, DOI 10.1086/605505; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; World Health Organization, 2009, CDC PROT REALT RTPCR; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	51	39	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11694	10.1371/journal.pone.0011694	http://dx.doi.org/10.1371/journal.pone.0011694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661476	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243300006
J	Jahan, I; Pan, N; Kersigo, J; Fritzsch, B				Jahan, Israt; Pan, Ning; Kersigo, Jennifer; Fritzsch, Bernd			Neurod1 Suppresses Hair Cell Differentiation in Ear Ganglia and Regulates Hair Cell Subtype Development in the Cochlea	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SENSORY EPITHELIA; NULL MICE; AUDITORY NEURONS; MATH1; GENE; SPECIFICATION; INNERVATION; FATE; SOX2	Background: At least five bHLH genes regulate cell fate determination and differentiation of sensory neurons, hair cells and supporting cells in the mammalian inner ear. Cross-regulation of Atoh1 and Neurog1 results in hair cell changes in Neurog1 null mice although the nature and mechanism of the cross-regulation has not yet been determined. Neurod1, regulated by both Neurog1 and Atoh1, could be the mediator of this cross-regulation. Methodology/Principal Findings: We used Tg(Pax2-Cre) to conditionally delete Neurod1 in the inner ear. Our data demonstrate for the first time that the absence of Neurod1 results in formation of hair cells within the inner ear sensory ganglia. Three cell types, neural crest derived Schwann cells and mesenchyme derived fibroblasts (neither expresses Neurod1) and inner ear derived neurons (which express Neurod1) constitute inner ear ganglia. The most parsimonious explanation is that Neurod1 suppresses the alternative fate of sensory neurons to develop as hair cells. In the absence of Neurod1, Atoh1 is expressed and differentiates cells within the ganglion into hair cells. We followed up on this effect in ganglia by demonstrating that Neurod1 also regulates differentiation of subtypes of hair cells in the organ of Corti. We show that in Neurod1 conditional null mice there is a premature expression of several genes in the apex of the developing cochlea and outer hair cells are transformed into inner hair cells. Conclusions/Significance: Our data suggest that the long noted cross-regulation of Atoh1 expression by Neurog1 might actually be mediated in large part by Neurod1. We suggest that Neurod1 is regulated by both Neurog1 and Atoh1 and provides a negative feedback for either gene. Through this and other feedback, Neurod1 suppresses alternate fates of neurons to differentiate as hair cells and regulates hair cell subtypes.	[Jahan, Israt; Pan, Ning; Kersigo, Jennifer; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Jahan, I (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu		Fritzsch, Bernd/0000-0002-4882-8398	NIH [R01 DC 005590]; CLAS; OVPR of the University of Iowa; Roy. J. Carver foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590, P30DC010362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLAS; OVPR of the University of Iowa; Roy. J. Carver foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a NIH grant (R01 DC 005590) to B. F. The support of CLAS and OVPR of the University of Iowa is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We like to thank Drs. K.-A. Nave and S. Goebbels, Max-Planck-Institute of Experimental Medicine, for providing the floxed Neurod1 mice used for this study and Drs. T. Ohyama and A. Groves for providing the Pax2-Cre line. The Leica TCS SP5 confocal microscope was purchased in part with a grant from the Roy. J. Carver foundation. We thank CLAS and the Office of the Vice President for Research (OVPR) for support. We wish to thank the following people for providing plasmids for in situ hybridization: Atoh1; Dr. Zoghbi; Neurog1, Dr. Ma; Fgf8, Dr. Pirvola; Pou4f3, Dr. Xiang; Nhlh1 and Nhlh2, Dr. Braun; Sox2, Dr. Cheah.	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Beisel K, 2008, CELL TISSUE RES, V333, P373, DOI 10.1007/s00441-008-0639-z; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chen P, 2002, DEVELOPMENT, V129, P2495; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; DELCERRO M, 1980, MICROSC ACTA, V83, P117; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Fritzsch B, 2000, NEUROREPORT, V11, pR35, DOI 10.1097/00001756-200011270-00013; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; FRITZSCH B, 2010, CMLSE IN PRESS; Fritzsch B., 2006, INT J COMP PSYCHOL, V19, P1; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Goebbels S, 2005, GENESIS, V42, P247, DOI 10.1002/gene.20138; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Hayashi T, 2008, J NEUROSCI, V28, P5991, DOI 10.1523/JNEUROSCI.1690-08.2008; Hayashi T, 2010, DEV DYNAM, V239, P1019, DOI 10.1002/dvdy.22236; Huang EJ, 2001, DEVELOPMENT, V128, P2421; JAHAN I, 2010, CELL TISSUE IN PRESS; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; Keithley EM, 1999, HEARING RES, V134, P71, DOI 10.1016/S0378-5955(99)00070-2; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly M, 2007, INT J DEV BIOL, V51, P535, DOI 10.1387/ijdb.072344mk; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kim WY, 2001, DEVELOPMENT, V128, P417; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Kruger M, 2006, EUR J NEUROSCI, V24, P1581, DOI 10.1111/j.1460-9568.2006.05051.x; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Matei VA, 2006, BRAIN RES BULL, V70, P33, DOI 10.1016/j.brainresbull.2005.11.007; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Ohyama T, 2007, INT J DEV BIOL, V51, P463, DOI 10.1387/ijdb.072320to; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pan N, 2009, CELL TISSUE RES, V337, P407, DOI 10.1007/s00441-009-0826-6; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Ray SK, 2007, MOL CELL BIOL, V27, P7839, DOI 10.1128/MCB.00438-07; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ryan AF, 2009, ADV OTO-RHINO-LARYNG, V66, P99, DOI 10.1159/000218210; Satoh T, 2005, DEVELOPMENT, V132, P1687, DOI 10.1242/dev.01730; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Sekerkova G, 2008, J COMP NEUROL, V509, P661, DOI 10.1002/cne.21755; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Xia AP, 2007, JARO-J ASSOC RES OTO, V8, P447, DOI 10.1007/s10162-007-0092-9; Xiang MQ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-2; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	76	98	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11661	10.1371/journal.pone.0011661	http://dx.doi.org/10.1371/journal.pone.0011661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661473	gold, Green Submitted, Green Published			2022-12-25	WOS:000280243300003
J	Szajnik, M; Czystowska, M; Szczepanski, MJ; Mandapathil, M; Whiteside, TL				Szajnik, Marta; Czystowska, Malgorzata; Szczepanski, Miroslaw J.; Mandapathil, Magis; Whiteside, Theresa L.			Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; OVARIAN-CANCER; NECK-CANCER; ENDOTHELIAL-CELLS; MEMBRANE-VESICLES; FAS LIGAND; EXOSOMES; HEAD; APOPTOSIS; MICROENVIRONMENT	Background: Tumor-derived microvesicles (TMV) or exosomes are present in body fluids of patients with cancer and might be involved in tumor progression. The frequency and suppressor functions of peripheral blood CD4(+)CD25(high)FOXP3(+) Treg are higher in patients with cancer than normal controls. The hypothesis is tested that TMV contribute to induction/expansion/and activation of human Treg. Methodology/Principal Findings: TMV isolated from supernatants of tumor cells but not normal cells induced the generation and enhanced expansion of human Treg. TMV also mediated conversion of CD4(+)CD25(neg) T cells into CD4(+)CD25(high)FOXP3(+) Treg. Upon co-incubation with TMV, Treg showed an increased FasL, IL-10, TGF-beta 1, CTLA-4, granzyme B and perforin expression (p < 0.05) and mediated stronger suppression of responder cell (RC) proliferation (p < 0.01). Purified Treg were resistant to TMV-mediated apoptosis relative to other T cells. TMV also increased phospho-SMAD2/3 and phospho-STAT3 expression in Treg. Neutralizing Abs specific for TGF-beta 1 and/or IL-10 significantly inhibited TMV ability to expand Treg. Conclusions/Significance: This study suggests that TMV have immunoregulatory properties. They induce Treg, promote Treg expansion, up-regulate Treg suppressor function and enhance Treg resistance to apoptosis. Interactions of TMV with Treg represent a newly-defined mechanism that might be involved in regulating peripheral tolerance by tumors and in supporting immune evasion of human cancers.	[Szajnik, Marta; Czystowska, Malgorzata; Szczepanski, Miroslaw J.; Mandapathil, Magis; Whiteside, Theresa L.] Univ Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whiteside, TL (corresponding author), Univ Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA.	whitesidetl@upmc.edu	Czystowska-Kuźmicz, Małgorzata/ABH-3220-2020; Czystowska-Kuźmicz, Małgorzata/U-7933-2018; Mandapathil, Magis/AFL-3260-2022; Czystowska-Kuzmicz, Malgorzata/AAC-6989-2020	Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; 	National Institutes of Health [PO1 CA109688]; Heidi L. Browning Ovarian Cancer Research Fund; National Heart Lung Blood Institute [NO1-HB37165]; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heidi L. Browning Ovarian Cancer Research Fund; National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health grant PO1 CA109688 (TLW) and Heidi L. Browning Ovarian Cancer Research Fund. Dr. Szajnik was supported by the National Heart Lung Blood Institute grant NO1-HB37165 (TLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2003, CANCER RES, V63, P5573; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Barry OP, 1997, J CLIN INVEST, V99, P2118, DOI 10.1172/JCI119385; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; Bergmann C, 2009, HEAD NECK-J SCI SPEC, V31, P371, DOI 10.1002/hed.20968; Castellana D, 2009, CANCER RES, V69, P785, DOI 10.1158/0008-5472.CAN-08-1946; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Czystowska M, 2009, CELL DEATH DIFFER, V16, P708, DOI 10.1038/cdd.2008.197; CZYSTOWSKA M, 2010, J MOL MED IN PRESS; Dolo V, 2000, BBA-MOL CELL BIOL L, V1486, P265, DOI 10.1016/S1388-1981(00)00063-9; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mandapathil M, 2009, CLIN CANCER RES, V15, P6348, DOI 10.1158/1078-0432.CCR-09-1143; Millimaggi D, 2007, NEOPLASIA, V9, P349, DOI 10.1593/neo.07133; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Whiteside TL, 2005, CANCER METAST REV, V24, P95, DOI 10.1007/s10555-005-5050-6; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; WHITESIDE TL, 2007, REV CANC BIOL THERAP, P89; Wieckowski EU, 2009, J IMMUNOL, V183, P3720, DOI 10.4049/jimmunol.0900970; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Woo EY, 2001, CANCER RES, V61, P4766	46	311	327	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11469	10.1371/journal.pone.0011469	http://dx.doi.org/10.1371/journal.pone.0011469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661468	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000280243300001
J	Kraft, P; Schwarz, T; Meijers, JCM; Stoll, G; Kleinschnitz, C				Kraft, Peter; Schwarz, Tobias; Meijers, Joost C. M.; Stoll, Guido; Kleinschnitz, Christoph			Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CARBOXYPEPTIDASE-B; MYOCARDIAL-INFARCTION; PROCARBOXYPEPTIDASE-U; INCREASED RISK; INFLAMMATION; GENE; IDENTIFICATION; POLYMORPHISMS; THROMBOLYSIS	Background: Thrombus formation is a key step in the pathophysiology of acute ischemic stroke and results from the activation of the coagulation cascade. Thrombin plays a central role in this coagulation system and contributes to thrombus stability via activation of thrombin-activatable fibrinolysis inhibitor (TAFIa). TAFIa counteracts endogenous fibrinolysis at different stages and elevated TAFI levels are a risk factor for thrombotic events including ischemic stroke. Although substantial in vitro data on the influence of TAFI on the coagulation-fibrinolysis-system exist, investigations on the consequences of TAFI inhibition in animal models of cerebral ischemia are still lacking. In the present study we analyzed stroke development and post stroke functional outcome in TAFI(-/-) mice. Methodology/Principal Findings: TAFI(-/-) mice and wild-type controls were subjected to 60 min transient middle cerebral artery occlusion (tMCAO) using the intraluminal filament method. After 24 hours, functional outcome scores were assessed and infarct volumes were measured from 2,3,5- Triphenyltetrazoliumchloride (TTC)-stained brain slices. Hematoxylin and eosin (H&E) staining was used to estimate the extent of neuronal cell damage. Thrombus formation within the infarcted brain areas was analyzed by immunoblot. Infarct volumes and functional outcomes did not significantly differ between TAFI(-/-) mice and controls (p>0.05). Histology revealed extensive ischemic neuronal damage regularly including the cortex and the basal ganglia in both groups. TAFI deficiency also had no influence on intracerebral fibrin(ogen) formation after tMCAO. Conclusion: Our study shows that TAFI does not play a major role for thrombus formation and neuronal degeneration after ischemic brain challenge.	[Kraft, Peter; Schwarz, Tobias; Stoll, Guido; Kleinschnitz, Christoph] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Wurzburg; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kraft, P (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.	christoph.kleinschnitz@mail.uni-wuerzburg.de	Meijers, J.C.M./S-5981-2019	Meijers, J.C.M./0000-0002-4198-6780	Deutsche Forschungsgemeinschaft [SFB 688]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB 688 (TP B1 to GS and A13 to CK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Boffa MB, 2007, CLIN BIOCHEM, V40, P431, DOI 10.1016/j.clinbiochem.2006.10.020; Bouckaert M, 2009, NAT REV NEUROL, V5, P477, DOI 10.1038/nrneurol.2009.116; Bouma BN, 2003, J THROMB HAEMOST, V1, P1566, DOI 10.1046/j.1538-7836.2003.00329.x; Brouns R, 2010, J THROMB HAEMOST, V8, P75, DOI 10.1111/j.1538-7836.2009.03663.x; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P165, DOI 10.1016/j.clineuro.2008.09.002; Colucci M, 2010, J THROMB HAEMOST, V8, P50; Colucci M, 2001, THROMB HAEMOSTASIS, V85, P661; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; de Bruijne ELE, 2009, J THROMB HAEMOST, V7, P919, DOI 10.1111/j.1538-7836.2009.03350.x; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Edwards MT, 1999, AM J NEURORADIOL, V20, P1682; EIKELBOOM JW, 2010, J THROMB HA IN PRESS; Franco RF, 2001, HAEMATOLOGICA, V86, P510; Hankey GJ, 2010, LANCET NEUROL, V9, P273, DOI 10.1016/S1474-4422(10)70038-7; Henry M, 2001, BLOOD, V97, P2053, DOI 10.1182/blood.V97.7.2053; Juhan-Vague I, 2002, ARTERIOSCL THROM VAS, V22, P867, DOI 10.1161/01.ATV.0000015445.22243.F4; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kozian DH, 2010, THROMB HAEMOSTASIS, V103, P976, DOI 10.1160/TH09-10-0682; Leebeek FWG, 2005, J THROMB HAEMOST, V3, P2211, DOI 10.1111/j.1538-7836.2005.01484.x; Leung LLK, 2008, ADV EXP MED BIOL, V632, P61, DOI 10.1007/978-0-387-78952-1_5; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; Mao SS, 2005, BLOOD COAGUL FIBRIN, V16, P407, DOI 10.1097/01.mbc.0000181175.62437.2a; Marti-Fabregas J, 2009, CEREBROVASC DIS, V27, P111, DOI 10.1159/000200448; Meltzer ME, 2009, HAEMATOL-HEMATOL J, V94, P811, DOI 10.3324/haematol.2008.002386; Montaner J, 2003, STROKE, V34, P1038, DOI 10.1161/01.STR.0000063139.06585.45; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; MORSER J, 2010, J THROMB HA IN PRESS; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nagashima M, 2002, J CLIN INVEST, V109, P101, DOI 10.1172/JCI12119; Rooth E, 2007, BLOOD COAGUL FIBRIN, V18, P365, DOI 10.1097/MBC.0b013e3281139c34; Santamaria A, 2003, STROKE, V34, P2387, DOI 10.1161/01.STR.0000088642.07691.15; Silveira A, 2000, THROMB HAEMOSTASIS, V84, P364; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Swaisgood CM, 2002, J CLIN INVEST, V110, P1275, DOI 10.1172/JCI200215082; van den Berg JSP, 2009, ACTA NEUROL SCAND, V120, P157, DOI 10.1111/j.1600-0404.2008.01140.x; van der Worp HB, 2005, J NEUROL, V252, P1108, DOI 10.1007/s00415-005-0802-3; van Tilburg NH, 2000, BLOOD, V95, P2855, DOI 10.1182/blood.V95.9.2855.009k02_2855_2859; Velde EAT, 2003, J THROMB HAEMOST, V1, P2087, DOI 10.1046/j.1538-7836.2003.00404.x	46	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11658	10.1371/journal.pone.0011658	http://dx.doi.org/10.1371/journal.pone.0011658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657835	Green Published, Green Submitted, gold			2022-12-25	WOS:000280065600019
J	Faustova, M; Sacherova, V; Sheets, HD; Svensson, JE; Taylor, DJ				Faustova, Marketa; Sacherova, Veronika; Sheets, H. David; Svensson, Jan-Erik; Taylor, Derek J.			Coexisting Cyclic Parthenogens Comprise a Holocene Species Flock in Eubosmina	PLOS ONE			English	Article							LONGISPINA LEYDIG CRUSTACEA; MORPHOLOGICAL VARIATION; CLADOCERA; HISTORY; POPULATIONS; DAPHNIA; EVOLUTION; RADIATION; COMPLEX; SEE	Background: Mixed breeding systems with extended clonal phases and weak sexual recruitment are widespread in nature but often thought to impede the formation of discrete evolutionary clusters. Thus, cyclic parthenogens, such as cladocerans and rotifers, could be predisposed to "species problems'' and a lack of discrete species. However, species flocks have been proposed for one cladoceran group, Eubosmina, where putative species are sympatric, and there is a detailed paleolimnological record indicating a Holocene age. These factors make the Eubosmina system suitable for testing the hypotheses that extended clonal phases and weak sexual recruitment inhibit speciation. Although common garden experiments have revealed a genetic component to the morphotypic variation, the evolutionary significance of the morphotypes remains controversial. Methodology/Principal Findings: In the present study, we tested the hypothesis of a single polymorphic species (i.e., mixing occurs but selection maintains genes for morphology) in four northern European lakes where the morphotypes coexist. Our evidence is based on nuclear DNA sequence, mitochondrial DNA sequence, and morphometric analysis of coexisting morphotypes. We found significant genetic differentiation, genealogical exclusivity, and morphometric differentiation for coexisting morphotypes. Conclusions: We conclude that the studied morphotypes represent a group of young species undergoing speciation with apparent reproductive barriers despite coexistence in the freshwater pelagic zone.	[Faustova, Marketa; Taylor, Derek J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Faustova, Marketa; Sacherova, Veronika] Charles Univ Prague, Dept Ecol, Prague, Czech Republic; [Sheets, H. David] Canisius Coll, Dept Phys, Buffalo, NY 14208 USA; [Svensson, Jan-Erik] Univ Coll Boras, Sch Engn, Boras, Sweden; [Svensson, Jan-Erik] Medins Biol AB, Molnlycke, Sweden	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Charles University Prague; University of Boras	Faustova, M (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	marfaustova@hotmail.com	Sacherová, Veronika/AAE-7237-2019; Sacherova, Veronika/M-4805-2017	Sacherova, Veronika/0000-0003-2311-8346	National Science Foundation [0331095]; Czech Ministry of Education [MSM0021620828]; Swedish Environmental Protection Agency [dnr 3094664-06 Nv]	National Science Foundation(National Science Foundation (NSF)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Swedish Environmental Protection Agency	Major research funding was provided by the National Science Foundation (DEB grant 0331095 to DJT). Additional research funding was provided by the Czech Ministry of Education (project MSM0021620828) to VS and MF and the Swedish Environmental Protection Agency (dnr 3094664-06 Nv) to J-ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2004, ZOOL J LINN SOC-LOND, V140, P171, DOI 10.1111/j.1096-3642.2003.00089.x; Adamowicz SJ, 2002, MOL ECOL, V11, P1209, DOI 10.1046/j.1365-294X.2002.01517.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Barraclough TG, 2003, EVOLUTION, V57, P2166; Bell Graham, 2009, P46; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; Bookstein F., 1996, IMAGE FUSION SHAPE V, P79; Bookstein FL, 1997, MED IMAGE ANAL, V1, P225, DOI DOI 10.1016/S1361-8415(97)85012-8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyne JA, 2004, SPECIATION, V37; Cristescu MEA, 2002, J EVOLUTION BIOL, V15, P838, DOI 10.1046/j.1420-9101.2002.00466.x; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Elmer KR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-60; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisk DL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-22; Flossner D, 1972, CRUSTACEA, P1; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Frey D. G., 1958, Archiv fuer Hydrobiologie, V54, P209; FREY DG, 1960, ECOLOGY, V41, P684, DOI 10.2307/1931802; FREY DG, 1962, J PALEONTOL, V36, P1133; FREY DG, 1962, JAPAN SOC LIMNOLOGY, V23, P145; FUTUYMA DJ, 2008, EVOLUTION, V62, P2446; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Goulden C. E., 1964, Archiv fuer Hydrobiologie, V60, P1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUNTHER J, 1993, INT REV GES HYDROBIO, V78, P1, DOI 10.1002/iroh.19930780102; Haney RA, 2003, J EVOLUTION BIOL, V16, P871, DOI 10.1046/j.1420-9101.2003.00594.x; Hellsten M, 1999, OECOLOGIA, V118, P23, DOI 10.1007/s004420050699; HELLSTEN ME, 1995, HYDROBIOLOGIA, V312, P1, DOI 10.1007/BF00018881; Hellsten ME, 2000, HYDROBIOLOGIA, V421, P157, DOI 10.1023/A:1003975203884; HOFMANN W, 1991, HYDROBIOLOGIA, V225, P81, DOI 10.1007/BF00028387; HOFMANN W, 1986, HYDROBIOLOGIA, V143, P119, DOI 10.1007/BF00026653; HOFMANN W, 1984, Z ZOOL SYST EVOL, V22, P294; HOFMANN W, 1987, HYDROBIOLOGIA, V145, P315, DOI 10.1007/BF02530293; HOFMANN W, 1977, ARCH HYDROBIOL, V80, P349; HOFMANN W, 1984, SCHWEIZ Z HYDROL, V46, P139, DOI 10.1007/BF02538104; HOFMANN W, 1978, Polskie Archiwum Hydrobiologii, V25, P167; HOFMANN W, 1987, J PLANKTON RES, V9, P381, DOI 10.1093/plankt/9.2.381; Hofmann Wolfgang, 1993, Lecture Notes in Earth Sciences, V49, P393; Hofmann Wolfgang, 1994, Faunistisch-Oekologische Mitteilungen, V6, P479; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; JOHNSEN GH, 1987, J PLANKTON RES, V9, P297, DOI 10.1093/plankt/9.2.297; Kerfoot WC, 2006, ARCH HYDROBIOL, V167, P147, DOI 10.1127/0003-9136/2006/0167-0147; KERFOOT WC, 1981, ECOLOGY, V62, P216, DOI 10.2307/1936683; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Lagergren R, 2000, FUNCT ECOL, V14, P380, DOI 10.1046/j.1365-2435.2000.00433.x; Lagergren R, 2000, J PLANKTON RES, V22, P1213, DOI 10.1093/plankt/22.6.1213; LIEDER U, 1996, SUSSWASSERFAUNA MITT, V8, P1; Lilljeborg W., 1901, N A REG SOC SCI UPSA, V19, P1; Little TJ, 1997, P ROY SOC B-BIOL SCI, V264, P1363, DOI 10.1098/rspb.1997.0189; LYNCH M, 1984, EVOLUTION, V38, P465, DOI 10.1111/j.1558-5646.1984.tb00312.x; Lynch M., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P3116; Maemets A, 1996, HYDROBIOLOGIA, V338, P105, DOI 10.1007/BF00031714; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mayr E., 1963, ANIMAL SPECIES EVOLU, pxiv; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; MORRAN L, 2009, NATURE, V462, P294; NAUWERCK A, 1978, ARCH HYDROBIOL, V82, P387; NAUWERCK A, 1991, HYDROBIOLOGIA, V225, P87, DOI 10.1007/BF00028388; NILSSEN JP, 1980, INT REV GES HYDROBIO, V65, P507, DOI 10.1002/iroh.19800650408; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Ritz MS, 2008, MOL PHYLOGENET EVOL, V49, P292, DOI 10.1016/j.ympev.2008.07.014; ROHLF F, 2004, TPSDIG 2 0; Sampson PD, 1996, NATO ADV SCI INST SE, V284, P211; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Shan R. K.c., 1969, Hydrobiologia, V34, P513; SHEETS HD, 2005, IMP SERIES SOFTWARE; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; TAYLOR DJ, 1992, LIMNOL OCEANOGR, V37, P658, DOI 10.4319/lo.1992.37.3.0658; Taylor DJ, 1999, P ROY SOC B-BIOL SCI, V266, P791, DOI 10.1098/rspb.1999.0707; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zink RM, 2002, AUK, V119, P864, DOI 10.1642/0004-8038(2002)119[0864:ANPOTE]2.0.CO;2	75	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11623	10.1371/journal.pone.0011623	http://dx.doi.org/10.1371/journal.pone.0011623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661283	Green Published, Green Submitted, gold			2022-12-25	WOS:000279980800012
J	Straud, S; Zubovych, I; de Brabander, JK; Roth, MG				Straud, Sarah; Zubovych, Iryna; de Brabander, Jef K.; Roth, Michael G.			Inhibition of Iron Uptake Is Responsible for Differential Sensitivity to V-ATPase Inhibitors in Several Cancer Cell Lines	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; ENDOPLASMIC-RETICULUM STRESS; CHOLESTEROL-METABOLISM; PROTON PUMP; PATHWAY; ALDOLASE; RECEPTOR; DISTINCT; PH; CHEMORESISTANCE	Many cell lines derived from tumors as well as transformed cell lines are far more sensitive to V-ATPase inhibitors than normal counterparts. The molecular mechanisms underlying these differences in sensitivity are not known. Using global gene expression data, we show that the most sensitive responses to HeLa cells to low doses of V-ATPase inhibitors involve genes responsive to decreasing intracellular iron or decreasing cholesterol and that sensitivity to iron uptake is an important determinant of V-ATPase sensitivity in several cancer cell lines. One of the most sensitive cell lines, melanoma derived SK-Mel-5, over-expresses the iron efflux transporter ferroportin and has decreased expression of proteins involved in iron uptake, suggesting that it actively suppresses cytoplasmic iron. SK-Mel-5 cells have increased production of reactive oxygen species and may be seeking to limit additional production of ROS by iron.	[Straud, Sarah; Zubovych, Iryna; de Brabander, Jef K.; Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Straud, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	michael.roth@utsouthwestern.edu		Roth, Michael/0000-0002-9056-332X	National Cancer Institute (NCI) [CA095471, CA09349]; National Institutes of Health (NIH) [5P30 AR41940]; Robert A. Welch Foundation [I-1422]; National Center for Research Resources (NCRR) [C06-RR15437]; NATIONAL CANCER INSTITUTE [P01CA095471, F32CA009349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041940] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants CA095471 and CA09349 from the National Cancer Institute (NCI), 5P30 AR41940 from the National Institutes of Health (NIH) and grant I-1422 from the Robert A. Welch Foundation. The research was conducted in a facility constructed with support from Research Facilities Improvement Program Grants C06-RR15437 from the National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruick RK, 2002, SCIENCE, V295, P807, DOI 10.1126/science.1069825; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Jean JC, 2006, AM J PHYSIOL-LUNG C, V291, pL950, DOI 10.1152/ajplung.00087.2006; Kida Y, 2001, HISTOCHEM CELL BIOL, V115, P189; Kim JW, 1999, J ORG CHEM, V64, P153, DOI 10.1021/jo9814997; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Porciuncula LO, 2003, NEUROREPORT, V14, P577, DOI 10.1097/01.wnr.0000060833.03650.f7; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; Scheel AA, 1996, BIOCHEMISTRY-US, V35, P10203, DOI 10.1021/bi960807x; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Yamada S, 2006, BIOCHEM BIOPH RES CO, V343, P1079, DOI 10.1016/j.bbrc.2006.03.051; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023	35	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11629	10.1371/journal.pone.0011629	http://dx.doi.org/10.1371/journal.pone.0011629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661293	Green Published, Green Submitted, gold			2022-12-25	WOS:000279980800017
J	Neumann, J; Schaale, K; Farhat, K; Endermann, T; Ulmer, AJ; Ehlers, S; Reiling, N				Neumann, Jan; Schaale, Kolja; Farhat, Katja; Endermann, Tobias; Ulmer, Artur J.; Ehlers, Stefan; Reiling, Norbert			Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages	FASEB JOURNAL			English	Article						innate immunity; Wnt signaling; inflammation	TOLL-LIKE RECEPTORS; BETA-CATENIN; SIGNALING PATHWAY; EPITHELIAL-CELLS; IN-VIVO; EXPRESSION; PROTEIN; ALPHA; RECOGNITION; DISEASE	Wnt/Frizzled signaling, essential for embryonic development, has also recently been implicated in the modulation of inflammatory processes. In the current study, we observed a reciprocal regulation of the Toll-like receptor (TLR)/nuclear factor-kappa B (NF-kappa B) and the Wnt/beta-catenin pathway after aerosol infection of mice with Mycobacterium tuberculosis: whereas proinflammatory mediators were substantially increased, beta-catenin signaling was significantly reduced. A systematic screen of Fzd homologs in infected mice identified Fzd1 mRNA to be significantly up-regulated during the course of infection. In vitro infection of murine macrophages led to a strong induction of Fzd1 that was dependent on TLRs, the myeloid differentiation response gene 88 (MyD88), and a functional NF-kappa B pathway. Flow cytometry demonstrated an elevated Fzd1 expression on macrophages in response to M. tuberculosis that was synergistically enhanced in the presence of IFN-gamma. Addition of the Fzd1 ligand Wnt3a induced Wnt/beta-catenin signaling in murine macrophages that was inhibited in the presence of a soluble Fzd1/Fc fusion protein. Furthermore, Wnt3a reduced TNF release, suggesting that Wnt3a promotes anti-inflammatory functions in murine macrophages. The current data support the notion that evolutionarily conserved Wnt/Fzd signaling is involved in balancing the inflammatory response to microbial stimulation of innate immune cells of vertebrate origin.-Neumann, J., Schaale, K., Farhat, K., Endermann, T., Ulmer, A. J., Ehlers, S., Reiling, N. Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J. 24, 4599-4612 (2010). www.fasebj.org	[Neumann, Jan; Schaale, Kolja; Endermann, Tobias; Reiling, Norbert] Leibniz Ctr Med & Biosci, Div Microbial Interface Biol, Res Ctr Borstel, D-23845 Borstel, Germany; [Farhat, Katja; Ulmer, Artur J.] Leibniz Ctr Med & Biosci, Div Cellular Immunol, Res Ctr Borstel, D-23845 Borstel, Germany; [Ehlers, Stefan] Univ Kiel, Kiel, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; University of Kiel	Reiling, N (corresponding author), Leibniz Ctr Med & Biosci, Div Microbial Interface Biol, Res Ctr Borstel, Pk Allee 22, D-23845 Borstel, Germany.	nreiling@fz-borstel.de	Schaale, Kolja/J-1587-2014; Ehlers, Stefan/B-4075-2010; Reiling, Norbert/D-6796-2013	Schaale, Kolja/0000-0002-4768-4652; Reiling, Norbert/0000-0001-6673-4291	Deutsche Forschungsgemeinschaft [SFB 415-C7, EXC306]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft grants SFB 415-C7 and EXC306 to N.R. and S.E. The authors declare that they have no conflicting financial interests. The authors gratefully acknowledge K. Kopp, K. Seeger, S. Kroger, and L. Dost for expert technical assistance.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Carayol N, 2002, AM J RESP CELL MOL, V26, P341, DOI 10.1165/ajrcmb.26.3.4684; Chacon MA, 2008, J CELL PHYSIOL, V217, P215, DOI 10.1002/jcp.21497; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Deutseher E, 2007, DEV BIOL, V307, P227, DOI 10.1016/j.ydbio.2007.04.036; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Gazit A, 1999, ONCOGENE, V18, P5959, DOI 10.1038/sj.onc.1202985; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Milovanovic T, 2004, INT J ONCOL, V25, P1337; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Qureshi ST, 2003, GENES IMMUN, V4, P87, DOI 10.1038/sj.gene.6363937; Reiling N, 2001, IMMUNOBIOLOGY, V204, P558, DOI 10.1078/0171-2985-00093; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; Roman-Roman S, 2004, J BIOL CHEM, V279, P5725, DOI 10.1074/jbc.M309233200; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yao RJ, 2001, BIOCHEM BIOPH RES CO, V286, P771, DOI 10.1006/bbrc.2001.5430; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	53	100	107	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2010	24	11					4599	4612		10.1096/fj.10-160994	http://dx.doi.org/10.1096/fj.10-160994			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20667980				2022-12-25	WOS:000283861100044
J	Lin, LC; Hsu, JH; Wang, LC				Lin, Lee-Chung; Hsu, Jen-Hung; Wang, Long-Chi			Identification of Novel Inhibitors of 1-Aminocyclopropane-1-carboxylic Acid Synthase by Chemical Screening in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLENE SIGNAL-TRANSDUCTION; F-BOX PROTEINS; ACC SYNTHASE; GENE FAMILY; L-AMINOETHOXYVINYLGLYCINE; ENDOPLASMIC-RETICULUM; RESPONSE PATHWAY; RECEPTOR FAMILY; BIOSYNTHESIS; ETO1	Ethylene is a gaseous hormone important for adaptation and survival in plants. To further understand the signaling and regulatory network of ethylene, we used a phenotype-based screening strategy to identify chemical compounds interfering with the ethylene response in Arabidopsis thaliana. By screening a collection of 10,000 structurally diverse small molecules, we identified compounds suppressing the constitutive triple response phenotype in the ethylene overproducer mutant eto1-4. The compounds reduced the expression of a reporter gene responsive to ethylene and the otherwise elevated level of ethylene in eto1-4. Structure and function analysis revealed that the compounds contained a quinazolinone backbone. Further studies with genetic mutants and transgenic plants involved in the ethylene pathway showed that the compounds inhibited ethylene biosynthesis at the step of converting S-adenosylmethionine to 1-aminocyclopropane-1-carboxylic acid (ACC) by ACC synthase. Biochemical studies with in vitro activity assay and enzyme kinetics analysis indicated that a representative compound was an uncompetitive inhibitor of ACC synthase. Finally, global gene expression profiling uncovered a significant number of genes that were co-regulated by the compounds and aminoethoxyvinylglycine, a potent inhibitor of ACC synthase. The use of chemical screening is feasible in identifying small molecules modulating the ethylene response in Arabidopsis seedlings. The discovery of such chemical compounds will be useful in ethylene research and can offer potentially useful agrochemicals for quality improvement in post-harvest agriculture.	[Lin, Lee-Chung; Hsu, Jen-Hung; Wang, Long-Chi] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Lin, Lee-Chung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Wang, LC (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	lwang@gate.sinica.edu.tw			National Science and Technology Program [94S0201]; National Science Council [NSC972311B001003]; Development Program of Industrialization for Agricultural Biotechnology [99S0030088]	National Science and Technology Program; National Science Council(Ministry of Science and Technology, Taiwan); Development Program of Industrialization for Agricultural Biotechnology	This work was supported by National Science and Technology Program Grant 94S0201 for initial chemical screening, National Science Council Grant NSC972311B001003, and Development Program of Industrialization for Agricultural Biotechnology Grant 99S0030088 for subsequent functional characterization (to L.-C. W.).	ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Barry CS, 1996, PLANT J, V9, P525, DOI 10.1046/j.1365-313X.1996.09040525.x; BEYER EM, 1976, PLANT PHYSIOL, V58, P268, DOI 10.1104/pp.58.3.268; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; Bleecker AB, 1998, PHILOS T ROY SOC B, V353, P1405, DOI 10.1098/rstb.1998.0295; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BOLLER T, 1979, PLANTA, V145, P293, DOI 10.1007/BF00454455; Capitani G, 2005, FEBS LETT, V579, P2458, DOI 10.1016/j.febslet.2005.03.048; Capitani G, 2002, J BIOL CHEM, V277, P49735, DOI 10.1074/jbc.M208427200; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Christians MJ, 2009, PLANT J, V57, P332, DOI 10.1111/j.1365-313X.2008.03693.x; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ENGLISH PJ, 1995, PLANT PHYSIOL, V109, P1435, DOI 10.1104/pp.109.4.1435; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huai Q, 2001, J BIOL CHEM, V276, P38210; HYODO H, 1986, PLANT CELL PHYSIOL, V27, P391; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Mhaske SB, 2006, TETRAHEDRON, V62, P9787, DOI 10.1016/j.tet.2006.07.098; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; OZAKI K, 1985, J MED CHEM, V28, P568, DOI 10.1021/jm50001a006; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; ROMAN G, 1995, GENETICS, V139, P1393; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Thomann A, 2005, FEBS LETT, V579, P3239, DOI 10.1016/j.febslet.2005.02.068; Toth R, 2010, TRENDS PLANT SCI, V15, P81, DOI 10.1016/j.tplants.2009.11.005; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; Tsuchisaka A, 2009, GENETICS, V183, P979, DOI 10.1534/genetics.109.107102; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xia Y, 2001, BIOORG MED CHEM LETT, V11, P1193, DOI 10.1016/S0960-894X(01)00190-1; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Yoshida H, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-14	57	31	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33445	33456		10.1074/jbc.M110.132498	http://dx.doi.org/10.1074/jbc.M110.132498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682786	Green Published, hybrid			2022-12-25	WOS:000283048200079
J	Angelucci, F; Dimastrogiovanni, D; Boumis, G; Brunori, M; Miele, AE; Saccoccia, F; Bellelli, A				Angelucci, Francesco; Dimastrogiovanni, Daniela; Boumis, Giovanna; Brunori, Maurizio; Miele, Adriana E.; Saccoccia, Fulvio; Bellelli, Andrea			Mapping the Catalytic Cycle of Schistosoma mansoni Thioredoxin Glutathione Reductase by X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BASE CATALYSIS; MECHANISM; MITOCHONDRIAL; PRAZIQUANTEL; EVOLUTION; SYSTEMS	Schistosomiasis is the second most widespread human parasitic disease. It is principally treated with one drug, praziquantel, that is administered to 100 million people each year; less sensitive strains of schistosomes are emerging. One of the most appealing drug targets against schistosomiasis is thioredoxin glutathione reductase (TGR). This natural chimeric enzyme is a peculiar fusion of a glutaredoxin domain with a thioredoxin selenocysteine (U)-containing reductase domain. Selenocysteine is located on a flexible C-terminal arm that is usually disordered in the available structures of the protein and is essential for the full catalytic activity of TGR. In this study, we dissect the catalytic cycle of Schistosoma mansoni TGR by structural and functional analysis of the U597C mutant. The crystallographic data presented herein include the following: the oxidized form (at 1.9 angstrom resolution); the NADPH-and GSH-bound forms (2.3 and 1.9 angstrom, respectively); and a different crystal form of the (partially) reduced enzyme (3.1 angstrom), showing the physiological dimer and the entire C terminus of one subunit. Whenever possible, we determined the rate constants for the interconversion between the different oxidation states of TGR by kinetic methods. By combining the crystallographic analysis with computer modeling, we were able to throw further light on the mechanism of action of S. mansoni TGR. In particular, we hereby propose the putative functionally relevant conformational change of the C terminus after the transfer of reducing equivalents from NADPH to the redox sites of the enzyme.	[Bellelli, Andrea] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, CNR Inst Mol Biol & Pathol, I-00185 Rome, Italy; Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Bellelli, A (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, CNR Inst Mol Biol & Pathol, Ple Aldo Moro 5, I-00185 Rome, Italy.	andrea.bellelli@uniroma1.it	Bellelli, Andrea/D-2785-2009; Miele, Adriana E./F-4083-2011; Saccoccia, Fulvio/ADI-5036-2022	Miele, Adriana E./0000-0002-4637-2606; Saccoccia, Fulvio/0000-0002-3527-6694; BOUMIS, Giovanna/0000-0001-5323-7288; Brunori, Maurizio/0000-0002-7795-1635	Fondazione Roma; Sapienza University of Rome Progetto Universita; Progetto Ateneo Federato; MIUR of Italy; European Community [FP7/2007-2013, 226716]	Fondazione Roma(Fondazione RomaEuropean Commission); Sapienza University of Rome Progetto Universita; Progetto Ateneo Federato; MIUR of Italy(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission)	This work was supported by Fondazione Roma (project title "Rational Approach to the Specific Inhibition of Plasmodium falciparum and Schistosoma mansoni"), Sapienza University of Rome Progetto Universita 2007 and 2008 and Progetto Ateneo Federato 2007 and 2008, MIUR of Italy FIRB/Proteomica 2007-protRBRN07BMCT, and the European Community Seventh Framework Programme FP7/2007-2013, Agreement 226716.	Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Angelucci F, 2007, PARASITOLOGY, V134, P1215, DOI 10.1017/S0031182007002600; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Argyrou A, 2002, BIOCHEMISTRY-US, V41, P14580, DOI 10.1021/bi020376k; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASCH PF, 1984, AM J TROP MED HYG, V33, P911, DOI 10.4269/ajtmh.1984.33.911; Bateman H, 1910, P CAMB PHILOS SOC, V15, P423; Bauer H, 2003, J BIOL CHEM, V278, P33020, DOI 10.1074/jbc.M303762200; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Cheng Q, 2009, J BIOL CHEM, V284, P3998, DOI 10.1074/jbc.M807068200; Cioli D, 2008, TRENDS PARASITOL, V24, P379, DOI 10.1016/j.pt.2008.05.006; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fritz-Wolf K, 2007, J MOL BIOL, V370, P116, DOI 10.1016/j.jmb.2007.04.044; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Hondal RJ, 2009, BBA-GEN SUBJECTS, V1790, P1501, DOI 10.1016/j.bbagen.2009.04.015; Huang HH, 2008, BIOCHEMISTRY-US, V47, P1721, DOI 10.1021/bi702040u; Huang HH, 2008, BIOCHEMISTRY-US, V47, P12769, DOI 10.1021/bi801449h; HUBER PW, 1980, BIOCHEMISTRY-US, V19, P4568, DOI 10.1021/bi00561a005; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Novoselov SV, 2003, PROTEIN SCI, V12, P372, DOI 10.1110/ps.0226503; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rai G, 2009, J MED CHEM, V52, P6474, DOI 10.1021/jm901021k; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Stothard JR, 2009, PARASITOLOGY, V136, P1665, DOI 10.1017/S0031182009991272; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Summa CM, 2007, P NATL ACAD SCI USA, V104, P3177, DOI 10.1073/pnas.0611593104; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Wahl MC, 2005, J MOL BIOL, V345, P1119, DOI 10.1016/j.jmb.2004.11.004; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001	42	48	50	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32557	32567		10.1074/jbc.M110.141960	http://dx.doi.org/10.1074/jbc.M110.141960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20659890	Green Published, hybrid			2022-12-25	WOS:000282683000070
J	Lee, AW; Champagne, N; Wang, XJ; Su, XD; Goodyer, C; Leblanc, AC				Lee, Andrea W.; Champagne, Nathalie; Wang, Xiaojun; Su, Xiao-Dong; Goodyer, Cynthia; Leblanc, Andrea C.			Alternatively Spliced Caspase-6B Isoform Inhibits the Activation of Caspase-6A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEURONS; APOPTOSIS; PROTEIN; DEGRADATION; EXPRESSION; CLEAVAGE; CLONING; VARIANT; DEATH; GENE	Caspase-6 (Casp6) is activated early in Alzheimer disease and involved in axonal degeneration, but the regulation of Casp6 activity has not been explored. Several alternatively spliced forms of caspases act as inhibitors of caspase activation. The CASP6 gene generates an alternatively spliced transcript known as CASP6 beta in addition to the CASP6 alpha that encodes pro-Casp6a. Here, we show that the CASP6 beta transcript and the pro-Casp6b protein are present in many cell lines, in primary human neurons, and in human brains. Unlike most other alternatively spliced caspase transcripts, pro-Casp6b contains a catalytic site. However, purified pro-Casp6b did not have caspase activity, nor did it inhibit already activated Casp6a. Pro-Casp6b prevented the proteolytic activation of pro-Casp6a in vitro and in cells. Pro-Casp6b interacts directly with pro-Casp6a. This work shows that pro-Casp6b is an inhibitor of pro-Casp6a activation. These results imply that pro-Casp6b could negatively regulate pro-Casp6a activation in neurons and prevent Casp6a-mediated axonal degeneration.	[Leblanc, Andrea C.] Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Wang, Xiaojun; Su, Xiao-Dong] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Lee, Andrea W.; Leblanc, Andrea C.] McGill Univ, Dept Neurol, Montreal, PQ H3H 1P3, Canada; [Lee, Andrea W.; Leblanc, Andrea C.] McGill Univ, Dept Neurosurg, Montreal, PQ H3H 1P3, Canada; [Goodyer, Cynthia] McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada	Lady Davis Institute; McGill University; Peking University; McGill University; McGill University; McGill University	Leblanc, AC (corresponding author), Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, 3755 Ch Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	andrea.leblanc@mcgill.ca			National Institutes of Health [MS/MH40965-01]; Canadian Institutes of Health Research (CIHR) [MOP81146, CCI-85682]; CIHR-National Science Foundation of China Joint Health Initiative; Fonds de la Recherche en Sante	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR-National Science Foundation of China Joint Health Initiative(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported, in whole or in part, by National Institutes of Health Grant MS/MH40965-01. This work was also supported by Canadian Institutes of Health Research (CIHR) Grants MOP81146 and CCI-85682, the CIHR-National Science Foundation of China Joint Health Initiative, the James McGill Professorship, and the Fonds de la Recherche en Sante (to A. C. L.).	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; ALNEMRI ES, 1995, J BIOL CHEM, V270, P4312, DOI 10.1074/jbc.270.9.4312; Denault J, 2002, CURRENT PROTOCOLS PR; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; Foley JD, 2004, J BIOL CHEM, V279, P32142, DOI 10.1074/jbc.M313683200; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Himeji D, 2002, BLOOD, V99, P4070, DOI 10.1182/blood.V99.11.4070; Huang YH, 2001, BIOCHEM BIOPH RES CO, V283, P762, DOI 10.1006/bbrc.2001.4871; Ito A, 2000, FEBS LETT, V470, P360, DOI 10.1016/S0014-5793(00)01351-X; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Mohr A, 2005, ONCOGENE, V24, P2421, DOI 10.1038/sj.onc.1208432; Morozov V, 2006, DEVELOPMENT, V133, P813, DOI 10.1242/dev.02262; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Seol DW, 1999, J BIOL CHEM, V274, P2072, DOI 10.1074/jbc.274.4.2072; Tounekti O, 2004, J NEUROCHEM, V89, P561, DOI 10.1111/j.1471-4159.2004.02349.x; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zandy AJ, 2007, INVEST OPHTH VIS SCI, V48, P293, DOI 10.1167/iovs.06-0656; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhang Y, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0007.2001	34	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31974	31984		10.1074/jbc.M110.152744	http://dx.doi.org/10.1074/jbc.M110.152744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20682790	Green Published, hybrid			2022-12-25	WOS:000282683000010
J	Feng, L; Wang, JD; Chen, JJ				Feng, Lin; Wang, Jiadong; Chen, Junjie			The Lys(63)-specific Deubiquitinating Enzyme BRCC36 Is Regulated by Two Scaffold Proteins Localizing in Different Subcellular Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; UBIQUITIN STRUCTURES; STRUCTURAL BASIS; DNA; BINDING; BRCA1; COMPLEX; RAP80; METALLOPROTEASE; DEGRADATION	BRCC36 is a member of the JAMM/MPN+ family of zinc metalloproteases that specifically cleaves Lys 63-linked polyubiquitin chains in vitro. We and others showed previously that BRCC36 is a component of the BRCA1-A complex, which consists of RAP80, CCDC98/ABRAXAS, BRCC45/BRE, MERIT40/NBA1, BRCC36, and BRCA1. This complex participates in the regulation of BRCA1 localization in response to DNA damage. Here we provide evidence indicating that BRCC36 regulates the abundance of Lys(63)-linked ubiquitin chains at chromatin and that one of its substrates is diubiquitinated histone H2A. Moreover, besides interacting with CCDC98 within the BRCA1-A complex, BRCC36 also associates with another protein KIAA0157, which shares significant sequence homology with CCDC98. Interestingly, although CCDC98 functions as an adaptor of BRCC36 and regulates BRCC36 activity in the nucleus, KIAA0157 mainly localizes in cytosol and activates BRCC36 in the cytoplasm. Moreover, these two complexes appear to exist in fine balance in vivo because reduction of KIAA0157 expression led to an increase of the BRCA1-A complex in the nucleus. Together, these results suggest that scaffold proteins not only participate in the regulation of BRCC36 activity but also determine its subcellular localization and cellular functions.	[Feng, Lin; Wang, Jiadong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org	Feng, Lin/B-5961-2012	Feng, Lin/0000-0001-6461-5838	National Institutes of Health [CA089239, CA016672]; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239 (to J. C.) and CA016672 (to M. D. Anderson Cancer Center).; Recipient of Department of Defense Era of Hope Scholar Award W81XWH-05-1-0470.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	38	85	93	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30982	30988		10.1074/jbc.M110.135392	http://dx.doi.org/10.1074/jbc.M110.135392			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20656690	Green Published, hybrid			2022-12-25	WOS:000282135500063
J	Liu, WH; Chang, LS				Liu, Wen-Hsin; Chang, Long-Sen			Suppression of ADAM17-mediated Lyn/Akt Pathways Induces Apoptosis of Human Leukemia U937 Cells BUNGARUS MULTICINCTUS PROTEASE INHIBITOR-LIKE PROTEIN-1 UNCOVERS THE CYTOTOXIC MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; ADAPTIVE EVOLUTION; GROWTH-FACTOR; CHYMOTRYPSIN INHIBITOR; UP-REGULATION; EXPRESSION; VENOM; DISINTEGRIN; NECROSIS; KINASE	Cell surface proteases have been demonstrated to play an important role in facilitating cell invasion into the extracellular matrix and may contribute significantly to extracellular matrix degradation by metastatic cancer cells. Abundant expression of these enzymes is associated with poor prognosis. Thus, protease inhibitors that repress cell surface proteases may be applicable to cancer therapy. Because soybean Kunitz-type trypsin inhibitor has been found to induce apoptotic death of human leukemia Jurkat cells, anti-leukemia activity of Bungarus multicinctus protease inhibitor-like protein-1 (PILP-1) is thus examined. PILP-1 induced apoptosis of human leukemia U937 cells, characteristic of loss of mitochondrial membrane potential, degradation of procaspase-8, and production of t-Bid. FADD down-regulation neither restored viability of PILP-1-treated cells nor attenuated production of active caspase-8 and t-Bid in PILP-1-treated cells, suggesting that the death receptor-mediated pathway was not involved in the cytotoxicity of PILP-1. It was found that PILP-1-evoked p38 MAPK activation and ERK inactivation led to PILP-1-induced cell death and down-regulation of ADAM17. Knockdown of ADAM17 by siRNA induced death of U937 cells and inactivation of Lyn and Akt. Immunoprecipitation suggested that ADAM17 and Lyn form complexes. Overexpression of ADAM17, LynY507F (gain of function), and constitutively active Akt suppressed the cytotoxic effects of PILP-1. PILP-1-elicited inactivation of Lyn and Akt was abrogated in cells with overexpressed ADAM17 or LynY507F. Taken together, our data indicate that ADAM17-mediated activation of Lyn/Akt maintains the viability of U937 cells and that suppression of the pathway is responsible for PILP-1-induced apoptosis.	[Liu, Wen-Hsin; Chang, Long-Sen] Natl Sun Yat Sen Univ, Kaohsiung Med Univ, Joint Res Ctr, Inst Biomed Sci, Kaohsiung 804, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University	Chang, LS (corresponding author), Natl Sun Yat Sen Univ, Kaohsiung Med Univ, Joint Res Ctr, Inst Biomed Sci, Kaohsiung 804, Taiwan.	lschang@mail.nsysu.edu.tw			National Science Council, Taiwan [NSC98-2320-B110-002-MY3]; National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center	This work was supported by Grant NSC98-2320-B110-002-MY3 from the National Science Council, Taiwan (to L.-S.C.), and a grant from National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center.	Arribas J, 2005, PROTEAS BIOL DIS, V4, P171; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Cardenas A, 2002, J CEREBR BLOOD F MET, V22, P1297, DOI 10.1097/01.WCB.0000033968.83623.D0; Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509; Chang LS, 2008, TOXICON, V51, P1490, DOI 10.1016/j.toxicon.2008.03.025; Chang LS, 2001, BIOCHEM BIOPH RES CO, V283, P862, DOI 10.1006/bbrc.2001.4878; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Karan D, 2003, INT J ONCOL, V23, P1365; Kempaiah P, 2008, APOPTOSIS, V13, P702, DOI 10.1007/s10495-008-0207-8; Kobayashi H, 2003, BIOL CHEM, V384, P749, DOI 10.1515/BC.2003.083; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lal A, 2002, CANCER RES, V62, P3335; Liu WH, 2009, J CELL MOL MED, V13, P1695, DOI 10.1111/j.1582-4934.2008.00473.x; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Moon DO, 2007, ACTA PHARMACOL SIN, V28, P1205, DOI 10.1111/j.1745-7254.2007.00615.x; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Rao BG, 2005, CURR PHARM DESIGN, V11, P295, DOI 10.2174/1381612053382115; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; RITONJA A, 1983, BIOCHIM BIOPHYS ACTA, V748, P429, DOI 10.1016/0167-4838(83)90189-9; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; SHAFQAT J, 1990, EUR J BIOCHEM, V194, P337, DOI 10.1111/j.1432-1033.1990.tb15622.x; Sierko E, 2007, SEMIN THROMB HEMOST, V33, P653, DOI 10.1055/s-2007-991532; Solomon KA, 1999, J IMMUNOL, V163, P4105; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Suzuki M, 2003, INT J CANCER, V104, P289, DOI 10.1002/ijc.10950; Takamune Y, 2008, BIOCHEM BIOPH RES CO, V365, P393, DOI 10.1016/j.bbrc.2007.11.010; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Troncoso MF, 2007, INT IMMUNOPHARMACOL, V7, P625, DOI 10.1016/j.intimp.2007.01.002; Tung EKK, 2009, INT J CANCER, V124, P1811, DOI 10.1002/ijc.24115; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Yan Y, 2009, CELL BIOL INT, V33, P158, DOI 10.1016/j.cellbi.2008.10.008; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	47	16	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30506	30515		10.1074/jbc.M110.156257	http://dx.doi.org/10.1074/jbc.M110.156257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20679348	hybrid, Green Published			2022-12-25	WOS:000282135500018
J	Zhu, NL; Wang, JH; Tsukamoto, H				Zhu, Nian-Ling; Wang, Jiaohong; Tsukamoto, Hidekazu			The Necdin-Wnt Pathway Causes Epigenetic Peroxisome Proliferator-activated Receptor gamma Repression in Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; DIFFERENTIATION; ADIPOGENESIS; INTERACTS; TRANSDIFFERENTIATION; PROTEIN; ACTS; CREB; MSX2	Hepatic stellate cells (HSCs), vitamin A-storing liver pericytes, undergo myofibroblastic trans-differentiation or "activation" to participate in liver wound healing. This cellular process involves loss of regulation by adipogenic transcription factors such as peroxisome proliferator-activated receptor gamma (PPAR gamma). Necdin, a melanoma antigen family protein, promotes neuronal and myogenic differentiation while inhibiting adipogenesis. The present study demonstrates that necdin is selectively expressed in HSCs among different liver cell types and induced during their activation in vitro and in vivo. Silencing of necdin with adenovirally expressed shRNA, reverses activated HSCs to quiescent cells in a manner dependent on PPAR gamma and suppressed canonical Wnt signaling. Promoter analysis, site-directed mutagenesis, and chromatin immunoprecipitation demonstrate that Wnt10b, a canonical Wnt induced in activated HSCs, is a direct target of necdin. Necdin silencing abrogates three epigenetic signatures implicated in repression of PPAR gamma: increased MeCP2 (methyl CpG binding protein 2) and HP-1 alpha co-repressor recruitments to Ppar gamma promoter and enhanced H3K27 dimethylation at the exon 5 locus, again in a manner dependent on suppressed canonical Wnt. These epigenetic effects are reproduced by antagonism of canonical Wnt signaling with Dikkopf-1. Our results demonstrate a novel necdin-Wnt pathway, which serves to mediate antiadipogenic HSC trans-differentiation via epigenetic repression of PPAR gamma.	[Zhu, Nian-Ling; Wang, Jiaohong; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, So Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90033 USA; [Zhu, Nian-Ling; Wang, Jiaohong; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Wang, Jiaohong; Tsukamoto, Hidekazu] Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA 90073 USA	University of Southern California; University of Southern California	Tsukamoto, H (corresponding author), Univ So Calif, Keck Sch Med, So Calif Res Ctr ALPD & Cirrhosis, 1333 San Pablo St,MMR-402, Los Angeles, CA 90033 USA.	htsukamo@usc.edu			National Institutes of Health [P50AA011999, R24AA012885, R21AA016682]; Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R21AA016682, R24AA012885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P50AA011999, R24AA012885, and R21AA016682. This work was also supported by the Medical Research Service of the Department of Veterans Affairs.	Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Galli A, 2000, HEPATOLOGY, V31, P101, DOI 10.1002/hep.510310117; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Houglum K, 1997, J CLIN INVEST, V99, P1322, DOI 10.1172/JCI119291; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; MacDougald OA, 2005, NAT CELL BIOL, V7, P543, DOI 10.1038/ncb0605-543; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365; Matsumoto K, 2001, GENE, V272, P173, DOI 10.1016/S0378-1119(01)00544-3; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Potter JJ, 1998, BIOCHEM BIOPH RES CO, V244, P178, DOI 10.1006/bbrc.1997.8193; Ren J, 2003, J NEUROSCI, V23, P1569; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sung CK, 2004, AM J PHYSIOL-GASTR L, V286, pG722, DOI 10.1152/ajpgi.00411.2003; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tsukamoto H, 1999, ALCOHOL CLIN EXP RES, V23, P911, DOI 10.1111/j.1530-0277.1999.tb04202.x; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; YAMADA M, 1987, HEPATOLOGY, V7, P1224, DOI 10.1002/hep.1840070609; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2	36	42	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30463	30471		10.1074/jbc.M110.156703	http://dx.doi.org/10.1074/jbc.M110.156703			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663865	hybrid, Green Published			2022-12-25	WOS:000282135500013
J	Shukla, AK; Kim, J; Ahn, S; Xiao, KH; Shenoy, SK; Liedtke, W; Lefkowitz, RJ				Shukla, Arun K.; Kim, Jihee; Ahn, Seungkirl; Xiao, Kunhong; Shenoy, Sudha K.; Liedtke, Wolfgang; Lefkowitz, Robert J.			Arresting a Transient Receptor Potential (TRP) Channel beta-ARRESTIN 1 MEDIATES UBIQUITINATION AND FUNCTIONAL DOWN-REGULATION OF TRPV4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; BETA-ARRESTINS; CELL-SURFACE; 7-TRANSMEMBRANE RECEPTORS; CATION CHANNEL; BETA(2)-ADRENERGIC RECEPTOR; INDUCED VASODILATATION; CALCIUM-CHANNELS; DOWN-REGULATION; BETA-ARRESTIN-2	beta-Arrestins, originally discovered to desensitize activated G protein-coupled receptors, (aka seven-transmembrane receptors, 7TMRs) also mediate 7TMR internalization and G protein-independent signaling via these receptors. More recently, several regulatory roles of beta-arrestins for atypical 7TMRs and non-7TM receptors have emerged. Here, we uncover an entirely novel regulatory role of beta-arrestins in crosstalk between the angiotensin receptor (AT1aR) and a member of the transient receptor potential (TRP) ion channel family, TRPV4. AT1aR and TRPV4 form a constitutive complex in the plasma membrane, and angiotensin stimulation leads to recruitment of beta-arrestin 1 to this complex. Surprisingly, angiotensin stimulation results in ubiquitination of TRPV4, a process that requires beta-arrestin 1, and subsequently to internalization and functional down-regulation of TRPV4. beta-Arrestin 1 interacts with, and acts as an adaptor for AIP4, an E3 ubiquitin ligase responsible for TRPV4 ubiquitination. Thus, our data provide the first evidence of a functional link between beta-arrestins and TRPV4 and uncovers an entirely novel mechanism to maintain appropriate intracellular Ca2+ concentration to avoid excessive Ca2+ signaling.	[Shukla, Arun K.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Shukla, Arun K.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Shukla, AK (corresponding author), Duke Univ, Med Ctr, Dept Med, 463 Carl Bldg,Res Dr, Durham, NC 27710 USA.	arun.shukla@receptor-biol.duke.edu	Liedtke, Wolfgang/GNH-1878-2022; Shenoy, Sudha/AAN-4075-2021; Xiao, Kunhong/AAG-4275-2020; Lefkowitz, Robert/AAW-2649-2021; Liedtke, Wolfgang B/G-4633-2011	Shenoy, Sudha/0000-0002-2565-4663; Xiao, Kunhong/0000-0002-1069-1226; shukla, arun/0000-0003-2910-8288	National Institutes of Health [HL16037, HL70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037, R01HL080525, R01HL070631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL16037 and HL70631 (to R. J. L.).	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Gao F, 2009, HYPERTENSION, V53, P228, DOI 10.1161/HYPERTENSIONAHA.108.117499; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Hannan MA, 2008, BBA-BIOMEMBRANES, V1778, P974, DOI 10.1016/j.bbamem.2008.01.011; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; *INV, 2006, FLUO 4 NW CALC ASS K; Jian MY, 2008, AM J RESP CELL MOL, V38, P386, DOI 10.1165/rcmb.2007-0192OC; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lipsky R, 2008, J BIOL CHEM, V283, P17221, DOI 10.1074/jbc.C800061200; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Matsusaka T, 1997, ANNU REV PHYSIOL, V59, P395, DOI 10.1146/annurev.physiol.59.1.395; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; O'Neill LAJ, 2009, J BIOL CHEM, V284, P8209, DOI 10.1074/jbc.R800070200; Patel PA, 2008, CIRC J, V72, P1725, DOI 10.1253/circj.CJ-08-0734; Patel PA, 2009, J MOL CELL CARDIOL, V46, P300, DOI 10.1016/j.yjmcc.2008.11.015; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shui Z, 2001, J BIOL CHEM, V276, P11691, DOI 10.1074/jbc.M011007200; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Verkhratsky A., 2007, V45, P465; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Wissenbach U, 2004, BIOL CELL, V96, P47, DOI 10.1016/j.biolcel.2003.12.003; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	62	78	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30115	30125		10.1074/jbc.M110.141549	http://dx.doi.org/10.1074/jbc.M110.141549			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650893	hybrid, Green Published			2022-12-25	WOS:000281984300049
J	Chambers, JE; Tavender, TJ; Oka, OBV; Warwood, S; Knight, D; Bulleid, NJ				Chambers, Joseph E.; Tavender, Timothy J.; Oka, Ojore B. V.; Warwood, Stacey; Knight, David; Bulleid, Neil J.			The Reduction Potential of the Active Site Disulfides of Human Protein Disulfide Isomerase Limits Oxidation of the Enzyme by Ero1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-LIKE DOMAINS; ENDOPLASMIC-RETICULUM; THIOL OXIDASE; GLUTATHIONE; RESIDUES; ERO1P; YEAST	Disulfide formation in newly synthesized proteins entering the mammalian endoplasmic reticulum is catalyzed by protein disulfide isomerase (PDI), which is itself thought to be directly oxidized by Ero1 alpha. The activity of Ero1 alpha is tightly regulated by the formation of noncatalytic disulfides, which need to be broken to activate the enzyme. Here, we have developed a novel PDI oxidation assay, which is able to simultaneously determine the redox status of the individual active sites of PDI. We have used this assay to confirm that when PDI is incubated with Ero1 alpha, only one of the active sites of PDI becomes directly oxidized with a slow turnover rate. In contrast, a deregulated mutant of Ero1 alpha was able to oxidize both PDI active sites at an equivalent rate to the wild type enzyme. When the active sites of PDI were mutated to decrease their reduction potential, both were now oxidized by wild type Ero1 alpha with a 12-fold increase in activity. These results demonstrate that the specificity of Ero1 alpha toward the active sites of PDI requires the presence of the regulatory disulfides. In addition, the rate of PDI oxidation is limited by the reduction potential of the PDI active site disulfide. The inability of Ero1 alpha to oxidize PDI efficiently likely reflects the requirement for PDI to act as both an oxidase and an isomerase during the formation of native disulfides in proteins entering the secretory pathway.	[Tavender, Timothy J.; Oka, Ojore B. V.; Bulleid, Neil J.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G46 6JN, Lanark, Scotland; [Chambers, Joseph E.; Warwood, Stacey; Knight, David] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Glasgow; University of Manchester	Bulleid, NJ (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk	Oka, Ojore/H-4456-2013; Chambers, Joseph/Z-5212-2019	Chambers, Joseph/0000-0003-4675-0053; Bulleid, Neil/0000-0002-9839-5279; Knight, David/0000-0001-8895-8560	Wellcome Trust [074081, 088053]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants 074081 and 088053.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; FREEDMAN RB, 1995, CURR OPIN STRUC BIOL, V5, P85, DOI 10.1016/0959-440X(95)80013-Q; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LU XJ, 1992, BIOCHEMISTRY-US, V31, P4205, DOI 10.1021/bi00132a008; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	27	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29200	29207		10.1074/jbc.M110.156596	http://dx.doi.org/10.1074/jbc.M110.156596			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20657012	Green Published, hybrid			2022-12-25	WOS:000281740100020
J	Wieczorek, A; Downey, CD; Dallmann, HG; McHenry, CS				Wieczorek, Anna; Downey, Christopher D.; Dallmann, H. Garry; McHenry, Charles S.			Only One ATP-binding DnaX Subunit Is Required for Initiation Complex Formation by the Escherichia coli DNA Polymerase III Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLAMP LOADER; DELTA; TAU; PURIFICATION; MECHANISM; MACHINE; GAMMA	The DnaX complex (DnaX(3)delta delta'chi psi) within the Escherichia coli DNApolymerase III holoenzyme serves to load the dimeric sliding clamp processivity factor, beta(2), onto DNA. The complex contains three DnaX subunits, which occur in two forms: tau and the shorter gamma, produced by translational frameshifting. Ten forms of E. coli DnaX complex containing all possible combinations of wild-type or a Walker A motif K51E variant tau or gamma have been reconstituted and rigorously purified. DnaX complexes containing three DnaX K51E subunits do not bind ATP. Comparison of their ability to support formation of initiation complexes, as measured by processive replication by the DNA polymerase III holoenzyme, indicates a minimal requirement for one ATP-binding DnaX subunit. DnaX complexes containing two mutant DnaX subunits support DNA synthesis at about two-thirds the level of their wild-type counterparts. beta(2) binding (determined functionally) is diminished 12-30-fold for DnaX complexes containing two K51E subunits, suggesting that multiple ATPs must be bound to place the DnaX complex into a conformation with maximal affinity for beta(2). DNA synthesis activity can be restored by increased concentrations of beta(2). In contrast, severe defects in ATP hydrolysis are observed upon introduction of a single K51E DnaX subunit. Thus, ATP binding, hydrolysis, and the ability to form initiation complexes are not tightly coupled. These results suggest that although ATP hydrolysis likely enhances beta(2) loading, it is not absolutely required in a mechanistic sense for formation of functional initiation complexes.	[Wieczorek, Anna; Downey, Christopher D.; Dallmann, H. Garry; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	charles.mchenry@colorado.edu			NIGMS [GM060273]; National Institutes of Health [F32GM084697]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084697, R01GM060273] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060273 from the NIGMS (to C. S. M.) and by National Institutes of Health Grant F32GM084697 (postdoctoral fellowship for C. D. D.).	Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Cull MG, 1995, METHOD ENZYMOL, V262, P22; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim S, 1996, J BIOL CHEM, V271, P4315; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Song MS, 2001, J BIOL CHEM, V276, P35165, DOI 10.1074/jbc.M100389200; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997	18	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29049	29053		10.1074/jbc.C110.165076	http://dx.doi.org/10.1074/jbc.C110.165076			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20675375	Green Published, hybrid			2022-12-25	WOS:000281740100005
J	Nunes, MC; Okada, M; Scheidig-Benatar, C; Cooke, BM; Scherf, A				Nunes, Marta C.; Okada, Mami; Scheidig-Benatar, Christine; Cooke, Brian M.; Scherf, Artur			Plasmodium falciparum FIKK Kinase Members Target Distinct Components of the Erythrocyte Membrane	PLOS ONE			English	Article							RED-BLOOD-CELLS; PHOSPHOPROTEIN GEL STAIN; INFECTED ERYTHROCYTES; CHONDROITIN SULFATE; MALARIA PARASITES; HOST-CELL; PROTEIN; PHOSPHORYLATION; FAMILY; CYTOSKELETON	Background: Modulation of infected host cells by intracellular pathogens is a prerequisite for successful establishment of infection. In the human malaria parasite Plasmodium falciparum, potential candidates for erythrocyte remodelling include the apicomplexan-specific FIKK kinase family (20 members), several of which have been demonstrated to be transported into the erythrocyte cytoplasm via Maurer's clefts. Methodology: In the current work, we have knocked out two members of this gene family (Pf fikk7.1 and Pf fikk12), whose products are localized at the inner face of the erythrocyte membrane. Both mutant parasite lines were viable and erythrocytes infected with these parasites showed no detectable alteration in their ability to adhere in vitro to endothelial receptors such as chondroitin sulfate A and CD36. However, we observed sizeable decreases in the rigidity of infected erythrocytes in both knockout lines. Mutant parasites were further analyzed using a phospho-proteomic approach, which revealed distinct phosphorylation profiles in ghost preparations of infected erythrocytes. Knockout parasites showed a significant reduction in the level of phosphorylation of a protein of approximately 80 kDa for FIKK12-KO in trophozoite stage and a large protein of about 300 kDa for FIKK7.1-KO in schizont stage. Conclusions: Our results suggest that FIKK members phosphorylate different membrane skeleton proteins of the infected erythrocyte in a stage-specific manner, inducing alterations in the mechanical properties of the parasite-infected red blood cell. This suggests that these host cell modifications may contribute to the parasites' survival in the circulation of the human host.	[Nunes, Marta C.; Okada, Mami; Scheidig-Benatar, Christine; Scherf, Artur] Inst Pasteur, CNRS, UR2581, Unite Biol Interact Hote Parasite, Paris, France; [Cooke, Brian M.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Monash University	Nunes, MC (corresponding author), Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.	nunesm@rmpru.co.za; ascherf@pasteur.fr	Scherf, Artur/A-9674-2014	Nunes, Marta/0000-0003-3788-878X; Scherf, Artur/0000-0003-2411-3328	Fond Dedier; Human Frontiers Science Program; NHMRC	Fond Dedier; Human Frontiers Science Program(Human Frontier Science Program); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work has been supported by the Fond Dedier, including a post doctoral fellowship to M.O., and BioMalPar. M.C.N. had financial support from the Human Frontiers Science Program. Brian Cooke is an Australian National Health and Medical Research Council Senior Research Fellow and is supported by grants from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; CHISHTI AH, 1994, BLOOD, V83, P3339; COHEN CM, 1992, SEMIN HEMATOL, V29, P244; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; EDER PS, 1986, BIOCHEMISTRY-US, V25, P1764, DOI 10.1021/bi00355a047; Fujioka H, 2002, CHEM IMMUNOL, V80, P1; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hora R, 2009, J BIOL CHEM, V284, P6260, DOI 10.1074/jbc.M809756200; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; LEECH JH, 1984, J CELL BIOL, V98, P1256, DOI 10.1083/jcb.98.4.1256; LU PW, 1985, J BIOL CHEM, V260, P4958; LUSTIGMAN S, 1990, MOL BIOCHEM PARASIT, V38, P261, DOI 10.1016/0166-6851(90)90029-L; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Murray J, 2004, ELECTROPHORESIS, V25, P2520, DOI 10.1002/elps.200406006; MURRAY MC, 1989, MOL BIOCHEM PARASIT, V34, P229, DOI 10.1016/0166-6851(89)90051-0; Noviyanti R, 2001, MOL BIOCHEM PARASIT, V114, P227, DOI 10.1016/S0166-6851(01)00266-3; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; RANGACHARI K, 1986, NATURE, V324, P364, DOI 10.1038/324364a0; Schneider AG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-30; Schulenberg B, 2004, ELECTROPHORESIS, V25, P2526, DOI 10.1002/elps.200406007; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; TAKAKUWA Y, 1986, J CLIN INVEST, V78, P80, DOI 10.1172/JCI112577; Takakuwa Y, 2000, INT J HEMATOL, V72, P298; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Ooij C, 2007, CELL MICROBIOL, V9, P573, DOI 10.1111/j.1462-5822.2006.00875.x; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WASSERMAN M, 1990, PARASITOL RES, V76, P681, DOI 10.1007/BF00931087; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Wu Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-105; ZHUO S, 1993, J BIOL CHEM, V268, P17754	42	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11747	10.1371/journal.pone.0011747	http://dx.doi.org/10.1371/journal.pone.0011747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668526	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243800020
J	Bryant, CM; Albertus, DL; Kim, S; Chen, G; Brambilla, C; Guedj, M; Arima, C; Travis, WD; Yatabe, Y; Takahashi, T; Brambilla, E; Beer, DG				Bryant, Christopher M.; Albertus, Daniel L.; Kim, Sinae; Chen, Guoan; Brambilla, Christian; Guedj, Mickael; Arima, Chinatsu; Travis, William D.; Yatabe, Yasushi; Takahashi, Takashi; Brambilla, Elisabeth; Beer, David G.			Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; SURVIVAL; CLASSIFICATION; MUTATIONS; NATION; GENOME	Lung adenocarcinoma (AD) represents a predominant type of lung cancer demonstrating significant morphologic and molecular heterogeneity. We sought to understand this heterogeneity by utilizing gene expression analyses of 432 AD samples and examining associations between 27 known cancer-related pathways and the AD subtype, clinical characteristics and patient survival. Unsupervised clustering of AD and gene expression enrichment analysis reveals that cell proliferation is the most important pathway separating tumors into subgroups. Further, AD with increased cell proliferation demonstrate significantly poorer outcome and an increased solid AD subtype component. Additionally, we find that tumors with any solid component have decreased survival as compared to tumors without a solid component. These results lead to the potential to use a relatively simple pathological examination of a tumor in order to determine its aggressiveness and the patient's prognosis. Additional results suggest the ability to use a similar approach to determine a patient's sensitivity to targeted treatment. We then demonstrated the consistency of these findings using two independent AD cohorts from Asia (N = 87) and Europe (N = 89) using the identical analytic procedures.	[Bryant, Christopher M.; Albertus, Daniel L.; Chen, Guoan; Beer, David G.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Beer, David G.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Kim, Sinae] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI USA; [Brambilla, Christian; Guedj, Mickael] Univ Grenoble 1, Programme Cartes Identite Tumeurs, Grenoble, France; [Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; [Arima, Chinatsu; Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc, Nagoya, Aichi 4648601, Japan; [Brambilla, Elisabeth] Univ Grenoble 1, Dept Anat & Cytol Pathol, Grenoble, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Memorial Sloan Kettering Cancer Center; Aichi Cancer Center; Nagoya University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bryant, CM (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	dgbeer@umich.edu	YATABE, Yasushi/J-6461-2014; Brambilla, Elisabeth MP/L-8796-2013; Chen, Guoan/J-9140-2018; Takahashi, Takashi/I-7262-2014	YATABE, Yasushi/0000-0003-1788-559X; Chen, Guoan/0000-0001-5608-6761; Takahashi, Takashi/0000-0003-0615-7001				Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ebi H, 2009, CANCER RES, V69, P4027, DOI 10.1158/0008-5472.CAN-08-3403; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358	14	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11712	10.1371/journal.pone.0011712	http://dx.doi.org/10.1371/journal.pone.0011712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661423	Green Submitted, Green Published, gold			2022-12-25	WOS:000280243300015
J	Lou, PH; Yang, GQ; Huang, L; Cui, YX; Pourbahrami, T; Radda, GK; Li, C; Han, WP				Lou, Phing-How; Yang, Guoqing; Huang, Lu; Cui, Yunxia; Pourbahrami, Tiffany; Radda, George K.; Li, Cai; Han, Weiping			Reduced Body Weight and Increased Energy Expenditure in Transgenic Mice Over-Expressing Soluble Leptin Receptor	PLOS ONE			English	Article							BOUND LEPTIN; MOUSE; PROTEIN; OBESITY; GENE; IDENTIFICATION; GENERATION; ADIPOSITY; CLONING; PLASMA	Background: Soluble leptin receptor (OBRe), one of several leptin receptor isoforms, is the only bona fide leptin binding protein in plasma. Our earlier studies demonstrated that OBRe modulates leptin levels in circulation. Both clinical and in vitro studies have shown that OBRe expression is inversely correlated to body weight and leptin levels. However, it is not clear whether OBRe plays an active role, either in collaboration with leptin or independently, in the maintenance of body weight. Methodology/Principal Findings: To investigate the function of OBRe in the regulation of energy homeostasis, we generated transgenic mice that express OBRe under the control of human serum amyloid P (hSAP) component gene promoter. The transgene led to approximately doubling of OBRe in circulation in the transgenic mice than in wild type control mice. Transgenic mice exhibited lower body weight at 4 weeks of age, and slower rate of weight gain when compared with control mice. Furthermore, transgenic mice had lower body fat content. Indirect calorimetry revealed that transgenic mice had reduced food intake, increased basal metabolic rate, and increased lipid oxidation, which could account for the differences in body weight and body fat content. Transgenic mice also showed higher total circulating leptin, with the majority of it being in the bound form, while the amount of free leptin is comparable between transgenic and control mice. Conclusions: These results are consistent with the role of OBRe as a leptin binding protein in regulating leptin's bioavailability and activity.	[Lou, Phing-How; Yang, Guoqing; Radda, George K.; Han, Weiping] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Huang, Lu; Cui, Yunxia; Pourbahrami, Tiffany; Li, Cai] Univ Texas SW Med Ctr Dallas, Touchstone Ctr Diabet Res, Dept Physiol, Dallas, TX 75390 USA; [Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore	Lou, PH (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore.	cai_li@merck.com; weiping_han@sbic.a-star.edu.sg			American Heart Association, Texas Affiliate [0255737Y]; Welch Foundation [I-1470]; National Institutes of Health [DK 60137]; A*STAR Biomedical Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060137] Funding Source: NIH RePORTER	American Heart Association, Texas Affiliate(American Heart Association); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by grants from the American Heart Association, Texas Affiliate (0255737Y, C. L.), the Welch Foundation (I-1470, C. L.), National Institutes of Health (DK 60137, C. L.) and A*STAR Biomedical Research Council (W. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabant G, 2000, DIABETOLOGIA, V43, P438, DOI 10.1007/s001250051326; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chan JL, 2002, DIABETES, V51, P2105, DOI 10.2337/diabetes.51.7.2105; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cohen SE, 2007, J BIOL CHEM, V282, P23672, DOI 10.1074/jbc.M704053200; Doring H, 1998, INT J OBESITY, V22, P83, DOI 10.1038/sj.ijo.0800547; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gavrilova O, 1997, J BIOL CHEM, V272, P30546, DOI 10.1074/jbc.272.48.30546; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Harper JA, 2002, BIOCHEM J, V361, P49, DOI 10.1042/0264-6021:3610049; Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lewandowski K, 1999, J CLIN ENDOCR METAB, V84, P300, DOI 10.1210/jc.84.1.300; Li C, 1998, J BIOL CHEM, V273, P10078, DOI 10.1074/jbc.273.16.10078; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Liu CL, 1997, ENDOCRINOLOGY, V138, P3548, DOI 10.1210/en.138.8.3548; Maamra M, 2001, ENDOCRINOLOGY, V142, P4389, DOI 10.1210/en.142.10.4389; Matsuda J, 1998, JPN J CANCER RES, V89, P150, DOI 10.1111/j.1349-7006.1998.tb00543.x; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ogier V, 2002, INT J OBESITY, V26, P496, DOI 10.1038/sj.ijo.0801951; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Shimizu H, 2002, NUTRITION, V18, P309, DOI 10.1016/S0899-9007(01)00787-0; Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913; Stuart JA, 2001, J BIOL CHEM, V276, P18633, DOI 10.1074/jbc.M011566200; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tu H, 2008, J CELL PHYSIOL, V214, P301, DOI 10.1002/jcp.21195; Tu H, 2007, J CELL PHYSIOL, V212, P215, DOI 10.1002/jcp.21020; Yoshimoto T, 1998, J IMMUNOL, V160, P588; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHAO X, 1992, J BIOCHEM-TOKYO, V111, P736, DOI 10.1093/oxfordjournals.jbchem.a123828	38	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11669	10.1371/journal.pone.0011669	http://dx.doi.org/10.1371/journal.pone.0011669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652026	Green Submitted, gold, Green Published			2022-12-25	WOS:000280109700004
J	Haase, T; Haase, N; Kraehling, JR; Behrends, S				Haase, Tobias; Haase, Nadine; Kraehling, Jan Robert; Behrends, Soenke			Fluorescent Fusion Proteins of Soluble Guanylyl Cyclase Indicate Proximity of the Heme Nitric Oxide Domain and Catalytic Domain	PLOS ONE			English	Article							ENERGY-TRANSFER MICROSCOPY; CRYSTAL-STRUCTURE; SIGNALING PROTEINS; BETA-1 SUBUNIT; LIVING CELLS; IN-VIVO; DIMERIZATION; EXPRESSION; BINDING; HELIX	Background: To examine the structural organisation of heterodimeric soluble guanylyl cyclase (sGC) Forster resonance energy transfer (FRET) was measured between fluorescent proteins fused to the amino-and carboxy-terminal ends of the sGC beta(1) and alpha subunits. Methodology/Principal Findings: Cyan fluorescent protein (CFP) was used as FRET donor and yellow fluorescent protein (YFP) as FRET acceptor. After generation of recombinant baculovirus, fluorescent-tagged sGC subunits were co-expressed in Sf9 cells. Fluorescent variants of sGC were analyzed in vitro in cytosolic fractions by sensitized emission FRET. Co-expression of the amino-terminally tagged alpha subunits with the carboxy-terminally tagged beta(1) subunit resulted in an enzyme complex that showed a FRET efficiency of 10% similar to fluorescent proteins separated by a helix of only 48 amino acids. Because these findings indicated that the amino-terminus of the alpha subunits is close to the carboxy-terminus of the beta(1) subunit we constructed fusion proteins where both subunits are connected by a fluorescent protein. The resulting constructs were not only fluorescent, they also showed preserved enzyme activity and regulation by NO. Conclusions/Significance: Based on the ability of an amino-terminal fragment of the beta(1) subunit to inhibit activity of an heterodimer consisting only of the catalytic domains (alpha(cat)beta(cat)), Winger and Marletta (Biochemistry 2005, 44: 4083-90) have proposed a direct interaction of the amino-terminal region of beta(1) with the catalytic domains. In support of such a concept of "trans'' regulation of sGC activity by the H-NOX domains our results indicate that the domains within sGC are organized in a way that allows for direct interaction of the amino-terminal regulatory domains with the carboxy-terminal catalytic region. In addition, we constructed "fluorescent-conjoined'' sGC's by fusion of the alpha amino-terminus to the beta(1) carboxy-terminus leading to a monomeric, fluorescent and functional enzyme complex. To our knowledge this represents the first example where a fluorescent protein links two different subunits of a higher ordered complex to yield a stoichometrically fixed functionally active monomer.	[Haase, Tobias; Haase, Nadine; Kraehling, Jan Robert; Behrends, Soenke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmakol Toxikol & Klin Pharm, Braunschweig, Germany	Braunschweig University of Technology	Haase, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmakol Toxikol & Klin Pharm, Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Haase, Tobias/A-4297-2010; Behrends, Sönke/A-2551-2010	Behrends, Sönke/0000-0002-9068-0729; Kraehling, Jan R./0000-0002-0979-2900; Haase, Tobias/0000-0002-7220-602X; Haase, Nadine/0000-0003-0727-1738	VolkswagenStiftung; Deutsche Forschungsgemeinschaft [INST 188/286-1]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the VolkswagenStiftung and the Deutsche Forschungsgemeinschaft (INST 188/286-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Bamberger AM, 2001, J CLIN ENDOCR METAB, V86, P909, DOI 10.1210/jc.86.2.909; Boon EM, 2006, J BIOL CHEM, V281, P21892, DOI 10.1074/jbc.M600557200; Efendiev R, 2006, FEBS LETT, V580, P5067, DOI 10.1016/j.febslet.2006.08.035; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; HAASE N, BEHRENDS S DIR UNPUB; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Koglin M, 2003, J BIOL CHEM, V278, P12590, DOI 10.1074/jbc.M212740200; Koglin M, 2002, BIOCHEM BIOPH RES CO, V292, P1057, DOI 10.1006/bbrc.2002.6764; Kolossov VL, 2008, EXP BIOL MED, V233, P238, DOI 10.3181/0707-RM-192; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Lembo A, 2010, GASTROENTEROLOGY, V138, pS53, DOI 10.1053/j.gastro.2009.12.050; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Schmidt H.H., 2009, HDB EXP PHARM, V191, pv; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Schultz G., 1984, METHOD ENZYMAT AN, P379; Shiga T, 2005, ZOOL SCI, V22, P735, DOI 10.2108/zsj.22.735; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zabel U, 1999, J BIOL CHEM, V274, P18149, DOI 10.1074/jbc.274.26.18149; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x; Zhao Y, 1998, BIOCHEMISTRY-US, V37, P4502, DOI 10.1021/bi972686m	41	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11617	10.1371/journal.pone.0011617	http://dx.doi.org/10.1371/journal.pone.0011617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657650	gold, Green Submitted, Green Published			2022-12-25	WOS:000279924500016
J	Yamashiro, S; Speicher, KD; Speicher, DW; Fowler, VM				Yamashiro, Sawako; Speicher, Kaye D.; Speicher, David W.; Fowler, Velia M.			Mammalian Tropomodulins Nucleate Actin Polymerization via Their Actin Monomer Binding and Filament Pointed End-capping Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL HALF; SKELETAL-MUSCLE; TROPOMYOSIN BINDING; ARP2/3 COMPLEX; CYTOSKELETAL DYNAMICS; STRUCTURAL BASIS; CYTOCHALASIN-D; ADP-ACTIN; PROTEIN; CELLS	Many actin-binding proteins have been shown to possess multiple activities to regulate filament dynamics. Tropomodulins (Tmod1-4) are a conserved family of actin filament pointed end-capping proteins. Our previous work has demonstrated that Tmod3 binds to monomeric actin in addition to capping pointed ends. Here, we show a novel actin-nucleating activity in mammalian Tmods. Comparison of Tmod isoforms revealed that Tmod1-3 but not Tmod4 nucleate actin filament assembly. All Tmods bind to monomeric actin, and Tmod3 forms a 1:1 complex with actin. By truncation and mutagenesis studies, we demonstrated that the second alpha-helix in the N-terminal domain of Tmod3 is essential for actin monomer binding. Chemical cross-linking and LC-MS/MS further indicated that residues in this second alpha-helix interact with actin subdomain 2, whereas Tmod3 N-terminal domain peptides distal to this alpha-helix interact with actin subdomain 1. Mutagenesis of Leu-73 to Asp, which disrupts the second alpha-helix of Tmod3, decreases both its actin monomer-binding and -nucleating activities. On the other hand, point mutations of residues in the C-terminal leucine-rich repeat domain of Tmod3 (Lys-317 in the fifth leucine-rich repeat beta-sheet and Lys-344 or Arg-345/Arg-346 in the C-terminal alpha 6-helix) significantly reduced pointed end-capping and nucleation without altering actin monomer binding. Taken together, our data indicate that Tmod3 binds actin monomers over an extended interface and that nucleating activity depends on actin monomer binding and pointed end-capping activities, contributed by N- and C-terminal domains of Tmod3, respectively. Tmod3 nucleation of actin assembly may regulate the cytoskeleton in dynamic cellular contexts.	[Yamashiro, Sawako; Fowler, Velia M.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Speicher, Kaye D.; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA	Scripps Research Institute; The Wistar Institute	Yamashiro, S (corresponding author), Scripps Res Inst, Dept Cell Biol, CB163,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	syamash@scripps.edu		Fowler, Velia/0000-0002-3161-8802; Yamashiro, Sawako/0000-0002-5980-0470	National Institutes of Health [HL083464, HL038794]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794, R01HL083464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083464 (to V. M. F.) and HL038794 (to D. W. S.).	Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; BABCOCK GG, 1994, J BIOL CHEM, V269, P27510; BRYAN J, 1988, J CELL BIOL, V106, P1553, DOI 10.1083/jcb.106.5.1553; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; COOPER JA, 1985, BIOCHEMISTRY-US, V24, P793, DOI 10.1021/bi00324a039; Cox PR, 2000, GENOMICS, V63, P97, DOI 10.1006/geno.1999.6061; Domanski M, 2004, J BIOL CHEM, V279, P23637, DOI 10.1074/jbc.M311413200; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Fischer RS, 2003, TRENDS CELL BIOL, V13, P593, DOI 10.1016/j.tcb.2003.09.007; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Fujisawa T, 2001, FEBS LETT, V498, P67, DOI 10.1016/S0014-5793(01)02498-X; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; JACKMAN MR, 1994, J CELL SCI, V107, P2547; Kong KY, 2006, J BIOL CHEM, V281, P9589, DOI 10.1074/jbc.M512064200; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2001, BIOPHYS J, V81, P345, DOI 10.1016/S0006-3495(01)75704-9; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Krieger I, 2001, ACTA CRYSTALLOGR D, V57, P743, DOI 10.1107/S0907444901003924; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Mannherz HG, 2009, CELL MOTIL CYTOSKEL, V66, P839, DOI 10.1002/cm.20371; MAREKOV LN, 2007, CURR PROTOC PROTEIN, V47; Moyer J. D., 2010, BLOOD IN PRESS; Mudry RE, 2003, J CELL BIOL, V162, P1057, DOI 10.1083/jcb.200305031; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; Safer D, 1997, BIOCHEMISTRY-US, V36, P5806, DOI 10.1021/bi970185v; SANGER JM, 1987, EUR J CELL BIOL, V43, P421; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Speicher K D, 2000, J Biomol Tech, V11, P74; STEVENSON BR, 1994, J CELL SCI, V107, P367; Wang JS, 2005, CELL MOTIL CYTOSKEL, V62, P35, DOI 10.1002/cm.20083; Weber A, 1999, J BIOL CHEM, V274, P34637, DOI 10.1074/jbc.274.49.34637; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	68	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33265	33280		10.1074/jbc.M110.144873	http://dx.doi.org/10.1074/jbc.M110.144873			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20650902	Green Published, hybrid			2022-12-25	WOS:000283048200063
J	Iturrioz, X; Gerbier, R; Leroux, V; Alvear-Perez, R; Maigret, B; Llorens-Cortes, C				Iturrioz, Xavier; Gerbier, Romain; Leroux, Vincent; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine			By Interacting with the C-terminal Phe of Apelin, Phe(255) and Trp(259) in Helix VI of the Apelin Receptor Are Critical for Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; HARMONIC MOLECULAR-SURFACES; 4TH TRANSMEMBRANE DOMAIN; LIGAND-BINDING; APJ RECEPTOR; IN-VIVO; CHOLECYSTOKININ-1 RECEPTOR; CARDIAC CONTRACTILITY; TRYPTOPHAN RESIDUES; ENDOGENOUS LIGAND	Apelin is the endogenous ligand of the orphan seven-transmembrane domain (TM) G protein-coupled receptor APJ. Apelin is involved in the regulation of body fluid homeostasis and cardiovascular functions. We previously showed the importance of the C-terminal Phe of apelin 17 (K17F) in the hypotensive activity of this peptide. Here, we show either by deleting the Phe residue (K16P) or by substituting it by an Ala (K17A), that it plays a crucial role in apelin receptor internalization but not in apelin binding or in G alpha(i)-protein coupling. Then we built a homology three-dimensional model of the human apelin receptor using the cholecystokinin receptor-1 model as a template, and we subsequently docked K17F into the binding site. We visualized a hydrophobic cavity at the bottom of the binding pocket in which the C-terminal Phe of K17F was embedded by Trp(152) in TMIV and Trp(259) and Phe(255) in TMVI. Using molecular modeling and site-directed mutagenesis studies, we further showed that Phe(255) and Trp(259) are key residues in triggering receptor internalization without playing a role in apelin binding or in G alpha(i)-protein coupling. These findings bring new insights into apelin receptor activation and show that Phe(255) and Trp(259), by interacting with the C-terminal Phe of the pyroglutamyl form of apelin 13 (pE13F) or K17F, are crucial for apelin receptor internalization.	[Iturrioz, Xavier; Gerbier, Romain; Alvear-Perez, Rodrigo; Llorens-Cortes, Catherine] Univ Paris 06, Coll France, INSERM, U691, FR-75005 Paris, France; [Leroux, Vincent; Maigret, Bernard] H Poincare Univ, Orpailleur Grp, LORIA, CNRS,UMR 7503, FR-54506 Nancy, France; [Gerbier, Romain] Univ Paris Descarte, FR-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; UDICE-French Research Universities; Universite Paris Cite	Llorens-Cortes, C (corresponding author), Coll France, INSERM, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	c.llorens-cortes@college-de-france.fr	Llorens-Cortes, Catherine/E-5839-2016; Iturrioz, Xavier/AAS-3555-2020; Llorens-Cortès, catherine/AAL-3893-2021; ITURRIOZ, Xavier/Q-4406-2017; GERBIER, Romain/ABF-2481-2020	Llorens-Cortes, Catherine/0000-0002-7667-0401; Iturrioz, Xavier/0000-0001-7143-8323; Llorens-Cortès, catherine/0000-0002-7667-0401; ITURRIOZ, Xavier/0000-0001-7143-8323; Gerbier, Romain/0000-0003-4617-4850; Leroux, Vincent/0000-0002-4142-0883	Agence Nationale pour la Recherche; Region Ile-de-France	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Region Ile-de-France(Region Ile-de-France)	This work was supported by the Agence Nationale pour la Recherche "Physique et Chimie du Vivant 2009."; Supported by a grant "Cardiovasculaires-Obesite-Diabete" from Region Ile-de-France.	Archer-Lahlou E, 2005, J MED CHEM, V48, P180, DOI 10.1021/jm049886y; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Befort K, 1996, J BIOL CHEM, V271, P10161, DOI 10.1074/jbc.271.17.10161; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Braden MR, 2006, MOL PHARMACOL, V70, P1956, DOI 10.1124/mol.106.028720; Cai W, 2008, J MOL MODEL, V14, P393, DOI 10.1007/s00894-008-0286-z; Cai WS, 2002, J MOL GRAPH MODEL, V20, P313, DOI 10.1016/S1093-3263(01)00134-6; Chauvin S, 2001, BIOCHEM PHARMACOL, V62, P329, DOI 10.1016/S0006-2952(01)00675-X; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Chen SH, 2002, BIOCHEMISTRY-US, V41, P6045, DOI 10.1021/bi012189c; Chen SH, 2002, BIOCHEMISTRY-US, V41, P588, DOI 10.1021/bi011868k; Chini B, 1996, FEBS LETT, V397, P201, DOI 10.1016/S0014-5793(96)01135-0; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Escrieut C, 2002, J BIOL CHEM, V277, P7546, DOI 10.1074/jbc.M108563200; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Han HMCB, 1998, MOL ENDOCRINOL, V12, P810, DOI 10.1210/me.12.6.810; Henin J, 2006, BIOPHYS J, V90, P1232, DOI 10.1529/biophysj.105.070599; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Iturrioz X, 2000, BIOCHEMISTRY-US, V39, P3061, DOI 10.1021/bi9925726; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Lenkei Z, 2000, J HISTOCHEM CYTOCHEM, V48, P1553, DOI 10.1177/002215540004801112; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; O'Carroll AM, 2003, J NEUROENDOCRINOL, V15, P661, DOI 10.1046/j.1365-2826.2003.01044.x; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pulakat L, 2004, BIOCHEM BIOPH RES CO, V319, P1138, DOI 10.1016/j.bbrc.2004.05.092; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Rhee MH, 2000, J NEUROCHEM, V75, P2485, DOI 10.1046/j.1471-4159.2000.0752485.x; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Suzuki T, 2009, J NEUROCHEM, V110, P1352, DOI 10.1111/j.1471-4159.2009.06227.x; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thomas A, 2002, PROTEINS, V48, P635, DOI 10.1002/prot.10191; Tikhonova IG, 2007, CURR TOP MED CHEM, V7, P1243; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; Zhou NM, 2003, VIROLOGY, V307, P22, DOI 10.1016/S0042-6822(02)00021-1	61	57	62	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32627	32637		10.1074/jbc.M110.127167	http://dx.doi.org/10.1074/jbc.M110.127167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20675385	hybrid, Green Published			2022-12-25	WOS:000282683000077
J	Lau, KM; Chan, QKY; Pang, JCS; Li, KKW; Yeung, WW; Chung, NYF; Lui, PC; Tam, YS; Li, HM; Zhou, L; Wang, Y; Mao, Y; Ng, HK				Lau, K-M; Chan, Q. K. Y.; Pang, J. C. S.; Li, K. K. W.; Yeung, W. W.; Chung, N. Y. F.; Lui, P. C.; Tam, Y-S; Li, H-M; Zhou, L.; Wang, Y.; Mao, Y.; Ng, H-K			Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion	ONCOGENE			English	Article						medulloblastoma; MCM2; MCM3; MCM7; migration; invasion	COMPARATIVE GENOMIC HYBRIDIZATION; PRIMITIVE NEUROECTODERMAL TUMORS; DNA-REPLICATION; MCM PROTEINS; PROLIFERATION MARKER; PEDIATRIC MEDULLOBLASTOMAS; INDEPENDENT PREDICTOR; CHECKPOINT KINASES; PROSTATE-CANCER; S-PHASE	Minichromosome maintenance (MCM) proteins 2-7 are important in DNA replication licensing. Functional roles beyond licensing are speculated. In addition, significances in medulloblastoma (MB) remain unclear. In this study, we showed the frequent deregulation of MCM2 and MCM3 expression in 7 MB cell lines and 31 clinical samples. Moreover, DAOY and ONS76 and the clinical samples expressed elevated MCM7 transcripts with genomic gain of the gene. Immunopositivity restricted to tumor cells was found in 41, 37 and 53 out of 73 MB cases for MCM2, MCM3 and MCM7, respectively. High-MCM3 expression was associated with poor prognosis. Knockdowns of these MCMs significantly inhibited anchorage-dependent and -independent MB cell growth. The inhibition of MCM3 expression by small interfering RNA knockdown was related to G1 arrest with reduced cyclin A expression, whereas the MCM2- and MCM7-knocked-down cells arrested at G2/M with increased cyclin A expression. Interestingly, we demonstrated the links of these MCMs with cell migration and invasion using wound-healing and Transwell migration/invasion assays. Exogenous overexpression of MCM2, MCM3 and MCM7 increased anchorage-independent cell growth, and also cell migration and invasion capabilities in MB cells. The knockdown reduced the number of filopodial cells and the cells with intense stress fibers by blocking cdc42 and Rho activation. Taken together, deregulation of MCM2, MCM3 and MCM7 expression might be involved in MB tumorigenesis and we revealed undefined roles of these MCMs in control of MB cell migration and invasion. Oncogene (2010) 29, 5475-5489; doi:10.1038/onc.2010.287; published online 26 July 2010	[Lau, K-M; Chan, Q. K. Y.; Pang, J. C. S.; Li, K. K. W.; Yeung, W. W.; Chung, N. Y. F.; Lui, P. C.; Tam, Y-S; Li, H-M; Ng, H-K] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Lau, K-M; Pang, J. C. S.; Ng, H-K] Chinese Univ Hong Kong, State Key Lab So China Oncol, Shatin, Hong Kong, Peoples R China; [Zhou, L.; Mao, Y.] Fudan Univ, Hua Shan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Wang, Y.] Fudan Univ, Hua Shan Hosp, Dept Neuropathol, Shanghai 200433, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Fudan University; Fudan University	Lau, KM (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Room 38018,Clinical Sci Bldg, Shatin, Hong Kong, Peoples R China.	kmlau@cuhk.edu.hk; hkng@cuhk.edu.hk	Ng, Ho Keung/I-3952-2015	Mao, Ying/0000-0001-8055-115X; Lau, Kin-Mang/0000-0001-5888-1937	Hong Kong Research Grants Council [472307]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by the Hong Kong Research Grants Council General Research Fund 472307.	Avet-Loiseau H, 1999, BRIT J CANCER, V79, P1843, DOI 10.1038/sj.bjc.6690293; Bailis JM, 2004, CURR OPIN GENET DEV, V14, P17, DOI 10.1016/j.gde.2003.11.002; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; BURKHART R, 1995, EUR J BIOCHEM, V228, P431; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Crevel G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000833; DaFonseca CJ, 2001, P NATL ACAD SCI USA, V98, P3034, DOI 10.1073/pnas.061487598; De Bortoli M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-223; Dudderidge TJ, 2007, BRIT J CANCER, V96, P1384, DOI 10.1038/sj.bjc.6603718; Dudderidge TJ, 2005, CLIN CANCER RES, V11, P2510, DOI 10.1158/1078-0432.CCR-04-1776; Eberhart CG, 2002, BRAIN PATHOL, V12, P36, DOI 10.1111/j.1750-3639.2002.tb00420.x; Endl E, 2001, J PATHOL, V195, P457, DOI 10.1002/path.978; Feng DR, 2003, CANCER RES, V63, P7356; Fitch MJ, 2003, J BIOL CHEM, V278, P25408, DOI 10.1074/jbc.M300699200; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Freeman A, 1999, CLIN CANCER RES, V5, P2121; GIANGASPERO F, 2000, PATHOLOGY GENETICS T, P129; Gilhuis HJ, 2000, CLIN NEUROL NEUROSUR, V102, P203, DOI 10.1016/S0303-8467(00)00112-8; Giordana MT, 1998, CHILD NERV SYST, V14, P256, DOI 10.1007/s003810050221; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Gonzalez MA, 2003, J CLIN ONCOL, V21, P4306, DOI 10.1200/JCO.2003.04.121; Ha SA, 2004, CLIN CANCER RES, V10, P8386, DOI 10.1158/1078-0432.CCR-04-1029; Hanna-Morris A, 2009, J CLIN PATHOL, V62, P325, DOI 10.1136/jcp.2007.054643; Haverty PM, 2002, NUCLEIC ACIDS RES, V30, P214, DOI 10.1093/nar/30.1.214; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Hui ABY, 2005, CLIN CANCER RES, V11, P4707, DOI 10.1158/1078-0432.CCR-05-0128; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Kato H, 2003, J SURG ONCOL, V84, P24, DOI 10.1002/jso.10287; Ke N, 2004, BIOTECHNIQUES, V36, P826, DOI 10.2144/04365ST07; Korkolopoulou P, 2005, HUM PATHOL, V36, P899, DOI 10.1016/j.humpath.2005.06.008; Lei M, 2005, CURR CANCER DRUG TAR, V5, P365, DOI 10.2174/1568009054629654; Lei M, 1996, MOL CELL BIOL, V16, P5081; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng MV, 2001, CLIN CANCER RES, V7, P2712; Nicholson JC, 1999, BRIT J CANCER, V80, P1322, DOI 10.1038/sj.bjc.6690525; Nishihara K, 2008, INT J ONCOL, V33, P245, DOI 10.3892/ijo_00000003; Nishizaki T, 1999, PEDIATR NEUROSURG, V31, P27, DOI 10.1159/000028827; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Ramnath N, 2001, J CLIN ONCOL, V19, P4259, DOI 10.1200/JCO.2001.19.22.4259; Reardon DA, 1997, CANCER RES, V57, P4042; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Rodins K, 2002, CLIN CANCER RES, V8, P1075; Rossi MR, 2006, GENE CHROMOSOME CANC, V45, P290, DOI 10.1002/gcc.20292; Schrader C, 2005, BRIT J CANCER, V93, P939, DOI 10.1038/sj.bjc.6602795; Scott WC, 2005, AM J DRUG ALCOHOL AB, V31, P455, DOI 10.1081/ADA-200056807; Shechter D, 2004, P NATL ACAD SCI USA, V101, P10845, DOI 10.1073/pnas.0404143101; Stoeber K, 2001, J CELL SCI, V114, P2027; Tachibana KEK, 2005, J PATHOL, V205, P123, DOI 10.1002/path.1708; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; TODOROV IT, 1994, J CELL SCI, V107, P253; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tong CYK, 2004, J NEUROSURG, V100, P187, DOI 10.3171/ped.2004.100.2.0187; Wharton SB, 2007, ACTA NEUROPATHOL, V113, P119, DOI 10.1007/s00401-006-0177-2; Wharton SB, 2001, NEUROPATH APPL NEURO, V27, P305, DOI 10.1046/j.0305-1846.2001.00333.x; Williams GH, 2007, CURR OPIN CELL BIOL, V19, P672, DOI 10.1016/j.ceb.2007.10.005; Yankulov K, 1999, MOL CELL BIOL, V19, P6154; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024	60	72	75	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	40					5475	5489		10.1038/onc.2010.287	http://dx.doi.org/10.1038/onc.2010.287			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FM	20661220				2022-12-25	WOS:000282945800005
J	Seong, HA; Jung, H; Ha, H				Seong, Hyun-A; Jung, Haiyoung; Ha, Hyunjung			Murine Protein Serine/Threonine Kinase 38 Stimulates TGF-beta Signaling in a Kinase-dependent Manner via Direct Phosphorylation of Smad Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE KINASE; RECEPTOR-ASSOCIATED PROTEIN; MIGRATION INHIBITORY FACTOR; NM23-H1 TUMOR-SUPPRESSOR; NUCLEAR ACCUMULATION; PHYSICAL INTERACTION; HEMATOPOIETIC-CELLS; MELK; EXPRESSION; SUBSTRATE	The present study demonstrated that murine protein serine/threonine kinase 38 (MPK38) coimmunoprecipitates with Smad proteins (Smad2, -3, -4, and -7) and that this association is mediated by the catalytic kinase domain of MPK38. The association between MPK38 and Smad2, -3, and -4 was significantly increased by TGF-beta or ASK1 signals, whereas these signals decreased association of MPK38 with Smad7. MPK38 stimulated TGF-beta-induced transcription required for TGF-beta-mediated biological functions, such as apoptosis and cell growth arrest, in a kinase-dependent manner. Knockdown of endogenous MPK38 showed an opposite effect, inhibiting TGF-beta signaling. MPK38-mediated phosphorylation of Smad proteins (Ser(245) of Smad2, Ser(204) of Smad3, Ser(343) of Smad4, and Thr(96) of Smad7) was also found to be crucial to the positive regulation of TGF-beta signaling induced by MPK38. In addition, MPK38 enhanced nuclear translocation of Smad3, as well as redistribution of Smad7 from the nucleus to the cytoplasm, in response to TGF-beta. Together, these results indicate that MPK38 functions as a stimulator of TGF-beta signaling through direct interaction with and phosphorylation of Smad proteins.	[Seong, Hyun-A; Jung, Haiyoung; Ha, Hyunjung] Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr			National Research Foundation of Korea [R0A-2007-000-20006-0]; Chungbuk National University	National Research Foundation of Korea(National Research Foundation of Korea); Chungbuk National University	This work was supported by Grant R0A-2007-000-20006-0 from the National Research Foundation of Korea and in part by Chungbuk National University Grant 2009.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; BACHVAROVA R, 1989, DEVELOPMENT, V106, P561; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Glesne D, 2006, ONCOGENE, V25, P4086, DOI 10.1038/sj.onc.1209436; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Heyer BS, 1999, DEV DYNAM, V215, P344; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung HY, 2010, J BIOL CHEM, V285, P54, DOI 10.1074/jbc.M109.045229; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Ohsugi M, 1996, DEV DYNAM, V206, P391, DOI 10.1002/(SICI)1097-0177(199608)206:4<391::AID-AJA5>3.0.CO;2-D; Pulaski L, 2001, J BIOL CHEM, V276, P14344, DOI 10.1074/jbc.M011019200; Roelen BAJ, 2003, AM J PHYSIOL-CELL PH, V285, pC823, DOI 10.1152/ajpcell.00053.2003; Saito R, 2005, MOL CELL BIOL, V25, P6682, DOI 10.1128/MCB.25.15.6682-6693.2005; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yang Y, 1999, APPL BIOCHEM BIOTECH, V80, P13, DOI 10.1385/ABAB:80:1:13; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135	38	40	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30959	30970		10.1074/jbc.M110.138370	http://dx.doi.org/10.1074/jbc.M110.138370			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659902	hybrid, Green Published			2022-12-25	WOS:000282135500061
J	Ma, T; Sadashivaiah, K; Chellaiah, MA				Ma, Tao; Sadashivaiah, Kavitha; Chellaiah, Meenakshi A.			Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CD44 SURFACE EXPRESSION; SRC KINASE-ACTIVITY; FREEZE-DRIED BONE; C-SRC; ALPHA(V)BETA(3) INTEGRIN; PODOSOME FORMATION; CELL-ADHESION; PROTEIN; ZONE	The aim of this study is to identify the exact mechanism(s) by which cytoskeletal structures are modulated during bone resorption. In this study, we have shown the possible role of different actin-binding and signaling proteins in the regulation of sealing ring formation. Our analyses have demonstrated a significant increase in cortactin and a corresponding decrease in L-plastin protein levels in osteoclasts subjected to bone resorption for 18 h in the presence of RANKL, M-CSF, and native bone particles. Time-dependent changes in the localization of L-plastin (in actin aggregates) and cortactin (in the sealing ring) suggest that these proteins may be involved in the initial and maturation phases of sealing ring formation, respectively. siRNA to cortactin inhibits this maturation process but not the formation of actin aggregates. Osteoclasts treated as above but with TNF-alpha demonstrated very similar effects as observed with RANKL. Osteoclasts treated with a neutralizing antibody to TNF-alpha displayed podosome-like structures in the entire subsurface and at the periphery of osteoclast. It is possible that TNF-alpha and RANKL-mediated signaling may play a role in the early phase of sealing ring configuration (i.e. either in the disassembly of podosomes or formation of actin aggregates). Furthermore, osteoclasts treated with alendronate or alpha v reduced the formation of the sealing ring but not actin aggregates. The present study demonstrates a novel mechanistic link between L-plastin and cortactin in sealing ring formation. These results suggest that actin aggregates formed by L-plastin independent of integrin signaling function as a core in assembling signaling molecules (integrin alpha v beta 3, Src, cortactin, etc.) involved in the maturation process.	[Ma, Tao; Sadashivaiah, Kavitha; Chellaiah, Meenakshi A.] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Chellaiah, MA (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, 650 W Baltimore St, Baltimore, MD 21201 USA.	mchellaiah@umaryland.edu			NIAMS [AR46292]; American Society for Bone and Mineral Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046292, R56AR046292] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Society for Bone and Mineral Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of multiple signaling molecules that play a part in the assembly of Health, NIAMS, Grant AR46292. This work was also supported by bridge funding provided by the American Society for Bone and Mineral Research.	Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Atkins GJ, 2000, J BONE MINER RES, V15, P640, DOI 10.1359/jbmr.2000.15.4.640; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; Banin S, 1996, CURR BIOL, V6, P981, DOI 10.1016/S0960-9822(02)00642-5; BECKER W, 1995, J PERIODONTOL, V66, P822, DOI 10.1902/jop.1995.66.9.822; BLAIR HC, 1986, J CELL BIOL, V102, P1164, DOI 10.1083/jcb.102.4.1164; Boissy P, 2002, ENDOCRINOLOGY, V143, P1913, DOI 10.1210/en.143.5.1913; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Carron CP, 2000, J ENDOCRINOL, V165, P587, DOI 10.1677/joe.0.1650587; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Chellaiah MA, 2003, MOL BIOL CELL, V14, P173, DOI 10.1091/mbc.E02-06-0354; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Chellaiah MA, 2007, J BIOL CHEM, V282, P10104, DOI 10.1074/jbc.M608957200; Chellaiah MA, 2009, J CELL PHYSIOL, V220, P382, DOI 10.1002/jcp.21777; Chen H, 2003, IMMUNITY, V19, P95, DOI 10.1016/S1074-7613(03)00172-9; Desai B, 2008, J BIOL CHEM, V283, P13856, DOI 10.1074/jbc.M709401200; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Duong LT, 1998, J CLIN INVEST, V102, P881, DOI 10.1172/JCI3212; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gupta A, 2003, J BONE MINER RES, V18, P669, DOI 10.1359/jbmr.2003.18.4.669; Hartman GD, 2000, EXPERT OPIN INV DRUG, V9, P1281, DOI 10.1517/13543784.9.6.1281; HOROWITZ MC, 1993, SCIENCE, V260, P626, DOI 10.1126/science.8480174; HORTON MA, 1993, J BONE MINER RES, V8, P239; Hurst IR, 2004, J BONE MINER RES, V19, P499, DOI 10.1359/JBMR.0301238; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kaji K, 2001, J BONE MINER RES, V16, P1593, DOI 10.1359/jbmr.2001.16.9.1593; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Lakkakorpi PT, 1999, J BIOL CHEM, V274, P4900, DOI 10.1074/jbc.274.8.4900; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; Lakkakorpi PT, 2001, J CELL SCI, V114, P149; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lam J, 2002, ANN RHEUM DIS, V61, P82; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271; Ma Tao, 2008, J Mol Signal, V3, P4, DOI 10.1186/1750-2187-3-4; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Matsubara T, 2006, J BONE MINER METAB, V24, P368, DOI 10.1007/s00774-006-0701-4; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mundy G, 2001, SEMIN ONCOL, V28, P2, DOI 10.1053/sonc.2001.25441; MURAKAMI H, 1995, BONE, V17, P137, DOI 10.1016/S8756-3282(95)00150-6; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakano K, 2001, MOL BIOL CELL, V12, P3515, DOI 10.1091/mbc.12.11.3515; Pacifici R, 1996, J BONE MINER RES, V11, P1043; PIPER K, 1995, CALCIFIED TISSUE INT, V56, P382, DOI 10.1007/BF00301607; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Samanna V, 2006, EXP CELL RES, V312, P2214, DOI 10.1016/j.yexcr.2006.03.022; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schwartz Z, 1998, J PERIODONTOL, V69, P1337, DOI 10.1902/jop.1998.69.12.1337; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; TAYLOR ML, 1989, ANAT EMBRYOL, V180, P427, DOI 10.1007/BF00305117; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417	74	43	45	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29911	29924		10.1074/jbc.M109.099697	http://dx.doi.org/10.1074/jbc.M109.099697			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650888	hybrid, Green Published			2022-12-25	WOS:000281984300028
J	Sakamoto, T; Seiki, M				Sakamoto, Takeharu; Seiki, Motoharu			A Membrane Protease Regulates Energy Production in Macrophages by Activating Hypoxia-inducible Factor-1 via a Non-proteolytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MATRIX-METALLOPROTEINASE; CYTOPLASMIC TAIL; CELL INVASION; UP-REGULATION; TUMOR-GROWTH; MT1-MMP; HIF-1-ALPHA; BINDING; PHOSPHORYLATION	Most cells produce ATP in the mitochondria by oxidative phosphorylation. However, macrophages, which are major players in the innate immune system, use aerobic glycolysis to produce ATP. HIF-1 (hypoxia-inducible factor-1) regulates expression of glycolysis-related genes and maintains macrophage glycolytic activity. However, it is unclear how HIF-1 activity is maintained in macrophages during normoxia. In this study, we found that macrophages lacking membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14), a potent invasion-promoting protease, exhibited considerably lower ATP levels than wild-type cells. HIF-1 was activated by an unanticipated function of MT1-MMP, which led to the stimulation of ATP production via glycolysis. The cytoplasmic tail of MT1-MMP bound to FIH-1 (factor inhibiting HIF-1), which led to the inhibition of the latter by its recently identified inhibitor, Mint3/APBA3. We have thus identified a new function of MT1-MMP to mediate production of ATP so as to support energy-dependent macrophage functions by a previously unknown non-proteolytic mechanism.	[Sakamoto, Takeharu; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Sakamoto, Takeharu/0000-0002-1225-1902; 	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Specific Coordination Fund for Promoting Science (to T. S.), by a grant-in-aid for scientific research on priority areas (i.e the "Integrative Research toward the Conquest of Cancer") (to M. S.), and by the Global Centers of Excellence Program "Center of Education and Research for the Advanced Genome-Based Medicine: For personalized medicine and the control of worldwide infectious diseases" (to T. S. and M. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Deryugina EI, 2002, CANCER RES, V62, P580; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Zucker S, 2002, LAB INVEST, V82, P1673, DOI 10.1097/01.LAB.0000041713.74852.2A	44	70	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29951	29964		10.1074/jbc.M110.132704	http://dx.doi.org/10.1074/jbc.M110.132704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663879	hybrid, Green Published			2022-12-25	WOS:000281984300032
J	Wang, YD; Mohsen, AW; Mihalik, SJ; Goetzman, ES; Vockley, J				Wang, Yudong; Mohsen, Al-Walid; Mihalik, Stephanie J.; Goetzman, Eric S.; Vockley, Jerry			Evidence for Physical Association of Mitochondrial Fatty Acid Oxidation and Oxidative Phosphorylation Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; ACYL-COA DEHYDROGENASE; BETA-OXIDATION; UBIQUINONE OXIDOREDUCTASE; MAMMALIAN MITOCHONDRIA; MULTIENZYME COMPLEX; YEAST MITOCHONDRIA; MOLECULAR-CLONING; PROTEIN COMPLEXES; ELECTRON-TRANSFER	Fatty acid beta-oxidation (FAO) and oxidative phosphorylation (OXPHOS) are key pathways involved in cellular energetics. Reducing equivalents from FAO enter OXPHOS at the level of complexes I and III. Genetic disorders of FAO and OXPHOS are among the most frequent inborn errors of metabolism. Patients with deficiencies of either FAO or OXPHOS often show clinical and/or biochemical findings indicative of a disorder of the other pathway. In this study, the physical and functional interactions between these pathways were examined. Extracts of isolated rat liver mitochondria were subjected to blue native polyacrylamide gel electrophoresis (BNGE) to separate OXPHOS complexes and supercomplexes followed by Western blotting using antisera to various FAO enzymes. Extracts were also subjected to sucrose density centrifugation and fractions analyzed by BNGE or enzymatic assays. Several FAO enzymes co-migrated with OXPHOS supercomplexes in different patterns in the gels. When palmitoyl-CoA was added to the sucrose gradient fractions containing OXPHOS supercomplexes in the presence of potassium cyanide, cytochrome c was reduced. Cytochrome c reduction was completely blocked by myxothiazol (a complex III inhibitor) and 3-mercaptopropionate (an inhibitor of the first step of FAO), but was only partially inhibited by rotenone (a complex I inhibitor). Although palmitoyl-CoA and octanoyl-CoA provided reducing equivalents to OXPHOS-containing supercomplex fractions, no accumulation of their intermediates was detected. In contrast, short branched acyl-CoA substrates were not metabolized by OXPHOS-containing supercomplex fractions. These data provide evidence of a multifunctional FAO complex within mitochondria that is physically associated with OXPHOS supercomplexes and promotes metabolic channeling.	Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Vockley, Jerry] Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vockley, J (corresponding author), 4401 Penn Ave, Pittsburgh, PA 15224 USA.	gerard.vockley@chp.edu	Wang, Yudong/ABG-1086-2021; Mohsen, Al-Walid/D-6577-2018; Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Wang, Yudong/0000-0003-3224-4555; Mohsen, Al-Walid/0000-0002-0096-5959; Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457	U.S. Public Health Service [DKR01-78775, DKR01-54936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076573, R01DK078775] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by U.S. Public Health Service Grants DKR01-78775 and DKR01-54936. To whom correspondence should be addressed: 4401 Penn Ave., Pittsburgh, PA 15224. Fax: 412-692-7816; E-mail: gerard.vockley@chp.edu.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; BENNETT MJ, 1994, J INHERIT METAB DIS, V17, P283, DOI 10.1007/BF00711808; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Enns GM, 2000, J PEDIATR-US, V136, P251, DOI 10.1016/S0022-3476(00)70111-9; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Fang J, 2001, EUR J BIOCHEM, V268, P3075, DOI 10.1046/j.1432-1327.2001.02205.x; FRASER JL, 1995, MODERN PATHOL, V8, P65; FRERMAN FE, 1987, BIOCHIM BIOPHYS ACTA, V893, P161, DOI 10.1016/0005-2728(87)90035-1; Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013; Goodpaster BH, 2002, OBES RES, V10, P575, DOI 10.1038/oby.2002.78; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Ishikawa M, 1997, BIOCHEM J, V328, P815, DOI 10.1042/bj3280815; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jethva R, 2008, MOL GENET METAB, V95, P195, DOI 10.1016/j.ymgme.2008.09.007; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KISPAL G, 1986, J BIOL CHEM, V261, P14209; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Mohsen AA, 1998, BIOCHEMISTRY-US, V37, P10325, DOI 10.1021/bi973096r; NADA MA, 1995, J BIOL CHEM, V270, P530, DOI 10.1074/jbc.270.2.530; Parker A, 2000, BIOCHEM J, V345, P429, DOI 10.1042/0264-6021:3450429; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PROCHASKA LJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P360, DOI 10.1016/0005-2728(81)90175-4; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; SUMEGI B, 1991, BIOCHIM BIOPHYS ACTA, V1081, P121, DOI 10.1016/0005-2760(91)90016-B; SUMEGI B, 1985, J BIOL CHEM, V260, P188; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Uchiyama A, 1996, J BIOL CHEM, V271, P30360, DOI 10.1074/jbc.271.48.30360; VAN COSTER R, 2001, PEDIATR RES, V50, P658; Venizelos N, 1998, J INHERIT METAB DIS, V21, P409, DOI 10.1023/A:1005310809714; Vockley J, 2000, METHOD ENZYMOL, V324, P241; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; Wang YD, 1998, ARCH BIOCHEM BIOPHYS, V352, P193, DOI 10.1006/abbi.1998.0590; WANG YD, 1995, BIOCHEMISTRY-US, V34, P7476, DOI 10.1021/bi00022a022; Yu WF, 2004, J BIOL CHEM, V279, P52160, DOI 10.1074/jbc.M409640200	44	108	109	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29834	29841		10.1074/jbc.M110.139493	http://dx.doi.org/10.1074/jbc.M110.139493			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663895	hybrid, Green Published			2022-12-25	WOS:000281984300019
J	Nakahara, Y; Kanamori, Y; Kiuchi, M; Kamimura, M				Nakahara, Yuichi; Kanamori, Yasushi; Kiuchi, Makoto; Kamimura, Manabu			Two Hemocyte Lineages Exist in Silkworm Larval Hematopoietic Organ	PLOS ONE			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; PARALYTIC PEPTIDE; LEPIDOPTERAN INSECT; MANDUCA-SEXTA; IN-VITRO; CELL; MOTH; DIFFERENTIATION; HEMOLYMPH; DIVISION	Background: Insects have multiple hemocyte morphotypes with different functions as do vertebrates, however, their hematopoietic lineages are largely unexplored with the exception of Drosophila melanogaster. Methodology/Principal Findings: To study the hematopoietic lineage of the silkworm, Bombyx mori, we investigated in vivo and in vitro differentiation of hemocyte precursors in the hematopoietic organ (HPO) into the four mature hemocyte subsets, namely, plasmatocytes, granulocytes, oenocytoids, and spherulocytes. Five days after implantation of enzymatically-dispersed HPO cells from a GFP-expressing transgenic line into the hemocoel of normal larvae, differentiation into plasmatocytes, granulocytes and oenocytoids, but not spherulocytes, was observed. When the HPO cells were cultured in vitro, plasmatocytes appeared rapidly, and oenocytoids possessing prophenol oxidase activity appeared several days later. HPO cells were also able to differentiate into a small number of granulocytes, but not into spherulocytes. When functionally mature plasmatocytes were cultured in vitro, oenocytoids were observed 10 days later. These results suggest that the hemocyte precursors in HPO first differentiate into plasmatocytes, which further change into oenocytoids. Conclusions/Significance: From these results, we propose that B. mori hemocytes can be divided into two major lineages, a granulocyte lineage and a plasmatocyte-oenocytoid lineage. The origins of the spherulocytes could not be determined in this study. We construct a model for the hematopoietic lineages at the larval stage of B. mori.	[Nakahara, Yuichi; Kanamori, Yasushi; Kiuchi, Makoto; Kamimura, Manabu] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan	Nakahara, Y (corresponding author), Teikyo Univ, Sch Med, Dept Biochem, Tokyo 173, Japan.	kamimura@affrc.go.jp			Bio-oriented Technology Research Advancement Institution (BRAIN) of Japan	Bio-oriented Technology Research Advancement Institution (BRAIN) of Japan	This work was supported by the Bio-oriented Technology Research Advancement Institution (BRAIN) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI H, 1973, International Journal of Insect Morphology and Embryology, V2, P207, DOI 10.1016/0020-7322(73)90029-9; AKAI H, 1971, J INSECT PHYSIOL, V17, P1665, DOI 10.1016/0022-1910(71)90062-X; ARNOLD JW, 1976, CAN J ZOOL, V54, P1003, DOI 10.1139/z76-112; ASHIDA M, 1988, TISSUE CELL, V20, P599, DOI 10.1016/0040-8166(88)90061-4; BEAULATON J, 1979, BIOCHIMIE, V61, P157, DOI 10.1016/S0300-9084(79)80064-4; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Gardiner EMM, 2000, ARCH INSECT BIOCHEM, V43, P147, DOI 10.1002/(SICI)1520-6327(200004)43:4&lt;147::AID-ARCH1&gt;3.0.CO;2-J; Gardiner EMM, 1999, J INSECT PHYSIOL, V45, P113, DOI 10.1016/S0022-1910(98)00092-4; Gupta A. P., 1979, INSECT HEMOCYTES DEV, P86; Han SS, 1998, ZOOL SCI, V15, P371, DOI 10.2108/zsj.15.371; HINKS CF, 1977, CAN J ZOOL, V55, P1740, DOI 10.1139/z77-225; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Imamura M, 2006, INSECT BIOCHEM MOLEC, V36, P429, DOI 10.1016/j.ibmb.2006.03.002; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; KURIHARA Y, 1992, APPL ENTOMOL ZOOL, V27, P225, DOI 10.1303/aez.27.225; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lavine MD, 2005, INSECT BIOCHEM MOLEC, V35, P1335, DOI 10.1016/j.ibmb.2005.08.005; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ling E, 2005, TISSUE CELL, V37, P101, DOI 10.1016/j.tice.2004.10.007; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Matsumoto Y, 2003, J BIOL CHEM, V278, P38579, DOI 10.1074/jbc.M305986200; MITSUHASHI J, 1988, APPL ENTOMOL ZOOL, V23, P488, DOI 10.1303/aez.23.488; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Nakahara Y, 2003, J INSECT PHYSIOL, V49, P907, DOI 10.1016/S0022-1910(03)00149-5; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nakahara Y, 2009, DEV COMP IMMUNOL, V33, P439, DOI 10.1016/j.dci.2008.09.005; Nardi JB, 2004, DEV GENES EVOL, V214, P19, DOI 10.1007/s00427-003-0371-3; Nardi JB, 2003, DEV GENES EVOL, V213, P477, DOI 10.1007/s00427-003-0352-6; Nittono Y., 1960, B SERIC EXP STA TOKY, V16, P171; OCHIAI M, 1992, CELL TISSUE RES, V268, P431, DOI 10.1007/BF00319149; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Saito T, 2003, APPL ENTOMOL ZOOL, V38, P583, DOI 10.1303/aez.2003.583; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; TAKADA M, 1971, JPN J ENTOMOL, V39, P385; Wago Haruhisa, 1991, P215; Wang CL, 2010, INSECT SCI, V17, P7, DOI 10.1111/j.1744-7917.2009.01288.x; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Yamashita M, 2001, J INSECT PHYSIOL, V47, P325, DOI 10.1016/S0022-1910(00)00144-X	46	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11816	10.1371/journal.pone.0011816	http://dx.doi.org/10.1371/journal.pone.0011816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676370	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520100007
J	Hwang, J; Graves, PM; Jima, D; Reithinger, R; Kachur, SP				Hwang, Jimee; Graves, Patricia M.; Jima, Daddi; Reithinger, Richard; Kachur, S. Patrick		Ethiopia MIS Working Grp	Knowledge of Malaria and Its Association with Malaria-Related Behaviors-Results from the Malaria Indicator Survey, Ethiopia, 2007	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; CHILDHOOD FEBRILE ILLNESSES; RANDOMIZED CONTROLLED-TRIAL; PREGNANT-WOMEN; BED NETS; TREATMENT SEEKING; RURAL ETHIOPIA; WESTERN KENYA; CHILDREN; OWNERSHIP	Background: In 2005, the Ministry of Health in Ethiopia launched a major effort to distribute over 20 million long-lasting insecticidal nets, provide universal access to artemisinin-based combination therapy (ACTs), and train 30,000 village-based health extension workers. Methods and Findings: A cross-sectional, nationally representative Malaria Indicator Survey was conducted during the malaria transmission season in 2007. Multivariate logistic regression analyses were performed to assess the effect of women's malaria knowledge on household ITN ownership and women's ITN use. In addition, we investigated the effect of mothers' malaria knowledge on their children under 5 years of age's (U5) ITN use and their access to fever treatment on behalf of their child U5. Malaria knowledge was based on a composite index about the causes, symptoms, danger signs and prevention of malaria. Approximately 67% of women (n = 5,949) and mothers of children U5 (n = 3,447) reported some knowledge of malaria. Women's knowledge of malaria was significantly associated with household ITN ownership (adjusted Odds Ratio [aOR] = 2.1; 95% confidence interval [CI] 1.6-2.7) and with increased ITN use for themselves (aOR = 1.8; 95% CI 1.3-2.5). Knowledge of malaria amongst mothers of children U5 was associated with ITN use for their children U5 (aOR = 1.6; 95% CI 1.1-2.4), but not significantly associated with their children U5 seeking care for a fever. School attendance was a significant factor in women's ITN use (aOR = 2.0; 95% CI 1.1-3.9), their children U5's ITN use (aOR = 4.4; 95% CI 1.6-12.1), and their children U5 having sought treatment for a fever (aOR = 6.5; 95% CI 1.9-22.9). Conclusions: Along with mass free distribution of ITNs and universal access to ACTs, delivery of targeted malaria educational information to women could improve ITN ownership and use. Efforts to control malaria could be influenced by progress towards broader goals of improving access to education, especially for women.	[Hwang, Jimee; Kachur, S. Patrick] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Hwang, Jimee] UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA USA; [Graves, Patricia M.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Jima, Daddi] Ethiopian Hlth & Nutr Res Inst, Addis Ababa, Ethiopia; [Reithinger, Richard] US Agcy Int Dev, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Emory University; Ethiopian Health & Nutrition Research Institute; United States Agency for International Development (USAID)	Hwang, J (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA USA.	jhwang@cdc.gov	Kachur, Patrick/ABE-7220-2021; Graves, Patricia M/J-8691-2014	Graves, Patricia M/0000-0002-5215-3901; Ngondi, Jeremiah/0000-0003-4357-4816	United States Agency for International Development; Carter Center; Malaria Control and Evaluation Partnership in Africa (MACEPA) at PATH	United States Agency for International Development(United States Agency for International Development (USAID)); Carter Center; Malaria Control and Evaluation Partnership in Africa (MACEPA) at PATH	The Ethiopian Federal Ministry of Health received funding for this national survey from the United States Agency for International Development, The Carter Center, and The Malaria Control and Evaluation Partnership in Africa (MACEPA) at PATH. Although the above funding partners provided technical assistance in the study design, data collection and analysis and preparation of the manuscript, all decisions to publish were made by the Ministry of Health. Centers for Disease Control and Prevention also provided technical assistance in the study design, data collection and analysis, and preparation of the manuscript, but did not provide funding for this evaluation. The opinions expressed in this paper are those of the authors and may not reflect the position of their employing organizations nor of the sources of funding.	Alaii JA, 2003, AM J TROP MED HYG, V68, P128, DOI 10.4269/ajtmh.2003.68.128; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], GLOB MAL ACT PLAN; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; *CENTR STAT AG MAC, 2006, ETH DEM HLTH SURV 20; Chirdan OO, 2008, ANN AFR MED, V7, P112, DOI 10.4103/1596-3519.55667; De La Cruz N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-61; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; DERESSA W, 2007, MALAR J, V6; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Deressa W, 2007, ACTA TROP, V102, P1, DOI 10.1016/j.actatropica.2007.02.009; Deribew A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-121; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Eng JLV, 2007, AM J TROP MED HYG, V77, P393, DOI 10.4269/ajtmh.2007.77.393; *ETH FED MIN HLTH, 2006, NAT 5 YEAR STRAT PLA; *ETH FED MIN HLTH, 2008, ETH NAT MAL IND SURV; *ETH FED MIN HLTH, 2008, HLTH HLTH REL IND RE; *ETH MIN HLTH FED, 2009, NAT STRAT PLAN MAL P; Fernando SD, 2008, T ROY SOC TROP MED H, V102, P1081, DOI 10.1016/j.trstmh.2008.06.007; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; *GOV REP ZAMB MIN, 2009, ZAMB NAT MAL IND SUR; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Hanson K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2434; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kazembe LN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-40; Kleinbaum D. G., 2005, LOGISTIC REGRESSION; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; KYAWT SK, 2004, AM J TROP MED PUBLIC, V35, P53; LYNCH C, 2006, KABP SURVEY ITN UTIL; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; NOOR A, 2009, DJIB NAT MAL IND SUR; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-5; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Pettifor A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-331; *PRES MAL IN, 2010, LANT HYD US GOV MAL; Rhee M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-35; Romaniuk J., 2006, J TARGETING MEASUREM, V15, P3; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Shargie EB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-321; SLUTSKER L, 1994, TROP MED PARASITOL, V45, P61; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; *UN SECR GEN BAN K, 2008, SECR GEN ANN ROLL BA; Waller J, 2004, BRIT J PSYCHOL, V95, P219, DOI 10.1348/000712604773952430; Wiseman V, 2007, AM J TROP MED HYG, V76, P830, DOI 10.4269/ajtmh.2007.76.830; YENENEH H, 1993, B WORLD HEALTH ORGAN, V71, P763	50	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11692	10.1371/journal.pone.0011692	http://dx.doi.org/10.1371/journal.pone.0011692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657782	Green Published, Green Accepted, gold			2022-12-25	WOS:000280197500030
J	Eronen, VP; Linden, RO; Lindroos, A; Kanerva, M; Aittokallio, T				Eronen, Ville-Pekka; Linden, Rolf O.; Lindroos, Anna; Kanerva, Mirella; Aittokallio, Tero			Genome-Wide Scoring of Positive and Negative Epistasis through Decomposition of Quantitative Genetic Interaction Fitness Matrices	PLOS ONE			English	Article							SYNTHETIC-LETHALITY ANALYSIS; INTERACTION NETWORKS; BUDDING YEAST; PATHWAY; ORGANIZATION; DATABASE; SPINDLE; COMPLEX; BIOLOGY; ACTIN	Recent technological developments in genetic screening approaches have offered the means to start exploring quantitative genotype-phenotype relationships on a large-scale. What remains unclear is the extent to which the quantitative genetic interaction datasets can distinguish the broad spectrum of interaction classes, as compared to existing information on mutation pairs associated with both positive and negative interactions, and whether the scoring of varying degrees of such epistatic effects could be improved by computational means. To address these questions, we introduce here a computational approach for improving the quantitative discrimination power encoded in the genetic interaction screening data. Our matrix approximation model decomposes the original double-mutant fitness matrix into separate components, representing variability across the array and query mutants, which can be utilized for estimating and correcting the single-mutant fitness effects, respectively. When applied to three large-scale quantitative interaction datasets in yeast, we could improve the accuracy of scoring various interaction classes beyond that obtained with the original fitness data, especially in synthetic genetic array (SGA) and in genetic interaction mapping (GIM) datasets. In addition to the known pairs of interactions used in the evaluation of the computational approach, a number of novel interaction pairs were also predicted, along with underlying biological mechanisms, which remained undetected by the original datasets. It was shown that the optimal choice of the scoring function depends heavily on the screening approach and on the interaction class under analysis. Moreover, a simple preprocessing of the fitness matrix could further enhance the discrimination power of the epistatic miniarray profiling (E-MAP) dataset. These systematic evaluation results provide in-depth information on the optimal analysis of the future, large-scale screening experiments. In general, the modeling framework, enabling accurate identification and classification of genetic interactions, provides a solid basis for completing and mining the genetic interaction networks in yeast and other organisms.	[Eronen, Ville-Pekka; Linden, Rolf O.; Aittokallio, Tero] Univ Turku, Dept Math, Biomath Res Grp, SF-20500 Turku, Finland; [Linden, Rolf O.; Aittokallio, Tero] Univ Turku, Data Min & Modeling Grp, Turku Ctr Biotechnol, SF-20500 Turku, Finland; [Lindroos, Anna; Kanerva, Mirella] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland	University of Turku; University of Turku; University of Turku	Eronen, VP (corresponding author), Univ Turku, Dept Math, Biomath Res Grp, SF-20500 Turku, Finland.	tero.aittokallio@utu.fi	Aittokallio, Tero/B-6583-2009	Aittokallio, Tero/0000-0002-0886-9769	Academy of Finland [120569, 133227]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (grants 120569 and 133227; http://www.aka.fi/en-gb/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Breker M, 2009, MOL BIOSYST, V5, P1473, DOI 10.1039/b907076c; Carter GW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000347; Casey FP, 2008, BIOINFORMATICS, V24, P2733, DOI 10.1093/bioinformatics/btn472; Chipman KC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-17; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Costanzo M, 2009, METHODS MOL BIOL, V548, P37, DOI 10.1007/978-1-59745-540-4_3; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; DELEEUW J, 2006, 2006041602 DEP STAT; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Dror O, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-69; Fawcett T., 2004, ROC GRAPHS NOTES PRA; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Golub G. H., 1989, MATRIX COMPUTATIONS; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Jarvinen AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003284; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Kahana JA, 1998, MOL BIOL CELL, V9, P1741, DOI 10.1091/mbc.9.7.1741; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Koh JLY, 2010, NUCLEIC ACIDS RES, V38, pD502, DOI 10.1093/nar/gkp820; Le Meur N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r135; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Liu L, 2003, P NATL ACAD SCI USA, V100, P13167, DOI 10.1073/pnas.1733249100; Ma XT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001922; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Meluh Pamela B., 2008, V416, P221, DOI 10.1007/978-1-59745-321-9_15; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Paladugu SR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-426; PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pu SY, 2008, BIOINFORMATICS, V24, P2376, DOI 10.1093/bioinformatics/btn440; Qi Y, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-288; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Smialowski P, 2010, NUCLEIC ACIDS RES, V38, pD540, DOI 10.1093/nar/gkp1026; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Thompson DA, 1999, GENETICS, V153, P621; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tukey JW, 1977, EXPLORATORY DATA ANA; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Ulitsky I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r140; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; Wang XQ, 1996, NUCLEIC ACIDS RES, V24, P4791, DOI 10.1093/nar/24.23.4791; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Ye P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-270; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034; Zhai C, 2008, BIOCHEM J, V415, P455, DOI 10.1042/BJ20080209; Zhang Lan V, 2005, J Biol, V4, P6, DOI 10.1186/jbiol23	62	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11611	10.1371/journal.pone.0011611	http://dx.doi.org/10.1371/journal.pone.0011611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657656	Green Submitted, Green Published, gold			2022-12-25	WOS:000279924500013
J	Veeravalli, KK; Chetty, C; Ponnala, S; Gondi, CS; Lakka, SS; Fassett, D; Klopfenstein, JD; Dinh, DH; Gujrati, M; Rao, JS				Veeravalli, Krishna Kumar; Chetty, Chandramu; Ponnala, Shivani; Gondi, Christopher S.; Lakka, Sajani S.; Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Gujrati, Meena; Rao, Jasti S.			MMP-9, uPAR and Cathepsin B Silencing Downregulate Integrins in Human Glioma Xenograft Cells In Vitro and In Vivo in Nude Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; FOCAL ADHESION KINASE; HUMAN BRAIN-TUMORS; MATRIX METALLOPROTEINASES; UROKINASE RECEPTOR; GENE-EXPRESSION; GLIOBLASTOMA-MULTIFORME; EXTRACELLULAR-MATRIX; CYTOPLASMIC DOMAIN; ANTISENSE UPA	Background: Involvement of MMP-9, uPAR and cathepsin B in adhesion, migration, invasion, proliferation, metastasis and tumor growth has been well established. In the present study, MMP-9, uPAR and cathepsin B genes were downregulated in glioma xenograft cells using shRNA plasmid constructs and we evaluated the involvement of integrins and changes in their adhesion, migration and invasive potential. Methodology/Principal Findings: MMP-9, uPAR and cathepsin B single shRNA plasmid constructs were used to downregulate these molecules in xenograft cells. We also used MMP-9/uPAR and MMP-9/cathepsin B bicistronic constructs to evaluate the cumulative effects. MMP-9, uPAR and cathepsin B downregulation significantly inhibits xenograft cell adhesion to several extracellular matrix proteins. Treatment with MMP-9, uPAR and cathepsin B shRNA of xenografts led to the downregulation of several alpha and beta integrins. In all the assays, we noticed more prominent effects with the bicistronic plasmid constructs when compared to the single plasmid shRNA constructs. FACS analysis demonstrated the expression of alpha V beta 3, alpha 6 beta 1 and alpha 9 beta 1 integrins in xenograft cells. Treatment with bicistronic constructs reduced alpha V beta 3, alpha 6 beta 1 and alpha 9 beta 1 integrin expressions in xenograft injected nude mice. Migration and invasion were also inhibited by MMP-9, uPAR and cathepsin B shRNA treatments as assessed by spheroid migration, wound healing, and Matrigel invasion assays. As expected, bicistronic constructs further inhibited the adhesion, migration and invasive potential of the xenograft cells as compared to individual treatments. Conclusions/Significance: Downregulation of MMP-9, uPAR and cathespin B alone and in combination inhibits adhesion, migration and invasive potential of glioma xenografts by downregulating integrins and associated signaling molecules. Considering the existence of integrin inhibitor-resistant cancer cells, our study provides a novel and effective approach to inhibiting integrins by downregulating MMP-9, uPAR and cathepsin B in the treatment of glioma.	[Veeravalli, Krishna Kumar; Chetty, Chandramu; Ponnala, Shivani; Gondi, Christopher S.; Lakka, Sajani S.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA; [Gujrati, Meena] Univ Illinois, Coll Med Peoria, Dept Pathol, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Veeravalli, KK (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu		Veeravalli, Krishna Kumar/0000-0002-2243-004X; Gondi, Christopher/0000-0002-3036-9920	National Institute of Neurological Disorders and Stroke (NINDS) [NS047699]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047699] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS NS047699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; BERQUIN IM, 1995, GENE, V159, P143, DOI 10.1016/0378-1119(95)00072-E; Brown MC, 2008, NEURO-ONCOLOGY, V10, P968, DOI 10.1215/15228517-2008-047; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Crowe DL, 1999, HISTOL HISTOPATHOL, V14, P665, DOI 10.14670/HH-14.665; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q; Goldbrunner RH, 1998, MICROSC RES TECHNIQ, V43, P250, DOI 10.1002/(SICI)1097-0029(19981101)43:3<250::AID-JEMT7>3.0.CO;2-C; Gondi CS, 2008, INT J ONCOL, V33, P783, DOI 10.3892/ijo_00000065; Gondi CS, 2006, MOL CANCER THER, V5, P3197, DOI 10.1158/1535-7163.MCT-05-0531; Gondi Christopher S., 2009, V487, P267, DOI 10.1007/978-1-60327-547-7_13; Gondi CS, 2003, ONCOGENE, V22, P5967, DOI 10.1038/sj.onc.1206535; GRONDAHLHANSEN J, 1993, CANCER RES, V53, P2513; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta SK, 2010, CELL ADHES MIGR, V4, P194, DOI 10.4161/cam.4.2.10900; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kachra Z, 1999, CLIN EXP METASTAS, V17, P555, DOI 10.1023/A:1006760632766; Lakka SS, 2005, BRAIN PATHOL, V15, P327; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200; Mahesparan R, 2003, ACTA NEUROPATHOL, V105, P49, DOI 10.1007/s00401-002-0610-0; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mohanam S, 1997, ONCOGENE, V14, P1351, DOI 10.1038/sj.onc.1200963; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Raithatha SA, 2000, NEURO-ONCOLOGY, V2, P145, DOI 10.1093/neuonc/2.3.145; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; RAO JS, 1993, CANCER RES, V53, P2208; RAO NK, 1995, J CLIN INVEST, V96, P465, DOI 10.1172/JCI118057; REMPEL SA, 1994, CANCER RES, V54, P6027; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Rooprai HK, 1998, INT J ONCOL, V13, P1153; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Shattil SJ, 1991, CURR OPIN CELL BIOL, V3, P869, DOI 10.1016/0955-0674(91)90062-4; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Young BA, 2001, MOL BIOL CELL, V12, P3214, DOI 10.1091/mbc.12.10.3214; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P	52	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11583	10.1371/journal.pone.0011583	http://dx.doi.org/10.1371/journal.pone.0011583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657647	gold, Green Published, Green Submitted			2022-12-25	WOS:000279924500003
J	Perrinjaquet, M; Vilar, M; Ibanez, CF				Perrinjaquet, Maurice; Vilar, Marcal; Ibanez, Carlos F.			Protein-tyrosine Phosphatase SHP2 Contributes to GDNF Neurotrophic Activity through Direct Binding to Phospho-Tyr(687) in the RET Receptor Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL SURVIVAL; C-RET; AUTOPHOSPHORYLATION SITES; GROWTH-FACTOR; ACTIVATION; DIFFERENTIATION; GFR-ALPHA-1; MUTATIONS; CELLS; ISOFORMS	The signaling mechanisms by which neurotrophic receptors regulate neuronal survival and axonal growth are still incompletely understood. In the receptor tyrosine kinase RET, a receptor for GDNF (glial cell line-derived neurotrophic factor), the functions of the majority of tyrosine residues that become phosphorylated are still unknown. Here we have identified the protein-tyrosine phosphatase SHP2 as a novel direct interactor of RET and the first effector known to bind to phosphorylated Tyr(687) in the juxtamembrane region of the receptor. We show that SHP2 is recruited to RET upon ligand binding in a cooperative fashion, such that both interaction with Tyr(687) and association with components of the Tyr(1062) signaling complex are required for stable recruitment of SHP2 to the receptor. SHP2 recruitment contributes to the ability of RET to activate the PI3K/AKT pathway and promote survival and neurite outgrowth in primary neurons. Furthermore, we find that activation of protein kinase A (PKA) by forskolin reduces the recruitment of SHP2 to RET and negatively affects ligand-mediated neurite outgrowth. In agreement with this, mutation of Ser(696), a known PKA phosphorylation site in RET, enhances SHP2 binding to the receptor and eliminates the effect of forskolin on ligand-induced outgrowth. Together, these findings establish SHP2 as a novel positive regulator of the neurotrophic activities of RET and reveal Tyr(687) as a critical platform for integration of RET and PKA signals. We anticipate that several other phosphotyrosines of unknown function in neuronal receptor tyrosine kinases will also support similar regulatory functions.	[Perrinjaquet, Maurice] Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden	Karolinska Institutet		carlos.ibanez@ki.se	Vilar, Marçal/B-4581-2016	Vilar, Marçal/0000-0002-9376-6544				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Asai N, 2006, DEVELOPMENT, V133, P4507, DOI 10.1242/dev.02616; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; CAILLAUD T, 1995, MOL NEUROBIOL, V10, P105, DOI 10.1007/BF02740670; Canty AJ, 2009, J NEUROSCI, V29, P10695, DOI 10.1523/JNEUROSCI.2658-09.2009; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; De Vita G, 2000, CANCER RES, V60, P3727; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Huang QH, 2002, J BIOL CHEM, V277, P29330, DOI 10.1074/jbc.M112450200; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; Kawamoto Y, 2004, J BIOL CHEM, V279, P14213, DOI 10.1074/jbc.M312600200; Kjaer S, 2006, ONCOGENE, V25, P7086, DOI 10.1038/sj.onc.1209698; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu X, 1996, J BIOL CHEM, V271, P5309, DOI 10.1074/jbc.271.10.5309; Marsh HN, 2003, J CELL BIOL, V163, P999, DOI 10.1083/jcb.200309036; Nielsen J, 2009, J NEUROSCI, V29, P11360, DOI 10.1523/JNEUROSCI.3239-09.2009; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Rossel M, 1997, ONCOGENE, V14, P265, DOI 10.1038/sj.onc.1200831; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Scott RP, 2005, J BIOL CHEM, V280, P13442, DOI 10.1074/jbc.M500507200; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017	41	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31867	U864		10.1074/jbc.M110.144923	http://dx.doi.org/10.1074/jbc.M110.144923			27	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682772	hybrid, Green Published			2022-12-25	WOS:000282764600078
J	Brown, JAL; Bourke, E; Liptrot, C; Dockery, P; Morrison, CG				Brown, J. A. L.; Bourke, E.; Liptrot, C.; Dockery, P.; Morrison, C. G.			MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification	ONCOGENE			English	Article						Mcph1/Brit1; centrosome; DNA damage response; checkpoint; ionizing radiation	DNA-DAMAGE RESPONSE; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; CHROMOSOME CONDENSATION; MITOTIC ENTRY; MICROCEPHALIN; PROTEIN; CANCER; ACTIVATION; CHECKPOINT	Microcephalin (MCPH1/BRIT1) is a potential tumour suppressor that localizes to the centrosome, forms ionizing radiation-induced nuclear foci (IRIF) and is involved in the DNA damage checkpoints that ensure genome stability. Here, we report the impact of Mcph1 disruption in the hyper-recombinogenic DT40 cell line. Mcph1(-/-) cells were viable and proliferated at the same rate as wildtype controls. Mcph1-deficient cells had intact G2-to-M checkpoint responses after ionizing radiation (IR) treatment, but showed moderate radiosensitivity. Light and electron microscopy indicated normal centrosome structures in Mcph1 null cells, but IR induced massive amplification of centrosome numbers in the absence of Mcph1. Mcph1 null cells formed gamma-H2AX and Rad51 IRIF, but resolved them more slowly than wild-type cells. Mcph1 deficiency caused sustained Chk1 phosphorylation after IR, dysregulating Cdk2 activity. These findings show that Mcph1 controls centrosome numbers after DNA damage, which may indicate a novel tumour suppressive mechanism for microcephalin. Oncogene (2010) 29, 5537-5544; doi:10.1038/onc.2010.302; published online 26 July 2010	[Brown, J. A. L.; Bourke, E.; Morrison, C. G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Liptrot, C.; Dockery, P.] Natl Univ Ireland Galway, Sch Med, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Morrison, CG (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Univ Rd, Galway, Ireland.	Ciaran.Morrison@nuigalway.ie	Morrison, Ciaran/AAH-2034-2019; Liptrot, Catherine/D-7056-2012; Morrison, Ciaran/B-6568-2008; Brown, James/H-3437-2019	Morrison, Ciaran/0000-0003-2401-7029; Liptrot, Catherine/0000-0003-3882-8084; Morrison, Ciaran/0000-0003-2401-7029; Brown, James/0000-0002-3155-0334; Bourke, Emer/0000-0002-2218-3114; Dockery, Peter/0000-0001-5103-6589	National Biophotonics and Imaging Platform; HEA [PRTLI4]; Health Research Board project [RP/2006/36]; Science Foundation Ireland [08/IN.1/B1029]	National Biophotonics and Imaging Platform; HEA; Health Research Board project; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank William Tsang and Brian Dynlacht for the Cep76 antibody, Andrew Jackson and Andrea Robertson for the MCPH1 mutant lymphoblastoid cells, Tiago Dantas for help with the EM and Noel Lowndes for critical reading of the paper. CL was funded by the National Biophotonics and Imaging Platform funded by the HEA under PRTLI4. This work was supported by the Health Research Board project grant RP/2006/36 and Science Foundation Ireland Principal Investigator award 08/IN.1/B1029.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bourke E, 2010, ONCOGENE, V29, P616, DOI 10.1038/onc.2009.340; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; LIPTROT C, 1992, ANIMAL CELL TECHNOLOGY : DEVELOPMENTS, PROCESSES AND PRODUCTS, P653; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; Tsang WY, 2009, DEV CELL, V16, P649, DOI 10.1016/j.devcel.2009.03.004; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128	34	27	29	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	40					5537	5544		10.1038/onc.2010.302	http://dx.doi.org/10.1038/onc.2010.302			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FM	20661222				2022-12-25	WOS:000282945800010
J	Liu, M; Hua, QX; Hu, SQ; Jia, WH; Yang, YW; Saith, SE; Whittaker, J; Arvan, P; Weiss, MA				Liu, Ming; Hua, Qing-Xin; Hu, Shi-Quan; Jia, Wenhua; Yang, Yanwu; Saith, Sunil Evan; Whittaker, Jonathan; Arvan, Peter; Weiss, Michael A.			Deciphering the Hidden Informational Content of Protein Sequences FOLDABILITY OF PROINSULIN HINGES ON A FLEXIBLE ARM THAT IS DISPENSABLE IN THE MATURE HORMONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; DIRECTING INSULIN INTERACTION; RECEPTOR-BINDING SURFACE; BIOLOGICAL-ACTIVITY; SIDE-CHAIN; ENDOPLASMIC-RETICULUM; MUTATIONAL ANALYSIS; CHIRAL MUTAGENESIS; STRUCTURAL SWITCH; ENERGY LANDSCAPE	Protein sequences encode both structure and foldability. Whereas the interrelationship of sequence and structure has been extensively investigated, the origins of folding efficiency are enigmatic. We demonstrate that the folding of proinsulin requires a flexible N-terminal hydrophobic residue that is dispensable for the structure, activity, and stability of the mature hormone. This residue (Phe(B1) in placental mammals) is variably positioned within crystal structures and exhibits H-1 NMR motional narrowing in solution. Despite such flexibility, its deletion impaired insulin chain combination and led in cell culture to formation of non-native disulfide isomers with impaired secretion of the variant proinsulin. Cellular folding and secretion were maintained by hydrophobic substitutions at B1 but markedly perturbed by polar or charged side chains. We propose that, during folding, a hydrophobic side chain at B1 anchors transient long-range interactions by a flexible N-terminal arm (residues B1-B8) to mediate kinetic or thermodynamic partitioning among disulfide intermediates. Evidence for the overall contribution of the arm to folding was obtained by alanine scanning mutagenesis. Together, our findings demonstrate that efficient folding of proinsulin requires N-terminal sequences that are dispensable in the native state. Such arm-dependent folding can be abrogated by mutations associated with beta-cell dysfunction and neonatal diabetes mellitus.	[Liu, Ming; Saith, Sunil Evan; Arvan, Peter] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Hua, Qing-Xin; Hu, Shi-Quan; Jia, Wenhua; Yang, Yanwu; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Case Western Reserve University	Arvan, P (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	parvan@umichigan.edu; michael.weiss@case.edu		Saith, Sunil/0000-0002-0249-6017; Liu, Ming/0000-0003-2665-4072	National Institutes of Health [DK48280, DK0697674]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK48280 (to P. A.) and DK0697674 (to M. A. W.) and a grant from the American Diabetes Association (to M. A. W.). This is a contribution from the Cleveland Center for Membrane and Structural Biology.	BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Bliss M., 1982, DISCOVERY INSULIN; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; Brange J, 1997, DIABETOLOGIA, V40, pS48, DOI 10.1007/s001250051400; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; BREMS DN, 1990, BIOCHEMISTRY-US, V29, P9289, DOI 10.1021/bi00491a026; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen Y, 2004, BIOCHEMISTRY-US, V43, P9225, DOI 10.1021/bi049710y; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; CUTFIELD JF, 1979, J MOL BIOL, V132, P85, DOI 10.1016/0022-2836(79)90497-2; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dinner AR, 1999, PROTEINS, V35, P34, DOI 10.1002/(SICI)1097-0134(19990401)35:1<34::AID-PROT4>3.0.CO;2-Q; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; FRANK BH, 1972, DIABETES, V21, P486, DOI 10.2337/diab.21.2.S486; FRANK BH, 1968, BIOCHEM BIOPH RES CO, V32, P155, DOI 10.1016/0006-291X(68)90362-8; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Guo ZY, 2005, ACTA BIOCH BIOPH SIN, V37, P673, DOI 10.1111/j.1745-7270.2005.00093.x; Guo ZY, 2002, BIOCHEMISTRY-US, V41, P1556, DOI 10.1021/bi011166v; HEJNAES KR, 1992, PROTEIN ENG, V5, P797, DOI 10.1093/protein/5.8.797; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; Hober S, 1999, FEBS LETT, V443, P271, DOI 10.1016/S0014-5793(98)01737-2; HOBER S, 1994, BIOCHEMISTRY-US, V33, P6758, DOI 10.1021/bi00188a003; Hober S, 1997, BIOCHEMISTRY-US, V36, P4616, DOI 10.1021/bi9611265; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; HUANG XF, 1994, J BIOL CHEM, V269, P20838; JORGENSEN LN, 1992, DIABETOLOGIA, V35, pA3; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; KITAGAWA K, 1984, BIOCHEMISTRY-US, V23, P1405, DOI 10.1021/bi00302a011; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pace CN, 2000, PROTEINS, P1; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; SCHWARTZ G, 1978, BIOCHEMISTRY-US, V17, P4550, DOI 10.1021/bi00614a029; SHAKHNOVICH E, 1991, PHYS REV LETT, V67, P1665, DOI 10.1103/PhysRevLett.67.1665; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; SMITH MC, 1989, J BIOL CHEM, V264, P9314; SNELL CR, 1975, J BIOL CHEM, V250, P6291; Sohma Y, 2010, J BIOL CHEM, V285, P5040, DOI 10.1074/jbc.M109.062992; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Steiner D F, 1969, Recent Prog Horm Res, V25, P207; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; Tiana G, 2000, PROTEINS, V39, P244, DOI 10.1002/(SICI)1097-0134(20000515)39:3<244::AID-PROT70>3.0.CO;2-#; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1989, BIOCHEMISTRY-US, V28, P9855, DOI 10.1021/bi00451a046; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921	104	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30989	31001		10.1074/jbc.M110.152645	http://dx.doi.org/10.1074/jbc.M110.152645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663888	hybrid, Green Published			2022-12-25	WOS:000282135500064
J	Seffernick, JL; Reynolds, E; Fedorov, AA; Fedorov, E; Almo, SC; Sadowsky, MJ; Wackett, LP				Seffernick, Jennifer L.; Reynolds, Erik; Fedorov, Alexander A.; Fedorov, Elena; Almo, Steven C.; Sadowsky, Michael J.; Wackett, Lawrence P.			X-ray Structure and Mutational Analysis of the Atrazine Chlorohydrolase TrzN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTHROBACTER-AURESCENS TC1; SITE-DIRECTED MUTAGENESIS; SP STRAIN ADP; SUBSTRATE-SPECIFICITY; CARBONIC-ANHYDRASE; MECHANISM; EVOLUTION; ENZYMES; CATABOLISM; CATALYSIS	Atrazine chlorohydrolase, TrzN (triazine hydrolase or atrazine chlorohydrolase 2), initiates bacterial metabolism of the herbicide atrazine by hydrolytic displacement of a chlorine substituent from the s-triazine ring. The present study describes crystal structures and reactivity of wild-type and active site mutant TrzN enzymes. The homodimer native enzyme structure, solved to 1.40 angstrom resolution, is a (beta alpha)(8) barrel, characteristic of members of the amidohydrolase superfamily. TrzN uniquely positions threonine 325 in place of a conserved aspartate that ligates the metal in most mononuclear amidohydrolases superfamily members. The threonine side chain oxygen atom is 3.3 angstrom from the zinc atom and 2.6 angstrom from the oxygen atom of zinc-coordinated water. Mutation of the threonine to a serine resulted in a 12-fold decrease in k(cat)/K-m, largely due to k(cat),, whereas the T325D and T325E mutants had immeasurable activity. The structure and kinetics of TrzN are reminiscent of carbonic anhydrase, which uses a threonine to assist in positioning water for reaction with carbon dioxide. An isosteric substitution in the active site glutamate, E241Q, showed a large diminution in activity with ametryn, no detectable activity with atratone, and a 10-fold decrease with atrazine, when compared with wild-type TrzN. Activity with the E241Q mutant was nearly constant from pH 6.0 to 10.0, consistent with the loss of a proton-donating group. Structures for TrzN-E241Q were solved with bound ametryn and atratone to 1.93 and 1.64 angstrom resolution, respectively. Both structure and kinetic determinations suggest that the Glu(241) side chain provides a proton to N-1 of the s-triazine substrate to facilitate nucleophilic displacement at the adjacent C-2.	[Wackett, Lawrence P.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Gortner Lab 140, St Paul, MN 55108 USA; [Seffernick, Jennifer L.; Reynolds, Erik; Sadowsky, Michael J.; Wackett, Lawrence P.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Seffernick, Jennifer L.; Sadowsky, Michael J.; Wackett, Lawrence P.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Fedorov, Alexander A.; Fedorov, Elena; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Yeshiva University; Albert Einstein College of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Wackett, LP (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Gortner Lab 140, 1479 Gortner Ave, St Paul, MN 55108 USA.	wacke003@umn.edu	Sadowsky, Michael/J-2507-2016	Sadowsky, Michael/0000-0001-8779-2781	Sygenta Crop Protection	Sygenta Crop Protection	This work was supported by a grant from Sygenta Crop Protection (to L.P.W. and M.J.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BHAUMIK D, 1993, J BIOL CHEM, V268, P5464; CHEN X, 1993, BIOCHEMISTRY-US, V32, P7861, DOI 10.1021/bi00082a004; de Jong RM, 2007, J BIOL CHEM, V282, P2440, DOI 10.1074/jbc.M608134200; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; de Souza ML, 1998, J BACTERIOL, V180, P1951, DOI 10.1128/JB.180.7.1951-1954.1998; de Souza ML, 1998, APPL ENVIRON MICROB, V64, P2323; deSouza ML, 1996, J BACTERIOL, V178, P4894, DOI 10.1128/jb.178.16.4894-4900.1996; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; HUANG CC, 2000, PAC S BIOCOMPUT, V12, P230; Huang S, 2002, BIOCHEMISTRY-US, V41, P7628, DOI 10.1021/bi020053o; IPPOLITO JA, 1995, P NATL ACAD SCI USA, V92, P5017, DOI 10.1073/pnas.92.11.5017; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; KREBS JF, 1993, J BIOL CHEM, V268, P27458; Krutz LJ, 2009, WEED SCI, V57, P427, DOI 10.1614/WS-09-010.1; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Meyer AH, 2009, ENVIRON SCI TECHNOL, V43, P8079, DOI 10.1021/es9013618; Mohamedali KA, 1996, BIOCHEMISTRY-US, V35, P1672, DOI 10.1021/bi9514119; Morris JH, 2007, BIOINFORMATICS, V23, P2345, DOI 10.1093/bioinformatics/btm329; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Piutti S, 2003, FEMS MICROBIOL LETT, V221, P111, DOI 10.1016/S0378-1097(03)00168-X; Scott C, 2009, APPL ENVIRON MICROB, V75, P2184, DOI 10.1128/AEM.02634-08; Seffernick JL, 2009, J BIOTECHNOL, V143, P17, DOI 10.1016/j.jbiotec.2009.06.004; Seffernick JL, 2000, APPL ENVIRON MICROB, V66, P4247, DOI 10.1128/AEM.66.10.4247-4252.2000; Seffernick JL, 2002, BIOCHEMISTRY-US, V41, P14430, DOI 10.1021/bi020415s; Seffernick JL, 2001, BIOCHEMISTRY-US, V40, P12747, DOI 10.1021/bi011293r; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shapir N, 2007, J BACTERIOL, V189, P674, DOI 10.1128/JB.01257-06; Shapir N, 2005, APPL ENVIRON MICROB, V71, P2214, DOI 10.1128/AEM.71.5.2214-2220.2005; Shapir N, 2006, J BACTERIOL, V188, P5859, DOI 10.1128/JB.00517-06; Sideraki V, 1996, BIOCHEMISTRY-US, V35, P15019, DOI 10.1021/bi961427e; Strong LC, 2002, APPL ENVIRON MICROB, V68, P5973, DOI 10.1128/AEM.68.12.5973-5980.2002; Strong LC, 2000, ENVIRON MICROBIOL, V2, P91, DOI 10.1046/j.1462-2920.2000.00079.x; Topp E, 2000, APPL ENVIRON MICROB, V66, P3134, DOI 10.1128/AEM.66.8.3134-3141.2000; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539	39	24	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30606	30614		10.1074/jbc.M110.138677	http://dx.doi.org/10.1074/jbc.M110.138677			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659898	Green Published, hybrid			2022-12-25	WOS:000282135500029
J	Toubarro, D; Lucena-Robles, M; Nascimento, G; Santos, R; Montiel, R; Verissimo, P; Pires, E; Faro, C; Coelho, AV; Simoes, N				Toubarro, Duarte; Lucena-Robles, Miguel; Nascimento, Gisela; Santos, Romana; Montiel, Rafael; Verissimo, Paula; Pires, Euclides; Faro, Carlos; Coelho, Ana V.; Simoes, Nelson			Serine Protease-mediated Host Invasion by the Parasitic Nematode Steinernema carpocapsae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTIVE HOOKWORM LARVAE; TRICHINELLA-SPIRALIS; ENTOMOPATHOGENIC NEMATODES; IDENTIFICATION; PURIFICATION; PROTEINS; CLONING; MATRIX; PATHOGENICITY; SPECIFICITY	Steinernema carpocapsae is an insect parasitic nematode used in biological control, which infects insects penetrating by mouth and anus and invading the hemocoelium through the midgut wall. Invasion has been described as a key factor in nematode virulence and suggested to be mediated by proteases. A serine protease cDNA from the parasitic stage was sequenced (sc-sp-1); the recombinant protein was produced in an Escherichia coli system, and a native protein was purified from the secreted products. Both proteins were confirmed by mass spectrometry to be encoded by the sc-sp-1 gene. Sc-SP-1 has a pI of 8.7, a molecular mass of 27.3 kDa, a catalytic efficiency of 22.2 x 10(4) s(-1) M-1 against N-succinyl-Ala-Ala-Pro-Phe-pNA, and is inhibited by chymostatin (IC 0.07) and PMSF (IC 0.73). Sc-SP-1 belongs to the chymotrypsin family, based on sequence and biochemical analysis. Only the nematode parasitic stage expressed sc-sp-1. These nematodes in the midgut lumen, prepared to invade the insect hemocoelium, expressed higher levels than those already in the hemocoelium. Moreover, parasitic nematode sense insect peritrophic membrane and hemolymph more quickly than they do other tissues, which initiates sc-sp-1 expression. Ex vivo, Sc-SP-1 was able to bind to insect midgut epithelium and to cause cell detachment from basal lamina. In vitro, Sc-SP-1 formed holes in an artificial membrane model (Matrigel), whereas Sc-SP-1 treated with PMSF did not, very likely because it hydrolyzes matrix glycoproteins. These findings highlight the S. carpocapsae-invasive process that is a key step in the parasitism thus opening new perspectives for improving nematode virulence to use in biological control.	[Simoes, Nelson] Univ Acores, CIRN, P-9501801 Ponta Delgada, Portugal; [Simoes, Nelson] Univ Acores, Dept Biol, P-9501801 Ponta Delgada, Portugal; [Santos, Romana; Coelho, Ana V.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780901 Oeiras, Portugal; [Verissimo, Paula; Pires, Euclides; Faro, Carlos] Univ Coimbra, CNC, P-3001401 Coimbra, Portugal; [Verissimo, Paula; Pires, Euclides; Faro, Carlos] Univ Coimbra, Dept Ciencias Vida, P-3001401 Coimbra, Portugal	Universidade dos Acores; Universidade dos Acores; Universidade Nova de Lisboa; Universidade de Coimbra; Universidade de Coimbra	Simoes, N (corresponding author), Univ Acores, CIRN, Apartado 1422, P-9501801 Ponta Delgada, Portugal.	simoes@uac.pt	Simões, Nelson/K-3843-2013; Montiel, Rafael/A-6774-2008; Santos, R./J-3461-2012; Toubarro, Duarte/K-3881-2013; Coelho, Ana V Varela/O-3977-2014; Coelho, Ana V/H-8885-2012; Verissimo, Paula/AAB-2281-2021	Simões, Nelson/0000-0003-3612-6759; Montiel, Rafael/0000-0001-8052-0679; Santos, R./0000-0001-7720-6806; Toubarro, Duarte/0000-0003-2025-9696; Coelho, Ana V Varela/0000-0002-6143-4203; Coelho, Ana V/0000-0002-6143-4203; Verissimo, Paula/0000-0003-0532-4242; Pires, Euclides/0000-0002-5853-0165; Faro, Carlos/0000-0002-0480-8379	Fundacao para a Ciencia e Tecnologia [POCTI/BSE/41630/2001]; Fundacao Lusa Americana para o Desenvolvimento [223/06]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/18986/2004, SFRH/BGCT/15324/2005l, POCI/AGR/56300/2004l, SFRH/BGCT/32473/2006]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Lusa Americana para o Desenvolvimento; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported in part by Project POCTI/BSE/41630/2001 founded by Fundacao para a Ciencia e Tecnologia and Project 223/06 founded by Fundacao Lusa Americana para o Desenvolvimento.; Supported by Grant SFRH/BD/18986/2004 from Fundacao para a Ciencia e Tecnologia, Portugal.; Supported by Grant SFRH/BGCT/15324/2005l from Fundacao para a Ciencia e Tecnologia, Portugal.; Supported by Grant POCI/AGR/56300/2004l from Fundacao para a Ciencia e Tecnologia, Portugal.; Supported by Grant SFRH/BGCT/32473/2006 from Fundacao para a Ciencia e Tecnologia, Portugal.	Akhurst R., 2012, PARASITES PATHOGENS, P1; Balasubramanian N, 2010, PARASITE IMMUNOL, V32, P165, DOI 10.1111/j.1365-3024.2009.01172.x; Balasubramanian N, 2009, INT J PARASITOL, V39, P975, DOI 10.1016/j.ijpara.2009.01.012; BEDDING RA, 1983, EXP PARASITOL, V55, P249, DOI 10.1016/0014-4894(83)90019-X; BEGLEY JW, 1990, ENTOMOPATHOGENIC NEM, P233; Burnell Ann, 2002, P241, DOI 10.1079/9780851995670.0241; Cwiklinski K, 2009, VET PARASITOL, V159, P268, DOI 10.1016/j.vetpar.2008.10.036; da Rocha-Azevedo B, 2010, EXP PARASITOL, V126, P79, DOI 10.1016/j.exppara.2009.08.004; Dalton JP, 2003, INT J PARASITOL, V33, P621, DOI 10.1016/S0020-7519(03)00057-2; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; Dowds Barbara C.A., 2002, P79, DOI 10.1079/9780851995670.0079; Dzik JM, 2006, ACTA BIOCHIM POL, V53, P33; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fahey EM, 2000, J CHROMATOGR B, V737, P225, DOI 10.1016/S0378-4347(99)00360-6; Gallego SG, 2005, PARASITOL INT, V54, P123, DOI 10.1016/j.parint.2005.02.002; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; GREWAL PS, 1994, PARASITOLOGY, V108, P207, DOI 10.1017/S003118200006830X; Gudmundsdottir E, 1996, COMP BIOCHEM PHYS B, V113, P795, DOI 10.1016/0305-0491(95)02109-4; Haffner A, 1998, EXP PARASITOL, V90, P26, DOI 10.1006/expr.1998.4313; Hao YJ, 2010, MOL BIOCHEM PARASIT, V169, P79, DOI 10.1016/j.molbiopara.2009.10.002; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Heinemeyer Jesco, 2007, V355, P343; HUBERT JJ, 1990, STAT SERIES U GUELPH, P1990; Ishibashi N., 1990, P139; Joshi MC, 2008, J BIOL CHEM, V283, P28287, DOI 10.1074/jbc.M804416200; Klein M. G., 1990, Entomopathogenic nematodes in biological control., P195; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANTZ MS, 1994, METHOD ENZYMOL, V235, P563; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; MARTOJA R, 1970, TECNICAS HISTOLOGIA, P341; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P633, DOI 10.1016/S0965-1748(00)00168-5; MCKERROW JH, 1985, J BIOL CHEM, V260, P3703; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Romaris F, 2002, MOL BIOCHEM PARASIT, V122, P149, DOI 10.1016/S0166-6851(02)00094-4; SAKANARI JA, 1990, J PARASITOL, V76, P625, DOI 10.2307/3282971; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Santos R, 2009, MAR BIOTECHNOL, V11, P686, DOI 10.1007/s10126-009-9182-5; Sellos D, 1999, BBA-PROTEIN STRUCT M, V1432, P419, DOI 10.1016/S0167-4838(99)00121-1; Simoes N, 1996, BIOCONTROL SCI TECHN, V6, P403, DOI 10.1080/09583159631370; Simoes N, 2000, J INVERTEBR PATHOL, V75, P47, DOI 10.1006/jipa.1999.4899; Todorova VK, 2000, FOLIA PARASIT, V47, P141, DOI 10.14411/fp.2000.027; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; Trap C, 2000, VET RES, V31, P461, DOI 10.1051/vetres:2000132; Trap C, 2006, PARASITOL RES, V98, P288, DOI 10.1007/s00436-005-0075-x; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; VELLAI T, 1999, COST 819 ENTOMOPATHO, P105; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; Williamson AL, 2006, INFECT IMMUN, V74, P961, DOI 10.1128/IAI.74.2.961-967.2006; Zhan B, 2002, MOL BIOCHEM PARASIT, V120, P291, DOI 10.1016/S0166-6851(01)00453-4; Zhang LL, 2004, COMP BIOCHEM PHYS C, V137, P115, DOI 10.1016/j.cca.2003.12.003	56	38	40	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30666	30675		10.1074/jbc.M110.129346	http://dx.doi.org/10.1074/jbc.M110.129346			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20656686	hybrid, Green Published			2022-12-25	WOS:000282135500035
J	Tsang, YH; Lamb, A; Romero-Gallo, J; Huang, B; Ito, K; Peek, RM; Ito, Y; Chen, LF				Tsang, Y. H.; Lamb, A.; Romero-Gallo, J.; Huang, B.; Ito, K.; Peek, R. M., Jr.; Ito, Y.; Chen, L. F.			Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation	ONCOGENE			English	Article						CagA; degradation; H. pylori; RUNX3; ubiquitination	GROWTH-FACTOR; EPITHELIAL-CELLS; BETA-CATENIN; EXPRESSION; CANCER; RISK; METHYLATION; COOPERATION; MECHANISMS; INFECTION	Chronic infection with cagA-positive Helicobacter pylori is the strongest risk factor for the development of gastric adenocarcinoma. The cagA gene product CagA is injected into gastric epithelial cells and disturbs cellular functions by physically interacting with and deregulating a variety of cellular signaling molecules. RUNX3 is a tumor suppressor in many tissues, and it is frequently inactivated in gastric cancer. In this study, we show that H. pylori infection inactivates the gastric tumor suppressor RUNX3 in a CagA-dependent manner. CagA directly associates with RUNX3 through a specific recognition of the PY motif of RUNX3 by a WW domain of CagA. Deletion of the WW domains of CagA or mutation of the PY motif in RUNX3 abolishes the ability of CagA to induce the ubiquitination and degradation of RUNX3, thereby extinguishing its ability to inhibit the transcriptional activation of RUNX3. Our studies identify RUNX3 as a novel cellular target of H. pylori CagA and also reveal a mechanism by which CagA functions as an oncoprotein by blocking the activity of gastric tumor suppressor RUNX3. Oncogene (2010) 29, 5643-5650; doi:10.1038/onc.2010.304; published online 2 August 2010	[Tsang, Y. H.; Lamb, A.; Huang, B.; Chen, L. F.] Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA; [Tsang, Y. H.; Ito, Y.] Inst Mol & Cell Biol, Proteos, Singapore; [Romero-Gallo, J.; Peek, R. M., Jr.] Vanderbilt Univ, Sch Med, Dept Med & Canc Biol, Div Gastroenterol, Nashville, TN 37212 USA; [Ito, K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan	University of Illinois System; University of Illinois Urbana-Champaign; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Vanderbilt University; Nagasaki University	Chen, LF (corresponding author), Univ Illinois, Coll Med, Dept Biochem, MC-714, Urbana, IL 61801 USA.	lfchen@life.illinois.edu			UIUC; NIH [DK-085158, DK-58587, CA-77955, CA-116087]; CMB-TG; NATIONAL CANCER INSTITUTE [P01CA116087, R29CA077955, R01CA077955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058587, R01DK085158, P30DK058404] Funding Source: NIH RePORTER	UIUC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CMB-TG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Hatakeyama (University of Tokyo, Japan) for providing the expression vector for CagA-HA and CagA-PRHA. This work is supported in part by ICR provided by UIUC and NIH Grants DK-085158 (to LFC) and DK-58587, CA-77955 and CA-116087 (to RMP). AL is a recipient of the CMB-TG. YHT is an A*STAR-Illinois Partnership fellow.	BLASER MJ, 1995, CANCER RES, V55, P2111; Chang TL, 2010, GASTROENTEROLOGY, V138, P255, DOI 10.1053/j.gastro.2009.08.044; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hsu PI, 2009, ANN SURG ONCOL, V16, P1686, DOI 10.1245/s10434-009-0428-2; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Katayama Y, 2009, BIOCHEM BIOPH RES CO, V388, P496, DOI 10.1016/j.bbrc.2009.08.003; Kitajima Y, 2008, ONCOL REP, V19, P197; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek Richard M Jr, 2005, Sci STKE, V2005, ppe14; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sugiura H, 2008, ONCOL REP, V19, P713; Wei DY, 2005, CANCER RES, V65, P4809, DOI 10.1158/0008-5472.CAN-04-3741; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05	32	72	75	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	41					5643	5650		10.1038/onc.2010.304	http://dx.doi.org/10.1038/onc.2010.304			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FX	20676134	Green Accepted			2022-12-25	WOS:000282946900010
J	Burke, SP; Smith, L; Smith, JB				Burke, Stephen P.; Smith, Lucinda; Smith, Jeffrey B.			cIAP1 Cooperatively Inhibits Procaspase-3 Activation by the Caspase-9 Apoptosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; ALPHA-DEPENDENT APOPTOSIS; KAPPA-B ACTIVATION; X-LINKED INHIBITOR; STRUCTURAL BASIS; CELL-DEATH; CYTOCHROME-C; BIR DOMAINS; XIAP; IAP	Although early studies of inhibitor of apoptosis proteins (IAPs) suggested that cIAP1 directly binds and inhibits caspases similarly to X-linked IAP (XIAP), a recent one found that micromolar concentrations of cIAP1 only weakly inhibit caspase-3, -7, or -9. Here, we show that cIAP1 specifically and cooperatively blocks the cytochrome c-dependent apoptosome in vitro. Hence, cIAP1 prevented the activation of procaspase-3 but had no effect on the processing of procaspase-9 or the activity of prior activated caspase-3. Like cIAP1, XIAP had no effect on procaspase-9 processing and was a more potent inhibitor of procaspase- 3 activation than of already activated caspase-3 activity. Inhibition of procaspase-3 activation depended on BIR2 and BIR3 of cIAP1 and was independent of BIR1, RING, CARD, and UBA domains. Smac prevented cIAP1 from inhibiting procaspase- 3 activation and reversed the inhibition by prior addition of cIAP1. A procaspase-9 mutant (D315A) that cannot produce the p12 subunit was resistant to inhibition by cIAP1. Therefore, the N-terminal Ala-Thr-Pro-Phe motif of the p12 subunit of the caspase-9 apoptosome facilitates apoptosome blockade. Consequently, cIAP1 cooperatively interacts with oligomerized processed caspase-9 in the apoptosome and blocks procaspase-3 activation.	[Smith, Jeffrey B.] Univ Alabama, Sch Med, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Smith, JB (corresponding author), Univ Alabama, Sch Med, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA.	jeff.smith@ccc.uab.edu		Burke, Stephen/0000-0002-8489-6953	National Institutes of Health [GM60383]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60383.	Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Davoodi J, 2004, J BIOL CHEM, V279, P40622, DOI 10.1074/jbc.M405963200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Eckelman BP, 2008, CELL DEATH DIFFER, V15, P920, DOI 10.1038/cdd.2008.6; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Goncalves RB, 2008, BIOCHEMISTRY-US, V47, P3832, DOI 10.1021/bi702248n; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Imoto I, 2002, CANCER RES, V62, P4860; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Qi S, 2008, INT J ORAL MAX SURG, V37, P1047, DOI 10.1016/j.ijom.2008.06.004; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vischioni B, 2006, HUM PATHOL, V37, P78, DOI 10.1016/j.humpath.2005.09.022; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006	47	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30061	30068		10.1074/jbc.M110.125955	http://dx.doi.org/10.1074/jbc.M110.125955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20667824	Green Published, hybrid			2022-12-25	WOS:000281984300044
J	Crellin, PK; Vivian, JP; Scoble, J; Chow, FM; West, NP; Brammananth, R; Proellocks, NI; Shahine, A; Le Nours, J; Wilce, MCJ; Britton, WJ; Coppel, RL; Rossjohn, J; Beddoe, T				Crellin, Paul K.; Vivian, Julian P.; Scoble, Judith; Chow, Frances M.; West, Nicholas P.; Brammananth, Rajini; Proellocks, Nicholas I.; Shahine, Adam; Le Nours, Jerome; Wilce, Matthew C. J.; Britton, Warwick J.; Coppel, Ross L.; Rossjohn, Jamie; Beddoe, Travis			Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTINASE-LIKE PROTEINS; CELL-WALL; MYCOLIC ACIDS; TUBERCULOSIS; BIOSYNTHESIS; IDENTIFICATION; CATALYZES; SERINE; ENZYME; STEP	The highly complex and unique mycobacterial cell wall is critical to the survival of Mycobacteria in host cells. However, the biosynthetic pathways responsible for its synthesis are, in general, incompletely characterized. Rv3802c from Mycobacterium tuberculosis is a partially characterized phospholipase/thioesterase encoded within a genetic cluster dedicated to the synthesis of core structures of the mycobacterial cell wall, including mycolic acids and arabinogalactan. Enzymatic assays performed with purified recombinant proteins Rv3802c and its close homologs from Mycobacterium smegmatis (MSMEG_6394) and Corynebacterium glutamicum (NCgl2775) show that they all have significant lipase activities that are inhibited by tetrahydrolipstatin, an anti-obesity drug that coincidently inhibits mycobacterial cell wall biosynthesis. The crystal structure of MSMEG_6394, solved to 2.9 angstrom resolution, revealed an alpha/beta hydrolase fold and a catalytic triad typically present in esterases and lipases. Furthermore, we demonstrate direct evidence of gene essentiality in M. smegmatis and show the structural consequences of loss of MSMEG_6394 function on the cellular integrity of the organism. These findings, combined with the predicted essentiality of Rv3802c in M. tuberculosis, indicate that the Rv3802c family performs a fundamental and indispensable lipase-associated function in mycobacteria.	[Crellin, Paul K.; Scoble, Judith; Brammananth, Rajini; Proellocks, Nicholas I.; Le Nours, Jerome; Coppel, Ross L.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Crellin, Paul K.; Vivian, Julian P.; Brammananth, Rajini; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Scoble, Judith; Shahine, Adam; Le Nours, Jerome; Wilce, Matthew C. J.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Chow, Frances M.; West, Nicholas P.; Britton, Warwick J.] Centenary Inst, Mycobacterial Res Program, Newtown, NSW 2042, Australia; [West, Nicholas P.; Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Monash University; Monash University; Monash University; University of Sydney; Centenary Institute; University of Sydney	Crellin, PK (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu	Coppel, Ross L/A-6626-2008; Rossjohn, Jamie/F-9032-2013; West, Nicholas P/C-3119-2008; Proellochs, Nick/ABB-5634-2020; Beddoe, Travis/F-3415-2014; Scoble, Judith A/B-4919-2016	Coppel, Ross L/0000-0002-4476-9124; Rossjohn, Jamie/0000-0002-2020-7522; West, Nicholas P/0000-0003-0955-9890; Proellochs, Nick/0000-0003-3750-1135; Beddoe, Travis/0000-0003-4550-2277; Scoble, Judith A/0000-0002-6652-0717; Crellin, Paul K/0000-0002-2017-4935; Britton, Warwick/0000-0001-6721-9646; Le Nours, Jerome/0000-0002-2221-7636; Vivian, Julian/0000-0002-9400-4437; Shahine, Adam/0000-0001-7717-4437	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics; National Health and Medical Research Council of Australia; Australian Research Council Federation; Pfizer	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Federation(Australian Research Council); Pfizer(Pfizer)	This work was supported in part by the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics and the National Health and Medical Research Council of Australia.; Supported by an Australian Research Council Federation Fellowship.; Supported by a Pfizer Senior Research Fellowship.	ANDERBERG RJ, 1995, BIOTECHNIQUES, V18, P217; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghosh D, 1999, ACTA CRYSTALLOGR D, V55, P779, DOI 10.1107/S0907444999000244; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUILHOT C, 1992, FEMS MICROBIOL LETT, V98, P181; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; HADVARY P, 1991, J BIOL CHEM, V266, P2021; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Ioerger T R, 1999, Proc Int Conf Intell Syst Mol Biol, P130; Ioerger TR, 2003, METHOD ENZYMOL, V374, P244, DOI 10.1016/S0076-6879(03)74012-9; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; MARTINEZ C, 1992, NATURE, V356, P615, DOI 10.1038/356615a0; Masaki K, 2005, APPL ENVIRON MICROB, V71, P7548, DOI 10.1128/AEM.71.11.7548-7550.2005; Meniche X, 2009, J BACTERIOL, V191, P7323, DOI 10.1128/JB.01042-09; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Richardson Jane S, 2003, Methods Biochem Anal, V44, P305; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; SOUTHERN EM, 1974, ANAL BIOCHEM, V62, P317, DOI 10.1016/0003-2697(74)90395-9; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; WHO, 2009, WHO TECH REP SER, V958, P1; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	46	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30050	30060		10.1074/jbc.M110.150094	http://dx.doi.org/10.1074/jbc.M110.150094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20656688	Green Published, hybrid			2022-12-25	WOS:000281984300043
J	Roberts, T; McGreevy, P; Valenzuela, M				Roberts, Taryn; McGreevy, Paul; Valenzuela, Michael			Human Induced Rotation and Reorganization of the Brain of Domestic Dogs	PLOS ONE			English	Article							OLFACTORY-BULB; MORPHOLOGY; TYPOLOGY; SKULL	Domestic dogs exhibit an extraordinary degree of morphological diversity. Such breed-to-breed variability applies equally to the canine skull, however little is known about whether this translates to systematic differences in cerebral organization. By looking at the paramedian sagittal magnetic resonance image slice of canine brains across a range of animals with different skull shapes (N = 13), we found that the relative reduction in skull length compared to width (measured by Cephalic Index) was significantly correlated to a progressive ventral pitching of the primary longitudinal brain axis (r = 0.83), as well as with a ventral shift in the position of the olfactory lobe (r = 0.81). Furthermore, these findings were independent of estimated brain size or body weight. Since brachycephaly has arisen from generations of highly selective breeding, this study suggests that the remarkable diversity in domesticated dogs' body shape and size appears to also have led to human-induced adaptations in the organization of the canine brain.	[Roberts, Taryn; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Valenzuela, Michael] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Valenzuela, Michael] Univ New S Wales, Brain & Ageing Res Program, Fac Med, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Roberts, T (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	taryn@bell.net; michaelv@unsw.edu.au		McGreevy, Paul/0000-0001-7220-8378; Valenzuela, Michael/0000-0001-7162-6607	University of New South Wales; Natural Sciences and Engineering Research Council of Canada	University of New South Wales; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	MV is supported by a University of New South Wales Vice Chancellor's Fellowship. TR was funded by a Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge K, 2005, ANAT REC PART A, V285A, P690, DOI 10.1002/ar.a.20201; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P37, DOI 10.1111/j.1740-8261.2008.01487.x; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V88, P323, DOI 10.1002/ajpa.1330880307; Coppinger Raymond, 1995, P21; CURTIS MA, 2009, PROGR BRAIN RES; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dickie AM, 2001, VET RADIOL ULTRASOUN, V42, P205, DOI 10.1111/j.1740-8261.2001.tb00926.x; Evans HE, 1979, MILLERS ANATOMY DOG; Evans KE, 2006, ANAT HISTOL EMBRYOL, V35, P221, DOI 10.1111/j.1439-0264.2005.00663.x; Flegel T, 2008, VET RADIOL ULTRASOUN, V49, P419, DOI 10.1111/j.1740-8261.2008.00400.x; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; GITTLEMAN JL, 1991, J ZOOL, V225, P253, DOI 10.1111/j.1469-7998.1991.tb03815.x; Goodwin D, 1997, ANIM BEHAV, V53, P297, DOI 10.1006/anbe.1996.0370; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; LIGNEREUX Y, 1991, REV MED VET-TOULOUSE, V142, P469; MARTONCIKOVA M, 2010, ACTA HISTOC IN PRESS; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; MCGREEVY PD, 2010, J VET BEHAV IN PRESS; Myers P., 2022, ANIMAL DIVERSITY WEB; Onar V, 2001, ANAT HISTOL EMBRYOL, V30, P41, DOI 10.1046/j.1439-0264.2001.00292.x; Ostrander EA, 2007, AM SCI, V95, P406, DOI 10.1511/2007.67.3724; REGODON S, 1993, ANN ANAT, V175, P361, DOI 10.1016/S0940-9602(11)80043-9; Schwarz T, 2000, VET RADIOL ULTRASOUN, V41, P220, DOI 10.1111/j.1740-8261.2000.tb01482.x; SEIFERLE E, 1966, ACTA ANAT, V63, P346, DOI 10.1159/000142799; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA	27	67	67	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11946	10.1371/journal.pone.0011946	http://dx.doi.org/10.1371/journal.pone.0011946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668685	Green Published, gold			2022-12-25	WOS:000280297300028
J	Costa, MD; Bajanca, F; Rodrigues, AJ; Tome, RJ; Corthals, G; Macedo-Ribeiro, S; Paulson, HL; Logarinho, E; Maciel, P				Costa, Maria do Carmo; Bajanca, Fernanda; Rodrigues, Ana-Joao; Tome, Ricardo J.; Corthals, Garry; Macedo-Ribeiro, Sandra; Paulson, Henry L.; Logarinho, Elsa; Maciel, Patricia			Ataxin-3 Plays a Role in Mouse Myogenic Differentiation through Regulation of Integrin Subunit Levels	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; DEVELOPMENTAL EXPRESSION; DEUBIQUITINATING ENZYMES; C-ELEGANS; PROTEIN; GENE; UBIQUITINATION; BINDING; DEGRADATION; PROTEASOME	Background: During myogenesis several transcription factors and regulators of protein synthesis and assembly are rapidly degraded by the ubiquitin-proteasome system (UPS). Given the potential role of the deubiquitinating enzyme (DUB) ataxin3 in the UPS, and the high expression of the murine ataxin-3 homolog in muscle during embryogenesis, we sought to define its role in muscle differentiation. Methodology/Principal Findings: Using immunofluorescence analysis, we found murine ataxin-3 (mATX3) to be highly expressed in the differentiated myotome of E9.5 mouse embryos. C2C12 myoblasts depleted of mATX3 by RNA interference exhibited a round morphology, cell misalignment, and a delay in differentiation following myogenesis induction. Interestingly, these cells showed a down-regulation of alpha 5 and alpha 7 integrin subunit levels both by immunoblotting and immunofluorescence. Mouse ATX3 was found to interact with a5 integrin subunit and to stabilize this protein by repressing its degradation through the UPS. Proteomic analysis of mATX3-depleted C2C12 cells revealed alteration of the levels of several proteins related to integrin signaling. Conclusions: Ataxin-3 is important for myogenesis through regulation of integrin subunit levels.	[Costa, Maria do Carmo; Bajanca, Fernanda; Rodrigues, Ana-Joao; Logarinho, Elsa; Maciel, Patricia] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Costa, Maria do Carmo; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Tome, Ricardo J.; Macedo-Ribeiro, Sandra; Logarinho, Elsa] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Corthals, Garry] Turku Ctr Biotechnol, Turku, Finland	Universidade do Minho; University of Michigan System; University of Michigan; Universidade do Porto; University of Turku	Costa, MD (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	pmaciel@ecsaude.uminho.pt	Maciel, Patrícia/B-5989-2009; Maciel, Patricia/AAH-2102-2020; Logarinho, Elsa/I-5616-2013; Corthals, Garry/G-9417-2016; Rodrigues, Ana João/D-3782-2012; Rodrigues, Ana/GYQ-6273-2022; Macedo-Ribeiro, Sandra/D-9258-2011	Maciel, Patrícia/0000-0002-0920-6350; Maciel, Patricia/0000-0002-0920-6350; Logarinho, Elsa/0000-0002-8741-0744; Corthals, Garry/0000-0001-9423-5596; Rodrigues, Ana João/0000-0003-1968-7968; Macedo-Ribeiro, Sandra/0000-0002-7698-1170; Bajanca, Fernanda/0000-0001-8846-6611; Pereira da Costa, Maria do Carmo/0000-0001-8466-4864	Fundacao para a Ciencia e a Tecnologia (FCT) [POCI/SAU-MMO/60412/2002, SFRH/BD/9759/2003, SFRH/BPD/28560/2006, SFRH/BPD/17368/2004, SFRH/BD/17066/2004, SFRH/BD/29947/2006]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [RO1 NS038712]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was financed by the Fundacao para a Ciencia e a Tecnologia (FCT) (POCI/SAU-MMO/60412/2002) and by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grant RO1 NS038712 to HLP. MCC, FB, AJR, and RJT were supported by the FCT fellowships (SFRH/BD/9759/2003 and SFRH/BPD/28560/2006), (SFRH/BPD/17368/2004), (SFRH/BD/17066/2004), (SFRH/BD/29947/2006), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Cachaco AS, 2005, DEV DYNAM, V232, P1069, DOI 10.1002/dvdy.20280; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chow MKM, 2004, BIOCHEM BIOPH RES CO, V322, P387, DOI 10.1016/j.bbrc.2004.07.131; Costa MD, 2004, GENOMICS, V84, P361, DOI 10.1016/j.ygeno.2004.02.012; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Gu YF, 2006, I C FIELD PROG LOGIC, P21, DOI 10.1109/FPL.2006.311190; GULLBERG D, 1998, FRONT BIOSCI, V3, P1039; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Rodrigues AJ, 2009, BIOCHEM BIOPH RES CO, V386, P575, DOI 10.1016/j.bbrc.2009.06.092; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Shen Lu, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P40; Shiraishi S, 2007, J BIOL CHEM, V282, P9017, DOI 10.1074/jbc.M611513200; Sporle R, 2001, DEV GENES EVOL, V211, P198, DOI 10.1007/s004270100139; Spurny R, 2007, J BIOL CHEM, V282, P8175, DOI 10.1074/jbc.M608473200; Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Tzvetkov N, 2007, BIOL CHEM, V388, P973, DOI 10.1515/BC.2007.107; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; WANG H, 2007, J NEUROCHEM; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	60	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11728	10.1371/journal.pone.0011728	http://dx.doi.org/10.1371/journal.pone.0011728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668528	Green Submitted, Green Published, gold			2022-12-25	WOS:000280243800008
J	Lin, YP; He, P; Wang, QH; Lu, DJ; Li, ZL; Wu, CS; Jiang, N				Lin, Yuping; He, Peng; Wang, Qinhong; Lu, Dajun; Li, Zilong; Wu, Changsheng; Jiang, Ning			The Alcohol Dehydrogenase System in the Xylose-Fermenting Yeast Candida maltosa	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ADH GENES; RESPIRATORY YEAST; MULTIPLE FORMS; MESSENGER-RNA; EVOLUTION; EXPRESSION; PROTEIN; FERMENTATION; PHYLOGENY	Background: The alcohol dehydrogenase (ADH) system plays a critical role in sugar metabolism involving in not only ethanol formation and consumption but also the general "cofactor balance'' mechanism. Candida maltosa is able to ferment glucose as well as xylose to produce a significant amount of ethanol. Here we report the ADH system in C. maltosa composed of three microbial group I ADH genes (CmADH1, CmADH2A and CmADH2B), mainly focusing on its metabolic regulation and physiological function. Methodology/Principal Findings: Genetic analysis indicated that CmADH2A and CmADH2B tandemly located on the chromosome could be derived from tandem gene duplication. In vitro characterization of enzymatic properties revealed that all the three CmADHs had broad substrate specificities. Homo-and heterotetramers of CmADH1 and CmADH2A were demonstrated by zymogram analysis, and their expression profiles and physiological functions were different with respect to carbon sources and growth phases. Fermentation studies of ADH2A-deficient mutant showed that CmADH2A was directly related to NAD regeneration during xylose metabolism since CmADH2A deficiency resulted in a significant accumulation of glycerol. Conclusions/Significance: Our results revealed that CmADH1 was responsible for ethanol formation during glucose metabolism, whereas CmADH2A was glucose-repressed and functioned to convert the accumulated ethanol to acetaldehyde. To our knowledge, this is the first demonstration of function separation and glucose repression of ADH genes in xylose-fermenting yeasts. On the other hand, CmADH1 and CmADH2A were both involved in ethanol formation with NAD regeneration to maintain NADH/NAD ratio in favor of producing xylitol from xylose. In contrast, CmADH2B was expressed at a much lower level than the other two CmADH genes, and its function is to be further confirmed.	[Lin, Yuping; He, Peng; Lu, Dajun; Li, Zilong; Wu, Changsheng; Jiang, Ning] Chinese Acad Sci, Ctr Microbial Biotechnol, Inst Microbiol, Beijing, Peoples R China; [Lin, Yuping; Li, Zilong; Wu, Changsheng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wang, Qinhong] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Lin, YP (corresponding author), Chinese Acad Sci, Ctr Microbial Biotechnol, Inst Microbiol, Beijing, Peoples R China.	wang_qh@tib.cas.cn; Jiangn@sun.im.ac.cn			National High Technology Research and Development Program of China [2006AA020101]; Chinese Academy of Sciences [KSCX2-YW-G-064, KSCX1-YW-11C3, KSCX1-YW-11E]; National Basic Research Program [2007CB707803]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program(National Basic Research Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2006AA020101), the National Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-YW-G-064, KSCX1-YW-11C3 and KSCX1-YW-11E) and the National Basic Research Program (973 Program, 2007CB707803). Q. W. is supported by the Bairenjihhua Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMORE R, 1991, GENE, V109, P89, DOI 10.1016/0378-1119(91)90592-Y; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; Bertram G, 1996, YEAST, V12, P115, DOI 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E; Bozzi A, 1997, BBA-PROTEIN STRUCT M, V1339, P133, DOI 10.1016/S0167-4838(96)00225-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brisdelli F, 2004, BIOCHIMIE, V86, P705, DOI 10.1016/j.biochi.2004.08.004; BRUINENBERG PM, 1984, APPL MICROBIOL BIOT, V19, P256, DOI 10.1007/BF00251847; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Cho JY, 1998, APPL ENVIRON MICROB, V64, P1350; Cho JY, 1999, APPL ENVIRON MICROB, V65, P2363; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; CIRIACY M, 1975, MUTAT RES, V29, P315, DOI 10.1016/0165-1218(75)90093-2; Daniel HM, 2001, INT J SYST EVOL MICR, V51, P1593, DOI 10.1099/00207713-51-4-1593; DENIS CL, 1983, J BIOL CHEM, V258, P1165; DENIS CL, 1981, J MOL BIOL, V148, P355, DOI 10.1016/0022-2836(81)90181-9; EKLUND H, 1990, EUR J BIOCHEM, V193, P303, DOI 10.1111/j.1432-1033.1990.tb19337.x; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fredlund E, 2006, YEAST, V23, P1137, DOI 10.1002/yea.1428; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Granstrom TB, 2007, APPL MICROBIOL BIOT, V74, P277, DOI 10.1007/s00253-006-0761-3; Guo C, 2006, J APPL MICROBIOL, V101, P1096, DOI 10.1111/j.1365-2672.2006.02994.x; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; INDRATI R, 1991, CAN J MICROBIOL, V37, P803, DOI 10.1139/m91-139; Jeffries T W, 1983, Adv Biochem Eng Biotechnol, V27, P1; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTSTORF U, 1968, ARCH BIOCHEM BIOPHYS, V126, P933, DOI 10.1016/0003-9861(68)90487-6; Mazzoni C, 2006, FEMS YEAST RES, V6, P421, DOI 10.1111/j.1567-1364.2005.00013.x; MAZZONI C, 1992, MOL MICROBIOL, V6, P2279, DOI 10.1111/j.1365-2958.1992.tb01403.x; Park YC, 2006, J IND MICROBIOL BIOT, V33, P1032, DOI 10.1007/s10295-006-0154-8; Passoth V, 1996, APPL BIOCHEM BIOTECH, V57-8, P201, DOI 10.1007/BF02941701; Passoth V, 2003, YEAST, V20, P39, DOI 10.1002/yea.933; PILGRIM D, 1987, MOL CELL BIOL, V7, P294, DOI 10.1128/MCB.7.1.294; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; SALIOLA M, 1991, YEAST, V7, P391, DOI 10.1002/yea.320070409; Saliola M, 2007, FEMS YEAST RES, V7, P693, DOI 10.1111/j.1567-1364.2007.00250.x; Saliola M, 2006, FEMS YEAST RES, V6, P1184, DOI 10.1111/j.1567-1364.2006.00103.x; SHAIN DH, 1992, MOL GEN GENET, V232, P479, DOI 10.1007/BF00266253; Smith MG, 2004, MOL CELL BIOL, V24, P3874, DOI 10.1128/MCB.24.9.3874-3884.2004; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2307, DOI 10.1128/AEM.70.4.2307-2317.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; WIESENFELD M, 1975, BIOCHIM BIOPHYS ACTA, V405, P500, DOI 10.1016/0005-2795(75)90115-4; WILLIAMSON VM, 1980, NATURE, V283, P214, DOI 10.1038/283214a0	47	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11752	10.1371/journal.pone.0011752	http://dx.doi.org/10.1371/journal.pone.0011752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668703	Green Submitted, gold, Green Published			2022-12-25	WOS:000280243800022
J	Gawlik, KI; Akerlund, M; Carmignac, V; Elamaa, H; Durbeej, M				Gawlik, Kinga I.; Akerlund, Mikael; Carmignac, Virginie; Elamaa, Harri; Durbeej, Madeleine			Distinct Roles for Laminin Globular Domains in Laminin alpha 1 Chain Mediated Rescue of Murine Laminin alpha 2 Chain Deficiency	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; BASEMENT-MEMBRANE; SKELETAL-MUSCLE; SCHWANN-CELLS; LAMININ-ALPHA-1 CHAIN; PERIPHERAL NEUROPATHY; INTEGRIN ALPHA-7-BETA-1; REGENERATIVE CAPACITY; DYSTROGLYCAN BINDING; SULFATIDE BINDING	Background: Laminin alpha 2 chain mutations cause congenital muscular dystrophy with dysmyelination neuropathy (MDC1A). Previously, we demonstrated that laminin alpha 1 chain ameliorates the disease in mice. Dystroglycan and integrins are major laminin receptors. Unlike laminin alpha 2 chain, alpha 1 chain binds the receptors by separate domains; laminin globular (LG) domains 4 and LG1-3, respectively. Thus, the laminin alpha 1 chain is an excellent tool to distinguish between the roles of dystroglycan and integrins in the neuromuscular system. Methodology/Principal Findings: Here, we provide insights into the functions of laminin alpha 1LG domains and the division of their roles in MDC1A pathogenesis and rescue. Overexpression of laminin alpha 1 chain that lacks the dystroglycan binding LG4-5 domains in alpha 2 chain deficient mice resulted in prolonged lifespan and improved health. Importantly, diaphragm and heart muscles were corrected, whereas limb muscles were dystrophic, indicating that different muscles have different requirements for LG4-5 domains. Furthermore, the regenerative capacity of the skeletal muscle did not depend on laminin alpha 1LG4-5. However, this domain was crucial for preventing apoptosis in limb muscles, essential for myelination in peripheral nerve and important for basement membrane assembly. Conclusions/Significance: These results show that laminin alpha 1LG domains and consequently their receptors have disparate functions in the neuromuscular system. Understanding these interactions could contribute to design and optimization of future medical treatment for MDC1A patients.	[Gawlik, Kinga I.; Akerlund, Mikael; Carmignac, Virginie; Elamaa, Harri; Durbeej, Madeleine] Lund Univ, Muscle Biol Unit, Dept Expt Med Sci, Lund, Sweden	Lund University	Gawlik, KI (corresponding author), Lund Univ, Muscle Biol Unit, Dept Expt Med Sci, Lund, Sweden.	madeleine.durbeej-hjalt@med.lu.se		Durbeej Hjalt, Madeleine/0000-0002-5491-2457	Association Francaise contre les Myopathies; Muscular Dystrophy Association; Anna-Greta Crafoord Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association(Muscular Dystrophy Association); Anna-Greta Crafoord Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	Funded by Association Francaise contre les Myopathies, Muscular Dystrophy Association, Anna-Greta Crafoord Foundation for Rheumatological Research, Greta and Johan Kock Foundation and Alfred Osterlund Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Allikian MJ, 2004, J CELL SCI, V117, P3821, DOI 10.1242/jcs.01234; Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; Cohn RD, 1999, J NEUROL SCI, V163, P140, DOI 10.1016/S0022-510X(99)00012-X; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Dupree JL, 1998, J NEUROCYTOL, V27, P649, DOI 10.1023/A:1006908013972; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2006, FEBS LETT, V580, P1759, DOI 10.1016/j.febslet.2006.02.027; GAWLIK KI, 2010, MUSCLE NERV IN PRESS; Gawlik KI, 2006, HUM MOL GENET, V15, P2690, DOI 10.1093/hmg/ddl201; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523; Goutebroze L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-29; Guo C, 2006, HUM MOL GENET, V15, P989, DOI 10.1093/hmg/ddl018; Hager M, 2005, AM J PATHOL, V167, P823, DOI 10.1016/S0002-9440(10)62054-8; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; JAROS E, 1979, NEUROPATH APPL NEURO, V5, P133, DOI 10.1111/j.1365-2990.1979.tb00666.x; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Mckee KK, 2009, J BIOL CHEM, V284, P8984, DOI 10.1074/jbc.M809719200; Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152; Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563; MIRSKY R, 1990, DEVELOPMENT, V109, P105; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Mukasa T, 1999, BIOCHEM BIOPH RES CO, V260, P139, DOI 10.1006/bbrc.1999.0829; Nakagawa M, 2001, GLIA, V35, P101, DOI 10.1002/glia.1075; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nodari A, 2008, J NEUROSCI, V28, P6714, DOI 10.1523/JNEUROSCI.0326-08.2008; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Previtali SC, 2003, MOL CELL NEUROSCI, V23, P210, DOI 10.1016/S1044-7431(03)00014-9; Previtali SC, 2003, J NEUROSCI, V23, P5520; Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102; Quijano-Roy S, 2004, MUSCLE NERVE, V29, P292, DOI 10.1002/mus.10544; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; Rooney JE, 2009, AM J PATHOL, V174, P256, DOI 10.2353/ajpath.2009.080522; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Sander S, 2000, J NEUROL NEUROSUR PS, V68, P483, DOI 10.1136/jnnp.68.4.483; Satz JS, 2008, J NEUROSCI, V28, P10567, DOI 10.1523/JNEUROSCI.2457-08.2008; Scheele S, 2005, P NATL ACAD SCI USA, V102, P1502, DOI 10.1073/pnas.0405095102; Sciandra F, 2007, TRENDS BIOTECHNOL, V25, P262, DOI 10.1016/j.tibtech.2007.04.002; SHORER Z, 1995, J CHILD NEUROL, V10, P472, DOI 10.1177/088307389501000610; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Tsiper MV, 2002, J CELL SCI, V115, P1005; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; VOIT T, 2004, MYOLOGY, P1203; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; von der Mark H, 2007, J MOL BIOL, V371, P1188, DOI 10.1016/j.jmb.2007.05.074; WILLIAMS RW, 1986, J COMP NEUROL, V246, P32, DOI 10.1002/cne.902460104; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158; Yurchenco PD, 2004, J CELL SCI, V117, P735, DOI 10.1242/jcs.00911	79	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11549	10.1371/journal.pone.0011549	http://dx.doi.org/10.1371/journal.pone.0011549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657839	Green Published, gold, Green Submitted			2022-12-25	WOS:000280065600003
J	Akhmedov, D; Braun, M; Mataki, C; Park, KS; Pozzan, T; Schoonjans, K; Rorsman, P; Wollheim, CB; Wiederkehr, A				Akhmedov, Dmitry; Braun, Matthias; Mataki, Chikage; Park, Kyu-Sang; Pozzan, Tullio; Schoonjans, Kristina; Rorsman, Patrik; Wollheim, Claes B.; Wiederkehr, Andreas			Mitochondrial matrix pH controls oxidative phosphorylation and metabolism-secretion coupling in INS-1E clonal beta cells	FASEB JOURNAL			English	Article						ATP; insulin; respiration; mtAlpHi/YC3.6	STIMULATED INSULIN-SECRETION; GLUCOSE-INDUCED CHANGES; RAT PANCREATIC-ISLETS; FLUORESCENT PROTEINS; ATP; CALCIUM; INTRAMITOCHONDRIAL; RELEASE; ATP/ADP; ADP	Glucose-evoked mitochondrial signals augment ATP synthesis in the pancreatic beta cell. This activation of energy metabolism increases the cytosolic ATP/ADP ratio, which stimulates plasma membrane electrical activity and insulin granule exocytosis. We have recently demonstrated that matrix pH increases during nutrient stimulation of the pancreatic beta cell. Here, we have tested whether mitochondrial matrix pH controls oxidative phosphorylation and metabolism-secretion coupling in the rat beta-cell line INS-1E. Acidification of the mitochondrial matrix pH by nigericin blunted nutrient-dependent respiratory and ATP responses (continuously monitored in intact cells). Using electrophysiology and single cell imaging, we find that the associated defects in energy metabolism suppress glucose-stimulated plasma membrane electrical activity and cytosolic calcium transients. The same parameters were unaffected after direct stimulation of electrical activity with tolbutamide, which bypasses mitochondrial function. Furthermore, lowered matrix pH strongly inhibited sustained, but not first-phase, insulin secretion. Our results demonstrate that the matrix pH exerts a control function on oxidative phosphorylation in intact cells and that this mode of regulation is of physiological relevance for the generation of downstream signals leading to insulin granule exocytosis. We propose that matrix pH serves a novel signaling role in sustained cell activation.-Akhmedov, D., Braun, M., Mataki, C., Park, K.-S., Pozzan, T., Schoonjans, K., Rorsman, P., Wollheim, C. B., Wiederkehr, A. Mitochondrial matrix pH controls oxidative phosphorylation and metabolism-secretion coupling in INS-1E clonal beta cells. FASEB J. 24, 4613-4626 (2010). www.fasebj.org	[Wiederkehr, Andreas] Univ Geneva, Dept Cell Physiol & Metab, Univ Med Ctr, CH-1211 Geneva 4, Switzerland; [Braun, Matthias; Rorsman, Patrik] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Mataki, Chikage; Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Lab Integrat Syst & Physiol, Lausanne, Switzerland; [Park, Kyu-Sang] Yonsei Univ, Dept Physiol, Wonju Coll Med, Wonju, South Korea; [Pozzan, Tullio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Pozzan, Tullio] CNR, Inst Neurosci, Padua, Italy	University of Geneva; University of Oxford; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Yonsei University; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Wiederkehr, A (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Univ Med Ctr, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	andreas.wiederkehr@unige.ch	Rorsman, Patrik/A-4331-2016	Rorsman, Patrik/0000-0001-7578-0767; Schoonjans, Kristina/0000-0003-1247-4265; Park, Kyu-Sang/0000-0003-0322-9807	Swiss National Foundation [310000-116750/1]; Ecole Polytechnique Federale de Lausanne; EuroDia [LSHM-CT-2006-518153]; European Community; Wellcome Trust; UK Medical Research Council	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Ecole Polytechnique Federale de Lausanne; EuroDia; European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Nicole Aebischer, Dale Brighouse, Olivier Dupont, Elodie Husi, and Danielle Nappey for expert technical assistance. The authors gratefully acknowledge the continued support by the Swiss National Foundation (310000-116750/1); the Ecole Polytechnique Federale de Lausanne; EuroDia (LSHM-CT-2006-518153), a European Community-funded project under framework program 6; the Wellcome Trust; and the UK Medical Research Council.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Das AM, 2003, MOL GENET METAB, V79, P71, DOI 10.1016/S1096-7192(03)00069-6; Detimary P, 1996, ENDOCRINOLOGY, V137, P4671, DOI 10.1210/en.137.11.4671; Doliba NM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1507, DOI 10.1152/ajpendo.00282.2006; DUCHEN MR, 1993, BIOCHEM J, V294, P35, DOI 10.1042/bj2940035; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; GREENBAUM NL, 1985, J BIOL CHEM, V260, P873; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HUTTON JC, 1980, DIABETOLOGIA, V18, P395; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; MALAISSE WJ, 1987, BIOCHIM BIOPHYS ACTA, V927, P190, DOI 10.1016/0167-4889(87)90134-0; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; OHTA M, 1990, J BIOL CHEM, V265, P17525; Ortsater H, 2002, PFLUG ARCH EUR J PHY, V444, P506, DOI 10.1007/s00424-002-0842-9; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; SCHULTZ V, 1993, ANAL BIOCHEM, V215, P302, DOI 10.1006/abio.1993.1591; SMITH PA, 1990, FEBS LETT, V261, P187, DOI 10.1016/0014-5793(90)80667-8; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302	32	49	50	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4613	4626		10.1096/fj.10-162222	http://dx.doi.org/10.1096/fj.10-162222			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20647546	Green Published			2022-12-25	WOS:000283861100045
J	Tong, FM; Billheimer, J; Shechtman, CF; Liu, Y; Crooke, R; Graham, M; Cohen, DE; Sturley, SL; Rader, DJ				Tong, Fumin; Billheimer, Jeffrey; Shechtman, Caryn F.; Liu, Ying; Crooke, Roseann; Graham, Mark; Cohen, David E.; Sturley, Stephen L.; Rader, Daniel J.			Decreased Expression of ARV1 Results in Cholesterol Retention in the Endoplasmic Reticulum and Abnormal Bile Acid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COENZYME-A; PLASMA-MEMBRANE; IN-VIVO; NUCLEAR RECEPTOR; HDL CHOLESTEROL; YEAST ARV1; TRANSPORT; ACYLTRANSFERASE; CELLS; RAT	Endoplasmic reticulum (ER) membrane cholesterol is maintained at an optimal concentration of similar to 5 mol % by the net impact of sterol synthesis, modification, and export. Arv1p was first identified in the yeast Saccharomyces cerevisiae as a key component of this homeostasis due to its probable role in intracellular sterol transport. Mammalian ARV1, which can fully complement the yeast lesion, encodes a ubiquitously expressed, resident ER protein. Repeated dosing of specific antisense oligonucleotides to ARV1 produced a marked reduction of ARV1 transcripts in liver, adipose, and to a lesser extent, intestine. This resulted in marked hypercholesterolemia, elevated serum bile acids, and activation of the hepatic farnesoid X receptor (FXR) regulatory pathway. Knockdown of ARV1 in murine liver and HepG2 cells was associated with accumulation of cholesterol in the ER at the expense of the plasma membrane and suppression of sterol regulatory element-binding proteins and their targets. These studies indicate a critical role of mammalian Arv1p in sterol movement from the ER and in the ensuing regulation of hepatic cholesterol and bile acid metabolism.	[Shechtman, Caryn F.; Liu, Ying; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Shechtman, Caryn F.; Liu, Ying; Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Tong, Fumin; Billheimer, Jeffrey; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Tong, Fumin; Billheimer, Jeffrey; Rader, Daniel J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Crooke, Roseann; Graham, Mark] ISIS Pharmaceut Inc, Carlsbad, CA 92008 USA; [Cohen, David E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Isis Pharmaceuticals Inc; Harvard University; Brigham & Women's Hospital	Sturley, SL (corresponding author), Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA.	sls37@columbia.edu; rader@mail.med.upenn.edu			National Institutes of Health [DK48873, DK56626, DK54320, HL59407]; Grant Training Fellowship in Nutrition [T32 DK007647]; Grant Training Fellowship in Translational Science [TL 1RR024158]; American Diabetes Association; Ara Parseghian Medical Research Foundation; Bristol Myers Squibb; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320, R37DK048873, R01DK048873, R01DK056626, T32DK007647, R29DK048873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Training Fellowship in Nutrition; Grant Training Fellowship in Translational Science; American Diabetes Association(American Diabetes Association); Ara Parseghian Medical Research Foundation; Bristol Myers Squibb(Bristol-Myers Squibb); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK48873 and DK56626 (to D. E. C.), Grant DK54320 (to S. L. S.), Grant HL59407 (to D. J. R.), and Grant Training Fellowships in Nutrition T32 DK007647 and Translational Science TL 1RR024158 (to C. F. S.). This work was also supported by the American Diabetes Association (F. T. and S. L. S.), the Ara Parseghian Medical Research Foundation (S. L. S.), and the Bristol Myers Squibb "Freedom to Discover" Unrestricted Cardiovascular Research Grant (to D. J. R.).	BILLHEIMER JT, 1981, ANAL BIOCHEM, V111, P331, DOI 10.1016/0003-2697(81)90570-4; Bravo I, 2007, BBA-GEN SUBJECTS, V1770, P979, DOI 10.1016/j.bbagen.2007.02.010; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HEUMAN DM, 1989, J LIPID RES, V30, P719; Jacobs NL, 1997, J LIPID RES, V38, P1973; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; LISCUM L, 1995, J BIOL CHEM, V270, P15443, DOI 10.1074/jbc.270.26.15443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Matveev S, 2001, ADV DRUG DELIVER REV, V49, P237, DOI 10.1016/S0169-409X(01)00138-7; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; MITROPOULOS KA, 1978, BIOCHIM BIOPHYS ACTA, V530, P99, DOI 10.1016/0005-2760(78)90130-3; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Paulusma CC, 2009, J BIOL CHEM, V284, P9947, DOI 10.1074/jbc.M808667200; Post SM, 1999, HEPATOLOGY, V30, P491, DOI 10.1002/hep.510300230; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; SINGER II, 1984, P NATL ACAD SCI-BIOL, V81, P5556, DOI 10.1073/pnas.81.17.5556; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; TAVANI DM, 1982, ENDOCRINOLOGY, V111, P794, DOI 10.1210/endo-111-3-794; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; VanPatten S, 2001, AM J PHYSIOL-GASTR L, V281, pG393, DOI 10.1152/ajpgi.2001.281.2.G393; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200	32	19	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33632	33641		10.1074/jbc.M110.165761	http://dx.doi.org/10.1074/jbc.M110.165761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20663892	hybrid, Green Published			2022-12-25	WOS:000283354000008
J	Nakatsu, Y; Sakoda, H; Kushiyama, A; Ono, H; Fujishiro, M; Horike, N; Yoneda, M; Ohno, H; Tsuchiya, Y; Kamata, H; Tahara, H; Isobe, T; Nishimura, F; Katagiri, H; Oka, Y; Fukushima, T; Takahashi, SI; Kurihara, H; Uchida, T; Asanoa, T				Nakatsu, Yusuke; Sakoda, Hideyuki; Kushiyama, Akifumi; Ono, Hiraku; Fujishiro, Midori; Horike, Nanao; Yoneda, Masayasu; Ohno, Haruya; Tsuchiya, Yoshihiro; Kamata, Hideaki; Tahara, Hidetoshi; Isobe, Toshiaki; Nishimura, Fusanori; Katagiri, Hideki; Oka, Yoshitomo; Fukushima, Toshiaki; Takahashi, Shin-Ichiro; Kurihara, Hiroki; Uchida, Takafumi; Asanoa, Tomoichiro			Pin1 Associates with and Induces Translocation of CRTC2 to the Cytosol, Thereby Suppressing cAMP-responsive Element Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL ISOMERASE PIN1; CREB COACTIVATOR CRTC2; BINDING-PROTEIN; HEPATIC GLUCONEOGENESIS; MODULATES GLUCONEOGENESIS; SUBSTRATE RECOGNITION; FUNCTIONAL-ANALYSIS; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; GENE-EXPRESSION	Pin1 is a unique regulator, which catalyzes the conversion of a specific phospho-Ser/Thr-Pro-containing motif in target proteins. Herein, we identified CRTC2 as a Pin1-binding protein by overexpressing Pin1 with Myc and FLAG tags in mouse livers and subsequent purification of the complex containing Pin1. The association between Pin1 and CRTC2 was observed not only in overexpression experiments but also endogenously in the mouse liver. Interestingly, Ser(136) in the nuclear localization signal of CRTC2 was shown to be involved in the association with Pin1. Pin1 overexpression in HepG2 cells attenuated forskolin- induced nuclear localization of CRTC2 and cAMP-responsive element (CRE) transcriptional activity, whereas gene knockdown of Pin1 by siRNA enhanced both. Pin1 also associated with CRTC1, leading to their cytosol localization, essentially similar to the action of CRTC2. Furthermore, it was shown that CRTC2 associated with Pin1 did not bind to CREB. Taken together, these observations indicate the association of Pin1 with CRTC2 to decrease the nuclear CBP.CRTC.CREB complex. Indeed, adenoviral gene transfer of Pin1 into diabetic mice improved hyperglycemia in conjunction with normalizing phosphoenolpyruvate carboxykinase mRNA expression levels, which is regulated by CRE transcriptional activity. In conclusion, Pin1 regulates CRE transcriptional activity, by associating with CRTC1 or CRTC2.	[Nakatsu, Yusuke; Yoneda, Masayasu; Ohno, Haruya; Tsuchiya, Yoshihiro; Kamata, Hideaki; Fukushima, Toshiaki; Asanoa, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Sakoda, Hideyuki; Ono, Hiraku; Fujishiro, Midori] Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Horike, Nanao; Kurihara, Hiroki] Univ Tokyo, Dept Physiol Chem & Metab, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Takahashi, Shin-Ichiro] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Tokyo 1000006, Japan; [Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima 7348553, Japan; [Isobe, Toshiaki] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 1920397, Japan; [Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima 7348553, Japan; [Katagiri, Hideki; Oka, Yoshitomo] Tohoku Univ, Div Mol Metab & Diabet, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Hiroshima University; University of Tokyo; University of Tokyo; University of Tokyo; Asahi Life Foundation; Hiroshima University; Tokyo Metropolitan University; Hiroshima University; Tohoku University; Tohoku University	Asanoa, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asano-tky@umin.ac.jp	Kushiyama, Akifumi/A-6386-2011; Kushiyama, Akifumi/W-5988-2019; Isobe, Toshiaki/Q-9279-2017; 祐介, 中津/AAP-8396-2020; Kamata, Hideaki/N-3907-2017	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276; Uchida, Takafumi/0000-0003-3665-4906; Ohno, Haruya/0000-0001-5400-1162; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Kurihara, Hiroki/0000-0002-6476-5593	Ministry of Education, Science, Sports, and Culture, Japan. [20790648]; Grants-in-Aid for Scientific Research [22780249] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Young Scientists 20790648 (to Y.N.) from the Ministry of Education, Science, Sports, and Culture, Japan.	Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Nibuya M, 1996, J NEUROSCI, V16, P2365; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Waki K, 2010, CANCER SCI, V101, P1678, DOI 10.1111/j.1349-7006.2010.01576.x; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	42	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33018	33027		10.1074/jbc.M110.137836	http://dx.doi.org/10.1074/jbc.M110.137836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20675384	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000283048200039
J	Koprivova, A; des Francs-Small, CC; Calder, G; Mugford, ST; Tanz, S; Lee, BR; Zechmann, B; Small, I; Kopriva, S				Koprivova, Anna; des Francs-Small, Catherine Colas; Calder, Grant; Mugford, Sam T.; Tanz, Sandra; Lee, Bok-Rye; Zechmann, Bernd; Small, Ian; Kopriva, Stanislav			Identification of a Pentatricopeptide Repeat Protein Implicated in Splicing of Intron 1 of Mitochondrial nad7 Transcripts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-I; NUCLEAR GENE; GLUTATHIONE HOMEOSTASIS; RESPIRATORY-CHAIN; PPR PROTEINS; ARABIDOPSIS; STRESS; METABOLISM; MUTANTS; REVEALS	Splicing of plant organellar transcripts is facilitated by members of a large protein family, the pentatricopeptide repeat proteins. We have identified a pentatricopeptide repeat protein in a genetic screen for mutants resistant to inhibition of root growth by buthionine sulfoximine (BSO), an inhibitor of glutathione synthesis and consequently named BIR6 (BSO-insensitive roots 6). BIR6 is involved in splicing of intron 1 of the mitochondrial nad7 transcript. Loss-of-function mutations in BIR6 result in a strongly reduced accumulation of fully processed nad7 transcript. This affects assembly of Complex I and results in moderate growth retardation. In agreement with disruption of Complex I function, the genes encoding alternative NADH oxidizing enzymes are induced in the mutant, and the mutant plants are less sensitive to mannitol and salt stress. Mutation in the BIR6 gene allowed normal root growth in presence of BSO and strongly attenuated depletion of glutathione content at these conditions. The same phenotype was observed with other mutants affected in function of Complex I, thus reinforcing the importance of Complex I function for cellular redox homeostasis.	[Koprivova, Anna; Mugford, Sam T.; Lee, Bok-Rye; Kopriva, Stanislav] John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; [Calder, Grant] John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [des Francs-Small, Catherine Colas; Tanz, Sandra; Zechmann, Bernd; Small, Ian] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Zechmann, Bernd] Graz Univ, Inst Plant Sci, A-8010 Graz, Austria	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Western Australia; University of Graz	Kopriva, S (corresponding author), John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England.	stanislav.kopriva@bbsrc.ac.uk	Tanz, Sandra K/C-2686-2011; Kopriva, Stanislav/C-7401-2013; Francs-Small, Catherine C Colas des/E-6279-2011; Francs-Small, Catherine Colas des/N-2992-2019; Small, Ian/AAR-5506-2021; Small, Ian D/C-1168-2008	Kopriva, Stanislav/0000-0002-7416-6551; Francs-Small, Catherine C Colas des/0000-0002-6386-5672; Francs-Small, Catherine Colas des/0000-0002-6386-5672; Small, Ian/0000-0001-5300-1216; Small, Ian D/0000-0001-5300-1216; Mugford, Sam/0000-0002-8537-5578; Tanz, Sandra/0000-0002-0632-4095; Zechmann, Bernd/0000-0002-7702-2588	Australian Research Council [CE0561495]; British Biotechnology and Biological Sciences Research Council [BB/E009912/1]; Korea Science and Engineering Foundation; Austrian Science Fund [FWF P20619]	Australian Research Council(Australian Research Council); British Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Austrian Science Fund(Austrian Science Fund (FWF))	Supported by Australian Research Council Grant CE0561495.; Supported by British Biotechnology and Biological Sciences Research Council Grant BB/E009912/1.; Supported by a post-doctoral fellowship from the Korea Science and Engineering Foundation.; Supported by Austrian Science Fund Grant FWF P20619.; Supported by the British Biotechnology and Biological Sciences Research Council. To whom correspondence should be addressed: John Innes Centre, Norwich NR4 7UH, UK. Tel.: 44-1603-450276; Fax: 44-1603-450014; E-mail: stanislav.kopriva@bbsrc.ac.uk.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; de Longevialle AF, 2008, PLANT J, V56, P157, DOI 10.1111/j.1365-313X.2008.03581.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Fisk DG, 1999, EMBO J, V18, P2621, DOI 10.1093/emboj/18.9.2621; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Garmier M, 2008, PLANT PHYSIOL, V148, P1324, DOI 10.1104/pp.108.125880; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Kerenyi Z, 2008, EMBO J, V27, P1585, DOI 10.1038/emboj.2008.88; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Leon G, 2007, PLANT PHYSIOL, V143, P1534, DOI 10.1104/pp.106.095158; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; Meyer AJ, 2008, J PLANT PHYSIOL, V165, P1390, DOI 10.1016/j.jplph.2007.10.015; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Mullineaux PM, 2005, PHOTOSYNTH RES, V86, P459, DOI 10.1007/s11120-005-8811-8; Nakagawa N, 2006, PLANT CELL PHYSIOL, V47, P772, DOI 10.1093/pcp/pcj051; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; PLA M, 1995, MOL GEN GENET, V248, P79, DOI 10.1007/BF02456616; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Thirkettle-Watts D, 2003, PLANT PHYSIOL, V133, P1158, DOI 10.1104/pp.103.028183; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260	50	105	109	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32192	32199		10.1074/jbc.M110.147603	http://dx.doi.org/10.1074/jbc.M110.147603			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20682769	Green Published, hybrid			2022-12-25	WOS:000282683000032
J	Gorbea, C; Pratt, G; Ustrell, V; Bell, R; Sahasrabudhe, S; Hughes, RE; Rechsteiner, M				Gorbea, Carlos; Pratt, Gregory; Ustrell, Vicenca; Bell, Russell; Sahasrabudhe, Sudhir; Hughes, Robert E.; Rechsteiner, Martin			A Protein Interaction Network for Ecm29 Links the 26 S Proteasome to Molecular Motors and Endosomal Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; GROWTH-FACTOR; UBIQUITIN CHAINS; REGGIE/FLOTILLIN PROTEINS; TYROSINE PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; DEUBIQUITINATING ENZYME; RETROGRADE TRANSPORT; PROTEOLYTIC PATHWAY; 3T3-L1 ADIPOCYTES	Ecm29 is a 200-kDa HEAT repeat protein that binds the 26 S proteasome. Genome-wide two-hybrid screens and mass spectrometry have identified molecular motors, endosomal components, and ubiquitin-proteasome factors as Ecm29-interacting proteins. The C-terminal half of human Ecm29 binds myosins and kinesins; its N-terminal region binds the endocytic proteins, Vps11, Rab11-FIP4, and rabaptin. Whereas full-length FLAG-Ecm29, its C-terminal half, and a small central fragment of Ecm29 remain bound to glycerol-gradient-separated 26 S proteasomes, the N-terminal half of Ecm29 does not. Confocal microscopy showed that Ecm-26 S proteasomes are present on flotillin-positive endosomes, but they are virtually absent from caveolin-and clathrin-decorated endosomes. Expression of the small central fragment of Ecm29 markedly reduces proteasome association with flotillin-positive endosomes. Identification of regions within Ecm29 capable of binding molecular motors, endosomal proteins, and the 26 S proteasome supports the hypothesis that Ecm29 serves as an adaptor for coupling 26 S proteasomes to specific cellular compartments.	[Rechsteiner, Martin] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Bell, Russell; Sahasrabudhe, Sudhir; Hughes, Robert E.] Prolexys Pharmaceut Inc, Salt Lake City, UT 84111 USA	Utah System of Higher Education; University of Utah	Rechsteiner, M (corresponding author), Univ Utah, Sch Med, Dept Biochem, 15 N Med Dr E,Rm 4100, Salt Lake City, UT 84112 USA.	marty@biochem.utah.edu	Gorbea, Carlos/L-4406-2019		National Institutes of Health [NS042892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS042892 (to M.R.).	Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bhattacharyya NP, 2008, FEBS J, V275, P4271, DOI 10.1111/j.1742-4658.2008.06563.x; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Bousquet-Dubouch MP, 2009, MOL CELL PROTEOMICS, V8, P1150, DOI 10.1074/mcp.M800193-MCP200; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2002, CURR BIOL, V12, pR529, DOI 10.1016/S0960-9822(02)01030-8; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghosh AK, 2004, J BIOL CHEM, V279, P36132, DOI 10.1074/jbc.M404189200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2006, ISR J CHEM, V46, P207, DOI 10.1560/742P-ET1J-8RLC-2JYV; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hartmann-Petersen R, 2004, CURR BIOL, V14, pR754, DOI 10.1016/j.cub.2004.09.012; He F, 2006, BIOCHEM BIOPH RES CO, V344, P95, DOI 10.1016/j.bbrc.2006.03.142; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kajava AV, 2004, J STRUCT BIOL, V146, P425, DOI 10.1016/j.jsb.2004.01.013; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lussier M, 1997, GENETICS, V147, P435; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medigeshi GR, 2003, TRAFFIC, V4, P802, DOI 10.1034/j.1600-0854.2003.00136.x; Melman L, 2002, MOL BIOL CELL, V13, P3325, DOI 10.1091/mbc.E02-03-0152; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Virshup DM, 2007, CELL, V129, P857, DOI 10.1016/j.cell.2007.05.015; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200	103	55	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31616	31633		10.1074/jbc.M110.154120	http://dx.doi.org/10.1074/jbc.M110.154120			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682791	Green Published, hybrid			2022-12-25	WOS:000282764600055
J	Higo, S; Asano, Y; Kato, H; Yamazaki, S; Nakano, A; Tsukamoto, O; Seguchi, O; Asai, M; Asakura, M; Asanuma, H; Sanada, S; Minamino, T; Komuro, I; Kitakaze, M; Takashima, S				Higo, Shuichiro; Asano, Yoshihiro; Kato, Hisakazu; Yamazaki, Satoru; Nakano, Atsushi; Tsukamoto, Osamu; Seguchi, Osamu; Asai, Mitsutoshi; Asakura, Masanori; Asanuma, Hiroshi; Sanada, Shoji; Minamino, Tetsuo; Komuro, Issei; Kitakaze, Masafumi; Takashima, Seiji			Isoform-specific Intermolecular Disulfide Bond Formation of Heterochromatin Protein 1 (HP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; HISTONE H3; TRANSCRIPTIONAL REPRESSION; LYSINE-9 METHYLATION; MAMMALIAN-CELLS; DOMAIN; COREPRESSOR; CHROMATIN; PHOSPHORYLATION; IDENTIFICATION	Three mammalian isoforms of heterochromatin protein 1 (HP1), alpha, beta, and gamma, play diverse roles in gene regulation. Despite their structural similarity, the diverse functions of these isoforms imply that they are additionally regulated by post-translational modifications. Here, we have identified intermolecular disulfide bond formation of HP1 cysteines in an isoform-specific manner. Cysteine 133 in HP1 alpha and cysteine 177 in HP1 gamma were involved in intermolecular homodimerization. Although both HP1 alpha and HP1 gamma contain reactive cysteine residues, only HP1 gamma readily and reversibly formed disulfide homodimers under oxidative conditions. Oxidatively dimerized HP1 gamma strongly and transiently interacted with TIF1 beta, a universal transcriptional co-repressor. Under oxidative conditions, HP1 gamma dimerized and held TIF1 beta in a chromatin component and inhibited its repression ability. Our results highlight a novel, isoform-specific role for HP1 as a sensor of the cellular redox state.	[Asano, Yoshihiro; Kato, Hisakazu; Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Mol Cardiol, Suita, Osaka 5650871, Japan; [Asai, Mitsutoshi; Sanada, Shoji; Minamino, Tetsuo] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Asano, Yoshihiro; Yamazaki, Satoru; Tsukamoto, Osamu; Seguchi, Osamu; Asakura, Masanori; Asanuma, Hiroshi; Kitakaze, Masafumi] Natl Cardiovasc Ctr, Dept Cardiovasc Med, Osaka 5658565, Japan	Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan	Takashima, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Cardiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takasima@medone.med.osaka-u.ac.jp		Kato, Hisakazu/0000-0003-4619-3680; Tsukamoto, Osamu/0000-0002-9504-8001	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Medical Association; Japan Incurable Diseases Research Foundation; Osaka Medical Research Foundation for Incurable Diseases; Suzuken Memorial Foundation; Japan China Medical Association	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Medical Association; Japan Incurable Diseases Research Foundation; Osaka Medical Research Foundation for Incurable Diseases; Suzuken Memorial Foundation; Japan China Medical Association	This work was supported by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan, grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, grants from the Japan Heart Foundation, grants from the Japan Cardiovascular Research Foundation, a grant from the Japan Society for the Promotion of Science, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Japan Medical Association, Japan Incurable Diseases Research Foundation, Osaka Medical Research Foundation for Incurable Diseases, Suzuken Memorial Foundation, and Japan China Medical Association.	Asano Y, 2004, NAT GENET, V36, P123, DOI 10.1038/ng1294; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Badugu R, 2005, CHROMOSOMA, V113, P370, DOI 10.1007/s00412-004-0324-2; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Cammas F, 2007, DIFFERENTIATION, V75, P627, DOI 10.1111/j.1432-0436.2007.00166.x; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Filesi I, 2002, J CELL SCI, V115, P1803; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Itokawa Y, 2009, BIOCHEM BIOPH RES CO, V388, P689, DOI 10.1016/j.bbrc.2009.08.065; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LE DB, 1996, EMBO J, V15, P6701; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen AL, 2002, EMBO J, V21, P5797, DOI 10.1093/emboj/cdf560; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Riclet R, 2009, MOL BIOL CELL, V20, P296, DOI 10.1091/mbc.E08-05-0510; Ritou E, 2007, J CELL SCI, V120, P3425, DOI 10.1242/jcs.012955; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Smallwood A, 2008, NAT STRUCT MOL BIOL, V15, P318, DOI 10.1038/nsmb.1385; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200	43	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31337	31347		10.1074/jbc.M110.155788	http://dx.doi.org/10.1074/jbc.M110.155788			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675861	Green Published, hybrid			2022-12-25	WOS:000282764600028
J	Maehara, Y; Miyano, K; Yuzawa, S; Akimoto, R; Takeya, R; Sumimoto, H				Maehara, Yuichi; Miyano, Kei; Yuzawa, Satoru; Akimoto, Risa; Takeya, Ryu; Sumimoto, Hideki			A Conserved Region between the TPR and Activation Domains of p67(phox) Participates in Activation of the Phagocyte NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAC; RESPIRATORY BURST OXIDASE; SH3 DOMAIN; COMPONENTS P47(PHOX); NOX-FAMILY; FLAVOCYTOCHROME B(558); SUPEROXIDE-PRODUCTION; PROTEIN P40(PHOX); NAD(P)H OXIDASES; BINDING	The phagocyte NADPH oxidase, dormant in resting cells, is activated during phagocytosis to produce superoxide, a precursor of microbicidal oxidants. The membrane-integrated protein gp91(phox) serves as the catalytic core, because it contains a complete electron-transporting apparatus from NADPH to molecular oxygen for superoxide production. Activation of gp91(phox) requires the cytosolic proteins p67(phox), p47(phox), and Rac (a small GTPase). p67(phox), comprising 526 amino acids, moves upon cell stimulation to the membrane together with p47(phox) and there interacts with Rac; these processes are prerequisite for gp91(phox) activation. Here we show that a region of p67(phox) (amino acids 190-200) C-terminal to the Rac-binding domain is evolutionarily well conserved and participates in oxidase activation at a later stage in conjunction with an activation domain. Alanine substitution for Tyr-198, Leu-199, or Val-204 abrogates the ability of p67(phox) to support superoxide production by gp91(phox)-based oxidase as well as its related oxidases Nox1 and Nox3; the activation also involves other invariant residues such as Leu-193, Asp-197, and Gly-200. Intriguingly, replacement of Gln-192 by alanine or that of Tyr-198 by phenylalanine or tryptophan rather enhances superoxide production by gp91(phox)-based oxidase, suggesting a tuning role for these residues. Furthermore, the Y198A/V204A or L199A/V204A substitution leads to not only a complete loss of the activity of the reconstituted oxidase system but also a significant decrease in p67(phox) interaction with the gp91(phox) NADPH-binding domain, although these mutations affect neither the protein integrity nor the Rac binding activity. Thus the extended activation domain of p67(phox) (amino acids 190-210) containing the D(Y/F) LGK motif plays an essential role in oxidase activation probably by interacting with gp91(phox).	[Maehara, Yuichi; Miyano, Kei; Yuzawa, Satoru; Akimoto, Risa; Takeya, Ryu; Sumimoto, Hideki] Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Maehara, Yuichi; Miyano, Kei; Yuzawa, Satoru; Akimoto, Risa; Takeya, Ryu; Sumimoto, Hideki] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Sumimoto, H (corresponding author), Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp		Yuzawa, Satoru/0000-0002-1031-5781	Ministry of Education, Culture, Sports, Science and Technology of Japan; CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants-in-aid for scientific research and Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Agency.	Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Berdichevsky Y, 2007, J BIOL CHEM, V282, P22122, DOI 10.1074/jbc.M701497200; Bissonnette SA, 2008, J BIOL CHEM, V283, P2108, DOI 10.1074/jbc.M706639200; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; FINAN P, 1994, J BIOL CHEM, V269, P13752; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Grizot S, 2001, J BIOL CHEM, V276, P21627, DOI 10.1074/jbc.M100893200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Hata K, 1997, BIOCHEM BIOPH RES CO, V241, P226, DOI 10.1006/bbrc.1997.7807; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Kao YY, 2008, J BIOL CHEM, V283, P12736, DOI 10.1074/jbc.M801010200; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LEUSEN JHW, 1995, J BIOL CHEM, V270, P11216, DOI 10.1074/jbc.270.19.11216; Maehara Y, 2009, BIOCHEM BIOPH RES CO, V379, P589, DOI 10.1016/j.bbrc.2008.12.112; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Miyano K, 2009, BIOCHEM J, V422, P373, DOI 10.1042/BJ20082182; Mizuki K, 2005, ARCH BIOCHEM BIOPHYS, V444, P185, DOI 10.1016/j.abb.2005.10.012; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; SUMIMOTO H, 2007, SCI STKE, pRE6, DOI DOI 10.1126/STKE.4012007RE6; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Taura M, 2009, BIOCHEM J, V419, P329, DOI 10.1042/BJ20082028; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Yuzawa S, 2009, J INNATE IMMUN, V1, P543, DOI 10.1159/000235656	49	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31435	31445		10.1074/jbc.M110.161166	http://dx.doi.org/10.1074/jbc.M110.161166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20679349	Green Published, hybrid			2022-12-25	WOS:000282764600038
J	Tokunaga, M; Ezoe, S; Tanaka, H; Satoh, Y; Fukushima, K; Matsui, K; Shibata, M; Tanimura, A; Oritani, K; Matsumura, I; Kanakura, Y				Tokunaga, Masahiro; Ezoe, Sachiko; Tanaka, Hirokazu; Satoh, Yusuke; Fukushima, Kentaro; Matsui, Keiko; Shibata, Masaru; Tanimura, Akira; Oritani, Kenji; Matsumura, Itaru; Kanakura, Yuzuru			BCR-ABL but Not JAK2 V617F Inhibits Erythropoiesis through the Ras Signal by Inducing p21(CIP1/WAF1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; ONCOGENE-INDUCED SENESCENCE; N-RAS; TUMOR SUPPRESSION; MEGAKARYOCYTIC DIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; MYELOPROLIFERATIVE DISORDERS; ERYTHROID-DIFFERENTIATION; INDUCED TRANSFORMATION; NUCLEAR TRANSLOCATION	BCR-ABL is a causative tyrosine kinase (TK) of chronic myelogenous leukemia (CML). In CML patients, although myeloid cells are remarkably proliferating, erythroid cells are rather decreased and anemia is commonly observed. This phenotype is quite different from that observed in polycythemia vera (PV) caused by JAK2 V617F, whereas both oncogenic TKs activate common downstream molecules at the level of hematopoietic stem cells (HSCs). To clarify this mechanism, we investigated the effects of BCR-ABL and JAK2 V617F on erythropoiesis. Enforced expression of BCR-ABL but not of JAK2 V617F in murine LSK (Lineage(-)Sca-1(hi)CD117(hi)) cells inhibited the development of erythroid cells. Among several signaling molecules downstream of BCR-ABL, an active mutant of N-Ras (N-RasE12) but not of STAT5 or phosphatidylinositol 3-kinase (PI3-K) inhibited erythropoiesis, while N-RasE12 enhanced the development of myeloid cells. BCR-ABL activated Ras signal more intensely than JAK2 V617F, and inhibition of Ras by manumycin A, a farnesyltransferase inhibitor, ameliorated erythroid colony formation of CML cells. As for the mechanisms of Ras-induced suppression of erythropoiesis, we found that GATA-1, an erythroid-specific transcription factor, blocked Ras-mediated mitogenic signaling at the level of MEK through the direct interaction. Furthermore, enforced expression of N-RasE12 in LSK cells derived from p53-, p16(INK4a)/p19(ARF)-, and p21(CIP1/WAF1)-null/wild-type mice revealed that suppressed erythroid cell growth by N-RasE12 was restored only by p21(CIP1/WAF1) deficiency, indicating that a cyclin-dependent kinase (CDK) inhibitor, p21(CIP1/WAF1), plays crucial roles in Ras-induced suppression of erythropoiesis. These data would, at least partly, explain why respective oncogenic TKs cause different disease phenotypes.	[Ezoe, Sachiko] Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan; [Matsumura, Itaru] Kinki Univ, Sch Med, Dept Internal Med, Div Hematol, Osaka 5898511, Japan; [Shibata, Masaru; Tanimura, Akira; Oritani, Kenji; Matsumura, Itaru; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan	Osaka University; Kindai University (Kinki University); Osaka University	Ezoe, S (corresponding author), Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan.	sezoe@bldon.med.osaka-u.ac.jp		Tanimura, Akira/0000-0002-2039-5543	Ministry of Education, Science, Sports, and Culture and Technology of Japan; Grants-in-Aid for Scientific Research [21591202] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports, and Culture and Technology of Japan.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baum KJ, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-5; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Darley RL, 2002, BLOOD, V100, P4185, DOI 10.1182/blood-2002-05-1358; Darley RL, 1997, J EXP MED, V185, P1337, DOI 10.1084/jem.185.7.1337; Delgado MD, 2000, ONCOGENE, V19, P783, DOI 10.1038/sj.onc.1203384; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Dohner K, 2008, HAEMATOL-HEMATOL J, V93, P976, DOI 10.3324/haematol.13345; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Ezoe S, 2005, J BIOL CHEM, V280, P13163, DOI 10.1074/jbc.M413461200; Flotho C, 1999, LEUKEMIA, V13, P32, DOI 10.1038/sj.leu.2401240; Fukushima K, 2009, J BIOL CHEM, V284, P7719, DOI 10.1074/jbc.M807489200; GRIFFIN JD, 1983, BLOOD, V61, P85; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jiang XY, 2002, BLOOD, V100, P3731, DOI 10.1182/blood-2002-05-1324; Khalaf WF, 2005, BLOOD, V105, P3538, DOI 10.1182/blood-2004-05-2021; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; MacKenzie KL, 1999, BLOOD, V93, P2043, DOI 10.1182/blood.V93.6.2043.406k17_2043_2056; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Matsumura I, 1996, BLOOD, V88, P3074, DOI 10.1182/blood.V88.8.3074.bloodjournal8883074; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; NEUBAUER A, 1994, LEUKEMIA, V8, P638; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; SAIKIA T, 1988, LEUKEMIA RES, V12, P499, DOI 10.1016/0145-2126(88)90117-8; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Small Donald, 2006, Hematology Am Soc Hematol Educ Program, P178; Sonoyama J, 2002, J BIOL CHEM, V277, P8076, DOI 10.1074/jbc.M111501200; Sui XW, 1998, BLOOD, V92, P1142, DOI 10.1182/blood.V92.4.1142.416k42_1142_1149; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Thiele J, 2000, LEUKEMIA LYMPHOMA, V36, P295, DOI 10.3109/10428190009148850; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wheadon H, 2003, BLOOD, V102, P1480, DOI 10.1182/blood-2002-09-2974; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Zeuner A, 2006, BLOOD, V107, P3495, DOI 10.1182/blood-2005-07-3037; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang J, 2007, BLOOD, V109, P5238, DOI 10.1182/blood-2006-09-047050	52	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31774	31782		10.1074/jbc.M110.118653	http://dx.doi.org/10.1074/jbc.M110.118653			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663870	hybrid, Green Published			2022-12-25	WOS:000282764600069
J	Yasutake, Y; Fujii, Y; Nishioka, T; Cheon, WK; Arisawa, A; Tamura, T				Yasutake, Yoshiaki; Fujii, Yoshikazu; Nishioka, Taiki; Cheon, Woo-Kwang; Arisawa, Akira; Tamura, Tomohiro			Structural Evidence for Enhancement of Sequential Vitamin D-3 Hydroxylation Activities by Directed Evolution of Cytochrome P450 Vitamin D-3 Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; ACTIVE-SITE; COMPLEX; BINDING; P450ERYF; TRANSFORMATION; MONOOXYGENASE; CHEMISTRY; CYP105A1	Vitamin D-3 hydroxylase (Vdh) isolated from actinomycete Pseudonocardia autotrophica is a cytochrome P450 (CYP) responsible for the biocatalytic conversion of vitamin D-3 (VD3) to 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)VD3) by P. autotrophica. Although its biological function is unclear, Vdh is capable of catalyzing the two-step hydroxylation of VD3, i.e. the conversion of VD3 to 25-hydroxyvitamin D-3 (25(OH)VD3) and then of 25(OH)VD3 to 1 alpha,25(OH)(2)VD3, a hormonal form of VD3. Here we describe the crystal structures of wild-type Vdh (Vdh-WT) in the substrate-free form and of the highly active quadruple mutant (Vdh-K1) generated by directed evolution in the substrate-free, VD3-bound, and 25(OH)VD3-bound forms. Vdh-WT exhibits an open conformation with the distal heme pocket exposed to the solvent both in the presence and absence of a substrate, whereas Vdh-K1 exhibits a closed conformation in both the substrate-free and substrate-bound forms. The results suggest that the conformational equilibrium was largely shifted toward the closed conformation by four amino acid substitutions scattered throughout the molecule. The substrate-bound structure of Vdh-K1 accommodates both VD3 and 25(OH)VD3 but in an anti-parallel orientation. The occurrence of the two secosteroid binding modes accounts for the regio-selective sequential VD3 hydroxylation activities. Moreover, these structures determined before and after directed evolution, together with biochemical and spectroscopic data, provide insights into how directed evolution has worked for significant enhancement of both the VD3 25-hydroxylase and 25(OH)VD3 1 alpha-hydroxylase activities.	[Yasutake, Yoshiaki; Cheon, Woo-Kwang; Tamura, Tomohiro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido 0628517, Japan; [Fujii, Yoshikazu; Nishioka, Taiki; Tamura, Tomohiro] Hokkaido Univ, Grad Sch Agr, Lab Mol Environm Microbiol, Sapporo, Hokkaido 0608589, Japan; [Fujii, Yoshikazu; Arisawa, Akira] Mercian Corp, Bioresource Labs, Shizuoka 4380078, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University	Tamura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, 2-17-2-1 Tsukisamu Higashi, Sapporo, Hokkaido 0628517, Japan.	t-tamura@aist.go.jp	Yasutake, Yoshiaki/H-8079-2018; Tamura, Tomohiro/M-4732-2018; Cheon, Wookwang/AAM-5839-2020	Yasutake, Yoshiaki/0000-0002-4521-7516; Tamura, Tomohiro/0000-0003-2409-6556; 	New Energy and Industrial Technology Development Organization (NEDO) of Japan	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the Development of Basic Technologies for Advanced Production Methods Using Microorganism Functions project of the New Energy and Industrial Technology Development Organization (NEDO) of Japan. Synchrotron radiation experiments were conducted under the approval of 2007G650 at Photon Factory.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COON MJ, 1992, FASEB J, V6, P669, DOI 10.1096/fasebj.6.2.1537454; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Cupp-Vickery J, 2000, P NATL ACAD SCI USA, V97, P3050, DOI 10.1073/pnas.050406897; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fasan R, 2008, J MOL BIOL, V383, P1069, DOI 10.1016/j.jmb.2008.06.060; Fujii Y, 2009, BIOCHEM BIOPH RES CO, V385, P170, DOI 10.1016/j.bbrc.2009.05.033; Gillam EMJ, 2008, CHEM RES TOXICOL, V21, P220, DOI 10.1021/tx7002849; Gillam EMJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P176, DOI 10.1016/j.abb.2007.04.033; Hayashi K, 2008, BIOCHEMISTRY-US, V47, P11964, DOI 10.1021/bi801222d; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Huang WC, 2007, J MOL BIOL, V373, P633, DOI 10.1016/j.jmb.2007.08.015; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Julsing MK, 2008, CURR OPIN CHEM BIOL, V12, P177, DOI 10.1016/j.cbpa.2008.01.029; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis JC, 2009, P NATL ACAD SCI USA, V106, P16550, DOI 10.1073/pnas.0908954106; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; Li SY, 2009, P NATL ACAD SCI USA, V106, P18463, DOI 10.1073/pnas.0907203106; Li SY, 2009, J BIOL CHEM, V284, P5723, DOI 10.1074/jbc.M807592200; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mitani Y, 2005, J BACTERIOL, V187, P2582, DOI 10.1128/JB.187.8.2582-2591.2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OMURA T, 1964, J BIOL CHEM, V239, P2370; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; SASAKI J, 1992, APPL MICROBIOL BIOT, V38, P152; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Sawada N, 2000, BIOCHEM BIOPH RES CO, V273, P977, DOI 10.1006/bbrc.2000.3050; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Shimada T, 2009, CHEM RES TOXICOL, V22, P1325, DOI 10.1021/tx900127s; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Sugimoto H, 2008, BIOCHEMISTRY-US, V47, P4017, DOI 10.1021/bi7023767; TAKEDA K, 1994, J FERMENT BIOENG, V78, P380, DOI 10.1016/0922-338X(94)90285-2; Tosha T, 2003, J BIOL CHEM, V278, P39809, DOI 10.1074/jbc.M304265200; VAGIN A, 1997, A J APPL CRYSTALLOGR, V30, P1022; Villalonga R, 2007, CHEM REV, V107, P3088, DOI 10.1021/cr050253g; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Yamamoto K, 2005, J BIOL CHEM, V280, P30511, DOI 10.1074/jbc.M505244200; Yasutake Y, 2009, ACTA CRYSTALLOGR F, V65, P372, DOI 10.1107/S1744309109007829; ZHU GD, 1995, CHEM REV, V95, P1877, DOI 10.1021/cr00038a007	49	33	35	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31193	31201		10.1074/jbc.M110.147009	http://dx.doi.org/10.1074/jbc.M110.147009			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667833	hybrid, Green Published			2022-12-25	WOS:000282764600013
J	Goncharenko-Khaider, N; Lane, D; Matte, I; Rancourt, C; Piche, A				Goncharenko-Khaider, N.; Lane, D.; Matte, I.; Rancourt, C.; Piche, A.			The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells	ONCOGENE			English	Article						death receptors; ovarian carcinoma; resistance; PI3K/Akt pathway; TRAIL; Bid	CISPLATIN-INDUCED APOPTOSIS; SIGNALING COMPLEX DISC; X-LINKED INHIBITOR; MEDIATED APOPTOSIS; KINASE; DEATH; PROTEIN; PHOSPHORYLATION; CHEMOTHERAPY; CLEAVAGE	Epithelial ovarian cancer (EOC) cells often show increased activity of the PI3K/Akt pathway. In addition, we have previously shown that EOC ascites induce Akt activation in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-sensitive EOC cell line, CaOV3, leading to TRAIL-mediated apoptosis inhibition. In this study, we investigated the role of Akt in intrinsic resistance to TRAIL, which is common in EOC cells. We report that Akt activation reduces the sensitivity of EOC cells to TRAIL. TRAIL-resistant SKOV3ip1 and COV2 cells were sensitized to TRAIL-induced apoptosis by PI3K or Akt inhibitors although inhibition of PI3K/Akt signaling pathway did not interfere with the recruitment and processing of caspase-8 to the death-inducing signaling complex. Conversely, overexpression of Akt1 in TRAIL-sensitive cells promoted resistance to TRAIL. Although the fact that TRAIL-induced caspase-8 activation was observed in both sensitive and resistant cell lines, Bid cleavage occurred only in sensitive cells or in SKOV3ip1 cells treated with LY294002. Bid expression was low in resistant cells and Akt activation down-regulated its expression. Depletion of Bid by siRNA in OVCAR3 cells was associated with a decrease in TRAIL-mediated apoptosis. Overexpression of Bid only in SKOV3ip1 cells enhanced TRAIL-induced apoptosis. Simultaneous blockade of Akt pathway further increased TRAIL-induced apoptosis. Thus, Akt acts upstream of mitochondria and inhibits TRAIL-induced apoptosis by decreasing Bid protein levels and possibly inhibiting its cleavage. Oncogene (2010) 29, 5523-5536; doi:10.1038/onc.2010.288; published online 26 July 2010	[Goncharenko-Khaider, N.; Lane, D.; Matte, I.; Rancourt, C.; Piche, A.] Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Piche, A (corresponding author), Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, 3001 12Ieme Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Alain.Piche@USherbrooke.ca			Cancer Research Society	Cancer Research Society	This study was supported by a Grant from the Cancer Research Society (A.P.). We wish to thank the Tumor Bank from the Reseau de Recherche en Cancer du Fond de Recherche en Sante du Quebec, Canada for providing the primary tumor cell samples. We also thank Dr Louis Valiquette for his assistance with the statistical analyses.	Asselin E, 2001, CANCER RES, V61, P1862; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Cuello M, 2001, GYNECOL ONCOL, V81, P380, DOI 10.1006/gyno.2001.6194; Cuello M, 2004, CELL DEATH DIFFER, V11, P527, DOI 10.1038/sj.cdd.4401387; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Fraser M, 2003, CANCER RES, V63, P7081; Griffith TS, 1998, J IMMUNOL, V161, P2833; Hu LM, 2002, CANCER RES, V62, P1087; Izeradjene K, 2005, ONCOGENE, V24, P2050, DOI 10.1038/sj.onc.1208397; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kandasamy K, 2002, CANCER RES, V62, P4929; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kang YC, 2004, CELL DEATH DIFFER, V11, P1287, DOI 10.1038/sj.cdd.4401489; Kim KM, 2005, J CELL BIOCHEM, V96, P376, DOI 10.1002/jcb.20512; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kim YH, 2007, J CELL BIOCHEM, V100, P998, DOI 10.1002/jcb.21098; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lane D, 2008, INT J GYNECOL CANCER, V18, P670, DOI 10.1111/j.1525-1438.2007.01062.x; Lane D, 2004, GYNECOL ONCOL, V93, P594, DOI 10.1016/j.ygyno.2004.03.029; Lane D, 2006, MOL CANCER THER, V5, P509, DOI 10.1158/1535-7163.MCT-05-0362; Lane D, 2010, ONCOGENE, V29, P3519, DOI 10.1038/onc.2010.107; Lane D, 2007, INT J CANCER, V121, P1227, DOI 10.1002/ijc.22840; Larribere L, 2004, CELL DEATH DIFFER, V11, P1084, DOI 10.1038/sj.cdd.4401475; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mabuchi S, 2007, CLIN CANCER RES, V13, P4261, DOI 10.1158/1078-0432.CCR-06-2770; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Page C, 2000, ANTICANCER RES, V20, P407; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Siervo-Sassi RR, 2003, CANCER LETT, V190, P61, DOI 10.1016/S0304-3835(02)00579-7; Westfall SD, 2005, MOL CANCER THER, V4, P1764, DOI 10.1158/1535-7163.MCT-05-0192; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	48	46	48	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	40					5523	5536		10.1038/onc.2010.288	http://dx.doi.org/10.1038/onc.2010.288			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FM	20661217	hybrid, Green Published			2022-12-25	WOS:000282945800009
J	Jiang, L; Allagnat, F; Nguidjoe, E; Kamagate, A; Pachera, N; Vanderwinden, JM; Brini, M; Carafoli, E; Eizirik, DL; Cardozo, AK; Herchuelz, A				Jiang, Lin; Allagnat, Florent; Nguidjoe, Evrard; Kamagate, Adama; Pachera, Nathalie; Vanderwinden, Jean-Marie; Brini, Marisa; Carafoli, Ernesto; Eizirik, Decio L.; Cardozo, Alessandra K.; Herchuelz, Andre			Plasma Membrane Ca2+-ATPase Overexpression Depletes Both Mitochondrial and Endoplasmic Reticulum Ca2+ Stores and Triggers Apoptosis in Insulin-secreting BRIN-BD11 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; CYTOSOLIC CA2+; INDUCED OSCILLATIONS; CYTOPLASMIC CA-2+; GLUCOSE; EXOCYTOSIS; STRESS; AEQUORIN; DEATH; LINE	Ca2+ may trigger apoptosis in beta-cells. Hence, the control of intracellular Ca2+ may represent a potential approach to prevent beta-cell apoptosis in diabetes. Our objective was to investigate the effect and mechanism of action of plasma membrane Ca2+-ATPase (PMCA) overexpression on Ca2+-regulated apoptosis in clonal beta-cells. Clonal beta-cells (BRIN-BD11) were examined for the effect of PMCA overexpression on cytosolic and mitochondrial [Ca2+] using a combination of aequorins with different Ca2+ affinities and on the ER and mitochondrial pathways of apoptosis. beta-cell stimulation generated microdomains of high [Ca2+] in the cytosol and subcellular heterogeneities in [Ca2+] among mitochondria. Overexpression of PMCA decreased [Ca2+] in the cytosol, the ER, and the mitochondria and activated the IRE1 alpha-XBP1s but inhibited the PRKR-like ER kinase-eIF2 alpha and the ATF6-BiP pathways of the ER-unfolded protein response. Increased Bax/Bcl-2 expression ratio was observed in PMCA overexpressing beta-cells. This was followed by Bax translocation to the mitochondria with subsequent cytochrome c release, opening of the permeability transition pore, and apoptosis. In conclusion, clonal beta-cell stimulation generates microdomains of high [Ca2+] in the cytosol and subcellular heterogeneities in [Ca2+] among mitochondria. PMCA overexpression depletes intracellular [Ca2+] stores and, despite a decrease in mitochondrial [Ca2+], induces apoptosis through the mitochondrial pathway. These data open the way to new strategies to control cellular Ca2+ homeostasis that could decrease beta-cell apoptosis in diabetes.	[Jiang, Lin; Nguidjoe, Evrard; Kamagate, Adama; Pachera, Nathalie; Herchuelz, Andre] Univ Libre Bruxelles, Fac Med, Lab Pharmacodynamie & Therapeut, B-1070 Brussels, Belgium; [Allagnat, Florent; Eizirik, Decio L.; Cardozo, Alessandra K.] Univ Libre Bruxelles, Fac Med, Expt Med Lab, B-1070 Brussels, Belgium; [Vanderwinden, Jean-Marie] Univ Libre Bruxelles, Fac Med, Neurophysiol Lab, B-1070 Brussels, Belgium; [Brini, Marisa] Univ Padua, Dept Biochem, I-35131 Padua, Italy; [Carafoli, Ernesto] Venetian Inst Mol Med, I-35131 Padua, Italy	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Padua; Veneto Institute Molecular Medicine	Herchuelz, A (corresponding author), Univ Libre Bruxelles, Fac Med, Lab Pharmacodynamie & Therapeut, Route Lennik,808,Batiment GE, B-1070 Brussels, Belgium.	herchu@ulb.ac.be	Carafoli, Ernesto/K-5192-2016; Allagnat, Florent/A-4471-2017; Allagnat, Florent/AAY-7188-2021; Allagnat, Florent/X-3772-2019; Brini, Marisa/K-5189-2016	Carafoli, Ernesto/0000-0002-7826-0094; Allagnat, Florent/0000-0001-6528-679X; Allagnat, Florent/0000-0001-6528-679X; NGUIDJOE, Evrard/0000-0002-5546-2259; Kupper Cardozo, Alessandra/0000-0001-7143-3696; Brini, Marisa/0000-0001-5141-0243	Belgian Fund for Scientific Research [3.4593.04, 3.4527.08]; European Foundation for the Study of Diabetes/Novo Nordisk Programme in Diabetes Research [2005/6]; Juvenile Diabetes Research Foundation International [1-2008-536]; Communaute Francaise de Belgique (Actions de Recherche Concertees); European Union; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State [IUAP P6/40]; Credit de Relations Internationales de l'Universite Libre de Bruxelles	Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); European Foundation for the Study of Diabetes/Novo Nordisk Programme in Diabetes Research; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Communaute Francaise de Belgique (Actions de Recherche Concertees); European Union(European Commission); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; Credit de Relations Internationales de l'Universite Libre de Bruxelles	This work has been supported by grants from the Belgian Fund for Scientific Research (Fonds Recherche Scientifique Medicale 3.4593.04 and 3.4527.08), the European Foundation for the Study of Diabetes/Novo Nordisk Programme in Diabetes Research (2005/6), the Juvenile Diabetes Research Foundation International (1-2008-536), the Communaute Francaise de Belgique (Actions de Recherche Concertees), the European Union (Integrated Project Naimit (FP7) of the European Community), and the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40).; Supported by a fellowship from the "Credit de Relations Internationales de l'Universite Libre de Bruxelles."	Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; BRINI M, 1994, CELL CALCIUM, V16, P259, DOI 10.1016/0143-4160(94)90089-2; Brini M, 2008, METHODS, V46, P160, DOI 10.1016/j.ymeth.2008.09.011; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Diaz-Horta O, 2002, DIABETES, V51, P1815, DOI 10.2337/diabetes.51.6.1815; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; GYLFE E, 1991, CELL CALCIUM, V12, P229, DOI 10.1016/0143-4160(91)90023-8; HERCHUELZ A, 1991, CELL CALCIUM, V12, P577, DOI 10.1016/0143-4160(91)90076-Q; HERCHUELZ A, 1981, DIABETES METAB, V7, P283; Jeffs GJ, 2008, EXP NEUROL, V210, P268, DOI 10.1016/j.expneurol.2007.10.013; Kamagate A, 2002, DIABETES, V51, P2773, DOI 10.2337/diabetes.51.9.2773; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Mehmet H, 2000, NATURE, V403, P29, DOI 10.1038/47377; Molinaro P, 2008, J NEUROSCI, V28, P1179, DOI 10.1523/JNEUROSCI.4671-07.2008; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakazaki M, 1998, DIABETOLOGIA, V41, P279, DOI 10.1007/s001250050904; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200; Pirot P, 2006, DIABETOLOGIA, V49, P1229, DOI 10.1007/s00125-006-0214-7; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Quesada I, 2000, J PHYSIOL-LONDON, V525, P159, DOI 10.1111/j.1469-7793.2000.t01-1-00159.x; Quesada I, 2008, CELL CALCIUM, V43, P39, DOI 10.1016/j.ceca.2007.03.001; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sokolow S, 2004, J CLIN INVEST, V113, P265, DOI 10.1172/JCI200418688; Takahashi N, 1997, J CELL BIOL, V138, P55, DOI 10.1083/jcb.138.1.55; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; THELER JM, 1992, J BIOL CHEM, V267, P18110; Van Eylen F, 1998, DIABETES, V47, P1873, DOI 10.2337/diabetes.47.12.1873; WANG JL, 1990, BIOCHEM BIOPH RES CO, V166, P813, DOI 10.1016/0006-291X(90)90882-N; WOLLHEIM CB, 1987, BIOSCIENCE REP, V7, P443, DOI 10.1007/BF01362507	48	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30634	30643		10.1074/jbc.M110.116681	http://dx.doi.org/10.1074/jbc.M110.116681			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20660595	hybrid, Green Published			2022-12-25	WOS:000282135500032
J	Wiemuth, D; Grunder, S				Wiemuth, Dominik; Gruender, Stefan			A Single Amino Acid Tunes Ca2+ Inhibition of Brain Liver Intestine Na+ Channel (BLINaC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; 3 HOMOLOGOUS SUBUNITS; FUNCTIONAL EXPRESSION; SODIUM-CHANNEL; MOLECULAR-CLONING; ALPHA-SUBUNIT; FAMILY; IDENTIFICATION; ION-CHANNEL-1; SYSTEM	Ion channels of the degenerin/epithelial Na+ channel gene family are Na+ channels that are blocked by the diuretic amiloride and are implicated in several human diseases. The brain liver intestine Na+ channel (BLINaC) is an ion channel of the degenerin/epithelial Na+ channel gene family with unknown function. In rodents, it is expressed mainly in brain, liver, and intestine, and to a lesser extent in kidney and lung. Expression of rat BLINaC (rBLINaC) in Xenopus oocytes leads to small un-selective currents that are only weakly sensitive to amiloride. Here, we show that rBLINaC is inhibited by micromolar concentrations of extracellular Ca2+. Removal of Ca2+ leads to robust currents and increases Na+ selectivity of the ion pore. Strikingly, the species ortholog from mouse (mBLINaC) has an almost 250-fold lower Ca2+ affinity than rBLINaC, rendering mBLINaC constitutively active at physiological concentrations of extracellular Ca2+. In addition, mBLINaC is more selective for Na+ and has a 700-fold higher amiloride affinity than rBLINaC. We show that a single amino acid in the extracellular domain determines these profound species differences. Collectively, our results suggest that rBLINaC is opened by an unknown ligand whereas mBLINaC is a constitutively open epithelial Na+ channel.	[Wiemuth, Dominik; Gruender, Stefan] Rhein Westfal TH Aachen, Dept Physiol, D-52074 Aachen, Germany	RWTH Aachen University	Grunder, S (corresponding author), Rhein Westfal TH Aachen, Dept Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	sgruender@ukaachen.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883				Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Grunder S, 1999, PFLUG ARCH EUR J PHY, V438, P709, DOI 10.1007/s004240051097; Grunder S, 2000, CHANNELOPATHIES - COMMON MECHANISMS IN AURA, ARRHYTHMIA AND ALKALOSIS, P277, DOI 10.1016/B978-044450489-0/50013-6; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Madeja M, 1995, J NEUROSCI METH, V63, P211, DOI 10.1016/0165-0270(95)00094-1; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sluka KA, 2009, CURR OPIN DRUG DISC, V12, P693; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	29	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30404	30410		10.1074/jbc.M110.153064	http://dx.doi.org/10.1074/jbc.M110.153064			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20656685	Green Published, hybrid			2022-12-25	WOS:000282135500006
J	Guan, SX; Blanchard, A; Zhang, PH; Zhu, ZY				Guan, Shengxi; Blanchard, Aine; Zhang, Penghua; Zhu, Zhenyu			Alteration of Sequence Specificity of the Type IIS Restriction Endonuclease BtsI	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; DNA RESTRICTION; CLEAVAGE; ENZYMES; VARIANTS; GENES	The Type IIS restriction endonuclease BtsI recognizes and digests at GCAGTG(2/0). It comprises two subunits: BtsIA and BtsIB. The BtsIB subunit contains the recognition domain, one catalytic domain for bottom strand nicking and part of the catalytic domain for the top strand nicking. BtsIA has the rest of the catalytic domain that is responsible for the DNA top strand nicking. BtsIA alone has no activity unless it mixes with BtsIB to reconstitute the BtsI activity. During characterization of the enzyme, we identified a BtsIB mutant R119A found to have a different digestion pattern from the wild type BtsI. After characterization, we found that BtsIB(R119A) is a novel restriction enzyme with a previously unreported recognition sequence CAGTG(2/0), which is named as BtsI-1. Compared with wild type BtsI, BtsI-1 showed different relative activities in NEB restriction enzyme reaction buffers NEB1, NEB2, NEB3 and NEB4 and less star activity. Similar to the wild type BtsIB subunit, the BtsI-1 B subunit alone can act as a bottom nicking enzyme recognizing CAGTG(-/0). This is the first successful case of a specificity change among this restriction endonuclease type.	[Guan, Shengxi; Blanchard, Aine; Zhang, Penghua; Zhu, Zhenyu] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Guan, SX (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	zhuz@neb.com			New England Biolabs	New England Biolabs	New England Biolabs supported the work. As the authors are all employed by New England Biolabs, the funders were involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Bellamy SRW, 2005, J MOL BIOL, V348, P641, DOI 10.1016/j.jmb.2005.02.035; Besnier CE, 2001, EMBO REP, V2, P782, DOI 10.1093/embo-reports/kve175; GINGERAS TR, 1978, NUCLEIC ACIDS RES, V5, P4105, DOI 10.1093/nar/5.11.4105; Heiter DF, 2005, J MOL BIOL, V348, P631, DOI 10.1016/j.jmb.2005.02.034; Joshi HK, 2006, J BIOL CHEM, V281, P23852, DOI 10.1074/jbc.M512339200; Jurenaite-Urbanaviciene S, 2007, P NATL ACAD SCI USA, V104, P10358, DOI 10.1073/pnas.0610365104; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5222, DOI 10.1093/nar/gkp535; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Rimseliene R, 2003, J MOL BIOL, V327, P383, DOI 10.1016/S0022-2836(03)00142-6; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Samuelson JC, 2002, J MOL BIOL, V319, P673, DOI 10.1016/S0022-2836(02)00343-1; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Xu SY, 2007, NUCLEIC ACIDS RES, V35, P4608, DOI 10.1093/nar/gkm481; Xu Y, 2001, P NATL ACAD SCI USA, V98, P12990, DOI 10.1073/pnas.241215698; Zhang PH, 2010, PROTEIN EXPRES PURIF, V69, P226, DOI 10.1016/j.pep.2009.09.003; Zhu ZY, 2004, J MOL BIOL, V337, P573, DOI 10.1016/j.jmb.2004.02.003; Zhu ZY, 2003, J MOL BIOL, V330, P359, DOI 10.1016/S0022-2836(03)00595-3	19	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11787	10.1371/journal.pone.0011787	http://dx.doi.org/10.1371/journal.pone.0011787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668693	gold, Green Published, Green Submitted			2022-12-25	WOS:000280297300019
J	Deere, JD; Higgins, J; Cannavo, E; Villalobos, A; Adamson, L; Fromentin, E; Schinazi, RF; Luciw, PA; North, TW				Deere, Jesse D.; Higgins, Joanne; Cannavo, Elda; Villalobos, Andradi; Adamson, Lourdes; Fromentin, Emilie; Schinazi, Raymond F.; Luciw, Paul A.; North, Thomas W.			Viral Decay Kinetics in the Highly Active Antiretroviral Therapy-Treated Rhesus Macaque Model of AIDS	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; REVERSE-TRANSCRIPTASE GENE; CD4(+) T-CELLS; INFECTED INDIVIDUALS; HIV-1; VIREMIA; REPLICATION; SUPPRESSION; PERSISTENCE; LYMPHOCYTES	To prevent progression to AIDS, persons infected with human immunodeficiency virus type 1 (HIV-1) must remain on highly active antiretroviral therapy (HAART) indefinitely since this modality does not eradicate the virus. The mechanisms involved in viral persistence during HAART are poorly understood, but an animal model of HAART could help elucidate these mechanisms and enable studies of HIV-1 eradication strategies. Due to the specificity of non-nucleoside reverse transcriptase (RT) inhibitors (NNRTIs) for HIV-1, we have used RT-SHIV, a chimeric virus of simian immunodeficiency virus with RT from HIV-1. This virus is susceptible to NNRTIs and causes an AIDS-like disease in rhesus macaques. In this study, two groups of HAART-treated, RT-SHIV-infected macaques were analyzed to determine viral decay kinetics. In the first group, viral loads were monitored with a standard TaqMan RT-PCR assay with a limit of detection of 50 viral RNA copies per mL. Upon initiation of HAART, viremia decayed in a bi-phasic manner with half-lives of 1.7 and 8.5 days, respectively. A third phase was observed with little further decay. In the second group, the macaques were followed longitudinally with a more sensitive assay utilizing ultracentrifugation to concentrate virus from plasma. Bi-phasic decay of viral RNA was also observed in these animals with half-lives of 1.8 and 5.8 days. Viral loads in these animals during a third phase ranged from 2-58 RNA copies/mL, with little decay over time. The viral decay kinetics observed in these macaques are similar to those reported for HIV-1 infected humans. These results demonstrate that low-level viremia persists in RT-SHIV-infected macaques despite a HAART regimen commonly used in humans.	[Deere, Jesse D.; Higgins, Joanne; Cannavo, Elda; Villalobos, Andradi; Adamson, Lourdes; Luciw, Paul A.; North, Thomas W.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Luciw, Paul A.] Univ Calif Davis, Dept Pathol, Sch Med, Davis, CA 95616 USA; [North, Thomas W.] Univ Calif Davis, Dept Vet Mol Biosci, Davis, CA 95616 USA; [Fromentin, Emilie; Schinazi, Raymond F.] Emory Univ, Sch Med, Biochem Pharmacol Lab, Ctr AIDS Res,Dept Pediat,Vet Affairs Med Ctr, Decatur, GA 30033 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Deere, JD (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	twnorth@ucdavis.edu	Deere, Jesse Dee/ABH-7940-2020; Schinazi, Raymond F/B-6777-2017	Deere, Jesse/0000-0002-2539-0338	NIH [P01-AI058708, T32-AI60555, 1R01-RR025996]; Department of Veterans Affairs; NIH CFAR [2P30-AI-050409]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060555, P30AI050409, P01AI058708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NIH CFAR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH program project grant P01-AI058708. J. D. Deere was supported by NIH training grant T32-AI60555 as well as NIH grant 1R01-RR025996 (TWN and RFS). RFS is also supported by NIH CFAR grant 2P30-AI-050409 and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Z, 2007, J VIROL, V81, P12145, DOI 10.1128/JVI.01301-07; BALZARINI J, 1995, BIOCHEM BIOPH RES CO, V211, P850, DOI 10.1006/bbrc.1995.1890; Balzarini J, 1997, J ACQ IMMUN DEF SYND, V15, P1, DOI 10.1097/00042560-199705010-00001; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cline AN, 2005, J MED PRIMATOL, V34, P303; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GARDNER MB, 1989, FASEB J, V3, P2593, DOI 10.1096/fasebj.3.14.2556312; GARDNER MB, 2004, AIDS OTHER MANIFESTA, P195; Gavegnano Christina, 2009, Antiviral Chemistry & Chemotherapy, V20, P63, DOI 10.3851/IMP1374; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; Giuffre AC, 2003, ANTIMICROB AGENTS CH, V47, P1756, DOI 10.1128/AAC.47.5.1756-1759.2003; GRANT CK, 1977, J IMMUNOL, V119, P401; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hofman MJ, 2004, ANTIMICROB AGENTS CH, V48, P3483, DOI 10.1128/AAC.48.9.3483-3490.2004; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; LUCIW PA, 1995, P NATL ACAD SCI USA, V92, P7490, DOI 10.1073/pnas.92.16.7490; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; North TW, 2005, J VIROL, V79, P7349, DOI 10.1128/JVI.79.12.7349-7354.2005; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perelson AS, 1997, AIDS, V11, pS17; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Soderberg K, 2002, J VIROL, V76, P5803, DOI 10.1128/JVI.76.11.5803-5806.2002; Tandon R, 2005, J VIROL METHODS, V130, P124, DOI 10.1016/j.jviromet.2005.06.017; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Van Rompay KKA, 2004, ANTIMICROB AGENTS CH, V48, P1469, DOI 10.1128/AAC.48.5.1469-1487.2004; Van Rompay KKA, 2002, J VIROL, V76, P6083, DOI 10.1128/JVI.76.12.6083-6092.2002; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565	53	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11640	10.1371/journal.pone.0011640	http://dx.doi.org/10.1371/journal.pone.0011640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668516	gold, Green Published, Green Submitted			2022-12-25	WOS:000280243800003
J	Peric, D; Durrant-Arico, C; Delenda, C; Dupre, T; De Lonlay, P; de Baulny, HO; Pelatan, C; Bader-Meunier, B; Danos, O; Chantret, I; Moore, SEH				Peric, Delphine; Durrant-Arico, Christelle; Delenda, Christophe; Dupre, Thierry; De Lonlay, Pascale; de Baulny, Helene Ogier; Pelatan, Cecile; Bader-Meunier, Brigitte; Danos, Olivier; Chantret, Isabelle; Moore, Stuart E. H.			The Compartmentalisation of Phosphorylated Free Oligosaccharides in Cells from a CDG Ig Patient Reveals a Novel ER-to-Cytosol Translocation Process	PLOS ONE			English	Article							POLYMANNOSE-TYPE OLIGOSACCHARIDES; LIPID-LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; CONGENITAL DISORDERS; GLYCOPEPTIDE EXPORT; GLYCOPROTEIN-BIOSYNTHESIS; DIPHOSPHATE OLIGOSACCHARIDES; SACCHAROMYCES-CEREVISIAE; TRANSBILAYER MOVEMENT; HEPG2 CELLS	Background: Biosynthesis of the dolichol linked oligosaccharide (DLO) required for protein N-glycosylation starts on the cytoplasmic face of the ER to give Man(5)GlcNAc(2)-PP-dolichol, which then flips into the ER for further glycosylation yielding mature DLO (Glc(3)Man(9)GlcNAc(2)-PP-dolichol). After transfer of Glc(3)Man(9)GlcNAc(2) onto protein, dolichol-PP is recycled to dolichol-P and reused for DLO biosynthesis. Because de novo dolichol synthesis is slow, dolichol recycling is rate limiting for protein glycosylation. Immature DLO intermediates may also be recycled by pyrophosphatase-mediated cleavage to yield dolichol-P and phosphorylated oligosaccharides (fOSGN2-P). Here, we examine fOSGN2-P generation in cells from patients with type I Congenital Disorders of Glycosylation (CDG I) in which defects in the dolichol cycle cause accumulation of immature DLO intermediates and protein hypoglycosylation. Methods and Principal Findings: In EBV-transformed lymphoblastoid cells from CDG I patients and normal subjects a correlation exists between the quantities of metabolically radiolabeled fOSGN2-P and truncated DLO intermediates only when these two classes of compounds possess 7 or less hexose residues. Larger fOSGN2-P were difficult to detect despite an abundance of more fully mannosylated and glucosylated DLO. When CDG Ig cells, which accumulate Man(7)GlcNAc(2)-PP-dolichol, are permeabilised so that vesicular transport and protein synthesis are abolished, the DLO pool required for Man(7)GlcNAc(2)-P generation could be depleted by adding exogenous glycosylation acceptor peptide. Under conditions where a glycotripeptide and neutral free oligosaccharides remain predominantly in the lumen of the ER, Man(7)GlcNAc(2)-P appears in the cytosol without detectable generation of ER luminal Man(7)GlcNAc(2)-P. Conclusions and Significance: The DLO pools required for N-glycosylation and fOSGN2-P generation are functionally linked and this substantiates the hypothesis that pyrophosphatase-mediated cleavage of DLO intermediates yields recyclable dolichol-P. The kinetics of cytosolic fOSGN2-P generation from a luminally-generated DLO intermediate demonstrate the presence of a previously undetected ER-to-cytosol translocation process for either fOSGN2-P or DLO.	[Peric, Delphine; Durrant-Arico, Christelle; Dupre, Thierry; Chantret, Isabelle; Moore, Stuart E. H.] INSERM, CRB3 U773, Paris, France; [Peric, Delphine; Dupre, Thierry; Chantret, Isabelle; Moore, Stuart E. H.] Univ Paris 07, Paris, France; [Durrant-Arico, Christelle] Univ Paris 05, Paris, France; [Delenda, Christophe; Danos, Olivier] Genethon, Evry, France; [Dupre, Thierry] Hop Bichat Claude Bernard, AP HP, F-75877 Paris 18, France; [De Lonlay, Pascale] Hop Necker Enfants Malad, Dept Pediat, Paris, France; [de Baulny, Helene Ogier] Hop Robert Debre, APHP, F-75019 Paris, France; [Pelatan, Cecile] Ctr Hosp, Serv Pediat, Le Mans, France; [Bader-Meunier, Brigitte] Hop Bicetre, APHP, Serv Hematol Biol, Paris, France; [Danos, Olivier] Hop Necker Enfants Malad, INSERM, U781, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Le Mans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Peric, D (corresponding author), CEA, DSV, iRCM, Lab Genet Radiosensibil, Fontenay Aux Roses, France.	Stuart.moore@inserm.fr	Moore, Stuart/AAF-3920-2021; CHANTRET, Isabelle/AAF-7134-2021	Moore, Stuart/0000-0002-1020-2242; CHANTRET, Isabelle/0000-0002-0896-1274; bader-meunier, brigitte/0000-0001-8476-8196	INSERM; Vaincre les Maladies Lysosomales (VLM); La Fondation pour la Recherche Medicale (FRM); European Community [LSHM-CT-2005-512131]; Mizutani Foundation; GIS - Institut des Maladies Rares/INSERM; Hospital/INSERM Contrat d'Interface; Association Francaise Contre les Myopathies (AFM)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Vaincre les Maladies Lysosomales (VLM); La Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Community(European Commission); Mizutani Foundation; GIS - Institut des Maladies Rares/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Hospital/INSERM Contrat d'Interface; Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by institutional funding from INSERM. Additional funding was obtained from: Vaincre les Maladies Lysosomales (VLM), La Fondation pour la Recherche Medicale (FRM), EUROGLYCANET: a European Community Coordination Action (LSHM-CT-2005-512131), the Mizutani Foundation, the GIS - Institut des Maladies Rares/INSERM funded French CDG Research Network. SM is funded by a Hospital/INSERM Contrat d'Interface. Apart from Genethon (Gene Vector Production Network, Genethon, Evry, France), which is funded by the Association Francaise Contre les Myopathies (AFM), who financed and designed the recombinant lentiviral vectors used in this study, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Ali BRS, 2000, J BIOL CHEM, V275, P33222, DOI 10.1074/jbc.M003845200; Ali BRS, 2000, GLYCOBIOLOGY, V10, P383, DOI 10.1093/glycob/10.4.383; ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BELARD M, 1988, BIOCHEM J, V255, P235; BHAKDI S, 1993, MED MICROBIOL IMMUN, V182, P167; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; CACAN R, 1992, GLYCOBIOLOGY, V2, P127, DOI 10.1093/glycob/2.2.127; CACAN R, 1987, EUR J BIOCHEM, V166, P469, DOI 10.1111/j.1432-1033.1987.tb13539.x; CACAN R, 1980, EUR J BIOCHEM, V106, P473, DOI 10.1111/j.1432-1033.1980.tb04594.x; Cacan R, 1997, TRENDS GLYCOSCI GLYC, V9, P365, DOI 10.4052/tigg.9.365; Chantret I, 2003, J BIOL CHEM, V278, P9962, DOI 10.1074/jbc.M211950200; Chantret I, 2002, J BIOL CHEM, V277, P25815, DOI 10.1074/jbc.M203285200; CHAPMAN A, 1979, CELL, V17, P509, DOI 10.1016/0092-8674(79)90259-9; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Dancourt J, 2006, PEDIATR RES, V59, P835, DOI 10.1203/01.pdr.0000219430.52532.8e; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Gao NG, 2002, J BIOL CHEM, V277, P39425, DOI 10.1074/jbc.M205195200; HANOVER JA, 1981, ARCH BIOCHEM BIOPHYS, V211, P1, DOI 10.1016/0003-9861(81)90423-9; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; HOFLACK B, 1981, EUR J BIOCHEM, V117, P285, DOI 10.1111/j.1432-1033.1981.tb06335.x; HSU AF, 1974, P NATL ACAD SCI USA, V71, P2391, DOI 10.1073/pnas.71.6.2391; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; Moore SEH, 1998, GLYCOBIOLOGY, V8, P373, DOI 10.1093/glycob/8.4.373; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; OLIVER GJA, 1975, BIOCHEM SOC T, V3, P666, DOI 10.1042/bst0030666; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; ROMISCH K, 1992, P NATL ACAD SCI USA, V89, P7227, DOI 10.1073/pnas.89.15.7227; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; ROSENWALD AG, 1990, J BIOL CHEM, V265, P14544; Rush JS, 2008, J BIOL CHEM, V283, P4087, DOI 10.1074/jbc.M707067200; Rush JS, 2009, J BIOL CHEM, V284, P19835, DOI 10.1074/jbc.M109.000893; Rush JS, 1998, GLYCOBIOLOGY, V8, P1195, DOI 10.1093/glycob/8.12.1195; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; SCHENK B, 2001, GLYCOBIOLOGY, V11, P61; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; SPIRO RG, 1983, J BIOL CHEM, V258, P9469; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V304, P326, DOI 10.1016/S0006-291X(03)00600-4; TROWBRIDGE IS, 1978, CELL, V14, P21, DOI 10.1016/0092-8674(78)90297-0; VARKI A, 1983, J BIOL CHEM, V258, P2808; Vuillaumier-Barrot S, 2000, J MED GENET, V37, P579, DOI 10.1136/jmg.37.8.579; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	47	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11675	10.1371/journal.pone.0011675	http://dx.doi.org/10.1371/journal.pone.0011675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652024	Green Submitted, Green Published, gold			2022-12-25	WOS:000280109700008
J	Darbandi-Tehrani, K; Hermand, P; Carvalho, S; Dorgham, K; Couvineau, A; Lacapere, JJ; Combadiere, C; Deterre, P				Darbandi-Tehrani, Kevin; Hermand, Patricia; Carvalho, Stephanie; Dorgham, Karim; Couvineau, Alain; Lacapere, Jean-Jacques; Combadiere, Christophe; Deterre, Philippe			Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assays	FASEB JOURNAL			English	Article						adherence; chemokine; GPCR; BRET; FRET	PROTEIN-COUPLED-RECEPTOR; LIVING CELLS; HETERO-OLIGOMERIZATION; DUFFY ANTIGEN/RECEPTOR; GPCR OLIGOMERIZATION; ANTITUMOR RESPONSES; CRYSTAL-STRUCTURE; INSULIN-RECEPTOR; BRET ANALYSIS; CHEMOKINE	The chemokine CX3CL1 is expressed as a membrane protein that forms a potent adhesive pair with its unique receptor CX3CR1. This receptor has 3 natural variants, V249-T280 (VT), I249-T280 (IT), and I249-M280 (IM), whose relative frequencies are significantly associated with the incidence of various inflammatory diseases. To assess the adhesive potency of CX3CR1 and the molecular diversity of its variants, we assayed their clustering status and their possible structural differences by fluorescence/bioluminescence resonance energy transfer (FRET or BRET) techniques. FRET assays by flow cytometry showed that the CX3CR1 variants cluster, in comparison with appropriate controls. BRET assays showed low nonspecific signals for VT and IT variants and high specific signals for IM, and thus pointed out a structural difference in this variant. We used molecular modeling to show how natural point mutations of CX3CR1 affect the packing of the 6th and 7th helices of this G-protein coupled receptor. Moreover, we found that the BRET technique is sensitive enough to detect these tiny changes. Consistently with our previous finding that CX3CL1 aggregates, our data here indicate that CX3CR1 clustering may contribute to the adhesiveness of the CX3CL1-CX3CR1 pair and may thus represent a new target for anti-inflammatory therapies.-Darbandi-Tehrani, K., Hermand, P., Carvalho, S., Dorgham, K., Couvineau, A., Lacapere, J.-J., Combadiere, C., Deterre, P. Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assays. FASEB J. 24, 4585-4598 (2010). www.fasebj.org	[Deterre, Philippe] Univ Paris 06, INSERM, UMR S 945, Fac Med Pitie Salpetriere,Lab Immun & Infect, F-75013 Paris, France; [Couvineau, Alain; Lacapere, Jean-Jacques] INSERM, U773, Ctr Rech Biomed Bichat Beaujon CRB3, Paris, France; [Couvineau, Alain; Lacapere, Jean-Jacques] Univ Paris Diderot, Fac Med Xavier Bichat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Deterre, P (corresponding author), Univ Paris 06, INSERM, UMR S 945, Fac Med Pitie Salpetriere,Lab Immun & Infect, 91 Blvd Hop, F-75013 Paris, France.	philippe.deterre@upmc.fr	Combadiere, Christophe/I-5639-2013; couvineau, alain/T-3466-2019; Deterre, Philippe/O-8984-2017; Dorgham, karim/A-2241-2016; couvineau, alain/G-3641-2013	Combadiere, Christophe/0000-0002-1755-4531; couvineau, alain/0000-0003-2912-5168; Deterre, Philippe/0000-0001-9303-0791; Dorgham, karim/0000-0001-9539-3203; couvineau, alain/0000-0003-2912-5168; HERMAND, Patricia/0000-0003-0628-9733	Association de Recherche contre le Cancer; Institut National de la Sante et de la Recherche Medicale; European FP6 [LSHB-CT-2005-518167]; ANR-Piribio [piribio09_443682]; Canceropole Ile-de-France; Ligue Nationale Contre le Cancer	Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); European FP6(European Commission); ANR-Piribio(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	The authors thank Amanda E. Proudfoot (Merck Serono, Geneva, Switzerland) for her generous gift of CX3CL1, Stefano Marullo (Institut Cochin, Paris, France) for providing the pRLuc and pEYFP plasmids, and Jeffrey K. Harrison (University of Florida College of Medicine, Jacksonville, FL, USA) for his generous gift of the murine CX3CR1 construct. The authors also thank Mehdi Daoudi, Marie-Camille Delsuc, James Vigneron, and Tamara Lopez for preliminary experiments; Mariano Ostuni for his help in subcellular fractionation; and Christophe Parizot and Olivier Pelle for their advice about flow cytometry analysis. This work was supported by grants from the Association de Recherche contre le Cancer, the Institut National de la Sante et de la Recherche Medicale (Programme National de Recherche sur Les Maladies Cardiovasculaires), European FP6 contracts INNO-CHEM (LSHB-CT-2005-518167 to C.C.), and ANR-Piribio (piribio09_443682, Adhekines). J.J.L. and P.D. are researchers from the Centre National de la Recherche Scientifique (CNRS). K.D.-T. was supported by a doctoral fellowship from Canceropole Ile-de-France and Ligue Nationale Contre le Cancer. The authors acknowledge the local Post-Genomic Platform of Pitie-Salpetriere (P3S) for providing access to the Fusion Packard reader and the local Cellular Imaging Platform of Pitie-Salpetriere (PICPS) for providing access to the confocal microscope.	Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Allen SJ, 2009, PROTEIN EXPRES PURIF, V66, P73, DOI 10.1016/j.pep.2009.03.001; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Angers S, 2001, LIFE SCI, V68, P2243, DOI 10.1016/S0024-3205(01)01012-8; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Batard P, 2002, CYTOMETRY, V48, P97, DOI 10.1002/cyto.10106; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Berchiche YA, 2007, J BIOL CHEM, V282, P5111, DOI 10.1074/jbc.C600270200; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Boute N, 2001, MOL PHARMACOL, V60, P640; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Bouvier M, 2007, NAT METHODS, V4, P3, DOI 10.1038/nmeth0107-3; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Combadiere B, 2007, M S-MED SCI, V23, P173, DOI 10.1051/medsci/2007232173; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Davis CN, 2006, J PHARMACOL EXP THER, V316, P356, DOI 10.1124/jpet.105.093039; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garin A, 2003, J IMMUNOL, V171, P5305, DOI 10.4049/jimmunol.171.10.5305; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hanyaloglu AC, 2002, J BIOL CHEM, V277, P50422, DOI 10.1074/jbc.M209340200; Hattori H, 2005, NEUROSCI LETT, V374, P132, DOI 10.1016/j.neulet.2004.10.042; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; Hermand P, 2008, J BIOL CHEM, V283, P30225, DOI 10.1074/jbc.M802638200; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jin ZH, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-41; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavergne E, 2003, CANCER RES, V63, P7468; Lavergne E, 2005, ARTERIOSCL THROM VAS, V25, P847, DOI 10.1161/01.ATV.0000157150.23641.36; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Levoye A, 2006, CHRONOBIOL INT, V23, P419, DOI 10.1080/07420520500521863; Ling WLW, 2002, GENE THER, V9, P907, DOI 10.1038/sj.gt.3301726; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maggio R, 2005, FEBS J, V272, P2939, DOI 10.1111/j.1742-4658.2005.04729.x; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; McDermott D H, 2000, Science, V290, P2031; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005; Milligan G, 2001, J CELL SCI, V114, P1265; Milligan G, 2005, J MOL NEUROSCI, V26, P161, DOI 10.1385/JMN:26:2-3:161; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Nadif R, 2006, CYTOKINE, V33, P171, DOI 10.1016/j.cyto.2006.01.001; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parmentier ML, 2002, TRENDS PHARMACOL SCI, V23, P268, DOI 10.1016/S0165-6147(02)02016-3; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Pin JP, 2004, BIOL CELL, V96, P335, DOI 10.1016/j.biolcel.2004.03.005; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Riemann D, 2005, BIOCHEM BIOPH RES CO, V331, P1408, DOI 10.1016/j.bbrc.2005.04.061; Rodero M, 2008, J CLIN ONCOL, V26, P5957, DOI 10.1200/JCO.2008.17.2833; Salahpour A, 2000, TRENDS ENDOCRIN MET, V11, P163, DOI 10.1016/S1043-2760(00)00260-5; Salahpour A, 2007, NAT METHODS, V4, P599, DOI 10.1038/nmeth0807-599; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Toth PT, 2004, J PHARMACOL EXP THER, V310, P8, DOI 10.1124/jpet.103.064956; Tournamille C, 2004, IMMUNOGENETICS, V55, P682, DOI 10.1007/s00251-003-0633-2; Tournamille C, 1997, J BIOL CHEM, V272, P16274, DOI 10.1074/jbc.272.26.16274; Tremblay K, 2006, GENES IMMUN, V7, P632, DOI 10.1038/sj.gene.6364340; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WOODCOCK S, 1992, PROTEIN ENG, V5, P629, DOI 10.1093/protein/5.7.629; WYNBERG H, 1980, NATURE, V286, P641, DOI 10.1038/286641a0; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660; Zhou JY, 2003, J PHARMACOL EXP THER, V305, P460, DOI 10.1124/jpet.102.048637	99	9	9	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4585	4598		10.1096/fj.10-156612	http://dx.doi.org/10.1096/fj.10-156612			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20667981				2022-12-25	WOS:000283861100043
J	BeGora, MD; Macleod, MJR; McCarry, BE; Summers, PS; Weretilnyk, EA				BeGora, Michael D.; Macleod, Mitchell J. R.; McCarry, Brian E.; Summers, Peter S.; Weretilnyk, Elizabeth A.			Identification of Phosphomethylethanolamine N-Methyltransferase from Arabidopsis and Its Role in Choline and Phospholipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATED ETHANOLAMINE MOIETIES; GLYCINE BETAINE SYNTHESIS; CROSS-PATHWAY REGULATION; PHOSPHOETHANOLAMINE-METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; SEQUENCE MOTIFS; RAPID METHOD; SPINACH; GENE	Three sequential methylations of phosphoethanolamine (PEA) are required for the synthesis of phosphocholine (PCho) in plants. A cDNA encoding an N-methyltransferase that catalyzes the last two methylation steps was cloned from Arabidopsis by heterologous complementation of a Saccharomyces cerevisiae cho2, opi3 mutant. The cDNA encodes phosphomethylethanolamine N-methyltransferase (PMEAMT), a polypeptide of 475 amino acids that is organized as two tandem methyltransferase domains. PMEAMT shows 87% amino acid identity to a related enzyme, phosphoethanolamine N-methyltransferase, an enzyme in plants that catalyzes all three methylations of PEA to PCho. PMEAMT cannot use PEA as a substrate, but assays using phosphomethylethanolamine as a substrate result in both phosphodimethylethanolamine and PCho as products. PMEAMT is inhibited by the reaction products PCho and S-adenosyl-L-homocysteine, a property reported for phosphoethanolamine N-methyltransferase from various plants. An Arabidopsis mutant with a T-DNA insertion associated with locus At1g48600 showed no transcripts encoding PMEAMT. Shotgun lipidomic analyses of leaves of atpmeamt and wild-type plants generated phospholipid profiles showing the content of phosphatidylmethylethanolamine to be altered relative to wild type with the content of a 34: 3 lipid molecular species 2-fold higher in mutant plants. In S. cerevisiae, an increase in PtdMEA in membranes is associated with reduced viability. This raises a question regarding the role of PMEAMT in plants and whether it serves to prevent the accumulation of PtdMEA to potentially deleterious levels.	[BeGora, Michael D.; Macleod, Mitchell J. R.; Summers, Peter S.; Weretilnyk, Elizabeth A.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4A8, Canada; [McCarry, Brian E.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4A8, Canada	McMaster University; McMaster University	Weretilnyk, EA (corresponding author), McMaster Univ, Dept Biol, Life Sci Bldg,Rm 536,1280 Main St W, Hamilton, ON L8S 4A8, Canada.	weretil@mcmaster.ca	Summers, Peter/F-3686-2011		Natural Science and Engineering Research Council	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Science and Engineering Research Council Discovery Grant (to E. A. W.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Basconcillo LS, 2009, J LIPID RES, V50, P1120, DOI 10.1194/jlr.M800443-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLIGNY R, 1990, J BIOL CHEM, V265, P1319; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COUGHLAN SJ, 1982, PLANTA, V154, P6, DOI 10.1007/BF00385490; Cruz-Ramirez A, 2004, PLANT CELL, V16, P2020, DOI 10.1105/tpc.103.018648; DATKO AH, 1988, PLANT PHYSIOL, V88, P854, DOI 10.1104/pp.88.3.854; DATKO AH, 1988, PLANT PHYSIOL, V88, P1338, DOI 10.1104/pp.88.4.1338; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HANSON AD, 1994, P NATL ACAD SCI USA, V91, P306, DOI 10.1073/pnas.91.1.306; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huang J, 2008, PLANT PHYSIOL BIOCH, V46, P647, DOI 10.1016/j.plaphy.2008.04.014; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Joshi CP, 1998, PLANT MOL BIOL, V37, P663, DOI 10.1023/A:1006035210889; Jost R, 2009, J BIOL CHEM, V284, P31962, DOI 10.1074/jbc.M109.022657; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Keogh MR, 2009, J BIOL CHEM, V284, P15439, DOI 10.1074/jbc.M109.005991; Lorenzin D, 2001, CAN J BOT, V79, P897, DOI 10.1139/cjb-79-8-897; MCGRAW P, 1989, GENETICS, V122, P317; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; McNeil SD, 2000, PLANT PHYSIOL, V124, P153, DOI 10.1104/pp.124.1.153; MINET M, 1992, PLANT J, V2, P417; Moffatt BA, 2001, PHYSIOL PLANTARUM, V113, P435, DOI 10.1034/j.1399-3054.2001.1130401.x; MOORE TS, 1976, PLANT PHYSIOL, V57, P383, DOI 10.1104/pp.57.3.382; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; MUDD SH, 1989, PLANT PHYSIOL, V90, P296, DOI 10.1104/pp.90.1.296; MUDD SH, 1989, PLANT PHYSIOL, V90, P306, DOI 10.1104/pp.90.1.306; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Nuccio ML, 1998, PLANT J, V16, P487, DOI 10.1046/j.1365-313x.1998.00316.x; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Peel GJ, 2010, PHYTOCHEMISTRY, V71, P404, DOI 10.1016/j.phytochem.2009.11.002; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smith DD, 2000, PHYSIOL PLANTARUM, V108, P286, DOI 10.1034/j.1399-3054.2000.108003286.x; Stolz J, 2003, YEAST, V20, P221, DOI 10.1002/yea.959; SUMMERS EF, 1988, GENETICS, V120, P909; SUMMERS PS, 1993, PLANT PHYSIOL, V103, P1269, DOI 10.1104/pp.103.4.1269; Wang XM, 2000, PROG LIPID RES, V39, P109, DOI 10.1016/S0163-7827(00)00002-3; WEIGEL D, 2002, ARABIDOPSIS LAB MANU, P176; WERETILNYK EA, 1995, PLANT PHYSIOL, V109, P1085, DOI 10.1104/pp.109.3.1085; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Wolf C, 2008, PROG LIPID RES, V47, P15, DOI 10.1016/j.plipres.2007.09.001; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061	53	34	37	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29147	29155		10.1074/jbc.M110.112151	http://dx.doi.org/10.1074/jbc.M110.112151			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20650897	Green Published, hybrid			2022-12-25	WOS:000281740100015
J	Bogs, J; Veits, J; Gohrbandt, S; Hundt, J; Stech, O; Breithaupt, A; Teifke, JP; Mettenleiter, TC; Stech, J				Bogs, Jessica; Veits, Jutta; Gohrbandt, Sandra; Hundt, Jana; Stech, Olga; Breithaupt, Angele; Teifke, Jens P.; Mettenleiter, Thomas C.; Stech, Juergen			Highly Pathogenic H5N1 Influenza Viruses Carry Virulence Determinants beyond the Polybasic Hemagglutinin Cleavage Site	PLOS ONE			English	Article							A VIRUSES; GENE REASSORTANTS; STALK-LENGTH; NEURAMINIDASE; EMERGENCE; SEQUENCE; RECOMBINATION; GLYCOSYLATION; CONSTELLATION; PATHOBIOLOGY	Highly pathogenic avian influenza viruses (HPAIV) originate from avirulent precursors but differ from all other influenza viruses by the presence of a polybasic cleavage site in their hemagglutinins (HA) of subtype H5 or H7. In this study, we investigated the ability of a low-pathogenic avian H5N1 strain to transform into an HPAIV. Using reverse genetics, we replaced the monobasic HA cleavage site of the low-pathogenic strain A/Teal/Germany/Wv632/2005 (H5N1) (TG05) by a polybasic motif from an HPAIV (TG05(poly)). To elucidate the virulence potential of all viral genes of HPAIV, we generated two reassortants carrying the HA from the HPAIV A/Swan/Germany/R65/06 (H5N1) (R65) plus the remaining genes from TG05 (TG05-HA(R65)) or in reversed composition the mutated TG05 HA plus the R65 genes (R65-HATG05(poly)). In vitro, TG05(poly) and both reassortants were able to replicate without the addition of trypsin, which is characteristic for HPAIV. Moreover, in contrast to avirulent TG05, the variants TG05(poly), TG05-HA(R65), and R65-HATG05(poly) are pathogenic in chicken to an increasing degree. Whereas the HA cleavage site mutant TG05(poly) led to temporary non-lethal disease in all animals, the reassortant TG05-HA(R65) caused death in 3 of 10 animals. Furthermore, the reassortant R65-HATG05(poly) displayed the highest lethality as 8 of 10 chickens died, resembling "natural" HPAIV strains. Taken together, acquisition of a polybasic HA cleavage site is only one necessary step for evolution of low-pathogenic H5N1 strains into HPAIV. However, these low-pathogenic strains may already have cryptic virulence potential. Moreover, besides the polybasic cleavage site, the additional virulence determinants of H5N1 HPAIV are located within the HA itself and in other viral proteins.	[Bogs, Jessica; Veits, Jutta; Gohrbandt, Sandra; Hundt, Jana; Stech, Olga; Mettenleiter, Thomas C.; Stech, Juergen] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany; [Breithaupt, Angele; Teifke, Jens P.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectol, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute	Bogs, J (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany.	juergen.stech@fli.bund.de	Mettenleiter, h. c. Thomas C./U-1016-2019; Breithaupt, Angele/B-6155-2013; Breithaupt, Angele/GON-7227-2022	Breithaupt, Angele/0000-0002-6373-5923; Teifke, Jens/0000-0001-7168-4970; Stech, Juergen/0000-0002-3187-702X	Forschungssofortprogramm Influenza of the German government [FSI 2.44]; European Commission [SSPE-CT-2006-44372 (Innflu)]	Forschungssofortprogramm Influenza of the German government; European Commission(European CommissionEuropean Commission Joint Research Centre)	Forschungssofortprogramm Influenza of the German government (FSI 2.44) and European Commission [SSPE-CT-2006-44372 (Innflu)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 2008, MANUAL DIAGNOSTIC TE; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; BOSCH FX, 1979, VIROLOGY, V95, P197, DOI 10.1016/0042-6822(79)90414-8; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DESHPANDE KL, 1985, VIROLOGY, V147, P49, DOI 10.1016/0042-6822(85)90226-0; DEWIT E, 2009, J VIROL; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; Garten Wolfgang, 2008, V27, P156; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; HORIMOTO T, 1995, VIROLOGY, V213, P223, DOI 10.1006/viro.1995.1562; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kalthoff D, 2008, PLOS ONE, V4, DOI 10.1371/journal.pone.0006170; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; KAWAOKA Y, 1985, VIROLOGY, V146, P130, DOI 10.1016/0042-6822(85)90059-5; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Klopfleisch R, 2006, VET PATHOL, V43, P463, DOI 10.1354/vp.43-4-463; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Ma WJ, 2010, J VIROL, V84, P2122, DOI 10.1128/JVI.01668-09; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; Pavlova SP, 2009, VACCINE, V27, P773, DOI 10.1016/j.vaccine.2008.11.033; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perdue ML, 1997, VIRUS RES, V49, P173, DOI 10.1016/S0168-1702(97)01468-8; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Pfeiffer J, 2009, VIRUS RES, V142, P108, DOI 10.1016/j.virusres.2009.01.019; ROHM C, 1995, VIROLOGY, V209, P664, DOI 10.1006/viro.1995.1301; ROTT R, 1976, J VIROL, V19, P54, DOI 10.1128/JVI.19.1.54-60.1976; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SCHAFER W, 1955, Z NATURFORSCH PT B, V10, P81, DOI 10.1515/znb-1955-0205; SCHOLTISSEK C, 1979, VIROLOGY, V95, P492, DOI 10.1016/0042-6822(79)90503-8; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stech J, 1999, J VIROL, V73, P1878, DOI 10.1128/JVI.73.3.1878-1884.1999; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; Stech O, 2009, J VIROL, V83, P5864, DOI 10.1128/JVI.02649-08; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; Zhirnov OP, 2009, VIROLOGY, V394, P57, DOI 10.1016/j.virol.2009.08.013	58	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11826	10.1371/journal.pone.0011826	http://dx.doi.org/10.1371/journal.pone.0011826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676399	Green Submitted, Green Published, gold			2022-12-25	WOS:000280371800021
J	De Paepe, M; De Monte, S; Robert, L; Lindner, AB; Taddei, F				De Paepe, Marianne; De Monte, Silvia; Robert, Lydia; Lindner, Ariel B.; Taddei, Francois			Emergence of Variability in Isogenic Escherichia coli Populations Infected by a Filamentous Virus	PLOS ONE			English	Article							HOST; EVOLUTION; DYNAMICS; REVEALS; GROWTH	The spread of epidemics not only depends on the average number of parasites produced per host, but also on the existence of highly infectious individuals. It is widely accepted that infectiousness depends on genetic and environmental determinants. However, even in clonal populations of host and viruses growing in homogeneous conditions, high variability can exist. Here we show that Escherichia coli cells commonly display high differentials in viral burst size, and address the kinetics of emergence of such variability with the non-lytic filamentous virus M13. By single-cell imaging of a virally-encoded fluorescent reporter, we monitor the viral charge distribution in infected bacterial populations at different time following infection. A mathematical model assuming autocatalytic virus replication and inheritance of bacterial growth rates quantitatively reproduces the experimental distributions, demonstrating that deterministic amplification of small host inhomogeneities is a mechanism sufficient to explain large and highly skewed distributions. This mechanism of amplification is general and may occur whenever a parasite has an initial phase of exponential growth within its host. Moreover, it naturally reproduces the shift towards higher virulence when the host is experimenting poor conditions, as observed commonly in host-parasite systems.	[De Paepe, Marianne; Robert, Lydia; Lindner, Ariel B.; Taddei, Francois] INSERM, U1001, Paris, France; [De Paepe, Marianne; Robert, Lydia; Lindner, Ariel B.; Taddei, Francois] Univ Paris 05, Paris, France; [De Monte, Silvia] Ecole Normale Super, UMR 7625, F-75231 Paris, France; [De Monte, Silvia] Univ Paris 06, UMR 7625, Paris, France; [De Monte, Silvia] CNRS, UMR 7625, Paris, France; [Robert, Lydia] AgroParisTech ENGREF, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech	De Paepe, M (corresponding author), INSERM, U1001, Paris, France.	demonte@biologie.ens.fr	Lindner, Ariel/K-9247-2019; Lindner, Ariel B/I-8503-2016	Lindner, Ariel/0000-0001-5015-6511; Lindner, Ariel B/0000-0001-5015-6511; De Monte, Silvia/0000-0001-7953-5494; Taddei, Francois/0000-0002-7894-0647; robert, lydia/0000-0002-0715-0322	Agence Nationale de la Recherche; Human Frontier Scientific Program; European Science Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontier Scientific Program(Human Frontier Science Program); European Science Foundation(European Science Foundation (ESF)European Commission)	This project was funded in part by Agence Nationale de la Recherche, Human Frontier Scientific Program and a EURY award from the European Science Foundation to F. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DELBRUCK M, 1945, J BACTERIOL, V50, P131; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Ganusov VV, 2002, EVOLUTION, V56, P213, DOI 10.1111/j.0014-3820.2002.tb01332.x; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; Kaltz O, 2003, EVOLUTION, V57, P1535, DOI 10.1111/j.0014-3820.2003.tb00361.x; KOCH AL, 1966, J THEOR BIOL, V12, P276, DOI 10.1016/0022-5193(66)90119-6; Kuo MY, 2000, CAN J MICROBIOL, V46, P841, DOI 10.1139/cjm-46-9-841; LERNER TJ, 1981, VIROLOGY, V115, P282, DOI 10.1016/0042-6822(81)90111-2; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Messenger SL, 1999, P ROY SOC B-BIOL SCI, V266, P397, DOI 10.1098/rspb.1999.0651; Nolan D, 2006, CURR OPIN IMMUNOL, V18, P413, DOI 10.1016/j.coi.2006.05.015; Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120; Poulin R, 1999, PARASITOL TODAY, V15, P28, DOI 10.1016/S0169-4758(98)01357-X; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; RUSSEL M, 2006, BACTERIOPHAGES, P146; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tsuru S, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036015; Zhu Y, 2009, VIROLOGY, V385, P39, DOI 10.1016/j.virol.2008.10.031	22	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11823	10.1371/journal.pone.0011823	http://dx.doi.org/10.1371/journal.pone.0011823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676396	gold, Green Published, Green Submitted			2022-12-25	WOS:000280371800020
J	Cussans, J; Goulson, D; Sanderson, R; Goffe, L; Darvill, B; Osborne, JL				Cussans, John; Goulson, David; Sanderson, Roy; Goffe, Louis; Darvill, Ben; Osborne, Juliet L.			Two Bee-Pollinated Plant Species Show Higher Seed Production when Grown in Gardens Compared to Arable Farmland	PLOS ONE			English	Article							FORAGING RANGE; POLLEN LIMITATION; LANDSCAPE-SCALE; INSECT VISITS; NEST DENSITY; BUMBLEBEE; CROPS; REPRODUCTION; HYMENOPTERA; EXTINCTION	Background: Insect pollinator abundance, in particular that of bees, has been shown to be high where there is a superabundance of floral resources; for example in association with mass-flowering crops and also in gardens where flowering plants are often densely planted. Since land management affects pollinator numbers, it is also likely to affect the resultant pollination of plants growing in these habitats. We hypothesised that the seed or fruit set of two plant species, typically pollinated by bumblebees and/or honeybees might respond in one of two ways: 1) pollination success could be reduced when growing in a floriferous environment, via competition for pollinators, or 2) pollination success could be enhanced because of increased pollinator abundance in the vicinity. Methodology/Principal Findings: We compared the pollination success of experimental plants of Glechoma hederacea L. and Lotus corniculatus L. growing in gardens and arable farmland. On the farms, the plants were placed either next to a mass-flowering crop (oilseed rape, Brassica napus L. or field beans, Vicia faba L.) or next to a cereal crop (wheat, Triticum spp.). Seed set of G. hederacea and fruit set of L. corniculatus were significantly higher in gardens compared to arable farmland. There was no significant difference in pollination success of G. hederacea when grown next to different crops, but for L. corniculatus, fruit set was higher in the plants growing next to oilseed rape when the crop was in flower. Conclusions/Significance: The results show that pollination services can limit fruit set of wild plants in arable farmland, but there is some evidence that the presence of a flowering crop can facilitate their pollination (depending on species and season). We have also demonstrated that gardens are not only beneficial to pollinators, but also to the process of pollination.	[Cussans, John; Osborne, Juliet L.] Rothamsted Res, Plant & Invertebrate Ecol Dept, Harpenden, Herts, England; [Goulson, David; Darvill, Ben] Univ Stirling, Sch Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Sanderson, Roy; Goffe, Louis] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Stirling; Newcastle University - UK	Cussans, J (corresponding author), Rothamsted Res, Plant & Invertebrate Ecol Dept, Harpenden, Herts, England.	juliet.osborne@bbsrc.ac.uk	Goulson, David/A-2462-2010; Osborne, Juliet L/I-6776-2012; Cussans, John/AAB-2306-2022; Cussans, John/A-2764-2010	Goulson, David/0000-0003-4421-2876; Goffe, Louis/0000-0002-3623-2458	Biotechnology and Biological Sciences Research Council of the UK [BB/E001491]; Biotechnology and Biological Sciences Research Council [BB/E001491/1, BB/E002757/1] Funding Source: researchfish; BBSRC [BB/E001491/1, BB/E002757/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded as part of Project BB/E001491, funded by the Biotechnology and Biological Sciences Research Council of the UK (URL:http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; Cresswell JE, 2000, ECOL ENTOMOL, V25, P249, DOI 10.1046/j.1365-2311.2000.00264.x; Darwin C, 1891, EFFECTS CROSS SELF F; *DEFR, 2009, AGR UK; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Frankie GW, 2009, J KANSAS ENTOMOL SOC, V82, P1, DOI 10.2317/JKES708.23.1; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; GOULSON D, J APPL ECOL IN PRESS; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Haughton AJ, 2003, PHILOS T ROY SOC B, V358, P1863, DOI 10.1098/rstb.2003.1408; Hawes C, 2003, PHILOS T ROY SOC B, V358, P1899, DOI 10.1098/rstb.2003.1406; Hegland SJ, 2009, ECOL RES, V24, P929, DOI 10.1007/s11284-008-0572-3; Herrmann F, 2007, MOL ECOL, V16, P1167, DOI 10.1111/j.1365-294X.2007.03226.x; Johnson SD, 2003, ECOLOGY, V84, P2919, DOI 10.1890/02-0471; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Knuth P, 1909, HDB FLOWER POLLINATI, VIII; Knuth P., 1908, HDB FLOWER POLLINATI, VII, DOI 10.1126/science.28.715.345; Knuth P.E.O.W., 1906, HDB FLOWER POLLINATI, VI; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; Moragues E, 2005, BIOL CONSERV, V122, P611, DOI 10.1016/j.biocon.2004.09.015; Nielsen C, 2008, BIOL INVASIONS, V10, P1353, DOI 10.1007/s10530-007-9210-1; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Thompson K, 1999, CONSERV BIOL, V13, P185, DOI 10.1046/j.1523-1739.1999.97353.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x	38	41	42	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11753	10.1371/journal.pone.0011753	http://dx.doi.org/10.1371/journal.pone.0011753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668704	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000280243800023
J	Oliveira, RF; Terrin, A; Di Benedetto, G; Cannon, RC; Koh, W; Kim, M; Zaccolo, M; Blackwell, KT				Oliveira, Rodrigo F.; Terrin, Anna; Di Benedetto, Giulietta; Cannon, Robert C.; Koh, Wonryull; Kim, MyungSook; Zaccolo, Manuela; Blackwell, Kim T.			The Role of Type 4 Phosphodiesterases in Generating Microdomains of cAMP: Large Scale Stochastic Simulations	PLOS ONE			English	Article							PROTEIN-KINASE-A; MAMMALIAN ADENYLYL-CYCLASE; RESONANCE ENERGY-TRANSFER; SMALL SUBCELLULAR VOLUMES; CYCLIC-AMP; CARDIAC MYOCYTES; BETA(2)-ADRENERGIC RECEPTOR; MEDIATED PHOSPHORYLATION; DIFFUSION-COEFFICIENTS; SIGNALING PATHWAYS	Cyclic AMP (cAMP) and its main effector Protein Kinase A (PKA) are critical for several aspects of neuronal function including synaptic plasticity. Specificity of synaptic plasticity requires that cAMP activates PKA in a highly localized manner despite the speed with which cAMP diffuses. Two mechanisms have been proposed to produce localized elevations in cAMP, known as microdomains: impeded diffusion, and high phosphodiesterase (PDE) activity. This paper investigates the mechanism of localized cAMP signaling using a computational model of the biochemical network in the HEK293 cell, which is a subset of pathways involved in PKA-dependent synaptic plasticity. This biochemical network includes cAMP production, PKA activation, and cAMP degradation by PDE activity. The model is implemented in NeuroRD: novel, computationally efficient, stochastic reaction-diffusion software, and is constrained by intracellular cAMP dynamics that were determined experimentally by real-time imaging using an Epac-based FRET sensor (H30). The model reproduces the high concentration cAMP microdomain in the submembrane region, distinct from the lower concentration of cAMP in the cytosol. Simulations further demonstrate that generation of the cAMP microdomain requires a pool of PDE4D anchored in the cytosol and also requires PKA-mediated phosphorylation of PDE4D which increases its activity. The microdomain does not require impeded diffusion of cAMP, confirming that barriers are not required for microdomains. The simulations reported here further demonstrate the utility of the new stochastic reaction-diffusion algorithm for exploring signaling pathways in spatially complex structures such as neurons.	[Oliveira, Rodrigo F.; Koh, Wonryull; Kim, MyungSook; Blackwell, Kim T.] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Terrin, Anna; Zaccolo, Manuela] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland; [Di Benedetto, Giulietta] Venetian Inst Mol Med, Padua, Veneto, Italy; [Cannon, Robert C.] Textensor Ltd, Edinburgh, Midlothian, Scotland	George Mason University; University of Glasgow; Veneto Institute Molecular Medicine	Oliveira, RF (corresponding author), George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA.	kblackw1@gmu.edu	Oliveira, Rodrigo Freire/Q-7155-2018; Di Benedetto, Giulietta/L-9842-2019; Zaccolo, Manuela/AAP-6706-2020; Zaccolo, Manuela/B-3802-2011	Oliveira, Rodrigo Freire/0000-0003-0312-1839; Di Benedetto, Giulietta/0000-0002-1489-3896; Zaccolo, Manuela/0000-0002-0934-3662; Oliveira, Rodrigo/0000-0002-3414-3339	HFSP; NSF-NIH [R01 AA16022]; Foundation Leducq [O6 CVD 02]; British Heart Foundation [PG/07/091/23698]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016022] Funding Source: NIH RePORTER	HFSP(Human Frontier Science Program); NSF-NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	An HFSP program grant (K. B. and M.Z.), the joint NSF-NIH CRCNS program through NIH grant R01 AA16022 (K. B.), Foundation Leducq (O6 CVD 02 to M.Z.) and the British Heart Foundation (PG/07/091/23698 to M.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Bhalla US, 2004, BIOPHYS J, V87, P733, DOI 10.1529/biophysj.104.040469; Bhalla US, 2004, BIOPHYS J, V87, P745, DOI 10.1529/biophysj.104.040501; Blackwell KT, 2006, J NEUROSCI METH, V157, P142, DOI 10.1016/j.jneumeth.2006.04.003; Blackwell KT, 2004, J COMPUT NEUROSCI, V17, P81, DOI 10.1023/B:JCNS.0000023866.88225.03; BODE DC, 1988, MOL CELL BIOCHEM, V82, P13; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; Cannon RC, 2007, NEUROINFORMATICS, V5, P127, DOI 10.1007/s12021-007-0004-5; Chen CH, 1999, BIOPHYS J, V76, P2861, DOI 10.1016/S0006-3495(99)77440-0; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Crook S, 2007, NEUROINFORMATICS, V5, P96, DOI 10.1007/s12021-007-0003-6; Dessauer CW, 1997, J BIOL CHEM, V272, P27787, DOI 10.1074/jbc.272.44.27787; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; FUSHIMI K, 1991, J CELL BIOL, V112, P719, DOI 10.1083/jcb.112.4.719; Gervasi N, 2007, J NEUROSCI, V27, P2744, DOI 10.1523/JNEUROSCI.5352-06.2007; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HABERMAN R, 1997, ELEMENTARY APPL PART; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Herman SB, 2000, MOL PHARMACOL, V57, P991; HUANG RC, 1991, J GEN PHYSIOL, V98, P835, DOI 10.1085/jgp.98.4.835; HUBLEY MJ, 1995, NMR BIOMED, V8, P72, DOI 10.1002/nbm.1940080205; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; KIM M, 2009, 13521C31 SOC NEUR; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Martin ACL, 2006, BIOCHEM SOC T, V34, P480, DOI 10.1042/BST0340480; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; OGREID D, 1981, FEBS LETT, V129, P282, DOI 10.1016/0014-5793(81)80184-6; OLIVEIRA RF, 2009, 13520C30 SOC NEUR; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SIEGEL RM, 2000, SCI STKE, pPL1; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; Zaccolo M, 2004, CIRC RES, V94, P866, DOI 10.1161/01.RES.0000123825.83803.CD; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2006, EUR J CELL BIOL, V85, P693, DOI 10.1016/j.ejcb.2006.01.002; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200	64	86	86	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11725	10.1371/journal.pone.0011725	http://dx.doi.org/10.1371/journal.pone.0011725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661441	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000280243300025
J	Schneider, BS; Soong, L; Coffey, LL; Stevenson, HL; Mcgee, CE; Higgs, S				Schneider, Bradley S.; Soong, Lynn; Coffey, Lark L.; Stevenson, Heather L.; McGee, Charles E.; Higgs, Stephen			Aedes aegypti Saliva Alters Leukocyte Recruitment and Cytokine Signaling by Antigen-Presenting Cells during West Nile Virus Infection	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; HOST IMMUNE-RESPONSE; NITRIC-OXIDE; IN-VITRO; GLAND EXTRACTS; T-CELLS; LYMPHOCYTE-PROLIFERATION; NONVIREMIC TRANSMISSION; INFLAMMATORY RESPONSE; MOUSE MACROPHAGES	West Nile virus (WNV) is transmitted during mosquito bloodfeeding. Consequently, the first vertebrate cells to contact WNV are cells in the skin, followed by those in the draining lymph node. Macrophages and dendritic cells are critical early responders in host defense against WNV infection, not just because of their role in orchestrating the immune response, but also because of their importance as sites of early peripheral viral replication. Antigen-presenting cell (APC) signals have a profound effect on host antiviral responses and disease severity. During transmission, WNV is intimately associated with mosquito saliva. Due to the ability of mosquito saliva to affect inflammation and immune responses, and the importance of understanding early events in WNV infection, we investigated whether mosquito saliva alters APC signaling during arbovirus infection, and if alterations in cell recruitment occur when WNV infection is initiated with mosquito saliva. Accordingly, experiments were performed with cultured dendritic cells and macrophages, flow cytometry was used to characterize infiltrating cell types in the skin and lymph nodes during early infection, and real-time RT-PCR was employed to evaluate virus and cytokine levels. Our in vitro results suggest that mosquito saliva significantly decreases the expression of interferon-beta and inducible nitric oxide synthase in macrophages (by as much as 50 and 70%, respectively), whilst transiently enhancing interleukin-10 (IL-10) expression. In vivo results indicate that the predominate effect of mosquito feeding is to significantly reduce the recruitment of T cells, leading the inoculation site of mice exposed to WNV alone to have up to 2.8 fold more t cells as mice infected in the presence of mosquito saliva. These shifts in cell population are associated with significantly elevated IL-10 and WNV (up to 4.0 and 10 fold, respectively) in the skin and draining lymph nodes. These results suggest that mosquito saliva dysregulates APC antiviral signaling, and reveal a possible mechanism for the observed enhancement of WNV disease mediated by mosquito saliva via a reduction of T lymphocyte and antiviral activity at the inoculation site, an elevated abundance of susceptible cell types, and a concomitant increase in immunoregulatory activity of IL-10.	[Schneider, Bradley S.; Soong, Lynn; Stevenson, Heather L.; McGee, Charles E.; Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA; [Soong, Lynn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Coffey, Lark L.] Inst Pasteur, Dept Virol, Viral Populat & Pathogenesis Grp, Paris, France	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schneider, BS (corresponding author), GVFI, San Francisco, CA USA.	sthiggs@UTMB.EDU		Coffey, Lark/0000-0002-0718-5146; Stevenson, Heather/0000-0002-0645-7621; Schneider, Bradley S/0000-0001-7642-0018	Centers for Disease Control Fellowship in Vector-Borne Infectious Diseases [T01/CCT622892]; National Institutes of Health [R01AI47246, AI47246]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047246] Funding Source: NIH RePORTER	Centers for Disease Control Fellowship in Vector-Borne Infectious Diseases; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	BSS, CEM, and HLS were supported by the Centers for Disease Control Fellowship in Vector-Borne Infectious Diseases T01/CCT622892. This research was supported by the National Institutes of Health grant number R01AI47246 and, in part, by the National Institutes of Health grant number AI47246 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2001, MOL MED, V7, P11, DOI 10.1007/BF03401834; Agrati C, 2001, AIDS RES HUM RETROV, V17, P1357, DOI 10.1089/08892220152596614; ANJILI CO, 1995, ACTA TROP, V60, P97, DOI 10.1016/0001-706X(95)00112-R; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; BenNathan D, 1996, ARCH VIROL, V141, P459, DOI 10.1007/BF01718310; Bishop JV, 2006, AM J TROP MED HYG, V75, P532, DOI 10.4269/ajtmh.2006.75.532; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x; CHAMBERS TJ, 2003, FLAVIVIRUSES PATHOGE; Chaturvedi UC, 1999, J MED VIROL, V59, P335, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;335::AID-JMV13&gt;3.0.CO;2-E; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Grisham MB, 1998, FREE RADICAL BIO MED, V25, P404, DOI 10.1016/S0891-5849(98)00094-X; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; HAAHR S, 1971, ARCH GES VIRUSFORSCH, V35, P1, DOI 10.1007/BF01249747; Hajnicka V, 2000, PARASITE IMMUNOL, V22, P201, DOI 10.1046/j.1365-3024.2000.00296.x; Higgs S, 2005, P NATL ACAD SCI USA, V102, P8871, DOI 10.1073/pnas.0503835102; Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x; Kenneth KR, 1998, J BIOL CHEM, V273, P20802, DOI 10.1074/jbc.273.33.20802; Kopecky J, 1999, PARASITE IMMUNOL, V21, P351, DOI 10.1046/j.1365-3024.1999.00233.x; Kuthejlova M, 2001, INFECT IMMUN, V69, P575, DOI 10.1128/IAI.69.1.575-578.2001; Limesand KH, 2003, J MED ENTOMOL, V40, P199, DOI 10.1603/0022-2585-40.2.199; Lin YL, 1997, J VIROL, V71, P5227, DOI 10.1128/JVI.71.7.5227-5235.1997; Lobigs M, 2003, VACCINE, V21, P1572, DOI 10.1016/S0264-410X(02)00743-0; Macaluso KR, 2001, ANN TROP MED PARASIT, V95, P413, DOI 10.1080/00034980120059081; MARLETTA MA, 1994, J MED CHEM, V37, P1899, DOI 10.1021/jm00039a001; Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008; Maxwell SS, 2005, ANN TROP MED PARASIT, V99, P661, DOI 10.1179/136485905X51490; McGee CE, 2007, AM J TROP MED HYG, V76, P424, DOI 10.4269/ajtmh.2007.76.424; Montgomery RR, 2004, INFECT IMMUN, V72, P2989, DOI 10.1128/IAI.72.5.2989-2994.2004; OFLAHERTY JT, 1994, LAB INVEST, V70, P816; Owhashi M, 2001, PARASITOL RES, V87, P376, DOI 10.1007/s004360000355; Pacsa AS, 2000, FEMS IMMUNOL MED MIC, V28, P151, DOI 10.1111/j.1574-695X.2000.tb01470.x; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Rakasz E, 1999, IMMUNOL LETT, V70, P89, DOI 10.1016/S0165-2478(99)00132-7; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Sanabria MXH, 2008, INFECT IMMUN, V76, P5100, DOI 10.1128/IAI.00438-08; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Soares MBP, 1998, J IMMUNOL, V160, P1811; Styer LM, 2006, AM J TROP MED HYG, V75, P337, DOI 10.4269/ajtmh.2006.75.337; Takhampunya R, 2006, J GEN VIROL, V87, P3003, DOI 10.1099/vir.0.81880-0; TAYLOR JL, 1980, J INFECT DIS, V142, P394, DOI 10.1093/infdis/142.3.394; THEODOS CM, 1993, PARASITE IMMUNOL, V15, P481, DOI 10.1111/j.1365-3024.1993.tb00634.x; Thomson SA, 1998, J IMMUNOL, V160, P1717; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; VARGIN VV, 1977, ACTA VIROL, V21, P114; Waitumbi J, 1998, INFECT IMMUN, V66, P1534, DOI 10.1128/IAI.66.4.1534-1537.1998; Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x; WANG L-Y, 1975, Chinese Journal of Microbiology, V8, P274; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; Zeidner NS, 1999, PARASITE IMMUNOL, V21, P35, DOI 10.1046/j.1365-3024.1999.00199.x; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	64	61	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11704	10.1371/journal.pone.0011704	http://dx.doi.org/10.1371/journal.pone.0011704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661470	gold, Green Published, Green Submitted			2022-12-25	WOS:000280243300010
J	Schulke, JP; Wochnik, GM; Lang-Rollin, I; Gassen, NC; Knapp, RT; Berning, B; Yassouridis, A; Rein, T				Schuelke, Jan-Philip; Wochnik, Gabriela Monika; Lang-Rollin, Isabelle; Gassen, Nils Christian; Knapp, Regina Theresia; Berning, Barbara; Yassouridis, Alexander; Rein, Theo			Differential Impact of Tetratricopeptide Repeat Proteins on the Steroid Hormone Receptors	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; FK506-BINDING IMMUNOPHILIN FKBP51; GLUCOCORTICOID-RECEPTOR; MOLECULAR CHAPERONES; NEGATIVE REGULATOR; SQUIRREL-MONKEY; CYCLOSPORINE-A; TPR DOMAINS; HSP90; BINDING	Background: Tetratricopeptide repeat (TPR) motif containing co-chaperones of the chaperone Hsp90 are considered control modules that govern activity and specificity of this central folding platform. Steroid receptors are paradigm clients of Hsp90. The influence of some TPR proteins on selected receptors has been described, but a comprehensive analysis of the effects of TPR proteins on all steroid receptors has not been accomplished yet. Methodology and Principal Findings: We compared the influence of the TPR proteins FK506 binding proteins 51 and 52, protein phosphatase-5, C-terminus of Hsp70 interacting protein, cyclophillin 40, hepatitis-virus-B X-associated protein-2, and tetratricopeptide repeat protein-2 on all six steroid hormone receptors in a homogeneous mammalian cell system. To be able to assess each cofactor's effect on the transcriptional activity of on each steroid receptor we employed transient transfection in a reporter gene assay. In addition, we evaluated the interactions of the TPR proteins with the receptors and components of the Hsp90 chaperone heterocomplex by coimmunoprecipitation. In the functional assays, corticosteroid and progesterone receptors displayed the most sensitive and distinct reaction to the TPR proteins. Androgen receptor's activity was moderately impaired by most cofactors, whereas the Estrogen receptors' activity was impaired by most cofactors only to a minor degree. Second, interaction studies revealed that the strongly receptor-interacting co-chaperones were all among the inhibitory proteins. Intriguingly, the TPR-proteins also differentially coprecipitated the heterochaperone complex components Hsp90, Hsp70, and p23, pointing to differences in their modes of action. Conclusion and Significance: The results of this comprehensive study provide important insight into chaperoning of diverse client proteins via the combinatorial action of (co)-chaperones. The differential effects of the TPR proteins on steroid receptors bear on all physiological processes related to steroid hormone activity.	[Schuelke, Jan-Philip; Wochnik, Gabriela Monika; Lang-Rollin, Isabelle; Gassen, Nils Christian; Knapp, Regina Theresia; Berning, Barbara; Rein, Theo] Max Planck Inst Psychiat, Chaperone Res Grp, Munich, Germany; [Yassouridis, Alexander] Max Planck Inst Psychiat, Biostat Grp, D-80804 Munich, Germany	Max Planck Society; Max Planck Society	Schulke, JP (corresponding author), Max Planck Inst Psychiat, Chaperone Res Grp, Munich, Germany.	theorein@mpipsykl.mpg.de		Rein, Theo/0000-0003-2850-4289	Max Planck Institute of Psychiatry	Max Planck Institute of Psychiatry(Max Planck Society)	The research was financed by the Max Planck Institute of Psychiatry. Therefore, no funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GA, 2002, MOL ENDOCRINOL, V16, P1352, DOI 10.1210/me.16.6.1352; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BINART N, 1995, BIOCHEM J, V311, P797, DOI 10.1042/bj3110797; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chadli A, 2008, BIOCHEMISTRY-US, V47, P2850, DOI 10.1021/bi7023332; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Clark CB, 2009, FREE RADICAL BIO MED, V47, P1440, DOI 10.1016/j.freeradbiomed.2009.08.012; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Froidevaux MSC, 2006, EMBO REP, V7, P1035, DOI 10.1038/sj.embor.7400778; Fukuyo Y, 2008, CANCER RES, V68, P6324, DOI 10.1158/0008-5472.CAN-07-6602; Gallo LI, 2007, BIOCHEMISTRY-US, V46, P14044, DOI 10.1021/bi701372c; Gougelet A, 2005, J STEROID BIOCHEM, V94, P71, DOI 10.1016/j.jsbmb.2005.01.018; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Herr AS, 2000, MOL PHARMACOL, V57, P732, DOI 10.1124/mol.57.4.732; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Ikeda K, 2004, MOL ENDOCRINOL, V18, P1131, DOI 10.1210/me.2003-0308; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Katzenellenbogen JA, 1996, MOL ENDOCRINOL, V10, P119, DOI 10.1210/me.10.2.119; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kirchheiner J, 2008, PHARMACOGENOMICS, V9, P841, DOI 10.2217/14622416.9.7.841; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lekman M, 2008, BIOL PSYCHIAT, V63, P1103, DOI 10.1016/j.biopsych.2007.10.026; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Moffatt NSC, 2008, BIOCHEMISTRY-US, V47, P8203, DOI 10.1021/bi800770g; Moosmann B, 1999, P NATL ACAD SCI USA, V96, P8867, DOI 10.1073/pnas.96.16.8867; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Periyasamy S, 2010, ONCOGENE, V29, P1691, DOI 10.1038/onc.2009.458; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; RENOIR JM, 1995, P NATL ACAD SCI USA, V92, P4977, DOI 10.1073/pnas.92.11.4977; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Rosenhagen MC, 2003, MOL ENDOCRINOL, V17, P1991, DOI 10.1210/me.2003-0141; Rosenhagen MC, 2001, BIOL CHEM, V382, P499, DOI 10.1515/BC.2001.063; Ruegg J, 2004, MOL CELL BIOL, V24, P9371, DOI 10.1128/MCB.24.21.9371-9382.2004; Samuni Y, 2010, FREE RADICAL BIO MED, V48, P1559, DOI 10.1016/j.freeradbiomed.2010.03.001; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Suuronen T, 2008, NEUROCHEM RES, V33, P1768, DOI 10.1007/s11064-008-9622-z; Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Warth R, 1997, BIOL CHEM, V378, P381, DOI 10.1515/bchm.1997.378.5.381; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; WILLOUR VL, 2008, MOL PSYCHIAT; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wochnik GM, 2004, FEBS LETT, V560, P35, DOI 10.1016/S0014-5793(04)00066-3; Wolf IM, 2009, J STEROID BIOCHEM, V113, P36, DOI 10.1016/j.jsbmb.2008.11.006; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e	94	77	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11717	10.1371/journal.pone.0011717	http://dx.doi.org/10.1371/journal.pone.0011717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661446	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300019
J	Bekeredjian, R; Walton, CB; MacCannell, KA; Ecker, J; Kruse, F; Outten, JT; Sutcliffe, D; Gerard, RD; Bruick, RK; Shohet, RV				Bekeredjian, Raffi; Walton, Chad B.; MacCannell, Keith A.; Ecker, Jennifer; Kruse, Fred; Outten, Joel T.; Sutcliffe, David; Gerard, Robert D.; Bruick, Richard K.; Shohet, Ralph V.			Conditional HIF-1 alpha Expression Produces a Reversible Cardiomyopathy	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; LACTATE-DEHYDROGENASE; PROLYL HYDROXYLATION; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; BINDING-SITES; HIF-ALPHA; COMPLEX	Background: The response to hypoxia in tissues is regulated by the heterodimeric transcription factor Hypoxia Inducible Factor-1 (HIF-1). Methodology/Principal Findings: We have created a strain of mice with inducible cardiomyocyte-specific expression of a mutated, oxygen-stable, form of HIF-1 alpha. Cardiac function steadily decreased with transgene expression, but recovered after the transgene was turned off. Using long-oligo microarrays, we identified 162 transcripts more than 3-fold dysregulated in these hearts after transgene expression. Among the down-regulated genes the transcript for SERCA was reduced 46% and the protein 92%. This led us to an evaluation of calcium flux that showed diminished reuptake of cytoplasmic calcium in myocytes from these hearts, suggesting a mechanism for cardiac dysfunction. Conclusions/Significance: These results provide a deeper understanding of transcriptional activity of HIF in the heart, and show that enhanced HIF-1 activity is sufficient to cause contractile dysfunction in the adult heart. HIF is stabilized in the myocardium of patients with ischemic cardiomyopathy, and our results suggest that HIF could be contributing directly to the contractile dysfunction in this disease.	[Walton, Chad B.; MacCannell, Keith A.; Ecker, Jennifer; Outten, Joel T.; Shohet, Ralph V.] Univ Hawaii, Dept Med, Honolulu, HI 96822 USA; [Bekeredjian, Raffi] Univ Heidelberg, Dept Cardiol, D-6900 Heidelberg, Germany; [Kruse, Fred; Sutcliffe, David; Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA	University of Hawaii System; Ruprecht Karls University Heidelberg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bekeredjian, R (corresponding author), Univ Heidelberg, Dept Cardiol, Bergheimer Str 58, D-6900 Heidelberg, Germany.	shohet@hawaii.edu			National Heart, Lung and Blood Institute [HL080532, HL073449]; National Center for Research Resources [RR16453]; American Heart Association; Bundesministerium Bildung und Forschung, Germany; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080532, UH1HL073449] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); Bundesministerium Bildung und Forschung, Germany; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant support has included: National Heart, Lung and Blood Institute HL080532, National Heart, Lung and Blood Institute HL073449, National Center for Research Resources RR16453, and an American Heart Association National Grant-in Aid Award (to RVS). Dr. Raffi Bekeredijan was funded by a Postdoctoral Research Fellowship Grant of the American Heart Association and is presently funded by the BioFuture grant of the Bundesministerium Bildung und Forschung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hernandez-Pampaloni M, 2005, EUR J NUCL MED MOL I, V32, P314, DOI 10.1007/s00259-004-1682-y; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Le Cras TD, 2004, AM J PHYSIOL-LUNG C, V287, pL134, DOI 10.1152/ajplung.00050.2004; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Tsuji T, 2009, AM J PHYSIOL-HEART C, V296, pH310, DOI 10.1152/ajpheart.00975.2008; Vahlhaus C, 2005, J CARDIAC SURG, V20, P412, DOI 10.1111/j.1540-8191.2005.2004107.x; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	38	94	99	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11693	10.1371/journal.pone.0011693	http://dx.doi.org/10.1371/journal.pone.0011693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657781	Green Published, gold, Green Submitted			2022-12-25	WOS:000280197500031
J	Xue, Q; Jenkins, SA; Gu, CF; Smeds, E; Liu, Q; Vasan, R; Russell, BH; Xu, Y				Xue, Qiong; Jenkins, Sarah A.; Gu, Chunfang; Smeds, Emanuel; Liu, Qing; Vasan, Ranga; Russell, Brooke H.; Xu, Yi			Bacillus anthracis Spore Entry into Epithelial Cells Is an Actin-Dependent Process Requiring c-Src and PI3K	PLOS ONE			English	Article							INTERNALIZATION; PROTEIN; MACROPHAGES; INHIBITION; FATE	Dissemination of Bacillus anthracis from the respiratory mucosa is a critical step in the establishment of inhalational anthrax. Recent in vitro and in vivo studies indicated that this organism was able to penetrate the lung epithelium by directly entering into epithelial cells of the lung; however the molecular details of B. anthracis breaching the epithelium were lacking. Here, using a combination of pharmacological inhibitors, dominant negative mutants, and colocalization experiments, we demonstrated that internalization of spores by epithelial cells was actin-dependent and was mediated by the Rho-family GTPase Cdc42 but not RhoA or Rac1. Phosphatidylinositol 3-kinase (PI3K) activity was also required as indicated by the inhibitory effects of PI3K inhibitors, wortmannin and LY294002, and a PI3K dominant negative (DN) mutant Delta p85 alpha. In addition, spore entry into epithelial cells (but not into macrophages) required the activity of Src as indicated by the inhibitory effect of Src family kinase (SFK) inhibitors, PP2 and SU6656, and specific siRNA knockdown of Src. Enrichment of PI3K and F-actin around spore attachment sites was observed and was significantly reduced by treatment with SFK and PI3K inhibitors, respectively. Moreover, B. anthracis translocation through cultured lung epithelial cells was significantly impaired by SFK inhibitors, suggesting that this signaling pathway is important for bacterial dissemination. The effect of the inhibitor on dissemination in vivo was then evaluated. SU6656 treatment of mice significantly reduced B. anthracis dissemination from the lung to distal organs and prolonged the median survival time of mice compared to the untreated control group. Together these results described a signaling pathway specifically required for spore entry into epithelial cells and provided evidence suggesting that this pathway is important for dissemination and virulence in vivo.	[Xue, Qiong; Gu, Chunfang; Smeds, Emanuel; Vasan, Ranga; Russell, Brooke H.; Xu, Yi] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX USA; [Jenkins, Sarah A.] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Liu, Qing] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Xue, Q (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX USA.	yxu@ibt.tamhsc.edu			National Institutes of Health (NIH) [AI061555, AI082306]; Region VI center for Biodefense and Emerging Infections [U54 AI057156]; Texas A&M Health Science Center (TAMHSC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082306, R21AI061555, U54AI057156] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region VI center for Biodefense and Emerging Infections; Texas A&M Health Science Center (TAMHSC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI061555 and AI082306 (http://www.niaid.nih.gov) to Y. Xu, a career development award from Region VI center for Biodefense and Emerging Infections (U54 AI057156 to D. Walker)(http://www.niaid.nih.gov), and start-up funds from Texas A&M Health Science Center (TAMHSC) (http://www.tamhsc.edu) to Y. Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett EG, 1998, AM J PHYSIOL-LUNG C, V275, pL1110, DOI 10.1152/ajplung.1998.275.6.L1110; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Chakrabarty K, 2007, INFECT IMMUN, V75, P3729, DOI 10.1128/IAI.00046-07; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Evans SE, 2010, AM J RESP CELL MOL, V42, P40, DOI 10.1165/rcmb.2008-0260OC; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; GLASSMAN HN, 1966, BACTERIOL REV, V30, P657, DOI 10.1128/MMBR.30.3.657-659.1966; Glomski IJ, 2007, J IMMUNOL, V178, P2646, DOI 10.4049/jimmunol.178.5.2646; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; HENDERSON D. W., 1956, JOUR HYG, V54, P28; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Kang TJ, 2005, INFECT IMMUN, V73, P7495, DOI 10.1128/IAI.73.11.7495-7501.2005; Oliva C, 2009, P NATL ACAD SCI USA, V106, P13957, DOI 10.1073/pnas.0902392106; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; Russell BH, 2008, INFECT IMMUN, V76, P3975, DOI 10.1128/IAI.00282-08; Russell BH, 2008, CELL MICROBIOL, V10, P945, DOI 10.1111/j.1462-5822.2007.01098.x; Russell BH, 2007, CELL MICROBIOL, V9, P1262, DOI 10.1111/j.1462-5822.2006.00869.x; Severgnini M, 2005, AM J RESP CRIT CARE, V171, P858, DOI 10.1164/rccm.200407-981OC; Tanaka M, 1999, BIOCHEM BIOPH RES CO, V255, P169, DOI 10.1006/bbrc.1999.0162; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Vietri NJ, 2006, P NATL ACAD SCI USA, V103, P7813, DOI 10.1073/pnas.0602748103; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Welkos S, 2002, J MED MICROBIOL, V51, P821, DOI 10.1099/0022-1317-51-10-821; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11665	10.1371/journal.pone.0011665	http://dx.doi.org/10.1371/journal.pone.0011665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652027	Green Published, Green Submitted, gold			2022-12-25	WOS:000280109700003
J	Shan, B; Hagood, JS; Zhuo, Y; Nguyen, HT; MacEwen, M; Morris, GF; Lasky, JA				Shan, Bin; Hagood, James S.; Zhuo, Ying; Nguyen, Hong T.; MacEwen, Mark; Morris, Gilbert F.; Lasky, Joseph A.			Thy-1 Attenuates TNF-alpha-Activated Gene Expression in Mouse Embryonic Fibroblasts via Src Family Kinase	PLOS ONE			English	Article							NECROSIS FACTOR-ALPHA; LUNG FIBROBLASTS; GROWTH-FACTOR; DIFFERENTIAL EXPRESSION; TYROSINE PHOSPHORYLATION; EPITHELIAL-CELLS; ADHESION; SUBPOPULATIONS; MIGRATION; BINDING	Heterogeneous surface expression of Thy-1 in fibroblasts modulates inflammation and may thereby modulate injury and repair. As a paradigm, patients with idiopathic pulmonary fibrosis, a disease with pathologic features of chronic inflammation, demonstrate an absence of Thy-1 immunoreactivity within areas of fibrotic activity (fibroblast foci) in contrast to the predominant Thy-1 expressing fibroblasts in the normal lung. Likewise, Thy-1 deficient mice display more severe lung fibrosis in response to an inflammatory injury than wildtype littermates. We investigated the role of Thy-1 in the response of fibroblasts to the pro-inflammatory cytokine TNF-alpha. Our study demonstrates distinct profiles of TNF-alpha-activated gene expression in Thy-1 positive (Thy-1+) and negative (Thy-12) subsets of mouse embryonic fibroblasts (MEF). TNF-alpha induced a robust activation of MMP-9, ICAM-1, and the IL-8 promoter driven reporter in Thy-12 MEFs, in contrast to only a modest increase in Thy-1+ counterparts. Consistently, ectopic expression of Thy-1 in Thy-12 MEFs significantly attenuated TNF-alpha-activated gene expression. Mechanistically, TNF-alpha activated Src family kinase (SFK) only in Thy-12 MEFs. Blockade of SFK activation abrogated TNF-alpha-activated gene expression in Thy-12 MEFs, whereas restoration of SFK activation rescued the TNF-alpha response in Thy-1+ MEFs. Our findings suggest that Thy-1 down-regulates TNF-alpha-activated gene expression via interfering with SFK-and NF-kappa B-mediated transactivation. The current study provides a novel mechanistic insight to the distinct roles of fibroblast Thy-1 subsets in inflammation.	[Shan, Bin; Zhuo, Ying; Nguyen, Hong T.; Lasky, Joseph A.] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Hagood, James S.; MacEwen, Mark] Univ Alabama, Sch Med, Dept Pediat, Birmingham, AL USA; [Morris, Gilbert F.] Tulane Univ, Dept Pathol, Hlth Sci Ctr, New Orleans, LA 70118 USA	Tulane University; University of Alabama System; University of Alabama Birmingham; Tulane University	Shan, B (corresponding author), Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA.	jlasky@tulane.edu		Shan, Bin/0000-0002-6869-2678	National Institutes of Health (NIH) [ES010046, HL063778, HL083480, HL065348, T32HL007973]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065348, R01HL083480, T32HL007973, R01HL082818, R01HL063778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010046] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by National Institutes of Health (NIH) grants ES010046, HL063778, and HL083480 awarded to J. A. L., and by HL065348, to J. S. H.; B. S. was supported by an NIH postdoctoral training grant T32HL007973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker TH, 2004, J BIOL CHEM, V279, P23510, DOI 10.1074/jbc.M402169200; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Borrello MA, 1996, CELL IMMUNOL, V173, P198, DOI 10.1006/cimm.1996.0268; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Fiedler MA, 1998, AM J RESP CELL MOL, V19, P259, DOI 10.1165/ajrcmb.19.2.3149; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Hagood JS, 2002, AM J RESP CELL MOL, V26, P702, DOI 10.1165/ajrcmb.26.6.4547; Hagood JS, 2001, CHEST, V120, p64S, DOI 10.1378/chest.120.1_suppl.S64; Hagood JS, 1999, AM J PHYSIOL-LUNG C, V277, pL218, DOI 10.1152/ajplung.1999.277.1.L218; HE HT, 1991, J EXP MED, V173, P515, DOI 10.1084/jem.173.2.515; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Hueber AO, 1997, CURR BIOL, V7, P705, DOI 10.1016/S0960-9822(06)00300-9; Koumas L, 2002, AM J PHYSIOL-CELL PH, V283, pC599, DOI 10.1152/ajpcell.00065.2002; Koumas L, 2002, EUR J IMMUNOL, V32, P477, DOI 10.1002/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U; MCINTOSH JC, 1994, EUR RESPIR J, V7, P2131, DOI 10.1183/09031936.94.07122131; PHIPPS RP, 1990, EUR J IMMUNOL, V20, P1723, DOI 10.1002/eji.1830200815; Phipps RP, 1997, J PERIODONTAL RES, V32, P159, DOI 10.1111/j.1600-0765.1997.tb01398.x; PHIPPS RP, 1989, AM J RESP CELL MOL, V1, P65, DOI 10.1165/ajrcmb/1.1.65; Rege TA, 2006, EXP CELL RES, V312, P3752, DOI 10.1016/j.yexcr.2006.07.029; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Saouaf SJ, 1997, BIOCHEM BIOPH RES CO, V234, P325, DOI 10.1006/bbrc.1997.6638; Shan B, 2005, J BIOL CHEM, V280, P1103, DOI 10.1074/jbc.M406293200; Shan B, 2005, EXP CELL RES, V305, P10, DOI 10.1016/j.yexcr.2004.09.033; Shan B, 2007, J MOL CELL CARDIOL, V42, P517, DOI 10.1016/j.yjmcc.2006.08.004; Smith TJ, 1997, ENDOCRINOLOGY, V138, P5576, DOI 10.1210/en.138.12.5576; Sumida A, 2008, ARCH MED RES, V39, P503, DOI 10.1016/j.arcmed.2008.02.005; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; Tagoe CE, 2008, J IMMUNOL, V181, P2813, DOI 10.4049/jimmunol.181.4.2813; Wu GD, 1997, J BIOL CHEM, V272, P2396; Wu SS, 2005, CELL SIGNAL, V17, P93, DOI 10.1016/j.cellsig.2004.06.001; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5	35	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11662	10.1371/journal.pone.0011662	http://dx.doi.org/10.1371/journal.pone.0011662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657842	gold, Green Submitted, Green Published			2022-12-25	WOS:000280065600020
J	Sherrid, AM; Rustad, TR; Cangelosi, GA; Sherman, DR				Sherrid, Ashley M.; Rustad, Tige R.; Cangelosi, Gerard A.; Sherman, David R.			Characterization of a Clp Protease Gene Regulator and the Reaeration Response in Mycobacterium tuberculosis	PLOS ONE			English	Article							LOW-OXYGEN TENSION; HYPOXIC RESPONSE; TRANSCRIPTIONAL-ACTIVATOR; SWISS-MODEL; EXPRESSION; CLGR; RESUSCITATION; BIOSYNTHESIS; MACROPHAGES; ADAPTATION	Mycobacterium tuberculosis (MTB) enters a non-replicating state when exposed to low oxygen tension, a condition the bacillus encounters in granulomas during infection. Determining how mycobacteria enter and maintain this state is a major focus of research. However, from a public health standpoint the importance of latent TB is its ability to reactivate. The mechanism by which mycobacteria return to a replicating state upon re-exposure to favorable conditions is not understood. In this study, we utilized reaeration from a defined hypoxia model to characterize the adaptive response of MTB following a return to favorable growth conditions. Global transcriptional analysis identified the similar to 100 gene Reaeration Response, induced relative to both log-phase and hypoxic MTB. This response includes chaperones and proteases, as well as the transcription factor Rv2745c, which we characterize as a Clp protease gene regulator (ClgR) orthologue. During reaeration, genes repressed during hypoxia are also upregulated in a wave of transcription that includes genes crucial to transcription, translation and oxidative phosphorylation and culminates in bacterial replication. In sum, this study defines a new transcriptional response of MTB with potential relevance to disease, and implicates ClgR as a regulator involved in resumption of replication following hypoxia.	[Sherrid, Ashley M.; Rustad, Tige R.; Cangelosi, Gerard A.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sherrid, Ashley M.] Univ Washington, Mol & Cellular Grad Program, Seattle, WA 98195 USA; [Cangelosi, Gerard A.; Sherman, David R.] Univ Washington, Pathobiol Program, Seattle, WA 98195 USA; [Cangelosi, Gerard A.; Sherman, David R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sherrid, AM (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@seattlebiomed.org			Paul G. Allen Family Foundation [8999]; Akibene Foundation	Paul G. Allen Family Foundation; Akibene Foundation	This work was supported by funding from the Paul G. Allen Family Foundation (grant #8999) and the Akibene Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bellier A, 2006, MICROBIOL-SGM, V152, P1021, DOI 10.1099/mic.0.28564-0; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; CRECYLAGARD V, 1999, MOL MICROBIOL, V32, P505; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Dawes SS, 2003, INFECT IMMUN, V71, P6124, DOI 10.1128/IAI.71.11.6124-6131.2003; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; GEDDEDAHL T, 1952, AM J HYG, V56, P139, DOI 10.1093/oxfordjournals.aje.a119547; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; HAAPANEN JH, 1959, AM REV RESPIR DIS, V80, P1; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Marks GB, 2000, AM J RESP CRIT CARE, V162, P1851, DOI 10.1164/ajrccm.162.5.2004154; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Novy FG, 1925, J INFECT DIS, V36, P168, DOI 10.1093/infdis/36.2.168; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rich AR, 1942, B JOHNS HOPKINS HOSP, V71, P345; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Russo S, 2009, J BIOL CHEM, V284, P5208, DOI 10.1074/jbc.M806591200; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Tufariello JM, 2006, INFECT IMMUN, V74, P2985, DOI 10.1128/IAI.74.5.2985-2995.2006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wayne L. G., 1998, Tubercle and Lung Disease, V79, P127, DOI 10.1054/tuld.1998.0015; WAYNE LG, 1977, INFECT IMMUN, V17, P528, DOI 10.1128/IAI.17.3.528-530.1977; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; World Health Organization, 2009, GLOB TUB CONTR EP ST	56	54	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11622	10.1371/journal.pone.0011622	http://dx.doi.org/10.1371/journal.pone.0011622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661284	Green Published, gold, Green Submitted			2022-12-25	WOS:000279980800011
J	Al-Jamal, KT; Toma, FM; Yilmazer, A; Ali-Boucetta, H; Nunes, A; Herrero, MA; Tian, BW; Eddaoui, A; Al-Jamal, WT; Bianco, A; Prato, M; Kostarelos, K				Al-Jamal, Khuloud T.; Toma, Francesca M.; Yilmazer, Acelya; Ali-Boucetta, Hanene; Nunes, Antonio; Herrero, Maria-Antonia; Tian, Bowen; Eddaoui, Ayad; Al-Jamal, Wafa' T.; Bianco, Alberto; Prato, Maurizio; Kostarelos, Kostas			Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes	FASEB JOURNAL			English	Article						RNA interference; gene transfer; knockdown; nanotechnology; nonviral	SMALL INTERFERING RNA; INTRACELLULAR DELIVERY; PLASMID DNA; SIRNA; TRANSPORTERS; APOPTOSIS; FUNCTIONALIZATION; NANOMATERIALS; CYTOTOXICITY; BINDING	One of the major obstacles to the clinical development of gene silencing by small interfering RNA (siRNA) is its effective cytoplasmic delivery. Carbon nanotubes have been proposed as novel nanomaterials that can offer significant advantages for the intracellular delivery of nucleic acids, such as siRNA. We recently demonstrated in a proof-of-principle study that amino-functionalized multiwalled carbon nanotubes (f-MWNT) can effectively deliver in vivo an siRNA sequence, triggering cell apoptosis that results in human lung xenograft eradication and prolonged survival. In the present study, we demonstrate how a newly synthesized series of polycationic dendron-MWNT constructs with a precisely tailored number of amino functions (dendron generations) can complex and effectively deliver double-stranded siRNA to achieve gene silencing in vitro. A systematic comparison between the f-MWNT series in terms of cellular uptake, cytotoxicity, and siRNA complexation is offered. Significant improvement in siRNA delivery with the dendron-MWNT conjugates is shown, and gene silencing was obtained in 2 human cell lines using 2 different siRNA sequences. The study reveals that through f-MWNT structure-biological function analysis novel nanotube-based siRNA transfer vectors can be designed with minimal cytotoxicity and effective delivery and gene-silencing capabilities.-Al-Jamal, K. T., Toma, F. M., Yilmazer, A., Ali-Boucetta, H., Nunes, A., Herrero, M.-A., Tian, B., Eddaoui, A., Al-Jamal, W. T., Bianco, A., Prato, M., Kostarelos, K. Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes. FASEB J. 24, 4354-4365 (2010). www.fasebj.org	[Al-Jamal, Khuloud T.; Yilmazer, Acelya; Ali-Boucetta, Hanene; Nunes, Antonio; Tian, Bowen; Al-Jamal, Wafa' T.; Kostarelos, Kostas] Univ London, Nanomed Lab, Ctr Drug Delivery Res, Sch Pharm, London WC1N 1AX, England; [Toma, Francesca M.; Herrero, Maria-Antonia; Prato, Maurizio] Univ Trieste, Ctr Excellence Nanostruct Mat, Dept Pharmaceut Sci, I-34127 Trieste, Italy; [Herrero, Maria-Antonia] Univ Castilla La Mancha, Dept Quim Organ, Fac Quim, E-13071 Ciudad Real, Spain; [Eddaoui, Ayad] UCL, Flow Cytometry Core Facil, Inst Child Hlth, London, England; [Bianco, Alberto] CNRS, Inst Biol Mol & Cellulaire, UPR Immunol & Chim Therapeut 9021, F-67000 Strasbourg, France	University of London; University College London; University of London School of Pharmacy; University of Trieste; Universidad de Castilla-La Mancha; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kostarelos, K (corresponding author), Univ London, Nanomed Lab, Ctr Drug Delivery Res, Sch Pharm, London WC1N 1AX, England.	a.bianco@ibmc-cnrs.unistra.fr; prato@units.it; kostas.kostarelos@pharmacy.ac.uk	Kostarelos, Kostas/AAP-6879-2021; herrero, Maria Antonia/I-4245-2014; Yilmazer, Acelya/L-4562-2013; Al-Jamal, Khuloud/ABD-5668-2021; Toma, Francesca/AAH-4991-2021; Herrero, Maria Antonia/ABC-3466-2020; Ali-Boucetta, Hanene/AAW-4390-2020; Prato, Maurizio/G-7067-2012; Toma, Francesca Maria/AAH-6326-2021	Kostarelos, Kostas/0000-0002-2224-6672; herrero, Maria Antonia/0000-0002-8860-9325; Yilmazer, Acelya/0000-0003-2712-7450; Herrero, Maria Antonia/0000-0002-8860-9325; Ali-Boucetta, Hanene/0000-0002-5175-5716; Prato, Maurizio/0000-0002-8869-8612; Toma, Francesca Maria/0000-0003-2332-0798; AL-JAMAL, KHULOUD/0000-0001-5165-2699; Eddaoudi, Ayad/0000-0001-5272-6426; Nunes, Antonio/0000-0002-9014-9030	University of Trieste; Italian Ministry of Education MUR [2006034372, RBIN04HC3S]; Regione Friuli Venezia-Giulia; School of Pharmacy, University of London; CNRS; Agence Nationale de la Recherche [ANR-05-JCJC-0031-01]; European Union [NMP4-CT-2006-031847, NMP4-CT-2006-033378, HEALTH-2007-201587]; Junta de Comunidades de Castilla la Mancha (Spain)	University of Trieste; Italian Ministry of Education MUR(Ministry of Education, Universities and Research (MIUR)); Regione Friuli Venezia-Giulia(Regione Friuli Venezia Giulia); School of Pharmacy, University of London; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission); Junta de Comunidades de Castilla la Mancha (Spain)(Junta de Comunidades de Castilla-La Mancha)	This work was supported by the University of Trieste; Italian Ministry of Education MUR (cofin Prot. 2006034372 and Firb RBIN04HC3S); Regione Friuli Venezia-Giulia; The School of Pharmacy, University of London; CNRS; and Agence Nationale de la Recherche (grant ANR-05-JCJC-0031-01). Partial support is also acknowledged by the European Union FP6 NEURONANO (NMP4-CT-2006-031847), NINIVE (NMP4-CT-2006-033378) and FP7 ANTICARB (HEALTH-2007-201587) programs. M.A.H. acknowledges support by the Junta de Comunidades de Castilla la Mancha (Spain) for the award of a postdoctoral fellowship.	Ali-Boucetta H, 2008, CHEM COMMUN, P459, DOI 10.1039/b712350g; Herrero MA, 2009, J AM CHEM SOC, V131, P9843, DOI 10.1021/ja903316z; Becker ML, 2007, ADV MATER, V19, P939, DOI 10.1002/adma.200602667; Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.005; Bianco A, 2008, EXPERT OPIN DRUG DEL, V5, P331, DOI 10.1517/17425247.5.3.331 ; Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020; Cai D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/34/345102; Campidelli S, 2006, J AM CHEM SOC, V128, P12544, DOI 10.1021/ja063697i; Chen JY, 2008, J AM CHEM SOC, V130, P16778, DOI 10.1021/ja805570f; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; DIVE C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P275, DOI 10.1016/0167-4889(92)90048-G; Gao LZ, 2006, CHEMBIOCHEM, V7, P239, DOI 10.1002/cbic.200500227; Hampel S, 2008, NANOMEDICINE-UK, V3, P175, DOI 10.2217/17435889.3.2.175; Herzog E, 2007, TOXICOL LETT, V174, P49, DOI 10.1016/j.toxlet.2007.08.009; Isobe H, 2006, ANGEW CHEM INT EDIT, V45, P6676, DOI 10.1002/anie.200601718; Jevprasesphant R, 2003, INT J PHARM, V252, P263, DOI 10.1016/S0378-5173(02)00623-3; Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v; Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k; Kang B, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/37/375103; Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Krajcik R, 2008, BIOCHEM BIOPH RES CO, V369, P595, DOI 10.1016/j.bbrc.2008.02.072; Lacerda L, 2007, NANO TODAY, V2, P38, DOI 10.1016/S1748-0132(07)70172-X; Lacerda L, 2007, ADV MATER, V19, P1480, DOI 10.1002/adma.200601412; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; Lanner JT, 2009, FASEB J, V23, P1728, DOI 10.1096/fj.08-116814; Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4782, DOI 10.1002/anie.200500042; Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468; Liu Z, 2007, ANGEW CHEM INT EDIT, V46, P2023, DOI 10.1002/anie.200604295; Monteiro-Riviere NA, 2009, TOXICOL APPL PHARM, V234, P222, DOI 10.1016/j.taap.2008.09.030; Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572; Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561; Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011; Wang XH, 2008, CHEMMEDCHEM, V3, P940, DOI 10.1002/cmdc.200700329; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613; YING Z, 2008, SCI CHINA SER B, V51, P1021; Yu BZ, 2007, CARBON, V45, P1921, DOI 10.1016/j.carbon.2007.06.015; Zhang ZH, 2006, CLIN CANCER RES, V12, P4933, DOI 10.1158/1078-0432.CCR-05-2831	46	68	69	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4354	4365		10.1096/fj.09-141036	http://dx.doi.org/10.1096/fj.09-141036			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20647548				2022-12-25	WOS:000283861100023
J	Chakraborty, J; Banerjee, S; Ray, P; Hossain, DMS; Bhattacharyya, S; Adhikary, A; Chattopadhyay, S; Das, T; Sa, G				Chakraborty, Juni; Banerjee, Shuvomoy; Ray, Pallab; Hossain, Dewan Md Sakib; Bhattacharyya, Sankar; Adhikary, Arghya; Chattopadhyay, Sreya; Das, Tanya; Sa, Gaurisankar			Gain of Cellular Adaptation Due to Prolonged p53 Impairment Leads to Functional Switchover from p53 to p73 during DNA Damage in Acute Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT KINASES CHK1; DELTA-NP73; APOPTOSIS; FAMILY; CYCLE; P63; EXPRESSION; INHIBITOR; PROTEIN; GROWTH	Tumor suppressor p53 plays the central role in regulating apoptosis in response to genotoxic stress. From an evolutionary perspective, the activity of p53 has to be backed up by other protein( s) in case of any functional impairment of this protein, to trigger DNA damage-induced apoptosis in cancer cells. We adopted multiple experimental approaches to demonstrate that in p53-impaired cancer cells, DNA damage caused accumulation of p53 paralogue p73 via Chk-1 that strongly impacted Bax expression and p53-independent apoptosis. On the contrary, when p53 function was restored by ectopic expression, Chk-2 induced p53 accumulation that in turn overshadowed p73 activity, suggesting an antagonistic interaction between p53 family members. To understand such interaction better, p53-expressing cells were impaired differentially for p53 activity. In wildtype p53-expressing cancer cells that were silenced for p53 for several generations, p73 was activated, whereas no such trend was observed when p53 was transiently silenced. Prolonged p53 interference, even in functional p53 settings, therefore, leads to the "gain of cellular adaptation" in a way that alters the cellular microenvironment in favor of p73 activation by altering p73-regulatory proteins, e.g. Chk1 activation and dominant negative p73 down-regulation. These findings not only unveil a hitherto unexplained mechanism underlying the functional switchover from p53 to p73, but also validate p73 as a promising and potential target for cancer therapy in the absence of functional p53.	[Chakraborty, Juni; Banerjee, Shuvomoy; Ray, Pallab; Hossain, Dewan Md Sakib; Bhattacharyya, Sankar; Adhikary, Arghya; Chattopadhyay, Sreya; Das, Tanya; Sa, Gaurisankar] Bose Inst, Div Mol Med, Kolkata 700054, India	Department of Science & Technology (India); Bose Institute	Sa, G (corresponding author), Bose Inst, Div Mol Med, P-1-12 CIT Scheme 7 M, Kolkata 700054, India.	gauri@bic.boseinst.ernet.in	Bhattacharyya, Sankar/GZH-3091-2022; Bhattacharyya, Sankar/AAK-2204-2020; Banerjee, Shuvomoy/AAZ-2479-2021	Bhattacharyya, Sankar/0000-0002-3235-4220; Banerjee, Shuvomoy/0000-0002-6936-1950	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by research grants from the Department of Science and Technology, Government of India.	Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Belloni L, 2006, ONCOGENE, V25, P3606, DOI 10.1038/sj.onc.1209321; Bhattacharyya S, 2007, J BIOL CHEM, V282, P15954, DOI 10.1074/jbc.M608189200; Bhattacharyya S, 2007, CANCER RES, V67, P362, DOI 10.1158/0008-5472.CAN-06-2583; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Damia G, 2004, CELL CYCLE, V3, P46; Damia G, 2001, J BIOL CHEM, V276, P10641, DOI 10.1074/jbc.M007178200; Durland-Busbice S, 2002, LEUKEMIA, V16, P2165, DOI 10.1038/sj.leu.2402647; Ehrhardt H, 2008, ONCOGENE, V27, P783, DOI 10.1038/sj.onc.1210666; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Grob TJ, 2002, CELL DEATH DIFFER, V9, P229, DOI 10.1038/sj.cdd.4401018; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Johnson RA, 2005, J BIOL CHEM, V280, P13213, DOI 10.1074/jbc.M414646200; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Kravchenko JE, 2008, P NATL ACAD SCI USA, V105, P6302, DOI 10.1073/pnas.0802091105; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Ng CP, 2004, J BIOL CHEM, V279, P8808, DOI 10.1074/jbc.M312215200; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Ra H, 2009, FEBS LETT, V583, P1516, DOI 10.1016/j.febslet.2009.04.008; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; Seifert H, 2009, LEUKEMIA, V23, P656, DOI 10.1038/leu.2008.375; Tannapfel A, 2008, CARCINOGENESIS, V29, P211, DOI 10.1093/carcin/bgm236; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang J, 2007, MOL CELL BIOL, V27, P3868, DOI 10.1128/MCB.02112-06	38	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33104	33112		10.1074/jbc.M110.122705	http://dx.doi.org/10.1074/jbc.M110.122705			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20675383	Green Published, hybrid			2022-12-25	WOS:000283048200048
J	Vassilevski, AA; Fedorova, IM; Maleeva, EE; Korolkova, YV; Efimova, SS; Samsonova, OV; Schagina, LV; Feofanov, AV; Magazanik, LG; Grishin, EV				Vassilevski, Alexander A.; Fedorova, Irina M.; Maleeva, Ekaterina E.; Korolkova, Yuliya V.; Efimova, Svetlana S.; Samsonova, Olga V.; Schagina, Ludmila V.; Feofanov, Alexei V.; Magazanik, Lev G.; Grishin, Eugene V.			Novel Class of Spider Toxin ACTIVE PRINCIPLE FROM THE YELLOW SAC SPIDER CHEIRACANTHIUM PUNCTORIUM VENOM IS A UNIQUE TWO-DOMAIN POLYPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; CYSTINE KNOT STRUCTURE; AMINO-ACID-SEQUENCE; CUPIENNIUS-SALEI; ION CHANNELS; ANTIMICROBIAL PEPTIDES; CYTOLYTIC PEPTIDES; CALCIUM-CHANNEL; SKELETAL-MUSCLE	Venom of the yellow sac spider Cheiracanthium punctorium (Miturgidae) was found unique in terms of molecular composition. Its principal toxic component CpTx 1 (15.1 kDa) was purified, and its full amino acid sequence (134 residues) was established by protein chemistry and mass spectrometry techniques. CpTx 1 represents a novel class of spider toxin with modular architecture. It consists of two different yet homologous domains (modules) each containing a putative inhibitor cystine knot motif, characteristic of the widespread single domain spider neurotoxins. Venom gland cDNA sequencing provided precursor protein (prepropeptide) structures of three CpTx 1 isoforms (a-c) that differ by single residue substitutions. The toxin possesses potent insecticidal (paralytic and lethal), cytotoxic, and membrane-damaging activities. In both fly and frog neuromuscular preparations, it causes stable and irreversible depolarization of muscle fibers leading to contracture. This effect appears to be receptor-independent and is inhibited by high concentrations of divalent cations. CpTx 1 lyses cell membranes, as visualized by confocal microscopy, and destabilizes artificial membranes in a manner reminiscent of other membrane-active peptides by causing numerous defects of variable conductance and leading to bilayer rupture. The newly discovered class of modular polypeptides enhances our knowledge of the toxin universe.	[Vassilevski, Alexander A.; Samsonova, Olga V.; Feofanov, Alexei V.; Grishin, Eugene V.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Fedorova, Irina M.; Magazanik, Lev G.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia; [Efimova, Svetlana S.; Schagina, Ludmila V.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Vassilevski, AA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Mik Lukho Maklaya,16-10, Moscow 117997, Russia.	avas@ibch.ru	Vassilevski, Alexander/S-3824-2016; Magazanik, Lev G/K-4380-2014; Feofanov, Alexey V/K-3082-2012; Efimova, Svetlana S./I-8716-2014	Vassilevski, Alexander/0000-0002-1359-0076; Magazanik, Lev G/0000-0002-5856-5798; Feofanov, Alexey V/0000-0002-1596-9506; Efimova, Svetlana S./0000-0002-2429-2007	Federal Agency for Education of the Russian Federation State [P1388]; Russian Foundation for Basic Research [08-04-00326, 08-04-00454, 09-04-00883]; Russian Scientific Schools [4821.2008.4, 3796.2010.4]; Russian Academy of Sciences	Federal Agency for Education of the Russian Federation State; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Schools; Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Federal Agency for Education of the Russian Federation State Contract P1388, the Russian Foundation for Basic Research Grants 08-04-00326, 08-04-00454, and 09-04-00883, the Russian Scientific Schools Grants 4821.2008.4 and 3796.2010.4, and the Program of Cell and Molecular Biology of the Russian Academy of Sciences.	Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; CHUA M, 1991, BIOPHYS J, V59, P1251, DOI 10.1016/S0006-3495(91)82340-2; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; Darbre A., 1986, PRACTICAL PROTEIN CH; Diego-Garcia E, 2007, PEPTIDES, V28, P31, DOI 10.1016/j.peptides.2006.06.012; ECAULT E, 1991, BRIT J PHARMACOL, V102, P523, DOI 10.1111/j.1476-5381.1991.tb12204.x; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; Fedorova IM, 2009, COMP BIOCHEM PHYS C, V149, P275, DOI 10.1016/j.cbpc.2008.07.010; Fitches E, 2004, J INSECT PHYSIOL, V50, P61, DOI 10.1016/j.jinsphys.2003.09.010; Foradori MJ, 2005, COMP BIOCHEM PHYS C, V141, P32, DOI 10.1016/j.cca.2005.05.001; Furman D. P., 1957, California Medicine, V87, P114; GERBER U, 1991, NEUROSCI LETT, V134, P53, DOI 10.1016/0304-3940(91)90507-P; Gomez MV, 2002, CELL MOL NEUROBIOL, V22, P579, DOI 10.1023/A:1021836403433; GRIMES PA, 1982, ARCH OPHTHALMOL-CHIC, V100, P635, DOI 10.1001/archopht.1982.01030030637022; Grishin E, 1999, EUR J BIOCHEM, V264, P276, DOI 10.1046/j.1432-1327.1999.00622.x; GRISHIN EV, 1989, TOXICON, V27, P541, DOI 10.1016/0041-0101(89)90115-3; Grishin EV, 1998, TOXICON, V36, P1693, DOI 10.1016/S0041-0101(98)00162-7; Khan SA, 2006, TRANSGENIC RES, V15, P349, DOI 10.1007/s11248-006-0007-2; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kozlov S, 2005, TOXICON, V46, P672, DOI 10.1016/j.toxicon.2005.07.009; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Kubista H, 2007, NEUROPHARMACOLOGY, V52, P1650, DOI 10.1016/j.neuropharm.2007.03.012; Kuhn-Nentwig L, 2003, CELL MOL LIFE SCI, V60, P2651, DOI 10.1007/s00018-003-3106-8; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; MAGAZANIK LG, 1992, NEUROSCIENCE, V46, P181, DOI 10.1016/0306-4522(92)90017-V; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mellor IR, 2004, TOXICON, V43, P493, DOI 10.1016/j.toxicon.2004.02.003; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Narahashi T, 2008, P JPN ACAD B-PHYS, V84, P147, DOI 10.2183/pjab.84.147; Nikolsky AS, 2009, BIOCHEM MOSC SUPPL S, V3, P245, DOI 10.1134/S1990747809030027; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Petrinos, 2009, PROTEIN BIOSYNTHESIS, P225; PLATNICK NI, 2009, WORLD SPIDER CATALOG; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Schaller J, 2001, CELL MOL LIFE SCI, V58, P1538, DOI 10.1007/PL00000794; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STOHR M, 1980, FLOW CYTOMETRY, V4, P96; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI [10.1042/BJ20071123, 10.1042/bj20071123]; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; Vetter RS, 2008, ANNU REV ENTOMOL, V53, P409, DOI 10.1146/annurev.ento.53.103106.093503; Vetter RS, 2006, AM J TROP MED HYG, V74, P1043, DOI 10.4269/ajtmh.2006.74.1043; Wehner F, 2006, ACTA PHYSIOL, V187, P21, DOI 10.1111/j.1748-1716.2006.01561.x; Wu CH, 2009, TOXICON, V54, P1183, DOI 10.1016/j.toxicon.2009.02.030; Wullschleger B, 2005, J EXP BIOL, V208, P2115, DOI 10.1242/jeb.01594; Wullschleger B, 2004, P NATL ACAD SCI USA, V101, P11251, DOI 10.1073/pnas.0402226101; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001	62	38	44	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32293	32302		10.1074/jbc.M110.104265	http://dx.doi.org/10.1074/jbc.M110.104265			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20657014	Green Published, hybrid			2022-12-25	WOS:000282683000042
J	Baekgaard, L; Mikkelsen, MD; Sorensen, DM; Hegelund, JN; Persson, DP; Mills, RF; Yang, Z; Husted, S; Andersen, JP; Buch-Pedersen, MJ; Schjoerring, JK; Williams, LE; Palmgren, MG				Baekgaard, Lone; Mikkelsen, Maria D.; Sorensen, Danny M.; Hegelund, Josefine N.; Persson, Daniel P.; Mills, Rebecca F.; Yang, Zhang; Husted, Soren; Andersen, Jens Peter; Buch-Pedersen, Morten J.; Schjoerring, Jan K.; Williams, Lorraine E.; Palmgren, Michael G.			A Combined Zinc/Cadmium Sensor and Zinc/Cadmium Export Regulator in a Heavy Metal Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT PLASMA-MEMBRANE; P-TYPE ATPASE; COPPER-TRANSPORTING ATPASE; WILSONS-DISEASE PROTEIN; N-TERMINAL DOMAIN; H+-ATPASE; BINDING DOMAIN; P-1B-TYPE ATPASE; MENKES PROTEIN; FUNCTIONAL EXPRESSION	Heavy metal pumps (P1B-ATPases) are important for cellular heavy metal homeostasis. AtHMA4, an Arabidopsis thaliana heavy metal pump of importance for plant Zn2+ nutrition, has an extended C-terminal domain containing 13 cysteine pairs and a terminal stretch of 11 histidines. Using a novel size-exclusion chromatography, inductively coupled plasma mass spectrometry approach we report that the C-terminal domain of AtHMA4 is a high affinity Zn2+ and Cd2+ chelator with capacity to bind 10 Zn2+ ions per C terminus. When AtHMA4 is expressed in a Zn2+-sensitive zrc1 cot1 yeast strain, sequential removal of the histidine stretch and the cysteine pairs confers a gradual increase in Zn2+ and Cd2+ tolerance and lowered Zn2+ and Cd2+ content of transformed yeast cells. We conclude that the C-terminal domain of AtHMA4 serves a dual role as Zn2+ and Cd2+ chelator (sensor) and as a regulator of the efficiency of Zn2+ and Cd2+ export. The identification of a post-translational handle on Zn2+ and Cd2+ transport efficiency opens new perspectives for regulation of Zn2+ nutrition and tolerance in eukaryotes.	[Yang, Zhang; Buch-Pedersen, Morten J.] Univ Copenhagen, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis, PUMPKIN,Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Hegelund, Josefine N.; Persson, Daniel P.; Husted, Soren; Schjoerring, Jan K.] Univ Copenhagen, Dept Agr & Ecol, DK-1871 Frederiksberg C, Denmark; [Mills, Rebecca F.; Williams, Lorraine E.] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England; [Andersen, Jens Peter] Aarhus Univ, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis, PUMPKIN,Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark	Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; University of Southampton; Aarhus University; Danmarks Grundforskningsfond	Palmgren, MG (corresponding author), Univ Copenhagen, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis, PUMPKIN,Dept Plant Biol & Biotechnol, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@life.ku.dk	Mikkelsen, Maria Dalgaard/AAP-3139-2021; Husted, Søren/H-4649-2014; Mikkelsen, Maria/R-1243-2016; Persson, Daniel Pergament/M-6819-2015; Palmgren, Michael/A-9808-2013; Schjoerring, Jan K./A-5387-2009; Hegelund, Josefine Nymark/N-4732-2014; Schjoerring, Jan K./M-4044-2019; Yang, Zhang/I-8934-2016	Mikkelsen, Maria Dalgaard/0000-0003-4297-6119; Husted, Søren/0000-0003-2020-1902; Persson, Daniel Pergament/0000-0003-3976-190X; Palmgren, Michael/0000-0002-9982-6114; Schjoerring, Jan K./0000-0002-2852-3298; Hegelund, Josefine Nymark/0000-0002-5663-9503; Schjoerring, Jan K./0000-0002-2852-3298; Andersen, Jens Peter/0000-0003-0654-4300; Yang, Zhang/0000-0002-4756-5813	European Union	European Union(European Commission)	This work was supported by the European Union Framework Programme 6 as part of the Integrated Project Public health impact of long term, low level mixed element exposure in susceptible population strata.	Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Bal N, 2001, FEBS LETT, V506, P249, DOI 10.1016/S0014-5793(01)02927-1; Banci L, 2002, J MOL BIOL, V317, P415, DOI 10.1006/jmbi.2002.5430; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Baunsgaard L, 1996, PLANT J, V10, P451, DOI 10.1046/j.1365-313X.1996.10030451.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; EREN E, 2007, J M BIOCH, V46, P7754; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Goodyer ID, 1999, HUM MOL GENET, V8, P1473, DOI 10.1093/hmg/8.8.1473; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Harrison MD, 1999, BBA-MOL BASIS DIS, V1453, P254, DOI 10.1016/S0925-4439(98)00110-0; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; Jensen PY, 1999, BBA-PROTEIN STRUCT M, V1434, P103, DOI 10.1016/S0167-4838(99)00161-2; Kjelstrup S, 2005, PHYS CHEM CHEM PHYS, V7, P4009, DOI 10.1039/b511990a; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; LUTSENKO S, 1995, J H BIOCH, V34, P15607; MAGER M, 1953, J HISTOCHEM CYTOCHEM, V1, P493, DOI 10.1177/1.6.493; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; MANDAL AK, 2003, J M BIOCH, V42, P11040; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Mitra B, 2001, BIOCHEMISTRY-US, V40, P7694, DOI 10.1021/bi010576g; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Persson DP, 2009, METALLOMICS, V1, P418, DOI 10.1039/b905688b; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Sumbilla C, 2002, J BIOL CHEM, V277, P13900, DOI 10.1074/jbc.M111155200; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; VILSEN B, 1998, J BIOCH, V37, P10961; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wong CKE, 2009, NEW PHYTOL, V181, P79, DOI 10.1111/j.1469-8137.2008.02637.x; Zimmermann M, 2009, BIOCHEMISTRY-US, V48, P11640, DOI 10.1021/bi901573b	58	57	60	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31243	31252		10.1074/jbc.M110.111260	http://dx.doi.org/10.1074/jbc.M110.111260			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20650903	Green Published, hybrid			2022-12-25	WOS:000282764600018
J	Ieguchi, K; Fujita, M; Ma, Z; Davari, P; Taniguchi, Y; Sekiguchi, K; Wang, B; Takada, YK; Takada, Y				Ieguchi, Katsuaki; Fujita, Masaaki; Ma, Zi; Davari, Parastoo; Taniguchi, Yukimasa; Sekiguchi, Kiyotoshi; Wang, Bobby; Takada, Yoko K.; Takada, Yoshikazu			Direct Binding of the EGF-like Domain of Neuregulin-1 to Integrins (alpha v beta 3 and alpha 6 beta 4) Is Involved in Neuregulin-1/ErbB Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; LIGAND-BINDING; CARCINOMA INVASION; TYROSINE KINASES; IN-VIVO; HEREGULIN; EXPRESSION; RECEPTOR; ADHESION; DIFFERENTIATION	Integrin-growth factor receptor cross-talk plays a role in growth factor signaling, but the specifics are unclear. In a current model, integrins and growth factor receptors independently bind to their ligands (extracellular matrix and growth factors, respectively). We discovered that neuregulin-1 (NRG1), either as an isolated EGF-like domain or as a native multi-domain form, binds to integrins alpha v beta 3 (with a K-D of 1.36 x 10(-7) M) and alpha 6 beta 4. Docking simulation predicted that three Lys residues at positions 180, 184, and 186 of the EGF-like domain are involved in integrin binding. Mutating these residues to Glu individually or in combination markedly suppressed integrin binding and ErbB3 phosphorylation. Mutating all three Lys residues to Glu (the 3KE mutation) did not affect the ability of NRG1 to bind to ErbB3 but markedly reduced the ability of NRG1 to induce ErbB3 phosphorylation and AKT and Erk1/2 activation in MCF-7 and T47D human breast cancer cells. This suggests that direct integrin binding to NRG1 is critical for NRG1/ErbB signaling. Notably, stimulation of cells with WT NRG1 induced co-precipitation of ErbB3 with alpha 6 beta 4 and with alpha v beta 3 to a much lower extent. This suggests that WT NRG1 induces integrin-NRG1-ErbB3 ternary complex formation. In contrast, the 3KE mutant was much less effective in inducing ternary complex formation than WT NRG1, suggesting that this process depends on the ability of NRG1 to bind to integrins. These results suggest that direct NRG1-integrin interaction mediates integrin-ErbB cross-talk and that alpha 6 beta 4 plays a major role in NRG-ErbB signaling in these cancer cells.	[Ieguchi, Katsuaki; Fujita, Masaaki; Ma, Zi; Davari, Parastoo; Wang, Bobby; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA; [Taniguchi, Yukimasa; Sekiguchi, Kiyotoshi] Osaka Univ, Lab Extracellular Matrix Biochem, Inst Prot Res, Suita, Osaka 5650871, Japan	University of California System; University of California Davis; Osaka University	Takada, Y (corresponding author), Univ Calif Davis, Dept Dermatol, Sch Med, Res 3 Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA131015, CA113298, CA093373, U19 NCDDG]; Department of Defense [W81XWH-10-1-0312]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20370046]; NATIONAL CANCER INSTITUTE [R01CA131015, U19CA113298, P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA131015, CA113298, CA093373, and U19 NCDDG grant (to Yoshikazu Takada). This work was also supported by Department of Defense Grant W81XWH-10-1-0312 (to Yoshikazu Takada) and Grant-in-aid for Scientific Research 20370046 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. S.).	Atlas E, 2003, MOL CANCER RES, V1, P165; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Busfield SJ, 1997, MOL CELL BIOL, V17, P4007, DOI 10.1128/MCB.17.7.4007; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; FALCIONI R, 1986, CANCER RES, V46, P5772; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Kamata T, 2001, INT J HEMATOL, V74, P382, DOI 10.1007/BF02982080; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Li QF, 2004, CANCER RES, V64, P7078, DOI 10.1158/0008-5472.CAN-04-1152; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2003, CLIN EXP METASTAS, V20, P569, DOI 10.1023/A:1025819521707; Liu W, 1999, BIOCHEM BIOPH RES CO, V261, P897, DOI 10.1006/bbrc.1999.1144; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Murgia C, 1998, EMBO J, V17, P3940, DOI 10.1093/emboj/17.14.3940; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schmitt A, 2008, EUR ARCH PSY CLIN N, V258, P35, DOI 10.1007/s00406-008-5019-x; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Tang CK, 1996, CANCER RES, V56, P3350; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Vellon L, 2005, ONCOGENE, V24, P3759, DOI 10.1038/sj.onc.1208452; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; Zhang XP, 1999, BIOCHEMISTRY-US, V38, P14424, DOI 10.1021/bi990323b	53	55	64	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31388	31398		10.1074/jbc.M110.113878	http://dx.doi.org/10.1074/jbc.M110.113878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682778	Green Published, hybrid			2022-12-25	WOS:000282764600033
J	Nemere, I; Garbi, N; Hammerling, GJ; Khanal, RC				Nemere, Ilka; Garbi, Natalio; Haemmerling, Gunter J.; Khanal, Ramesh C.			Intestinal Cell Calcium Uptake and the Targeted Knockout of the 1,25D(3)-MARRS (Membrane-associated, Rapid Response Steroid-binding) Receptor/PDIA3/Erp57	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; ESTROGEN-RECEPTORS; INITIATED ACTIONS; 1,25(OH)(2)D-3; TRANSPORT; HORMONE; D-3	We have crossed ERp57(flx/flx) mice with commercially available mice expressing villin-driven cre-recombinase. Lysates of intestinal epithelial cells were prepared from knock-out (KO) mice and littermates (LM) and used in Western blot analyses with Ab099 against the N terminus of the 1,25D(3)-MARRS (membrane-associated, rapid response steroid-binding) receptor: LM mice exhibited one positive band, which was absent in preparations from KO mice. Saturation analyses of cell lysates with [H-3] 1,25D(3) revealed negligible binding in preparations from either female or male KOs. Lysates from female and male LM mice had similar affinities but different numbers of binding sites. Isolated enterocytes were tested for steroid-stimulated calcium uptake. Treatment of cells from female or male LM mice with 1,25D(3) elicited enhanced calcium uptake in females and males within 5 min. Intestinal cells from KO mice exhibited a severely blunted or completely absent response to hormone. Confocal microscopy of intestinal cells revealed the presence of cell surface vitamin D receptors. However, antibodies to the vitamin D receptor failed to block 1,25D(3)-stimulated calcium uptake. In chick enterocytes we have found that the PKA pathway mediates calcium uptake. The time course for activation of PKA in mouse enterocytes paralleled that for enhanced calcium uptake and for LM females reached 250% of controls within 5 min, and 150% of controls in cells prepared from LM males. Enterocytes from female or male KO mice failed to exhibit steroid hormone-stimulated PKA activity, but did respond to forskolin with enhanced calcium uptake. We conclude that the 1,25D(3)-MARRS receptor is of central importance to steroid hormone-stimulated calcium uptake in mammalian intestinal cells.	[Nemere, Ilka; Khanal, Ramesh C.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA; [Garbi, Natalio; Haemmerling, Gunter J.] German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany	Utah System of Higher Education; Utah State University; Helmholtz Association; German Cancer Research Center (DKFZ)	Nemere, I (corresponding author), Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA.	ilka.nemere@usu.edu	Garbi, Natalio/H-7666-2014; Garbi, Natalio/B-9147-2009					Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Khanal RC, 2008, J CELL BIOCHEM, V105, P1109, DOI 10.1002/jcb.21913; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kumar P, 2007, MOL ENDOCRINOL, V21, P1370, DOI 10.1210/me.2006-0360; Lambert JR, 2007, BIOCHEM BIOPH RES CO, V361, P189, DOI 10.1016/j.bbrc.2007.07.012; Larsson B, 2003, ENDOCRINOLOGY, V144, P1726, DOI 10.1210/en.2002-221060; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; NEMERE I, 1981, ENDOCRINOLOGY, V108, P1450, DOI 10.1210/endo-108-4-1450; Nemere I, 2004, P NATL ACAD SCI USA, V101, P7392, DOI 10.1073/pnas.0402207101; Nemere I, 2000, AM J PHYSIOL-ENDOC M, V278, pE1104, DOI 10.1152/ajpendo.2000.278.6.E1104; Nemere K, 2005, STEROIDS, V70, P455, DOI 10.1016/j.steroids.2005.02.005; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Sterling TM, 2005, J ENDOCRINOL, V185, P81, DOI 10.1677/joe.1.05945; Sterling TM, 2007, STEROIDS, V72, P151, DOI 10.1016/j.steroids.2006.11.003; SZEGO CM, 1985, NATURE, V317, P88, DOI 10.1038/317088a0; Tubbs C, 2010, GEN COMP ENDOCR, V165, P144, DOI 10.1016/j.ygcen.2009.06.017; Wali RK, 2003, J CELL BIOCHEM, V88, P794, DOI 10.1002/jcb.10432; Walters MR, 2004, CELL MOL LIFE SCI, V61, P2309, DOI 10.1007/s00018-004-4065-4	20	62	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31859	U940		10.1074/jbc.M110.116954	http://dx.doi.org/10.1074/jbc.M110.116954			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682787	hybrid, Green Published			2022-12-25	WOS:000282764600077
J	Zhuo, DX; Niu, XH; Chen, YC; Xin, DQ; Guo, YL; Mao, ZB				Zhuo, De Xiang; Niu, Xiao Hua; Chen, Yi Cheng; Xin, Dian Qi; Guo, Ying Lu; Mao, Ze Bin			Vitamin D-3 Up-regulated Protein 1(VDUP1) Is Regulated by FOXO3A and miR-17-5p at the Transcriptional and Post-transcriptional Levels, Respectively, in Senescent Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-BINDING PROTEIN-2; REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; OXIDATIVE STRESS; MESSENGER-RNA; EXPRESSION; CANCER; GROWTH; CELLS; GENE	Vitamin D-3 up-regulated protein 1 (VDUP1) plays multifunctional roles in diverse cellular responses, particularly in its relation to proliferation, apoptosis, differentiation, and diseases such as cancer and stress-related diseases. In this study, we demonstrated that VDUP1 was up-regulated during the senescence process. Our results showed that overexpression of VDUP1 in young cells caused typical signs of senescence. We also found that VDUP1 knockdown delayed the onset of Ras-induced cellular senescence. Subsequently, we found that FOXO3A, whose activity increased in senescent cells, transcriptionally up-regulates VDUP1 expression and miR-17-5p, whose expression decreased in senescent cells, directly interacted with the 3'-un-translated region of VDUP1 transcripts, and destabilized VDUP1 mRNA in young cells. These results indicated that VDUP1 expression was regulated by FOXO3A at the transcriptional level and by miR-17-5p at the post-transcriptional levels during the senescence process.	[Zhuo, De Xiang; Mao, Ze Bin] Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Niu, Xiao Hua; Chen, Yi Cheng; Xin, Dian Qi; Guo, Ying Lu] Peking Univ, Dept Urol, Hosp 1, Beijing 100034, Peoples R China; [Niu, Xiao Hua; Chen, Yi Cheng; Xin, Dian Qi; Guo, Ying Lu] Peking Univ, Inst Urol, Beijing 100034, Peoples R China	Peking University; Peking University; Peking University	Mao, ZB (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China.	zbmao@bjmu.edu.cn			National Basic Research Programs of China [2007CB507400]; National Science Foundation of China [30672201, 306210021]	National Basic Research Programs of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Programs of China Grant 2007CB507400 and the National Science Foundation of China Grants 30672201 and 306210021.	Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Campisi J, 2000, IN VIVO, V14, P183; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; Dutta KK, 2005, LAB INVEST, V85, P798, DOI 10.1038/labinvest.3700280; Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO;2-1; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; HAYFLICK L, 1975, FED PROC, V34, P9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Mawal-Dewan M, 2002, J BIOL CHEM, V277, P7857, DOI 10.1074/jbc.M104515200; Nishinaka Y, 2004, CANCER RES, V64, P1287, DOI 10.1158/0008-5472.CAN-03-0908; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Takahashi Y, 2002, ONCOL REP, V9, P75; TANG ZQ, 1994, MECH AGEING DEV, V73, P57, DOI 10.1016/0047-6374(94)90038-8; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yang XQ, 1998, BREAST CANCER RES TR, V48, P33, DOI 10.1023/A:1005929714900; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	41	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31491	31501		10.1074/jbc.M109.068387	http://dx.doi.org/10.1074/jbc.M109.068387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20656682	hybrid, Green Published			2022-12-25	WOS:000282764600043
J	Ferrari-Amorotti, G; Mariani, SA; Novi, C; Cattelani, S; Pecorari, L; Corradini, F; Soliera, AR; Manzotti, G; Fragliasso, V; Zhang, Y; Martinez, RV; Lam, EWF; Guerzoni, C; Calabretta, B				Ferrari-Amorotti, Giovanna; Mariani, Samanta Antonella; Novi, Chiara; Cattelani, Sara; Pecorari, Luisa; Corradini, Francesca; Soliera, Angela Rachele; Manzotti, Gloria; Fragliasso, Valentina; Zhang, Ying; Martinez, Robert V.; Lam, Eric W. -F.; Guerzoni, Clara; Calabretta, Bruno			The Biological Effects of C/EBP alpha in K562 Cells Depend on the Potency of the N-terminal Regulatory Region, Not on Specificity of the DNA Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ABL-EXPRESSING CELLS; GRANULOCYTIC DIFFERENTIATION; TRANSCRIPTION FACTOR; PROTEIN-ALPHA; HEMATOPOIETIC-CELLS; INITIATING CELLS; DOWN-REGULATION; IN-VIVO; GENE	The transcription factor C/EBP alpha is more potent than C/EBP beta in inducing granulocitic differentiation and inhibiting BCR/ABL-expressing cells. We took a "domain swapping" approach to assess biological effects, modulation of gene expression, and binding to C/EBP alpha-regulated promoters by wild-type and chimeric C/EBP alpha/C/EBP beta proteins. Wild-type and N-C/EBP alpha+ C/EBP beta-DBD induced transcription of the granulocyte-colony stimulating factor receptor (G-CSFR) gene, promoted differentiation, and suppressed proliferation of K562 cells vigorously; instead, wild-type C/EBP beta and N-C/EBP beta+C/EBP alpha-DBD had modest effects, although they bound the G-CSFR promoter like wild-type C/EBP alpha and N-C/EBP alpha+C/EBP beta-DBD. Chimeric proteins consisting of the TAD of VP16 and the DBD of C/EBP alpha or C/EBP beta inhibited proliferation and induced differentiation of K562 cells as effectively as wild-type C/EBP alpha. Gene expression profiles induced by C/EBP alpha resembled those modulated by N-C/EBP alpha+C/EBP beta-DBD, whereas C/EBP beta induced a pattern similar to that of N-C/EBP beta+C/EBP alpha-DBD. C/EBP alpha activation induced changes in the expression of more cell cycle- and apoptosis-related genes than the other proteins and enhanced Imatinib-induced apoptosis of K562 cells. Expression of FOXO3a, a novel C/EBP alpha-regulated gene, was required for apoptosis but not for differentiation induction or proliferation inhibition of K562 cells.	[Guerzoni, Clara] Rizzoli Inst, Oncol Res Unit, I-40136 Bologna, Italy; [Ferrari-Amorotti, Giovanna; Mariani, Samanta Antonella; Novi, Chiara; Cattelani, Sara; Pecorari, Luisa; Corradini, Francesca; Manzotti, Gloria; Fragliasso, Valentina; Calabretta, Bruno] Univ Modena & Reggio Emilia, Dept Biol Sci, I-41100 Modena, Italy; [Soliera, Angela Rachele; Calabretta, Bruno] Dept Canc Biol, Philadelphia, PA 19107 USA; [Soliera, Angela Rachele; Calabretta, Bruno] Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Zhang, Ying; Martinez, Robert V.] Wyeth Res, Dept Biol Technol, Cambridge, MA 02140 USA; [Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Canc Res UK Labs, Dept Oncol, London W12 0NN, England	Universita di Modena e Reggio Emilia; Jefferson University; Pfizer; Cancer Research UK; Imperial College London	Guerzoni, C (corresponding author), Rizzoli Inst, Oncol Res Unit, 1-10 Barbiano St, I-40136 Bologna, Italy.	clara.guerzoni@ior.it; B-Calabretta@mail.jci.tju.edu	Fragliasso, Valentina/K-4657-2016; fragliasso, valentina/AAA-2291-2022; Lam, Eric W-F/AAW-8566-2020; Manzotti, Gloria/J-7235-2016	Fragliasso, Valentina/0000-0002-4189-0316; Lam, Eric W-F/0000-0003-1274-3576; Manzotti, Gloria/0000-0002-0639-3605; Mariani, Samanta Antonella/0000-0003-4950-0607	National Institutes of Health (NCI) [CA95111]; Fondazione Cassa di Risparmio di Modena; Programmi di Ricerca di Rilevante Interesse Nazionale; Fondazione Cassa di Risparmio di Vignola; Associazione Italiana Ricerca sul Cancro; NATIONAL CANCER INSTITUTE [R01CA095111] Funding Source: NIH RePORTER; Cancer Research UK [12011] Funding Source: researchfish	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondazione Cassa di Risparmio di Modena; Programmi di Ricerca di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Cassa di Risparmio di Vignola; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported, in whole or in part, by National Institutes of Health Grant CA95111 (NCI; to B. C.). This study was supported by grants from Fondazione Cassa di Risparmio di Modena, Programmi di Ricerca di Rilevante Interesse Nazionale (PRIN2007), Fondazione Cassa di Risparmio di Vignola (to B. C.) and by the Associazione Italiana Ricerca sul Cancro (to C. G.).	Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; D'Alo F, 2003, BLOOD, V102, P3163, DOI 10.1182/blood-2003-02-0479; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Ferrari-Amorotti G, 2006, BLOOD, V108, P1353, DOI 10.1182/blood-2006-01-011833; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Guerzoni C, 2006, CELL CYCLE, V5, P1254, DOI 10.4161/cc.5.12.2808; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; HEIBLING D, 2004, P NATL ACAD SCI USA, V101, P13312; Helbling D, 2005, BLOOD, V106, P1369, DOI 10.1182/blood-2004-11-4392; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; MCKNIGHT JLC, 1987, P NATL ACAD SCI USA, V84, P7061, DOI 10.1073/pnas.84.20.7061; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; PRESTON CM, 1988, CELL, V52, P425, DOI 10.1016/S0092-8674(88)80035-7; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tavor S, 2003, J BIOL CHEM, V278, P52651, DOI 10.1074/jbc.M307077200; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zheng R, 2004, BLOOD, V103, P1883, DOI 10.1182/blood-2003-06-1978	47	6	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30837	30850		10.1074/jbc.M110.128272	http://dx.doi.org/10.1074/jbc.M110.128272			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659895	hybrid, Green Published			2022-12-25	WOS:000282135500051
J	Ralle, M; Huster, D; Vogt, S; Schirrmeister, W; Burkhead, JL; Capps, TR; Gray, L; Lai, B; Maryon, E; Lutsenko, S				Ralle, Martina; Huster, Dominik; Vogt, Stefan; Schirrmeister, Wiebke; Burkhead, Jason L.; Capps, Tony R.; Gray, Lawrence; Lai, Barry; Maryon, Edward; Lutsenko, Svetlana			Wilson Disease at a Single Cell Level INTRACELLULAR COPPER TRAFFICKING ACTIVATES COMPARTMENT-SPECIFIC RESPONSES IN HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-FLUORESCENCE MICROSCOPY; PRIMARY HEMOCHROMATOSIS; LIVER; INFLAMMATION; ACCUMULATION; METABOLISM; MICE	Wilson disease(WD) is a severe hepato-neurologic disorder that affects primarily children and young adults. WD is caused by mutations in ATP7B and subsequent copper overload. However, copper levels alone do not predict severity of the disease. We demonstrate that temporal and spatial distribution of copper in hepatocytes may play an important role in WD pathology. High resolution synchrotron-based x-ray fluorescence imaging in situ indicates that copper does not continuously accumulate in Atp7b(-/-) hepatocytes, but reaches a limit at 90-300 fmol. The lack of further accumulation is associated with the loss of copper transporter Ctr1 from the plasma membrane and the appearance of copper-loaded lymphocytes and extracellular copper deposits. The WD progression is characterized by changes in subcellular copper localization and transcriptome remodeling. The synchrotron-based x-ray fluorescence imaging and mRNA profiling both point to the key role of nucleus in the initial response to copper overload and suggest time-dependent sequestration of copper in deposits as a protective mechanism. The metabolic pathways, up-regulated in response to copper, show compartmentalization that parallels changes in subcellular copper concentration. In contrast, significant down-regulation of lipid metabolism is observed at all stages of WD irrespective of copper distribution. These observations suggest new stage-specific as well as general biomarkers for WD. The model for the dynamic role of copper in WD is proposed.	[Ralle, Martina] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Huster, Dominik] Univ Leipzig, Inst Med Phys & Biophys, D-04109 Leipzig, Sachsen, Germany; [Huster, Dominik; Schirrmeister, Wiebke] Univ Magdeburg, Dept Med, D-39104 Magdeburg, Germany; [Vogt, Stefan; Lai, Barry] Argonne Natl Lab, Argonne, IL 60439 USA; [Maryon, Edward] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Gray, Lawrence; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA	Oregon Health & Science University; Leipzig University; Otto von Guericke University; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University	Ralle, M (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rallem@ohsu.edu; lutsenko@jhmi.edu	Burkhead, Jason/C-9612-2013; Gray, Lawrence/F-4281-2011; Vogt, Stefan/J-7937-2013; Ralle, Martina/H-2936-2019; Vogt, Stefan/B-9547-2009	Burkhead, Jason/0000-0001-5457-311X; Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513	National Institutes of Health [P01 GM067166]; German Research Foundation [Hu932/3-2]; U.S. Department of Energy, Office of Science [DE-AC-02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM067166 (to S. L.). This work was also supported by German Research Foundation Grant Hu932/3-2 (to D. H.). The use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science Contract DE-AC-02-06CH11357.	Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; CARMICHAEL PL, 1995, MUTAT RES-FUND MOL M, V326, P235, DOI 10.1016/0027-5107(94)00177-7; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; Dijkstra M, 1997, HEPATOLOGY, V26, P962, DOI 10.1053/jhep.1997.v26.pm0009328320; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; GOLDFISCHER S, 1980, AM J PATHOL, V99, P715; GOLDFISCHER S, 1968, AM J PATHOL, V53, P883; Hall MD, 2003, J BIOL INORG CHEM, V8, P726, DOI 10.1007/s00775-003-0471-6; HANAICHI T, 1984, LAB INVEST, V51, P592; HAYWOOD S, 1985, EXP MOL PATHOL, V43, P209, DOI 10.1016/0014-4800(85)90041-3; Hou TJ, 2000, PROTEIN SCI, V9, P2302, DOI 10.1110/ps.9.12.2302; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonas L, 2001, ULTRASTRUCT PATHOL, V25, P111; Kemner KM, 2004, SCIENCE, V306, P686, DOI 10.1126/science.1103524; Liu Wen, 2003, Hepatobiliary Pancreat Dis Int, V2, P270; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mcrae R, 2006, J STRUCT BIOL, V155, P22, DOI 10.1016/j.jsb.2005.09.013; MILANINO R, 1985, INT J TISSUE REACT, V7, P469; MILANINO R, 1985, AGENTS ACTIONS, V16, P504, DOI 10.1007/BF01983655; Nair J, 1998, CANCER EPIDEM BIOMAR, V7, P435; Paunesku T, 2003, NAT MATER, V2, P343, DOI 10.1038/nmat875; Pilloni L, 1998, HISTOPATHOLOGY, V33, P28, DOI 10.1046/j.1365-2559.1998.00455.x; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; VANESPEN P, 2002, SPECTRUM EVALUATION, P239; Wagner D, 2005, MICROBIOL-SGM, V151, P323, DOI 10.1099/mic.0.27213-0; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; WHITEHOUSE MW, 1978, AGENTS ACTIONS, V8, P85, DOI 10.1007/BF01972407; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Yun W, 1999, REV SCI INSTRUM, V70, P2238, DOI 10.1063/1.1149744	31	77	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30875	30883		10.1074/jbc.M110.114447	http://dx.doi.org/10.1074/jbc.M110.114447			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20647314	hybrid, Green Published			2022-12-25	WOS:000282135500054
J	Carter, CL; Lin, C; Liu, CY; Yang, L; Liu, ZR				Carter, C. L.; Lin, C.; Liu, C-Y; Yang, L.; Liu, Z-R			Phosphorylated p68 RNA helicase activates snail1 transcription by promoting HDAC1 dissociation from the snail1 promoter	ONCOGENE			English	Article						p68 RNA helicase; Snail1; transcription activation; HDAC1; Mi-2/NuRD	EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN-RECEPTOR-ALPHA; E-CADHERIN EXPRESSION; HISTONE ACETYLATION; TUMOR PROGRESSION; BETA-CATENIN; CHROMATIN; PROTEIN; COMPLEX; CANCER	The nuclear p68 RNA helicase is a prototypical member of the DEAD-box family of RNA helicases. p68 RNA helicase has been implicated in cell proliferation and early organ development and maturation. However, the functional role of p68 RNA helicase in these biological processes at the molecular level is not well understood. We previously reported that tyrosine phosphorylation of p68 RNA helicase mediates the effects of platelet-derived growth factor (PDGF) in induction of epithelial mesenchymal transition by promoting beta-catenin nuclear translocation. Here, we report that phosphorylation of p68 RNA helicase at Y593 upregulates transcription of the Snail1 gene. The phosphorylated p68 activates transcription of the Snail1 gene by promoting histone deacetylase (HDAC) 1 dissociation from the Snail1 promoter. Our results showed that p68 interacted with the nuclear remodeling and deacetylation complex MBD3:Mi-2/NuRD. Thus, our data suggested that a DEAD-box RNA unwindase could potentially regulate gene expression by functioning as a protein 'displacer' to modulate protein-protein interactions at the chromatin-remodeling complex. Oncogene (2010) 29, 5427-5436; doi: 10.1038/onc.2010.276; published online 2 August 2010	[Carter, C. L.; Lin, C.; Liu, C-Y; Yang, L.; Liu, Z-R] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Liu, ZR (corresponding author), Georgia State Univ, Dept Biol, Univ Plaza,24 Peachtree Ctr Ave, Atlanta, GA 30303 USA.	biozrl@langate.gsu.edu	Yang, Liuqing/B-7935-2011		National Institute of Health [GM063874, CA118113]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA118113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063874] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Roger Bridgeman for antibody p68-rgg production. We also thank Birgit Neuhaus for assistance in confocal imaging. This paper is greatly improved by critical comments from Jenny Yang, Mike Kirberger, Julian A. Johnson and Heena Dey. This study is supported in part by Research Grants from National Institute of Health (GM063874), (CA118113) and Georgia Cancer Coalition to ZR Liu.	Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; CRAWFORD L, 1982, J VIROL, V42, P612, DOI 10.1128/JVI.42.2.612-620.1982; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Fearon ER, 2003, CANCER CELL, V3, P307, DOI 10.1016/S1535-6108(03)00087-4; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; Forsberg EC, 2001, BIOESSAYS, V23, P820, DOI 10.1002/bies.1117; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LANE DP, 1980, NATURE, V288, P167, DOI 10.1038/288167a0; Liu ZR, 1998, MOL CELL BIOL, V18, P6910, DOI 10.1128/MCB.18.12.6910; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miyoshi A, 2005, BRIT J CANCER, V92, P252, DOI 10.1038/sj.bjc.6602266; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Nyormoi O, 2003, CLIN EXP METASTAS, V20, P251, DOI 10.1023/A:1022991302172; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Rodrigo I, 1999, EXP CELL RES, V248, P358, DOI 10.1006/excr.1999.4438; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wei Y, 2001, Yi Chuan Xue Bao, V28, P991; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yang LQ, 2005, CELL SIGNAL, V17, P1495, DOI 10.1016/j.cellsig.2005.03.008; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yang LQ, 2004, PROTEIN EXPRES PURIF, V35, P327, DOI 10.1016/j.pep.2004.02.004; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	48	30	31	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	39					5427	5436		10.1038/onc.2010.276	http://dx.doi.org/10.1038/onc.2010.276			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664EZ	20676135	Green Accepted			2022-12-25	WOS:000282944500009
J	Kamata, M; Liang, M; Liu, S; Nagaoka, Y; Chen, ISY				Kamata, Masakazu; Liang, Min; Liu, Shirley; Nagaoka, Yoshiko; Chen, Irvin S. Y.			Live Cell Monitoring of hiPSC Generation and Differentiation Using Differential Expression of Endogenous microRNAs	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; LENTIVIRAL VECTORS; GENE-EXPRESSION; TRANSGENE EXPRESSION; IPS CELLS; FIBROBLASTS; INDUCTION; LINES; RETROVIRUSES; CONVERSION	Human induced pluripotent stem cells (hiPSCs) provide new possibilities for regenerative therapies. In order for this potential to be achieved, it is critical to efficiently monitor the differentiation of these hiPSCs into specific lineages. Here, we describe a lentiviral reporter vector sensitive to specific microRNAs ( miRNA) to show that a single vector bearing multiple miRNA target sequences conjugated to different reporters can be used to monitor hiPSC formation and subsequent differentiation from human fetal fibroblasts (HFFs). The reporter vector encodes EGFP conjugated to the targets of human embryonic stem cell (hESC) specific miRNAs (miR-302a and miR-302d) and mCherry conjugated to the targets of differentiated cells specific miRNAs (miR-142-3p, miR-155, and miR-223). The vector was used to track reprogramming of HFF to iPSC. HFFs co-transduced with this reporter vector and vectors encoding 4 reprogramming factors (OCT4, SOX2, KLF4 and cMYC) were mostly positive for EGFP (67%) at an early stage of hiPSC formation. EGFP expression gradually disappeared and mCherry expression increased indicating less miRNAs specific to differentiated cells and expression of miRNAs specific to hESCs. Upon differentiation of the hiPSC into embryoid bodies, a large fraction of these hiPSCs regained EGFP expression and some of those cells became single positive for EGFP. Further differentiation into neural lineages showed distinct structures demarcated by either EGFP or mCherry expression. These findings demonstrate that a miRNA dependent reporter vector can be a useful tool to monitor living cells during reprogramming of hiPSC and subsequent differentiation to lineage specific cells.	[Kamata, Masakazu; Liang, Min; Liu, Shirley; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Nagaoka, Yoshiko] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kamata, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017	Chen, Irvin/0000-0003-1199-2415; Kamata, Masakazu/0000-0003-0323-3742	California Institute for Regenerative Medicine (CIRM) [RS1-00172-1]; National Institutes of Health (NIH) [AI055281, AI069350, AI028697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069350, P30AI028697] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the California Institute for Regenerative Medicine (CIRM) RS1-00172-1 and by the National Institutes of Health (NIH) AI055281, AI069350, and AI028697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2007, BLOOD, V109, P2797, DOI 10.1182/blood-2006-10-049312; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kung SKP, 2000, J VIROL, V74, P3668, DOI 10.1128/JVI.74.8.3668-3681.2000; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; LIANG M, 2010, J GENE MED IN PRESS; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Motohashi T, 2007, STEM CELLS, V25, P402, DOI 10.1634/stemcells.2006-0323; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas S, 2008, HUM MOL GENET, V17, P3411, DOI 10.1093/hmg/ddn235; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai KN, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/917084; VANIN EF, 1994, J VIROL, V68, P4241, DOI 10.1128/JVI.68.7.4241-4250.1994; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	59	30	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11834	10.1371/journal.pone.0011834	http://dx.doi.org/10.1371/journal.pone.0011834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676373	Green Published, gold			2022-12-25	WOS:000280520100012
J	Leal, E; Villanova, FE				Leal, Elcio; Villanova, Fabiola E.			Diversity of HIV-1 Subtype B: Implications to the Origin of BF Recombinants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO; ENVELOPE GLYCOPROTEIN; CELL TURNOVER; V3 REGION; T-CELLS; INFECTION; EVOLUTIONARY; TROPISM; BRAZIL	Background: The HIV-1 subtype B epidemic in Brazil is peculiar because of the high frequency of isolates having the GWGR tetramer at V3 loop region. It has been suggested that GWGR is a distinct variant and less pathogenic than other subtype B isolates. Methodology/Principal Findings: Ninety-four percent of the HIV-1 subtype B worldwide sequences (7689/8131) obtained from the Los Alamos HIV database contain proline at the tetramer of the V3 loop of the env gene (GPGR) and only 0.74% (60/8131) have tryptophan (GWGR). By contrast, 48.4% (161/333) of subtype B isolates from Brazil have proline, 30.6% (102/333) contain tryptophan and 10.5% (35/333) have phenylalanine (F) at the second position of the V3 loop tip. The proportion of tryptophan and phenylalanine in Brazilian isolates is much higher than in worldwide subtype B sequences (chi-square test, p = 0.0001). The combined proportion of proline, tryptophan and phenylalanine (GPGR+GWGR+GFGR) of Brazilian isolates corresponds to 89% of all amino acids in the V3 loop. Phylogenetic analysis revealed that almost all subtype B isolates in Brazil have a common origin regardless of their motif (GWGR, GPGR, GGGR, etc.) at the V3 tetramer. This shared ancestral origin was also observed in CRF28_BF and CRF29_BF in a genome region (free of recombination) derived from parental subtype B. These results imply that tryptophan substitution (e.g., GWGR-to-GxGR), which was previously associated with the change in the coreceptor usage within the host, also occurs at the population level. Conclusions/Significance: Based on the current findings and previous study showing that tryptophan and phenylalanine in the V3 loop are related with coreceptor usage, we propose that tryptophan and phenylalanine in subtype B isolates in Brazil are kept by selective mechanisms due to the distinct coreceptor preferences in target cells of GWGR, GFGR and GFGR viruses.	[Leal, Elcio; Villanova, Fabiola E.] Fed Univ Para, BR-66059 Belem, Para, Brazil	Universidade Federal do Para	Leal, E (corresponding author), Fed Univ Para, BR-66059 Belem, Para, Brazil.	elcioleal@gmail.com	Leal, Elcio/M-5275-2019; VILLANOVA, FABIOLA E/E-7437-2013; Leal, Elcio/J-6236-2016	Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/52841-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grants no. 07/52841-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; CHOE H, 1996, CELL, V85, P1; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; da Silva J, 2006, GENETICS, V174, P1689, DOI 10.1534/genetics.106.062885; Davenport MP, 2002, TRENDS MICROBIOL, V10, P275, DOI 10.1016/S0966-842X(02)02370-3; Diaz RS, 2008, VIROLOGY, V381, P184, DOI 10.1016/j.virol.2008.08.014; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hladik F, 1999, J VIROL, V73, P5833, DOI 10.1128/JVI.73.7.5833-5842.1999; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KOOT M, 1993, J INFECT DIS, V168, P733, DOI 10.1093/infdis/168.3.733; KUIKEN CL, 1992, J VIROL, V66, P5704; KUIKEN CL, 1999, COMPUTATIONAL EVOLUT; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal E, 2008, VIROLOGY, V381, P222, DOI 10.1016/j.virol.2008.08.029; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; LOUWAGIE J, 1994, AIDS RES HUM RETROV, V10, P561, DOI 10.1089/aid.1994.10.561; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Martins LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002651; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569; Ndung'u T, 2000, VIROLOGY, V278, P390, DOI 10.1006/viro.2000.0583; Peeters M, 1999, Med Trop (Mars), V59, P449; POTTS KE, 1993, AIDS, V7, P1191, DOI 10.1097/00002030-199309000-00007; Ribeiro RM, 2006, J VIROL, V80, P802, DOI 10.1128/JVI.80.2.802-809.2006; Santoro-Lopes G, 2000, AIDS RES HUM RETROV, V16, P953, DOI 10.1089/08892220050058362; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; SotoRamirez LE, 1996, SCIENCE, V271, P1291, DOI 10.1126/science.271.5253.1291; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; van Rij RP, 2003, VIROLOGY, V314, P451, DOI 10.1016/S0042-6822(03)00454-9; Vanham G, 2000, AIDS, V14, P2299, DOI 10.1097/00002030-200010200-00011; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011	47	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11833	10.1371/journal.pone.0011833	http://dx.doi.org/10.1371/journal.pone.0011833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676362	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520100011
J	Koen, EL; Garroway, CJ; Wilson, PJ; Bowman, J				Koen, Erin L.; Garroway, Colin J.; Wilson, Paul J.; Bowman, Jeff			The Effect of Map Boundary on Estimates of Landscape Resistance to Animal Movement	PLOS ONE			English	Article							CIRCUIT-THEORY; GENE FLOW; CORRIDORS; MODELS; SCALE	Background: Artificial boundaries on a map occur when the map extent does not cover the entire area of study; edges on the map do not exist on the ground. These artificial boundaries might bias the results of animal dispersal models by creating artificial barriers to movement for model organisms where there are no barriers for real organisms. Here, we characterize the effects of artificial boundaries on calculations of landscape resistance to movement using circuit theory. We then propose and test a solution to artificially inflated resistance values whereby we place a buffer around the artificial boundary as a substitute for the true, but unknown, habitat. Methodology/Principal Findings: We randomly assigned landscape resistance values to map cells in the buffer in proportion to their occurrence in the known map area. We used circuit theory to estimate landscape resistance to organism movement and gene flow, and compared the output across several scenarios: a habitat-quality map with artificial boundaries and no buffer, a map with a buffer composed of randomized habitat quality data, and a map with a buffer composed of the true habitat quality data. We tested the sensitivity of the randomized buffer to the possibility that the composition of the real but unknown buffer is biased toward high or low quality. We found that artificial boundaries result in an overestimate of landscape resistance. Conclusions/Significance: Artificial map boundaries overestimate resistance values. We recommend the use of a buffer composed of randomized habitat data as a solution to this problem. We found that resistance estimated using the randomized buffer did not differ from estimates using the real data, even when the composition of the real data was varied. Our results may be relevant to those interested in employing Circuitscape software in landscape connectivity and landscape genetics studies.	[Koen, Erin L.; Wilson, Paul J.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Bowman, Jeff] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON, Canada	Trent University; Ministry of Natural Resources & Forestry	Koen, EL (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	erinkoen@trentu.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Garroway, Colin/0000-0002-0955-0688	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc.gc.ca) scholarship to ELK and CJG, and a NSERC grant to JB and PJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Bowman J, 2005, FOREST CHRON, V81, P801, DOI 10.5558/tfc81801-6; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Dixon JD, 2006, CONSERV BIOL, V20, P155, DOI 10.1111/j.1523-1739.2005.00292.x; Haddad NM, 2003, ECOLOGY, V84, P609, DOI 10.1890/0012-9658(2003)084[0609:CUBDT]2.0.CO;2; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Pascual-Hortal L, 2007, LANDSCAPE URBAN PLAN, V83, P176, DOI 10.1016/j.landurbplan.2007.04.003; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Roberts JH, 2007, T AM FISH SOC, V136, P971, DOI 10.1577/T06-215.1; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; SHAH VB, 2008, P 7 PYTH SCI C PAS 2; Theobald D.M., 2006, CONNECTIVITY CONSERV, P416, DOI DOI 10.1017/CBO9780511754821.019; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Verbeylen G, 2003, LANDSCAPE ECOL, V18, P791, DOI 10.1023/B:LAND.0000014492.50765.05	22	75	76	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11785	10.1371/journal.pone.0011785	http://dx.doi.org/10.1371/journal.pone.0011785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668690	gold, Green Published, Green Submitted			2022-12-25	WOS:000280297300017
J	TeKippe, M; Aballay, A				TeKippe, Michael; Aballay, Alejandro			C. elegans Germline-Deficient Mutants Respond to Pathogen Infection Using Shared and Distinct Mechanisms	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; INNATE IMMUNITY; DROSOPHILA-MELANOGASTER; SIGNALING PATHWAY; TUMOR-GROWTH; LINE; LONGEVITY; BACTERIAL; DAF-16	Reproduction extracts a cost in resources that organisms are then unable to utilize to deal with a multitude of environmental stressors. In the nematode C. elegans, development of the germline shortens the lifespan of the animal and increases its susceptibility to microbial pathogens. Prior studies have demonstrated germline-deficient nematodes to have increased resistance to Gram negative bacteria. We show that germline-deficient strains display increased resistance across a broad range of pathogens including Gram positive and Gram negative bacteria, and the fungal pathogen Cryptococcus neoformans. Furthermore, we show that the FOXO transcription factor DAF-16, which regulates longevity and immunity in C. elegans, appears to be crucial for maintaining longevity in both wild-type and germline-deficient backgrounds. Our studies indicate that germline-deficient mutants glp-1 and glp-4 respond to pathogen infection using common and different mechanisms that involve the activation of DAF-16.	[TeKippe, Michael; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA	Duke University	TeKippe, M (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	a.aballay@duke.edu			National Institutes of Health [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977, R37GM070977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM070977 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Anyanful A, 2009, CELL HOST MICROBE, V5, P450, DOI 10.1016/j.chom.2009.04.012; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Davies S, 2005, EXP GERONTOL, V40, P784, DOI 10.1016/j.exger.2005.07.009; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Fedorka KM, 2007, P ROY SOC B-BIOL SCI, V274, P1211, DOI 10.1098/rspb.2006.0394; Fedorka KM, 2004, EVOLUTION, V58, P2478; FRANCIS R, 1995, GENETICS, V139, P579; FRANCIS R, 1995, GENETICS, V139, P607; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gami MS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-45; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gwynn DM, 2005, P ROY SOC B-BIOL SCI, V272, P1803, DOI 10.1098/rspb.2005.3089; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; ROBERTS TM, 1982, J CELL BIOL, V92, P113, DOI 10.1083/jcb.92.1.113; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; WARD S, 1978, GENETICS, V88, P285; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	48	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11777	10.1371/journal.pone.0011777	http://dx.doi.org/10.1371/journal.pone.0011777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668681	Green Submitted, Green Published, gold			2022-12-25	WOS:000280297300012
J	Alaoui-El-Azher, M; Mans, JJ; Baker, HV; Chen, C; Progulske-Fox, A; Lamont, RJ; Handfield, M				Alaoui-El-Azher, Mounia; Mans, Jeffrey J.; Baker, Henry V.; Chen, Casey; Progulske-Fox, Ann; Lamont, Richard J.; Handfield, Martin			Role of the ATM-Checkpoint Kinase 2 Pathway in CDT-Mediated Apoptosis of Gingival Epithelial Cells	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; HUMAN T-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; CYCLE ARREST; DNA-DAMAGE; G(2) ARREST; PROTEIN; PHOSPHORYLATION; FIBROBLASTS; INHIBITION	The cytolethal distending toxin (CDT) of the oral pathogen Aggregatibacter actinomycetemcomitans induces cell cycle arrest and apoptosis in various cell types. Western analysis, pharmacological inhibition and siRNA silencing were performed in human immortalized gingival keratinocytes (HIGK) to dissect the functional role of the ataxia telangiectasia mutated (ATM) pathway in the signal transduction steps triggered by the CDT. Infection of HIGK was associated with a time-dependent induction of cytoplasmic histone-associated DNA fragmentation. However, in the absence of CDT, infected HIGK underwent reversible DNA strand breaks but not apoptosis, while caspase 3 activity, p21 levels, and HIGK viability were unaffected. Caspase 9 activity was attenuated in the CDT mutant-infected HIGK compared to wild-type infected cells. Pharmacological inhibition and siRNA-silencing of the ATM downstream effector, the protein kinase checkpoint kinase 2 (Chk2), significantly impacted CDT-mediated apoptosis. Together, these findings provide insight on the specificity of the ATM-Chk2 pathway in response to the CDT of A. actinomycetemcomitans in oral epithelial cells, which ultimately leads to apoptosis. We further propose the existence of an unidentified factor that is distinct from the CDT, and involved with a reversible DNA fragmentation that does not trigger terminal apoptosis in oral epithelial cells. This model potentially explains conflicting reports on the biological activity of the A. actinomycetemcomitans CDT.	[Alaoui-El-Azher, Mounia; Mans, Jeffrey J.; Progulske-Fox, Ann; Lamont, Richard J.; Handfield, Martin] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Alaoui-El-Azher, Mounia; Mans, Jeffrey J.; Progulske-Fox, Ann; Lamont, Richard J.; Handfield, Martin] Univ Florida, Coll Dent, Ctr Mol Microbiol, Gainesville, FL USA; [Baker, Henry V.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Chen, Casey] Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Southern California	Alaoui-El-Azher, M (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	mhandfield@dental.ufl.edu		Baker, Henry/0000-0002-8273-5320	United States National Institute of Dental and Craniofacial Research, National Institutes of Health, NIH/NIDCR [DE16715, DE11111]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE011111, R01DE011111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016715] Funding Source: NIH RePORTER	United States National Institute of Dental and Craniofacial Research, National Institutes of Health, NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by the United States National Institute of Dental and Craniofacial Research, National Institutes of Health, NIH/NIDCR DE16715 (MH) and DE11111() RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Belibasakis GN, 2004, APMIS, V112, P674, DOI 10.1111/j.1600-0463.2004.apm1121006.x; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; da Silva RM, 2005, J PERIODONTOL, V76, P590, DOI 10.1902/jop.2005.76.4.590; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Frisan T, 2002, INT J MED MICROBIOL, V291, P495; Frisk A, 2001, MICROB PATHOGENESIS, V30, P313, DOI 10.1006/mpat.2000.0436; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Handfield M, 2005, CELL MICROBIOL, V7, P811, DOI 10.1111/j.1462-5822.2005.00513.x; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; LAGERGARD T, 1993, MICROB PATHOGENESIS, V14, P417, DOI 10.1006/mpat.1993.1041; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Levenbrown Y, 2008, NEUROSCI LETT, V447, P96, DOI 10.1016/j.neulet.2008.09.076; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Mintz KP, 2000, INFECT IMMUN, V68, P6580, DOI 10.1128/IAI.68.12.6580-6586.2000; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; Oda D, 1996, EXP CELL RES, V226, P164, DOI 10.1006/excr.1996.0215; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; Ohguchi M, 1998, INFECT IMMUN, V66, P5980, DOI 10.1128/IAI.66.12.5980-5987.1998; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sato T, 2002, INFECT IMMUN, V70, P528, DOI 10.1128/IAI.70.2.528-534.2002; Shenker BJ, 2006, INFECT IMMUN, V74, P2080, DOI 10.1128/IAI.74.4.2080-2092.2006; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; SREENIVASAN PK, 1991, INFECT IMMUN, V59, P4621, DOI 10.1128/IAI.59.12.4621-4627.1991; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; van Winkelhoff AJ, 1999, PERIODONTOL 2000, V20, P122; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Wang Y, 2005, INFECT IMMUN, V73, P3749, DOI 10.1128/IAI.73.6.3749-3753.2005; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	43	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11714	10.1371/journal.pone.0011714	http://dx.doi.org/10.1371/journal.pone.0011714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668524	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800006
J	Branco, S; Ree, RH				Branco, Sara; Ree, Richard H.			Serpentine Soils Do Not Limit Mycorrhizal Fungal Diversity	PLOS ONE			English	Article							ECTOMYCORRHIZAL COMMUNITIES; CENOCOCCUM-GEOPHILUM; EVOLUTION; SYSTEMATICS; ADAPTATION; LIFE; DIVERGENCE; TOLERANCE; RADIATION; ECOLOGY	Background: Physiologically stressful environments tend to host depauperate and specialized biological communities. Serpentine soils exemplify this phenomenon by imposing well-known constraints on plants; however, their effect on other organisms is still poorly understood. Methodology/Principal Findings: We used a combination of field and molecular approaches to test the hypothesis that serpentine fungal communities are species-poor and specialized. We conducted surveys of ectomycorrhizal fungal diversity from adjacent serpentine and non-serpentine sites, described fungal communities using nrDNA Internal Transcribed Spacer (ITS) fragment and sequence analyses, and compared their phylogenetic community structure. Although we detected low fungal overlap across the two habitats, we found serpentine soils to support rich fungal communities that include representatives from all major fungal lineages. We failed to detect the phylogenetic signature of endemic clades that would result from specialization and adaptive radiation within this habitat. Conclusions/Significance: Our results indicate that serpentine soils do not constitute an extreme environment for ectomycorrhizal fungi, and raise important questions about the role of symbioses in edaphic tolerance and the maintenance of biodiversity.	[Branco, Sara] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Branco, Sara; Ree, Richard H.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Branco, Sara] Ctr Invest Montanha, Braganca, Portugal	University of Chicago; Field Museum of Natural History (Chicago); Instituto Politecnico de Braganca	Branco, S (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	sbranco@uchicago.edu			University of Chicago; Fulbright Commission (Portugal); Fundacao Calouste Gulbenkian (Portugal); Field Museum Women's Board Graduate Fellowship; Pritzker Foundation	University of Chicago(University of Chicago); Fulbright Commission (Portugal); Fundacao Calouste Gulbenkian (Portugal); Field Museum Women's Board Graduate Fellowship; Pritzker Foundation	This study was funded by the University of Chicago Hinds Funds. S. Branco is supported by the Fulbright Commission (Portugal), Fundacao Calouste Gulbenkian (Portugal), and the Field Museum Women's Board Graduate Fellowship. This research was carried out in the Field Museum's Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR C, 2002, THESIS U TECNICA LIS; Alexander E.B., 2007, SERPENTINE GEOECOLOG; ANTONOVICS J., 1971, Advances in Ecological Research, V7, P1, DOI 10.1016/S0065-2504(08)60202-0; Avis PG, 2008, NEW PHYTOL, V179, P472, DOI 10.1111/j.1469-8137.2008.02491.x; Avis PG, 2003, NEW PHYTOL, V160, P239, DOI 10.1046/j.1469-8137.2003.00865.x; Binder M, 2006, MYCOLOGIA, V98, P971, DOI 10.3852/mycologia.98.6.971; Blaudez D, 2000, MYCOL RES, V104, P1366, DOI 10.1017/S0953756200003166; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Branco S, 2009, NORTHEAST NAT, V16, P329, DOI 10.1656/045.016.0524; Brooks R.R., 1987, SERPENTINE ITS VEGET; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Clarke A, 1996, TRENDS ECOL EVOL, V11, P212, DOI 10.1016/0169-5347(96)10029-X; DION P, 2008, MICROBIOLOGY EXTREME, P369; Douhan GW, 2007, CURR GENET, V52, P191, DOI 10.1007/s00294-007-0150-1; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Espeland M, 2008, MOL PHYLOGENET EVOL, V48, P904, DOI 10.1016/j.ympev.2008.06.006; Fitzsimons MS, 2010, PLANT SOIL, V330, P393, DOI 10.1007/s11104-009-0213-9; Freckman DW, 1997, ECOLOGY, V78, P363, DOI 10.1890/0012-9658(1997)078[0363:LDASNC]2.0.CO;2; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; Gardes M, 1996, CAN J BOT, V74, P1572, DOI 10.1139/b96-190; Gehring CA, 1998, ECOLOGY, V79, P1562, DOI 10.1890/0012-9658(1998)079[1562:EFCSOP]2.0.CO;2; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Haase M, 1998, HYDROBIOLOGIA, V367, P43, DOI 10.1023/A:1003219931171; Hansen K, 2006, MYCOLOGIA, V98, P1029, DOI 10.3852/mycologia.98.6.1029; Harris DJ, 1998, MOL PHYLOGENET EVOL, V10, P37, DOI 10.1006/mpev.1997.0463; Hartley J, 1997, PLANT SOIL, V189, P303, DOI 10.1023/A:1004255006170; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kazakou E, 2008, BIOL REV, V83, P495, DOI 10.1111/j.1469-185X.2008.00051.x; Kruckeberg A. R., 2002, GEOLOGY PLANT LIFE E; KRUCKEBERG AR, 1954, ECOLOGY, V35, P267, DOI 10.2307/1931126; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maddison WP, 2008, MESQUITE MODULAR SYS; Malpas J., 1992, ECOLOGY AREAS SERPEN, P7, DOI 10.1007/978-94-011-3722-5_2; MATHENY B, 2006, MOL PHYLLOGENET EVOL, V43, P430; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Miller SL, 2006, MYCOLOGIA, V98, P960, DOI 10.3852/mycologia.98.6.960; Moncalvo JM, 2006, MYCOLOGIA, V98, P937, DOI 10.3852/mycologia.98.6.937; Morris MH, 2008, NEW PHYTOL, V178, P167, DOI 10.1111/j.1469-8137.2007.02348.x; Moser AM, 2009, PLANT SOIL, V315, P185, DOI 10.1007/s11104-008-9743-9; OKANEN J, 2005, VEGAN COMMUNITY ECOL; Panaccione DG, 2001, MYCOLOGIA, V93, P645, DOI 10.2307/3761819; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parrent JL, 2010, NEW PHYTOL, V185, P882, DOI 10.1111/j.1469-8137.2010.03190.x; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Proctor J, 1999, TRENDS ECOL EVOL, V14, P334, DOI 10.1016/S0169-5347(99)01698-5; Ram HYM, 1997, CURR SCI INDIA, V72, P306; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Sugiyama J, 2006, MYCOLOGIA, V98, P996, DOI 10.3852/mycologia.98.6.996; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Taylor AFS, 2002, PLANT SOIL, V244, P19, DOI 10.1023/A:1020279815472; Urban A, 2008, MYCORRHIZA, V18, P339, DOI 10.1007/s00572-008-0189-y; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Walker JF, 2005, MOL ECOL, V14, P829, DOI 10.1111/j.1365-294X.2005.02455.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; White T., 1990, PCR PROTOCOLS GUIDE, P315; WILKINSON DM, 1995, OIKOS, V72, P298, DOI 10.2307/3546233; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	67	34	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11757	10.1371/journal.pone.0011757	http://dx.doi.org/10.1371/journal.pone.0011757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668696	gold, Green Submitted, Green Published			2022-12-25	WOS:000280243800026
J	Jovanovic, K; Pastor, AM; O'Donovan, MJ				Jovanovic, Ksenija; Pastor, Angel M.; O'Donovan, Michael J.			The Use of PRV-Bartha to Define Premotor Inputs to Lumbar Motoneurons in the Neonatal Spinal Cord of the Mouse	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RETROGRADE TRANSSYNAPTIC TRANSPORT; PSEUDORABIES VIRUS; RENSHAW CELLS; SUPRACHIASMATIC NUCLEUS; SYNAPTIC ACTIONS; REFLEX PATHWAYS; INTERNEURONS; NEURONS; PARVALBUMIN	Background: The neonatal mouse has become a model system for studying the locomotor function of the lumbar spinal cord. However, information about the synaptic connectivity within the governing neural network remains scarce. A neurotropic pseudorabies virus (PRV) Bartha has been used to map neuronal connectivity in other parts of the nervous system, due to its ability to travel trans-neuronally. Its use in spinal circuits regulating locomotion has been limited and no study has defined the time course of labelling for neurons known to project monosynaptically to motoneurons. Methodology/Principal Findings: Here we investigated the ability of PRV Bartha, expressing green and/or red fluorescence, to label spinal neurons projecting monosynaptically to motoneurons of two principal hindlimb muscles, the tibialis anterior (TA) and gastrocnemius (GC). As revealed by combined immunocytochemistry and confocal microscopy, 24-32 h after the viral muscle injection the label was restricted to the motoneuron pool while at 32-40 h the fluorescence was seen in interneurons throughout the medial and lateral ventral grey matter. Two classes of ipsilateral interneurons known to project monosynaptically to motoneurons (Renshaw cells and cells of origin of C-terminals) were consistently labeled at 40 h post-injection but also a group in the ventral grey matter contralaterally. Our results suggest that the labeling of last order interneurons occurred 8-12 h after motoneuron labeling and we presume this is the time taken by the virus to cross one synapse, to travel retrogradely and to replicate in the labeled cells. Conclusions/Significance: The study establishes the time window for virally - labelling monosynaptic projections to lumbar motoneurons following viral injection into hindlimb muscles. Moreover, it provides a good foundation for intracellular targeting of the labeled neurons in future physiological studies and better understanding the functional organization of the lumbar neural networks.	[Jovanovic, Ksenija; O'Donovan, Michael J.] Natl Inst Neurol Disorders & Stroke, Dev Neurobiol Sect, NIH, Bethesda, MD 20892 USA; [Jovanovic, Ksenija] Hosp Nacl Paraplejicos, Lab Reparac Neural & Biomat, Toledo, Spain; [Pastor, Angel M.] Univ Seville, Dept Fisiol & Zool, Fac Biol, Seville, Spain	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Hospital Nacional de Paraplejicos; University of Sevilla	Jovanovic, K (corresponding author), Natl Inst Neurol Disorders & Stroke, Dev Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	ODonovM@ninds.nih.gov	o'donovan, michael/A-2357-2015; Pastor, Angel M. M/A-6385-2010	o'donovan, michael/0000-0003-2487-7547; Pastor, Angel M. M/0000-0002-6213-7454	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; MICINN-FEDER, Spain [PET2008-0226, BFU2009-07121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002787] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MICINN-FEDER, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland to Michael O'Donovan and the grants PET2008-0226 and BFU2009-07121 from MICINN-FEDER, Spain to Angel M. Pastor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; Anelli R, 2005, J NEUROCYTOL, V34, P369, DOI 10.1007/s11068-006-8724-2; Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Boldogkoi Z, 2009, NAT METHODS, V6, P127, DOI [10.1038/NMETH.1292, 10.1038/nmeth.1292]; BRINK E, 1983, J PHYSIOL-LONDON, V343, P361, DOI 10.1113/jphysiol.1983.sp014897; Brittle EE, 2004, J VIROL, V78, P12951, DOI 10.1128/JVI.78.23.12951-12963.2004; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CARD JP, 1990, J NEUROSCI, V10, P1974; Carr PA, 1998, NEUROREPORT, V9, P2657, DOI 10.1097/00001756-199808030-00043; Chamberlin NL, 2007, J PHYSIOL-LONDON, V579, P515, DOI 10.1113/jphysiol.2006.121889; Clowry GJ, 1997, DEV BRAIN RES, V102, P197, DOI 10.1016/S0165-3806(97)00098-9; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dekkers J, 2004, NEUROSCIENCE, V123, P459, DOI 10.1016/j.neuroscience.2003.07.013; DOBBINS EG, 1995, J COMP NEUROL, V357, P376, DOI 10.1002/cne.903570305; DOBBINS EG, 1994, J COMP NEUROL, V86, P47; Dougherty KJ, 2010, J NEUROSCI, V30, P24, DOI 10.1523/JNEUROSCI.4821-09.2010; EDGLEY SA, 1989, J PHYSIOL-LONDON, V411, P469, DOI 10.1113/jphysiol.1989.sp017584; Enquist LW, 2002, J INFECT DIS, V186, pS209, DOI 10.1086/344278; GAZELIUS H, 2009, NEUR M PLANN CHIC IL; Geiman RJ, 2000, J COMP NEUROL, V426, P130, DOI 10.1002/1096-9861(20001009)426:1<130::AID-CNE9>3.0.CO;2-7; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Granstedt AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006923; HAMM TM, 1990, J NEUROPHYSIOL, V63, P395, DOI 10.1152/jn.1990.63.3.395; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147, DOI 10.1113/jphysiol.1986.sp015965; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V226, P805, DOI 10.1113/jphysiol.1972.sp010011; Jankowska E, 2005, J PHYSIOL-LONDON, V565, P645, DOI 10.1113/jphysiol.2005.083014; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V222, P623, DOI 10.1113/jphysiol.1972.sp009818; JANOWSKA E, 1971, ACTA PHYSIOL SCAND, V81, P428, DOI 10.1111/j.1748-1716.1971.tb04918.x; JOVANOVIC K, 2006, 5 FOR EUR NEUR VIENN; Kerman IA, 2003, J NEUROSCI, V23, P4657; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kim ES, 2000, BRAIN RES, V857, P41, DOI 10.1016/S0006-8993(99)02332-X; KUYPERS HGJM, 1990, TRENDS NEUROSCI, V13, P71, DOI 10.1016/0166-2236(90)90071-H; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; LEONG SK, 1990, J NEUROSCI METH, V32, P15, DOI 10.1016/0165-0270(90)90067-P; Marina N, 2008, AUTON NEUROSCI-BASIC, V139, P15, DOI 10.1016/j.autneu.2007.12.004; McCarthy KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000640; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; Nishimaru H, 2006, J NEUROSCI, V26, P5320, DOI 10.1523/JNEUROSCI.5127-05.2006; NOGA BR, 1987, EXP BRAIN RES, V66, P99; Pastor AM, 2003, J NEUROPHYSIOL, V89, P793, DOI 10.1152/jn.00498.2002; Pickard GE, 2002, J NEUROSCI, V22, P2701, DOI 10.1523/JNEUROSCI.22-07-02701.2002; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Ptak K, 2005, J NEUROSCI, V25, P5159, DOI 10.1523/JNEUROSCI.4238-04.2005; Puskar Z, 1997, J COMP NEUROL, V389, P377, DOI 10.1002/(SICI)1096-9861(19971222)389:3<377::AID-CNE2>3.0.CO;2-Y; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; RENSHAW B, 1946, J NEUROPHYSIOL, V9, P191, DOI 10.1152/jn.1946.9.3.191; ROTTOPERCELAY DM, 1992, BRAIN RES, V574, P291, DOI 10.1016/0006-8993(92)90829-X; Shintani T, 2003, J APPL PHYSIOL, V95, P1453, DOI 10.1152/japplphysiol.00558.2003; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; Smeraski CA, 2004, J COMP NEUROL, V471, P298, DOI 10.1002/cne.20030; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; STRACK AM, 1990, J NEUROSCI, V10, P2139; THOMAS RC, 1965, NATURE, V206, P211, DOI 10.1038/206211b0; TISSENBAUM HA, 1991, CAN J PHYSIOL PHARM, V69, P1769, DOI 10.1139/y91-261; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010; Wilson JM, 2004, J COMP NEUROL, V474, P13, DOI 10.1002/cne.20089; Xu C, 2006, NEUROSCIENCE, V138, P561, DOI 10.1016/j.neuroscience.2005.11.016; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; ZHANG JH, 1990, J COMP NEUROL, V302, P715, DOI 10.1002/cne.903020404	67	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11743	10.1371/journal.pone.0011743	http://dx.doi.org/10.1371/journal.pone.0011743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668534	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800017
J	Cannon, SB; Ilut, D; Farmer, AD; Maki, SL; May, GD; Singer, SR; Doyle, JJ				Cannon, Steven B.; Ilut, Dan; Farmer, Andrew D.; Maki, Sonja L.; May, Gregory D.; Singer, Susan R.; Doyle, Jeff J.			Polyploidy Did Not Predate the Evolution of Nodulation in All Legumes	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; GENE DUPLICATION; WHOLE-GENOME; PHYLOGENY; DIVERSIFICATION; PALEOPOLYPLOIDY; LEGUMINOSAE; ANGIOSPERMS; SEQUENCES; FAMILY	Background: Several lines of evidence indicate that polyploidy occurred by around 54 million years ago, early in the history of legume evolution, but it has not been known whether this event was confined to the papilionoid subfamily (Papilionoideae; e. g. beans, medics, lupins) or occurred earlier. Determining the timing of the polyploidy event is important for understanding whether polyploidy might have contributed to rapid diversification and radiation of the legumes near the origin of the family; and whether polyploidy might have provided genetic material that enabled the evolution of a novel organ, the nitrogen-fixing nodule. Although symbioses with nitrogen-fixing partners have evolved in several lineages in the rosid I clade, nodules are widespread only in legume taxa, being nearly universal in the papilionoids and in the mimosoid subfamily (e. g., mimosas, acacias) - which diverged from the papilionoid legumes around 58 million years ago, soon after the origin of the legumes. Methodology/Principal Findings: Using transcriptome sequence data from Chamaecrista fasciculata, a nodulating member of the mimosoid clade, we tested whether this species underwent polyploidy within the timeframe of legume diversification. Analysis of gene family branching orders and synonymous-site divergence data from C. fasciculata, Glycine max (soybean), Medicago truncatula, and Vitis vinifera (grape; an outgroup to the rosid taxa) establish that the polyploidy event known from soybean and Medicago occurred after the separation of the mimosoid and papilionoid clades, and at or shortly before the Papilionoideae radiation. Conclusions: The ancestral legume genome was not fundamentally polyploid. Moreover, because there has not been an independent instance of polyploidy in the Chamaecrista lineage there is no necessary connection between polyploidy and nodulation in legumes. Chamaecrista may serve as a useful model in the legumes that lacks a paleopolyploid history, at least relative to the widely studied papilionoid models.	[Cannon, Steven B.] Iowa State Univ, USDA ARS, Corn Insects & Crop Genom Res Unit, Ames, IA 50011 USA; [Ilut, Dan; Doyle, Jeff J.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Farmer, Andrew D.; May, Gregory D.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Maki, Sonja L.; Singer, Susan R.] Carleton Coll, Dept Biol, Northfield, MN 55057 USA	Iowa State University; United States Department of Agriculture (USDA); Cornell University; National Center for Genome Resources (NCGR); Carleton College	Cannon, SB (corresponding author), Iowa State Univ, USDA ARS, Corn Insects & Crop Genom Res Unit, Ames, IA 50011 USA.	steven.cannon@ars.usda.gov		Ilut, Daniel/0000-0001-7497-9109	National Science Foundation [DEB-0746571, DUE-0837375]	National Science Foundation(National Science Foundation (NSF))	Supported by the National Science Foundation (grants DEB-0746571 and DUE-0837375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertioli DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-45; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bruneau A, 2008, BOTANY, V86, P697, DOI 10.1139/B08-058; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Doyle JJ, 1997, AM J BOT, V84, P541, DOI 10.2307/2446030; DOYLE JJ, 1994, ANNU REV ECOL SYST, V25, P325; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Foster CM, 1998, PLANT SOIL, V205, P103, DOI 10.1023/A:1004309414388; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; James EK, 1999, NEW PHYTOL, V142, P219, DOI 10.1046/j.1469-8137.1999.00394.x; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee A, 2006, PLANT SIGNAL BEHAV, V1, P161, DOI 10.4161/psb.1.4.3143; Lewis G, 2005, LEGUMES WORLD; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mathesius U, 2000, MOL PLANT MICROBE IN, V13, P617, DOI 10.1094/MPMI.2000.13.6.617; MGSC, 2007, MED TRUNC GEN MT2 0; Mudge J, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-15; NAISBITT T, 1992, NEW PHYTOL, V122, P487, DOI 10.1111/j.1469-8137.1992.tb00077.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; OHRI D, 1986, PLANT SYST EVOL, V153, P223, DOI 10.1007/BF00983689; Pennington RT, 2001, SYST BOT, V26, P537; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Ravi V, 2007, MOL PHYLOGENET EVOL, V44, P488, DOI 10.1016/j.ympev.2006.11.014; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; SCHMUTZ J, 2009, NATURE IN PRESS; Singer SR, 2009, PLANT PHYSIOL, V151, P1041, DOI 10.1104/pp.109.144774; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Sprent J.I., 2009, LEGUME NODULATION GL; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; TRINICK MJ, 1989, APPL ENVIRON MICROB, V55, P2046, DOI 10.1128/AEM.55.8.2046-2055.1989; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wikstrom N, 2003, SYST ASSOC SPEC VOL, P142; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846	56	57	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11630	10.1371/journal.pone.0011630	http://dx.doi.org/10.1371/journal.pone.0011630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661290	gold, Green Published, Green Submitted			2022-12-25	WOS:000279980800018
J	Hewitt, CA; Ling, KH; Merson, TD; Simpson, KM; Ritchie, ME; King, SL; Pritchard, MA; Smyth, GK; Thomas, T; Scott, HS; Voss, AK				Hewitt, Chelsee A.; Ling, King-Hwa; Merson, Tobias D.; Simpson, Ken M.; Ritchie, Matthew E.; King, Sarah L.; Pritchard, Melanie A.; Smyth, Gordon K.; Thomas, Tim; Scott, Hamish S.; Voss, Anne K.			Gene Network Disruptions and Neurogenesis Defects in the Adult Ts1Cje Mouse Model of Down Syndrome	PLOS ONE			English	Article							TRISOMY 16 MOUSE; HIGH-RESOLUTION MRI; NEURAL STEM-CELL; TS65DN MICE; IN-VIVO; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; BEHAVIORAL ABNORMALITIES; NEURONAL MIGRATION; MAMMALIAN BRAIN	Background: Down syndrome (DS) individuals suffer mental retardation with further cognitive decline and early onset Alzheimer's disease. Methodology/Principal Findings: To understand how trisomy 21 causes these neurological abnormalities we investigated changes in gene expression networks combined with a systematic cell lineage analysis of adult neurogenesis using the Ts1Cje mouse model of DS. We demonstrated down regulation of a number of key genes involved in proliferation and cell cycle progression including Mcm7, Brca2, Prim1, Cenpo and Aurka in trisomic neurospheres. We found that trisomy did not affect the number of adult neural stem cells but resulted in reduced numbers of neural progenitors and neuroblasts. Analysis of differentiating adult Ts1Cje neural progenitors showed a severe reduction in numbers of neurons produced with a tendency for less elaborate neurites, whilst the numbers of astrocytes was increased. Conclusions/Significance: We have shown that trisomy affects a number of elements of adult neurogenesis likely to result in a progressive pathogenesis and consequently providing the potential for the development of therapies to slow progression of, or even ameliorate the neuronal deficits suffered by DS individuals.	[Hewitt, Chelsee A.; Ling, King-Hwa; Merson, Tobias D.; Simpson, Ken M.; Ritchie, Matthew E.; King, Sarah L.; Smyth, Gordon K.; Thomas, Tim; Scott, Hamish S.; Voss, Anne K.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Thomas, Tim; Voss, Anne K.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Hewitt, Chelsee A.] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Ling, King-Hwa; Scott, Hamish S.] Univ Adelaide, Sch Med, Dept Mol Pathol, Ctr Canc Biol,Inst Med & Vet Sci, Adelaide, SA, Australia; [Ling, King-Hwa; Scott, Hamish S.] Univ Adelaide, Sch Med, Hanson Inst, SA Pathol, Adelaide, SA, Australia; [Ling, King-Hwa; Scott, Hamish S.] Univ Adelaide, Sch Med, Adelaide Canc Res Inst, Adelaide, SA, Australia; [Pritchard, Melanie A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Ling, King-Hwa] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Serdang, Malaysia	Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Centre for Cancer Biology; Institute Medical & Veterinary Science Australia; University of Adelaide; Hanson Institute; SA Pathology; University of Adelaide; University of Adelaide; Monash University; Universiti Putra Malaysia	Hewitt, CA (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	Chelsee.Hewitt@Petermac.org; hamish.scott@health.sa.gov.au	Ritchie, Matthew/I-3874-2019; Smyth, Gordon/B-5276-2008; Ling, King-Hwa/M-2349-2018; Voss, Anne K/F-5110-2013; Merson, Tobias D/D-5375-2015; Scott, Hamish/B-2122-2009	Ritchie, Matthew/0000-0002-7383-0609; Smyth, Gordon/0000-0001-9221-2892; Ling, King-Hwa/0000-0002-3968-7263; Voss, Anne K/0000-0002-3853-9381; Merson, Tobias D/0000-0002-7246-3608; Scott, Hamish/0000-0002-5813-631X; Thomas, Tim/0000-0002-7623-8344; Hewitt, Chelsee/0000-0001-7472-6128	APEX Foundation for Research into Intellectual Disability Limited; National Health and Medical Research Council [171601, 461204, 575512, 219176, 257501, 257529]; Melbourne International Fee Remission Scholarship (MIFRS); Universiti Putra Malaysia Staff Training Scholarship (UPMSTS); Adelaide Fee Scholarship International (AFSI)	APEX Foundation for Research into Intellectual Disability Limited; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Fee Remission Scholarship (MIFRS); Universiti Putra Malaysia Staff Training Scholarship (UPMSTS); Adelaide Fee Scholarship International (AFSI)	This work was supported by the APEX Foundation for Research into Intellectual Disability Limited to C. H.; National Health and Medical Research Council fellowships 171601 and 461204 to H. S. S. and 575512 to A. K. V.; National Health and Medical Research Council Grants 219176, 257501 and 257529 to H. S. S. and G. K. S. K.-H. L. was a recipient of Melbourne International Fee Remission Scholarship (MIFRS) and Universiti Putra Malaysia Staff Training Scholarship (UPMSTS), and an Adelaide Fee Scholarship International (AFSI) equivalent award. The microarrays were performed by the Australian Genome Research Facility, which was established through the Commonwealth-funded Major National Research Facilities program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, J ANAT, V80, P37; Anderson L, 2007, EXP NEUROL, V204, P512, DOI 10.1016/j.expneurol.2006.12.025; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Aylward EH, 1999, AM J PSYCHIAT, V156, P564; Aylward EH, 1997, ARCH NEUROL-CHICAGO, V54, P209, DOI 10.1001/archneur.1997.00550140077016; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Benavides-Piccione R, 2004, PROG NEUROBIOL, V74, P111, DOI 10.1016/j.pneurobio.2004.08.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bersu ET, 1998, DEV BRAIN RES, V109, P115, DOI 10.1016/S0165-3806(98)00070-4; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; CASERTA MT, 1990, MOL BRAIN RES, V7, P269, DOI 10.1016/0169-328X(90)90037-E; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P; Chen WM, 2004, GENET EPIDEMIOL, V26, P265, DOI 10.1002/gepi.10315; Clark S, 2006, EXP NEUROL, V200, P256, DOI 10.1016/j.expneurol.2006.02.005; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Contestabile A, 2009, BRAIN PATHOL, V19, P224, DOI 10.1111/j.1750-3639.2008.00168.x; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; DELAMONTE SM, 1990, J NEUROPATH EXP NEUR, V49, P509, DOI 10.1097/00005072-199009000-00006; Demas GE, 1998, BEHAV BRAIN RES, V90, P199, DOI 10.1016/S0166-4328(97)00116-2; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; FLOREZ J, 1992, BIOMEDICAL CONCERNS, P159; GEARHART JD, 1986, BRAIN RES BULL, V16, P789, DOI 10.1016/0361-9230(86)90075-4; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Granholm AC, 2003, HIPPOCAMPUS, V13, P905, DOI 10.1002/hipo.10130; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; GRAUSZ H, 1991, PROG CLIN BIOL RES, V373, P169; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Haydar TF, 1996, J NEUROSCI, V16, P6175; Haydar TF, 2000, J NEUROSCI, V20, P4156; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hyde LA, 2002, BRAIN RES, V945, P26, DOI 10.1016/S0006-8993(02)02500-3; Hyde LA, 2001, BEHAV BRAIN RES, V118, P53, DOI 10.1016/S0166-4328(00)00313-2; ISHIHARA K, 2009, CEREB CORTEX ADV ACC; JERNIGAN TL, 1993, ARCH NEUROL-CHICAGO, V50, P186, DOI 10.1001/archneur.1993.00540020062019; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LACEYCASEM ML, 1994, CRIT REV NEUROBIOL, V8, P293; Langaas M, 2005, J ROY STAT SOC B, V67, P555, DOI 10.1111/j.1467-9868.2005.00515.x; Lockrow J, 2009, EXP NEUROL, V216, P278, DOI 10.1016/j.expneurol.2008.11.021; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Machon O, 2005, MOL CELL NEUROSCI, V30, P388, DOI 10.1016/j.mcn.2005.08.003; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Merson TD, 2006, J NEUROSCI, V26, P11359, DOI 10.1523/JNEUROSCI.2247-06.2006; Moldrich RX, 2009, J NEUROSCI RES, V87, P3143, DOI 10.1002/jnr.22131; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; ORourke NA, 1996, NEURON, V16, P1061, DOI 10.1016/S0896-6273(00)80130-0; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Pace R, 2006, CLAVIER, V45, P2; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Patterson D, 2009, HUM GENET, V126, P195, DOI 10.1007/s00439-009-0696-8; Pinter JD, 2001, AM J PSYCHIAT, V158, P1659, DOI 10.1176/appi.ajp.158.10.1659; Pinter JD, 2001, NEUROLOGY, V56, P972, DOI 10.1212/WNL.56.7.972; RAZ N, 1995, NEUROLOGY, V45, P356, DOI 10.1212/WNL.45.2.356; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; REEVES RH, 1986, BRAIN RES BULL, V16, P803, DOI 10.1016/0361-9230(86)90076-6; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Roper RJ, 2006, P NATL ACAD SCI USA, V103, P1452, DOI 10.1073/pnas.0510750103; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Rueda N, 2005, NEUROSCI LETT, V380, P197, DOI 10.1016/j.neulet.2005.01.039; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Santa-Olalla J, 2003, EUR J NEUROSCI, V18, P1073, DOI 10.1046/j.1460-9568.2003.02824.x; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; SHIRATORI A, 1995, GENOMICS, V28, P350, DOI 10.1006/geno.1995.1155; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SYLVESTER PE, 1983, J MENT DEFIC RES, V27, P227; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; TAKASHIMA S, 1989, BRAIN DEV-JPN, V11, P131, DOI 10.1016/S0387-7604(89)80082-8; THOMAS T, 1993, DEVELOPMENT, V117, P253; Thomas T, 2000, DEVELOPMENT, V127, P2537; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Voss AK, 2000, DEVELOPMENT, V127, P5449; Voss AK, 2006, EMBO J, V25, P3652, DOI 10.1038/sj.emboj.7601234; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Winter TC, 2000, RADIOLOGY, V214, P533, DOI 10.1148/radiology.214.2.r00fe40533; WISNIEWSKI KE, 1990, AM J MED GENET, P274; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	110	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11561	10.1371/journal.pone.0011561	http://dx.doi.org/10.1371/journal.pone.0011561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661276	Green Published, gold			2022-12-25	WOS:000279980800001
J	Iizuka, Y; Okuno, T; Saeki, K; Uozaki, H; Okada, S; Misaka, T; Sato, T; Toh, H; Fukayama, M; Takeda, N; Kita, Y; Shimizu, T; Nakamura, M; Yokomizo, T				Iizuka, Yoshiko; Okuno, Toshiaki; Saeki, Kazuko; Uozaki, Hiroshi; Okada, Shinji; Misaka, Takumi; Sato, Tetsuya; Toh, Hiroyuki; Fukayama, Masashi; Takeda, Naoki; Kita, Yoshihiro; Shimizu, Takao; Nakamura, Motonao; Yokomizo, Takehiko			Protective role of the leukotriene B-4 receptor BLT2 in murine inflammatory colitis	FASEB JOURNAL			English	Article						arachidonic cascade; eicosanoids; G-protein-coupled receptor; inflammatory bowel diseases	T-CELL RECRUITMENT; COLONIC INFLAMMATION; ULCERATIVE-COLITIS; RESOLVIN E1; ACTIVATION; ACID; ANTAGONIST; PROLIFERATION; SC-41930; DISEASE	BLT2 is a low-affinity leukotriene B-4 (LTB4) receptor that is activated by 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT) and LTB4. Despite the well-defined proinflammatory roles of BLT1, the in vivo functions of BLT2 remain elusive. To clarify the role of BLT receptors in intestinal inflammation, we assessed susceptibility to dextran sodium sulfate (DSS)-induced colitis in mice lacking either BLT1 or BLT2. BLT2(-/-) mice exhibited increased sensitivity to DSS as compared to wild-type and BLT1(-/-) mice, with more severe body weight loss and inflammation. Expression of inflammatory cytokines such as interferon (IFN)-gamma, interleukin (IL)-1 beta, and IL-6, chemokines such as CXC chemokine ligand 9 (CXCL9) and C-C motif chemokine 19 (CCL19), and metalloproteinases was highly up-regulated in the colons of DSS-treated BLT2(-/-) mice, and there was an enhanced accumulation of activated macrophages. Phosphorylation of the signal transducer and activator of transcription 3 (STAT3) was also markedly accelerated in the crypts of DSS-treated BLT2(-/-) mice. Madin-Darby canine kidney II (MDCKII) cells transfected with BLT2 exhibited enhanced barrier function as measured by transepithelial electrical resistance (TER) and FITC-dextran leakage through MDCK monolayers. Thus, BLT2 is expressed in colon cryptic cells and appears to protect against DSS-induced colitis, possibly by enhancing barrier function in epithelial cells of the colon. These novel results suggest a direct anti-inflammatory role of BLT2 that is distinct from the proinflammatory roles of BLT1.-Iizuka, Y., Okuno, T., Saeki, K., Uozaki, H., Okada, S., Misaka, T., Sato, T., Toh, H., Fukayama, M., Takeda, N., Kita, Y., Shimizu, T., Nakamura, M., Yokomizo, T. Protective role of the leukotriene B-4 receptor BLT2 in murine inflammatory colitis. FASEB J. 24, 4678-4690 (2010). www.fasebj.org	[Iizuka, Yoshiko; Kita, Yoshihiro; Shimizu, Takao; Nakamura, Motonao] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Iizuka, Yoshiko; Kita, Yoshihiro; Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Uozaki, Hiroshi; Fukayama, Masashi] Univ Tokyo, Fac Med, Dept Pathol, Tokyo 1130033, Japan; [Okada, Shinji; Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1130033, Japan; [Sato, Tetsuya; Toh, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Yokomizo, Takehiko] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan; [Takeda, Naoki] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto, Japan	Kyushu University; University of Tokyo; University of Tokyo; University of Tokyo; Kyushu University; Japan Science & Technology Agency (JST); Kumamoto University	Yokomizo, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	moto-nakamura@umin.net; yokomizo@med.kyushu-u.ac.jp	OKADA, Shinji/AFS-7710-2022; Yokomizo, Takehiko/P-5673-2016; Shimizu, Takao/AAV-7052-2021	OKADA, Shinji/0000-0002-4465-9961; Yokomizo, Takehiko/0000-0002-5219-1553; Misaka, Takumi/0000-0002-9547-5767	Japan Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation; Mitsubishi Foundation; Uehara Memorial Foundation; Sankyo Foundation of Life Science; Japan Society for the Promotion of Science	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Sankyo Foundation of Life Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank T. Nakamura, M. Amago, and members of the Kyushu University Support Center for Education and Research for DNA microarray analysis; Dr. J. Miyazaki (Osaka University, Osaka, Japan) for pCXN vector; Drs. A. Yoshimura (Keio University, Tokyo, Japan), T. Chinen, K. Morohashi, and K. Miyabayashi (Kyushu University), K. Kabashima (Kyoto University, Kyoto, Japan), Y. Kurihara and M. Arita (Tokyo University, Tokyo, Japan), and our laboratory members for valuable advice and discussions. This work was supported by Grants-in-Aid for Scientific Research from the Japan Ministry of Education, Culture, Sports, Science, and Technology (to T.Y., M.N., T.O., K.S., and T.S.), and grants from Takeda Science Foundation, Mitsubishi Foundation, the Uehara Memorial Foundation, Sankyo Foundation of Life Science, and the Japan Society for the Promotion of Science (Global COE program) (to T.Y.).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; BOUCHELOUCHE PN, 1995, EUR J GASTROEN HEPAT, V7, P349; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Cho KJ, 2010, AM J RESP CELL MOL, V42, P294, DOI 10.1165/rcmb.2008-0445OC; COOPER HS, 1993, LAB INVEST, V69, P238; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; FRETLAND DJ, 1995, INFLAMMATION, V19, P503, DOI 10.1007/BF01539131; FRETLAND DJ, 1989, AGENTS ACTIONS, V27, P395, DOI 10.1007/BF01972832; FRETLAND DJ, 1990, J PHARMACOL EXP THER, V255, P572; GERTNER DJ, 1994, GUT, V35, P1429, DOI 10.1136/gut.35.10.1429; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Kim GY, 2009, ARTERIOSCL THROM VAS, V29, P915, DOI 10.1161/ATVBAHA.109.185793; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; LAURITSEN K, 1986, GASTROENTEROLOGY, V91, P837, DOI 10.1016/0016-5085(86)90684-0; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; LIN AH, 1984, PROSTAGLANDINS, V28, P837, DOI 10.1016/0090-6980(84)90038-8; Luster AD, 2004, NAT REV IMMUNOL, V4, P711, DOI 10.1038/nri1438; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Rigby RJ, 2007, ONCOGENE, V26, P4833, DOI 10.1038/sj.onc.1210286; Shao WH, 2006, J IMMUNOL, V176, P6254, DOI 10.4049/jimmunol.176.10.6254; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toda A, 2010, BIOCHIMIE, V92, P682, DOI 10.1016/j.biochi.2009.12.002; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151	41	78	78	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4678	4690		10.1096/fj.10-165050	http://dx.doi.org/10.1096/fj.10-165050			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20667973				2022-12-25	WOS:000284824400009
J	Vedhachalam, C; Chetty, PS; Nickel, M; Dhanasekaran, P; Lund-Katz, S; Rothblat, GH; Phillips, MC				Vedhachalam, Charulatha; Chetty, Palaniappan Sevugan; Nickel, Margaret; Dhanasekaran, Padmaja; Lund-Katz, Sissel; Rothblat, George H.; Phillips, Michael C.			Influence of Apolipoprotein (Apo) A-I Structure on Nascent High Density Lipoprotein (HDL) Particle Size Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; ABCA1-MEDIATED CHOLESTEROL EFFLUX; CELLULAR LIPID EFFLUX; C-TERMINAL DOMAIN; PRE-BETA-HDL; PLASMA-MEMBRANE; HEART-DISEASE; BINDING; ABCA1; MACROPHAGE	The principal protein of high density lipoprotein (HDL), apolipoprotein (apo) A-I, in the lipid-free state contains two tertiary structure domains comprising an N-terminal helix bundle and a less organized C-terminal domain. It is not known how the properties of these domains modulate the formation and size distribution of apoA-I-containing nascent HDL particles created by ATP-binding cassette transporter A1 (ABCA1)-mediated efflux of cellular phospholipid and cholesterol. To address this issue, proteins corresponding to the two domains of human apoA-I (residues 1-189 and 190-243) and mouse apoA-I (residues 1-186 and 187-240) together with some human/mouse domain hybrids were examined for their abilities to form HDL particles when incubated with either ABCA1-expressing cells or phospholipid multilamellar vesicles. Incubation of human apoA-I with cells gave rise to two sizes of HDL particles (hydrodynamic diameter, 8 and 10 nm), and removal or disruption of the C-terminal domain eliminated the formation of the smaller particle. Variations in apoA-I domain structure and physical properties exerted similar effects on the rates of formation and sizes of HDL particles created by either spontaneous solubilization of phospholipid multilamellar vesicles or the ABCA1-mediated efflux of cellular lipids. It follows that the sizes of nascent HDL particles are determined at the point at which cellular phospholipid and cholesterol are solubilized by apoA-I; apparently, this is the rate-determining step in the overall ABCA1-mediated cellular lipid efflux process. The stability of the apoA-I N-terminal helix bundle domain and the hydrophobicity of the C-terminal domain are important determinants of both nascent HDL particle size and their rate of formation.	[Vedhachalam, Charulatha; Chetty, Palaniappan Sevugan; Nickel, Margaret; Dhanasekaran, Padmaja; Lund-Katz, Sissel; Rothblat, George H.; Phillips, Michael C.] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Lipid Res Grp,Gastroenterol Hepatol & Nutr Div, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Phillips, MC (corresponding author), Univ Penn, Sch Med, Childrens Hosp Philadelphia, Lipid Res Grp,Gastroenterol Hepatol & Nutr Div, Suite 1102,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	phillipsmi@email.chop.edu		Phillips, Michael/0000-0002-7147-8007	National Institutes of Health [HL22633]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL22633.	Alexander ET, 2009, J LIPID RES, V50, P1409, DOI 10.1194/jlr.M800578-JLR200; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Burgess JW, 1999, BIOCHEMISTRY-US, V38, P14524, DOI 10.1021/bi990930z; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; DREXEL H, 1992, AM J CARDIOL, V70, P436, DOI 10.1016/0002-9149(92)91186-8; Duong PT, 2008, J LIPID RES, V49, P1006, DOI 10.1194/jlr.M700506-JLR200; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Faulkner LE, 2008, J LIPID RES, V49, P1322, DOI 10.1194/jlr.M800048-JLR200; Favari E, 2002, BIOCHEM BIOPH RES CO, V299, P801, DOI 10.1016/S0006-291X(02)02745-6; Fukuda M, 2007, J LIPID RES, V48, P882, DOI 10.1194/jlr.M600495-JLR200; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Krimbou L, 2005, J LIPID RES, V46, P1668, DOI 10.1194/jlr.M500038-JLR200; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; POWNALL HJ, 1981, BIOCHEMISTRY-US, V20, P6630, DOI 10.1021/bi00526a017; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Segall ML, 2002, J LIPID RES, V43, P1688, DOI 10.1194/jlr.M200157-JLR200; Sviridov D, 1996, J BIOL CHEM, V271, P33277, DOI 10.1074/jbc.271.52.33277; SWANEY JB, 1983, J BIOL CHEM, V258, P1254; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8	45	35	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31965	31973		10.1074/jbc.M110.126292	http://dx.doi.org/10.1074/jbc.M110.126292			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679346	Green Published, hybrid			2022-12-25	WOS:000282683000009
J	Hsieh, YC; Wu, YJ; Chiang, TY; Kuo, CY; Shrestha, KL; Chao, CF; Huang, YC; Chuankhayan, P; Wu, WG; Li, YK; Chen, CJ				Hsieh, Yin-Cheng; Wu, Yue-Jin; Chiang, Tzu-Ying; Kuo, Chueh-Yuan; Shrestha, Keshab Lal; Chao, Cheng-Fu; Huang, Yen-Chieh; Chuankhayan, Phimonphan; Wu, Wen-Guey; Li, Yaw-Kuen; Chen, Chun-Jung			Crystal Structures of Bacillus cereus NCTU2 Chitinase Complexes with Chitooligomers Reveal Novel Substrate Binding for Catalysis A CHITINASE WITHOUT CHITIN BINDING AND INSERTION DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPOSED AROMATIC RESIDUES; X-RAY-STRUCTURE; SERRATIA-MARCESCENS; FAMILY-18 CHITINASE; CRYSTALLOGRAPHIC ANALYSIS; ASPERGILLUS-FUMIGATUS; ASSISTED CATALYSIS; CIRCULANS WL-12; PROTEIN MODELS; HYDROLYSIS	Chitinases hydrolyze chitin, an insoluble linear polymer of N-acetyl-D-glucosamine (NAG)(n), into nutrient sources. Bacillus cereus NCTU2 chitinase (ChiNCTU2) predominantly produces chitobioses and belongs to glycoside hydrolase family 18. The crystal structure of wild-type ChiNCTU2 comprises only a catalytic domain, unlike other chitinases that are equipped with additional chitin binding and insertion domains to bind substrates into the active site. Lacking chitin binding and chitin insertion domains, ChiNCTU2 utilizes two dynamic loops (Gly-67-Thr-69 and Ile-106-Val-112) to interact with (NAG)(n), generating novel substrate binding and distortion for catalysis. Gln-109 is crucial for direct binding with substrates, leading to conformational changes of two loops with a maximum shift of similar to 4.6 angstrom along the binding cleft. The structures of E145Q, E145Q/Y227F, and E145G/Y227F mutants complexed with (NAG)(n) reveal (NAG)(2), (NAG)(2), and (NAG)(4) in the active site, respectively, implying various stages of reaction: before hydrolysis, E145G/Y227F with (NAG)(4); in an intermediate state, E145Q/Y227F with a boat-form NAG at the -1 subsite, -1-(NAG); after hydrolysis, E145Q with a chair form -1-(NAG). Several residues were confirmed to play catalytic roles: Glu-145 in cleavage of the glycosidic bond between -1-(NAG) and -1-(NAG); Tyr-227 in the conformational change of -1-(NAG); Asp-143 and Gln-225 in stabilizing the conformation of -1-(NAG). Additionally, Glu-190 acts in the process of product release, and Tyr-193 coordinates with water for catalysis. Residues Asp-143, E145Q, Glu190, and Tyr-193 exhibit multiple conformations for functions. The inhibitors zinc ions and cyclo-(L-His-L-Pro) are located at various positions and confirm the catalytic-site topology. Together with kinetics analyses of related mutants, the structures of ChiNCTU2 and its mutant complexes with (NAG)(n) provide new insights into its substrate binding and the mechanistic action.	[Wu, Yue-Jin; Shrestha, Keshab Lal; Chao, Cheng-Fu; Li, Yaw-Kuen] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 30010, Taiwan; [Huang, Yen-Chieh; Chuankhayan, Phimonphan; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Chiang, Tzu-Ying; Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30043, Taiwan; [Hsieh, Yin-Cheng; Kuo, Chueh-Yuan; Wu, Wen-Guey] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30043, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan	National Yang Ming Chiao Tung University; National Synchrotron Radiation Research Center; National Tsing Hua University; National Tsing Hua University; National Cheng Kung University	Li, YK (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 30010, Taiwan.	ykl@cc.nctu.edu.tw; cjchen@nsrrc.org.tw	Chen, Chun-Jung/A-6880-2011	Chen, Chun-Jung/0000-0002-5157-4288	National Science Council (NSC) [95-2923-B-213-001-MY3, 95-2313-B-009-001-MY3, 96-2113-M-009-012-MY3]; National Synchrotron Radiation Center [973RSB02, 983RSB02]; MOE-AU Program	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Synchrotron Radiation Center; MOE-AU Program	This work was supported in part by National Science Council (NSC) Grants 95-2923-B-213-001-MY3 and 95-2313-B-009-001-MY3, National Synchrotron Radiation Center Grants 973RSB02 and 983RSB02 (to C.-J.C.), and the MOE-AU Program and NSC Grant 96-2113-M-009-012-MY3 (to Y.-K.L.).	Brameld KA, 1998, J AM CHEM SOC, V120, P3571, DOI 10.1021/ja972282h; BRUNEL B, 1994, FEMS MICROBIOL ECOL, V14, P331, DOI 10.1111/j.1574-6941.1994.tb00118.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavada BS, 2006, FEBS J, V273, P3962, DOI 10.1111/j.1742-4658.2006.05400.x; Cohen-Kupiec R, 1998, CURR OPIN BIOTECH, V9, P270, DOI 10.1016/S0958-1669(98)80058-X; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1, DOI 10.1111/j.1574-6968.1999.tb13405.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Felse PA, 1999, APPL MICROBIOL BIOT, V51, P141, DOI 10.1007/s002530051374; FLACH J, 1992, EXPERIENTIA, V48, P701, DOI 10.1007/BF02124285; GRAHAM LS, 1994, CAN J BOT, V72, P1057, DOI 10.1139/b94-132; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Houston DR, 2004, J MED CHEM, V47, P5713, DOI 10.1021/jm049940a; Hu HY, 2004, ACTA CRYSTALLOGR D, V60, P939, DOI 10.1107/S0907444904005190; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Jaques AK, 2003, MICROBIOL-SGM, V149, P2931, DOI 10.1099/mic.0.26476-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Kuo CY, 2006, ACTA CRYSTALLOGR F, V62, P916, DOI 10.1107/S1744309106031423; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008654; Lonhienne T, 2001, J BACTERIOL, V183, P1773, DOI 10.1128/JB.183.5.1773-1779.2001; Nakamura T, 2008, J MOL BIOL, V381, P670, DOI 10.1016/j.jmb.2008.06.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Pleban S, 1997, LETT APPL MICROBIOL, V25, P284, DOI 10.1046/j.1472-765X.1997.00224.x; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; SILOSUH LA, 1994, APPL ENVIRON MICROB, V60, P2023, DOI 10.1128/AEM.60.6.2023-2030.1994; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Takaya N, 1998, MICROBIOL-SGM, V144, P2647, DOI 10.1099/00221287-144-9-2647; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2004, J BIOL CHEM, V279, P3612, DOI 10.1074/jbc.M310057200; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Wen CM, 2002, BIOTECHNOL APPL BIOC, V35, P213, DOI 10.1042/BA20020001; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	59	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31603	31615		10.1074/jbc.M110.149310	http://dx.doi.org/10.1074/jbc.M110.149310			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685646	hybrid, Green Published			2022-12-25	WOS:000282764600054
J	Yamaguchi, H; Chen, CT; Chou, CK; Pal, A; Bornmann, W; Hortobagyi, GN; Hung, MC				Yamaguchi, H.; Chen, C-T; Chou, C-K; Pal, A.; Bornmann, W.; Hortobagyi, G. N.; Hung, M-C			Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation	ONCOGENE			English	Article						HDAC inhibitors; E1A; apoptosis; Bim; gene therapy	OVARIAN-CANCER CELLS; HUMAN BREAST-CANCER; GENE-THERAPY; CLINICAL-TRIAL; HER-2/NEU-OVEREXPRESSING BREAST; E1A-LIPOSOME COMPLEX; TUMOR-CELLS; IN-VIVO; EXPRESSION; DELIVERY	Histone deacetylase inhibitors (HDACi) are potent anticancer agents for variety of cancer types. Suberoylanilide hydroxamic acid (SAHA) has been approved as a drug to treat cutaneous T cell lymphoma, and the combination of HDACi and other agents have been actively tested in many clinical trials. Adenovirus 5 early region 1A (E1A) has been shown to exhibit high tumor suppressor activity, and gene therapy using E1A has been tested in clinical trials. Here, we showed that proapoptotic activity of HDACi was robustly enhanced by E1A in multiple cancer cells, but not in normal cells. Moreover, we showed that combination of E1A gene therapy and SAHA showed high therapeutic efficacy with low toxicity in vivo ovarian and breast xenograft models. SAHA downregulated Bcl-XL and upregulated proapoptotic BH3-only protein Bim, whose expression was further enhanced by E1A in cancer cells. These alterations of Bcl-2 family proteins were critical for apoptosis induced by the combination in cancer cells. SAHA enhanced acetylation of histone H3 in Bim promoter region, while E1A upregulated Egr-1, which was directly involved in Bim transactivation. Together, our results provide not only a novel insight into the mechanisms underlying anti-tumor activity of E1A, but also a rationale for the combined HDACi and E1A gene therapy in future clinical trials. Oncogene (2010) 29, 5619-5629; doi:10.1038/onc.2010.295; published online 2 August 2010	[Yamaguchi, H.; Chen, C-T; Chou, C-K; Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, C-T; Hung, M-C] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Pal, A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Bornmann, W.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Hortobagyi, G. N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Hung, M-C] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; [Hung, M-C] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung, Taiwan; [Hung, M-C] Asia Univ, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 079, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; CHOU, CHAO-KAI/0000-0001-5231-5264	SPORE Grant in ovarian cancer and breast cancer [P50 CA83639, PO50 CA116199]; National Breast Cancer Foundation; MDACC China Medical University and Hospital Sister Institution; Cancer Center [CA16672]; Cancer Research Center of Excellence [DOH99-TD-C-111-005]; Taiwan Department of Health; MARCUS Foundation; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311, P50CA083639, P50CA116199, P30CA016672] Funding Source: NIH RePORTER	SPORE Grant in ovarian cancer and breast cancer; National Breast Cancer Foundation; MDACC China Medical University and Hospital Sister Institution; Cancer Center; Cancer Research Center of Excellence; Taiwan Department of Health; MARCUS Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Jingwen Liu (Palo Alto Health Care System) and Thomas E Eling (National Institute of Health) for Egr-1 dominant negative expression plasmid and Egr-1 luciferase plasmid, respectively. We thank Dr Yongkun Wei for help in carrying out statistical analysis of xenograft experiments. We thank Drs Jennifer L. Hsu and Stephanie Miller for help in preparation of this paper. This work was supported by a SPORE Grant in ovarian cancer and breast cancer (P50 CA83639 and PO50 CA116199), the National Breast Cancer Foundation, MDACC China Medical University and Hospital Sister Institution Fund, Cancer Center Support Grant CA16672, DOH99-TD-C-111-005 Cancer Research Center of Excellence, Taiwan Department of Health, and the MARCUS Foundation. In memoriam, Mrs Serena Lin-Guo for her courageous fight against breast cancer.	Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Brader KR, 1997, CLIN CANCER RES, V3, P2017; Burgess A, 2004, ONCOGENE, V23, P6693, DOI 10.1038/sj.onc.1207893; BYRD PJ, 1988, ONCOGENE, V2, P477; Chang JY, 1997, ONCOGENE, V14, P561, DOI 10.1038/sj.onc.1200861; Chou CK, 2009, MOL CARCINOGEN, V48, P1048, DOI 10.1002/mc.20557; Cook JL, 2005, FRONT BIOSCI-LANDMRK, V10, P1396, DOI 10.2741/1628; Day CP, 2006, CANCER GENE THER, V13, P706, DOI 10.1038/sj.cgt.7700945; Deng J, 1998, ONCOGENE, V17, P2167, DOI 10.1038/sj.onc.1202148; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; FRISCH SM, 1991, P NATL ACAD SCI USA, V88, P9077, DOI 10.1073/pnas.88.20.9077; Frisch SM, 2004, CLIN CANCER RES, V10, P2905, DOI 10.1158/1078-0432.CCR-04-0644; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Hortobagyi GN, 2001, J CLIN ONCOL, V19, P3422, DOI 10.1200/JCO.2001.19.14.3422; Hubberstey AV, 2002, CANCER GENE THER, V9, P321, DOI 10.1038/sj.cgt.7700436; Hung MC, 2000, ADV EXP MED BIOL, V465, P171; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Liao Y, 2004, CANCER GENE THER, V11, P594, DOI 10.1038/sj.cgt.7700743; Liao Y, 2007, ADV EXP MED BIOL, V608, P144; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Lo HW, 2005, ADV GENET, V54, P235, DOI 10.1016/S0065-2660(05)54010-0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Madhusudan S, 2004, CLIN CANCER RES, V10, P2986, DOI 10.1158/1078-0432.CCR-03-0291; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Pirollo KF, 2008, CANCER RES, V68, P1247, DOI 10.1158/0008-5472.CAN-07-5810; RAO L, 1992, P NATL ACAD SCI USA, V89, P7742, DOI 10.1073/pnas.89.16.7742; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Stoff-Khalili MA, 2006, CANCER GENE THER, V13, P633, DOI 10.1038/sj.cgt.7700929; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Ueno NT, 2002, CANCER RES, V62, P6712; Ueno NT, 2000, CLIN CANCER RES, V6, P250; Ueno NT, 1997, ONCOGENE, V15, P953, DOI 10.1038/sj.onc.1201250; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Villaret D, 2002, HEAD NECK-J SCI SPEC, V24, P661, DOI 10.1002/hed.10107; Wang YN, 2006, MOL PHARMACOL, V69, P85, DOI 10.1124/mol.105.016220; Xie XM, 2007, CANCER CELL, V12, P52, DOI 10.1016/j.ccr.2007.05.009; Xie XM, 2009, MOL CANCER THER, V8, P2375, DOI 10.1158/1535-7163.MCT-09-0056; Xing X, 1997, GENE THER, V4, P238, DOI 10.1038/sj.gt.3300376; Xing X, 1998, GENE THER, V5, P1538, DOI 10.1038/sj.gt.3300771; Xu WS, 2006, P NATL ACAD SCI USA, V103, P15540, DOI 10.1073/pnas.0607518103; Yamaguchi H, 2003, CANCER RES, V63, P1483; YAN DH, 1991, ONCOGENE, V6, P343; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoo GH, 2001, CLIN CANCER RES, V7, P1237; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; YU DH, 1991, MOL CELL BIOL, V11, P1745, DOI 10.1128/MCB.11.3.1745; YU DH, 1993, CANCER RES, V53, P891; YU DH, 1995, ONCOGENE, V11, P1383; Zhang F, 2003, J BIOL CHEM, V278, P44246, DOI 10.1074/jbc.M305564200	58	21	23	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	41					5619	5629		10.1038/onc.2010.295	http://dx.doi.org/10.1038/onc.2010.295			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FX	20676141	Green Accepted			2022-12-25	WOS:000282946900008
J	Casasanto, D; Jasmin, K				Casasanto, Daniel; Jasmin, Kyle			Good and Bad in the Hands of Politicians: Spontaneous Gestures during Positive and Negative Speech	PLOS ONE			English	Article								Background: According to the body-specificity hypothesis, people with different bodily characteristics should form correspondingly different mental representations, even in highly abstract conceptual domains. In a previous test of this proposal, right- and left-handers were found to associate positive ideas like intelligence, attractiveness, and honesty with their dominant side and negative ideas with their non-dominant side. The goal of the present study was to determine whether 'body-specific' associations of space and valence can be observed beyond the laboratory in spontaneous behavior, and whether these implicit associations have visible consequences. Methodology and Principal Findings: We analyzed speech and gesture (3012 spoken clauses, 1747 gestures) from the final debates of the 2004 and 2008 US presidential elections, which involved two right-handers (Kerry, Bush) and two left-handers (Obama, McCain). Blind, independent coding of speech and gesture allowed objective hypothesis testing. Right- and left-handed candidates showed contrasting associations between gesture and speech. In both of the left-handed candidates, left-hand gestures were associated more strongly with positive-valence clauses and right- hand gestures with negative-valence clauses; the opposite pattern was found in both right- handed candidates. Conclusions: Speakers associate positive messages more strongly with dominant hand gestures and negative messages with non-dominant hand gestures, revealing a hidden link between action and emotion. This pattern cannot be explained by conventions in language or culture, which associate 'good' with 'right' but not with 'left'; rather, results support and extend the body-specificity hypothesis. Furthermore, results suggest that the hand speakers use to gesture may have unexpected (and probably unintended) communicative value, providing the listener with a subtle index of how the speaker feels about the content of the co-occurring speech.	[Casasanto, Daniel; Jasmin, Kyle] Max Planck Inst Psycholinguist, Neurobiol Language Grp, Nijmegen, Netherlands; [Casasanto, Daniel] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Casasanto, Daniel] New Sch Social Res, Dept Psychol, New York, NY 10011 USA	Max Planck Society; Radboud University Nijmegen; The New School	Casasanto, D (corresponding author), Max Planck Inst Psycholinguist, Neurobiol Language Grp, Nijmegen, Netherlands.	casasanto@alum.mit.edu		Jasmin, Kyle/0000-0001-9723-8207	National Research Service [F32MH072502]; Spanish Ministry of Education and Science [SEJ2006-04732/PSIC]; DGI; Consejeria de Innovacion; Ciencia y Empresa; Junta de Andalucia; European Regional Development Fund (ERDF) [P09-SEJ-4772]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH072502] Funding Source: NIH RePORTER	National Research Service; Spanish Ministry of Education and Science(Spanish Government); DGI; Consejeria de Innovacion; Ciencia y Empresa; Junta de Andalucia(Junta de Andalucia); European Regional Development Fund (ERDF)(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by National Research Service Award #F32MH072502, by a grant from the Spanish Ministry of Education and Science #SEJ2006-04732/PSIC, DGI, and by a grant from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, and the European Regional Development Fund (ERDF), Project P09-SEJ-4772, to D. Casasanto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN G, 1966, CHIRONOMIA TREATISE; Beale I.L., 2020, PSYCHOL LEFT RIGHT; Beilock SL, 2007, PSYCHOL SCI, V18, P51, DOI 10.1111/j.1467-9280.2007.01848.x; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Goldin-Meadow S., 2003, HEARING GESTURE OUR; Hane AA, 2008, DEV PSYCHOL, V44, P1491, DOI 10.1037/a0012855; Kita S., 2001, GESTURE, V1, P73, DOI DOI 10.1075/GEST.1.1.06KIT; Maxwell JS, 2007, PSYCHOL SCI, V18, P1113, DOI 10.1111/j.1467-9280.2007.02033.x; McNeill D., 1992, HAND MIND WHAT GESTU; Oppenheimer DM, 2008, TRENDS COGN SCI, V12, P237, DOI 10.1016/j.tics.2008.02.014; Ozyurek A, 2002, J MEM LANG, V46, P688, DOI 10.1006/jmla.2001.2826; QUINTILIANUS MF, 1920, T I ORATORIA; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Willems RM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.039.2009; Willems RM, 2010, PSYCHOL SCI, V21, P67, DOI 10.1177/0956797609354072	16	90	96	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11805	10.1371/journal.pone.0011805	http://dx.doi.org/10.1371/journal.pone.0011805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633QX	20676371	Green Published, gold			2022-12-25	WOS:000280520100003
J	Dimairo, M; MacPherson, P; Bandason, T; Zezai, A; Munyati, SS; Butterworth, AE; Mungofa, S; Rusikaniko, S; Fielding, K; Mason, PR; Corbett, EL				Dimairo, Munyaradzi; MacPherson, Peter; Bandason, Tsitsi; Zezai, Abbas; Munyati, Shungu S.; Butterworth, Anthony E.; Mungofa, Stanley; Rusikaniko, Simba; Fielding, Katherine; Mason, Peter R.; Corbett, Elizabeth L.			The Risk and Timing of Tuberculosis Diagnosed in Smear-Negative TB Suspects: A 12 Month Cohort Study in Harare, Zimbabwe	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RECONSTITUTION INFLAMMATORY SYNDROME; RESOURCE-LIMITED SETTINGS; HIGH-HIV-PREVALENCE; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; IMMUNE RECONSTITUTION; SOUTH-AFRICA; FOLLOW-UP; INFECTION	Background: Cases of smear-negative TB have increased dramatically in high prevalence HIV settings and pose considerable diagnostic and management challenges. Methods and Findings: Between February 2006 and July 2007, a cohort study nested within a cluster-randomised trial of community-based case finding strategies for TB in Harare, Zimbabwe was undertaken. Participants who had negative sputum smears and remained symptomatic of TB were follow-up for one year with standardised investigations including HIV testing, repeat sputum smears, TB culture and chest radiography. Defaulters were actively traced to the community. The objectives were to investigate the incidence and risk factors for TB. TB was diagnosed in 218 (18.2%) participants, of which 39.4% was bacteriologically confirmed. Most cases (84.2%) were diagnosed within 3 months, but TB incidence remained high thereafter (111.3 per 1000 person-years, 95% CI: 86.6 to 146.3). HIV prevalence was 63.3%, and HIV-infected individuals had a 3.5-fold higher risk of tuberculosis than HIV-negative individuals. Conclusion: We found that diagnosis of TB was insensitive and slow, even with early radiography and culture. Until more sensitive and rapid diagnostic tests become widely available, a much more proactive and integrated approach towards prompt initiation of ART, ideally from within TB clinics and without waiting for TB to be excluded, is needed to minimise the risk and consequences of diagnostic delay.	[Dimairo, Munyaradzi; Bandason, Tsitsi; Zezai, Abbas; Munyati, Shungu S.; Mason, Peter R.] Biomed Res & Training Inst, Harare, Zimbabwe; [MacPherson, Peter] Univ Liverpool, Wellcome Trust Trop Ctr, Liverpool L69 3BX, Merseyside, England; [Butterworth, Anthony E.; Corbett, Elizabeth L.] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England; [Mungofa, Stanley] Harare City Hlth, Harare, Zimbabwe; [Rusikaniko, Simba] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Fielding, Katherine] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England	Biomedical Research Training Institute; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine	Dimairo, M (corresponding author), Biomed Res & Training Inst, Harare, Zimbabwe.	p.macpherson@liv.ac.uk	MacPherson, Peter/AHD-2477-2022; Dimairo, Munya/U-6905-2019	MacPherson, Peter/0000-0002-0329-9613; Fielding, Katherine/0000-0002-6524-3754; Corbett, Elizabeth/0000-0002-3552-3181; Dimairo, Munyaradzi/0000-0002-9311-6920	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	ELC receives funding from the Wellcome Trust, UK. PM is funded by the Wellcome Trust Clinical PhD programme at the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Carlin JB, 2008, STATA J, V8, P49, DOI 10.1177/1536867X0800800104; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; CORBETT EL, 2009, LANCET; CRAMPIN AC, 2009, AIDS IN PRESS; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; *FDN INN NEW DIAGN, 2009, RAP SCAL INT MOL DIA; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Harries AD, 2009, INT J TUBERC LUNG D, V13, P6; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Harries AD, 1997, INT J TUBERC LUNG D, V1, P346; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2009, CLIN CHEST MED, V30, P797, DOI 10.1016/j.ccm.2009.08.013; MORGAN MA, 1983, J CLIN MICROBIOL, V18, P384, DOI 10.1128/JCM.18.2.384-388.1983; Munyati SS, 2005, CLIN INFECT DIS, V40, P1818, DOI 10.1086/429912; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Mutetwa R, 2009, INT J TUBERC LUNG D, V13, P1253; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2009, GLOB TUB CONTR 2009; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	34	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11849	10.1371/journal.pone.0011849	http://dx.doi.org/10.1371/journal.pone.0011849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676374	Green Published, Green Accepted, gold			2022-12-25	WOS:000280520100019
J	Moharregh-Khiabani, D; Blank, A; Skripuletz, T; Miller, E; Kotsiari, A; Gudi, V; Stangel, M				Moharregh-Khiabani, Darius; Blank, Alexander; Skripuletz, Thomas; Miller, Elvira; Kotsiari, Alexandra; Gudi, Viktoria; Stangel, Martin			Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse	PLOS ONE			English	Article							BRAIN-BARRIER PERMEABILITY; INDUCED DEMYELINATION; MULTIPLE-SCLEROSIS; GLIAL-CELLS; IN-VITRO; RAT; OLIGODENDROCYTES; DIMETHYLFUMARATE; DIFFERENTIATION; NEUROTOXICANT	Background: Fumaric acid esters (FAE) are a group of compounds which are currently under investigation as an oral treatment for relapsing-remitting multiple sclerosis. One of the suggested modes of action is the potential of FAE to exert a neuroprotective effect. Methodology/Principal Findings: We have investigated the impact of monomethylfumarate (MMF) and dimethylfumaric acid (DMF) on de- and remyelination using the toxic cuprizone model where the blood-brain-barrier remains intact and only scattered T-cells and peripheral macrophages are found in the central nervous system (CNS), thus excluding the influence of immunomodulatory effects on peripheral immune cells. FAE showed marginally accelerated remyelination in the corpus callosum compared to controls. However, we found no differences for demyelination and glial reactions in vivo and no cytoprotective effect on oligodendroglial cells in vitro. In contrast, DMF had a significant inhibitory effect on lipopolysaccharide (LPS) induced nitric oxide burst in microglia and induced apoptosis in peripheral blood mononuclear cells (PBMC). Conclusions: These results contribute to the understanding of the mechanism of action of fumaric acids. Our data suggest that fumarates have no or only little direct protective effects on oligodendrocytes in this toxic model and may act rather indirectly via the modulation of immune cells.	[Moharregh-Khiabani, Darius; Blank, Alexander; Skripuletz, Thomas; Miller, Elvira; Kotsiari, Alexandra; Gudi, Viktoria; Stangel, Martin] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Gudi, Viktoria; Stangel, Martin] Ctr Syst Neurosci, Hannover, Germany	Hannover Medical School	Moharregh-Khiabani, D (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	Stangel.Martin@MH-Hannover.de	Stangel, Martin/AAH-5345-2020; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	Georg-Christoph-Lichtenberg Fellowship; State of Lower Saxony; Biogen Idec	Georg-Christoph-Lichtenberg Fellowship; State of Lower Saxony(European Commission); Biogen Idec(Biogen)	This study was partly supported by the Georg-Christoph-Lichtenberg Fellowship by the State of Lower Saxony and by Biogen Idec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER DA, 1987, J NEUROL SCI, V78, P125, DOI 10.1016/0022-510X(87)90055-4; Cammer W, 1999, J NEUROL SCI, V168, P116, DOI 10.1016/S0022-510X(99)00181-1; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; Heine S, 2006, J NEUROIMMUNOL, V177, P173, DOI 10.1016/j.jneuroim.2006.04.016; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; KONDO A, 1987, BRAIN RES, V425, P186, DOI 10.1016/0006-8993(87)90499-9; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Lindner M, 2008, GLIA, V56, P1104, DOI 10.1002/glia.20682; Lindner M, 2009, NEUROSCI LETT, V453, P120, DOI 10.1016/j.neulet.2009.02.004; Linker Ralf A, 2008, Expert Rev Neurother, V8, P1683, DOI 10.1586/14737175.8.11.1683; Litjens NHR, 2004, EUR J IMMUNOL, V34, P565, DOI 10.1002/eji.200324174; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Norkute A, 2009, J NEUROSCI RES, V87, P1343, DOI 10.1002/jnr.21946; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rehbinder C, 1996, LAB ANIM, V30, P193, DOI 10.1258/002367796780684881; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SKRIPULETZ T, 2009, BRAIN PATHOL; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Stangel M, 2003, J NEUROIMMUNOL, V138, P25, DOI 10.1016/S0165-5728(03)00087-0; Stangel M, 2000, J NEUROIMMUNOL, V103, P195, DOI 10.1016/S0165-5728(99)00241-6; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Treumer F, 2003, J INVEST DERMATOL, V121, P1383, DOI 10.1111/j.1523-1747.2003.12605.x; Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013; Yang MH, 2009, J ETHNOPHARMACOL, V121, P130, DOI 10.1016/j.jep.2008.10.010; Zhu KJ, 2001, J INVEST DERMATOL, V116, P203, DOI 10.1046/j.1523-1747.2001.01159.x	34	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11769	10.1371/journal.pone.0011769	http://dx.doi.org/10.1371/journal.pone.0011769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668697	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800033
J	Brusko, TM; Koya, RC; Zhu, S; Lee, MR; Putnam, AL; McClymont, SA; Nishimura, MI; Han, SH; Chang, LJ; Atkinson, MA; Ribas, A; Bluestone, JA				Brusko, Todd M.; Koya, Richard C.; Zhu, Shirley; Lee, Michael R.; Putnam, Amy L.; McClymont, Stephanie A.; Nishimura, Michael I.; Han, Shuhong; Chang, Lung-Ji; Atkinson, Mark A.; Ribas, Antoni; Bluestone, Jeffrey A.			Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer	PLOS ONE			English	Article							ADOPTIVE TRANSFER; AUTOIMMUNE-DISEASES; MELANOMA ANTIGEN; FOXP3 EXPRESSION; CUTTING EDGE; EX-VIVO; EXPANSION; THERAPY; TOLERANCE; SUPPRESSION	Background: Therapies directed at augmenting regulatory T cell (Treg) activities in vivo as a systemic treatment for autoimmune disorders and transplantation may be associated with significant off-target effects, including a generalized immunosuppression that may compromise beneficial immune responses to infections and cancer cells. Adoptive cellular therapies using purified expanded Tregs represents an attractive alternative to systemic treatments, with results from animal studies noting increased therapeutic potency of antigen-specific Tregs over polyclonal populations. However, current methodologies are limited in terms of the capacity to isolate and expand a sufficient quantity of endogenous antigen-specific Tregs for therapeutic intervention. Moreover, FOXP3+ Tregs fall largely within the CD4+ T cell subset and are thus routinely MHC class II-specific, whereas class I-specific Tregs may function optimally in vivo by facilitating direct tissue recognition. Methodology/Principal Findings: To overcome these limitations, we have developed a novel means for generating large numbers of antigen-specific Tregs involving lentiviral T cell receptor (TCR) gene transfer into in vitro expanded polyclonal natural Treg populations. Tregs redirected with a high-avidity class I-specific TCR were capable of recognizing the melanoma antigen tyrosinase in the context of HLA-A*0201 and could be further enriched during the expansion process by antigen-specific reactivation with peptide loaded artificial antigen presenting cells. These in vitro expanded Tregs continued to express FOXP3 and functional TCRs, and maintained the capacity to suppress conventional T cell responses directed against tyrosinase, as well as bystander T cell responses. Using this methodology in a model tumor system, murine Tregs designed to express the tyrosinase TCR effectively blocked antigen-specific effector T cell (Teff) activity as determined by tumor cell growth and luciferase reporter-based imaging. Conclusions/Significance: These results support the feasibility of class I-restricted TCR transfer as a promising strategy to redirect the functional properties of Tregs and provide for a more efficacious adoptive cell therapy.	[Brusko, Todd M.; Zhu, Shirley; Lee, Michael R.; Putnam, Amy L.; McClymont, Stephanie A.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Koya, Richard C.; Ribas, Antoni] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA; [Nishimura, Michael I.] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Han, Shuhong; Chang, Lung-Ji] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Atkinson, Mark A.] Univ Florida, Coll Med, Dept Pathol & Lab Med, Gainesville, FL 32610 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Medical University of South Carolina; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brusko, TM (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	Jeff.Bluestone@ucsf.edu		Brusko, Todd/0000-0003-2878-9296	NIH Autoimmunity Center of Excellence; Juvenile Diabetes Research Foundation Center; Dee and William Brehm Foundation for Diabetes Research; JDRF; NATIONAL CANCER INSTITUTE [R01CA104947] Funding Source: NIH RePORTER	NIH Autoimmunity Center of Excellence; Juvenile Diabetes Research Foundation Center(Juvenile Diabetes Research Foundation); Dee and William Brehm Foundation for Diabetes Research; JDRF(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by, in part, by the NIH Autoimmunity Center of Excellence Grant as well as a Juvenile Diabetes Research Foundation Center Grant (Collaborative Center for Cell Therapy), and The Dee and William Brehm Foundation for Diabetes Research. T. B. is supported by a JDRF advanced post-doctoral fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JD, 2008, J IMMUNOTHER, V31, P1, DOI 10.1097/CJI.0b013e31815c193f; Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Alyanakian MA, 2003, P NATL ACAD SCI USA, V100, P15806, DOI 10.1073/pnas.2636971100; Battaglia M, 2006, SEMIN IMMUNOL, V18, P120, DOI 10.1016/j.smim.2006.01.007; BLUESTONE JA, 2004, PROCNATLACADSCIUSA; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Brusko TM, 2005, J IMMUNOL, V174, P5181, DOI 10.4049/jimmunol.174.9.5181; Brusko Todd M, 2007, Immunol Invest, V36, P607, DOI 10.1080/08820130701790368; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Brusko TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007980; Chatenoud L, 2001, IMMUNOL REV, V182, P149, DOI 10.1034/j.1600-065X.2001.1820112.x; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Deaglio S, 2007, J EXP MED; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Govers C, 2010, TRENDS MOL MED, V16, P77, DOI 10.1016/j.molmed.2009.12.004; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Hombach AA, 2009, GENE THER, V16, P1088, DOI 10.1038/gt.2009.75; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Levine BL, 2002, NAT MED, V8, P47, DOI 10.1038/nm0102-47; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; MITCHISON NA, 1955, J EXP MED, V102, P157, DOI 10.1084/jem.102.2.157; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nishimura MI, 1999, CANCER RES, V59, P6230; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Paulos CM, 2008, IMMUNOL RES, V42, P182, DOI 10.1007/s12026-008-8070-9; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Porter DL, 2005, BONE MARROW TRANSPL, V35, P935, DOI 10.1038/sj.bmt.1704953; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Ribas A, 1997, CANCER RES, V57, P2865; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Roszkowski JJ, 2005, CANCER RES, V65, P1570, DOI 10.1158/0008-5472.CAN-04-2076; Roszkowski JJ, 2003, J IMMUNOL, V170, P2582, DOI 10.4049/jimmunol.170.5.2582; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Setiady YY, 2006, BLOOD, V107, P1056, DOI 10.1182/blood-2005-08-3088; St Clair EW, 2007, ANNU REV MED, V58, P329, DOI 10.1146/annurev.med.58.061705.145449; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Tahara H, 2003, J IMMUNOL, V171, P2154, DOI 10.4049/jimmunol.171.4.2154; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thomas S, 2007, EXPERT OPIN BIOL TH, V7, P1207, DOI 10.1517/14712598.7.8.1207; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	57	110	115	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11726	10.1371/journal.pone.0011726	http://dx.doi.org/10.1371/journal.pone.0011726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20668510	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300026
J	Xia, CH; Yablonka-Reuveni, Z; Gong, XH				Xia, Chun-hong; Yablonka-Reuveni, Zipora; Gong, Xiaohua			LRP5 Is Required for Vascular Development in Deeper Layers of the Retina	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; MULLER CELLS; NORRIE-DISEASE; EXPRESSION; MUTATIONS; MICE; ANGIOGENESIS; FRIZZLED-4; GROWTH; MODEL	Background: The low-density lipoprotein receptor-related protein 5 (LRP5) plays an important role in the development of retinal vasculature. LRP5 loss-of-function mutations cause incomplete development of retinal vessel network in humans as well as in mice. To understand the underlying mechanism for how LRP5 mutations lead to retinal vascular abnormalities, we have determined the retinal cell types that express LRP5 and investigated specific molecular and cellular functions that may be regulated by LRP5 signaling in the retina. Methods and Findings: We characterized the development of retinal vasculature in LRP5 mutant mice using specific retinal cell makers and a GFP transgene expressed in retinal endothelial cells. Our data revealed that retinal vascular endothelial cells predominantly formed cell clusters in the inner-plexiform layer of LRP5 mutant retina rather than sprouting out or migrating into deeper layers to form normal vascular network in the retina. The IRES-beta-galactosidase (LacZ) report gene under the control of the endogenous LRP5 promoter was highly expressed in Muller cells and was also weakly detected in endothelial cells of the retinal surface vasculature. Moreover, the LRP5 mutant mice had a reduction of a Muller cell-specific glutamine transporter, Slc38a5, and showed a decrease in b-wave amplitude of electroretinogram. Conclusions: LRP5 is not only essential for vascular endothelial cells to sprout, migrate and/or anastomose in the deeper plexus during retinal vasculature development but is also important for the functions of Muller cells and retinal interneurons. Muller cells may utilize LRP5-mediated signaling pathway to regulate vascular development in deeper layers and to maintain the function of retinal interneurons.	[Xia, Chun-hong; Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Xia, Chun-hong; Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Yablonka-Reuveni, Zipora] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle	Xia, CH (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	chxia@berkeley.edu			East Bay Community Foundation; National Institutes of Health (NIH) [AG021566]; NATIONAL EYE INSTITUTE [R01EY013849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021566] Funding Source: NIH RePORTER	East Bay Community Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by an East Bay Community Foundation grant (XG) and a National Institutes of Health (NIH) grant AG021566 (ZYR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; GARIANO RF, 1994, INVEST OPHTH VIS SCI, V35, P3442; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kirillova I, 2007, DEV BIOL, V311, P449, DOI 10.1016/j.ydbio.2007.08.056; Li Q, 2002, EXP EYE RES, V74, P615, DOI 10.1006/exer.2002.1170; LIU H, INVEST OPHTHALMOL VI, V51, P1059; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mu H, 2009, MOL BIOL REP, V36, P2147, DOI 10.1007/s11033-008-9428-8; Provis JM, 2001, PROG RETIN EYE RES, V20, P799, DOI 10.1016/S1350-9462(01)00012-X; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Umapathy NS, 2005, INVEST OPHTH VIS SCI, V46, P3980, DOI 10.1167/iovs.05-0488; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	26	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11676	10.1371/journal.pone.0011676	http://dx.doi.org/10.1371/journal.pone.0011676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652025	Green Submitted, Green Published, gold			2022-12-25	WOS:000280109700009
J	Goswami, C; Kuhn, J; Heppenstall, PA; Hucho, T				Goswami, Chandan; Kuhn, Julia; Heppenstall, Paul A.; Hucho, Tim			Importance of Non-Selective Cation Channel TRPV4 Interaction with Cytoskeleton and Their Reciprocal Regulations in Cultured Cells	PLOS ONE			English	Article							RECEPTOR POTENTIAL VANILLOID-4; PAINFUL PERIPHERAL NEUROPATHY; SUBMEMBRANEOUS MICROTUBULE CYTOSKELETON; ACETYLATED ALPHA-TUBULIN; ROOT GANGLION NEURONS; KINASE-C-EPSILON; MECHANICAL HYPERALGESIA; INFLAMMATORY PAIN; EPITHELIAL-CELLS; DETYROSINATED TUBULIN	Background: TRPV4 and the cellular cytoskeleton have each been reported to influence cellular mechanosensitive processes as well as the development of mechanical hyperalgesia. If and how TRPV4 interacts with the microtubule and actin cytoskeleton at a molecular and functional level is not known. Methodology and Principal Findings: We investigated the interaction of TRPV4 with cytoskeletal components biochemically, cell biologically by observing morphological changes of DRG-neurons and DRG-neuron-derived F-11 cells, as well as functionally with calcium imaging. We find that TRPV4 physically interacts with tubulin, actin and neurofilament proteins as well as the nociceptive molecules PKC epsilon and CamKII. The C-terminus of TRPV4 is sufficient for the direct interaction with tubulin and actin, both with their soluble and their polymeric forms. Actin and tubulin compete for binding. The interaction with TRPV4 stabilizes microtubules even under depolymerizing conditions in vitro. Accordingly, in cellular systems TRPV4 colocalizes with actin and microtubules enriched structures at submembranous regions. Both expression and activation of TRPV4 induces striking morphological changes affecting lamellipodial, filopodial, growth cone, and neurite structures in non-neuronal cells, in DRG-neuron derived F11 cells, and also in IB4-positive DRG neurons. The functional interaction of TRPV4 and the cytoskeleton is mutual as Taxol, a microtubule stabilizer, reduces the Ca2+-influx via TRPV4. Conclusions and Significance: TRPV4 acts as a regulator for both, the microtubule and the actin. In turn, we describe that microtubule dynamics are an important regulator of TRPV4 activity. TRPV4 forms a supra-molecular complex containing cytoskeletal proteins and regulatory kinases. Thereby it can integrate signaling of various intracellular second messengers and signaling cascades, as well as cytoskeletal dynamics. This study points out the existence of cross-talks between nonselective cation channels and cytoskeleton at multiple levels. These cross talks may help us to understand the molecular basis of the Taxol-induced neuropathic pain development commonly observed in cancer patients.	[Goswami, Chandan; Kuhn, Julia; Hucho, Tim] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Goswami, Chandan] Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India; [Heppenstall, Paul A.] Charite, Klin Anaesthesiol & Operat Intens Med, D-13353 Berlin, Germany	Max Planck Society; National Institute of Science Education & Research (NISER); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Goswami, C (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany.	goswami@molgen.mpg.de	Hucho, Tim/Q-5218-2018; Hucho, Tim/F-8973-2010	Hucho, Tim/0000-0002-4147-9308; 	Max Planck Institute for Molecular Genetics (Berlin, Germany); National Institute of Science Education and Research, India	Max Planck Institute for Molecular Genetics (Berlin, Germany); National Institute of Science Education and Research, India	Funding from Max Planck Institute for Molecular Genetics (Berlin, Germany) is gratefully acknowledged. CG is now supported by National Institute of Science Education and Research, India. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Alenghat FJ, 2004, EXP CELL RES, V301, P23, DOI 10.1016/j.yexcr.2004.08.003; Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Belmadani S, 2004, MOL CELL BIOCHEM, V258, P35, DOI 10.1023/B:MCBI.0000012834.43990.b6; BELTRAMO DM, 1987, EUR J BIOCHEM, V162, P137, DOI 10.1111/j.1432-1033.1987.tb10553.x; Bender FLP, 2005, CELL PHYSIOL BIOCHEM, V15, P183, DOI 10.1159/000083651; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Bhave G, 2003, NEURON, V39, P577, DOI 10.1016/S0896-6273(03)00500-2; Blase C, 2009, EUR J CELL BIOL, V88, P131, DOI 10.1016/j.ejcb.2008.10.003; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boulais N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006528; Boulais N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007759; CANTIELLO HF, 1993, J BIOL CHEM, V268, P4596; Cardone L, 2002, J MOL BIOL, V320, P663, DOI 10.1016/S0022-2836(02)00479-5; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Cuajungco MP, 2007, BBA-MOL BASIS DIS, V1772, P1022, DOI 10.1016/j.bbadis.2007.01.002; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Dina OA, 2003, NEURON, V39, P613, DOI 10.1016/S0896-6273(03)00473-2; Dina OA, 2001, NEUROSCIENCE, V108, P507, DOI 10.1016/S0306-4522(01)00425-0; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Goswami C, 2007, J NEUROCHEM, V103, P1319, DOI 10.1111/j.1471-4159.2007.04846.x; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2007, FEBS J, V274, P760, DOI 10.1111/j.1742-4658.2006.05621.x; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Goswami C, 2008, FEBS J, V275, P4684, DOI 10.1111/j.1742-4658.2008.06617.x; Goswami C, 2008, FEBS J, V275, P4653, DOI 10.1111/j.1742-4658.2008.06613.x; Gradilone SA, 2007, P NATL ACAD SCI USA, V104, P19138, DOI 10.1073/pnas.0705964104; Han P, 2007, BIOCHEM PHARMACOL, V73, P1635, DOI 10.1016/j.bcp.2006.12.035; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; Hucho TB, 2006, EUR J NEUROSCI, V24, P527, DOI 10.1111/j.1460-9568.2006.04913.x; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Kuhn J, 2008, EUR J NEUROSCI, V27, P1700, DOI 10.1111/j.1460-9568.2008.06131.x; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; LEDIZET M, 1986, J CELL BIOL, V103, P13, DOI 10.1083/jcb.103.1.13; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Liu YJ, 2006, IEEE ANTENN WIREL PR, V5, P4, DOI 10.1109/LAWP.2005.863611; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Luo F, 2008, J PHARMACOL EXP THER, V325, P267, DOI 10.1124/jpet.107.132167; Ma YY, 2008, BIOL PHARM BULL, V31, P426, DOI 10.1248/bpb.31.426; Malik B, 2008, CURR NEUROL NEUROSCI, V8, P56, DOI 10.1007/s11910-008-0010-5; MANESS PF, 1990, CIBA F SYMP, V150, P57; Martinez-Salgado C, 2007, J NEUROPHYSIOL, V98, P3802, DOI 10.1152/jn.00860.2007; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mofrad MRK, 2005, ACTA BIOMATER, V1, P281, DOI 10.1016/j.actbio.2005.02.008; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Pan Z, 2008, CELL CALCIUM, V44, P374, DOI 10.1016/j.ceca.2008.01.008; Peng HQ, 2010, BIOCHEM BIOPH RES CO, V391, P1721, DOI 10.1016/j.bbrc.2009.12.140; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; Ramadass R, 2007, ARCH BIOCHEM BIOPHYS, V463, P27, DOI 10.1016/j.abb.2007.01.036; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; RODRIGUEZ JA, 1979, BIOCHEM BIOPH RES CO, V89, P893, DOI 10.1016/0006-291X(79)91862-X; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; Tanner KD, 1998, J COMP NEUROL, V395, P481; Teilmann SC, 2005, MOL REPROD DEV, V71, P444, DOI 10.1002/mrd.20312; Topp KS, 2000, J COMP NEUROL, V424, P563; VOTER WA, 1991, CELL MOTIL CYTOSKEL, V18, P55, DOI 10.1002/cm.970180106; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Waning J, 2007, CELL CALCIUM, V42, P17, DOI 10.1016/j.ceca.2006.11.005; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Webster DR, 1997, J MOL CELL CARDIOL, V29, P2813, DOI 10.1006/jmcc.1997.0517; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443	101	110	112	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11654	10.1371/journal.pone.0011654	http://dx.doi.org/10.1371/journal.pone.0011654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657843	gold, Green Published, Green Submitted			2022-12-25	WOS:000280065600017
J	Hautier, Y; Saner, P; Philipson, C; Bagchi, R; Ong, RC; Hector, A				Hautier, Yann; Saner, Philippe; Philipson, Christopher; Bagchi, Robert; Ong, Robert C.; Hector, Andy			Effects of Seed Predators of Different Body Size on Seed Mortality in Bornean Logged Forest	PLOS ONE			English	Article							DISTANCE-DEPENDENCE; SMALL MAMMALS; RAIN-FORESTS; TREE; DISPERSAL; DENSITY; DIPTEROCARPACEAE; RECRUITMENT; DIVERSITY; DYNAMICS	Background: The Janzen-Connell hypothesis proposes that seed and seedling enemies play a major role in maintaining high levels of tree diversity in tropical forests. However, human disturbance may alter guilds of seed predators including their body size distribution. These changes have the potential to affect seedling survival in logged forest and may alter forest composition and diversity. Methodology/Principal Findings: We manipulated seed density in plots beneath con- and heterospecific adult trees within a logged forest and excluded vertebrate predators of different body sizes using cages. We show that small and large-bodied predators differed in their effect on con- and heterospecific seedling mortality. In combination small and large-bodied predators dramatically decreased both con- and heterospecific seedling survival. In contrast, when larger-bodied predators were excluded small-bodied predators reduced conspecific seed survival leaving seeds coming from the distant tree of a different species. Conclusions/Significance: Our results suggest that seed survival is affected differently by vertebrate predators according to their body size. Therefore, changes in the body size structure of the seed predator community in logged forests may change patterns of seed mortality and potentially affect recruitment and community composition.	[Hautier, Yann; Saner, Philippe; Philipson, Christopher; Bagchi, Robert; Hector, Andy] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Ong, Robert C.] Forest Res Ctr, Sabah Forestry Dept, Sandakan, Sabah, Malaysia	University of Zurich; Pusat Penyelidikan Hutan	Hautier, Y (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	yann.hautier@ieu.uzh.ch	Bagchi, Robert/F-1732-2011; Hautier, Yann/I-2526-2019; Hector, Andrew/H-4199-2011; Hautier, Yann/D-5426-2015	Bagchi, Robert/0000-0003-4035-4105; Hautier, Yann/0000-0003-4347-7741; Hector, Andrew/0000-0002-1309-7716; Hautier, Yann/0000-0003-4347-7741; Philipson, Christopher/0000-0001-8987-7260	Swiss National Foundation [3100A0-107572, 31003A_125461/1]; Royal Society [RS243]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Royal Society(Royal Society of London)	This project is funded by Swiss National Foundation grants 3100A0-107572 and 31003A_125461/1 to A.H. and is part of the Royal Society Southeast Asia Rain Forest Research Programme (Project No. RS243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Economic Planning Unit Sabah, Malaysia approved this field study. This is paper N degrees 2 of the Sabah Biodiversity Experiment.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Beck H, 2004, OIKOS, V106, P27, DOI 10.1111/j.0030-1299.2004.12864.x; Bennett EL, 2000, BIOL RESOURCE MANAGE, P305; Blate GM, 1998, OIKOS, V82, P522, DOI 10.2307/3546373; Blundell AG, 2004, ECOLOGY, V85, P704, DOI 10.1890/01-4101; BODMER RE, 1991, BIOTROPICA, V23, P255, DOI 10.2307/2388202; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Capistran-Barradas A, 2006, BIOTROPICA, V38, P203, DOI 10.1111/j.1744-7429.2006.00116.x; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; CURRAN LM, 2000, ECOL MONOGR, P101; Dalling JW, 1998, J ECOL, V86, P674, DOI 10.1046/j.1365-2745.1998.00298.x; DeMattia EA, 2004, ECOLOGY, V85, P2161, DOI 10.1890/03-0254; Faraway JJ., 2005, EXTENDING LINEAR MOD; Freckleton RP, 2006, P R SOC B, V273, P2909, DOI 10.1098/rspb.2006.3660; Gelman A., 2007, DATA ANAL USING REGR; Gilbert Gregory S., 2005, P141, DOI 10.1017/CBO9780511541971.007; Gould K., 1989, Malayan Nature Journal, V42, P245; Hammond D. S., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P51; Harper J. L., 1977, Population biology of plants.; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; ITOH A, 1995, J TROP ECOL, V11, P517, DOI 10.1017/S0266467400009068; Jansen Patrick A., 2002, P209, DOI 10.1079/9780851995250.0209; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; MAINDONALD D, 2007, DATA ANAL GRAPHICS U; MARSH CW, 1992, PHILOS T ROY SOC B, V335, P331, DOI 10.1098/rstb.1992.0025; Maycock CR, 2005, J VEG SCI, V16, P635, DOI 10.1111/j.1654-1103.2005.tb02406.x; McConkey KR, 2002, INT J PRIMATOL, V23, P123, DOI 10.1023/A:1013253909046; Naito Y, 2008, FOREST ECOL MANAG, V256, P375, DOI 10.1016/j.foreco.2008.04.031; Nakagawa M, 2005, BIOTROPICA, V37, P389, DOI 10.1111/j.1744-7429.2005.00051.x; NATAWIRIA D, 1986, B PENELITIAN HUTAN P, V472, P1; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; R Development Core Team, 2008, LANG ENV STAT COMP; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stoll P, 2005, ECOLOGY, V86, P3048, DOI 10.1890/04-1540; Takeuchi Y, 2007, FOREST ECOL MANAG, V247, P167, DOI 10.1016/j.foreco.2007.04.028; TERBORGH J, 1993, VEGETATIO, V108, P375; TOY RJ, 1991, J TROP ECOL, V7, P49, DOI 10.1017/S0266467400005058; Turner I.M, 2001, ASIAN J TROPICAL BIO, V4, P1; Wells K, 2005, RAFFLES B ZOOL, V53, P281; Wells K, 2006, J ANIM ECOL, V75, P1212, DOI 10.1111/j.1365-2656.2006.01144.x; Wells K, 2009, J TROP ECOL, V25, P555, DOI 10.1017/S0266467409990058; Whitmore T. C., 1998, INTRO TROPICAL RAINF; Wong ST, 2005, J TROP ECOL, V21, P627, DOI 10.1017/S0266467405002622; Wright SJ, 2001, BIOTROPICA, V33, P583, DOI 10.1111/j.1744-7429.2001.tb00217.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; Wyatt JL, 2004, OECOLOGIA, V140, P26, DOI 10.1007/s00442-004-1554-y	57	24	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11651	10.1371/journal.pone.0011651	http://dx.doi.org/10.1371/journal.pone.0011651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657841	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000280065600015
J	Sjodin, A; Svensson, K; Lindgren, M; Forsman, M; Larsson, P				Sjodin, Andreas; Svensson, Kerstin; Lindgren, Marie; Forsman, Mats; Larsson, Par			Whole-Genome Sequencing Reveals Distinct Mutational Patterns in Closely Related Laboratory and Naturally Propagated Francisella tularensis Strains	PLOS ONE			English	Article							SCHU S4; IDENTIFICATION; VIRULENCE; REPLICATION; MUTANTS; GENERATION; EVOLUTION; INFECTION; NOVICIDA; SCREEN	The F. tularensis type A strain FSC198 from Slovakia and a second strain FSC043, which has attenuated virulence, are both considered to be derivatives of the North American F. tularensis type A strain SCHU S4. These strains have been propagated under different conditions: the FSC198 has undergone natural propagation in the environment, while the strain FSC043 has been cultivated on artificial media in laboratories. Here, we have compared the genome sequences of FSC198, FSC043, and SCHU S4 to explore the possibility that the contrasting propagation conditions may have resulted in different mutational patterns. We found four insertion/deletion events (INDELs) in the strain FSC043, as compared to the SCHU S4, while no single nucleotide polymorphisms (SNPs) or variable number of tandem repeats (VNTRs) were identified. This result contrasts with previously reported findings for the strain FSC198, where eight SNPs and three VNTR differences, but no INDELs exist as compared to the SCHU S4 strain. The mutations detected in the laboratory and naturally propagated type A strains, respectively, demonstrate distinct patterns supporting that analysis of mutational spectra might be a useful tool to reveal differences in past growth conditions. Such information may be useful to identify leads in a microbial forensic investigation.	[Sjodin, Andreas; Svensson, Kerstin; Forsman, Mats; Larsson, Par] FOI Swedish Def Res Agcy, Div CBRN Secur & Def, Umea, Sweden; [Lindgren, Marie] Umea Univ, Dept Clin Microbiol & Clin Bacteriol, Umea, Sweden; [Lindgren, Marie] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden	FOI - Swedish Defence Research Agency; Umea University; Umea University	Sjodin, A (corresponding author), FOI Swedish Def Res Agcy, Div CBRN Secur & Def, Umea, Sweden.	par.larsson@foi.se	Sjödin, Andreas/A-7245-2008; Forsman, Mats/A-1426-2016	Sjödin, Andreas/0000-0001-5350-4219; Forsman, Mats/0000-0002-4466-5325	Swedish Ministry of Foreign Affairs [A4952]; Swedish Civil Contingencies Agency [B4055]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [AI60689]; Swedish Medical Research Council; Medical Faculty, Umea University, Umea, Sweden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060689] Funding Source: NIH RePORTER	Swedish Ministry of Foreign Affairs; Swedish Civil Contingencies Agency; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Medical Faculty, Umea University, Umea, Sweden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the Swedish Ministry of Foreign Affairs, project A4952, the Swedish Civil Contingencies Agency, project B4055, and the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under grant No. AI60689. Grant support was obtained from the Swedish Medical Research Council and the Medical Faculty, Umea University, Umea, Sweden. The work was performed in part at the Umea Centre for Microbial Research (UCMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JR, 2007, ANN NY ACAD SCI, V1105, P138, DOI 10.1196/annals.1409.010; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Frank DW, 2007, ANN NY ACAD SCI, V1105, P67, DOI 10.1196/annals.1409.008; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gurycova D, 1998, EUR J EPIDEMIOL, V14, P797, DOI 10.1023/A:1007537405242; HESSELBROCK W, 1945, J BACTERIOL, V49, P209, DOI 10.1128/JB.49.3.209-231.1945; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2000, J CLIN MICROBIOL, V38, P4180, DOI 10.1128/JCM.38.11.4180-4185.2000; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Larsson P, 2007, EMERG INFECT DIS, V13, P1725, DOI 10.3201/eid1311.070603; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; MARTH G, MARTHLAB PROJECT PAG; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Read A, 2008, J MED ENTOMOL, V45, P1108, DOI 10.1603/0022-2585(2008)45[1108:FGRFRI]2.0.CO;2; Salomonsson E, 2009, MICROBIOL-SGM, V155, P2546, DOI 10.1099/mic.0.028183-0; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Tucker JB, 2009, BIOSECUR BIOTERROR, V7, P389, DOI 10.1089/bsp.2009.0043; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11556	10.1371/journal.pone.0011556	http://dx.doi.org/10.1371/journal.pone.0011556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657845	Green Published, gold, Green Submitted			2022-12-25	WOS:000280065600004
J	Giliberto, L; d'Abramo, C; Acker, CM; Davies, P; D'Adamio, L				Giliberto, Luca; d'Abramo, Cristina; Acker, Christopher Michael; Davies, Peter; D'Adamio, Luciano			Transgenic Expression of the Amyloid-beta Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease-Like Traits In Vivo	PLOS ONE			English	Article							GAMMA-SECRETASE; A-BETA; PRESENILIN MUTATIONS; SYNAPTIC PLASTICITY; TERMINAL FRAGMENT; TALKING POINT; APP; MICE; TAU; PHOSPHORYLATION	Background: Regulated intramembranous proteolysis of the amyloid-beta precursor protein by the gamma-secretase yields amyloid-beta, which is the major component of the amyloid plaques found in Alzheimer's disease (AD), and the APP intracellular domain (AID). In vitro studies have involved AID in apoptosis and gene transcription. In vivo studies, which utilize transgenic mice expressing AID in the forebrain, only support a role for AID in apoptosis but not gene transcription. Methodology/Principal Findings: Here, we have further characterized several lines of AID transgenic mice by crossing them with human Tau-bearing mice, to determine whether over-expression of AID in the forebrain provokes AD-like pathologic features in this background. We have found no evidence that AID overexpression induces AD-like characteristics, such as activation of GSK-3 beta, hyperphosphorylation of Tau and formation of neurofibrillary pathology. Conclusions/Significance: Overall, these data suggest that AID transgenic mice do not represent a model that reproduces the overt biochemical and anatomo-pathologic lesions observed in AD patients. They can still be a valuable tool to understand the role of AID in enhancing the cell sensitivity to apoptotic stimuli, whose pathways still need to be characterized.	[Giliberto, Luca; d'Abramo, Cristina; Davies, Peter] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA; [Acker, Christopher Michael; Davies, Peter] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Northwell Health; Yeshiva University; Yeshiva University	Giliberto, L (corresponding author), N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA.	lgiliberto@nshs.edu; luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	Alzheimer Disease Research Grant [A2003-076]; National Institutes of Health (NIH) [RO1 AG22024, RO1 AG21588, R21 AG027139]; NATIONAL INSTITUTE ON AGING [R37AG022102, R21AG027139, R01AG022024, R01AG021588] Funding Source: NIH RePORTER	Alzheimer Disease Research Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Alzheimer Disease Research Grant A2003-076 (LD) and National Institutes of Health (NIH) grants RO1 AG22024 (LD), RO1 AG21588 (LD), and R21 AG027139 (LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bertrand E, 2001, MOL CELL NEUROSCI, V18, P503, DOI 10.1006/mcne.2001.1030; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; DAVIES P, 1999, ALZHEIMERS DIS METHO, P361; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Garringer HJ, 2010, BRAIN STRUCT FUNCT, V214, P235, DOI 10.1007/s00429-009-0221-9; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Leroy K, 2007, AM J PATHOL, V171, P976, DOI 10.2353/ajpath.2007.070345; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200	53	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11609	10.1371/journal.pone.0011609	http://dx.doi.org/10.1371/journal.pone.0011609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661273	gold, Green Published, Green Submitted			2022-12-25	WOS:000279980800006
J	Lane, SD; Steinberg, JL; Ma, LS; Hasan, KM; Kramer, LA; Zuniga, EA; Narayana, PA; Moeller, FG				Lane, Scott D.; Steinberg, Joel L.; Ma, Liangsuo; Hasan, Khader M.; Kramer, Larry A.; Zuniga, Edward A.; Narayana, Ponnada A.; Moeller, Frederick Gerard			Diffusion Tensor Imaging and Decision Making in Cocaine Dependence	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; NUCLEUS-ACCUMBENS; MEAN DIFFUSIVITY; RISK-TAKING; BRAIN; PERFORMANCE; ABNORMALITIES; REGISTRATION	Background: Chronic stimulant abuse is associated with both impairment in decision making and structural abnormalities in brain gray and white matter. Recent data suggest these structural abnormalities may be related to functional impairment in important behavioral processes. Methodology/Principal Findings: In 15 cocaine-dependent and 18 control subjects, we examined relationships between decision-making performance on the Iowa Gambling Task (IGT) and white matter integrity as measured by diffusion tensor imaging (DTI). Whole brain voxelwise analyses showed that, relative to controls, the cocaine group had lower fractional anisotropy (FA) and higher mean of the second and third eigenvalues (lambda perpendicular to) in frontal and parietal white matter regions and the corpus callosum. Cocaine subjects showed worse performance on the IGT, notably over the last 40 trials. Importantly, FA and lambda perpendicular to values in these regions showed a significant relationship with IGT performance on the last 40 trials. Conclusions: Compromised white matter integrity in cocaine dependence may be related to functional impairments in decision making.	[Lane, Scott D.; Steinberg, Joel L.; Ma, Liangsuo; Zuniga, Edward A.; Moeller, Frederick Gerard] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX USA; [Lane, Scott D.; Hasan, Khader M.; Narayana, Ponnada A.; Moeller, Frederick Gerard] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Program Neurosci, Houston, TX USA; [Hasan, Khader M.; Kramer, Larry A.; Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Lane, SD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX USA.	scott.d.lane@uth.tmc.edu	Hasan, Khader M./ABB-5767-2020		National Institutes of Health (NIH) [P50 DA 09262, K02 DA 00403, R01 DA 15392, R01 NS 52505, R01 EB002095, S10 RR19186]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA009262, K02DA000403, R01DA015392] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the following National Institutes of Health (NIH) grants: P50 DA 09262 and K02 DA 00403 to FGM, R01 DA 15392 to SDL, R01 NS 52505 to KMH, R01 EB002095 and S10 RR19186 to PAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson J.L.R., 2007, TR07JA1 FMRIB; Bartzokis G, 2002, BIOL PSYCHIAT, V51, P605, DOI 10.1016/S0006-3223(02)01315-X; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Busemeyer JR, 2002, PSYCHOL ASSESSMENT, V14, P253, DOI 10.1037//1040-3590.14.3.253; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Cohen MX, 2008, NEUROIMAGE, V39, P1396, DOI 10.1016/j.neuroimage.2007.10.004; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fellows LK, 2007, ANN NY ACAD SCI, V1121, P421, DOI 10.1196/annals.1401.023; First M. B., 2014, SCID 5 105 STRUCTURE; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Gloria R, 2009, PSYCHOPHYSIOLOGY, V46, P681, DOI 10.1111/j.1469-8986.2009.00823.x; Gulani V, 2001, MAGNET RESON MED, V45, P191, DOI 10.1002/1522-2594(200102)45:2<191::AID-MRM1025>3.0.CO;2-9; Hasan KM, 2006, MAGN RESON MED, V56, P130, DOI 10.1002/mrm.20935; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Herrera JJ, 2008, J NEUROSCI RES, V86, P443, DOI 10.1002/jnr.21481; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kellogg SH, 2003, DRUG ALCOHOL DEPEN, V69, P137, DOI 10.1016/S0376-8716(02)00308-3; Knutson B, 2007, ANN NY ACAD SCI, V1104, P54, DOI 10.1196/annals.1390.020; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lane SD, 2006, EXP CLIN PSYCHOPHARM, V14, P254, DOI 10.1037/1064-1297.14.2.254; Lane SD, 2000, DRUG ALCOHOL DEPEN, V60, P179, DOI 10.1016/S0376-8716(99)00155-6; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Moeller FG, 2007, PSYCHIAT RES-NEUROIM, V154, P253, DOI 10.1016/j.pscychresns.2006.11.004; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Narayana PA, 2009, PSYCHIAT RES-NEUROIM, V171, P242, DOI 10.1016/j.pscychresns.2008.04.004; Northoff G, 2006, HUM BRAIN MAPP, V27, P572, DOI 10.1002/hbm.20202; O'Neill J, 2001, ADDICT BIOL, V6, P347, DOI 10.1080/13556210020077073; Ojima K, 1996, INT J DEV NEUROSCI, V14, P649, DOI 10.1016/0736-5748(95)00105-0; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Shiffman S., 1995, NIAAA RES MONOGRAPH, V30, P17; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stout JC, 2004, PSYCHON B REV, V11, P742, DOI 10.3758/BF03196629; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tucker KA, 2004, BIOL PSYCHIAT, V56, P527, DOI 10.1016/j.biopsych.2004.06.031; van den Bos W, 2007, COGN AFFECT BEHAV NE, V7, P337, DOI 10.3758/CABN.7.4.337; Vorhold V, 2008, ANN NY ACAD SCI, V1128, P41, DOI 10.1196/annals.1399.006; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilson SJ, 2008, J ABNORM PSYCHOL, V117, P428, DOI 10.1037/0021-843X.117.2.428; Yechiam E, 2005, PSYCHON B REV, V12, P387, DOI 10.3758/BF03193783; Yechiam E, 2008, PSYCHON B REV, V15, P44, DOI 10.3758/PBR.15.1.44	72	73	73	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11591	10.1371/journal.pone.0011591	http://dx.doi.org/10.1371/journal.pone.0011591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661285	gold, Green Published, Green Submitted			2022-12-25	WOS:000279980800004
J	Bancells, C; Villegas, S; Blanco, FJ; Benitez, S; Gallego, I; Beloki, L; Perez-Cuellar, M; Ordonez-Llanos, J; Sanchez-Quesa, JL				Bancells, Cristina; Villegas, Sandra; Blanco, Francisco J.; Benitez, Sonia; Gallego, Isaac; Beloki, Lorea; Perez-Cuellar, Montserrat; Ordonez-Llanos, Jordi; Luis Sanchez-Quesa, Jose			Aggregated Electronegative Low Density Lipoprotein in Human Plasma Shows a High Tendency toward Phospholipolysis and Particle Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; ACTIVATING-FACTOR ACETYLHYDROLASE; HUMAN AORTIC PROTEOGLYCANS; OXIDATIVE MODIFICATION; LDL PARTICLES; FAMILIAL HYPERCHOLESTEROLEMIA; CHEMOKINE RELEASE; BINDING-AFFINITY; A(2); SPECTROSCOPY	Aggregation and fusion of lipoproteins trigger subendothelial retention of cholesterol, promoting atherosclerosis. The tendency of a lipoprotein to form fused particles is considered to be related to its atherogenic potential. We aimed to isolate and characterize aggregated and nonaggregated subfractions of LDL from human plasma, paying special attention to particle fusion mechanisms. Aggregated LDL was almost exclusively found in electronegative LDL (LDL(-)), a minor modified LDL subfraction, but not in native LDL (LDL(+)). The main difference between aggregated (agLDL(-)) and nonaggregated LDL(-) (nagLDL(-)) was a 6-fold increased phospholipase C-like activity in agLDL(-). agLDL(-) promoted the aggregation of LDL(+) and nagLDL(-). Lipoprotein fusion induced by alpha-chymotrypsin proteolysis was monitored by NMR and visualized by transmission electron microscopy. Particle fusion kinetics was much faster in agLDL(-) than in nagLDL(-) or LDL(+). NMR and chromatographic analysis revealed a rapid and massive phospholipid degradation in agLDL(-) but not in nagLDL(-) or LDL(+). Choline-containing phospholipids were extensively degraded, and ceramide, diacylglycerol, monoacylglycerol, and phosphorylcholine were the main products generated, suggesting the involvement of phospholipase C-like activity. The properties of agLDL(-) suggest that this subfraction plays a major role in atherogenesis by triggering lipoprotein fusion and cholesterol accumulation in the arterial wall.	[Luis Sanchez-Quesa, Jose] Hosp Santa Creu & Sant Pau, Serv Bioquim, Dept Bioquim, Inst Invest Biomed St Pau, Barcelona 08025, Spain; [Bancells, Cristina; Villegas, Sandra; Gallego, Isaac; Beloki, Lorea; Ordonez-Llanos, Jordi] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles 08193, Spain; [Blanco, Francisco J.] CIC BioGUNE, Derio 48160, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; CIC bioGUNE; Basque Foundation for Science	Sanchez-Quesa, JL (corresponding author), Hosp Santa Creu & Sant Pau, Serv Bioquim, Dept Bioquim, Inst Invest Biomed St Pau, C Antoni Maria Claret 167, Barcelona 08025, Spain.	jsanchezq@santpau.cat	cancer, biogune/H-7276-2012; Ordonez-Llanos, Jordi/B-4961-2011; Villegas, Sandra/D-8789-2011; Ordonez-Llanos, Jorge/N-1126-2019; Villegas, Sandra/ABF-8206-2021; Ordonez-Llanos, Jorge/AAE-3088-2020; Ordonez-Llanos, Jorge/A-9335-2010; Blanco, Francisco J/D-4401-2009	Ordonez-Llanos, Jordi/0000-0003-4896-5832; Villegas, Sandra/0000-0001-8644-4304; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Villegas, Sandra/0000-0001-8644-4304; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Blanco, Francisco J/0000-0003-2545-4319; Bancells, Cristina/0000-0003-4819-218X; Sanchez-Quesada, Jose Luis/0000-0003-0224-591X	Instituto de Salud Carlos III [PI060500, PI070148]; Sociedad para la Promocion y Reconversion Industrial	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Sociedad para la Promocion y Reconversion Industrial	This work was supported by Instituto de Salud Carlos III Grants PI060500 and PI070148 and by an ETORTEK-2008 grant from Sociedad para la Promocion y Reconversion Industrial.	Ala-Korpela M, 1998, J LIPID RES, V39, P1705; Asatryan L, 2005, J LIPID RES, V46, P115, DOI 10.1194/jlr.M400306-JLR200; Bancells C, 2008, BIOCHEMISTRY-US, V47, P8186, DOI 10.1021/bi800537h; Bancells C, 2009, J LIPID RES, V50, P446, DOI 10.1194/jlr.M800318-JLR200; Banfi C, 2009, PROTEOMICS, V9, P1344, DOI 10.1002/pmic.200800566; Benitez S, 2004, ATHEROSCLEROSIS, V177, P299, DOI 10.1016/j.atherosclerosis.2004.07.027; Benitez S, 2004, BIOCHEMISTRY-US, V43, P15863, DOI 10.1021/bi048825z; Benitez S, 2004, AM J CARDIOL, V93, P414, DOI 10.1016/j.amjcard.2003.10.034; Benitez S, 2003, CIRCULATION, V108, P92, DOI 10.1161/01.CIR.0000072791.40232.8F; Benitez S, 2007, BBA-MOL CELL BIOL L, V1771, P613, DOI 10.1016/j.bbalip.2007.03.001; Benitez S, 2006, BBA-MOL CELL BIOL L, V1761, P1014, DOI 10.1016/j.bbalip.2006.03.020; Bhakdi S, 2004, THROMB HAEMOSTASIS, V91, P639, DOI 10.1160/TH-03-12-d733; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; Campos H, 2001, J LIPID RES, V42, P1239; Chen HH, 2007, J LIPID RES, V48, P177, DOI 10.1194/jlr.M500481-JLR200; De Castellarnau C, 2000, ARTERIOSCL THROM VAS, V20, P2281; Duarte IF, 2009, ANAL CHEM, V81, P5023, DOI 10.1021/ac900545q; Forte T, 1972, Adv Lipid Res, V10, P1; Gaubatz JW, 2007, J LIPID RES, V48, P348, DOI 10.1194/jlr.M600249-JLR200; HERMANN M, 1992, ARTERIOSCLER THROMB, V12, P1503, DOI 10.1161/01.ATV.12.12.1503; Karlsson H, 2005, PROTEOMICS, V5, P551, DOI 10.1002/pmic.200300938; LODGE JK, 1995, BBA-LIPID LIPID MET, V1256, P130, DOI 10.1016/0005-2760(94)00253-U; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Oorni K, 2000, J LIPID RES, V41, P1703; Oorni K, 1998, J BIOL CHEM, V273, P29127, DOI 10.1074/jbc.273.44.29127; Parasassi T, 2001, FREE RADICAL BIO MED, V31, P82, DOI 10.1016/S0891-5849(01)00555-X; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; Pentikainen MO, 2001, J LIPID RES, V42, P916; Plihtari R, 2010, J LIPID RES, V51, P1801, DOI 10.1194/jlr.M003103; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sanchez-Quesada JL, 2004, CURR OPIN LIPIDOL, V15, P329, DOI [10.1097/00041433-200406000-00014, 10.1097/01.mol.0000130093.54381.22]; Sanchez-Quesada JL, 2003, ATHEROSCLEROSIS, V166, P261, DOI 10.1016/S0021-9150(02)00374-X; Sanchez-Quesada JL, 2002, J LIPID RES, V43, P699; Sanchez-Quesada JL, 2001, J CLIN ENDOCR METAB, V86, P3243, DOI 10.1210/jc.86.7.3243; SanchezQuesada JL, 1997, ATHEROSCLEROSIS, V132, P207, DOI 10.1016/S0021-9150(97)00108-1; Sevanian A, 1997, J LIPID RES, V38, P419; Soininen P, 2007, BIOCHEM BIOPH RES CO, V360, P290, DOI 10.1016/j.bbrc.2007.06.058; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; Tai MH, 2006, ATHEROSCLEROSIS, V186, P448, DOI 10.1016/j.atherosclerosis.2005.08.022; Ursini F, 2002, BIOL CHEM, V383, P599, DOI 10.1515/BC.2002.062; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916; Ziouzenkova O, 2000, BLOOD PURIFICAT, V18, P169, DOI 10.1159/000014415	43	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32425	32435		10.1074/jbc.M110.139691	http://dx.doi.org/10.1074/jbc.M110.139691			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20670941	Green Published, hybrid			2022-12-25	WOS:000282683000056
J	Meyer-Hoffert, U; Wu, ZH; Kantyka, T; Fischer, J; Latendorf, T; Hansmann, B; Bartels, J; He, YH; Glaser, R; Schroder, JM				Meyer-Hoffert, Ulf; Wu, Zhihong; Kantyka, Tomasz; Fischer, Jan; Latendorf, Ties; Hansmann, Britta; Bartels, Joachim; He, Yinghong; Glaeser, Regine; Schroeder, Jens-Michael			Isolation of SPINK6 in Human Skin SELECTIVE INHIBITOR OF KALLIKREIN-RELATED PEPTIDASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE INHIBITOR; THYMIC STROMAL LYMPHOPOIETIN; CORNEUM CHYMOTRYPTIC ENZYME; KAZAL-TYPE INHIBITOR; STRATUM-CORNEUM; NETHERTON-SYNDROME; LAMELLAR GRANULES; HUMAN EPIDERMIS; LEKTI; DESQUAMATION	Kallikrein-related peptidases (KLKs) play a central role in skin desquamation. They are tightly controlled by specific inhibitors, including the lymphoepithelial Kazal-type inhibitor (LEKTI) encoded by SPINK5 and LEKTI-2 encoded by SPINK9. Herein, we identify SPINK6 as a selective inhibitor of KLKs in the skin. Unlike LEKTI but similar to LEKTI-2, SPINK6 possesses only one typical Kazal domain. Its mRNA was detected to be expressed at low levels in several tissues and was induced during keratinocyte differentiation. Natural SPINK6 was purified from human plantar stratum corneum extracts. Immunohistochemical analyses revealed SPINK6 expression in the stratum granulosum of human skin at various anatomical localizations and in the skin appendages, including sebaceous glands and sweat glands. SPINK6 expression was decreased in lesions of atopic dermatitis. Using KLK5, KLK7, KLK8, KLK14, thrombin, trypsin, plasmin, matriptase, prostasin, mast cell chymase, cathepsin G, neutrophil elastase, and chymotrypsin, inhibition with recombinant SPINK6 was detected only for KLK5, KLK7, and KLK14, with apparent K-t values of 1.33, 1070, and 0.5 nM, respectively. SPINK6 inhibited desquamation of human plantar callus in an ex vivo model. Our findings suggest that SPINK6 plays a role in modulating the activity of KLKs in human skin. A selective inhibition of KLKs by SPINK6 might have therapeutic potential when KLK activity is elevated.	[Meyer-Hoffert, Ulf; Wu, Zhihong; Kantyka, Tomasz; Fischer, Jan; Latendorf, Ties; Hansmann, Britta; Bartels, Joachim; He, Yinghong; Glaeser, Regine; Schroeder, Jens-Michael] Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Kantyka, Tomasz] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland	University of Kiel; Schleswig Holstein University Hospital; Jagiellonian University	Schroder, JM (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Schittenhelmstr 7, D-24105 Kiel, Germany.	jschroeder@dermatology.uni-kiel.de	Meyer-Hoffert, Ulf/F-4623-2012; Wu, Zhihong/AAK-3433-2020; Wu, Zhihong/G-3569-2011	Meyer-Hoffert, Ulf/0000-0003-2305-1428; Kantyka, Tomasz/0000-0003-3023-2382; Bartels, Joachim/0000-0003-4395-4552	Deutsche Forschungsgemeinschaft [SCHR305/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SCHR305/4-1.	Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; GRIFFITHS WAD, 1998, TXB DERMATOLOGY; Hachem JP, 2006, J INVEST DERMATOL, V126, P2074, DOI 10.1038/sj.jid.5700351; Hale JE, 2004, ANAL BIOCHEM, V333, P174, DOI 10.1016/j.ab.2004.04.013; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; LUNDSTROM A, 1988, J INVEST DERMATOL, V91, P340, DOI 10.1111/1523-1747.ep12475679; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Meyer-Hoffert U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004372; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; SONDELL B, 1995, J INVEST DERMATOL, V104, P819, DOI 10.1111/1523-1747.ep12607007; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; Wu ZH, 2009, J INVEST DERMATOL, V129, P1446, DOI 10.1038/jid.2008.370; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	35	74	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32174	32181		10.1074/jbc.M109.091850	http://dx.doi.org/10.1074/jbc.M109.091850			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20667819	Green Published, hybrid			2022-12-25	WOS:000282683000030
J	Chen, XW; Ren, L; Kim, S; Carpino, N; Daniel, JL; Kunapuli, SP; Tsygankov, AY; Pei, DH				Chen, Xianwen; Ren, Lige; Kim, Soochong; Carpino, Nicholas; Daniel, James L.; Kunapuli, Satya P.; Tsygankov, Alexander Y.; Pei, Dehua			Determination of the Substrate Specificity of Protein-tyrosine Phosphatase TULA-2 and Identification of Syk as a TULA-2 Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ACTIVATION; STS-1; CBL; ENDOCYTOSIS; INHIBITOR; PLATELETS; BIND; GPVI	TULA-1 (UBASH3A/STS-2) and TULA-2 (p70/STS-1) represent a novel class of protein-tyrosine phosphatases. Previous studies suggest that TULA-2 is sequence-selective toward phosphotyrosyl (Tyr(P)) peptides. In this work the substrate specificity of TULA-1 and -2 was systematically evaluated by screening a combinatorial Tyr(P) peptide library. Although TULA-1 showed no detectable activity toward any of the Tyr(P) peptides in the library, TULA-2 recognizes two distinct classes of Tyr(P) substrates. On the N-terminal side of Tyr(P), the class I substrates contain a proline at the Tyr(P)-1 position, a hydrophilic residue at the Tyr(P)-2 position, and aromatic hydrophobic residues at positions Tyr(P)-3 and beyond. The class II substrates typically contain two or more acidic residues, especially at Tyr(P)-1 to Tyr(P)-3 positions, and aromatic hydrophobic residues at other positions. At the C-terminal side of Tyr(P), TULA-2 generally prefers acidic and aromatic residues. The library screening results were confirmed by kinetic analysis of representative peptides selected from the library as well as Tyr(P) peptides derived from various Tyr(P) proteins. TULA-2 is highly active toward peptides corresponding to the Tyr(P)-323 and Tyr(P)-352 sites of Syk, and the Tyr(P)-397 site of focal adhesion kinase and has lower activity toward other Tyr(P) sites in these proteins. In glycoprotein VI-stimulated platelets, knock-out of the TULA-2 gene significantly increased the phosphorylation level of Syk at Tyr-323 and Tyr-352 sites and to a lesser degree at the Tyr-525/526 sites. These results suggest that Syk is a bona fide TULA-2 substrate in platelets.	[Chen, Xianwen; Ren, Lige; Pei, Dehua] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Carpino, Nicholas] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Tsygankov, Alexander Y.] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Daniel, James L.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Daniel, James L.; Kunapuli, Satya P.; Tsygankov, Alexander Y.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Chen, Xianwen; Ren, Lige; Pei, Dehua] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Ohio; Ohio State University	Tsygankov, AY (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA.	tsygan@temple.edu; pei.3@osu.edu	Pei, Dehua/P-4594-2016; Tsygankov, Alexander Y/K-6205-2017	Pei, Dehua/0000-0002-2057-6934; 	National Institutes of Health [CA132855]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA132855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA132855. This work was also supported by the Pennsylvania Department of Health (to A. Y. T.).	Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Bertelsen V, 2007, EXP CELL RES, V313, P1696, DOI 10.1016/j.yexcr.2007.02.017; Bhavaraju K, 2008, EUR J PHARMACOL, V580, P285, DOI 10.1016/j.ejphar.2007.11.009; Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Chen YT, 2009, BIOCHEMISTRY-US, V48, P8129, DOI 10.1021/bi9008648; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Garaud M, 2007, J AM CHEM SOC, V129, P5366, DOI 10.1021/ja071275i; Gopishetty B, 2008, ORG LETT, V10, P4605, DOI 10.1021/ol801868a; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Leon S, 1998, BIOORG MED CHEM LETT, V8, P2997, DOI 10.1016/S0960-894X(98)00534-4; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Quinton TM, 2002, BLOOD, V99, P3228, DOI 10.1182/blood.V99.9.3228; Raguz J, 2007, FEBS LETT, V581, P4767, DOI 10.1016/j.febslet.2007.08.077; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Shankar H, 2006, CURR DRUG TARGETS, V7, P1253, DOI 10.2174/138945006778559166; Smirnova EV, 2008, VIROLOGY, V372, P10, DOI 10.1016/j.virol.2007.10.012; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Thakkar A, 2006, ANAL CHEM, V78, P5935, DOI 10.1021/ac0607414; THOMAS DH, 2010, BLOOD IN PRESS; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Tsygankov AY, 2008, IUBMB LIFE, V60, P224, DOI 10.1002/iub.36; Tsygankov AY, 2009, CELL MOL LIFE SCI, V66, P2949, DOI 10.1007/s00018-009-0071-x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Wattenhofer M, 2001, HUM GENET, V108, P140, DOI 10.1007/s004390000453; Wee JLK, 2006, CURR DRUG TARGETS, V7, P1265; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Zahedi RP, 2006, BBA-PROTEINS PROTEOM, V1764, P1963, DOI 10.1016/j.bbapap.2006.08.017	37	35	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31268	31276		10.1074/jbc.M110.114181	http://dx.doi.org/10.1074/jbc.M110.114181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670933	Green Published, hybrid			2022-12-25	WOS:000282764600021
J	Otto, B; Uehlein, N; Sdorra, S; Fischer, M; Ayaz, M; Belastegui-Macadam, X; Heckwolf, M; Lachnit, M; Pede, N; Priem, N; Reinhard, A; Siegfart, S; Urban, M; Kaldenhoff, R				Otto, Beate; Uehlein, Norbert; Sdorra, Sven; Fischer, Matthias; Ayaz, Muhammad; Belastegui-Macadam, Xana; Heckwolf, Marlies; Lachnit, Magdalena; Pede, Nadine; Priem, Nadine; Reinhard, Andre; Siegfart, Sven; Urban, Michael; Kaldenhoff, Ralf			Aquaporin Tetramer Composition Modifies the Function of Tobacco Aquaporins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE AQUAPORINS; INTRINSIC PROTEINS; WATER CHANNELS; PERMEABILITY; TRANSPORT; NTAQP1; ARABIDOPSIS; FAMILY; GENES; CELLS	Heterologous expression in yeast cells revealed that NtAQP1, a member of the so-called PIP1 aquaporin subfamily, did not display increased water transport activity in comparison with controls. Instead, an increased CO2-triggered intracellular acidification was observed. NtPIP2;1, which belongs to the PIP2 subfamily of plant aquaporins, behaved as a true aquaporin but lacked a CO2-related function. Results from split YFP experiments, protein chromatography, and gel electrophoresis indicated that the proteins form heterotetramers when coexpressed in yeast. Tetramer composition had effects on transport activity as demonstrated by analysis of artificial heterotetramers with a defined proportion of NtAQP1 to NtPIP2;1. A single NtPIP2;1 aquaporin in a tetramer was sufficient to significantly increase the water permeability of the respective yeast cells. With regard to CO2-triggered intracellular acidification, a cooperative effect was observed, where maximum rates were measured when the tetramer consisted of NtAQP1 aquaporins only. The results confirm the model of an aquaporin monomer as a functional unit for water transport and suggest that, for CO2-related transport processes, a structure built up by the tetramer is the basis of this function.	[Heckwolf, Marlies; Lachnit, Magdalena; Pede, Nadine; Priem, Nadine; Reinhard, Andre; Siegfart, Sven; Kaldenhoff, Ralf] Tech Univ Darmstadt, Inst Bot, Dept Appl Plant Sci, D-64287 Darmstadt, Germany; [Fischer, Matthias] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Belastegui-Macadam, Xana] Iden Biotechnol, Mutilva Baja 31192, Spain	Technical University of Darmstadt; Max Planck Society	Kaldenhoff, R (corresponding author), Tech Univ Darmstadt, Inst Bot, Dept Appl Plant Sci, D-64287 Darmstadt, Germany.	kaldenhoff@bio.tu-darmstadt.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft grant (to R. K.).	BAUDIN V, 1993, PROTEIN SCI, V2, P1320, DOI 10.1002/pro.5560020815; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Cooper GJ, 2002, J PHYSIOL-LONDON, V542, P17, DOI 10.1113/jphysiol.2002.023218; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Flexas J, 2006, PLANT J, V48, P427, DOI 10.1111/j.1365-313X.2006.02879.x; HAMES BD, 1981, GEL ELECTROPHORESIS, P14; Heymann JB, 1998, J STRUCT BIOL, V121, P191, DOI 10.1006/jsbi.1997.3951; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Kaldenhoff R, 2006, ACTA PHYSIOL, V187, P169, DOI 10.1111/j.1748-1716.2006.01563.x; KALDENHOFF R, 2005, PROGR BOT, V67, P206; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; Kirber MT, 2007, NAT METHODS, V4, P767, DOI 10.1038/nmeth1007-767; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marin-Olivier M, 2000, PLANT J, V24, P231, DOI 10.1046/j.1365-313x.2000.00874.x; Moshelion M, 2002, PLANT CELL, V14, P727, DOI 10.1105/tpc.010351; Moshelion M, 2004, PLANT PHYSIOL, V135, P2301, DOI 10.1104/pp.104.043000; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; RICARD J, 1987, EUR J BIOCHEM, V166, P255, DOI 10.1111/j.1432-1033.1987.tb13510.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Strand L, 2009, BIOCHEMISTRY-US, V48, P5785, DOI 10.1021/bi802231q; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Terashima I, 2002, PLANT CELL PHYSIOL, V43, P70, DOI 10.1093/pcp/pcf001; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686; Zelazny E, 2009, PLANT J, V57, P346, DOI 10.1111/j.1365-313X.2008.03691.x; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104	44	116	123	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31253	31260		10.1074/jbc.M110.115881	http://dx.doi.org/10.1074/jbc.M110.115881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20657033	Green Published, hybrid			2022-12-25	WOS:000282764600019
J	Chan, DI; Chu, BCH; Lau, CKY; Hunter, HN; Byers, DM; Vogel, HJ				Chan, David I.; Chu, Byron C. H.; Lau, Cheryl K. Y.; Hunter, Howard N.; Byers, David M.; Vogel, Hans J.			NMR Solution Structure and Biophysical Characterization of Vibrio harveyi Acyl Carrier Protein A75H EFFECTS OF DIVALENT METAL IONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MOLECULAR-DYNAMICS SIMULATIONS; ACP SYNTHETASE-ACTIVITY; TORSION ANGLE DYNAMICS; ESCHERICHIA-COLI; BETA-KETOACYL; PROGRAM; BINDING; APO; BIOSYNTHESIS	Bacterial acyl carrier protein (ACP) is a highly anionic, 9 kDa protein that functions as a cofactor protein in fatty acid biosynthesis. Escherichia coli ACP is folded at neutral pH and in the absence of divalent cations, while Vibrio harveyi ACP, which is very similar at 86% sequence identity, is unfolded under the same conditions. V. harveyi ACP adopts a folded conformation upon the addition of divalent cations such as Ca2+ and Mg2+ and a mutant, A75H, was previously identified that restores the folded conformation at pH 7 in the absence of divalent cations. In this study we sought to understand the unique folding behavior of V. harveyi ACP using NMR spectroscopy and biophysical methods. The NMR solution structure of V. harveyi ACP A75H displays the canonical ACP structure with four helices surrounding a hydrophobic core, with a narrow pocket closed off from the solvent to house the acyl chain. His-75, which is charged at neutral pH, participates in a stacking interaction with Tyr-71 in the far C-terminal end of helix IV. pH titrations and the electrostatic profile of ACP suggest that V. harveyi ACP is destabilized by anionic charge repulsion around helix II that can be partially neutralized by His-75 and is further reduced by divalent cation binding. This is supported by differential scanning calorimetry data which indicate that calcium binding further increases the melting temperature of V. harveyi ACP A75H by similar to 20 degrees C. Divalent cation binding does not alter ACP dynamics on the ps-ns timescale as determined by N-15 NMR relaxation experiments, however, it clearly stabilizes the protein fold as observed by hydrogen-deuterium exchange studies. Finally, we demonstrate that the E. coli ACP H75A mutant is similarly unfolded as wild-type V. harveyi ACP, further stressing the importance of this particular residue for proper protein folding.	[Chan, David I.; Chu, Byron C. H.; Lau, Cheryl K. Y.; Hunter, Howard N.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada; [Byers, David M.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 1X5, Canada; [Byers, David M.] Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS B3H 1X5, Canada	University of Calgary; Dalhousie University; Dalhousie University	Vogel, HJ (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Natural Sciences Engineering Research Council of Canada; Canadian Institute of Health Research; Alberta Heritage Foundation for Medical Research	Natural Sciences Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by operating grants from the Natural Sciences Engineering Research Council of Canada (to D. M. B.) and the Canadian Institute of Health Research (to H.J.V.).; Recipient of a Scientist award from the Alberta Heritage Foundation for Medical Research. To whom correspondence should be addressed: 2500 University Dr. NW, Calgary, Alberta T2N 1N4, Canada. Tel.: 403-220-6006; Fax: 403-289-9311; E-mail: vogel@ucalgary.ca.	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; BYERS DM, 1985, P NATL ACAD SCI USA, V82, P6085, DOI 10.1073/pnas.82.18.6085; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chan DI, 2010, BIOCHEMISTRY-US, V49, P2860, DOI 10.1021/bi901713r; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; delaRoche MA, 1997, ARCH BIOCHEM BIOPHYS, V344, P159, DOI 10.1006/abbi.1997.0203; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gong H, 2003, BIOCHEM BIOPH RES CO, V302, P35, DOI 10.1016/S0006-291X(03)00108-6; Gong HS, 2008, BBA-PROTEINS PROTEOM, V1784, P1835, DOI 10.1016/j.bbapap.2008.07.017; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; GUERRA DJ, 1988, J BIOL CHEM, V263, P4386; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HORVATH LA, 1994, PROTEIN SCI, V3, P103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KEATING DH, 1995, J BIOL CHEM, V270, P22229, DOI 10.1074/jbc.270.38.22229; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMBALOT RH, 1997, VITAMINS COENZYMES, V279, P254; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Park SJ, 2004, J BIOCHEM, V135, P337, DOI 10.1093/jb/mvh041; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SCHULZ H, 1969, J BIOL CHEM, V244, P6577; SCHULZ H, 1975, J BIOL CHEM, V250, P2299; SKELTON NJ, 1992, J MOL BIOL, V227, P1100, DOI 10.1016/0022-2836(92)90524-N; TENER DM, 1990, EUR J BIOCHEM, V189, P559, DOI 10.1111/j.1432-1033.1990.tb15523.x; Upadhyay SK, 2009, J BIOL CHEM, V284, P22390, DOI 10.1074/jbc.M109.014829; Volkman BF, 2001, BIOCHEMISTRY-US, V40, P7964, DOI 10.1021/bi010355a; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wu BN, 2009, PROTEIN SCI, V18, P240, DOI 10.1002/pro.11; WUTHRICK K, 1986, NMR PROTEINS NUCL AC; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d; Zornetzer GA, 2010, BIOCHEMISTRY-US, V49, P470, DOI 10.1021/bi9014659	48	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30558	30566		10.1074/jbc.M110.128298	http://dx.doi.org/10.1074/jbc.M110.128298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659901	Green Published, hybrid			2022-12-25	WOS:000282135500024
J	Gersting, SW; Staudigl, M; Truger, MS; Messing, DD; Danecka, MK; Sommerhoff, CP; Kemter, KF; Muntau, AC				Gersting, Soren W.; Staudigl, Michael; Truger, Marietta S.; Messing, Dunja D.; Danecka, Marta K.; Sommerhoff, Christian P.; Kemter, Kristina F.; Muntau, Ania C.			Activation of Phenylalanine Hydroxylase Induces Positive Cooperativity toward the Natural Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBAL CONFORMATIONAL TRANSITION; SUBSTRATE-BINDING; RAT-LIVER; ESCHERICHIA-COLI; WILD-TYPE; PHENYLKETONURIA MUTATIONS; REGULATORY PROPERTIES; ALLOSTERIC REGULATION; CATALYTIC ACTIVATION; MILD PHENYLKETONURIA	Protein misfolding with loss-of-function of the enzyme phenylalanine hydroxylase (PAH) is the molecular basis of phenylketonuria in many individuals carrying missense mutations in the PAH gene. PAH is complexly regulated by its substrate L-Phenylalanine and its natural cofactor 6R-L-erythro-5,6,7,8-tetrahydro-biopterin (BH4). Sapropterin dihydrochloride, the synthetic form of BH4, was recently approved as the first pharmacological chaperone to correct the loss-of-function phenotype. However, current knowledge about enzyme function and regulation in the therapeutic setting is scarce. This illustrates the need for comprehensive analyses of steady state kinetics and allostery beyond single residual enzyme activity determinations to retrace the structural impact of missense mutations on the phenylalanine hydroxylating system. Current standard PAH activity assays are either indirect (NADH) or discontinuous due to substrate and product separation before detection. We developed an automated fluorescence-based continuous real-time PAH activity assay that proved to be faster and more efficient but as precise and accurate as standard methods. Wild-type PAH kinetic analyses using the new assay revealed cooperativity of activated PAH toward BH4, a previously unknown finding. Analyses of structurally preactivated variants substantiated BH4-dependent cooperativity of the activated enzyme that does not rely on the presence of L-Phenylalanine but is determined by activating conformational rearrangements. These findings may have implications for an individualized therapy, as they support the hypothesis that the patient's metabolic state has a more significant effect on the interplay of the drug and the conformation and function of the target protein than currently appreciated.	[Kemter, Kristina F.; Muntau, Ania C.] Dr von Hauner Childrens Hosp, Dept Mol Pediat, D-80337 Munich, Germany; [Sommerhoff, Christian P.] Univ Munich, Surg Clin, Dept Clin Chem & Clin Biochem, D-80336 Munich, Germany	University of Munich; University of Munich	Muntau, AC (corresponding author), Lindwurmstr 4, D-80337 Munich, Germany.	ania.muntau@med.lmu.de	Gersting, Soeren W/D-4612-2011	Gersting, Soeren W/0000-0001-7482-4748	Bavarian Genome Research Network (BayGene)	Bavarian Genome Research Network (BayGene)	This work was supported by the Bavarian Genome Research Network (BayGene).	Andersen OA, 2003, J MOL BIOL, V333, P747, DOI 10.1016/j.jmb.2003.09.004; Andersen OA, 2002, J MOL BIOL, V320, P1095, DOI 10.1016/S0022-2836(02)00560-0; BAILEY SW, 1980, ANAL BIOCHEM, V107, P156, DOI 10.1016/0003-2697(80)90506-0; BAILEY SW, 1978, J BIOL CHEM, V253, P1598; Bjorgo E, 2001, EUR J BIOCHEM, V268, P997, DOI 10.1046/j.1432-1327.2001.01958.x; Brock DA, 2003, J BIOL CHEM, V278, P52262, DOI 10.1074/jbc.M309101200; Chehin R, 1998, FEBS LETT, V422, P225, DOI 10.1016/S0014-5793(97)01596-2; Copeland R. A., 2004, ENZYMES PRACTICAL IN; CORNISHBOWDEN A, 1987, J THEOR BIOL, V124, P1, DOI 10.1016/S0022-5193(87)80248-5; Davis MD, 1997, P NATL ACAD SCI USA, V94, P491, DOI 10.1073/pnas.94.2.491; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Erlandsen H, 2000, BIOCHEMISTRY-US, V39, P2208, DOI 10.1021/bi992531+; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Fiege B, 2007, J PEDIATR-US, V150, P627, DOI 10.1016/j.jpeds.2007.02.017; FISHER DB, 1973, J BIOL CHEM, V248, P4345; Flatmark T, 2001, ANAL BIOCHEM, V294, P95, DOI 10.1006/abio.2001.5163; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Gersting SW, 2010, HUM MOL GENET, V19, P2039, DOI 10.1093/hmg/ddq085; Hutt DM, 2005, J BIOL CHEM, V280, P20197, DOI 10.1074/jbc.M412920200; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kappock TJ, 1995, J BIOL CHEM, V270, P30532, DOI 10.1074/jbc.270.51.30532; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Knappskog PM, 1996, EUR J BIOCHEM, V242, P813, DOI 10.1111/j.1432-1033.1996.0813r.x; KNAPPSKOG PM, 1995, BIOCHEMISTRY-US, V34, P11790, DOI 10.1021/bi00037a017; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LEDLEY FD, 1987, J BIOL CHEM, V262, P2228; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Levy HL, 2007, LANCET, V370, P504, DOI 10.1016/S0140-6736(07)61234-3; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; MITNAUL LJ, 1995, P NATL ACAD SCI USA, V92, P885, DOI 10.1073/pnas.92.3.885; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Muntau AC, 2002, NEW ENGL J MED, V347, P2122, DOI 10.1056/NEJMoa021654; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Pauwels F, 2003, J BIOL CHEM, V278, P16658, DOI 10.1074/jbc.M300157200; Perez B, 2005, MOL GENET METAB, V86, pS11, DOI 10.1016/j.ymgme.2005.06.009; Pey AL, 2005, MOL GENET METAB, V86, pS43, DOI 10.1016/j.ymgme.2005.04.008; Pey AL, 2004, HUM MUTAT, V24, P388, DOI 10.1002/humu.20097; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Sawicki A, 2008, J BIOL CHEM, V283, P31294, DOI 10.1074/jbc.M805792200; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; SHIMAN R, 1994, J BIOL CHEM, V269, P24647; SHIMAN R, 1990, J BIOL CHEM, V265, P11633; SHIMAN R, 1980, J BIOL CHEM, V255, P4793; SHIMAN R, 1982, J BIOL CHEM, V257, P1213; SHIMAN R, 1994, J BIOL CHEM, V269, P24637; Solstad T, 2003, EUR J BIOCHEM, V270, P981, DOI 10.1046/j.1432-1033.2003.03471.x; Stokka AJ, 2004, J BIOL CHEM, V279, P26571, DOI 10.1074/jbc.M400879200; Teigen K, 1999, J MOL BIOL, V294, P807, DOI 10.1006/jmbi.1999.3288; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Trefz FK, 2009, J PEDIATR-US, V154, P700, DOI 10.1016/j.jpeds.2008.11.040; Velloso LM, 2008, EMBO REP, V9, P199, DOI 10.1038/sj.embor.7401154; Volner A, 2003, J BIOL INORG CHEM, V8, P121, DOI 10.1007/s00775-002-0395-6; Waters PJ, 2000, MOL GENET METAB, V69, P101, DOI 10.1006/mgme.2000.2965; XIA T, 1994, J BIOL CHEM, V269, P24657; Zschocke J, 2003, HUM MUTAT, V21, P345, DOI 10.1002/humu.10192	59	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30686	30697		10.1074/jbc.M110.124016	http://dx.doi.org/10.1074/jbc.M110.124016			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20667834	Green Published, hybrid			2022-12-25	WOS:000282135500037
J	Smirnov, A; Comte, C; Mager-Heckel, AM; Addis, V; Krasheninnikov, IA; Martin, RP; Entelis, N; Tarassov, I				Smirnov, Alexandre; Comte, Caroline; Mager-Heckel, Anne-Marie; Addis, Vanessa; Krasheninnikov, Igor A.; Martin, Robert P.; Entelis, Nina; Tarassov, Ivan			Mitochondrial Enzyme Rhodanese Is Essential for 5 S Ribosomal RNA Import into Human Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOMES; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; PROTEIN CHAPERONES; PRECURSOR PROTEIN; MOLECULAR-MODEL; BINDING; DNA; SUBUNIT; YEAST	5 S rRNA is an essential component of ribosomes. In eukaryotic cells, it is distinguished by particularly complex intracellular traffic, including nuclear export and re-import. The finding that in mammalian cells 5 S rRNA can eventually escape its usual circuit toward nascent ribosomes to get imported into mitochondria has made the scheme more complex, and it has raised questions about both the mechanism of 5 S rRNA mitochondrial targeting and its function inside the organelle. Previously, we showed that import of 5 S rRNA into mitochondria requires unknown cytosolic proteins. Here, one of them was identified as mitochondrial thiosulfate sulfurtransferase, rhodanese. Rhodanese in its misfolded form was found to possess a strong and specific 5 S rRNA binding activity, exploiting sites found earlier to function as signals of 5 S rRNA mitochondrial localization. The interaction with 5 S rRNA occurs cotranslationally and results in formation of a stable complex in which rhodanese is preserved in a compact enzymatically inactive conformation. Human 5 S rRNA in a branched Mg2+-free form, upon its interaction with misfolded rhodanese, demonstrates characteristic functional traits of Hsp40 cochaperones implicated in mitochondrial precursor protein targeting, suggesting that it may use this mechanism to ensure its own mitochondrial localization. Finally, silencing of the rhodanese gene caused not only a proportional decrease of 5 S rRNA import but also a general inhibition of mitochondrial translation, indicating the functional importance of the imported 5 S rRNA inside the organelle.	[Tarassov, Ivan] Univ Strasbourg, CNRS, UDS, Dept Mol & Cellular Genet,UMR 7156, F-67084 Strasbourg, France; [Smirnov, Alexandre; Krasheninnikov, Igor A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Mol Biol, Moscow 119992, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Lomonosov Moscow State University	Tarassov, I (corresponding author), Univ Strasbourg, CNRS, UDS, Dept Mol & Cellular Genet,UMR 7156, 21 Rue Rene Descartes, F-67084 Strasbourg, France.	i.tarassov@unistra.fr	Smirnov, Alexandre/H-4253-2019	Smirnov, Alexandre/0000-0002-9142-7979; Tarassov, Ivan/0000-0001-8763-6703; Entelis, Nina/0000-0002-7915-5528	CNRS; Universite de Strasbourg; Moscow State University; Association Francaise Contre les Myopathies; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Russian Foundation for Basic Research; ARCUS	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Moscow State University; Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); ARCUS	This work was supported by the CNRS, Universite de Strasbourg, Moscow State University, Association Francaise Contre les Myopathies, Agence Nationale de la Recherche, Fondation pour la Recherche Medicale, Russian Foundation for Basic Research, and ARCUS (cooperation program Alsace-Russia-Ukraine).	Artigues A, 2002, J BIOL CHEM, V277, P25047, DOI 10.1074/jbc.M203474200; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Batey RT, 1998, RNA, V4, P984, DOI 10.1017/S1355838298980426; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; DULBECCO R, 1959, VIROLOGY, V8, P396, DOI 10.1016/0042-6822(59)90043-1; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; EGEBJERG J, 1989, J MOL BIOL, V206, P651, DOI 10.1016/0022-2836(89)90573-1; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; FOX JW, 1979, J BIOL CHEM, V254, P139; Funari SS, 2000, J BIOL CHEM, V275, P31283, DOI 10.1074/jbc.M004974200; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GLICK B, 1991, ANNU REV GENET, V25, P21; Gliubich F, 1996, J BIOL CHEM, V271, P21054, DOI 10.1074/jbc.271.35.21054; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; GUDDAT U, 1990, CELL, V60, P619, DOI 10.1016/0092-8674(90)90665-2; Hanas JS, 2002, GENE, V282, P43, DOI 10.1016/S0378-1119(01)00796-X; Hardesty B, 1995, BIOCHEM CELL BIOL, V73, P1199, DOI 10.1139/o95-129; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HENDRICK JP, 1993, P NATL ACAD SCI USA, V90, P10216, DOI 10.1073/pnas.90.21.10216; HENIS YI, 1976, EUR J BIOCHEM, V71, P529, DOI 10.1111/j.1432-1033.1976.tb11141.x; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Kim HK, 2010, BIOCHEM BIOPH RES CO, V391, P1177, DOI 10.1016/j.bbrc.2009.11.176; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; KUDLICKI W, 1995, J BIOL CHEM, V270, P10650, DOI 10.1074/jbc.270.18.10650; Kudlicki W, 1996, J BIOL CHEM, V271, P31160, DOI 10.1074/jbc.271.49.31160; KULINSKI T, 1991, NUCLEIC ACIDS RES, V19, P2449, DOI 10.1093/nar/19.9.2449; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Lin EL, 2001, NUCLEIC ACIDS RES, V29, P2510, DOI 10.1093/nar/29.12.2510; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; MENDOZA JA, 1991, J BIOL CHEM, V266, P13587; MILLER DM, 1991, J BIOL CHEM, V266, P4686; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Nishikori S, 2008, GENES CELLS, V13, P827, DOI 10.1111/j.1365-2443.2008.01214.x; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; OGATA K, 1993, EUR J BIOCHEM, V213, P1277, DOI 10.1111/j.1432-1033.1993.tb17879.x; Okada S, 2000, FEBS LETT, V485, P153, DOI 10.1016/S0014-5793(00)02184-0; OSTERBERG R, 1976, EUR J BIOCHEM, V68, P481, DOI 10.1111/j.1432-1033.1976.tb10835.x; Panda M, 2000, J BIOL CHEM, V275, P63, DOI 10.1074/jbc.275.1.63; Radman-Livaja M, 2005, P NATL ACAD SCI USA, V102, P3913, DOI 10.1073/pnas.0500844102; Rudt F, 1996, EMBO J, V15, P1383, DOI 10.1002/j.1460-2075.1996.tb00480.x; Ryan MT, 1997, INT REV CYTOL, V174, P127, DOI 10.1016/S0074-7696(08)62117-8; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Semrad K, 2004, RNA, V10, P1855, DOI 10.1261/rna.7121704; Silberg JJ, 1998, J BACTERIOL, V180, P6617, DOI 10.1128/JB.180.24.6617-6624.1998; Skibinska L, 2004, BIOPOLYMERS, V73, P316, DOI 10.1002/bip.10598; Smirnov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1418, DOI 10.1134/S000629790813004X; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Smith MW, 2001, MOL CELL BIOL, V21, P8264, DOI 10.1128/MCB.21.24.8264-8275.2001; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tarassov I, 2007, CELL CYCLE, V6, P2473, DOI 10.4161/cc.6.20.4783; Thoms S, 2002, FEBS LETT, V520, P107, DOI 10.1016/S0014-5793(02)02777-1; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; TOOTS I, 1982, NUCLEIC ACIDS RES, V10, P3381, DOI 10.1093/nar/10.11.3381; Waltner M, 1996, J BIOL CHEM, V271, P21226, DOI 10.1074/jbc.271.35.21226; Weber F, 2000, METH MOL B, V140, P111; WESTHOF E, 1989, J MOL BIOL, V207, P417, DOI 10.1016/0022-2836(89)90264-7; YOSHIONARI S, 1994, FEBS LETT, V338, P137, DOI 10.1016/0014-5793(94)80351-X; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	74	65	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30792	30803		10.1074/jbc.M110.151183	http://dx.doi.org/10.1074/jbc.M110.151183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663881	hybrid, Green Published			2022-12-25	WOS:000282135500047
J	Yamasaki, M; Sendall, TJ; Harris, LE; Lewis, GMW; Huntington, JA				Yamasaki, Masayuki; Sendall, Timothy J.; Harris, Laura E.; Lewis, Giles M. W.; Huntington, James A.			Loop-Sheet Mechanism of Serpin Polymerization Tested by Reactive Center Loop Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALPHA-1-PROTEINASE INHIBITOR; ALPHA(1)-ANTITRYPSIN; ALPHA-1-ANTITRYPSIN; POLYMERS; PEPTIDE; MODEL; SITE	The serpin mechanism of protease inhibition involves the rapid and stable incorporation of the reactive center loop (RCL) into central beta-sheet A. Serpins therefore require a folding mechanism that bypasses the most stable "loop-inserted" conformation to trap the RCL in an exposed and metastable state. This unusual feature of serpins renders them highly susceptible to point mutations that lead to the accumulation of hyperstable misfolded polymers in the endoplasmic reticulum of secretory cells. The ordered and stable protomer-protomer association in serpin polymers has led to the acceptance of the "loop-sheet" hypothesis of polymerization, where a portion of the RCL of one protomer incorporates in register into sheet A of another. Although this mechanism was proposed 20 years ago, no study has ever been conducted to test its validity. Here, we describe the properties of a variant of alpha(1)-antitrypsin with a critical hydrophobic section of the RCL substituted with aspartic acid (P8-P6). In contrast to the control, the variant was unable to polymerize when incubated with small peptides or when cleaved in the middle of the RCL (accepted models of loop-sheet polymerization). However, when induced by guanidine HCl or heat, the variant polymerized in a manner indistinguishable from the control. Importantly, the Asp mutations did not affect the ability of the Z or Siiyama alpha(1)-antitrypsin variants to polymerize in COS-7 cells. These results argue strongly against the loop-sheet hypothesis and suggest that, in serpin polymers, the P8-P6 region is only a small part of an extensive domain swap.	[Yamasaki, Masayuki; Sendall, Timothy J.; Harris, Laura E.; Lewis, Giles M. W.; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jah52@cam.ac.uk		Lewis, Giles/0000-0002-8743-8608	Medical Research Council; MRC [G0801899] Funding Source: UKRI; Medical Research Council [G0801899] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council senior nonclinical fellowship (J. A. H.) and a Medical Research Council project grant. This work was carried out with the support of the Diamond Light Source.	Belorgey D, 2007, PRION, V1, P15, DOI 10.4161/pri.1.1.3974; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang WSW, 1997, PROTEIN SCI, V6, P89; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunstone MA, 2000, PROTEIN SCI, V9, P417; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; HUNTINGTON JA, 2010, BIOL CHEM IN PRESS; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; KNAUPP AS, J MOL BIOL, V396, P375; Leslie A., 1992, JOINT CCP4 EACMB NEW; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MIRANDA E, 2010, HEPATOLOGY IN PRESS; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pedersen KE, 2003, BIOCHEM J, V372, P747, DOI 10.1042/BJ20021868; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	32	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30752	30758		10.1074/jbc.M110.156042	http://dx.doi.org/10.1074/jbc.M110.156042			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20667823	Green Published, hybrid			2022-12-25	WOS:000282135500043
J	Yang, SF; Chen, MK; Hsieh, YS; Chung, TT; Hsieh, YH; Lin, CW; Su, JL; Tsai, MH; Tang, CH				Yang, Shun-Fa; Chen, Mu-Kuan; Hsieh, Yih-Shou; Chung, Tsung-Te; Hsieh, Yi-Hsien; Lin, Chiao-Wen; Su, Jen-Liang; Tsai, Ming-Hsui; Tang, Chih-Hsin			Prostaglandin E-2/EP1 Signaling Pathway Enhances Intercellular Adhesion Molecule 1 (ICAM-1) Expression and Cell Motility in Oral Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-DELTA; GENE-EXPRESSION; CYCLOOXYGENASE INHIBITORS; PHOSPHORYLATION; OVEREXPRESSION; ACTIVATION; MECHANISM; ROTTLERIN; INVASION; SUBTYPE	Oral squamous cell carcinoma has a striking tendency to migrate and metastasize. Cyclooxygenase (COX)-2, the inducible isoform of prostaglandin (PG) synthase, has been implicated in tumor metastasis. However, the effects of COX-2 on human oral cancer cells are largely unknown. We found that overexpression of COX-2 or exogenous PGE(2) increased migration and intercellular adhesion molecule 1 (ICAM)-1 expression in human oral cancer cells. Using pharmacological inhibitors, activators, and genetic inhibition of EP receptors, we discovered that the EP1 receptor, but not other PGE receptors, is involved in PGE(2)-mediated cell migration and ICAM-1 expression. PGE(2)-mediated migration and ICAM-1 up-regulation were attenuated by inhibitors of protein kinase C (PKC)delta, and c-Src. Activation of the PKC delta, c-Src, and AP-1 signaling pathway occurred after PGE(2) treatment. PGE(2)-induced expression of ICAM-1 and migration activity were inhibited by a specific inhibitor, siRNA, and mutants of PKC delta, c-Src, and AP-1. In addition, migration-prone sublines demonstrated that cells with increased migration ability had higher expression of COX-2 and ICAM-1. Taken together, these results indicate that the PGE(2) and EP1 interaction enhanced migration of oral cancer cells through an increase in ICAM-1 production.	[Tang, Chih-Hsin] China Med Univ, Coll Med, Dept Pharmacol, Sch Med,Grad Inst Canc Biol, Taichung 404, Taiwan; [Yang, Shun-Fa; Chen, Mu-Kuan; Chung, Tsung-Te] Chung Shan Med Univ, Inst Med, Taichung 402, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 402, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua Cty 402, Taiwan; [Hsieh, Yih-Shou; Hsieh, Yi-Hsien; Lin, Chiao-Wen] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 402, Taiwan; [Chung, Tsung-Te] Show Chwan Mem Hosp, Dept Otolaryngol, Changhua Cty 500, Taiwan; [Su, Jen-Liang] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Su, Jen-Liang] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Tsai, Ming-Hsui] China Med Univ Hosp, Dept Otolaryngol, Taichung 404, Taiwan; [Tang, Chih-Hsin] China Med Univ & Hosp, Sch Med, Dept Pharmacol, Taichung 404, Taiwan; [Tang, Chih-Hsin] China Med Univ & Hosp, Grad Inst Basic Med Sci, Taichung 404, Taiwan	China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; Show Chwan Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, CH (corresponding author), China Med Univ, Coll Med, Dept Pharmacol, Sch Med,Grad Inst Canc Biol, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	chtang@mail.cmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Tang, Chih Hsin/O-5212-2015	Yang, Shun-Fa/0000-0002-0365-7927; Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC-97-2314-B-040-025-MY3]; China Medical University [CMU98-OC-02, DOH99-TD-C-111-005]; Taiwan Department of Health	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Taiwan Department of Health	This work was supported by National Science Council of Taiwan Grant NSC-97-2314-B-040-025-MY3, China Medical University Grant CMU98-OC-02, China Medical University Hospital Cancer Research of Excellence Grant DOH99-TD-C-111-005, and by the Taiwan Department of Health.	Basu A, 2008, CANCER RES, V68, P2795, DOI 10.1158/0008-5472.CAN-07-6244; BERK BC, 1990, J BIOL CHEM, V265, P17334; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Duperray A, 1997, J BIOL CHEM, V272, P435; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; Fulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hida T, 1998, CANCER RES, V58, P3761; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Huang WC, 2004, CARCINOGENESIS, V25, P1925, DOI 10.1093/carcin/bgh211; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Kozaki K, 2001, ONCOGENE, V20, P4228, DOI 10.1038/sj.onc.1204561; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Leitges M, 2001, LAB INVEST, V81, P1087, DOI 10.1038/labinvest.3780321; Lyons AJ, 2007, INT J ORAL MAX SURG, V36, P671, DOI 10.1016/j.ijom.2007.04.002; Ma L, 2002, P NATL ACAD SCI USA, V99, P13243, DOI 10.1073/pnas.202392199; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Roebuck KA, 1999, INT J MOL MED, V4, P223; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rozic JG, 2001, INT J CANCER, V93, P497, DOI 10.1002/ijc.1376; SANO H, 1995, CANCER RES, V55, P3785; Smith DA, 2000, PAC HIST REV, V69, P145, DOI 10.2307/3641273; Su JL, 2004, CANCER RES, V64, P554, DOI 10.1158/0008-5472.CAN-03-1301; SUGIMOTO Y, 1992, J BIOL CHEM, V267, P6463; Sun YJ, 2002, CANCER RES, V62, P6323; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Tang CH, 2008, CARCINOGENESIS, V29, P35, DOI 10.1093/carcin/bgm220; Thomas GJ, 2001, CRIT REV ORAL BIOL M, V12, P479, DOI 10.1177/10454411010120060301; Tokuda H, 2009, HORM METAB RES, V41, P333, DOI 10.1055/s-0028-1103300; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; WATABE A, 1993, J BIOL CHEM, V268, P20175; Weinreb M, 2001, BONE, V28, P275, DOI 10.1016/S8756-3282(00)00447-6; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Zimmerman T, 2008, CURR PHARM DESIGN, V14, P2128, DOI 10.2174/138161208785740225	44	60	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29808	29816		10.1074/jbc.M110.108183	http://dx.doi.org/10.1074/jbc.M110.108183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647315	hybrid, Green Published			2022-12-25	WOS:000281984300016
J	Marri, PR; Paniscus, M; Weyand, NJ; Rendon, MA; Calton, CM; Hernandez, DR; Higashi, DL; Sodergren, E; Weinstock, GM; Rounsley, SD; So, M				Marri, Pradeep Reddy; Paniscus, Mary; Weyand, Nathan J.; Rendon, Maria A.; Calton, Christine M.; Hernandez, Diana R.; Higashi, Dustin L.; Sodergren, Erica; Weinstock, George M.; Rounsley, Steven D.; So, Magdalene			Genome Sequencing Reveals Widespread Virulence Gene Exchange among Human Neisseria Species	PLOS ONE			English	Article							REPEAT-ENCLOSED ELEMENTS; DNA-SEQUENCE; GONORRHOEAE; MENINGITIDIS; COMMENSAL; STRAIN; TRANSFORMATION; EXPRESSION; IDENTIFICATION; RECOMBINATION	Commensal bacteria comprise a large part of the microbial world, playing important roles in human development, health and disease. However, little is known about the genomic content of commensals or how related they are to their pathogenic counterparts. The genus Neisseria, containing both commensal and pathogenic species, provides an excellent opportunity to study these issues. We undertook a comprehensive sequencing and analysis of human commensal and pathogenic Neisseria genomes. Commensals have an extensive repertoire of virulence alleles, a large fraction of which has been exchanged among Neisseria species. Commensals also have the genetic capacity to donate DNA to, and take up DNA from, other Neisseria. Our findings strongly suggest that commensal Neisseria serve as reservoirs of virulence alleles, and that they engage extensively in genetic exchange.	[Marri, Pradeep Reddy; Paniscus, Mary; Weyand, Nathan J.; Rendon, Maria A.; Calton, Christine M.; Hernandez, Diana R.; Higashi, Dustin L.; Rounsley, Steven D.; So, Magdalene] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Paniscus, Mary] Univ Arizona, Grad Interdisciplinary Program Genet, Tucson, AZ USA; [Weyand, Nathan J.; Rendon, Maria A.; Calton, Christine M.; Hernandez, Diana R.; Higashi, Dustin L.; So, Magdalene] Univ Arizona, Dept Immunol, Tucson, AZ USA; [Rounsley, Steven D.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Calton, Christine M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; Oregon Health & Science University; Washington University (WUSTL)	Marri, PR (corresponding author), Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA.	pradeepm@email.arizona.edu	So, Magdalene/ABB-8918-2020; Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Calton, Christine/0000-0002-5189-5006; Rendon, Maria/0000-0001-8971-0567; So, Magdalene/0000-0001-8301-0674	National Institutes of Health (NIH) [R01 AI068033-01, U54HG004968]; BIO5 Institute and College of Medicine, University of Arizona; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068033] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIO5 Institute and College of Medicine, University of Arizona; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH) grant R01 AI068033-01 and by funds from the BIO5 Institute and College of Medicine, University of Arizona, awarded to MS. Additional support was provided by NIH grant U54HG004968 to GMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho EL, 2000, MICROB PATHOGENESIS, V28, P81, DOI 10.1006/mpat.1999.0325; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bauer FJ, 1999, MOL MICROBIOL, V31, P903, DOI 10.1046/j.1365-2958.1999.01230.x; Bennett JS, 2009, INT J MED MICROBIOL, V299, P133, DOI 10.1016/j.ijmm.2008.06.010; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; BERGER U, 1972, MED MICROBIOL IMMUN, V158, P121, DOI 10.1007/BF02120477; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; BOWLER LD, 1994, J BACTERIOL, V176, P333, DOI 10.1128/JB.176.2.333-337.1994; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CATLIN BW, 1960, SCIENCE, V131, P608, DOI 10.1126/science.131.3400.608-a; Cornelissen CN, 2004, IRON TRANSPORT IN BACTERIA, P256; CORREIA FF, 1986, J BACTERIOL, V167, P1009, DOI 10.1128/jb.167.3.1009-1015.1986; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; Glitza IC, 2008, INT J HYG ENVIR HEAL, V211, P263, DOI 10.1016/j.ijheh.2007.05.006; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagen TA, 2006, MOL MICROBIOL, V62, P1144, DOI 10.1111/j.1365-2958.2006.05429.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hill SA, 2009, FEMS MICROBIOL REV, V33, P521, DOI 10.1111/j.1574-6976.2009.00171.x; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; Janda WM, 2003, MANUAL CLIN MICROBIO, P585; Jordan PW, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-21; Kaplan JB, 2002, APPL ENVIRON MICROB, V68, P4943, DOI 10.1128/AEM.68.10.4943-4950.2002; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; KNAPP J S, 1988, Clinical Microbiology Reviews, V1, P415; Lee SW, 2005, CELL MICROBIOL, V7, P1271, DOI 10.1111/j.1462-5822.2005.00551.x; Linz B, 2000, MOL MICROBIOL, V36, P1049, DOI 10.1046/j.1365-2958.2000.01932.x; Liu SV, 2002, J BACTERIOL, V184, P6163, DOI 10.1128/JB.184.22.6163-6173.2002; MAIDEN MC, 1998, CLIN INFECT DIS   S1, V27, P1; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; MURALIDHARAN K, 1987, A VAN LEEUW J MICROB, V53, P435, DOI 10.1007/BF00415499; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; Qvarnstrom Y, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-11; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saez Nieto J A, 1998, Int Microbiol, V1, P59; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; SEIFERT HS, 1990, J BACTERIOL, V172, P40, DOI 10.1128/JB.172.1.40-46.1990; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Snyder LAS, 2001, J BACTERIOL, V183, P1233, DOI 10.1128/JB.183.4.1233-1241.2001; Snyder LAS, 2007, MOL BIOL EVOL, V24, P2802, DOI 10.1093/molbev/msm215; Snyder LAS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-128; Snyder LAS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-70; Stabler RA, 2005, MICROBIOL-SGM, V151, P2907, DOI 10.1099/mic.0.28099-0; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tonjum T, 2005, BERGEYS MANUAL SYSTE, P777; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	59	140	144	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11835	10.1371/journal.pone.0011835	http://dx.doi.org/10.1371/journal.pone.0011835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676376	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520100013
J	Nalam, RL; Andreu-Vieyra, C; Matzuk, MM				Nalam, Roopa L.; Andreu-Vieyra, Claudia; Matzuk, Martin M.			Absence of Inhibin Alpha and Retinoblastoma Protein Leads to Early Sertoli Cell Dysfunction	PLOS ONE			English	Article							CACHEXIA-LIKE SYNDROME; TUMOR-SUPPRESSOR GENE; HORMONE; SMAD3; MICE; RB; TUMORIGENESIS; INACTIVATION; PROGRESSION	Sertoli cells, the support cells of mammalian spermatogenesis, are regulated by a number of nuclear factors and express retinoblastoma (RB) tumor suppressor protein. We hypothesized that RB is an important mediator of Sertoli cell tumorigenesis in inhibin alpha knockout (Inha KO) mice. In our previous mouse studies, we found that conditional knockout (cKO) of Rb in Sertoli cells caused progressive Sertoli cell dysfunction. Initially, loss of RB had no gross effect on Sertoli cell function as the mice were fertile with normal testis weights at 6 weeks of age, but by 10-14 weeks of age, mutant mice demonstrated severe Sertoli cell dysfunction and infertility. Although double knockout (dKO) of Rb and Inha did not result in exacerbation of the tumorigenic phenotype of Inha-null mice, we found that the dKO mice demonstrate an acceleration of Sertoli cell dysfunction compared to Rb cKO mice. Specifically, in contrast to Rb cKO mice, Inha/Rb dKO mice showed signs of Sertoli cell dysfunction as early as 4 weeks of age. These results demonstrate that RB is not essential for Sertoli cell tumorigenesis in Inha KO mice but that loss of Inha accelerates the infertility phenotype of Rb cKO mice.	[Nalam, Roopa L.; Andreu-Vieyra, Claudia; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Nalam, Roopa L.; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Nalam, RL (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mmatzuk@bcm.tmc.edu			National Institutes of Health [CA60651]; Edward J. and Josephine G. Hudson Scholar Fund; NATIONAL CANCER INSTITUTE [R01CA060651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward J. and Josephine G. Hudson Scholar Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by National Institutes of Health grant CA60651 (to M. M. M.) and the Edward J. and Josephine G. Hudson Scholar Fund (to R.L.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Vieyra C, 2007, ENDOCRINOLOGY, V148, P3837, DOI 10.1210/en.2006-1590; BEAMER WG, 1988, BIOL REPROD, V38, P899, DOI 10.1095/biolreprod38.4.899; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burns KH, 2003, MOL ENDOCRINOL, V17, P2053, DOI 10.1210/me.2003-0038; Burns KH, 2003, MOL ENDOCRINOL, V17, P2039, DOI 10.1210/me.2003-0039; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Cipriano SC, 2001, MOL ENDOCRINOL, V15, P985, DOI 10.1210/me.15.6.985; Coerver KA, 1996, MOL ENDOCRINOL, V10, P534, DOI 10.1210/me.10.5.534; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kumar TR, 1999, MOL ENDOCRINOL, V13, P851, DOI 10.1210/me.13.6.851; Kumar TR, 1996, ENDOCRINOLOGY, V137, P4210, DOI 10.1210/en.137.10.4210; Li QL, 2007, MOL HUM REPROD, V13, P675, DOI 10.1093/molehr/gam055; Li QL, 2007, MOL ENDOCRINOL, V21, P2472, DOI 10.1210/me.2007-0147; Looyenga BD, 2007, MOL ENDOCRINOL, V21, P2440, DOI 10.1210/me.2006-0402; Marino S, 2000, GENE DEV, V14, P994; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Nagaraja AK, 2008, MOL CELL ENDOCRINOL, V294, P19, DOI 10.1016/j.mce.2008.06.019; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; SKINNER MK, 2005, SERTOLI CELL BIOL, pR15; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169; Yan W, 2003, APMIS, V111, P174, DOI 10.1034/j.1600-0463.2003.1110121.x	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11797	10.1371/journal.pone.0011797	http://dx.doi.org/10.1371/journal.pone.0011797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676395	Green Published, gold, Green Submitted			2022-12-25	WOS:000280371800006
J	Gupte, S; Labinskyy, N; Gupte, R; Csiszar, A; Ungvari, Z; Edwards, JG				Gupte, Sachin; Labinskyy, Nazar; Gupte, Rakhee; Csiszar, Anna; Ungvari, Zoltan; Edwards, John G.			Role of NAD(P)H Oxidase in Superoxide Generation and Endothelial Dysfunction in Goto-Kakizaki (GK) Rats as a Model of Nonobese NIDDM	PLOS ONE			English	Article							SPONTANEOUSLY DIABETIC RATS; INCREASED OXIDATIVE STRESS; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; DECREASED SUSCEPTIBILITY; PERIPHERAL NEUROPATHY; METABOLIC SYNDROME; BASEMENT-MEMBRANE; GENE-EXPRESSION	Background: Cardiovascular disease is the leading cause of mortality in diabetics, and it has a complex etiology that operates on several levels. Endothelial dysfunction and increased generation of reactive oxygen species are believed to be an underlying cause of vascular dysfunction and coronary artery disease in diabetes. This impairment is likely the result of decreased bioavailability of nitric oxide (NO) within the vasculature. However, it is unclear whether hyperglycemia per se stimulates NADPH oxidase-derived superoxide generation in vascular tissue. Methods and Results: This study focused on whether NADPH oxidase-derived superoxide is elevated in vasculature tissue evoking endothelial/smooth muscle dysfunction in the hyperglycemic (169+/-4 mg%) Goto-Kakizaki (GK) rat. By dihydroethidine fluorescence staining, we determined that aorta superoxide levels were significantly elevated in 9 month-old GK compared with age matched Wistar (GK; 195+/-6%, Wistar; 100+/-3.5%). Consistent with these findings, 10(-6) mol/L acetylcholine-induced relaxation of the carotid artery was significantly reduced in GK rats compared with age matched Wistar (GK; 41+/-7%, Wistar; 100+/-5%) and measurements in the aorta showed a similar trend (p = .08). In contrast, relaxation to the NO donor SNAP was unaltered in GK compared to Wistar. Endothelial dysfunction was reversed by lowering of superoxide with apocynin, a specific Nox inhibitor. Conclusions: The major findings from this study are that chronic hyperglycemia induces significant vascular dysfunction in both the aorta and small arteries. Hyperglycemic induced increases in NAD(P)H oxidase activity that did not come from an increase in the expression of the NAD(P)H oxidase subunits, but more likely as a result of chronic activation via intracellular signaling pathways.	[Gupte, Sachin; Gupte, Rakhee] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Csiszar, Anna; Ungvari, Zoltan] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA; [Labinskyy, Nazar; Csiszar, Anna; Edwards, John G.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	University of South Alabama; University of Oklahoma System; University of Oklahoma Health Sciences Center; New York Medical College	Gupte, S (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.	j_edwards@nymc.edu	Ungvari, Zoltan/ADU-0095-2022; Ungvari, Zoltan/GZK-8127-2022		National Institutes of Health [HL077256, HL43023, HL085352]; American Heart Association [0435070]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077256, R01HL085352, P01HL043023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health under the following grant numbers: HL077256, HL43023, HL085352; as well by the American Heart Association (Grant#0435070). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; BATH PMW, 1991, ARTERIOSCLER THROMB, V11, P254, DOI 10.1161/01.ATV.11.2.254; Bitar MS, 2005, EUR J PHARMACOL, V511, P53, DOI 10.1016/j.ejphar.2005.01.014; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Cheng ZJ, 2001, HYPERTENSION, V37, P433, DOI 10.1161/01.HYP.37.2.433; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH1882, DOI 10.1152/ajpheart.412.2008; Csiszar A, 2007, AM J PATHOL, V170, P388, DOI 10.2353/ajpath.2007.060708; Debin R, 2009, FUND CLIN PHARMACOL, V23, P59, DOI 10.1111/j.1472-8206.2008.00659.x; Ding H, 2007, EUR J PHARMACOL, V561, P121, DOI 10.1016/j.ejphar.2006.12.034; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Ferreira FML, 1999, LIFE SCI, V65, P1013, DOI 10.1016/S0024-3205(99)00332-X; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; GRAHAM KA, CANC BIOL THER, V10; Grijalva J, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-34; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Hainsey T, 2002, MED SCI SPORT EXER, V34, P1249, DOI 10.1097/00005768-200208000-00004; Hilenski L, 2004, ARTERIOSCLER THROMB, V24, P1; Janssen U, 2003, KIDNEY INT, V63, P2162, DOI 10.1046/j.1523-1755.2003.00007.x; Kinoshita H, 2008, HYPERTENSION, V52, P507, DOI 10.1161/HYPERTENSIONAHA.108.118216; KITAHARA A, 1978, TOHOKU J EXP MED, V126, P7, DOI 10.1620/tjem.126.7; Kobayashi T, 2004, AM J PHYSIOL-HEART C, V287, pH135, DOI 10.1152/ajpheart.01074.2003; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lin JM, 2001, DIABETES, V50, P2737, DOI 10.2337/diabetes.50.12.2737; Liu S, 2007, FREE RADICAL BIO MED, V42, P852, DOI 10.1016/j.freeradbiomed.2006.12.025; Meininger CJ, 2000, BIOCHEM J, V349, P353, DOI 10.1042/0264-6021:3490353; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Murakawa Y, 2002, DIABETES-METAB RES, V18, P473, DOI 10.1002/dmrr.326; Oliveira Paulo J, 2002, Rev Port Cardiol, V21, P759; Oliveira PJ, 2001, BIOSCIENCE REP, V21, P45; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Phillips AO, 2001, AM J KIDNEY DIS, V37, P400, DOI 10.1053/ajkd.2001.21322; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P1; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x; Rafalski K, 2007, MED SCI SPORT EXER, V39, P75, DOI 10.1249/01.mss.0000240324.08406.3d; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007; Rajesh M, 2009, J CELL MOL MED, V13, P2330, DOI 10.1111/j.1582-4934.2008.00564.x; Rosen P, 2006, DIABETES-METAB RES, V22, P323, DOI 10.1002/dmrr.623; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Serpillon S, 2009, AM J PHYSIOL-HEART C, V297, pH153, DOI 10.1152/ajpheart.01142.2008; Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001; Ungvari Z, 2003, ARTERIOSCL THROM VAS, V23, P418, DOI 10.1161/01.ATV.0000061735.85377.40; Ungvari Z, 1999, CARDIOVASC RES, V43, P1018, DOI 10.1016/S0008-6363(99)00106-6; Vesely DL, 1999, METABOLISM, V48, P771, DOI 10.1016/S0026-0495(99)90178-6; Wallace KJ, 2004, PHYSIOL GENOMICS, V19, P1, DOI 10.1152/physiolgenomics.00114.2004; Wallis RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002962; Witte K, 2002, NITRIC OXIDE-BIOL CH, V6, P85, DOI 10.1006/niox.2001.0363; YAGIHASHI S, 1979, TOHOKU J EXP MED, V127, P359, DOI 10.1620/tjem.127.359; YAGIHASHI S, 1982, TOHOKU J EXP MED, V138, P39, DOI 10.1620/tjem.138.39; YAGIHASHI S, 1978, DIABETOLOGIA, V15, P309, DOI 10.1007/BF02573824; Yasuda K, 2002, CLIN EXP PHARMACOL P, V29, P1001, DOI 10.1046/j.1440-1681.2002.03757.x; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	56	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11800	10.1371/journal.pone.0011800	http://dx.doi.org/10.1371/journal.pone.0011800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668682	gold, Green Published, Green Submitted			2022-12-25	WOS:000280297300026
J	Wang, GH; Wang, YD; Teng, MX; Zhang, DN; Li, L; Liu, YL				Wang, Guohua; Wang, Yadong; Teng, Mingxiang; Zhang, Denan; Li, Lang; Liu, Yunlong			Signal Transducers and Activators of Transcription-1 (STAT1) Regulates microRNA Transcription in Interferon gamma-Stimulated HeLa Cells	PLOS ONE			English	Article							DNA-BINDING-SITES; CHROMATIN-IMMUNOPRECIPITATION; PROFILING REVEALS; NETWORK MOTIFS; BREAST-CANCER; UP-REGULATION; C-FOS; GENOME; GENES; DATABASE	Background: Constructing and modeling the gene regulatory network is one of the central themes of systems biology. With the growing understanding of the mechanism of microRNA biogenesis and its biological function, establishing a microRNA mediated gene regulatory network is not only desirable but also achievable. Methodology: In this study, we propose a bioinformatics strategy to construct the microRNA-mediated regulatory network using genome-wide binding patterns of transcription factor(s) and RNA polymerase II (RPol II), derived using chromatin immunoprecipitation following next generation sequencing (ChIP-seq) technology. Our strategy includes three key steps, identification of transcription start sites and promoter regions of primary microRNA transcripts using RPol II binding patterns, selection of cooperating transcription factors that collaboratively function with the transcription factors targeted by ChIP-seq assay, and construction of the network that contains regulatory cascades of both transcription factors and microRNAs. Principal Findings: Using CAMDA (Critical Assessment of Massive Data Analysis) 2009 data set that includes ChIP-seq data on RPol II and STAT1 (signal transducers and activators of transcription 1) in HeLa S3 cells in control condition and with interferon gamma stimulation, we first identified promoter regions of 83 microRNAs in HeLa cells. We then identified two potential STAT1 collaborating factors, AP-1 and C/EBP (CCAAT enhancer-binding proteins), and further established eight feedback network elements that may regulate cellular response during interferon gamma stimulation. Conclusions: This study offers a bioinformatics strategy to provide testable hypotheses on the mechanisms of microRNA-mediated transcriptional regulation, based upon genome-wide protein-DNA interaction data derived from ChIP-seq experiments.	[Wang, Guohua; Wang, Yadong; Teng, Mingxiang; Zhang, Denan] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Teng, Mingxiang; Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Teng, Mingxiang; Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Dept Med, Div Biostat, Indianapolis, IN USA; [Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Liu, Yunlong] Indiana Univ, Sch Med, Ctr Med Genom, Indianapolis, IN USA	Harbin Institute of Technology; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Wang, GH (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China.	ydwang@hit.edu.cn; yunliu@iupui.edu	Zhang, Denan/ABE-7528-2021; Wang, Guohua/GLR-7939-2022	Teng, Mingxiang/0000-0002-8536-8941	U.S. National Institutes of Health [AA017941, CA113001]; China 863 High-Tech Program [2007AA02Z302]; China Natural Science Foundation [60901075, 60973078]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017941] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 863 High-Tech Program(National High Technology Research and Development Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by the U.S. National Institutes of Health grants AA017941 (Y.L.), CA113001 (L.L and Y. L.), China 863 High-Tech Program 2007AA02Z302 (Y.L.), and China Natural Science Foundation 60901075 (G.W.), 60973078 (Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; *AFF, 2001, AFF MICR SUIT US GUI; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; DO H, 2009, J NUTR BIOCH; GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Liu YL, 2006, GENOMICS, V88, P452, DOI 10.1016/j.ygeno.2006.04.006; Lo RKH, 2006, CELL SIGNAL, V18, P2143, DOI 10.1016/j.cellsig.2006.04.004; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WANG G, PLOS ONE UNPUB; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	49	55	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11794	10.1371/journal.pone.0011794	http://dx.doi.org/10.1371/journal.pone.0011794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668688	Green Submitted, Green Published, gold			2022-12-25	WOS:000280297300022
J	Fordyce, JA				Fordyce, James A.			Interpreting the gamma Statistic in Phylogenetic Diversification Rate Studies: A Rate Decrease Does Not Necessarily Indicate an Early Burst	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; MOLECULAR PHYLOGENIES; BIRDS	Background: Phylogenetic hypotheses are increasingly being used to elucidate historical patterns of diversification rate-variation. Hypothesis testing is often conducted by comparing the observed vector of branching times to a null, pure-birth expectation. A popular method for inferring a decrease in speciation rate, which might suggest an early burst of diversification followed by a decrease in diversification rate is the gamma statistic. Methodology: Using simulations under varying conditions, I examine the sensitivity of gamma to the distribution of the most recent branching times. Using an exploratory data analysis tool for lineages through time plots, tree deviation, I identified trees with a significant gamma statistic that do not appear to have the characteristic early accumulation of lineages consistent with an early, rapid rate of cladogenesis. I further investigated the sensitivity of the gamma statistic to recent diversification by examining the consequences of failing to simulate the full time interval following the most recent cladogenic event. The power of gamma to detect rate decrease at varying times was assessed for simulated trees with an initial high rate of diversification followed by a relatively low rate. Conclusions: The gamma statistic is extraordinarily sensitive to recent diversification rates, and does not necessarily detect early bursts of diversification. This was true for trees of various sizes and completeness of taxon sampling. The gamma statistic had greater power to detect recent diversification rate decreases compared to early bursts of diversification. Caution should be exercised when interpreting the gamma statistic as an indication of early, rapid diversification.	Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37916 USA	University of Tennessee System; University of Tennessee Knoxville	Fordyce, JA (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37916 USA.	jfordyce@utk.edu						Barraclough TG, 2002, MOL BIOL EVOL, V19, P1706, DOI 10.1093/oxfordjournals.molbev.a003993; Dornburg A, 2008, SYST BIOL, V57, P905, DOI 10.1080/10635150802562392; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Jiggins CD, 2006, EVOLUTION, V60, P1454, DOI 10.1111/j.0014-3820.2006.tb01224.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Development Core Team, 2009, R FDN STAT COMP; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; RAMBAUT AP, 2002, PHYLOGEN V1 0; Weir JT, 2006, EVOLUTION, V60, P842; [No title captured]	15	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11781	10.1371/journal.pone.0011781	http://dx.doi.org/10.1371/journal.pone.0011781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668707	gold, Green Submitted, Green Published			2022-12-25	WOS:000280243800036
J	Suchard, MS; Mayne, E; Green, VA; Shalekoff, S; Donninger, SL; Stevens, WS; Gray, CM; Tiemessen, CT				Suchard, Melinda S.; Mayne, Elizabeth; Green, Victoria A.; Shalekoff, Sharon; Donninger, Samantha L.; Stevens, Wendy S.; Gray, Clive M.; Tiemessen, Caroline T.			FOXP3 Expression Is Upregulated in CD4(+)T Cells in Progressive HIV-1 Infection and Is a Marker of Disease Severity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MESSENGER-RNA EXPRESSION; GROWTH-FACTOR-BETA; T-CELLS; DENDRITIC CELLS; TGF-BETA; PERIPHERAL-BLOOD; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; IMMUNE ACTIVATION	Background: Understanding the role of different classes of T cells during HIV infection is critical to determining which responses correlate with protective immunity. To date, it is unclear whether alterations in regulatory T cell (Treg) function are contributory to progression of HIV infection. Methodology: FOXP3 expression was measured by both qRT-PCR and by flow cytometry in HIV-infected individuals and uninfected controls together with expression of CD25, GITR and CTLA-4. Cultured peripheral blood mononuclear cells were stimulated with anti-CD3 and cell proliferation was assessed by CFSE dilution. Principal Findings: HIV infected individuals had significantly higher frequencies of CD4(+) FOXP3(+) T cells (median of 8.11%; range 1.33%-26.27%) than healthy controls (median 3.72%; range 1.3-7.5%; P = 0.002), despite having lower absolute counts of CD4+ FOXP3+ T cells. There was a significant positive correlation between the frequency of CD4+ FOXP3+ T cells and viral load (rho = 0.593 P = 0.003) and a significant negative correlation with CD4 count (rho = -0.423 P = 0.044). 48% of our patients had CD4 counts below 200 cells/mu l and these patients showed a marked elevation of FOXP3 percentage (median 10% range 4.07%-26.27%). Assessing the mechanism of increased FOXP3 frequency, we found that the high FOXP3 levels noted in HIV infected individuals dropped rapidly in unstimulated culture conditions but could be restimulated by T cell receptor stimulation. This suggests that the high FOXP3 expression in HIV infected patients is likely due to FOXP3 upregulation by individual CD4(+) T cells following antigenic or other stimulation. Conclusions/Significance: FOXP3 expression in the CD4(+) T cell population is a marker of severity of HIV infection and a potential prognostic marker of disease progression.	[Suchard, Melinda S.; Mayne, Elizabeth; Green, Victoria A.; Stevens, Wendy S.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Suchard, Melinda S.; Mayne, Elizabeth; Green, Victoria A.; Stevens, Wendy S.] Univ Witwatersrand, Johannesburg, South Africa; [Green, Victoria A.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Suchard, Melinda S.; Mayne, Elizabeth; Green, Victoria A.; Shalekoff, Sharon; Donninger, Samantha L.; Gray, Clive M.; Tiemessen, Caroline T.] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Bath; National Institute for Communicable Diseases (NICD)	Suchard, MS (corresponding author), Natl Hlth Lab Serv, Johannesburg, South Africa.	thesuchards@telkomsa.net		Suchard, Melinda Shelley/0000-0002-6978-4654; Gray, Clive/0000-0002-9293-901X; Tiemessen, Caroline/0000-0002-0991-1690; Mayne, Elizabeth/0000-0002-6360-3488	Sarum St Michael Educational Charity, England [309456]; University of Bath Alumni Fund, England; Calne Rotary Club; South African AIDS Vaccine Initiative (SAAVI); Wellcome Trust; National Institutes of Health; Elizabeth Glazer Paediatric AIDS Foundation	Sarum St Michael Educational Charity, England; University of Bath Alumni Fund, England; Calne Rotary Club; South African AIDS Vaccine Initiative (SAAVI); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glazer Paediatric AIDS Foundation	Financial assistance was provided by Sarum St Michael Educational Charity, England (registered charity number 309456,, ssmsarum@waitrose.com, no Web site), the University of Bath Alumni Fund, England (www.alumni.bath.ac.uk), Calne Rotary Club (www.calne.org.uk/community/groups/rotaryclub), the South African AIDS Vaccine Initiative (SAAVI), the Wellcome Trust (http://www.wellcome.ac.uk/Funding/index.htm), the National Institutes of Health and the Elizabeth Glazer Paediatric AIDS Foundation International Leadership Award. CTT is a Wellcome Trust International Senior Research Fellow (076352/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Apoil PA, 2005, JAIDS-J ACQ IMM DEF, V39, P381, DOI 10.1097/01.qai.0000169662.30783.2d; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Billerbeck E, 2008, HUM IMMUNOL, V69, P771, DOI 10.1016/j.humimm.2008.07.016; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; Chen W, 2007, CURR MED CHEM, V14, P2245, DOI 10.2174/092986707781696591; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chougnet C, 2006, J LEUKOCYTE BIOL, V80, P994, DOI 10.1189/jlb.0306135; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, TRANSPL IMMUNOL, V17, P58, DOI 10.1016/j.trim.2006.09.017; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Firan M, 2006, BLOOD, V107, P619, DOI 10.1182/blood-2005-06-2277; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gazzola L, 2006, AM J RESP CRIT CARE, V174, P356, DOI 10.1164/ajrccm.174.3.356; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Goleva E, 2005, J ALLERGY CLIN IMMUN, V116, P1094, DOI 10.1016/j.jaci.2005.08.051; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Hoji A, 2008, AIDS RES HUM RETROV, V24, P1087, DOI 10.1089/aid.2008.0041; Hougardy JM, 2007, MICROBES INFECT, V9, P1325, DOI 10.1016/j.micinf.2007.06.004; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jiang H, 2005, J CLIN INVEST, V115, P302, DOI 10.1172/JCI200523879; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Koch SD, 2008, HUM IMMUNOL, V69, P737, DOI 10.1016/j.humimm.2008.08.281; Kolte L, 2009, CLIN EXP IMMUNOL, V155, P44, DOI 10.1111/j.1365-2249.2008.03803.x; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Levy Y, 2006, CURR OPIN HIV AIDS, V1, P69, DOI 10.1097/01.COH.0000194101.89944.a5; Li L, 2007, TUBERCULOSIS, V87, P526, DOI 10.1016/j.tube.2007.07.004; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Montes M, 2006, AIDS, V20, P1669, DOI 10.1097/01.aids.0000238415.98194.38; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Qin XJ, 2008, CHINESE MED J-PEKING, V121, P581, DOI 10.1097/00029330-200804010-00002; Rallon NI, 2009, CLIN EXP IMMUNOL, V155, P35, DOI 10.1111/j.1365-2249.2008.03797.x; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Savarino A, 2000, AIDS, V14, P1079, DOI 10.1097/00002030-200006160-00004; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Seddiki Nabila, 2008, Curr HIV/AIDS Rep, V5, P20, DOI 10.1007/s11904-008-0004-6; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Vogtenhuber C, 2008, J IMMUNOL, V181, P8767, DOI 10.4049/jimmunol.181.12.8767; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu B, 2007, J IMMUNOL, V178, P3688, DOI 10.4049/jimmunol.178.6.3688; Zhang R, 2006, BLOOD, V107, P1989, DOI 10.1182/blood-2005-07-2731; Zhang ZN, 2008, JPN J INFECT DIS, V61, P391; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	84	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11762	10.1371/journal.pone.0011762	http://dx.doi.org/10.1371/journal.pone.0011762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668701	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800030
J	Almecija, S; Moya-Sola, S; Alba, DM				Almecija, Sergio; Moya-Sola, Salvador; Alba, David M.			Early Origin for Human-Like Precision Grasping: A Comparative Study of Pollical Distal Phalanges in Fossil Hominins	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; OLDUVAI GORGE; AUSTRALOPITHECUS-AFRICANUS; MORPHOLOGICAL AFFINITIES; POSTCRANIAL SPECIMENS; HAND MORPHOLOGY; TOOL BEHAVIOR; MIOCENE; EVOLUTION; KENYA	Background: The morphology of human pollical distal phalanges (PDP) closely reflects the adaptation of human hands for refined precision grip with pad-to-pad contact. The presence of these precision grip-related traits in the PDP of fossil hominins has been related to human-like hand proportions (i.e. short hands with a long thumb) enabling the thumb and finger pads to contact. Although this has been traditionally linked to the appearance of stone tool-making, the alternative hypothesis of an earlier origin-related to the freeing of the hands thanks to the advent of terrestrial bipedalism-is also possible given the human-like intrinsic hand proportion found in australopiths. Methodology/Principal Findings: We perform morphofunctional and morphometric (bivariate and multivariate) analyses of most available hominin pollical distal phalanges, including Orrorin, Australopithecus, Paranthropous and fossil Homo, in order to investigate their morphological affinities. Our results indicate that the thumb morphology of the early biped Orrorin is more human-like than that of australopiths, in spite of its ancient chronology (ca. 6 Ma). Moreover, Orrorin already displays typical human-like features related to precision grasping. Conclusions: These results reinforce previous hypotheses relating the origin of refined manipulation of natural objects-not stone tool-making-with the relaxation of locomotor selection pressures on the forelimbs. This suggests that human hand length proportions are largely plesiomorphic, in the sense that they more closely resemble the relatively short-handed Miocene apes than the elongated hand pattern of extant hominoids. With the advent of terrestrial bipedalism, these hand proportions may have been co-opted by early hominins for enhanced manipulative capabilities that, in turn, would have been later co-opted for stone tool-making in the genus Homo, more encephalized than the previous australopiths. This hypothesis remains may be further tested by the finding of more complete hands of unequivocally biped early hominins.	[Almecija, Sergio; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol, Cerdanyola Del Valles, Barcelona, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Dept BABVE, Inst Catala Paleontol & Unitat Antropol Biol, ICREA, Cerdanyola Del Valles, Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP)	Almecija, S (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol, Cerdanyola Del Valles, Barcelona, Spain.	sergi.almecija@icp.cat	Almécija, Sergio/ABG-8129-2020; Alba, David/G-9716-2015	Almécija, Sergio/0000-0003-1373-1497; Alba, David/0000-0002-8886-5580; Moya-Sola, Salvador/0000-0001-8506-1061	Generalitat de Catalunya [2006 FI 00065, 2008 BE1 00370, 2009 SGR 754 GRC]; U.S. National Science Foundation under NSF [BCS-0321893]; European Commission; Spanish Ministerio de Ciencia e Innovacion [CGL2008-00325/BTE, RYC-2009-04533]; ICREA Funding Source: Custom	Generalitat de Catalunya(Generalitat de Catalunya); U.S. National Science Foundation under NSF(National Science Foundation (NSF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ICREA(ICREA)	This research has been supported by the Generalitat de Catalunya (predoctoral fellowship 2006 FI 00065 and travel grant 2008 BE1 00370 to S. A., and 2009 SGR 754 GRC), the U.S. National Science Foundation under NSF Award #BCS-0321893, the European Commission's Research Infrastructure (SYNTHESYS project grant to S. A.), and the Spanish Ministerio de Ciencia e Innovacion (CGL2008-00325/BTE, and RYC-2009-04533 to D. M. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; ALBA DM, 2010, J ANTHR SCI IN PRESS; Almecija S, 2009, J VERTEBR PALEONTOL, V29, p53A; Almecija S, 2009, J HUM EVOL, V57, P284, DOI 10.1016/j.jhevol.2009.02.008; BEGUN DR, 1994, J HUM EVOL, V26, P89, DOI 10.1006/jhev.1994.1008; Darwin G., 1871, P423; DAY MH, 1966, NATURE, V211, P929, DOI 10.1038/211929a0; ETTER HF, 1973, FOLIA PRIMATOL, V20, P331, DOI 10.1159/000155585; Gommery D, 2006, GEOBIOS-LYON, V39, P372, DOI 10.1016/j.geobios.2005.03.002; Green DJ, 2008, J HUM EVOL, V54, P705, DOI 10.1016/j.jhevol.2007.10.007; Harrison T, 2010, SCIENCE, V327, P532, DOI 10.1126/science.1184703; Hartwig WC, 1998, AM J PHYS ANTHROPOL, V106, P401, DOI 10.1002/(SICI)1096-8644(199807)106:3<401::AID-AJPA11>3.0.CO;2-4; JOLLY CJ, 1970, DIVERSE APPROACHES H, P323; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; Keith A, 1929, J BONE JOINT SURG, V11, P10; LEAKEY LSB, 1959, NATURE, V184, P491, DOI 10.1038/184491a0; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Madar SI, 2002, J HUM EVOL, V42, P705, DOI 10.1006/jhev.2002.0554; Marzke MW, 2010, AM J PHYS ANTHROPOL, V141, P38, DOI 10.1002/ajpa.21112; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; MCHENRY HM, 1976, AM J PHYS ANTHROPOL, V45, P77, DOI 10.1002/ajpa.1330450110; Mittra ES, 2007, AM J PHYS ANTHROPOL, V134, P449, DOI 10.1002/ajpa.20687; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 2008, FOLIA PRIMATOL, V79, P215, DOI 10.1159/000113458; Nakatsukasa M, 2003, PRIMATES, V44, P371, DOI 10.1007/s10329-003-0051-y; Nakatsukasa Masato, 2002, Zeitschrift fuer Morphologie und Anthropologie, V83, P361; NAPIER J. R., 1960, PROC ZOOL SOC LONDON, V134, P647; Napier J. R., 1993, HANDS; Napier JR, 1967, HDB LIVING PRIMATES; PILBEAM DR, 1980, POSTILLA, V181, P1; PREUSCHOFT H, 1973, CHIMPANZEE, V6, P34; Preuschoft H, 1993, HANDS PRIMATES, P245; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Ricklan D. E., 1988, THESIS; RICKLAN DE, 1987, J HUM EVOL, V16, P643, DOI 10.1016/0047-2484(87)90018-2; Robinson J.T., 1972, EARLY HOMINID POSTUR; ROSE MD, 1992, J HUM EVOL, V22, P255, DOI 10.1016/0047-2484(92)90058-H; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shrewsbury MM, 2003, AM J PHYS ANTHROPOL, V121, P30, DOI 10.1002/ajpa.10192; SHREWSBURY MM, 1986, HUM EVOL, V1, P233; SMITH SL, 1995, AM J PHYS ANTHROPOL, V96, P283, DOI 10.1002/ajpa.1330960306; Smith SL, 2000, AM J PHYS ANTHROPOL, V113, P329, DOI 10.1002/1096-8644(200011)113:3<329::AID-AJPA5>3.0.CO;2-B; Straus WL, 1942, Q REV BIOL, V17, P228, DOI 10.1086/394656; SUSMAN RL, 1994, SCIENCE, V265, P1570, DOI 10.1126/science.8079169; SUSMAN RL, 1988, SCIENCE, V240, P781, DOI 10.1126/science.3129783; Susman RL, 1998, J HUM EVOL, V35, P23, DOI 10.1006/jhev.1998.0220; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V51, P311, DOI 10.1002/ajpa.1330510303; SUSMAN RL, 1989, AM J PHYS ANTHROPOL, V79, P451, DOI 10.1002/ajpa.1330790403; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Tocheri MW, 2003, AM J PHYS ANTHROPOL, V122, P101, DOI 10.1002/ajpa.10235; Tuttle R, 1970, CHIMPANZEE, P167; TUTTLE RH, 1966, AM J PHYS ANTHROPOL, V24, P191, DOI 10.1002/ajpa.1330240207; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; TUTTLE RH, 1969, J MORPHOL, V128, P309, DOI 10.1002/jmor.1051280304; VANDERMEERSCH B, 1991, SQUELETTE MOUSTERIEN, V2, P169; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Whitehead Paul F., 1993, P96	59	68	69	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11727	10.1371/journal.pone.0011727	http://dx.doi.org/10.1371/journal.pone.0011727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	630AN	20661444	Green Published, gold			2022-12-25	WOS:000280243300027
J	Klein, N				Klein, Nicole			Long Bone Histology of Sauropterygia from the Lower Muschelkalk of the Germanic Basin Provides Unexpected Implications for Phylogeny	PLOS ONE			English	Article							GROWTH-PATTERNS; REPTILIA; INTERRELATIONSHIPS; NETHERLANDS; WINTERSWIJK; NOTHOSAURUS; SKELETON; SIGNAL; BIRTH; SKULL	Background: Sauropterygia is an abundant and successful group of Triassic marine reptiles. Phylogenetic relationships of Triassic Sauropterygia have always been unstable and recently questioned. Although specimens occur in high numbers, the main problems are rareness of diagnostic material from the Germanic Basin and uniformity of postcranial morphology of eosauropterygians. In the current paper, morphotypes of humeri along with their corresponding bone histologies for Lower to Middle Muschelkalk sauropterygians are described and interpreted for the first time in a phylogenetic context. Methodology/Principal Findings: Nothosaurus shows a typical plesiomorphic lamellar-zonal bone type, but varying growth patterns and the occurrence of a new humerus morphotype point to a higher taxonomic diversity than was known. In contrast to the enormous morphological variability of eosauropterygian humeri not assigned to Nothosaurus, their long bone histology is relatively uniform and can be divided into two histotypes. Unexpectedly, both of these histotypes reveal abundant fibrolamellar bone throughout the cortex. This pushes the origin of fibrolamellar bone in Sauropterygia back from the Cretaceous to the early Middle Triassic (early Anisian). Histotype A is assigned to Cymatosaurus, a basal member of the Pistosauroidea, which includes the plesiosaurs as derived members. Histotype B is related to the pachypleurosaur Anarosaurus. Contrary to these new finds, the stratigraphically younger pachypleurosaur Neusticosaurus shows the plesiomorphic lamellar-zonal bone type and an incomplete endochondral ossification, like Nothosaurus. Conclusions/Significance: Histological results hypothetically discussed in a phylogenetical context have a large impact on the current phylogenetic hypothesis of Sauropterygia, leaving the pachypleurosaurs polyphyletic. On the basis of histological data, Neusticosaurus would be related to Nothosaurus, whereas Anarosaurus would follow the pistosaur clade. Furthermore, the presence of fibrolamellar bone, which is accompanied with increased growth rates and presumably even with increased metabolic rates, already in Anarosaurus and Cymatosaurus can explain the success of the Pistosauroidea, the only sauropterygian group to survive into the Jurassic and give rise to the pelagic plesiosaur radiation.	Univ Bonn, Steinmann Inst Geol Mineral & Palaeontol, D-5300 Bonn, Germany	University of Bonn	Klein, N (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaeontol, D-5300 Bonn, Germany.	nklein@uni-bonn.de			Deutsche Forschungsgemeinschaft [KL 2127/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Deutsche Forschungsgemeinschaft (project KL 2127/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERS P, 2005, PALARCHS J VERTEBRAT, P33; Albers P. C., 2005, PALARCHS J VERTEBRAT, P1; Albers PCH, 2003, J PALEONTOL, V77, P738, DOI 10.1666/0022-3360(2003)077<0738:ANSOTS>2.0.CO;2; Bickelmann C, 2008, J VERTEBR PALEONTOL, V28, P326, DOI 10.1671/0272-4634(2008)28[326:APSAIH]2.0.CO;2; Bottcher R., 1990, STUTTGARTER BEITRA B, V164, P1; BUCHWITZ M, 2008, TERRA NOSTRA, pA61; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; CASTANET J, 1994, GERONTOLOGY, V40, P174, DOI 10.1159/000213586; Castanet J., 1993, BONE, P245; Cheng YN, 2004, NATURE, V432, P383, DOI 10.1038/nature03050; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; CORMACK DH, 1987, HAMS HISTOLOGY; Cubo J, 2005, SYST BIOL, V54, P562, DOI 10.1080/10635150591003461; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; de Buffrenil Vivian, 1992, Revue de Paleobiologie, V11, P397; de Ricqles A., 1976, Annales Paleont (Vert), V62, P71; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; de Ricqles Armand, 2001, P289; Enlow D. H., 1957, Texas Journal of Science, V9, P186; ENLOW DH, 1969, BIOL REPTILIA, V1, P117; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Fostowicz-Frelik L, 2010, LETHAIA, V43, P137, DOI 10.1111/j.1502-3931.2009.00179.x; Francillon-Vieillot H., 1990, SKELETAL BIOMINERALI, V1, P471; GROSS W, 1934, Z ANAT ENTWICKLUNGS, V203, P731; Hill RV, 2005, SYST BIOL, V54, P530, DOI 10.1080/10635150590950326; Holmes R, 2008, J VERTEBR PALEONTOL, V28, P76, DOI 10.1671/0272-4634(2008)28[76:NIOTSO]2.0.CO;2; KIPRIJANOFF V, 1881, MEMOIRES ACAD IMPERI, V28, P1; Klein N., 2009, TERRA NOSTRA, V2009, p61A; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2009, J VERTEBR PALEONTOL, V29, p127A; Klein N, 2009, ACTA PALAEONTOL POL, V54, P589, DOI 10.4202/app.2008.0083; Klein N, 2009, J VERTEBR PALEONTOL, V29, P665, DOI 10.1671/039.029.0327; Krahl A, 2009, J VERTEBR PALEONTOL, V29, p129A; LUKAS V, 1991, Geologisches Jahrbuch Hessen, V119, P119; NOPSCA F, 1934, ACTA ZOOLOGICA, V15, P431; Oosterink H. W., 2003, STARINGIA, V11, P1; OOSTERINK HW, 1986, WETENSCHAPPELIJKE ME, V178, P1; PEABODY FE, 1961, J MORPHOL, V108, P11, DOI 10.1002/jmor.1051080103; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Reid R.E.H., 1997, P403; Rieppel, 1994, FIELDIANA GEOL, V28, P1, DOI DOI 10.5962/BHL.TITLE.3399; Rieppel O, 2002, ZOOL J LINN SOC-LOND, V135, P33, DOI 10.1046/j.1096-3642.2002.00019.x; Rieppel O, 1998, J VERTEBR PALEONTOL, V18, P545, DOI 10.1080/02724634.1998.10011082; Rieppel O, 1998, ZOOL J LINN SOC-LOND, V124, P1; Rieppel O.C., 2000, HDB PALAOHERPETOLOGI; Rieppel OC, 1997, FIELDIANA, V36, P1; Rieppel Olivier, 1995, Fieldiana Geology, V32, P1; Rieppel Olivier, 1997, P121, DOI 10.1016/B978-012155210-7/50009-0; Rieppel Olivier, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V197, P383; RUEGG GH, 1981, SEDIMENTOLOGISCHE AF, V63, P7; SANDER P M, 1989, Philosophical Transactions of the Royal Society of London B Biological Sciences, V325, P561, DOI 10.1098/rstb.1989.0103; SANDER PM, 1990, ANN SCI NAT ZOOL, V13, P213; Schroeaer H., 1914, Abhandlungen K Preussischen Geologischen Landesanst Berlin, V65, P1; Seitz ALL, 1907, NOVA ACTA ABHANDLUNG, V87, P230; *SKPT, 2008, SUBK PERM TRIAS; Stein K, 2009, J VERTEBR PALEONTOL, V29, p185A; SUES HD, 1987, ZOOL J LINN SOC-LOND, V90, P109, DOI 10.1111/j.1096-3642.1987.tb01351.x; Volz W., 1902, PAL ONTOGRAPHICA, V49, P121; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Zangerl R, 1935, ABHANDLUNGEN SCHWEIZ, V66, P1	61	64	67	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11613	10.1371/journal.pone.0011613	http://dx.doi.org/10.1371/journal.pone.0011613			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657768	Green Submitted, gold, Green Published			2022-12-25	WOS:000280197500008
J	Krummel, B; Strassburg, A; Ernst, M; Reiling, N; Eker, B; Rath, H; Hoerster, R; Wappler, W; Glaewe, A; Schoellhorn, V; Sotgiu, G; Lange, C				Krummel, Benjamin; Strassburg, Alan; Ernst, Martin; Reiling, Norbert; Eker, Barbara; Rath, Heidrun; Hoerster, Robert; Wappler, Waltraud; Glaewe, Andrea; Schoellhorn, Volker; Sotgiu, Giovanni; Lange, Christoph			Potential Role for IL-2 ELISpot in Differentiating Recent and Remote Infection in Tuberculosis Contact Tracing	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSE; FACTOR-ALPHA; IFN-GAMMA; TNF-ALPHA; SKIN-TEST; T-CELLS; DIAGNOSIS	Interferon (IFN)-gamma release assays (IGRA) have improved tuberculosis contact tracing, but discrimination of recent from remote Mycobacterium tuberculosis contacts is not possible by IGRA alone. We present results of a tuberculosis contact investigation with a new early-secretory-antigenic-target (ESAT)-6 and culture-filtrate-protein (CFP)-10 specific interleukin (IL)-2 ELISpot in addition to ESAT-6 and CFP-10 specific IFN-gamma ELISpot and tuberculin skin testing (TST). Results of the TST, IFN-gamma ELISpot and IL-2 ELISpot were positive in 6/172 (3.4%), 7/167 (4.2%) and 6/196 (3.1%) of contacts, respectively. Close contact (>= 100 hours) to the index case increased the risk of positive results in the IFN-gamma ELISpot, TST, and IL-2 ELISpot by 40.8, 19.3, and 2.5 times, respectively. Individuals with a positive IFN-gamma ELISpot/negative IL-2 ELISpot result had a median (IQR) duration of index case exposure of 568 hours (133_1000) compared to individuals with a positive IFN-gamma ELISpot/positive IL-2 ELISpot result (median = 24 hours; 20_130; p-value = 0.047). Combination of a M. tuberculosis specific IFN-gamma ELISpot with a M. tuberculosis specific IL-2 ELISpot significantly improved the identification of individuals with the highest risk of recent M. tuberculosis infection and is a promising method that should be explored to target tuberculosis preventive chemotherapy.	[Krummel, Benjamin; Strassburg, Alan; Eker, Barbara; Hoerster, Robert; Wappler, Waltraud; Glaewe, Andrea; Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Ernst, Martin] Res Ctr Borstel, Div Immune Cell Analyt, Borstel, Germany; [Reiling, Norbert] Res Ctr Borstel, Div Microbial Interface Biol, Borstel, Germany; [Rath, Heidrun] Dept Publ Hlth, Lubeck, Germany; [Schoellhorn, Volker] Autoimmun Diagnost GmbH, Strassberg, Germany; [Sotgiu, Giovanni] Univ Sassari, Inst Hyg & Prevent Med, I-07100 Sassari, Italy	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; University of Sassari	Krummel, B (corresponding author), Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany.	clange@fz-borstel.de	Reiling, Norbert/D-6796-2013; Lange, Christoph/J-6289-2012; Sotgiu, Giovanni/N-1032-2017	Reiling, Norbert/0000-0001-6673-4291; Lange, Christoph/0000-0002-9691-4741; Sotgiu, Giovanni/0000-0002-1600-4474	Research Center Borstel; Leibniz Center for Medicine and Biomedical Research, Germany	Research Center Borstel; Leibniz Center for Medicine and Biomedical Research, Germany	The study was funded by the Research Center Borstel, Leibniz Center for Medicine and Biomedical Research, Germany. ELISPOT plates and reagents were kindly provided free of charge by Autoimmun Diagnostika (AID), Strasberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Buettner M, 2005, J IMMUNOL, V174, P4203, DOI 10.4049/jimmunol.174.7.4203; Byrd TF, 1997, J CLIN INVEST, V99, P2518, DOI 10.1172/JCI119436; Diel R, 2007, Pneumologie, V61, P440, DOI 10.1055/s-2007-959219; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Goletti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003417; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; *IUTLD, 1982, B WORLD HEALTH ORGAN, V60, P555; JAFARI C, 2009, AM J RESP CRIT CARE; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Vincenti D, 2003, MOL MED, V9, P105, DOI 10.1007/BF03402042; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Wolfe F, 2004, ARTHRITIS RHEUM-US, V50, P372, DOI 10.1002/art.20009	32	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11670	10.1371/journal.pone.0011670	http://dx.doi.org/10.1371/journal.pone.0011670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652022	Green Published, Green Submitted, gold			2022-12-25	WOS:000280109700005
J	Forbi, JC; Vaughan, G; Purdy, MA; Campo, DS; Xia, GL; Ganova-Raeva, LM; Ramachandran, S; Thai, H; Khudyakov, YE				Forbi, Joseph C.; Vaughan, Gilberto; Purdy, Michael A.; Campo, David S.; Xia, Guo-liang; Ganova-Raeva, Lilia M.; Ramachandran, Sumathi; Thai, Hong; Khudyakov, Yury E.			Epidemic History and Evolutionary Dynamics of Hepatitis B Virus Infection in Two Remote Communities in Rural Nigeria	PLOS ONE			English	Article							GENOTYPE-E STRAINS; GENETIC DIVERSITY; C VIRUS; PHYLOGENETIC ANALYSIS; SURFACE-ANTIGEN; BLOOD-DONORS; WEST; AFRICA; SUBGENOTYPES; ERADICATION	Background: In Nigeria, hepatitis B virus (HBV) infection has reached hyperendemic levels and its nature and origin have been described as a puzzle. In this study, we investigated the molecular epidemiology and epidemic history of HBV infection in two semi-isolated rural communities in North/Central Nigeria. It was expected that only a few, if any, HBV strains could have been introduced and effectively transmitted among these residents, reflecting limited contacts of these communities with the general population in the country. Methods and Findings: Despite remoteness and isolation, similar to 11% of the entire population in these communities was HBV-DNA seropositive. Analyses of the S-gene sequences obtained from 55 HBV-seropositive individuals showed the circulation of 37 distinct HBV variants. These HBV isolates belong predominantly to genotype E (HBV/E) (n = 53, 96.4%), with only 2 classified as sub-genotype A3 (HBV/A3). Phylogenetic analysis showed extensive intermixing between HBV/E variants identified in these communities and different countries in Africa. Quasispecies analysis of 22 HBV/E strains using end-point limiting-dilution real-time PCR, sequencing and median joining networks showed extensive intra-host heterogeneity and inter-host variant sharing. To investigate events that resulted in such remarkable HBV/E diversity, HBV full-size genome sequences were obtained from 47 HBV/E infected persons and P gene was subjected to Bayesian coalescent analysis. The time to the most recent common ancestor (tMRCA) for these HBV/E variants was estimated to be year 1952 (95% highest posterior density (95% HPD): 1927-1970). Using additional HBV/E sequences from other African countries, the tMRCA was estimated to be year 1948 (95% HPD: 1924-1966), indicating that HBV/E in these remote communities has a similar time of origin with multiple HBV/E variants broadly circulating in West/Central Africa. Phylogenetic analysis and statistical neutrality tests suggested rapid HBV/E population expansion. Additionally, skyline plot analysis showed an increase in the size of the HBV/E-infected population over the last similar to 30-40 years. Conclusions: Our data suggest a massive introduction and relatively recent HBV/E expansion in the human population in Africa. Collectively, these data show a significant shift in the HBV/E epidemic dynamics in Africa over the last century.	[Forbi, Joseph C.; Vaughan, Gilberto; Purdy, Michael A.; Campo, David S.; Xia, Guo-liang; Ganova-Raeva, Lilia M.; Ramachandran, Sumathi; Thai, Hong; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Forbi, JC (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	gzf7@cdc.gov	Campo, David S./C-5072-2011	Campo, David S./0000-0002-8970-3436	American Society for Microbiology (ASM); Coordinating Center for Infectious Diseases (CCID) at the Centers for Disease Control and Prevention (CDC), Atlanta-USA	American Society for Microbiology (ASM); Coordinating Center for Infectious Diseases (CCID) at the Centers for Disease Control and Prevention (CDC), Atlanta-USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was directly supported by the American Society for Microbiology (ASM) (www.asm.org) and the Coordinating Center for Infectious Diseases (CCID) at the Centers for Disease Control and Prevention (CDC), Atlanta-USA. J.C.F. received the ASM/CCID postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Depla E, 2008, J VIROL, V82, P435, DOI 10.1128/JVI.01505-07; Dreesman JM, 2006, EPIDEMIOL INFECT, V134, P1102, DOI 10.1017/S0950268806005942; Drucker E, 2001, LANCET, V358, P1989, DOI 10.1016/S0140-6736(01)06967-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fasola FA, 2008, INTERVIROLOGY, V51, P427, DOI 10.1159/000209671; Foege W H, 1973, Prog Med Virol, V15, P205; FOEGE WH, 1975, B WORLD HEALTH ORGAN, V52, P209; Forbi JC, 2008, REV INST MED TROP SP, V50, P219, DOI 10.1590/S0036-46652008000400006; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Fu YX, 1996, GENETICS, V143, P557; GANEM D, 2001, FIELDS VIROLOGY, P2923; Garmiri P, 2009, J GEN VIROL, V90, P2442, DOI 10.1099/vir.0.012013-0; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Grischow JD, 2006, AFRICA, V76, P381, DOI 10.1353/afr.2006.0041; Hawkins AE, 1996, J VIROL METHODS, V60, P81, DOI 10.1016/0166-0934(96)02048-4; HERBERT EW, 1975, J AFR HIST, V16, P539, DOI 10.1017/S0021853700014547; HOUILLON D, 1905, ANN HYGIENE MED COLO, V8, P546; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Isiugo-Abanihe U C, 2006, Afr J Med Med Sci, V35 Suppl, P45; KALIDI I, 1988, TISSUE ANTIGENS, V31, P98, DOI 10.1111/j.1399-0039.1988.tb02070.x; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Lehman EM, 2009, J VIRAL HEPATITIS, V16, P650, DOI 10.1111/j.1365-2893.2009.01115.x; Makuwa M, 2006, J MED VIROL, V78, P1175, DOI 10.1002/jmv.20678; Mast E., 2004, VACCINES, P299; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Nainan OV, 2002, J MED VIROL, V68, P319, DOI 10.1002/jmv.10206; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1993, J GEN VIROL, V74, P1341, DOI 10.1099/0022-1317-74-7-1341; Odemuyiwa SO, 2001, J MED VIROL, V65, P463, DOI 10.1002/jmv.2058; OKAMOTO H, 1987, J VIROL, V61, P3030, DOI 10.1128/JVI.61.10.3030-3034.1987; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Olubuyide IO, 1997, QJM-MON J ASSOC PHYS, V90, P417, DOI 10.1093/qjmed/90.6.417; Patterson K. David, 1981, HLTH COLONIAL GHANA; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Sadoh AE, 2008, PUBLIC HEALTH, V122, P1318, DOI 10.1016/j.puhe.2008.06.003; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson SC, 1997, J VIRAL HEPATITIS, V4, P135, DOI 10.1111/j.1365-2893.1997.tb00216.x; Uko GP, 1997, DIS MARKERS, V13, P123; Uwaezuoke SN, 2007, J TROP PEDIATRICS, V53, P62, DOI 10.1093/tropej/fml081; *WHO, 2005, WHO VACC PREV DIS MO; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Zaaijer HL, 2008, J VIRAL HEPATITIS, V15, P239, DOI 10.1111/j.1365-2893.2007.00938.x; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	65	67	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11615	10.1371/journal.pone.0011615	http://dx.doi.org/10.1371/journal.pone.0011615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657838	Green Submitted, gold, Green Published			2022-12-25	WOS:000280065600007
J	Hamilton, DL; Philp, A; MacKenzie, MG; Baar, K				Hamilton, D. Lee; Philp, Andrew; MacKenzie, Matthew G.; Baar, Keith			A Limited Role for PI(3,4,5)P-3 Regulation in Controlling Skeletal Muscle Mass in Response to Resistance Exercise	PLOS ONE			English	Article							PROTEIN-KINASE-B; BANNAYAN-ZONANA-SYNDROME; PHOSPHOINOSITIDE 3-KINASE; SIGNALING PATHWAYS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; GLYCOGEN-METABOLISM; GERMLINE MUTATIONS; INSULIN-RESISTANCE; MAMMALIAN TARGET; TUMOR-SUPPRESSOR	Background: Since activation of the PI3K/(protein kinase B; PKB/akt) pathway has been shown to alter muscle mass and growth, the aim of this study was to determine whether resistance exercise increased insulin like growth factor (IGF) I/phosphoinositide 3-kinase (PI3K) signalling and whether altering PI(3,4,5)P-3 metabolism genetically would increase load induced muscle growth. Methodology/Principal Findings: Acute and chronic resistance exercise in wild type and muscle specific PTEN knockout mice were used to address the role of PI(3,4,5)P-3 regulation in the development of skeletal muscle hypertrophy. Acute resistance exercise did not increase either IGF-1 receptor phosphorylation or IRS1/2 associated p85. Since insulin/IGF signalling to PI3K was unchanged, we next sought to determine whether inactivation of PTEN played a role in load-induced muscle growth. Muscle specific knockout of PTEN resulted in small but significant increases in heart (PTEN+/+ = 5.00 +/- 0.02 mg/g, PTEN-/- = 5.50 +/- 0.09 mg/g), and TA (PTEN+/+ = 1.74 +/- 0.04 mg/g, PTEN-/- = 1.89 +/- 0.03) muscle mass, while the GTN, SOL, EDL and PLN remain unchanged. Following ablation, hypertrophy of the PLN, SOL or EDL muscles was similar between PTEN-/- and PTEN+/+ animals. Even though there were some changes in overload-induced PKB and S6K1 phosphorylation, 1 hr following acute resistance exercise there was no difference in the phosphorylation state of S6K1 Thr389 between genotypes. Conclusions/Significance: These data suggest that physiological loading does not lead to the enhanced activation of thePI3K/PKB/mTORC1 axis and that neither PI3K activation nor PTEN, and by extension PI(3,4,5)P-3 levels, play a significant role in adult skeletal muscle growth.	[Hamilton, D. Lee; Philp, Andrew; MacKenzie, Matthew G.; Baar, Keith] Univ Dundee, Div Mol Physiol, Dundee, Scotland	University of Dundee	Hamilton, DL (corresponding author), Univ Dundee, Div Mol Physiol, Dundee, Scotland.	FMBLab@googlemail.com		Philp, Andrew/0000-0003-3860-4136; Hamilton, David/0000-0002-5620-4788; Baar, Keith/0000-0001-9337-6186	Wellcome Trust [077426]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Wellcome Trust Project Grant 077426 awarded to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Baar K, 2006, ESSAYS BIOCHEM, V42, P61, DOI 10.1042/bse0420061; BACKER JM, 1993, J BIOL CHEM, V268, P8204; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cairns SP, 2007, J APPL PHYSIOL, V103, P359, DOI 10.1152/japplphysiol.01267.2006; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COHEN B, 1990, P NATL ACAD SCI USA, V87, P4458, DOI 10.1073/pnas.87.12.4458; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Delibegovic M, 2003, DIABETES, V52, P596, DOI 10.2337/diabetes.52.3.596; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Kishimoto H, 2003, CELL STRUCT FUNCT, V28, P11; Lackey J, 2007, ONCOGENE, V26, P7132, DOI 10.1038/sj.onc.1210520; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; MacKenzie MG, 2009, J PHYSIOL-LONDON, V587, P253, DOI 10.1113/jphysiol.2008.159830; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; MCGEE SL, 2008, J PHYSL; MOUNIER R, 2009, FASEB J; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.017; Plyley MJ, 1998, J APPL PHYSIOL, V84, P902, DOI 10.1152/jappl.1998.84.3.902; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Song YH, 2005, J INVEST MED, V53, P135, DOI 10.2310/6650.2005.00309; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Toole BJ, 2007, CELL SIGNAL, V19, P1044, DOI 10.1016/j.cellsig.2006.11.013; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005	58	58	59	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11624	10.1371/journal.pone.0011624	http://dx.doi.org/10.1371/journal.pone.0011624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661274	Green Published, gold, Green Submitted			2022-12-25	WOS:000279980800013
J	Tseng, HC; Arasteh, A; Paranjpe, A; Teruel, A; Yang, W; Behel, A; Alva, JA; Walter, G; Head, C; Ishikawa, TO; Herschman, HR; Cacalano, N; Pyle, AD; Park, NH; Jewett, A				Tseng, Han-Ching; Arasteh, Aida; Paranjpe, Avina; Teruel, Antonia; Yang, Wendy; Behel, Armin; Alva, Jackelyn A.; Walter, Gina; Head, Christian; Ishikawa, Tomo-o; Herschman, Harvey R.; Cacalano, Nicholas; Pyle, April D.; Park, No-Hee; Jewett, Anahid			Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; CYTOKINE PRODUCTION; T-LYMPHOCYTE; EXPRESSION; CANCER; APOPTOSIS; PROLIFERATION; SECRETION; DEATH; INACTIVATION	The aims of this study are to demonstrate the increased lysis of stem cells but not their differentiated counterparts by the NK cells and to determine whether disturbance in cell differentiation is a cause for increased sensitivity to NK cell mediated cytotoxicity. Increased cytotoxicity and augmented secretion of IFN-gamma were both observed when PBMCs or NK cells were co-incubated with primary UCLA oral squamous carcinoma stem cells (UCLA-OSCSCs) when compared to differentiated UCLA oral squamous carcinoma cells (UCLA-OSCCs). In addition, human embryonic stem cells (hESCs) were also lysed greatly by the NK cells. Moreover, NK cells were found to lyse human Mesenchymal Stem Cells (hMSCs), human dental pulp stem cells (hDPSCs) and human induced pluripotent stem cells (hiPSCs) significantly more than their differentiated counterparts or parental lines from which they were derived. It was also found that inhibition of differentiation or reversion of cells to a less-differentiated phenotype by blocking NF kappa B or targeted knock down of COX2 in monocytes significantly augmented NK cell cytotoxicity and secretion of IFN-gamma. Taken together, these results suggest that stem cells are significant targets of the NK cell cytotoxicity. However, to support differentiation of a subset of tumor or healthy untransformed primary stem cells, NK cells may be required to lyse a number of stem cells and/or those which are either defective or incapable of full differentiation in order to lose their cytotoxic function and gain the ability to secrete cytokines (split anergy). Therefore, patients with cancer may benefit from repeated allogeneic NK cell transplantation for specific elimination of cancer stem cells.	[Tseng, Han-Ching; Arasteh, Aida; Paranjpe, Avina; Teruel, Antonia; Yang, Wendy; Behel, Armin; Walter, Gina; Park, No-Hee; Jewett, Anahid] Univ Calif Los Angeles, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Sch Med & Dent, Div Oral Biol & Oral Med, Los Angeles, CA 90024 USA; [Alva, Jackelyn A.; Pyle, April D.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Sch Med & Dent, BSCRC, Los Angeles, CA USA; [Head, Christian] Univ Calif Los Angeles, Div Head & Neck Surg, Dept Surg, Sch Med & Dent, Los Angeles, CA 90024 USA; [Head, Christian; Herschman, Harvey R.; Cacalano, Nicholas; Pyle, April D.; Park, No-Hee; Jewett, Anahid] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Med & Dent, Los Angeles, CA 90024 USA; [Ishikawa, Tomo-o; Herschman, Harvey R.] Univ Calif Los Angeles, Dept Biol Chem, Sch Med & Dent, Los Angeles, CA 90024 USA; [Cacalano, Nicholas] Univ Calif Los Angeles, Dept Radiat Oncol, Sch Med & Dent, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tseng, HC (corresponding author), Univ Calif Los Angeles, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Sch Med & Dent, Div Oral Biol & Oral Med, Los Angeles, CA 90024 USA.	ajewett@ucla.edu			University of California Los Angeles (UCLA) School of Dentistry and Academic Senate Faculty	University of California Los Angeles (UCLA) School of Dentistry and Academic Senate Faculty	This work was funded by University of California Los Angeles (UCLA) School of Dentistry and Academic Senate Faculty seed grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Banerjee AG, 2002, MOL CANCER THER, V1, P1265; Bennett MW, 1998, J IMMUNOL, V160, P5669; Camp BJ, 1996, ANN SURG ONCOL, V3, P176, DOI 10.1007/BF02305798; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Gimmi CD, 1996, NAT MED, V2, P1367, DOI 10.1038/nm1296-1367; Han X, 1997, GYNECOL ONCOL, V65, P391, DOI 10.1006/gyno.1997.4668; Jewett A, 2006, J DENT RES, V85, P1061, DOI 10.1177/154405910608501201; Jewett A, 2006, CANCER IMMUNOL IMMUN, V55, P1052, DOI 10.1007/s00262-005-0093-7; Jewett A, 2006, CLIN CANCER RES, V12, P1994, DOI 10.1158/1078-0432.CCR-05-2306; Jewett A, 1996, J IMMUNOL, V156, P907; Jewett A, 2003, HUM IMMUNOL, V64, P505, DOI 10.1016/S0198-8859(03)00039-9; JEWETT A, 1995, J CLIN IMMUNOL, V15, P35, DOI 10.1007/BF01489488; Jewett A, 1997, J IMMUNOL, V159, P4815; Jewett A, 2008, CANCER IMMUNOL IMMUN, V57, P1053, DOI 10.1007/s00262-007-0437-6; Jewett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009874; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kolenko V, 1997, J IMMUNOL, V159, P3057; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mancini AJ, 2008, ARCH DERMATOL, V144, P342, DOI 10.1001/archderm.144.3.342; MIESCHER S, 1988, CANCER RES, V48, P6992; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; Mulder WMC, 1997, GUT, V40, P113, DOI 10.1136/gut.40.1.113; NAKAGOMI H, 1993, CANCER RES, V53, P5610; Narasimha AJ, 2010, ARTERIOSCL THROM VAS, V30, P260, DOI 10.1161/ATVBAHA.109.198762; Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4; Opitz OG, 2002, J CLIN INVEST, V110, P761, DOI 10.1172/JCI200215324; Paranjpe A, 2007, FREE RADICAL BIO MED, V43, P1394, DOI 10.1016/j.freeradbiomed.2007.07.011; PARK NH, 1991, CARCINOGENESIS, V12, P1627, DOI 10.1093/carcin/12.9.1627; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Qin J, 1997, Zhonghua Yi Xue Za Zhi, V77, P167; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929; Swan EA, 2003, ORAL ONCOL, V39, P648, DOI 10.1016/S1368-8375(03)00049-6; Tae K, 2000, CLIN CANCER RES, V6, P2821; Teruel A, 2008, CANCER IMMUNOL IMMUN, V57, P359, DOI 10.1007/s00262-007-0375-3; Thomas GR, 2004, CANCER IMMUNOL IMMUN, V53, P33, DOI 10.1007/s00262-003-0433-4; TSUBOI I, 1995, CYTOKINE, V7, P372, DOI 10.1006/cyto.1995.0047; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; ZHANG Q, CANC LETT, V289, P151	46	101	103	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11590	10.1371/journal.pone.0011590	http://dx.doi.org/10.1371/journal.pone.0011590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661281	Green Published, Green Submitted, gold			2022-12-25	WOS:000279980800003
J	Martino, MM; Hubbell, JA				Martino, Mikael M.; Hubbell, Jeffrey A.			The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain	FASEB JOURNAL			English	Article						extracellular matrix; heparin-binding domain; tissue engineering	HEPARAN-SULFATE; CELL-MIGRATION; EXTRACELLULAR-MATRIX; BIOLOGICAL-ACTIVITY; CONTROLLED-RELEASE; ENDOTHELIAL-CELLS; FIBRIN GELS; VITRONECTIN; PROTEIN; DIFFERENTIATION	It has recently been shown that some growth factors (GFs) have strong interactions with nonproteoglycan extracellular matrix proteins. Relevant here, the 12th-14th type three repeats of fibronectin (FN III12-14) have been shown to bind insulin-like growth factor binding-protein-3, fibroblast growth factor (FGF)-2, and vascular endothelial growth factor (VEGF)-A with high affinity. Since FN III12-14 is known to bind GFs from different families, we hypothesized that this domain could be highly promiscuous in its GF-binding capacity. We used biochemical approaches and surface plasmon resonance to investigate such interactions with recombinant FN III12-14. We found that FN III12-14 binds most of the GFs from the platelet-derived growth factor (PDGF)/VEGF and FGF families and some GFs from the transforming growth factor-beta and neurotrophin families, with K-D values in the nanomolar range, without inhibiting GF activity. Overall, 25 new binding interactions were identified. In a clinically relevant fibrin matrix, a fibrin-binding variant of FN III12-14 was highly effective as a GF delivery system. For instance, in matrices functionalized with FN III12-14, PDGF-BB-induced sprouting of human smooth muscle cell spheroids was greatly enhanced. We show that FN III12-14 is a highly promiscuous ligand for GFs and also holds great potential in clinical healing applications.-Martino, M. M., Hubbell, J. A. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor binding domain. FASEB J. 24, 4711-4721 (2010). www.fasebj.org	[Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Regenerat Med & Pharmacobiol, CH-1015 Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Regenerat Med & Pharmacobiol, Stn 15, CH-1015 Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	Hubbell, Jeffrey A/A-9266-2008; Martino, Mikaël M/N-9345-2013	Hubbell, Jeffrey A/0000-0003-0276-5456; Martino, Mikaël M/0000-0002-5012-4605	European Community [NMP-LA-2008-214402]; Swiss National Science Foundation	European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank the Proteomic Core Facility of the Ecole Polytechnique Federale de Lausanne for MALDI-TOF analysis. This work was funded in part by the European Community's Seventh Framework Programme in the project Angioscaff NMP-LA-2008-214402 and by the Swiss National Science Foundation.	BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bossard C, 2004, CANCER RES, V64, P7507, DOI 10.1158/0008-5472.CAN-04-0287; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Gui YT, 2001, J CLIN ENDOCR METAB, V86, P2104, DOI 10.1210/jc.86.5.2104; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086; MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Martin JA, 2002, OSTEOARTHR CARTILAGE, V10, P556, DOI 10.1053/joca.2002.0791; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; MOORADIAN DL, 1989, J CELL BIOCHEM, V41, P189, DOI 10.1002/jcb.240410404; MOSHER DF, 1976, J BIOL CHEM, V251, P1639; Noble A, 2003, ENDOCRINOLOGY, V144, P2417, DOI 10.1210/en.2002-221138; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4; Peng H, 2004, BLOOD, V103, P2114, DOI 10.1182/blood-2003-08-2638; Rahman S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-8; Sahni A, 2006, BLOOD, V107, P126, DOI 10.1182/blood-2005-06-2460; Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769; Schoppet M, 2002, LAB INVEST, V82, P37, DOI 10.1038/labinvest.3780393; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Smith EM, 2009, P NATL ACAD SCI USA, V106, P21683, DOI 10.1073/pnas.0902510106; Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Xu QJ, 2004, J BIOL CHEM, V279, P4269, DOI 10.1074/jbc.M311586200; Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8	40	227	232	1	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4711	4721		10.1096/fj.09-151282	http://dx.doi.org/10.1096/fj.09-151282			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20671107				2022-12-25	WOS:000284824400012
J	Damo, SM; Phillips, AH; Young, AL; Li, S; Woods, VL; Wemmer, DE				Damo, Steven M.; Phillips, Aaron H.; Young, Anisa L.; Li, Sheng; Woods, Virgil L., Jr.; Wemmer, David E.			Probing the Conformation of a Prion Protein Fibril with Hydrogen Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUTION NMR-SPECTROSCOPY; BETA(2)-MICROGLOBULIN AMYLOID FIBRILS; STRAUSSLER-SCHEINKER-DISEASE; HYDROGEN/DEUTERIUM EXCHANGE; MASS-SPECTROMETRY; TRANSGENIC MICE; SOLVENT ACCESSIBILITY; SYNTHETIC PEPTIDE; Y145STOP VARIANT; AMIDE-PROTON	A fragment of the prion protein, PrP(89-143, P101L), bearing a mutation implicated in familial prion disease, forms fibrils that have been shown to induce prion disease when injected intracerebrally into transgenic mice expressing full-length PrP containing the P101L mutation. In this study, we utilize amide hydrogen exchange measurements to probe the organization of the peptide in its fibrillar form. We determined the extent of hydrogen exchange first by tandem proteolysis, liquid chromatography, and mass spectrometry (HXMS) and then by exchange-quenched NMR. Although single amide resolution is afforded by NMR measurements, HXMS is well suited to the study of natural prions because it does not require labeling with NMR active isotopes. Thus, natural prions obtained from infected animals can be compared with model systems such as PrP(89-143, P101L) studied here. In our study, we find two segments of sequence that display a high level of protection from exchange, residues 102-109 and 117-136. In addition, there is a region that displays exchange behavior consistent with the presence of a conformationally heterogeneous turn. We discuss our data with respect to several structural models proposed for infectious PrP aggregates and highlight HXMS as one of the few techniques well suited to studying natural prions.	[Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Sch Med, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Young, Anisa L.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Woods, VL (corresponding author), Univ Calif San Diego, Sch Med, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; dewemmer@berkeley.edu		Damo, Steven/0000-0002-1483-7712	Army Prion Research Program [DMAD17-03-1-0476]; National Institutes of Health [AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, GM066170]; Innovative Technologies for the Molecular Analysis of Cancer [CA099835, CA118595]; University of California [UC10591]; NATIONAL CANCER INSTITUTE [R21CA118595, R21CA099835, R33CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, R01AI081982, P01AI068730, R21AI076961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684, R01GM066170, F32GM020501, R01GM020501] Funding Source: NIH RePORTER	Army Prion Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Technologies for the Molecular Analysis of Cancer; University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Army Prion Research Program Grant DMAD17-03-1-0476. Development of the HXMS methodology was supported by National Institutes of Health Grants AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, and GM066170 (to V. L. W.), Innovative Technologies for the Molecular Analysis of Cancer Program Grants CA099835 and CA118595 (to V. L. W.), and Discovery Grant UC10591 from the University of California IUCRP Program, BiogenIDEC corporate sponsor (to V. L. W.).	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Brown DR, 2003, J NEUROCHEM, V87, P377, DOI 10.1046/j.1471-4159.2003.02046.x; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; DeArmond SJ, 1996, CURR TOP MICROBIOL, V207, P125; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Garnett AP, 2003, J BIOL CHEM, V278, P6795, DOI 10.1074/jbc.M209280200; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Keller R., 2004, COMPUTER AIDED RESON, V1; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Lim KH, 2006, SOLID STATE NUCL MAG, V29, P183, DOI 10.1016/j.ssnmr.2005.09.017; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Nazabal A, 2005, J BIOL CHEM, V280, P13220, DOI 10.1074/jbc.M413185200; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Piccardo P, 2001, AM J PATHOL, V158, P2201, DOI 10.1016/S0002-9440(10)64692-5; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner Stanley B., 2004, VVolume 41, P89; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sakudo A, 2004, BIOCHEM BIOPH RES CO, V313, P850, DOI 10.1016/j.bbrc.2003.12.020; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang SSS, 2003, BIOCHEMISTRY-US, V42, P9507, DOI 10.1021/bi0342766; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; ZHANG YZ, 1995, PROTEIN SCI, V4, P804; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	72	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32303	32311		10.1074/jbc.M110.114504	http://dx.doi.org/10.1074/jbc.M110.114504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679344	Green Published, hybrid			2022-12-25	WOS:000282683000043
J	Durand, S; Feldhammer, M; Bonneil, E; Thibault, P; Pshezhetsky, AV				Durand, Stephanie; Feldhammer, Matthew; Bonneil, Eric; Thibault, Pierre; Pshezhetsky, Alexey V.			Analysis of the Biogenesis of Heparan Sulfate Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Provides Insights into the Mechanism Underlying Its Complete Deficiency in Mucopolysaccharidosis IIIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE TYPE-C; MEMBRANE-PROTEINS; COENZYME-A; TRANSMEMBRANE ACETYLATION; HGSNAT GENE; LYSOSOMES; MUTATIONS; SPECTRUM; CHANNEL; BINDING	Heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase (HGSNAT) catalyzes the transmembrane acetylation of heparan sulfate in lysosomes required for its further catabolism. Inherited deficiency of HGSNAT in humans results in lysosomal storage of heparan sulfate and causes the severe neurodegenerative disease, mucopolysaccharidosis IIIC (MPS IIIC). Previously we have cloned the HGSNAT gene, identified molecular defects in MPS IIIC patients, and found that all missense mutations prevented normal folding and trafficking of the enzyme. Therefore characterization of HGSNAT biogenesis and intracellular trafficking became of central importance for understanding the molecular mechanism underlying the disease and developing future therapies. In the current study we show that HGSNAT is synthesized as a catalytically inactive 77-kDa precursor that is transported to the lysosomes via an adaptor protein-mediated pathway that involves conserved tyrosine-and dileucine-based lysosomal targeting signals in its C-terminal cytoplasmic domain with a contribution from a dileucine-based signal in the N-terminal cytoplasmic loop. In the lysosome, the precursor is cleaved into a 29-kDa N-terminal alpha-chain and a 48-kDa C-terminal beta-chain, and assembled into active similar to 440-kDa oligomers. The subunits are held together by disulfide bonds between at least two cysteine residues (Cys(123) and Cys(434)) in the lysosomal luminal loops of the enzyme. We speculate that proteolytic cleavage allows the nucleophile residue, His(269), in the active site to access the substrate acetyl-CoA in the cytoplasm, for further transfer of the acetyl group to the terminal glucosamine on heparan sulfate. Altogether our results identify intralysosomal oligomerization and proteolytic cleavage as two steps crucial for functional activation of HGSNAT.	[Pshezhetsky, Alexey V.] Univ Montreal, CHU St Justine, Serv Genet Med, Dept Med Genet, Montreal, PQ H3T 1C5, Canada; [Feldhammer, Matthew; Thibault, Pierre; Pshezhetsky, Alexey V.] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1C5, Canada; [Pshezhetsky, Alexey V.] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Pshezhetsky, Alexey V.] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ H3A 2B2, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Pshezhetsky, AV (corresponding author), Univ Montreal, CHU St Justine, Serv Genet Med, Dept Med Genet, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	alexei.pchejetski@umontreal.ca		A, Pshezhetsky/0000-0002-6612-1062	March of Dimes Foundation; Sanfilippo Children's Research Foundation; Canadian Institutes for Health Research [MOP84430]; National Science and Engineering Research Council (NSERC); Fonds de la Recherche en Sante du Quebec	March of Dimes Foundation(March of Dimes); Sanfilippo Children's Research Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by research grants from the March of Dimes Foundation, the Sanfilippo Children's Research Foundation, and Canadian Institutes for Health Research Grant MOP84430 (to A. V. P.), and operating grants from the National Science and Engineering Research Council (NSERC) (to P. T.). The Institute of Research in Immunology and Cancer receives infrastructure support funds from the Fonds de la Recherche en Sante du Quebec.	Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; BAME KJ, 1986, J BIOL CHEM, V261, P127; BAME KJ, 1985, J BIOL CHEM, V260, P1293; BAME KJ, 1986, SCIENCE, V233, P1087, DOI 10.1126/science.3090688; BARTSOCAS C, 1979, EUR J PEDIATR, V130, P251, DOI 10.1007/BF00441361; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Callahan JW, 2009, J PROTEOMICS, V72, P23, DOI 10.1016/j.jprot.2008.11.007; Coutinho MF, 2008, CLIN GENET, V74, P194, DOI 10.1111/j.1399-0004.2008.01040.x; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Fedele Anthony Olind, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9488; Feldhammer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007434; Feldhammer M, 2009, HUM MUTAT, V30, P918, DOI 10.1002/humu.20986; FREEMAN C, 1983, BIOCHEM INT, V6, P663; Graham DRM, 2005, PROTEOMICS, V5, P2309, DOI 10.1002/pmic.200401249; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; HE W, 1994, PRENATAL DIAG, V14, P17, DOI 10.1002/pd.1970140104; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hrebicek M, 2006, AM J HUM GENET, V79, P807, DOI 10.1086/508294; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; PSHEZHETSKY AV, 1993, BIOCHEM BIOPH RES CO, V195, P354, DOI 10.1006/bbrc.1993.2051; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; ROME LH, 1983, J BIOL CHEM, V258, P3006; Ruijter GJG, 2008, MOL GENET METAB, V93, P104, DOI 10.1016/j.ymgme.2007.09.011; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; VALSTAR MJ, 2008, J INHERIT METAB DIS, V93, P104; Vesa J, 2002, MOL BIOL CELL, V13, P2410, DOI 10.1091/mbc.E02-01-0031	38	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31233	31242		10.1074/jbc.M110.141150	http://dx.doi.org/10.1074/jbc.M110.141150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20650889	Green Published, hybrid			2022-12-25	WOS:000282764600017
J	Kumar, PA; Kotlyarevska, K; Dejkhmaron, P; Reddy, GR; Lu, CX; Bhojani, MS; Menon, RK				Kumar, P. Anil; Kotlyarevska, Kateryna; Dejkhmaron, Prapai; Reddy, Gaddameedi R.; Lu, Chunxia; Bhojani, Mahaveer S.; Menon, Ram K.			Growth Hormone (GH)-dependent Expression of a Natural Antisense Transcript Induces Zinc Finger E-box-binding Homeobox 2 (ZEB2) in the Glomerular Podocyte A NOVEL ACTION OF GH WITH IMPLICATIONS FOR THE PATHOGENESIS OF DIABETIC NEPHROPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; URINARY ALBUMIN EXCRETION; E-CADHERIN; KIDNEY-DISEASE; IN-VITRO; MICROALBUMINURIA; MELLITUS; PROTEIN; CYTOSKELETON; METASTASIS	Growth hormone (GH) excess results in structural and functional changes in the kidney and is implicated as a causative factor in the development of diabetic nephropathy (DN). Glomerular podocytes are the major barrier to the filtration of serum proteins, and altered podocyte function and/or reduced podocyte number is a key event in the pathogenesis of DN. We have previously shown that podocytes are a target for GH action. To elucidate the molecular basis for the effects of GH on the podocyte, we conducted microarray and RT-quantitative PCR analyses of immortalized human podocytes and identified zinc finger E-box-binding homeobox 2 (ZEB2) to be up-regulated in a GH dose- and time-dependent manner. We established that the GH-dependent increase in ZEB2 levels is associated with increased transcription of a ZEB2 natural antisense transcript required for efficient translation of the ZEB2 transcript. GH down-regulated expression of E-and P-cadherins, targets of ZEB2, and inhibited E-cadherin promoter activity. Mutation of ZEB2 binding sites on the E-cadherin promoter abolished this effect of GH on the E-cadherin promoter. Whereas GH increased podocyte permeability to albumin in a paracellular albumin influx assay, shRNA-mediated knockdown of ZEB2 expression abrogated this effect. We conclude that GH increases expression of ZEB2 in part by increasing expression of a ZEB2 natural antisense transcript. GH-dependent increase in ZEB2 expression results in loss of P- and E-cadherins in podocytes and increased podocyte permeability to albumin. Decreased expression of P- and E-cadherins is implicated in podocyte dysfunction and epithelial-mesenchymal transition observed in DN. We speculate that the actions of GH on ZEB2 and P-and E-cadherin expression play a role in the pathogenesis of microalbuminuria of DN.	[Menon, Ram K.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Menon, RK (corresponding author), Univ Michigan, Sch Med, D1205 MPB SPC 5718,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rammenon@umich.edu	Pasupulati, Anil Kumar/F-8002-2011		National Institutes of Health [T32 DK071212, DK49845, P60DK-20572]; D.R.E.A.M. Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK049845, P60DK020572, T32DK071212, R01DK049845, R29DK049845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D.R.E.A.M. Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 DK071212 (to K. K.), DK49845 (to R. K. M.), and P60DK-20572 (to the Michigan Diabetes Research and Training Center) and the D.R.E.A.M. Foundation.	Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6; Baldelli R, 2008, J CLIN ENDOCR METAB, V93, P710, DOI 10.1210/jc.2007-1197; Baudet ML, 2009, ENDOCRINOLOGY, V150, P2758, DOI 10.1210/en.2008-1242; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; BLANKESTIJN PJ, 1993, J CLIN ENDOCR METAB, V77, P498, DOI 10.1210/jc.77.2.498; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; CHRISTIANSEN JS, 1981, EUR J CLIN INVEST, V11, P487, DOI 10.1111/j.1365-2362.1981.tb02018.x; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Correa LL, 2009, ARQ BRAS ENDOCRINOL, V53, P963, DOI 10.1590/S0004-27302009000800009; Cummings EA, 1998, DIABETES, V47, P1341, DOI 10.2337/diabetes.47.8.1341; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Giroldi LA, 1997, BIOCHEM BIOPH RES CO, V241, P453, DOI 10.1006/bbrc.1997.7831; Han X, 2009, GUT, V58, P49, DOI 10.1136/gut.2007.145094; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; HOOGENBERG K, 1993, ACTA ENDOCRINOL-COP, V129, P151, DOI 10.1530/acta.0.1290151; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Lu CX, 2001, J BIOL CHEM, V276, P22892, DOI 10.1074/jbc.M011647200; Manelli F, 2000, METABOLISM, V49, P634, DOI 10.1016/S0026-0495(00)80040-2; Mathieson PW, 2009, CURR OPIN NEPHROL HY, V18, P206, DOI 10.1097/MNH.0b013e328326f3ca; MAUER SM, 1994, KIDNEY INT, V45, P612, DOI 10.1038/ki.1994.80; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pantaleon M, 1997, P NATL ACAD SCI USA, V94, P5125, DOI 10.1073/pnas.94.10.5125; Reddy GR, 2008, CURR OPIN NEPHROL HY, V17, P32, DOI 10.1097/MNH.0b013e3282f2904d; Reddy GR, 2007, ENDOCRINOLOGY, V148, P2045, DOI 10.1210/en.2006-1285; Reidy K, 2009, AM J KIDNEY DIS, V54, P590, DOI 10.1053/j.ajkd.2009.07.003; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stitt-Cavanagh E, 2009, THESCIENTIFICWORLDJO, V9, P1127, DOI 10.1100/tsw.2009.133; Susztak K, 2006, J AM SOC NEPHROL, V17, P361, DOI 10.1681/ASN.2005101109; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Xu ZG, 2005, NEPHROL DIAL TRANSPL, V20, P524, DOI 10.1093/ndt/gfh642; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B; 2003, JAMA, V290, P2159	44	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31148	31156		10.1074/jbc.M110.132332	http://dx.doi.org/10.1074/jbc.M110.132332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682777	Green Published, hybrid			2022-12-25	WOS:000282764600008
J	Nowotarski, SL; Shantz, LM				Nowotarski, Shannon L.; Shantz, Lisa M.			Cytoplasmic Accumulation of the RNA-binding Protein HuR Stabilizes the Ornithine Decarboxylase Transcript in a Murine Nonmelanoma Skin Cancer Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TRANSLATIONAL CONTROL; EXPRESSION; POLYAMINES; INDUCTION; LOCALIZATION; GENE; DIFLUOROMETHYLORNITHINE; PHOSPHORYLATION; PREVENTION	Ornithine decarboxylase (ODC) is the first and usually rate-limiting enzyme in the polyamine biosynthetic pathway. Under normal physiological conditions, polyamine content and ODC enzyme activity are highly regulated. However, the induction of ODC activity is an early step in neoplastic transformation. The studies described here use normal mouse keratinocytes (C5N cells), and spindle carcinoma cells (A5 cells) to explore the regulation of ODC in nonmelanoma skin cancer development. Previous results have shown that induction of ODC activity is both necessary and sufficient for the promotion of skin tumors. We see a marked increase in ODC enzyme activity in A5 cells compared with C5N keratinocytes, which correlates with a 4-fold stabilization of ODC mRNA. These data suggest that ODC is post-transcriptionally regulated in skin tumor development. Thus, we sought to investigate whether the ODC transcript interacts with the RNA-binding protein HuR, which is known to bind to and stabilize its target mRNAs. We show that HuR is able to bind to the ODC 3'-UTR in A5 cells but not in C5N cells. Immunofluorescence results reveal that HuR is present in both the nucleus and cytoplasm of A5 cells, whereas C5N cells exhibit strictly nuclear localization of HuR. Knockdown experiments in A5 cells showed that when HuR is depleted, ODCRNA becomes less stable, and ODC enzyme activity decreases. Together, these data support the hypothesis that HuR plays a causative role in ODC up-regulation during nonmelanoma skin cancer development by binding to and stabilizing the ODC transcript.	[Nowotarski, Shannon L.; Shantz, Lisa M.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Shantz, LM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Rm C4731,500 Univ Dr, Hershey, PA 17033 USA.	lms17@psu.edu		Shantz, Lisa/0000-0001-8814-4022	National Institutes of Health [CA82768, CA142051]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R03CA142051, R01CA082768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA82768 and CA142051. This work was also supported by the Pennsylvania Department of Health Tobacco CURE Funds.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Atasoy U, 1998, J CELL SCI, V111, P3145; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bailey HH, 2010, CANCER PREV RES, V3, P35, DOI 10.1158/1940-6207.CAPR-09-0096; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; COLEMAN CS, 1998, POLYAMINE PROTOCOLS, V79, P41; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Einspahr JG, 2002, CLIN CANCER RES, V8, P149; Elmets CA, 2010, CANCER PREV RES, V3, P8, DOI 10.1158/1940-6207.CAPR-09-0248; Erkinheimo TL, 2003, CANCER RES, V63, P7591; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Feith DJ, 2001, CANCER RES, V61, P6073; Feith DJ, 2005, CANCER RES, V65, P572; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gilmour SK, 2007, TOXICOL APPL PHARM, V224, P249, DOI 10.1016/j.taap.2006.11.023; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; Koljonen V, 2008, J CUTAN PATHOL, V35, P10, DOI 10.1111/j.1600-0560.2007.00762.x; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mimori K, 1998, INT J ONCOL, V12, P597; OBRIEN TG, 1976, CANCER RES, V36, P2644; OBrien TG, 1997, CANCER RES, V57, P2630; Origanti S, 2007, CANCER RES, V67, P4834, DOI 10.1158/0008-5472.CAN-06-4627; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Shantz LM, 1999, INT J BIOCHEM CELL B, V31, P107, DOI 10.1016/S1357-2725(98)00135-6; Shantz LM, 2004, BIOCHEM J, V377, P257, DOI 10.1042/BJ20030778; Smith MK, 1998, CARCINOGENESIS, V19, P1409, DOI 10.1093/carcin/19.8.1409; Soler AP, 1998, CANCER RES, V58, P1654; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; WALLON UM, 1995, MOL CELL BIOCHEM, V146, P39, DOI 10.1007/BF00926879; Xiao L, 2007, MOL BIOL CELL, V18, P4579, DOI 10.1091/mbc.E07-07-0675; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Zhang J, 2008, MOL CARCINOGEN, V47, P974, DOI 10.1002/mc.20450; Zhao BW, 2001, MOL CARCINOGEN, V32, P92, DOI 10.1002/mc.1068; Zhao BW, 2000, MOL CARCINOGEN, V29, P212, DOI 10.1002/1098-2744(200012)29:4<212::AID-MC1003>3.0.CO;2-0; Zou TT, 2008, BIOCHEM J, V409, P389, DOI 10.1042/BJ20070860; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200; Zoumpourlis V, 2003, CARCINOGENESIS, V24, P1159, DOI 10.1093/carcin/bgg067	56	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31885	31894		10.1074/jbc.M110.148767	http://dx.doi.org/10.1074/jbc.M110.148767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685649	Green Published, hybrid			2022-12-25	WOS:000282764600080
J	Rana, S; Baranski, TJ				Rana, Soumendra; Baranski, Thomas J.			Third Extracellular Loop (EC3)-N Terminus Interaction Is Important for Seven-transmembrane Domain Receptor Function IMPLICATIONS FOR AN ACTIVATION MICROSWITCH REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LIGAND-BINDING SITE; C5A RECEPTOR; CRYSTAL-STRUCTURE; ANGIOTENSIN-II; CHEMOKINE RECEPTOR; CORECEPTOR ACTIVITY; CYSTEINE RESIDUES; HIV-1 CORECEPTOR; DISULFIDE BOND	The canonical heptahelical bundle architecture of seven-transmembrane domain (7TM) receptors is intertwined by three intra- and three extracellular loops, whose local conformations are important in receptor signaling. Many 7TM receptors contain a cysteine residue in the third extracellular loop (EC3) and a complementary cysteine residue on the N terminus. The functional role of such EC3-N terminus conserved cysteine pairs remains unclear. This study explores the role of the EC3-N terminus cysteine pairs on receptor conformation and G protein activation by disrupting them in the chemokine receptor CXCR4, while engineering a novel EC3-N terminus cysteine pair into the complement factor 5a receptor (C5aR), a chemo attractant receptor that lacks it. Mutated CXCR4 and C5aRs were expressed in engineered yeast. Mutation of the cysteine pair with the serine pair (C28S/C274S) in constitutively active mutant CXCR4 abrogated the receptor activation, whereas mutation with the aromatic pair (C28F-C274F) or the salt bridge pair (C28R/C274E), respectively, rescued or retained the receptor activation in response to CXCL12. In this context, the cysteine pair (Cys(30) and Cys(272)) engineered into the EC3-N terminus (Ser(30) and Ser(272)) of a novel constitutively active mutant of C5aR restrained the constitutive signaling without affecting the C5a-induced activation. Further mutational studies demonstrated a previously unappreciated role for Ser(272) on EC3 of C5aR and its interaction with the N terminus, thus defining a new microswitch region within the C5aR. Similar results were obtained with mutated CXCR4 and C5aRs expressed in COS-7 cells. These studies demonstrate a novel role of the EC3-N terminus cysteine pairs in G protein-coupled receptor activation and signaling.	[Rana, Soumendra; Baranski, Thomas J.] Washington Univ, Sch Med, Dept Med, Div Metab Endocrinol & Lipid Res, St Louis, MO 63110 USA	Washington University (WUSTL)	Baranski, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Metab Endocrinol & Lipid Res, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	baranski@wustl.edu		Rana, Soumendra/0000-0003-4878-9066	National Institutes of Health [GM071634, GM071634-03S109]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM071634 and GM071634-03S109 (to T.J.B.).	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Ai LS, 2002, BIOCHEMISTRY-US, V41, P8332, DOI 10.1021/bi025855y; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Berchiche YA, 2007, J BIOL CHEM, V282, P5111, DOI 10.1074/jbc.C600270200; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Buck E, 2005, J BIOL CHEM, V280, P4009, DOI 10.1074/jbc.C400500200; Cain SA, 2003, BIOCHEM PHARMACOL, V66, P1833, DOI 10.1016/S0006-2952(03)00473-8; Cain SA, 2001, BIOCHEMISTRY-US, V40, P14047, DOI 10.1021/bi011055w; Chabot DJ, 1999, J VIROL, V73, P6598, DOI 10.1128/JVI.73.8.6598-6609.1999; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Correa SAA, 2006, REGUL PEPTIDES, V134, P132, DOI 10.1016/j.regpep.2006.02.008; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Derksen DJ, 2008, CHEMBIOCHEM, V9, P1898, DOI 10.1002/cbic.200800272; Derksen DJ, 2006, J AM CHEM SOC, V128, P14252, DOI 10.1021/ja066203q; Ding ZR, 2003, BLOOD, V101, P3908, DOI 10.1182/blood-2002-10-3027; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Evans BJ, 2009, METHOD ENZYMOL, V460, P399, DOI 10.1016/S0076-6879(09)05220-3; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Feng YH, 2000, FEBS LETT, V484, P133, DOI 10.1016/S0014-5793(00)02141-4; Fleury Y, 1996, J BIOL CHEM, V271, P14421, DOI 10.1074/jbc.271.24.14421; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gerber BO, 2001, J BIOL CHEM, V276, P3394, DOI 10.1074/jbc.M007748200; Gilchrist A, 2007, TRENDS PHARMACOL SCI, V28, P431, DOI 10.1016/j.tips.2007.06.012; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hagemann IS, 2008, J BIOL CHEM, V283, P7763, DOI 10.1074/jbc.M709467200; Higginbottom A, 2005, J BIOL CHEM, V280, P17831, DOI 10.1074/jbc.M410797200; Hoffmann C, 1999, J BIOL CHEM, V274, P14639, DOI 10.1074/jbc.274.21.14639; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; KOLAKOWSKI LF, 1995, J BIOL CHEM, V270, P18077, DOI 10.1074/jbc.270.30.18077; Kristiansen K, 1996, PROTEINS, V26, P81, DOI 10.1002/(SICI)1097-0134(199609)26:1<81::AID-PROT8>3.0.CO;2-J; Lawson Z, 2004, BIOCHEM SOC T, V32, P1048, DOI 10.1042/BST0321048; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Limatola C, 2005, EXP CELL RES, V307, P65, DOI 10.1016/j.yexcr.2005.02.020; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; MERY L, 1994, J BIOL CHEM, V269, P3457; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Short AJ, 1999, BRIT J PHARMACOL, V128, P511, DOI 10.1038/sj.bjp.0702847; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Torrice MM, 2009, P NATL ACAD SCI USA, V106, P11919, DOI 10.1073/pnas.0903260106; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Vaidehi N, 2002, P NATL ACAD SCI USA, V99, P12622, DOI 10.1073/pnas.122357199; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Visiers I, 2002, METHOD ENZYMOL, V343, P329; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200	65	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31472	31483		10.1074/jbc.M110.129213	http://dx.doi.org/10.1074/jbc.M110.129213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663868	Green Published, hybrid			2022-12-25	WOS:000282764600041
J	Yepuru, M; Eswaraka, J; Kearbey, JD; Barrett, CM; Raghow, S; Veverka, KA; Miller, DD; Dalton, JT; Narayanan, R				Yepuru, Muralimohan; Eswaraka, Jeetendra; Kearbey, Jeffrey D.; Barrett, Christina M.; Raghow, Sharan; Veverka, Karen A.; Miller, Duane D.; Dalton, James T.; Narayanan, Ramesh			Estrogen Receptor-beta-selective Ligands Alleviate High-fat Diet- and Ovariectomy-induced Obesity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; GENE-EXPRESSION; INSULIN-RESISTANCE; ALPHA; ACID; MECHANISMS; TARGET; DRUG; IDENTIFICATION; ANTAGONIST	Obesity is an epidemic problem affecting millions of people in the Western hemisphere and costs the United States economy more than $200 billion annually. Currently, there are no effective treatments to combat obesity. Recent studies have implicated the constitutive activity of estrogen receptor (ER) beta as an important regulator of metabolic diseases. However, the potential of ER-beta-selective ligands to offset obesity is not clear. We evaluated the pharmacological effect of ER-beta-selective ligands (beta-LGNDs) in animal models of high-fat diet-and ovariectomy-induced obesity. Ligand binding, transactivation, and uterotrophic studies with beta-LGNDs demonstrated selectivity for ER-beta over ER-alpha. Animals fed a high-fat diet showed a significant increase in body weight, and this weight gain was attenuated by beta-LGNDs. High-fat diet-mediated increases in serum cholesterol, leptin, glucose, and fat accumulation in organs were also reduced by beta-LGNDs. In addition, MRI scanning indicated that beta-LGNDs altered body composition by reducing fat mass and increasing lean body mass. Organ weights and gene expression analyses demonstrated that adipose tissue is the center of action for beta-LGNDs, and the reduction in body weight is likely due to increased energy expenditure. In vitro and in vivo mechanistic studies indicated that the anti-obesity effects of beta-LGNDs were due to indirect peroxisome proliferator-activated receptor gamma antagonistic actions requiring the ligand binding domain of ER-beta and through abrogation of the ability of PGC-1 to coactivate peroxisome proliferator-activated receptor gamma. In conclusion, these studies indicate that ligand-activated ER-beta is a potential therapeutic target to combat obesity and obesity-related metabolic diseases.	[Yepuru, Muralimohan; Eswaraka, Jeetendra; Kearbey, Jeffrey D.; Barrett, Christina M.; Raghow, Sharan; Veverka, Karen A.; Miller, Duane D.; Dalton, James T.; Narayanan, Ramesh] GTx Inc, Preclin Res & Dev, Memphis, TN 38163 USA		Dalton, JT (corresponding author), GTx Inc, Preclin Res & Dev, 3 North Dunlap, Memphis, TN 38163 USA.	jdalton@gtxinc.com; rnarayanan@gtxinc.com		Dalton, James T/0000-0002-3915-7326				Allende-Vigo MZ, 2008, P R HEALTH SCI J, V27, P190; Andrews ZB, 2010, ENDOCRINOLOGY, V151, P2078, DOI 10.1210/en.2009-0850; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Barros RPA, 2006, TRENDS MOL MED, V12, P425, DOI 10.1016/j.molmed.2006.07.004; Bhat RA, 2004, J STEROID BIOCHEM, V88, P17, DOI 10.1016/j.jsbmb.2003.10.009; Billin AN, 2008, EXPERT OPIN INV DRUG, V17, P1465, DOI [10.1517/13543784.17.10.1465, 10.1517/13543784.17.10.1465 ]; Blackburn GL, 2009, OBESITY, V17, P842, DOI 10.1038/oby.2008.578; Capeau J, 2008, DIABETES METAB, V34, P649, DOI 10.1016/S1262-3636(08)74600-7; Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002; Chang P, 2009, NAT REV DRUG DISCOV, V8, P529, DOI 10.1038/nrd2938; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fabricatore AN, 2006, ANNU REV CLIN PSYCHO, V2, P357, DOI 10.1146/annurev.clinpsy.2.022305.095249; Fan XT, 2006, P NATL ACAD SCI USA, V103, P19338, DOI 10.1073/pnas.0609663103; FLEGAL KM, 2010, L R JAMA, V303, P235; Follettie MT, 2006, ENDOCRINOLOGY, V147, P714, DOI 10.1210/en.2005-0600; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gurevich-Panigrahi T, 2009, CURR MED CHEM, V16, P506, DOI 10.2174/092986709787315568; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hsieh RW, 2006, J BIOL CHEM, V281, P17909, DOI 10.1074/jbc.M513684200; Jezek P, 1998, INT J BIOCHEM CELL B, V30, P1163, DOI 10.1016/S1357-2725(98)00076-4; Jiang JH, 2005, ANTICANCER RES, V25, P4081; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; Kaplan LM, 2010, GASTROENTEROL CLIN N, V39, P69, DOI 10.1016/j.gtc.2010.01.001; Kersten S, 2008, PPAR RES, V2008, DOI 10.1155/2008/132960; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Leite CE, 2009, PHARMACOL REP, V61, P217, DOI 10.1016/S1734-1140(09)70025-8; Liang YQ, 2002, INT J OBESITY, V26, P1103, DOI 10.1038/sj.ijo.0802054; Lim William K, 2007, Recent Pat CNS Drug Discov, V2, P107; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Maeda K, 1997, GENE, V190, P227, DOI 10.1016/S0378-1119(96)00730-5; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Morani A, 2008, J INTERN MED, V264, P128, DOI 10.1111/j.1365-2796.2008.01976.x; Moreira FA, 2009, REV BRAS PSIQUIATR, V31, P145, DOI 10.1590/S1516-44462009000200012; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P409, DOI 10.1016/j.bbadis.2008.09.005; Nakamura T, 2008, TOXICOLOGY, V253, P117, DOI 10.1016/j.tox.2008.09.006; Nakano R, 2006, BIOCHEM PHARMACOL, V72, P42, DOI 10.1016/j.bcp.2006.03.023; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pallottini V., 2008, Infectious Disorders - Drug Targets, V8, P52; Paquette A, 2008, MENOPAUSE, V15, P1169, DOI 10.1097/gme.0b013e31817b8159; Pravettoni A, 2007, MOL CELL ENDOCRINOL, V263, P46, DOI 10.1016/j.mce.2006.08.008; Quintao ECR, 2010, ATHEROSCLEROSIS, V209, P1, DOI 10.1016/j.atherosclerosis.2009.08.002; Reisin E, 2009, MED CLIN N AM, V93, P733, DOI 10.1016/j.mcna.2009.02.010; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Rother E, 2009, DEUT MED WOCHENSCHR, V134, P1057, DOI 10.1055/s-0029-1222567; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Shin ES, 2007, J NUTR, V137, P1127, DOI 10.1093/jn/137.5.1127; Stevenson Julian, 2009, Biochem J, V420, pe1, DOI 10.1042/BJ20090445; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang YF, 2010, BIOCHEM PHARMACOL, V80, P80, DOI 10.1016/j.bcp.2010.03.013; Yu R, 2009, FORUM NUTR, V61, P95, DOI 10.1159/000212742; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	72	89	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31292	31303		10.1074/jbc.M110.147850	http://dx.doi.org/10.1074/jbc.M110.147850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20657011	Green Published, hybrid			2022-12-25	WOS:000282764600024
J	Ma, Z; Liu, Z; Wu, RF; Terada, LS				Ma, Z.; Liu, Z.; Wu, R-F; Terada, L. S.			p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior	ONCOGENE			English	Article						anoikis; Shc; pRB; metastasis; small cell lung cancer	PAPILLOMAVIRUS TYPE-16 E7; CELL-CYCLE; RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; K-RAS; ACTIVATION; ANOIKIS; KINASE; PATHWAY; DIFFERENTIATION	Normal tissue cells survive and proliferate only while anchored to solid substrate. Conversely, transformed cells both survive and proliferate following detachment, having lost attachment context through unclear mechanisms. p66(Shc) is a focal adhesion-associated protein that reports cell attachment through a RhoA-dependent mechanosensory test. We find that human small cell lung cancer (SCLC) cells and mouse Lewis lung carcinoma (LLC), which display aggressive metastatic behavior, lack both p66(Shc) and retinoblastoma (pRB) and bypass anoikis. Re-expression of p66(Shc) in these cells restores anoikis and provides striking protection from metastasis by LLC cells in vivo. Notably, knockdown of p66(Shc) in normal epithelial cells leads to unrestrained Ras activation, preventing anoikis through downstream suppression of RhoA but blocking proliferation in a pRB-dependent manner, thus mimicking oncogenic Ras. Conversely, LLC and SCLC cells display constitutive Ras activation necessary to bypass anoikis, which is reversed by re-expression of p66(Shc). p66(Shc) therefore coordinates Ras-dependent control of proliferation and anchorage sensation, which can be defeated in the evolution of highly metastatic tumors by combined loss of both p66(Shc) and pRB. Oncogene (2010) 29, 5559-5567; doi:10.1038/onc.2010.326; published online 2 August 2010	[Ma, Z.; Liu, Z.; Wu, R-F; Terada, L. S.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Pulm & Crit Care, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Terada, LS (corresponding author), Univ Texas SW, Dept Internal Med, 5323 Harry Hines Blvd,MC 8558, Dallas, TX 75390 USA.	Lance.Terada@utsouthwestern.edu		Terada, Lance/0000-0001-7441-9734	NHLBI [R01-HL067256, R01-HL061897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061897, R01HL067256] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Dr John Shelton for assistance with histology and Drs Ralph P Mason and Li Liu for technical support with in vivo GFP imaging. This work was supported by grants to LST by the NHLBI (R01-HL067256 and R01-HL061897).	Attwell S, 2000, ONCOGENE, V19, P3811, DOI 10.1038/sj.onc.1203711; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Grignani F, 1998, CANCER RES, V58, P14; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Ma Z, 2007, J CELL BIOL, V179, P23, DOI 10.1083/jcb.200706097; MABRY M, 1988, P NATL ACAD SCI USA, V85, P6523, DOI 10.1073/pnas.85.17.6523; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Mittnacht S, 1997, CURR BIOL, V7, P219, DOI 10.1016/S0960-9822(97)70094-0; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Takahashi C, 2006, NAT GENET, V38, P118, DOI 10.1038/ng1703; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Wu RF, 2007, J BIOL CHEM, V282, P37412, DOI 10.1074/jbc.M704481200	26	43	46	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	41					5559	5567		10.1038/onc.2010.326	http://dx.doi.org/10.1038/onc.2010.326			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FX	20676142	Green Accepted			2022-12-25	WOS:000282946900003
J	Oram, SH; Thoms, JAI; Pridans, C; Janes, ME; Kinston, SJ; Anand, S; Landry, JR; Lock, RB; Jayaraman, PS; Huntly, BJ; Pimanda, JE; Gottgens, B				Oram, S. H.; Thoms, J. A. I.; Pridans, C.; Janes, M. E.; Kinston, S. J.; Anand, S.; Landry, J-R; Lock, R. B.; Jayaraman, P-S; Huntly, B. J.; Pimanda, J. E.; Goettgens, B.			A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients	ONCOGENE			English	Article						LMO2; leukaemia; transcriptional regulation; human; ChIP-on-chip; chromatin immunoprecipitation	LIM-PROTEIN RBTN2; GENE-THERAPY; CELL LEUKEMIA; ETS; ONCOGENE; DOMAIN; ERG; ELEMENTS; SCL; TRANSLOCATIONS	The T-cell oncogene Lim-only 2 (LMO2) critically influences both normal and malignant haematopoiesis. LMO2 is not normally expressed in T cells, yet ectopic expression is seen in the majority of T-acute lymphoblastic leukaemia (T-ALL) patients with specific translocations involving LMO2 in only a subset of these patients. Ectopic lmo2 expression in thymocytes of transgenic mice causes T-ALL, and retroviral vector integration into the LMO2 locus was implicated in the development of clonal T-cell disease in patients undergoing gene therapy. Using array-based chromatin immunoprecipitation, we now demonstrate that in contrast to B-acute lymphoblastic leukaemia, human T-ALL samples largely use promoter elements with little influence from distal enhancers. Active LMO2 promoter elements in T-ALL included a previously unrecognized third promoter, which we demonstrate to be active in cell lines, primary T-ALL patients and transgenic mice. The ETS factors ERG and FLI1 previously implicated in lmo2-dependent mouse models of T-ALL bind to the novel LMO2 promoter in human T-ALL samples, while in return LMO2 binds to blood stem/progenitor enhancers in the FLI1 and ERG gene loci. Moreover, LMO2, ERG and FLI1 all regulate the +1 enhancer of HHEX/PRH, which was recently implicated as a key mediator of early progenitor expansion in LMO2-driven T-ALL. Our data therefore suggest that a self-sustaining triad of LMO2/ERG/FLI1 stabilizes the expression of important mediators of the leukaemic phenotype such as HHEX/PRH. Oncogene (2010) 29, 5796-5808; doi: 10.1038/onc.2010.320; published online 2 August 2010	[Oram, S. H.; Pridans, C.; Kinston, S. J.; Anand, S.; Huntly, B. J.; Goettgens, B.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Thoms, J. A. I.; Janes, M. E.; Pimanda, J. E.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Thoms, J. A. I.; Janes, M. E.; Pimanda, J. E.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Landry, J-R] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Lock, R. B.] Univ New S Wales, Childrens Canc Inst Australia, Sydney, NSW, Australia; [Jayaraman, P-S] Univ Birmingham, Birmingham Univ Stem Cell Ctr, Birmingham, W Midlands, England	University of Cambridge; University of New South Wales Sydney; University of New South Wales Sydney; Universite de Montreal; Children's Cancer Institute; University of New South Wales Sydney; University of Birmingham	Gottgens, B (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	BG200@CAM.AC.UK	Thoms, Julie/H-6123-2019; Lock, Richard/G-4253-2013; huntly, brian JP/E-6725-2014; Pridans, Clare/AAF-9953-2020	Thoms, Julie/0000-0002-4876-7230; huntly, brian JP/0000-0003-0312-161X; Pridans, Clare/0000-0001-9423-557X; Lock, Richard/0000-0002-3436-9071; Gottgens, Berthold/0000-0001-6302-5705; /0000-0002-6500-9095	Kay Kendall Leukaemia Fund; Medical Research Council; Cancer Research UK; National Health and Research Council of Australia; National Institute for Health Research Cambridge Biomedical Research Centre; Leukaemia and Lymphoma Research UK; MRC [G0800784, G116/187] Funding Source: UKRI; Medical Research Council [G116/187, G0800784, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	Kay Kendall Leukaemia Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Health and Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Leukaemia and Lymphoma Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	We thank the Kay Kendall Leukaemia Fund, Medical Research Council, Cancer Research UK, National Health and Research Council of Australia, the National Institute for Health Research Cambridge Biomedical Research Centre and Leukaemia and Lymphoma Research UK for grant funding. We are grateful to Michelle Hammet and Tina Hamilton for assistance with pronuclear microinjections and to Professor Sally Kinsey, Leeds Teaching Hospitals, for assistance with sourcing patient material.	Appert A, 2009, CANCER RES, V69, P4784, DOI 10.1158/0008-5472.CAN-08-4774; Asnafi V, 2004, BLOOD, V104, P4173, DOI 10.1182/blood-2003-11-3944; Baldus CD, 2007, J CLIN ONCOL, V25, P3739, DOI 10.1200/JCO.2007.11.5253; Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Bohne A, 2009, LEUKEMIA RES, V33, P817, DOI 10.1016/j.leukres.2008.11.012; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; Crable SC, 2003, BLOOD, V101, P4757, DOI 10.1182/blood-2002-09-2702; CRIST WM, 1993, STEM CELLS, V11, P81, DOI 10.1002/stem.5530110202; Dave UP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000491; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Ferrando AA, 2004, BLOOD, V103, P1909, DOI 10.1182/blood-2003-07-2577; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; Garand R, 1993, Recent Results Cancer Res, V131, P283; Gottgens B, 2004, MOL CELL BIOL, V24, P1870, DOI 10.1128/MCB.24.5.1870-1883.2004; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hammond SM, 2005, LEUKEMIA RES, V29, P89, DOI 10.1016/j.leukres.2004.05.013; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Huang XL, 2006, BLOOD, V107, P3153, DOI 10.1182/blood-2005-08-3206; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kruse EA, 2009, P NATL ACAD SCI USA, V106, P13814, DOI 10.1073/pnas.0906556106; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Landry JR, 2005, BLOOD, V106, P2680, DOI 10.1182/blood-2004-12-4755; LARSON RC, 1995, ONCOGENE, V11, P853; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Rabbitts T. H., 1997, Leukemia (Basingstoke), V11, P271; RAIMONDI SC, 2007, ATLAS GENET CYTOGENE, V11, P69; ROYERPOKORA B, 1995, ONCOGENE, V10, P1353; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Valge-Archer V, 1998, ONCOGENE, V17, P3199, DOI 10.1038/sj.onc.1202353; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	46	32	35	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	43					5796	5808		10.1038/onc.2010.320	http://dx.doi.org/10.1038/onc.2010.320			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20676125	Green Published			2022-12-25	WOS:000283586200005
J	Petrova, V; Satyshur, KA; George, NP; McCaslin, D; Cox, MM; Keck, JL				Petrova, Vessela; Satyshur, Kenneth A.; George, Nicholas P.; McCaslin, Darrell; Cox, Michael M.; Keck, James L.			X-ray Crystal Structure of the Bacterial Conjugation Factor PsiB, a Negative Regulator of RecA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-SEX FACTOR; ESCHERICHIA-COLI; SOS INHIBITOR; PROTEIN; DNA; INDUCTION; ACTIN; MODEL; CAPZ; RECIPIENT	During bacterial conjugation, genetic material from one cell is transferred to another as single-stranded DNA. The introduction of single-stranded DNA into the recipient cell would ordinarily trigger a potentially deleterious transcriptional response called SOS, which is initiated by RecA protein filaments formed on the DNA. During F plasmid conjugation, however, the SOS response is suppressed by PsiB, an F-plasmid-encoded protein that binds and sequesters free RecA to prevent filament formation. Among the many characterized RecA modulator proteins, PsiB is unique in using sequestration as an inhibitory mechanism. We describe the crystal structure of PsiB from the Escherichia coli F plasmid. The stucture of PsiB is surprisingly similar to CapZ, a eukaryotic actin filament capping protein. Structure-directed neutralization of electronegative surfaces on PsiB abrogates RecA inhibition whereas neutralization of an electropositive surface element enhances PsiB inhibition of RecA. Together, these studies provide a first molecular view of PsiB and highlight its use as a reagent in studies of RecA activity.	[Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Med Sci Ctr 550, Madison, WI 53706 USA; [McCaslin, Darrell; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Med Sci Ctr 550, 1300 Univ Ave, Madison, WI 53706 USA.	jlkeck@wisc.edu		Satyshur, Kenneth/0000-0001-9371-2493; Keck, James/0000-0002-5961-0220	National Institutes of Health [GM32335, GM068061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068061, U01GM032335, R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32335 (to M.M.C.) and GM068061 (to J.L.K.).	Althorpe NJ, 1999, MOL MICROBIOL, V31, P133, DOI 10.1046/j.1365-2958.1999.01153.x; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; BAGDASARIAN M, 1986, P NATL ACAD SCI USA, V83, P5723, DOI 10.1073/pnas.83.15.5723; BAGDASARIAN M, 1992, MOL MICROBIOL, V6, P885, DOI 10.1111/j.1365-2958.1992.tb01539.x; BAGDASARIAN M, 1980, J BACTERIOL, V141, P464, DOI 10.1128/JB.141.2.464-469.1980; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Courcelle J, 2001, GENETICS, V158, P41; Cox M.M., 2007, TOPICS CURRENT GENET, P53; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; GOLUB E, 1988, J BACTERIOL, V170, P4392, DOI 10.1128/jb.170.9.4392-4394.1988; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; HUG C, 1992, J CELL BIOL, V116, P923, DOI 10.1083/jcb.116.4.923; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laue TM, 1995, METHOD ENZYMOL, V259, P427; LEDERBERG J, 1953, SCIENCE, V118, P169, DOI 10.1126/science.118.3059.169; LINDSLEY JE, 1989, J MOL BIOL, V205, P695, DOI 10.1016/0022-2836(89)90315-X; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Narra HP, 2006, CURR BIOL, V16, pR705, DOI 10.1016/j.cub.2006.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; PHIZICKY EM, 1981, CELL, V25, P259, DOI 10.1016/0092-8674(81)90251-8; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Voloshin ON, 2001, GENE DEV, V15, P415, DOI 10.1101/gad.862901; Wigle TJ, 2009, J BIOMOL SCREEN, V14, P1092, DOI 10.1177/1087057109342126; WILLETTS N, 1987, ESCHERICHIA COLI SAL, P1110; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167	41	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30615	30621		10.1074/jbc.M110.152298	http://dx.doi.org/10.1074/jbc.M110.152298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659894	hybrid, Green Published			2022-12-25	WOS:000282135500030
J	Beagle, B; Johnson, GVW				Beagle, Brandon; Johnson, Gail V. W.			Differential Modulation of TCF/LEF-1 Activity by the Soluble LRP6-ICD	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; AMINO-TERMINAL ENHANCER; BETA-CATENIN PATHWAY; TRANSCRIPTIONAL REPRESSION; MEDIATED TRANSCRIPTION; WNT CORECEPTOR; GENE FAMILY; INTRACELLULAR DOMAIN; SIGNALING PATHWAY; GAMMA-SECRETASE	The canonical Wnt/beta-catenin (Wnt) pathway is a master transcriptional regulatory signaling pathway that controls numerous biological processes including proliferation and differentiation. As such, transcriptional activity of the Wnt pathway is tightly regulated and/or modulated by numerous proteins at the level of the membrane, cytosol and/or nucleus. In the nucleus, transcription of Wnt target genes by TCF/LEF-1 is repressed by the long Groucho/TLE co-repressor family. However, a truncated member of the Groucho/TLE family, amino terminal enhancer of Split (AES) can positively modulate TCF/LEF-1 activity by antagonizing long Groucho/TLE members in a dominant negative manner. We have previously shown the soluble intracellular domain of the LRP6 receptor, a receptor required for activation of the Wnt pathway, can positively regulate transcriptional activity within the Wnt pathway. In the current study, we show the soluble LRP6 intracellular domain (LRP6-ICD) can also translocate to the nucleus in CHO and HEK 293T cells and in contrast to cytosolic LRP6-ICD; nuclear LRP6-ICD represses TCF/LEF-1 activity. In agreement with previous reports, we show AES enhances TCF/LEF-1 mediated reporter transcription and further we demonstrate that AES activity is spatially regulated in HEK 293T cells. LRP6-ICD interacts with AES exclusively in the nucleus and represses AES mediated TCF/LEF-1 reporter transcription. These results suggest that LRP6-ICD can differentially modulate Wnt pathway transcriptional activity depending upon its subcellular localization and differential protein-protein interactions.	[Beagle, Brandon; Johnson, Gail V. W.] Univ Rochester, Dept Anesthesiol, Rochester, NY 14627 USA; [Beagle, Brandon; Johnson, Gail V. W.] Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA; [Beagle, Brandon; Johnson, Gail V. W.] Univ Rochester, Dept Physiol, Rochester, NY 14642 USA; [Beagle, Brandon; Johnson, Gail V. W.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Rochester; University of Rochester; University of Rochester; University of Alabama System; University of Alabama Birmingham	Beagle, B (corresponding author), Univ Rochester, Dept Anesthesiol, Rochester, NY 14627 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	National Institutes of Health [F31 AG030788]; NATIONAL INSTITUTE ON AGING [F31AG030788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health; Contract grant number: F31 AG030788. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Bajoghli B, 2007, DEV GENES EVOL, V217, P613, DOI 10.1007/s00427-007-0167-y; Bardwell L, 2008, CURR BIOL, V18, pR910, DOI 10.1016/j.cub.2008.07.082; Beagle B, 2009, J CELL BIOCHEM, V108, P886, DOI 10.1002/jcb.22318; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Courey AJ, 2001, GENE DEV, V15, P2786; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Katayama R, 2010, J CELL SCI, V123, P23, DOI 10.1242/jcs.058602; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Kinoshita A, 2002, J NEUROCHEM, V82, P839, DOI 10.1046/j.1471-4159.2002.01016.x; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Landman N, 2004, CYTOKINE GROWTH F R, V15, P337, DOI 10.1016/j.cytogfr.2004.04.001; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Louie SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004310; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MALLO M, 1995, DEV DYNAM, V204, P338, DOI 10.1002/aja.1002040311; Mallo M, 1995, CELL MOL BIOL RES, V41, P435; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Mi KH, 2007, J NEUROCHEM, V101, P517, DOI 10.1111/j.1471-4159.2007.04447.x; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Milakovic T, 2004, J BIOL CHEM, V279, P8715, DOI 10.1074/jbc.M308479200; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Rave-Harel N, 2005, J BIOL CHEM, V280, P30975, DOI 10.1074/jbc.M502315200; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; SAKAI T, MOL BIOL EVOL, V27, P1097; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tago K, 2000, GENE DEV, V14, P1741; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Tezuka N, 2007, BIOCHEM BIOPH RES CO, V356, P648, DOI 10.1016/j.bbrc.2007.03.019; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yokomizo T, 2008, GENE DEV, V22, P960, DOI 10.1101/gad.1669908; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhao JS, 2009, TRENDS BIOTECHNOL, V27, P131, DOI 10.1016/j.tibtech.2008.11.007	60	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11821	10.1371/journal.pone.0011821	http://dx.doi.org/10.1371/journal.pone.0011821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676368	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520100008
J	Delhanty, PJD; Sun, YX; Visser, JA; van Kerkwijk, A; Huisman, M; van IJcken, WFJ; Swagemakers, S; Smith, RG; Themmen, APN; van der Lely, AJ				Delhanty, Patric J. D.; Sun, Yuxiang; Visser, Jenny A.; van Kerkwijk, Anke; Huisman, Martin; van IJcken, Wilfred F. J.; Swagemakers, Sigrid; Smith, Roy G.; Themmen, Axel P. N.; van der Lely, Aart-Jan			Unacylated Ghrelin Rapidly Modulates Lipogenic and Insulin Signaling Pathway Gene Expression in Metabolically Active Tissues of GHSR Deleted Mice	PLOS ONE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; DES-ACYL GHRELIN; GLUCOSE-UPTAKE; ENDOTHELIAL LIPASE; LIPID-METABOLISM; DESACYL GHRELIN; SKELETAL-MUSCLE; ADIPOCYTES; SENSITIVITY; OBESITY	Background: There is increasing evidence that unacylated ghrelin (UAG) improves insulin sensitivity and glucose homeostasis; however, the mechanism for this activity is not fully understood since a UAG receptor has not been discovered. Methodology/Principal Findings: To assess potential mechanisms of UAG action in vivo, we examined rapid effects of UAG on genome-wide expression patterns in fat, muscle and liver of growth hormone secretagogue receptor (GHSR)-ablated mice using microarrays. Expression data were analyzed using Ingenuity Pathways Analysis and Gene Set Enrichment Analysis. Regulation of subsets of these genes was verified by quantitative PCR in an independent experiment. UAG acutely regulated clusters of genes involved in glucose and lipid metabolism in all three tissues, consistent with enhancement of insulin sensitivity. Conclusions/Significance: Fat, muscle and liver are central to the control of lipid and glucose homeostasis. UAG rapidly modulates the expression of metabolically important genes in these tissues in GHSR-deleted mice indicating a direct, GHSR-independent, action of UAG to improve insulin sensitivity and metabolic profile.	[Delhanty, Patric J. D.; Visser, Jenny A.; van Kerkwijk, Anke; Huisman, Martin; Themmen, Axel P. N.; van der Lely, Aart-Jan] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Swagemakers, Sigrid] Erasmus MC, Ctr Bioinformat, Rotterdam, Netherlands; [Swagemakers, Sigrid] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Sun, Yuxiang] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Sun, Yuxiang] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Smith, Roy G.] Scripps Res Inst Florida, Dept Metab & Aging, Jupiter, FL USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Baylor University; United States Department of Agriculture (USDA); Baylor College of Medicine; Scripps Research Institute	Delhanty, PJD (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	p.delhanty@erasmusmc.nl	Visser, Jenny A./F-8156-2011; van ijcken, willem/N-9805-2018	van ijcken, willem/0000-0002-0421-8301	ZonMW, The Netherlands [91203022]; Alize Pharma SAS, Lyon, France; NATIONAL INSTITUTE ON AGING [R01AG019230] Funding Source: NIH RePORTER	ZonMW, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Alize Pharma SAS, Lyon, France; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Financial support for the study was provided by a Programme Grant from ZonMW, The Netherlands (#91203022) and Alize Pharma SAS, Lyon, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Andrews ZB, 2010, ENDOCRINOLOGY, V151, P2078, DOI 10.1210/en.2009-0850; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; BROGLIO F, 2007, 89 END SOC M TOR, P89; Davies JS, 2009, MOL ENDOCRINOL, V23, P914, DOI 10.1210/me.2008-0432; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; Derosa G, 2008, ENDOTHELIUM-J ENDOTH, V15, P219, DOI 10.1080/10623320802228815; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Florian M, 2010, ENDOCRINOLOGY, V151, P482, DOI 10.1210/en.2009-0624; Gauna C, 2004, J CLIN ENDOCR METAB, V89, P5035, DOI 10.1210/jc.2004-0363; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Granata R, 2010, J MOL ENDOCRINOL, V45, P9, DOI 10.1677/JME-09-0141; Greco AV, 2002, DIABETES, V51, P144, DOI 10.2337/diabetes.51.1.144; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Heijboer AC, 2006, DIABETOLOGIA, V49, P732, DOI 10.1007/s00125-006-0138-2; Herrema H, 2008, HEPATOLOGY, V47, P1894, DOI 10.1002/hep.22284; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inhoff T, 2008, PEPTIDES, V29, P2159, DOI 10.1016/j.peptides.2008.09.014; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lamarche B, 2007, CURR OPIN LIPIDOL, V18, P298, DOI 10.1097/MOL.0b013e328133857f; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; Lee ES, 2008, REGUL PEPTIDES, V151, P71, DOI 10.1016/j.regpep.2008.05.001; Li Y, 2008, J BIOL CHEM, V283, P9168, DOI 10.1074/jbc.M800104200; Liu JH, 2008, J CLIN ENDOCR METAB, V93, P1980, DOI 10.1210/jc.2007-2235; Mano-Otagiri A, 2009, J ENDOCRINOL, V201, P341, DOI 10.1677/JOE-08-0374; Muccioli G, 2004, EUR J PHARMACOL, V498, P27, DOI 10.1016/j.ejphar.2004.07.066; Palmer DG, 2002, BIOCHEM BIOPH RES CO, V291, P439, DOI 10.1006/bbrc.2002.6467; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Qiu GS, 2009, ARTERIOSCL THROM VAS, V29, P84, DOI 10.1161/ATVBAHA.108.176487; Ross DA, 2006, MOL ENDOCRINOL, V20, P698, DOI 10.1210/me.2005-0325; Sangiao-Alvarellos S, 2009, ENDOCRINOLOGY, V150, P4562, DOI 10.1210/en.2009-0482; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Scroyen I, 2009, THROMB HAEMOSTASIS, V101, P388, DOI 10.1160/TH08-06-0401; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Venugopal J, 2007, J CELL BIOCHEM, V101, P369, DOI 10.1002/jcb.21173; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang WZ, 2008, ENDOCRINOLOGY, V149, P4710, DOI 10.1210/en.2008-0263; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	57	92	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11749	10.1371/journal.pone.0011749	http://dx.doi.org/10.1371/journal.pone.0011749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668691	Green Published, Green Submitted, gold			2022-12-25	WOS:000280297300003
J	Higgs, R; Lazzari, E; Wynne, C; Gabhann, JN; Espinosa, A; Wahren-Herlenius, M; Jefferies, CA				Higgs, Rowan; Lazzari, Elisa; Wynne, Claire; Gabhann, Joan Ni; Espinosa, Alexander; Wahren-Herlenius, Marie; Jefferies, Caroline A.			Self Protection from Anti-Viral Responses-Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors	PLOS ONE			English	Article							INTERFERON-ALPHA INDUCTION; IFN REGULATORY FACTOR-3; INNATE IMMUNE-RESPONSE; TRIM FAMILY PROTEINS; I INTERFERON; GENE-EXPRESSION; MEDIATED DEGRADATION; AUTOANTIGEN RO52; E3 LIGASE; UBIQUITINATION	Ro52 is a member of the TRIM family of single-protein E3 ligases and is also a target for autoantibody production in systemic lupus erythematosus and Sjogren's syndrome. We previously demonstrated a novel function of Ro52 in the ubiquitination and proteasomal degradation of IRF3 following TLR3/4 stimulation. We now present evidence that Ro52 has a similar role in regulating the stability and activity of IRF7. Endogenous immunoprecipitation of Ro52-bound proteins revealed that IRF7 associates with Ro52, an effect which increases following TLR7 and TLR9 stimulation, suggesting that Ro52 interacts with IRF7 post-pathogen recognition. Furthermore, we show that Ro52 ubiquitinates IRF7 in a dose-dependent manner, resulting in a decrease in total IRF7 expression and a subsequent decrease in IFN-alpha production. IRF7 stability was increased in bone marrow-derived macrophages from Ro52-deficient mice stimulated with imiquimod or CpG-B, consistent with a role for Ro52 in the negative regulation of IRF7 signalling. Taken together, these results suggest that Ro52-mediated ubiquitination promotes the degradation of IRF7 following TLR7 and TLR9 stimulation. As Ro52 is known to be IFN-inducible, this system constitutes a negative-feedback loop that acts to protect the host from the prolonged activation of the immune response.	[Higgs, Rowan; Lazzari, Elisa; Wynne, Claire; Gabhann, Joan Ni; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut & RSCI Res Inst, Dublin 2, Ireland; [Espinosa, Alexander; Wahren-Herlenius, Marie] Karolinska Inst, Dept Med, Stockholm, Sweden	Royal College of Surgeons - Ireland; Karolinska Institutet	Higgs, R (corresponding author), Royal Coll Surgeons Ireland, Mol & Cellular Therapeut & RSCI Res Inst, Dublin 2, Ireland.	cjefferies@rcsi.ie	Lazzari, Elisa/K-7804-2016; Lazzari, Elisa/O-6394-2019; Jefferies, Caroline/AAI-1543-2021; Wahren-Herlenius, Marie/AAN-6942-2021; Lazzari, Elisa/AAE-6437-2019	Lazzari, Elisa/0000-0001-5299-7525; Lazzari, Elisa/0000-0001-5299-7525; Jefferies, Caroline/0000-0002-8879-6722; Wahren-Herlenius, Marie/0000-0002-0915-7245; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952; Wynne, Claire/0000-0002-0481-8366	Science Foundation Ireland [05/PICA/B815, 08/IN.1/B2091]; Health Research Board (HRB) in Ireland [PHD/2007/11, RFP/2006/121]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board (HRB) in Ireland	This work was supported by funding from Science Foundation Ireland (http://www.sfi.ie/home/index.asp) under grant no. 05/PICA/B815 and 08/IN.1/B2091, and from the Health Research Board (HRB) in Ireland (http://www.hrb.ie/) under Grant No PHD/2007/11 and RFP/2006/121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Bolland S, 2009, J EXP MED, V206, P1647, DOI 10.1084/jem.20091507; CHAN EKL, 1991, J CLIN INVEST, V87, P68, DOI 10.1172/JCI115003; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Espinosa A, 2006, J IMMUNOL, V176, P6277, DOI 10.4049/jimmunol.176.10.6277; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122; Saira K, 2007, J VIROL, V81, P3077, DOI 10.1128/JVI.02064-06; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wahren-Herlenius M, 1999, IMMUNOL TODAY, V20, P234, DOI 10.1016/S0167-5699(99)01458-9; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011	33	92	96	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11776	10.1371/journal.pone.0011776	http://dx.doi.org/10.1371/journal.pone.0011776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668674	Green Published, gold, Green Submitted			2022-12-25	WOS:000280297300011
J	Bi, M; Kao, WHL; Boerwinkle, E; Hoogeveen, RC; Rasmussen-Torvik, LJ; Astor, BC; North, KE; Coresh, J; Kottgen, A				Bi, Mark; Kao, Wen Hong Linda; Boerwinkle, Eric; Hoogeveen, Ron C.; Rasmussen-Torvik, Laura J.; Astor, Brad C.; North, Kari E.; Coresh, Josef; Koettgen, Anna			Association of rs780094 in GCKR with Metabolic Traits and Incident Diabetes and Cardiovascular Disease: The ARIC Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; GLUCOKINASE REGULATORY PROTEIN; CORONARY-ARTERY-DISEASE; FASTING PLASMA-GLUCOSE; MIDDLE-AGED ADULTS; C-REACTIVE PROTEIN; ATHEROSCLEROSIS RISK; TRIGLYCERIDE LEVELS; LOCI	Objective: The minor T-allele of rs780094 in the glucokinase regulator gene (GCKR) associates with a number of metabolic traits including higher triglyceride levels and improved glycemic regulation in study populations of mostly European ancestry. Using data from the Atherosclerosis Risk in Communities (ARIC) Study, we sought to replicate these findings, examine them in a large population-based sample of African American study participants, and to investigate independent associations with other metabolic traits in order to determine if variation in GKCR contributes to their observed clustering. In addition, we examined the association of rs780094 with incident diabetes, coronary heart disease (CHD), and stroke over up mean follow-up times of 8, 15, and 15 years, respectively. Research Design and Methods: Race-stratified analyses were conducted among 10,929 white and 3,960 black participants aged 45-64 at baseline assuming an additive genetic model and using linear and logistic regression and Cox proportional hazards models. Results: Previous findings replicated among white participants in multivariable adjusted models: the T-allele of rs780094 was associated with lower fasting glucose (p = 10(-7)) and insulin levels (p = 10(-6)), lower insulin resistance (HOMA-IR, p = 10(-9)), less prevalent diabetes (p = 10(-6)), and higher CRP (p = 10(-8)), 2-h postprandial glucose (OGTT, p = 10(-6)), and triglyceride levels (p = 10(-31)). Moreover, the T-allele was independently associated with higher HDL cholesterol levels (p = 0.022), metabolic syndrome prevalence (p = 0.043), and lower beta-cell function measured as HOMA-B (p = 0.011). Among black participants, the T-allele was associated only with higher triglyceride levels (p = 0.004) and lower insulin levels (p = 0.002) and HOMA-IR (p = 0.013). Prospectively, the T-allele was associated with reduced incidence of diabetes (p = 10(-4)) among white participants, but not with incidence of CHD or stroke. Conclusions: Our findings indicate rs780094 has independent associations with multiple metabolic traits as well as incident diabetes, but not incident CHD or stroke. The magnitude of association between the SNP and most traits was of lower magnitude among African American compared to white participants.	[Bi, Mark] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Kao, Wen Hong Linda; Astor, Brad C.; Coresh, Josef; Koettgen, Anna] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX USA; [Hoogeveen, Ron C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Rasmussen-Torvik, Laura J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Koettgen, Anna] Univ Hosp Freiburg, Div Renal, Freiburg, Germany	University of Nebraska System; University of Nebraska Lincoln; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Freiburg	Bi, M (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	akottgen@jhsph.edu	Kottgen, Anna/D-2920-2012	Rasmussen-Torvik, Laura/0000-0002-0820-7300; Hoogeveen, Ron/0000-0003-2399-4653	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055020, N01HC055018, N01HC055022, N01HC055019, N01HC055016, N01HC055021, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R42HL055018, R41HL055019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; INGELSSON E, 2010, DIABETES; Jaromi L, 2010, J MOL NEUROSCI, V41, P121, DOI 10.1007/s12031-009-9301-9; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; KOZIAN DH, 2010, HORM METAB RES; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; National Heart Lung and Blood Institute, ATH RISK COMM ARIC S; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Perez-Martinez P, 2009, AM J CLIN NUTR, V89, P391, DOI 10.3945/ajcn.2008.26363; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Reynolds K, 2005, AM J MED SCI, V330, P273, DOI 10.1097/00000441-200512000-00004; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; SJOGREN M, 2008, DIABETOLOGIA; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Stark K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007729; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; TAM CH, 2008, DIABETES; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Wang L, 2003, AM J CLIN NUTR, V78, P91; Weissglas-Volkov D, 2010, CIRC-CARDIOVASC GENE, V3, P31, DOI 10.1161/CIRCGENETICS.109.908004; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	41	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11690	10.1371/journal.pone.0011690	http://dx.doi.org/10.1371/journal.pone.0011690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661421	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300005
J	Guo, JY; Ye, GY; Dong, SZ; Liu, SS				Guo, Jian-Yang; Ye, Gong-Yin; Dong, Sheng-Zhang; Liu, Shu-Sheng			An Invasive Whitefly Feeding on a Virus-Infected Plant Increased Its Egg Production and Realized Fecundity	PLOS ONE			English	Article							LEAF CURL-VIRUS; BEMISIA-TABACI HEMIPTERA; GRAIN APHID HOMOPTERA; NON-B-BIOTYPE; TOMATO; TRANSMISSION; BEGOMOVIRUSES; ALEYRODIDAE; ACQUISITION; GEMINIVIRUS	Background: Plant-pathogenic begomoviruses have a complex association with their insect vectors. The interactions of begomoviruses and reproduction of their vectors are poorly understood. Bemisia tabaci is known to transmit many begomoviruses, and the spread of B. tabaci, especially the B and Q 'biotypes', has been accompanied by the epidemics of begomoviruses. One of these identified disease-causing agents was Tomato yellow leaf curl China virus (TYLCCNV). Methodology/Principal Findings: In this study, we compared the egg production and realized fecundity of two 'biotypes' or putative species of the whitefly B. tabaci, including the alien invasive B and the indigenous ZHJ1 from Zhejiang, China, feeding on either healthy or TYLCCNV-infected tobacco plants. The ovary of the whitefly was composed of 12-22 telotrophic ovarioles. According to the morphology of the oocytes and level of yolk content, oocytes in ovarioles were divided into four developmental phases (I-IV). Significantly higher proportion of immature oocytes (phase II, III) and mature oocytes (phase IV) was observed in ovary of females that fed on TYLCCNV-infected tobacco compared to that on healthy plants. Moreover, there was significant increase of eggs laid of B whitefly that fed on TYLCCNV-infected tobacco plants during the early developmental stages. In contrast, the proportion of oocytes of different developmental phases and eggs laid had no significant differences between ZHJ1 whiteflies feeding on TYLCCNV-infected and non-infected host plants. Conclusions/Significance: The invasive B whitefly benefits from feeding on a begomovirus-infected plant through increased egg production and realized fecundity.	[Guo, Jian-Yang; Ye, Gong-Yin; Liu, Shu-Sheng] Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci,Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, Sheng-Zhang] China Jiliang Univ, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; China Jiliang University	Guo, JY (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci,Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	chu@zju.edu.cn	Liu, Shu-Sheng/D-2300-2013	Dong, Shengzhang/0000-0002-8218-4688	National Nature Science Foundation of China [30730061]; National Basic Research Programme of China [2009CB119203]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programme of China(National Basic Research Program of China)	Financial support from the National Nature Science Foundation of China (30730061) (http://www.nsfc.gov.cn/Portal0/default124.htm) and the National Basic Research Programme of China (2009CB119203) (http://www.most.gov.cn/) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Colvin J, 2006, ADV VIRUS RES, V67, P419, DOI 10.1016/S0065-3527(06)67011-5; Colvin J, 2004, PLANT PATHOL, V53, P577, DOI 10.1111/j.0032-0862.2004.01062.x; Costa HS, 1996, ANN ENTOMOL SOC AM, V89, P694, DOI 10.1093/aesa/89.5.694; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Cui XF, 2004, J VIROL, V78, P13966, DOI 10.1128/JVI.78.24.13966-13974.2004; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; FERERES A, 1989, ENVIRON ENTOMOL, V18, P388, DOI 10.1093/ee/18.3.388; GAMEEL O I, 1974, Revue de Zoologie Africaine, V88, P784; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jiu M, 2006, J PHYTOPATHOL, V154, P587, DOI 10.1111/j.1439-0434.2006.01151.x; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Lambiase S, 1997, INT J INSECT MORPHOL, V26, P9, DOI 10.1016/S0020-7322(97)88103-2; Lapidot M, 2001, PHYTOPATHOLOGY, V91, P1209, DOI 10.1094/PHYTO.2001.91.12.1209; LI M, 2010, J PEST MANA IN PRESS, V56, DOI DOI 10.1111/J.1744-7917.2010.01354.X; Li ZH, 2005, PHYTOPATHOLOGY, V95, P902, DOI 10.1094/PHYTO-95-0902; Li Zheng-Xi, 2005, Insect Science, V12, P421, DOI 10.1111/j.1744-7917.2005.00053.x; Liu J, 2009, ANN APPL BIOL, V155, P439, DOI 10.1111/j.1744-7348.2009.00366.x; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mann RS, 2008, FLA ENTOMOL, V91, P249, DOI 10.1653/0015-4040(2008)91[249:POBTHA]2.0.CO;2; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; McKenzie CL, 2002, FLA ENTOMOL, V85, P367, DOI 10.1653/0015-4040(2002)085[0367:EOTMVT]2.0.CO;2; McKenzie CL, 2002, ARCH INSECT BIOCHEM, V49, P203, DOI 10.1002/arch.10020; MEHTA P, 1994, J ECON ENTOMOL, V87, P1291, DOI 10.1093/jee/87.5.1291; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Polston JE, 2008, J INSECT SCI, V8, P39; Pyka-Fosciak G, 2008, INT J DEV BIOL, V52, P259, DOI 10.1387/ijdb.072338gp; QUIROZ C, 1991, J ECON ENTOMOL, V84, P1920, DOI 10.1093/jee/84.6.1920; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Sinisterra XH, 2005, J GEN VIROL, V86, P1525, DOI 10.1099/vir.0.80665-0; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Szklarzewicz T, 2001, PROTOPLASMA, V218, P45, DOI 10.1007/BF01288359; SZKLARZEWICZ T, 2008, ACTA ZOOLOGICA, V90, P123; Tang Q., 2007, DPS DATA PROCESSING; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zang Lian-Sheng, 2005, Acta Entomologica Sinica, V48, P742; ZEIDAN M, 1991, J GEN VIROL, V72, P2607, DOI 10.1099/0022-1317-72-11-2607; Zhou XP, 2003, J GEN VIROL, V84, P237, DOI 10.1099/vir.0.18608-0	48	38	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11713	10.1371/journal.pone.0011713	http://dx.doi.org/10.1371/journal.pone.0011713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20676356	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243300016
J	Von Holle, B; Wei, Y; Nickerson, D				Von Holle, Betsy; Wei, Yun; Nickerson, David			Climatic Variability Leads to Later Seasonal Flowering of Floridian Plants	PLOS ONE			English	Article							PHENOLOGICAL RESPONSE; PERSPECTIVE; SUCCESS	Understanding species responses to global change will help predict shifts in species distributions as well as aid in conservation. Changes in the timing of seasonal activities of organisms over time may be the most responsive and easily observable indicator of environmental changes associated with global climate change. It is unknown how global climate change will affect species distributions and developmental events in subtropical ecosystems or if climate change will differentially favor nonnative species. Contrary to previously observed trends for earlier flowering onset of plant species with increasing spring temperatures from mid and higher latitudes, we document a trend for delayed seasonal flowering among plants in Florida. Additionally, there were few differences in reproductive responses by native and nonnative species to climatic changes. We argue that plants in Florida have different reproductive cues than those from more northern climates. With global change, minimum temperatures have become more variable within the temperate-subtropical zone that occurs across the peninsula and this variation is strongly associated with delayed flowering among Florida plants. Our data suggest that climate change varies by region and season and is not a simple case of species responding to consistently increasing temperatures across the region. Research on climate change impacts need to be extended outside of the heavily studied higher latitudes to include subtropical and tropical systems in order to properly understand the complexity of regional and seasonal differences of climate change on species responses.	[Von Holle, Betsy] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Wei, Yun; Nickerson, David] Univ Cent Florida, Dept Stat, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Von Holle, B (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	vonholle@mail.ucf.edu	Von Holle, Betsy/GZG-5112-2022	Von Holle, Betsy/0000-0002-3116-3027	Invasive Plant Management Section of the Florida Fish and Wildlife Conservation Commission; Office of Research of the University of Central Florida; UCF Department of Biology	Invasive Plant Management Section of the Florida Fish and Wildlife Conservation Commission; Office of Research of the University of Central Florida; UCF Department of Biology	Funding for this research was provided to BVH by the Invasive Plant Management Section of the Florida Fish and Wildlife Conservation Commission, the Office of Research of the University of Central Florida, and research start-up dollars provided by the UCF Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Box EO, 1995, VEGETATIO, V121, P101, DOI 10.1007/BF00044676; Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x; *CTR FC, 2008, MONTHL TEMP PREC DAT; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; ESTRELLA N, 2009, COMMUNICATION; *FLEPPC, 2007, WILDLAND WEEDS, V10; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Miller-Rushing AJ, 2006, AM J BOT, V93, P1667, DOI 10.3732/ajb.93.11.1667; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; NOAA Satellite and Information Service N, 2009, STAT CLIM GLOB AN AN; Otto S, 2007, WEED RES, V47, P488, DOI 10.1111/j.1365-3180.2007.00594.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Primack D, 2004, AM J BOT, V91, P1260, DOI 10.3732/ajb.91.8.1260; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Rencher AC, 2002, METHODS MULTIVARIATE; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schmitz DC, 2007, NAT AREA J, V27, P251, DOI 10.3375/0885-8608(2007)27[251:FIPRHP]2.0.CO;2; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; VINOD HD, 1973, COMMUN STAT, V2, P115, DOI DOI 10.1080/03610927308827060; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, FOLIA GEOBOT, V37, P129, DOI 10.1007/BF02803195; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARD DB, 1990, PALMETTO, V89, P3; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wunderlin R.P., 2003, GUIDE VASCULAR PLANT	31	28	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11500	10.1371/journal.pone.0011500	http://dx.doi.org/10.1371/journal.pone.0011500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657765	Green Published, gold			2022-12-25	WOS:000280197500003
J	Demorest, ZL; MacDuff, DA; Brown, WL; Morham, SG; Parise, LV; Harris, RS				Demorest, Zachary L.; MacDuff, Donna A.; Brown, William L.; Morham, Scott G.; Parise, Leslie V.; Harris, Reuben S.			The Interaction between AID and CIB1 Is Nonessential for Antibody Gene Diversification by Gene Conversion or Class Switch Recombination	PLOS ONE			English	Article							ACTIVATION-INDUCED DEAMINASE; INDUCED CYTIDINE DEAMINASE; KINASE-A PHOSPHORYLATION; NF-KAPPA-B; SOMATIC HYPERMUTATION; LENTIVIRAL VECTOR; STRESS GRANULES; URACIL EXCISION; NUCLEAR-EXPORT; EDITING ENZYME	Activation-induced deaminase (AID) initiates somatic hypermutation, gene conversion and class switch recombination by deaminating variable and switch region DNA cytidines to uridines. AID is predominantly cytoplasmic and must enter the nuclear compartment to initiate these distinct antibody gene diversification reactions. Nuclear AID is relatively short-lived, as it is efficiently exported by a CRM1-dependent mechanism and it is susceptible to proteasome-dependent degradation. To help shed light on mechanisms of post-translational regulation, a yeast-based screen was performed to identify AID-interacting proteins. The calcium and integrin binding protein CIB1 was identified by sequencing and the interaction was confirmed by immunoprecipitation experiments. The AID/CIB1 resisted DNase and RNase treatment, and it is therefore unlikely to be mediated by nucleic acid. The requirement for CIB1 in AID-mediated antibody gene diversification reactions was assessed in CIB1-deficient DT40 cells and in knockout mice, but immunoglobulin gene conversion and class switch recombination appeared normal. The DT40 system was also used to show that CIB1 over-expression has no effect on gene conversion and that AID-EGFP subcellular localization is normal. These combined data demonstrate that CIB1 is not required for AID to mediate antibody gene diversification processes. It remains possible that CIB1 has an alternative, a redundant or a subtle non-limiting regulatory role in AID biology.	[Demorest, Zachary L.; MacDuff, Donna A.; Brown, William L.; Harris, Reuben S.] Univ Minnesota, Beckman Ctr Genome Engn, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Morham, Scott G.] Myriad Pharmaceut, Salt Lake City, UT USA; [Parise, Leslie V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill	Demorest, ZL (corresponding author), Univ Minnesota, Beckman Ctr Genome Engn, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu	MacDuff, Donna/AAD-2786-2019; Brown, William/GXN-2777-2022	MacDuff, Donna/0000-0002-6183-6827; 	National Institutes of Health [GM090437, 2-P01-HL45100]; University of Minnesota; Doctoral Dissertation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); Doctoral Dissertation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, GM090437 (to RSH) and 2-P01-HL45100 (to LVP) and, in part, by a University of Minnesota Leukemia Research Fund Grant (to RSH) and a Doctoral Dissertation Fellowship (to DAM). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SM is an employee of Myriad Pharmaceuticals, Inc., ProNet Division and this funder had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bai Y, 2003, GENE THER, V10, P1446, DOI 10.1038/sj.gt.3302026; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Bhutani N., 2009, NATURE; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chatterji M, 2007, J IMMUNOL, V179, P5274, DOI 10.4049/jimmunol.179.8.5274; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; CHIU S, 2005, TAIWAN J ANTHR, V3, P1; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; DeNofrio JC, 2008, THROMB HAEMOSTASIS, V100, P847, DOI 10.1160/TH08-06-0351; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Gourzi P, 2007, J EXP MED, V204, P259, DOI 10.1084/jem.20061801; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; MacDuff DA, 2006, MOL IMMUNOL, V43, P1099, DOI 10.1016/j.molimm.2005.07.024; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NAIK MU, 2010, INT J CANC IN PRESS; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; POPP C, NATURE; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934; Xu KL, 2001, MOL THER, V3, P97, DOI 10.1006/mthe.2000.0238; Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06	53	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11660	10.1371/journal.pone.0011660	http://dx.doi.org/10.1371/journal.pone.0011660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652029	Green Submitted, Green Published, gold			2022-12-25	WOS:000280109700002
J	Fischer, NO; Blanchette, CD; Segelke, BW; Corzett, M; Chromy, BA; Kuhn, EA; Bench, G; Hoeprich, PD				Fischer, Nicholas O.; Blanchette, Craig D.; Segelke, Brent W.; Corzett, Michele; Chromy, Brett A.; Kuhn, Edward A.; Bench, Graham; Hoeprich, Paul D.			Isolation, Characterization, and Stability of Discretely-Sized Nanolipoprotein Particles Assembled with Apolipophorin-III	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEINS; PHOSPHOLIPID-BILAYER NANODISCS; MEMBRANE-PROTEINS; MOLECULAR-DYNAMICS; LIPID-BILAYERS; AMPHOTERICIN-B; BOMBYX-MORI; BINDING; MORPHOLOGY	Background: Nanolipoprotein particles (NLPs) are discoidal, nanometer-sized particles comprised of self-assembled phospholipid membranes and apolipoproteins. NLPs assembled with human apolipoproteins have been used for myriad biotechnology applications, including membrane protein solubilization, drug delivery, and diagnostic imaging. To expand the repertoire of lipoproteins for these applications, insect apolipophorin-III (apoLp-III) was evaluated for the ability to form discretely-sized, homogeneous, and stable NLPs. Methodology: Four NLP populations distinct with regards to particle diameters (ranging in size from 10 nm to >25 nm) and lipid-to-apoLp-III ratios were readily isolated to high purity by size exclusion chromatography. Remodeling of the purified NLP species over time at 4 degrees C was monitored by native gel electrophoresis, size exclusion chromatography, and atomic force microscopy. Purified 20 nm NLPs displayed no remodeling and remained stable for over 1 year. Purified NLPs with 10 nm and 15 nm diameters ultimately remodeled into 20 nm NLPs over a period of months. Intra-particle chemical cross-linking of apoLp-III stabilized NLPs of all sizes. Conclusions: ApoLp-III-based NLPs can be readily prepared, purified, characterized, and stabilized, suggesting their utility for biotechnological applications.	[Fischer, Nicholas O.; Blanchette, Craig D.; Segelke, Brent W.; Corzett, Michele; Chromy, Brett A.; Kuhn, Edward A.; Bench, Graham; Hoeprich, Paul D.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Fischer, NO (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	hoeprich2@llnl.gov	Fischer, Nicholas/AAE-2409-2019	Fischer, Nicholas/0000-0001-7575-4390; Kuhn, Edward/0000-0002-5521-3404; Bench, Graham/0000-0002-1969-6867; Segelke, Brent/0000-0003-3358-5028	U.S. Department of Energy by Lawrence Livermore National Laboratory [LLNL-JRNL-427664, DE-AC52-07NA27344, LLNL-JRNL-420683]; Lawrence Livermore National Laboratory [06-SI-003, 09-LW-077]	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	The authors thank Dr. Robert Ryan for providing reagents. This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory (LLNL-JRNL-427664) under Contract DE-AC52-07NA27344.; This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory (LLNL-JRNL-420683) under Contract DE-AC52-07NA27344 with support from Lawrence Livermore National Laboratory (LDRD, 06-SI-003 and 09-LW-077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SE, 2009, J AM CHEM SOC, V131, P7508, DOI 10.1021/ja809251f; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Blanchette CD, 2008, J LIPID RES, V49, P1420, DOI 10.1194/jlr.M700586-JLR200; Blanchette CD, 2009, INT J MOL SCI, V10, P2958, DOI 10.3390/ijms10072958; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Chetty PS, 2003, BIOCHEMISTRY-US, V42, P15061, DOI 10.1021/bi035456i; Chromy BA, 2007, J AM CHEM SOC, V129, P14348, DOI 10.1021/ja074753y; DAMODARAN KV, 1994, BIOPHYS J, V66, P1076, DOI 10.1016/S0006-3495(94)80889-6; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Fang YL, 2003, BIOCHEMISTRY-US, V42, P13260, DOI 10.1021/bi0354031; Fischer NO, 2010, BIOCONJUGATE CHEM, V21, P1018, DOI 10.1021/bc100083d; Fischer NO, 2009, BIOCONJUGATE CHEM, V20, P460, DOI 10.1021/bc8003155; Frias JC, 2006, NANO LETT, V6, P2220, DOI 10.1021/nl061498r; Gianazza E, 2002, BIOCHEM J, V366, P245, DOI 10.1042/BJ20020058; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1085, P71, DOI 10.1016/0005-2760(91)90233-8; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Kim J, 2009, CHEM SOC REV, V38, P372, DOI 10.1039/b709883a; Li H, 2004, ACAD RADIOL, V11, P1251, DOI 10.1016/j.acra.2004.08.007; LIANG HQ, 1995, BBA-LIPID LIPID MET, V1257, P31, DOI 10.1016/0005-2760(95)00055-H; Lyukmanova EN, 2008, J AM CHEM SOC, V130, P2140, DOI 10.1021/ja0777988; Marcato PD, 2008, J NANOSCI NANOTECHNO, V8, P2216, DOI 10.1166/jnn.2008.274; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Miyazaki M, 2009, BIOCHEMISTRY-US, V48, P7756, DOI 10.1021/bi900785x; Nakano M, 2009, J AM CHEM SOC, V131, P8308, DOI 10.1021/ja9017013; Narayanaswami V, 2000, EUR J BIOCHEM, V267, P728, DOI 10.1046/j.1432-1327.2000.01050.x; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nguyen TS, 2008, BBA-BIOMEMBRANES, V1778, P303, DOI 10.1016/j.bbamem.2007.10.005; Nikanjarn M, 2007, J CONTROL RELEASE, V124, P163, DOI 10.1016/j.jconrel.2007.09.007; Oda MN, 2006, J LIPID RES, V47, P260, DOI 10.1194/jlr.D500033-JLR200; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; Redmond KA, 2007, INT J PHARM, V339, P246, DOI 10.1016/j.ijpharm.2007.02.033; Rensen PCN, 2001, ADV DRUG DELIVER REV, V47, P251, DOI 10.1016/S0169-409X(01)00109-0; Reviakine I, 2000, LANGMUIR, V16, P1473, DOI 10.1021/la990806g; Richter RP, 2005, BIOPHYS J, V88, P3422, DOI 10.1529/biophysj.104.053728; RYAN RO, 1995, J LIPID RES, V36, P1066; Rye K, 2006, J LIPID RES, V47, P1025, DOI 10.1194/jlr.M500525-JLR200; Schwendener RA, 2007, ADV EXP MED BIOL, V620, P117; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Settasatian N, 2008, J LIPID RES, V49, P115, DOI 10.1194/jlr.M700220-JLR200; Tarek M, 2003, BIOPHYS J, V85, P2287, DOI 10.1016/S0006-3495(03)74653-0; Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026; Tufteland M, 2008, J PHARM SCI-US, V97, P4425, DOI 10.1002/jps.21325; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WIENTZEK M, 1994, J BIOL CHEM, V269, P4605; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Yamauchi Y, 2000, ARCH INSECT BIOCHEM, V43, P16, DOI 10.1002/(SICI)1520-6327(200001)43:1&lt;16::AID-ARCH3&gt;3.0.CO;2-W; Zhu K, 2007, BIOCHEMISTRY-US, V46, P6299, DOI 10.1021/bi700079w	58	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11643	10.1371/journal.pone.0011643	http://dx.doi.org/10.1371/journal.pone.0011643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657844	Green Submitted, Green Published, gold			2022-12-25	WOS:000280065600009
J	Nilsson, EE; Savenkova, MI; Schindler, R; Zhang, B; Schadt, EE; Skinner, MK				Nilsson, Eric E.; Savenkova, Marina I.; Schindler, Ryan; Zhang, Bin; Schadt, Eric E.; Skinner, Michael K.			Gene Bionetwork Analysis of Ovarian Primordial Follicle Development	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; BONE MORPHOGENETIC PROTEIN-4; ANTI-MULLERIAN HORMONE; INITIATES FOLLICULOGENESIS; MOUSE OVARY; IN-VITRO; TRANSITION; NETWORKS; PROMOTES; EXPRESSION	Ovarian primordial follicles are critical for female reproduction and comprise a finite pool of gametes arrested in development. A systems biology approach was used to identify regulatory gene networks essential for primordial follicle development. Transcriptional responses to eight different growth factors known to influence primordial follicles were used to construct a bionetwork of regulatory genes involved in rat primordial follicle development. Over 1,500 genes were found to be regulated by the various growth factors and a network analysis identified critical gene modules involved in a number of signaling pathways and cellular processes. A set of 55 genes was identified as potential critical regulators of these gene modules, and a sub-network associated with development was determined. Within the network two previously identified regulatory genes were confirmed (i.e., Pdgfa and Fgfr2) and a new factor was identified, connective tissue growth factor ( CTGF). CTGF was tested in ovarian organ cultures and found to stimulate primordial follicle development. Therefore, the relevant gene network associated with primordial follicle development was validated and the critical genes and pathways involved in this process were identified. This is one of the first applications of network analysis to a normal developmental process. These observations provide insights into potential therapeutic targets for preventing ovarian disease and promoting female reproduction.	[Nilsson, Eric E.; Savenkova, Marina I.; Schindler, Ryan; Skinner, Michael K.] Washington State Univ, Ctr Reprod Biol, Sch Mol Biosci, Pullman, WA 99164 USA; [Zhang, Bin; Schadt, Eric E.] Sage Bionetworks, Seattle, WA USA	Washington State University	Nilsson, EE (corresponding author), Washington State Univ, Ctr Reprod Biol, Sch Mol Biosci, Pullman, WA 99164 USA.	skinner@wsu.edu.edu	Nilsson, Eric/AAR-5021-2020; Savenkova, Marina/AAN-9927-2021		National Institutes of Health (NIH) [R01 HD043093-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) R01 HD043093-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Dole G, 2008, REPRODUCTION, V135, P671, DOI 10.1530/REP-07-0405; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Garor R, 2009, FERTIL STERIL, V91, P1967, DOI 10.1016/j.fertnstert.2008.04.075; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Harlow CR, 2002, MOL CELL ENDOCRINOL, V187, P23, DOI 10.1016/S0303-7207(01)00702-X; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hutt KJ, 2006, BIOL REPROD, V75, P421, DOI 10.1095/biolreprod.106.051516; Kezele P, 2005, BIOL REPROD, V73, P967, DOI 10.1095/biolreprod.105.043117; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Matos MHT, 2007, REPROD FERT DEVELOP, V19, P677, DOI 10.1071/RD07021; Nilsson E, 2001, MOL CELL ENDOCRINOL, V175, P123, DOI 10.1016/S0303-7207(01)00391-4; Nilsson EE, 2004, MOL CELL ENDOCRINOL, V214, P19, DOI 10.1016/j.mce.2003.12.001; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Nilsson E, 2007, REPRODUCTION, V134, P209, DOI 10.1530/REP-07-0119; Nilsson EE, 2006, REPRODUCTION, V131, P1007, DOI 10.1530/rep.1.00978; OKTAY K, 1995, BIOL REPROD, V53, P295, DOI 10.1095/biolreprod53.2.295; Pangas SA, 2007, SEMIN REPROD MED, V25, P225, DOI 10.1055/s-2007-980216; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Tanwar PS, 2008, ANIM REPROD SCI, V106, P232, DOI 10.1016/j.anireprosci.2007.04.015; Winrow CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005161; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	43	39	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11637	10.1371/journal.pone.0011637	http://dx.doi.org/10.1371/journal.pone.0011637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661288	Green Published, gold, Green Submitted			2022-12-25	WOS:000279980800021
J	Cao, Y; Szabolcs, A; Dutta, SK; Yaqoob, U; Jagavelu, K; Wang, L; Leof, EB; Urrutia, RA; Shah, VH; Mukhopadhyay, D				Cao, Ying; Szabolcs, Annamaria; Dutta, Shamit K.; Yaqoob, Usman; Jagavelu, Kumaravelu; Wang, Ling; Leof, Edward B.; Urrutia, Raul A.; Shah, Vijay H.; Mukhopadhyay, Debabrata			Neuropilin-1 Mediates Divergent R-Smad Signaling and the Myofibroblast Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PULMONARY-FIBROSIS; EPITHELIAL-CELLS; TUMOR BIOLOGY; I RECEPTORS; L45 LOOP; ACTIVATION; PHOSPHORYLATION; EXPRESSION	The transforming growth factor-beta (TGF-beta) superfamily is one of the most diversified cell signaling pathways and regulates many physiological and pathological processes. Recently, neuropilin-1 (NRP-1) was reported to bind and activate the latent form of TGF-beta 1 (LAP-TGF-beta 1). We investigated the role of NRP-1 on Smad signaling in stromal fibroblasts upon TGF-beta stimulation. Elimination of NRP-1 in stromal fibroblast cell lines increases Smad1/5 phosphorylation and downstream responses as evidenced by up-regulation of inhibitor of differentiation (Id-1). Conversely, NRP-1 loss decreases Smad2/3 phosphorylation and its responses as shown by down-regulation of alpha-smooth muscle actin (alpha-SMA) and also cells exhibit more quiescent phenotypes and growth arrest. Moreover, we also observed that NRP-1 expression is increased during the culture activation of hepatic stellate cells (HSCs), a liver resident fibroblast. Taken together, our data suggest that NRP-1 functions as a key determinant of the diverse responses downstream of TGF-beta 1 that are mediated by distinct Smad proteins and promotes myofibroblast phenotype.	[Mukhopadhyay, Debabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Yaqoob, Usman; Jagavelu, Kumaravelu; Urrutia, Raul A.; Shah, Vijay H.] Mayo Clin, Coll Med, GI Res Unit, Rochester, MN 55905 USA; [Leof, Edward B.] Mayo Clin, Coll Med, Thorac Dis Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Mukhopadhyay, D (corresponding author), Guggenheim 1321C,200 1st St SW, Rochester, MN 55905 USA.	mukhopadhyay.debabrata@mayo.edu	Jagavelu, Kumaravelu/L-8053-2019	Jagavelu, Kumaravelu/0000-0002-9235-0600	National Institutes of Health [CA78383, HL072178, HL70567]; Mayo Clinic; American Cancer Society; Bruce and Martha Atwater Foundation; NATIONAL CANCER INSTITUTE [R29CA078383, R01CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086990, R01HL072178, R01HL070567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, P30DK084567, R01DK059615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; American Cancer Society(American Cancer Society); Bruce and Martha Atwater Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA78383, HL072178, and HL70567. This work was also supported by a Mayo Clinic Pancreatic Cancer SPORE Pilot grant, a grant from the American Cancer Society as well as the Bruce and Martha Atwater Foundation.	Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; FRIEDMAN SL, 1994, J BIOL CHEM, V269, P10551; GATZA CE, 2008, ATLAS GENET CYTOGENE; Gellibert FO, 2004, J MED CHEM, V47, P4494, DOI 10.1021/jm0400247; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Guo BQ, 2004, ANTICANCER RES, V24, P1337; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hempel N, 2008, CARCINOGENESIS, V29, P905, DOI 10.1093/carcin/bgn049; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lin L, 2008, AM J PATHOL, V173, P337, DOI 10.2353/ajpath.2008.070915; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Mann DA, 2002, GUT, V50, P891, DOI 10.1136/gut.50.6.891; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Obreo J, 2004, CELL PHYSIOL BIOCHEM, V14, P301, DOI 10.1159/000080340; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; RODRIGUEZBARBER.A, 2006, J M CELL PHYSL BIOCH, V18, P135; Romeo PH, 2002, ADV EXP MED BIOL, V515, P49; Roulot D, 1999, HEPATOLOGY, V29, P1730, DOI 10.1002/hep.510290622; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Schramek H, 2009, LAB INVEST, V89, P1304, DOI 10.1038/labinvest.2009.96; Shimizu M, 2000, J CELL BIOL, V148, P1283, DOI 10.1083/jcb.148.6.1283; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Vincent KJ, 2001, GUT, V49, P713, DOI 10.1136/gut.49.5.713; Vrochides D, 1996, HEPATOLOGY, V23, P1650, DOI 10.1053/jhep.1996.v23.pm0008675189; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200	46	60	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31840	31848		10.1074/jbc.M110.151696	http://dx.doi.org/10.1074/jbc.M110.151696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675371	Green Published, hybrid			2022-12-25	WOS:000282764600075
J	Longley, MJ; Humble, MM; Sharief, FS; Copeland, WC				Longley, Matthew J.; Humble, Margaret M.; Sharief, Farida S.; Copeland, William C.			Disease Variants of the Human Mitochondrial DNA Helicase Encoded by C10orf2 Differentially Alter Protein Stability, Nucleotide Hydrolysis, and Helicase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SINGLE-STRANDED-DNA; ONSET SPINOCEREBELLAR ATAXIA; RECESSIVE TWINKLE MUTATIONS; STRUCTURE-FUNCTION DEFECTS; PRIMASE-HELICASE; GENE MUTATION; MTDNA MAINTENANCE; BACTERIOPHAGE T7; LINKER REGION	Missense mutations in the human C10orf2 gene, encoding the mitochondrial DNA (mtDNA) helicase, co-segregate with mitochondrial diseases such as adult-onset progressive external ophthalmoplegia, hepatocerebral syndrome with mtDNA depletion syndrome, and infantile-onset spinocerebellar ataxia. To understand the biochemical consequences of C10orf2 mutations, we overproduced wild type and 20 mutant forms of human mtDNA helicase in Escherichia coli and developed novel schemes to purify the recombinant enzymes to near homogeneity. A combination of molecular crowding, non-ionic detergents, Mg2+ ions, and elevated ionic strength was required to combat insolubility and intrinsic instability of certain mutant variants. Asystematic biochemical assessment of the enzymes included analysis of DNA binding affinity, DNA helicase activity, the kinetics of nucleotide hydrolysis, and estimates of thermal stability. In contrast to other studies, we found that all 20 mutant variants retain helicase function under optimized in vitro conditions despite partial reductions in DNA binding affinity, nucleotide hydrolysis, or thermal stability for some mutants. Such partial defects are consistent with the delayed presentation of mitochondrial diseases associated with mutation of C10orf2.	[Longley, Matthew J.; Humble, Margaret M.; Sharief, Farida S.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	National Institutes of Health through the NIEHS [ES 065078]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065078] Funding Source: NIH RePORTER	National Institutes of Health through the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health through the NIEHS (Grant ES 065078) (to W.C.C.).	Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C; Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280; Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Houshmand M, 2006, NEUROL INDIA, V54, P182; Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Leipe DD, 2000, GENOME RES, V10, P5; Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Lonnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200; Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200; Naimi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627; Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006; Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242; VAN GOETHEM G, 2003, HUM MUTAT, V22, P175; VAN HOVE JLK, 2009, AM J MED GENET A A, V149, P861; Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198; Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663	62	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29690	29702		10.1074/jbc.M110.151795	http://dx.doi.org/10.1074/jbc.M110.151795			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20659899	hybrid, Green Published			2022-12-25	WOS:000281984300004
J	Yevenes, GE; Moraga-Cid, G; Avila, A; Guzman, L; Figueroa, M; Peoples, RW; Aguayo, LG				Yevenes, Gonzalo E.; Moraga-Cid, Gustavo; Avila, Ariel; Guzman, Leonardo; Figueroa, Maximiliano; Peoples, Robert W.; Aguayo, Luis G.			Molecular Requirements for Ethanol Differential Allosteric Modulation of Glycine Receptors Based on Selective G beta gamma Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; EXTRACELLULAR DOMAIN; SYNAPTIC-TRANSMISSION; SUBUNIT; RESIDUES; LOOP-2; ELECTROSTATICS; SENSITIVITY; MECHANISMS	It is now believed that the allosteric modulation produced by ethanol in glycine receptors (GlyRs) depends on alcohol binding to discrete sites within the protein structure. Thus, the differential ethanol sensitivity of diverse GlyR isoforms and mutants was explained by the presence of specific residues in putative alcohol pockets. Here, we demonstrate that ethanol sensitivity in two ligand-gated ion receptor members, the GlyR adult alpha(1) and embryonic alpha(2) subunits, can be modified through selective mutations that rescued or impaired G beta gamma modulation. Even though both isoforms were able to physically interact with G beta gamma, only the alpha(1) GlyR was functionally modulated by G beta gamma and pharmacological ethanol concentrations. Remarkably, the simultaneous switching of two transmembrane and a single extracellular residue in alpha(2) GlyRs was enough to generate GlyRs modulated by G beta gamma and low ethanol concentrations. Interestingly, although we found that these TM residues were different to those in the alcohol binding site, the extracellular residue was recently implicated in conformational changes important to generate a pre-open-activated state that precedes ion channel gating. Thus, these results support the idea that the differential ethanol sensitivity of these two GlyR isoforms rests on conformational changes in transmembrane and extracellular residues within the ion channel structure rather than in differences in alcohol binding pockets. Our results describe the molecular basis for the differential ethanol sensitivity of two ligand-gated ion receptor members based on selective G beta gamma modulation and provide a new mechanistic framework for allosteric modulations of abuse drugs.	[Yevenes, Gonzalo E.; Moraga-Cid, Gustavo; Avila, Ariel; Guzman, Leonardo; Aguayo, Luis G.] Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile; [Figueroa, Maximiliano] Univ Concepcion, Dept Biochem & Mol Biol, Concepcion, Chile; [Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53233 USA	Universidad de Concepcion; Universidad de Concepcion; Marquette University	Aguayo, LG (corresponding author), Univ Concepcion, Dept Physiol, Neurophysiol Lab, POB 160-C, Concepcion, Chile.	laguayo@udec.cl	Moraga-Cid, Gustavo/AAC-3314-2021; Guzman, Jose/AAM-7649-2020; Ávila, Ariel/Z-2817-2019	Guzman, Jose/0000-0001-9596-5494; Ávila, Ariel/0000-0002-7867-9186; Yevenes, Gonzalo/0000-0003-0294-4075	National Institute on Alcohol Abuse and Alcoholism [RO1 AA15150]; Comision Nacional de Investigacion Cientifica y Tecnologica [AT-4040102]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015150] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Comision Nacional de Investigacion Cientifica y Tecnologica; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institute on Alcohol Abuse and Alcoholism Grant RO1 AA15150 (to L.G.A.). This work was also supported by Comision Nacional de Investigacion Cientifica y Tecnologica Grant AT-4040102 (to G.E.Y.).	Absalom NL, 2004, EXP PHYSIOL, V89, P145, DOI 10.1113/expphysiol.2003.026815; Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; Agnati LF, 2005, J HISTOCHEM CYTOCHEM, V53, P941, DOI 10.1369/jhc.4A6355.2005; Aguayo LG, 2004, BRAIN RES REV, V47, P33, DOI 10.1016/j.brainresrev.2004.06.007; Aguayo Luis G., 2002, Current Topics in Medicinal Chemistry, V2, P869, DOI 10.2174/1568026023393426; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crawford DK, 2008, J BIOL CHEM, V283, P27698, DOI 10.1074/jbc.M802384200; Crawford DK, 2007, J NEUROCHEM, V102, P2097, DOI 10.1111/j.1471-4159.2007.04680.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eggers ED, 2000, J NEUROPHYSIOL, V84, P2409, DOI 10.1152/jn.2000.84.5.2409; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; Graham BA, 2006, J NEUROSCI, V26, P4880, DOI 10.1523/JNEUROSCI.3991-05.2006; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Kandel ER, 2000, PRINCIPLES NEURAL SC, p[175, 207]; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Maksay G, 2001, NEUROPHARMACOLOGY, V41, P369, DOI 10.1016/S0028-3908(01)00071-5; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Mangin JA, 2003, J PHYSIOL-LONDON, V553, P369, DOI 10.1113/jphysiol.2003.052142; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mascia MP, 1996, MOL PHARMACOL, V50, P402; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Miller PS, 2004, BRIT J PHARMACOL, V143, P19, DOI 10.1038/sj.bjp.0705875; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Perkins DI, 2008, J NEUROCHEM, V106, P1337, DOI 10.1111/j.1471-4159.2008.05476.x; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; Qi ZH, 2007, J BIOL CHEM, V282, P33052, DOI 10.1074/jbc.M707233200; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Ruiz-Velasco V, 2001, J PHYSIOL-LONDON, V537, P679; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sebe JY, 2006, J NEUROPHYSIOL, V96, P391, DOI 10.1152/jn.00086.2006; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Tapia JC, 1998, SYNAPSE, V28, P185; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wallner M, 2006, PHARMACOL THERAPEUT, V112, P513, DOI 10.1016/j.pharmthera.2006.05.004; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200	54	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30203	30213		10.1074/jbc.M110.134676	http://dx.doi.org/10.1074/jbc.M110.134676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647311	Green Published, hybrid			2022-12-25	WOS:000281984300057
J	Yoshiko, Y; Oizumi, K; Hasegawa, T; Minamizaki, T; Tanne, K; Maeda, N; Aubin, JE				Yoshiko, Yuji; Oizumi, Kiyoshi; Hasegawa, Takuro; Minamizaki, Tomoko; Tanne, Kazuo; Maeda, Norihiko; Aubin, Jane E.			A Subset of Osteoblasts Expressing High Endogenous Levels of PPAR gamma Switches Fate to Adipocytes in the Rat Calvaria Cell Culture Model	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; MESENCHYMAL STEM-CELLS; PEROXISOME-PROLIFERATOR; BONE-MARROW; GENE-TRANSCRIPTION; TRABECULAR BONE; ADIPOSE-TISSUE; IN-VITRO; C/EBP-ALPHA; DIFFERENTIATION	Background: Understanding fate choice and fate switching between the osteoblast lineage (ObL) and adipocyte lineage (AdL) is important to understand both the developmental inter-relationships between osteoblasts and adipocytes and the impact of changes in fate allocation between the two lineages in normal aging and certain diseases. The goal of this study was to determine when during lineage progression ObL cells are susceptible to an AdL fate switch by activation of endogenous peroxisome proliferator-activated receptor (PPAR)gamma. Methodology/Principal Findings: Multiple rat calvaria cells within the ObL developmental hierarchy were isolated by either fractionation on the basis of expression of alkaline phosphatase or retrospective identification of single cell-derived colonies, and treated with BRL-49653 (BRL), a synthetic ligand for PPAR gamma. About 30% of the total single cell-derived colonies expressed adipogenic potential (defined cytochemically) when BRL was present. Profiling of ObL and AdL markers by qRT-PCR on amplified cRNA from over 160 colonies revealed that BRL-dependent adipogenic potential correlated with endogenous PPAR gamma mRNA levels. Unexpectedly, a significant subset of relatively mature ObL cells exhibited osteoadipogenic bipotentiality. Western blotting and immunocytochemistry confirmed that ObL cells co-expressed multiple mesenchymal lineage determinants (runt-related transcription factor 2 (Runx2), PPAR gamma, Sox9 and MyoD which localized in the cytoplasm initially, and only Runx2 translocated to the nucleus during ObL progression. Notably, however, some cells exhibited both PPARc and Runx2 nuclear labeling with concomitant upregulation of expression of their target genes with BRL treatment. Conclusions/Significance: We conclude that not only immature but a subset of relatively mature ObL cells characterized by relatively high levels of endogenous PPARc expression can be switched to the AdL. The fact that some ObL cells maintain capacity for adipogenic fate selection even at relatively mature developmental stages implies an unexpected plasticity with important implications in normal and pathological bone development.	[Yoshiko, Yuji; Minamizaki, Tomoko; Maeda, Norihiko] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral Growth & Dev Biol, Hiroshima, Japan; [Oizumi, Kiyoshi] Daiichi Sankyo Co, Biol Res Labs 3, Tokyo, Japan; [Hasegawa, Takuro; Tanne, Kazuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthodont & Craniofacial Dev Biol, Hiroshima, Japan; [Aubin, Jane E.] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada	Hiroshima University; Daiichi Sankyo Company Limited; Hiroshima University; University of Toronto	Yoshiko, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral Growth & Dev Biol, Hiroshima, Japan.	yyuji@hiroshima-u.ac.jp		Aubin, Jane E./0000-0002-7268-5235	Ministry of Education, Science, Sports and Culture of Japan [13771074]; Canadian Institutes of Health Research [FRN 83704]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (13771074 to YY) and the Canadian Institutes of Health Research (FRN 83704 to JEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Aoyagi K, 2003, BIOCHEM BIOPH RES CO, V300, P915, DOI 10.1016/S0006-291X(02)02967-4; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Bellows CG, 2001, J BONE MINER RES, V16, P1983, DOI 10.1359/jbmr.2001.16.11.1983; Bruedigam C, 2008, FEBS LETT, V582, P1618, DOI 10.1016/j.febslet.2008.04.012; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Fux C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh001; Garcia T, 2002, BONE, V31, P205, DOI 10.1016/S8756-3282(02)00781-0; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Hasegawa T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-71; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Jackson SM, 2000, FEBS LETT, V471, P119, DOI 10.1016/S0014-5793(00)01372-7; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Johnson TE, 1999, ENDOCRINOLOGY, V140, P3245, DOI 10.1210/en.140.7.3245; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Khan E, 2003, J LAB CLIN MED, V142, P29, DOI 10.1016/S0022-2143(03)00058-1; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Kodama Y, 1998, J BONE MINER RES, V13, P1370, DOI 10.1359/jbmr.1998.13.9.1370; Lazarenko OP, 2006, BONE, V38, P74, DOI 10.1016/j.bone.2005.07.008; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Malaval L, 1999, J CELL BIOCHEM, V74, P616; Maurin AC, 2005, CALCIFIED TISSUE INT, V76, P385, DOI 10.1007/s00223-004-0108-y; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Rosen ED, 2000, GENE DEV, V14, P1293; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Sloop KW, 1998, BIOCHEM BIOPH RES CO, V251, P142, DOI 10.1006/bbrc.1998.9432; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tornvig L, 2001, CALCIFIED TISSUE INT, V69, P46, DOI 10.1007/s002230020018; TURKSEN K, 1991, J CELL BIOL, V114, P373, DOI 10.1083/jcb.114.2.373; Umayahara Y, 1997, J BIOL CHEM, V272, P31793, DOI 10.1074/jbc.272.50.31793; Yoshiko Y, 2003, ENDOCRINOLOGY, V144, P4134, DOI 10.1210/en.2003-0130; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang SL, 2006, BONE, V38, P662, DOI 10.1016/j.bone.2005.10.025; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	51	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11782	10.1371/journal.pone.0011782	http://dx.doi.org/10.1371/journal.pone.0011782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668686	Green Submitted, Green Published, gold			2022-12-25	WOS:000280297300016
J	Falentin, H; Deutsch, SM; Jan, G; Loux, V; Thierry, A; Parayre, S; Maillard, MB; Dherbecourt, J; Cousin, FJ; Jardin, J; Siguier, P; Couloux, A; Barbe, V; Vacherie, B; Wincker, P; Gibrat, JF; Gaillardin, C; Lortal, S				Falentin, Helene; Deutsch, Stephanie-Marie; Jan, Gwenael; Loux, Valentin; Thierry, Anne; Parayre, Sandrine; Maillard, Marie-Bernadette; Dherbecourt, Julien; Cousin, Fabien J.; Jardin, Julien; Siguier, Patricia; Couloux, Arnaud; Barbe, Valerie; Vacherie, Benoit; Wincker, Patrick; Gibrat, Jean-Francois; Gaillardin, Claude; Lortal, Sylvie			The Complete Genome of Propionibacterium freudenreichii CIRM-BIA1(T), a Hardy Actinobacterium with Food and Probiotic Applications	PLOS ONE			English	Article							PROPIONATE FORMATION; METABOLIC-ACTIVITY; GROWTH STIMULATOR; PROTEIN-SYNTHESIS; ACID; VITAMIN-B-12; ADAPTATION; GENES; IDENTIFICATION; BIOSYNTHESIS	Background: Propionibacterium freudenreichii is essential as a ripening culture in Swiss-type cheeses and is also considered for its probiotic use [1]. This species exhibits slow growth, low nutritional requirements, and hardiness in many habitats. It belongs to the taxonomic group of dairy propionibacteria, in contrast to the cutaneous species P. acnes. The genome of the type strain, P. freudenreichii subsp. shermanii CIRM-BIA1 (CIP 103027(T)), was sequenced with an 11-fold coverage. Methodology/Principal Findings: The circular chromosome of 2.7 Mb of the CIRM-BIA1 strain has a GC-content of 67% and contains 22 different insertion sequences (3.5% of the genome in base pairs). Using a proteomic approach, 490 of the 2439 predicted proteins were confirmed. The annotation revealed the genetic basis for the hardiness of P. freudenreichii, as the bacterium possesses a complete enzymatic arsenal for de novo biosynthesis of aminoacids and vitamins (except panthotenate and biotin) as well as sequences involved in metabolism of various carbon sources, immunity against phages, duplicated chaperone genes and, interestingly, genes involved in the management of polyphosphate, glycogen and trehalose storage. The complete biosynthesis pathway for a bifidogenic compound is described, as well as a high number of surface proteins involved in interactions with the host and present in other probiotic bacteria. By comparative genomics, no pathogenicity factors found in P. acnes or in other pathogenic microbial species were identified in P. freudenreichii, which is consistent with the Generally Recognized As Safe and Qualified Presumption of Safety status of P. freudenreichii. Various pathways for formation of cheese flavor compounds were identified: the Wood-Werkman cycle for propionic acid formation, amino acid degradation pathways resulting in the formation of volatile branched chain fatty acids, and esterases involved in the formation of free fatty acids and esters. Conclusions/Significance: With the exception of its ability to degrade lactose, P. freudenreichii seems poorly adapted to dairy niches. This genome annotation opens up new prospects for the understanding of the P. freudenreichii probiotic activity.	[Falentin, Helene; Deutsch, Stephanie-Marie; Jan, Gwenael; Thierry, Anne; Parayre, Sandrine; Maillard, Marie-Bernadette; Dherbecourt, Julien; Cousin, Fabien J.; Jardin, Julien; Lortal, Sylvie] INRA, UMR 1253, F-35042 Rennes, France; [Falentin, Helene; Deutsch, Stephanie-Marie; Jan, Gwenael; Thierry, Anne; Parayre, Sandrine; Maillard, Marie-Bernadette; Dherbecourt, Julien; Cousin, Fabien J.; Jardin, Julien; Lortal, Sylvie] AGROCAMPUS OUEST, UMR 1253, Rennes, France; [Loux, Valentin; Gibrat, Jean-Francois] INRA, UR1077, Unite Math Informat & Genome, Jouy En Josas, France; [Siguier, Patricia] CNRS, UMR5100, Lab Microbiol & Genet Mol, Toulouse, France; [Couloux, Arnaud; Barbe, Valerie; Vacherie, Benoit; Wincker, Patrick] Genoscope CEA, CNRS, UMR8030, Evry, France; [Couloux, Arnaud; Barbe, Valerie; Vacherie, Benoit; Wincker, Patrick] Univ Evry, Evry, France; [Gaillardin, Claude] AgroParisTech, CNRS, INRA, UMR2585,UMR1238, Thiverval Grignon, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Falentin, H (corresponding author), INRA, UMR 1253, F-35042 Rennes, France.	helene.falentin@rennes.inra.fr	Jan, Gwenael/K-6767-2014; Falentin, Helene/N-9088-2017; Falentin, Hélène/ABD-2801-2020; Thierry, Anne/C-4760-2014; JARDIN, Julien/A-3241-2012; Thierry, Anne/AAX-1150-2020; Thierry, Anne/AGH-4955-2022	Falentin, Helene/0000-0001-6254-5303; Thierry, Anne/0000-0002-9170-2889; JARDIN, Julien/0000-0003-0520-9391; Thierry, Anne/0000-0002-9170-2889; Siguier, Patricia/0000-0003-1620-6495; Couloux, Arnaud/0000-0003-2356-0062; Loux, Valentin/0000-0002-8268-915X; Vacherie, Benoit/0000-0002-1564-0575; Deutsch, Stephanie-Marie/0000-0002-5570-5193; Cousin, Fabien/0000-0001-6874-387X	INRA; Genoscope	INRA; Genoscope	INRA and Genoscope supported the cost of the complete project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou R, 2006, INT J FOOD MICROBIOL, V108, P301, DOI 10.1016/j.ijfoodmicro.2005.11.015; Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BECK S, 1995, ARCH MICROBIOL, V163, P182; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Benz M, 1998, APPL ENVIRON MICROB, V64, P4507; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bougle D, 1999, SCAND J GASTROENTERO, V34, P144, DOI 10.1080/00365529950172998; Boyaval P, 1999, LAIT, V79, P59, DOI 10.1051/lait:199914; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Bryson K, 2006, NUCLEIC ACIDS RES, V34, P3533, DOI 10.1093/nar/gkl471; Cardoso FS, 2007, MICROBIOL-SGM, V153, P270, DOI 10.1099/mic.0.29262-0; Cardoso FS, 2004, INT J FOOD MICROBIOL, V91, P195, DOI 10.1016/S0168-1605(03)00387-8; Chopin MC, 2002, J BACTERIOL, V184, P2030, DOI 10.1128/JB.184.7.2030-2033.2002; CLARK JE, 1986, J BACTERIOL, V168, P1212, DOI 10.1128/jb.168.3.1212-1219.1986; Cousin FJ, 2011, DAIRY SCI TECHNOL, V91, P1, DOI 10.1051/dst/2010032; CROW VL, 1986, APPL ENVIRON MICROB, V52, P359, DOI 10.1128/AEM.52.2.359-365.1986; Cummins C.S., 1986, BERGEYS MANUAL SYSTE, P1346; CUMMINS CS, 1992, PROKARYOTES; DEBORDE C, 1998, THESIS ENSAR AGROCAM; Deborde C, 1996, J MAGN RESON ANAL, V2, P297; Deutsch SM, 2008, INT J FOOD MICROBIOL, V125, P252, DOI 10.1016/j.ijfoodmicro.2008.04.006; Deutsch SM, 2010, APPL ENVIRON MICROB, V76, P2740, DOI 10.1128/AEM.02591-09; Dherbecourt J, 2008, J APPL MICROBIOL, V105, P977, DOI 10.1111/j.1365-2672.2008.03830.x; Dherbecourt J, 2010, APPL ENVIRON MICROB, V76, P1181, DOI 10.1128/AEM.02453-09; Dherbecourt J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-16; DUPUIS C, 1995, APPL MICROBIOL BIOT, V42, P750, DOI [10.1007/s002530050326, 10.1007/BF00171957]; de Palencia PF, 2009, APPL ENVIRON MICROB, V75, P4887, DOI 10.1128/AEM.00394-09; FROHLICHWYDER MT, 2004, APPL ENVIRON MICROB, V64, P4507; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guglielmetti S, 2008, APPL ENVIRON MICROB, V74, P4695, DOI 10.1128/AEM.00124-08; HAESELEER F, 1992, NUCLEIC ACIDS RES, V20, P1420, DOI 10.1093/nar/20.6.1420; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Herve C, 2001, APPL ENVIRON MICROB, V67, P231, DOI 10.1128/AEM.67.1.231-238.2001; Herve C, 2007, INT J FOOD MICROBIOL, V113, P303, DOI 10.1016/j.ijfoodmicro.2006.08.013; Hojo K., 2002, Bioscience and Microflora, V21, P115; Isawa K, 2002, BIOSCI BIOTECH BIOCH, V66, P679, DOI 10.1271/bbb.66.679; Jan G, 2002, LAIT, V82, P131, DOI 10.1051/lait:2001012; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Jan G, 2001, APPL ENVIRON MICROB, V67, P2029, DOI 10.1128/AEM.67.5.2029-2036.2001; JOHNS AT, 1952, J GEN MICROBIOL, V6, P123, DOI 10.1099/00221287-6-1-2-123; JOHNS AT, 1951, J GEN MICROBIOL, V5, P326, DOI 10.1099/00221287-5-2-326; KANEKO T, 1994, J DAIRY SCI, V77, P393, DOI 10.3168/jds.S0022-0302(94)76965-4; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kiatpapan P, 2003, ACS SYM SER, V862, P221; Kichenaradja P, 2010, NUCLEIC ACIDS RES, V38, pD62, DOI 10.1093/nar/gkp947; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lan A, 2008, BRIT J NUTR, V100, P1251, DOI 10.1017/S0007114508978284; Lan A, 2007, BRIT J NUTR, V97, P714, DOI 10.1017/S0007114507433001; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; LEMEE R, 1994, LAIT, V74, P241, DOI 10.1051/lait:1994420; Leverrier P, 2005, FOOD MICROBIOL, V22, P11, DOI 10.1016/j.fm.2004.05.003; Leverrier P, 2004, ARCH MICROBIOL, V181, P215, DOI 10.1007/s00203-003-0646-0; Leverrier P, 2003, APPL ENVIRON MICROB, V69, P3809, DOI 10.1128/AEM.69.7.3809-3818.2003; LEVERRIER P, 2003, THESIS; MACY JM, 1978, J BACTERIOL, V134, P84, DOI 10.1128/JB.134.1.84-91.1978; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MEURICE G, 2004, THESIS ECOLE NATL SU; MEURICE G, 2004, SILICO BIOL, V4; Miskin JE, 1997, MICROBIOL-UK, V143, P1745, DOI 10.1099/00221287-143-5-1745; Murooka Y, 2005, LAIT, V85, P9, DOI 10.1051/lait:2004035; NG SKC, 1973, CAN J MICROBIOL, V19, P715, DOI 10.1139/m73-116; Ouwehand AC, 2002, LAIT, V82, P123, DOI 10.1051/lait:2001011; Piao Y, 2004, J BIOSCI BIOENG, V98, P167, DOI 10.1016/S1389-1723(04)00261-0; Rigoulay C, 2004, FEMS MICROBIOL LETT, V237, P279, DOI 10.1016/j.femsle.2004.06.046; Roessner CA, 2002, MICROBIOL-SGM, V148, P1845, DOI 10.1099/00221287-148-6-1845; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; Sanchez B, 2006, ENVIRON MICROBIOL, V8, P1825, DOI 10.1111/j.1462-2920.2006.01067.x; SCHINK B, 1987, ARCH MICROBIOL, V147, P321, DOI 10.1007/BF00406127; Schroeckh V, 2006, ANTON LEEUW INT J G, V89, P359, DOI 10.1007/s10482-005-9039-5; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Suoniemi A, 2002, LAIT, V82, P81, DOI 10.1051/lait:2001007; Thierry A, 2005, LAIT, V85, P57, DOI 10.1051/lait:2004036; Thierry A, 2005, J AGR FOOD CHEM, V53, P4157, DOI 10.1021/jf0481195; Thierry A, 2002, LAIT, V82, P17, DOI 10.1051/lait:2001002; Thybert D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-637; TORAYA T, 1980, J BACTERIOL, V141, P1439, DOI 10.1128/JB.141.3.1439-1442.1980; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van Luijk N, 2002, LAIT, V82, P45, DOI 10.1051/lait:201004; von Freudenreich E., 1906, ZENTRALBL BAKTERIOL, V17, P529; Wood H G, 1981, Curr Top Cell Regul, V18, P255; Yebra MJ, 2007, APPL ENVIRON MICROB, V73, P3850, DOI 10.1128/AEM.00243-07	91	131	145	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11748	10.1371/journal.pone.0011748	http://dx.doi.org/10.1371/journal.pone.0011748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668525	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243800021
J	Ling, S; Cheng, A; Pumpens, P; Michalak, M; Holoshitz, J				Ling, Song; Cheng, Andrew; Pumpens, Paul; Michalak, Marek; Holoshitz, Joseph			Identification of the Rheumatoid Arthritis Shared Epitope Binding Site on Calreticulin	PLOS ONE			English	Article							CELL-SURFACE CALRETICULIN; RECEPTOR CALRETICULIN; CHAPERONE FUNCTION; P-DOMAIN; PEPTIDE; DISEASE; C1Q; SUSCEPTIBILITY; PATHWAY; ACTIVATION	Background: The rheumatoid arthritis (RA) shared epitope (SE), a major risk factor for severe disease, is a five amino acid motif in the third allelic hypervariable region of the HLA-DR beta chain. The molecular mechanisms by which the SE affects susceptibility to - and severity of - RA are unknown. We have recently demonstrated that the SE acts as a ligand that interacts with cell surface calreticulin (CRT) and activates innate immune signaling. In order to better understand the molecular basis of SE-RA association, here we have undertaken to map the SE binding site on CRT. Principal Findings: Surface plasmon resonance (SPR) experiments with domain deletion mutants suggested that the SE binding site is located in the P-domain of CRT. The role of this domain as a SE-binding region was further confirmed by a sulfosuccinimidyl-2-[6-(biotinamido)-2-(p-azido-benzamido) hexanoamido] ethyl-1,3-dithiopropionate (sulfo-SBED) photoactive cross-linking method. In silico analysis of docking interactions between a conformationally intact SE ligand and the CRT P-domain predicted the region within amino acid residues 217-224 as a potential SE binding site. Site-directed mutagenesis demonstrated involvement of residues Glu(217) and Glu(223) - and to a lesser extent residue Asp(220) - in cell-free SPR-based binding and signal transduction assays. Significance: We have characterized here the molecular basis of a novel ligand-receptor interaction between the SE and CRT. The interaction represents a structurally and functionally well-defined example of cross talk between the adaptive and innate immune systems that could advance our understanding of the pathogenesis of autoimmunity.	[Ling, Song; Cheng, Andrew; Holoshitz, Joseph] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pumpens, Paul] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Michigan System; University of Michigan; Latvian Biomedical Research & Study Centre; University of Alberta	Ling, S (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	songlin@med.unich.edu; jholo@med.umich.edu	Pumpens, Paul/A-2163-2008		US National Institutes of Health [AR55170, UL1RR02498, AI47331, GM088560, AR20557, AR56786, AR48310]; University of Michigan Global Reach Collaborative Research; Arthritis Foundation; American College of Rheumatology Research and Education Foundation; Canadian Institutes of Health Research [MOP-15291]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557, R21AR056786, P30AR048310, R21AR055170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088560] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Global Reach Collaborative Research; Arthritis Foundation; American College of Rheumatology Research and Education Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Joseph Holoshitz was supported by grants from the US National Institutes of Health (AR55170, UL1RR02498, AI47331, GM088560, AR20557, AR56786 and AR48310), by the University of Michigan Global Reach Collaborative Research and by Basic Research Grants from the Arthritis Foundation and the American College of Rheumatology Research and Education Foundation. Marek Michalak was supported by the Canadian Institutes of Health Research (MOP-15291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKSH S, 1992, PROTEIN EXPRES PURIF, V3, P322, DOI 10.1016/1046-5928(92)90008-K; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Donnelly S, 2006, ARTHRITIS RHEUM-US, V54, P1543, DOI 10.1002/art.21783; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; Eggleton P, 1999, SCAND J IMMUNOL, V49, P466; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Holoshitz J, 2007, ANN NY ACAD SCI, V1110, P73, DOI 10.1196/annals.1423.009; Hurst GB, 2004, J AM SOC MASS SPECTR, V15, P832, DOI 10.1016/S1044-0305(04)00154-0; LaCava A, 1997, J CLIN INVEST, V100, P658, DOI 10.1172/JCI119577; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Ling S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2111; Ling S, 2007, J IMMUNOL, V179, P6359, DOI 10.4049/jimmunol.179.9.6359; Ling S, 2006, ARTHRITIS RHEUM-US, V54, P3423, DOI 10.1002/art.22178; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Mattey DL, 2001, J RHEUMATOL, V28, P232; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oladiran A, 2010, DEV COMP IMMUNOL, V34, P396, DOI 10.1016/j.dci.2009.11.005; Radaev S, 2003, ANNU REV BIOPH BIOM, V32, P93, DOI 10.1146/annurev.biophys.32.110601.142347; Santhoshkumar P, 2002, BBA-PROTEINS PROTEOM, V1598, P115, DOI 10.1016/S0167-4838(02)00356-4; Steino A, 2004, SCAND J IMMUNOL, V59, P485, DOI 10.1111/j.0300-9475.2004.01425.x; Stuart GR, 1997, IMMUNOPHARMACOLOGY, V38, P73, DOI 10.1016/S0162-3109(97)00076-3; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Udupa PEG, 2005, EXP EYE RES, V80, P185, DOI 10.1016/j.exer.2004.08.028; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; WUCHERPFENNIG KW, 1995, J EXP MED, V181, P1597, DOI 10.1084/jem.181.5.1597; Yoshida T, 2003, J COMPUT CHEM, V24, P319, DOI 10.1002/jcc.10161; Zavala-Ruiz Z, 2004, CHEM BIOL, V11, P1395, DOI 10.1016/j.chembiol.2004.08.007	39	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11703	10.1371/journal.pone.0011703	http://dx.doi.org/10.1371/journal.pone.0011703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661469	Green Submitted, Green Published, gold			2022-12-25	WOS:000280243300009
J	Sylvester, M; Kliche, S; Lange, S; Geithner, S; Klemm, C; Schlosser, A; Grossmann, A; Stelzl, U; Schraven, B; Krause, E; Freund, C				Sylvester, Marc; Kliche, Stefanie; Lange, Sabine; Geithner, Sabine; Klemm, Clementine; Schlosser, Andreas; Grossmann, Arndt; Stelzl, Ulrich; Schraven, Burkhart; Krause, Eberhard; Freund, Christian			Adhesion and Degranulation Promoting Adapter Protein (ADAP) Is a Central Hub for Phosphotyrosine-Mediated Interactions in T Cells	PLOS ONE			English	Article							EXTENDED SH3 DOMAIN; PHOSPHORYLATION SITES; FUNCTIONAL ASSOCIATION; INTEGRIN ACTIVATION; INTERACTION NETWORK; ACTIN CYTOSKELETON; MASS-SPECTROMETRY; TYROSINE KINASES; HUMAN PLATELETS; CUTTING EDGE	TCR stimulation leads to an increase in cellular adhesion among other outcomes. The adhesion and degranulation promoting adapter protein (ADAP) is known to be rapidly phosphorylated after T cell stimulation and relays the TCR signal to adhesion molecules of the integrin family. While three tyrosine phosphorylation sites have been characterized biochemically, the binding capabilities and associated functions of several other potential phosphotyrosine motifs remain unclear. Here, we utilize in vitro phosphorylation and mass spectrometry to map novel phosphotyrosine sites in the C-terminal part of human ADAP (486-783). Individual tyrosines were then mutated to phenylalanine and their relevance for cellular adhesion and migration was tested experimentally. Functionally important tyrosine residues include two sites within the folded hSH3 domains of ADAP and two at the C-terminus. Furthermore, using a peptide pulldown approach in combination with stable isotope labeling in cell culture (SILAC) we identified SLP-76, PLC gamma, PIK3R1, Nck, CRK, Gads, and RasGAP as phospho-dependent binding partners of a central YDDV motif of ADAP. The phosphorylation-dependent interaction between ADAP and Nck was confirmed by yeast two-hybrid analysis, immunoprecipitation and binary pulldown experiments, indicating that ADAP directly links integrins to modulators of the cytoskeleton independent of SLP-76.	[Sylvester, Marc; Geithner, Sabine; Freund, Christian] Leibniz Inst Mol Pharmakol FMP, Prot Engn Grp, Berlin, Germany; [Sylvester, Marc; Geithner, Sabine; Freund, Christian] Free Univ Berlin, Fachbereich Biol, D-1000 Berlin, Germany; [Kliche, Stefanie; Schraven, Burkhart] Otto Von Guericke Univ, Inst Mol & Klin Immunol, Magdeburg, Germany; [Lange, Sabine; Klemm, Clementine; Krause, Eberhard] Leibniz Inst Mol Pharmacol, Mass Spectrometry Grp, Berlin, Germany; [Schlosser, Andreas] Charite, Inst Med Immunol CCM, D-13353 Berlin, Germany; [Grossmann, Arndt; Stelzl, Ulrich] Max Planck Inst Mol Genet, Otto Warburg Lab, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Otto von Guericke University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Sylvester, M (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark.		Stelzl, Ulrich/J-9506-2015	Stelzl, Ulrich/0000-0003-2500-3585; Sylvester, Marc/0000-0002-4275-0200	Max-Planck Society; Nationales Genom-Forschungs-Netz-plus [01GS08171]; Deutsche Forschungsgemeinschaft [SFB740]	Max-Planck Society(Max Planck Society); Nationales Genom-Forschungs-Netz-plus; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work in the lab of U.S. is supported by the Max-Planck Society and Nationales Genom-Forschungs-Netz-plus (NeuroNet TP3, 01GS08171). C. F. was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bezman N, 2007, IMMUNOL REV, V218, P9, DOI 10.1111/j.1600-065X.2007.00541.x; Boerth NJ, 2000, J BIOL CHEM, V275, P5143, DOI 10.1074/jbc.275.7.5143; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; Coppolino MG, 2001, J CELL SCI, V114, P4307; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; DASILVA AJ, 1993, J EXP MED, V178, P2107, DOI 10.1084/jem.178.6.2107; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Geng LP, 1999, J IMMUNOL, V163, P5753; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goss VL, 2006, BLOOD, V107, P4888, DOI 10.1182/blood-2005-08-3399; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Heuer K, 2005, J MOL BIOL, V348, P1025, DOI 10.1016/j.jmb.2005.02.069; Heuer K, 2004, STRUCTURE, V12, P603, DOI 10.1016/j.str.2004.02.021; Heuer K, 2006, J MOL BIOL, V361, P94, DOI 10.1016/j.jmb.2006.06.004; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hunter AJ, 2000, J IMMUNOL, V164, P1143, DOI 10.4049/jimmunol.164.3.1143; Klemm C, 2006, J MASS SPECTROM, V41, P1623, DOI 10.1002/jms.1129; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Koga S, 2005, J BIOL CHEM, V280, P31564, DOI 10.1074/jbc.M502703200; Kosco KA, 2008, MOL IMMUNOL, V45, P510, DOI 10.1016/j.molimm.2007.05.024; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Lettau M, 2010, PROTEIN SCI, V19, P658, DOI 10.1002/pro.334; Li L, 2008, NUCLEIC ACIDS RES, V36, P3263, DOI 10.1093/nar/gkn161; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Mamchak AA, 2008, J IMMUNOL, V181, P5374, DOI 10.4049/jimmunol.181.8.5374; Marie-Cardine A, 1999, EUR J IMMUNOL, V29, P1175, DOI 10.1002/(SICI)1521-4141(199904)29:04<1175::AID-IMMU1175>3.0.CO;2-Z; Miller ML, 2008, MOL CELL PROTEOMICS, V7, P181, DOI 10.1074/mcp.M700241-MCP200; Mulhern TD, 1997, STRUCTURE, V5, P1313, DOI 10.1016/S0969-2126(97)00283-9; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Okabe S, 2006, BLOOD CELL MOL DIS, V36, P308, DOI 10.1016/j.bcmd.2005.12.035; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Piotukh K, 2007, FREE RADICAL BIO MED, V43, P1263, DOI 10.1016/j.freeradbiomed.2007.06.010; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Schlosser A, 2005, ANAL CHEM, V77, P5243, DOI 10.1021/ac050232m; Schneider H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001718; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; TORTI M, 1992, P NATL ACAD SCI USA, V89, P7796, DOI 10.1073/pnas.89.16.7796; Trojan P, 2008, BBA-MOL CELL RES, V1783, P1248, DOI 10.1016/j.bbamcr.2008.01.006; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zimmermann J, 2007, BIOCHEMISTRY-US, V46, P6971, DOI 10.1021/bi700437r	54	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11708	10.1371/journal.pone.0011708	http://dx.doi.org/10.1371/journal.pone.0011708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661443	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300012
J	Wang, Y; Gao, WL; Svitkin, YV; Chen, APC; Cheng, YC				Wang, Ying; Gao, Wenli; Svitkin, Yuri V.; Chen, Annie Pei-Chun; Cheng, Yung-Chi			DCB-3503, a Tylophorine Analog, Inhibits Protein Synthesis through a Novel Mechanism	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; IN-VITRO TRANSLATION; CELL-FREE SYSTEM; APOLIPOPROTEIN-B; CANCER CELLS; PHOSPHORYLATION; ELONGATION; RESISTANCE; ALKALOIDS; REPRESSOR	Background: DCB-3503, a tylophorine analog, inhibits the growth of PANC-1 (human pancreatic ductal cancer cell line) and HepG2 (human hepatocellular cancer cell line) tumor xenografts in nude mice. The inhibition of growth leads to cancer cell differentiation instead of cell death. However, the mechanisms of action of tylophorine analogs is unknown. Methodology/Principal Findings: In this study, we show that DCB-3503 suppresses the expression of pro-oncogenic or pro-survival proteins with short half-lives, including cyclin D1, survivin, beta-catenin, p53, and p21, without decreasing their mRNA levels. Proteasome inhibitor reversed the inhibitory effect of DCB-3503 on expression of these proteins. DCB-3503 inhibited the incorporation of radiolabeled amino acid and thymidine, and to a much lesser degree of uridine, in a panel of cell lines. The mechanism of inhibition of protein synthesis is different from that of cycloheximide (CHX) as assayed in cell culture and HeLa in vitro translation system. Furthermore, in contrast to rapamycin, DCB-3503 does not affect protein synthesis through the mTOR pathway. DCB-3503 treatment shifts the sedimentation profiles of ribosomes and mRNAs towards the polysomal fractions while diminishing monosome abundance, indicative of the inhibition of the elongation step of protein synthesis. Preferential down regulation of several studied proteins under these conditions is likely due to the relative short half-lives of these proteins. Conclusion/Significance: The inhibitory effect of DCB-3503 on translation is apparently distinct from any of the current anticancer compounds targeting protein synthesis. Translation inhibitors with novel mechanism could complement current chemotherapeutic agents for the treatment of human cancers and suppress the occurrence of drug resistance.	[Wang, Ying; Gao, Wenli; Chen, Annie Pei-Chun; Cheng, Yung-Chi] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Svitkin, Yuri V.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Svitkin, Yuri V.] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada	Yale University; McGill University; McGill University	Wang, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	yccheng@yale.edu	Wang, Ying/T-9438-2018	Wang, Ying/0000-0002-1407-2668; Svitkin, Yuri/0000-0003-3819-2143	NCI [CA-63477]; NATIONAL CANCER INSTITUTE [U01CA063477, R01CA063477] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant CA-63477. The funder designed the study, data collection and analysis, prepared and decided to publish the manuscript.	ADELI K, 1992, BIOCHEM CELL BIOL, V70, P1301, DOI 10.1139/o92-177; Adi S, 2001, ENDOCRINOLOGY, V142, P498, DOI 10.1210/en.142.1.498; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Budihardjo II, 2000, MOL PHARMACOL, V57, P529, DOI 10.1124/mol.57.3.529; Buniatian A A, 1979, Akush Ginekol (Mosk), P13; Choi JY, 2006, ARTHRITIS RHEUM, V54, P3277, DOI 10.1002/art.22119; Chopra R. N. L.-C., 1935, INDIAN J MED RES, V23, P263; CREWS CM, 1994, J BIOL CHEM, V269, P15411; DONALDSO.GR, 1968, BIOCHEM BIOPH RES CO, V31, P104, DOI 10.1016/0006-291X(68)90037-5; Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501; Gao W, 2008, BIOORG MED CHEM LETT, V18, P704, DOI 10.1016/j.bmcl.2007.11.054; Gao WL, 2007, BIOORG MED CHEM LETT, V17, P4338, DOI 10.1016/j.bmcl.2007.05.021; Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GRANT P, 1974, J BACTERIOL, V120, P1308, DOI 10.1128/JB.120.3.1308-1314.1974; HUANG MT, 1972, MOL PHARMACOL, V8, P538; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Leung CH, 2006, MOL PHARMACOL, V70, P1946, DOI 10.1124/mol.106.028480; Ma Y, 2005, CANCER RES, V65, P6476, DOI 10.1158/0008-5472.CAN-05-0370; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Mikami S, 2006, J BIOTECHNOL, V127, P65, DOI 10.1016/j.jbiotec.2006.06.018; Mohammadi A, 1996, BIOCHEM BIOPH RES CO, V228, P852, DOI 10.1006/bbrc.1996.1743; MOLLA A, 1993, J VIROL, V67, P5932, DOI 10.1128/JVI.67.10.5932-5938.1993; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; Nomura M, 2005, BIOCHEM BIOPH RES CO, V335, P900, DOI 10.1016/j.bbrc.2005.07.160; Olie RA, 2000, CANCER RES, V60, P2805; Robert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005428; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sah NK, 2003, J BIOL CHEM, V278, P20593, DOI 10.1074/jbc.M211010200; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shiah HS, 2006, MOL CANCER THER, V5, P2484, DOI 10.1158/1535-7163.MCT-06-0146; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Suriano G, 2005, GENE CHROMOSOME CANC, V42, P238, DOI 10.1002/gcc.20135; Svitkin Yuri V., 2004, V257, P155; TUJEBAJEVA RM, 1992, BIOCHIM BIOPHYS ACTA, V1129, P177, DOI 10.1016/0167-4781(92)90484-H; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; WILLINGHAM W, 1981, BIOCHIM BIOPHYS ACTA, V654, P169, DOI 10.1016/0005-2787(81)90168-4; Wu CJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-25; Xi Z, 2005, BIOORG MED CHEM LETT, V15, P2673, DOI 10.1016/j.bmcl.2005.02.022; Yamada H, 1996, INT J HEMATOL, V65, P31; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; You X, 2006, ARTHRITIS RHEUM-US, V54, P877, DOI 10.1002/art.21640; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D	48	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11607	10.1371/journal.pone.0011607	http://dx.doi.org/10.1371/journal.pone.0011607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657652	Green Published, Green Submitted, gold			2022-12-25	WOS:000279924500010
J	Fonseca, AV; Freund, D; Bornhauser, M; Corbeil, D				Fonseca, Ana-Violeta; Freund, Daniel; Bornhaeuser, Martin; Corbeil, Denis			Polarization and Migration of Hematopoietic Stem and Progenitor Cells Rely on the RhoA/ROCK I Pathway and an Active Reorganization of the Microtubule Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RHO; POLYTOPIC MEMBRANE-PROTEIN; PLASMA-MEMBRANE; FOCAL ADHESIONS; T-LYMPHOCYTES; STRESS FIBERS; EZRIN/RADIXIN/MOESIN PROTEINS; TRANSENDOTHELIAL MIGRATION; NEUTROPHIL MIGRATION; IMMUNE INTERACTIONS	Understanding the physiological migration of hematopoietic progenitors is important, not only for basic stem cell research, but also in view of their therapeutic relevance. Here, we investigated the role of the Rho kinase pathway in the morphology and migration of hematopoietic progenitors using an ex vivo co-culture consisting of human primary CD34(+) progenitors and mesenchymal stromal cells. The addition of the Rho kinase inhibitor Y-27632 led to the abolishment of the uropod and microvillar-like structures of hematopoietic progenitors, concomitant with a redistribution of proteins found therein (prominin-1 and ezrin). Y-27632-treated cells displayed a deficiency in migration. Time-lapse video microscopy revealed impairment of the rear pole retraction. Interestingly, the knockdown of ROCK I, but not ROCK II, using RNA interference (RNAi) was sufficient to cause the referred morphological and migrational changes. Unexpectedly, the addition of nocodazole to either Y-27632- or ROCK I RNAi-treated cells could restore their polarized morphology and migration suggesting an active role for the microtubule network in tail retraction. Finally, we could demonstrate using RNAi that RhoA, the upstream regulator of ROCK, is involved in these processes. Collectively, our data provide new insights regarding the role of RhoA/ROCK I and the microtubules in the migration of stem cells.	[Fonseca, Ana-Violeta; Freund, Daniel; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, D-01307 Dresden, Germany; [Bornhaeuser, Martin; Corbeil, Denis] Tech Univ Dresden, Deutsch Forsch Gemeinschaft Res Ctr, D-01307 Dresden, Germany; [Bornhaeuser, Martin] Univ Hosp, Med Clin & Polyclin 1, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Corbeil, D (corresponding author), Tech Univ Dresden, Tissue Engn Labs, Tatzberg 47-49, D-01307 Dresden, Germany.	corbeil@biotec.tu-dresden.de	Corbeil, Denis/A-6519-2010; Bornhäuser, Martin/F-8101-2010; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/L-2340-2019	Corbeil, Denis/0000-0003-1181-3659	Deutsche Forschungsgemeinschaft (DFG) [SFB 655 B2, SFB/TR83 6, SFB 655 B3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (DFG Grant SFB 655 B2).; Supported by the DFG (Grants SFB/TR83 # 6 and SFB 655 B3).	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Barreiro O, 2007, IMMUNOL REV, V218, P147, DOI 10.1111/j.1600-065X.2007.00529.x; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Corbeil D, 1999, J CELL SCI, V112, P1023; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; delPozo MA, 1997, J CELL BIOL, V137, P493; Eddy RJ, 2000, J CELL SCI, V113, P1287; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Freund D, 2010, CYTOTHERAPY, V12, P131, DOI 10.3109/14653240903476438; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Giebel B, 2007, CELL CYCLE, V6, P2201, DOI 10.4161/cc.6.18.4658; Gillette JM, 2009, NAT CELL BIOL, V11, P303, DOI 10.1038/ncb1838; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Von Levetzow G, 2006, STEM CELLS DEV, V15, P278, DOI 10.1089/scd.2006.15.278; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yonemura S, 2002, J CELL SCI, V115, P2569; Yoshinaga-Ohara N, 2002, EXP CELL RES, V278, P112, DOI 10.1006/excr.2002.5571	56	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31661	31671		10.1074/jbc.M110.145037	http://dx.doi.org/10.1074/jbc.M110.145037			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682776	Green Published, hybrid			2022-12-25	WOS:000282764600058
J	Taylor, M; Navarro-Garcia, F; Huerta, J; Burress, H; Massey, S; Ireton, K; Teter, K				Taylor, Michael; Navarro-Garcia, Fernando; Huerta, Jazmin; Burress, Helen; Massey, Shane; Ireton, Keith; Teter, Ken			Hsp90 Is Required for Transfer of the Cholera Toxin A1 Subunit from the Endoplasmic Reticulum to the Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION PATHWAY; CELL CHAPERONE HSP90; BOTULINUM C2 TOXIN; RETRO-TRANSLOCATION; MAMMALIAN-CELLS; INTRACELLULAR TRAFFICKING; CYSTIC-FIBROSIS; CULTURED-CELLS; RETROTRANSLOCATION; POLYPEPTIDE	Cholera toxin (CT) is an AB(5) toxin that moves from the cell surface to the endoplasmic reticulum (ER) by retrograde vesicular transport. In the ER, the catalytic A1 subunit dissociates from the rest of the toxin and enters the cytosol by exploiting the quality control system of ER-associated degradation (ERAD). The driving force for CTA1 dislocation into the cytosol is unknown. Here, we demonstrate that the cytosolic chaperone Hsp90 is required for CTA1 passage into the cytosol. Hsp90 bound to CTA1 in an ATP-dependent manner that was blocked by geldanamycin (GA), an established Hsp90 inhibitor. CT activity against cultured cells and ileal loops was also blocked by GA, as was the ER-to-cytosol export of CTA1. Experiments using RNA interference or N-ethylcarboxamidoadenosine, a drug that inhibits ER-localized GRP94 but not cytosolic Hsp90, confirmed that the inhibitory effects of GA resulted specifically from the loss of Hsp90 activity. This work establishes a functional role for Hsp90 in the ERAD-mediated dislocation of CTA1.	[Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Navarro-Garcia, Fernando; Huerta, Jazmin] Ctr Invest & Estudios Avanzados IPN CINVESTAV ZAC, Dept Cell Biol, Mexico City 07000, DF, Mexico	State University System of Florida; University of Central Florida; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Teter, K (corresponding author), 12722 Res Pkwy,Biomol Res Annex, Orlando, FL 32826 USA.	kteter@mail.ucf.edu	Navarro-Garcia, Fernando/A-3980-2011	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI073783 (to K. T.).	Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Castro MG, 2001, CELL MICROBIOL, V3, P45, DOI 10.1046/j.1462-5822.2001.00092.x; CHANG FH, 1989, J BIOL CHEM, V264, P5352; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; FISHMAN PH, 1982, J CELL BIOL, V93, P860, DOI 10.1083/jcb.93.3.860; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; Haug G, 2004, INFECT IMMUN, V72, P3066, DOI 10.1128/IAI.72.5.3066-3068.2004; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0; Kaiser E, 2009, CELL MICROBIOL, V11, P780, DOI 10.1111/j.1462-5822.2009.01291.x; Kato J, 2007, MOL CELL BIOL, V27, P5534, DOI 10.1128/MCB.00302-07; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Marshall RS, 2008, J BIOL CHEM, V283, P15869, DOI 10.1074/jbc.M709316200; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; McConnell E, 2007, BIOCHEM BIOPH RES CO, V355, P1087, DOI 10.1016/j.bbrc.2007.02.077; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; NAMBIAR MP, 1993, J CELL PHYSIOL, V154, P222, DOI 10.1002/jcp.1041540203; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Ratts R, 2003, J CELL BIOL, V160, P1139, DOI 10.1083/jcb.200210028; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wernick NLB, 2010, J BIOL CHEM, V285, P6145, DOI 10.1074/jbc.M109.062067; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	50	54	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31261	31267		10.1074/jbc.M110.148981	http://dx.doi.org/10.1074/jbc.M110.148981			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667832	hybrid, Green Published			2022-12-25	WOS:000282764600020
J	Mueller, GM; Maarouf, AB; Kinlough, CL; Sheng, N; Kashlan, OB; Okumura, S; Luthy, S; Kleyman, TR; Hughey, RP				Mueller, Gunhild M.; Maarouf, Ahmad B.; Kinlough, Carol L.; Sheng, Nan; Kashlan, Ossama B.; Okumura, Sora; Luthy, Sarah; Kleyman, Thomas R.; Hughey, Rebecca P.			Cys Palmitoylation of the beta Subunit Modulates Gating of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; ALPHA-SUBUNIT; LIPID RAFTS; A6 CELLS; APICAL MEMBRANE; PROTEIN PALMITOYLATION; FUNCTIONAL EXPRESSION; MEDIATED ENDOCYTOSIS; PROTEOLYTIC CLEAVAGE; SURFACE EXPRESSION	The epithelial Na+ channel (ENaC) is comprised of three homologous subunits (alpha, beta, and gamma) that have a similar topology with two transmembrane domains, a large extracellular region, and cytoplasmic N and C termini. Although ENaC activity is regulated by a number of factors, palmitoylation of its cytoplasmic Cys residues has not been previously described. Fatty acid-exchange chemistry was used to determine whether channel subunits were Cys-palmitoylated. We observed that only the beta and gamma subunits were modified by Cys palmitoylation. Analyses of ENaCs with mutant beta subunits revealed that Cys-43 and Cys-557 were palmitoylated. Xenopus oocytes expressing ENaC with a beta C43A, C557A mutant had significantly reduced amiloride-sensitive whole cell currents, enhanced Na+ self-inhibition, and reduced single channel P-o when compared with wild-type ENaC, while membrane trafficking and levels of surface expression were unchanged. Computer modeling of cytoplasmic domains indicated that beta Cys-43 is in proximity to the first transmembrane alpha helix, whereas beta Cys-557 is within an amphipathic alpha-helix contiguous with the second transmembrane domain. We propose that beta subunit palmitoylation modulates channel gating by facilitating interactions between cytoplasmic domains and the plasma membrane.	[Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu			National Institutes of Health [DK65161]; National Institutes of Health (Pittsburgh Center for Kidney Research) [DK079307]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, K01DK078734, P30DK079307, R56DK065161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (Pittsburgh Center for Kidney Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK65161 (to T. R. K. and R. P. H.) and DK079307 (Pittsburgh Center for Kidney Research).; Supported by a postdoctoral fellowship award from the American Heart Association.	Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bruns JB, 2003, AM J PHYSIOL-RENAL, V285, pF600, DOI 10.1152/ajprenal.00095.2003; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Crane JM, 2009, BIOPHYS J, V97, P3010, DOI 10.1016/j.bpj.2009.09.017; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Heneghan JF, 2009, J GEN PHYSIOL, V134, P369, DOI 10.1085/jgp.200910203; Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; May A, 1997, J AM SOC NEPHROL, V8, P1813; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Mulugeta S, 2003, J BIOL CHEM, V278, P47979, DOI 10.1074/jbc.M308210200; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Suzuki H, 2008, BBA-BIOMEMBRANES, V1778, P1181, DOI 10.1016/j.bbamem.2007.12.007; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yik JHN, 2002, J BIOL CHEM, V277, P40844, DOI 10.1074/jbc.M204780200; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	71	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30453	30462		10.1074/jbc.M110.151845	http://dx.doi.org/10.1074/jbc.M110.151845			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663869	hybrid, Green Published			2022-12-25	WOS:000282135500012
J	Yuasa, N; Zhang, W; Goto, T; Sakaue, H; Matsumoto-Takasaki, A; Kimura, M; Ohshima, H; Tsuchida, Y; Koizumi, T; Sakai, K; Kojima, T; Yamamoto, K; Nakata, M; Fujita-Yamaguchi, Y				Yuasa, Noriyuki; Zhang, Wei; Goto, Tomohiro; Sakaue, Hiroyuki; Matsumoto-Takasaki, Ayano; Kimura, Miyo; Ohshima, Hiroya; Tsuchida, Yasunobu; Koizumi, Tomoyuki; Sakai, Keiko; Kojima, Takumi; Yamamoto, Kazuo; Nakata, Munehiro; Fujita-Yamaguchi, Yoko			Production of Anti-carbohydrate Antibodies by Phage Display Technologies POTENTIAL IMPAIRMENT OF CELL GROWTH AS A RESULT OF ENDOGENOUS EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN ANTIBODIES; TERMINAL MANNOSE RESIDUES; ENDOPLASMIC-RETICULUM; FUCOSYL-TRANSFERASE; TUMOR-GROWTH; SELECTION; PROTEIN; AFFINITY; RECEPTOR; ANTIGEN	Anti-mannotriose (Man3) antibodies were previously isolated from a Keio phage library displaying human single chain variable fragments (scFvs) using a neoglycolipid, Man3-dipalmitoylphosphatidylethanolamine. Of three genes constructed, the 5A3 clone was expressed in mouse myeloma NS0 cells as a conjugate with human IgG(1) Fc (scFv-Fc) and characterized (Sakai, K., Shimizu, Y., Chiba, T., Matsumoto-Takasaki, A., Kusada, Y., Zhang, W., Nakata, M., Kojima, N., Toma, K., Takayanagi, A., Shimizu, N., and Fujita-Yamaguchi, Y. (2007) Biochemistry 46, 253-262; Zhang, W., Matsumoto- Takasaki, A., Kusada, Y., Sakaue, H., Sakai, K., Nakata, M., and Fujita-Yamaguchi, Y. (2007) Biochemistry 46, 263-270). Similarly, anti-Le(x) phages were screened from the same library with lacto-N-fucopentaose III (LNFPIII; Le(x))-dipalmitoylphosphatidylethanolamine. Of five phage clones isolated, two scFv genes were constructed to express scFv-Fc proteins in NS0 cells. As was experienced with anti-Man3 scFv-Fc clones, only one anti-LNFPIII clone, 1F12, was successfully produced and purified as an scFv-Fc protein. Although anti-LNFPIII 1F12 and anti-Man3 5A3 scFv-Fc proteins were secreted into media, a decline in scFv-Fc production was observed with both stable clones during early passages. Transient expression of anti-LNFPIII and anti-Man3 scFv-Fc genes in COS-7 cells and subsequent analyses of scFv-Fc protein expression revealed accumulation of translated proteins in the endoplasmic reticulum for scFv-Fc proteins derived from clones that did not survive as stable clones. This report describes the following: (i) isolation of anti-LNFPIII scFv genes; (ii) purification of anti-LNFPIII scFv-Fc proteins from stably and transiently expressed cells; and (iii) extracellular or intracellular localization of two anti-LNFPIII and three anti-Man3 scFv-Fc proteins. The results suggest that expression of anti-Man3 and other anti-carbohydrate antibodies in mammalian cells is disadvantageous for cell growth.	[Yuasa, Noriyuki; Zhang, Wei; Goto, Tomohiro; Sakaue, Hiroyuki; Matsumoto-Takasaki, Ayano; Kimura, Miyo; Ohshima, Hiroya; Tsuchida, Yasunobu; Koizumi, Tomoyuki; Sakai, Keiko; Nakata, Munehiro; Fujita-Yamaguchi, Yoko] Tokai Univ, Sch Engn, Dept Appl Biochem, Kanagawa 2591292, Japan; [Kojima, Takumi; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	Tokai University; University of Tokyo	Fujita-Yamaguchi, Y (corresponding author), 4-1-1 Kitakaname, Kanagawa 2591292, Japan.	yamaguch@keyaki.cc.u-tokai.ac.jp			Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [22570125]	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant from the Core Research for Evolutional Science and Technology (CREST) Project, Japan Science and Technology Agency (JST), and Grant 22570125 from the Japan Society for the Promotion of Science.	DENG SJ, 1994, J BIOL CHEM, V269, P9533; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fribley A, 2009, METHODS MOL BIOL, V559, P191, DOI 10.1007/978-1-60327-017-5_14; GERSTEN KM, 1995, J BIOL CHEM, V270, P25047, DOI 10.1074/jbc.270.42.25047; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; KABAT EA, 1991, SEQUENCES PROTEINS I, V1, P103; KODA Y, 1993, BLOOD, V82, P2915; Lee KJ, 2002, J AM CHEM SOC, V124, P12439, DOI 10.1021/ja020737j; Li SL, 2000, CANCER IMMUNOL IMMUN, V49, P243, DOI 10.1007/s002620000115; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Mao SL, 1999, P NATL ACAD SCI USA, V96, P6953, DOI 10.1073/pnas.96.12.6953; Mintz M, 2008, J PROTEOME RES, V7, P2435, DOI 10.1021/pr700842m; NEUMAIER M, 1990, CANCER RES, V50, P2128; Ono KI, 2003, J BIOSCI BIOENG, V95, P231, DOI 10.1016/S1389-1723(03)80022-1; Ravn P, 2004, J MOL BIOL, V343, P985, DOI 10.1016/j.jmb.2004.08.052; Sachdev D, 2003, CANCER RES, V63, P627; Sakai K, 2007, BIOCHEMISTRY-US, V46, P253, DOI 10.1021/bi061875e; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Shimizu Y, 2001, J CHROMATOGR B, V754, P127, DOI 10.1016/S0378-4347(00)00594-6; STOLL MS, 1988, BIOCHEM J, V256, P661, DOI 10.1042/bj2560661; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wu AM, 1996, IMMUNOTECHNOLOGY, V2, P21, DOI 10.1016/1380-2933(95)00027-5; Wu AM, 2001, PROTEIN ENG, V14, P1025, DOI 10.1093/protein/14.12.1025; Ye JJ, 2003, HORM METAB RES, V35, P836; Zhang W, 2007, BIOCHEMISTRY-US, V46, P263, DOI 10.1021/bi0618767	28	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30587	30597		10.1074/jbc.M110.107284	http://dx.doi.org/10.1074/jbc.M110.107284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20667829	Green Published, hybrid			2022-12-25	WOS:000282135500027
J	Collard, F; Stroobant, V; Lamosa, P; Kapanda, CN; Lambert, DM; Muccioli, GG; Poupaert, JH; Opperdoes, F; Van Schaftingen, E				Collard, Francois; Stroobant, Vincent; Lamosa, Pedro; Kapanda, Coco N.; Lambert, Didier M.; Muccioli, Giulio G.; Poupaert, Jacques H.; Opperdoes, Fred; Van Schaftingen, Emile			Molecular Identification of N-Acetylaspartylglutamate Synthase and beta-Citrylglutamate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-GLUTAMIC ACID; ALPHA-ASPARTYLGLUTAMIC ACID; CENTRAL-NERVOUS-SYSTEM; L-ASPARTIC ACID; BRAIN; RAT; ACETYLASPARTATE; NAAG; BIOSYNTHESIS; PROTEIN	The purpose of the present work was to determine the identity of the enzymes that synthesize N-acetylaspartylglutamate (NAAG), the most abundant dipeptide present in vertebrate central nervous system (CNS), and beta-citrylglutamate, a structural analogue of NAAG present in testis and immature brain. Previous evidence suggests that NAAG is not synthesized on ribosomes but presumably is synthesized by a ligase. As attempts to detect this ligase in brain extracts failed, we searched the mammalian genomes for putative enzymes that could catalyze this type of reaction. Mammalian genomes were found to encode two putative ligases homologous to Escherichia coli RIMK, which ligates glutamates to the C terminus of ribosomal protein S6. One of them, named RIMKLA, is almost exclusively expressed in the CNS, whereas RIMKLB, which shares 65% sequence identity with RIMKLA, is expressed in CNS and testis. Both proteins were expressed in bacteria or HEK293T cells and purified. RIMKLA catalyzed the ATP-dependent synthesis of N-acetylaspartylglutamate from N-acetylaspartate and L-glutamate. RIMKLB catalyzed this reaction as well as the synthesis of beta-citrylglutamate. The nature of the reaction products was confirmed by mass spectrometry and NMR. RIMKLA was shown to produce stoichiometric amounts of NAAG and ADP, in agreement with its belonging to the ATP-grasp family of ligases. The molecular identification of these two enzymes will facilitate progress in the understanding of the function of NAAG and beta-citrylglutamate.	[Van Schaftingen, Emile] Catholic Univ Louvain, Chim Physiol Lab, B-1200 Brussels, Belgium; [Stroobant, Vincent] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Opperdoes, Fred] de Duve Inst, Trop Dis Res Unit, B-1200 Brussels, Belgium; [Kapanda, Coco N.; Lambert, Didier M.; Muccioli, Giulio G.; Poupaert, Jacques H.] Catholic Univ Louvain, Unite Chim Pharmaceut & Radiopharm, Louvain Drug Res Inst, CHAM7230, B-1200 Brussels, Belgium; [Kapanda, Coco N.; Lambert, Didier M.; Muccioli, Giulio G.; Poupaert, Jacques H.] Catholic Univ Louvain, Pharmacol Bioact Lipids Lab, Louvain Drug Res Inst, CHAM7230, B-1200 Brussels, Belgium; [Lamosa, Pedro] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Ctr Ressonancia Magnet Antonio Xavier, Estacao Agron Nacl, P-2780157 Oeiras, Portugal	Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; National Institute for Agricultural Research Portugal; Universidade Nova de Lisboa	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Chim Physiol Lab, Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Opperdoes, Fred/N-9922-2019; Opperdoes, Frederik R/C-8897-2018; Van+Schaftingen, Emile/AAF-5532-2020	Opperdoes, Fred/0000-0003-1984-3764; Opperdoes, Frederik R/0000-0003-1984-3764; Van Schaftingen, Emile/0000-0002-6199-7647; Lamosa, Pedro/0000-0002-3003-1516; Muccioli, Giulio/0000-0002-1600-9259	Belgian Science Policy [P6/05, P6/28]; Region Wallonne; Asco Industries; Programa Operacional Ciencia e Inovacao; Fundacao para a Ciencia e a Tecnologia, Portugal	Belgian Science Policy(Belgian Federal Science Policy Office); Region Wallonne; Asco Industries; Programa Operacional Ciencia e Inovacao; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grants from the Interuniversity Attraction Poles Program-Belgian Science Policy (Networks P6/05 and P6/28), by the Desordres Inflammatoires dans les Affections Neurologiques center of excellence program of the Region Wallonne, and by a grant from Asco Industries (to E. V. S.). The NMR spectrometers are part of the National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao 2010" and Fundacao para a Ciencia e a Tecnologia, Portugal.	Arun P, 2006, J NEUROCHEM, V98, P2034, DOI 10.1111/j.1471-4159.2006.04068.x; Burlina AP, 2006, ADV EXP MED BIOL, V576, P283; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; Bzdega T, 1997, J NEUROCHEM, V69, P2270; CANGRO CB, 1987, J NEUROCHEM, V49, P1579, DOI 10.1111/j.1471-4159.1987.tb01030.x; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Delplanque J, 2004, J BIOL CHEM, V279, P46606, DOI 10.1074/jbc.M407678200; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gehl LM, 2004, J NEUROCHEM, V90, P989, DOI 10.1111/j.1471-4159.2004.02578.x; Hamada-Kanazawa M, 2010, BIOL PHARM BULL, V33, P729, DOI 10.1248/bpb.33.729; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KANG WK, 1989, MOL GEN GENET, V217, P281, DOI 10.1007/BF02464894; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kogo H, 2010, J HUM GENET, V55, P293, DOI 10.1038/jhg.2010.26; Li H, 2003, P NATL ACAD SCI USA, V100, P9785, DOI 10.1073/pnas.1733391100; Lieberman EM, 2006, ADV EXP MED BIOL, V576, P303; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; MIYAKE M, 1982, BIOCHIM BIOPHYS ACTA, V719, P495, DOI 10.1016/0304-4165(82)90238-0; MIYAKE M, 1978, BIOCHIM BIOPHYS ACTA, V544, P656, DOI 10.1016/0304-4165(78)90340-9; MIYAKE M, 1981, J NEUROCHEM, V36, P804, DOI 10.1111/j.1471-4159.1981.tb01665.x; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Moffett JR, 2006, ADV EXP MED BIOL, V576, P7; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; REICHELT KL, 1973, J NEUROCHEM, V21, P849, DOI 10.1111/j.1471-4159.1973.tb07529.x; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyson RL, 1998, NEUROSCI LETT, V251, P181, DOI 10.1016/S0304-3940(98)00527-8; Veiga-da-Cunha M, 2010, J BIOL CHEM, V285, P18888, DOI 10.1074/jbc.M110.110924; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wroblewska B, 1997, J NEUROCHEM, V69, P174	36	36	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29826	29833		10.1074/jbc.M110.152629	http://dx.doi.org/10.1074/jbc.M110.152629			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20657015	Green Published, hybrid			2022-12-25	WOS:000281984300018
J	Gao, D; Nong, SW; Huang, XQ; Lu, YG; Zhao, HY; Lin, YJ; Man, Y; Wang, S; Yang, JF; Li, JA				Gao, Dan; Nong, Shanwei; Huang, Xiuqing; Lu, Yonggang; Zhao, Hongye; Lin, Yajun; Man, Yong; Wang, Shu; Yang, Jiefu; Li, Jian			The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38(MAPK) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL DYSFUNCTION; ACTIVATED SIGNALING PATHWAYS; FREE FATTY-ACIDS; NF-KAPPA-B; OXIDATIVE STRESS; SKELETAL-MUSCLE; GLUCOSE OUTPUT; GLUCONEOGENESIS; INHIBITION; EXPRESSION	Elevated plasma free fatty acid (FFA) levels in obesity may play a pathogenic role in the development of insulin resistance. However, molecular mechanisms linking FFA to insulin resistance remain poorly understood. Oxidative stress acts as a link between FFA and hepatic insulin resistance. NADPH oxidase 3 (NOX3)-derived reactive oxygen species (ROS) may mediate the effect of TNF-alpha on hepatocytes, in particular the drop in cellular glycogen content. In the present study, we define the critical role of NOX3-derived ROS in insulin resistance in db/db mice and HepG2 cells treated with palmitate. The db/db mice displayed increased serum FFA levels, excess generation of ROS, and up-regulation of NOX3 expression, accompanied by increased lipid accumulation and impaired glycogen content in the liver. Similar results were obtained from palmitate-treated HepG2 cells. The exposure of palmitate elevated ROS production and NOX3 expression and, in turn, increased gluconeogenesis and reduced glycogen content in HepG2 cells. We found that palmitate induced hepatic insulin resistance through JNK and p38(MAPK) pathways, which are rescued by siRNA-mediated NOX3 reduction. In conclusion, our data demonstrate a critical role of NOX3-derived ROS in palmitate-induced insulin resistance in hepatocytes, indicating that NOX3 is the predominant source of palmitate-induced ROS generation and that NOX3-derived ROS may drive palmitate-induced hepatic insulin resistance through JNK and p38(MAPK) pathways.	[Gao, Dan; Nong, Shanwei; Huang, Xiuqing; Lu, Yonggang; Zhao, Hongye; Lin, Yajun; Man, Yong; Wang, Shu; Yang, Jiefu; Li, Jian] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China; [Gao, Dan; Nong, Shanwei; Huang, Xiuqing; Lu, Yonggang; Zhao, Hongye; Lin, Yajun; Man, Yong; Wang, Shu; Yang, Jiefu; Li, Jian] Minist Hlth, Beijing Inst Geriatr, Beijing 100730, Peoples R China; [Gao, Dan; Lu, Yonggang; Zhao, Hongye; Li, Jian] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Gao, Dan; Lu, Yonggang; Zhao, Hongye; Li, Jian] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Yang, JF (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China.	ltaoy@263.net; lijian@bjhmoh.cn	LI, RUIJIAN/GYJ-0470-2022		National Basic Research Program of China [2006CB503910]; National Natural Science Foundation of China [30572082]; Natural Science Foundation of Beijing [7052059]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by National Basic Research Program of China Grant 2006CB503910), National Natural Science Foundation of China Grant 30572082, and Natural Science Foundation of Beijing Grant 7052059.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Archuleta TL, 2009, FREE RADICAL BIO MED, V47, P1486, DOI 10.1016/j.freeradbiomed.2009.08.014; Azevedo-Martins AK, 2006, TOXICOL IN VITRO, V20, P1106, DOI 10.1016/j.tiv.2006.02.007; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Ciaraldi TP, 2006, AM J PHYSIOL-ENDOC M, V291, pE891, DOI 10.1152/ajpendo.00176.2006; Davis JE, 2009, HORM METAB RES, V41, P523, DOI 10.1055/s-0029-1202852; Delbosc S, 2005, ATHEROSCLEROSIS, V179, P43, DOI 10.1016/j.atherosclerosis.2004.10.018; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Fridlyand LE, 2006, DIABETES OBES METAB, V8, P136, DOI 10.1111/j.1463-1326.2005.00496.x; Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; Ghosh J, 2009, TOXICOL APPL PHARM, V240, P73, DOI 10.1016/j.taap.2009.07.008; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Haber EP, 2006, INT REV CYTOL, V248, P1, DOI 10.1016/S0074-7696(06)48001-3; Haus JM, 2010, J CLIN ENDOCR METAB, V95, P323, DOI 10.1210/jc.2009-1101; Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ito Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2191, DOI 10.1271/bbb.60135; Jensen J, 2006, AM J PHYSIOL-ENDOC M, V290, pE154, DOI 10.1152/ajpendo.00330.2005; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kamata Y, 2007, NEUROSCIENCE, V146, P1073, DOI 10.1016/j.neuroscience.2007.03.001; Kaneto H, 2004, DRUG NEWS PERSPECT, V17, P447, DOI 10.1358/dnp.2004.17.7.863704; Katakam AK, 2005, J ENDOCRINOL, V187, P237, DOI 10.1677/joe.1.06411; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Li LF, 2010, FEBS LETT, V584, P995, DOI 10.1016/j.febslet.2010.01.044; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu JR, 2010, AM J PHYSIOL-ENDOC M, V298, pE565, DOI 10.1152/ajpendo.00467.2009; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Petersen KF, 2006, OBESITY, V14, p34S, DOI 10.1038/oby.2006.280; Ragheb R, 2009, BIOCHEM BIOPH RES CO, V389, P211, DOI 10.1016/j.bbrc.2009.08.106; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Wu MY, 2007, ANN NUTR METAB, V51, P270, DOI 10.1159/000105448; Yu X, 2009, ACTA BIOCH BIOPH SIN, V41, P1027, DOI 10.1093/abbs/gmp097	50	238	253	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29965	29973		10.1074/jbc.M110.128694	http://dx.doi.org/10.1074/jbc.M110.128694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647313	hybrid, Green Published			2022-12-25	WOS:000281984300033
J	Li, CY; Yu, SL; Nakamura, F; Pentikainen, OT; Singh, N; Yin, SM; Xin, W; Sy, MS				Li, Chaoyang; Yu, Shuiliang; Nakamura, Fumihiko; Pentikainen, Olli T.; Singh, Neena; Yin, Shaoman; Xin, Wei; Sy, Man-Sun			Pro-prion Binds Filamin A, Facilitating Its Interaction with Integrin beta 1, and Contributes to Melanomagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; STRUCTURAL BASIS; ARP2/3 COMPLEX; CELL-MIGRATION; PROTEIN; EXPRESSION; ACTIVATION; DISEASE; CYTOSKELETON; TRAFFICKING	Filamin A (FLNA) is an integrator of cell mechanics and signaling. The spreading and migration observed in FLNA sufficient A7 melanoma cells but not in the parental FLNA deficient M2 cells have been attributed to FLNA. In A7 and M2 cells, the normal prion (PrP) exists as pro-PrP, retaining its glycosylphosphatidyl-inositol (GPI) anchor peptide signal sequence (GPIPSS). The GPI-PSS of PrP has a FLNA binding motif and binds FLNA. Reducing PrP expression in A7 cells alters the spatial distribution of FLNA and organization of actin and diminishes cell spreading and migration. Integrin beta 1 also binds FLNA. In A7 cells, FLNA, PrP, and integrin beta 1 exist as two independent, yet functionally linked, complexes; they are FLNA with PrP or FLNA with integrin beta 1. Reducing PrP expression in A7 cells decreases the amount of integrin beta 1 bound to FLNA. A PrP GPI-PSS synthetic peptide that crosses the cell membrane inhibitsA7 cell spreading and migration. Thus, in A7 cells FLNA does not act alone; the binding of pro-PrP enhances association between FLNA and integrin beta 1, which then promotes cell spreading and migration. Pro-PrP is detected in melanoma in situ but not in melanocyte. Invasive melanoma has more pro-PrP. The binding of pro-PrP to FLNA, therefore, contributes to melanomagenesis.	[Sy, Man-Sun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Xin, Wei] Case Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Nakamura, Fumihiko] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA; [Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol, Environm Sci & Nanosci Ctr, FI-40014 Jyvaskyla, Finland	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Jyvaskyla	Sy, MS (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Rm 5131,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	man-sun.sy@case.edu	Pentikäinen, Olli T/E-1980-2012; Nakamura, Fumihiko/N-5476-2016	Pentikäinen, Olli T/0000-0001-7188-4016; Nakamura, Fumihiko/0000-0002-6872-4246	National Institutes of Health [R21-CA133559-01]; Skin Disease Research Center, NIAMS [AR039750]; NATIONAL CANCER INSTITUTE [R21CA133559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skin Disease Research Center, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-CA133559-01 and Pilot Grant AR039750 (Skin Disease Research Center, NIAMS; to M.-S.S. and K. Cooper).	AKASAKA T, 1995, J INVEST DERMATOL, V105, P104, DOI 10.1111/1523-1747.ep12313396; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; BOUFFARD D, 1994, HUM PATHOL, V25, P709, DOI 10.1016/0046-8177(94)90305-0; BYERS HR, 1991, AM J PATHOL, V139, P423; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Chiesa R, 2009, PLOS BIOL, V7, P439, DOI 10.1371/journal.pbio.1000075; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Edward Michael, 1995, Current Opinion in Oncology, V7, P185, DOI 10.1097/00001622-199503000-00015; Feng SJ, 2003, BLOOD, V102, P2122, DOI 10.1182/blood-2002-12-3805; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; He HJ, 2003, J BIOL CHEM, V278, P27096, DOI 10.1074/jbc.M301003200; Hegde RS, 2003, TRENDS NEUROSCI, V26, P337, DOI 10.1016/S0166-2236(03)00143-7; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; High Whitney A, 2007, Adv Dermatol, V23, P61, DOI 10.1016/j.yadr.2007.07.009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2008, EXP CELL RES, V314, P834, DOI 10.1016/j.yexcr.2007.11.022; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Pammer J, 1998, AM J PATHOL, V153, P1353, DOI 10.1016/S0002-9440(10)65720-3; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Playford MP, 2010, J BIOL CHEM, V285, P17156, DOI 10.1074/jbc.M109.080523; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Soderling SH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.255pe5; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Yin S, 2008, J BIOL CHEM, V283, P25446, DOI 10.1074/jbc.M800814200; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zhu TN, 2007, J BIOL CHEM, V282, P14816, DOI 10.1074/jbc.M611430200	46	42	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30328	30339		10.1074/jbc.M110.147413	http://dx.doi.org/10.1074/jbc.M110.147413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650901	Green Published, hybrid			2022-12-25	WOS:000281984300068
J	Quintero, CA; Giraudo, CG; Villarreal, M; Montich, G; Maccioni, HJF				Quintero, Cristian A.; Giraudo, Claudio G.; Villarreal, Marcos; Montich, Guillermo; Maccioni, Hugo J. F.			Identification of a Site in Sar1 Involved in the Interaction with the Cytoplasmic Tail of Glycolipid Glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM EXPORT; COPII COAT; ER EXPORT; TRANSPORT VESICLES; GOLGI-APPARATUS; CARGO SELECTION; PROTEINS; COMPLEX; ENERGY; SUBUNIT	Glycolipid glycosyltransferases (GGT) are transported from the endoplasmic reticulum (ER) to the Golgi, their site of residence, via COPII vesicles. An interaction of a (R/K) X(R/K) motif at their cytoplasmic tail (CT) with Sar1 is critical for the selective concentration in the transport vesicles. In this work using computational docking, we identify three putative binding pockets in Sar1(sites A, B, and C) involved in the interaction with the (R/K) X(R/K) motif. Sar1 mutants with alanine replacement of amino acids in site A were tested in vitro and in cells. In vitro, mutant versions showed a reduced ability to bind immobilized peptides with the CT sequence of GalT2. In cells, Sar1 mutants (Sar1(D198A)) specifically affect the exiting of GGT from the ER, resulting in an ER/Golgi concentration ratio favoring the ER. Neither the typical Golgi localization of GM130 nor the exiting and transport of the G protein of the vesicular stomatitis virus were affected. The protein kinase inhibitor H89 produced accumulation of Sec23, Sar1, and GalT2 at the ER exit sites; Sar1(D189A) also accumulated at these sites, but in this case GalT2 remained disperse along ER membranes. The results indicate that amino acids in site A of Sar1 are involved in the interaction with the CT of GGT for concentration at ER exiting sites.	[Quintero, Cristian A.; Giraudo, Claudio G.; Villarreal, Marcos; Montich, Guillermo; Maccioni, Hugo J. F.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CIQUIBIC,CONICET, RA-5000 Cordoba, Argentina	National University of Cordoba	Maccioni, HJF (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CIQUIBIC,CONICET, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	maccioni@dqb.fcq.unc.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica del Ministerio de Ciencia; Tecnologia e Innovacion Productiva de la Nacion Argentina; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba; Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica del Ministerio de Ciencia(ANPCyT); Tecnologia e Innovacion Productiva de la Nacion Argentina; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica del Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion Argentina, from the Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba, and from the Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina. H. J. F. M., M. V., and G. M. are career members, and CQ fellow, of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina.	Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lavigne P, 2000, PROTEIN SCI, V9, P252; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Storrie B, 2000, TRENDS CELL BIOL, V10, P385, DOI 10.1016/S0962-8924(00)01818-3; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x	32	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30340	30346		10.1074/jbc.M110.128868	http://dx.doi.org/10.1074/jbc.M110.128868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650895	Green Published, hybrid			2022-12-25	WOS:000281984300069
J	Zhu, XJ; Liu, XY; Jin, Q; Cai, YQ; Yang, YH; Zhou, TH				Zhu, Xiao-Jing; Liu, Xunyan; Jin, Qi; Cai, Yuqi; Yang, Yuehong; Zhou, Tianhua			The L279P Mutation of Nuclear Distribution Gene C (NudC) Influences Its Chaperone Activity and Lissencephaly Protein 1 (LIS1) Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; NEURONAL MIGRATION; CYTOPLASMIC DYNEIN; ASPERGILLUS-NIDULANS; MOVEMENT PROTEIN; P23; ATPASE; HEAT-SHOCK-PROTEIN-90; COMPONENT; MACHINERY	LIS1, a gene mutated in classical lissencephaly, plays essential roles in cytoplasmic dynein regulation, mitosis and cell migration. However, the regulation of LIS1 (lissencephaly protein 1) protein remains largely unknown. Genetic studies in Aspergillus nidulans have uncovered that the Nud (nuclear distribution) pathway is involved in the regulation of cytoplasmic dynein complex and a temperature-sensitive mutation in the nudC gene (L146P) greatly reduces the protein levels of NudF, an Aspergillus ortholog of LIS1. Here, we showed that L146 in Aspergillus NudC and its flanking region were highly conservative during evolution. The similar mutation in human NudC (L279P) obviously led to reduced LIS1 and cellular phenotypes similar to those of LIS1 down-regulation. To explore the underlying mechanism, we found that the p23 domain-containing protein NudC bound to the molecular chaperone Hsp90, which is also associated with LIS1. Inhibition of Hsp90 chaperone function by either geldanamycin or radicicol resulted in a decrease in LIS1 levels. Ectopic expression of Hsp90 partially reversed the degradation of LIS1 caused by overexpression of NudC-L279P. Furthermore, NudC was found to regulate the ATPase activity of Hsp90, which was repressed by the mutation of L279P. Interestingly, NudC itself was shown to possess a chaperone function, which also was suppressed by the L279P mutation. Together, these data suggest that NudC may be involved in the regulation of LIS1 stability by its chaperone function.	[Zhou, Tianhua] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, TH (corresponding author), Zhejiang Univ, Sch Med, Dept Cell Biol, POB 16,388 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	tzhou@zju.edu.cn	zhou, tianhua/K-4908-2013	zhou, tianhua/0000-0002-1791-2124; yang, Yuehong/0000-0001-5438-8395	Natural Scientific Foundation of China [30671070, 30771107, 30901714]; Ministry of Science and Technology of China [2007CB914500]; Ministry of Education of China [NCET-06-0530]; Science Foundation of Chinese University; Natural Scientific Foundation of Zhejiang Province, China [Z2100247, Y2100106, Y207382]; Department of Health of Zhejiang Province [WKJ2006-2- 014]; Department of Science and Technology of Zhejiang Province [2009F80032]; Postdoctoral Scientific Foundation of China [20080441267]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Department of Health of Zhejiang Province; Department of Science and Technology of Zhejiang Province; Postdoctoral Scientific Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the Natural Scientific Foundation of China (30671070, 30771107, and 30901714), the Ministry of Science and Technology of China (2007CB914500), the Ministry of Education of China (NCET-06-0530), the Science Foundation of Chinese University, the Natural Scientific Foundation of Zhejiang Province, China (Z2100247, Y2100106, and Y207382), the Department of Health of Zhejiang Province (WKJ2006-2- 014), the Department of Science and Technology of Zhejiang Province (2009F80032), and the Postdoctoral Scientific Foundation of China (20080441267).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chiu YH, 1997, MOL BIOL CELL, V8, P1735, DOI 10.1091/mbc.8.9.1735; CHIU YH, 1995, GENETICS, V141, P453; Chiu YH, 1997, GENETICS, V145, P707; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Faircloth LM, 2009, CELL STRESS CHAPERON, V14, P95, DOI 10.1007/s12192-008-0061-1; Fang SP, 2009, CELL IMMUNOL, V259, P49, DOI 10.1016/j.cellimm.2009.05.012; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Jurkuta RJ, 2009, PLANT CELL, V21, P1957, DOI 10.1105/tpc.108.065284; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; LO NC, 1997, HUM MOL GENET, V6, P157; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Morishima Y, 2003, J BIOL CHEM, V278, P48754, DOI 10.1074/jbc.M309814200; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perez DE, 2009, PLANT PHYSIOL, V151, P241, DOI 10.1104/pp.109.142125; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Riera J, 2009, CELL MOL LIFE SCI, V66, P2383, DOI 10.1007/s00018-009-0025-3; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tu CJ, 2005, J PROTEOME RES, V4, P1265, DOI 10.1021/pr0497529; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zabka M, 2008, BIOCHEM BIOPH RES CO, V370, P179, DOI 10.1016/j.bbrc.2008.03.055; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103	61	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29903	29910		10.1074/jbc.M110.105494	http://dx.doi.org/10.1074/jbc.M110.105494			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20675372	hybrid, Green Published			2022-12-25	WOS:000281984300027
J	Phillips, A; Teunisse, A; Lam, S; Lodder, K; Darley, M; Emaduddin, M; Wolf, A; Richter, J; de Lange, J; Verlaan-de Vries, M; Lenos, K; Bohnke, A; Bartel, F; Blaydes, JP; Jochemsen, AG				Phillips, Anna; Teunisse, Amina; Lam, Suzanne; Lodder, Kirsten; Darley, Matthew; Emaduddin, Muhammad; Wolf, Anja; Richter, Julia; de Lange, Job; Verlaan-de Vries, Matty; Lenos, Kristiaan; Boehnke, Anja; Bartel, Frank; Blaydes, Jeremy P.; Jochemsen, Aart G.			HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; HUMAN TUMOR-CELLS; DNA-DAMAGE; TRANSCRIPTION-FACTOR; IN-VIVO; P53-BINDING PROTEIN; GENOTOXIC STRESS; LIGASE ACTIVITY; HUMAN MDM2; ACTIVATION	The p53 regulatory network is critically involved in preventing the initiation of cancer. In unstressed cells, p53 is maintained at low levels and is largely inactive, mainly through the action of its two essential negative regulators, HDM2 and HDMX. p53 abundance and activity are up-regulated in response to various stresses, including DNA damage and oncogene activation. Active p53 initiates transcriptional and transcription-independent programs that result in cell cycle arrest, cellular senescence, or apoptosis. p53 also activates transcription of HDM2, which initially leads to the degradation of HDMX, creating a positive feedback loop to obtain maximal activation of p53. Subsequently, when stress-induced post-translational modifications start to decline, HDM2 becomes effective in targeting p53 for degradation, thus attenuating the p53 response. To date, no clear function for HDMX in this critical attenuation phase has been demonstrated experimentally. Like HDM2, the HDMX gene contains a promoter (P2) in its first intron that is potentially inducible by p53. We show that p53 activation in response to a plethora of p53-activating agents induces the transcription of a novel HDMX mRNA transcript from the HDMX-P2 promoter. This mRNA is more efficiently translated than that expressed from the constitutive HDMX-P1 promoter, and it encodes a long form of HDMX protein, HDMX-L. Importantly, we demonstrate that HDMX-L cooperates with HDM2 to promote the ubiquitination of p53 and that p53-induced HDMX transcription from the P2 promoter can play a key role in the attenuation phase of the p53 response, to effectively diminish p53 abundance as cells recover from stress.	[Phillips, Anna; Darley, Matthew; Emaduddin, Muhammad; Blaydes, Jeremy P.] Univ Southampton, Southampton Gen Hosp, Southampton Canc Res UK Ctr, Sch Med, Southampton SO16 6YD, Hants, England; [Teunisse, Amina; Lam, Suzanne; Lodder, Kirsten; de Lange, Job; Verlaan-de Vries, Matty; Lenos, Kristiaan; Jochemsen, Aart G.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Wolf, Anja; Richter, Julia; Boehnke, Anja; Bartel, Frank] Univ Halle Wittenberg, Fac Med, D-06108 Halle, Germany	University of Southampton; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Martin Luther University Halle Wittenberg	Blaydes, JP (corresponding author), Univ Southampton, Southampton Gen Hosp, Southampton Canc Res UK Ctr, Sch Med, Southampton SO16 6YD, Hants, England.	j.p.blaydes@soton.ac.uk; a.g.jochemsen@lumc.nl	Blaydes, Jeremy/AAC-6939-2019	Blaydes, Jeremy/0000-0001-8525-0209; de Lange, Job/0000-0002-9002-8829	Association for International Cancer Research [07-0437, 05-273]; Dutch Cancer Society [UL 2006-3595]; European Community [503576]; Wilhelm-Sander-Stiftung [2006.010.1]; Deutsche Krebshilfe [108424]; University of Halle-Wittenberg [12/40]; Fritz-Thyssen-Stiftung [Az 10.09.2.117]	Association for International Cancer Research; Dutch Cancer Society(KWF Kankerbestrijding); European Community(European Commission); Wilhelm-Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); University of Halle-Wittenberg; Fritz-Thyssen-Stiftung	This work was supported by Association for International Cancer Research Grants 07-0437 (to J. P. B.) and 05-273 (to A. G. J.), Dutch Cancer Society Grant UL 2006-3595, and European Community FP6 funding (Contract 503576) (to A. G. J.). This work was also supported by Wilhelm-Sander-Stiftung Grant 2006.010.1, Deutsche Krebshilfe Grant 108424, Wilhelm-Roux-Programm of the University of Halle-Wittenberg Grant 12/40, and Fritz-Thyssen-Stiftung Grant Az 10.09.2.117.	Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Bauer S, 2010, EUR UROL, V57, P679, DOI 10.1016/j.eururo.2009.06.014; Blaydes JP, 1998, ONCOGENE, V16, P3317, DOI 10.1038/sj.onc.1201880; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burger H, 1999, INT J CANCER, V81, P620, DOI 10.1002/(SICI)1097-0215(19990517)81:4<620::AID-IJC19>3.3.CO;2-J; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kessler BM, 2007, J PROTEOME RES, V6, P4163, DOI 10.1021/pr0702161; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Landers JE, 1997, CANCER RES, V57, P3562; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Li BZ, 2010, CELL CYCLE, V9, P1411, DOI 10.4161/cc.9.7.11255; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Markey M, 2008, ONCOGENE, V27, P6657, DOI 10.1038/onc.2008.266; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Onel K, 2004, MOL CANCER RES, V2, P1; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Phelps M, 2003, CANCER RES, V63, P2616; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tait L, 1996, INT J ONCOL, V9, P263; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Wahl GM, 2006, CELL DEATH DIFFER, V13, P973, DOI 10.1038/sj.cdd.4401911; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang YYV, 2009, CELL CYCLE, V8, P3443, DOI 10.4161/cc.8.21.9744; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wiederschain D, 2001, J BIOL CHEM, V276, P27999, DOI 10.1074/jbc.M102400200; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Wynford-Thomas D, 1998, CARCINOGENESIS, V19, P29, DOI 10.1093/carcin/19.1.29; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584	73	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29111	29127		10.1074/jbc.M110.129726	http://dx.doi.org/10.1074/jbc.M110.129726			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20659896	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000281740100012
J	Cheshenko, N; Trepanier, JB; Segarra, TJ; Fuller, AO; Herold, BC				Cheshenko, Natalia; Trepanier, Janie B.; Segarra, Theodore J.; Fuller, A. Oveta; Herold, Betsy C.			HSV Usurps Eukaryotic Initiation Factor 3 Subunit M for Viral Protein Translation: Novel Prevention Target	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TO-CELL SPREAD; HIV-1 ACQUISITION; GLYCOPROTEIN-B; GENITAL HERPES; PORCINE CELLS; C-TERMINUS; ENTRY; RECEPTOR; TYPE-1	Prevention of genital herpes is a global health priority. B5, a recently identified ubiquitous human protein, was proposed as a candidate HSV entry receptor. The current studies explored its role in HSV infection. Viral plaque formation was reduced by similar to 90% in human cells transfected with small interfering RNA targeting B5 or nectin-1, an established entry receptor. However, the mechanisms were distinct. Silencing of nectin-1 prevented intracellular delivery of viral capsids, nuclear transport of a viral tegument protein, and release of calcium stores required for entry. In contrast, B5 silencing had no effect on these markers of entry, but inhibited viral protein translation. Specifically, viral immediate early genes, ICP0 and ICP4, were transcribed, polyadenylated and transported from the nucleus to the cytoplasm, but the viral transcripts did not associate with ribosomes or polysomes in B5-silenced cells. In contrast, immediate early gene viral transcripts were detected in polysome fractions isolated from control cells. These findings are consistent with sequencing studies demonstrating that B5 is eukaryotic initiation factor 3 subunit m (eIF3m). Although B5 silencing altered the polysome profile of cells, silencing had little effect on cellular RNA or protein expression and was not cytotoxic, suggesting that this subunit is not essential for host cellular protein synthesis. Together these results demonstrate that B5 plays a major role in the initiation of HSV protein translation and could provide a novel target for strategies to prevent primary and recurrent herpetic disease.	[Cheshenko, Natalia; Trepanier, Janie B.; Segarra, Theodore J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Cheshenko, Natalia; Trepanier, Janie B.; Segarra, Theodore J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA; [Fuller, A. Oveta] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan	Cheshenko, N (corresponding author), Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA.	betsy.herold@einstein.yu.edu	Cheshenko, Natalia/ABF-5896-2021	Herold, Betsy/0000-0001-9974-0786	NIH [AI061679, AI70202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061679, U19AI070202, R01AI061679] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI061679 and AI70202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown OJ, 2007, BIOPHYS J, V93, P1068, DOI 10.1529/biophysj.106.100958; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Cheshenko N, 2005, J BIOL CHEM, V280, P31116, DOI 10.1074/jbc.M503518200; Cheshenko N, 2004, ANTIMICROB AGENTS CH, V48, P2025, DOI 10.1128/AAC.48.6.2025-2036.2004; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Cheshenko N, 2002, J GEN VIROL, V83, P2247, DOI 10.1099/0022-1317-83-9-2247; Cheshenko N, 2007, MOL BIOL CELL, V18, P3119, DOI 10.1091/mbc.E07-01-0062; Chew SK, 2009, NATURE, V460, P123, DOI 10.1038/nature08087; Conrad NK, 2008, METHOD ENZYMOL, V449, P317, DOI 10.1016/S0076-6879(08)02415-4; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; GELMAN IH, 1985, P NATL ACAD SCI USA, V82, P5265, DOI 10.1073/pnas.82.16.5265; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Herold BC, 1997, ANTIMICROB AGENTS CH, V41, P2776, DOI 10.1128/AAC.41.12.2776; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Kutluay SB, 2009, J VIROL, V83, P3436, DOI 10.1128/JVI.02349-08; Larralde O, 2006, J VIROL, V80, P1588, DOI 10.1128/JVI.80.3.1588-1591.2006; Mesquita PMM, 2008, J VIROL, V82, P6576, DOI 10.1128/JVI.00335-08; Mohr I, 2004, INT REV IMMUNOL, V23, P199, DOI 10.1080/08830180490265600; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Perez A, 2005, J VIROL, V79, P7419, DOI 10.1128/JVI.79.12.7419-7430.2005; Perez A, 1998, VIRUS RES, V58, P21, DOI 10.1016/S0168-1702(98)00097-5; Perez-Romero P, 2005, J VIROL, V79, P7431, DOI 10.1128/JVI.79.12.7431-7437.2005; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Roberts Craig, 2005, Herpes, V12, P10; SUBRAMANIAN G, 1995, J GEN VIROL, V76, P2375, DOI 10.1099/0022-1317-76-9-2375; Walsh D, 2006, GENE DEV, V20, P461, DOI 10.1101/gad.1375006; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wilson SS, 2009, EXPERT REV ANTI-INFE, V7, P559, DOI [10.1586/eri.09.34, 10.1586/ERI.09.34]; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	33	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11829	10.1371/journal.pone.0011829	http://dx.doi.org/10.1371/journal.pone.0011829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676407	Green Submitted, Green Published, gold			2022-12-25	WOS:000280371800023
J	Dibble, CF; Horst, JA; Malone, MH; Park, K; Temple, B; Cheeseman, H; Barbaro, JR; Johnson, GL; Bencharit, S				Dibble, Christopher F.; Horst, Jeremy A.; Malone, Michael H.; Park, Kun; Temple, Brenda; Cheeseman, Holly; Barbaro, Justin R.; Johnson, Gary L.; Bencharit, Sompop			Defining the Functional Domain of Programmed Cell Death 10 through Its Interactions with Phosphatidylinositol-3,4,5-Trisphosphate	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; PROTEIN-STRUCTURE PREDICTION; SIZE-EXCLUSION CHROMATOGRAPHY; LASER-LIGHT SCATTERING; CRYSTAL-STRUCTURE; MEMBRANE CURVATURE; NATURAL-HISTORY; COILED-COILS; BAR-DOMAIN; MUTATIONS	Cerebral cavernous malformations (CCM) are vascular abnormalities of the central nervous system predisposing blood vessels to leakage, leading to hemorrhagic stroke. Three genes, Krit1 (CCM1), OSM (CCM2), and PDCD10 (CCM3) are involved in CCM development. PDCD10 binds specifically to PtdIns(3,4,5) P3 and OSM. Using threading analysis and multi-template modeling, we constructed a three-dimensional model of PDCD10. PDCD10 appears to be a six-helical-bundle protein formed by two heptad-repeat-hairpin structures (alpha 1-3 and alpha 4-6) sharing the closest 3D homology with the bacterial phosphate transporter, PhoU. We identified a stretch of five lysines forming an amphipathic helix, a potential PtdIns(3,4,5) P3 binding site, in the alpha 5 helix. We generated a recombinant wild-type (WT) and three PDCD10 mutants that have two (Delta 2KA), three (Delta 3KA), and five (Delta 5KA) K to A mutations. Delta 2KA and Delta 3KA mutants hypothetically lack binding residues to PtdIns(3,4,5) P3 at the beginning and the end of predicted helix, while Delta 5KA completely lacks all predicted binding residues. The WT, Delta 2KA, and Delta 3KA mutants maintain their binding to PtdIns(3,4,5) P3. Only the Delta 5KA abolishes binding to PtdIns(3,4,5) P3. Both Delta 5KA and WT show similar secondary and tertiary structures; however, Delta 5KA does not bind to OSM. When WT and Delta 5KA are co-expressed with membrane-bound constitutively-active PI3 kinase (p110-CAAX), the majority of the WT is co-localized with p110-CAAX at the plasma membrane where PtdIns(3,4,5) P3 is presumably abundant. In contrast, the Delta 5KA remains in the cytoplasm and is not present in the plasma membrane. Combining computational modeling and biological data, we propose that the CCM protein complex functions in the PI3K signaling pathway through the interaction between PDCD10 and PtdIns(3,4,5) P3.	[Dibble, Christopher F.; Malone, Michael H.; Temple, Brenda; Johnson, Gary L.; Bencharit, Sompop] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Dibble, Christopher F.; Malone, Michael H.; Temple, Brenda; Johnson, Gary L.; Bencharit, Sompop] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Park, Kun; Cheeseman, Holly; Barbaro, Justin R.; Bencharit, Sompop] Univ N Carolina, Sch Dent, Dept Prosthodont, Chapel Hill, NC 27599 USA; [Park, Kun; Cheeseman, Holly; Barbaro, Justin R.; Bencharit, Sompop] Univ N Carolina, Dent Res Ctr, Sch Dent, Chapel Hill, NC 27599 USA; [Horst, Jeremy A.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Horst, Jeremy A.] Univ Washington, Sch Dent, Dept Oral Biol, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dibble, CF (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	Sompop_Bencharit@dentistry.unc.edu	Bencharit, Sompop/AAO-8563-2020		National Institutes of Health (NIH) [HL092338, GM068820, GM068820-S1, T32GM80079]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092338, F30HL108598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F30DE017522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079, R01GM068820] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the National Institutes of Health (NIH) grant HL092338 (to S. B.) GM068820 and GM068820-S1 (to G.L.J.), and T32GM80079 (to C. F. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; Becker Y, 2007, VIRUS GENES, V34, P233, DOI 10.1007/s11262-007-0082-3; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen L, 2009, J NEUROSURG-SPINE, V10, P3, DOI 10.3171/2008.9.SPI0822; Cheng YH, 2007, COMM COM INF SC, V2, P1; Clatterbuck RE, 2002, J NEUROSURG, V97, P227, DOI 10.3171/spi.2002.97.2.0227; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; Davenport WJ, 2001, NEUROLOGY, V56, P540, DOI 10.1212/WNL.56.4.540; DELCURLING O, 1991, J NEUROSURG, V75, P702, DOI 10.3171/jns.1991.75.5.0702; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Dupre N, 2003, CAN J NEUROL SCI, V30, P122, DOI 10.1017/S0317167100053385; Eerola I, 2000, HUM MOL GENET, V9, P1351, DOI 10.1093/hmg/9.9.1351; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gidh AV, 2006, J CHROMATOGR A, V1114, P102, DOI 10.1016/j.chroma.2006.02.044; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hung LH, 2005, NUCLEIC ACIDS RES, V33, pW77, DOI 10.1093/nar/gki403; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kryshtafovych A, 2005, PROTEINS, V61, P19, DOI 10.1002/prot.20718; Labauge P, 1998, LANCET, V352, P1892, DOI 10.1016/S0140-6736(98)03011-6; Laberge-Le Couteulx S, 2002, ARCH OPHTHALMOL-CHIC, V120, P217; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Marti-Renom MA, 2001, BIOINFORMATICS, V17, P746, DOI 10.1093/bioinformatics/17.8.746; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Murphy GA, 2002, J BIOL CHEM, V277, P9966, DOI 10.1074/jbc.M109059200; Oganesyan V, 2005, J BACTERIOL, V187, P4238, DOI 10.1128/JB.187.12.4238-4244.2005; Oliva A, 2001, J PHARMACEUT BIOMED, V25, P833, DOI 10.1016/S0731-7085(01)00359-4; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PICKETT SD, 1993, J MOL BIOL, V231, P825, DOI 10.1006/jmbi.1993.1329; Prutzman KC, 2004, STRUCTURE, V12, P881, DOI 10.1016/S0969-2126(04)00097-8; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Russell DS, 1989, PATHOLOGY TUMOURS NE, P730; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Saraf MC, 2003, PROTEIN ENG, V16, P397, DOI 10.1093/protein/gzg053; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Verlaan DJ, 2004, ANN NEUROL, V55, P757, DOI 10.1002/ana.20112; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Wang K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000181; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zabramski JM, 1999, NEUROSURG CLIN N AM, V10, P395, DOI 10.1016/S1042-3680(18)30174-8; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zhang J, 2000, NEUROSURGERY, V46, P1272, DOI 10.1097/00006123-200005000-00064; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	70	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11740	10.1371/journal.pone.0011740	http://dx.doi.org/10.1371/journal.pone.0011740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668527	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243800014
J	Chang, NH; Cheung, YH; Loh, C; Pau, E; Roy, V; Cai, YC; Wither, J				Chang, Nan-Hua; Cheung, Yui-Ho; Loh, Christina; Pau, Evelyn; Roy, Valerie; Cai, Yong-Chun; Wither, Joan			B Cell Activating Factor (BAFF) and T Cells Cooperate to Breach B Cell Tolerance in Lupus-Prone New Zealand Black (NZB) Mice	PLOS ONE			English	Article							FC-GAMMA-RIIB; LYMPHOCYTE STIMULATOR; TRANSGENIC MICE; AUTOIMMUNE-DISEASE; PROMOTER REGION; SELF-TOLERANCE; CUTTING EDGE; IN-VIVO; SURVIVAL; ERYTHEMATOSUS	The presence of autoantibodies in New Zealand Black (NZB) mice suggests a B cell tolerance defect however the nature of this defect is unknown. To determine whether defects in B cell anergy contribute to the autoimmune phenotype in NZB mice, soluble hen egg lysozyme (sHEL) and anti-HEL Ig transgenes were bred onto the NZB background to generate double transgenic (dTg) mice. NZB dTg mice had elevated levels of anti-HEL antibodies, despite apparently normal B cell functional anergy in-vitro. NZB dTg B cells also demonstrated increased survival and abnormal entry into the follicular compartment following transfer into sHEL mice. Since this process is dependent on BAFF, BAFF serum and mRNA levels were assessed and were found to be significantly elevated in NZB dTg mice. Treatment of NZB sHEL recipient mice with TACI-Ig reduced NZB dTg B cell survival following adoptive transfer, confirming the role of BAFF in this process. Although NZB mice had modestly elevated BAFF, the enhanced NZB B cell survival response appeared to result from an altered response to BAFF. In contrast, T cell blockade had a minimal effect on B cell survival, but inhibited anti-HEL antibody production. The findings suggest that the modest BAFF elevations in NZB mice are sufficient to perturb B cell tolerance, particularly when acting in concert with B cell functional abnormalities and T cell help.	[Chang, Nan-Hua; Cheung, Yui-Ho; Loh, Christina; Pau, Evelyn; Roy, Valerie; Cai, Yong-Chun] Toronto Western Res Inst, Arthrit Ctr Excellence, Toronto, ON, Canada; [Cheung, Yui-Ho; Loh, Christina; Pau, Evelyn; Wither, Joan] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Wither, Joan] Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Chang, NH (corresponding author), Toronto Western Res Inst, Arthrit Ctr Excellence, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca		Wither, Joan/0000-0001-5961-9228	Canadian Institutes of Health Research; Arthritis Centre of Excellence of the University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Centre of Excellence of the University of Toronto(University of Toronto)	This work was supported by a grant from the Canadian Institutes of Health Research (Joan Wither). Joan Wither is supported by The Arthritis Centre of Excellence of the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; Chang NH, 2004, J IMMUNOL, V172, P1553, DOI 10.4049/jimmunol.172.3.1553; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Culton DA, 2006, J IMMUNOL, V176, P790, DOI 10.4049/jimmunol.176.2.790; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Fang W, 1998, IMMUNITY, V9, P35, DOI 10.1016/S1074-7613(00)80586-5; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hase H, 2004, BLOOD, V103, P2257, DOI 10.1182/blood-2003-08-2694; Hippen KL, 2005, J IMMUNOL, V175, P909, DOI 10.4049/jimmunol.175.2.909; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; IZUI S, 1978, J IMMUNOL, V121, P2213; Jiang Y, 1999, INT IMMUNOL, V11, P1685, DOI 10.1093/intimm/11.10.1685; Jongstra-Bilen J, 1997, J IMMUNOL, V159, P5810; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mandik-Nayak L, 2000, INT IMMUNOL, V12, P353, DOI 10.1093/intimm/12.3.353; MANNY N, 1979, J IMMUNOL, V122, P1220; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; MOUTSOPOULOS HM, 1977, J IMMUNOL, V119, P1639; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Rahman ZSM, 2005, J IMMUNOL, V175, P1440, DOI 10.4049/jimmunol.175.3.1440; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; RAVECHE ES, 1982, J IMMUNOL, V129, P1219; Roy V, 2005, J IMMUNOL, V175, P7363, DOI 10.4049/jimmunol.175.11.7363; Roy V, 2007, EUR J IMMUNOL, V37, P2645, DOI 10.1002/eji.200737334; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; WANGEL AG, 1982, CLIN EXP IMMUNOL, V49, P41; Wither JE, 2000, CLIN IMMUNOL, V94, P51, DOI 10.1006/clim.1999.4806; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	51	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11691	10.1371/journal.pone.0011691	http://dx.doi.org/10.1371/journal.pone.0011691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20661465	Green Published, Green Submitted, gold			2022-12-25	WOS:000280197500029
J	Siddappa, NB; Watkins, JD; Wassermann, KJ; Song, RJ; Wang, W; Kramer, VG; Lakhashe, S; Santosuosso, M; Poznansky, MC; Novembre, FJ; Villinger, F; Else, JG; Montefiori, DC; Rasmussen, RA; Ruprecht, RM				Siddappa, Nagadenahalli B.; Watkins, Jennifer D.; Wassermann, Klemens J.; Song, Ruijiang; Wang, Wendy; Kramer, Victor G.; Lakhashe, Samir; Santosuosso, Michael; Poznansky, Mark C.; Novembre, Francis J.; Villinger, Francois; Else, James G.; Montefiori, David C.; Rasmussen, Robert A.; Ruprecht, Ruth M.			R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; GP120 ENVELOPE GLYCOPROTEIN; ACUTE HIV-1 INFECTION; PASSAGED IN-VIVO; ANTIBODY-RESPONSE; TYPE-1 GP120; GASTROINTESTINAL-TRACT; LINKED GLYCOSYLATION; RHESUS-MONKEYS	Background: HIV-1 clade C (HIV-C) predominates worldwide, and anti-HIV-C vaccines are urgently needed. Neutralizing antibody (nAb) responses are considered important but have proved difficult to elicit. Although some current immunogens elicit antibodies that neutralize highly neutralization-sensitive (tier 1) HIV strains, most circulating HIVs exhibiting a less sensitive (tier 2) phenotype are not neutralized. Thus, both tier 1 and 2 viruses are needed for vaccine discovery in nonhuman primate models. Methodology/Principal Findings: We constructed a tier 1 simian-human immunodeficiency virus, SHIV-1157ipEL, by inserting an "early,'' recently transmitted HIV-C env into the SHIV-1157ipd3N4 backbone [ 1] encoding a "late'' form of the same env, which had evolved in a SHIV-infected rhesus monkey (RM) with AIDS. SHIV-1157ipEL was rapidly passaged to yield SHIV-1157ipEL-p, which remained exclusively R5-tropic and had a tier 1 phenotype, in contrast to "late'' SHIV-1157ipd3N4 (tier 2). After 5 weekly low-dose intrarectal exposures, SHIV-1157ipEL-p systemically infected 16 out of 17 RM with high peak viral RNA loads and depleted gut CD4(+) T cells. SHIV-1157ipEL-p and SHIV-1157ipd3N4 env genes diverge mostly in V1/V2. Molecular modeling revealed a possible mechanism for the increased neutralization resistance of SHIV-1157ipd3N4 Env: V2 loops hindering access to the CD4 binding site, shown experimentally with nAb b12. Similar mutations have been linked to decreased neutralization sensitivity in HIV-C strains isolated from humans over time, indicating parallel HIV-C Env evolution in humans and RM. Conclusions/Significance: SHIV-1157ipEL-p, the first tier 1 R5 clade C SHIV, and SHIV-1157ipd3N4, its tier 2 counterpart, represent biologically relevant tools for anti-HIV-C vaccine development in primates.	[Siddappa, Nagadenahalli B.; Watkins, Jennifer D.; Wassermann, Klemens J.; Song, Ruijiang; Wang, Wendy; Kramer, Victor G.; Lakhashe, Samir; Rasmussen, Robert A.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Siddappa, Nagadenahalli B.; Watkins, Jennifer D.; Song, Ruijiang; Lakhashe, Samir; Santosuosso, Michael; Poznansky, Mark C.; Rasmussen, Robert A.; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Santosuosso, Michael; Poznansky, Mark C.] Massachusetts Gen Hosp E, Partners AIDS Res Ctr & Infect Dis Med, Charlestown, MA USA; [Novembre, Francis J.; Villinger, Francois; Else, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Novembre, Francis J.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Villinger, Francois; Else, James G.] Emory Univ, Div Pathol & Lab Med, Atlanta, GA 30322 USA; [Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Emory University; Emory University; Emory University; Duke University	Siddappa, NB (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu	Poznansky, Mark C/M-4996-2015; Lakhashe, Samir/F-1150-2014	Poznansky, Mark C/0000-0003-1344-7103; Wassermann PhD, Klemens/0000-0001-9719-7548; Byrareddy, Siddappa/0000-0002-7423-1763	National Institutes of Health [P01 AI048240, R01 DE012937, R01 DE016013];  [RR-00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012937, R01DE016013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants P01 AI048240, R01 DE012937, and R01 DE016013 to R. M. R. Base grant RR-00165 provided support to the Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; Balfe P, 2004, VIROLOGY, V318, P267, DOI 10.1016/j.virol.2003.09.022; BASKIN GB, 1995, AIDS RES HUM RETROV, V11, P273, DOI 10.1089/aid.1995.11.273; Blay WM, 2006, J VIROL, V80, P999, DOI 10.1128/JVI.80.2.999-1014.2006; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Burke B, 2007, CURR HIV RES, V5, P625, DOI 10.2174/157016207782418533; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Cheng-Mayer C, 1999, J VIROL, V73, P5294, DOI 10.1128/JVI.73.7.5294-5300.1999; Chenine AL, 2010, J INFECT DIS, V201, P1155, DOI 10.1086/651274; Ching LK, 2008, J VIROL, V82, P949, DOI 10.1128/JVI.02143-07; Cline AN, 2005, J MED PRIMATOL, V34, P303; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Geffin R, 2003, VIROLOGY, V310, P207, DOI 10.1016/S0042-6822(03)00137-5; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Kraft Z, 2007, J VIROL, V81, P6402, DOI 10.1128/JVI.00424-07; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laird ME, 2008, J VIROL, V82, P11054, DOI 10.1128/JVI.01341-08; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mattapallil JJ, 1998, J VIROL, V72, P6421, DOI 10.1128/JVI.72.8.6421-6429.1998; Montefiori DC, 2003, J IMMUNOL, V170, P3906, DOI 10.4049/jimmunol.170.7.3906; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Rasmussen RA, 2007, AIDS, V21, P1841, DOI 10.1097/QAD.0b013e32828684ea; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Siddappa NB, 2009, J VIROL, V83, P1422, DOI 10.1128/JVI.02066-08; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; TREMBLAY M, 1990, J INFECT DIS, V162, P735, DOI 10.1093/infdis/162.3.735; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Vlasak J, 2006, AIDS, V20, P2135, DOI 10.1097/QAD.0b013e328010beb5; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Ye YJ, 2000, J VIROL, V74, P11955, DOI 10.1128/JVI.74.24.11955-11962.2000; Zhang H, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-67; Zwick MB, 2003, J VIROL, V77, P6965, DOI 10.1128/JVI.77.12.6965-6978.2003	60	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11689	10.1371/journal.pone.0011689	http://dx.doi.org/10.1371/journal.pone.0011689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657739	gold, Green Submitted, Green Published			2022-12-25	WOS:000280197500028
J	Yakub, M; Iqbal, MP				Yakub, Mohsin; Iqbal, Mohammad Perwaiz			Association of Blood Lead (Pb) and Plasma Homocysteine: A Cross Sectional Survey in Karachi, Pakistan	PLOS ONE			English	Article							ASCORBIC-ACID; VITAMINS B6; FOLIC-ACID; HYPERHOMOCYSTEINEMIA; POPULATION; FOLATE; B12	Background: High blood lead (Pb) and hyperhomocysteinemia have been found to be associated with cardiovascular disease (CVD). Mean blood Pb and mean plasma homocysteine levels have been reported to be high in Pakistani population. The objective of the present study was to assess the relationship of blood Pb to the risk of hyperhomocysteinemia in a low income urban population of Karachi, Pakistan. Methodology/Principal Findings: In a cross sectional survey, 872 healthy adults (355 males, 517 females; age 18-60 years) were recruited from a low income urban population of Karachi. Fasting venous blood was obtained and assessed for blood Pb and plasma/serum homocysteine, folate, pyridoxal phosphate (PLP, a coenzymic form of vitamin B6) and vitamin B12. The study population had median (IQR) blood Pb of 10.82 mu g/dL (8.29-13.60). Prevalence of high blood Pb (levels >10 mu g/dL) was higher in males compared to females (62.5% males vs 56% females; p value = 0.05). Mean +/- SD/median (IQR) value of plasma homocysteine was significantly higher in the highest quartile of blood Pb compared to the lowest quartile 16.13 +/- 11.2 mu mol/L vs 13.28 +/- 9.7 mu mol/L/13.15 (10.33-17.81) mu mol/L vs 11.09 (8.65 14.31) mu mol/L (p value < 0.001). Daily consumption of fruit juice had a positive influence on both levels of plasma homocysteine and blood Pb. Compared with the lowest quartile of blood Pb, the OR for hyperhomocysteinemia was 1.69 (95% CI, 1.00 to 2.85) for the fourth quartile when the model was adjusted for age, gender, folate and vitamin B12. Conclusions/Significance: This study showed a relationship between blood Pb and hyperhomocysteinemia in a general population of Karachi, Pakistan. The harmful effect of Pb on cardiovascular system could be due to its association with hyperhomocysteinemia.	[Yakub, Mohsin; Iqbal, Mohammad Perwaiz] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan	Aga Khan University	Yakub, M (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	mohsin.yakub@aku.edu	Iqbal, Mohammed/GYA-1556-2022; Iqbal, Mohammad Perwaiz/I-6763-2015		University Research Council; Aga Khan University [IUJ (70136)]; Pakistan Science Foundation [PSF/Res/S-AKU/Med (210)]; Pakistan Scientific Development Project	University Research Council; Aga Khan University; Pakistan Science Foundation; Pakistan Scientific Development Project	This work was funded by grants from University Research Council, Aga Khan University [IUJ (70136)], Pakistan Science Foundation [PSF/Res/S-AKU/Med (210)] and Pakistan Scientific Development Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir Muhammad, 2004, J Coll Physicians Surg Pak, V14, P518; Agha Farida, 2005, JPMA Journal of the Pakistan Medical Association, V55, P410; CAMP VM, 1983, CLIN CHEM, V29, P642; CHANARIN I, 1989, LAB HAEMATOLOGY, P131; Chia SE, 2007, OCCUP ENVIRON MED, V64, P688, DOI 10.1136/oem.2006.030882; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; Etzel RA, 1998, PEDIATRICS, V101, P1072; Glenn BS, 2003, EPIDEMIOLOGY, V14, P30, DOI 10.1097/00001648-200301000-00011; HernandezAvila M, 1997, ENVIRON RES, V74, P116, DOI 10.1006/enrs.1997.3756; Hertz-Picciotto I, 2000, AM J EPIDEMIOL, V152, P829, DOI 10.1093/aje/152.9.829; Iqbal M. Perwaiz, 2003, Pakistan Journal of Zoology, V35, P231; Iqbal M Perwaiz, 2006, J Pak Med Assoc, V56, P282; Iqbal MP, 2009, JCPSP-J COLL PHYSICI, V19, P308, DOI 05.2009/JCPSP.308312; Iqbal MP, 2005, NUTR METAB CARDIOVAS, V15, P100, DOI 10.1016/j.numecd.2004.05.003; KHAWAJA MA, 2002, BLOOD LEAD LEVELS SC; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Navas-Acien A, 2004, CIRCULATION, V109, P3196, DOI 10.1161/01.CIR.0000130848.18636.B2; QUADROS EV, 2000, MODERN ANAL METHODOL; Rahbar MH, 2002, B WORLD HEALTH ORGAN, V80, P769; Samman S, 2003, J NUTR, V133, P2188, DOI 10.1093/jn/133.7.2188; Schafer JH, 2005, ENVIRON HEALTH PERSP, V113, P31, DOI 10.1289/ehp.7369; SCHRAGER TF, 2006, IS CTR DIS CONTROLS; Simon JA, 1999, JAMA-J AM MED ASSOC, V281, P2289, DOI 10.1001/jama.281.24.2289; Son JY, 2009, ENVIRON RES, V109, P738, DOI 10.1016/j.envres.2009.03.012; Tariq SA, 2007, MOL BIOTECHNOL, V37, P62, DOI 10.1007/s12033-007-0045-x; Yakub M, 2009, J CHEM SOC PAKISTAN, V31, P319	26	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11706	10.1371/journal.pone.0011706	http://dx.doi.org/10.1371/journal.pone.0011706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657730	Green Submitted, gold, Green Published			2022-12-25	WOS:000280197500038
J	van Kampen, SC; Ramsay, AR; Anthony, RM; Klatser, PR				van Kampen, Sanne C.; Ramsay, Andrew R.; Anthony, Richard M.; Klatser, Paul R.			Retooling National TB Control Programmes (NTPs) with New Diagnostics: The NTP Perspective	PLOS ONE			English	Article							SMEAR MICROSCOPY; SPUTUM; TUBERCULOSIS; FLUORESCENCE	Background: A delay is evident between the development of new policies on TB diagnostics and their implementation at country level. The Stop TB Partnership would benefit from information from national TB program (NTP) managers on progress towards implementation of new recommendations as well as the opportunities and challenges encountered in the process. Methods and Findings: To solicit information on the introduction of new TB diagnostics at country level, questionnaires were sent out to NTP managers of high-burden TB countries and a subset of managers was interviewed. The results indicate that about 50% of high-burden TB countries are using the TB diagnostic tools newly recommended by the World Health Organization (WHO). Most NTP managers reported that new diagnostics would only be implemented when officially endorsed by the WHO. All countries have plans to adopt newly endorsed diagnostics at reference laboratory level, while approaches to optimize smear microscopy at lower levels of the health service are given less attention. NTP managers reported diverse challenges to the implementation of new diagnostics. Conclusions: More information on the obstacles and advantages of introducing new diagnostic tools should be provided to NTP managers to ensure the rational adoption of new diagnostics. A single recommendation covering the introduction of a package of diagnostic tools might be preferable to NTP managers and facilitate implementation in high-burden TB countries.	[van Kampen, Sanne C.; Ramsay, Andrew R.] WHO, UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva, Switzerland; [van Kampen, Sanne C.; Anthony, Richard M.; Klatser, Paul R.] Free Univ Amsterdam, Athena Inst, NL-1081 HV Amsterdam, Netherlands; [van Kampen, Sanne C.; Anthony, Richard M.; Klatser, Paul R.] KIT Biomed Res, Royal Trop Inst KIT, Amsterdam, Netherlands	The World Bank; World Health Organization; Vrije Universiteit Amsterdam	van Kampen, SC (corresponding author), WHO, UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva, Switzerland.	sanne.vankampen@gmail.com	Anthony, Richard/AAP-3406-2020; Anthony, Richard M/G-5654-2010	Anthony, Richard/0000-0002-0550-5273; Anthony, Richard M/0000-0002-0550-5273; van Kampen, Sanne/0000-0002-1519-5248; Klatser, Paul/0000-0003-3868-2409; Klatser, Paul/0000-0003-2127-9138	WHO/TDR	WHO/TDR(World Health Organization)	This work was essentially unfunded, but costs of telephone interviews were borne by WHO/TDR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Pai M, 2009, EXPERT REV MOL DIAGN, V9, P637, DOI [10.1586/erm.09.48, 10.1586/ERM.09.48]; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/398767; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; *WHO, 2007, REV CAS DEF SPUT SME; *WHO, 2007, EXP GROUP M GEN; *WHO STAG TB, 2009, 9 M 9 11 NOV 2009 GE; *WHO STOP TB PARTN, 2007, GLOB MDR TB XDR TB R; *WHO STOP TB PARTN, 2008, NEW LAB DIAGN TOOLS; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2007, US LIQ TB CULT DRUG; World Health Organization, 2009, GLOB TUB CONTR EP ST	15	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11649	10.1371/journal.pone.0011649	http://dx.doi.org/10.1371/journal.pone.0011649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20661463	Green Published, Green Submitted, gold			2022-12-25	WOS:000280065600013
J	Tian, YA; Crump, CJ; Li, YM				Tian, Yuan; Crump, Christina J.; Li, Yue-Ming			Dual Role of alpha-Secretase Cleavage in the Regulation of gamma-Secretase Activity for Amyloid Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; BETA-SECRETASE; CEREBROSPINAL-FLUID; NICASTRIN; SUBSTRATE; COMPLEX; MECHANISM; RELEASE; STATE	Processing of the amyloid precursor protein (APP) by beta- and gamma-secretases generates pathogenic beta-amyloid (A beta) peptides associated with Alzheimer disease (AD), whereas cleavage of APP by alpha-secretases precludes A beta formation. Little is known about the role of alpha-secretase cleavage in gamma-secretase regulation. Here, we show that alpha-secretase-cleaved APP C-terminal product (alpha CTF) functions as an inhibitor of gamma-secretase. We demonstrate that the substrate inhibitory domain (ASID) within alpha CTF, which is bisected by the alpha-secretase cleavage site, contributes to this negative regulation because deleting or masking this domain turns alpha CTF into a better substrate for gamma-secretase. Moreover, alpha-secretase cleavage can potentiate the inhibitory effect of ASID. Inhibition of gamma-secretase activity by alpha CTF is observed in both in vitro and cellular systems. This work reveals an unforeseen role for alpha-secretase in generating an endogenous gamma-secretase inhibitor that down-regulates the production of A beta. Deregulation of this feedback mechanism may contribute to the pathogenesis of AD.	[Li, Yue-Ming] Cornell Univ, Dept Pharmacol, Joan Weill Grad Sch Med Sci, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Tian, Yuan] Cornell Univ, Program Physiol Biophys & Syst Biol, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Li, YM (corresponding author), Cornell Univ, Dept Pharmacol, Joan Weill Grad Sch Med Sci, New York, NY 10021 USA.	liy2@mskcc.org	LI, Yue/GRS-8071-2022		National Institutes of Health [AG026660]; Alzheimer Association; American Health Assistance Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); American Health Assistance Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG026660 (to Y.-M.L.). This work was also supported by the Alzheimer Association (Y.-M.L.) and the American Health Assistance Foundation (Y.-M.L.).	Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; McCafferty DG, 1997, BIOCHEMISTRY-US, V36, P10498, DOI 10.1021/bi970543u; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; Placanica L, 2010, BIOCHEMISTRY-US, V49, P2796, DOI 10.1021/bi901388t; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shelton CC, 2009, P NATL ACAD SCI USA, V106, P20228, DOI 10.1073/pnas.0910757106; Shelton CC, 2009, ASSAY DRUG DEV TECHN, V7, P461, DOI 10.1089/adt.2009.0202; Shelton CC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-22; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tian Y, 2010, NAT STRUCT MOL BIOL, V17, P151, DOI 10.1038/nsmb.1743; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	33	33	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32549	32556		10.1074/jbc.M110.128439	http://dx.doi.org/10.1074/jbc.M110.128439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20675367	Green Published, hybrid			2022-12-25	WOS:000282683000069
J	Kapoor, N; Gupta, R; Menon, ST; Folta-Stogniew, E; Raleigh, DP; Sakmar, TP				Kapoor, Neeraj; Gupta, Ruchi; Menon, Santosh T.; Folta-Stogniew, Ewa; Raleigh, Daniel P.; Sakmar, Thomas P.			Nucleobindin 1 Is a Calcium-regulated Guanine Nucleotide Dissociation Inhibitor of G alpha(i1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INDEPENDENT ACTIVATORS; GOLOCO MOTIF; BINDING-PROTEIN; CA2+-BINDING PROTEIN; LEUCINE-ZIPPER; CALNUC BINDS; GOLGI; TRANSDUCIN; RHODOPSIN; MECHANISM	Nucleobindin 1 (NUCB1) is a widely expressed multidomain calcium-binding protein whose precise physiological and biochemical functions are not well understood. We engineered and heterologously expressed a soluble form of NUCB1 (sNUCB1) and characterized its biophysical and biochemical properties. We show that sNUCB1 exists as a dimer in solution and that each monomer binds two divalent calcium cations. Calcium binding causes conformational changes in sNUCB1 as judged by circular dichroism and fluorescence spectroscopy experiments. Earlier reports suggested that NUCB1 might interact with heterotrimeric G protein alpha subunits. We show that dimeric calcium-free sNUCB1 binds to expressed G alpha(i1) and that calcium binding inhibits the interaction. The binding of sNUCB1 to G alpha(i1) inhibits its basal rate of GDP release and slows its rate and extent of GTP gamma S uptake. Additionally, our tissue culture experiments show that sNUCB1 prevents receptor-mediated G alpha(i)-dependent inhibition of adenylyl cyclase. Thus, we conclude that sNUCB1 is a calcium-dependent guanine nucleotide dissociation inhibitor (GDI) for G alpha(i1). To our knowledge, sNUCB1 is the first example of a calcium-dependent GDI for heterotrimeric G proteins. We also show that the mechanism of GDI activity of sNUCB1 is unique and does not arise from the consensus GoLoco motif found in RGS proteins. We propose that cytoplasmic NUCB1 might function to regulate heterotrimeric G protein trafficking and G protein-coupled receptor-mediated signal transduction pathways.	[Sakmar, Thomas P.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [Folta-Stogniew, Ewa] Yale Univ, Sch Med, WM Keck Fdn, Biotechnol Resource Lab, New Haven, CT 06520 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Grad Program Biochem & Struct Biol, Stony Brook, NY 11794 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Grad Program Biophys, Stony Brook, NY 11794 USA	Rockefeller University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	sakmar@mail.rockefeller.edu	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953; raleigh, daniel/0000-0003-3248-7493	National Institutes of Health [GM078114]; Rockefeller/Sloan-Kettering/Weill Cornell Tri-Institutional Training Program in Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller/Sloan-Kettering/Weill Cornell Tri-Institutional Training Program in Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078114. This work was also supported by Rockefeller/Sloan-Kettering/Weill Cornell Tri-Institutional Training Program in Chemical Biology.	Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; Brodeur J, 2009, TRAFFIC, V10, P1098, DOI 10.1111/j.1600-0854.2009.00933.x; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; CUMMINS PG, 1981, J PHYS E SCI INSTRUM, V14, P1171, DOI 10.1088/0022-3735/14/10/019; de Alba E, 2004, BIOCHEMISTRY-US, V43, P10039, DOI 10.1021/bi049310a; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; KANAI Y, 1992, IMMUNOL LETT, V32, P43; Kanuru M, 2009, FEBS J, V276, P2529, DOI 10.1111/j.1742-4658.2009.06977.x; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kimple Randall J, 2002, Mol Interv, V2, P88, DOI 10.1124/mi.2.2.88; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Leclerc P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002229; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Lin P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-15; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; MIURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1388, DOI 10.1006/bbrc.1994.1384; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; PHILLIPS SR, 1986, CURR EYE RES, V5, P611, DOI 10.3109/02713688609015126; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tsukumo Y, 2009, J BIOL CHEM, V284, P27500, DOI 10.1074/jbc.M109.021592; Usachev YM, 1995, J PHYSIOL-LONDON, V489, P309, DOI 10.1113/jphysiol.1995.sp021052; VANHOLDE KE, 1958, J PHYS CHEM-US, V62, P734, DOI 10.1021/j150564a025; WANG SN, 1994, PATHOL INT, V44, P844, DOI 10.1111/j.1440-1827.1994.tb01682.x; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; Willard FS, 2004, METHOD ENZYMOL, V389, P56; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756	52	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31647	31660		10.1074/jbc.M110.148429	http://dx.doi.org/10.1074/jbc.M110.148429			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20679342	Green Published, hybrid			2022-12-25	WOS:000282764600057
J	Kuzyk, A; Kastyak, M; Agrawal, V; Gallant, M; Sivakumar, G; Rak, M; Del Bigio, MR; Westaway, D; Julian, R; Gough, KM				Kuzyk, Alexandra; Kastyak, Marzena; Agrawal, Veena; Gallant, Meghan; Sivakumar, Gajjeraman; Rak, Margaret; Del Bigio, Marc R.; Westaway, David; Julian, Robert; Gough, Kathleen M.			Association among Amyloid Plaque, Lipid, and Creatine in Hippocampus of TgCRND8 Mouse Model for Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; WHITE-MATTER; H-1 MRS; BRAIN; PEPTIDE; INFLAMMATION; IMPAIRMENT; HYPOTHESIS; DEPOSITION; PATHWAYS	Amyloid peptide (A beta)aggregation in the brain is a characteristic feature of Alzheimer disease (AD). Previously, we reported the discovery of focally elevated creatine deposits in brain tissue from TgCRND8 mice, which express double mutant (K670N/M671L and V717F) amyloid protein precursor. In this study, frozen hippocampal tissue sections from 5-, 8-, 11-, 14-, and 17-month old TgCRND8 and littermate control mice were examined with Fourier transform infrared microspectroscopy to explore the distribution of lipid, creatine, and dense core plaque deposits. Lipid distribution throughout the hippocampus was similar in transgenic (Tg) and non-Tg littermates at all ages. Dense core plaques were always found to lie within a thin (30-50 mu m) lipid envelope, confirmed by imaging through serial sections. Creatine deposits were found in all TgCRND8 mice; the extent of deposition increased with age. Minor creatine deposits appeared in the oldest littermate controls. Distribution in the serial sections showed moderate correlation between layers, slightly disturbed by the freeze/thaw process. Creatine deposits in Tg mice were not specifically co-localized with plaques or lipid halos. The dimension of the lipid envelope is comparable with that of the diffuse halo of nonaggregated amyloid, implying a dynamic association in vivo, postulated to have a significant role in the evolving neurotoxicity.	[Rak, Margaret; Gough, Kathleen M.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Del Bigio, Marc R.] Univ Manitoba, Dept Pathol, Winnipeg, MB R3E 0W3, Canada; [Westaway, David] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5G 1L5, Canada; [Westaway, David] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; [Julian, Robert] Univ Wisconsin Madison, Ctr Synchrotron Radiat, Stoughton, WI 53589 USA	University of Manitoba; University of Manitoba; University of Toronto; University of Toronto; University of Wisconsin System; University of Wisconsin Madison	Gough, KM (corresponding author), Univ Manitoba, Dept Chem, 360 Parker Bldg, Winnipeg, MB R3T 2N2, Canada.	kmgough@cc.umanitoba.ca		Del Bigio, Marc/0000-0001-8366-0394	Canadian Institutes of Health Research; Manitoba Health Research Council; Natural Sciences and Engineering Research Council of Canada (NSERC) Canada; National Science Foundation [DMR-08442]; Natural Sciences and Engineering Research Council of Canada (NSERC); University of Manitoba; McCrorie-West Family Fellowship for Alzheimer Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Natural Sciences and Engineering Research Council of Canada (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Manitoba; McCrorie-West Family Fellowship for Alzheimer Research	This work was supported by Canadian Institutes of Health Research, the Manitoba Health Research Council, and Natural Sciences and Engineering Research Council of Canada (NSERC) Canada. The Synchotron Research Center is funded by National Science Foundation Award DMR-08442. Access to The National Synchrotron Light Source (NSLS) was made available in part through the Canadian Light Source Participating Research Team.; Supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Post Graduate Scholarship A (PGS-A) scholarship, a University of Manitoba Graduate fellowship, and the McCrorie-West Family Fellowship for Alzheimer Research.	Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Bhargava R, 2007, ANAL BIOANAL CHEM, V389, P1155, DOI 10.1007/s00216-007-1511-9; Boimel M, 2009, J NEUROPATH EXP NEUR, V68, P314, DOI 10.1097/NEN.0b013e31819ac3cb; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Brief EE, 2009, NMR BIOMED, V22, P349, DOI 10.1002/nbm.1349; Charlton RA, 2007, BRAIN RES, V1164, P108, DOI 10.1016/j.brainres.2007.06.027; Chew SF, 2007, TISSUE ANTIGENS, V69, P252, DOI 10.1111/j.1399-0039.2006.00775.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; FABIAN H, 1993, APPL SPECTROSC, V47, P1513, DOI 10.1366/0003702934067469; Gallant M, 2006, J BIOL CHEM, V281, P5, DOI 10.1074/jbc.C500244200; Gough KM, 2010, VIB SPECTROSC, V53, P71, DOI 10.1016/j.vibspec.2010.01.015; Hort J, 2007, P NATL ACAD SCI USA, V104, P4042, DOI 10.1073/pnas.0611314104; Huang W, 2001, NEUROLOGY, V57, P626, DOI 10.1212/WNL.57.4.626; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Li XF, 2006, MOL CELL NEUROSCI, V31, P263, DOI 10.1016/j.mcn.2005.09.015; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miller VM, 2009, BRAIN RES, V1276, P22, DOI 10.1016/j.brainres.2009.04.029; Modrego PJ, 2006, CNS DRUGS, V20, P867, DOI 10.2165/00023210-200620100-00006; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P774, DOI 10.1097/NEN.0b013e3181aacbe9; Perluigi M, 2009, PROTEOM CLIN APPL, V3, P682, DOI 10.1002/prca.200800161; Pfefferbaum A, 1999, ARCH GEN PSYCHIAT, V56, P185, DOI 10.1001/archpsyc.56.2.185; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Rak M, 2007, BIOPOLYMERS, V87, P207, DOI 10.1002/bip.20820; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Siedlak SL, 2009, FREE RADICAL RES, V43, P156, DOI 10.1080/10715760802644694; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Vitiello G, 2010, J PEPT SCI, V16, P115, DOI 10.1002/psc.1207; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998	32	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31202	31207		10.1074/jbc.M110.142174	http://dx.doi.org/10.1074/jbc.M110.142174			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682779	Green Published, hybrid			2022-12-25	WOS:000282764600014
J	Mast, N; Charvet, C; Pikuleva, IA; Stout, CD				Mast, Natalia; Charvet, Casey; Pikuleva, Irina A.; Stout, C. David			Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTAMINE H-3; CYTOCHROME-P450 46A1; CRYSTAL-STRUCTURES; IN-VITRO; 24-HYDROXYLASE; HOMEOSTASIS; INHIBITION; COMPLEXES; 24S-HYDROXYCHOLESTEROL; CRYSTALLOGRAPHY	Cytochrome P450 46A1 (CYP46A1) initiates the major pathway of cholesterol elimination from the brain and thereby controls cholesterol turnover in this organ. We determined x-ray crystal structures of CYP46A1 in complex with four structurally distinct pharmaceuticals; antidepressant tranylcypromine (2.15 angstrom), anticonvulsant thioperamide (1.65 angstrom), antifungal voriconazole (2.35 angstrom), and antifungal clotrimazole (2.50 angstrom). All four drugs are nitrogen-containing compounds that have nanomolar affinity for CYP46A1 in vitro yet differ in size, shape, hydrophobicity, and type of the nitrogen ligand. Structures of the co-complexes demonstrate that each drug binds in a single orientation to the active site with tranylcypromine, thioperamide, and voriconazole coordinating the heme iron via their nitrogen atoms and clotrimazole being at a 4 angstrom distance from the heme iron. We show here that clotrimazole is also a substrate for CYP46A1. High affinity for CYP46A1 is determined by a set of specific interactions, some of which were further investigated by solution studies using structural analogs of the drugs and the T306A CYP46A1 mutant. Collectively, our results reveal how diverse inhibitors can be accommodated in the CYP46A1 active site and provide an explanation for the observed differences in the drug-induced spectral response. Co-complexes with tranylcypromine, thioperamide, and voriconazole represent the first structural characterization of the drug binding to a P450 enzyme.	[Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Scripps Research Institute; Case Western Reserve University	Pikuleva, IA (corresponding author), 2085 Adelbert Rd,Rm 303, Cleveland, OH 44106 USA.	iap8@case.edu; dave@scripps.edu		Pikuleva, Irina/0000-0001-9742-6232	United States Public Health Service [GM62882, AG024336]; National Institutes of Health [T32 EY07157]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; NIGMS; NATIONAL EYE INSTITUTE [T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024336] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Health Service Grants GM62882 and AG024336 (to I. A. P). This work was also supported in part by National Institutes of Health Grant T32 EY07157 (an NEI predoctoral research training fellowship from the Visual Sciences Training Program, to C. C.).; We thank Dr. M. Shimoji for generating the T306A CYP46A1 mutant. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and by the NIGMS. We are grateful to the SSRL staff for generous support.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balding PR, 2008, J PHYS CHEM A, V112, P12911, DOI 10.1021/jp802087w; Berlin M, 2006, BIOORG MED CHEM LETT, V16, P989, DOI 10.1016/j.bmcl.2005.10.087; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celanire S, 2005, DRUG DISCOV TODAY, V10, P1613, DOI 10.1016/S1359-6446(05)03625-1; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P76; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; Frieling H, 2006, EUR ARCH PSY CLIN N, V256, P268, DOI 10.1007/s00406-006-0660-8; Halford RW, 2009, P NATL ACAD SCI USA, V106, P3502, DOI 10.1073/pnas.0813349106; Hlavica P, 2006, BBA-PROTEINS PROTEOM, V1764, P645, DOI 10.1016/j.bbapap.2006.01.013; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Lazewska D, 2009, BIOORG MED CHEM LETT, V19, P6682, DOI 10.1016/j.bmcl.2009.10.005; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Podust LM, 2009, J BIOL CHEM, V284, P25211, DOI 10.1074/jbc.M109.017632; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sabo JA, 2000, ANN PHARMACOTHER, V34, P1032, DOI 10.1345/aph.19237; See RF, 1998, INORG CHEM, V37, P5369, DOI 10.1021/ic971462p; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614	38	52	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31783	31795		10.1074/jbc.M110.143313	http://dx.doi.org/10.1074/jbc.M110.143313			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667828	hybrid, Green Published			2022-12-25	WOS:000282764600070
J	Montanier, C; Flint, JE; Bolam, DN; Xie, HF; Liu, ZY; Rogowski, A; Weiner, DP; Ratnaparkhe, S; Nurizzo, D; Roberts, SM; Turkenburg, JP; Davies, GJ; Gilbert, HJ				Montanier, Cedric; Flint, James E.; Bolam, David N.; Xie, Hefang; Liu, Ziyuan; Rogowski, Artur; Weiner, David P.; Ratnaparkhe, Supriya; Nurizzo, Didier; Roberts, Shirley M.; Turkenburg, Johan P.; Davies, Gideon J.; Gilbert, Harry J.			Circular Permutation Provides an Evolutionary Link between Two Families of Calcium-dependent Carbohydrate Binding Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENS SUBSP CELLULOSA; CELL-WALL DEGRADATION; SECONDARY-STRUCTURE; ALPHA-MANNOSIDASES; LIGAND-BINDING; XYLANASE; DOMAINS; PROTEIN; COMPLEX; RECOGNITION	The microbial deconstruction of the plant cell wall is a critical biological process, which also provides important substrates for environmentally sustainable industries. Enzymes that hydrolyze the plant cell wall generally contain non-catalytic carbohydrate binding modules (CBMs) that contribute to plant cell wall degradation. Here we report the biochemical properties and crystal structure of a family of CBMs (CBM60) that are located in xylanases. Uniquely, the proteins display broad ligand specificity, targeting xylans, galactans, and cellulose. Some of the CBM60s display enhanced affinity for their ligands through avidity effects mediated by protein dimerization. The crystal structure of vCBM60, displays a beta-sandwich with the ligand binding site comprising a broad cleft formed by the loops connecting the two beta-sheets. Ligand recognition at site 1 is, exclusively, through hydrophobic interactions, whereas binding at site 2 is conferred by polar interactions between a protein-bound calcium and the O2 and O3 of the sugar. The observation, that ligand recognition at site 2 requires only a beta-linked sugar that contains equatorial hydroxyls at C2 and C3, explains the broad ligand specificity displayed by vCBM60. The ligand-binding apparatus of vCBM60 displays remarkable structural conservation with a family 36 CBM (CBM36); however, the residues that contribute to carbohydrate recognition are derived from different regions of the two proteins. Three-dimensional structure-based sequence alignments reveal that CBM36 and CBM60 are related by circular permutation. The biological and evolutionary significance of the mechanism of ligand recognition displayed by family 60 CBMs is discussed.	[Montanier, Cedric; Flint, James E.; Bolam, David N.; Xie, Hefang; Liu, Ziyuan; Rogowski, Artur; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Weiner, David P.] Verenium Corp, San Diego, CA 92121 USA; [Nurizzo, Didier] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Roberts, Shirley M.; Turkenburg, Johan P.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Ratnaparkhe, Supriya; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Newcastle University - UK; European Synchrotron Radiation Facility (ESRF); University of York - UK; University System of Georgia; University of Georgia	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	h.j.gilbert@ccrc.uga.edu	Montanier, Cédric/P-7727-2019; Davies, Gideon J/A-9042-2011	Montanier, Cédric/0000-0002-8205-7160; Davies, Gideon J/0000-0002-7343-776X; Flint, James/0000-0003-2923-7813; Bolam, David/0000-0003-0314-3122; Turkenburg, Johan/0000-0001-6992-6838	Biotechnology and Biological Sciences Research Council; National Science Foundation [IOS-0923992]; Department of Energy [DE-FG02-09ER16076]; Newcastle University; Biotechnology and Biological Sciences Research Council [BB/C005074/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Newcastle University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council. This work was also supported in part by a grant from the National Science Foundation Plant Genome Program (IOS-0923992) and the Department of Energy (DE-FG02-09ER16076).; Recipient of a fellowship from Newcastle University.	Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424; Abou Hachem M, 2000, BIOCHEM J, V345, P53, DOI 10.1042/0264-6021:3450053; Abou-Hachem M, 2002, BIOCHEMISTRY-US, V41, P5720, DOI 10.1021/bi012094a; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2002, MOL MICROBIOL, V43, P187, DOI 10.1046/j.1365-2958.2002.02730.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brett C. T., 1996, TOPICS PLANT FUNCTIO; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Emami K, 2002, J BACTERIOL, V184, P4124, DOI 10.1128/JB.184.15.4124-4133.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERREIRA LMA, 1993, BIOCHEM J, V294, P349, DOI 10.1042/bj2940349; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; GILKES NR, 1992, J BIOL CHEM, V267, P6743; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; HALL J, 1989, MOL MICROBIOL, V3, P1211, DOI 10.1111/j.1365-2958.1989.tb00271.x; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; McCartney L, 2003, PLANT J, V33, P447, DOI 10.1046/j.1365-313X.2003.01640.x; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; Montanier C, 2009, PLOS BIOL, V7, P687, DOI 10.1371/journal.pbio.1000071; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy T, 2002, J BACTERIOL, V184, P4925, DOI 10.1128/JB.184.17.4925-4929.2002; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Reitinger S, 2010, BIOCHEMISTRY-US, V49, P2464, DOI 10.1021/bi100036f; Ryttersgaard C, 2004, J MOL BIOL, V341, P107, DOI 10.1016/j.jmb.2004.05.017; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simpson PJ, 1999, STRUCTURE, V7, P853, DOI 10.1016/S0969-2126(99)80108-7; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	60	29	29	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31742	31754		10.1074/jbc.M110.142133	http://dx.doi.org/10.1074/jbc.M110.142133			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20659893	Green Published, hybrid			2022-12-25	WOS:000282764600066
J	Hildebrandt, MAT; Gu, J; Lin, J; Ye, Y; Tan, W; Tamboli, P; Wood, CG; Wu, X				Hildebrandt, M. A. T.; Gu, J.; Lin, J.; Ye, Y.; Tan, W.; Tamboli, P.; Wood, C. G.; Wu, X.			Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma	ONCOGENE			English	Article						renal cell carcinoma; microRNA; methylation; metastasis; miR-9	HUMAN BREAST-CANCER; MICRORNAS; EXPRESSION; MIR-9	The long-term prognosis for clear cell renal cell carcinoma (ccRCC) is dramatically altered by the development of metastatic recurrence. However, there are very few indicators that can predict which patient will develop a recurrence. MicroRNAs regulate many cellular processes and have been shown to be associated with cancer development and recurrence. More recently it has been shown that microRNA genes can be epigenetically modified in cancer, resulting in aberrant silencing of microRNA genes with tumor suppressor functions. In this study, we show that two genes encoding for hsa-miR-9 are significantly hypermethylated in ccRCC tumors compared with adjacent normal tissues (P-value <0.001 for both miR-9-1 and miR-9-3) resulting in decreased expression, and that the methylation of these genes was more significant in DNA obtained from the primary tumor for patients who developed a recurrence (P-value: 0.012 and 0.009 for miR-9-1 and miR-9-3, respectively) than in tumors from nonrecurrent patients. Furthermore, methylation of miR-9-3 was significantly associated with an increased risk of recurrence (hazard ratio: 5.85, 95% confidence intervals: 1.30-26.35) and high methylation levels of either miR-9-1 or miR-9-3 resulted in a significant, nearly 30-month decrease in recurrence-free survival time (P-value: 0.034 and 0.007 for miR-9-1 and miR-9-3, respectively). Our results demonstrate that hsa-miR-9 is involved in the development of ccRCC while also having a role in the development of metastatic recurrence. Oncogene (2010) 29, 5724-5728; doi:10.1038/onc.2010.305; published online 2 August 2010	[Wu, X.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, Houston, TX 77030 USA; [Tamboli, P.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wood, C. G.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, 1155 Pressler Blvd, Houston, TX 77030 USA.	xwu@mdanderson.org	Gu, Jian/Q-4780-2018	Gu, Jian/0000-0003-3499-0973	National Institute of Health [R01 CA098897]; NATIONAL CANCER INSTITUTE [R01CA098897, K07CA134831] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported, in part, by National Institute of Health Grant R01 CA098897.	Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hsu PY, 2009, CANCER RES, V69, P5936, DOI 10.1158/0008-5472.CAN-08-4914; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CELL CYCLE, V6, P1455; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Pantuck AJ, 2001, J UROLOGY, V166, P1611, DOI 10.1016/S0022-5347(05)65640-6; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	15	177	192	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5724	5728		10.1038/onc.2010.305	http://dx.doi.org/10.1038/onc.2010.305			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20676129				2022-12-25	WOS:000283262500008
J	Kang, X; Li, J; Zou, Y; Yi, J; Zhang, H; Cao, M; Yeh, ETH; Cheng, J				Kang, X.; Li, J.; Zou, Y.; Yi, J.; Zhang, H.; Cao, M.; Yeh, E. T. H.; Cheng, J.			PIASy stimulates HIF1 alpha SUMOylation and negatively regulates HIF1 alpha activity in response to hypoxia	ONCOGENE			English	Article						HIF1 alpha; hypoxia; PIASy; SUMOylation	TRANSCRIPTIONAL ACTIVITY; INDUCIBLE-FACTOR; TUMOR ANGIOGENESIS; CONJUGATING ENZYME; SUMO MODIFICATION; GENE-ACTIVATION; NUCLEAR-BODIES; HIF-ALPHA; PROTEIN; FAMILY	Hypoxia-inducible factor-1 alpha (HIF1 alpha) is a crucial regulator of the cellular response to hypoxia through its regulation of genes that control erythropoiesis, angiogenesis and anaerobic metabolism. We have previously shown that HIF1 alpha stability is regulated by SUMOylation under the hypoxic condition. However, how HIF1 alpha became SUMOylated during hypoxia is still unknown. In this study we identify PIASy as a specific E3 ligase for hypoxia-induced HIF1 alpha SUMOylation. Hypoxia promotes translocation of HIF1 alpha to the nucleus to facilitate its binding to PIASy, enabling the conjugation of HIF1 alpha by SUMO1. We further show that PIASy negatively regulates hypoxia-induced HIF1 alpha stability and transactivation. Knocking down PIASy increases the angiogenic activity of endothelial cells. Moreover, we show an inverse relationship between expression of PIASy and tumor angiogenesis in colon cancer. Thus, we define an important role of PIASy in hypoxia signaling through promoting HIF1 alpha SUMOylation. Oncogene (2010) 29, 5568-5578; doi:10.1038/onc.2010.297; published online 26 July 2010	[Cheng, J.] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Dept Mol & Cell Biol, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200025, Peoples R China; [Kang, X.; Li, J.; Zou, Y.; Yi, J.; Cao, M.; Cheng, J.] Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, E Inst Shanghai Municipal Educ Commiss, Chinese Minist Educ,Sch Med, Shanghai 200025, Peoples R China; [Zhang, H.] Chinese Acad Med Sci, Canc Hosp, Dept Abdominal Surg, Beijing 100037, Peoples R China; [Zhang, H.] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yeh, E. T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Yeh, E. T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute	Cheng, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Canc Inst, Dept Mol & Cell Biol, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200025, Peoples R China.	jkcheng@shsmu.edu.cn			National Natural Science Foundation of China [30772462, 30800579]; National Key Scientific Program in China [2009CB918403]; State Key Laboratory of Oncogenes and Related Genes [91-08-06]; E-Institutes of Shanghai Municipal Education Commission [E09013]; NIH [CA239520]; NATIONAL CANCER INSTITUTE [R01CA139520] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Program in China; State Key Laboratory of Oncogenes and Related Genes; E-Institutes of Shanghai Municipal Education Commission; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Natural Science Foundation of China (30772462, to JC; 30800579 to XK), National Key Scientific Program in China (2009CB918403, to JC), State Key Laboratory of Oncogenes and Related Genes (91-08-06, to JC), E-Institutes of Shanghai Municipal Education Commission (E09013, to JC) and NIH grants (CA239520, to ETHY). ETHY is the McNair Scholar of the Texas Heart Institute, St Luke Episcopal Hospital.	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Gruber M, 2006, CURR OPIN HEMATOL, V13, P169, DOI 10.1097/01.moh.0000219663.88409.35; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Matsuura T, 2005, EXP CELL RES, V308, P65, DOI 10.1016/j.yexcr.2005.04.022; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	44	48	54	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	41					5568	5578		10.1038/onc.2010.297	http://dx.doi.org/10.1038/onc.2010.297			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FX	20661221				2022-12-25	WOS:000282946900004
J	Aoyama, T; Okamoto, T; Fukiage, K; Otsuka, S; Furu, M; Ito, K; Jin, YH; Ueda, M; Nagayama, S; Nakayama, T; Nakamura, T; Toguchida, J				Aoyama, Tomoki; Okamoto, Takeshi; Fukiage, Kenichi; Otsuka, Seiji; Furu, Moritoshi; Ito, Kinya; Jin, Yonghui; Ueda, Michiko; Nagayama, Satoshi; Nakayama, Tomitaka; Nakamura, Takashi; Toguchida, Junya			Histone Modifiers, YY1 and p300, Regulate the Expression of Cartilage-specific Gene, Chondromodulin-I, in Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; TRANSCRIPTION; CHONDROCYTES; CANCER; ACETYLATION; CHROMATIN; BINDING; FAMILY; GROWTH; SP3	Elucidating the regulatory mechanism for tissue-specific gene expression is key to understanding the differentiation process. The chondromodulin-I gene (ChM-I) is a cartilage-specific gene, the expression of which is regulated by the transcription factor, Sp3. The binding of Sp3 to the core-promoter region is regulated by the methylation status of the Sp3-binding motif as we reported previously. In this study, we have investigated the molecular mechanisms of the down-regulation of ChM-I expression in mesenchymal stem cells (MSCs) and normal mesenchymal tissues other than cartilage. The core-promoter region of cells in bone and peripheral nerve tissues was hypermethylated, whereas the methylation status in cells of other tissues including MSCs did not differ from that in cells of cartilage, suggesting the presence of inhibitory mechanisms other than DNA methylation. We found that a transcriptional repressor, YY1, negatively regulated the expression of ChM-I by recruiting histone deacetylase and thus inducing the deacetylation of associated histones. As for a positive regulator, we found that a transcriptional co-activator, p300, bound to the core-promoter region with Sp3, inducing the acetylation of histone. Inhibition of YY1 in combination with forced expression of p300 and Sp3 restored the expression of ChM-I in cells with a hypomethylated promoter region, but not in cells with hypermethylation. These results suggested that the expression of tissue-specific genes is regulated in two steps; reversible down-regulation by transcriptional repressor complex and tight down-regulation via DNA methylation.	[Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan; [Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Aoyama, Tomoki; Okamoto, Takeshi; Fukiage, Kenichi; Furu, Moritoshi; Nakayama, Tomitaka; Nakamura, Takashi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan; [Nagayama, Satoshi] Kyoto Univ, Grad Sch Med, Dept Surg & Surg Basic Sci, Kyoto 6068507, Japan; [Otsuka, Seiji; Ito, Kinya] Nagoya City Univ, Grad Sch Med Sci, Dept Musculoskeletal Med, Nagoya, Aichi 4678601, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Nagoya City University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	togjun@frontier.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research [21390420] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science, from the Ministry of Education, Culture, Sports, Science, and Technology, and from the Ministry of Health, Labor, and Welfare.	Aoyama T, 2005, J BONE MINER RES, V20, P377, DOI 10.1359/JBMR.041122; Aoyama T, 2004, J BIOL CHEM, V279, P28789, DOI 10.1074/jbc.M401273200; Aoyama T, 2008, BIOCHEM BIOPH RES CO, V365, P124, DOI 10.1016/j.bbrc.2007.10.135; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HIRAKI Y, 1991, BIOCHEM BIOPH RES CO, V175, P971, DOI 10.1016/0006-291X(91)91660-5; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Kishikawa S, 2002, EUR J BIOCHEM, V269, P2961, DOI 10.1046/j.1432-1033.2002.02972.x; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakao M, 2001, GENE, V278, P25, DOI 10.1016/S0378-1119(01)00721-1; Noer A, 2006, MOL BIOL CELL, V17, P3543, DOI 10.1091/mbc.E06-04-0322; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pasini D, 2008, COLD SH Q B, V73, P253, DOI 10.1101/sqb.2008.73.009; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THONAR EJMA, 1983, J BIOL CHEM, V258, P1564; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhao W, 2005, J BIOCHEM, V137, P431, DOI 10.1093/jb/mvi048	32	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29842	29850		10.1074/jbc.M110.116319	http://dx.doi.org/10.1074/jbc.M110.116319			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663886	Green Published, hybrid			2022-12-25	WOS:000281984300020
J	Jayadeva, G; Kurimchak, A; Garriga, J; Sotillo, E; Davis, AJ; Haines, DS; Mumby, M; Grana, X				Jayadeva, Girish; Kurimchak, Alison; Garriga, Judit; Sotillo, Elena; Davis, Anthony J.; Haines, Dale S.; Mumby, Marc; Grana, Xavier			B55 alpha PP2A Holoenzymes Modulate the Phosphorylation Status of the Retinoblastoma-related Protein p107 and Its Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; PHOSPHATASE 2A; REGULATORY SUBUNIT; PRB DEPHOSPHORYLATION; DNA-DAMAGE; P130; QUIESCENCE; INTERACTS; ARREST; FAMILY	Pocket proteins negatively regulate transcription of E2F-dependent genes and progression through the G(0)/G(1) transition and the cell cycle restriction point in G(1). Pocket protein repressor activities are inactivated via phosphorylation at multiple Pro-directed Ser/Thr sites by the coordinated action of G(1) and G(1)/S cyclin-dependent kinases. These phosphorylations are reversed by the action of two families of Ser/Thr phosphatases: PP1, which has been implicated in abrupt dephosphorylation of retinoblastoma protein (pRB) in mitosis, and PP2A, which plays a role in an equilibrium that counteracts cyclin-dependent kinase (CDK) action throughout the cell cycle. However, the identity of the trimeric PP2A holoenzyme(s) functioning in this process is unknown. Here we report the identification of a PP2A trimeric holoenzyme containing B55 alpha, which plays a major role in restricting the phosphorylation state of p107 and inducing its activation in human cells. Our data also suggest targeted selectivity in the interaction of pocket proteins with distinct PP2A holoenzymes, which is likely necessary for simultaneous pocket protein activation.	[Jayadeva, Girish; Kurimchak, Alison; Garriga, Judit; Sotillo, Elena; Haines, Dale S.; Grana, Xavier] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Haines, Dale S.; Grana, Xavier] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Davis, Anthony J.; Mumby, Marc] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Grana, X (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, AHP Bldg,Rm 308,3307 N Broad St, Philadelphia, PA 19140 USA.	xavier@temple.edu		Davis, Anthony/0000-0003-0184-3651; Grana, Xavier/0000-0001-7134-0473; Sotillo, Elena/0000-0002-3993-1932	National Institutes of Health [CA095569, K02 AI01823]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [P01CA095569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI001823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA095569 (to X. G., J. G., and D. S. H.) and a National Institutes of Health Career Development Award (K02 AI01823) (to X. G.). This work was also supported by a grant from the Pennsylvania Department of Health (to X. G.).	Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; Garriga J, 2004, CELL CYCLE, V3, P1320, DOI 10.4161/cc.3.10.1183; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Grana X, 2008, CANCER BIOL THER, V7, P842, DOI 10.4161/cbt.7.6.6298; Kolupaeva V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003447; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; MAYOL X, 1995, ONCOGENE, V11, P801; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Sotillo E, 2008, J BIOL CHEM, V283, P11280, DOI 10.1074/jbc.M709055200; Sotillo E, 2010, CONTEMP CANCER RES, P3, DOI 10.1007/978-1-4419-1770-6_1; Swanhart LM, 2007, DEV DYNAM, V236, P2567, DOI 10.1002/dvdy.21265; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; Voorhoeve PM, 1999, ONCOGENE, V18, P679, DOI 10.1038/sj.onc.1202289; Vuocolo S, 2003, J BIOL CHEM, V278, P41881, DOI 10.1074/jbc.M302715200; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhang ZG, 2003, J VIROL, V77, P12660, DOI 10.1128/JVI.77.23.12660-12670.2003	29	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29863	29873		10.1074/jbc.M110.162354	http://dx.doi.org/10.1074/jbc.M110.162354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663872	hybrid, Green Published			2022-12-25	WOS:000281984300023
J	Kamps, AR; Pruitt, MM; Herriges, JC; Coffman, CR				Kamps, Angela R.; Pruitt, Margaret M.; Herriges, John C.; Coffman, Clark R.			An Evolutionarily Conserved Arginine Is Essential for Tre1 G Protein-Coupled Receptor Function During Germ Cell Migration in Drosophila melanogaster	PLOS ONE			English	Article							ALPHA(1B)-ADRENERGIC RECEPTOR; CONSTITUTIVE ACTIVITY; STRUCTURE PREDICTION; CHEMOKINE RECEPTORS; ARG-TYR; ACTIVATION; DISRUPTION; CXCR4; MODEL; DEATH	Background: G protein-coupled receptors (GPCRs) play central roles in mediating cellular responses to environmental signals leading to changes in cell physiology and behaviors, including cell migration. Numerous clinical pathologies including metastasis, an invasive form of cell migration, have been linked to abnormal GPCR signaling. While the structures of some GPCRs have been defined, the in vivo roles of conserved amino acid residues and their relationships to receptor function are not fully understood. Trapped in endoderm 1 (Tre1) is an orphan receptor of the rhodopsin class that is necessary for primordial germ cell migration in Drosophila melanogaster embryos. In this study, we employ molecular genetic approaches to identify residues in Tre1 that are critical to its functions in germ cell migration. Methodology/Principal Findings: First, we show that the previously reported scattershot mutation is an allele of tre1. The scattershot allele results in an in-frame deletion of 8 amino acids at the junction of the third transmembrane domain and the second intracellular loop of Tre1 that dramatically impairs the function of this GPCR in germ cell migration. To further refine the molecular basis for this phenotype, we assayed the effects of single amino acid substitutions in transgenic animals and determined that the arginine within the evolutionarily conserved E/N/DRY motif is critical for receptor function in mediating germ cell migration within an intact developing embryo. Conclusions/Significance: These structure-function studies of GPCR signaling in native contexts will inform future studies into the basic biology of this large and clinically important family of receptors.	[Kamps, Angela R.; Pruitt, Margaret M.; Herriges, John C.; Coffman, Clark R.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	Iowa State University	Kamps, AR (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	ccoffman@iastate.edu			National Science Foundation [IOB-0235332]; Roy J. Carver Charitable Trust [08-3185]; Center for Integrated Animal Genomics at Iowa State University; Iowa Agriculture and Home Economics Experiment Station	National Science Foundation(National Science Foundation (NSF)); Roy J. Carver Charitable Trust; Center for Integrated Animal Genomics at Iowa State University; Iowa Agriculture and Home Economics Experiment Station	This work was supported by grants from the National Science Foundation (IOB-0235332), the Roy J. Carver Charitable Trust (08-3185), the Center for Integrated Animal Genomics at Iowa State University, and the Iowa Agriculture and Home Economics Experiment Station. URLs: http://www.nsf.gov/; http://www.carvertrust.org/; http://www.ciag.iastate.edu/; http://www.iahees.iastate.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Angelova K, 2002, J BIOL CHEM, V277, P32202, DOI 10.1074/jbc.M203272200; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berchiche YA, 2007, J BIOL CHEM, V282, P5111, DOI 10.1074/jbc.C600270200; Brink CB, 2004, BRIT J CLIN PHARMACO, V57, P373, DOI 10.1111/j.1365-2125.2003.02046.x; BURNETT C, 2005, THESIS U COLL LONDON; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Coffman CR, 2003, ANN NY ACAD SCI, V995, P117, DOI 10.1111/j.1749-6632.2003.tb03215.x; Coffman CR, 2002, GENETICS, V162, P273; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dumstrei K, 2004, J CELL SCI, V117, P4787, DOI 10.1242/jcs.01362; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GLOOR GB, 1993, GENETICS, V135, P81; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; HAY B, 1988, DEVELOPMENT, V103, P625; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Holmes AL, 1998, GENETICS, V148, P1189; Johansen KM, 2004, METH MOL B, V247, P215; JONES PG, 1995, EUR J PHARM-MOLEC PH, V288, P251, DOI 10.1016/0922-4106(95)90036-5; Kamps AR, 2005, ANN NY ACAD SCI, V1049, P17, DOI 10.1196/annals.1334.003; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; KUNWAR PS, 2008, J CELL BIOL; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Rosenkilde MM, 2005, MOL PHARMACOL, V68, P11, DOI 10.1124/mol.105.011239; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Scheer A, 2000, MOL PHARMACOL, V57, P219; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; Sonnenblick BP, 1941, P NATL ACAD SCI USA, V27, P484, DOI 10.1073/pnas.27.10.484; SONNENBLICK BP, 1950, EARLY EMBRYOLOGY DRO; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; UNDERWOOD EM, 1980, DEV BIOL, V77, P303, DOI 10.1016/0012-1606(80)90476-5; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; YAMADA Y, 2007, THESIS IOWA STATE U; Zhang ML, 2005, J BIOL CHEM, V280, P26169, DOI 10.1074/jbc.M502102200; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	57	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11839	10.1371/journal.pone.0011839	http://dx.doi.org/10.1371/journal.pone.0011839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676220	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520100015
J	Zhang, LL; Blackman, BE; Schonemann, MD; Zogovic-Kapsalis, T; Pan, XY; Tagliaferri, M; Harris, HA; Cohen, I; Pera, RAR; Mellon, SH; Weiner, RI; Leitman, DC				Zhang, Lili; Blackman, Brigitte E.; Schonemann, Marcus D.; Zogovic-Kapsalis, Tatjana; Pan, Xiaoyu; Tagliaferri, Mary; Harris, Heather A.; Cohen, Isaac; Pera, Renee A. Reijo; Mellon, Synthia H.; Weiner, Richard I.; Leitman, Dale C.			Estrogen Receptor beta-Selective Agonists Stimulate Calcium Oscillations in Human and Mouse Embryonic Stem Cell-Derived Neurons	PLOS ONE			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR RECEPTOR; PLASMA-MEMBRANE; BREAST-CANCER; HYPOTHALAMIC NEURONS; HORMONE NEURONS; ER-ALPHA; HIPPOCAMPAL-NEURONS; COUPLED RECEPTOR; BASAL FOREBRAIN	Estrogens are used extensively to treat hot flashes in menopausal women. Some of the beneficial effects of estrogens in hormone therapy on the brain might be due to nongenomic effects in neurons such as the rapid stimulation of calcium oscillations. Most studies have examined the nongenomic effects of estrogen receptors (ER) in primary neurons or brain slices from the rodent brain. However, these cells can not be maintained continuously in culture because neurons are post-mitotic. Neurons derived from embryonic stem cells could be a potential continuous, cell-based model to study nongenomic actions of estrogens in neurons if they are responsive to estrogens after differentiation. In this study ER-subtype specific estrogens were used to examine the role of ER alpha and ER beta on calcium oscillations in neurons derived from human (hES) and mouse embryonic stem cells. Unlike the undifferentiated hES cells the differentiated cells expressed neuronal markers, ER beta, but not ER alpha. The non-selective ER agonist 17 beta-estradiol (E(2)) rapidly increased [Ca(2+)]i oscillations and synchronizations within a few minutes. No change in calcium oscillations was observed with the selective ER alpha agonist 4,4',4 ''-(4-Propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol (PPT). In contrast, the selective ER beta agonists, 2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN), MF101, and 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3 benzoxazol-5-ol (ERB-041; WAY-202041) stimulated calcium oscillations similar to E2. The ER beta agonists also increased calcium oscillations and phosphorylated PKC, AKT and ERK1/2 in neurons derived from mouse ES cells, which was inhibited by nifedipine demonstrating that ER beta activates L-type voltage gated calcium channels to regulate neuronal activity. Our results demonstrate that ER beta signaling regulates nongenomic pathways in neurons derived from ES cells, and suggest that these cells might be useful to study the nongenomic mechanisms of estrogenic compounds.	[Zhang, Lili; Blackman, Brigitte E.; Schonemann, Marcus D.; Zogovic-Kapsalis, Tatjana; Mellon, Synthia H.; Weiner, Richard I.; Leitman, Dale C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Zhang, Lili; Blackman, Brigitte E.; Schonemann, Marcus D.; Zogovic-Kapsalis, Tatjana; Mellon, Synthia H.; Weiner, Richard I.; Leitman, Dale C.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Pan, Xiaoyu] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Tagliaferri, Mary; Cohen, Isaac] Bionovo Inc, Emeryville, CA USA; [Harris, Heather A.] Wyeth Ayerst Res, Womens Hlth & Musculoskeletal Biol, Collegeville, PA USA; [Pera, Renee A. Reijo] Stanford Univ, Dept Obstet & Gynecol, Ctr Human Embryon Stem Cell Res & Educ, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Leitman, Dale C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Pfizer; Stanford University; University of California System; University of California Berkeley	Zhang, LL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	dale@leitmanlab.com		Reijo Pera, Renee/0000-0002-6487-1329	National Center for Complementary and Alternative Medicine [AT002173]; Bionovo, Inc.; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002173] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Bionovo, Inc.; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a grant from the National Center for Complementary and Alternative Medicine (AT002173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. D. C. L. has received financial support for research from Bionovo, Inc. D. C. L. conceived and designed the experiments, analyzed the data and wrote the paper.	Abe H, 2008, ENDOCRINOLOGY, V149, P1155, DOI 10.1210/en.2007-0942; Abraham IM, 2003, J NEUROSCI, V23, P5771; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barragan M, 2002, BLOOD, V99, P2969, DOI 10.1182/blood.V99.8.2969; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Beyer C, 1999, ANAT EMBRYOL, V199, P379, DOI 10.1007/s004290050236; Beyer C, 1998, EUR J NEUROSCI, V10, P255, DOI 10.1046/j.1460-9568.1998.00045.x; Blurton-Jones M, 2002, J COMP NEUROL, V452, P276, DOI 10.1002/cne.10393; Bowe J, 2006, J ENDOCRINOL, V191, P399, DOI 10.1677/joe.1.06919; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; CHEN Q, ENDOCRINOLOGY, V151, P281; Chu ZG, 2009, J NEUROSCI, V29, P5616, DOI 10.1523/JNEUROSCI.0352-09.2009; Constantin S, 2009, ENDOCRINOLOGY, V150, P1400, DOI 10.1210/en.2008-0979; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Ettinger B, 2003, OBSTET GYNECOL, V102, P1225, DOI 10.1016/j.obstetgynecol.2003.08.007; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fink G, 1996, CELL MOL NEUROBIOL, V16, P325, DOI 10.1007/BF02088099; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Fried G, 2004, EUR J NEUROSCI, V20, P2345, DOI 10.1111/j.1460-9568.2004.03693.x; FUESHKO S, 1994, DEV BIOL, V166, P331, DOI 10.1006/dbio.1994.1319; GITZEN JF, 1987, PSYCHONEUROENDOCRINO, V12, P3; Gorosito SV, 2008, J NEUROSCI RES, V86, P145, DOI 10.1002/jnr.21466; GRADY D, 2009, MENOPAUSE; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; JORDAN VC, 1975, EUR J CANCER, V11, P205, DOI 10.1016/0014-2964(75)90119-X; Kelly MJ, 2008, MOL CELL ENDOCRINOL, V290, P14, DOI 10.1016/j.mce.2008.04.014; KELLY MJ, 1977, EXP BRAIN RES, V30, P43; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Manas ES, 2004, J AM CHEM SOC, V126, P15106, DOI 10.1021/ja047633o; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUMOTO A, 1981, J COMP NEUROL, V197, P197, DOI 10.1002/cne.901970203; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MERRIAM GR, 1982, AM J PHYSIOL, V243, pE310, DOI 10.1152/ajpendo.1982.243.4.E310; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Moore JP, 2002, J NEUROSCI, V22, P8932; Nadal A, 2001, NEWS PHYSIOL SCI, V16, P251; Navarro CE, 2003, MOL ENDOCRINOL, V17, P1792, DOI 10.1210/me.2003-0040; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; O'Neill EE, 2008, BRAIN RES, V1222, P1, DOI 10.1016/j.brainres.2008.05.036; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Opas EE, 2006, MATURITAS, V53, P210, DOI 10.1016/j.maturitas.2005.04.006; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Powell CE, 2001, J STEROID BIOCHEM, V77, P97, DOI 10.1016/S0960-0760(01)00040-1; Qiu J, 2003, J NEUROSCI, V23, P9529; Qiu J, 2008, STEROIDS, V73, P985, DOI 10.1016/j.steroids.2007.11.008; Qiu J, 2006, J NEUROSCI, V26, P5649, DOI 10.1523/JNEUROSCI.0327-06.2006; Rao SP, 2007, GLIA, V55, P1680, DOI 10.1002/glia.20564; Rao SP, 2006, GLIA, V53, P817, DOI 10.1002/glia.20341; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roy D, 1999, ENDOCRINOLOGY, V140, P5045, DOI 10.1210/en.140.11.5045; Sakamoto H, 2007, ENDOCRINOLOGY, V148, P5842, DOI 10.1210/en.2007-0436; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Sheldahl LC, 2008, NEUROSCIENCE, V153, P751, DOI 10.1016/j.neuroscience.2008.02.035; Shughrue PJ, 2002, ENDOCRINOLOGY, V143, P1643, DOI 10.1210/en.143.5.1643; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Szego EM, 2006, J NEUROSCI, V26, P4104, DOI 10.1523/JNEUROSCI.0222-06.2006; Temple JL, 2005, ENDOCRINOLOGY, V146, P558, DOI 10.1210/en.2004-1117; TERASAWA E, 1993, ENDOCRINOLOGY, V133, P2379, DOI 10.1210/en.133.5.2379; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Titolo D, 2008, J NEUROSCI, V28, P6473, DOI 10.1523/JNEUROSCI.0514-08.2008; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Vida B, 2008, J NEUROENDOCRINOL, V20, P1270, DOI 10.1111/j.1365-2826.2008.01787.x; Wade CB, 2001, ENDOCRINOLOGY, V142, P2336, DOI 10.1210/en.142.6.2336; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Yoshida H, 2004, NEUROENDOCRINOLOGY, V80, P2, DOI 10.1159/000080519; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhao LQ, 2006, J PHARMACOL EXP THER, V319, P1124, DOI 10.1124/jpet.106.109504; Zhao LQ, 2009, ENDOCRINOLOGY, V150, P770, DOI 10.1210/en.2008-0715	89	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11791	10.1371/journal.pone.0011791	http://dx.doi.org/10.1371/journal.pone.0011791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668547	gold, Green Submitted, Green Published			2022-12-25	WOS:000280371800005
J	Castle, JC; Armour, CD; Lower, M; Haynor, D; Biery, M; Bouzek, H; Chen, RH; Jackson, S; Johnson, JM; Rohl, CA; Raymond, CK				Castle, John C.; Armour, Christopher D.; Loewer, Martin; Haynor, David; Biery, Matthew; Bouzek, Heather; Chen, Ronghua; Jackson, Stuart; Johnson, Jason M.; Rohl, Carol A.; Raymond, Christopher K.			Digital Genome-Wide ncRNA Expression, Including SnoRNAs, across 11 Human Tissues Using PolyA-Neutral Amplification	PLOS ONE			English	Article							NONCODING RNA; TELOMERE MAINTENANCE; PRADER-WILLI; GENE; IDENTIFICATION; TRANSCRIPTS	Non-coding RNAs (ncRNAs) are an essential class of molecular species that have been difficult to monitor on high throughput platforms due to frequent lack of polyadenylation. Using a polyadenylation-neutral amplification protocol and next-generation sequencing, we explore ncRNA expression in eleven human tissues. ncRNAs 7SL, U2, 7SK, and HBII-52 are expressed at levels far exceeding mRNAs. C/D and H/ACA box snoRNAs are associated with rRNA methylation and pseudouridylation, respectively: spleen expresses both, hypothalamus expresses mainly C/D box snoRNAs, and testes show enriched expression of both H/ACA box snoRNAs and RNA telomerase TERC. Within the snoRNA 14q cluster, 14q(I-6) is expressed at much higher levels than other cluster members. More reads align to mitochondrial than nuclear tRNAs. Many lincRNAs are actively transcribed, particularly those overlapping known ncRNAs. Within the Prader-Willi syndrome loci, the snoRNA HBII-85 (group I) cluster is highly expressed in hypothalamus, greater than in other tissues and greater than group II or III. Additionally, within the disease locus we find novel transcription across a 400,000 nt span in ovaries. This genome-wide polyA-neutral expression compendium demonstrates the richness of ncRNA expression, their high expression patterns, their function-specific expression patterns, and is publicly available.	[Castle, John C.; Loewer, Martin] Inst Translat Oncol & Immunol, Mainz, Germany; [Armour, Christopher D.; Biery, Matthew; Raymond, Christopher K.] Nugen Inc, Seattle, WA USA; [Haynor, David; Bouzek, Heather] Univ Washington, Seattle, WA 98195 USA; [Chen, Ronghua; Jackson, Stuart; Johnson, Jason M.; Rohl, Carol A.] Merck Res Labs, Boston, MA USA; [Castle, John C.; Armour, Christopher D.; Haynor, David; Biery, Matthew; Bouzek, Heather; Chen, Ronghua; Jackson, Stuart; Johnson, Jason M.; Rohl, Carol A.; Raymond, Christopher K.] Rosetta Inpharmat, Seattle, WA USA	University of Washington; University of Washington Seattle; Merck & Company; Merck & Company	Castle, JC (corresponding author), Inst Translat Oncol & Immunol, Mainz, Germany.	castle@uni-mainz.de; carmour@nugeninc.com	Rohl, Carol/I-2589-2012	Rohl, Carol/0000-0002-9229-3917; Biery, Matthew/0000-0003-3315-982X	Rosetta Inpharmatics LLC; Merck Co., Inc.	Rosetta Inpharmatics LLC; Merck Co., Inc.(Merck & Company)	Most authors previously worked for Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co., Inc. Rosetta/Merck paid employee salaries and funded the original research. Merck employees have reviewed the manuscript and approved the data release. Further analysis was done by JCC at TRON, a not-for-profit institute.	AGARWAL S, 2010, NATURE; Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; CASTLE JC, 2010, BMC GENOMIC IN PRESS; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Charette M, 2000, IUBMB LIFE, V49, P341; Christov CP, 2008, BRIT J CANCER, V98, P981, DOI 10.1038/sj.bjc.6604254; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LEIBOVITCH MP, 1991, BIOCHEM BIOPH RES CO, V180, P1241, DOI 10.1016/S0006-291X(05)81329-4; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; LI H, 2009, BWA BURROWS WHEELER; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; WATSON JB, 1987, MOL CELL BIOL, V7, P3324, DOI 10.1128/MCB.7.9.3324; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206	35	87	92	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11779	10.1371/journal.pone.0011779	http://dx.doi.org/10.1371/journal.pone.0011779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668672	Green Submitted, Green Published, gold			2022-12-25	WOS:000280297300014
J	Hu, C; Zhang, R; Wang, CR; Yu, WH; Lu, JY; Ma, XJ; Wang, J; Jiang, F; Tang, SS; Bao, YQ; Xiang, KS; Jia, WP				Hu, Cheng; Zhang, Rong; Wang, Congrong; Yu, Weihui; Lu, Jingyi; Ma, Xiaojing; Wang, Jie; Jiang, Feng; Tang, Shanshan; Bao, Yuqian; Xiang, Kunsan; Jia, Weiping			Effects of GCK, GCKR, G6PC2 and MTNR1B Variants on Glucose Metabolism and Insulin Secretion	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; PANCREATIC BETA-CELL; TYPE-2 DIABETES RISK; CHINESE POPULATION; COMMON VARIANT; HOMEOSTASIS; MELATONIN; ASSOCIATION; DEFINITION; RESISTANCE	Background: Single nucleotide polymorphisms (SNPs) from GCK, GCKR, G6PC2 and MTNR1B were found to modulate the fasting glucose levels. The current study aimed to replicate this association in the Chinese population and further analyze their effects on biphasic insulin secretion. Methods/Principal Findings: SNPs from GCK, GCKR, G6PC2 and MTNR1B were genotyped in the Shanghai Chinese, including 3,410 type 2 diabetes patients and 3,412 controls. The controls were extensively phenotyped for the traits related to glucose metabolism and insulin secretion. We replicated the association between GCK rs1799884, G6PC2 rs16856187 and MTNR1B rs10830963 and fasting glucose in our samples (p = 0.0003 similar to 2.06x10(-8)). GCK rs1799884 and G6PC2 rs16856187 showed association to HOMA-beta, insulinogenic index and both first-and second-phases insulin secretion (p = 0.0030 similar to 0.0396). MTNR1B rs10830963 was associated to HOMA-beta, insulinogenic index and first-phase insulin secretion (p = 0.0102 similar to 0.0426), but not second-phase insulin secretion (p = 0.9933). Combined effect analyses showed individuals carrying more risk allele for high fasting glucose tended to have a higher glucose levels at both fasting and 2 h during OGTTs (p = 1.76x10(-13) and 0.0009, respectively), as well as lower HOMA-beta, insulinogenic index and both first-and second-phases insulin secretion (p = 0.0321 similar to 1.1x10(-7)). Conclusions/Significance: We showed that SNPs from GCK, G6PC2 and MTNR1B modulated the fasting glucose levels in the normoglycaemic population while SNPs from G6PC2 and GCKR was associated with type 2 diabetes. Moreover, we found GCK and G6PC2 genetic variants were associated to both first-and second-phases insulin secretion while MTNR1B genetic variant was associated with first-phase insulin secretion, but not second-phase insulin secretion.	[Hu, Cheng; Wang, Jie; Bao, Yuqian; Xiang, Kunsan; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Hu, Cheng; Zhang, Rong; Wang, Congrong; Yu, Weihui; Lu, Jingyi; Ma, Xiaojing; Jiang, Feng; Tang, Shanshan; Xiang, Kunsan; Jia, Weiping] Shanghai Diabet Inst, Shanghai, Peoples R China; [Hu, Cheng; Zhang, Rong; Wang, Congrong; Yu, Weihui; Lu, Jingyi; Ma, Xiaojing; Wang, Jie; Jiang, Feng; Tang, Shanshan; Bao, Yuqian; Xiang, Kunsan; Jia, Weiping] Shanghai Clin Ctr Diabet, Shanghai, Peoples R China	Shanghai Jiao Tong University	Hu, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	王, 从容/HDM-0959-2022; Hu, Cheng/C-3346-2008; Jia, Weiping/B-7483-2012	王, 从容/0000-0002-8645-1114; Hu, Cheng/0000-0003-4314-2386; 	Shanghai Municipal Education Commission and Shanghai Education Development Foundation [09CG07]; National Natural Science Foundation of China [30630061, 30800617]; National 973 Program [2006CB503901]; National 863 Program [2006AA02A409]; Shanghai Rising-Star Program [09QA1404400]; Shanghai Municipality for Basic Research [08dj1400601]; Shanghai Key Laboratory of Diabetes Mellitus [08DZ2230200]; Shanghai Municipal Hospitals [SHDC12007316]	Shanghai Municipal Education Commission and Shanghai Education Development Foundation(Shanghai Municipal Education Commission (SHMEC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China); National 863 Program(National High Technology Research and Development Program of China); Shanghai Rising-Star Program; Shanghai Municipality for Basic Research; Shanghai Key Laboratory of Diabetes Mellitus; Shanghai Municipal Hospitals	This work was supported by the "Chen Guang'' project (09CG07) from Shanghai Municipal Education Commission and Shanghai Education Development Foundation, National Natural Science Foundation of China (30630061 and 30800617), National 973 Program (2006CB503901), National 863 Program (2006AA02A409), Shanghai Rising-Star Program (09QA1404400), major program of Shanghai Municipality for Basic Research (08dj1400601), Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200) and Shanghai Municipal Hospitals' Project of Chronic Disease Prevention and Treatment (SHDC12007316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Hu C, 2010, DIABETOLOGIA, V53, P290, DOI 10.1007/s00125-009-1594-2; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Peschke E, 2006, J PINEAL RES, V40, P184, DOI 10.1111/j.1600-079X.2005.00297.x; Petit L, 1999, BIOCHEM PHARMACOL, V58, P633, DOI 10.1016/S0006-2952(99)00134-3; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Stumvoll M, 2001, DIABETES CARE, V24, P796, DOI 10.2337/diacare.24.4.796; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Zhang SC, 2009, OBESITY, V17, P1581, DOI 10.1038/oby.2009.125	29	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11761	10.1371/journal.pone.0011761	http://dx.doi.org/10.1371/journal.pone.0011761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668700	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800029
J	Su, TT				Su, Tin Tin			The Effect of a DNA Damaging Agent on Embryonic Cell Cycles of the Cnidarian Hydractinia echinata	PLOS ONE			English	Article							SEA-URCHIN EMBRYOS; MIDBLASTULA TRANSITION; CHECKPOINT; CAFFEINE; REPLICATION; INHIBITION; APOPTOSIS; XENOPUS; REPAIR; ATM	The onset of gastrulation at the Mid-Blastula Transition can accompany profound changes in embryonic cell cycles including the introduction of gap phases and the transition from maternal to zygotic control. Studies in Xenopus and Drosophila embryos have also found that cell cycles respond to DNA damage differently before and after MBT (or its equivalent, MZT, in Drosophila). DNA checkpoints are absent in Xenopus cleavage cycles but are acquired during MBT. Drosophila cleavage nuclei enter an abortive mitosis in the presence of DNA damage whereas post-MZT cells delay the entry into mitosis. Despite attributes that render them workhorses of embryonic cell cycle studies, Xenopus and Drosophila are hardly representative of diverse animal forms that exist. To investigate developmental changes in DNA damage responses in a distant phylum, I studied the effect of an alkylating agent, Methyl Methanesulfonate (MMS), on embryos of Hydractinia echinata. Hydractinia embryos are found to differ from Xenopus embryos in the ability to respond to a DNA damaging agent in early cleavage but are similar to Xenopus and Drosophila embryos in acquiring stronger DNA damage responses and greater resistance to killing by MMS after the onset of gastrulation. This represents the first study of DNA damage responses in the phylum Cnidaria.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Su, TT (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	tin.su@colorado.edu			Laura and Arthur Colwin Endowed Summer Research Fellowship; Woods Hole Marine Biology Lab; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087276] Funding Source: NIH RePORTER	Laura and Arthur Colwin Endowed Summer Research Fellowship; Woods Hole Marine Biology Lab; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a Laura and Arthur Colwin Endowed Summer Research Fellowship, Woods Hole Marine Biology Lab, to T. T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Byrum C.A., 2004, P33; Conn CW, 2004, DEV CELL, V7, P275, DOI 10.1016/j.devcel.2004.07.003; Duncan T, 2004, CURR BIOL, V14, pR305, DOI 10.1016/j.cub.2004.03.050; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Epel D, 2003, EVOL DEV, V5, P83, DOI 10.1046/j.1525-142X.2003.03013.x; Frank U, 2001, BIOESSAYS, V23, P963, DOI 10.1002/bies.1137; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Halanych KM, 2001, AM ZOOL, V41, P629, DOI 10.1668/0003-1569(2001)041[0629:ABROMP]2.0.CO;2; Jaklevic BR, 2004, CURR BIOL, V14, P23, DOI 10.1016/j.cub.2003.12.032; Le Bouffant R, 2007, CELL MOL LIFE SCI, V64, P1723, DOI 10.1007/s00018-007-7173-0; Le Bouffant R, 2008, EXP CELL RES, V314, P961, DOI 10.1016/j.yexcr.2007.12.014; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Patel R, 1997, ZYGOTE, V5, P127, DOI 10.1017/S0967199400003804; Peng AM, 2008, CELL CYCLE, V7, P3, DOI 10.4161/cc.7.1.5157; PLICKERT G, 1988, DEVELOPMENT, V103, P795; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Su TT, 2000, CURR BIOL, V10, P119, DOI 10.1016/S0960-9822(00)00300-6; Su TT, 2001, CURR BIOL, V11, P8, DOI 10.1016/S0960-9822(00)00042-7; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; Verma DPS, 2001, ANNU REV PLANT PHYS, V52, P751, DOI 10.1146/annurev.arplant.52.1.751	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11760	10.1371/journal.pone.0011760	http://dx.doi.org/10.1371/journal.pone.0011760			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668699	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243800028
J	Pool, R; Montgomery, CM; Morar, NS; Mweemba, O; Ssali, A; Gafos, M; Lees, S; Stadler, J; Crook, A; Nunn, A; Hayes, R; McCormack, S				Pool, Robert; Montgomery, Catherine M.; Morar, Neetha S.; Mweemba, Oliver; Ssali, Agnes; Gafos, Mitzy; Lees, Shelley; Stadler, Jonathan; Crook, Angela; Nunn, Andrew; Hayes, Richard; McCormack, Sheena			A Mixed Methods and Triangulation Model for Increasing the Accuracy of Adherence and Sexual Behaviour Data: The Microbicides Development Programme	PLOS ONE			English	Article							CLINICAL-TRIALS; QUALITATIVE METHODS; VALIDITY; WOMEN; FEASIBILITY; MULTIMETHOD; IMPROVEMENT; PREVENTION; BIOMARKERS; HIV/AIDS	Background: The collection of accurate data on adherence and sexual behaviour is crucial in microbicide (and other HIV-related) research. In the absence of a "gold standard'' the collection of such data relies largely on participant self-reporting. After reviewing available methods, this paper describes a mixed method/triangulation model for generating more accurate data on adherence and sexual behaviour in a multi-centre vaginal microbicide clinical trial. In a companion paper some of the results from this model are presented [1]. Methodology/Principal Findings: Data were collected from a random subsample of 725 women (7.7% of the trial population) using structured interviews, coital diaries, in-depth interviews, counting returned gel applicators, focus group discussions, and ethnography. The core of the model was a customised, semi-structured in-depth interview. There were two levels of triangulation: first, discrepancies between data from the questionnaires, diaries, in-depth interviews and applicator returns were identified, discussed with participants and, to a large extent, resolved; second, results from individual participants were related to more general data emerging from the focus group discussions and ethnography. A democratic and equitable collaboration between clinical trialists and qualitative social scientists facilitated the success of the model, as did the preparatory studies preceding the trial. The process revealed some of the underlying assumptions and routinised practices in "clinical trial culture'' that are potentially detrimental to the collection of accurate data, as well as some of the shortcomings of large qualitative studies, and pointed to some potential solutions. Conclusions/Significance: The integration of qualitative social science and the use of mixed methods and triangulation in clinical trials are feasible, and can reveal (and resolve) inaccuracies in data on adherence and sensitive behaviours, as well as illuminating aspects of "trial culture'' that may also affect data accuracy.	[Pool, Robert; Montgomery, Catherine M.] Univ Barcelona, Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Morar, Neetha S.] MRC, HIV Prevent Res Unit, Durban, South Africa; [Mweemba, Oliver] Univ Zambia, Dept Community Med, Lusaka, Zambia; [Ssali, Agnes] Uganda Virus Res Inst, Med Res Council UK, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Gafos, Mitzy] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Lees, Shelley; Hayes, Richard] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; [Stadler, Jonathan] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Crook, Angela; Nunn, Andrew; McCormack, Sheena] MRC, Clin Trials Unit, London, England; [Pool, Robert] Univ Amsterdam, Ctr Global Hlth & Inequal, Amsterdam, Netherlands	ISGlobal; CRESIB; University of Barcelona; University of Zambia; Uganda Virus Research Institute; University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; Medical Research Council Clinical Trials Unit; University of Amsterdam	Pool, R (corresponding author), Univ Barcelona, Ctr Int Hlth Res CRESIB, Barcelona, Spain.	robert.pool@cresib.cat		Gafos, Mitzy/0000-0002-7894-1498; Montgomery, Catherine/0000-0002-5829-6137; Stadler, Jonathan/0000-0002-2325-2660; Nunn, Andrew/0000-0002-9158-4595; Hayes, Richard/0000-0002-1729-9892; Ssali, Agnes/0000-0003-4801-0411	UK Department for International Development through the Medical Research Council; MRC [G0901756, G0700837, G0100137] Funding Source: UKRI; Medical Research Council [G0901756, G0700837, G0100137] Funding Source: researchfish	UK Department for International Development through the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project described in this paper was funded by the UK Department for International Development through the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CF, 2007, SEX TRANSM INFECT, V83, P490, DOI 10.1136/sti.2007.024810; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bernabe-Ortiz A, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-11; BLAIKIE NWH, 1991, QUAL QUANT, V25, P115, DOI 10.1007/BF00145701; BRADBURN J, 1995, PSYCHO-ONCOLOGY, V4, P107, DOI 10.1002/pon.2960040204; Bradley F, 1999, BMJ-BRIT MED J, V318, P711; Brewer John., 2006, FDN MULTIMETHOD RES; CAMPBELL DT, 1959, PSYCHOL B, V56; Creswell J, DESIGNING CONDUCTING, V3rd; Creswell JohnW., 2006, RES SCH, V13, P1; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Evans RL, 2003, J MANIP PHYSIOL THER, V26, P502, DOI 10.1016/S0161-4754(03)00107-6; Gibson G, 2004, AGE AGEING, V33, P422, DOI 10.1093/ageing/afh136; Glaser B, 1978, DISCOV GROUNDED THEO; Gregson S, 2004, SEX TRANSM INFECT, V80, P36, DOI 10.1136/sti.2004.012088; Imrie J, 2007, LANCET, V370, P10, DOI 10.1016/S0140-6736(07)61026-5; KAGANSON N, 2006, MICR 2006 C CAP TOWN; Lagakos SW, 2008, METHODOLOGICAL CHALL; Massey A, 1999, STUD EDUC ETHNOG, V2, P183; MAUK CK, 2009, SEXUALLY TRANSMITTED, V36, pS73; MAUK CK, 2009, SEXUALLY TRANSMITTED, V36, pS81; MCVARISH L, 2009, USE COMPUTER ASSISTE; MENSCH BS, 2008, 17 INT AIDS C MEX CI; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Mueller MR, 2004, QUAL HEALTH RES, V14, P704, DOI 10.1177/1049732304263627; Murtagh J, 2007, QUAL SAF HEALTH CARE, V16, P224, DOI 10.1136/qshc.2006.018499; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Orr DP, 1997, SEX TRANSM DIS, V24, P261, DOI 10.1097/00007435-199705000-00005; Paterniti DA, 2005, CANCER-AM CANCER SOC, V104, P3015, DOI 10.1002/cncr.21522; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Pool R, 2006, AIDS CARE, V18, P479, DOI 10.1080/09540120500221639; POOL R, 2008, P 2007 ROYAL DUTCH A, P55; POOL R, 2010, PLOS ONE; Rabago D, 2006, ANN FAM MED, V4, P295, DOI 10.1370/afm.552; Sandelowski M, 1996, RES NURS HEALTH, V19, P359, DOI 10.1002/(SICI)1098-240X(199608)19:4<359::AID-NUR9>3.3.CO;2-8; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Tashakkori A., 1998, MIXED METHODOLOGY CO; Tolley EE, 2010, AIDS BEHAV, V14, P1124, DOI 10.1007/s10461-009-9635-x; Turner AN, 2009, J CLIN EPIDEMIOL, V62, P759, DOI 10.1016/j.jclinepi.2008.07.011; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; van de Wijgert J, 2009, LANCET, V373, P721, DOI 10.1016/S0140-6736(09)60437-2; Wallace A, 2004, SEX TRANSM DIS, V31, P465, DOI 10.1097/01.olq.0000135986.35216.ba; Wallace AR, 2007, CONTRACEPTION, V76, P53, DOI 10.1016/j.contraception.2006.10.012; ZENILMAN JM, 1995, SEX TRANSM DIS, V22, P15, DOI 10.1097/00007435-199501000-00003; ATN062	47	52	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11600	10.1371/journal.pone.0011600	http://dx.doi.org/10.1371/journal.pone.0011600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KQ	20657778	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000280197500007
J	Schastak, S; Ziganshyna, S; Gitter, B; Wiedemann, P; Claudepierre, T				Schastak, Stanislaw; Ziganshyna, Svitlana; Gitter, Burkhard; Wiedemann, Peter; Claudepierre, Thomas			Efficient Photodynamic Therapy against Gram-Positive and Gram-Negative Bacteria Using THPTS, a Cationic Photosensitizer Excited by Infrared Wavelength	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL RESISTANCE; PSEUDOMONAS-AERUGINOSA; PORPHYRIN DERIVATIVES; ESCHERICHIA-COLI; BASIC PRINCIPLES; PHOTOINACTIVATION; INFECTIONS; SUSCEPTIBILITY; EPIDEMIOLOGY	The worldwide rise in the rates of antibiotic resistance of bacteria underlines the need for alternative antibacterial agents. A promising approach to kill antibiotic-resistant bacteria uses light in combination with a photosensitizer to induce a phototoxic reaction. Concentrations of 1, 10 and 100 mu M of tetrahydroporphyrin-tetratosylat (THPTS) and different incubation times (30, 90 and 180min) were used to measure photodynamic efficiency against two Gram-positive strains of S. aureus (MSSA and MRSA), and two Gram-negative strains of E. coli and P. aeruginosa. We found that phototoxicity of the drug is independent of the antibiotic resistance pattern when incubated in PBS for the investigated strains. Also, an incubation with 100 mu M THPTS followed by illumination, yielded a 6lg (>= 99.999%) decrease in the viable numbers of all bacteria strains tested, indicating that the THPTS drug has a high degree of photodynamic inactivation. We then modulated incubation time, photosensitizer concentration and monitored the effect of serum on the THPTS activity. In doing so, we established the conditions to obtain the strongest bactericidal effect. Our results suggest that this new and highly pure synthetic compound should improve the efficiency of photodynamic therapy against multiresistant bacteria and has a significant potential for clinical applications in the treatment of nosocomial infections.	[Schastak, Stanislaw; Wiedemann, Peter; Claudepierre, Thomas] Univ Leipzig, Fac Med, Dept Ophthalmol, Leipzig, Germany; [Ziganshyna, Svitlana] Univ Leipzig, Fac Med, Dept Anaesthesia & Intens Care Med, Leipzig, Germany; [Gitter, Burkhard] Biolitec AG, Res & Dev, Jena, Germany	Leipzig University; Leipzig University; Biolitec AG	Schastak, S (corresponding author), Univ Leipzig, Fac Med, Dept Ophthalmol, Leipzig, Germany.	stas@medizin.uni-leipzig.de		Claudepierre, Thomas/0000-0001-6968-8518	Biolitec AG; Ophthalmology Department at the Faculty of Medicine of the University of Leipzig; Novartis-Pharma Germany; French Foundation "Gueules Cassees"; Stiferverbrand fur die Deutsche Wissenchaft	Biolitec AG; Ophthalmology Department at the Faculty of Medicine of the University of Leipzig; Novartis-Pharma Germany; French Foundation "Gueules Cassees"; Stiferverbrand fur die Deutsche Wissenchaft	This work was funded by Biolitec AG and by the Ophthalmology Department at the Faculty of Medicine of the University of Leipzig. T. C. is supported by grants from Novartis-Pharma Germany, from the French Foundation "Gueules Cassees" and from the "Stiferverbrand fur die Deutsche Wissenchaft". Other than the input of the authors in the wording of the manuscript, and in providing materials and approving permission to publish freely, Biolitec AG as a funder had no direct role in the conception of the method, the study design, data collection, or analysis. Novartis Pharma-Germany, Foundation "Gueules Cassees", "Stiferverbrand fur die Deutsche Wissenchaft" and the Ophthalmology Department as funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-70; Banfi S, 2006, J PHOTOCH PHOTOBIO B, V85, P28, DOI 10.1016/j.jphotobiol.2006.04.003; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Caminos DA, 2006, PHOTOCH PHOTOBIO SCI, V5, P56, DOI 10.1039/b513511g; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Costa L, 2008, PHOTOCH PHOTOBIO SCI, V7, P415, DOI 10.1039/b712749a; Diekema DJ, 2004, CLIN INFECT DIS, V38, P78, DOI 10.1086/380457; Engelmann FM, 2007, J BIOENERG BIOMEMBR, V39, P175, DOI 10.1007/s10863-007-9075-0; Felmingham D, 2005, J ANTIMICROB CHEMOTH, V56, P3, DOI 10.1093/jac/dki297; Ferro S, 2007, INT J BIOCHEM CELL B, V39, P1026, DOI 10.1016/j.biocel.2007.02.001; Fotinos N, 2008, ANTIMICROB AGENTS CH, V52, P1366, DOI 10.1128/AAC.01372-07; Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542; Gillham MI, 2009, J ANTIMICROB CHEMOTH, V63, P728, DOI 10.1093/jac/dkp007; Gupta MR, 2009, TRANSPL INFECT DIS, V11, P424, DOI 10.1111/j.1399-3062.2009.00422.x; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2003, J INFECT DIS, V187, P1717, DOI 10.1086/375244; Jenkins TC, 2009, INFECT CONT HOSP EP, V30, P233, DOI 10.1086/595963; JEVONS MP, 1963, LANCET, V1, P904; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Jori G, 2006, J ENVIRON PATHOL TOX, V25, P505, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.320; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Lazzeri D, 2004, PHOTOCHEM PHOTOBIOL, V80, P286, DOI 10.1562/2004-03-08-RA-105.1; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328; MacKenzie FM, 2006, CLIN MICROBIOL INFEC, V12, P1185, DOI 10.1111/j.1469-0691.2006.01549.x; Maisch T, 2007, PHOTOCH PHOTOBIO SCI, V6, P545, DOI 10.1039/b614770d; Maisch T, 2005, ANTIMICROB AGENTS CH, V49, P1542, DOI 10.1128/AAC.49.4.1542-1552.2005; Maisch T, 2007, LASER MED SCI, V22, P83, DOI 10.1007/s10103-006-0409-7; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; NITZAN Y, 1983, CURR MICROBIOL, V8, P279, DOI 10.1007/BF01577728; Raab O, 1900, Z BIOL-MUNICH, V39, P524; Rammelkamp CH, 1942, P SOC EXP BIOL MED, V51, P386, DOI 10.3181/00379727-51-13986; Schastak S, 2008, METHOD FIND EXP CLIN, V30, P129, DOI 10.1358/mf.2008.30.2.1165448; Seaton RA, 2008, J ANTIMICROB CHEMOTH, V62, P15, DOI 10.1093/jac/dkn368; Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8; Tappeiner H.v., 1904, DEUT ARCH KLIN MED, V80, P427; Tappeiner H.V., 1904, DMW DTSCH MED WOCHEN, V30, P579, DOI [10.1055/s-0029-1187467, DOI 10.1055/S-0029-1187467]; Wainwright M, 2004, INT BIODETER BIODEGR, V53, P119, DOI 10.1016/j.ibiod.2003.11.006; Witte W, 2007, ZBL CHIR, V132, P124, DOI 10.1055/s-2007-960652; Zolfaghari PS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-27; EARSS EUROPEAN ANTIM, P21	42	69	72	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11674	10.1371/journal.pone.0011674	http://dx.doi.org/10.1371/journal.pone.0011674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652031	gold, Green Submitted, Green Published			2022-12-25	WOS:000280109700007
J	Buchanan, DD; Sweet, K; Drini, M; Jenkins, MA; Win, AK; English, DR; Walsh, MD; Clendenning, M; McKeone, DM; Walters, RJ; Roberts, A; Pearson, SA; Pavluk, E; Hopper, JL; Gattas, MR; Goldblatt, J; George, J; Suthers, GK; Phillips, KD; Woodall, S; Arnold, J; Tucker, K; Muir, A; Field, M; Greening, S; Gallinger, S; Perrier, R; Baron, JA; Potter, JD; Haile, R; Frankel, W; de la Chapelle, A; Macrae, F; Rosty, C; Walker, NI; Parry, S; Young, JP				Buchanan, Daniel D.; Sweet, Kevin; Drini, Musa; Jenkins, Mark A.; Win, Aung Ko; English, Dallas R.; Walsh, Michael D.; Clendenning, Mark; McKeone, Diane M.; Walters, Rhiannon J.; Roberts, Aedan; Pearson, Sally-Ann; Pavluk, Erika; Hopper, John L.; Gattas, Michael R.; Goldblatt, Jack; George, Jill; Suthers, Graeme K.; Phillips, Kerry D.; Woodall, Sonja; Arnold, Julie; Tucker, Kathy; Muir, Amanda; Field, Michael; Greening, Sian; Gallinger, Steven; Perrier, Renee; Baron, John A.; Potter, John D.; Haile, Robert; Frankel, Wendy; de la Chapelle, Albert; Macrae, Finlay; Rosty, Christophe; Walker, Neal I.; Parry, Susan; Young, Joanne P.			Risk Factors for Colorectal Cancer in Patients with Multiple Serrated Polyps: A Cross-Sectional Case Series from Genetics Clinics	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; CIGARETTE-SMOKING; HYPERPLASTIC POLYPOSIS; BRAF MUTATIONS; LIFE-STYLE; MICROSATELLITE INSTABILITY; ADENOMATOUS POLYPOSIS; TOBACCO SMOKING; EARLY-ONSET; LONG-TERM	Background: Patients with multiple serrated polyps are at an increased risk for developing colorectal cancer (CRC). Recent reports have linked cigarette smoking with the subset of CRC that develops from serrated polyps. The aim of this work therefore was to investigate the association between smoking and the risk of CRC in high-risk genetics clinic patients presenting with multiple serrated polyps. Methods and Findings: We identified 151 Caucasian individuals with multiple serrated polyps including at least 5 outside the rectum, and classified patients into non-smokers, current or former smokers at the time of initial diagnosis of polyposis. Cases were individuals with multiple serrated polyps who presented with CRC. Controls were individuals with multiple serrated polyps and no CRC. Multivariate logistic regression was performed to estimate associations between smoking and CRC with adjustment for age at first presentation, sex and co-existing traditional adenomas, a feature that has been consistently linked with CRC risk in patients with multiple serrated polyps. CRC was present in 56 (37%) individuals at presentation. Patients with at least one adenoma were 4 times more likely to present with CRC compared with patients without adenomas (OR = 4.09; 95% CI 1.27 to 13.14; P = 0.02). For females, the odds of CRC decreased by 90% in current smokers as compared to never smokers (OR = 0.10; 95% CI 0.02 to 0.47; P = 0.004) after adjusting for age and adenomas. For males, there was no relationship between current smoking and CRC. There was no statistical evidence of an association between former smoking and CRC for both sexes. Conclusion: A decreased odds for CRC was identified in females with multiple serrated polyps who currently smoke, independent of age and the presence of a traditional adenoma. Investigations into the biological basis for these observations could lead to non-smoking-related therapies being developed to decrease the risk of CRC and colectomy in these patients.	[Buchanan, Daniel D.; Walsh, Michael D.; Clendenning, Mark; McKeone, Diane M.; Walters, Rhiannon J.; Roberts, Aedan; Pearson, Sally-Ann; Pavluk, Erika; Rosty, Christophe; Young, Joanne P.] Queensland Inst Med Res, Familial Canc Lab, Herston, Qld, Australia; [Buchanan, Daniel D.; Walsh, Michael D.; Young, Joanne P.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Sweet, Kevin; Frankel, Wendy; de la Chapelle, Albert] Ohio State Univ, Columbus, OH 43210 USA; [Drini, Musa] Canberra Hosp, Dept Gastroenterol & Hepatol, Garran, ACT, Australia; [Jenkins, Mark A.; Win, Aung Ko; English, Dallas R.; Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr MEGA Epidemiol, Carlton, Vic 3053, Australia; [Gattas, Michael R.] Royal Childrens Hosp, Queensland Clin Genet Serv, Herston, Qld, Australia; [Goldblatt, Jack] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA 6009, Australia; [Goldblatt, Jack; George, Jill] Genet Serv Western Australia, Subiaco, WA, Australia; [Suthers, Graeme K.] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Suthers, Graeme K.; Phillips, Kerry D.] S Australian Clin Genet Serv, Adelaide, SA, Australia; [Woodall, Sonja; Arnold, Julie; Parry, Susan] Auckland City Hosp, Familial GI Canc Registry, Auckland, New Zealand; [Tucker, Kathy] Prince Wales Hosp, Hereditary Canc Clin, Randwick, NSW 2031, Australia; [Muir, Amanda; Field, Michael] Royal N Shore Hosp, Dept Clin Genet, Sydney, NSW, Australia; [Greening, Sian] Wollongong Hosp, Illawarra Canc Ctr, Wollongong, NSW, Australia; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Mt Sinai Hosp, D Zane Cohen Digest Dis Clin Res Ctr, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Canc Care Ontario, Toronto, ON, Canada; [Perrier, Renee] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Perrier, Renee] BC Canc Agcy, Vancouver, BC, Canada; [Baron, John A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Potter, John D.] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Haile, Robert] Univ So Calif, USC Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Macrae, Finlay] Royal Melbourne Hosp, Dept Colorectal Med & Genet, Parkville, Vic 3050, Australia; [Rosty, Christophe] Univ Queensland, Dept Mol & Cellular Pathol, Herston, Qld, Australia; [Walker, Neal I.] Envoi Pathol, Herston, Qld, Australia; [Parry, Susan] Middlemore Hosp, Dept Gastroenterol, Auckland 6, New Zealand	QIMR Berghofer Medical Research Institute; University of Queensland; University System of Ohio; Ohio State University; Australian National University; Canberra Hospital; University of Melbourne; Royal Children's Hospital Brisbane; University of Western Australia; University of Adelaide; Auckland City Hospital; Royal North Shore Hospital; University of Sydney; Wollongong Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Cancer Care Ontario; University of British Columbia; British Columbia Cancer Agency; Dartmouth College; Fred Hutchinson Cancer Center; University of Southern California; Royal Melbourne Hospital; University of Queensland	Buchanan, DD (corresponding author), Queensland Inst Med Res, Familial Canc Lab, Herston, Qld, Australia.	Joanne.Young@qimr.edu.au	Win, Aung K./J-6204-2015; Rosty, Christophe/F-1796-2010; Sweet, Kevin/E-4172-2011; Walker, Neal I/E-7233-2011; Young, Joanne P/H-7774-2014; Walker, Neal I/E-7039-2011; Young, Joanne P/B-9981-2011; Gallinger, Steven/E-4575-2013; Roberts, Aedan/B-9878-2013; Toon, Christopher W/G-3610-2012; English, Dallas/AAH-5005-2019; Jenkins, Mark/P-7803-2015	Win, Aung K./0000-0002-2794-5261; Roberts, Aedan/0000-0002-6429-6133; English, Dallas/0000-0001-7828-8188; Jenkins, Mark/0000-0002-8964-6160; Potter, John/0000-0001-5439-1500; Rosty, Christophe/0000-0001-7671-2651; Frankel, Wendy/0000-0003-1658-1009; Buchanan, Daniel/0000-0003-2225-6675; Woodall, Sonja/0000-0002-9910-5560; Young, Joanne/0000-0002-1514-1522; Pearson, Sally-Ann/0000-0002-7421-7195	Cancer Council Queensland; Hicks Foundation in Victoria; National Cancer Institute [1R01CA123010]; RFA [CA-95-011, U01 CA097735]; NATIONAL CANCER INSTITUTE [U01CA097735, R01CA123010] Funding Source: NIH RePORTER	Cancer Council Queensland(Cancer Council Queensland); Hicks Foundation in Victoria; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RFA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Cancer Council Queensland, the Hicks Foundation in Victoria, and the National Cancer Institute through 1R01CA123010 (Genetics of Serrated Neoplasia) and RFA #CA-95-011 through cooperative agreements with the Australasian Colorectal Cancer Family Registry (U01 CA097735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JA, 2008, GASTROENTEROLOGY, V134, P617, DOI 10.1053/j.gastro.2007.12.015; Anderson JC, 2003, AM J GASTROENTEROL, V98, P2777, DOI 10.1111/j.1572-0241.2003.08671.x; Anderson JC, 2006, ARCH INTERN MED, V166, P1669, DOI 10.1001/archinte.166.15.1669-b; Beach R, 2005, AM J PATHOL, V166, P1069, DOI 10.1016/S0002-9440(10)62327-9; BOPARAI KS, 2009, GUT; Botteri E, 2008, GASTROENTEROLOGY, V134, P388, DOI 10.1053/j.gastro.2007.11.007; Buc E, 2006, DIS COLON RECTUM, V49, P1893, DOI 10.1007/s10350-006-0704-1; BUCHANAN D, 2010, INT J IN PRESS  0115; Burt R, 2000, WHO INT CLASSIFICATI, P135; Burt RW, 1996, GASTROENTEROLOGY, V110, P950, DOI 10.1053/gast.1996.v110.agast960950; Chow E, 2006, GASTROENTEROLOGY, V131, P30, DOI 10.1053/j.gastro.2006.03.046; Colangelo LA, 2004, CANCER-AM CANCER SOC, V100, P288, DOI 10.1002/cncr.11923; Colditz GA, 2004, CANCER, V100, P223, DOI 10.1002/cncr.20011; Ferrandez A, 2004, AM J GASTROENTEROL, V99, P2012, DOI 10.1111/j.1572-0241.2004.30021.x; Giovannucci E, 2004, DIGEST LIVER DIS, V36, P643, DOI 10.1016/j.dld.2004.06.012; Gupta C, 2007, AM J GASTROENTEROL, V102, P211; Hannan LM, 2009, CANCER EPIDEM BIOMAR, V18, P3362, DOI 10.1158/1055-9965.EPI-09-0661; Huang CS, 2008, GASTROENTEROLOGY, V134, pA606; Hyman NH, 2004, DIS COLON RECTUM, V47, P2101, DOI 10.1007/s10350-004-0709-6; Jarrar AM, 2009, DIS COLON RECTUM, V52, P1949, DOI 10.1007/DCR.0b013e3181b5450c; Jass JR, 2008, PATHOL RES PRACT, V204, P431, DOI 10.1016/j.prp.2008.03.008; Jass JR, 2007, GASTROENTEROL CLIN N, V36, P927, DOI 10.1016/j.gtc.2007.08.009; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Ji BT, 2006, CANCER EPIDEM BIOMAR, V15, P897, DOI 10.1158/1055-9965.EPI-05-0883; Lage P, 2004, AM J GASTROENTEROL, V99, P1779, DOI 10.1111/j.1572-0241.2004.30178.x; Leggett BA, 2001, AM J SURG PATHOL, V25, P177, DOI 10.1097/00000478-200102000-00005; Limburg PJ, 2003, CLIN GASTROENTEROL H, V1, P202, DOI 10.1053/jcgh.2003.50030; Luchtenborg M, 2005, AM J EPIDEMIOL, V161, P806, DOI 10.1093/aje/kwi114; LUCHTENBORG M, 2007, HAWAII MED J, V66; MILLAR P, 2005, BIC STATA MODULE EVA; MORABIA A, 1990, AM J CLIN NUTR, V52, P933, DOI 10.1093/ajcn/52.5.933; Morimoto LM, 2002, CANCER EPIDEM BIOMAR, V11, P1012; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; PAI RK, AM J SURG PATHOL; Paskett ED, 2007, JNCI-J NATL CANCER I, V99, P1729, DOI 10.1093/jnci/djm176; PEPPONE LJ, 2008, J CANC RES CLIN ONCO; Rashid A, 2000, GASTROENTEROLOGY, V119, P323, DOI 10.1053/gast.2000.9361; Renaut A. J, 2002, Colorectal Dis, V4, P213, DOI 10.1046/j.1463-1318.2002.00354.x; Rozek LS, 2010, CANCER EPIDEM BIOMAR, V19, P838, DOI 10.1158/1055-9965.EPI-09-1112; Rubio CA, 2006, ENDOSCOPY, V38, P266, DOI 10.1055/s-2006-925026; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHRUBSOLE MJ, 2008, AM J EPIDEMIOL; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; SODERLUND S, GASTROENTEROLOGY; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; StataCorp L, 2007, STAT DAT AN STAT SOF; Strine TW, 2005, AM J PREV MED, V28, P182, DOI 10.1016/j.amepre.2004.10.002; Sweet K, 2005, JAMA-J AM MED ASSOC, V294, P2465, DOI 10.1001/jama.294.19.2465; Terry MB, 1998, AM J EPIDEMIOL, V147, P903; Torlakovic E, 1996, GASTROENTEROLOGY, V110, P748, DOI 10.1053/gast.1996.v110.pm8608884; Toyomura K, 2004, CANCER SCI, V95, P72, DOI 10.1111/j.1349-7006.2004.tb03173.x; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; WALKER RG, 2010, AM J GASTROENTEROL; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Widome R, 2007, PREV MED, V45, P442, DOI 10.1016/j.ypmed.2007.07.016; WILLIAMS GT, 1980, HISTOPATHOLOGY, V4, P155, DOI 10.1111/j.1365-2559.1980.tb02909.x; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Yeoman Andrew, 2007, N Z Med J, V120, pU2827; Young J, 2008, GASTROENTEROLOGY, V135, P323, DOI 10.1053/j.gastro.2008.03.080; Young J, 2006, CANCER EPIDEM BIOMAR, V15, P1778, DOI 10.1158/1055-9965.EPI-06-0164	63	57	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11636	10.1371/journal.pone.0011636	http://dx.doi.org/10.1371/journal.pone.0011636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661287	Green Published, gold, Green Submitted			2022-12-25	WOS:000279980800020
J	Kim, H; Lee, W; Lee, S				Kim, Hyojoong; Lee, Wonhoon; Lee, Seunghwan			Morphometric Relationship, Phylogenetic Correlation, and Character Evolution in the Species-Rich Genus Aphis (Hemiptera: Aphididae)	PLOS ONE			English	Article							MYZUS-PERSICAE HEMIPTERA; GOSSYPII GLOVER; HOST-PLANT; MORPHOLOGICAL VARIATION; MITOCHONDRIAL; NUCLEAR; RATES; DNA; DIVERSITY; POPULATIONS	Background: The species-rich genus Aphis consists of more than 500 species, many of them host-specific on a wide range of plants, yet very similar in general appearance due to convergence toward particular morphological types. Most species have been historically clustered into four main phenotypic groups (gossypii, craccivora, fabae, and spiraecola groups). To confirm the morphological hypotheses between these groups and to examine the characteristics that determine them, multivariate morphometric analyses were performed using 28 characters measured/counted from 40 species. To infer whether the morphological relationships are correlated with the genetic relationships, we compared the morphometric dataset with a phylogeny reconstructed from the combined dataset of three mtDNA and one nuclear DNA regions. Principal Findings: Based on a comparison of morphological and molecular datasets, we confirmed morphological reduction or regression in the gossypii group unlike in related groups. Most morphological characteristics of the gossypii group were less variable than for the other groups. Due to these, the gossypii group could be morphologically well separated from the craccivora, fabae, and spiraecola groups. In addition, the correlation of the rates of evolution between morphological and DNA datasets was highly significant in their diversification. Conclusions: The morphological separation between the gossypii group and the other species-groups are congruent with their phylogenetic relationships. Analysis of trait evolution revealed that the morphological traits found to be significant based on the morphometric analyses were confidently correlated with the phylogeny. The dominant patterns of trait evolution resulting in increased rates of short branches and temporally later evolution are likely suitable for the modality of Aphis speciation because they have adapted species-specifically, rapidly, and more recently on many different host plants.	[Kim, Hyojoong] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Kim, Hyojoong] Ewha Womans Univ, Res Inst EcoSci, Seoul, South Korea; [Lee, Wonhoon; Lee, Seunghwan] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Kim, H (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	seung@snu.ac.kr	Kim, Hyojoong/AAT-8734-2021; Lee, Seunghwan/E-4992-2011	Kim, Hyojoong/0000-0002-1706-2991	Korean Government [KRF-2009-371-C00001]; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [500-20080241]; USDA-ARS [58-1926-7-154F]	Korean Government(Korean Government); Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (KRF-2009-371-C00001) (http://www.nrf.go.kr). This research was supported by the grant no. 500-20080241 from the Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (http://www.ipet.re.kr). H. Kim and S. Lee were also supported by USDA-ARS Specific Cooperative Agreement no. 58-1926-7-154F (http://www.ars.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2009, EVOLUTION, V63, P663, DOI 10.1111/j.1558-5646.2008.00573.x; Ahrens D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-234; Armbruster WS, 2009, P NATL ACAD SCI USA, V106, P18085, DOI 10.1073/pnas.0907051106; Blackman RL, 2002, SYST ENTOMOL, V27, P323, DOI 10.1046/j.1365-3113.2002.00181.x; BLACKMAN RL, 1994, EUR J ENTOMOL, V91, P7; BLACKMAN RL, 2006, APHIDS WORLDS HERBAC, V2; BONER C, 1952, MITTEILUNGEN THTIRIN, V3, P1; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Brevault T, 2008, AGR FOREST ENTOMOL, V10, P215, DOI 10.1111/j.1461-9563.2008.00377.x; Bromham L, 2002, EVOLUTION, V56, P1921; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Charaabi K, 2008, B ENTOMOL RES, V98, P333, DOI 10.1017/S0007485307005585; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Cooper N, 2009, J EVOLUTION BIOL, V22, P1024, DOI 10.1111/j.1420-9101.2009.01714.x; DIXON AFG, 1987, APHIDS THEIR BIOL NA, V2, P197; Durante MPM, 2003, CAN ENTOMOL, V135, P187, DOI 10.4039/n02-065; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Fuller SJ, 1999, MOL ECOL, V8, P1867, DOI 10.1046/j.1365-294x.1999.00782.x; Hales D, 2000, AUST J ENTOMOL, V39, P123, DOI 10.1046/j.1440-6055.2000.00160.x; Heie O. E., 1995, APHIDOIDEA HEMIPTE 3, VVI; Heie OE, 1994, APHIDOIDEA HEMIPTE 2; HEIE OE, 1986, APHIDOIDEA HEMIPTERA, V3; Heie Ole E., 1994, P409; HOLMAN J, 1987, ACTA ENTOMOL BOHEMOS, V84, P353; Iglisch I., 1970, Z. angew. Ent., V65, P304; Jacob F. H., 1945, Proceedings of the Royal Entomological Society of London (B), V14, P102; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2008, MOL CELLS, V25, P510; Kim H, 2006, ENTOMOL NEWS, V117, P155, DOI 10.3157/0013-872X(2006)117[155:TNSOTG]2.0.CO;2; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee S, 2006, EC INSECTS KOREA S35; Lozier JD, 2008, ZOOTAXA, P1; Lozier JD, 2007, EVOLUTION, V61, P1353, DOI 10.1111/j.1558-5646.2007.00110.x; Margaritopoulos JT, 2007, APPL ENTOMOL ZOOL, V42, P329, DOI 10.1303/aez.2007.329; Margaritopoulos JT, 2007, BIOL J LINN SOC, V91, P687, DOI 10.1111/j.1095-8312.2007.00828.x; Margaritopoulos JT, 2000, B ENTOMOL RES, V90, P233, DOI 10.1017/S0007485300000353; Margaritopoulos JT, 2006, B ENTOMOL RES, V96, P153, DOI 10.1079/BER2005410; Moran NA, 1999, SYST ENTOMOL, V24, P85, DOI 10.1046/j.1365-3113.1999.00076.x; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Nylander JAA, 2004, MRMODELTEST 2 0 PROG; Omland KE, 1997, EVOLUTION, V51, P1381, DOI [10.2307/2411190, 10.1111/j.1558-5646.1997.tb01461.x]; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL M, 2008, CONTINUOUS DRAFT MAN; Pagel M., 2007, BAYESTRAITS VERSION; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PASHCHENKO NF, 1997, ENTOMOLOGICAL REV, V77, P871; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; PICKETT JA, 1992, ANNU REV ENTOMOL, V37, P67, DOI 10.1146/annurev.en.37.010192.000435; Poultos KD, 2007, EUR J ENTOMOL, V104, P235, DOI 10.14411/eje.2007.037; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Qiao GX, 2008, ZOOTAXA, P1; Rakauskas R, 2008, CENT EUR J BIOL, V3, P307, DOI 10.2478/s11535-008-0020-y; Rambaut A., 2007, TRACER 1 5; Raymond B, 2001, BIOL J LINN SOC, V74, P205, DOI 10.1111/j.1095-8312.2001.tb01387.x; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sloane MA, 2001, GENET RES, V77, P251, DOI 10.1017/S0016672301005018; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STROYAN HLG, 1984, HDB IDENT BR INSEC 6, V2; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Takahashi R., 1966, Transactions of the American Entomological Society, V92, P519; Thieme T., 1987, P314; Tosh CR, 2004, ECOL ENTOMOL, V29, P488, DOI 10.1111/j.0307-6946.2004.00621.x; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2	66	62	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11608	10.1371/journal.pone.0011608	http://dx.doi.org/10.1371/journal.pone.0011608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657654	gold, Green Published, Green Submitted			2022-12-25	WOS:000279924500011
J	Meech, R; Gomez, M; Woolley, C; Barro, M; Hulin, JA; Walcott, EC; Delgado, J; Makarenkova, HP				Meech, Robyn; Gomez, Mariana; Woolley, Christopher; Barro, Marietta; Hulin, Julie-Ann; Walcott, Elisabeth C.; Delgado, Jary; Makarenkova, Helen P.			The Homeobox Transcription Factor Barx2 Regulates Plasticity of Young Primary Myofibers	PLOS ONE			English	Article							MUSCLE SATELLITE CELL; PLURIPOTENT STEM-CELLS; LIMB REGENERATION; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; HOMEODOMAIN PROTEIN; SELF-RENEWAL; DIGIT TIP; EXPRESSION; GENE	Background: Adult mammalian muscle retains incredible plasticity. Muscle growth and repair involves the activation of undifferentiated myogenic precursors called satellite cells. In some circumstances, it has been proposed that existing myofibers may also cleave and produce a pool of proliferative cells that can re-differentiate into new fibers. Such myofiber dedifferentiation has been observed in the salamander blastema where it may occur in parallel with satellite cell activation. Moreover, ectopic expression of the homeodomain transcription factor Msx1 in differentiated C2C12 myotubes has been shown to induce their dedifferentiation. While it remains unclear whether dedifferentiation and redifferentiaton occurs endogenously in mammalian muscle, there is considerable interest in induced dedifferentiation as a possible regenerative tool. Methodology/Principal Findings: We previously showed that the homeobox protein Barx2 promotes myoblast differentiation. Here we report that ectopic expression of Barx2 in young immature myotubes derived from cell lines and primary mouse myoblasts, caused cleavage of the syncytium and downregulation of differentiation markers. Microinjection of Barx2 cDNA into immature myotubes derived from primary cells led to cleavage and formation of mononucleated cells that were able to proliferate. However, injection of Barx2 cDNA into mature myotubes did not cause cleavage. Barx2 expression in C2C12 myotubes increased the expression of cyclin D1, which may promote cell cycle re-entry. We also observed differential muscle gene regulation by Barx2 at early and late stages of muscle differentiation which may be due to differential recruitment of transcriptional activator or repressor complexes to muscle specific genes by Barx2. Conclusions/Significance: We show that Barx2 regulates plasticity of immature myofibers and might act as a molecular switch controlling cell differentiation and proliferation.	[Meech, Robyn; Gomez, Mariana; Woolley, Christopher; Barro, Marietta; Hulin, Julie-Ann; Makarenkova, Helen P.] Scripps Res Inst, La Jolla, CA 92037 USA; [Meech, Robyn] Flinders Univ S Australia, Beford Pk, SA, Australia; [Walcott, Elisabeth C.; Delgado, Jary; Makarenkova, Helen P.] Inst Neurosci, San Diego, CA USA	Scripps Research Institute; Flinders University South Australia	Meech, R (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	hmakarenk@scripps.edu		Hulin, Julie-Ann/0000-0003-4886-0416; Meech, Robyn/0000-0002-6831-0801	National Institutes of Health [5R01AR053163-02]; Association Francaise contre les Myopathies; Neurosciences Support Foundation; French and Masserini Charitable Trusts; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Neurosciences Support Foundation; French and Masserini Charitable Trusts; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant 5R01AR053163-02 (to H. P. M.) and by a grant from the Association Francaise contre les Myopathies (to H. P. M.). The study was also supported by Neurosciences Support Foundation (to H. P. M. and E. C. W). Additional support (to M. G.) was provided by the French and Masserini Charitable Trusts and (to J.D.) by the G. Harold and Leila Y. Mathers Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CH, 2006, WOUND REPAIR REGEN, V14, P398, DOI 10.1111/j.1743-6109.2006.00139.x; Anderson DM, 2009, DEV DYNAM, V238, P572, DOI 10.1002/dvdy.21873; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Bendall AJ, 1999, DEVELOPMENT, V126, P4965; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Cossins J, 2002, DEVELOPMENT, V129, P2195; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; CREWS L, 1995, P ROY SOC B-BIOL SCI, V259, P161, DOI 10.1098/rspb.1995.0024; Desai NS, 2006, J NEUROSCI, V26, P2215, DOI 10.1523/JNEUROSCI.4310-05.2006; Duca KA, 1998, BBA-MOL CELL RES, V1401, P1, DOI 10.1016/S0167-4889(97)00118-3; Ebelt H, 2008, CARDIOVASC RES, V80, P219, DOI 10.1093/cvr/cvn194; Edelman DB, 2000, J BIOL CHEM, V275, P21737, DOI 10.1074/jbc.M909998199; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Koshiba K, 1998, J EXP ZOOL, V282, P703, DOI 10.1002/(SICI)1097-010X(19981215)282:6<703::AID-JEZ6>3.0.CO;2-P; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; MAKARENKOVA HP, 2009, J BIOL CHEM; Meech R, 2003, J BIOL CHEM, V278, P8269, DOI 10.1074/jbc.M207617200; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; Mescher AL, 1996, INT J DEV BIOL, V40, P785; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Odelberg SJ, 2004, PLOS BIOL, V2, P1068, DOI 10.1371/journal.pbio.0020232; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Olson LE, 2005, P NATL ACAD SCI USA, V102, P3708, DOI 10.1073/pnas.0500519102; Oviedo NJ, 2009, SEMIN CELL DEV BIOL, V20, P557, DOI 10.1016/j.semcdb.2009.04.005; Prindull GA, 2007, EXP HEMATOL, V35, P691, DOI 10.1016/j.exphem.2007.01.047; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Shinin Vasily, 2009, V482, P295, DOI 10.1007/978-1-59745-060-7_19; Slack JMW, 2006, TRENDS CELL BIOL, V16, P273, DOI 10.1016/j.tcb.2006.04.007; SONG KN, 1992, NATURE, V360, P477, DOI 10.1038/360477a0; Springer ML, 2002, CELL MOTIL CYTOSKEL, V51, P177, DOI 10.1002/cm.10022; Stocum DL, 1997, SCIENCE, V276, P15, DOI 10.1126/science.276.5309.15; Straube WL, 2004, CLONING STEM CELLS, V6, P333, DOI 10.1089/clo.2004.6.333; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Tsonis PA, 2004, MOL INTERV, V4, P81, DOI 10.1124/mi.4.2.4; TSONIS PA, 1995, SEMIN CELL BIOL, V6, P127, DOI 10.1006/scel.1995.0018; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	51	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11612	10.1371/journal.pone.0011612	http://dx.doi.org/10.1371/journal.pone.0011612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657655	Green Submitted, Green Published, gold			2022-12-25	WOS:000279924500014
J	Messadi, E; Vincent, MP; Griol-Charhbili, V; Mandet, C; Colucci, J; Krege, JH; Bruneval, P; Bouby, N; Smithies, O; Alhenc-Gelas, F; Richer, C				Messadi, Erij; Vincent, Marie-Pascale; Griol-Charhbili, Violaine; Mandet, Chantal; Colucci, Juliana; Krege, John H.; Bruneval, Patrick; Bouby, Nadine; Smithies, Oliver; Alhenc-Gelas, Francois; Richer, Christine			Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia	FASEB JOURNAL			English	Article						renin inhibition; kinins; genetically modified mice	CORONARY-ARTERY-DISEASE; TISSUE KALLIKREIN; KNOCKOUT MICE; CARDIOVASCULAR HOMEOSTASIS; DELETION POLYMORPHISM; CARDIAC-HYPERTROPHY; GENE POLYMORPHISM; BLOOD PRESSURES; INFARCTION; BRADYKININ	Angiotensin I-converting enzyme (ACE; kininase II) levels in humans are genetically determined. ACE levels have been linked to risk of myocardial infarction, but the association has been inconsistent, and the causality underlying it remains undocumented. We tested the hypothesis that genetic variation in ACE levels influences myocardial tolerance to ischemia. We studied ischemia-reperfusion injury in mice bearing 1 (ACE1c), 2 (ACE2c, wild type), or 3 (ACE3c) functional copies of the ACE gene and displaying an ACE level range similar to humans. Infarct size in ACE1c was 29% lower than in ACE2c (P<0.05). Pretreatment with a kinin B2 receptor antagonist suppressed this reduction. In ACE3c, infarct size was the same as in ACE2c. But ischemic preconditioning, which reduced infarct size in ACE2c (similar to 63%, P<0.001) and ACE1c (-52%, P<0.05), was not efficient in ACE3c (-2%, NS, P<0.01 vs. ACE2c). In ACE3c, ischemic preconditioning did not decrease myocardial inflammation or cardiomyocyte apoptosis. Pretreatment with a renin inhibitor had no cardioprotective effect in ACE2c, but in ACE3c partially restored (38%) the cardioprotection of ischemic preconditioning. Thus, a modest genetic increase in ACE impairs myocardial tolerance to ischemia. ACE level plays a critical role in cardiac ischemia, through both kinin and angiotensin mediated mechanisms.-Messadi, E., Vincent, M.-P., Griol-Charhbili, V., Mandet, C., Colucci, J., Krege, J. H., Bruneval, P., Bouby, N., Smithies, O., Alhenc-Gelas, F., Richer, C. Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB J. 24, 4691-4700 (2010). www.fasebj.org	[Messadi, Erij; Vincent, Marie-Pascale; Griol-Charhbili, Violaine; Mandet, Chantal; Colucci, Juliana; Bruneval, Patrick; Bouby, Nadine; Alhenc-Gelas, Francois; Richer, Christine] Ctr Rech Cordeliers, INSERM, U872, F-75270 Paris, France; [Mandet, Chantal; Bruneval, Patrick; Alhenc-Gelas, Francois] Univ Paris 05, Paris, France; [Krege, John H.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Bruneval, Patrick; Alhenc-Gelas, Francois; Richer, Christine] AP HP, Paris, France; [Smithies, Oliver] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Richer, Christine] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Eli Lilly; Assistance Publique Hopitaux Paris (APHP); University of North Carolina; University of North Carolina Chapel Hill; UDICE-French Research Universities; Universite Paris Saclay	Richer, C (corresponding author), Ctr Rech Cordeliers, INSERM, U872, 15 Rue Ecole Med, F-75270 Paris, France.	christine.giudicelli@crc.jussieu.fr	BOUBY, Nadine/AAF-5565-2021; Alhenc-Gelas, Francois/F-9511-2017; Bouby, Nadine/G-8621-2013; Colucci, Juliana/B-4513-2012	BOUBY, Nadine/0000-0002-2338-9480; Colucci, Juliana/0000-0003-3078-0514	INSERM; National Research Agency [ANR 05-PCOD-029]; Universities Paris-Descartes; Pierre and Marie Curie; Paris-Sud; European Community [LSHM-CT-2003-503254]; Ministere de la Recherche; Academie of Medecine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049277] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); National Research Agency(French National Research Agency (ANR)); Universities Paris-Descartes; Pierre and Marie Curie; Paris-Sud; European Community(European Commission); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Academie of Medecine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Georges Zadigue for his excellent technical assistance. This study was supported by INSERM, the National Research Agency (ANR 05-PCOD-029), Universities Paris-Descartes, Pierre and Marie Curie, and Paris-Sud. This study was performed in the European Vascular Genomics Network, a Network of Excellence supported by the European Community's Sixth Framework Program for Research Priority 1 "Life sciences, genomics and biotechnology for health" (contract no, LSHM-CT-2003-503254). E. M. and V.G.-C. were supported by fellowships from the Ministere de la Recherche and from Academie of Medecine. The results were presented in part at the High Blood Pressure Research Conference 2008 (Atlanta, GA, USA).	ALHENCGELAS F, 2000, HDB PHYSL 7, V3, P81; Aouam K, 2005, AM J PHYSIOL-HEART C, V288, pH2763, DOI 10.1152/ajpheart.00657.2004; Bergaya S, 2001, CIRC RES, V88, P593, DOI 10.1161/01.RES.88.6.593; Bodin S, 2009, KIDNEY INT, V76, P395, DOI 10.1038/ki.2009.208; Brown NJ, 2000, CIRCULATION, V102, P2190; CAMBIEN F, 1994, CIRCULATION, V90, P669, DOI 10.1161/01.CIR.90.2.669; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CAMBIEN F, 1988, AM J HUM GENET, V43, P774; COSTEROUSSE O, 1994, AM J PHYSIOL-ENDOC M, V267, pE745, DOI 10.1152/ajpendo.1994.267.5.E745; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33, DOI 10.1042/bj2900033; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363; Evangelista FS, 2006, PHYSIOL GENOMICS, V27, P231, DOI 10.1152/physiolgenomics.00022.2006; FALKENHAHN M, 1995, HYPERTENSION, V25, P219, DOI 10.1161/01.HYP.25.2.219; GOTO M, 1995, CIRC RES, V77, P611, DOI 10.1161/01.RES.77.3.611; Huang W, 2001, P NATL ACAD SCI USA, V98, P13330, DOI 10.1073/pnas.231476798; Krege JH, 1997, HYPERTENSION, V29, P150, DOI 10.1161/01.HYP.29.1.150; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDBROOK J, 1994, CARDIOVASC RES, V28, P303, DOI 10.1093/cvr/28.3.303; MATTU RK, 1995, CIRCULATION, V91, P270, DOI 10.1161/01.CIR.91.2.270; MENARD J, 1972, ENDOCRINOLOGY, V90, P422, DOI 10.1210/endo-90-2-422; Messadi-Laribi E, 2007, J PHARMACOL EXP THER, V323, P210, DOI 10.1124/jpet.107.124859; Muller DN, 1997, HYPERTENSION, V29, P98, DOI 10.1161/01.HYP.29.1.98; Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003; Pan HL, 2000, AM J PHYSIOL-HEART C, V279, pH116; Pons S, 2008, EUR J HEART FAIL, V10, P343, DOI 10.1016/j.ejheart.2008.02.002; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Samani NJ, 1996, CIRCULATION, V94, P708, DOI 10.1161/01.CIR.94.4.708; Sato M, 2000, CIRCULATION, V102, P346; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; SUN Y, 1994, CARDIOVASC RES, V28, P1623, DOI 10.1093/cvr/28.11.1623; Takahashi N, 2003, ENDOCRINOLOGY, V144, P2184, DOI 10.1210/en.2002-221045; Tian BH, 1997, HYPERTENSION, V30, P128, DOI 10.1161/01.HYP.30.1.128; Tschope C, 2000, J HYPERTENS, V18, P223, DOI 10.1097/00004872-200018020-00014; Tschope C, 2000, BRIT J PHARMACOL, V129, P1537, DOI 10.1038/sj.bjp.0703239; Xiao HD, 2008, AM J PHYSIOL-HEART C, V294, pH659, DOI 10.1152/ajpheart.01147.2007; Yang XP, 1997, HYPERTENSION, V30, P735, DOI 10.1161/01.HYP.30.3.735; Yang XP, 1999, HYPERTENSION, V34, P24, DOI 10.1161/01.HYP.34.1.24; YELLON DM, 1993, LANCET, V342, P276, DOI 10.1016/0140-6736(93)91819-8; Zintzaras E, 2008, ARCH INTERN MED, V168, P1077, DOI 10.1001/archinte.168.10.1077	43	19	20	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4691	4700		10.1096/fj.10-165902	http://dx.doi.org/10.1096/fj.10-165902			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20667972	Green Published			2022-12-25	WOS:000284824400010
J	Su, JL; Chiou, J; Tang, CH; Zhao, M; Tsai, CH; Chen, PS; Chang, YW; Chien, MH; Peng, CY; Hsiao, M; Kuo, ML; Yen, ML				Su, Jen-Liang; Chiou, Jean; Tang, Chih-Hsin; Zhao, Ming; Tsai, Chun-Hao; Chen, Pai-Sheng; Chang, Yi-Wen; Chien, Ming-Hsien; Peng, Chu-Ying; Hsiao, Michael; Kuo, Ming-Liang; Yen, Men-Luh			CYR61 Regulates BMP-2-dependent Osteoblast Differentiation through the alpha(v)beta(3) Integrin/Integrin-linked Kinase/ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; IMMEDIATE-EARLY GENE; MESENCHYMAL STEM-CELLS; INTEGRIN ALPHA(V)BETA(3); COUPLED RECEPTORS; BREAST-CANCER; MAPK CASCADES; IN-VITRO; EXPRESSION; ACTIVATION	Osteoporosis is one of the most common bone pathologies. A number of novel molecules have been reported to increase bone formation including cysteine-rich protein 61 (CYR61), a ligand of integrin receptor, but mechanisms remain unclear. It is known that bone morphogenetic proteins (BMPs), especially BMP-2, are crucial regulators of osteogenesis. However, the interaction between CYR61 and BMP-2 is unclear. We found that CYR61 significantly increases proliferation and osteoblastic differentiation in MC3T3-E1 osteoblasts and primary cultured osteoblasts. CYR61 enhances mRNA and protein expression of BMP-2 in a time-and dose-dependent manner. Moreover, CYR61-mediated proliferation and osteoblastic differentiation are significantly decreased by knockdown of BMP-2 expression or inhibition of BMP-2 activity. In this study we found integrin alpha(v)beta(3) is critical for CYR61-mediated BMP-2 expression and osteoblastic differentiation. We also found that integrin-linked kinase, which is downstream of the alpha(v)beta(3) receptor, is involved in CYR61-induced BMP-2 expression and subsequent osteoblastic differentiation through an ERK-dependent pathway. Taken together, our results show that CYR61 up-regulates BMP-2mRNA and protein expression, resulting in enhanced cell proliferation and osteoblastic differentiation through activation of the alpha(v)beta(3) integrin/integrin-linked kinase/ERK signaling pathway.	[Yen, Men-Luh] Natl Taiwan Univ Hosp, Dept Primary Care Med, Taipei 100, Taiwan; [Su, Jen-Liang; Chiou, Jean] China Med Univ, Canc Biol & Drug Discovery PhD Degree Program, Shenyang, Peoples R China; [Su, Jen-Liang; Peng, Chu-Ying] China Med Univ, Grad Inst Canc Biol, Shenyang, Peoples R China; [Tang, Chih-Hsin] China Med Univ, Dept Pharmacol, Coll Med, Shenyang, Peoples R China; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Shenyang, Peoples R China; [Su, Jen-Liang; Chiou, Jean; Chang, Yi-Wen] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthoped, Taichung 404, Taiwan; [Su, Jen-Liang] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Zhao, Ming] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Chen, Pai-Sheng; Chien, Ming-Hsien; Hsiao, Michael] Natl Taiwan Univ Hosp, Inst Toxicol, Coll Med, Taipei 100, Taiwan; [Chen, Pai-Sheng; Chien, Ming-Hsien; Kuo, Ming-Liang] Natl Taiwan Univ Hosp, Angiogenesis Res Ctr, Taipei 100, Taiwan; [Yen, Men-Luh] Natl Taiwan Univ Hosp, Dept Obstet Gynecol, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan; [Hsiao, Michael] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University Hospital; China Medical University; China Medical University; China Medical University; China Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; University of Missouri System; University of Missouri Kansas City; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan	Yen, ML (corresponding author), Natl Taiwan Univ Hosp, Dept Primary Care Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.	mlyen@ntu.edu.tw	Chiou, Jean/G-8255-2014; Tang, Chih Hsin/O-5212-2015; Chen, Pai-Sheng/G-2130-2012; Hsiao, Michael/U-6238-2019; Tsai, Chun-Hao/H-3140-2013	Chiou, Jean/0000-0001-6926-0159; Tang, Chih Hsin/0000-0002-7113-8352; Chen, Pai-Sheng/0000-0003-0513-1467; Hsiao, Michael/0000-0001-8529-9213; YEN, MEN-LUH/0000-0003-3800-3664; Tsai, Chun-Hao/0000-0002-4428-3132	National Science Council [NSC 97-2314-B-002-060-MY3, NSC98-3111-B-002-009, NSC 96-2320-B-004-MY2, NSC 97-2320-B-039-039-MY3, NSC 98-2815-C-039-082-B]; National Science Council of Taiwan [TMS-094-2-B-023]; National Health Research Institutes, Taiwan [NHRI-EX97-9712BC]; Department of Health Executive Yuan, Taiwan [DOH97-TD-G-111-024]; China Medical University [CMU96-220, CMU96-189, CMU97-277]; M.D. Anderson Cancer Center	National Science Council(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Department of Health Executive Yuan, Taiwan; China Medical University(China Medical University); M.D. Anderson Cancer Center	This work was supported in part by National Science Council Grants NSC 97-2314-B-002-060-MY3, NSC98-3111-B-002-009 (to M.-L.Y.), National Science Council Grants NSC 96-2320-B-004-MY2, NSC 97-2320-B-039-039-MY3, and NSC 98-2815-C-039-082-B, Taiwan Merit Scholarship TMS-094-2-B-023 from the National Science Council of Taiwan, National Health Research Institutes Grant NHRI-EX97-9712BC from Taiwan, Department of Health Executive Yuan Grant DOH97-TD-G-111-024 from Taiwan, China Medical University Grants CMU96-220, CMU96-189, and CMU97-277, and an Odyssey Scholarship from M.D. Anderson Cancer Center (to J.-L.S.).	Babic AM, 1999, MOL CELL BIOL, V19, P2958; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Cortizo AM, 2003, MOL CELL BIOCHEM, V250, P1, DOI 10.1023/A:1024934008982; Craig TA, 2010, BIOCHEM BIOPH RES CO, V392, P36, DOI 10.1016/j.bbrc.2009.12.143; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heller LC, 1999, J BIOL CHEM, V274, P1394, DOI 10.1074/jbc.274.3.1394; Hirasaki S, 2001, HEPATOL RES, V19, P294, DOI 10.1016/S1386-6346(00)00101-7; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Knosp WM, 2004, DEVELOPMENT, V131, P4581, DOI 10.1242/dev.01327; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Lechner A, 2000, BONE, V27, P53, DOI 10.1016/S8756-3282(00)00294-5; Leng E, 2002, J BIOMED SCI, V9, P59, DOI 10.1007/BF02256579; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; LOWRY OH, 1954, J BIOL CHEM, V207, P19; Maier S, 2008, BBA-MOL CELL RES, V1783, P1150, DOI 10.1016/j.bbamcr.2008.01.013; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Meyer RA, 2003, J BONE JOINT SURG AM, V85A, P1243, DOI 10.2106/00004623-200307000-00010; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; OBRIEN TP, 1992, CELL GROWTH DIFFER, V3, P645; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Randell A, 1995, OSTEOPOROSIS INT, V5, P427, DOI 10.1007/BF01626603; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rodriguez JP, 2004, J CELL BIOCHEM, V92, P745, DOI 10.1002/jcb.20119; Schutze N, 1998, ENDOCRINOLOGY, V139, P1761, DOI 10.1210/en.139.4.1761; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-45; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; STYRKARSDOTTIR U, 2003, PLOS BIOL, V3, P1; Su JL, 2007, J BIOL CHEM, V282, P19385, DOI 10.1074/jbc.M702452200; Suzuki A, 1999, ENDOCRINOLOGY, V140, P3177, DOI 10.1210/en.140.7.3177; Sykaras Nikitas, 2003, J Oral Sci, V45, P57; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Tang CH, 2008, EUR J PHARMACOL, V579, P40, DOI 10.1016/j.ejphar.2007.10.013; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Tang CH, 2007, J BIOL CHEM, V282, P2346, DOI 10.1074/jbc.M603070200; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Virdi AS, 1998, CELL MOL BIOL, V44, P1237; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu JB, 2008, EUR J PHARMACOL, V588, P333, DOI 10.1016/j.ejphar.2008.04.030; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08; Zhou SH, 2003, MOL ENDOCRINOL, V17, P56, DOI 10.1210/me.2002-0210	67	89	96	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31325	31336		10.1074/jbc.M109.087122	http://dx.doi.org/10.1074/jbc.M109.087122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675382	Green Published, hybrid			2022-12-25	WOS:000282764600027
J	Antico-Arciuch, VG; Dima, M; Liao, XH; Refetoff, S; Di Cristofano, A				Antico-Arciuch, V. G.; Dima, M.; Liao, X-H; Refetoff, S.; Di Cristofano, A.			Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females	ONCOGENE			English	Article						thyroid cancer; Pten; estrogen	GENETIC ALTERATIONS; CANCER CELLS; MOLECULAR-MECHANISMS; TARGETED EXPRESSION; PAPILLARY; PATHWAY; MICE; GROWTH; TUMORS; PROLIFERATION	It is well known that thyroid disease is more frequent in women than in men; however, the molecular basis for this gender-based difference is still poorly understood. The activation of phosphoinositide 3-kinase (PI3K), through different mechanisms including loss of the PTEN tumor suppressor, is being increasingly recognized as a major player in the development of thyroid neoplastic lesions. Loss of Pten in the mouse thyroid results in a significant increase in the thyrocyte proliferative index, which is more prominent in the female mice. In this study, we show that 52% of the Pten(-/-) female mice, but only 12% of the males, develop follicular adenomas by 1 year of age. In addition, 50% of female mutants, but only 35% of males older than 1 year of age develop invasive, and often metastatic, follicular carcinomas. Mutant females have a significantly shorter overall survival compared with male mutants. Hormonal manipulation experiments established a direct role of estrogens in controlling the increased thyrocyte proliferation index in mutant females. Further-more, while genetic ablation of one Cdkn1b allele accelerated the development of neoplastic lesions, it also abolished the gender differences in survival and reduced the difference in neoplastic lesion development rate, underlining a key role of p27 in mediating estrogen action in the thyroid follicular cells. These data, based on a clinically relevant model of thyroid follicular carcinoma, provide, to the best of our knowledge, for the first time in vivo evidence that circulating estrogens are directly responsible for the increased female susceptibility to thyroid disease, at least on activation of the PI3K pathway, and provide new insights into the gender-based differences characterizing thyroid neoplastic disorders. Oncogene (2010) 29, 5678-5686; doi:10.1038/onc.2010.308; published online 2 August 2010	[Di Cristofano, A.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Price Ctr Genet & Translat Med, Bronx, NY 10461 USA; [Liao, X-H; Refetoff, S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Refetoff, S.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Refetoff, S.] Univ Chicago, Comm Genet, Chicago, IL 60637 USA	Yeshiva University; Albert Einstein College of Medicine; University of Chicago; University of Chicago; University of Chicago	Di Cristofano, A (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Price Ctr Genet & Translat Med, 1301 Morris Pk Ave,Room 302, Bronx, NY 10461 USA.	antonio.dicristofano@einstein.yu.edu	Di Cristofano, Antonio/B-4148-2016; Refetoff, Samuel/ABB-1263-2021; di cristofano, antonio/AAJ-3796-2020	Refetoff, Samuel/0000-0003-0164-8231; di cristofano, antonio/0000-0003-2537-3228	AECC; NIH [CA97097, CA128943, DK15070, DK20595]; NATIONAL CANCER INSTITUTE [R01CA128943, R01CA097097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, R01DK015070, P60DK020595, R37DK015070] Funding Source: NIH RePORTER	AECC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Animal Housing and the Histotechnology and Comparative Pathology Facilities of Albert Einstein College of Medicine. This study was supported by the AECC Core Grant, and by NIH grants to ADC (CA97097 and CA128943) and SR (DK15070 and DK20595).	Chen GG, 2008, CURR CANCER DRUG TAR, V8, P367, DOI 10.2174/156800908785133150; Foster JS, 2003, J BIOL CHEM, V278, P41355, DOI 10.1074/jbc.M302830200; Garcia-Rostan G, 2005, CANCER RES, V65, P10199, DOI 10.1158/0008-5472.CAN-04-4259; Hou P, 2008, CANCER, V113, P2440, DOI 10.1002/cncr.23869; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Jhiang SM, 1996, ENDOCRINOLOGY, V137, P375, DOI 10.1210/en.137.1.375; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Kumar A, 2010, INT J ONCOL, V36, P1067, DOI 10.3892/ijo_00000588; Lacroix L, 2001, THYROID, V11, P1017, DOI 10.1089/105072501753271699; Libutti SK, 2005, CANCER J, V11, P104, DOI 10.1097/00130404-200503000-00003; Lu CX, 2010, ENDOCRINOLOGY, V151, P1929, DOI 10.1210/en.2009-1017; Manole D, 2001, J CLIN ENDOCR METAB, V86, P1072, DOI 10.1210/jc.86.3.1072; Miller KA, 2009, CANCER RES, V69, P3689, DOI 10.1158/0008-5472.CAN-09-0024; Pohlenz J, 1999, THYROID, V9, P1265, DOI 10.1089/thy.1999.9.1265; Rajoria S, 2010, THYROID, V20, P33, DOI 10.1089/thy.2009.0296; Sodre AKMB, 2008, J CLIN ENDOCR METAB, V93, P4141, DOI 10.1210/jc.2007-0353; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Vasko VV, 2007, CURR OPIN ONCOL, V19, P11, DOI 10.1097/CCO.0b013e328011ab86; Vitagliano D, 2006, ONCOGENE, V25, P5467, DOI 10.1038/sj.onc.1209527; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wang YG, 2007, J CLIN ENDOCR METAB, V92, P2387, DOI 10.1210/jc.2006-2019; Yeager N, 2008, CANCER RES, V68, P444, DOI 10.1158/0008-5472.CAN-07-3030; Yeager N, 2007, CANCER RES, V67, P959, DOI 10.1158/0008-5472.CAN-06-3524	24	43	44	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5678	5686		10.1038/onc.2010.308	http://dx.doi.org/10.1038/onc.2010.308			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20676139	Green Accepted			2022-12-25	WOS:000283262500004
J	Dejager, L; Pinheiro, I; Puimege, L; Fan, YD; Gremeaux, L; Vankelecom, H; Libert, C				Dejager, Lien; Pinheiro, Iris; Puimege, Leen; Fan, Ye-Dong; Gremeaux, Lies; Vankelecom, Hugo; Libert, Claude			Increased Glucocorticoid Receptor Expression and Activity Mediate the LPS Resistance of SPRET/EI Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TUMOR-NECROSIS-FACTOR; HORMONE-RECEPTORS; FEEDBACK-CONTROL; GENE; MECHANISMS; STRESS; LIPOPOLYSACCHARIDE; TRANSCRIPTION; BIOSYNTHESIS	SPRET/Ei mice are extremely resistant to acute LPS-induced lethal inflammation when compared with C57BL/6. We found that in vivo SPRET/Ei mice exhibit strongly reduced expression levels of cytokines and chemokines. To investigate the role of the potent anti-inflammatory glucocorticoid receptor (GR) in the SPRET/Ei phenotype, mice were treated with the GR antagonist RU486 or bilateral adrenalectomy. Under such conditions, both C57BL/6 and SPRET/Ei mice were strongly sensitized to LPS, and the differences in LPS response between SPRET/Ei and C57BL/6 mice were completely gone. These results underscore the central role of GR in the LPS hyporesponsiveness of SPRET/Ei mice. Compared with C57BL/6, SPRET/Ei mice were found to express higher GR levels, which were reflected in increased GR transactivation. Using a backcross mapping strategy, we demonstrate that the high GR transcription levels are linked to the Nr3c1 (GR) locus on chromosome 18 itself. Unexpectedly, SPRET/Ei mice exhibit a basal overactivation of the hypothalamic-pituitary-adrenal axis, namely strongly increased corticosterone levels, ACTH levels, and adrenocortical size. As a consequence of the excess of circulating glucocorticoids (GCs), levels of hepatic gluconeogenic enzymes are increased, and insulin secretion from pancreatic beta-cells is impaired, both of which result in hyperglycemia and glucose intolerance in SPRET/Ei mice. We conclude that SPRET/Ei mice are unique as they display an unusual combination of elevated GR expression and increased endogenous GC levels. Hence, these mice provide a new and powerful tool for the study of GR- and GC-mediated mechanisms, including immune repressive functions, neuroendocrine regulation, insulin secretion, and carbohydrate metabolism.	[Libert, Claude] VIB, DMBR, B-9052 Ghent, Belgium; [Dejager, Lien; Pinheiro, Iris; Puimege, Leen; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Fan, Ye-Dong] Ghent Univ Hosp, Dept Surg, B-9000 Ghent, Belgium; [Gremeaux, Lies; Vankelecom, Hugo] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Tissue Plast, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; KU Leuven	Libert, C (corresponding author), VIB, DMBR, Technol Pk 927, B-9052 Ghent, Belgium.	Claude.Libert@dmbr.VIB-UGent.be		Pinheiro, Iris/0000-0003-3098-4445; Vankelecom, Hugo/0000-0002-2251-7284	Fund for Scientific Research, Flanders; Belgian Interuniversity Attraction Poles program [IAP VI/18]; Belgische Vereniging tegen Kanker	Fund for Scientific Research, Flanders(FWO); Belgian Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Belgische Vereniging tegen Kanker	This work was supported by the Fund for Scientific Research, Flanders, the Belgian Interuniversity Attraction Poles program (IAP VI/18), and the Belgische Vereniging tegen Kanker.	Aguilera G, 2004, PEPTIDES, V25, P319, DOI 10.1016/j.peptides.2004.02.002; ALDAMLUJI S, 1993, AM J PHYSIOL, V264, pE208, DOI 10.1152/ajpendo.1993.264.2.E208; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; AUTELITANO DJ, 1990, NEUROENDOCRINOLOGY, V51, P123, DOI 10.1159/000125327; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; BESSER G M, 1973, Clinical Endocrinology, V2, P175, DOI 10.1111/j.1365-2265.1973.tb00417.x; BONHOMME F, 1978, EXPERIENTIA, V34, P1140, DOI 10.1007/BF01922917; BROUCKAERT PG, 1989, AGENTS ACTIONS, V26, P196, DOI 10.1007/BF02126607; Chen AM, 2005, P NATL ACAD SCI USA, V102, P2620, DOI 10.1073/pnas.0409583102; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Cole TJ, 2001, MOL CELL ENDOCRINOL, V173, P193, DOI 10.1016/S0303-7207(00)00407-X; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; Davani B, 2004, DIABETES, V53, pS51, DOI 10.2337/diabetes.53.2007.S51; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; DeRijk RH, 2008, EUR J PHARMACOL, V583, P303, DOI 10.1016/j.ejphar.2007.11.072; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; FINK G, 1997, PRINCIPLES MED BIO A, V10, P30; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Gadek-Michalska A, 2004, J PHYSIOL PHARMACOL, V55, P663; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Gomez F, 1998, AM J PHYSIOL-REG I, V274, pR420, DOI 10.1152/ajpregu.1998.274.2.R420; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Larsson H, 1999, DIABETOLOGIA, V42, P936, DOI 10.1007/s001250051251; LENZEN S, 1984, ENDOCR REV, V5, P411, DOI 10.1210/edrv-5-3-411; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Mahieu T, 2006, P NATL ACAD SCI USA, V103, P2292, DOI 10.1073/pnas.0510874103; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; MCMAHON M, 1988, DIABETES METAB REV, V4, P17, DOI 10.1002/dmr.5610040105; Meyer AS, 1997, J STEROID BIOCHEM, V62, P97, DOI 10.1016/S0960-0760(97)00014-9; MILLER WL, 1995, ADRENAL CORTEX; Nikodemova M., 2002, Archives of Physiology and Biochemistry, V110, P123, DOI 10.1076/apab.110.1.123.901; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283; Paust HJ, 2006, EXP CLIN ENDOCR DIAB, V114, P6, DOI 10.1055/s-2005-873007; PHILIPPE J, 1990, ENDOCRINOLOGY, V127, P1640, DOI 10.1210/endo-127-4-1640; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; POTTER E, 1991, NATURE, V349, P423, DOI 10.1038/349423a0; Putignano P, 2001, EUR J ENDOCRINOL, V145, P165, DOI 10.1530/eje.0.1450165; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Reichardt HM, 1998, J STEROID BIOCHEM, V65, P111, DOI 10.1016/S0960-0760(97)00181-7; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Reichardt HM, 1996, MOL MED, V2, P735, DOI 10.1007/BF03401657; Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Saag Kenneth G, 2002, Curr Rheumatol Rep, V4, P218, DOI 10.1007/s11926-002-0068-z; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHATZBERG AF, 1985, J PSYCHIAT RES, V19, P57, DOI 10.1016/0022-3956(85)90068-8; SILVER LM, 1995, MOUSE GENETICS CONCE, P227; Spinazzi R, 2006, PHARMACOL REV, V58, P46, DOI 10.1124/pr.58.1.4; Staelens J, 2002, P NATL ACAD SCI USA, V99, P9340, DOI 10.1073/pnas.142293699; SVEC F, 1985, LIFE SCI, V36, P2359, DOI 10.1016/0024-3205(85)90339-X; TAYLOR T, 1983, J CLIN ENDOCR METAB, V57, P592, DOI 10.1210/jcem-57-3-592; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Yeager MP, 2004, ACTA ANAESTH SCAND, V48, P799, DOI 10.1111/j.1399-6576.2004.00434.x; Zhang JH, 2009, J BIOL CHEM, V284, P6249, DOI 10.1074/jbc.M807997200; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	82	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31073	31086		10.1074/jbc.M110.154484	http://dx.doi.org/10.1074/jbc.M110.154484			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663891	Green Published, hybrid			2022-12-25	WOS:000282135500072
J	Kreis, NN; Sanhaji, M; Kramer, A; Sommer, K; Rodel, F; Strebhardt, K; Yuan, J				Kreis, N. N.; Sanhaji, M.; Kraemer, A.; Sommer, K.; Roedel, F.; Strebhardt, K.; Yuan, J.			Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells	ONCOGENE			English	Article						targeting cyclin B1; p53 stabilization; HPV 16/18; p14ARF and Ser315 phosphorylation of p53	INHIBITS PROLIFERATION; E6; PHOSPHORYLATION; DEGRADATION; ACTIVATION; INCREASES; APOPTOSIS; PROTEIN; MDM2; ARF	Abrogation of functional p53 is responsible for malignant cell transformation and the maintenance of malignant state of human papillomavirus-infected cancer cells. Thus, restoration of p53 has been regarded as an important strategy for molecular intervention combating papillomavirus-associated malignancies. We show here that depleting cyclin B1 stabilizes and reactivates p53 in papillomavirus-infected cervical cancer cell lines HeLa and CaSki. HeLa cells depleted of cyclin B1 exhibit mitotic defects in spindle formation and chromosome alignment. Downregulation of cyclin B1 increases p14 alternative reading frame of p16, the positive regulator of p53, and decreases phosphorylation of Ser315 in p53. Whereas RO-3306, a selective inhibitor of cyclin-dependent kinase 1 (Cdk1), suppresses this phosphorylation at Ser315 of p53, ZM447439, targeting Aurora A/B kinases, shows no effect. Further analyses in HeLa cells and HCT116 p53(-/-) cells suggest that the Ser315 phosphorylation by Cdk1 regulates negatively the protein stability and the function of p53. Moreover, increased p53 in HeLa cells is functional by showing its increased downstream effectors p21, mouse double minute 2 and Bax. Restoration of p53 and silencing cyclin B1 render cervical carcinoma cells more susceptible to DNA damage agent camptothecin. Taken together, targeting cyclin B1 might be an attractive strategy for preventing and treating papillomavirus-associated cancer by reactivating p53 and by reducing the Cdk1 activity. Oncogene (2010) 29, 5591-5603; doi:10.1038/onc.2010.290; published online 26 July 2010	[Kreis, N. N.; Sanhaji, M.; Kraemer, A.; Strebhardt, K.; Yuan, J.] Goethe Univ Frankfurt, Sch Med, Dept Gynecol & Obstet, D-60590 Frankfurt, Germany; [Sommer, K.] Goethe Univ Frankfurt, Sch Med, Dept Traumatol & Reconstruct Surg, D-60590 Frankfurt, Germany; [Roedel, F.] Goethe Univ Frankfurt, Sch Med, Dept Radiotherapy & Oncol, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Yuan, J (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Gynecol & Obstet, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	yuan@em.uni-frankfurt.de	Kreis, Nina-Naomi/AAF-5407-2019; Strebhardt, Klaus/E-8765-2011	Kreis, Nina-Naomi/0000-0003-4304-0160; Strebhardt, Klaus/0000-0003-2173-9763	Deutsche Krebshilfe [107594, 108553]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work is supported by the Deutsche Krebshilfe (# 107594 and # 108553). We are grateful to Dr B Vogelstein, Ludwig Center at Johns Hopkins, Howard Hughes Medical Institute, Baltimore, for HCT116 p53(+ / +) and p53(- / -) cell lines, and Dr K Hoppe-Seyler, Deutsches Krebsforschungszentrum, Heidelberg, for CaSki cell line. We thank Ms Roth and Ms Zimmer for their excellent technical support.	Androic I, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-391; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; BUTZ K, 1995, ONCOGENE, V10, P927; Cho NH, 2006, CANCER LETT, V232, P170, DOI 10.1016/j.canlet.2005.02.026; Demidenko ZN, 2004, CANCER RES, V64, P3653, DOI 10.1158/0008-5472.CAN-04-0204; Dickson MA, 2009, CURR ONCOL, V16, P120; FUCHS B, 1995, EUR J BIOCHEM, V228, P625, DOI 10.1111/j.1432-1033.1995.0625m.x; Gallagher SJ, 2006, INT J BIOCHEM CELL B, V38, P1637, DOI 10.1016/j.biocel.2006.02.008; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kreis NN, 2009, CELL CYCLE, V8, P460, DOI 10.4161/cc.8.3.7651; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lu WG, 2001, ONCOGENE, V20, P3206, DOI 10.1038/sj.onc.1204412; Pathirana D, 2009, VACCINE, V27, P4551, DOI 10.1016/j.vaccine.2009.03.086; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Rampias T, 2009, JNCI-J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Yuan J, 2006, ONCOGENE, V25, P1753, DOI 10.1038/sj.onc.1209202; Yuan JP, 2004, ONCOGENE, V23, P5843, DOI 10.1038/sj.onc.1207757; Zhao M., 2006, Experimental Oncology, V28, P44	32	40	40	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	41					5591	5603		10.1038/onc.2010.290	http://dx.doi.org/10.1038/onc.2010.290			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FX	20661218				2022-12-25	WOS:000282946900006
J	Yang, W; Zou, J; Xia, R; Vaal, ML; Seymour, VA; Luo, JH; Beech, DJ; Jiang, LH				Yang, Wei; Zou, Jie; Xia, Rong; Vaal, Meriel L.; Seymour, Victoria A.; Luo, Jianhong; Beech, David J.; Jiang, Lin-Hua			State-dependent Inhibition of TRPM2 Channel by Acidic pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; RECEPTOR POTENTIAL CHANNEL-2; NONSELECTIVE CATION CHANNEL; PEROXIDE-INDUCED TOXICITY; RAT STRIATAL NEURONS; HYDROGEN-PEROXIDE; MOLECULAR DETERMINANTS; INTRACELLULAR CALCIUM; BETA-CELLS; CA2+ ENTRY	Transient receptor potential melastatin 2 (TRPM2) channel fulfills an important role in oxidative stress signaling in immune and other cells, to which local extracellular acidosis is known to occur under physiological or pathological conditions and impose significant effects on their functions. Here, we investigated whether the ADP-ribose-activated TRPM2 channel is a target for modulation by extracellular acidic pH by patch clamp recording of HEK293 cells expressing hTRPM2 channel. Induced whole cell or single channel currents were rapidly inhibited upon subsequent exposure to acidic pH. The inhibition in the steady state was complete, voltage-independent, and pH-independent in the range of pH 4.0-6.0. The inhibition was irreversible upon returning to pH 7.3, suggesting channel inactivation. In contrast, exposure of closed channels to acidic pH reduced the subsequent channel activation in a pH-dependent manner with an IC50 for H+ of 20 mu M (pH 4.7) and rendered subsequent current inhibition largely reversible, indicating differential or state-dependent inhibition and inactivation. Alanine substitution of residues in the outer vestibule of the pore including Lys(952) and Asp(1002) significantly slowed down or reduced acidic pH-induced inhibition and prevented inactivation. The results suggest that acidic pH acts as a negative feedback mechanism where protons bind to the outer vestibule of the TRPM2 channel pore and inhibit the TRPM2 channels in a state-dependent manner.	[Yang, Wei; Zou, Jie; Xia, Rong; Vaal, Meriel L.; Seymour, Victoria A.; Beech, David J.; Jiang, Lin-Hua] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Yang, Wei; Luo, Jianhong] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China	University of Leeds; Zhejiang University	Jiang, LH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.	l.h.jiang@leeds.ac.uk	Jiang, Lin-Hua/D-2030-2010; Jiang, Lin-Hua/AAU-1078-2020; Luo, jian/HGE-7331-2022	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Vaal, Meriel/0000-0003-4371-7792; Beech, David/0000-0002-7683-9422	Wellcome Trust; Alzheimer's Research Trust; Royal Society; University of Leeds-Chinese Scholarship Council; United Kingdom overseas research scholarship; Alzheimers Research UK [ART-PPG2009A-2] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Alzheimer's Research Trust; Royal Society(Royal Society of London); University of Leeds-Chinese Scholarship Council; United Kingdom overseas research scholarship; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported in part by research grants from the Wellcome Trust and Alzheimer's Research Trust (to L.-H.J.), a Royal Society fellowship (to W.Y.), a University of Leeds-Chinese Scholarship Council research scholarship (to J.Z.), and a United Kingdom overseas research scholarship (to R. X.).	Bari MR, 2009, J CELL MOL MED, V13, P3260, DOI 10.1111/j.1582-4934.2009.00737.x; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Campo B, 2003, J IMMUNOL, V170, P1167, DOI 10.4049/jimmunol.170.3.1167; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; EDLOW DW, 1971, P SOC EXP BIOL MED, V137, P1328; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P179, DOI 10.1080/10799890600637522; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Heiner I, 2003, BIOCHEM J, V371, P1045, DOI 10.1042/BJ20021975; Hill K, 2006, NEUROPHARMACOLOGY, V50, P89, DOI 10.1016/j.neuropharm.2005.08.021; Ishii M, 2006, J PHARMACOL SCI, V101, P174, DOI 10.1254/jphs.SCJ06001X; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Kraft R, 2006, BRIT J PHARMACOL, V148, P264, DOI 10.1038/sj.bjp.0706739; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; Liu X, 2009, BRIT J PHARMACOL, V156, P135, DOI 10.1111/j.1476-5381.2008.00002.x; Mao JZ, 2002, J BIOL CHEM, V277, P46166, DOI 10.1074/jbc.M205438200; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Mei ZZ, 2009, J MEMBRANE BIOL, V230, P93, DOI 10.1007/s00232-009-9190-4; NIELSON DW, 1981, P NATL ACAD SCI-BIOL, V78, P7119, DOI 10.1073/pnas.78.11.7119; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Numata T, 2008, J BIOL CHEM, V283, P15097, DOI 10.1074/jbc.M709261200; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; SIMMEN HP, 1993, AM J SURG, V166, P24, DOI 10.1016/S0002-9610(05)80576-8; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Spelta V, 2002, BRIT J PHARMACOL, V135, P1524, DOI 10.1038/sj.bjp.0704591; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yamamoto S, 2007, BBA-MOL BASIS DIS, V1772, P958, DOI 10.1016/j.bbadis.2007.03.006; Zhang WY, 2007, AM J PHYSIOL-CELL PH, V292, pC1746, DOI 10.1152/ajpcell.00569.2006	53	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30411	30418		10.1074/jbc.M110.139774	http://dx.doi.org/10.1074/jbc.M110.139774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20660597	hybrid, Green Published			2022-12-25	WOS:000282135500007
J	Klose, C; Ejsing, CS; Garcia-Saez, AJ; Kaiser, HJ; Sampaio, JL; Surma, MA; Shevchenko, A; Schwille, P; Simons, K				Klose, Christian; Ejsing, Christer S.; Garcia-Saez, Ana J.; Kaiser, Hermann-Josef; Sampaio, Julio L.; Surma, Michal A.; Shevchenko, Andrej; Schwille, Petra; Simons, Kai			Yeast Lipids Can Phase-separate into Micrometer-scale Membrane Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SACCHAROMYCES-CEREVISIAE; BILAYER-MEMBRANES; PLASMA-MEMBRANE; CELL-MEMBRANES; MODEL MEMBRANES; BIOLOGICAL-MEMBRANES; SURFACE DELIVERY; EPITHELIAL-CELLS; STEROL STRUCTURE	The lipid raft concept proposes that biological membranes have the potential to form functional domains based on a selective interaction between sphingolipids and sterols. These domains seem to be involved in signal transduction and vesicular sorting of proteins and lipids. Although there is biochemical evidence for lipid raft-dependent protein and lipid sorting in the yeast Saccharomyces cerevisiae, direct evidence for an interaction between yeast sphingolipids and the yeast sterol ergosterol, resulting in membrane domain formation, is lacking. Here we show that model membranes formed from yeast total lipid extracts possess an inherent self-organization potential resulting in liquid-disordered-liquid-ordered phase coexistence at physiologically relevant temperature. Analyses of lipid extracts from mutants defective in sphingolipid metabolism as well as reconstitution of purified yeast lipids in model membranes of defined composition suggest that membrane domain formation depends on specific interactions between yeast sphingolipids and ergosterol. Taken together, these results provide a mechanistic explanation for lipid raft-dependent lipid and protein sorting in yeast.	[Surma, Michal A.; Shevchenko, Andrej; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Ejsing, Christer S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Garcia-Saez, Ana J.; Schwille, Petra] Tech Univ Dresden, Inst Biophys, Biotechnol Ctr BIOTEC, D-01307 Dresden, Germany	Max Planck Society; University of Southern Denmark; Technische Universitat Dresden	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	simons@mpi-cbg.de	Ejsing, Christer S/R-5922-2016; Schwille, Petra/A-4983-2010; Surma, Michal/B-1955-2016; Sampaio, Julio/B-5487-2012; Sampaio, Julio/S-3810-2019; Saez, Ana J. Garcia/U-1611-2019	Surma, Michal/0000-0001-7833-2214; Sampaio, Julio/0000-0002-2881-7827; Klose, Christian/0000-0003-2853-4533; Simons, Kai/0000-0002-9231-9996; Ejsing, Christer S./0000-0003-4963-0276	EUFP6 [LSHB-CT2007-037740]; Deutsche Forschungsgemeinschaft; Schwerpunktprogramm [1175]; Bundesministerium fur Bildung und Forschung (BMBF) [0313827, 03FO1212]; Max Planck Institute	EUFP6(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Schwerpunktprogramm; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Institute(Foundation CELLEX)	This work was supported by EUFP6 "PRISM" Grant LSHB-CT2007-037740, Deutsche Forschungsgemeinschaft "Schwerpunktprogramm 1175," Bundesministerium fur Bildung und Forschung (BMBF) "BioChance Plus" Grant 0313827, and BMBF "ForMaT" Grant 03FO1212. This work was also supported by a predoctoral stipend from the Max Planck Institute (to C.K.).	Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Aittoniemi J, 2007, BIOPHYS J, V92, P1125, DOI 10.1529/biophysj.106.088427; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Beattie ME, 2005, BIOPHYS J, V89, P1760, DOI 10.1529/biophysj.104.049635; Bjorkbom A, 2010, BBA-BIOMEMBRANES, V1798, P453, DOI 10.1016/j.bbamem.2009.11.003; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dupre S, 2003, TRAFFIC, V4, P83, DOI 10.1034/j.1600-0854.2003.40204.x; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Garcia-Saez AJ, 2010, METHODS MOL BIOL, V606, P493, DOI 10.1007/978-1-60761-447-0_33; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Guo W, 2002, BIOPHYS J, V83, P1465, DOI 10.1016/S0006-3495(02)73917-9; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; HECHTBERGER P, 1995, FEBS LETT, V367, P201, DOI 10.1016/0014-5793(95)00567-S; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; IPSEN JH, 1989, BIOPHYS J, V56, P661, DOI 10.1016/S0006-3495(89)82713-4; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Levental I, 2008, J AM CHEM SOC, V130, P9025, DOI 10.1021/ja800948c; Li ZG, 2006, J ORG CHEM, V71, P1718, DOI 10.1021/jo052029x; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maulik PR, 1996, BIOPHYS J, V70, P2256, DOI 10.1016/S0006-3495(96)79791-6; MCINTOSH TJ, 1992, BIOCHEMISTRY-US, V31, P2012, DOI 10.1021/bi00122a017; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Niemela PS, 2009, BBA-BIOMEMBRANES, V1788, P122, DOI 10.1016/j.bbamem.2008.08.018; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Ramstedt B, 2002, FEBS LETT, V531, P33, DOI 10.1016/S0014-5793(02)03406-3; Ries J, 2006, BIOPHYS J, V91, P1915, DOI 10.1529/biophysj.106.082297; Rog T, 2006, BIOPHYS J, V91, P3756, DOI 10.1529/biophysj.106.080887; RUOCCO MJ, 1983, BIOPHYS J, V43, P91, DOI 10.1016/S0006-3495(83)84327-6; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SLATER JL, 1988, PROG LIPID RES, V27, P325, DOI 10.1016/0163-7827(88)90010-0; Stottrup BL, 2006, BIOPHYS J, V90, P3176, DOI 10.1529/biophysj.105.072959; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; URBINA JA, 1995, BBA-BIOMEMBRANES, V1238, P163, DOI 10.1016/0005-2736(95)00117-L; VAN MEER G, 2008, NAT REV MOL CELL BIO, V9, P112; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	64	80	81	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30224	30232		10.1074/jbc.M110.123554	http://dx.doi.org/10.1074/jbc.M110.123554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647309	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000281984300059
J	Strait, KA; Stricklett, PK; Kohan, RM; Kohan, DE				Strait, Kevin A.; Stricklett, Peter K.; Kohan, Rachel M.; Kohan, Donald E.			Identification of Two Nuclear Factor of Activated T-cells (NFAT)-response Elements in the 5 '-Upstream Regulatory Region of the ET-1 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCT-SPECIFIC KNOCKOUT; MEDULLARY COLLECTING DUCT; ENDOTHELIN-1 GENE-EXPRESSION; TRANSCRIPTION FACTOR; SODIUM RETENTION; CAUSES HYPERTENSION; BINDING PROTEIN; BLOOD-PRESSURE; NFAT; EXCRETION	Collecting duct-derived ET-1 regulates salt excretion and blood pressure. We have reported the presence of an inner medullary collecting duct (IMCD)-specific enhancer region in the 5'-upstream ET-1 promoter (Strait, K. A., Stricklett, P. K., Kohan, J. L., Miller, M. B., and Kohan, D. E. (2007) Am. J. Physiol. Renal Physiol. 293, F601-F606). The current studies provide further characterization of the ET-1 5'-upstream distal promoter to identify the IMCD-specific enhancer elements. Deletion studies identified two regions of the 5'-upstream ET-1 promoter, -1725 to -1319 bp and -1319 to -1026 bp, which were required for maximal promoter activity in transfected rat IMCD cells. Transcription factor binding site analysis of these regions identified two consensus nuclear factor of activated T-cells (NFAT) binding sites at -1263 and -1563. EMSA analysis using nuclear extracts from IMCD cells showed that both the -1263 and the -1563 NFAT sites in the ET-1 distal promoter competed for NFAT binding to previously identified NFAT sites in the IL-2 and TNF genes. Gel supershift analysis showed that each of the NFAT binding sites in the ET-1 promoter bound NFAT proteins derived from IMCD nuclear extracts, but they selectively bound different NFAT isoforms; ET-1263 bound NFATc1, whereas ET-1563 bound NFATc3. Site-directed mutagenesis of either the ET-1263 or the ET-1563 sites prevented NFAT binding and reduced ET-1 promoter activity. Thus, NFAT appears to be an important regulator of ET-1 transcription in IMCD cells, and thus, it may play a role in controlling blood pressure through ET-1 regulation of renal salt excretion.	[Strait, Kevin A.; Stricklett, Peter K.; Kohan, Rachel M.; Kohan, Donald E.] Univ Utah, Hlth Sci Ctr, Div Nephrol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kohan, DE (corresponding author), Univ Utah, Hlth Sci Ctr, Div Nephrol, 1900 East 30 North, Salt Lake City, UT 84132 USA.	donald.kohan@hsc.utah.edu			National Institutes of Health [DK96392]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant DK96392 (to D. E. K.).	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; Falvo JV, 2008, P NATL ACAD SCI USA, V105, P19637, DOI 10.1073/pnas.0810648105; GALLEGO MS, 1996, AM J PHYSIOL, V271, P451; Ge YQ, 2005, AM J PHYSIOL-RENAL, V289, pF692, DOI 10.1152/ajprenal.00100.2005; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Ge YQ, 2006, AM J PHYSIOL-RENAL, V291, pF1274, DOI 10.1152/ajprenal.00190.2006; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; INOUE A, 1989, J BIOL CHEM, V264, P14954; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; KAWANA M, 1995, MOL CELL BIOL, V15, P4225; KITAMURA K, 1989, BIOCHEM BIOPH RES CO, V161, P348, DOI 10.1016/0006-291X(89)91603-3; Kohan DE, 2006, CURR OPIN NEPHROL HY, V15, P34, DOI 10.1097/01.mnh.0000186852.15889.1a; Kohan DE, 1997, AM J KIDNEY DIS, V29, P2, DOI 10.1016/S0272-6386(97)90004-4; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEE ME, 1990, J BIOL CHEM, V265, P10446; LEE ME, 1991, J BIOL CHEM, V266, P19034; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MIGAS I, 1995, AM J HYPERTENS, V8, P748, DOI 10.1016/0895-7061(95)00115-6; Modesti PA, 1998, AM J PHYSIOL-HEART C, V275, pH1070, DOI 10.1152/ajpheart.1998.275.3.H1070; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; PERNOW J, 1989, J CARDIOVASC PHARM, V13, pS205, DOI 10.1097/00005344-198900135-00058; Quehenberger P, 2000, DIABETES, V49, P1561, DOI 10.2337/diabetes.49.9.1561; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodriguez-Pascual F, 2004, J CARDIOVASC PHARM, V44, pS39, DOI 10.1097/01.fjc.0000166216.27544.22; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Strait KA, 2007, AM J PHYSIOL-RENAL, V293, pF601, DOI 10.1152/ajprenal.00085.2007; TASAKA K, 1994, GEN PHARMACOL-VASC S, V25, P1059, DOI 10.1016/0306-3623(94)90120-1; TOMITA K, 1991, CONTRIB NEPHROL, V95, P207; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YANG TX, 1993, AM J PHYSIOL, V264, pF684, DOI 10.1152/ajprenal.1993.264.4.F684; ZEIDEL ML, 1989, AM J PHYSIOL, V257, pC1101, DOI 10.1152/ajpcell.1989.257.6.C1101; ZEILER M, 1995, J CARDIOVASC PHARM, V26, pS513; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	37	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28520	28528		10.1074/jbc.M110.153189	http://dx.doi.org/10.1074/jbc.M110.153189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20647310	Green Published, hybrid			2022-12-25	WOS:000281594000016
J	Hu, YM; Shamaei-Tousi, A; Liu, YJ; Coates, A				Hu, Yanmin; Shamaei-Tousi, Alireza; Liu, Yingjun; Coates, Anthony			A New Approach for the Discovery of Antibiotics by Targeting Non-Multiplying Bacteria: A Novel Topical Antibiotic for Staphylococcal Infections	PLOS ONE			English	Article							LEVEL MUPIROCIN RESISTANCE; RNA-POLYMERASE; MYCOBACTERIUM-TUBERCULOSIS; STATIONARY-PHASE; AUREUS; MUTATIONS; DRUGS; DECOLONIZATION; CHEMOTHERAPY; PREVALENCE	In a clinical infection, multiplying and non-multiplying bacteria co-exist. Antibiotics kill multiplying bacteria, but they are very inefficient at killing non-multipliers which leads to slow or partial death of the total target population of microbes in an infected tissue. This prolongs the duration of therapy, increases the emergence of resistance and so contributes to the short life span of antibiotics after they reach the market. Targeting non-multiplying bacteria from the onset of an antibiotic development program is a new concept. This paper describes the proof of principle for this concept, which has resulted in the development of the first antibiotic using this approach. The antibiotic, called HT61, is a small quinolone-derived compound with a molecular mass of about 400 Daltons, and is active against non-multiplying bacteria, including methicillin sensitive and resistant, as well as Panton-Valentine leukocidin-carrying Staphylococcus aureus. It also kills mupirocin resistant MRSA. The mechanism of action of the drug is depolarisation of the cell membrane and destruction of the cell wall. The speed of kill is within two hours. In comparison to the conventional antibiotics, HT61 kills non-multiplying cells more effectively, 6 logs versus less than one log for major marketed antibiotics. HT61 kills methicillin sensitive and resistant S. aureus in the murine skin bacterial colonization and infection models. No resistant phenotype was produced during 50 serial cultures over a one year period. The antibiotic caused no adverse affects after application to the skin of minipigs. Targeting non-multiplying bacteria using this method should be able to yield many new classes of antibiotic. These antibiotics may be able to reduce the rate of emergence of resistance, shorten the duration of therapy, and reduce relapse rates.	[Hu, Yanmin; Coates, Anthony] Univ London, Ctr Infect, Div Cellular & Mol Med, London, England; [Hu, Yanmin; Shamaei-Tousi, Alireza; Liu, Yingjun; Coates, Anthony] Helperby Therapeut Grp Plc, London, England	University of London	Hu, YM (corresponding author), Univ London, Ctr Infect, Div Cellular & Mol Med, London, England.	acoates@sgul.ac.uk		Coates, Anthony/0000-0001-8052-3175; Hu, Yanmin/0000-0003-0630-5342	Helperby Therapeutics (UK); Helperby Therapeutics	Helperby Therapeutics (UK); Helperby Therapeutics	This work was funded by a grant from Helperby Therapeutics (UK). Helperby Therapeutics also financially supported YM. The funders had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allsop A, 1998, CLIN INFECT DIS, V27, pS141; Belley A, 2009, ANTIMICROB AGENTS CH, V53, P918, DOI 10.1128/AAC.00766-08; BRADLEY SF, 1995, INFECT CONT HOSP EP, V16, P354; Butler MS, 2006, BIOCHEM PHARMACOL, V71, P919, DOI 10.1016/j.bcp.2005.10.012; CAPOBIANCO JO, 1989, ANTIMICROB AGENTS CH, V33, P156, DOI 10.1128/AAC.33.2.156; CASEWELL MW, 1985, J ANTIMICROB CHEMOTH, V15, P523, DOI 10.1093/jac/15.5.523; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Coates ARM, 2007, BRIT J PHARMACOL, V152, P1147, DOI 10.1038/sj.bjp.0707432; Coates ARM, 2008, TRENDS PHARMACOL SCI, V29, P143, DOI 10.1016/j.tips.2007.12.001; Coates Anthony R M, 2006, Drugs R D, V7, P133, DOI 10.2165/00126839-200607030-00001; Coates T, 2009, J ANTIMICROB CHEMOTH, V64, P9, DOI 10.1093/jac/dkp159; Cookson BD, 1998, J ANTIMICROB CHEMOTH, V41, P11, DOI 10.1093/jac/41.1.11; Cuevas O, 2007, CLIN MICROBIOL INFEC, V13, P250, DOI 10.1111/j.1469-0691.2006.01672.x; Del Pozo JL, 2006, INT J ARTIF ORGANS, V29, P379, DOI 10.1177/039139880602900407; DOEBBELING BN, 1994, ARCH INTERN MED, V154, P1505, DOI 10.1001/archinte.154.13.1505; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Drusano GL, 2009, ANTIMICROB AGENTS CH, V53, P2266, DOI 10.1128/AAC.01680-08; ELLNER JJ, 1979, MEDICINE, V58, P145, DOI 10.1097/00005792-197903000-00003; Fenollar F, 2007, INT J ANTIMICROB AG, V30, pS7, DOI 10.1016/j.ijantimicag.2007.06.024; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Hair PI, 2007, DRUGS, V67, P1483, DOI 10.2165/00003495-200767100-00008; Hu YM, 2003, ANTIMICROB AGENTS CH, V47, P653, DOI 10.1128/AAC.47.2.653-657.2003; Hurdle JG, 2005, J ANTIMICROB CHEMOTH, V56, P1166, DOI 10.1093/jac/dki387; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017; Kugelberg E, 2005, ANTIMICROB AGENTS CH, V49, P3435, DOI 10.1128/AAC.49.8.3435-3441.2005; LEVIN ME, 1993, MOL MICROBIOL, V8, P277, DOI 10.1111/j.1365-2958.1993.tb01572.x; MARKS J, 1990, J CLIN PATHOL, V43, P774, DOI 10.1136/jcp.43.9.774; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; McLeod GI, 1996, J BACTERIOL, V178, P3683, DOI 10.1128/jb.178.13.3683-3688.1996; MITCHISON DA, 1979, CHEST, V76, P771, DOI 10.1378/chest.76.6_Supplement.771; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; Mitchison DA, 2004, SEMIN RESP CRIT CARE, V25, P307, DOI 10.1055/s-2004-829503; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Mody L, 2003, CLIN INFECT DIS, V37, P1467, DOI 10.1086/379325; Moellering RC, 1998, CLIN INFECT DIS, V27, pS135; Schmitz FJ, 1998, J ANTIMICROB CHEMOTH, V42, P489, DOI 10.1093/jac/42.4.489; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; STEWART MH, 1992, APPL ENVIRON MICROB, V58, P2649, DOI 10.1128/AEM.58.8.2649-2653.1992; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; TUOMANEN E, 1986, REV INFECT DIS, V8, pS279; Walker ES, 2003, INFECT CONT HOSP EP, V24, P342, DOI 10.1086/502218; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; WILLIAMS DL, 1994, ANTIMICROB AGENTS CH, V38, P2380, DOI 10.1128/AAC.38.10.2380; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; YAMADA T, 1985, ANTIMICROB AGENTS CH, V27, P921, DOI 10.1128/AAC.27.6.921; Yang JA, 2006, J KOREAN MED SCI, V21, P827, DOI 10.3346/jkms.2006.21.5.827; Yates RR, 1999, CHEST, V115, p24S, DOI 10.1378/chest.115.suppl_1.24S; Zappia G, 2007, MINI-REV MED CHEM, V7, P389, DOI 10.2174/138955707780363783; Zegans ME, 2002, DNA CELL BIOL, V21, P415, DOI 10.1089/10445490260099700; ZIERSKI M, 1973, PNEUMONOLOGIE, V150, P1, DOI 10.1007/BF02097148	51	47	52	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11818	10.1371/journal.pone.0011818	http://dx.doi.org/10.1371/journal.pone.0011818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676403	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000280371800018
J	Zhao, HW; Zhou, D; Nizet, V; Haddad, GG				Zhao, Huiwen W.; Zhou, Dan; Nizet, Victor; Haddad, Gabriel G.			Experimental Selection for Drosophila Survival in Extremely High O-2 Environments	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; ANTIMICROBIAL PEPTIDE; NEUTROPHIL DEFENSINS; EUROPEAN ANCESTRY; CELL APOPTOSIS; HYPEROXIA; MELANOGASTER; OXYGEN; EXPRESSION	Although oxidative stress is deleterious to mammals, the mechanisms underlying oxidant susceptibility or tolerance remain to be elucidated. In this study, through a long-term laboratory selection over many generations, we generated a Drosophila melanogaster strain that can live and reproduce in very high O-2 environments (90% O-2), a lethal condition to naive flies. We demonstrated that tolerance to hyperoxia was heritable in these flies and that these hyperoxia-selected flies exhibited phenotypic differences from naive flies, such as a larger body size and increased weight by 20%. Gene expression profiling revealed that 227 genes were significantly altered in expression and two third of these genes were down-regulated. Using a mutant screen strategy, we studied the role of some altered genes (up-or down-regulated in the microarrays) by testing the survival of available corresponding P-element or UAS construct lines under hyperoxic conditions. We report that down-regulation of several candidate genes including Tropomyosin 1, Glycerol 3 phosphate dehydrogenase, CG33129, and UGP as well as up-regulation of Diptericin and Attacin conferred tolerance to severe hyperoxia. In conclusion, we identified several genes that were not only altered in hyperoxia-selected flies but we also prove that these play an important role in hyperoxia survival. Thus our study provides a molecular basis for understanding the mechanisms of hyperoxia tolerance.	[Zhao, Huiwen W.; Zhou, Dan; Nizet, Victor; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Zhao, Huiwen W.; Zhou, Dan; Nizet, Victor; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; [Zhao, Huiwen W.; Zhou, Dan; Nizet, Victor; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Pharmacol & Drug Discovery, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nizet, Victor; Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Zhao, HW (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu	Nizet, Victor/AAF-3190-2019; Zhou, Dan/T-7203-2017	Zhou, Dan/0000-0001-6401-9040; Nizet, Victor/0000-0003-3847-0422	NIH [RO1NS037756, 1R21HL093611, PO1HD032573]; American Heart Association [0835188N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant RO1NS037756, 1R21HL093611 and PO1HD032573 to Gabriel G. Haddad and American Heart Association grant 0835188N to Dan Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Barker GF, 2006, AM J RESP CELL MOL, V35, P277, DOI 10.1165/rcmb.2005-0340OC; Bhandari V, 2008, FRONT BIOSCI-LANDMRK, V13, P6653, DOI 10.2741/3179; Bhandari V, 2007, J IMMUNOL, V178, P4993, DOI 10.4049/jimmunol.178.8.4993; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Chen L, 2004, MOL BRAIN RES, V131, P93, DOI 10.1016/j.molbrainres.2004.08.013; Chetty A, 2008, PEDIATR PULM, V43, P297, DOI 10.1002/ppul.20777; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; Dudley R, 1998, J EXP BIOL, V201, P1043; Fatma N, 2009, FREE RADICAL RES, V43, P783, DOI 10.1080/10715760903062887; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Gorter AD, 1998, J INFECT DIS, V178, P1067, DOI 10.1086/515667; GREKSA LP, 1988, AM J PHYS ANTHROPOL, V75, P77, DOI 10.1002/ajpa.1330750109; GREKSA LP, 1985, ANN HUM BIOL, V12, P225, DOI 10.1080/03014468500007721; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs EGJ, 2000, J PEDIATR ENDOCR MET, V13, P387; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Khurana V, 2008, J ALZHEIMERS DIS, V15, P541; Kreuz AJ, 1996, J CELL BIOL, V135, P673, DOI 10.1083/jcb.135.3.673; KUBO E, AM J PHYSL CELL PHYS, V298, pC342; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Mantell LL, 2000, MOL GENET METAB, V71, P359, DOI 10.1006/mgme.2000.3046; Masalunga C, 2007, PEDIATR RES, V62, P78, DOI 10.1203/PDR.0b013e3180674dc6; Meng M, 2007, GENE, V389, P186, DOI 10.1016/j.gene.2006.11.006; Merritt TJS, 2006, GENETICS, V172, P293, DOI 10.1534/genetics.105.047035; Morrow Genevieve, 2008, Biotechnology Journal, V3, P728, DOI 10.1002/biot.200800015; Ogawa Y, 2007, INFLAMM RES, V56, P334, DOI 10.1007/s00011-007-7052-z; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720; Peck LS, 2005, J EXP ZOOL PART A, V303A, P968, DOI 10.1002/jez.a.211; Perez-Gracia E, 2009, ACTA NEUROPATHOL, V118, P497, DOI 10.1007/s00401-009-0574-4; Ross CR, 2007, CHEM BIOL DRUG DES, V70, P154, DOI 10.1111/j.1747-0285.2007.00540.x; Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; van Wetering S, 1999, J ALLERGY CLIN IMMUN, V104, P1131, DOI 10.1016/S0091-6749(99)70004-7; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; WEBSTER NR, 1987, BRIT J ANAESTH, V59, P760, DOI 10.1093/bja/59.6.760; Wright CJ, 2009, AM J PHYSIOL-LUNG C, V296, pL296, DOI 10.1152/ajplung.90499.2008; Wu JP, 2004, CIRCULATION, V109, P1660, DOI 10.1161/01.CIR.0000124067.35915.E0; Xun ZY, 2008, J PROTEOME RES, V7, P3911, DOI 10.1021/pr800207h; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490	53	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11701	10.1371/journal.pone.0011701	http://dx.doi.org/10.1371/journal.pone.0011701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668515	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243800004
J	Aboul-Enein, F; Krssak, M; Hoftberger, R; Prayer, D; Kristoferitsch, W				Aboul-Enein, Fahmy; Krssak, Martin; Hoeftberger, Romana; Prayer, Daniela; Kristoferitsch, Wolfgang			Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 Tesla	PLOS ONE			English	Article							APPEARING WHITE-MATTER; H-1 MR SPECTROSCOPY; MULTIPLE-SCLEROSIS; METABOLITE CONCENTRATIONS; RELAXATION-TIMES; HUMAN BRAIN; ABSOLUTE QUANTIFICATION; AXONAL DAMAGE; WATER; DEMYELINATION	Background: Reduced N-acetyl-aspartate (NAA) levels in magnetic resonance spectroscopy (MRS) may visualize axonal damage even in the normal appearing white matter (NAWM). Demyelination and axonal degeneration are a hallmark in multiple sclerosis (MS). Objective: To define the extent of axonal degeneration in the NAWM in the remote from focal lesions in patients with relapsing-remitting (RRMS) and secondary progressive MS (SPMS). Material and Methods: 37 patients with clinical definite MS (27 with RRMS, 10 with SPMS) and 8 controls were included. We used 2D H-1-MR-chemical shift imaging (TR = 1500ms, TE = 135ms, nominal resolution 1ccm) operating at 3Tesla to assess the metabolic pattern in the fronto-parietal NAWM. Ratios of NAA to creatine (Cr) and choline (Cho) and absolute concentrations of the metabolites in the NAWM were measured in each voxel matching exclusively white matter on the anatomical T2 weighted MR images. Results: No significant difference of absolute concentrations for NAA, Cr and Cho or metabolite ratios were found between RRMS and controls. In SPMS, the NAA/Cr ratio and absolute concentrations for NAA and Cr were significantly reduced compared to RRMS and to controls. Conclusions: In our study SPMS patients, but not RRMS patients were characterized by low NAA levels. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression.	[Aboul-Enein, Fahmy; Kristoferitsch, Wolfgang] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Krssak, Martin; Prayer, Daniela] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Hoeftberger, Romana] Med Univ Vienna, Inst Neurol, Vienna, Austria	Donauspital; Medical University of Vienna; Medical University of Vienna	Aboul-Enein, F (corresponding author), SMZ Ost Donauspital, Dept Neurol, Vienna, Austria.	fahmy.aboul-enein@telering.at	Krssak, Martin/AAU-8183-2020	Krssak, Martin/0000-0001-9717-803X	Multiple Sklerose Forschungsgesellschaft Wien; Medical Research Society Vienna, DC; European Union [HCM-CHRX-CT94-0432, ERB-FMRX-CT970160]	Multiple Sklerose Forschungsgesellschaft Wien; Medical Research Society Vienna, DC; European Union(European Commission)	This study was funded by the Multiple Sklerose Forschungsgesellschaft Wien (www.ms-ges.or.at) and by the Medical Research Society Vienna, DC (www.mfg22.at). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; For MR Spectroscopy analysis MRUI software was used (http://www.mrui.uab.es./mrui). MRUI development and improvement was secured thanks to the European Union project HCM-CHRX-CT94-0432 (1994-1997) and TMR/Networks ERB-FMRX-CT970160 (1998-2001).<SUP>17</SUP>	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; BAGORY M, 2007, C P IEEE ENG MED BIO, V1, P3458; Bellmann-Strobl J, 2009, EUR RADIOL, V19, P2066, DOI 10.1007/s00330-009-1364-z; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Bonneville F, 2002, AM J NEURORADIOL, V23, P371; Brief EE, 2009, NMR BIOMED, V22, P349, DOI 10.1002/nbm.1349; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; CONFAVREUX C, 1996, MCALPINES MULTIPLE S, P183; De Stefano N, 2007, NEUROLOGY, V69, P1942, DOI 10.1212/01.wnl.0000291557.62706.d3; De Stefano N, 1999, BRAIN, V122, P1933, DOI 10.1093/brain/122.10.1933; DEBEER R, 1992, NMR BIOMED, V5, P171, DOI 10.1002/nbm.1940050403; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Helms G, 2000, MAGNET RESON MED, V43, P102, DOI 10.1002/(SICI)1522-2594(200001)43:1<102::AID-MRM12>3.0.CO;2-I; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Kirov II, 2009, J NEUROL NEUROSUR PS, V80, P1330, DOI 10.1136/jnnp.2009.176263; Kolind SH, 2009, MAGN RESON MED, V62, P106, DOI 10.1002/mrm.21966; Kreis R, 1997, PROG NUCL MAG RES SP, V31, P155, DOI 10.1016/S0079-6565(97)00014-9; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Leary SM, 2000, MAGN RESON IMAGING, V18, P455, DOI 10.1016/S0730-725X(00)00131-4; Li DKB, 2006, NEUROLOGY, V66, P1384, DOI 10.1212/01.wnl.0000210506.00078.5c; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Sarchielli P, 1999, BRAIN, V122, P513, DOI 10.1093/brain/122.3.513; Sijens PE, 2006, EUR RADIOL, V16, P489, DOI 10.1007/s00330-005-2839-1; Tintore M, 2000, AM J NEURORADIOL, V21, P702; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; van Walderveen MAA, 1999, ANN NEUROL, V46, P79, DOI 10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.3.CO;2-0; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vrenken H, 2005, MAGNET RESON MED, V53, P256, DOI 10.1002/mrm.20366; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Wattjes MP, 2007, AM J NEURORADIOL, V28, P1517, DOI 10.3174/ajnr.A0594; Wattjes MP, 2006, EUR RADIOL, V16, P2067, DOI 10.1007/s00330-006-0195-4	38	53	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11625	10.1371/journal.pone.0011625	http://dx.doi.org/10.1371/journal.pone.0011625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652023	gold, Green Submitted, Green Published			2022-12-25	WOS:000280109700001
J	Sugimoto, C; Watanabe, S; Naruse, T; Kajiwara, E; Shiino, T; Umano, N; Ueda, K; Sato, H; Ohgimoto, S; Hirsch, V; Villinger, F; Ansari, AA; Kimura, A; Miyazawa, M; Suzuki, Y; Yamamoto, N; Nagai, Y; Mori, K				Sugimoto, Chie; Watanabe, Satoru; Naruse, Taeko; Kajiwara, Eiji; Shiino, Teiichiro; Umano, Natsuko; Ueda, Kayoko; Sato, Hirotaka; Ohgimoto, Shinji; Hirsch, Vanessa; Villinger, Francois; Ansari, Aftab A.; Kimura, Akinori; Miyazawa, Masaaki; Suzuki, Yasuo; Yamamoto, Naoki; Nagai, Yoshiyuki; Mori, Kazuyasu			Protection of Macaques with Diverse MHC Genotypes against a Heterologous SIV by Vaccination with a Deglycosylated Live-Attenuated SIV	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; CLASS-I; RHESUS MACAQUES; REPLICATION; SIVMAC239; NEUTRALIZATION; INFECTION; AIDS; GLYCOSYLATION	HIV vaccine development has been hampered by issues such as undefined correlates of protection and extensive diversity of HIV. We addressed these issues using a previously established SIV-macaque model in which SIV mutants with deletions of multiple gp120 N-glycans function as potent live attenuated vaccines to induce near-sterile immunity against the parental pathogenic SIVmac239. In this study, we investigated the protective efficacy of these mutants against a highly pathogenic heterologous SIVsmE543-3 delivered intravenously to rhesus macaques with diverse MHC genotypes. All 11 vaccinated macaques contained the acute-phase infection with blood viral loads below the level of detection between 4 and 10 weeks postchallenge (pc), following a transient but marginal peak of viral replication at 2 weeks in only half of the challenged animals. In the chronic phase, seven vaccinees contained viral replication for over 80 weeks pc, while four did not. Neutralizing antibodies against challenge virus were not detected. Although overall levels of SIV specific T cell responses did not correlate with containment of acute and chronic viral replication, a critical role of cellular responses in the containment of viral replication was suggested. Emergence of viruses with altered fitness due to recombination between the vaccine and challenge viruses and increased gp120 glycosylation was linked to the failure to control SIV. These results demonstrate the induction of effective protective immune responses in a significant number of animals against heterologous virus by infection with deglycosylated attenuated SIV mutants in macaques with highly diverse MHC background. These findings suggest that broad HIV cross clade protection is possible, even in hosts with diverse genetic backgrounds. In summary, results of this study indicate that deglycosylated live-attenuated vaccines may provide a platform for the elucidation of correlates of protection needed for a successful HIV vaccine against diverse isolates.	[Sugimoto, Chie; Watanabe, Satoru; Shiino, Teiichiro; Ueda, Kayoko; Sato, Hirotaka; Yamamoto, Naoki; Mori, Kazuyasu] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Sugimoto, Chie; Watanabe, Satoru; Ueda, Kayoko; Sato, Hirotaka; Mori, Kazuyasu] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan; [Sugimoto, Chie; Suzuki, Yasuo; Mori, Kazuyasu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Naruse, Taeko; Kimura, Akinori] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Div Med Sci,Chiyoda Ku, Tokyo, Japan; [Kajiwara, Eiji; Umano, Natsuko; Miyazawa, Masaaki] Kinki Univ, Sch Med, Dept Immunol, Osaka 589, Japan; [Ohgimoto, Shinji] Osaka City Univ, Grad Sch Med, Dept Virol, Abeno Ku, Osaka 558, Japan; [Hirsch, Vanessa] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Villinger, Francois; Ansari, Aftab A.; Mori, Kazuyasu] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Villinger, Francois] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Aichi, Japan; [Nagai, Yoshiyuki] RIKEN, Ctr Res Network Infect Dis, Chiyoda Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Kindai University (Kinki University); Osaka Metropolitan University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Emory University; Chubu University; RIKEN	Sugimoto, C (corresponding author), Tulane Natl Primate Res Ctr, Div Immunol, Covington, LA USA.	mori@nibio.go.jp	Kimura, Akinori/I-5989-2018; Miyazawa, Masaaki/AAA-3916-2020; Naruse, Taeko/ABA-3089-2021	Kimura, Akinori/0000-0002-4933-2132; Miyazawa, Masaaki/0000-0002-7300-119X; Yasuo, Suzuki/0000-0003-3518-5642; Mori, Kazuyasu/0000-0002-1841-6376; Sato, Hirotaka/0000-0002-8321-9731	Health Sciences Research Grants; Ministry of Health, Labor, and Welfare in Japan; Ministry of Education, Culture, Sports, Science and Technology in Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000686] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390143] Funding Source: KAKEN	Health Sciences Research Grants; Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by AIDS research grants from the Health Sciences Research Grants, from the Ministry of Health, Labor, and Welfare in Japan, and from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetrei C, 2005, J VIROL, V79, P8991, DOI 10.1128/JVI.79.14.8991-9005.2005; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hendel H, 1999, J IMMUNOL, V162, P6942; Hirsch V, 1997, J VIROL, V71, P1608, DOI 10.1128/JVI.71.2.1608-1620.1997; Johnson WE, 2003, J VIROL, V77, P9993, DOI 10.1128/JVI.77.18.9993-10003.2003; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kim EY, 2005, J VIROL, V79, P4886, DOI 10.1128/JVI.79.8.4886-4895.2005; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Means RE, 1997, J VIROL, V71, P7895, DOI 10.1128/JVI.71.10.7895-7902.1997; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mori K, 2005, J VIROL, V79, P10386, DOI 10.1128/JVI.79.16.10386-10396.2005; Mori K, 2001, J VIROL, V75, P4023, DOI 10.1128/JVI.75.9.4023-4028.2001; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Ohgimoto S, 1998, J VIROL, V72, P8365, DOI 10.1128/JVI.72.10.8365-8370.1998; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Sugimoto C, 2003, J VIROL, V77, P4169, DOI 10.1128/JVI.77.7.4169-4180.2003; Sugimoto C, 2008, J GEN VIROL, V89, P554, DOI 10.1099/vir.0.83186-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsukamoto T, 2008, AIDS, V22, P993, DOI 10.1097/QAD.0b013e3282f88d1b; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	31	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11678	10.1371/journal.pone.0011678	http://dx.doi.org/10.1371/journal.pone.0011678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652030	Green Published, Green Submitted, gold			2022-12-25	WOS:000280109700010
J	Sheeba, V; Fogle, KJ; Holmes, TC				Sheeba, Vasu; Fogle, Keri J.; Holmes, Todd C.			Persistence of Morning Anticipation Behavior and High Amplitude Morning Startle Response Following Functional Loss of Small Ventral Lateral Neurons in Drosophila	PLOS ONE			English	Article							PIGMENT-DISPERSING FACTOR; CIRCADIAN PACEMAKER NEURONS; PDF NEURONS; HUNTINGTONS-DISEASE; CLOCK NEURONS; RHYTHMS; MELANOGASTER; NEUROPEPTIDE; CELLS; OSCILLATOR	Light-activated large ventral lateral clock neurons (large LNv) modulate behavioral arousal and sleep in Drosophila while their counterparts, the small LNv (s-LNv) are important for circadian behavior. Recently, it has been proposed that the pattern of day-night locomotor behavioral activity is mediated by two anatomically distinct oscillators composed of a morning oscillator in the small LNv and an evening oscillator in the lateral dorsal neurons and an undefined number of dorsal pacemaker neurons. This contrasts with a circuit described by network models which are not as anatomically constrained. By selectively ablating the small LNv while sparing the large LNv, we tested the relative importance of the small and large LNv for regulating morning behavior of animals living in standard light/dark cycles. Behavioral anticipation of the onset of morning and the high amplitude morning startle response which coincides with light onset are preserved in small LNv functionally-ablated animals. However, the amplitude of the morning behavioral peak is severely attenuated in these animals during the transition from regular light/dark cycles to constant darkness, providing further support that small LNv are necessary for circadian behavior. The large LNv, in combination with the network of other circadian neurons, in the absence of functional small LNv are sufficient for the morning anticipation and the high amplitude light-activated morning startle response.	[Sheeba, Vasu; Fogle, Keri J.; Holmes, Todd C.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA	University of California System; University of California Irvine	Sheeba, V (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	tholmes@uci.edu		Holmes, Todd/0000-0001-8152-8832; Vasu, Sheeba/0000-0003-2924-7130	National Science Foundation (NSF) [IBN-0757242]; National Institutes of Health (NIH) [NS046750]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046750] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation (NSF) grant IBN-0757242 (www.nsf.gov), and National Institutes of Health (NIH) grant NS046750 (www.nih.gov) to TCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Cusumano P, 2009, NAT NEUROSCI, V12, P1431, DOI 10.1038/nn.2429; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Gu HY, 2006, J NEUROSCI, V26, P265, DOI 10.1523/JNEUROSCI.4109-05.2006; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; Holmes TC, 2007, COLD SPRING HARB MON, V49, P19; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kadener S, 2006, P NATL ACAD SCI USA, V103, P13537, DOI 10.1073/pnas.0605962103; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Petri B, 1997, J NEUROSCI, V17, P4087; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Quintero JE, 2003, J NEUROSCI, V23, P8070; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Shafer OT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008298; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sheeba V, 2008, CRIT REV BIOCHEM MOL, V43, P37, DOI [10.1080/10409230701829128, 10.1080/10409230701829128 ]; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Taghert PH, 2006, J BIOL RHYTHM, V21, P445, DOI 10.1177/0748730406293910; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wu Y, 2008, PLOS BIOL, V6, P2512, DOI 10.1371/journal.pbio.0060273; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984; Wulbeck C, 2008, J BIOL RHYTHM, V23, P409, DOI 10.1177/0748730408322699; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; ZHANG L, CURR BIOL, V20, P591; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	63	47	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11628	10.1371/journal.pone.0011628	http://dx.doi.org/10.1371/journal.pone.0011628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661292	Green Published, gold			2022-12-25	WOS:000279980800016
J	Liu, QQ; Gauthier, MS; Sun, L; Ruderman, N; Lodish, H				Liu, Qingqing; Gauthier, Marie-Soleil; Sun, Lei; Ruderman, Neil; Lodish, Harvey			Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio	FASEB JOURNAL			English	Article						acyl-CoA synthetases; adipokine	FATTY-ACID TRANSPORT; SKELETAL-MUSCLE CELLS; MEMBRANE-TRANSPORT; PLASMA-MEMBRANE; GLUCOSE-UPTAKE; OXIDATION; METABOLISM; CARBOXYLASE; INHIBITION; EXPRESSION	Adiponectin activates AMP-activated protein kinase (AMPK) in adipocytes, but the underlying mechanism remains unclear. Here we tested the hypothesis that AMP, generated in activating fatty acids to their CoA derivatives, catalyzed by acyl-CoA synthetases, is involved in AMPK activation by adiponectin. Moreover, in adipocytes, insulin affects the subcellular localization of acyl-CoA synthetase FATP1. Thus, we also tested whether insulin activates AMPK in these cells and, if so, whether it activates through a similar mechanism. We examined these hypotheses by measuring the AMP/ATP ratio and AMPK activation on adiponectin and insulin stimulation and after knocking down acyl-CoA synthetases in adipocytes. We show that adiponectin activation of AMPK is accompanied by an similar to 2-fold increase in the cellular AMP/ATP ratio. Moreover, FATP1 and Acsl1, the 2 major acyl-CoA synthetase isoforms in adipocytes, are essential for AMPK activation by adiponectin. We also show that after 40 min. insulin activated AMPK in adipocytes, which was coupled with a 5-fold increase in the cellular AMP/ATP ratio. Knockdown studies show that FATP1 and Acsl1 are required for these processes, as well as for stimulation of long-chain fatty acid uptake by adiponection and insulin. These studies demonstrate that a change in cellular energy state is associated with AMPK activation by both adiponectin and insulin, which requires the activity of FATP1 and Acsl1.-Liu, Q., Gauthier, M.-L., Sun, L., Ruderman, N., Lodish, H. Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio. FASEB J. 24, 4229-4239 (2010). www.fasebj.org	[Liu, Qingqing; Sun, Lei; Lodish, Harvey] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gauthier, Marie-Soleil; Ruderman, Neil] Boston Univ, Sch Med, Dept Med, Endocrinol Sect,Diabet Res Unit, Boston, MA 02118 USA; [Lodish, Harvey] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Boston University; Massachusetts Institute of Technology (MIT)	Lodish, H (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	lodish@wi.mit.edu	liu, qingqing/HHD-0360-2022	Ruderman, Neil/0000-0002-6589-6587	American Diabetes Association [7-04-MN-27]; National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases [2R01 DK0467618-20]; NIH/National Heart, Lung, and Blood Institute [P01 HL 066105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Tsu-Shuen Tsao (University of Arizona, Tucson, AZ, USA) for providing the adiponectin C22A expression vector, Dr. Kelly Wong and Dr. Yutong Sun for insightful discussions and critical reading of the manuscript, and Dr. Julia Xu for technical assistance for nucleotide studies. This work was supported by a mentor-based fellowship from the American Diabetes Association, award 7-04-MN-27; National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases grant 2R01 DK0467618-20 (to H.F.L.); and NIH/National Heart, Lung, and Blood Institute grant P01 HL 066105 (to M.K.).	Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; Black Paul N, 2007, Novartis Found Symp, V286, P127; BLACK PN, 2007, NOVART FDN SYMP, V286, P162; BLACK PN, 2007, NOVART FDN SYMP, V286, P138; BLACK PN, 2007, NOVART FDN SYMP, V286, P196; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Folmes CDL, 2006, CIRC RES, V99, P61, DOI 10.1161/01.RES.0000229656.05244.11; Gamble J, 1997, METABOLISM, V46, P1270, DOI 10.1016/S0026-0495(97)90229-8; Gargiulo CE, 1999, J LIPID RES, V40, P881; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; HESLER CB, 1990, J BIOL CHEM, V265, P6600; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Koh HJ, 2007, BIOCHEM J, V403, P473, DOI 10.1042/BJ20061479; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Passonneau J. V., 1993, ENZYMATIC ANAL PRACT, p[157, 272]; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; RODBELL M, 1964, J BIOL CHEM, V239, P375; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Suzuki S, 2007, FEBS LETT, V581, P809, DOI 10.1016/j.febslet.2007.01.046; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Watkins PA, 1997, PROG LIPID RES, V36, P55, DOI 10.1016/S0163-7827(97)00004-0; Wiczer BM, 2009, BIOCHEM BIOPH RES CO, V387, P234, DOI 10.1016/j.bbrc.2009.06.114; Winder WW, 2000, J APPL PHYSIOL, V89, P2430, DOI 10.1152/jappl.2000.89.6.2430; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Wong KA, 2006, J BIOL CHEM, V281, P36434, DOI 10.1074/jbc.M607410200; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Wu XD, 2003, DIABETES, V52, pA1; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	60	53	53	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4229	4239		10.1096/fj.10-159723	http://dx.doi.org/10.1096/fj.10-159723			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20667975	Green Published			2022-12-25	WOS:000283861100011
J	Wang, XC; Blanchard, J; Kohlbrenner, E; Clement, N; Linden, RM; Radu, A; Grundke-Iqbal, I; Iqbal, K				Wang, Xiaochuan; Blanchard, Julie; Kohlbrenner, Erik; Clement, Nathalie; Linden, R. Michael; Radu, Aurelian; Grundke-Iqbal, Inge; Iqbal, Khalid			The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment	FASEB JOURNAL			English	Article						A beta; adeno-associated virus-induced expression; glycogen synthase kinase-3 beta; hyperphosphorylation of tau; neurofibrillary degeneration; nontransgenic rat model of Alzheimer disease; SET	GLYCOGEN-SYNTHASE KINASE-3-BETA; ABNORMALLY PHOSPHORYLATED-TAU; INCREASES PHOSPHORYLATION; KINASE 3-BETA; UP-REGULATION; P70 S6; 2A; HYPERPHOSPHORYLATION; ACTIVATION; BRAIN	Development of rational therapeutic treatments of Alzheimer disease (AD) requires the elucidation of the etiopathogenic mechanisms of neurofibrillary degeneration and beta-amyloidosis, the two hallmarks of this disease. Here we show, employing an adeno-associated virus serotype 1 (AAV1)-induced expression of the C-terminal fragment (I-2CTF) of I-2(PP2A), also called SET, in rat brain, decrease in protein phosphatase 2A (PP2A) activity, abnormal hyperphosphorylation of tau, and neurodegeneration; littermates treated identically but with vector only, i.e., AAV1-enhanced green fluorescent protein (GFP), served as a control. Furthermore, there was an increase in the level of activated glycogen synthase kinase-3 beta and enhanced expression of intraneuronal A beta in AAV1-I-2CTF animals. Morris water maze behavioral test revealed that infection with AAV1-I-2CTF induced spatial reference memory and memory consolidation deficits and a decrease in the brain level of pSer133-CREB. These findings suggest a novel etiopathogenic mechanism of AD, which is initiated by the cleavage of I-2(PP2A), producing I-2CTF, and describe a novel disease-relevant nontransgenic animal model of AD.-Wang, X., Blanchard, J., Kohlbrenner, E., Clement, N., Linden, R. M., Radu, A., Grundke-Iqbal, I., Iqbal, K. The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment. FASEB J. 24, 4420-4432 (2010). www.fasebj.org	[Wang, Xiaochuan; Blanchard, Julie; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Kohlbrenner, Erik; Clement, Nathalie; Linden, R. Michael] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA; [Radu, Aurelian] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA	Institute for Basic Research in Developmental Disabilities; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com			New York State Office of Mental Retardation and Developmental Disabilities; National Institutes of Health/National Institute of Aging [AG019158]; National Natural Science Foundation of China [30871259]; Education Ministry of China [NCET-07-0332]; NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER	New York State Office of Mental Retardation and Developmental Disabilities; National Institutes of Health/National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Ministry of China(Ministry of Education, China); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to Dr. Jian-Zhi Wang (Tongji Medical College, Wuhan, China) for a kind gift of HEK293/tau cells; to Drs. Fei Liu, Bin Li, and Guo-Hua Fan for helpful technical suggestions during the conduct of this study; to Dr. Ezzat El-Akkad for preparation of digital images; and to Ms. Janet Murphy for secretarial assistance. This work was supported in part by the New York State Office of Mental Retardation and Developmental Disabilities and a research grant from the National Institutes of Health/National Institute of Aging, grant AG019158, and a 1-yr fellowship to Dr. Xiaochuan Wang from the National Natural Science Foundation of China (30871259) and the Education Ministry of China (NCET-07-0332). Author contributions: X.W. performed most of the experiments and analyses; J.B. carried out some of the immunohistochemical and all behavioral studies and analyses; E. K., N.C., and R.M.L. generated recombinant AAV1 and did the vector packaging and tittering; A.R. directed the generation of the I<INF>2CTF</INF> recombinant plasmids; I.G.I. directed and analyzed all immunohistochemical and immunochemical studies and the preparation of the manuscript; K.I. designed and oversaw the research project and directed most of the experiments, analyses, and writing.	ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Alonso AD, 2006, P NATL ACAD SCI USA, V103, P8864, DOI 10.1073/pnas.0603214103; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Avila J, 2010, EXPERT REV NEUROTHER, V10, P703, DOI 10.1586/ERN.10.40; Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/14728222.7.1.101; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; GANDY SE, 1993, ANN NY ACAD SCI, V695, P117, DOI 10.1111/j.1749-6632.1993.tb23038.x; Gantier R, 2000, NEUROSCI LETT, V283, P217, DOI 10.1016/S0304-3940(00)00949-6; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; Henckaerts E, 2009, P NATL ACAD SCI USA, V106, P7571, DOI 10.1073/pnas.0806821106; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2005, ANN NEUROL, V58, P748, DOI 10.1002/ana.20639; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Lawlor PA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-11; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu GP, 2008, NEUROBIOL AGING, V29, P1348, DOI 10.1016/j.neurobiolaging.2007.03.012; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Michel G, 1998, BBA-GEN SUBJECTS, V1380, P177, DOI 10.1016/S0304-4165(97)00139-6; Nicolia V, 2010, J ALZHEIMERS DIS, V19, P895, DOI 10.3233/JAD-2010-1284; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Pei JJ, 1998, J NEURAL TRANSM, V105, P69, DOI 10.1007/s007020050039; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sengupta A, 2006, NEUROCHEM RES, V31, P1473, DOI 10.1007/s11064-006-9205-9; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sontag JM, 2008, J NEUROSCI, V28, P11477, DOI 10.1523/JNEUROSCI.2816-08.2008; Sun L, 2003, NEUROSCIENCE, V118, P1175, DOI 10.1016/S0306-4522(02)00697-8; Suzuki T, 1997, BIOCHEMISTRY-US, V36, P4643, DOI 10.1021/bi962618k; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Zhang YH, 2005, FEBS LETT, V579, P6230, DOI 10.1016/j.febslet.2005.09.095; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	61	69	74	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4420	4432		10.1096/fj.10-158477	http://dx.doi.org/10.1096/fj.10-158477			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20651003	Green Published			2022-12-25	WOS:000283861100028
J	Canals, D; Jenkins, RW; Roddy, P; Hernandez-Corbacho, MJ; Obeid, LM; Hannun, YA				Canals, Daniel; Jenkins, Russell W.; Roddy, Patrick; Hernandez-Corbacho, Maria Jose; Obeid, Lina M.; Hannun, Yusuf A.			Differential Effects of Ceramide and Sphingosine 1-Phosphate on ERM Phosphorylation PROBING SPHINGOLIPID SIGNALING AT THE OUTER PLASMA MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL-MIGRATION; ACTIN-BINDING; EZRIN; CYTOSKELETON; MOESIN; SPHINGOMYELIN; CARCINOMA; CANCER; PHASE	ERM proteins are regulated by phosphorylation of the most C-terminal threonine residue, switching them from an activated to an inactivated form. However, little is known about the control of this regulation. Previous work in our group demonstrated that secretion of acid sphingomyelinase acts upstream of ERM dephosphorylation, suggesting the involvement of sphingomyelin (SM) hydrolysis in ERM regulation. To define the role of specific lipids, we employed recombinant bacterial sphingomyelinase (bSMase) as a direct probe of SM metabolism at the plasma membrane. bSMase induced a rapid dose-and time-dependent decrease in ERM dephosphorylation. ERM dephosphorylation was driven by ceramide generation and not by sphingomyelin depletion, as shown using recombinant sphingomyelinase D. The generation of ceramide at the plasma membrane was sufficient for ERM regulation, and no intracellular SM hydrolysis was required, as was visualized using Venus-tagged lysenin probe, which specifically binds SM. Interestingly, hydrolysis of plasma membrane bSMase-induced ceramide using bacterial ceramidase caused ERM hyperphosphorylation and formation of cell surface protrusions. The effects of plasma membrane ceramide hydrolysis were due to sphingosine 1-phosphate formation, as ERM phosphorylation was blocked by an inhibitor of sphingosine kinase and induced by sphingosine 1-phosphate. Taken together, these results demonstrate a new regulatory mechanism of ERM phosphorylation by sphingolipids with opposing actions of ceramide and sphingosine 1-phosphate. The approach also defines a tool kit to probe sphingolipid signaling at the plasma membrane.	[Canals, Daniel; Jenkins, Russell W.; Roddy, Patrick; Hernandez-Corbacho, Maria Jose; Obeid, Lina M.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAW-1998-2021; Garcia-Caro, Pedro/A-4238-2010; Canals, Daniel/AAJ-8176-2021	Canals, Daniel/0000-0002-9293-5123; Garcia-Caro, Pedro/0000-0002-5064-0845; obeid, lina/0000-0002-0734-0847	National Institutes of Health [CA87584, CA97132]; NATIONAL CANCER INSTITUTE [R01CA087584, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA87584 and CA97132.	Abiatari I, 2010, J CELL MOL MED, V14, P1166, DOI 10.1111/j.1582-4934.2009.00772.x; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chigorno V, 2005, J BIOL CHEM, V280, P2668, DOI 10.1074/jbc.M407749200; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Contreras F. -Xabier, 2009, V462, P155, DOI 10.1007/978-1-60327-115-8_10; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; Fais S, 2003, J LEUKOCYTE BIOL, V73, P556, DOI 10.1189/jlb.1102568; French KJ, 2003, CANCER RES, V63, P5962; Gassert E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000623; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Hla T, 2004, PROSTAG OTH LIPID M, V73, P1, DOI 10.1016/j.prostaglandins.2003.11.001; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Liu X, 2008, FRONT BIOSCI-LANDMRK, V13, P2293, DOI 10.2741/2843; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; MeivarLevy I, 1997, J BIOL CHEM, V272, P1558, DOI 10.1074/jbc.272.3.1558; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Pohl A, 2009, MOL MEMBR BIOL, V26, P194, DOI 10.1080/09687680902733815; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Smith ER, 2000, METHOD ENZYMOL, V312, P361; Takenouchi H, 2004, J CELL SCI, V117, P3911, DOI 10.1242/jcs.01246; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Yu H, 2009, GENES CELLS, V14, P597, DOI 10.1111/j.1365-2443.2009.01295.x; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	46	55	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32476	32485		10.1074/jbc.M110.141028	http://dx.doi.org/10.1074/jbc.M110.141028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679347	hybrid, Green Published			2022-12-25	WOS:000282683000061
J	El Hiani, Y; Linsdell, P				El Hiani, Yassine; Linsdell, Paul			Changes in Accessibility of Cytoplasmic Substances to the Pore Associated with Activation of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CL-CHANNEL; CONFORMATIONAL-CHANGES; ION-CHANNEL; CFTR; BINDING; CYSTEINE; ARCHITECTURE; PERMEATION; VESTIBULE	Opening of the cystic fibrosis transmembrane conductance regulator Cl- channel is dependent both on phosphorylation and on ATP binding and hydrolysis. However, the mechanisms by which these cytoplasmic regulatory factors open the Cl- channel pore are not known. We have used patch clamp recording to investigate the accessibility of cytoplasmically applied cysteine-reactive reagents to cysteines introduced along the length of the pore-lining sixth transmembrane region (TM6) of a cysteine-less variant of cystic fibrosis transmembrane conductance regulator. We find that methanethiosulfonate (MTS) reagents modify irreversibly cysteines substituted for TM6 residues Phe-337, Thr-338, Ser-341, Ile-344, Val-345, Met-348, Ala-349, Arg-352, and Gln-353 when applied to the cytoplasmic side of open channels. However, the apparent rate of modification by internal [2-sulfonatoethyl] methanethiosulfonate (MTSES), a negatively charged MTS reagent, is dependent on the activation state of the channels. In particular, cysteines introduced far along the axis of TM6 from the inside (T338C, S341C, I344C) showed no evidence of significant modification even after prolonged pretreatment of non-activated channels with internal MTSES. In contrast, cysteines introduced closer to the inside of TM6 (V345C, M348C) were readily modified in both activated and non-activated channels. Access of a per-meant anion, Au(CN)(2)(-), to T338C was similarly dependent upon channel activation state. The pattern of MTS modification we observe allows us to designate different pore-lining amino acid side chains to distinct functional regions of the channel pore. One logical interpretation of these findings is that cytoplasmic access to residues at the narrowest region of the pore changes concomitant with activation.	[El Hiani, Yassine; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 1X5, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 1X5, Canada.	paul.linsdell@dal.ca		Linsdell, Paul/0000-0001-6257-6273; El Hiani, Yassine/0000-0002-1251-5066	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	AKABAS MH, 1994, J BIOL CHEM, V269, P14865; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fatehi M, 2008, J BIOL CHEM, V283, P6102, DOI 10.1074/jbc.M707736200; Fatehi M, 2009, J MEMBRANE BIOL, V228, P151, DOI 10.1007/s00232-009-9167-3; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Gong XD, 2003, J GEN PHYSIOL, V122, P673, DOI 10.1085/jgp.200308889; Gong XD, 2002, J PHYSIOL-LONDON, V540, P39, DOI 10.1113/jphysiol.2001.013235; Hug MJ, 2003, NEWS PHYSIOL SCI, V18, P38, DOI 10.1152/nips.01412.2002; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 2002, J PHYSIOL-LONDON, V540, P29, DOI 10.1113/jphysiol.2001.013234; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Liu XH, 2004, BIOPHYS J, V87, P3826, DOI 10.1529/biophysj.104.050534; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McCarty NA, 2000, J EXP BIOL, V203, P1947; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Miller C, 2010, P NATL ACAD SCI USA, V107, P959, DOI 10.1073/pnas.0913576107; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; Pilewski JM, 1999, PHYSIOL REV, V79, P215; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Serrano JR, 2006, BIOPHYS J, V91, P1737, DOI 10.1529/biophysj.105.078899; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Tang L, 2009, J CYST FIBROS, V8, P115, DOI 10.1016/j.jcf.2008.10.004; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Xu YP, 2009, P NATL ACAD SCI USA, V106, P20515, DOI 10.1073/pnas.0911412106; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	59	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32126	32140		10.1074/jbc.M110.113332	http://dx.doi.org/10.1074/jbc.M110.113332			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20675380	hybrid, Green Published			2022-12-25	WOS:000282683000026
J	Ortuno, MJ; Ruiz-Gaspa, S; Rodriguez-Carballo, E; Susperregui, ARG; Bartrons, R; Rosa, JL; Ventura, F				Jose Ortuno, Maria; Ruiz-Gaspa, Silvia; Rodriguez-Carballo, Edgardo; Susperregui, Antonio R. G.; Bartrons, Ramon; Luis Rosa, Jose; Ventura, Francesc			p38 Regulates Expression of Osteoblast-specific Genes by Phosphorylation of Osterix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR OSTERIX; ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEINS; MESENCHYMAL STEM-CELLS; OSTEOCALCIN GENE; MINERAL DENSITY; TRANSGENIC MICE; UP-REGULATION; DIFFERENTIATION; PROMOTER	Osterix, a zinc finger transcription factor, is specifically expressed in osteoblasts and osteocytes of all developing bones. Because no bone formation occurs in Osx-null mice, Osterix is thought to be an essential regulator of osteoblast differentiation. We report that, in several mesenchymal and osteoblastic cell types, BMP-2 induces an increase in expression of the two isoforms of Osterix arising from two alternative promoters. We identified a consensus Sp1 sequence (GGGCGG) as Osterix binding regions in the fibromodulin and the bone sialoprotein promoters in vitro and in vivo. Furthermore, we show that Osterix is a novel substrate for p38 MAPK in vitro and in vivo and that Ser-73 and Ser-77 are the regulatory sites phosphorylated by p38. Our data also demonstrate that Osterix is able to increase recruitment of p300 and Brg1 to the promoters of its target genes fibromodulin and bone sialoprotein in vivo and that it directly associates with these cofactors through protein-protein interactions. Phosphorylation of Osterix at Ser-73/77 increased its ability to recruit p300 and SWI/SNF to either fibromodulin or bone sialoprotein promoters. We therefore propose that Osterix binds to Sp1 sequences on target gene promoters and that its phosphorylation by p38 enhances recruitment of coactivators to form transcriptionally active complexes.	[Jose Ortuno, Maria; Ruiz-Gaspa, Silvia; Rodriguez-Carballo, Edgardo; Susperregui, Antonio R. G.; Bartrons, Ramon; Luis Rosa, Jose; Ventura, Francesc] Univ Barcelona, Dept Ciencias Fisiol 2, IDIBELL, E-08907 Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Ventura, F (corresponding author), Univ Barcelona, Dept Ciencias Fisiol 2, IDIBELL, C Feixa Llarga S-N, E-08907 Barcelona, Spain.	fventura@ub.edu	Ventura, Francesc/ABG-2285-2020; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Rodriguez-Carballo, Eddie/0000-0003-4321-508X; Bartrons, Ramon/0000-0001-9349-5847; Ortuno Romero, Maria Jose/0000-0002-0200-9952	Ministerio de Educacion y Ciencia (MEC) [BFU2008-02010]; Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud [RD06/0020]; University of Barcelona; IDIBELL	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud(Instituto de Salud Carlos III); University of Barcelona; IDIBELL	This work was supported in part by Ministerio de Educacion y Ciencia (MEC) Grant BFU2008-02010 and Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud Grant RD06/0020.; Recipient of a fellowship from the University of Barcelona.; Recipient of a fellowship from the IDIBELL.	Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Caverzasio J, 2008, J BONE MINER RES, V23, P1389, DOI 10.1359/JBMR.080410; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen JK, 1996, J BONE MINER RES, V11, P654; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fan DW, 2007, J CELL PHYSIOL, V211, P577, DOI 10.1002/jcp.21016; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hatta M, 2006, INT J MOL MED, V17, P425; Jin HL, 2009, HUM MOL GENET, V18, P2729, DOI 10.1093/hmg/ddp205; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Lee HW, 2008, J BONE MINER RES, V23, P1227, DOI 10.1359/JBMR.080325; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee JY, 2006, MOL CELLS, V22, P182; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Milona M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-43; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0; Okamura H, 2009, BIOCHEM BIOPH RES CO, V379, P440, DOI 10.1016/j.bbrc.2008.12.094; Paz J, 2005, MATRIX BIOL, V24, P341, DOI 10.1016/j.matbio.2005.05.009; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Sun FY, 2009, NUCLEIC ACIDS RES, V37, P3897, DOI 10.1093/nar/gkp261; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhao YH, 2008, EUR J ORAL SCI, V116, P199, DOI 10.1111/j.1600-0722.2008.00533.x	56	101	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31985	31994		10.1074/jbc.M110.123612	http://dx.doi.org/10.1074/jbc.M110.123612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20682789	Green Published, hybrid			2022-12-25	WOS:000282683000011
J	Eckert, K; Saliou, JM; Monlezun, L; Vigouroux, A; Atmane, N; Caillat, C; Quevillon-Cheruel, S; Madiona, K; Nicaise, M; Lazereg, S; Van Dorsselaer, A; Sanglier-Cianferani, S; Meyer, P; Morera, S				Eckert, Kelvin; Saliou, Jean-Michel; Monlezun, Laura; Vigouroux, Armelle; Atmane, Noureddine; Caillat, Christophe; Quevillon-Cheruel, Sophie; Madiona, Karine; Nicaise, Magali; Lazereg, Sylvie; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah; Meyer, Philippe; Morera, Solange			The Pih1-Tah1 Cochaperone Complex Inhibits Hsp90 Molecular Chaperone ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; PROTEIN; BINDING; HYDROLYSIS; DIMERIZATION; ACTIVATION; MECHANISM; SYSTEM; NOP17P; STI1	Hsp90 (heat shock protein 90) is an ATP-dependent molecular chaperone regulated by collaborating proteins called cochaperones. This machinery is involved in the conformational activation of client proteins like signaling kinases, transcription factors, or ribonucleoproteins (RNP) such as telomerase. TPR (TetratricoPeptide Repeat)-containing protein associated with Hsp90 (Tah1) and protein interacting with Hsp90 (Pih1) have been identified in Saccharomyces cerevisiae as two Hsp90 cochaperones involved in chromatin remodeling complexes and small nucleolar RNP maturation. Tah1 possesses a minimal TPR domain and binds specifically to the Hsp90 C terminus, whereas Pih1 displays no homology to other protein motifs and has been involved in core RNP protein interaction. While Pih1 alone was unstable and was degraded from its N terminus, we showed that Pih1 and Tah1 form a stable heterodimeric complex that regulates Hsp90 ATPase activity. We used different biophysical approaches such as analytical ultracentrifugation, microcalorimetry, and noncovalent mass spectrometry to characterize the Pih1-Tah1 complex and its interaction with Hsp90. We showed that the Pih1-Tah1 heterodimer binds to Hsp90 with a similar affinity and the same stoichiometry as Tah1 alone. However, the Pih1-Tah1 complex antagonizes Tah1 activity on Hsp90 and inhibits the chaperone ATPase activity. We further identified the region within Pih1 responsible for interaction with Tah1 and inhibition of Hsp90, allowing us to suggest an interaction model for the Pih1-Tah1/Hsp90 complex. These results, together with previous reports, suggest a role for the Pih1-Tah1 cochaperone complex in the recruitment of client proteins such as core RNP proteins to Hsp90.	[Caillat, Christophe; Madiona, Karine] CNRS, LEBS, F-91198 Gif Sur Yvette, France; [Saliou, Jean-Michel; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah] Univ Strasbourg, IPHC, Lab Spectrometrie Masse BioOrgan, F-67087 Strasbourg, France; [Quevillon-Cheruel, Sophie; Nicaise, Magali] Univ Paris Sud, IBBMC, CNRS, F-91405 Orsay, France; [Lazereg, Sylvie] CNRS, ICSN, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay		meyer@lebs.cnrs-gif.fr; morera@lebs.cnrs-gif.fr	Meyer, Philippe/AAC-6038-2019	Meyer, Philippe/0000-0002-6220-0679; MONLEZUN, Laura/0000-0003-4661-3366; christophe, caillat/0000-0003-2959-1871; morera, solange/0000-0001-7781-0448; Cianferani, Sarah/0000-0003-4013-4129	CNRS; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; University of Strasbourg UdS; Region Alsace; Agence Nationale pour la Recherche [ANR-05-JCJC, 015101]; Sidaction; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); University of Strasbourg UdS(European Commission); Region Alsace(Region Grand-Est); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Sidaction; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was funded by the CNRS, the Agence Nationale de la Recherche, the Association pour la Recherche sur le Cancer, the University of Strasbourg UdS, and the Region Alsace.; Supported by a grant from the Agence Nationale pour la Recherche (ANR-05-JCJC No. 015101) (to S. M.).; Supported by Sidaction.; Supported by the Fondation pour la Recherche Medicale.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Cantor C.R., 1980, TECHNIQUES STUDY BIO; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Millson SH, 2004, CELL STRESS CHAPERON, V9, P359, DOI 10.1379/CSC-29R1.1; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Niewiarowski A, 2010, BIOCHEM J, V429, P113, DOI 10.1042/BJ20100489; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Papin C, 2010, FEBS J, V277, P2705, DOI [10.1111/j.1742-4658.2010.07687.x, 10.1111/j.1742-464X.2010.07687.x]; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Sanglier S, 2008, METHODS MOL BIOL, V484, P217, DOI 10.1007/978-1-59745-398-1_15; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shevchenko A, 2000, ANAL CHEM, V72, P2132, DOI 10.1021/ac9913659; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sommer N, 2004, BIOCHEM BIOPH RES CO, V323, P809, DOI 10.1016/j.bbrc.2004.08.170; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061; Zhao RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009934	45	51	52	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31304	31312		10.1074/jbc.M110.138263	http://dx.doi.org/10.1074/jbc.M110.138263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663878	Green Published, hybrid			2022-12-25	WOS:000282764600025
J	Saxena, UH; Owens, L; Graham, JR; Cooper, GM; Hansen, U				Saxena, Utsav H.; Owens, Laura; Graham, Julie R.; Cooper, Geoffrey M.; Hansen, Ulla			Prolyl Isomerase Pin1 Regulates Transcription Factor LSF (TFCP2) by Facilitating Dephosphorylation at Two Serine-Proline Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; THYMIDYLATE SYNTHASE EXPRESSION; HEPATOCELLULAR-CARCINOMA; MITOGENIC STIMULATION; BINDING-ACTIVITY; SWITCH REGIONS; PHOSPHORYLATION; CELLS; ISOMERIZATION; OVEREXPRESSION	Transcription factor LSF is essential for cell cycle progression, being required for activating expression of the thymidylate synthase (Tyms) gene at the G1/S transition. We previously established that phosphorylation of LSF in early G1 at Ser-291 and Ser-309 inhibits its transcriptional activity and that dephosphorylation later in G1 is required for its reactivation. Here we reveal the role of prolyl cis-trans isomerase Pin1 in activating LSF, by facilitating dephosphorylation at both Ser-291 and Ser-309. We demonstrate that Pin1 binds LSF both in vitro and in vivo. Using coimmunoprecipitation assays, we identify three SP/TP motifs in LSF (at residues Ser-291, Ser-309, and Thr-329) that are required and sufficient for association with Pin1. Co-expression of Pin1 enhances LSF transactivation potential in reporter assays. The Pin1-dependent enhancement of LSF activity requires residue Thr-329 in LSF, requires both the WW and PPiase domains of Pin1, and correlates with hypophosphorylation of LSF at Ser-291 and Ser-309. These findings support a model in which the binding of Pin1 at the Thr-329-Pro-330 motif in LSF permits isomerization by Pin1 of the peptide bonds at the nearby phosphorylated SP motifs (Ser-291 and Ser-309) to the trans configuration, thereby facilitating their dephosphorylation.	[Saxena, Utsav H.; Owens, Laura; Graham, Julie R.; Cooper, Geoffrey M.; Hansen, Ulla] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Hansen, U (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	uhansen@bu.edu		Hansen, Ulla/0000-0001-9803-4185	Public Health Service National Institutes of Health [R01 CA-081157, R01 CA-18689]; NATIONAL CANCER INSTITUTE [R01CA018689, R01CA081157] Funding Source: NIH RePORTER	Public Health Service National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Public Health Service National Institutes of Health Grants R01 CA-081157 (to U. H.) and R01 CA-18689 (to G. M. C.).	Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Bruni P, 2002, J BIOL CHEM, V277, P35481, DOI 10.1074/jbc.M205227200; CACIOPPO R, 2007, THESIS BOSTON U; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Drouin EE, 2002, J IMMUNOL, V168, P2847, DOI 10.4049/jimmunol.168.6.2847; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; Hansen U, 2009, CELL CYCLE, V8, P2146, DOI 10.4161/cc.8.14.9089; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lippens G, 2007, FEBS J, V274, P5211, DOI 10.1111/j.1742-4658.2007.06057.x; LU KP, 1993, J BIOL CHEM, V268, P8769; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Pagon Z, 2003, J CELL BIOCHEM, V89, P733, DOI 10.1002/jcb.10549; Pang R, 2004, ONCOGENE, V23, P4182, DOI 10.1038/sj.onc.1207493; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Powell CMH, 2000, EMBO J, V19, P4665, DOI 10.1093/emboj/19.17.4665; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rasband W.S., 1997, IMAGE J; Repetny KJ, 2009, EUR J IMMUNOL, V39, P1387, DOI 10.1002/eji.200838226; Saxena UH, 2009, MOL CELL BIOL, V29, P2335, DOI 10.1128/MCB.00687-08; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Volker JL, 1997, GENE DEV, V11, P1435, DOI 10.1101/gad.11.11.1435; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Ylisastigui L, 2005, J VIROL, V79, P5952, DOI 10.1128/JVI.79.10.5952-5962.2005; Yoo BK, 2010, P NATL ACAD SCI USA, V107, P8357, DOI 10.1073/pnas.1000374107; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	36	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31139	31147		10.1074/jbc.M109.078808	http://dx.doi.org/10.1074/jbc.M109.078808			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682773	hybrid, Green Published			2022-12-25	WOS:000282764600007
J	Takekoshi, T; Tada, Y; Watanabe, T; Sugaya, M; Hoashi, T; Komine, M; Kawashima, T; Shimizu, T; Hau, CS; Asahina, A; Yokomizo, T; Sato, S; Tamaki, K				Takekoshi, Tomonori; Tada, Yayoi; Watanabe, Takahiro; Sugaya, Makoto; Hoashi, Toshihiko; Komine, Mayumi; Kawashima, Tomohiko; Shimizu, Teruo; Hau, Carren Sy; Asahina, Akihiko; Yokomizo, Takehiko; Sato, Shinichi; Tamaki, Kunihiko			Identification of a Novel Marker for Dendritic Cell Maturation, Mouse Transmembrane Protein 123	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MOLECULES; MHC CLASS-II; LANGERHANS CELLS; EXOGENOUS ANTIGENS; IL-12 PRODUCTION; LYMPH-NODES; CD40; RECEPTOR; EXPRESSION; LIGATION	Dendritic cells (DCs) are a group of professional antigen-presenting cells, and many genes are known to be associated with their maturation. We compared the transcriptional profiles of immature and mature mouse Langerhans cells using the suppressive, subtractive hybridization method and identified a novel gene of unknown function, termed herein transmembrane protein 123 (Tmem123), of which mRNA expression was enhanced in mature but not in immature Langerhans cells. Its expression was also enhanced in other mature DCs such as bone marrow-derived DCs (BMDCs) and splenic DCs. Interestingly, CD40 expression was up-regulated on mature BMDCs cultured with colchicine concurrently with the enhanced expression of Tmem123 compared with that of fresh BMDCs. Furthermore, the expression of CD40 was enhanced on Tmem123-transfected DC2.4 cells, a mouse BMDC-derived cell line, compared with that on mock-transfected DC2.4 cells. This enhancement of CD40 expression did not occur after deletion of lysosome/endosome targeting YXX phi motifs (where X is any amino acid and phi is a bulky hydrophobic amino acid) in the Tmem123 cytoplasmic tail. By stimulation with anti-CD40 monoclonal antibody, these transfectants secreted an increased amount of IL-12/23 p40 compared with mock-transfected DC2.4 cells. Thus, our study demonstrates that Tmem123 may be used as a new maturation marker in DCs and that this molecule may be closely associated with the cell surface expression of CD40.	[Tada, Yayoi; Kawashima, Tomohiko; Shimizu, Teruo; Hau, Carren Sy; Asahina, Akihiko; Sato, Shinichi] Univ Tokyo, Dept Dermatol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Komine, Mayumi] Jichi Med Univ, Grad Sch Med, Dept Dermatol, Shimotsuke, Tochigi 3290431, Japan; [Shimizu, Teruo] Teikyo Univ, Sch Med, Dept Dermatol, Itabashi Ku, Tokyo 1738605, Japan; [Asahina, Akihiko] Sagamihara Natl Hosp, Dept Dermatol, Kanagawa 2520392, Japan; [Yokomizo, Takehiko] Kyushu Univ, Japan Sci & Technol Agcy, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 8128582, Japan	University of Tokyo; Jichi Medical University; Teikyo University; Japan Science & Technology Agency (JST); Kyushu University	Tada, Y (corresponding author), Univ Tokyo, Dept Dermatol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ytada-tky@umin.ac.jp	Lee, Moo Hyun/AAK-4266-2020; 菅谷, 誠/GWC-3786-2022; Yokomizo, Takehiko/P-5673-2016; Koji, Yoshimura/J-9154-2018	Lee, Moo Hyun/0000-0002-4082-1677; Yokomizo, Takehiko/0000-0002-5219-1553; Komine, Mayumi/0000-0002-1086-1803	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. W., K. T., and T. Y.).	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cao WX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-26; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cho M, 2008, INT IMMUNOL, V20, P155, DOI 10.1093/intimm/dxm127; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Evans SJ, 2002, EUR J NEUROSCI, V16, P409, DOI 10.1046/j.1460-9568.2002.02097.x; FloresRomo L, 1997, J EXP MED, V185, P341, DOI 10.1084/jem.185.2.341; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hashimoto S, 2000, BLOOD, V96, P2206, DOI 10.1182/blood.V96.6.2206.h8002206_2206_2214; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Ma FR, 2001, P NATL ACAD SCI USA, V98, P9778, DOI 10.1073/pnas.171322898; MALLABIABARRENA A, 1995, EMBO J, V14, P2257, DOI 10.1002/j.1460-2075.1995.tb07220.x; Mizumoto N, 2005, BLOOD, V106, P3082, DOI 10.1182/blood-2005-03-1161; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Nuriya S, 1996, INT IMMUNOL, V8, P917, DOI 10.1093/intimm/8.6.917; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Riedl E, 2000, BLOOD, V96, P4276; Saeki H, 1999, J IMMUNOL, V162, P2472; Salgado CG, 1999, J INVEST DERMATOL, V113, P1021, DOI 10.1046/j.1523-1747.1999.00785.x; Shen ZH, 1997, J IMMUNOL, V158, P2723; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Tada Y, 2000, J IMMUNOL, V164, P5113, DOI 10.4049/jimmunol.164.10.5113; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Tone M, 2001, P NATL ACAD SCI USA, V98, P1751, DOI 10.1073/pnas.98.4.1751; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Tsukamoto N, 1999, P NATL ACAD SCI USA, V96, P1234, DOI 10.1073/pnas.96.4.1234; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Zhang CG, 1998, P NATL ACAD SCI USA, V95, P6290, DOI 10.1073/pnas.95.11.6290	35	8	8	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31876	31884		10.1074/jbc.M110.118877	http://dx.doi.org/10.1074/jbc.M110.118877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685650	hybrid, Green Published			2022-12-25	WOS:000282764600079
J	Brodkorb, D; Gottschall, M; Marmulla, R; Luddeke, F; Harder, J				Brodkorb, Danny; Gottschall, Matthias; Marmulla, Robert; Lueddeke, Frauke; Harder, Jens			Linalool Dehydratase-Isomerase, a Bifunctional Enzyme in the Anaerobic Degradation of Monoterpenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENITRIFYING ALCALIGENES-DEFRAGRANS; ETHYLBENZENE DEHYDROGENASE; INITIAL REACTION; ALPHA-PINENE; SP. NOV.; TRANSFORMATION; METABOLISM; BACTERIUM; EMISSIONS; PATHWAY	Castellaniella (ex Alcaligenes) defragrans strain 65Phen mineralizes monoterpenes in the absence of oxygen. Soluble cell extracts anaerobically catalyzed the isomerization of geraniol to linalool and the dehydration of linalool to myrcene. The linalool dehydratase was present in cells grown on monoterpenes, but not if grown on acetate. We purified the novel enzyme similar to 1800-fold to complete homogeneity. The native enzyme had a molecular mass of 160 kDa. Denaturing gel electrophoresis revealed one single protein band with a molecular mass of 40 kDa, which indicated a homotetramer as native conformation. The aerobically purified enzyme was anaerobically activated in the presence of 2 mM DTT. The linalool dehydratase catalyzed in vitro two reactions in both directions depending on the thermodynamic driving forces: a water secession from the tertiary alcohol linalool to the corresponding acyclic monoterpene myrcene and an isomerization of the primary allylalcohol geraniol in its stereoisomer linalool. The specific activities (V(max)) were 140 nanokatals mg(-1) for the linalool dehydratase and 410 nanokatals mg(-1) for the geraniol isomerase, with apparent K(m) values of 750 mu M and 500 mu M, respectively. The corresponding open reading frame was identified and revealed a precursor protein with a signal peptide for a periplasmatic location. The amino acid sequence did not affiliate with any described enzymes. We suggest naming the enzyme linalool dehydratase-isomerase according to its bifunctionality and placing it as a member of a new protein family within the hydrolyases (EC 4.2.1. X).	[Brodkorb, Danny; Gottschall, Matthias; Marmulla, Robert; Lueddeke, Frauke; Harder, Jens] Max Planck Inst Marine Microbiol, Dept Microbiol, D-28359 Bremen, Germany	Max Planck Society	Harder, J (corresponding author), Max Planck Inst Marine Microbiol, Dept Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	jharder@mpi-bremen.de			Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society.	AECKERSBERG F, 1991, ARCH MICROBIOL, V156, P5, DOI 10.1007/BF00418180; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Erman W.F, 1985, CHEM MONOTERPENES EN; EVANS PJ, 1992, APPL ENVIRON MICROB, V58, P496, DOI 10.1128/AEM.58.2.496-501.1992; Farooq A, 2004, CURR ORG CHEM, V8, P353, DOI 10.2174/1385272043485945; Fichan I, 1999, J CHEM ENG DATA, V44, P56, DOI 10.1021/je980070+; Forster-Fromme K, 2008, FEMS MICROBIOL LETT, V286, P78, DOI 10.1111/j.1574-6968.2008.01266.x; Foss S, 1998, SYST APPL MICROBIOL, V21, P365, DOI 10.1016/S0723-2020(98)80046-5; Foss S, 1997, FEMS MICROBIOL LETT, V149, P71, DOI 10.1016/S0378-1097(97)00057-8; Foss S, 1998, SYST APPL MICROBIOL, V21, P237, DOI 10.1016/S0723-2020(98)80028-3; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; HARDER J, 1995, APPL ENVIRON MICROB, V61, P3804, DOI 10.1128/AEM.61.11.3804-3808.1995; Harder J, 2000, BIODEGRADATION, V11, P55, DOI 10.1023/A:1026552724696; HARTMANS S, 1991, J GEN MICROBIOL, V137, P2555, DOI 10.1099/00221287-137-11-2555; Heider J, 2007, CURR OPIN CHEM BIOL, V11, P188, DOI 10.1016/j.cbpa.2007.02.027; Heyen U, 2000, APPL ENVIRON MICROB, V66, P3004, DOI 10.1128/AEM.66.7.3004-3009.2000; Heyen U, 1998, FEMS MICROBIOL LETT, V169, P67, DOI 10.1111/j.1574-6968.1998.tb13300.x; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Kamens R, 1999, ENVIRON SCI TECHNOL, V33, P1430, DOI 10.1021/es980725r; Kampfer P, 2006, INT J SYST EVOL MICR, V56, P815, DOI 10.1099/ijs.0.63989-0; Kiendler-Scharr A, 2009, NATURE, V461, P381, DOI 10.1038/nature08292; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Kniemeyer O, 2001, J BIOL CHEM, V276, P21381, DOI 10.1074/jbc.M101679200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Pare PW, 1997, NATURE, V385, P30, DOI 10.1038/385030a0; Rabus R, 2001, J BACTERIOL, V183, P1707, DOI 10.1128/JB.183.5.1707-1715.2001; SCHMID C, 1992, TREES-STRUCT FUNCT, V6, P32, DOI 10.1007/BF00224496; Sun ZT, 2009, MICROBIOL-SGM, V155, P2775, DOI 10.1099/mic.0.027623-0; Thompson ML, 2010, APPL MICROBIOL BIOT, V85, P721, DOI 10.1007/s00253-009-2182-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUDGILL PW, 1986, TERPINOID METABOLISM, P483; van der Werf MJ, 1999, APPL ENVIRON MICROB, V65, P2092; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; ZIMMERMAN PR, 1978, GEOPHYS RES LETT, V5, P679, DOI 10.1029/GL005i008p00679	38	45	63	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30436	30442		10.1074/jbc.M109.084244	http://dx.doi.org/10.1074/jbc.M109.084244			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663876	Green Published, hybrid			2022-12-25	WOS:000282135500010
J	De-la-Pena, C; Badri, DV; Lei, ZT; Watson, BS; Brandao, MM; Silva-Filho, MC; Sumner, LW; Vivanco, JM				De-la-Pena, Clelia; Badri, Dayakar V.; Lei, Zhentian; Watson, Bonnie S.; Brandao, Marcelo M.; Silva-Filho, Marcio C.; Sumner, Lloyd W.; Vivanco, Jorge M.			Root Secretion of Defense-related Proteins Is Development-dependent and Correlated with Flowering Time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENESIS-RELATED PROTEINS; PREDICTING SUBCELLULAR-LOCALIZATION; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; 2-DIMENSIONAL ELECTROPHORESIS; APOPLASTIC PROTEINS; SIGNAL EXCHANGE; GROWTH; RESISTANCE; CHITINASE	Proteins found in the root exudates are thought to play a role in the interactions between plants and soil organisms. To gain a better understanding of protein secretion by roots, we conducted a systematic proteomic analysis of the root exudates of Arabidopsis thaliana at different plant developmental stages. In total, we identified 111 proteins secreted by roots, the majority of which were exuded constitutively during all stages of development. However, defense-related proteins such as chitinases, glucanases, myrosinases, and others showed enhanced secretion during flowering. Defense-impaired mutants npr1-1 and NahG showed lower levels of secretion of defense proteins at flowering compared with the wild type. The flowering-defective mutants fca-1, stm-4, and co-1 showed almost undetectable levels of defense proteins in their root exudates at similar time points. In contrast, root secretions of defense-enhanced cpr5-2 mutants showed higher levels of defense proteins. The proteomics data were positively correlated with enzymatic activity assays for defense proteins and with in silico gene expression analysis of genes specifically expressed in roots of Arabidopsis. In conclusion, our results show a clear correlation between defense-related proteins secreted by roots and flowering time.	[Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; [Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Lei, Zhentian; Watson, Bonnie S.; Sumner, Lloyd W.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; [Brandao, Marcelo M.; Silva-Filho, Marcio C.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, BR-13400970 Piracicaba, SP, Brazil	Colorado State University; Colorado State University; Noble Research Institute; Universidade de Sao Paulo	Vivanco, JM (corresponding author), Colorado State Univ, Ctr Rhizosphere Biol, 217 Shepardson Bldg, Ft Collins, CO 80523 USA.	j.vivanco@colostate.edu	Sumner, Lloyd W/A-3270-2013; Silva-Filho, Marcio/F-2639-2012; BrandÃo, Marcelo/AAX-5691-2020; Brandão, Marcelo/C-1421-2012	Sumner, Lloyd W/0000-0002-4086-663X; Silva-Filho, Marcio/0000-0003-2129-0388; Brandão, Marcelo/0000-0001-9130-7611; Watson, Bonnie/0000-0003-2222-8156; De-la-Pena, Clelia/0000-0002-9093-9489	National Science Foundation [MCB-0542642, MCB-0950857, DBI-0109732]; Consejo Nacional de Ciencia y Tecnologia, Mexico [165181]; Samuel Roberts Noble Foundation	National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Samuel Roberts Noble Foundation	This work was supported in part by National Science Foundation Grants MCB-0542642 and MCB-0950857 (to J.M.V.).; Supported by Graduate Scholarship 165181 from Consejo Nacional de Ciencia y Tecnologia, Mexico. Present address: Unidad de Biotecnologia, Centro de Investigacion Cientifica de Yucatan, Calle 43 No. 130, Col. Chuburna de Hidalgo, C.P. 97200, Merida, Yucatan, Mexico.; Supported by The Samuel Roberts Noble Foundation.; We are grateful to the Vivanco laboratory for commenting on the manuscript and Dr. Daniel K. Manter (United States Department of Agriculture-Agricultural Research Scientist) for technical advice. The ABI QSTAR Pulsar i was supported by the National Science Foundation Grant DBI-0109732 and The Samuel Roberts Noble Foundation.	ABELES FB, 1970, PLANT PHYSIOL, V45, P395, DOI 10.1104/pp.45.4.395; Agerbirk N, 2009, PHYTOCHEM REV, V8, P101, DOI 10.1007/s11101-008-9098-0; Aires A, 2009, J APPL MICROBIOL, V106, P2096, DOI 10.1111/j.1365-2672.2009.04181.x; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Balasubrahmanyam A, 2000, PLANT SCI, V154, P13, DOI 10.1016/S0168-9452(99)00192-2; Baldwin IT, 2002, CURR OPIN PLANT BIOL, V5, P351, DOI 10.1016/S1369-5266(02)00263-7; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Basu U, 2006, PLANT SOIL, V286, P357, DOI 10.1007/s11104-006-9048-9; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chandler J, 1996, PLANT J, V10, P637, DOI 10.1046/j.1365-313X.1996.10040637.x; Charmont S, 2005, PHYTOCHEMISTRY, V66, P453, DOI 10.1016/j.phytochem.2004.12.013; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Cipollini DF, 1999, J CHEM ECOL, V25, P271, DOI 10.1023/A:1020842712349; Cole M, 2006, NUCLEIC ACIDS RES, V34, P1281, DOI 10.1093/nar/gkl016; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; Davis JM, 2002, MOL PLANT MICROBE IN, V15, P380, DOI 10.1094/MPMI.2002.15.4.380; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ESAKA M, 1990, PLANT PHYSIOL, V93, P1037, DOI 10.1104/pp.93.3.1037; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Friedrich L, 1995, PLANT MOL BIOL, V29, P959, DOI 10.1007/BF00014969; Grunwald I, 2003, PHYSIOL PLANTARUM, V119, P192, DOI 10.1034/j.1399-3054.2003.00202.x; Guan Y, 2008, J EXP BOT, V59, P3475, DOI 10.1093/jxb/ern197; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hashem FA, 2000, PHYTOTHER RES, V14, P284, DOI 10.1002/1099-1573(200006)14:4&lt;284::AID-PTR599&gt;3.0.CO;2-Y; Heil M, 2008, J CHEM ECOL, V34, P601, DOI 10.1007/s10886-008-9464-9; Hiilovaara-Teijo M, 1999, PLANT PHYSIOL, V121, P665, DOI 10.1104/pp.121.2.665; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horiuchi J, 2005, PLANTA, V222, P848, DOI 10.1007/s00425-005-0025-y; Hugot K, 1999, PLANT J, V20, P163, DOI 10.1046/j.1365-313x.1999.00587.x; Hugot K, 2004, PLANT PHYSIOL, V134, P858, DOI 10.1104/pp.103.034173; Kaplan F, 2009, J CHEM ECOL, V35, P878, DOI 10.1007/s10886-009-9670-0; KAWAOKA A, 1994, PLANT CELL REP, V13, P149, DOI 10.1007/BF00239882; Lei Z, 2005, MOL CELL PROTEOMICS, V4, P1812, DOI 10.1074/mcp.D500005-MCP200; Leitner M, 2008, PHYTOCHEMISTRY, V69, P2029, DOI 10.1016/j.phytochem.2008.04.019; LEUNG DWM, 1992, PHYTOCHEMISTRY, V31, P1899, DOI 10.1016/0031-9422(92)80330-H; LI ZC, 1990, J PLANT PHYSIOL, V136, P398, DOI 10.1016/S0176-1617(11)80026-X; LOTAN T, 1989, PLANT CELL, V1, P881, DOI 10.1105/tpc.1.9.881; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; LUDWIG A, 1990, FEMS MICROBIOL LETT, V69, P61, DOI [10.1016/0378-1097(90)90413-K, 10.1111/j.1574-6968.1990.tb04175.x]; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Micallef SA, 2009, PLANT SIGNAL BEHAV, V4, P777, DOI 10.1093/jxb/erp053; Mishina TE, 2007, PHYSIOL PLANTARUM, V131, P448, DOI 10.1111/j.1399-3054.2007.00977.x; Mithofer A, 2002, MOL PLANT PATHOL, V3, P163, DOI 10.1046/j.1364-3703.2002.00109.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEALE AD, 1990, PLANT CELL, V2, P673, DOI 10.1105/tpc.2.7.673; Nobrega FM, 2005, PLANT SOIL, V272, P223, DOI 10.1007/s11104-004-4954-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Olivieri F, 1998, PHYSIOL PLANTARUM, V104, P232, DOI 10.1034/j.1399-3054.1998.1040211.x; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pongrac P, 2008, J CHEM ECOL, V34, P1038, DOI 10.1007/s10886-008-9502-7; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Ramirez MG, 2004, J MICROBIOL METH, V56, P213, DOI 10.1016/j.mimet.2003.10.011; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Raybould AF, 2001, HEREDITY, V87, P383, DOI 10.1046/j.1365-2540.2001.00954.x; REDDY PM, 2007, DYNAMIC SOIL DYNAMIC, V1, P83; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; SAMAC DA, 1990, PLANT PHYSIOL, V93, P907, DOI 10.1104/pp.93.3.907; Sanon A, 2009, PLANT SOIL, V321, P259, DOI 10.1007/s11104-009-0010-5; SHEPHERD T, 1993, ANN BOT-LONDON, V72, P155, DOI 10.1006/anbo.1993.1094; STACEY G, 1995, SOIL BIOL BIOCHEM, V27, P473, DOI 10.1016/0038-0717(95)98622-U; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Sumner LW, 2002, RAPID COMMUN MASS SP, V16, P160, DOI 10.1002/rcm.555; Textor S, 2009, PHYTOCHEM REV, V8, P149, DOI 10.1007/s11101-008-9117-1; TILTON RC, 1973, APPL MICROBIOL, V26, P658, DOI 10.1128/AEM.26.5.658-665.1973; Traw MB, 2003, MOL ECOL, V12, P1125, DOI 10.1046/j.1365-294X.2003.01815.x; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; VanderWesthuizen AJ, 1996, AUST J PLANT PHYSIOL, V23, P645; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wasternack C, 2006, J PLANT PHYSIOL, V163, P297, DOI 10.1016/j.jplph.2005.10.014; Wen FS, 2007, PLANT PHYSIOL, V143, P773, DOI 10.1104/pp.106.091637; Yu JQ, 2003, BIOCHEM SYST ECOL, V31, P129, DOI 10.1016/S0305-1978(02)00150-3; Zeng RS, 2003, J CHEM ECOL, V29, P1337, DOI 10.1023/A:1024257218558; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	91	67	68	3	55	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30654	30665		10.1074/jbc.M110.119040	http://dx.doi.org/10.1074/jbc.M110.119040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20682788	Green Published, hybrid			2022-12-25	WOS:000282135500034
J	Durairaj, G; Chaurasia, P; Lahudkar, S; Malik, S; Shukla, A; Bhaumik, SR				Durairaj, Geetha; Chaurasia, Priyasri; Lahudkar, Shweta; Malik, Shivani; Shukla, Abhijit; Bhaumik, Sukesh R.			Regulation of Chromatin Assembly/Disassembly by Rtt109p, a Histone H3 Lys(56)-specific Acetyltransferase, in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION MACHINERY; LYSINE-56 ACETYLATION; H3K56 ACETYLATION; GENE-EXPRESSION; ELONGATION; FACT; EVICTION; PROMOTER; PROTEIN	Rtt109p, a histone acetyltransferase, associates with active genes and acetylates lysine 56 on histone H3 in Saccharomyces cerevisiae. However, the functional role of Rtt109p or H3 Lys(56) acetylation in chromatin assembly/disassembly (and hence gene expression) immediately switching transcription on or off has not been clearly elucidated in vivo. Here, we show that Rtt109p promotes the eviction of histone H3 from a fast inducible yeast gene, GAL1, following transcriptional initiation via histone H3 Lys(56) acetylation. Conversely, the deposition of histone H3 to GAL1 is significantly decreased in the presence of Rtt109p following transcriptional termination. Intriguingly, we also find that the deposition of histone H2B on preexisting non-acetylated histone H3 Lys(56) at GAL1 in Delta rtt109 is significantly increased independently of histone H3 deposition immediately following transcriptional termination subsequent to a short induction. Consistently, histone H2B is not efficiently evicted from GAL1 in the absence of Rtt109p immediately following transcriptional induction. Furthermore, we show that the stimulated eviction or reduced deposition of histones by Rtt109p promotes the association of RNA polymerase II with GAL1 and hence the synthesis of GAL1 mRNA. These results, taken together, support the fact that Rtt109p regulates the deposition/eviction of histone H2B in addition to its role in stimulating histone H3 eviction, thus providing insight into chromatin assembly/disassembly and hence gene expression in vivo.	[Durairaj, Geetha; Chaurasia, Priyasri; Lahudkar, Shweta; Malik, Shivani; Shukla, Abhijit; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu			National Institutes of Health [1R15GM088798-01]; American Heart Association [0635008N, 0710187Z]; American Cancer Society [06-52]; Mallinckrodt Foundation; Southern Illinois University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); Mallinckrodt Foundation; Southern Illinois University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01. This work was also supported by American Heart Association National Scientist Development Grant 0635008N, American Cancer Society Research Scholar Grant 06-52, a Mallinckrodt Foundation award, and several internal grants from Southern Illinois University.; Supported by American Heart Association Predoctoral Fellowship 0710187Z. Present address: Dept. of Pathology, Massachusetts General Hospital and Harvard Medical School, Richard B Simches Bldg., 185 Cambridge St., Boston, MA 02114.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; da Rosa JL, 2010, P NATL ACAD SCI USA, V107, P1594, DOI 10.1073/pnas.0912427107; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Lin WC, 2006, CURR OPIN GENET DEV, V16, P137, DOI 10.1016/j.gde.2006.02.002; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; Malik S, 2009, J BIOL CHEM, V284, P35714, DOI 10.1074/jbc.M109.035709; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Ohsawa R, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-11; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Shukla A, 2009, J MOL BIOL, V389, P238, DOI 10.1016/j.jmb.2009.04.018; Stavropoulos P, 2008, P NATL ACAD SCI USA, V105, P12236, DOI 10.1073/pnas.0805813105; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Varv S, 2010, MOL CELL BIOL, V30, P1467, DOI 10.1128/MCB.01151-09; Watanabe S, 2010, BBA-GENE REGUL MECH, V1799, P480, DOI 10.1016/j.bbagrm.2010.01.009; Williams G, 2007, SIGHT SOUND, V17, P88; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yang JH, 2010, DNA REPAIR, V9, P414, DOI 10.1016/j.dnarep.2009.12.022	54	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30472	30479		10.1074/jbc.M110.113225	http://dx.doi.org/10.1074/jbc.M110.113225			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20668333	Green Published, hybrid			2022-12-25	WOS:000282135500014
J	Mooney, SM; Goel, A; D'Assoro, AB; Salisbury, JL; Janknecht, R				Mooney, Steven M.; Goel, Apollina; D'Assoro, Antonino B.; Salisbury, Jeffrey L.; Janknecht, Ralf			Pleiotropic Effects of p300-mediated Acetylation on p68 and p72 RNA Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ER81; ETS PROTEIN ER81; ESTROGEN-RECEPTOR-ALPHA; CREB-BINDING-PROTEIN; DEAD-BOX PROTEINS; BREAST-CANCER; PROSTATE-CANCER; COLORECTAL-CANCER; ANDROGEN RECEPTOR; CELL-GROWTH	Here, we demonstrate that p68 (DDX5) and p72 (DDX17), two homologous RNA helicases and transcriptional cofactors, are substrates for the acetyltransferase p300 in vitro and in vivo. Mutation of acetylation sites affected the binding of p68/p72 to histone deacetylases, but not to p300 or estrogen receptor. Acetylation additionally increased the stability of p68 and p72 RNA helicase and stimulated their ability to coactivate the estrogen receptor, thereby potentially contributing to its aberrant activation in breast tumors. Also, acetylation of p72, but not of p68 RNA helicase, enhanced p53-dependent activation of the MDM2 promoter, pointing at another mechanism of how p72 acetylation may facilitate carcinogenesis by boosting the negative p53-MDM2 feedback loop. Furthermore, blocking p72 acetylation caused cell cycle arrest and apoptosis, revealing an essential role for p72 acetylation. In conclusion, our report has identified for the first time that acetylation modulates RNA helicases and provides multiple mechanisms how acetylation of p68 and p72 may affect normal and tumor cells.	[Janknecht, Ralf] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic	Janknecht, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St,Biomed Res Ctr BRC-1464, Oklahoma City, OK 73104 USA.	ralf-janknecht@ouhsc.edu		Salisbury, Jeffrey/0000-0001-9257-4578; Janknecht, Ralf/0000-0003-1741-1562	Dept. of Defense [W81XWH-06-1-0492]	Dept. of Defense(United States Department of Defense)	This work was supported by Grant W81XWH-06-1-0492 from the Dept. of Defense Breast Cancer Research Program.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; BENLEVY R, 1994, EMBO J, V13, P3302, DOI 10.1002/j.1460-2075.1994.tb06632.x; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Bosc DG, 2002, J CELL BIOCHEM, V86, P174, DOI 10.1002/jcb.10205; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Castoria G, 2008, FRONT BIOSCI-LANDMRK, V13, P1318, DOI 10.2741/2764; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Haro L, 2005, GENOMICS, V85, P493, DOI 10.1016/j.ygeno.2004.12.003; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Endoh H, 1999, MOL CELL BIOL, V19, P5363; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fuchs B, 2004, CLIN CANCER RES, V10, P1344, DOI 10.1158/1078-0432.CCR-03-0038; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Goodman RH, 2000, GENE DEV, V14, P1553; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hall PS, 2009, EUR J CANCER, V45, P12, DOI 10.1016/j.ejca.2008.10.013; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Janknecht R, 1996, CURR BIOL, V6, P951, DOI 10.1016/S0960-9822(02)00636-X; Janknecht R, 2001, J BIOL CHEM, V276, P41856, DOI 10.1074/jbc.M106630200; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Kapitanovic S, 1997, GASTROENTEROLOGY, V112, P1103, DOI 10.1016/S0016-5085(97)70120-3; Kim TD, 2008, BIOCHEM BIOPH RES CO, V366, P563, DOI 10.1016/j.bbrc.2007.12.013; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Lamm GM, 1996, NUCLEIC ACIDS RES, V24, P3739, DOI 10.1093/nar/24.19.3739; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; MONTE D, 1995, ONCOGENE, V11, P771; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Nishio Y, 2006, UROLOGY, V68, P110, DOI 10.1016/j.urology.2006.01.060; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Osako T, 1998, ONCOLOGY-BASEL, V55, P548, DOI 10.1159/000011911; Osman I, 2005, J UROLOGY, V174, P2174, DOI 10.1097/01.ju.0000181205.23233.65; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Papoutsopoulou S, 2000, MOL CELL BIOL, V20, P7300, DOI 10.1128/MCB.20.19.7300-7310.2000; Park DI, 2007, INT J COLORECTAL DIS, V22, P491, DOI 10.1007/s00384-006-0192-8; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Rossow KL, 2001, CANCER RES, V61, P2690; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Shin S, 2007, J CELL BIOCHEM, V101, P1252, DOI 10.1002/jcb.21250; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Shin S, 2008, J CELL BIOCHEM, V105, P866, DOI 10.1002/jcb.21884; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang L, 2007, ONCOGENE, V26, P6082, DOI 10.1038/sj.onc.1210427; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	82	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30443	30452		10.1074/jbc.M110.143792	http://dx.doi.org/10.1074/jbc.M110.143792			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663877	Green Published, hybrid			2022-12-25	WOS:000282135500011
J	Seo, N; Russell, BH; Rivera, JJ; Liang, XW; Xu, XJ; Afshar-Kharghan, V; Hook, M				Seo, Neungseon; Russell, Brooke H.; Rivera, Jose J.; Liang, Xiaowen; Xu, Xuejun; Afshar-Kharghan, Vahid; Hoeoek, Magnus			An Engineered alpha 1 Integrin-binding Collagenous Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; GLYCOPROTEIN-VI; SCL2 PROTEINS; IN-VIVO; ALPHA(2)BETA(1); ALPHA(1)BETA(1); ALPHA-2-BETA-1; RECOGNITION; ACTIVATION; RECEPTORS	Collagen is an extracellular matrix structural component that can regulate cellular processes through its interaction with the integrins, alpha 1 beta 1, alpha 2 beta 1, alpha 10 beta 1, and alpha 11 beta 1. Collagen-like proteins have been identified in a number of bacterial species. Here, we used Scl2 from Streptococcus pyogenes serotype M28 strain MGAS6274 as a backbone for the introduction of discrete integrin-binding sequences. The introduced sequences GLPGER, GFPGER, or GFPGEN did not affect triple helix stability of the Scl (Streptococcal collagen-like) protein. Using ELISA and surface plasmon resonance, we determined that Scl2(GLPGER) and Scl2(GFPGER) bound to recombinant human alpha 1 and alpha 2 I-domains in a metal ion-dependent manner and without a requirement for hydroxyproline. We predicted a novel and selective integrin-binding sequence, GFPGEN, through the use of computer modeling and demonstrated that Scl2(GFPGEN) shows specificity toward the alpha 1 I-domain and does not bind the alpha 2 I-domain. Using C2C12 cells, we determined that intact integrins interact with the modified Scl2 proteins with the same selectivity as recombinant I-domains. These modified Scl2 proteins also acted as cell attachment substrates for fibroblast, endothelial, and smooth muscle cells. However, the modified Scl2 proteins were unable to aggregate platelets. These results indicate that Scl2 is a suitable backbone for the introduction of mammalian integrin-binding sequences, and these sequences may be manipulated to individually target alpha 1 beta 1 and alpha 2 beta 1.	[Seo, Neungseon; Russell, Brooke H.; Rivera, Jose J.; Liang, Xiaowen; Xu, Xuejun; Hoeoek, Magnus] Texas A&M Univ Syst Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Inst Biosci & Technol, Houston, TX 77030 USA; [Afshar-Kharghan, Vahid] MD Anderson Canc Ctr, Program Hematol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center	Hook, M (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mhook@ibt.tamhsc.edu		Liang, Xiaowen/0000-0002-6174-2951				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bella J, 2000, STRUCTURE, V8, pR121, DOI 10.1016/S0969-2126(00)00153-2; BURKEL WE, 1989, MED PROG TECHNOL, V14, P165; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Cosemans JMEM, 2008, J THROMB HAEMOST, V6, P1253, DOI 10.1111/j.1538-7836.2008.03041.x; COSGRIFFHERNAND.E, 2010, ACTA BIOMAT IN PRESS; Deb A, 2004, CIRCULATION, V110, P2673, DOI 10.1161/01.CIR.0000139842.15651.B2; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farndale RW, 2007, J THROMB HAEMOST, V5, P220, DOI 10.1111/j.1538-7836.2007.02521.x; Graf K, 2003, J CARDIOVASC PHARM, V41, P89, DOI 10.1097/00005344-200301000-00012; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Hoe NP, 2007, FEMS MICROBIOL LETT, V277, P142, DOI 10.1111/j.1574-6968.2007.00955.x; Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; JIMENEZ SA, 1973, J BIOL CHEM, V248, P720; Kadler KE, 1996, BIOCHEM J, V316, P1; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Karlstrom A, 2004, VET MICROBIOL, V104, P179, DOI 10.1016/j.vetmic.2004.09.014; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Munnix ICA, 2008, J THROMB HAEMOST, V6, P2132, DOI 10.1111/j.1538-7836.2008.03167.x; Ogle BM, 1999, TISSUE ENG, V5, P387, DOI 10.1089/ten.1999.5.387; Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Pozzi M, 1998, J CELL BIOL, V142, P587; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; San Antonio JD, 2009, AM J PATHOL, V175, P1338, DOI 10.2353/ajpath.2009.090234; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	43	49	51	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31046	31054		10.1074/jbc.M110.151357	http://dx.doi.org/10.1074/jbc.M110.151357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20675378	Green Published, hybrid			2022-12-25	WOS:000282135500069
J	Malhotra, N; Robertson, E; Kang, J				Malhotra, Nidhi; Robertson, Elizabeth; Kang, Joonsoo			SMAD2 Is Essential for TGF beta-mediated Th17 Cell Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; T-CELLS; T(H)17; DIFFERENTIATION; PLASTICITY; PROMOTES	TGF beta is the quintessential cytokine of T cell homeostasis. TGF beta signaling is required for the efficient differentiation and maintenance of CD4(+)FOXP3(+) T cells that inhibit immune responses. Conversely, in conjunction with the inflammatory cytokine IL-6, TGF beta promotes Th17 cell differentiation. The mechanism by which TGF beta signals synergize with IL-6 to generate inflammatory versus immunosuppressive T cell subsets is unclear. TGF beta signaling activates receptor SMADs, SMAD2 and SMAD3, which associate with a variety of nuclear factors to regulate gene transcription. Defining relative contributions of distinct SMAD molecules for CD4 T cell differentiation is critical for mapping the versatile intracellular TGF beta-signaling pathways that tailor TGF beta activities to the state of host interaction with pathogens. We show here that SMAD2 is essential for Th17 cell differentiation and that it acts in part by modulating the expression of IL-6R on T cells. Although mice lacking SMAD2 specifically in T cells do not develop spontaneous lymphoproliferative autoimmunity, Smad2-deficient T cells are impaired in their response to TGF beta in vitro and in vivo, and they are more pathogenic than controls when transferred into lymphopenic mice. These results demonstrate that SMAD2 is uniquely essential for TGF beta signaling in CD4(+) T effector cell differentiation.	[Malhotra, Nidhi; Kang, Joonsoo] Univ Massachusetts, Grad Program Immunol & Virol, Dept Pathol, Sch Med, Worcester, MA 01655 USA; [Robertson, Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford	Kang, J (corresponding author), Univ Massachusetts, Grad Program Immunol & Virol, Dept Pathol, Sch Med, 55 Lake Ave N,S3-137, Worcester, MA 01655 USA.	Joonsoo.Kang@umassmed.edu		kang, joonsoo/0000-0001-8419-7995	National Institutes of Health [RO1 AI054670]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI054670 (to J. K.).; We thank Dr. R. Flavell for providing the Smad2<SUP>fl/fl</SUP> mice. We also thank the University of Massachusetts Medical School Flow Cytometry Core Facility staff for cell sorting, Dr. J. Leong and E. Mallick for assistance with C. rodentium infections, Dr. A. Mizoguchi for advice in colonic lymphocyte isolations, Anurag Gupta for technical assistance, and members of the Kang laboratory for advice and comments on the manuscript. Core resources supported by the Diabetes Endocrinology Research Center Grant DK32520 were used for this work.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huber S, 2009, J IMMUNOL, V182, P4633, DOI 10.4049/jimmunol.0803143; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mizoguchi A, 1996, J EXP MED, V183, P847, DOI 10.1084/jem.183.3.847; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	23	63	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29044	29048		10.1074/jbc.C110.156745	http://dx.doi.org/10.1074/jbc.C110.156745			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20656683	Green Published, hybrid			2022-12-25	WOS:000281740100004
J	Jurczyk, A; Pino, SC; O'Sullivan-Murphy, B; Addorio, M; Lidstone, EA; Diiorio, P; Lipson, KL; Standley, C; Fogarty, K; Lifshitz, L; Urano, F; Mordes, JP; Greiner, DL; Rossini, AA; Bortell, R				Jurczyk, Agata; Pino, Steven C.; O'Sullivan-Murphy, Bryan; Addorio, Martha; Lidstone, Erich A.; Diiorio, Philip; Lipson, Kathryn L.; Standley, Clive; Fogarty, Kevin; Lifshitz, Lawrence; Urano, Fumihiko; Mordes, John P.; Greiner, Dale L.; Rossini, Aldo A.; Bortell, Rita			A Novel Role for the Centrosomal Protein, Pericentrin, in Regulation of Insulin Secretory Vesicle Docking in Mouse Pancreatic beta-cells	PLOS ONE			English	Article							GAMMA-TUBULIN; MICROTUBULE ORGANIZATION; SPINDLE ORGANIZATION; EXOCYTOSIS; COMPLEX; FUSION; MUTATIONS; MEMBRANE; GRANULES; KENDRIN	The centrosome is important for microtubule organization and cell cycle progression in animal cells. Recently, mutations in the centrosomal protein, pericentrin, have been linked to human microcephalic osteodysplastic primordial dwarfism (MOPD II), a rare genetic disease characterized by severe growth retardation and early onset of type 2 diabetes among other clinical manifestations. While the link between centrosomal and cell cycle defects may account for growth deficiencies, the mechanism linking pericentrin mutations with dysregulated glucose homeostasis and pre-pubertal onset of diabetes is unknown. In this report we observed abundant expression of pericentrin in quiescent pancreatic beta-cells of normal animals which led us to hypothesize that pericentrin may have a critical function in beta-cells distinct from its known role in regulating cell cycle progression. In addition to the typical centrosome localization, pericentrin was also enriched with secretory vesicles in the cytoplasm. Pericentrin overexpression in beta-cells resulted in aggregation of insulin-containing secretory vesicles with cytoplasmic, but not centrosomal, pericentriolar material and an increase in total levels of intracellular insulin. RNAi-mediated silencing of pericentrin in secretory beta-cells caused dysregulated secretory vesicle hypersecretion of insulin into the media. Together, these data suggest that pericentrin may regulate the intracellular distribution and secretion of insulin. Mice transplanted with pericentrin-depleted islets exhibited abnormal fasting hypoglycemia and inability to regulate blood glucose normally during a glucose challenge, which is consistent with our in vitro data. This previously unrecognized function for a centrosomal protein to mediate vesicle docking in secretory endocrine cells emphasizes the adaptability of these scaffolding proteins to regulate diverse cellular processes and identifies a novel target for modulating regulated protein secretion in disorders such as diabetes.	[Jurczyk, Agata; Pino, Steven C.; O'Sullivan-Murphy, Bryan; Addorio, Martha; Lidstone, Erich A.; Diiorio, Philip; Mordes, John P.; Greiner, Dale L.; Rossini, Aldo A.; Bortell, Rita] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Lidstone, Erich A.] Western New England Coll, Dept Phys & Biol Sci, Springfield, MA USA; [Standley, Clive; Fogarty, Kevin; Lifshitz, Lawrence] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA USA; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA; [Urano, Fumihiko; Greiner, Dale L.; Rossini, Aldo A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Western New England University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jurczyk, A (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	Rita.Bortell@umassmed.edu	Urano, Fumihiko/AAF-4492-2020	O'Sullivan-Murphy, Bryan/0000-0002-1426-5013	National Institutes of Health [AI46629, DK53006, DK49106, DK25306]; Beta Cell Biology Consortium; Juvenile Diabetes Research Foundation; Iacocca Foundation; Helmsley Foundation; National Institute of Diabetes and Digestive and Kidney Diseases [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053006, R01DK049106, R01DK067493, P30DK032520, R37DK025306, R01DK025306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beta Cell Biology Consortium; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Iacocca Foundation; Helmsley Foundation; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants AI46629, DK53006, DK49106 and DK25306, the Beta Cell Biology Consortium, and grants from the Juvenile Diabetes Research Foundation, the Iacocca Foundation, and the Helmsley Foundation. Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 from the National Institute of Diabetes and Digestive and Kidney Diseases were used; RB is a member of the UMass DERC (DK32520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma N, 2002, ENDOCR J, V49, P449, DOI 10.1507/endocrj.49.449; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; ENDOHYAMAGAMI S, DEV BIOL; FARSHORI PQ, 1994, J SUBMICR CYTOL PATH, V26, P137; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hayat M.A., 1986, BASIC TECHNIQUES TRA, V1st ed.; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Kubo A, 2003, J CELL SCI, V116, P919, DOI 10.1242/jcs.00282; Kuemmel D, 2008, CURR PROTEIN PEPT SC, V9, P197, DOI 10.2174/138920308783955252; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu QQ, 2001, J CELL SCI, V114, P797; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2006, BIOCHEM BIOPH RES CO, V351, P745, DOI 10.1016/j.bbrc.2006.10.101; Miyoshi K, 2006, DEV GENES EVOL, V216, P537, DOI 10.1007/s00427-006-0065-8; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Varadi A, 2003, BIOCHEM BIOPH RES CO, V311, P272, DOI 10.1016/j.bbrc.2003.09.208; WILLEMS M, 2009, J MED GENET; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11812	10.1371/journal.pone.0011812	http://dx.doi.org/10.1371/journal.pone.0011812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676397	gold, Green Published			2022-12-25	WOS:000280371800014
J	Utskarpen, A; Massol, R; van Deurs, B; Lauvrak, SU; Kirchhausen, T; Sandvig, K				Utskarpen, Audrun; Massol, Ramiro; van Deurs, Bo; Lauvrak, Silje Ugland; Kirchhausen, Tomas; Sandvig, Kirsten			Shiga Toxin Increases Formation of Clathrin-Coated Pits through Syk Kinase	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RETROGRADE TRANSPORT; PLASMA-MEMBRANE; ACTIVATION; RECEPTOR; BINDING; INTERNALIZATION; PROTEIN; CELLS; TRAFFICKING	Clathrin-dependent endocytosis is a main entry mechanism for the glycolipid-binding Shiga toxin (Stx), although clathrin-independent pathways are also involved. Binding of Stx to its receptor Gb3 not only is essential for Stx retrograde transport to the endoplasmic reticulum and toxicity but also activates signaling through the tyrosine kinase Syk. We previously described that Syk activity is important for Stx entry, but it remained unclear how this kinase modulates endocytosis of Stx. Here we characterized the effects of Stx and Syk on clathrin-coated pit formation. We found that acute treatment with Stx results in an increase in the number of clathrin-coated profiles as determined by electron microscopy and on the number of structures containing the endocytic AP-2 adaptor at the plasma membrane determined by live-cell spinning disk confocal imaging. These responses to Stx require functional Syk activity. We propose that a signaling pathway mediated by Syk and modulated by Stx leads to an increased number of endocytic clathrin-coated structures, thus providing a possible mechanism by which Stx enhances its own endocytosis.	[Utskarpen, Audrun; Lauvrak, Silje Ugland; Sandvig, Kirsten] Univ Oslo, Ctr Canc Biomed, Fac Div Norwegian Radium Hosp, Oslo, Norway; [Utskarpen, Audrun; Lauvrak, Silje Ugland; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Utskarpen, Audrun; Sandvig, Kirsten] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Massol, Ramiro] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Massol, Ramiro] Harvard Univ, Sch Med, Childrens Hospital Boston, Boston, MA 02115 USA; [van Deurs, Bo] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	University of Oslo; University of Oslo; University of Oslo; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Copenhagen; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Utskarpen, A (corresponding author), Univ Oslo, Ctr Canc Biomed, Fac Div Norwegian Radium Hosp, Oslo, Norway.	kirchhausen@crystal.harvard.edu; ksandvig@radium.uio.no	Utskarpen, Audrun/GRS-0436-2022		Norwegian Cancer Society; Rikshospitalet University Hospital; Norwegian Research Council; University of Oslo; EMBO (European Molecular Biology Organization); National Institutes of Health [GM075252]; Harvard Digestive Diseases Center National Institutes of Health [P30 DK034854]; Danish Medical Research Council; Danish Cancer Society; NERCE [U54 A1057159]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK084424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	Norwegian Cancer Society(Norwegian Cancer Society); Rikshospitalet University Hospital; Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Oslo; EMBO (European Molecular Biology Organization)(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); NERCE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was received from the Norwegian Cancer Society, Rikshospitalet University Hospital, the Norwegian Research Council, and the University of Oslo (AU, KS, SL). AU received an EMBO (European Molecular Biology Organization) short-term fellowship. The work was supported in part by a National Institutes of Health grant GM075252 (TK) and a NERCE grant U54 A1057159 (TK), a grant (P30 DK034854) from the Harvard Digestive Diseases Center National Institutes of Health (RM), and the Danish Medical Research Council and the Danish Cancer Society (BvD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie EC, 2000, J NEUROSCI, V20, P7325; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Chakrabandhu K, 2008, CELL DEATH DIFFER, V15, P1824, DOI 10.1038/cdd.2008.115; CONNOLLY JL, 1984, J CELL BIOL, V98, P457, DOI 10.1083/jcb.98.2.457; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; Mori T, 2000, EXP HEMATOL, V28, P1260, DOI 10.1016/S0301-472X(00)00538-5; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; Sandvig K., 2005, COMPREHENSIVE SOURCE, P310; Shimizu T, 2003, BBA-BIOMEMBRANES, V1612, P186, DOI 10.1016/S0005-2736(03)00130-5; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Torgersen ML, 2005, FEBS J, V272, P4103, DOI 10.1111/j.1742-4658.2005.04835.x; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Walchli S, 2009, CELL SIGNAL, V21, P1161, DOI 10.1016/j.cellsig.2009.03.005; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4	28	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e10944	10.1371/journal.pone.0010944	http://dx.doi.org/10.1371/journal.pone.0010944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668539	Green Submitted, Green Published, gold			2022-12-25	WOS:000280371800001
J	Sznitman, R; Gupta, M; Hager, GD; Arratia, PE; Sznitman, J				Sznitman, Raphael; Gupta, Manaswi; Hager, Gregory D.; Arratia, Paulo E.; Sznitman, Josue			Multi-Environment Model Estimation for Motility Analysis of Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; MACHINE VISION; NEMATODE; BEHAVIOR; TRACKING; SYSTEM; LOCOMOTION; LINEAGE; GENE	The nematode Caenorhabditis elegans is a well-known model organism used to investigate fundamental questions in biology. Motility assays of this small roundworm are designed to study the relationships between genes and behavior. Commonly, motility analysis is used to classify nematode movements and characterize them quantitatively. Over the past years, C. elegans' motility has been studied across a wide range of environments, including crawling on substrates, swimming in fluids, and locomoting through microfluidic substrates. However, each environment often requires customized image processing tools relying on heuristic parameter tuning. In the present study, we propose a novel Multi-Environment Model Estimation (MEME) framework for automated image segmentation that is versatile across various environments. The MEME platform is constructed around the concept of Mixture of Gaussian (MOG) models, where statistical models for both the background environment and the nematode appearance are explicitly learned and used to accurately segment a target nematode. Our method is designed to simplify the burden often imposed on users; here, only a single image which includes a nematode in its environment must be provided for model learning. In addition, our platform enables the extraction of nematode 'skeletons' for straightforward motility quantification. We test our algorithm on various locomotive environments and compare performances with an intensity-based thresholding method. Overall, MEME outperforms the threshold-based approach for the overwhelming majority of cases examined. Ultimately, MEME provides researchers with an attractive platform for C. elegans' segmentation and 'skeletonizing' across a wide range of motility assays.	[Sznitman, Raphael; Gupta, Manaswi; Hager, Gregory D.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Arratia, Paulo E.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Sznitman, Josue] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Johns Hopkins University; University of Pennsylvania; Princeton University	Sznitman, R (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	sznitman@princeton.edu	Hager, Gregory D/A-3222-2010	Sznitman, Raphael/0000-0001-6791-4753	National Institutes of Health (Bethesda MD, USA); Lewis-Sigler Institute for Integrative Genomics, Princeton U.; Department of Mechanical Engineering and Applied Mechanics, U. of Penn; MRC Lab of Molecular Biology, Cambridge U.	National Institutes of Health (Bethesda MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lewis-Sigler Institute for Integrative Genomics, Princeton U.; Department of Mechanical Engineering and Applied Mechanics, U. of Penn; MRC Lab of Molecular Biology, Cambridge U.	Strains of C. elegans were obtained from the Caenorhabditis elegans Genetic Stock Center (University of Minnesota), supported by the National Institutes of Health (Bethesda MD, USA). The authors would like to thank Dr. R. Ghosh (Lewis-Sigler Institute for Integrative Genomics, Princeton U.), X. Shen (Department of Mechanical Engineering and Applied Mechanics, U. of Penn), and Dr. A. E. X. Brown (MRC Lab of Molecular Biology, Cambridge U.) for their support and helpful discussions.	Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; Barrow H. G., 1977, P 5 INT JOINT C ART, P659; Berri S, 2009, HFSP J, V3, P186, DOI 10.2976/1.3082260; Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; BRENNER S, 1974, GENETICS, V77, P71; Buckingham SD, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-84; Buckingham Steven D., 2008, Invertebrate Neuroscience, V8, P121, DOI 10.1007/s10158-008-0077-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chamberlain JS, 2000, CURR BIOL, V10, pR795, DOI 10.1016/S0960-9822(00)00768-5; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; DUBLINTHALER BJ, 2008, PLOS ONE, V3, pE3735; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; FLEURET F, 2005, P ANN C NEUR INF PRO, P371; Gavrila DM, 2007, IEEE T PATTERN ANAL, V29, P1408, DOI 10.1109/TPAMI.2007.1062; Geng W, 2003, GENETICS, V165, P1117; Ghosh R, 2008, J EXP BIOL, V211, P3703, DOI 10.1242/jeb.023606; Hoshi K, 2006, J NEUROSCI METH, V157, P355, DOI 10.1016/j.jneumeth.2006.05.002; Huang KM, 2008, J NEUROSCI METH, V171, P153, DOI 10.1016/j.jneumeth.2008.01.027; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Huang KM, 2009, J SIGNAL PROCESS SYS, V55, P113, DOI 10.1007/s11265-008-0182-x; Isard M, 1998, INT J COMPUT VISION, V29, P5, DOI 10.1023/A:1008078328650; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Korta J, 2007, J EXP BIOL, V210, P2383, DOI 10.1242/jeb.004572; LAIRD NM, 1997, J ROY STAT SOC, V39, P1; Li FF, 2006, IEEE T PATTERN ANAL, V28, P594, DOI 10.1109/TPAMI.2006.79; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Link E M, 2000, Pharmacogenomics, V1, P203, DOI 10.1517/14622416.1.2.203; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Piccardi M, 2004, IEEE SYS MAN CYBERN, P3099, DOI 10.1109/ICSMC.2004.1400815; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rankin CH, 2002, NAT REV GENET, V3, P622, DOI 10.1038/nrg864; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Roussel N, 2007, IEEE T BIO-MED ENG, V54, P1786, DOI 10.1109/TBME.2007.894981; Shi WW, 2008, LAB CHIP, V8, P1432, DOI 10.1039/b808753a; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Stauffer C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P246, DOI 10.1109/CVPR.1999.784637; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sznitman J, 2010, EXP MECH, V50, P1303, DOI 10.1007/s11340-010-9339-1; Sznitman J, 2010, BIOPHYS J, V98, P617, DOI 10.1016/j.bpj.2009.11.010; SZNITMAN R, 2010, IEEE T PATT IN PRESS, V99; SZNITMAN R, 2009, IEEE 12 INT C COMP V, P1222; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tsechpenakis G, 2008, IEEE T BIO-MED ENG, V55, P1539, DOI 10.1109/TBME.2008.918582; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xiong GL, 2006, PATTERN RECOGN LETT, V27, P838, DOI 10.1016/j.patrec.2005.11.015	55	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11631	10.1371/journal.pone.0011631	http://dx.doi.org/10.1371/journal.pone.0011631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661478	gold, Green Published, Green Submitted			2022-12-25	WOS:000280243300002
J	Zhang, QX; Shi, YH; Wada, J; Malakauskas, SM; Liu, MD; Ren, YZ; Du, CY; Duan, HJ; Li, YM; Li, Y; Zhang, YL				Zhang, Qingxian; Shi, Yonghong; Wada, Jun; Malakauskas, Sandra M.; Liu, Maodong; Ren, Yunzhuo; Du, Chunyang; Duan, Huijun; Li, Yingmin; Li, Ying; Zhang, Yanling			In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7	PLOS ONE			English	Article							GROWTH-FACTOR; CELL-PROLIFERATION; ANTAGONIST GREMLIN-1; MESANGIAL CELLS; RENAL FIBROSIS; MESSENGER-RNA; HIGH GLUCOSE; EXPRESSION; KIDNEY; MODEL	Diabetic nephropathy is a complex and poorly understood disease process, and our current treatment options are limited. It remains critical, then, to identify novel therapeutic targets. Recently, a developmental protein and one of the bone morphogenetic protein antagonists, Gremlin, has emerged as a novel modulator of diabetic nephropathy. The high expression and strong co-localization with transforming growth factor-beta 1 in diabetic kidneys suggests a role for Gremlin in the pathogenesis of diabetic nephropathy. We have constructed a gremlin siRNA plasmid and have examined the effect of Gremlin inhibition on the progression of diabetic nephropathy in a mouse model. CD-1 mice underwent uninephrectomy and STZ treatment prior to receiving weekly injections of the plasmid. Inhibition of Gremlin alleviated proteinuria and renal collagen IV accumulation 12 weeks after the STZ injection and inhibited renal cell proliferation and apoptosis. In vitro experiments, using mouse mesangial cells, revealed that the transfect ion of gremlin siRNA plasmid reversed high glucose induced abnormalities, such as increased cell proliferation and apoptosis and increased collagen IV production. The decreased matrix metalloprotease level was partially normalized by transfection with gremlin siRNA plasmid. Additionally, we observed recovery of bone morphogenetic protein-7 signaling activity, evidenced by increases in phosphorylated Smad 5 protein levels. We conclude that inhibition of Gremlin exerts beneficial effects on the diabetic kidney mainly through maintenance of BMP-7 activity and that Gremlin may serve as a novel therapeutic target in the management of diabetic nephropathy.	[Zhang, Qingxian; Liu, Maodong; Li, Ying; Zhang, Yanling] Hebei Med Univ, Dept Nephrol, Third Hosp, Shijiazhuang, Peoples R China; [Shi, Yonghong; Ren, Yunzhuo; Du, Chunyang; Duan, Huijun; Li, Yingmin] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China; [Wada, Jun] Okayama Univ, Grad Sch Med, Dept Med & Clin Sci, Okayama, Japan; [Malakauskas, Sandra M.] Univ Alabama, Div Nephrol, Birmingham, AL USA	Hebei Medical University; Hebei Medical University; Okayama University; University of Alabama System; University of Alabama Birmingham	Zhang, QX (corresponding author), Hebei Med Univ, Dept Nephrol, Third Hosp, Shijiazhuang, Peoples R China.	zhang2199@126.com	WADA, Jun/B-2023-2011	WADA, Jun/0000-0003-1468-5170	Scientific Research Foundation for Returned Scholars, Ministry of Education of China [2008139]; Natural Science Foundation of Hebei Province [C20080000940]; Science and Technology Commission Foundation of Hebei Province [072761229]; Health Commission of Hebei Province [08007]; Natural Science Foundation of China [30940035]; Science Fund for Distinguished Young Scholars of Hebei Province	Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Science and Technology Commission Foundation of Hebei Province; Health Commission of Hebei Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Distinguished Young Scholars of Hebei Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Scientific Research Foundation for Returned Scholars, Ministry of Education of China (No. 2008139; http://www.moe.edu.cn/), the Natural Science Foundation of Hebei Province (No. C20080000940; www.hensf.gov.cn), a grant from the Key Applied Basic Research Programs of Science and Technology Commission Foundation of Hebei Province (No. 072761229; www.heinfo.gov.cn), the Health Commission of Hebei Province (No. 08007; www.hebwst.gov.cn), the Natural Science Foundation of China (No. 30940035, www.nsfc.gov.cn), and the Science Fund for Distinguished Young Scholars of Hebei Province (www.hee.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chen B, 2002, BIOCHEM BIOPH RES CO, V295, P1135, DOI 10.1016/S0006-291X(02)00828-8; Dolan V, 2005, AM J KIDNEY DIS, V45, P1034, DOI 10.1053/j.ajkd.2005.03.014; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Fioretto P, 2006, KIDNEY INT, V69, P907, DOI 10.1038/sj.ki.5000153; Fioretto P, 1998, CURR OPIN NEPHROL HY, V7, P489, DOI 10.1097/00041552-199809000-00001; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; HELDER MN, 1995, J HISTOCHEM CYTOCHEM, V43, P1035, DOI 10.1177/43.10.7560881; Hensey C, 2002, NEPHROL DIAL TRANSPL, V17, P73, DOI 10.1093/ndt/17.suppl_9.73; Hruska KA, 2000, AM J PHYSIOL-RENAL, V279, pF130, DOI 10.1152/ajprenal.2000.279.1.F130; Kitten AM, 1999, J CELL PHYSIOL, V181, P410, DOI 10.1002/(SICI)1097-4652(199912)181:3<410::AID-JCP4>3.0.CO;2-H; Lappin DWP, 2002, NEPHROL DIAL TRANSPL, V17, P65, DOI 10.1093/ndt/17.suppl_9.65; Maciel TT, 2008, J MOL CELL CARDIOL, V44, P370, DOI 10.1016/j.yjmcc.2007.10.021; Marchant Karen, 2008, Br J Nurs, V17, P356; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; McMahon R, 2000, J BIOL CHEM, V275, P9901, DOI 10.1074/jbc.275.14.9901; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Nishimura R, 2003, FRONT BIOSCI, V8, pS275, DOI 10.2741/1049; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Otani H, 2007, AM J PHYSIOL-RENAL, V292, pF1513, DOI 10.1152/ajprenal.00402.2006; OZKAYNAK E, 1991, BIOCHEM BIOPH RES CO, V179, P116, DOI 10.1016/0006-291X(91)91342-A; Pavel E, 2007, INT J DEV BIOL, V51, P273, DOI 10.1387/ijdb.062249ep; Petrovic MG, 2008, MOL VIS, V14, P1382; Preisig P, 1999, KIDNEY INT, V56, P1193, DOI 10.1046/j.1523-1755.1999.00708.x; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; *US REN DAT SYST, 1999, AM J KIDNEY DIS S, V34, pS1; VUKICEVIC S, 1994, BIOCHEM BIOPH RES CO, V198, P693, DOI 10.1006/bbrc.1994.1100; Vukicevic S, 1996, P NATL ACAD SCI USA, V93, P9021, DOI 10.1073/pnas.93.17.9021; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Wang SN, 2006, J AM SOC NEPHROL, V17, P2504, DOI 10.1681/ASN.2006030278; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002	36	43	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11709	10.1371/journal.pone.0011709	http://dx.doi.org/10.1371/journal.pone.0011709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661431	gold, Green Published, Green Submitted			2022-12-25	WOS:000280243300013
J	Habchi, J; Mamelli, L; Darbon, H; Longhi, S				Habchi, Johnny; Mamelli, Laurent; Darbon, Herve; Longhi, Sonia			Structural Disorder within Henipavirus Nucleoprotein and Phosphoprotein: From Predictions to Experimental Assessment	PLOS ONE			English	Article							MEASLES-VIRUS NUCLEOPROTEIN; C-TERMINAL DOMAIN; INTRINSICALLY UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION FEATURES; NUCLEOCAPSID-BINDING DOMAIN; NATIVELY UNFOLDED PROTEINS; HENDRA-VIRUS; P-PROTEINS; V-PROTEIN; CRYSTAL-STRUCTURE	Henipaviruses are newly emerged viruses within the Paramyxoviridae family. Their negative-strand RNA genome is packaged by the nucleoprotein (N) within alpha-helical nucleocapsid that recruits the polymerase complex made of the L protein and the phosphoprotein (P). To date structural data on Henipaviruses are scarce, and their N and P proteins have never been characterized so far. Using both computational and experimental approaches we herein show that Henipaviruses N and P proteins possess large intrinsically disordered regions. By combining several disorder prediction methods, we show that the N-terminal domain of P (PNT) and the C-terminal domain of N (N-TAIL) are both mostly disordered, although they contain short order-prone segments. We then report the cloning, the bacterial expression, purification and characterization of Henipavirus PNT and N-TAIL domains. By combining gel filtration, dynamic light scattering, circular dichroism and nuclear magnetic resonance, we show that both N-TAIL and PNT belong to the premolten globule sub-family within the class of intrinsically disordered proteins. This study is the first reported experimental characterization of Henipavirus P and N proteins. The evidence that their respective N-terminal and C-terminal domains are highly disordered under native conditions is expected to be invaluable for future structural studies by helping to delineate N and P protein domains amenable to crystallization. In addition, following previous hints establishing a relationship between structural disorder and protein interactivity, the present results suggest that Henipavirus PNT and N-TAIL domains could be involved in manifold protein-protein interactions.	[Habchi, Johnny] CNRS, UMR 6098, Marseille, France; Univ Aix Marseille 1, Marseille, France; Univ Aix Marseille 2, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Habchi, J (corresponding author), CNRS, UMR 6098, Campus Luminy, Marseille, France.	Sonia.Longhi@afmb.univ-mrs.fr	LONGHI, Sonia/M-5305-2014	LONGHI, Sonia/0000-0002-6829-6771	Agence Nationale de la Recherche [ANR-08-PCVI-0020-01]; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was carried out with the financial support of the Agence Nationale de la Recherche, specific program "Physico-Chimie du Vivant'', ANR-08-PCVI-0020-01. LM was supported by a post-doctoral fellowship by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belle V, 2008, PROTEINS, V73, P973, DOI 10.1002/prot.22125; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; BHELLA D, 2007, MEASLES VIRUS NUCLOP; Blanchard L, 2004, VIROLOGY, V319, P201, DOI 10.1016/j.virol.2003.10.029; Bodart JF, 2008, J MAGN RESON, V192, P252, DOI 10.1016/j.jmr.2008.03.006; Boumlic A, 2010, FEBS J, V277, P774, DOI 10.1111/j.1742-4658.2009.07527.x; Bourhis J.-M., 2005, Virologie (Montrouge), V9, P367, DOI 10.1684/vir.2011.2399; Bourhis J.M., 2007, MEASLES VIRUS NUCLEO, P1; Bourhis JM, 2007, CURR PROTEIN PEPT SC, V8, P135, DOI 10.2174/138920307780363451; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; BOWDEN TA, 2010, ARCHITECTURE HENDRA; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Brocca S, 2009, PROTEINS, V76, P731, DOI 10.1002/prot.22385; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Chandonia JM, 1999, PROTEINS, V35, P293; Chen A, 2003, VIRUS RES, V98, P123, DOI 10.1016/j.virusres.2003.09.003; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; CHINCHAR VG, 1981, VIROLOGY, V109, P59, DOI 10.1016/0042-6822(81)90471-2; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Colombo M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-59; COUTURIER M, 2009, J MOL RECOG IN PRESS; Csizmok V, 2006, MOL CELL PROTEOMICS, V5, P265, DOI 10.1074/mcp.M500181-MCP200; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; CURRAN J, 1994, VIROLOGY, V202, P875, DOI 10.1006/viro.1994.1409; DahlmanWright K, 1996, BIOCHEMISTRY-US, V35, P1323, DOI 10.1021/bi952409k; De BP, 1999, MICROSC RES TECHNIQ, V47, P114, DOI 10.1002/(SICI)1097-0029(19991015)47:2<114::AID-JEMT4>3.3.CO;2-5; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; DESHPANDE KL, 1985, VIROLOGY, V140, P125, DOI 10.1016/0042-6822(85)90451-9; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2007, CURR PROTEIN PEPT SC, V8, P161, DOI 10.2174/138920307780363406; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DUNKER AK, 1998, PAC S BIOCOMP, V3, P473; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Ferron F, 2005, J GEN VIROL, V86, P743, DOI 10.1099/vir.0.80590-0; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fontana A, 1997, FOLD DES, V2, pR17, DOI 10.1016/S1359-0278(97)00010-2; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; GELY S, 2010, J MOL RECOG IN PRESS; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; HE B, 2009, CELL RES; Houben K, 2007, BIOPHYS J, V93, P2830, DOI 10.1529/biophysj.107.108829; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; IWASAKI M, 2009, J VIROL; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Jordan IK, 2000, MOL BIOL EVOL, V17, P75, DOI 10.1093/oxfordjournals.molbev.a026240; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Karlin D, 2002, VIROLOGY, V302, P420, DOI 10.1006/viro.2002.1634; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Kavalenka A, 2010, BIOPHYS J, V98, P1055, DOI 10.1016/j.bpj.2009.11.036; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kingston RL, 2008, J MOL BIOL, V379, P719, DOI 10.1016/j.jmb.2007.12.080; Kovacs E, 2010, P NATL ACAD SCI USA, V107, P5429, DOI 10.1073/pnas.0907841107; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Laine D, 2003, J VIROL, V77, P11332, DOI 10.1128/JVI.77.21.11332-11346.2003; Laine D, 2005, J GEN VIROL, V86, P1771, DOI 10.1099/vir.0.80791-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; LISTON P, 1995, VIRUS RES, V38, P241, DOI 10.1016/0168-1702(95)00067-Z; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Lou ZY, 2006, FEBS J, V273, P4538, DOI 10.1111/j.1742-4658.2006.05459.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morin B, 2006, J PHYS CHEM B, V110, P20596, DOI 10.1021/jp063708u; MOYER SA, 1990, J GEN VIROL, V71, P775, DOI 10.1099/0022-1317-71-4-775; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; RANCUREL C, 2009, J VIROL; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sato H, 2006, VIROLOGY, V352, P121, DOI 10.1016/j.virol.2006.04.013; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Sleeman K, 2008, J GEN VIROL, V89, P1300, DOI 10.1099/vir.0.83582-0; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Tarbouriech N, 2000, VIROLOGY, V266, P99, DOI 10.1006/viro.1999.0066; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky V. N., 2002, J BIOL CHEM, V25, P25; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; UVERSKY VN, 2010, INSTRUMENTAL ANAL IN, P525; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VANHOY M, 1993, CELL, V72, P587, DOI 10.1016/0092-8674(93)90077-4; Wang LF, 2000, J VIROL, V74, P9972, DOI 10.1128/JVI.74.21.9972-9979.2000; Watanabe N, 1996, MED MICROBIOL IMMUN, V185, P89, DOI 10.1007/s004300050019; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; WU J, 1992, ANAL BIOCHEM, V200, P359, DOI 10.1016/0003-2697(92)90479-Q; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	138	60	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11684	10.1371/journal.pone.0011684	http://dx.doi.org/10.1371/journal.pone.0011684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657787	gold, Green Published, Green Submitted			2022-12-25	WOS:000280197500024
J	Steer, B; Adler, B; Jonjic, S; Stewart, JP; Adler, H				Steer, Beatrix; Adler, Barbara; Jonjic, Stipan; Stewart, James P.; Adler, Heiko			A Gammaherpesvirus Complement Regulatory Protein Promotes Initiation of Infection by Activation of Protein Kinase Akt/PKB	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; BACTERIAL ARTIFICIAL CHROMOSOME; FOCAL ADHESION KINASE; EPSTEIN-BARR VIRUS; PHOSPHATIDYLINOSITOL 3-KINASE; MONOCLONAL-ANTIBODIES; MICROTUBULE DYNAMICS; SIGNAL-TRANSDUCTION; PSEUDORABIES VIRUS; IMMUNE EVASION	Background: Viruses have evolved to evade the host's complement system. The open reading frames 4 (ORF4) of gammaherpesviruses encode homologs of regulators of complement activation (RCA) proteins, which inhibit complement activation at the level of C3 and C4 deposition. Besides complement regulation, these proteins are involved in heparan sulfate and glycosaminoglycan binding, and in case of MHV-68, also in viral DNA synthesis in macrophages. Methodology/Principal Findings: Here, we made use of MHV-68 to study the role of ORF4 during infection of fibroblasts. While attachment and penetration of virions lacking the RCA protein were not affected, we observed a delayed delivery of the viral genome to the nucleus of infected cells. Analysis of the phosphorylation status of a variety of kinases revealed a significant reduction in phosphorylation of the protein kinase Akt in cells infected with ORF4 mutant virus, when compared to cells infected with wt virus. Consistent with a role of Akt activation in initial stages of infection, inhibition of Akt signaling in wt virus infected cells resulted in a phenotype resembling the phenotype of the ORF4 mutant virus, and activation of Akt by addition of insulin partially reversed the phenotype of the ORF4 mutant virus. Importantly, the homologous ORF4 of KSHV was able to rescue the phenotype of the MHV-68 ORF4 mutant, indicating that ORF4 is functionally conserved and that ORF4 of KSHV might have a similar function in infection initiation. Conclusions/Significance: In summary, our studies demonstrate that ORF4 contributes to efficient infection by activation of the protein kinase Akt and thus reveal a novel function of a gammaherpesvirus RCA protein.	[Steer, Beatrix; Adler, Heiko] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Hematopoiet Cell Transplantat, Inst Mol Immunol, Munich, Germany; [Adler, Barbara] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Jonjic, Stipan] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia; [Stewart, James P.] Univ Liverpool, Dept Med Microbiol, Ctr Comparat Infect Dis, Liverpool L69 3BX, Merseyside, England	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Rijeka; University of Liverpool	Steer, B (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Hematopoiet Cell Transplantat, Inst Mol Immunol, Munich, Germany.	h.adler@helmholtz-muenchen.de	Adler, Heiko/M-7355-2014; Stewart, James/A-6034-2012; Jonjic, Stipan/C-5657-2016	Adler, Heiko/0000-0002-6481-6709; Stewart, James/0000-0002-8928-2037; Jonjic, Stipan/0000-0001-5003-3108	Deutsche Forschungsgemeinschaft (DFG) [Ad 121/2-1, 2-4]; Bundesministerium fuer Bildung und Forschung (BMBF); Nationales Genomforschungsnetz [FKZ 01GS0802]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Nationales Genomforschungsnetz	This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG), Ad 121/2-1 to 2-4, and from the Bundesministerium fuer Bildung und Forschung (BMBF), Nationales Genomforschungsnetz (NGFNplus, FKZ 01GS0802), to H.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Blue CE, 2004, VIROLOGY, V319, P176, DOI 10.1016/j.virol.2003.11.029; Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; COOPER NR, 1991, IMMUNOL TODAY, V12, P327, DOI 10.1016/0167-5699(91)90010-Q; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Covarrubias S, 2009, J VIROL, V83, P9554, DOI 10.1128/JVI.01051-09; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FODOR WL, 1995, J VIROL, V69, P3889, DOI 10.1128/JVI.69.6.3889-3892.1995; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gillet L, 2009, J GEN VIROL, V90, P602, DOI 10.1099/vir.0.005785-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001669; HARRIS SL, 1990, J INFECT DIS, V162, P331, DOI 10.1093/infdis/162.2.331; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; Kapadia SB, 2002, IMMUNITY, V17, P143, DOI 10.1016/S1074-7613(02)00369-2; Kapadia SB, 1999, J VIROL, V73, P7658, DOI 10.1128/JVI.73.9.7658-7670.1999; KARGER A, 1993, VIROLOGY, V194, P654, DOI 10.1006/viro.1993.1305; Klupp BG, 1998, J VIROL, V72, P1949, DOI 10.1128/JVI.72.3.1949-1958.1998; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; Krishnan HH, 2006, J VIROL, V80, P1167, DOI 10.1128/JVI.80.3.1167-1180.2006; Lachmann PJ, 1997, IMMUNOL REV, V159, P69, DOI 10.1111/j.1600-065X.1997.tb01007.x; Laquerre S, 1998, J VIROL, V72, P6119, DOI 10.1128/JVI.72.7.6119-6130.1998; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mark L, 2006, MOL IMMUNOL, V43, P1665, DOI 10.1016/j.molimm.2005.09.016; Mark L, 2007, MOL IMMUNOL, V44, P11, DOI 10.1016/j.molimm.2006.06.018; Mark L, 2007, J VIROL, V81, P4166, DOI 10.1128/JVI.02069-06; Mathew E, 1998, J VIROL, V72, P2429, DOI 10.1128/JVI.72.3.2429-2438.1998; MCNEARNEY TA, 1987, J EXP MED, V166, P1525, DOI 10.1084/jem.166.5.1525; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; MILLER N, 1988, J VIROL, V62, P2366, DOI 10.1128/JVI.62.7.2366-2372.1988; Mullick J, 2003, J VIROL, V77, P3878, DOI 10.1128/JVI.77.6.3878-3881.2003; Nakano MY, 2000, J VIROL, V74, P7085, DOI 10.1128/JVI.74.15.7085-7095.2000; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Okamura H, 2007, CELL BIOL INT, V31, P119, DOI 10.1016/j.cellbi.2006.09.014; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Peng L, 2010, J GEN VIROL, V91, P463, DOI 10.1099/vir.0.015073-0; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Raghu H, 2007, J VIROL, V81, P7941, DOI 10.1128/JVI.02848-06; ROIZMAN B, 1985, VIROLOGY, P69; ROTHER RP, 1994, J VIROL, V68, P730, DOI 10.1128/JVI.68.2.730-737.1994; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sahu A, 1998, IMMUNOL RES, V17, P109, DOI 10.1007/BF02786436; Sanlioglu S, 2000, J VIROL, V74, P9184, DOI 10.1128/JVI.74.19.9184-9196.2000; SHAMAWALIA N, 2005, J VIROL, V79, P10308; Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004; Sieczkarski SB, 2005, CURR TOP MICROBIOL, V285, P1; Singh AK, 2006, J BIOL CHEM, V281, P23119, DOI 10.1074/jbc.M603085200; Spiller OB, 2006, J VIROL, V80, P4068, DOI 10.1128/JVI.80.8.4068-4078.2006; Spiller OB, 2003, J VIROL, V77, P592, DOI 10.1128/JVI.77.1.592-599.2003; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Tarakanova VL, 2010, VIROLOGY, V396, P323, DOI 10.1016/j.virol.2009.10.030; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; Tomlinson CC, 2008, J VIROL, V82, P6514, DOI 10.1128/JVI.02637-07; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wu TT, 2000, J VIROL, V74, P3659, DOI 10.1128/JVI.74.8.3659-3667.2000; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	69	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11672	10.1371/journal.pone.0011672	http://dx.doi.org/10.1371/journal.pone.0011672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657771	Green Submitted, Green Published, gold			2022-12-25	WOS:000280197500017
J	Andreasson, K; Eriksson, M; Tegerstedt, K; Ramqvist, T; Dalianis, T				Andreasson, Kalle; Eriksson, Mathilda; Tegerstedt, Karin; Ramqvist, Torbjorn; Dalianis, Tina			CD4(+) and CD8(+) T Cells Can Act Separately in Tumour Rejection after Immunization with Murine Pneumotropic Virus Chimeric Her2/neu Virus-Like Particles	PLOS ONE			English	Article							NK CELLS; ANTITUMOR IMMUNITY; IFN-GAMMA; DNA VACCINATION; HEPARAN-SULFATE; DENDRITIC CELLS; POLYOMA-VIRUS; ANTIGEN; MICE; EXPRESSION	Background: Immunization with murine pneumotropic virus virus-like particles carrying Her2/neu (Her2MPtVLPs) prevents tumour outgrowth in mice when given prophylactically, and therapeutically if combined with the adjuvant CpG. We investigated which components of the immune system are involved in tumour rejection, and whether long-term immunological memory can be obtained. Methodology and Results: During the effector phase in BALB/c mice, only depletion of CD4(+) and CD8(+) in combination, with or without NK cells, completely abrogated tumour protection. Depletion of single CD4(+), CD8(+) or NK cell populations only had minor effects. During the immunization/induction phase, combined depletion of CD4(+) and CD8(+) cells abolished protection, while depletion of each individual subset had no or negligible effect. When tumour rejection was studied in knock-out mice with a C57B1/6 background, protection was lost in CD4(-/-) CD8(-/-) and CD4(-/-), but not in CD8(-/-) mice. In contrast, when normal C57B1/6 mice were depleted of different cell types, protection was lost irrespective of whether only CD4(+), only CD8(+), or CD4(+) and CD8(+) cells in combination were eradicated. No anti-Her2/neu antibodies were detected but a Her2/neu-specific IFN gamma response was seen. Studies of long-term memory showed that BALB/c mice could be protected against tumour development when immunized together with CpG as long as ten weeks before challenge. Conclusion: Her2MPtVLP immunization is efficient in stimulating several compartments of the immune system, and induces an efficient immune response including long-term memory. In addition, when depleting mice of isolated cellular compartments, tumour protection is not as efficiently abolished as when depleting several immune compartments together.	[Andreasson, Kalle; Eriksson, Mathilda; Tegerstedt, Karin; Ramqvist, Torbjorn; Dalianis, Tina] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Andreasson, K (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Karl.Andreasson@ltv.se		Dalianis, Tina/0000-0001-7022-2424; Andreasson, Karl-Magnus/0000-0002-5981-1962	Swedish Cancer Foundation; Swedish Medical Research Council; Gustav Vth Jubilee Society; Stockholm Cancer Society; European Union [LSHB-CT-2004-005246]; Stockholm City Council; Karolinska Institutet	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Gustav Vth Jubilee Society; Stockholm Cancer Society; European Union(European Commission); Stockholm City Council; Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Foundation, the Swedish Medical Research Council, the Gustav Vth Jubilee Society, the Stockholm Cancer Society, a European Union Sixth Framework Programme project (LSHB-CT-2004-005246, COMPUVAC), the Stockholm City Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson K, 2009, INT J CANCER, V124, P150, DOI 10.1002/ijc.23920; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Boura E, 2005, FEBS LETT, V579, P6549, DOI 10.1016/j.febslet.2005.10.062; Braun SE, 2000, J IMMUNOL, V164, P4025, DOI 10.4049/jimmunol.164.8.4025; Bronte V, 2000, CANCER RES, V60, P253; Cheng WF, 2003, GENE THER, V10, P1311, DOI 10.1038/sj.gt.3301982; Disis ML, 2000, BREAST CANCER RES TR, V62, P245, DOI 10.1023/A:1006438507898; FRIED H, 1981, VIROLOGY, V109, P188, DOI 10.1016/0042-6822(81)90485-2; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Huebener N, 2009, MOL CANCER THER, V8, P2392, DOI 10.1158/1535-7163.MCT-09-0107; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kosaka A, 2007, INT IMMUNOL, V19, P249, DOI 10.1093/intimm/dxl140; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Lin ML, 2006, XENOTRANSPLANTATION, V13, P536, DOI 10.1111/j.1399-3089.2006.00348.x; Lindencrona JA, 2004, INT J CANCER, V109, P259, DOI 10.1002/ijc.11654; Mendiratta SK, 2001, CANCER RES, V61, P859; Moore ML, 2008, VIRAL IMMUNOL, V21, P327, DOI 10.1089/vim.2008.0003; Najar HM, 2007, EUR J IMMUNOL, V37, P2242, DOI 10.1002/eji.200636212; Nawrath M, 2001, J MOL MED-JMM, V79, P133, DOI 10.1007/s001090000159; O IS, 2003, CANCER GENE THER, V10, P678, DOI 10.1038/sj.cgt.7700620; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; Piechocki MP, 2001, CELL IMMUNOL, V212, P138, DOI 10.1006/cimm.2001.1853; PUPA SM, 1993, CANCER RES, V53, P5864; REDMOND MJ, 1993, VACCINE, V11, P273, DOI 10.1016/0264-410X(93)90029-W; Riezebos-Brilman A, 2007, GENE THER, V14, P1695, DOI 10.1038/sj.gt.3303036; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Schafer K, 1999, INT J CANCER, V81, P881, DOI 10.1002/(SICI)1097-0215(19990611)81:6<881::AID-IJC8>3.3.CO;2-K; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Snyder LA, 2006, VACCINE, V24, P3340, DOI 10.1016/j.vaccine.2006.01.014; Song K, 2000, GENE THER, V7, P1527, DOI 10.1038/sj.gt.3301274; Sorensen MR, 2009, EUR J IMMUNOL, V39, P2725, DOI 10.1002/eji.200939543; Sugiura D, 2008, CANCER SCI, V99, P2477, DOI 10.1111/j.1349-7006.2008.00967.x; Takehara T, 2007, INT J CANCER, V120, P1252, DOI 10.1002/ijc.22152; Tegerstedt K, 2005, CANCER RES, V65, P5953, DOI 10.1158/0008-5472.CAN-05-0335; Tegerstedt K, 2003, J GEN VIROL, V84, P3443, DOI 10.1099/vir.0.19443-0; Tegerstedt K, 2007, CANCER IMMUNOL IMMUN, V56, P1335, DOI 10.1007/s00262-007-0281-8; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Ueda R, 2008, INT J CANCER, V122, P2274, DOI 10.1002/ijc.23366; Wang LF, 2009, VACCINE, V28, P561, DOI 10.1016/j.vaccine.2009.09.119; Wen T, 1998, IMMUNOL LETT, V61, P187, DOI 10.1016/S0165-2478(98)00022-4; Wu HJ, 2007, J EXP MED, V204, P1911, DOI 10.1084/jem.20070285; Zhai YF, 1996, J IMMUNOL, V156, P700	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11580	10.1371/journal.pone.0011580	http://dx.doi.org/10.1371/journal.pone.0011580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657846	Green Submitted, Green Published, gold			2022-12-25	WOS:000280065600005
J	Maestre, A; Muskus, C; Duque, V; Agudelo, O; Liu, P; Takagi, A; Ntumngia, FB; Adams, JH; Sim, KL; Hoffman, SL; Corradin, G; Velez, ID; Wang, RB				Maestre, Amanda; Muskus, Carlos; Duque, Victoria; Agudelo, Olga; Liu, Pu; Takagi, Akihide; Ntumngia, Francis B.; Adams, John H.; Sim, Kim Lee; Hoffman, Stephen L.; Corradin, Giampietro; Velez, Ivan D.; Wang, Ruobing			Acquired Antibody Responses against Plasmodium vivax Infection Vary with Host Genotype for Duffy Antigen Receptor for Chemokines (DARC)	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PAPUA-NEW-GUINEA; BLOOD-GROUP LOCUS; FALCIPARUM MALARIA; IMMUNE-RESPONSES; PREERYTHROCYTIC ANTIGENS; NEGATIVE INDIVIDUALS; NATURAL-SELECTION; DENDRITIC CELLS; STAGE INFECTION	Background: Polymorphism of the Duffy Antigen Receptor for Chemokines (DARC) is associated with susceptibility to and the severity of Plasmodium vivax malaria in humans. P. vivax uses DARC to invade erythrocytes. Individuals lacking DARC are 'resistant' to P. vivax erythrocytic infection. However, susceptibility to P. vivax in DARC+ individuals is reported to vary between specific DARC genotypes. We hypothesized that the natural acquisition of antibodies to P. vivax blood stages may vary with the host genotype and the level of DARC expression. Furthermore, high parasitemia has been reported to effect the acquisition of immunity against pre-erythrocytic parasites. We investigated the correlation between host DARC genotypes and the frequency and magnitude of antibodies against P. vivax erythrocytic stage antigens. Methodology/Findings: We assessed the frequencies and magnitudes of antibody responses against P. vivax and P. falciparum sporozoite and erythrocytic antigens in Colombian donors from malaria-endemic regions. The frequency and level of naturally-acquired antibodies against the P. vivax erythrocytic antigens merozoite surface protein 1 (PvMSP1) and Duffy binding protein (PvDBP) varied with the host DARC genotypes. Donors with one negative allele (FY*B/FY*Bnull and FY*A/FY*Bnull) were more likely to have anti-PvMSP1 and anti-PvDBP antibodies than those with two positive alleles (FY*B/FY*B and FY*A/FY*B). The lower IgG3 and IgG1 components of the total IgG response may account for the decreased responses to P. vivax erythrocytic antigens with FY*A/FY*B and FY*B/FY*B genotypes. No such association was detected with P. falciparum erythrocytic antigens, which does not use DARC for erythrocyte invasion. Conclusion/Significance: Individuals with higher DARC expression, which is associated with higher susceptibility to P. vivax infection, exhibited low frequencies and magnitudes of P. vivax blood-stage specific antibody responses. This may indicate that one of the primary mechanisms by which P. vivax evades host immunity is through DARC indirectly down-regulating humoral responses against erythrocytic invasion and development.	[Maestre, Amanda] Univ Antioquia, Fac Med, Grp Salud & Comunidad, Medellin, Colombia; [Muskus, Carlos; Duque, Victoria; Agudelo, Olga; Velez, Ivan D.] Univ Antioquia, Fac Med, PECET, Medellin, Colombia; [Liu, Pu; Takagi, Akihide; Wang, Ruobing] SBRI, Seattle, WA USA; [Ntumngia, Francis B.; Adams, John H.] Univ S Florida, Tampa, FL USA; [Sim, Kim Lee] Prot Potential LLC, Rockville, MD USA; [Hoffman, Stephen L.] Sanaria, Rockville, MD USA; [Corradin, Giampietro] Univ Lausanne, Dept Biochem, Lausanne, Switzerland	Universidad de Antioquia; Universidad de Antioquia; Center for Infectious Disease Research; State University System of Florida; University of South Florida; Sanaria Inc.; University of Lausanne	Maestre, A (corresponding author), Univ Antioquia, Fac Med, Grp Salud & Comunidad, Medellin, Colombia.	ruobing.wang@seattlebiomed.org	Muskus, Carlos Enrique/AAF-5247-2022; Muskus, Carlos Enrique/AFJ-8423-2022; Adams, John H./ABB-8458-2020; Adams, John/G-1800-2015	Adams, John H./0000-0003-3707-7979; Adams, John/0000-0003-3707-7979; Ntumngia, Francis/0000-0001-9867-3534	NIH [R01 AI057592]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057592, R01AI064478] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH R01 grant (AI057592) and Non-Government research support. The funders had no role in study design, data collection and analysis, decision for publication, or preparation of the manuscript.	Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; Barbedo MB, 2007, MEM I OSWALDO CRUZ, V102, P335, DOI 10.1590/S0074-02762007005000040; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Blair S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-14; Carmona-Fonseca J, 2004, LATREIA, V17, P34; CARMONAFONSECA J, 2003, LATREIA, V16, P34; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; Cavasini CE, 2006, HUM BIOL, V78, P215, DOI 10.1353/hub.2006.0034; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chittenden VA, 2008, VOICES, V34, P24; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; FORABOSCO P, 1995, ANN HUM GENET, V59, P291, DOI 10.1111/j.1469-1809.1995.tb00749.x; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Gardner L, 2004, BIOCHEM BIOPH RES CO, V321, P306, DOI 10.1016/j.bbrc.2004.06.146; GELPI AP, 1976, SCIENCE, V191, P1284, DOI 10.1126/science.1257752; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; GREENWOOD BM, 1972, LANCET, V1, P169; Gruner AC, 2003, TRENDS PARASITOL, V19, P74, DOI 10.1016/S1471-4922(02)00067-3; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; Horne K, 2009, INFLAMM RES, V58, P431, DOI 10.1007/s00011-009-0023-9; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kalmbach Y, 2009, PARASITOL RES, V104, P575, DOI 10.1007/s00436-008-1232-9; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; Kasehagen LJ, 2006, AM J TROP MED HYG, V75, P588, DOI 10.4269/ajtmh.2006.75.588; Kemp K, 2002, CLIN EXP IMMUNOL, V127, P151, DOI 10.1046/j.1365-2249.2002.01714.x; KREMSNER PG, 1990, J INFECT DIS, V161, P1025, DOI 10.1093/infdis/161.5.1025; Kumar R, 2007, OPT LASER TECHNOL, V39, P256, DOI 10.1016/j.optlastec.2005.08.008; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Lopez JA, 2001, EUR J IMMUNOL, V31, P1989, DOI 10.1002/1521-4141(200107)31:7&lt;1989::AID-IMMU1989&gt;3.0.CO;2-M; LYON JA, 1987, J IMMUNOL, V138, P895; MARCHAND C, 1990, B WORLD HEALTH ORGAN, V68, P158; MATHEW S, 1994, CYTOGENET CELL GENET, V67, P68, DOI 10.1159/000133801; MENARD D, 2010, P NATL ACAD SCI US; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Moreno A, 2008, VACCINE, V26, P4338, DOI 10.1016/j.vaccine.2008.06.010; Mueller I, 2009, VACCINE, V27, P5633, DOI [10.1016/j.vaccine.2009.07.018, 10.1016/j.vaccine.2009.08.112]; Nogueira PA, 2006, INFECT IMMUN, V74, P2726, DOI 10.1128/IAI.74.5.2726-2733.2006; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; Oliveira-Ferreira J, 2004, ACTA TROP, V92, P63, DOI 10.1016/j.actatropica.2004.02.011; ORJIH AU, 1979, CLIN EXP IMMUNOL, V38, P1; *PAHO, 2003, CD44INF3 PAHO; Pogo AO, 2000, SEMIN HEMATOL, V37, P122, DOI 10.1016/S0037-1963(00)90037-4; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; RILEY E, 1990, IMMUNOL LETT, V25, P221, DOI 10.1016/0165-2478(90)90119-B; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; SMITH MT, 1993, HUMAN ADAPTATION; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Valderrama-Aguirre A, 2005, AM J TROP MED HYG, V73, P16, DOI 10.4269/ajtmh.2005.73.16; Vergara C, 2008, AM J RESP CRIT CARE, V178, P1017, DOI 10.1164/rccm.200801-182OC; Wang RB, 2005, EUR J IMMUNOL, V35, P1859, DOI 10.1002/eji.200425807; WERTHEIMER SP, 1989, EXP PARASITOL, V69, P340, DOI 10.1016/0014-4894(89)90083-0; Wickramarachchi T, 2007, INT J PARASITOL, V37, P199, DOI 10.1016/j.ijpara.2006.09.002; Wipasa J, 2001, J IMMUNOL, V167, P3903, DOI 10.4049/jimmunol.167.7.3903; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Woolley IJ, 2000, TRANSFUSION, V40, P949, DOI 10.1046/j.1537-2995.2000.40080949.x; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013; Zijlstra A, 2006, CANCER CELL, V10, P177, DOI 10.1016/j.ccr.2006.08.012; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	79	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11437	10.1371/journal.pone.0011437	http://dx.doi.org/10.1371/journal.pone.0011437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20664684	Green Submitted, Green Published, gold			2022-12-25	WOS:000279924500001
J	Tang, K; Huang, HZ; Jiao, NZ; Wu, CH				Tang, Kai; Huang, Hongzhan; Jiao, Nianzhi; Wu, Cathy H.			Phylogenomic Analysis of Marine Roseobacters	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; GENOME INNOVATION; EVOLUTION; BACTERIA; DATABASE; CORE; IDENTIFICATION; METABOLISM; DIVERSITY; ALGORITHM	Background: Members of the Roseobacter clade which play a key role in the biogeochemical cycles of the ocean are diverse and abundant, comprising 10-25% of the bacterioplankton in most marine surface waters. The rapid accumulation of whole-genome sequence data for the Roseobacter clade allows us to obtain a clearer picture of its evolution. Methodology/Principal Findings: In this study about 1,200 likely orthologous protein families were identified from 17 Roseobacter bacteria genomes. Functional annotations for these genes are provided by iProClass. Phylogenetic trees were constructed for each gene using maximum likelihood (ML) and neighbor joining (NJ). Putative organismal phylogenetic trees were built with phylogenomic methods. These trees were compared and analyzed using principal coordinates analysis (PCoA), approximately unbiased (AU) and Shimodaira-Hasegawa (SH) tests. A core set of 694 genes with vertical descent signal that are resistant to horizontal gene transfer (HGT) is used to reconstruct a robust organismal phylogeny. In addition, we also discovered the most likely 109 HGT genes. The core set contains genes that encode ribosomal apparatus, ABC transporters and chaperones often found in the environmental metagenomic and metatranscriptomic data. These genes in the core set are spread out uniformly among the various functional classes and biological processes. Conclusions/Significance: Here we report a new multigene-derived phylogenetic tree of the Roseobacter clade. Of particular interest is the HGT of eleven genes involved in vitamin B12 synthesis as well as key enzynmes for dimethylsulfoniopropionate (DMSP) degradation. These aquired genes are essential for the growth of Roseobacters and their eukaryotic partners.	[Tang, Kai; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Huang, Hongzhan; Wu, Cathy H.] Georgetown Univ, Washington, DC USA; [Huang, Hongzhan; Wu, Cathy H.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE USA	Xiamen University; Georgetown University; University of Delaware	Tang, K (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	jiao@xmu.edu.cn; wuc@georgetown.edu	Crozier, Laura B./A-4821-2010	Wu, Cathy/0000-0001-6379-8601	National Institutes of Health (NIH) [U01-HG02712]; NSFC [40906079]; MOST [2007CB815904]; Ph.D. Programs Foundation of Ministry of Education of China [200803841021]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG002712] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); MOST; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The bioinformatics infrastructure for this study was supported in part by National Institutes of Health (NIH) grant U01-HG02712. This work was supported by NSFC 40906079, the MOST project 2007CB815904 and Ph.D. Programs Foundation of Ministry of Education of China 200803841021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Beiko RG, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-15; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bouxin G, 2005, J VEG SCI, V16, P355, DOI 10.1111/j.1654-1103.2005.tb02374.x; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Brown JR, 2004, BIOESSAYS, V26, P463, DOI 10.1002/bies.20030; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Castresana J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-216; Charlebois RL, 2003, NATURE, V421, P217, DOI 10.1038/421217a; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Eisen JA, 2003, SCIENCE, V300, P1706, DOI 10.1126/science.1086292; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Galtier N, 2008, PHILOS T R SOC B, V363, P4023, DOI 10.1098/rstb.2008.0144; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Poptsova MS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-45; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schouls LM, 2003, J BACTERIOL, V185, P7241, DOI 10.1128/JB.185.24.7241-7246.2003; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor GT, 2008, LIMNOL OCEANOGR, V53, P1862, DOI 10.4319/lo.2008.53.5.1862; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; Wu CH, 2004, COMPUT BIOL CHEM, V28, P87, DOI 10.1016/j.compbiolchem.2003.10.003; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78; Zhao YL, 2009, ISME J, V3, P364, DOI 10.1038/ismej.2008.115; Zhaxybayeva O, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-37; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	59	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11604	10.1371/journal.pone.0011604	http://dx.doi.org/10.1371/journal.pone.0011604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657646	Green Submitted, Green Published, gold			2022-12-25	WOS:000279924500008
J	Batabyal, D; McKenzie, JL; Johnson, KA				Batabyal, Dipanwita; McKenzie, Jessica L.; Johnson, Kenneth A.			Role of Histidine 932 of the Human Mitochondrial DNA Polymerase in Nucleotide Discrimination and Inherited Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HIV REVERSE-TRANSCRIPTASE; NUCLEOSIDE ANALOGS; CRYSTAL-STRUCTURE; ALPERS-SYNDROME; KINETIC-DATA; INDUCED-FIT; REPLICATION; MUTATIONS; FIDELITY	The human mitochondrial DNA polymerase (pol gamma) is nuclearly encoded and is solely responsible for the replication and repair of the mitochondrial genome. The progressive accumulation of mutations within the mitochondrial genome is thought to be related to aging, and mutations in the pol gamma gene are responsible for numerous heritable disorders including progressive external opthalmoplegia, Alpers syndrome, and parkinsonism. Here we investigate the kinetic effect of H932Y, a mutation associated with opthalmoplegia. Mutations H932Y and H932A reduce the specificity constant governing correct nucleotide incorporation 150- and 70-fold, respectively, without significantly affecting fidelity of incorporation or the maximum rate of incorporation. However, this leads to only a 2-fold reduction in rate of incorporation at a physiological nucleotide concentration (similar to 100 mu M). Surprisingly, incorporation of T: T or C: T mismatches catalyzed by either H932Y or H932A mutants was followed by slow pyrophosphate release (or fast pyrophosphate rebinding). Also, H932Y readily catalyzed incorporation of multiple mismatches, which may have a profound physiological impact over time. His-932 is thought to contact the beta-phosphate of the incoming nucleotide, so it is perhaps surprising that H932Y appears to slow rather than accelerate pyrophosphate release.	[Batabyal, Dipanwita; McKenzie, Jessica L.; Johnson, Kenneth A.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [R01 GM 044613]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 044613 (to K. A. J.). This work was also supported by the Welch Foundation (F-1604) to K. A. J.).	Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316; Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Roitberg AE, 2007, J PHYS CHEM B, V111, P2415, DOI 10.1021/jp068335b; STEITZ TA, 1993, COLD SPRING HARB SYM, V58, P495, DOI 10.1101/SQB.1993.058.01.056; Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; Truniger V, 2002, NUCLEIC ACIDS RES, V30, P1483, DOI 10.1093/nar/30.7.1483; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200	35	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34191	34201		10.1074/jbc.M110.156182	http://dx.doi.org/10.1074/jbc.M110.156182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20685647	Green Published, hybrid			2022-12-25	WOS:000283354000064
J	Mosialou, I; Zannis, VI; Kardassis, D				Mosialou, Ioanna; Zannis, Vassilis I.; Kardassis, Dimitris			Regulation of Human Apolipoprotein M Gene Expression by Orphan and Ligand-dependent Nuclear Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; BETA-HDL FORMATION; TRANSCRIPTIONAL REGULATION; CHOLESTEROL EFFLUX; IN-VITRO; PROXIMAL PROMOTER; RESPONSE ELEMENTS; SIGNAL PEPTIDE; PLASMA	Apolipoprotein M (apoM) plays an important role in the biogenesis and the metabolism of anti-atherogenic HDL particles in plasma and is expressed primarily in the liver and the kidney. We investigated the role of hormone nuclear receptors in apoM gene regulation in hepatic cells. Overexpression via adenovirus-mediated gene transfer and siRNA-mediated gene silencing established that hepatocyte nuclear factor 4 (HNF-4) is an important regulator of apoM gene transcription in hepatic cells. apoM promoter deletion analysis combined with DNA affinity precipitation and chromatin immunoprecipitation assays revealed that HNF-4 binds to a hormone-response element (HRE) in the proximal apoM promoter (nucleotides -33 to -21). Mutagenesis of this HRE decreased basal hepatic apoM promoter activity to 10% of control and abolished the HNF4-mediated transactivation of the apoM promoter. In addition to HNF-4, homodimers of retinoid X receptor and heterodimers of retinoid X receptor with receptors for retinoic acid, thyroid hormone, fibrates (peroxisome proliferator-activated receptor), and oxysterols (liver X receptor) were shown to bind with different affinities to the proximal HRE in vitro and in vivo. Ligands of these receptors strongly induced human apoM gene transcription and apoM promoter activity in HepG2 cells, whereas mutations in the proximal HRE abolished this induction. These findings provide novel insights into the role of apoM in the regulation of HDL by steroid hormones and into the development of novel HDL-based therapies for diseases such as diabetes, obesity, metabolic syndrome, and coronary artery disease that affect a large proportion of the population in Western countries.	[Kardassis, Dimitris] Univ Crete, Sch Med, Dept Biochem, Iraklion 71003, Greece; Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71003, Greece; [Zannis, Vassilis I.] Boston Univ, Med Ctr, Mol Genet Sect, Boston, MA 02118 USA	University of Crete; Foundation for Research & Technology - Hellas (FORTH); Boston University	Kardassis, D (corresponding author), Univ Crete, Sch Med, Dept Biochem, Iraklion 71003, Greece.	kardasis@imbb.forth.gr		Zannis, Vassilis/0000-0002-1295-7155	Greek Ministry of Development, General Secretariat for Research and Technology [PENED03-780]; Institute of Molecular Biology and Biotechnology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048739] Funding Source: NIH RePORTER	Greek Ministry of Development, General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Institute of Molecular Biology and Biotechnology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Greek Ministry of Development, General Secretariat for Research and Technology Grant PENED03-780, and by Institute of Molecular Biology and Biotechnology internal funds (to D. K.).	Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Axler O, 2007, J LIPID RES, V48, P1772, DOI 10.1194/jlr.M700113-JLR200; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Calayir E, 2008, CURR PHARM BIOTECHNO, V9, P516, DOI 10.2174/138920108786786376; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Christoffersen C, 2008, J BIOL CHEM, V283, P18765, DOI 10.1074/jbc.M800695200; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Dahlback B, 2009, CELL MOL LIFE SCI, V66, P559, DOI 10.1007/s00018-009-8764-8; Davidson MH, 2007, AM J CARDIOL, V100, p32N, DOI 10.1016/j.amjcard.2007.08.011; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Dullaart RPF, 2009, CLIN CHIM ACTA, V406, P129, DOI 10.1016/j.cca.2009.06.010; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hao GQ, 2007, CLIN BIOCHEM, V40, P1108, DOI 10.1016/j.clinbiochem.2007.04.023; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Houck KA, 2004, MOL GENET METAB, V83, P184, DOI 10.1016/j.ymgme.2004.07.007; Hu YW, 2010, BBA-MOL CELL BIOL L, V1801, P100, DOI 10.1016/j.bbalip.2009.10.013; Kardassis D, 1997, ARTERIOSCL THROM VAS, V17, P222, DOI 10.1161/01.ATV.17.1.222; Kardassis D., 2007, HIGH DENSITY LIPOPRO, P237; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; KRITIS AA, 1993, NUCLEIC ACIDS RES, V21, P5882, DOI 10.1093/nar/21.25.5882; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lavrentiadou SN, 1999, BIOCHEMISTRY-US, V38, P964, DOI 10.1021/bi981068i; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MILLER GJ, 1975, LANCET, V1, P16; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Naiki T, 2002, J BIOL CHEM, V277, P14011, DOI 10.1074/jbc.M105403200; Nielsen LB, 2009, TRENDS ENDOCRIN MET, V20, P66, DOI 10.1016/j.tem.2008.11.003; Niu NF, 2007, DIABETES-METAB RES, V23, P21, DOI 10.1002/dmrr.641; Piek E, 1999, J CELL SCI, V112, P4557; Plomgaard P, 2009, J INTERN MED, V266, P258, DOI 10.1111/j.1365-2796.2009.02095.x; Qian A, 2000, BIOCHEM BIOPH RES CO, V276, P837, DOI 10.1006/bbrc.2000.3549; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Skupien Jan, 2007, Rev Diabet Stud, V4, P231, DOI 10.1900/RDS.2007.4.231; SLADEK FM, 1994, RECEPTOR, V4, P64; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Varga G, 2007, BIODRUGS, V21, P117, DOI 10.2165/00063030-200721020-00006; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Venteclef N, 2008, J BIOL CHEM, V283, P3694, DOI 10.1074/jbc.M706382200; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Wan YJY, 1998, EXP CELL RES, V238, P241, DOI 10.1006/excr.1997.3851; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Wolfrum C, 2008, J BIOL CHEM, V283, P16940, DOI 10.1074/jbc.M801930200; Wu XP, 2009, CLIN BIOCHEM, V42, P17, DOI 10.1016/j.clinbiochem.2008.10.008; Xu N, 2006, BIOCHEM BIOPH RES CO, V342, P1174, DOI 10.1016/j.bbrc.2006.02.022; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Xu WW, 2008, CLIN EXP PHARMACOL P, V35, P546, DOI 10.1111/j.1440-1681.2007.04822.x; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; ZANNIS VI, 1993, ADV HUM GENET, V21, P145; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis; Zannis VI., 2004, MOL MECH ATHEROSCLER, V8, P111; Zhang X, 2008, BIOCHEM BIOPH RES CO, V371, P114, DOI 10.1016/j.bbrc.2008.04.017; Zhang XY, 2007, BBA-MOL CELL BIOL L, V1771, P879, DOI 10.1016/j.bbalip.2007.04.020; Zhang XY, 2003, ACTA HISTOCHEM, V105, P67, DOI 10.1078/0065-1281-00687	68	28	33	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30719	30730		10.1074/jbc.M110.131771	http://dx.doi.org/10.1074/jbc.M110.131771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20660599	Green Published, hybrid			2022-12-25	WOS:000282135500040
J	Webby, CJ; Jiao, WT; Hutton, RD; Blackmore, NJ; Baker, HM; Baker, EN; Jameson, GB; Parker, EJ				Webby, Celia J.; Jiao, Wanting; Hutton, Richard D.; Blackmore, Nicola J.; Baker, Heather M.; Baker, Edward N.; Jameson, Geoffrey B.; Parker, Emily J.			Synergistic Allostery, a Sophisticated Regulatory Network for the Control of Aromatic Amino Acid Biosynthesis in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE SYNTHASE; ACTINOMYCETE AMYCOLATOPSIS-METHANOLICA; SOLANUM-TUBEROSUM-L; ESCHERICHIA-COLI; SHIKIMATE PATHWAY; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; SUBSTRATE AMBIGUITY	The shikimate pathway, responsible for aromatic amino acid biosynthesis, is required for the growth of Mycobacterium tuberculosis and is a potential drug target. The first reaction is catalyzed by 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS). Feedback regulation of DAH7PS activity by aromatic amino acids controls shikimate pathway flux. Whereas Mycobacterium tuberculosis DAH7PS (MtuDAH7PS) is not inhibited by the addition of Phe, Tyr, or Trp alone, combinations cause significant loss of enzyme activity. In the presence of 200 mu M Phe, only 2.4 mu M Trp is required to reduce enzymic activity to 50%. Reaction kinetics were analyzed in the presence of inhibitory concentrations of Trp/Phe or Trp/Tyr. In the absence of inhibitors, the enzyme follows Michaelis-Menten kinetics with respect to substrate erythrose 4-phosphate (E4P), whereas the addition of inhibitor combinations caused significant homotropic cooperativity with respect to E4P, with Hill coefficients of 3.3 (Trp/Phe) and 2.8 (Trp/Tyr). Structures of MtuDAH7PS/Trp/Phe, MtuDAH7PS/Trp, and MtuDAH7PS/Phe complexes were determined. The MtuDAH7PS/Trp/Phe homotetramer binds four Trp and six Phe molecules. Binding sites for both aromatic amino acids are formed by accessory elements to the core DAH7PS (beta/alpha)(8) barrel that are unique to the type II DAH7PS family and contribute to the tight dimer and tetramer interfaces. A comparison of the liganded and unliganded MtuDAH7PS structures reveals changes in the interface areas associated with inhibitor binding and a small displacement of the E4P binding loop. These studies uncover a previously unrecognized mode of control for the branched pathways of aromatic amino acid biosynthesis involving synergistic inhibition by specific pairs of pathway end products.	[Jiao, Wanting; Hutton, Richard D.; Blackmore, Nicola J.; Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch 8040, New Zealand; [Jiao, Wanting; Hutton, Richard D.; Blackmore, Nicola J.; Parker, Emily J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8040, New Zealand; [Webby, Celia J.; Jameson, Geoffrey B.] Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand; [Baker, Heather M.; Baker, Edward N.] Univ Auckland, Ctr Mol Biodiscovery, Auckland 1020, New Zealand; [Baker, Heather M.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1020, New Zealand	University of Canterbury; University of Canterbury; Massey University; University of Auckland; University of Auckland	Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Private Bag 4800, Christchurch 8040, New Zealand.	emily.parker@canterbury.ac.nz	Jiao, Wanting/I-3159-2019	Jiao, Wanting/0000-0002-0234-7206; Baker, Edward/0000-0003-2456-7661; Parker, Emily/0000-0002-9571-9987; Jameson, Geoffrey/0000-0003-4839-0784	Maurice Wilkins Centre for Molecular Biodiscovery; Health Research Council of New Zealand; New Zealand Marsden Fund [UOC710]; Massey University; New Zealand Tertiary Education Commission	Maurice Wilkins Centre for Molecular Biodiscovery; Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Massey University; New Zealand Tertiary Education Commission	This work was funded by the Maurice Wilkins Centre for Molecular Biodiscovery, the Health Research Council of New Zealand, and the New Zealand Marsden Fund (UOC710).; Recipient of a Massey University Vice Chancellor's Doctoral Scholarship.; Recipient of a New Zealand Tertiary Education Commission Top Doctoral Scholarship.	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Braxton BL, 1996, BIOCHEMISTRY-US, V35, P11918, DOI 10.1021/bi961305m; Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ijpara.2003.10.006; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DYER WE, 1990, J BIOL CHEM, V265, P1608; EUVERINK GJW, 1995, APPL ENVIRON MICROB, V61, P3796, DOI 10.1128/AEM.61.11.3796-3803.1995; Gosset G, 2001, J BACTERIOL, V183, P4061, DOI 10.1128/JB.183.13.4061-4070.2001; Guo JT, 2002, J AM CHEM SOC, V124, P10642, DOI 10.1021/ja026628m; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Helmstaedt K, 2005, P NATL ACAD SCI USA, V102, P9784, DOI 10.1073/pnas.0504238102; HOFFMANN PJ, 1972, BIOCHIM BIOPHYS ACTA, V268, P550, DOI 10.1016/0005-2744(72)90352-X; Jensen RA, 2002, J MOL EVOL, V54, P416, DOI 10.1007/s00239-001-0031-z; Kloosterman H, 2003, MICROBIOL-SGM, V149, P3321, DOI 10.1099/mic.0.26494-0; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Lin XH, 2009, PROTEIN EXPRES PURIF, V64, P8, DOI 10.1016/j.pep.2008.09.020; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Rattan A, 1998, EMERG INFECT DIS, V4, P195, DOI 10.3201/eid0402.980207; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schnappauf G, 1998, ARCH MICROBIOL, V169, P517, DOI 10.1007/s002030050605; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; Silakowski B, 2000, ARCH MICROBIOL, V173, P403, DOI 10.1007/s002030000162; Stokstad E, 2000, SCIENCE, V287, P2391; Subramaniam PS, 1998, J BACTERIOL, V180, P119, DOI 10.1128/JB.180.1.119-127.1998; TRIBE DE, 1976, J BACTERIOL, V127, P1085, DOI 10.1128/JB.127.3.1085-1097.1976; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; WALLACE BJ, 1967, J BACTERIOL, V93, P237, DOI 10.1128/JB.93.1.237-244.1967; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, ACTA CRYSTALLOGR F, V61, P403, DOI 10.1107/S1744309105007931; Webby CJ, 2005, BIOCHEM J, V390, P223, DOI 10.1042/BJ20050259; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Wu J, 2005, BIOCHEM J, V390, P583, DOI 10.1042/BJ20050294; WYMAN J, 1972, CURRENT TOPICS CELLU, V6, P209; ZHAO JM, 1992, PLANT PHYSIOL, V100, P1075, DOI 10.1104/pp.100.2.1075	49	52	52	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30567	30576		10.1074/jbc.M110.111856	http://dx.doi.org/10.1074/jbc.M110.111856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20667835	Green Published, hybrid			2022-12-25	WOS:000282135500025
J	Goussetis, DJ; Altman, JK; Glaser, H; McNeer, JL; Tallman, MS; Platanias, LC				Goussetis, Dennis J.; Altman, Jessica K.; Glaser, Heather; McNeer, Jennifer L.; Tallman, Martin S.; Platanias, Leonidas C.			Autophagy Is a Critical Mechanism for the Induction of the Antileukemic Effects of Arsenic Trioxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PROTEIN-KINASE PATHWAY; MALIGNANT GLIOMA-CELLS; MAMMALIAN TARGET; CELLULAR-RESPONSES; MYELOMA CELLS; UP-REGULATION; CANCER-CELLS; S6 KINASE; DEATH	Arsenic trioxide (As2O3) exhibits potent antitumor effects in vitro and in vivo, but the precise mechanisms by which it generates such responses are not well understood. We provide evidence that As2O3 is a potent inducer of autophagy in leukemia cells. Such induction of autophagy by As2O3 appears to require activation of the MEK/ERK pathway but not the AKT/mammalian target of rapamycin or JNK pathways. In efforts to understand the functional relevance of arsenic-induced autophagy, we found that pharmacological inhibitors of autophagy or molecular targeting of beclin 1 or Atg7 results in reversal of the suppressive effects of As2O3 on leukemic cell lines and primary leukemic progenitors from acute myelogenous leukemia patients. Altogether, our data provide direct evidence that autophagic cell death is critical for the generation of the effects of As2O3 on acute myelogenous leukemia cells and raise the potential of modulation of elements of the autophagic machinery as an approach to enhance the antitumor properties of As2O3 and possibly other heavy metal derivatives.	[Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [R01CA121192, R01CA77816, T32CA070085]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA077816, R01CA121192, T32CA070085, P30CA060553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA121192, R01CA77816, and T32CA070085. This work was also supported by a Merit Review grant from the Department of Veterans Affairs.	Altman JK, 2008, J BIOL CHEM, V283, P1992, DOI 10.1074/jbc.M705227200; Apel A, 2009, INT J CANCER, V125, P991, DOI 10.1002/ijc.24500; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Chen GQ, 1996, BLOOD, V88, P1052; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Dolniak B, 2008, J BIOL CHEM, V283, P12034, DOI 10.1074/jbc.M708816200; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Grander D, 2009, AUTOPHAGY, V5, P1198, DOI 10.4161/auto.5.8.10122; Huang YC, 2009, CHEM-BIOL INTERACT, V181, P254, DOI 10.1016/j.cbi.2009.06.020; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kamitsuji Y, 2008, CELL DEATH DIFFER, V15, P1712, DOI 10.1038/cdd.2008.107; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Laane E, 2009, CELL DEATH DIFFER, V16, P1018, DOI 10.1038/cdd.2009.46; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; McCafferty-Grad J, 2003, MOL CANCER THER, V2, P1155; Miller WH, 2002, CANCER RES, V62, P3893; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Paglin S, 2001, CANCER RES, V61, P439; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Shackelford D, 2006, CANCER RES, V66, P11360, DOI 10.1158/0008-5472.CAN-06-1774; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Tallman MS, 2008, SEMIN HEMATOL, V45, pS25, DOI 10.1053/j.seminhematol.2008.07.008; Tanaka-Kagawa T, 2003, BRIT J DERMATOL, V149, P1116, DOI 10.1111/j.1365-2133.2003.05704.x; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Yamamoto S, 2008, ANTICANCER RES, V28, P1585; Yoon P, 2006, MOL CANCER THER, V5, P2815, DOI 10.1158/1535-7163.MCT-06-0263; Yu L, 2004, CELL CYCLE, V3, P1124; Zhang QY, 2009, P NATL ACAD SCI USA, V106, P3378, DOI 10.1073/pnas.0813142106	47	105	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29989	29997		10.1074/jbc.M109.090530	http://dx.doi.org/10.1074/jbc.M109.090530			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20656687	Green Published, hybrid			2022-12-25	WOS:000281984300036
J	Sayama, K; Yamamoto, M; Shirakata, Y; Hanakawa, Y; Hirakawa, S; Dai, XJ; Tohyama, M; Tokumaru, S; Shin, MS; Sakurai, H; Akira, S; Hashimoto, K				Sayama, Koji; Yamamoto, Masahiro; Shirakata, Yuji; Hanakawa, Yasushi; Hirakawa, Satoshi; Dai, Xiuju; Tohyama, Mikiko; Tokumaru, Sho; Shin, Myoung-Sook; Sakurai, Hiroaki; Akira, Shizuo; Hashimoto, Koji			E2 Polyubiquitin-conjugating Enzyme Ubc13 in Keratinocytes Is Essential for Epidermal Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SEVERE LIVER DEGENERATION; GAMMA-DEFICIENT MICE; INCONTINENTIA PIGMENTI; KINASE; TAK1; ACTIVATION; SKIN; DIFFERENTIATION; APOPTOSIS	The E2 polyubiquitin-conjugating enzyme Ubc13 is a mediator of innate immune reactions. Ubc13 mediates the conjugation of keratin (K)63-linked polyubiquitin chains onto TNF receptor-associated factor 6 and IKK gamma during NF-kappa B activation. In contrast to K48-linked polyubiquitin chains, K63-linked polyubiquitin chains function in nonproteasomal biological processes. Although Ubc13 has been shown to be critical for Toll-like receptor (TLR) and IL-1 receptor signaling, the function of Ubc13 in the epidermis has not been studied. We generated keratinocyte-specific Ubc13-deficient mice (Ubc13(flox/flox)K5-Cre). At birth, the skin of the Ubc13(flox/flox)K5-Cre mice was abnormally shiny and smooth; in addition, the mice did not grow and died by postnatal day 2. Histological analysis showed atrophy of the epidermis with keratinocyte apoptosis. Immunohistochemical analyses revealed reduced proliferation, abnormal differentiation, and apoptosis of keratinocytes in the Ubc13(flox/flox)K5-Cre mouse epidermis. In culture, Ubc13(flox/flox)K5-Cre keratinocyte growth was impaired, and spontaneous cell death occurred. Moreover, the deletion of Ubc13 from cultured Ubc13(flox/flox) keratinocytes by means of an adenoviral vector carrying Cre recombinase also resulted in spontaneous cell death. Therefore, Ubc13 is essential for keratinocyte growth, differentiation, and survival. Analyses of intracellular signaling revealed that the IL-1 and TNF-induced activation of JNK, p38, and NF-kappa B pathways was impaired in Ubc13(flox/flox)K5-Cre keratinocytes. In conclusion, Ubc13 appears to be essential for epidermal integrity in mice.	[Sayama, Koji; Tohyama, Mikiko; Tokumaru, Sho; Hashimoto, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan; [Yamamoto, Masahiro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Shin, Myoung-Sook; Sakurai, Hiroaki] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan	Ehime University; Osaka University; University of Toyama	Sayama, K (corresponding author), Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan.	sayama@m.ehime-u.ac.jp	Sakurai, Hiroaki/AAE-4294-2019; Akira, Shizuo/C-3134-2009	Sakurai, Hiroaki/0000-0003-0657-9570	Ministries of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Takeda Science Foundation; Mishima Kaiun Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Kowa Life Science Foundation; Yasuda Medical Foundation	Ministries of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Kowa Life Science Foundation; Yasuda Medical Foundation	This work was supported by grants from the Ministries of Education, Culture, Sports, Science, and Technology of Japan; by Health and Labor Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labor, and Welfare of Japan; and by grants from the Takeda Science Foundation, Mishima Kaiun Memorial Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Naito Foundation, Kowa Life Science Foundation, and the Yasuda Medical Foundation.	Dai XJ, 2008, J DERMATOL SCI, V50, P53, DOI 10.1016/j.jdermsci.2007.10.011; Dai XJ, 2004, J INVEST DERMATOL, V123, P1078, DOI 10.1111/j.0022-202X.2004.23503.x; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Morioka S, 2009, ONCOGENE, V28, P2257, DOI 10.1038/onc.2009.110; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Rudolph D, 2000, GENE DEV, V14, P854; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2002, J BIOL CHEM, V277, P40390, DOI 10.1074/jbc.M112423200; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Smahi A, 2000, NATURE, V405, P466; Stratis A, 2006, J INVEST DERMATOL, V126, P614, DOI 10.1038/sj.jid.5700092; Takeda J, 2000, J DERMATOL SCI, V23, P147, DOI 10.1016/S0923-1811(00)00082-7; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	34	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30042	30049		10.1074/jbc.M110.106484	http://dx.doi.org/10.1074/jbc.M110.106484			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663875	Green Published, hybrid			2022-12-25	WOS:000281984300042
J	Watanabe, Y; Noda, NN; Kumeta, H; Suzuki, K; Ohsumi, Y; Inagaki, F				Watanabe, Yasunori; Noda, Nobuo N.; Kumeta, Hiroyuki; Suzuki, Kuninori; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			Selective Transport of alpha-Mannosidase by Autophagic Pathways STRUCTURAL BASIS FOR CARGO RECOGNITION BY Atg19 AND Atg34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOPLASM; PROTEIN; DOMAIN; COMPONENTS; MECHANISM; DYNAMICS; ATG8/LC3; DISEASE; TARGET	In the yeast Saccharomyces cerevisiae, a precursor form of aminopeptidase I (prApe1) and alpha-mannosidase (Ams1) are selectively transported to the vacuole through the cytoplasm-to-vacuole targeting pathway under vegetative conditions and through autophagy under starvation conditions. Atg19 plays a central role in these processes by linking Ams1 and prApe1 to Atg8 and Atg11. However, little is known about the molecular mechanisms of cargo recognition by Atg19. Here, we report structural and functional analyses of Atg19 and its paralog, Atg34. A protease-resistant domain was identified in the C-terminal region of Atg19, which was also conserved in Atg34. In vitro pulldown assays showed that the C-terminal domains of both Atg19 and Atg34 are responsible for Ams1 binding; these domains are hereafter referred to as Ams1-binding domains (ABDs). The transport of Ams1, but not prApe1, was blocked in atg19 Delta atg34 Delta cells expressing Atg19(Delta ABD), indicating that ABD is specifically required for Ams1 transport. We then determined the solution structures of the ABDs of Atg19 and Atg34 using NMR spectroscopy. Both ABD structures have a canonical immunoglobulin fold consisting of eight beta-strands with highly conserved loops clustered at one side of the fold. These facts, together with the results of a mutational analysis, suggest that ABD recognizes Ams1 using these conserved loops.	[Watanabe, Yasunori; Noda, Nobuo N.; Kumeta, Hiroyuki; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Suzuki, Kuninori; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan	Hokkaido University; Tokyo Institute of Technology	Noda, NN (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, N-12,W-6, Sapporo, Hokkaido 0600812, Japan.	nn@pharm.hokudai.ac.jp; finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Watanabe, Yasunori/0000-0002-7846-680X; Noda, Nobuo/0000-0002-6940-8069; Kumeta, Hiroyuki/0000-0003-3713-2122	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on priority areas and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Manjithaya R, 2010, FEBS LETT, V584, P1367, DOI 10.1016/j.febslet.2010.01.019; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muyldermans S, 2001, J Biotechnol, V74, P277; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Noda T, 2009, INT IMMUNOL, V21, P1199, DOI 10.1093/intimm/dxp088; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; OPHEIM DJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P121, DOI 10.1016/0005-2744(78)90110-9; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Watanabe Y, 2009, ACTA CRYSTALLOGR F, V65, P571, DOI 10.1107/S1744309109015826; YOSHIHISA T, 1988, J BIOL CHEM, V263, P5158	37	39	42	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30026	30033		10.1074/jbc.M110.143545	http://dx.doi.org/10.1074/jbc.M110.143545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20659891	Green Published, hybrid			2022-12-25	WOS:000281984300040
J	Innamorato, NG; Jazwa, A; Rojo, AI; Garcia, C; Fernandez-Ruiz, J; Grochot-Przeczek, A; Stachurska, A; Jozkowicz, A; Dulak, J; Cuadrado, A				Innamorato, Nadia G.; Jazwa, Agnieszka; Rojo, Ana I.; Garcia, Concepcion; Fernandez-Ruiz, Javier; Grochot-Przeczek, Anna; Stachurska, Anna; Jozkowicz, Alicja; Dulak, Jozef; Cuadrado, Antonio			Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; THERAPEUTIC TARGET; SUBSTANTIA-NIGRA; NEURODEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS; ALPHA-SYNUCLEIN; CARBON-MONOXIDE; COMPLEX I; IRON	Background: The transcription factor Nrf2 (NF-E2-related factor 2) and its target gene products, including heme oxygenase-1 (HO-1), elicit an antioxidant response that may have therapeutic value for Parkinson's disease (PD). However, HO-1 protein levels are increased in dopaminergic neurons of Parkinson's disease (PD) patients, suggesting its participation in free-iron deposition, oxidative stress and neurotoxicity. Before targeting Nrf2 for PD therapy it is imperative to determine if HO-1 is neurotoxic or neuroprotective in the basal ganglia. Methodology: We addressed this question by comparing neuronal damage and gliosis in Nrf2- or HO-1-knockout mice submitted to intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) for five consecutive days. Nrf2- knockout mice showed exacerbated gliosis and dopaminergic nigrostriatal degeneration, as determined by immunohistochemical staining of tyrosine hydroxylase in striatum (STR) and substantia nigra (SN) and by HPLC determination of striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC). On the other hand, the severity of gliosis and dopaminergic degeneration in HO-1-null mice was neither increased nor reduced. Regarding free-iron deposition, both Nrf2- and HO-1-deficient mice exhibited similar number of deposits as determined by Perl's staining, therefore indicating that these proteins do not contribute significantly to iron accumulation or clearance in MPTP-induced Parkinsonism. Conclusions: These results suggest that HO-1 does not protect or enhance the sensitivity to neuronal death in Parkinson's disease and that pharmacological or genetic intervention on Nrf2 may provide a neuroprotective benefit as add on therapy with current symptomatic protocols.	[Innamorato, Nadia G.; Jazwa, Agnieszka; Rojo, Ana I.; Garcia, Concepcion; Fernandez-Ruiz, Javier; Cuadrado, Antonio] Inst Invest Sanitaria La Paz IdiPaz, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Innamorato, Nadia G.; Rojo, Ana I.; Cuadrado, Antonio] UAM, Dept Bioquim, Madrid, Spain; [Innamorato, Nadia G.; Rojo, Ana I.; Cuadrado, Antonio] UAM, Inst Invest Biomed Alberto Sols, CSIC, Madrid, Spain; [Jazwa, Agnieszka; Grochot-Przeczek, Anna; Stachurska, Anna; Jozkowicz, Alicja; Dulak, Jozef] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Garcia, Concepcion; Fernandez-Ruiz, Javier] UCM, Dept Bioquim & Biol Mol, Inst Univ Invest Neuroquim, Fac Med, Madrid, Spain	CIBERNED; Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Jagiellonian University; Complutense University of Madrid	Innamorato, NG (corresponding author), Inst Invest Sanitaria La Paz IdiPaz, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	jozef.dulak@uj.edu.pl; antonio.cuadrado@uam.es	Jazwa-Kusior, Agnieszka/Q-1092-2017; Garcia, Concepcion M C/H-9138-2015; Rojo, Ana I/AAA-5203-2019	Garcia, Concepcion M C/0000-0003-2482-1148; Rojo, Ana I/0000-0002-0312-5867; Cuadrado, Antonio/0000-0002-4039-7140; Cuadrado, Antonio/0000-0002-3444-9012; Grochot-Przeczek, Anna/0000-0003-0533-7254	Spanish Ministry of Science and Innovation [SAF2007-62646]; European Union [POIG.02.01.00-12-064/08, 02.02.00-00-014/08]; Universidad Autonoma of Madrid	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Universidad Autonoma of Madrid	This work was supported by grant SAF2007-62646 from the Spanish Ministry of Science and Innovation. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 and 02.02.00-00-014/08). N.I. is recipient of a FPU fellowship of Universidad Autonoma of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; BENSHACHAR D, 1991, J NEUROCHEM, V56, P1441, DOI 10.1111/j.1471-4159.1991.tb11444.x; Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-B; Burton NC, 2006, NEUROTOXICOLOGY, V27, P1094, DOI 10.1016/j.neuro.2006.07.019; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; Castellani R, 1996, BRAIN RES, V737, P195, DOI 10.1016/0006-8993(96)00729-9; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Cuadrado A, 2009, EXPERT OPIN THER TAR, V13, P319, DOI [10.1517/13543780802716501, 10.1517/13543780802716501 ]; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Gille G, 2004, ANN NY ACAD SCI, V1018, P533, DOI 10.1196/annals.1296.066; Glinka Y, 1996, J NEUROCHEM, V66, P2004; Grunblatt E, 2001, J NEUROCHEM, V78, P1, DOI 10.1046/j.1471-4159.2001.00397.x; Grunblatt E, 1999, MOVEMENT DISORD, V14, P612, DOI 10.1002/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hirsch EC, 1998, MOVEMENT DISORD, V13, P39; Hu XM, 2008, J IMMUNOL, V181, P7194, DOI 10.4049/jimmunol.181.10.7194; Huang E, 2005, J NEUROSCI RES, V80, P268, DOI 10.1002/jnr.20444; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li MH, 2006, FREE RADICAL BIO MED, V41, P1079, DOI 10.1016/j.freeradbiomed.2006.06.010; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; MOCHIZUKI H, 1994, NEUROSCI LETT, V168, P251, DOI 10.1016/0304-3940(94)90462-6; MORRIS CM, 1994, NEURODEGENERATION, V3, P277; Mundel S, 2002, NEUROCHEM RES, V27, P1231, DOI 10.1023/A:1020989812576; Olivares D, 2009, INT J MOL SCI, V10, P1226, DOI 10.3390/ijms10031226; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rojo AI, 2006, EUR J NEUROSCI, V24, P1874, DOI 10.1111/j.1460-9568.2006.05060.x; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Samoylenko A, 2008, ANTIOXID REDOX SIGN, V10, P1163, DOI 10.1089/ars.2007.1968; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Sherer TB, 2002, J NEUROSCI, V22, P7006; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Snyder AM, 2009, BBA-GEN SUBJECTS, V1790, P606, DOI 10.1016/j.bbagen.2008.08.005; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; Tsuchihashi SI, 2006, J IMMUNOL, V177, P4749, DOI 10.4049/jimmunol.177.7.4749; Turkseven S, 2007, J CELL BIOCHEM, V100, P815, DOI 10.1002/jcb.21138; WEST RW, 1993, CARCINOGENESIS, V14, P285, DOI 10.1093/carcin/14.2.285; YOUDIM MBH, 1993, MOVEMENT DISORD, V8, P1, DOI 10.1002/mds.870080102; Zeevalk GD, 2008, BIOMED PHARMACOTHER, V62, P236, DOI 10.1016/j.biopha.2008.01.017	54	106	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11838	10.1371/journal.pone.0011838	http://dx.doi.org/10.1371/journal.pone.0011838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676377	gold, Green Published			2022-12-25	WOS:000280520100014
J	Yang, Q; Vernet, M; Orssaud, C; Bonfils, P; Londero, A; Kapoula, Z				Yang, Qing; Vernet, Marine; Orssaud, Christophe; Bonfils, Pierre; Londero, Alain; Kapoula, Zoi			Central Crosstalk for Somatic Tinnitus: Abnormal Vergence Eye Movements	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; CONVERGENCE INSUFFICIENCY; SUPERIOR COLLICULUS; BINOCULAR CONTROL; ADAPTIVE-CHANGES; SACCADES; PRIMATE; NEURONS; CORTEX; ACCOMMODATION	Background: Frequent oulomotricity problems with orthoptic testing were reported in patients with tinnitus. This study examines with objective recordings vergence eye movements in patients with somatic tinnitus patients with ability to modify their subjective tinnitus percept by various movements, such as jaw, neck, eye movements or skin pressure. Methods: Vergence eye movements were recorded with the Eyelink II video system in 15 (23-63 years) control adults and 19 (36-62 years) subjects with somatic tinnitus. Findings: 1) Accuracy of divergence but not of convergence was lower in subjects with somatic tinnitus than in control subjects. 2) Vergence duration was longer and peak velocity was lower in subjects with somatic tinnitus than in control subjects. 3) The number of embedded saccades and the amplitude of saccades coinciding with the peak velocity of vergence were higher for tinnitus subjects. Yet, saccades did not increase peak velocity of vergence for tinnitus subjects, but they did so for controls. 4) In contrast, there was no significant difference of vergence latency between these two groups. Interpretation: The results suggest dysfunction of vergence areas involving cortical-brainstem-cerebellar circuits. We hypothesize that central auditory dysfunction related to tinnitus percept could trigger mild cerebellar-brainstem dysfunction or that tinnitus and vergence dysfunction could both be manifestations of mild cortical-brainstem-cerebellar syndrome reflecting abnormal cross-modality interactions between vergence eye movements and auditory signals.	[Yang, Qing; Vernet, Marine; Kapoula, Zoi] Hop Europeen Georges Pompidou, Grp IRIS, CNRS, Serv Ophtalmol ORL Stomatol, Paris, France; [Orssaud, Christophe] Hop Europeen Georges Pompidou, Serv Ophtalmol, Paris, France; [Bonfils, Pierre; Londero, Alain] Univ Paris 05, Serv ORL & Chirurg Cervico Faciale, Hop Europeen Georges Pompidou, Fac Med Paris Descartes, Paris, France; [Bonfils, Pierre; Londero, Alain] Lab CNRS, UMR 7060, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Yang, Q (corresponding author), Hop Europeen Georges Pompidou, Grp IRIS, CNRS, Serv Ophtalmol ORL Stomatol, Paris, France.	qing.yang@egp.aphp.fr	Orssaud, Christophe/ACM-6549-2022	Lauwereyns, Jan/0000-0003-0551-2550; Vernet, Marine/0000-0001-7331-3567				Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Busettini C, 2005, J NEUROPHYSIOL, V94, P2312, DOI 10.1152/jn.01337.2004; Busettini C, 2005, J NEUROPHYSIOL, V94, P2295, DOI 10.1152/jn.01336.2004; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; GAMLIN PDR, 1995, J NEUROPHYSIOL, V73, P2115, DOI 10.1152/jn.1995.73.5.2115; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Jozefowicz-Korczynska Magdalena, 2002, Int Tinnitus J, V8, P100; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kapoula Z, 2001, NEUROREPORT, V12, P4041, DOI 10.1097/00001756-200112210-00037; KAPOULA Z, 2009, AURIS NASUS LARYNX; LEIGH RJ, 2006, NEUROLOGY E IN PRESS; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mezzalira Raquel, 2007, Int Tinnitus J, V13, P152; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Richter HO, 2004, EUR J NEUROSCI, V20, P2722, DOI 10.1111/j.1460-9568.2004.03743.x; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Suzuki S, 2004, NEUROSCI RES, V49, P39, DOI 10.1016/j.neures.2004.01.009; Takagi M, 2003, PROG BRAIN RES, V142, P19; Takagi M, 2001, INVEST OPHTH VIS SCI, V42, P1479; TAKAGI M, 1995, VISION RES, V35, P3373, DOI 10.1016/0042-6989(95)00073-N; TONNDORF J, 1981, J LARYNGOL OTOL, P18; Tzelepi A, 2004, EXP BRAIN RES, V155, P439, DOI 10.1007/s00221-003-1741-9; Versino M, 1996, BRAIN, V119, P1933, DOI 10.1093/brain/119.6.1933; Walton MMG, 2003, J NEUROPHYSIOL, V90, P1124, DOI 10.1152/jn.00877.2002; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624; ZEE DS, 1989, REV NEUROL, V145, P613	38	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11845	10.1371/journal.pone.0011845	http://dx.doi.org/10.1371/journal.pone.0011845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676372	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520100017
J	Hsu, JL; Yu, LS; Sullivan, E; Bowman, M; Mistlberger, RE; Tecott, LH				Hsu, Jennifer L.; Yu, Lisa; Sullivan, Elinor; Bowman, Melodi; Mistlberger, Ralph E.; Tecott, Laurence H.			Enhanced Food Anticipatory Activity Associated with Enhanced Activation of Extrahypothalamic Neural Pathways in Serotonin(2C) Receptor Null Mutant Mice	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ENTRAINABLE CIRCADIAN-RHYTHMS; CONSTITUTIVE ACTIVITY; FEEDING SCHEDULES; GENE-EXPRESSION; LIMBIC SYSTEM; IN-VIVO; C-FOS; RATS; CLOCK	The ability to entrain circadian rhythms to food availability is important for survival. Food-entrained circadian rhythms are characterized by increased locomotor activity in anticipation of food availability (food anticipatory activity). However, the molecular components and neural circuitry underlying the regulation of food anticipatory activity remain unclear. Here we show that serotonin(2C) receptor (5-HT2CR) null mutant mice subjected to a daytime restricted feeding schedule exhibit enhanced food anticipatory activity compared to wild-type littermates, without phenotypic differences in the impact of restricted feeding on food consumption, body weight loss, or blood glucose levels. Moreover, we show that the enhanced food anticipatory activity in 5-HT2CR null mutant mice develops independent of external light cues and persists during two days of total food deprivation, indicating that food anticipatory activity in 5-HT2CR null mutant mice reflects the locomotor output of a food-entrainable oscillator. Whereas restricted feeding induces c-fos expression to a similar extent in hypothalamic nuclei of wild-type and null mutant animals, it produces enhanced expression in the nucleus accumbens and other extrahypothalamic regions of null mutant mice relative to wild-type subjects. These data suggest that 5-HT2CRs gate food anticipatory activity through mechanisms involving extrahypothalamic neural pathways.	[Hsu, Jennifer L.] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Yu, Lisa; Bowman, Melodi; Tecott, Laurence H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Sullivan, Elinor] Oregon Natl Primate Res Ctr, Dept Neurosci, Beaverton, OR USA; [Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon National Primate Research Center; Simon Fraser University	Hsu, JL (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	larry.tecott@ucsf.edu		Sullivan, Elinor/0000-0003-2630-8890; Bowman, Melodi/0000-0002-5975-7329	Bristol Myers Squib Foundation	Bristol Myers Squib Foundation	This work was supported by the Bristol Myers Squib Foundation Freedom to Discover Award (LHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLAH L, 2009, J NEUROSCIENCE; Abe H, 2007, AM J PHYSIOL-REG I, V292, pR607, DOI 10.1152/ajpregu.00331.2006; Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Albrecht U, 2006, J PHYSIOL-PARIS, V100, P243, DOI 10.1016/j.jphysparis.2007.05.004; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; De Deurwaerdere P, 2004, J NEUROSCI, V24, P3235, DOI 10.1523/JNEUROSCI.0112-04.2004; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Feillet CA, 2006, J PHYSIOL-PARIS, V100, P252, DOI 10.1016/j.jphysparis.2007.05.002; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Lax P, 1999, CHRONOBIOL INT, V16, P281, DOI 10.3109/07420529909116858; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; Mistlberger RE, 2003, BRAIN RES, V980, P161, DOI 10.1016/S0006-8993(03)02755-0; MISTLBERGER RE, 1993, PHYSIOL BEHAV, V53, P509, DOI 10.1016/0031-9384(93)90145-6; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; Mistlberger RE, 1999, BRAIN RES, V842, P73, DOI 10.1016/S0006-8993(99)01836-3; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Navailles S, 2006, J NEUROCHEM, V99, P1311, DOI 10.1111/j.1471-4159.2006.04188.x; Nonogaki K, 2003, DIABETES, V52, P315, DOI 10.2337/diabetes.52.2.315; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Rocha BA, 2002, J NEUROSCI, V22, P10039; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SHIBATA S, 1995, PHARMACOL BIOCHEM BE, V51, P541, DOI 10.1016/0091-3057(95)90577-8; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304	48	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11802	10.1371/journal.pone.0011802	http://dx.doi.org/10.1371/journal.pone.0011802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668550	gold, Green Published, Green Submitted			2022-12-25	WOS:000280371800008
J	Silva, LCR; Anand, M; Leithead, MD				Silva, Lucas C. R.; Anand, Madhur; Leithead, Mark D.			Recent Widespread Tree Growth Decline Despite Increasing Atmospheric CO2	PLOS ONE			English	Article							WATER-USE EFFICIENCY; NITROGEN LIMITATION; CLIMATE-CHANGE; RING EVIDENCE; ELEVATED CO2; FOREST; DELTA-C-13; CARBON; ECOSYSTEMS; FEEDBACKS	Background: The synergetic effects of recent rising atmospheric CO2 and temperature are expected to favor tree growth in boreal and temperate forests. However, recent dendrochronological studies have shown site-specific unprecedented growth enhancements or declines. The question of whether either of these trends is caused by changes in the atmosphere remains unanswered because dendrochronology alone has not been able to clarify the physiological basis of such trends. Methodology/Principal Findings: Here we combined standard dendrochronological methods with carbon isotopic analysis to investigate whether atmospheric changes enhanced water use efficiency (WUE) and growth of two deciduous and two coniferous tree species along a 9 degrees latitudinal gradient across temperate and boreal forests in Ontario, Canada. Our results show that although trees have had around 53% increases in WUE over the past century, growth decline (measured as a decrease in basal area increment - BAI) has been the prevalent response in recent decades irrespective of species identity and latitude. Since the 1950s, tree BAI was predominantly negatively correlated with warmer climates and/or positively correlated with precipitation, suggesting warming induced water stress. However, where growth declines were not explained by climate, WUE and BAI were linearly and positively correlated, showing that declines are not always attributable to warming induced stress and additional stressors may exist. Conclusions: Our results show an unexpected widespread tree growth decline in temperate and boreal forests due to warming induced stress but are also suggestive of additional stressors. Rising atmospheric CO2 levels during the past century resulted in consistent increases in water use efficiency, but this did not prevent growth decline. These findings challenge current predictions of increasing terrestrial carbon stocks under climate change scenarios.	[Silva, Lucas C. R.; Anand, Madhur; Leithead, Mark D.] Univ Guelph, Sch Environm Sci, Global Ecol Change Lab, Guelph, ON N1G 2W1, Canada	University of Guelph	Silva, LCR (corresponding author), Univ Guelph, Sch Environm Sci, Global Ecol Change Lab, Guelph, ON N1G 2W1, Canada.	manand@uoguelph.ca	Silva, Lucas/AAA-2476-2022; Silva, Lucas C R/E-1202-2016	Silva, Lucas/0000-0002-4838-327X; Silva, Lucas C R/0000-0002-4838-327X	Inter-American Institute for Global Change Research; Natural Sciences and Engineering Council of Canada; Canadian Foundation for Innovation; University of Guelph	Inter-American Institute for Global Change Research; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); University of Guelph	This work was funded by Inter-American Institute for Global Change Research, the Natural Sciences and Engineering Council of Canada, the Canadian Foundation for Innovation, and the University of Guelph grants to M.A. who holds the Canada Research Chair in Global Ecological Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow SW, 2007, FOREST ECOL MANAG, V243, P310, DOI 10.1016/j.foreco.2007.03.027; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Caplat P, 2008, THEOR ECOL-NETH, V1, P209, DOI 10.1007/s12080-008-0021-5; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; DeLuca TH, 2008, SCIENCE, V320, P1181, DOI 10.1126/science.1154836; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; FRANCEY RJ, 1982, NATURE, V297, P28, DOI 10.1038/297028a0; Gradowski T, 2006, FOREST ECOL MANAG, V226, P104, DOI 10.1016/j.foreco.2005.12.062; Guiot J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009972; Hietz P, 2005, TREE PHYSIOL, V25, P745, DOI 10.1093/treephys/25.6.745; Hill AR, 1999, WATER RESOUR RES, V35, P811, DOI 10.1029/1998WR900083; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; Jeziorski A, 2008, SCIENCE, V322, P1374, DOI 10.1126/science.1164949; LAMARCHE VC, 1984, SCIENCE, V225, P1019, DOI 10.1126/science.225.4666.1019; Leotard G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005377; Linares JC, 2009, OECOLOGIA, V161, P611, DOI 10.1007/s00442-009-1409-7; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Manning WJ, 2005, ENVIRON POLLUT, V137, P443, DOI 10.1016/j.envpol.2005.01.031; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Novak K, 2007, TREE PHYSIOL, V27, P941, DOI 10.1093/treephys/27.7.941; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Schleser GH, 1985, OECOLOGIA, V65, P536, DOI 10.1007/BF00379669; Schulman E., 1956, DENDROCLIMATIC CHANG; Silva LCR, 2009, GLOBAL CHANGE BIOL, V15, P2387, DOI 10.1111/j.1365-2486.2009.01859.x; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; STERNBERG LDL, 1989, OECOLOGIA, V81, P51, DOI 10.1007/BF00377009; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Weiner J, 2001, OIKOS, V94, P374, DOI 10.1034/j.1600-0706.2001.940219.x	34	123	130	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11543	10.1371/journal.pone.0011543	http://dx.doi.org/10.1371/journal.pone.0011543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657763	Green Published, gold, Green Submitted			2022-12-25	WOS:000280197500004
J	Devignot, S; Sapet, C; Duong, V; Bergon, A; Rihet, P; Ong, S; Lorn, PT; Chroeung, N; Ngeav, S; Tolou, HJ; Buchy, P; Couissinier-Paris, P				Devignot, Stephanie; Sapet, Cedric; Duong, Veasna; Bergon, Aurelie; Rihet, Pascal; Ong, Sivuth; Lorn, Patrich T.; Chroeung, Norith; Ngeav, Sina; Tolou, Hugues J.; Buchy, Philippe; Couissinier-Paris, Patricia			Genome-Wide Expression Profiling Deciphers Host Responses Altered during Dengue Shock Syndrome and Reveals the Role of Innate Immunity in Severe Dengue	PLOS ONE			English	Article							EOSINOPHIL-DERIVED NEUROTOXIN; DENSITY-LIPOPROTEIN RECEPTOR-1; GENE TRANSCRIPT ABUNDANCE; BLOOD MONONUCLEAR-CELLS; LIPID BODY FORMATION; PERIPHERAL-BLOOD; T-CELLS; MATRIX METALLOPROTEINASES; SYSTEMIC INFLAMMATION; OXIDATIVE STRESS	Background: Deciphering host responses contributing to dengue shock syndrome (DSS), the life-threatening form of acute viral dengue infections, is required to improve both the differential prognosis and the treatments provided to DSS patients, a challenge for clinicians. Methodology/Principal Findings: Based on a prospective study, we analyzed the genome-wide expression profiles of whole blood cells from 48 matched Cambodian children: 19 progressed to DSS while 16 and 13 presented respectively classical dengue fever (DF) or dengue hemorrhagic fever grades I/II (DHF). Using multi-way analysis of variance (ANOVA) and adjustment of p-values to control the False Discovery Rate (FDR<10%), we identified a signature of 2959 genes differentiating DSS patients from both DF and DHF, and showed a strong association of this DSS-gene signature with the dengue disease phenotype. Using a combined approach to analyse the molecular patterns associated with the DSS-gene signature, we provide an integrative overview of the transcriptional responses altered in DSS children. In particular, we show that the transcriptome of DSS children blood cells is characterized by a decreased abundance of transcripts related to T and NK lymphocyte responses and by an increased abundance of anti-inflammatory and repair/remodeling transcripts. We also show that unexpected pro-inflammatory gene patterns at the interface between innate immunity, inflammation and host lipid metabolism, known to play pathogenic roles in acute and chronic inflammatory diseases associated with systemic vascular dysfunction, are transcriptionnally active in the blood cells of DSS children. Conclusions/Significance: We provide a global while non exhaustive overview of the molecular mechanisms altered in of DSS children and suggest how they may interact to lead to final vascular homeostasis breakdown. We suggest that some mechanisms identified should be considered putative therapeutic targets or biomarkers of progression to DSS.	[Devignot, Stephanie; Sapet, Cedric; Tolou, Hugues J.; Couissinier-Paris, Patricia] Antenne de Marseille IMTSSA, French Army Biomed Res Inst, IRBA, Marseille, France; [Devignot, Stephanie; Sapet, Cedric; Tolou, Hugues J.; Couissinier-Paris, Patricia] Unite Virol, Marseille, France; [Duong, Veasna; Ong, Sivuth; Buchy, Philippe] Inst Pasteur Cambodia, Dept Virol, Phnom Penh, Cambodia; [Bergon, Aurelie; Rihet, Pascal] TAGC INSERM, U928, Marseille, France; [Lorn, Patrich T.; Chroeung, Norith; Ngeav, Sina] Kampong Cham Prov Hosp, Kampong Cham, Cambodia	UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Devignot, S (corresponding author), Antenne de Marseille IMTSSA, French Army Biomed Res Inst, IRBA, Marseille, France.	parisp@imtssa.fr	Rihet, Pascal/AAD-2018-2022; Devignot, Stéphanie/AAC-5765-2019; Rihet, Pascal/L-2173-2016; Veasna, Duong/I-9684-2014; Bergon, Aurélie/M-4977-2016; Rihet, Pascal/GQP-1381-2022	Rihet, Pascal/0000-0002-9459-3905; Devignot, Stéphanie/0000-0002-0618-5611; Rihet, Pascal/0000-0002-9459-3905; Veasna, Duong/0000-0003-0353-1678; Bergon, Aurélie/0000-0003-1518-4562; Rihet, Pascal/0000-0002-9459-3905; BUCHY, Philippe/0000-0003-1372-3008	French Army Medical Health Service (Service de Sante des Armees Francaises) [PRC 2007-13]	French Army Medical Health Service (Service de Sante des Armees Francaises)	This work was supported by a clinical research program PRC 2007-13 from the French Army Medical Health Service (Service de Sante des Armees Francaises). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attie AD, 2001, J LIPID RES, V42, P1717; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Barlic J, 2007, J LEUKOCYTE BIOL, V82, P226, DOI 10.1189/jlb.1206761; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Buchy Philippe, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P178; Butthep P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P246; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Chaturvedi UC, 2007, FEMS IMMUNOL MED MIC, V50, P285, DOI 10.1111/j.1574-695X.2007.00273.x; Chen XP, 2007, CARDIOVASC DRUG REV, V25, P146, DOI 10.1111/j.1527-3466.2007.00009.x; Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P1259, DOI 10.1161/01.ATV.0000133192.39901.be; Claus RA, 2010, CURR MOL MED, V10, P227, DOI 10.2174/156652410790963358; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; de Assis EF, 2003, J IMMUNOL, V171, P2090, DOI 10.4049/jimmunol.171.4.2090; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dyrskjot L, 2007, CLIN CANCER RES, V13, P3545, DOI 10.1158/1078-0432.CCR-06-2940; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feezor RJ, 2005, CLIN INFECT DIS, V41, pS427, DOI 10.1086/431993; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Forte TM, 2002, J LIPID RES, V43, P477; Galley HF, 2004, BRIT J ANAESTH, V93, P105, DOI 10.1093/bja/aeh163; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gilroy DW, 2004, FASEB J, V18, P489, DOI 10.1096/fj.03-0837com; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hennuyer N, 2005, ARTERIOSCL THROM VAS, V25, P1897, DOI 10.1161/01.ATV.0000175756.56818.ee; Homaidan FR, 2002, CURR PROTEIN PEPT SC, V3, P467, DOI 10.2174/1389203023380585; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Hung NT, 2005, AM J TROP MED HYG, V72, P370; Joshi PC, 2001, J IMMUNOL, V166, P885, DOI 10.4049/jimmunol.166.2.885; Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70; Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Khun S, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-10; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Koraka P, 2004, J MED VIROL, V72, P445, DOI 10.1002/jmv.20007; Kruger PS, 2009, CRIT CARE RESUSC, V11, P305; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; LEE CY, 2008, ANTIOXID REDOX SIGNA; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Lima JJ, 2009, CURR OPIN PULM MED, V15, P57, DOI 10.1097/MCP.0b013e32831da8be; Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127; Long HT, 2009, J INFECT DIS, V199, P537, DOI 10.1086/596507; Lorente L, 2010, CRIT CARE, V14, DOI 10.1186/cc8211; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Marik PE, 2006, CRIT CARE CLIN, V22, P151, DOI 10.1016/j.ccc.2005.08.008; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mosig S, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-60; Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7; Murgue B, 2010, MICROBES INFECT, V12, P113, DOI 10.1016/j.micinf.2009.11.006; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Ng CFS, 2007, J CLIN VIROL, V40, P202, DOI 10.1016/j.jcv.2007.08.017; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Panpanich R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003488.pub2; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Peters KG, 1998, CIRC RES, V83, P342, DOI 10.1161/01.RES.83.3.342; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; QATANANI M, 2009, J CLIN INVEST; Quinn K, 2008, AM J PHYSIOL-HEART C, V295, pH1817, DOI 10.1152/ajpheart.00472.2008; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Ray G, 1999, J TROP PEDIATRICS, V45, P4, DOI 10.1093/tropej/45.1.4; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Renier G, 2007, CURR DIABETES REV, V3, P103, DOI 10.2174/157339907780598225; Reynes JM, 2003, J CLIN MICROBIOL, V41, P3864, DOI 10.1128/JCM.41.8.3864-3867.2003; Rossi A, 2009, CURR VASC PHARMACOL, V7, P185, DOI 10.2174/157016109787455725; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Schmitz G, 2008, REV PHYSIOL BIOCH P, V160, P93, DOI 10.1007/112_2008_802; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Soundravally R, 2008, PLATELETS, V19, P447, DOI 10.1080/09537100802155284; STOBO JD, 1979, J CLIN INVEST, V64, P1188, DOI 10.1172/JCI109572; Sur S, 1998, J LEUKOCYTE BIOL, V63, P715, DOI 10.1002/jlb.63.6.715; Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x; Szanto A, 2008, FEBS LETT, V582, P106, DOI 10.1016/j.febslet.2007.11.020; Tang BMP, 2007, AM J RESP CRIT CARE, V176, P676, DOI 10.1164/rccm.200612-1819OC; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femsim.2004.10.004; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; WHO, 1997, DENG HAEM FEV DIAGN; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; World Health Organization, 2009, DENGUE GUIDELINES DI; Yagmur E, 2006, AM J GASTROENTEROL, V101, P1244, DOI 10.1111/j.1572-0241.2006.00543.x; Yang D, 2004, J IMMUNOL, V173, P6134, DOI 10.4049/jimmunol.173.10.6134; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105	136	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11671	10.1371/journal.pone.0011671	http://dx.doi.org/10.1371/journal.pone.0011671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652028	Green Published, Green Submitted, gold			2022-12-25	WOS:000280109700006
J	Chan, TC; King, CC; Yen, MY; Chiang, PH; Huang, CS; Hsiao, CK				Chan, Ta-Chien; King, Chwan-Chuen; Yen, Muh-Yong; Chiang, Po-Huang; Huang, Chao-Sheng; Hsiao, Chuhsing K.			Probabilistic Daily ILI Syndromic Surveillance with a Spatio-Temporal Bayesian Hierarchical Model	PLOS ONE			English	Article							INFLUENZA SURVEILLANCE; HEALTH SURVEILLANCE; TRANSMISSION; VIRUS; TEMPERATURE; OUTBREAKS; HUMIDITY; DISEASE; TAIWAN; IMPACT	Background: For daily syndromic surveillance to be effective, an efficient and sensible algorithm would be expected to detect aberrations in influenza illness, and alert public health workers prior to any impending epidemic. This detection or alert surely contains uncertainty, and thus should be evaluated with a proper probabilistic measure. However, traditional monitoring mechanisms simply provide a binary alert, failing to adequately address this uncertainty. Methods and Findings: Based on the Bayesian posterior probability of influenza-like illness (ILI) visits, the intensity of outbreak can be directly assessed. The numbers of daily emergency room ILI visits at five community hospitals in Taipei City during 2006-2007 were collected and fitted with a Bayesian hierarchical model containing meteorological factors such as temperature and vapor pressure, spatial interaction with conditional autoregressive structure, weekend and holiday effects, seasonality factors, and previous ILI visits. The proposed algorithm recommends an alert for action if the posterior probability is larger than 70%. External data from January to February of 2008 were retained for validation. The decision rule detects successfully the peak in the validation period. When comparing the posterior probability evaluation with the modified Cusum method, results show that the proposed method is able to detect the signals 1-2 days prior to the rise of ILI visits. Conclusions: This Bayesian hierarchical model not only constitutes a dynamic surveillance system but also constructs a stochastic evaluation of the need to call for alert. The monitoring mechanism provides earlier detection as well as a complementary tool for current surveillance programs.	[Chan, Ta-Chien; King, Chwan-Chuen; Hsiao, Chuhsing K.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan; [Chan, Ta-Chien; Chiang, Po-Huang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Hlth Policy Res, Zhunan, Taiwan; [King, Chwan-Chuen; Hsiao, Chuhsing K.] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Yen, Muh-Yong] Taipei City Hosp, Taipei City Govt, Dept Dis Control & Prevent, Taipei, Taiwan; [Huang, Chao-Sheng] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; National Taiwan University; Taipei City Hospital; Taipei Medical University	Chan, TC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan.	ckhsiao@ntu.edu.tw	Chiang, Po-Huang/E-3996-2010; Chan, Ta-Chien/C-8992-2012	hsiao, chuhsing kate/0000-0003-4905-8484; King, Chwan-Chuen/0000-0002-6078-2601	National Science Council, R.O.C. [NSC-98-2922-I-002-462]; Taipei City Government [96001-62-032]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan); Taipei City Government	The preliminary results of this study were partially presented in the 2009 International Society for Disease Surveillance Eighth Annual Conference. The traveling subsidy was from National Science Council, R.O.C. (NSC-98-2922-I-002-462). This study was financially supported in part by Taipei City Government Grant 96001-62-032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2008, J Prev Med Hyg, V49, P131; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cazelles B, 2006, PLOS MED, V3, P1212, DOI 10.1371/journal.pmed.0030328; *CDC, 2008, LAB VIR SURV REP; Chan TC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-26; Charland KML, 2009, EPIDEMIOL INFECT, V137, P1377, DOI 10.1017/S0950268809002283; CHARLAND KM, 2009, EPIDEMIOL INFECT, P1; CHINGYIHSIAO, 2007, COMP CHIEF COMPLAINT; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Georgantopoulos P, 2009, AM J EPIDEMIOL, V170, P1533, DOI 10.1093/aje/kwp305; Hutwagner LC, 2005, STAT MED, V24, P543, DOI 10.1002/sim.2034; Kelly H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005079; Klauss G, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-33; Le Strat Y, 1999, STAT MED, V18, P3463, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3463::AID-SIM409>3.3.CO;2-9; Lee JE, 2007, GEOSPATIAL HEALTH, V1, P243, DOI 10.4081/gh.2007.272; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Martinez-Beneito MA, 2008, STAT MED, V27, P4455, DOI 10.1002/sim.3320; MNATSAKANYAN ZR, 2009, J AM MED INFORM ASS; Mugglin AS, 2002, STAT MED, V21, P2703, DOI 10.1002/sim.1217; Plummer M, 2009, CODA OUTPUT ANAL DIA; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; R Core Team, 2022, R LANG ENV STAT COMP; Sebastiani P, 2006, STAT MED, V25, P1803, DOI 10.1002/sim.2566; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Spiegelhalter D. J., 2008, WINBUGS VERSION 1 4; STROUP DF, 1989, STAT MED, V8, P323, DOI 10.1002/sim.4780080312; van Dijk A, 2009, EMERG INFECT DIS, V15, P799, DOI 10.3201/eid1505.081174; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250; Zhou HF, 2008, STAT MED, V27, P5907, DOI 10.1002/sim.3409	35	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11626	10.1371/journal.pone.0011626	http://dx.doi.org/10.1371/journal.pone.0011626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661275	gold, Green Submitted, Green Published			2022-12-25	WOS:000279980800014
J	Inouye, K; Tsuzuki, S; Yasumoto, M; Kojima, K; Mochida, S; Fushiki, T				Inouye, Kuniyo; Tsuzuki, Satoshi; Yasumoto, Makoto; Kojima, Kenji; Mochida, Seiya; Fushiki, Tohru			Identification of the Matriptase Second CUB Domain as the Secondary Site for Interaction with Hepatocyte Growth Factor Activator Inhibitor Type-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE 1/MATRIPTASE; RECOMBINANT MATRIPTASE; ZYMOGEN ACTIVATION; CRYSTAL-STRUCTURE; BINDING-PROTEIN; EXPRESSION; CLEAVAGE; PROTEOLYSIS; DELETION; CLONING	Matriptase is a type II transmembrane serine protease comprising 855 amino acid residues. The extracellular region of matriptase comprises a noncatalytic stem domain (containing two tandem repeats of complement proteases C1r/C1s-urchin embryonic growth factor-bone morphogenetic protein (CUB) domain) and a catalytic serine protease domain. The stem domain of matriptase contains site(s) for facilitating the interaction of this protease with the endogenous inhibitor, hepatocyte growth factor activator inhibitor type-1 (HAI-1). The present study aimed to identify these site(s). Analyses using a secreted variant of recombinant matriptase comprising the entire extracellular domain (MAT), its truncated variants, and a recombinant HAI-1 variant with an entire extracellular domain (HAI-1-58K) revealed that the second CUB domain (CUB domain II, Cys(340)-Pro(452)) likely contains the site(s) of interest. We also found that MAT undergoes cleavage between Lys(379) and Val(380) within CUB domain II and that the C-terminal residues after Val(380) are responsible for facilitating the interaction with HAI-1-58K. A synthetic peptide corresponding to Val(380)-Asp(390) markedly increased the matriptase-inhibiting activity of HAI-1-58K, whereas the peptides corresponding to Val(380)-Val(389) and Phe(382)-Asp(390) had no effect. HAI-1-58K precipitated with immobilized streptavidin resins to which a synthetic peptide Val(380)-Pro(392) with a biotinylated lysine residue at its C terminus was bound, suggesting direct interaction between CUB domain II and HAI-1. These results led to the identification of the matriptase CUB domain II, which facilitates the primary inhibitory interaction between this protease and HAI-1.	[Inouye, Kuniyo; Yasumoto, Makoto; Kojima, Kenji] Kyoto Univ, Grad Sch Agr, Lab Enzyme Chem, Div Food Sci & Biotechnol,Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Inouye, K (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Enzyme Chem, Div Food Sci & Biotechnol,Sakyo Ku, Kyoto 6068502, Japan.	inouye@kais.kyoto-u.ac.jp		Tsuzuki, Satoshi/0000-0003-4385-0075	Japan Society for the Promotion of Science [17380065, 20380061]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grants-in-aid for Scientific Research (Nos. 17380065 and 20380061, to K. I.) from the Japan Society for the Promotion of Science.	Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Ge WT, 2006, J BIOL CHEM, V281, P7406, DOI 10.1074/jbc.M510687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; HURSH DA, 1987, SCIENCE, V237, P1487, DOI 10.1126/science.3498216; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Kojima K, 2009, J BIOCHEM, V145, P783, DOI 10.1093/jb/mvp036; Kojima K, 2009, BIOSCI BIOTECH BIOCH, V73, P454, DOI 10.1271/bbb.80713; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Miyake Y, 2010, BBA-PROTEINS PROTEOM, V1804, P156, DOI 10.1016/j.bbapap.2009.09.025; Miyake Y, 2009, CYTOTECHNOLOGY, V60, P95, DOI 10.1007/s10616-009-9219-7; Miyake Y, 2009, J BIOCHEM, V146, P273, DOI 10.1093/jb/mvp066; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; Mochida S, 2009, ENZYME MICROB TECH, V45, P288, DOI 10.1016/j.enzmictec.2009.06.008; Murai N, 2009, CYTOTECHNOLOGY, V59, P169, DOI 10.1007/s10616-009-9205-0; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Qiu D, 2007, BIOCHEM SOC T, V35, P583, DOI 10.1042/BST0350583; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tao ZY, 2005, BLOOD, V106, P4139, DOI 10.1182/blood-2005-05-2029; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Tsuzuki S, 2003, BIOCHEM J, V372, P227, DOI 10.1042/BJ20021891; Varela PF, 1997, J MOL BIOL, V274, P635, DOI 10.1006/jmbi.1997.1424; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Yamasaki Y, 2003, J NUTR SCI VITAMINOL, V49, P27, DOI 10.3177/jnsv.49.27; Zeng L, 2005, WORLD J GASTROENTERO, V11, P6202, DOI 10.3748/wjg.v11.i39.6202; Zhang Y, 1998, CYTOGENET CELL GENET, V83, P56, DOI 10.1159/000015125	53	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33394	33403		10.1074/jbc.M110.115816	http://dx.doi.org/10.1074/jbc.M110.115816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682770	Green Published, hybrid			2022-12-25	WOS:000283048200074
J	Wang, JH; Cai, S; Chen, YA				Wang, Jianghai; Cai, Sheng; Chen, Yuan			Mechanism of E1-E2 Interaction for the Inhibition of Ubl Adenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ACTIVATING ENZYME; SUMO E1; CONJUGATION; E2; INSIGHTS; COMPLEX; NEDD8; UBC9; PROTEINS; AFFINITY	Conjugates of ubiquitin or its homologues to other proteins occur by strictly ordered steps with ordered addition of substrates for each step. High concentrations of E2 were shown to inhibit the formation of E2 similar to Ubl thioester and Ubl similar to target conjugates. We investigated the mechanism of such inhibitory effect of the SUMO E2 and whether the E2 has two binding sites on its E1, one for the inhibitory effect and one for productive SUMOylation. NMR methods in combination with mutagenesis and biochemical assays revealed that Ubc9 binds to two flexible domains of its free E1 simultaneously, suggesting extensive domain movements in the free E1. Further, interaction of free E1 and E2 inhibits SUMO adenylation, and the interfaces responsible for the inhibition were the same as those required for productive transfer of SUMO from E1 to E2. This study indicates a conformational flexibility-dependent mechanism to control the strictly ordered steps in Ubl modifications.	[Wang, Jianghai; Cai, Sheng; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Chen, YA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA.	ychen@coh.org			National Institutes of Health [R01GM074748, R01GM086171]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074748, R01GM086171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074748 and R01GM086171.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Wee KE, 2000, J PROTEIN CHEM, V19, P489, DOI 10.1023/A:1026501515450	22	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33457	33462		10.1074/jbc.M110.135582	http://dx.doi.org/10.1074/jbc.M110.135582			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682785	hybrid, Green Published			2022-12-25	WOS:000283048200080
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			Asn(415) in the beta 11-beta 12 Linker Decreases Proton-dependent Desensitization of ASIC1.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; RECEPTOR; SITE; PSALMOTOXIN-1; ARCHITECTURE; AFFINITY; PORE	Neurons of the mammalian nervous system express the proton-sensing ion channel ASIC1. Low concentrations of protons in the normal range of extracellular pH, pH 7.4-7.3, shut the pore by a conformational transition referred as steady-state desensitization. Therefore, the potential of local acidification to open ASIC1 relies on proton affinity for desensitization. This property is important physiologically and also can be exploited to develop strategies to increase or decrease the channel response to protons. In a previous study (Li, T., Yang, Y., and Canessa, C. M. (2010) J. Biol. Chem. 285, 22706-22712), we found that Leu-85 in the beta 1-beta 2 linker of the extracellular domain decreases the apparent proton affinity for steady-state desensitization and retards openings, slowing down the time course of the macroscopic currents. Here, we show that Asn-415 in the beta 11-beta 12 linker works together with the beta 1-beta 2 linker to stabilize a closed conformation that delays transition from the closed to the desensitized state. Substitutions of Asn-415 for Cys, Ser, or Gly render ASIC1 responsive to small increases in proton concentrations near the baseline physiological pH.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Cecilia.canessa@yale.edu	Li, Tianbo/C-6118-2012		Leducq Foundation	Leducq Foundation(Leducq Foundation)	Supported in part by the Leducq Foundation.	CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang YS, 2004, J GEN PHYSIOL, V124, P163, DOI 10.1085/jgp.200409057; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	21	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31285	31291		10.1074/jbc.M110.160382	http://dx.doi.org/10.1074/jbc.M110.160382			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675379	Green Published, hybrid			2022-12-25	WOS:000282764600023
J	Padanyi, R; Xiong, YN; Antalffy, G; Lor, K; Paszty, K; Strehler, EE; Enyedi, A				Padanyi, Rita; Xiong, Yuning; Antalffy, Geza; Lor, Krisztina; Paszty, Katalin; Strehler, Emanuel E.; Enyedi, Agnes			Apical Scaffolding Protein NHERF2 Modulates the Localization of Alternatively Spliced Plasma Membrane Ca2+ Pump 2B Variants in Polarized Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; PDZ-INTERACTING DOMAIN; NA+/H+ EXCHANGER NHE3; BETA(2)-ADRENERGIC RECEPTOR; FUNCTIONAL EXPRESSION; CA2+-ATPASE ISOFORM-2; PARATHYROID-HORMONE; ACTIN CYTOSKELETON; HAIR BUNDLES; RAT-BRAIN	The membrane localization of the plasma membrane Ca2+ ATPase isoform 2 (PMCA2) in polarized cells is determined by alternative splicing; the PMCA2w/b splice variant shows apical localization, whereas the PMCA2z/b and PMCA2x/b variants are mostly basolateral. We previously reported that PMCA2b interacts with the PDZ protein Na+/H+ exchanger regulatory factor 2 (NHERF2), but the role of this interaction for the specific membrane localization of PMCA2 is not known. Here we show that co-expression of NHERF2 greatly enhanced the apical localization of GFP-tagged PMCA2w/b in polarized Madin-Darby canine kidney cells. GFP-PMCA2z/b was also redirected to the apical membrane by NHERF2, whereas GFP-PMCA2x/b remained exclusively basolateral. In the presence of NHERF2, GFP-PMCA2w/b co-localized with the actin-binding protein ezrin even after disruption of the actin cytoskeleton by cytochalasin D or latrunculin B. Surface biotinylation and fluorescence recovery after photobleaching experiments demonstrated that NHERF2-mediated anchorage to the actin cytoskeleton reduced internalization and lateral mobility of the pump. Our results show that the specific interaction with NHERF2 enhances the apical concentration of PMCA2w/b by anchoring the pump to the apical membrane cytoskeleton. The data also suggest that the x/b splice form of PMCA2 contains a dominant lateral targeting signal, whereas the targeting and localization of the z/b form are more flexible and not fully determined by intrinsic sequence features.	[Xiong, Yuning; Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Padanyi, Rita; Antalffy, Geza; Lor, Krisztina; Enyedi, Agnes] Natl Blood Ctr, Dept Mol Cell Biol, H-1113 Budapest, Hungary; [Paszty, Katalin] Semmelweis Univ, Hungarian Acad Sci, Membrane Res Grp, H-1067 Budapest, Hungary	Mayo Clinic; Hungarian Academy of Sciences; Semmelweis University	Strehler, EE (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	strehler.emanuel@mayo.edu; enyedi@kkk.org.hu	Pászty, Katalin/X-3785-2019; Enyedi, Agnes/N-9742-2013	Enyedi, Agnes/0000-0002-7366-9376; Paszty, Katalin/0000-0003-2457-8555	National Institutes of Health [NS51769]; Hungarian Academy of Sciences [OTKA K49476, CK 80283, ETT 215/2009]; OTKA [D48496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Academy of Sciences(Hungarian Academy of Sciences); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS51769 (to E. E. S.). This work was also supported in part by Hungarian Academy of Sciences Grants OTKA K49476, CK 80283, and ETT 215/2009 (to A. E.) and by OTKA Postdoctoral Fellowship D48496 (to R.P.).	Baggaley E, 2007, J BIOL CHEM, V282, P37678, DOI 10.1074/jbc.M703416200; Burette A, 2003, J COMP NEUROL, V467, P464, DOI 10.1002/cne.10933; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cha B, 2008, CLIN EXP PHARMACOL P, V35, P863, DOI 10.1111/j.1440-1681.2008.04931.x; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Grati M, 2006, J CELL SCI, V119, P2995, DOI 10.1242/jcs.03030; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Kip SN, 2003, AM J PHYSIOL-RENAL, V284, pF122, DOI 10.1152/ajprenal.00161.2002; Kruger WA, 2009, J BIOL CHEM, V284, P1820, DOI 10.1074/jbc.M804590200; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Padanyi R, 2009, BBA-MOL CELL RES, V1793, P1023, DOI 10.1016/j.bbamcr.2008.11.007; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Paszty K, 2005, BIOCHEM J, V391, P687, DOI 10.1042/BJ20051012; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Xiong YN, 2009, BIOCHEM BIOPH RES CO, V384, P32, DOI 10.1016/j.bbrc.2009.04.044; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856	42	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31704	31712		10.1074/jbc.M110.164137	http://dx.doi.org/10.1074/jbc.M110.164137			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663896	Green Published, hybrid			2022-12-25	WOS:000282764600062
J	Palomera-Sanchez, Z; Bucio-Mendez, A; Valadez-Graham, V; Reynaud, E; Zurita, M				Palomera-Sanchez, Zoraya; Bucio-Mendez, Alyeri; Valadez-Graham, Viviana; Reynaud, Enrique; Zurita, Mario			Drosophila p53 Is Required to Increase the Levels of the dKDM4B Demethylase after UV-induced DNA Damage to Demethylate Histone H3 Lysine 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; CHROMATIN STRUCTURE; GENE-EXPRESSION; METHYLATION; MELANOGASTER; MAINTENANCE; PROTEINS; REGIONS	Chromatin undergoes a variety of changes in response to UV-induced DNA damage, including histone acetylation. In human and Drosophila cells, this response is affected by mutations in the tumor suppressor p53. In this work, we report that there is a global decrease in trimethylated Lys-9 in histone H3 (H3K9me3) in salivary gland cells in wild type flies in response to UV irradiation. In contrast, flies with mutations in the Dmp53 gene have reduced basal levels of H3K9me3, which are then increased after UV irradiation. The reduction of H3K9me3 in response to DNA damage occurs preferentially in heterochromatin. Our experiments demonstrate that UV irradiation enhances the levels of Lys-9 demethylase (dKDM4B) transcript and protein in wild type flies, but not in Dmp53 mutant flies. Dmp53 binds to a DNA element in the dKdm4B gene as a response to UV irradiation. Furthermore, heterozygous mutants for the dKdm4B gene are more sensitive to UV irradiation; they are deficient in the removal of cyclobutane-pyrimidine dimers, and the decrease of H3K9me3 levels following DNA damage is not observed in dKdm4B mutant flies. We propose that in response to UV irradiation, Dmp53 enhances the expression of the dKDM4B histone demethylase, which demethylates H3K9me3 preferentially in heterochromatin regions. This mechanism appears to be essential for the proper function of the nucleotide excision repair system.	[Palomera-Sanchez, Zoraya; Bucio-Mendez, Alyeri; Valadez-Graham, Viviana; Reynaud, Enrique; Zurita, Mario] Univ Nacl Autonoma Mexico, Dept Dev Genet, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Zurita, M (corresponding author), Univ Nacl Autonoma Mexico, Dept Dev Genet, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico.	marioz@ibt.unam.mx		Valadez, Viviana/0000-0002-2556-7375	PAPIIT/UNAM [IN 20109-3]; Consejo Nacional de Ciencia y Tecnologia [48550]; Howard Hughes Medical Institute; Loreal-Organizacion de las Naciones Unidas para la Educacion, Ciencia y Cultura-Academia Mexicana de Ciencias (UNESCO-AMC)	PAPIIT/UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Loreal-Organizacion de las Naciones Unidas para la Educacion, Ciencia y Cultura-Academia Mexicana de Ciencias (UNESCO-AMC)	This work was supported by funds from PAPIIT/UNAM grant no. IN 20109-3, Consejo Nacional de Ciencia y Tecnologia Grant 48550, and funds from the Howard Hughes Medical Institute (to M.Z.).; Supported by a Loreal-Organizacion de las Naciones Unidas para la Educacion, Ciencia y Cultura-Academia Mexicana de Ciencias (UNESCO-AMC) scholarship.	Adamsen BL, 2007, INT J ONCOL, V31, P1491; Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Aguilar-Fuentes J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000253; Allison SJ, 2003, CANCER RES, V63, P6674; Bostelman LJ, 2007, DNA REPAIR, V6, P383, DOI 10.1016/j.dnarep.2006.12.010; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Castro J, 2002, DNA REPAIR, V1, P359, DOI 10.1016/S1568-7864(02)00012-5; Chaudhuri S, 2009, NUCLEIC ACIDS RES, V37, P1690, DOI 10.1093/nar/gkp003; Feuerhahn S, 2008, TRENDS GENET, V24, P467, DOI 10.1016/j.tig.2008.07.003; Fregoso M, 2007, MOL CELL BIOL, V27, P3640, DOI 10.1128/MCB.00030-07; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Lin CH, 2008, MOL CELL, V32, P696, DOI 10.1016/j.molcel.2008.11.008; Lloret-Llinares M, 2008, NUCLEIC ACIDS RES, V36, P2852, DOI 10.1093/nar/gkn098; Merino C, 2002, MOL BIOL CELL, V13, P3246, DOI 10.1091/mbc.E02-02-0087; Nag R, 2009, MUTAT RES-REV MUTAT, V682, P13, DOI 10.1016/j.mrrev.2009.01.002; Nicholson TB, 2009, EPIGENETICS-US, V4, P129, DOI 10.4161/epi.4.3.8443; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rebollar E, 2006, FEBS LETT, V580, P642, DOI 10.1016/j.febslet.2005.12.083; Reynaud E, 1999, MOL BIOL CELL, V10, P1191, DOI 10.1091/mbc.10.4.1191; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; SMERDON MJ, 1983, BIOCHEMISTRY-US, V22, P3516, DOI 10.1021/bi00283a033; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sugasawa K, 2009, DNA REPAIR, V8, P969, DOI 10.1016/j.dnarep.2009.05.001; Sun H, 2009, TOXICOL APPL PHARM, V237, P258, DOI 10.1016/j.taap.2009.04.008; Teng YM, 2002, J MOL BIOL, V316, P489, DOI 10.1006/jmbi.2001.5383; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Warnock LJ, 2008, ONCOGENE, V27, P1639, DOI 10.1038/sj.onc.1210787	44	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31370	31379		10.1074/jbc.M110.128462	http://dx.doi.org/10.1074/jbc.M110.128462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675387	Green Published, hybrid			2022-12-25	WOS:000282764600031
J	Janiszewska, M; De Vito, C; Le Bitoux, MA; Fusco, C; Stamenkovic, I				Janiszewska, Michalina; De Vito, Claudio; Le Bitoux, Marie-Aude; Fusco, Carlo; Stamenkovic, Ivan			Transportin Regulates Nuclear Import of CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; PROTEIN IMPORT; MECHANISM; RECEPTOR; RECOGNITION; INHIBITION; HYALURONAN; ADHESION; GROWTH; DOMAIN	CD44 is a facultative cell surface proteoglycan that serves as the principal cell surface receptor for hyaluronan ( HA). Studies have shown that in addition to participating in numerous signaling pathways, CD44 becomes internalized upon engagement by ligand and that a portion of its intracellular domain can translocate to the nucleus where it is believed to play a functional role in cell proliferation and survival. However, the mechanisms whereby fragments of CD44 enter the nucleus have not been elucidated. Here we show that CD44 interacts with two import receptors of the importin beta superfamily, importin beta itself and transportin. Inhibition of importin beta-dependent transport failed to block CD44 accumulation in the nucleus. By contrast, inhibition of the transportin-dependent pathway abrogated CD44 import. Mutagenesis of the intracellular domain of CD44 revealed that the 20 membrane-proximal residues contain sequences required for transportin-mediated nuclear transport. Our observations provide evidence that CD44 interacts with importin family members and identify the transportin-dependent pathway as the mechanism whereby full-length CD44 enters the nucleus.	[Janiszewska, Michalina; De Vito, Claudio; Le Bitoux, Marie-Aude; Fusco, Carlo; Stamenkovic, Ivan] Univ Lausanne, CHU Vaudois, Inst Pathol, Div Expt Pathol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Stamenkovic, I (corresponding author), Univ Lausanne, CHU Vaudois, Inst Pathol, Div Expt Pathol, 25 Rue Bugnon, CH-1011 Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Fusco, Carlo/AAC-7332-2022					ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; Arnold M, 2006, J BIOL CHEM, V281, P5492, DOI 10.1074/jbc.M513281200; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Palyi-Krekk Z, 2008, CANCER LETT, V263, P231, DOI 10.1016/j.canlet.2008.01.014; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331	27	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30548	30557		10.1074/jbc.M109.075838	http://dx.doi.org/10.1074/jbc.M109.075838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663864	Green Published, hybrid			2022-12-25	WOS:000282135500023
J	Shimizu, T; Ishikawa, T; Sugihara, E; Kuninaka, S; Miyamoto, T; Mabuchi, Y; Matsuzaki, Y; Tsunoda, T; Miya, F; Morioka, H; Nakayama, R; Kobayashi, E; Toyama, Y; Kawai, A; Ichikawa, H; Hasegawa, T; Okada, S; Ito, T; Ikeda, Y; Suda, T; Saya, H				Shimizu, T.; Ishikawa, T.; Sugihara, E.; Kuninaka, S.; Miyamoto, T.; Mabuchi, Y.; Matsuzaki, Y.; Tsunoda, T.; Miya, F.; Morioka, H.; Nakayama, R.; Kobayashi, E.; Toyama, Y.; Kawai, A.; Ichikawa, H.; Hasegawa, T.; Okada, S.; Ito, T.; Ikeda, Y.; Suda, T.; Saya, H.			c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis	ONCOGENE			English	Article						osteosarcoma; differentiation; animal model; PPAR gamma	MESENCHYMAL STEM-CELLS; TRANSCRIPTIONAL REGULATION; OSTEOBLAST LINEAGE; EXPRESSION; DIFFERENTIATION; PROTEIN; CANCER; GENE; MICE; PATHOGENESIS	The development of cancer is due to the growth and proliferation of transformed normal cells. Recent evidence suggests that the nature of oncogenic stress and the state of the cell of origin critically affect both tumorigenic activity and tumor histological type. However, this mechanistic relationship in mesenchymal tumors is currently largely unexplored. To clarify these issues, we established a mouse osteosarcoma (OS) model through overexpression of c-MYC in bone marrow stromal cells (BMSCs) derived from Ink4a/Arf (-/-) mice. Single-cell cloning revealed that c-MYC-expressing BMSCs are composed of two distinctly different clones: highly tumorigenic cells, similar to bipotent-committed osteo-chondral progenitor cells, and low-tumorigenic tripotent cells, similar to mesenchymal stem cells (MSCs). It is noteworthy that both bipotent and tripotent cells were capable of generating histologically similar, lethal OS, suggesting that both committed progenitor cells and MSCs can become OS cells of origin. Shifting mesenchymal differentiation by depleting PPAR gamma in tripotent MSC-like cells and overexpressing PPAR gamma in bipotent cells affected cell proliferation and tumorigenic activity. Our findings indicate that differentiation potential has a key role in OS tumorigenic activity, and that the suppression of adipogenic ability is a critical factor for the development of OS. Oncogene (2010) 29, 5687-5699; doi:10.1038/onc.2010.312; published online 2 August 2010	[Saya, H.] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo 1608582, Japan; [Shimizu, T.; Sugihara, E.; Saya, H.] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Ishikawa, T.] Daiichi Sankyo Co Ltd, Kasai R& Ctr, Tokyo, Japan; [Miyamoto, T.; Morioka, H.; Nakayama, R.; Kobayashi, E.; Toyama, Y.] Keio Univ, Dept Orthoped Surg, Tokyo 1608582, Japan; [Miyamoto, T.] Japan Sci & Technol Agcy, Saitama, Japan; [Mabuchi, Y.; Matsuzaki, Y.] Keio Univ, Dept Physiol, Tokyo 1608582, Japan; [Tsunoda, T.; Miya, F.] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Kawai, A.] Natl Canc Ctr, Orthoped Div, Tokyo, Japan; [Ichikawa, H.] Natl Canc Ctr, Res Inst, Canc Transcriptome Project, Tokyo 104, Japan; [Hasegawa, T.] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Okada, S.] Kumamoto Univ, Grad Sch Med Sci, Ctr AIDS Res, Div Hemopoiesis, Kumamoto, Japan; [Ito, T.] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto, Japan; [Ikeda, Y.] Keio Univ, Dept Internal Med, Tokyo 1608582, Japan; [Suda, T.] Keio Univ, Sakaguchi Lab, Dept Cell Differentiat, Tokyo 1608582, Japan	Keio University; Japan Science & Technology Agency (JST); Daiichi Sankyo Company Limited; Keio University; Japan Science & Technology Agency (JST); Keio University; RIKEN; National Cancer Center - Japan; National Cancer Center - Japan; Sapporo Medical University; Kumamoto University; Kumamoto University; Keio University; Keio University	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hsaya@a5.keio.jp	Kuninaka, Shinji/J-7158-2013; Saya, Hideyuki/J-4325-2013; Okada, Seiji/F-5785-2013; Sugihara, Eiji/J-8058-2013; Mabuchi, Yo/L-1535-2013; Tsunoda, Tatsuhiko/K-2061-2014; Toyama, Yoshiaki/K-5743-2013; Suda, Toshio/H-6761-2013	Mabuchi, Yo/0000-0001-8008-3966; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Suda, Toshio/0000-0001-7540-1771; Sugihara, Eiji/0000-0002-3233-1045; Miya, Fuyuki/0000-0001-6758-2015; Saya, Hideyuki/0000-0001-6610-1902	Ministry of Education, Science, Sports, and Culture of Japan; National Institute of Biomedical Innovation, Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation)	We are grateful to I Ishimatsu and N Suzuki for technical assistance. We thank K Arai for secretarial assistance. This work was partly supported by grants from the Ministry of Education, Science, Sports, and Culture of Japan (TS and HS) and a grant from the National Institute of Biomedical Innovation, Japan (HS).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; BARRIOS C, 1994, AM J CLIN ONCOL-CANC, V17, P273, DOI 10.1097/00000421-199406000-00019; Benassi MS, 2001, CANCER-AM CANCER SOC, V92, P3062, DOI 10.1002/1097-0142(20011215)92:12<3062::AID-CNCR10161>3.0.CO;2-X; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Dannenberg AJ, 2001, LANCET ONCOL, V2, P544, DOI 10.1016/S1470-2045(01)00488-0; Dass CR, 2006, CLIN EXP METASTAS, V23, P367, DOI 10.1007/s10585-006-9046-6; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fletcher C.D.M, 2002, OSTEOGENIC TUMOURS W; Fujino RS, 2006, MOL ENDOCRINOL, V20, P904, DOI 10.1210/me.2005-0423; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Li N, 2009, CANCER-AM CANCER SOC, V115, P4795, DOI 10.1002/cncr.24519; Lopez-Guerrero JA, 2004, DIAGN MOL PATHOL, V13, P81; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mandal D, 2007, GENE, V386, P131, DOI 10.1016/j.gene.2006.08.030; Miller SFC, 2007, GENE EXPR PATTERNS, V7, P635, DOI 10.1016/j.modgep.2006.12.002; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; Rosen ED, 2000, GENE DEV, V14, P1293; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Thomas G, 2003, J BIOL CHEM, V278, P50563, DOI 10.1074/jbc.M307310200; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104	50	113	122	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5687	5699		10.1038/onc.2010.312	http://dx.doi.org/10.1038/onc.2010.312			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20676132				2022-12-25	WOS:000283262500005
J	Fagart, J; Hillisch, A; Huyet, J; Barfacker, L; Fay, M; Pleiss, U; Pook, E; Schafer, S; Rafestin-Oblin, ME; Kolkhof, P				Fagart, Jerome; Hillisch, Alexander; Huyet, Jessica; Baerfacker, Lars; Fay, Michel; Pleiss, Ulrich; Pook, Elisabeth; Schaefer, Stefan; Rafestin-Oblin, Marie-Edith; Kolkhof, Peter			A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL BLOCKERS; LIGAND-BINDING DOMAIN; STRUCTURAL BASIS; ALDOSTERONE BLOCKER; ANDROGEN RECEPTOR; HEART-FAILURE; HYPERTENSION; MECHANISMS; PSEUDOHYPOALDOSTERONISM; MUTATIONS	Limitations of current steroidal mineralocorticoid receptor (MR) antagonists have stimulated the search for a new generation of molecules. We screened for novel nonsteroidal compounds and identified MR antagonists derived from the chemical class of dihydropyridines. Chemical optimization resulted in BR-4628, which displays high in vitro and in vivo MR potency as well as selectivity with respect to the other steroid hormone receptors and the L-type calcium channel. Biochemical studies demonstrated that BR-4628 forms complexes with MR that do not promote the recruitment of transcriptional co-regulators. Docking experiments, using the crystal structure of the MR ligand-binding domain in an agonist conformation, revealed that BR-4628 accommodates in the MR ligand-binding cavity differently in comparison with the classical steroidal MR antagonists. An alanine scanning mutagenesis approach, based on BR-4628 docking, allowed identifying its anchoring mode within the ligand-binding cavity. Altogether, we propose that BR-4628 is a bulky antagonist that inactivates MR through a passive mechanism. It represents the prototype of a new class of MR antagonists.	[Schaefer, Stefan; Kolkhof, Peter] Bayer Schering Pharma AG, Dept Cardiol Res, Global Drug Discovery, D-42096 Wuppertal, Germany; [Hillisch, Alexander; Baerfacker, Lars] Bayer Schering Pharma AG, Dept Med Chem, Global Drug Discovery, D-42096 Wuppertal, Germany; [Pleiss, Ulrich] Bayer Schering Pharma AG, Dept Isotope Chem, Global Drug Discovery, D-42096 Wuppertal, Germany; [Pook, Elisabeth] Bayer Schering Pharma AG, Dept Lead Discovery, Global Drug Discovery, D-42096 Wuppertal, Germany; [Rafestin-Oblin, Marie-Edith] CRB3, INSERM, U773, F-75870 Paris, France; [Fagart, Jerome; Huyet, Jessica; Fay, Michel; Rafestin-Oblin, Marie-Edith] Univ Paris 07, F-75018 Paris, France	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Kolkhof, P (corresponding author), Bayer Schering Pharma AG, Dept Cardiol Res, Global Drug Discovery, Aprather Weg 18A, D-42096 Wuppertal, Germany.	Peter.Kolkhof@bayerhealthcare.com	Fagart, Jerome/S-4581-2018; Hillisch, Alexander/AAN-5872-2021	Fagart, Jerome/0000-0002-7965-0553; Hillisch, Alexander/0000-0002-4228-2347				Auzou G, 2000, MOL PHARMACOL, V58, P684, DOI 10.1124/mol.58.4.684; Bayer Healthcare Ag, 2007, 4-chromenonyl-1,4-dihydropyridines and their use, Patent No. [2007025604, WO2007025604]; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Bonvalet JP, 1998, KIDNEY INT, pS49; Brandish Philip E., 2008, Journal of Pharmacological and Toxicological Methods, V57, P155, DOI 10.1016/j.vascn.2008.01.002; CLAIRE M, 1978, FEBS LETT, V88, P295, DOI 10.1016/0014-5793(78)80197-5; CORVOL P, 1976, NOUV PRESSE MED, V5, P691; Couette B, 1998, MOL ENDOCRINOL, V12, P855, DOI 10.1210/me.12.6.855; Croom Katherine F, 2005, Am J Cardiovasc Drugs, V5, P51, DOI 10.2165/00129784-200505010-00007; DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650; DEGASPARO M, 1989, J STEROID BIOCHEM, V32, P223, DOI 10.1016/0022-4731(89)90169-6; Delcayre C, 1999, CARDIOVASC RES, V43, P7, DOI 10.1016/S0008-6363(99)00088-7; Dietz JD, 2008, HYPERTENSION, V51, P742, DOI 10.1161/HYPERTENSIONAHA.107.103580; EHLERT FJ, 1982, LIFE SCI, V30, P2191, DOI 10.1016/0024-3205(82)90293-4; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Fagart J, 2005, MOL PHARMACOL, V67, P1714, DOI 10.1124/mol.104.010710; Funder JW, 2005, NAT CLIN PRACT ENDOC, V1, P4, DOI 10.1038/ncpendmet0016; Funder JW, 2005, J STEROID BIOCHEM, V93, P121, DOI 10.1016/j.jsbmb.2004.12.010; Garthwaite SM, 2004, MOL CELL ENDOCRINOL, V217, P27, DOI 10.1016/j.mce.2003.10.005; Geller DS, 1998, NAT GENET, V19, P279, DOI 10.1038/966; Geller DS, 2006, J AM SOC NEPHROL, V17, P1429, DOI 10.1681/ASN.2005111188; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; GOUILLEUX F, 1991, NUCLEIC ACIDS RES, V19, P1563, DOI 10.1093/nar/19.7.1563; HORISBERGER JD, 1992, HYPERTENSION, V19, P221, DOI 10.1161/01.HYP.19.3.221; Hultman ML, 2005, MOL ENDOCRINOL, V19, P1460, DOI 10.1210/me.2004-0537; Huyet J, 2007, MOL PHARMACOL, V72, P563, DOI 10.1124/mol.107.036459; JEUNEMAITRE X, 1987, AM J CARDIOL, V60, P820, DOI 10.1016/0002-9149(87)91030-7; KAGAWA CM, 1957, SCIENCE, V126, P1015, DOI 10.1126/science.126.3281.1015; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KOLKHOF P, 2008, NUCL RECEPTORS DRUG, P409; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; LIDDLE GW, 1957, SCIENCE, V126, P1016, DOI 10.1126/science.126.3281.1016; Meredith PA, 2004, J HYPERTENS, V22, P1641, DOI 10.1097/00004872-200409000-00002; MEYER H, 1981, ARZNEIMITTEL-FORSCH, V31-1, P407; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pujo L, 2007, HUM MUTAT, V28, P33, DOI 10.1002/humu.20371; Sartorato P, 2004, MOL ENDOCRINOL, V18, P2151, DOI 10.1210/me.2003-0408; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Soderholm AA, 2005, J MED CHEM, V48, P917, DOI 10.1021/jm0495879; Weinberger MH, 2002, AM J HYPERTENS, V15, P709, DOI 10.1016/S0895-7061(02)02957-6; Zhang JH, 2008, J STEROID BIOCHEM, V109, P279, DOI 10.1016/j.jsbmb.2008.03.018	46	127	130	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29932	29940		10.1074/jbc.M110.131342	http://dx.doi.org/10.1074/jbc.M110.131342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650892	Green Published, hybrid			2022-12-25	WOS:000281984300030
J	Holgren, C; Dougherty, U; Edwin, F; Cerasi, D; Taylor, I; Fichera, A; Joseph, L; Bissonnette, M; Khare, S				Holgren, C.; Dougherty, U.; Edwin, F.; Cerasi, D.; Taylor, I.; Fichera, A.; Joseph, L.; Bissonnette, M.; Khare, S.			Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas	ONCOGENE			English	Article						sprouty-2; colon; cancer; metastasis; Ras; c-Met	HEPATOCYTE GROWTH-FACTOR; PROTEIN-KINASE PATHWAY; COLORECTAL-CANCER; URSODEOXYCHOLIC ACID; TYROSINE KINASE; HEPATOCELLULAR-CARCINOMA; ORTHOTOPIC IMPLANTATION; LIVER METASTASES; PROSTATE-CANCER; RAS ACTIVATION	Sprouty negatively regulates receptor tyrosine kinase signals by inhibiting Ras/extracellular signal-regulated kinase (ERK) pathways. Sprouty is downregulated in breast, prostate and liver cancers and appears to function as a tumor suppressor. The role of sprouty in colonic neoplasia, however, has not been investigated. Sprouty-2 protein and mRNA transcripts were significantly upregulated in human colonic adenocarcinomas. Strikingly, the c-Met receptor was also upregulated in tumors with increased sprouty-2. To delineate a potential causal relationship between sprouty-2 and c-Met, K-ras mutant HCT-116 colon cancer cells were transduced with purified TAT-sprouty-2 protein or stably transfected with full-length human sprouty-2 gene. Sprouty-2 upregulation significantly increased cell proliferation by accelerating cell cycle transition. Sprouty-2 transfectants showed strong upregulation of c-Met protein and mRNA transcripts and hepatocyte growth factor-stimulated ERK and Akt phosphorylation and enhanced cell migration and invasion. In contrast, knockdown of c-Met by small interfering RNA (siRNA) significantly decreased cell proliferation, migration and invasion in sprouty-2 transfectants. Further, knockdown of sprouty-2 by siRNA in parental HT-29 and LS-174T colon cancer cells also decreased cell invasion. Sprouty-2 transfectants formed significantly larger tumor xenografts and showed increased proliferation and angiogenesis and suppressed apoptosis. Sprouty-2 tumors metastasized to the liver from cecal orthotopic implants, suggesting that sprouty-2 might also enhance metastatic signals. Thus, in colon cancer sprouty functions as an oncogene and its effects are mediated in part by c-Met upregulation. Oncogene (2010) 29, 5241-5253; doi:10.1038/onc.2010.264; published online 26 July 2010	[Holgren, C.; Khare, S.] Loyola Univ Chicago, Dept Med, Maywood, IL 60153 USA; [Holgren, C.; Khare, S.] Hines Vet Affairs Med Ctr, Hines, IL USA; [Dougherty, U.; Cerasi, D.; Taylor, I.; Bissonnette, M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Edwin, F.] Loyola Univ Chicago, Dept Pharmacol, Maywood, IL 60153 USA; [Fichera, A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Joseph, L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; University of Chicago; Loyola University Chicago; University of Chicago; University of Chicago	Khare, S (corresponding author), Loyola Univ Chicago, Dept Med, Bldg 54,2160 S 1st Ave, Maywood, IL 60153 USA.	skhare@lumc.edu			VA merit award;  [CA036745]; NATIONAL CANCER INSTITUTE [R03CA097540, R37CA036745, R01CA036745] Funding Source: NIH RePORTER	VA merit award(US Department of Veterans Affairs); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were funded in part by Grant CA036745 (to M Bissonnette) and VA merit award (to S Khare).	Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Brett D, 2001, ONCOGENE, V20, P4581, DOI 10.1038/sj.onc.1204610; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Cerda SR, 2001, GASTROENTEROLOGY, V120, P1700, DOI 10.1053/gast.2001.24843; Corps AN, 1997, INT J CANCER, V73, P151, DOI 10.1002/(SICI)1097-0215(19970926)73:1<151::AID-IJC23>3.0.CO;2-I; Dougherty U, 2009, CLIN CANCER RES, V15, P6780, DOI 10.1158/1078-0432.CCR-09-1678; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Fujita S, 1997, JPN J CLIN ONCOL, V27, P378, DOI 10.1093/jjco/27.6.378; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Harris R. E., 2009, Inflammopharmacology, V17, P55, DOI 10.1007/s10787-009-8049-8; Huerta S, 2006, AM J SURG, V191, P517, DOI 10.1016/j.amjsurg.2005.11.009; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kammula US, 2007, CANCER LETT, V248, P219, DOI 10.1016/j.canlet.2006.07.007; Kanayama M, 2007, AM J PHYSIOL-GASTR L, V293, pG230, DOI 10.1152/ajpgi.00068.2007; Kermorgant S, 2001, CARCINOGENESIS, V22, P1035, DOI 10.1093/carcin/22.7.1035; Khare S, 2003, CANCER RES, V63, P3517; Khare S, 2008, NUTR CANCER, V60, P389, DOI 10.1080/01635580701883003; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kwabi-Addo B, 2004, CANCER RES, V64, P4728, DOI 10.1158/0008-5472.CAN-03-3759; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee M, 2006, BIOCHEM BIOPH RES CO, V350, P450, DOI 10.1016/j.bbrc.2006.09.067; Li N, 2007, J BIOL CHEM, V282, P16764, DOI 10.1074/jbc.M610835200; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Lito P, 2008, J BIOL CHEM, V283, P2002, DOI 10.1074/jbc.M709046200; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Minowada G, 2009, AM J RESP CELL MOL, V40, P31, DOI 10.1165/rcmb.2008-0147OC; Nakanishi K, 1999, CLIN EXP METASTAS, V17, P507, DOI 10.1023/A:1006685218766; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Pelletier G, 2003, HEPATOLOGY, V37, P887, DOI 10.1053/jhep.2003.50118; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Shoji T, 2003, CANCER LETT, V195, P235, DOI 10.1016/S0304-3835(02)00108-8; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Teranishi N, 2007, INT J ONCOL, V30, P593; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vaculova A, 2006, FEBS LETT, V580, P6565, DOI 10.1016/j.febslet.2006.11.004; Wang L., 2008, Experimental Oncology, V30, P42; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049; Zeng ZS, 2004, CLIN EXP METASTAS, V21, P409, DOI 10.1007/s10585-005-1617-4	57	57	59	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	38					5241	5253		10.1038/onc.2010.264	http://dx.doi.org/10.1038/onc.2010.264			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	653KE	20661223	Green Accepted			2022-12-25	WOS:000282089100003
J	Wang, HJ; Jin, YL; Reddy, MVPL; Podolsky, R; Liu, SY; Yang, P; Bode, B; Reed, JC; Steed, RD; Anderson, SW; Steed, L; Hopkins, D; Huang, YH; She, JX				Wang, Hongjie; Jin, Yulan; Reddy, M. V. Prasad Linga; Podolsky, Robert; Liu, Siyang; Yang, Ping; Bode, Bruce; Reed, John Chip; Steed, R. Dennis; Anderson, Stephen W.; Steed, Leigh; Hopkins, Diane; Huang, Yihua; She, Jin-Xiong			Genetically Dependent ERBB3 Expression Modulates Antigen Presenting Cell Function and Type 1 Diabetes Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; CANCER; LOCI; POLYMORPHISMS; METAANALYSIS; FAMILY	Type 1 diabetes (T1D) is an autoimmune disease resulting from the complex interaction between multiple susceptibility genes, environmental factors and the immune system. Over 40 T1D susceptibility regions have been suggested by recent genome-wide association studies; however, the specific genes and their role in the disease remain elusive. The objective of this study is to identify the susceptibility gene(s) in the 12q13 region and investigate the functional link to the disease pathogenesis. A total of 19 SNPs in the 12q13 region were analyzed by the TaqMan assay for 1,434 T1D patients and 1,865 controls. Thirteen of the SNPs are associated with T1D (best p = 4 x 10(-11)), thus providing confirmatory evidence for at least one susceptibility gene in this region. To identify candidate genes, expression of six genes in the region was analyzed by real-time RT-PCR for PBMCs from 192 T1D patients and 192 controls. SNP genotypes in the 12q13 region are the main factors that determine ERBB3 mRNA levels in PBMCs. The protective genotypes for T1D are associated with higher ERBB3 mRNA level (p < 10(-10)). Furthermore, ERBB3 protein is expressed on the surface of CD11c(+) cells (dendritic cells and monocytes) in peripheral blood after stimulation with LPS, polyI:C or CpG. Subjects with protective genotypes have significantly higher percentages of ERBB3(+) monocytes and dendritic cells (p = 1.1 x 10(-9)); and the percentages of ERBB3(+) cells positively correlate with the ability of APC to stimulate T cell proliferation (R-2 = 0.90, p < 0.0001). Our results indicate that ERBB3 plays a critical role in determining APC function and potentially T1D pathogenesis.	[Wang, Hongjie; Jin, Yulan; Reddy, M. V. Prasad Linga; Podolsky, Robert; Liu, Siyang; Yang, Ping; Steed, Leigh; Hopkins, Diane; Huang, Yihua; She, Jin-Xiong] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Podolsky, Robert] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Bode, Bruce] Atlanta Diabet Associates, Atlanta, GA USA; [Reed, John Chip; Steed, R. Dennis] SE Endocrine & Diabet, Atlanta, GA USA; [Anderson, Stephen W.] Pediat Endocrine Associates, Atlanta, GA USA; [She, Jin-Xiong] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wang, HJ (corresponding author), Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@mail.mcg.edu	REDDY, M.V. PRASAD LINGA/H-6330-2012; Podolsky, Robert/GRY-0740-2022		National Institutes of Health [2RO1HD37800, 4R33DK069878, 4R33HD050196]; Juvenile Diabetes Research Foundation International [JDRF 1-2004-661]; Georgia Research Alliance; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037800, R33HD050196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK069878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Georgia Research Alliance; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by grants from the National Institutes of Health (2RO1HD37800, 4R33DK069878, 4R33HD050196) and Juvenile Diabetes Research Foundation International (JDRF 1-2004-661) (JXS). JXS is an eminent scholar supported by the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata T, 2009, J CLIN ENDOCR METAB, V94, P231, DOI 10.1210/jc.2008-0718; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; de Kok JB, 2002, HUM MUTAT, V19, P554, DOI 10.1002/humu.10076; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Fruman DA, 2007, BIOCHEM SOC T, V35, P177, DOI 10.1042/BST0350177; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Koutras AK, 2008, BRIT J CANCER, V99, P1775, DOI 10.1038/sj.bjc.6604769; Kritzik MR, 2000, J ENDOCRINOL, V165, P67, DOI 10.1677/joe.0.1650067; Lin SH, 2008, CLIN CANCER RES, V14, P3729, DOI 10.1158/1078-0432.CCR-08-0472; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	33	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11789	10.1371/journal.pone.0011789	http://dx.doi.org/10.1371/journal.pone.0011789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668683	Green Published, gold, Green Submitted			2022-12-25	WOS:000280297300020
J	Morandi, F; Ferretti, E; Bocca, P; Prigione, I; Raffaghello, L; Pistoia, V				Morandi, Fabio; Ferretti, Elisa; Bocca, Paola; Prigione, Ignazia; Raffaghello, Lizzia; Pistoia, Vito			A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; G MOLECULES; TH17 CELLS; B-CELLS; DIFFERENTIAL EXPRESSION; TYROSINE-PHOSPHATASE; HELPER-CELLS; ANTIGEN; LYMPHOCYTES; RESPONSES	Background: In recent years, many immunoregulatory functions have been ascribed to soluble HLA-G (sHLA-G). Since chemotaxis is crucial for an efficient immune response, we have investigated for the first time the effects of sHLA-G on chemokine receptor expression and function in different human T cell populations. Methodology/Principal Findings: T cell populations isolated from peripheral blood were stimulated in the presence or absence of sHLA-G. Chemokine receptors expression was evaluated by flow cytometry. sHLA-G downregulated expression of i) CCR2, CXCR3 and CXCR5 in CD4(+) T cells, ii) CXCR3 in CD8(+) T cells, iii) CXCR3 in Th1 clones iv) CXCR3 in TCR V delta 2 gamma 9 T cells, and upregulated CXCR4 expression in TCR V delta 2 gamma 9 T cells. sHLA-G inhibited in vitro chemotaxis of i) CD4(+) T cells towards CCL2, CCL8, CXCL10 and CXCL11, ii) CD8+ T cells towards CXCL10 and CXCL11, iii) Th1 clones towards CXCL10, and iv) TCR V delta 2 gamma 9 T cells towards CXCL10 and CXCL11. Downregulation of CXCR3 expression on CD4+ T cells by sHLA-G was partially reverted by adding a blocking antibody against ILT2/CD85j, a receptor for sHLA-G, suggesting that sHLA-G downregulated chemokine receptor expression mainly through the interaction with ILT2/CD85j. Follicular helper T cells (T(FH)) were isolated from human tonsils and stimulated as described above. sHLA-G impaired CXCR5 expression in T(FH) and chemotaxis of the latter cells towards CXCL13. Moreover, sHLA-G expression was detected in tonsils by immunohistochemistry, suggesting a role of sHLA-G in local control of T(FH) cell chemotaxis. Intracellular pathways were investigated by Western Blot analysis on total extracts from CD4+ T cells. Phosphorylation of Stat5, p70 s6k, beta-arrestin and SHP2 was modulated by sHLA-G treatment. Conclusions/Significance: Our data demonstrated that sHLA-G impairs expression and functionality of different chemokine receptors in T cells. These findings delineate a novel mechanism whereby sHLA-G modulates T cell recruitment in physiological and pathological conditions.	[Morandi, Fabio; Ferretti, Elisa; Bocca, Paola; Prigione, Ignazia; Raffaghello, Lizzia; Pistoia, Vito] G Gaslini Childrens Hosp, Lab Oncol, Genoa, Italy		Morandi, F (corresponding author), G Gaslini Childrens Hosp, Lab Oncol, Genoa, Italy.	fabiomorandi@ospedale-gaslini.ge.it	Bocca, Paola/AAB-3381-2021; Prigione, Ignazia/K-3011-2016; Morandi, Fabio/I-1185-2012	Bocca, Paola/0000-0002-7498-209X; Prigione, Ignazia/0000-0002-0877-6255; Raffaghello, Lizzia/0000-0003-2357-0607; Morandi, Fabio/0000-0002-2849-7595	Ministero della Salute, Progetti di Ricerca Corrente	Ministero della Salute, Progetti di Ricerca Corrente(Ministry of Health, Italy)	This work has been supported by grants from "Ministero della Salute, Progetti di Ricerca Corrente". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Annunziato F, 1999, MICROBES INFECT, V1, P103, DOI 10.1016/S1286-4579(99)80021-5; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bainbridge DRJ, 2000, J REPROD IMMUNOL, V48, P17, DOI 10.1016/S0165-0378(00)00070-X; Berencsi K, 2007, CANCER IMMUNOL IMMUN, V56, P359, DOI 10.1007/s00262-006-0190-2; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; Carosella ED, 1999, CELL MOL LIFE SCI, V55, P327, DOI 10.1007/s000180050295; Chen J, 2004, ONCOGENE, V23, P3659, DOI 10.1038/sj.onc.1207471; Chen ZW, 2005, CLIN IMMUNOL, V116, P202, DOI 10.1016/j.clim.2005.04.005; Ciprandi G, 2008, ALLERGY, V63, P1335, DOI 10.1111/j.1398-9995.2008.01741.x; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Corcione A, 2004, CLIN CANCER RES, V10, P964, DOI 10.1158/1078-0432.CCR-1182-3; Costa P, 2001, AIDS, V15, P965, DOI 10.1097/00002030-200105250-00004; Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189; Fons P, 2006, BLOOD, V108, P2608, DOI 10.1182/blood-2005-12-019919; FORSTER R, 1994, BLOOD, V84, P830; FUJII T, 1994, J IMMUNOL, V153, P5516; Garcia G, 2007, ALLERGY, V62, P170, DOI 10.1111/j.1398-9995.2006.01216.x; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Gros F, 2008, EUR J IMMUNOL, V38, P742, DOI 10.1002/eji.200736918; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; KIRSZENBAUM M, 1994, P NATL ACAD SCI USA, V91, P4209, DOI 10.1073/pnas.91.10.4209; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Locati M, 2002, ALLERGY, V57, P972, DOI 10.1034/j.1398-9995.2002.02166.x; Menier C, 2008, LEUKEMIA, V22, P578, DOI 10.1038/sj.leu.2405050; MORETTA L, 1991, IMMUNOL REV, V120, P117; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Nakajima H, 2003, J IMMUNOL, V171, P6611, DOI 10.4049/jimmunol.171.12.6611; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pistoia V, 2007, SEMIN CANCER BIOL, V17, P469, DOI 10.1016/j.semcancer.2007.07.004; Prigione I, 2006, MICROBES INFECT, V8, P552, DOI 10.1016/j.micinf.2005.08.008; PRIGIONE I, 2009, INTERFERONGAMMA IL 1; Prigione I, 2009, STEM CELLS, V27, P693, DOI 10.1634/stemcells.2008-0687; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sebti Y, 2003, HUM IMMUNOL, V64, P1093, DOI 10.1016/j.humimm.2003.08.345; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Sorensen TL, 2002, MULT SCLER J, V8, P104, DOI 10.1191/1352458502ms781oa; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Ugurel S, 2001, CANCER, V92, P369, DOI 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U; van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100; Winter D, 2007, J IMMUNOL, V179, P4272, DOI 10.4049/jimmunol.179.6.4272; Wischhusell J, 2007, SEMIN CANCER BIOL, V17, P459, DOI 10.1016/j.semcancer.2007.07.005; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	61	36	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11763	10.1371/journal.pone.0011763	http://dx.doi.org/10.1371/journal.pone.0011763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668702	Green Submitted, Green Published, gold			2022-12-25	WOS:000280243800031
J	Van Grol, J; Subauste, C; Andrade, RM; Fujinaga, K; Nelson, J; Subauste, CS				Van Grol, Jennifer; Subauste, Cecilia; Andrade, Rosa M.; Fujinaga, Koh; Nelson, Julie; Subauste, Carlos S.			HIV-1 Inhibits Autophagy in Bystander Macrophage/Monocytic Cells through Src-Akt and STAT3	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FOCAL ADHESION KINASE; TAT PROTEIN; T-CELLS; ANTIMICROBIAL ACTIVITY; EPITHELIAL-CELLS; GROWTH-FACTOR; MONOCYTES; APOPTOSIS; IL-10	Autophagy is a homeostatic mechanism of lysosomal degradation. Defective autophagy has been linked to various disorders such as impaired control of pathogens and neurodegeneration. Autophagy is regulated by a complex array of signaling pathways that act upstream of autophagy proteins. Little is known about the role of altered regulatory signaling in disorders associated with defective autophagy. In particular, it is not known if pathogens inhibit autophagy by modulation of upstream regulatory pathways. Cells infected with HIV-1 blocked rapamycin-induced autophagy and CD40-induced autophagic killing of Toxoplasma gondii in bystander (non-HIV-1 infected) macrophage/monocytic cells. Blockade of autophagy was dependent on Src-Akt and STAT3 triggered by HIV-1 Tat and IL-10. Neutralization of the upstream receptors VEGFR, beta-integrin or CXCR4, as well as of HIV-1 Tat or IL-10 restored autophagy in macrophage/monocytic cells exposed to HIV-1-infected cells. Defective autophagic killing of T. gondii was detected in monocyte-derived macrophages from a subset of HIV-1(+) patients. This defect was also reverted by neutralization of Tat or IL-10. These studies revealed that a pathogen can impair autophagy in non-infected cells by activating counter-regulatory pathways. The fact that pharmacologic manipulation of cell signaling restored autophagy in cells exposed to HIV-1-infected cells raises the possibility of therapeutic manipulation of cell signaling to restore autophagy in HIV-1 infection.	[Van Grol, Jennifer; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Van Grol, Jennifer; Fujinaga, Koh; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Van Grol, Jennifer; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Subauste, Cecilia] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Andrade, Rosa M.] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH USA; [Nelson, Julie] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati; University of North Carolina; University of North Carolina Chapel Hill	Van Grol, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	carlos.subauste@case.edu	Nelson, Julie/ABE-7315-2021	Subauste, Carlos/0000-0002-5602-1439	NIH [AI48406, EY018341, P30 EY11373]; American Heart Association Ohio Valley Affiliate; Case/UHC Center for AIDS Research NIH [AI36219]; NATIONAL EYE INSTITUTE [R01EY018341, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI048406] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Ohio Valley Affiliate(American Heart Association); Case/UHC Center for AIDS Research NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grant AI48406 (C. S. S.), EY EY018341 (C. S. S.), the American Heart Association Ohio Valley Affiliate (C. S. S.), Case/UHC Center for AIDS Research NIH Grant AI36219 and NIH Grant P30 EY11373. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; Albini A, 1998, J BIOL CHEM, V273, P15895, DOI 10.1074/jbc.273.26.15895; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Andrade RM, 2005, INFECT IMMUN, V73, P3115, DOI 10.1128/IAI.73.5.3115-3123.2005; Andrade RM, 2003, J IMMUNOL, V171, P6750, DOI 10.4049/jimmunol.171.12.6750; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Aoki H, 2007, FASEB J, V21, P2918, DOI 10.1096/fj.06-6941com; Avraham HK, 2004, J IMMUNOL, V173, P6228, DOI 10.4049/jimmunol.173.10.6228; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; CHANAKYA HN, 1997, BIOENERGY NEWS, V1, P11; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Chehimi J, 1996, AIDS RES HUM RETROV, V12, P1141, DOI 10.1089/aid.1996.12.1141; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Ghezzi S, 2000, BIOCHEM BIOPH RES CO, V270, P992, DOI 10.1006/bbrc.2000.2523; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hagiwara E, 1996, AIDS RES HUM RETROV, V12, P127, DOI 10.1089/aid.1996.12.127; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Horn Leora, 2009, Proc Am Thorac Soc, V6, P206, DOI 10.1513/pats.200807-066LC; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; Konnikova L, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-23; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Leghmari K, 2008, EUR J CELL BIOL, V87, P947, DOI 10.1016/j.ejcb.2008.06.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Naif HM, 1998, J VIROL, V72, P830, DOI 10.1128/JVI.72.1.830-836.1998; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pahan K, 2000, J NEUROCHEM, V75, P576, DOI 10.1046/j.1471-4159.2000.0750576.x; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P369, DOI 10.1080/17402520600645712; Ponnusamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1361, DOI 10.1152/ajprenal.00251.2009; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Scheidegger P, 2001, BIOCHEM J, V353, P569, DOI 10.1042/0264-6021:3530569; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shih WL, 2010, CANCER LETT, V290, P223, DOI 10.1016/j.canlet.2009.09.014; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sonza S, 2001, AIDS, V15, P17, DOI 10.1097/00002030-200101050-00005; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Tachado SD, 2008, J BIOL CHEM, V283, P33191, DOI 10.1074/jbc.M805067200; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tangsinmankong N, 2000, CYTOKINE, V12, P1506, DOI 10.1006/cyto.2000.0741; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836; Zhou JH, 2001, J IMMUNOL, V167, P4436, DOI 10.4049/jimmunol.167.8.4436; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x	79	95	96	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11733	10.1371/journal.pone.0011733	http://dx.doi.org/10.1371/journal.pone.0011733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661303	Green Published, gold, Green Submitted			2022-12-25	WOS:000280243300031
J	Knapp, B; Omasits, U; Schreiner, W; Epstein, MM				Knapp, Bernhard; Omasits, Ulrich; Schreiner, Wolfgang; Epstein, Michelle M.			A Comparative Approach Linking Molecular Dynamics of Altered Peptide Ligands and MHC with In Vivo Immune Responses	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; BINDING-AFFINITY; RECOGNITION; SIMULATION; EPITOPE; MODEL; PROLIFERATION	Background: The recognition of peptide in the context of MHC by T lymphocytes is a critical step in the initiation of an adaptive immune response. However, the molecular nature of the interaction between peptide and MHC and how it influences T cell responsiveness is not fully understood. Results: We analyzed the immunological consequences of the interaction of MHC class II (I-A(u)) restricted 11-mer peptides of myelin basic protein with amino acid substitutions at position 4. These mutant peptides differ in MHC binding affinity, CD4(+) T cell priming, and alter the severity of peptide-induced experimental allergic encephalomyelitis. Using molecular dynamics, a computational method of quantifying intrinsic movements of proteins at high resolution, we investigated conformational changes in MHC upon peptide binding. We found that irrespective of peptide binding affinity, MHC deformation appears to influence costimulation, which then leads to effective T cell priming and disease induction. Although this study compares in vivo and molecular dynamics results for three altered peptide ligands, further investigation with similar complexes is essential to determine whether spatial rearrangement of peptide-MHC and costimulatory complexes is an additional level of T cell regulation.	[Knapp, Bernhard; Omasits, Ulrich; Schreiner, Wolfgang] Med Univ Vienna, Dept Biomed Comp Simulat & Bioinformat, Vienna, Austria; [Epstein, Michelle M.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Knapp, B (corresponding author), Med Univ Vienna, Dept Biomed Comp Simulat & Bioinformat, Vienna, Austria.	Michelle.Epstein@meduniwien.ac.at		Epstein, Michelle/0000-0002-4755-0224; Goldmann, Ulrich/0000-0003-1120-6912	Austrian Ministry of Education, Science and Culture [GZ 4003/2-VI/4c/2004]; Austrian Science Fund [FWF P22258-B12]; NIAID, NIH [5R01AI026791]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026791] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 22258] Funding Source: researchfish	Austrian Ministry of Education, Science and Culture; Austrian Science Fund(Austrian Science Fund (FWF)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is supported in part by the Austrian Grid Project of the Austrian Ministry of Education, Science and Culture (GZ 4003/2-VI/4c/2004), the Austrian Science Fund (FWF P22258-B12), and by grant number 5R01AI026791 from NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; FRITZ RB, 1983, J IMMUNOL, V130, P191; Fugger L, 1996, MOL MED, V2, P181, DOI 10.1007/BF03401615; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Knapp B, 2009, MOL IMMUNOL, V46, P1839, DOI 10.1016/j.molimm.2009.01.009; KUMAR V, 1995, P NATL ACAD SCI USA, V92, P9510, DOI 10.1073/pnas.92.21.9510; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Mantzourani ED, 2006, J MOL GRAPH MODEL, V25, P17, DOI 10.1016/j.jmgm.2005.09.010; Mantzourani ED, 2006, J MED CHEM, V49, P6683, DOI 10.1021/jm060040z; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Rognan D, 2000, J COMPUT AID MOL DES, V14, P53, DOI 10.1023/A:1008142830353; SMILEK DE, 1991, P NATL ACAD SCI USA, V88, P9633, DOI 10.1073/pnas.88.21.9633; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sundberg EJ, 2002, J MOL BIOL, V319, P449, DOI 10.1016/S0022-2836(02)00370-4; Varani L, 2007, P NATL ACAD SCI USA, V104, P13080, DOI 10.1073/pnas.0703702104; Wan S, 2008, MOL IMMUNOL, V45, P1221, DOI 10.1016/j.molimm.2007.09.022; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Zachou Kalliopi, 2004, J Autoimmune Dis, V1, P2, DOI 10.1186/1740-2557-1-2; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	32	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11653	10.1371/journal.pone.0011653	http://dx.doi.org/10.1371/journal.pone.0011653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657836	gold, Green Published			2022-12-25	WOS:000280065600016
J	Ventura, CL; Malachowa, N; Hammer, CH; Nardone, GA; Robinson, MA; Kobayashi, SD; DeLeo, FR				Ventura, Christy L.; Malachowa, Natalia; Hammer, Carl H.; Nardone, Glenn A.; Robinson, Mary Ann; Kobayashi, Scott D.; DeLeo, Frank R.			Identification of a Novel Staphylococcus aureus Two-Component Leukotoxin Using Cell Surface Proteomics	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; WALL ASSOCIATED PROTEINS; NUCLEOTIDE-SEQUENCE; GAMMA-HEMOLYSIN; POLYMORPHONUCLEAR LEUKOCYTES; GEL-ELECTROPHORESIS; VIRULENCE; GENES; INFECTIONS; LUKF	Staphylococcus aureus is a prominent human pathogen and leading cause of bacterial infection in hospitals and the community. Community-associated methicillin-resistant S. aureus (CA-MRSA) strains such as USA300 are highly virulent and, unlike hospital strains, often cause disease in otherwise healthy individuals. The enhanced virulence of CA-MRSA is based in part on increased ability to produce high levels of secreted molecules that facilitate evasion of the innate immune response. Although progress has been made, the factors that contribute to CA-MRSA virulence are incompletely defined. We analyzed the cell surface proteome (surfome) of USA300 strain LAC to better understand extracellular factors that contribute to the enhanced virulence phenotype. A total of 113 identified proteins were associated with the surface of USA300 during the late-exponential phase of growth in vitro. Protein A was the most abundant surface molecule of USA300, as indicated by combined Mascot score following analysis of peptides by tandem mass spectrometry. Unexpectedly, we identified a previously uncharacterized two-component leukotoxin-herein named LukS-H and LukF-G (LukGH)-as two of the most abundant surface-associated proteins of USA300. Rabbit antibody specific for LukG indicated it was also freely secreted by USA300 into culture media. We used wild-type and isogenic lukGH deletion strains of USA300 in combination with human PMN pore formation and lysis assays to identify this molecule as a leukotoxin. Moreover, LukGH synergized with PVL to enhance lysis of human PMNs in vitro, and contributed to lysis of PMNs after phagocytosis. We conclude LukGH is a novel two-component leukotoxin with cytolytic activity toward neutrophils, and thus potentially contributes to S. aureus virulence.	[Ventura, Christy L.; Malachowa, Natalia; Kobayashi, Scott D.; DeLeo, Frank R.] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT USA; [Hammer, Carl H.; Nardone, Glenn A.; Robinson, Mary Ann] NIAID, Res Technol Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ventura, CL (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	fdeleo@niaid.nih.gov		DeLeo, Frank/0000-0003-3150-2516; Kobayashi, Scott/0000-0002-5705-1381; Ventura, Christy/0000-0002-5084-1567	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051, ZIAAI001079] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Billion A, 2006, BIOINFORMATICS, V22, P2819, DOI 10.1093/bioinformatics/btl466; CHOORIT W, 1995, FEBS LETT, V357, P260, DOI 10.1016/0014-5793(94)01372-8; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FINCKBARBANCON V, 1991, RES MICROBIOL, V142, P75, DOI 10.1016/0923-2508(91)90099-V; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; Graves SF, 2010, MICROBES INFECT, V12, P446, DOI 10.1016/j.micinf.2010.02.005; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Jones RC, 2008, J BACTERIOL, V190, P5265, DOI 10.1128/JB.00383-08; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P1960, DOI 10.1271/bbb.61.1960; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Luong T, 2002, INFECT IMMUN, V70, P444, DOI 10.1128/IAI.70.2.444-450.2002; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nandakumar R, 2005, J PROTEOME RES, V4, P250, DOI 10.1021/pr049866k; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Nygaard TK, 2008, CURR OPIN INFECT DIS, V21, P147, DOI 10.1097/QCO.0b013e3282f64819; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Panton PN, 1932, LANCET, V1, P506; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; Prevost G, 2001, CURR TOP MICROBIOL, V257, P53; PREVOST G, 1995, INFECT IMMUN, V63, P4121; RAHMAN A, 1991, BIOCHEM BIOPH RES CO, V181, P138, DOI 10.1016/S0006-291X(05)81392-0; RAHMAN A, 1992, BIOCHEM BIOPH RES CO, V184, P640, DOI 10.1016/0006-291X(92)90637-Z; RAHMAN A, 1993, BIOSCI BIOTECH BIOCH, V57, P1234, DOI 10.1271/bbb.57.1234; Robert J, 2005, CLIN MICROBIOL INFEC, V11, P585, DOI 10.1111/j.1469-0691.2005.01173.x; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Sakata N, 2005, CURR MICROBIOL, V50, P47, DOI 10.1007/s00284-004-4381-9; Solis N, 2010, PROTEOMICS, V10, P2037, DOI 10.1002/pmic.200900564; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; Szmigielski S, 1998, ZBL BAKT-INT J MED M, V288, P383; Taverna F, 2007, VET MICROBIOL, V119, P240, DOI 10.1016/j.vetmic.2006.09.007; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WOODIN AM, 1960, BIOCHEM J, V75, P158, DOI 10.1042/bj0750158	55	163	173	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11634	10.1371/journal.pone.0011634	http://dx.doi.org/10.1371/journal.pone.0011634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661294	gold, Green Published, Green Submitted			2022-12-25	WOS:000279980800019
J	Wassenberg, MWM; de Wit, GA; van Hout, BA; Bonten, MJM				Wassenberg, Marjan W. M.; de Wit, G. Ardine; van Hout, Ben A.; Bonten, Marc J. M.			Quantifying Cost-Effectiveness of Controlling Nosocomial Spread of Antibiotic-Resistant Bacteria: The Case of MRSA	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; METHICILLIN-RESISTANT; LIFE EXPECTANCY; INFECTION; SURVEILLANCE; MORTALITY; OUTCOMES; HOSPITALS	Background: The costs and benefits of controlling nosocomial spread of antibiotic-resistant bacteria are unknown. Methods: We developed a mathematical algorithm to determine cost-effectiveness of infection control programs and explored the dynamical interactions between different epidemiological variables and cost-effectiveness. The algorithm includes occurrence of nosocomial infections, attributable mortality, costs and efficacy of infection control and how antibiotic-resistant bacteria affect total number of infections: do infections with antibiotic-resistant bacteria replace infections caused by susceptible bacteria (replacement scenario) or occur in addition to them (addition scenario). Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia was used for illustration using observational data on S. aureus bacteremia (SAB) in our hospital (n = 189 between 2001-2004, all being methicillin-susceptible S. aureus [MSSA]). Results: In the replacement scenario, the costs per life year gained range from (sic)45,912 to (sic)6590 for attributable mortality rates ranging from 10% to 50%. Using (sic)20,000 per life year gained as a threshold, completely preventing MRSA would be cost-effective in the replacement scenario if attributable mortality of MRSA is >= 21%. In the addition scenario, infection control would be cost saving along the entire range of estimates for attributable mortality. Conclusions: Cost-effectiveness of controlling antibiotic-resistant bacteria is highly sensitive to the interaction between infections caused by resistant and susceptible bacteria (addition or replacement) and attributable mortality. In our setting, controlling MRSA would be cost saving for the addition scenario but would not be cost-effective in the replacement scenario if attributable mortality would be <21%.	[Wassenberg, Marjan W. M.] Univ Med Ctr, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Wassenberg, Marjan W. M.; Bonten, Marc J. M.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [de Wit, G. Ardine; van Hout, Ben A.; Bonten, Marc J. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Wit, G. Ardine] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Wassenberg, MWM (corresponding author), Univ Med Ctr, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	M.W.M.Wassenberg@umcutrecht.nl		de Wit, G. Ardine/0000-0002-1375-7657	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO))	MJMB was supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors have no support or funding to report.	Albertsen PC, 1996, J UROLOGY, V156, P127, DOI 10.1016/S0022-5347(01)65964-0; Ammerlaan H, 2009, CLIN INFECT DIS, V49, P997, DOI 10.1086/605555; Barnett AG, 2009, AM J EPIDEMIOL, V170, P1186, DOI 10.1093/aje/kwp249; Bjorholt I, 2004, EUR J CLIN MICROBIOL, V23, P688, DOI 10.1007/s10096-004-1198-1; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Casparie A F, 1998, Ned Tijdschr Geneeskd, V142, P2075; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Graves N, 2007, INFECT CONT HOSP EP, V28, P280, DOI 10.1086/512642; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Jernigan JA, 1995, INFECT CONT HOSP EP, V16, P686; Karchmer TB, 2002, J HOSP INFECT, V51, P126, DOI 10.1053/jhin.2002.1200; Lee BY, 2010, INFECT CONT HOSP EP, V31, P598, DOI 10.1086/652524; LINNEMANN CC, 1982, AM J EPIDEMIOL, V115, P941, DOI 10.1093/oxfordjournals.aje.a113381; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; OOSTENBRINK JB, 2004, STANDAARD KOSTPRIJZE; Papia G, 1999, INFECT CONT HOSP EP, V20, P473, DOI 10.1086/501655; *RAAD VOLKSG ZORG, 2006, ZINN DUURZ ZORG; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; *RIVM, 2005, EUR ANT RES SURV SYS; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Shurland S, 2007, INFECT CONT HOSP EP, V28, P273, DOI 10.1086/512627; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Styers David, 2006, Ann Clin Microbiol Antimicrob, V5, P2; Tacconelli E, 2006, J HOSP INFECT, V64, P251, DOI 10.1016/j.jhin.2006.07.001; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; Vriens M, 2002, EUR J CLIN MICROBIOL, V21, P782, DOI 10.1007/s10096-002-0811-4; *WERKGR INF, 2008, MRSA ZIEK; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P466, DOI 10.1111/j.1469-0691.2005.01153.x; West TE, 2006, INFECT CONT HOSP EP, V27, P233, DOI 10.1086/500372; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	37	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11562	10.1371/journal.pone.0011562	http://dx.doi.org/10.1371/journal.pone.0011562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661278	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000279980800002
J	Screpanti, E; Santaguida, S; Nguyen, T; Silvestri, R; Gussio, R; Musacchio, A; Hamel, E; De Wulf, P				Screpanti, Emanuela; Santaguida, Stefano; Nguyen, Tam; Silvestri, Romano; Gussio, Rick; Musacchio, Andrea; Hamel, Ernest; De Wulf, Peter			A Screen for Kinetochore-Microtubule Interaction Inhibitors Identifies Novel Antitubulin Compounds	PLOS ONE			English	Article							TUBULIN; COLCHICINE; AGENTS; BINDING; COMPLEX	Background: Protein assemblies named kinetochores bind sister chromatids to the mitotic spindle and orchestrate sister chromatid segregation. Interference with kinetochore activity triggers a spindle checkpoint mediated arrest in mitosis, which frequently ends in cell death. We set out to identify small compounds that inhibit kinetochore-microtubule binding for use in kinetochore-spindle interaction studies and to develop them into novel anticancer drugs. Methodology/Principal Findings: A fluorescence microscopy-based in vitro assay was developed to screen compound libraries for molecules that prevented the binding of a recombinant human Ndc80 kinetochore complex to taxol-stabilized microtubules. An active compound was identified that acted at the microtubule level. More specifically, by localizing to the colchicine-binding site in ab-tubulin the hit compound prevented the Ndc80 complex from binding to the microtubule surface. Next, structure-activity analyses distinguished active regions in the compound and led to the identification of highly potent analogs that killed cancer cells with an efficacy equaling that of established spindle drugs. Conclusions/Significance: The compound identified in our screen and its subsequently identified analogs represent new antitubulin chemotypes that can be synthetically developed into a novel class of antimitotic spindle drugs. In addition, they are stereochemically unique as their R- and S-isomers mimic binding of colchicine and podophyllotoxin, respectively, two antitubulin drugs that interact differently with the tubulin interface. Model-driven manipulation of our compounds promises to advance insight into how antitubulin drugs act upon tubulin. These advances in turn may lead to tailor-made colchicine site agents which would be valuable new assets to fight a variety of tumors, including those that have become resistant to the (antispindle) drugs used today.	[Screpanti, Emanuela; Santaguida, Stefano; Musacchio, Andrea; De Wulf, Peter] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Nguyen, Tam; Gussio, Rick] NCI, Informat Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21701 USA; [Silvestri, Romano] Univ Roma La Sapienza, Dept Med Chem & Technol, Rome, Italy; [Hamel, Ernest] NCI, Toxicol & Pharmacol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21701 USA	IRCCS European Institute of Oncology (IEO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Screpanti, E (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, Milan, Italy.	peter.dewulf@ifom-ieo-campus.it	Santaguida, Stefano/ABH-5433-2020; santaguida, stefano/G-2716-2010	Santaguida, Stefano/0000-0002-1501-6190; Silvestri, Romano/0000-0003-2489-0178; De Wulf, Peter/0000-0001-9772-5881; Musacchio, Andrea/0000-0003-2362-8784	Istituto Pasteur - Fondazione Cenci Bolognetti; Progetti di Ricerca di Universita-Anno; Universita di Roma; Associazione Italiana per la Ricerca sul Cancro; Association of International Cancer Research; Fondazione Italiana per la Ricerca sul Cancro	Istituto Pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Progetti di Ricerca di Universita-Anno; Universita di Roma; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association of International Cancer Research; Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This research was supported by grants from the Istituto Pasteur - Fondazione Cenci Bolognetti (http://www.istitutopasteur.it/site/index.php), and Progetti di Ricerca di Universita-Anno 2008, Universita di Roma "La Sapienza'' (http://www.uniroma1.it/) to RS, grant 4535 from the Associazione Italiana per la Ricerca sul Cancro (http://www.AIRC.it) to AM, and grant 08-0465 from the Association of International Cancer Research (http://www.AICR.org.uk) to PDW. ES and SS acknowledge a post-doctoral and doctoral fellowship, respectively, from the Fondazione Italiana per la Ricerca sul Cancro (http://www.fondazionefirc.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATTACHARYYA B, 1977, FEBS LETT, V75, P159, DOI 10.1016/0014-5793(77)80075-6; Cao TM, 2008, AM J HEMATOL, V83, P390, DOI 10.1002/ajh.21104; Carlson RO, 2008, EXPERT OPIN INV DRUG, V17, P707, DOI [10.1517/13543784.17.5.707, 10.1517/13543784.17.5.707 ]; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; HAMEL E, 1981, BIOCHIM BIOPHYS ACTA, V675, P226, DOI 10.1016/0304-4165(81)90231-2; Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KANG GJ, 1990, J BIOL CHEM, V265, P10255; Liu Song-Tao, 2009, P455, DOI 10.1007/978-0-387-69076-6_15; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nguyen TL, 2005, J MED CHEM, V48, P6107, DOI 10.1021/jm050502t; Parodi B, 2002, BIOTECHNIQUES, V32, P432, DOI 10.2144/02322rr05; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107	23	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11603	10.1371/journal.pone.0011603	http://dx.doi.org/10.1371/journal.pone.0011603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657644	Green Published, Green Submitted, gold			2022-12-25	WOS:000279924500007
J	Ward-Paige, C; Flemming, JM; Lotze, HK				Ward-Paige, Christine; Flemming, Joanna Mills; Lotze, Heike K.			Overestimating Fish Counts by Non-Instantaneous Visual Censuses: Consequences for Population and Community Descriptions	PLOS ONE			English	Article							SIZE-STRUCTURE; REEF; SHARKS; DENSITY; BIOMASS; CARCHARIAS; ABUNDANCE; TRANSECT; IDENTIFICATION; FISHERIES	Background: Increasingly, underwater visual censuses (UVC) are used to assess fish populations. Several studies have demonstrated the effectiveness of protected areas for increasing fish abundance or provided insight into the natural abundance and structure of reef fish communities in remote areas. Recently, high apex predator densities (>100,000 individuals.km(-2)) and biomasses (>4 tonnes.ha(-1)) have been reported for some remote islands suggesting the occurrence of inverted trophic biomass pyramids. However, few studies have critically evaluated the methods used for sampling conspicuous and highly mobile fish such as sharks. Ideally, UVC are done instantaneously, however, researchers often count animals that enter the survey area after the survey has started, thus performing non-instantaneous UVC. Methodology/Principal Findings: We developed a simulation model to evaluate counts obtained by divers deploying non-instantaneous belt-transect and stationary-point-count techniques. We assessed how fish speed and survey procedure (visibility, diver speed, survey time and dimensions) affect observed fish counts. Results indicate that the bias caused by fish speed alone is huge, while survey procedures had varying effects. Because the fastest fishes tend to be the largest, the bias would have significant implications on their biomass contribution. Therefore, caution is needed when describing abundance, biomass, and community structure based on non-instantaneous UVC, especially for highly mobile species such as sharks. Conclusions/Significance: Based on our results, we urge that published literature state explicitly whether instantaneous counts were made and that survey procedures be accounted for when non-instantaneous counts are used. Using published density and biomass values of communities that include sharks we explore the effect of this bias and suggest that further investigation may be needed to determine pristine shark abundances and the existence of inverted biomass pyramids. Because such studies are used to make important management and conservation decisions, incorrect estimates of animal abundance and biomass have serious and significant implications.	[Ward-Paige, Christine; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Ward-Paige, C (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	globalshark@gmail.com		Ward-Paige, Christine A./0000-0002-2394-9898; Mills Flemming, Joanna/0000-0002-3517-3089; Lotze, Heike/0000-0001-6258-1304	Natural Sciences and Engineering Research Council of Canada; Lenfest Ocean Program; Pew Charitable Trusts; RAM	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lenfest Ocean Program; Pew Charitable Trusts; RAM	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada to R. A. Myers, H. K. Lotze, J. Mills Flemming, by the Lenfest Ocean Program and The Pew Charitable Trusts with grants to R. A. Myers and H. K. Lotze. These funders did not play a role in conducting the study or in preparing the manuscript.; We thank W. Blanchard for helping to write the simulation AnimDens, C. Minto for initial simulation discussion, and B. Worm, D. Tittensor, H. Whitehead, L. Lucifora, V. Garcia and C. Mora for discussions and valuable comments on the manuscript. We thank RAM for the support and encouragement he always provided.	Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Ault JS, 2006, B MAR SCI, V78, P633; Bansemer CS, 2008, MAR FRESHWATER RES, V59, P322, DOI 10.1071/MF07184; BOHNSACK JA, 1986, NMFSSEFC215 NOAA; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Buck KR, 1996, AQUAT MICROB ECOL, V10, P283; Buray N, 2009, CYBIUM, V33, P21; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Eggleston DB, 2004, B MAR SCI, V75, P175; Forrester GE, 2008, ECOLOGY, V89, P2980, DOI 10.1890/07-1546.1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; GRAY J, 1971, HOW FISHES SWIM, P228; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; GUTMAN M, 1990, J RANGE MANAGE, V43, P535, DOI 10.2307/4002359; Harborne AR, 2008, ECOL APPL, V18, P1689, DOI 10.1890/07-0454.1; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Heupel MR, 2007, PAC SCI, V61, P383, DOI 10.2984/1534-6188(2007)61[383:EAORSA]2.0.CO;2; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Johansen JL, 2007, MAR FRESHWATER RES, V58, P233, DOI 10.1071/MF06136; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; PIONTKOVSKI SA, 1995, MAR ECOL PROG SER, V117, P219, DOI 10.3354/meps117219; *R CDT, 2005, R LANG ENV STAT COMP; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Rowat D, 2009, ORYX, V43, P591, DOI 10.1017/S0030605309990408; Sale P.F., 1983, Coral Reefs, V2, P37, DOI 10.1007/BF00304730; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SMITH MPL, 1989, ENVIRON BIOL FISH, V26, P29, DOI 10.1007/BF00002473; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; WATSON RA, 1995, ECOL MODEL, V77, P205, DOI 10.1016/0304-3800(93)E0085-H; Watson RA, 1997, ECOL MODEL, V104, P103, DOI 10.1016/S0304-3800(97)00117-8; WEBB PW, 1982, FISH B-NOAA, V80, P803	46	137	138	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11722	10.1371/journal.pone.0011722	http://dx.doi.org/10.1371/journal.pone.0011722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661304	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300022
J	Sweeney, E; Roberts, D; Corbo, T; Jacenko, O				Sweeney, Elizabeth; Roberts, Douglas; Corbo, Tina; Jacenko, Olena			Congenic Mice Confirm That Collagen X Is Required for Proper Hematopoietic Development	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IMMUNO-OSSEOUS DYSPLASIA; STEM-CELL NICHE; HEPARAN-SULFATE PROTEOGLYCANS; CARTILAGE-HAIR-HYPOPLASIA; MARROW-STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; B LYMPHOPOIESIS; NULL MICE	The link between endochondral skeletal development and hematopoiesis in the marrow was established in the collagen X transgenic (Tg) and null (KO) mice. Disrupted function of collagen X, a major hypertrophic cartilage matrix protein, resulted in skeletal and hematopoietic defects in endochondrally derived tissues. Manifestation of the disease phenotype was variable, ranging from perinatal lethality in a subset of mice, to altered lymphopoiesis and impaired immunity in the surviving mice. To exclude contribution of strain specific modifiers to this variable manifestation of the skeleto-hematopoietic phenotype, C57Bl/6 and DBA/2J collagen X congenic lines were established. Comparable disease manifestations confirmed that the skeleto-hematopoietic alterations are an inherent outcome of disrupted collagen X function. Further, colony forming cell assays, complete blood count analysis, serum antibody ELISA, and organ outgrowth studies established altered lymphopoiesis in all collagen X Tg and KO mice and implicated opportunistic infection as a contributor to the severe disease phenotype. These data support a model where endochondral ossification-specific collagen X contributes to the establishment of a hematopoietic niche at the chondro-osseous junction.	[Sweeney, Elizabeth; Roberts, Douglas; Corbo, Tina; Jacenko, Olena] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Sweeney, E (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	jacenko@vet.upenn.edu		Sweeney, Timothy/0000-0002-3596-1093	National Institutes of Health [DK57904, AR053804 NRSA]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057904, R01DK088334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by National Institutes of Health; DK57904 (to OJ) and AR053804 NRSA (to ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Borghesi LA, 1999, BLOOD, V93, P140, DOI 10.1182/blood.V93.1.140.401k40_140_148; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; BRUNO E, 1995, EXP HEMATOL, V23, P1212; BUCHINSKY FJ, 1995, J BONE MINER RES, V10, P1556; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campbell MR, 2004, AM J PATHOL, V164, P487, DOI 10.1016/S0002-9440(10)63139-2; CastriotaScanderbeg A, 1997, J MED GENET, V34, P854, DOI 10.1136/jmg.34.10.854; CEDERBAUM SD, 1976, J PEDIATR-US, V89, P737, DOI 10.1016/S0022-3476(76)80793-7; Cham B, 2002, SEMIN HEMATOL, V39, P107, DOI 10.1053/shem.2002.31916; Chan C.K., 2008, NATURE; Chan D, 1998, MATRIX BIOL, V17, P169, DOI 10.1016/S0945-053X(98)90056-7; Chung KS, 1997, DEV DYNAM, V208, P544; CORDER WT, 1995, AM J MED GENET, V57, P626, DOI 10.1002/ajmg.1320570422; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dianzani I, 2000, Paediatr Drugs, V2, P345, DOI 10.2165/00128072-200002050-00002; ENG VM, 1995, J EXP MED, V181, P1893, DOI 10.1084/jem.181.5.1893; Gress CJ, 2000, J CELL BIOL, V149, P983, DOI 10.1083/jcb.149.4.983; Guggenheim R, 2006, BONE MARROW TRANSPL, V38, P751, DOI 10.1038/sj.bmt.1705520; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Hermanns P, 2006, AM J MED GENET A, V140A, P2121, DOI 10.1002/ajmg.a.31331; Hirose J, 2002, IMMUNOL REV, V189, P28, DOI 10.1034/j.1600-065X.2002.18904.x; Hubbard V, 2006, PEDIATR DERMATOL, V23, P373, DOI 10.1111/j.1525-1470.2006.00260.x; Jacenko O, 1996, ANN NY ACAD SCI, V785, P278, DOI 10.1111/j.1749-6632.1996.tb56283.x; JACENKO O, 1993, PROG CLIN BIOL RES, V383, P427; Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; Jacenko O, 2001, AM J PATHOL, V159, P2257, DOI 10.1016/S0002-9440(10)63076-3; JACENKO O, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P327; JACENKO O, 1998, CELLS MAT, V8, P123; JACOBSEN SEW, 1994, J EXP MED, V180, P75, DOI 10.1084/jem.180.1.75; Johansson C, 2006, MICROB PATHOGENESIS, V41, P49, DOI 10.1016/j.micpath.2006.03.004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Kuijpers TW, 2004, PEDIATRICS, V114, pE387, DOI 10.1542/peds.2003-0651-F; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lemoli RM, 2008, HAEMATOLOGICA, V93, P321, DOI 10.3324/haematol.12616; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Lucke T, 2007, AM J MED GENET A, V143A, P2040, DOI 10.1002/ajmg.a.31878; Marrella V, 2008, TRENDS IMMUNOL, V29, P133, DOI 10.1016/j.it.2007.12.001; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Nilsson SK, 1997, BLOOD, V89, P4013, DOI 10.1182/blood.V89.11.4013; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osmond D G, 1990, Semin Immunol, V2, P173; PATCHEN ML, 1991, BLOOD, V77, P472; Rodgers KD, 2008, DEV DYNAM, V237, P2622, DOI 10.1002/dvdy.21593; ROSATI R, 1994, NAT GENET, V8, P129, DOI 10.1038/ng1094-129; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sekhar RV, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e54; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Siebertz B, 1999, BIOCHEM J, V344, P937, DOI 10.1042/0264-6021:3440937; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; SOYER AD, 1995, SPINE, V20, P2335, DOI 10.1097/00007632-199511000-00012; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Sweeney E, 2008, DEV DYNAM, V237, P2693, DOI 10.1002/dvdy.21594; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Verfaillie CATHERINE M., 1999, Hematology, V4, P321; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yoshimoto M, 2003, EXP HEMATOL, V31, P733, DOI 10.1016/S0301-472X(03)00108-5; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; JACKSON LABS CONGENI	68	62	63	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9518	10.1371/journal.pone.0009518	http://dx.doi.org/10.1371/journal.pone.0009518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20657826	Green Submitted, Green Published, gold			2022-12-25	WOS:000275063400023
